data_5m1h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5m1h _Structure_validation_residue.Date_analyzed 2016-10-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 304' ' ' VAL . 2.8 p . . . . . 0 N--CA 1.43 -1.462 0 CA-C-O 120.96 0.41 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.724 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 27.8 mt -77.96 122.27 85.24 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-O 121.989 0.9 . . . . 0.0 111.851 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 308' ' ' GLN . 25.4 Cg_endo -72.62 -14.02 27.32 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 124.887 3.725 . . . . 0.0 111.417 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.696 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 3.5 tp 34.71 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 C-N-CA 128.296 2.638 . . . . 0.0 116.088 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.63 ' HG2' HG21 ' A' ' 307' ' ' ILE . 61.6 mm-40 -58.71 -34.4 71.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.643 0.777 . . . . 0.0 110.41 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.492 ' HB3' HG12 ' A' ' 338' ' ' VAL . 7.6 t-160 -60.93 -47.41 86.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.583 173.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 307' ' ' ILE . 67.7 mt -61.76 -48.41 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 124.157 0.983 . . . . 0.0 112.68 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.696 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 9.5 mtp-105 -58.5 -31.56 67.99 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.655 0.382 . . . . 0.0 111.258 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 38.5 t -69.67 -32.78 71.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.56 0.695 . . . . 0.0 109.66 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.599 HG11 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.22 -41.23 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.942 177.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.663 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 33.6 p -82.33 -36.18 27.16 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.939 1.352 . . . . 0.0 109.807 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.66 32.73 8.39 Favored Glycine 0 N--CA 1.432 -1.576 0 CA-C-N 112.203 -2.271 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 46.9 mt-10 55.75 165.35 0.06 OUTLIER Pre-proline 0 N--CA 1.437 -1.085 0 C-N-CA 124.062 0.945 . . . . 0.0 113.429 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.454 ' HB3' HD12 ' A' ' 324' ' ' ILE . 33.1 Cg_exo -44.27 146.73 1.78 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.547 2.831 . . . . 0.0 113.095 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.426 ' HD2' HD11 ' A' ' 324' ' ' ILE . 68.9 Cg_endo -88.09 -102.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.739 2.292 . . . . 0.0 111.171 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.404 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 11.2 mmm180 -102.36 -79.94 0.52 Allowed 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.284 0.564 . . . . 0.0 111.188 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.531 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 8.6 m-20 -94.75 164.17 20.38 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.51 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.73 -48.11 9.67 Favored 'Trans proline' 0 CA--C 1.512 -0.577 0 C-N-CA 122.975 2.45 . . . . 0.0 110.613 168.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -25.91 6.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.218 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 63.7 mt-10 -81.73 -33.5 31.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 0.0 111.226 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.719 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -48.38 -42.37 52.96 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -173.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.677 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.97 -63.23 0.31 Allowed 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 123.089 2.526 . . . . 0.0 113.019 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.548 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -61.23 -37.25 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.246 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.663 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -57.63 -36.53 71.94 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.569 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.486 HD12 HG12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -70.59 -49.49 47.17 Favored 'General case' 0 N--CA 1.401 -2.916 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.457 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.75 -24.11 24.4 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.887 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -74.48 -42.14 59.52 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.994 0.902 . . . . 0.0 110.882 173.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.565 ' HB3' HG22 ' A' ' 314' ' ' THR . 49.2 m-20 -94.24 -23.63 17.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.522 -168.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.58 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.66 -50.29 9.75 Favored Pre-proline 0 C--N 1.308 -1.239 0 C-N-CA 124.523 1.129 . . . . 0.0 113.829 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 53.3 Cg_endo -63.19 -31.48 74.68 Favored 'Trans proline' 0 CA--C 1.51 -0.693 0 C-N-CA 122.473 2.115 . . . . 0.0 111.557 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.483 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -74.38 -42.44 59.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.501 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 332' ' ' ALA . 95.5 mt -58.27 -48.01 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.947 174.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.39 -17.96 2.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.496 -1.684 . . . . 0.0 112.368 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.09 -52.8 5.52 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.03 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' ' 309' ' ' HIS . 96.8 t -57.78 -71.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 123.506 1.622 . . . . 0.0 110.238 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.724 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.6 123.46 72.6 Favored Pre-proline 0 N--CA 1.403 -2.82 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.588 -174.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.697 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 74.1 Cg_endo -72.7 -17.22 26.25 Favored 'Trans proline' 0 CA--C 1.495 -1.454 0 C-N-CA 123.947 3.098 . . . . 0.0 110.267 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.442 ' O ' HG21 ' A' ' 341' ' ' VAL . 2.6 p 32.62 66.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 111.683 -2.508 . . . . 0.0 110.103 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.547 ' N ' HD13 ' A' ' 346' ' ' LEU . 46.6 p -79.08 4.11 15.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.738 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.807 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.2 p -140.74 159.5 62.34 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.546 ' HB3' HD12 ' A' ' 369' ' ' LEU . 70.5 Cg_exo -60.33 -46.21 19.18 Favored 'Trans proline' 0 CA--C 1.498 -1.296 0 C-N-CA 123.571 2.847 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.628 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -41.33 -56.52 2.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.4 175.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.807 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.9 mt -55.85 -51.24 68.22 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.051 -1.432 . . . . 0.0 111.0 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.503 ' HA ' HD12 ' A' ' 350' ' ' ILE . 4.7 ttm180 -49.83 -48.06 51.2 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.959 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 1.08 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.7 m -68.88 -47.1 66.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.949 -177.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.56 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.0 mtp180 -62.37 -34.3 76.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.857 ' O ' HG12 ' A' ' 354' ' ' ILE . 28.1 mt -58.24 -53.04 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.753 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.613 ' O ' HD23 ' A' ' 355' ' ' LEU . 19.7 mt -57.81 -53.89 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 121.922 0.868 . . . . 0.0 111.201 -170.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.538 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 13.5 m-20 -63.89 -35.68 81.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.133 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 307' ' ' ILE . . . -70.56 -29.91 66.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.68 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.857 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.03 -58.85 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 122.945 1.355 . . . . 0.0 110.118 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.719 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.13 -27.95 57.27 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.182 -167.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.74 -72.56 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.341 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -106.63 52.15 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.562 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.649 HD21 ' HB2' ' A' ' 361' ' ' LEU . 12.7 p-10 -89.88 129.45 36.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 122.861 0.464 . . . . 0.0 109.911 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.555 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -48.24 -71.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.881 -170.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.37 6.68 5.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.523 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.649 ' HB2' HD21 ' A' ' 358' ' ' ASN . 3.5 mt -70.96 -6.19 36.76 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.582 0.706 . . . . 0.0 109.962 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.538 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 19.5 t -63.7 78.89 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.413 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.749 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.9 mm? -61.14 -179.69 0.16 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.184 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 366' ' ' GLY . 49.2 p -119.76 157.71 51.57 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.436 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 1.08 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 57.7 Cg_endo -69.79 25.32 0.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.115 1.876 . . . . 0.0 113.254 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -134.32 -4.0 2.97 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.647 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.88 -21.21 13.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.119 0.961 . . . . 0.0 110.451 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.911 ' HB2' ' SG ' ' A' ' 348' ' ' CYS . 3.8 m -94.41 24.16 4.7 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.638 -168.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.598 ' N ' HD11 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -54.9 -35.89 64.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.332 1.063 . . . . 0.0 109.356 -172.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.06 159.48 23.15 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.304 172.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.608 ' O ' HG12 ' A' ' 375' ' ' VAL . 58.7 m95 -69.63 -35.48 75.28 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.575 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.32 -41.96 98.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.969 -175.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 92.0 p -67.47 -44.48 78.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.906 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.553 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -63.43 -52.83 59.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 371' ' ' TRP . 15.3 m -56.11 -45.03 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.453 0.645 . . . . 0.0 109.559 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.672 ' O ' HD13 ' A' ' 380' ' ' ILE . . . -59.05 -45.66 90.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.999 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.512 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 24.0 m -68.05 -37.24 81.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.289 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -61.73 -34.83 76.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.677 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 68.1 t80 -73.38 -45.15 56.51 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.461 1.124 . . . . 0.0 109.097 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.6 -33.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 112.647 -2.07 . . . . 0.0 111.167 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.41 -44.39 95.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.538 0.685 . . . . 0.0 111.068 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.415 HG21 ' O ' ' A' ' 378' ' ' LEU . 32.7 p -93.73 -23.68 18.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.82 -167.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 30.6 m80 -109.55 23.75 14.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.57 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.91 36.15 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 114.223 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m 66.27 159.54 0.13 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 111.494 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.582 ' CE2' HD23 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -129.47 151.22 77.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -96.32 54.1 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 110.906 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.629 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.02 8.16 0.72 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -70.69 -45.65 64.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.102 0.477 . . . . 0.0 110.479 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.648 ' O ' HG12 ' A' ' 394' ' ' VAL . 75.6 mt-30 -75.26 -28.17 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -170.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.698 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.34 -31.61 45.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.025 0.829 . . . . 0.0 112.115 -170.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.617 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -53.18 41.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.925 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.511 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 18.2 m-20 -67.48 -37.48 82.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.3 m -58.5 -45.75 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 110.616 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 399' ' ' VAL . 9.5 mm -58.25 -47.16 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.855 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 34.0 mmtt -52.42 -39.86 61.48 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 124.205 0.94 . . . . 0.0 111.893 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -77.39 -44.62 12.75 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.68 -1.247 . . . . 0.0 113.146 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.709 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.4 mt -69.39 -42.72 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 111.749 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 395' ' ' ILE . 4.2 m -57.09 -43.96 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.562 0.696 . . . . 0.0 110.226 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.496 ' N ' HG22 ' A' ' 399' ' ' VAL . 6.1 t70 -58.47 -39.76 80.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.861 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 47.7 mt-30 -86.38 -53.62 4.9 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.28 -173.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.51 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.6 OUTLIER -113.19 -30.85 6.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.107 -166.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.29 165.83 12.09 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.856 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.593 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.1 -43.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -56.32 -50.57 71.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.92 0.391 . . . . 0.0 111.871 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.557 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.54 -51.42 62.93 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.705 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.709 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.33 -41.41 65.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.567 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 48.0 t80 -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.635 0.731 . . . . 0.0 109.366 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.786 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.3 m -59.91 -53.42 58.1 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.808 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.623 HD12 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 117.887 0.312 . . . . 0.0 110.681 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.28 -45.24 83.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.405 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.617 ' HE3' ' HA ' ' A' ' 417' ' ' GLN . 0.4 OUTLIER -70.41 -32.21 69.74 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.645 0.723 . . . . 0.0 111.075 177.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.786 ' HG3' ' O ' ' A' ' 409' ' ' THR . 49.7 mtm -68.65 -48.04 65.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.53 0.681 . . . . 0.0 109.521 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.654 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 15.3 mt -59.66 -40.14 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.653 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.792 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -78.32 -17.23 56.85 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.803 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 86.78 47.05 4.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.839 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.617 ' HA ' ' HE3' ' A' ' 412' ' ' MET . 0.8 OUTLIER 57.96 47.54 14.81 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.792 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -125.89 74.36 1.42 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.612 1.673 . . . . 0.0 106.953 161.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.473 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 2.1 p90 -58.57 -33.49 70.0 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.165 -2.288 . . . . 0.0 110.826 -160.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -55.11 -43.45 74.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.495 -165.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.579 HD21 ' ND2' ' A' ' 418' ' ' ASN . 2.0 pp -63.42 -49.63 72.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.242 0.544 . . . . 0.0 110.721 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.544 HG21 ' N ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -60.71 -39.45 81.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.834 1.302 . . . . 0.0 109.207 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.544 ' N ' HG21 ' A' ' 422' ' ' VAL . 41.2 t -61.91 -44.36 96.95 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.076 -2.329 . . . . 0.0 111.723 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.98 -40.74 82.97 Favored Glycine 0 C--N 1.316 -0.557 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.713 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -71.4 -41.92 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.623 0.725 . . . . 0.0 110.167 175.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.4 mm -55.13 -42.74 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.483 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.695 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 3.3 tmm_? -58.86 -36.05 73.96 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 123.201 1.477 . . . . 0.0 109.383 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.08 -8.34 69.18 Favored Glycine 0 C--N 1.283 -2.397 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.224 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.617 ' CD1' HG21 ' A' ' 399' ' ' VAL . 11.1 m-85 -105.6 -0.55 25.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.55 142.84 82.29 Favored Pre-proline 0 N--CA 1.406 -2.637 0 CA-C-O 123.585 1.66 . . . . 0.0 113.017 170.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.694 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 67.6 Cg_endo -70.75 -55.25 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.386 1 C-N-CA 126.164 4.576 . . . . 0.0 113.212 -172.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.535 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -118.79 143.5 17.48 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.372 -178.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.608 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.31 -26.77 68.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.992 0.396 . . . . 0.0 111.268 -177.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.46 79.32 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.701 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.5 t -58.25 -51.54 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.807 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -55.29 -53.33 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 99.9 m -61.85 -56.67 16.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.169 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.19 -45.93 79.59 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.57 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.817 ' O ' HD23 ' A' ' 443' ' ' LEU . 41.8 mt -59.66 -53.15 61.41 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.651 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.711 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 39.8 mm-40 -51.51 -35.44 40.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 O-C-N 124.882 1.364 . . . . 0.0 110.683 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.39 -60.59 2.17 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -76.09 -50.29 15.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.77 -0.581 . . . . 0.0 111.901 -172.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.88 63.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.384 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.711 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 8.2 t70 -73.95 -41.85 61.4 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.129 0.966 . . . . 0.0 110.747 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.18 -8.15 43.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.601 ' HB3' HG22 ' A' ' 451' ' ' THR . 51.5 mm-40 -51.77 157.16 1.24 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.377 1.561 . . . . 0.0 114.186 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.402 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.7 mp -53.87 -32.92 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.841 -2.89 . . . . 0.0 115.191 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.562 ' H ' ' HB ' ' A' ' 451' ' ' THR . 68.9 m-20 -135.18 178.22 7.2 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.432 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.8 p-10 -66.54 -51.48 56.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -22.98 63.62 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.601 HG22 ' HB3' ' A' ' 446' ' ' GLU . 31.1 m -57.79 -39.5 77.67 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 119.888 1.222 . . . . 0.0 109.398 170.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.604 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 75.7 mtt180 -60.72 -30.42 69.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.356 172.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.567 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.84 -35.36 59.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.164 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.93 -43.16 25.3 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.654 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.437 ' HG1' ' HG3' ' A' ' 446' ' ' GLU . 40.2 p -101.46 -2.09 31.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.295 -169.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.608 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.2 t80 -49.04 -54.58 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.827 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 26.3 mm -69.97 -26.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.499 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.72 -42.96 63.59 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.612 ' O ' HG22 ' A' ' 463' ' ' VAL . 39.7 m-70 -67.3 -31.04 71.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.562 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.677 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -64.37 -53.89 41.53 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.174 0.987 . . . . 0.0 109.093 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.45 -30.69 71.42 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.799 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 458' ' ' GLN . . . -66.94 -48.67 67.9 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.463 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.716 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 34.2 t -65.35 -36.24 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.471 175.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.5 m-30 -60.17 -13.9 14.54 Favored 'General case' 0 C--O 1.202 -1.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.625 168.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.3 tp10 -95.52 -51.93 4.34 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.213 -0.929 . . . . 0.0 112.467 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.716 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -62.62 -41.36 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.374 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.504 ' CD1' HG21 ' A' ' 435' ' ' VAL . 6.7 mt -83.94 -17.51 40.4 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.804 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.31 49.67 60.1 Favored Glycine 0 C--O 1.211 -1.294 0 CA-C-N 111.481 -2.599 . . . . 0.0 113.239 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.5 OUTLIER -102.86 172.91 6.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 123.951 0.9 . . . . 0.0 110.149 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.722 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.6 p30 -92.64 -39.59 11.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -161.96 -75.57 0.05 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.197 159.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.694 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -66.26 71.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.064 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.47 42.0 2.46 Favored Glycine 0 C--N 1.275 -2.817 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.217 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.722 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.6 mm-40 -80.24 -54.83 5.38 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.472 1.13 . . . . 0.0 111.102 -174.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.1 t 68.91 61.16 0.33 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.372 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.804 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.401 0 CA-C-N 111.023 -2.808 . . . . 0.0 111.893 174.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.431 -1.396 0 CA-C-O 120.824 0.345 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.758 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.7 mt -77.2 123.66 87.12 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 122.026 0.917 . . . . 0.0 112.657 -174.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 308' ' ' GLN . 37.4 Cg_endo -73.55 -20.04 20.99 Favored 'Trans proline' 0 CA--C 1.502 -1.106 0 C-N-CA 124.881 3.721 . . . . 0.0 111.116 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 3.6 tp 41.03 -63.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 127.833 2.453 . . . . 0.0 115.584 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.614 ' HG2' HG23 ' A' ' 307' ' ' ILE . 69.7 mm-40 -59.35 -33.67 71.43 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 123.409 0.684 . . . . 0.0 110.631 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.497 ' HB3' HG13 ' A' ' 338' ' ' VAL . 8.7 t-160 -60.5 -47.79 84.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.514 172.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.592 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 64.9 mt -60.28 -48.66 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 123.875 0.87 . . . . 0.0 112.091 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.69 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 14.1 mtp180 -57.5 -30.45 65.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 122.852 0.461 . . . . 0.0 111.798 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -34.17 74.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.462 0.648 . . . . 0.0 109.957 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.595 HG11 ' N ' ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.92 -40.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.515 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.727 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 36.3 p -81.91 -36.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.827 1.298 . . . . 0.0 109.793 -176.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 85.93 36.03 10.66 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 112.315 -2.221 . . . . 0.0 111.064 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 53.97 168.21 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.402 ' HB3' HD13 ' A' ' 324' ' ' ILE . 63.7 Cg_exo -47.13 147.13 5.63 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.674 2.916 . . . . 0.0 113.55 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.512 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 18.0 Cg_endo -96.94 -105.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.769 2.979 . . . . 0.0 113.378 -170.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.459 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 15.5 mmt180 -86.52 -86.26 0.15 Allowed 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 123.207 0.603 . . . . 0.0 110.687 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.459 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 22.6 m-20 -102.9 166.36 12.04 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.036 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.501 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 34.5 Cg_exo -58.35 -50.35 9.94 Favored 'Trans proline' 0 CA--C 1.511 -0.631 0 C-N-CA 122.536 2.158 . . . . 0.0 110.571 169.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -60.32 -11.72 7.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.295 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -92.19 -22.52 19.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.257 . . . . 0.0 111.591 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.674 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -49.71 -40.88 56.4 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.692 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 7.9 Cg_endo -49.61 -62.56 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.916 2.411 . . . . 0.0 113.05 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.641 ' O ' ' HG3' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -60.46 -37.2 73.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 122.329 1.062 . . . . 0.0 110.303 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.727 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 63.1 t90 -58.56 -38.05 77.02 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.741 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.504 HD12 HG12 ' A' ' 351' ' ' ILE . 0.6 OUTLIER -70.85 -50.59 33.62 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.453 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -54.36 -24.05 28.73 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.554 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.641 ' HG3' ' O ' ' A' ' 326' ' ' ILE . 21.4 mtp180 -75.21 -40.59 59.08 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 122.271 1.034 . . . . 0.0 112.0 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.542 ' HB3' HG23 ' A' ' 314' ' ' THR . 43.0 m-20 -94.27 -24.41 17.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.511 -1.677 . . . . 0.0 113.195 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.563 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.67 -49.28 13.3 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 124.635 1.174 . . . . 0.0 113.803 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.5 Cg_endo -60.78 -34.41 91.64 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 122.464 2.109 . . . . 0.0 111.488 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.505 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -74.06 -43.39 57.93 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.544 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 332' ' ' ALA . 94.1 mt -58.26 -47.08 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.013 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -13.8 2.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.995 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.86 -51.18 4.62 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.26 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 309' ' ' HIS . 94.6 t -57.81 -70.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 123.128 1.442 . . . . 0.0 109.846 170.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.758 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -87.4 125.68 64.79 Favored Pre-proline 0 N--CA 1.408 -2.526 0 CA-C-N 111.644 -2.526 . . . . 0.0 111.885 -175.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.658 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.1 Cg_endo -70.83 -19.71 30.68 Favored 'Trans proline' 0 CA--C 1.493 -1.566 0 C-N-CA 123.736 2.957 . . . . 0.0 110.283 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.404 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.6 p 33.24 70.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.54 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.571 ' N ' HD11 ' A' ' 346' ' ' LEU . 68.7 p -79.96 2.65 22.77 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.684 -2.053 . . . . 0.0 112.821 -170.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.813 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 18.0 p -143.22 161.65 46.8 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-O 121.457 0.646 . . . . 0.0 109.753 177.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.1 -40.67 32.26 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 124.403 3.402 . . . . 0.0 109.8 172.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -47.86 -55.11 10.56 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.625 -2.079 . . . . 0.0 110.298 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.813 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.7 mt -57.64 -51.38 69.76 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.817 -175.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 10.1 ttm180 -52.92 -42.06 65.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.934 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.53 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 42.0 t -68.26 -49.95 57.13 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.972 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.657 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 60.3 mtp180 -61.14 -37.64 83.57 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.476 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.868 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -57.44 -52.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 O-C-N 123.371 0.419 . . . . 0.0 111.006 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.604 ' O ' HD23 ' A' ' 355' ' ' LEU . 18.3 mt -58.38 -54.19 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 122.098 0.952 . . . . 0.0 110.964 -172.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 21.8 m-20 -63.96 -35.62 81.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.004 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.447 ' HB3' HD13 ' A' ' 307' ' ' ILE . . . -70.77 -29.22 65.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.876 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.868 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.8 mm -56.67 -59.49 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 CA-C-O 122.794 1.283 . . . . 0.0 110.161 174.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.664 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.87 -26.3 54.07 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 111.977 -2.374 . . . . 0.0 109.772 -167.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.58 -71.68 1.56 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.065 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -115.85 33.07 5.37 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.949 -176.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.662 HD21 ' HB2' ' A' ' 361' ' ' LEU . 22.6 p-10 -58.32 134.32 56.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.572 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -47.77 -72.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 C-N-CA 124.237 1.015 . . . . 0.0 112.854 -170.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -131.62 7.6 5.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.758 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 358' ' ' ASN . 2.6 mt -70.89 -4.59 25.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.669 0.747 . . . . 0.0 109.942 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.556 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 8.7 t -63.62 80.31 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.994 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.704 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.7 mm? -60.35 -170.82 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 30.5 p -124.77 157.49 65.88 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.598 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 53.0 Cg_exo -46.65 -37.73 21.05 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.09 1.86 . . . . 0.0 111.491 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 369' ' ' LEU . . . -86.05 2.96 87.62 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.693 -0.685 . . . . 0.0 114.594 -172.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.409 ' HB2' HD11 ' A' ' 363' ' ' LEU . 24.2 m-20 -109.21 -22.15 12.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.916 0.865 . . . . 0.0 110.083 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 62.7 m -94.3 19.74 9.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.67 -169.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -58.74 -41.27 86.06 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.897 -170.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.9 157.25 27.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 113.276 -1.783 . . . . 0.0 109.373 170.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.635 ' O ' HG12 ' A' ' 375' ' ' VAL . 51.5 m95 -69.59 -35.89 75.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.442 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.95 -38.56 91.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.352 -174.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 37.1 t -70.25 -44.0 69.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.11 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 351' ' ' ILE . . . -63.33 -52.17 62.98 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 371' ' ' TRP . 14.9 m -55.63 -46.35 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.494 0.664 . . . . 0.0 110.192 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.646 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -58.52 -37.5 75.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.848 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.47 HG22 HD12 ' A' ' 363' ' ' LEU . 39.0 m -75.29 -41.75 56.37 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.931 -171.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 381' ' ' ARG . 0.1 OUTLIER -58.82 -34.42 71.5 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.821 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.692 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 30.0 t80 -70.99 -49.1 48.96 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.49 1.138 . . . . 0.0 109.627 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.03 -32.12 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.976 170.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -60.0 -34.4 73.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.878 0.471 . . . . 0.0 111.451 175.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 26.1 p -103.83 -23.34 13.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.956 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -110.12 22.94 14.96 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.15 17.04 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 114.359 0.504 . . . . 0.0 114.359 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m 66.64 154.79 0.09 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.386 0.613 . . . . 0.0 111.236 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -119.12 154.57 53.52 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 389' ' ' HIS . 83.2 Cg_endo -96.09 54.55 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.36 2.707 . . . . 0.0 111.207 167.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.603 ' HA ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.0 -7.44 0.07 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 387' ' ' PRO . 7.8 t60 -69.21 -43.79 73.4 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.659 0.266 . . . . 0.0 111.235 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.645 ' O ' HG12 ' A' ' 394' ' ' VAL . 75.2 mt-30 -69.38 -26.24 64.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.687 ' O ' HG23 ' A' ' 394' ' ' VAL . 3.8 mm? -54.03 -29.82 45.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.354 0.525 . . . . 0.0 110.976 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.24 -53.29 38.61 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.683 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.531 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 34.4 m-20 -64.36 -41.38 96.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.861 0.464 . . . . 0.0 111.947 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.72 -45.2 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.249 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.689 ' O ' HG21 ' A' ' 399' ' ' VAL . 6.8 mm -58.05 -47.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.161 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 27.3 mmtt -52.78 -42.62 65.19 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.027 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -75.7 -44.91 18.96 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.494 -1.336 . . . . 0.0 112.637 -173.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.712 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.1 mt -69.87 -41.46 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 117.16 0.48 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 395' ' ' ILE . 4.3 m -57.35 -43.57 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.54 0.686 . . . . 0.0 110.381 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.47 ' N ' HG23 ' A' ' 399' ' ' VAL . 2.7 t70 -65.66 -37.43 86.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.975 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 74.4 mt-30 -82.56 -52.63 6.66 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.458 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.56 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -115.14 -30.39 6.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.031 -167.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 128.33 164.69 11.63 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.043 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.606 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -63.75 -43.01 97.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 122.653 0.381 . . . . 0.0 111.783 -176.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.574 ' HB2' HG21 ' A' ' 457' ' ' ILE . . . -57.26 -50.41 72.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.294 0.568 . . . . 0.0 111.246 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.492 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -63.37 -52.04 63.35 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 179.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.712 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.74 -40.41 66.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 176.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 32.9 t80 -58.4 -43.53 88.61 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.765 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.4 m -62.84 -53.18 58.11 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.624 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.599 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.7 mm? -60.14 -49.49 77.42 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.249 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.14 -42.34 87.59 Favored Glycine 0 C--N 1.314 -0.649 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.255 -174.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.582 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.17 -31.84 66.29 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 116.686 0.243 . . . . 0.0 110.956 179.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.765 ' HG3' ' O ' ' A' ' 409' ' ' THR . 50.8 mtm -69.51 -47.98 62.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 109.742 173.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.646 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 16.1 mt -59.02 -40.58 85.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.453 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.646 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.2 OUTLIER -77.08 -8.82 58.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.394 -177.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.42 33.54 7.97 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.952 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.582 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 4.2 mm-40 57.26 48.46 15.03 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.054 -1.073 . . . . 0.0 112.814 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.601 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -120.17 63.53 0.83 Allowed 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 165.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.482 ' HE1' ' O ' ' A' ' 449' ' ' ASP . 1.0 OUTLIER -44.59 -35.02 2.37 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.426 -2.624 . . . . 0.0 112.871 -163.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 423' ' ' SER . 39.5 mt-30 -55.71 -43.01 76.08 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -165.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.62 HD11 ' HG ' ' A' ' 415' ' ' SER . 1.9 pp -63.39 -48.4 78.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 412' ' ' MET . 0.7 OUTLIER -60.54 -38.99 79.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.579 1.181 . . . . 0.0 109.059 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.502 ' N ' HG22 ' A' ' 422' ' ' VAL . 35.9 t -59.62 -46.34 89.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.356 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.9 -39.03 76.97 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.207 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.1 -40.56 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.582 0.706 . . . . 0.0 110.24 174.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.446 HD12 HG22 ' A' ' 395' ' ' ILE . 1.8 mm -58.13 -45.21 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.023 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.635 ' C ' ' HD3' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -59.72 -29.53 68.19 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.76 1.267 . . . . 0.0 108.746 -174.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.17 -15.37 74.52 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 112.71 -2.041 . . . . 0.0 112.562 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.568 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 10.2 m-85 -101.17 -0.33 36.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.27 142.9 80.6 Favored Pre-proline 0 N--CA 1.414 -2.263 0 CA-C-O 123.653 1.692 . . . . 0.0 113.626 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.641 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 66.9 Cg_endo -71.71 -61.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.227 4.618 . . . . 0.0 113.603 -172.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.559 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.15 142.17 17.04 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.147 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.6 ' HA ' ' CG1' ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.96 -27.47 68.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.316 0.558 . . . . 0.0 111.701 -176.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.22 -48.89 77.66 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.612 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.2 t -61.61 -37.66 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.485 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.6 ' CG1' ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.13 -44.19 65.48 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.261 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 67.1 m -71.9 -54.94 8.47 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.433 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.0 -46.11 78.84 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.414 0.446 . . . . 0.0 111.168 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.773 ' O ' HD21 ' A' ' 443' ' ' LEU . 21.1 mt -60.11 -54.11 49.8 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.47 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.752 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.26 -33.59 29.03 Favored 'General case' 0 N--CA 1.405 -2.69 0 O-C-N 125.487 1.742 . . . . 0.0 111.108 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.1 -59.81 2.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -75.76 -50.19 15.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.978 0.354 . . . . 0.0 111.895 -173.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.773 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -59.0 -24.7 63.01 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.623 -178.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.752 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 7.2 t70 -73.32 -41.05 63.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.882 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -72.31 -8.16 53.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -172.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.507 ' HB3' HG22 ' A' ' 451' ' ' THR . 6.1 mm-40 -56.85 162.76 2.23 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.176 1.465 . . . . 0.0 114.317 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.82 -33.52 34.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 111.31 -2.677 . . . . 0.0 115.974 -168.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.539 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.9 m-20 -145.03 -175.73 4.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.482 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.7 m-20 -65.11 -56.81 10.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.414 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.58 -25.21 67.31 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 177.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.539 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 17.0 m -56.85 -44.02 81.74 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.708 1.14 . . . . 0.0 109.47 170.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.713 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 27.6 mtm-85 -62.13 -29.45 70.35 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.774 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.591 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.25 -28.67 62.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.032 0.92 . . . . 0.0 109.449 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -86.21 -43.73 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.22 -171.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.8 p -103.44 -3.99 24.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.932 -169.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.669 ' HB2' ' O ' ' A' ' 452' ' ' ARG . 8.8 t80 -49.12 -53.58 20.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.668 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.574 HG21 ' HB2' ' A' ' 405' ' ' ALA . 21.4 mm -71.17 -25.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.521 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.97 -43.54 62.13 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.578 ' O ' HG21 ' A' ' 463' ' ' VAL . 80.1 m-70 -67.92 -31.1 70.63 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.215 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.673 HD22 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.8 -53.98 42.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.165 0.984 . . . . 0.0 109.177 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -61.61 -30.41 70.67 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.785 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -69.06 -47.57 64.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.585 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.712 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 45.6 t -66.06 -35.78 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.314 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.0 m-30 -61.12 -14.09 21.98 Favored 'General case' 0 C--O 1.2 -1.504 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.647 168.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 6.3 tp10 -93.36 -52.03 4.71 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.444 -0.785 . . . . 0.0 112.323 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.712 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -62.98 -41.31 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.421 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.47 ' CD1' HG23 ' A' ' 435' ' ' VAL . 5.7 mt -84.33 -17.12 40.53 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.734 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 66.1 49.35 58.5 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 111.633 -2.53 . . . . 0.0 113.336 173.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.6 OUTLIER -101.81 -176.59 3.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.056 0.943 . . . . 0.0 110.04 -179.21 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.731 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.8 p30 -105.11 -40.63 5.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 167.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.435 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -159.06 -79.38 0.06 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.335 -2.211 . . . . 0.0 110.91 158.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.641 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.5 OUTLIER -61.41 73.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -170.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.482 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.73 44.69 0.71 Allowed Glycine 0 C--N 1.274 -2.864 0 CA-C-N 110.462 -3.063 . . . . 0.0 113.227 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.731 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.1 mm-40 -79.66 -55.19 5.19 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.273 1.035 . . . . 0.0 111.223 -173.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.7 t 65.69 47.81 2.07 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.912 -2.403 . . . . 0.0 108.095 -173.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.734 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.605 0 CA-C-N 109.808 -3.36 . . . . 0.0 112.303 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.432 -1.331 0 CA-C-O 120.816 0.341 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.771 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 47.6 mt -71.11 121.19 83.46 Favored Pre-proline 0 N--CA 1.426 -1.665 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 57.8 Cg_endo -82.09 58.21 6.56 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 124.92 3.746 . . . . 0.0 109.592 170.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.658 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 1.7 tp -45.52 -47.38 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 112.12 -2.309 . . . . 0.0 113.347 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.618 ' HA ' ' OE1' ' A' ' 308' ' ' GLN . 16.7 mm-40 -65.63 -35.65 81.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.327 0.584 . . . . 0.0 111.282 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.508 ' HB3' HG13 ' A' ' 338' ' ' VAL . 6.3 t-160 -61.89 -47.41 85.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.615 173.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.544 ' O ' HG22 ' A' ' 314' ' ' THR . 67.5 mt -61.25 -49.62 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.058 0.943 . . . . 0.0 113.043 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 28.1 mtp180 -59.93 -29.57 68.47 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.05 0.54 . . . . 0.0 111.602 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 69.4 m -69.67 -33.26 72.31 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.606 0.717 . . . . 0.0 110.266 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.593 HG11 ' N ' ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.27 -40.86 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.936 177.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.644 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 34.4 p -82.13 -36.47 27.43 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.805 1.288 . . . . 0.0 109.928 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.23 34.42 9.67 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 112.323 -2.217 . . . . 0.0 110.813 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 33.2 mt-10 52.46 170.24 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.445 ' HB3' HD13 ' A' ' 324' ' ' ILE . 93.7 Cg_exo -49.63 150.67 8.53 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.213 2.609 . . . . 0.0 113.246 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.451 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 42.4 Cg_endo -93.37 -104.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.444 2.763 . . . . 0.0 112.11 -174.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.43 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 20.0 mmt180 -95.17 -84.58 0.33 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.515 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 12.1 m-20 -96.07 163.47 20.86 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.876 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.473 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.75 -48.64 12.19 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.732 2.288 . . . . 0.0 110.434 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.425 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -56.36 -17.14 6.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.509 -1.678 . . . . 0.0 113.562 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 39.7 mt-10 -87.38 -27.97 22.46 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.368 -0.208 . . . . 0.0 110.993 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.647 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.09 -43.69 69.31 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.675 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 3.5 Cg_endo -46.64 -65.35 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.098 2.532 . . . . 0.0 112.997 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.555 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.61 -37.62 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.317 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.644 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.5 t90 -57.68 -34.05 69.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.114 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.533 HD13 HG12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -70.58 -50.23 39.46 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.38 -23.73 27.73 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.903 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.511 ' HD2' HG23 ' A' ' 406' ' ' THR . 2.4 mtm-85 -73.23 -40.78 64.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.317 1.056 . . . . 0.0 110.369 175.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.552 ' HB3' HG23 ' A' ' 314' ' ' THR . 56.6 m-20 -97.75 -24.91 15.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.716 -1.584 . . . . 0.0 114.004 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.549 ' HA ' HD11 ' A' ' 335' ' ' ILE . . . -42.66 -49.72 13.07 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.4 Cg_endo -61.13 -32.93 91.68 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.495 2.13 . . . . 0.0 111.528 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.501 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -73.97 -43.51 57.89 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.483 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 332' ' ' ALA . 92.9 mt -57.44 -47.24 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.942 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 36.9 t70 -55.93 -14.78 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.202 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.82 -47.37 6.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.429 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 309' ' ' HIS . 92.2 t -63.49 -72.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.296 1.522 . . . . 0.0 109.946 169.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.771 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -84.05 122.48 75.93 Favored Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.665 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.7 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.2 Cg_endo -72.23 -17.25 27.86 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.094 3.196 . . . . 0.0 110.159 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.42 ' O ' HG21 ' A' ' 341' ' ' VAL . 2.4 p 33.89 67.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.068 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.541 ' N ' HD11 ' A' ' 346' ' ' LEU . 41.5 p -78.35 0.7 24.5 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.775 -2.012 . . . . 0.0 112.572 -170.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.822 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -138.06 159.09 69.78 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.463 ' HB3' HD13 ' A' ' 369' ' ' LEU . 68.1 Cg_exo -60.53 -44.94 24.0 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 123.583 2.855 . . . . 0.0 108.797 172.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.619 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -44.99 -52.43 8.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.722 -2.035 . . . . 0.0 110.776 176.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.822 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.0 mt -56.94 -52.3 65.73 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.518 ' HA ' HD13 ' A' ' 350' ' ' ILE . 25.3 ttm180 -49.94 -46.23 51.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.603 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.945 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 8.2 m -68.12 -50.86 52.12 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.146 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.69 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 35.2 mtt180 -61.23 -34.82 75.75 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.409 0.443 . . . . 0.0 111.105 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.861 ' O ' HG12 ' A' ' 354' ' ' ILE . 32.7 mt -56.22 -51.5 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.898 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.576 ' O ' HD21 ' A' ' 355' ' ' LEU . 21.7 mt -60.38 -53.84 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 123.832 0.707 . . . . 0.0 111.744 -172.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.69 ' OD1' ' HA ' ' A' ' 349' ' ' ARG . 0.0 OUTLIER -60.41 -36.13 77.42 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.822 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.465 ' HB2' HD12 ' A' ' 307' ' ' ILE . . . -71.19 -29.79 65.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.861 HG12 ' O ' ' A' ' 350' ' ' ILE . 4.3 mm -58.03 -59.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 CA-C-O 123.082 1.42 . . . . 0.0 110.493 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.647 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -78.62 -26.96 45.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.26 -167.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.85 -78.7 0.2 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.903 -1.499 . . . . 0.0 113.023 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -102.4 36.31 4.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.415 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.658 HD21 ' HB2' ' A' ' 361' ' ' LEU . 22.0 p-10 -70.63 131.46 43.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.069 0.461 . . . . 0.0 110.649 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.552 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -49.62 -72.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -169.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.9 2.94 6.91 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.885 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.658 ' HB2' HD21 ' A' ' 358' ' ' ASN . 2.2 mt -72.46 -4.62 31.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.943 0.877 . . . . 0.0 109.953 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 8.2 t -69.18 70.55 0.24 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.378 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 367' ' ' ASP . 1.5 mm? -55.03 172.31 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.5 p -120.27 159.4 47.74 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.325 -175.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.831 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.1 Cg_endo -53.3 -9.98 1.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.156 2.57 . . . . 0.0 113.215 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -103.49 -17.99 15.8 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.261 0.864 . . . . 0.0 115.261 -174.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.469 ' HB2' HD11 ' A' ' 363' ' ' LEU . 4.9 m-20 -105.72 -23.61 12.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.617 1.208 . . . . 0.0 110.649 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.945 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 8.6 t -96.18 25.24 5.02 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.653 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 369' ' ' LEU . 0.2 OUTLIER -54.39 -37.01 64.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.635 0.731 . . . . 0.0 110.467 -170.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.26 161.2 20.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.514 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.55 ' O ' HG11 ' A' ' 375' ' ' VAL . 30.3 m95 -69.41 -36.67 76.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.544 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.5 OUTLIER -64.31 -40.47 95.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.531 -174.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.1 t -69.08 -43.11 75.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.44 -53.44 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 371' ' ' TRP . 15.6 m -57.55 -43.02 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.624 0.726 . . . . 0.0 109.731 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.701 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -64.13 -42.75 96.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.272 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.498 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 22.8 m -69.32 -37.93 77.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.768 -173.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -61.33 -34.61 75.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.58 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.675 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 56.9 t80 -75.33 -43.98 47.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.161 0.982 . . . . 0.0 109.414 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.1 mp -52.08 -33.01 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.245 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.604 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.42 -34.63 74.23 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 123.141 0.576 . . . . 0.0 111.956 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.8 p -111.05 -23.53 10.87 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -165.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -109.98 25.6 11.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.63 50.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.959 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 64.12 164.39 0.13 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.023 0.439 . . . . 0.0 111.269 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.561 ' CE2' HD23 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -130.41 153.67 81.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 389' ' ' HIS . 85.8 Cg_endo -99.37 54.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.571 2.847 . . . . 0.0 111.248 165.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.645 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.5 -0.53 0.18 Allowed 'General case' 0 C--O 1.231 0.1 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.4 t60 -69.13 -44.51 72.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.951 0.405 . . . . 0.0 110.571 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.564 ' O ' HG23 ' A' ' 394' ' ' VAL . 27.6 mt-30 -75.01 -26.03 59.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.687 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.2 mm? -53.62 -31.71 48.31 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.28 0.945 . . . . 0.0 111.515 -174.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.676 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.45 -56.26 24.42 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.701 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.479 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 51.6 t30 -64.56 -34.47 78.32 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 110.717 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 390' ' ' GLN . 44.9 t -53.55 -53.64 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.645 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.752 ' O ' HG21 ' A' ' 399' ' ' VAL . 7.0 mm -59.15 -48.26 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 175.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 39.9 mmtt -52.71 -38.47 60.77 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 124.185 0.928 . . . . 0.0 112.056 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.57 -45.26 8.73 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.607 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.687 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.1 mt -70.33 -40.68 78.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 117.762 0.781 . . . . 0.0 111.271 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.752 HG21 ' O ' ' A' ' 395' ' ' ILE . 5.4 m -57.75 -44.0 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.575 0.702 . . . . 0.0 110.028 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.499 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.2 t70 -60.38 -36.62 78.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.576 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -91.19 -55.56 3.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.645 ' HG2' ' CG2' ' A' ' 406' ' ' THR . 3.0 tp10 -106.42 -34.42 7.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.245 0.545 . . . . 0.0 112.289 -172.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 129.97 167.29 12.03 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.511 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.587 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.55 -43.16 96.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -174.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.57 ' HB3' HG22 ' A' ' 457' ' ' ILE . . . -56.62 -51.0 70.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.645 ' CG2' ' HG2' ' A' ' 402' ' ' GLU . 0.9 OUTLIER -66.03 -48.79 69.96 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.756 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.687 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.96 -39.68 66.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 41.1 t80 -57.06 -47.2 81.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.676 0.75 . . . . 0.0 109.189 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.774 ' O ' ' HG3' ' A' ' 413' ' ' MET . 15.6 m -59.62 -53.0 63.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.008 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.597 HD11 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.49 -49.12 78.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.784 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.2 -42.47 88.19 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.18 -174.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.555 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.944 0.372 . . . . 0.0 110.746 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.774 ' HG3' ' O ' ' A' ' 409' ' ' THR . 65.5 mtm -69.57 -48.31 60.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.418 0.628 . . . . 0.0 110.047 175.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.701 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 17.0 mt -59.61 -37.56 78.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.376 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.79 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -77.76 -16.22 58.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.722 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.95 4.02 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.179 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.555 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 50.19 48.49 22.05 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 124.49 1.116 . . . . 0.0 113.91 -177.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.79 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -121.1 65.06 0.86 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 123.419 1.581 . . . . 0.0 107.294 166.01 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.485 ' HD2' ' HB2' ' A' ' 423' ' ' SER . 0.4 OUTLIER -44.17 -35.06 2.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.52 -2.582 . . . . 0.0 112.984 -164.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 423' ' ' SER . 53.5 mt-30 -54.66 -45.62 73.89 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -165.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.572 HD22 ' ND2' ' A' ' 418' ' ' ASN . 2.2 pp -62.75 -48.82 77.52 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.02 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.537 HG21 ' N ' ' A' ' 423' ' ' SER . 0.6 OUTLIER -61.28 -39.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 122.7 1.238 . . . . 0.0 109.04 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.537 ' N ' HG21 ' A' ' 422' ' ' VAL . 31.3 t -60.27 -46.58 89.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.405 -2.18 . . . . 0.0 111.718 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.85 -38.7 75.04 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.656 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 422' ' ' VAL . 2.3 mt -71.96 -40.97 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.441 0.638 . . . . 0.0 110.285 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 395' ' ' ILE . 1.6 mm -57.94 -44.09 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.618 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.517 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -58.23 -31.95 67.86 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 124.826 1.25 . . . . 0.0 109.046 -175.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.45 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -71.98 -13.36 75.82 Favored Glycine 0 C--N 1.301 -1.409 0 CA-C-N 113.0 -1.909 . . . . 0.0 112.595 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.625 ' CD1' HG22 ' A' ' 399' ' ' VAL . 11.0 m-85 -102.52 0.15 33.14 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.67 138.76 86.25 Favored Pre-proline 0 N--CA 1.408 -2.574 0 CA-C-O 123.752 1.739 . . . . 0.0 113.126 171.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.643 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 57.7 Cg_endo -68.58 -58.13 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.285 1 C-N-CA 126.34 4.694 . . . . 0.0 113.556 -170.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.544 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.51 143.46 18.1 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.96 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.609 ' HA ' ' CG1' ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -27.53 69.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.433 0.617 . . . . 0.0 111.857 -173.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.72 78.3 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.61 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.4 t -61.17 -36.9 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.617 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.609 ' CG1' ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -73.19 -43.16 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -175.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 24.0 m -71.6 -55.61 7.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.923 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.8 83.51 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.81 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.788 ' O ' HD21 ' A' ' 443' ' ' LEU . 29.2 mt -65.02 -54.24 33.47 Favored 'General case' 0 CA--C 1.477 -1.836 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.244 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.678 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.2 mp0 -52.18 -33.4 40.49 Favored 'General case' 0 N--CA 1.409 -2.515 0 O-C-N 125.21 1.569 . . . . 0.0 110.372 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.678 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -60.07 2.41 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 172.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -75.1 -49.47 19.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.839 -0.538 . . . . 0.0 112.116 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.788 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.81 -24.35 64.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.629 0.728 . . . . 0.0 111.774 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.697 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.1 t70 -72.8 -43.4 62.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.528 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.7 mt-30 -69.67 -8.35 46.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.621 ' HB3' HG22 ' A' ' 451' ' ' THR . 55.6 mm-40 -51.68 154.96 1.77 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 123.148 1.451 . . . . 0.0 114.267 -176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.519 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.8 mp -52.68 -32.48 17.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 111.444 -2.616 . . . . 0.0 115.409 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.559 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.5 m-20 -141.88 178.79 7.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.997 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 452' ' ' ARG . 6.0 p-10 -63.01 -51.15 67.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -23.71 62.46 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.621 HG22 ' HB3' ' A' ' 446' ' ' GLU . 19.2 m -59.58 -40.35 87.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 120.011 1.278 . . . . 0.0 109.264 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 61.8 mtt180 -60.19 -31.25 69.95 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.36 171.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.521 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.36 -28.99 57.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.079 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.4 -43.84 13.29 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.047 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.507 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -103.06 -1.36 29.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.352 -168.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 452' ' ' ARG . 5.6 t80 -48.88 -55.33 12.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.633 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.57 HG22 ' HB3' ' A' ' 405' ' ' ALA . 25.9 mm -70.32 -25.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.56 -43.28 63.65 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.556 ' O ' HG21 ' A' ' 463' ' ' VAL . 49.4 m-70 -67.71 -32.06 72.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.541 172.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.677 HD22 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.12 -53.39 54.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 122.172 0.987 . . . . 0.0 108.895 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -61.99 -31.1 71.44 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.629 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 458' ' ' GLN . . . -67.18 -49.5 64.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.503 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.769 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 38.5 t -65.95 -34.38 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.8 m-30 -63.1 -14.6 50.42 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.617 169.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 7.4 tp10 -94.44 -52.29 4.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.889 0.852 . . . . 0.0 111.601 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.769 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.0 pt -63.33 -41.47 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.278 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 463' ' ' VAL . 7.2 mt -83.94 -17.78 39.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.763 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.41 50.13 57.24 Favored Glycine 0 C--O 1.218 -0.882 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.159 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.6 OUTLIER -100.9 172.78 6.83 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.036 0.934 . . . . 0.0 110.275 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.774 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 16.0 p30 -88.7 -44.16 10.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 166.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -162.18 -72.92 0.05 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.776 162.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.643 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -61.33 68.87 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.486 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.47 43.92 0.57 Allowed Glycine 0 C--N 1.275 -2.824 0 CA-C-N 110.715 -2.948 . . . . 0.0 113.564 173.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.774 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 30.3 mm-40 -82.25 -55.62 4.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 122.578 1.18 . . . . 0.0 111.054 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 44.2 t 69.12 55.04 0.42 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.368 -2.651 . . . . 0.0 108.307 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.763 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 110.584 -3.007 . . . . 0.0 111.544 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.432 ' H ' HG11 ' A' ' 304' ' ' VAL . 1.5 p . . . . . 0 N--CA 1.428 -1.538 0 CA-C-O 121.423 0.63 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.814 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 54.4 mt -72.86 124.65 90.98 Favored Pre-proline 0 N--CA 1.423 -1.794 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.317 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.501 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 60.5 Cg_endo -83.0 53.78 4.52 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 124.969 3.779 . . . . 0.0 109.797 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.776 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 2.8 tp -43.06 -46.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 112.237 -2.256 . . . . 0.0 113.672 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.533 ' HG2' HG21 ' A' ' 307' ' ' ILE . 54.4 mm-40 -65.59 -36.29 83.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.692 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.468 ' HB3' HG12 ' A' ' 338' ' ' VAL . 7.4 t-160 -61.09 -46.21 91.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.315 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' A' ' 307' ' ' ILE . 68.6 mt -62.84 -49.61 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 124.263 1.025 . . . . 0.0 113.254 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.776 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 22.9 mtp180 -59.27 -30.3 68.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 121.888 -0.507 . . . . 0.0 111.259 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 59.5 m -69.59 -32.72 71.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.557 0.694 . . . . 0.0 110.01 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.21 -40.58 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.022 177.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.609 ' N ' HG12 ' A' ' 313' ' ' VAL . 35.9 p -82.56 -37.53 25.0 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.788 1.28 . . . . 0.0 109.976 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.04 34.09 7.83 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.817 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 35.7 mt-10 53.52 169.42 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 316' ' ' GLU . 25.4 Cg_exo -44.06 151.39 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.795 2.997 . . . . 0.0 113.621 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 17.2 Cg_endo -97.97 -108.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.356 2.704 . . . . 0.0 112.601 -174.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.452 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 9.6 mmm180 -92.47 -82.02 0.33 Allowed 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.592 0.71 . . . . 0.0 111.277 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.473 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 28.3 m-20 -102.63 158.63 31.39 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.133 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.445 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.1 Cg_exo -59.4 -49.67 10.1 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.654 2.236 . . . . 0.0 110.685 172.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -22.56 12.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.224 -1.807 . . . . 0.0 113.035 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.473 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -85.97 -24.37 26.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.672 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.0 OUTLIER -51.21 -40.95 71.95 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.684 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.4 Cg_endo -49.8 -62.22 0.45 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.903 2.402 . . . . 0.0 112.773 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.575 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.09 -37.18 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.236 177.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.644 ' CH2' HG21 ' A' ' 354' ' ' ILE . 55.5 t90 -58.35 -36.46 73.48 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.007 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.503 HD13 HG12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -69.85 -49.99 46.97 Favored 'General case' 0 N--CA 1.396 -3.125 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.523 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.08 -24.04 26.63 Favored Glycine 0 C--N 1.311 -0.824 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.151 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.3 mtt180 -73.99 -41.68 61.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.042 0.925 . . . . 0.0 110.576 174.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.562 ' HB3' HG23 ' A' ' 314' ' ' THR . 56.9 m-20 -95.68 -23.6 16.93 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.82 -169.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.541 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -43.5 -48.89 18.5 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.365 1.066 . . . . 0.0 113.727 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.1 Cg_endo -60.03 -34.56 94.73 Favored 'Trans proline' 0 CA--C 1.508 -0.796 0 C-N-CA 122.548 2.166 . . . . 0.0 111.539 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.506 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -73.4 -43.56 60.26 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.476 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 332' ' ' ALA . 97.1 mt -57.95 -48.24 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.872 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 31.8 t70 -54.27 -15.48 1.6 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.199 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.43 -51.65 4.83 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.508 HG23 HG21 ' A' ' 313' ' ' VAL . 91.1 t -59.17 -72.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.255 1.502 . . . . 0.0 109.998 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.814 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.4 OUTLIER -87.98 121.07 70.87 Favored Pre-proline 0 N--CA 1.405 -2.69 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.685 -176.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.594 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.3 Cg_endo -72.92 -20.76 21.81 Favored 'Trans proline' 0 CA--C 1.496 -1.422 0 C-N-CA 123.736 2.957 . . . . 0.0 110.362 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.623 HG22 ' CD2' ' A' ' 339' ' ' PHE . 2.7 t 46.07 61.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 111.715 -2.493 . . . . 0.0 109.92 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.596 ' N ' HD11 ' A' ' 346' ' ' LEU . 35.9 p -75.85 5.56 6.24 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.914 -172.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.764 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -141.89 159.28 59.98 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 347' ' ' ARG . 56.2 Cg_exo -61.81 -44.3 21.7 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 123.924 3.083 . . . . 0.0 108.994 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.675 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -50.07 -44.17 51.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.037 -1.892 . . . . 0.0 111.523 175.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.769 ' O ' HG13 ' A' ' 350' ' ' ILE . 14.9 mt -59.21 -52.25 66.47 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 344' ' ' PRO . 11.5 mmt180 -45.3 -52.44 9.71 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 125.249 1.593 . . . . 0.0 110.66 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.979 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -65.66 -49.2 69.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.713 -175.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.669 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.7 mtt180 -61.56 -39.31 90.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.872 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.6 mt -57.31 -55.43 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.788 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.351 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.652 ' O ' HD21 ' A' ' 355' ' ' LEU . 20.1 mt -57.65 -53.34 45.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 O-C-N 124.764 1.29 . . . . 0.0 110.736 -170.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.588 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 11.7 m-20 -63.14 -36.46 83.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.211 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.46 ' HB3' HD13 ' A' ' 307' ' ' ILE . . . -71.46 -30.61 66.21 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.173 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.872 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.2 mm -56.04 -58.09 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 CA-C-O 122.797 1.284 . . . . 0.0 110.312 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.672 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.99 -26.77 54.27 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.086 -2.325 . . . . 0.0 109.726 -168.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 73.69 -71.47 1.34 Allowed Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.93 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -113.21 37.88 3.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.941 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.633 HD21 ' HB2' ' A' ' 361' ' ' LEU . 20.2 p-10 -66.99 133.61 50.3 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.042 0.448 . . . . 0.0 110.563 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.562 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.1 mp -51.01 -77.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 124.409 1.084 . . . . 0.0 112.871 -169.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -124.92 7.0 8.26 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.492 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.633 ' HB2' HD21 ' A' ' 358' ' ' ASN . 2.6 mt -72.39 -4.63 31.19 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.67 0.748 . . . . 0.0 109.655 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.588 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 23.1 t -63.84 76.95 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.332 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.47 HD21 ' CD2' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -62.55 173.48 1.24 Allowed 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.7 p -122.05 156.39 59.89 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.896 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.979 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 6.7 Cg_endo -56.76 -3.54 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.856 2.37 . . . . 0.0 114.286 -172.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.502 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -104.59 -12.05 29.42 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.409 ' HB2' HD13 ' A' ' 363' ' ' LEU . 16.1 m-20 -109.25 -20.39 12.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.023 0.916 . . . . 0.0 110.853 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 17.1 p -96.75 15.21 22.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.117 -164.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.502 HD11 ' O ' ' A' ' 366' ' ' GLY . 1.3 mt -58.75 -40.98 85.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.879 -161.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.88 163.15 16.98 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.223 170.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.512 ' O ' HG13 ' A' ' 375' ' ' VAL . 41.3 m95 -68.81 -35.74 77.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.554 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.2 p30 -62.73 -40.2 96.45 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.875 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.7 m -71.39 -41.04 70.14 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.066 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.508 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -66.53 -52.19 48.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.544 HG21 ' HE1' ' A' ' 413' ' ' MET . 15.8 m -56.38 -45.36 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.377 0.608 . . . . 0.0 109.86 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.635 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -59.93 -42.37 93.81 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.105 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.506 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 19.6 m -70.81 -36.86 73.15 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.232 -172.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -62.99 -33.32 75.15 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.425 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.684 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.1 t80 -75.6 -44.5 42.63 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.433 1.111 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.512 HD11 ' O ' ' A' ' 376' ' ' ALA . 1.1 mp -52.45 -33.22 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.503 169.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.67 -41.69 95.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.168 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 378' ' ' LEU . 28.7 p -99.91 -22.99 15.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.123 -168.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . 0.519 ' HB3' HE22 ' A' ' 390' ' ' GLN . 36.6 m80 -111.14 22.64 15.01 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.21 20.9 16.97 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.7 m 66.96 159.87 0.14 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.265 0.533 . . . . 0.0 111.519 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.418 ' HZ ' ' HB3' ' A' ' 414' ' ' LEU . 0.2 OUTLIER -127.93 156.06 76.65 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 389' ' ' HIS . 77.0 Cg_endo -97.95 54.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.46 2.773 . . . . 0.0 111.643 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.606 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.28 -1.27 0.14 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.1 t60 -69.79 -46.12 66.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.143 0.497 . . . . 0.0 110.938 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.623 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.6 mt-30 -74.7 -25.59 59.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.749 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.87 -30.62 46.55 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.772 0.715 . . . . 0.0 111.283 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.638 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.47 -50.23 57.64 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.509 174.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.516 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 5.7 m-20 -67.89 -40.56 83.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.852 0.461 . . . . 0.0 111.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.681 HG21 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.14 -44.12 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.003 0.43 . . . . 0.0 110.438 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -58.35 -47.12 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.18 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.652 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 32.3 mmtt -53.07 -41.39 64.83 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.097 0.873 . . . . 0.0 111.897 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -76.75 -44.64 14.66 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.025 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.745 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -69.96 -40.81 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 117.302 0.551 . . . . 0.0 111.767 -178.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 395' ' ' ILE . 5.0 m -57.75 -43.47 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.745 0.783 . . . . 0.0 109.721 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.439 ' N ' HG21 ' A' ' 399' ' ' VAL . 17.6 t70 -56.15 -43.7 78.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.252 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 33.1 mm-40 -84.1 -54.27 4.95 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.47 -172.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -110.58 -29.34 8.09 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.516 0.674 . . . . 0.0 112.535 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.78 171.38 14.04 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.688 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.586 ' HA ' HG11 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.3 -44.42 97.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -57.18 -51.05 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.927 0.394 . . . . 0.0 112.005 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.586 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.2 m -64.18 -51.2 64.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.553 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.745 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.55 -43.15 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.574 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 30.3 t80 -55.58 -46.32 77.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.686 0.755 . . . . 0.0 109.197 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.816 ' O ' ' HG3' ' A' ' 413' ' ' MET . 13.0 m -57.92 -52.68 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.353 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.594 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.66 -48.74 80.45 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.32 -42.62 89.13 Favored Glycine 0 C--N 1.313 -0.724 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.003 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.606 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -72.71 -32.52 65.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.823 0.311 . . . . 0.0 110.833 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.816 ' HG3' ' O ' ' A' ' 409' ' ' THR . 62.5 mtm -69.36 -46.6 66.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.09 174.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.635 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.16 -39.17 85.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.74 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.762 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -77.1 -16.87 59.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.057 -178.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.84 47.01 3.78 Favored Glycine 0 C--N 1.308 -1.018 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.024 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.606 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 49.71 48.69 21.24 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.521 1.128 . . . . 0.0 113.892 -177.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.762 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -123.57 66.0 1.01 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.481 ' HB3' ' CE ' ' A' ' 412' ' ' MET . 14.4 p90 -51.48 -31.84 25.02 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.701 -161.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.476 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 34.1 mt-30 -53.89 -43.25 69.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.596 -165.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.623 HD21 ' ND2' ' A' ' 418' ' ' ASN . 2.0 pp -63.06 -48.1 80.1 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.329 0.585 . . . . 0.0 110.855 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.541 ' HA ' HD13 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -62.31 -38.97 82.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.588 1.185 . . . . 0.0 109.101 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.527 ' N ' HG22 ' A' ' 422' ' ' VAL . 30.7 t -59.64 -45.95 90.45 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.301 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.47 87.27 Favored Glycine 0 C--N 1.316 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.844 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 422' ' ' VAL . 2.1 mt -71.09 -41.31 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -56.43 -43.98 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.285 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.687 ' HD2' ' O ' ' A' ' 427' ' ' ARG . 1.8 tmm_? -56.97 -35.38 69.08 Favored 'General case' 0 N--CA 1.406 -2.647 0 C-N-CA 124.962 1.305 . . . . 0.0 109.837 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.74 -13.12 74.93 Favored Glycine 0 C--N 1.29 -1.985 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.948 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.652 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.5 m-85 -100.08 -3.64 31.49 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.508 ' CB ' HG11 ' A' ' 436' ' ' VAL . 3.9 mm? -59.24 142.96 85.71 Favored Pre-proline 0 N--CA 1.412 -2.329 0 CA-C-O 123.438 1.59 . . . . 0.0 112.875 173.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.684 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 88.5 Cg_endo -72.23 -53.25 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.083 4.522 . . . . 0.0 113.338 -170.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -120.94 140.33 14.08 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.615 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -63.19 -26.53 68.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.164 0.482 . . . . 0.0 111.776 -175.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.2 -48.46 78.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.687 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.4 t -58.44 -51.89 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.705 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.8 OUTLIER -54.87 -51.43 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 118.096 0.407 . . . . 0.0 109.945 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.447 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 86.4 m -62.67 -57.33 11.39 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.14 -44.76 79.54 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.368 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.851 ' O ' HD23 ' A' ' 443' ' ' LEU . 40.0 mt -59.72 -53.71 54.83 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.73 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.706 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 39.1 mm-40 -51.5 -35.14 39.05 Favored 'General case' 0 N--CA 1.417 -2.123 0 O-C-N 124.899 1.374 . . . . 0.0 110.669 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.32 -60.37 2.28 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 176.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.74 -51.71 10.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.378 0.535 . . . . 0.0 112.385 -172.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.851 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.74 -25.46 63.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.522 0.677 . . . . 0.0 111.575 -177.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.747 ' N ' HD22 ' A' ' 443' ' ' LEU . 10.7 t70 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.657 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 34.6 mt-30 -71.56 -6.85 43.8 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.612 ' HB3' HG23 ' A' ' 451' ' ' THR . 25.2 mm-40 -51.86 161.25 0.58 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 123.662 1.696 . . . . 0.0 114.614 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.457 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -56.99 -33.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 110.443 -3.071 . . . . 0.0 115.199 -172.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.576 ' H ' ' HB ' ' A' ' 451' ' ' THR . 66.4 m-20 -138.96 179.99 6.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.457 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 8.9 p-10 -64.43 -55.32 21.67 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -23.52 64.77 Favored 'General case' 0 N--CA 1.402 -2.868 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 446' ' ' GLU . 25.4 m -58.82 -41.51 87.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.756 1.162 . . . . 0.0 109.677 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.548 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 48.2 mtt180 -60.16 -30.0 69.04 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.201 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.574 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.03 -33.64 59.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 109.877 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.02 -42.83 31.23 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.333 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.532 ' HG1' ' HG3' ' A' ' 446' ' ' GLU . 38.3 p -101.34 -4.18 27.46 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.375 -169.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.641 ' CE1' HD22 ' A' ' 460' ' ' LEU . 7.4 t80 -49.25 -52.82 24.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.846 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 22.9 mm -71.75 -27.01 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.519 ' O ' ' HB1' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.56 -42.45 64.65 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 463' ' ' VAL . 25.9 m80 -67.6 -31.17 71.03 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.473 -1.694 . . . . 0.0 109.96 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.695 HD23 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.41 -54.05 34.32 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 122.188 0.994 . . . . 0.0 109.165 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.724 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -62.26 -32.31 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.034 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.68 -53.27 58.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.922 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.693 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 25.9 t -63.45 -34.27 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-O 121.806 0.812 . . . . 0.0 110.287 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.2 m-30 -60.93 -14.39 22.22 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.191 169.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.724 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 45.0 mt-10 -93.81 -48.37 6.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.824 -1.173 . . . . 0.0 112.652 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.693 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.4 pt -64.6 -39.94 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.049 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.475 ' HB2' ' HG ' ' A' ' 469' ' ' LEU . 7.3 mt -84.46 -16.84 41.11 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.788 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.02 51.05 56.49 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 111.73 -2.486 . . . . 0.0 113.219 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.8 OUTLIER -101.28 177.4 4.94 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.13 0.972 . . . . 0.0 109.88 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.675 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.5 p30 -96.46 -44.11 7.33 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.474 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -157.39 -74.61 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.457 -2.156 . . . . 0.0 110.351 160.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.684 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -59.01 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -172.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.556 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.96 42.69 0.37 Allowed Glycine 0 C--N 1.275 -2.854 0 CA-C-N 111.423 -2.626 . . . . 0.0 113.613 173.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.675 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 31.2 mm-40 -81.32 -51.99 7.78 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 122.79 1.281 . . . . 0.0 111.453 -172.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.4 t 68.91 61.47 0.33 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.171 -2.74 . . . . 0.0 109.037 -173.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.788 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 110.923 -2.853 . . . . 0.0 111.463 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.43 -1.472 0 CA-C-O 121.032 0.444 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.742 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 31.9 mt -78.74 125.56 84.02 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 121.89 0.852 . . . . 0.0 111.878 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 308' ' ' GLN . 26.0 Cg_endo -74.97 -12.04 21.57 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.99 3.793 . . . . 0.0 111.663 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.707 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.1 tp 30.31 -64.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 O-C-N 126.973 2.671 . . . . 0.0 115.996 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.627 ' HG2' HG21 ' A' ' 307' ' ' ILE . 66.6 mm-40 -58.24 -33.24 69.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.466 0.65 . . . . 0.0 110.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.52 ' HB3' HG11 ' A' ' 338' ' ' VAL . 5.7 t-160 -61.42 -48.83 79.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.646 172.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 307' ' ' ILE . 64.2 mt -59.06 -48.38 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 124.111 0.965 . . . . 0.0 112.51 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.5 mtp-105 -58.33 -30.83 67.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 122.613 0.365 . . . . 0.0 111.456 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.7 m -69.92 -33.22 71.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.573 0.701 . . . . 0.0 109.882 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.15 -40.49 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.785 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.651 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.22 -36.7 26.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.646 1.212 . . . . 0.0 110.024 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.26 34.72 7.91 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.107 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 45.9 mt-10 56.77 165.81 0.07 OUTLIER Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.447 ' HB3' HD13 ' A' ' 324' ' ' ILE . 43.0 Cg_exo -44.97 147.31 2.03 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.517 2.812 . . . . 0.0 113.032 175.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.462 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 39.6 Cg_endo -93.16 -104.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.358 2.705 . . . . 0.0 112.169 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.421 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 10.8 mmt180 -95.92 -85.21 0.33 Allowed 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 121.259 0.552 . . . . 0.0 111.113 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.508 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 16.5 m-20 -97.37 164.46 17.64 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.733 -175.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 -49.39 10.92 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.655 2.237 . . . . 0.0 110.546 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.55 -13.96 2.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.309 -1.768 . . . . 0.0 113.401 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.508 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 14.9 mt-10 -90.52 -29.2 18.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.374 -0.204 . . . . 0.0 111.201 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.681 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.7 -42.87 70.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.696 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.8 Cg_endo -47.65 -63.74 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.097 2.531 . . . . 0.0 113.05 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.556 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.97 -36.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.428 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.651 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 44.7 t90 -57.82 -36.08 71.74 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.83 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.524 HD13 HG12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -70.55 -49.74 44.83 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.433 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.78 -23.74 23.17 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.804 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.35 -42.19 59.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.947 0.88 . . . . 0.0 110.948 173.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.558 ' HB3' HG21 ' A' ' 314' ' ' THR . 52.6 m-20 -94.78 -24.05 17.26 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.492 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.544 ' HA ' HD11 ' A' ' 335' ' ' ILE . . . -42.43 -49.65 12.38 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.8 Cg_endo -61.66 -32.9 87.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.564 2.176 . . . . 0.0 111.662 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.489 ' CB ' HG12 ' A' ' 313' ' ' VAL . . . -73.75 -44.43 56.22 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.305 -1.77 . . . . 0.0 109.547 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.544 HD11 ' HA ' ' A' ' 332' ' ' ALA . 93.6 mt -56.11 -47.74 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.934 173.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.0 -13.96 2.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.6 -1.636 . . . . 0.0 112.327 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.59 -51.15 4.7 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.529 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.52 HG11 ' HB3' ' A' ' 309' ' ' HIS . 83.2 t -58.68 -71.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 123.351 1.548 . . . . 0.0 109.743 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.742 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.29 123.64 72.88 Favored Pre-proline 0 N--CA 1.402 -2.853 0 CA-C-N 111.261 -2.7 . . . . 0.0 111.953 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.718 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.5 Cg_endo -72.36 -17.1 27.52 Favored 'Trans proline' 0 CA--C 1.494 -1.485 0 C-N-CA 124.163 3.242 . . . . 0.0 110.543 175.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 2.5 p 33.29 69.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 111.907 -2.406 . . . . 0.0 110.088 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.558 ' N ' HD12 ' A' ' 346' ' ' LEU . 62.4 p -80.72 6.06 13.92 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.844 -170.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.787 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 14.7 p -143.06 160.71 51.62 Favored Pre-proline 0 N--CA 1.434 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.491 ' HB3' HD12 ' A' ' 369' ' ' LEU . 50.6 Cg_exo -62.62 -45.05 15.11 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.591 2.861 . . . . 0.0 108.739 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.661 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -44.78 -52.24 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.784 175.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.787 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.6 mt -56.72 -51.55 68.41 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 17.7 ttm-85 -49.79 -47.84 50.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.595 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 1.077 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -68.15 -48.07 66.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.472 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 53.7 mtt180 -60.25 -37.77 81.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.113 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.862 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -56.87 -52.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.572 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.608 ' O ' HD22 ' A' ' 355' ' ' LEU . 21.1 mt -58.56 -53.38 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.905 0.86 . . . . 0.0 111.248 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 18.6 m-20 -63.13 -36.2 82.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.987 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.463 ' HB1' HD13 ' A' ' 307' ' ' ILE . . . -70.89 -29.5 65.61 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.79 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.862 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.14 -60.13 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.052 1.406 . . . . 0.0 110.067 173.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.681 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -74.55 -27.53 60.56 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 111.961 -2.381 . . . . 0.0 109.883 -167.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.98 -71.68 0.29 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.941 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -111.68 54.05 0.56 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.644 HD21 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -84.93 133.28 34.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.564 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -47.84 -73.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 124.042 0.937 . . . . 0.0 112.664 -170.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.27 5.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.192 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.644 ' HB2' HD21 ' A' ' 358' ' ' ASN . 3.6 mt -69.98 -5.08 23.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.587 0.708 . . . . 0.0 110.127 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.55 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 25.2 t -59.12 82.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.393 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -65.55 178.38 1.0 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.791 177.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.7 p -122.02 153.94 61.09 Favored Pre-proline 0 N--CA 1.437 -1.088 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.867 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 3.2 Cg_exo -53.94 -11.14 2.26 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.007 2.472 . . . . 0.0 113.107 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -111.29 -2.19 27.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.442 ' HB2' HD13 ' A' ' 363' ' ' LEU . 19.4 m-20 -106.32 -21.62 13.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.741 1.27 . . . . 0.0 110.542 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 1.077 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 34.8 t -98.24 25.29 6.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.597 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.595 ' N ' HD11 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -54.57 -34.3 61.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.127 0.965 . . . . 0.0 109.806 -173.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.42 159.04 24.99 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.869 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.592 ' O ' HG11 ' A' ' 375' ' ' VAL . 46.4 m95 -68.91 -35.71 77.15 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.612 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -59.54 -46.85 87.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.126 -176.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 62.4 m -67.29 -41.9 84.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.111 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.616 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.48 63.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.592 HG11 ' O ' ' A' ' 371' ' ' TRP . 14.4 m -57.87 -44.43 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.588 0.709 . . . . 0.0 109.603 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.697 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -61.46 -41.08 96.68 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.102 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.501 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 22.4 m -71.47 -39.14 71.12 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.619 -173.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.9 mt -61.58 -33.45 73.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.31 0.576 . . . . 0.0 110.328 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.696 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 41.6 t80 -73.08 -47.16 46.97 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.211 1.005 . . . . 0.0 109.489 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.501 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.45 -32.77 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 113.14 -1.845 . . . . 0.0 111.796 169.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.26 -32.72 71.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 123.014 0.525 . . . . 0.0 111.564 175.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.0 p -109.01 -23.65 11.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.388 -167.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -110.52 22.51 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.23 17.91 33.15 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 114.47 0.548 . . . . 0.0 114.47 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.0 m 66.2 160.41 0.14 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.232 0.539 . . . . 0.0 111.374 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -128.2 155.67 77.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -101.88 63.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.972 3.115 . . . . 0.0 111.216 164.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.563 ' HA ' HD21 ' A' ' 391' ' ' LEU . 3.4 mmt 53.01 5.55 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -70.32 -48.2 57.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.247 0.546 . . . . 0.0 111.173 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.617 ' O ' HG11 ' A' ' 394' ' ' VAL . 78.1 mt-30 -75.61 -28.69 58.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.889 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -54.62 -31.28 57.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.61 0.641 . . . . 0.0 112.157 -170.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.635 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.42 -51.93 48.22 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.862 -1.161 . . . . 0.0 110.543 173.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.53 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 8.8 m-20 -68.56 -38.21 80.57 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 122.95 0.5 . . . . 0.0 112.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.657 ' O ' HG13 ' A' ' 398' ' ' ILE . 1.6 m -58.16 -44.72 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.711 ' O ' HG21 ' A' ' 399' ' ' VAL . 9.5 mm -58.47 -48.35 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.214 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.2 mmtt -52.8 -40.27 63.11 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 124.051 0.845 . . . . 0.0 112.031 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.94 -44.88 13.0 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.926 -173.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.717 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.3 mt -69.65 -41.9 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 117.33 0.565 . . . . 0.0 111.686 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.711 HG21 ' O ' ' A' ' 395' ' ' ILE . 4.3 m -57.28 -45.21 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.609 0.719 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.9 t70 -60.85 -37.16 81.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.193 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 27.1 mt-30 -88.31 -52.67 5.08 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.555 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -113.26 -30.67 6.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.963 -167.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.69 164.5 11.65 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.754 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.592 ' HA ' HG11 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -64.04 -42.54 96.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -175.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.556 ' HB3' HG23 ' A' ' 457' ' ' ILE . . . -58.12 -50.32 73.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.791 0.329 . . . . 0.0 111.511 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -62.31 -52.41 63.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.717 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -42.67 66.18 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.489 ' HB3' HD13 ' A' ' 457' ' ' ILE . 39.1 t80 -56.15 -47.08 78.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.567 0.699 . . . . 0.0 109.226 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.805 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.3 m -58.86 -53.01 63.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.743 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.617 HD12 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.67 -49.23 78.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.783 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.488 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.08 -43.05 88.47 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.042 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.536 ' HE3' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.03 -31.37 66.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.773 0.287 . . . . 0.0 111.158 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.805 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.2 mtm -70.92 -46.53 62.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.669 0.747 . . . . 0.0 109.599 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.697 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.78 -42.0 92.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.066 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.889 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 74.8 m -78.76 2.48 19.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.34 53.86 9.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.363 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.536 ' HA ' ' HE3' ' A' ' 412' ' ' MET . 1.4 mp0 46.01 56.98 5.55 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.85 0.86 . . . . 0.0 112.926 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.572 ' O ' HD23 ' A' ' 421' ' ' LEU . 48.1 t30 -122.47 65.63 0.94 Allowed 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 162.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.472 ' O ' HG23 ' A' ' 422' ' ' VAL . 0.3 OUTLIER -48.79 -36.28 16.27 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.594 -173.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 423' ' ' SER . 45.0 mt-30 -57.08 -50.58 72.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -168.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.765 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 0.2 OUTLIER -59.37 -50.43 73.98 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.365 -178.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.765 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.35 -38.27 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 122.675 1.226 . . . . 0.0 109.233 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.564 ' N ' HG23 ' A' ' 422' ' ' VAL . 19.2 t -59.94 -49.63 76.94 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.299 -2.228 . . . . 0.0 111.585 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.69 -36.13 77.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.375 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.537 HD13 ' HA ' ' A' ' 422' ' ' VAL . 4.3 mt -72.51 -39.72 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.627 0.727 . . . . 0.0 110.112 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.449 HD11 ' HB1' ' A' ' 407' ' ' ALA . 1.7 mm -62.76 -41.63 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.569 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -57.18 -34.4 68.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 125.916 1.686 . . . . 0.0 108.64 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.457 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -73.01 -11.57 78.92 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.725 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.607 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.9 m-85 -105.52 -0.27 26.0 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.536 HD12 HG12 ' A' ' 435' ' ' VAL . 3.7 mm? -58.01 141.35 81.35 Favored Pre-proline 0 N--CA 1.412 -2.328 0 CA-C-O 123.566 1.65 . . . . 0.0 113.411 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.693 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 57.6 Cg_endo -70.04 -60.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 1 C-N-CA 126.444 4.763 . . . . 0.0 113.43 -170.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.593 ' O ' HG13 ' A' ' 436' ' ' VAL . . . -110.09 141.45 16.23 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.606 ' HA ' ' CG1' ' A' ' 436' ' ' VAL . 0.0 OUTLIER -59.58 -30.07 68.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.361 0.58 . . . . 0.0 111.831 -174.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.05 -48.96 77.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.58 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.6 t -62.86 -35.6 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.524 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.606 ' CG1' ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.14 -46.63 57.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 38.4 m -72.65 -54.21 9.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.337 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.53 -46.16 80.76 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.342 0.401 . . . . 0.0 111.348 -174.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.774 ' O ' HD22 ' A' ' 443' ' ' LEU . 17.7 mt -60.92 -54.2 47.97 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.71 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.672 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.77 -33.6 35.94 Favored 'General case' 0 N--CA 1.407 -2.596 0 O-C-N 125.709 1.881 . . . . 0.0 110.64 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.664 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -59.86 2.52 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -47.53 27.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.581 0.628 . . . . 0.0 111.66 -173.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -59.23 -25.24 63.85 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 111.427 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.744 ' N ' HD21 ' A' ' 443' ' ' LEU . 13.4 t70 -73.94 -42.2 60.9 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.795 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.664 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 40.9 mt-30 -70.65 -9.74 57.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -172.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.634 ' HB3' HG23 ' A' ' 451' ' ' THR . 38.4 mm-40 -50.28 157.73 0.65 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 123.361 1.553 . . . . 0.0 115.094 -174.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.514 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.27 -32.41 19.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 110.937 -2.847 . . . . 0.0 115.408 -170.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.551 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 9.2 m-20 -140.93 178.64 7.22 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.424 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 2.3 m-20 -62.56 -54.51 38.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -24.27 66.17 Favored 'General case' 0 N--CA 1.404 -2.736 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.634 HG23 ' HB3' ' A' ' 446' ' ' GLU . 19.5 m -59.45 -40.96 88.55 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 119.992 1.269 . . . . 0.0 109.388 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.572 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 67.0 mtt180 -61.82 -29.29 70.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.304 172.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.476 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -31.73 60.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.041 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.05 -42.98 13.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.47 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.507 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.4 p -101.88 -0.94 33.19 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.723 -170.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.64 ' CE1' HD22 ' A' ' 460' ' ' LEU . 7.1 t80 -49.29 -55.96 11.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.003 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.556 HG23 ' HB3' ' A' ' 405' ' ' ALA . 24.6 mm -70.05 -24.73 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.72 -44.66 61.42 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.566 ' O ' HD23 ' A' ' 439' ' ' LEU . 47.3 m-70 -65.49 -32.02 73.4 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.15 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.672 HD23 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.54 -53.82 41.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.209 1.004 . . . . 0.0 109.263 -178.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -61.96 -30.42 70.91 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.187 -1.824 . . . . 0.0 110.74 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.556 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.76 -48.48 66.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.722 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 42.2 t -66.76 -34.71 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.489 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.547 ' OH ' HG11 ' A' ' 404' ' ' VAL . 19.2 m-30 -62.21 -13.96 33.09 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.617 167.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.8 tp10 -93.41 -52.94 4.28 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.414 -0.804 . . . . 0.0 112.242 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.722 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.3 pt -62.07 -41.73 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.132 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 469' ' ' LEU . 5.4 mt -84.14 -17.34 40.39 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.73 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.63 49.87 57.51 Favored Glycine 0 C--O 1.219 -0.801 0 CA-C-N 111.515 -2.584 . . . . 0.0 113.223 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.8 OUTLIER -102.68 -179.17 3.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 123.861 0.864 . . . . 0.0 110.402 -178.302 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.631 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.0 p30 -100.82 -40.6 7.23 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -160.73 -76.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.121 160.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.693 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -64.32 67.81 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.41 ' HA2' HD13 ' A' ' 469' ' ' LEU . . . 41.04 39.84 2.16 Favored Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.425 -2.625 . . . . 0.0 113.361 173.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.631 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 9.9 mm-40 -79.19 -51.87 8.92 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.529 1.157 . . . . 0.0 111.324 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.6 t 64.7 61.44 0.82 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 111.806 -2.452 . . . . 0.0 109.24 -172.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-N 110.391 -3.095 . . . . 0.0 111.49 171.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.429 -1.504 0 CA-C-O 121.118 0.485 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.786 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 33.4 mt -74.1 125.57 89.99 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-O 122.222 1.011 . . . . 0.0 112.221 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 308' ' ' GLN . 29.4 Cg_endo -74.58 -16.99 21.07 Favored 'Trans proline' 0 CA--C 1.503 -1.042 0 C-N-CA 124.954 3.77 . . . . 0.0 111.193 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.636 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.3 tp 36.82 -64.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 C-N-CA 128.225 2.61 . . . . 0.0 115.881 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.635 ' HG2' HG21 ' A' ' 307' ' ' ILE . 62.1 mm-40 -58.58 -34.03 70.62 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.561 0.696 . . . . 0.0 110.344 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.492 ' HB3' HG12 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.04 -47.99 83.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.927 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 307' ' ' ILE . 67.6 mt -61.75 -49.22 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 124.253 1.021 . . . . 0.0 112.624 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.636 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 0.9 OUTLIER -58.26 -31.4 67.39 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 122.697 0.399 . . . . 0.0 111.369 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 27.5 t -69.88 -33.34 72.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.533 0.682 . . . . 0.0 109.664 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.82 -41.02 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.659 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.704 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 35.5 p -82.91 -35.89 25.75 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.733 1.254 . . . . 0.0 110.206 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.27 32.06 12.85 Favored Glycine 0 C--N 1.302 -1.342 0 CA-C-N 112.305 -2.225 . . . . 0.0 110.696 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.4 mt-10 51.79 172.86 0.03 OUTLIER Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.488 ' HB3' HD13 ' A' ' 324' ' ' ILE . 71.8 Cg_exo -48.15 149.46 6.05 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.994 2.462 . . . . 0.0 113.687 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.491 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 16.3 Cg_endo -97.62 -106.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.992 3.128 . . . . 0.0 113.183 -171.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.455 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 2.9 mmm180 -88.91 -78.37 0.35 Allowed 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 123.239 0.616 . . . . 0.0 110.506 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.491 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.9 m-20 -108.88 160.69 26.44 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.067 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.3 Cg_exo -60.13 -48.17 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 122.544 2.163 . . . . 0.0 110.107 168.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -46.83 -26.19 0.92 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.851 -1.977 . . . . 0.0 112.743 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.491 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -93.52 -22.0 19.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.683 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -47.71 -42.48 45.4 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.726 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.3 Cg_endo -46.38 -64.8 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.185 2.59 . . . . 0.0 113.009 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.567 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.21 -37.02 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.209 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.704 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 54.5 t90 -58.55 -36.44 73.92 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.139 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.5 HD11 HG12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -69.94 -49.96 46.73 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.22 -23.65 26.2 Favored Glycine 0 C--N 1.311 -0.817 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.156 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.577 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.7 mtt180 -73.6 -41.73 62.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.128 0.966 . . . . 0.0 110.598 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.569 ' HB3' HG21 ' A' ' 314' ' ' THR . 55.9 m-20 -97.57 -22.7 16.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.023 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.558 ' HA ' HD13 ' A' ' 335' ' ' ILE . . . -43.3 -48.65 16.83 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.2 Cg_endo -61.02 -33.67 91.67 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 122.584 2.19 . . . . 0.0 111.606 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.487 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -73.26 -42.73 62.17 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.559 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 332' ' ' ALA . 98.6 mt -57.79 -49.3 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.055 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 27.3 t70 -53.43 -17.57 2.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.501 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.24 5.75 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.024 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' ' 309' ' ' HIS . 85.3 t -58.24 -71.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-O 123.354 1.55 . . . . 0.0 110.205 170.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.786 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -87.63 124.43 67.62 Favored Pre-proline 0 N--CA 1.406 -2.675 0 CA-C-N 111.288 -2.687 . . . . 0.0 111.863 -175.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.688 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.5 Cg_endo -72.57 -19.24 24.88 Favored 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 123.809 3.006 . . . . 0.0 110.41 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.405 HG21 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 33.35 70.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.233 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.544 ' N ' HD11 ' A' ' 346' ' ' LEU . 63.4 p -80.83 3.78 21.39 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.749 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.794 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 28.2 p -141.78 154.54 65.9 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -60.15 -36.79 87.47 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 124.323 3.349 . . . . 0.0 109.563 171.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.641 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.7 -53.41 39.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.602 172.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.794 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.8 mt -56.73 -54.76 42.49 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.027 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.611 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 33.3 ttm105 -50.26 -41.17 49.99 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 125.511 1.757 . . . . 0.0 110.61 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.521 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 52.1 t -67.76 -48.94 64.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.666 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.641 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.6 mtt180 -61.11 -38.3 85.85 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.598 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.873 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.1 mt -57.14 -54.63 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.254 -0.579 . . . . 0.0 111.528 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.633 ' O ' HD21 ' A' ' 355' ' ' LEU . 14.9 mt -56.98 -54.39 30.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 124.566 1.166 . . . . 0.0 110.812 -171.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.585 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 37.0 m-20 -64.66 -34.57 78.6 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.288 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.457 ' HB1' HD12 ' A' ' 307' ' ' ILE . . . -70.99 -31.12 67.56 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.94 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.873 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.5 mm -56.7 -58.35 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-O 122.821 1.296 . . . . 0.0 110.539 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.683 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.35 -26.71 55.98 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.007 -2.36 . . . . 0.0 109.871 -168.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.28 -68.84 0.68 Allowed Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.611 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -114.92 35.62 4.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.932 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.669 HD21 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -66.95 127.61 33.22 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.047 0.451 . . . . 0.0 110.794 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.552 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -49.0 -70.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.985 -169.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.67 5.17 7.05 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.443 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.669 ' HB2' HD21 ' A' ' 358' ' ' ASN . 4.4 mt -72.68 -3.59 25.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.557 0.694 . . . . 0.0 110.199 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.585 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 11.3 t -62.29 83.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.843 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.56 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.7 mm? -62.7 -174.24 0.06 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.905 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 63.8 p -125.11 157.41 67.21 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 23.4 Cg_exo -49.14 -31.63 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.839 1.693 . . . . 0.0 111.072 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -87.4 -3.78 81.27 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.961 -172.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.443 ' HB2' HD13 ' A' ' 363' ' ' LEU . 37.4 m-20 -104.88 -21.0 13.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.223 1.011 . . . . 0.0 109.274 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.611 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 65.1 m -86.14 23.69 1.48 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.402 -171.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.86 -36.29 72.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.045 0.926 . . . . 0.0 109.835 -174.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.88 162.43 26.72 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.392 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.539 ' O ' HG12 ' A' ' 375' ' ' VAL . 41.8 m95 -70.62 -36.65 73.59 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.595 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.15 -39.93 83.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.911 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 75.3 p -73.41 -43.69 59.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.641 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.29 -52.38 63.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.549 HG22 ' HE1' ' A' ' 413' ' ' MET . 14.0 m -57.28 -44.08 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.611 0.719 . . . . 0.0 109.548 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.663 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -61.08 -44.14 97.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.041 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.504 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 29.3 m -69.34 -38.19 78.04 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.168 -172.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 3.0 mt -61.05 -33.71 73.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 110.473 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.726 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.5 t80 -75.76 -45.01 38.7 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.308 1.052 . . . . 0.0 109.233 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.1 mp -52.12 -33.25 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.147 170.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.552 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.9 OUTLIER -60.78 -47.1 87.85 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.734 0.778 . . . . 0.0 110.899 176.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 378' ' ' LEU . 37.8 p -93.93 -23.36 18.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.998 -166.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . 0.406 ' HB3' HE22 ' A' ' 390' ' ' GLN . 52.7 m80 -111.22 23.08 14.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.22 20.84 30.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.639 0.616 . . . . 0.0 114.639 173.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.407 HG23 HG13 ' A' ' 380' ' ' ILE . 2.9 m 64.13 157.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -175.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.81 157.52 57.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 389' ' ' HIS . 87.2 Cg_endo -96.5 52.54 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.481 2.787 . . . . 0.0 111.783 168.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.583 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.02 -8.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -177.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 387' ' ' PRO . 7.7 t60 -69.56 -42.81 74.03 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.042 -0.411 . . . . 0.0 110.943 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.687 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.2 mt-30 -68.32 -27.11 66.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.676 ' O ' HG23 ' A' ' 394' ' ' VAL . 3.7 mm? -53.5 -30.16 39.9 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.342 0.519 . . . . 0.0 111.015 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 396' ' ' LYS . . . -54.81 -51.88 50.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.676 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.569 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.1 m-20 -69.73 -37.0 76.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.982 0.513 . . . . 0.0 112.085 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.694 ' O ' HG13 ' A' ' 398' ' ' ILE . 1.4 m -58.3 -47.72 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.588 ' O ' HG21 ' A' ' 399' ' ' VAL . 4.3 mm -57.99 -48.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 173.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.569 ' HE3' ' HA ' ' A' ' 393' ' ' ASN . 0.2 OUTLIER -52.43 -46.32 66.34 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.836 -177.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.91 50.19 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.018 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.731 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -70.59 -41.49 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 117.143 0.472 . . . . 0.0 111.7 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 404' ' ' VAL . 6.5 m -56.45 -41.91 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.809 0.814 . . . . 0.0 110.181 -177.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.495 ' N ' HG23 ' A' ' 399' ' ' VAL . 0.8 OUTLIER -67.49 -34.61 77.48 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.07 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -85.47 -54.67 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -107.8 -30.77 8.34 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.692 0.758 . . . . 0.0 112.329 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.38 170.71 14.01 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.532 -175.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.603 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.82 -45.11 95.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -172.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.581 ' HB3' HG23 ' A' ' 457' ' ' ILE . . . -57.32 -50.57 72.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.604 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.1 m -63.06 -51.15 67.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.731 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.7 -43.93 69.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.484 ' HB3' HD13 ' A' ' 457' ' ' ILE . 34.0 t80 -54.7 -45.23 73.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.735 0.779 . . . . 0.0 109.157 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.825 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.2 m -59.33 -52.65 64.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.502 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.42 -49.35 77.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.081 176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.511 ' HA2' HD13 ' A' ' 414' ' ' LEU . . . -56.12 -42.83 88.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.906 -173.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.62 ' HE1' ' NE2' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -31.6 65.56 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.541 0.17 . . . . 0.0 111.121 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.825 ' HG3' ' O ' ' A' ' 409' ' ' THR . 57.7 mtm -70.97 -45.58 63.86 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.381 0.61 . . . . 0.0 109.655 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.663 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 19.3 mt -60.28 -39.44 86.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.481 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.553 ' HB2' HD21 ' A' ' 421' ' ' LEU . 6.6 p -76.44 -2.57 32.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.766 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 79.78 31.04 41.36 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.62 ' NE2' ' HE1' ' A' ' 412' ' ' MET . 4.0 mm-40 68.12 52.63 0.66 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.134 -1.033 . . . . 0.0 111.668 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.64 ' O ' HD22 ' A' ' 421' ' ' LEU . 22.9 t30 -117.41 74.9 0.95 Allowed 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 160.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.505 ' O ' HG22 ' A' ' 422' ' ' VAL . 0.3 OUTLIER -53.98 -35.95 62.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.143 -173.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' A' ' 423' ' ' SER . 25.2 mt-30 -57.61 -49.77 75.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -168.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.749 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 0.2 OUTLIER -59.59 -50.43 73.91 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.34 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.749 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.28 -38.2 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.738 1.256 . . . . 0.0 109.269 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 427' ' ' ARG . 24.5 t -59.59 -50.46 73.81 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 112.271 -2.24 . . . . 0.0 111.473 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.99 71.39 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.302 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.51 HD13 ' HA ' ' A' ' 422' ' ' VAL . 6.1 mt -73.15 -40.91 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.72 0.772 . . . . 0.0 110.484 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 395' ' ' ILE . 1.5 mm -63.42 -42.75 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.228 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.57 ' HA ' ' CD2' ' A' ' 430' ' ' LEU . 0.1 OUTLIER -59.77 -31.17 69.41 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.714 -176.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.432 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.46 -20.12 79.25 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.108 174.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.498 ' CG ' HG22 ' A' ' 399' ' ' VAL . 10.0 m-85 -98.45 1.96 47.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -176.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.57 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.44 145.64 67.27 Favored Pre-proline 0 N--CA 1.417 -2.09 0 CA-C-O 123.647 1.689 . . . . 0.0 113.83 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.698 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 60.1 Cg_endo -71.53 -64.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 1 C-N-CA 126.099 4.533 . . . . 0.0 113.063 -172.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.57 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.49 140.2 15.28 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.133 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.584 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.16 -27.17 68.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.948 0.374 . . . . 0.0 111.8 -176.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -59.92 -47.24 86.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.685 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.9 t -60.42 -51.7 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.232 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.88 ' O ' ' HG2' ' A' ' 440' ' ' GLN . 0.7 OUTLIER -51.76 -59.52 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 66.5 m -61.21 -55.52 31.14 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.252 -173.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.66 -44.36 81.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.894 -176.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.777 ' O ' HD23 ' A' ' 443' ' ' LEU . 17.3 mt -59.7 -55.0 39.8 Favored 'General case' 0 CA--C 1.469 -2.155 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.248 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.88 ' HG2' ' O ' ' A' ' 436' ' ' VAL . 5.4 mm100 -53.57 -34.34 57.97 Favored 'General case' 0 N--CA 1.409 -2.52 0 O-C-N 125.627 1.829 . . . . 0.0 109.787 -177.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -71.33 -60.04 2.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 176.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -47.77 27.65 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 121.585 -0.697 . . . . 0.0 111.742 -173.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.25 -25.7 64.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.708 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.738 ' N ' HD22 ' A' ' 443' ' ' LEU . 9.2 t70 -73.74 -41.42 62.54 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.418 1.104 . . . . 0.0 110.738 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -69.57 -6.6 32.11 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -173.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.6 ' HB3' HG21 ' A' ' 451' ' ' THR . 38.2 mm-40 -49.63 161.46 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.707 1.718 . . . . 0.0 114.435 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.521 ' HB ' HG22 ' A' ' 451' ' ' THR . 1.8 mp -57.18 -31.73 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 110.525 -3.034 . . . . 0.0 114.938 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.554 ' H ' ' HB ' ' A' ' 451' ' ' THR . 9.1 m-20 -143.85 -179.22 6.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.654 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 8.5 p-10 -64.42 -53.54 46.84 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 175.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.6 HG21 ' HB3' ' A' ' 446' ' ' GLU . 24.3 m -58.53 -39.21 79.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.553 171.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.666 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 30.7 mtm-85 -63.52 -29.57 70.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.425 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.93 -31.97 63.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.853 0.835 . . . . 0.0 109.643 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.46 -43.86 13.23 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.436 -1.257 . . . . 0.0 112.435 -170.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.531 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 35.6 p -102.34 -1.41 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.011 -168.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.644 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.4 t80 -49.05 -53.28 20.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.581 HG23 ' HB3' ' A' ' 405' ' ' ALA . 24.9 mm -71.2 -25.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.14 -43.31 64.86 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.569 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.3 m-70 -66.7 -31.15 71.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.615 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.695 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.5 -53.92 35.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.181 0.991 . . . . 0.0 109.293 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.658 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.14 -32.06 72.61 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.136 173.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.608 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.93 -53.24 57.16 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.685 ' CG1' ' HA ' ' A' ' 435' ' ' VAL . 26.0 t -63.23 -33.84 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.345 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.8 m-30 -61.28 -15.3 33.81 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.136 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 16.9 mm-40 -91.14 -49.18 6.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.141 -0.974 . . . . 0.0 112.753 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.683 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -65.8 -39.3 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.027 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.442 ' CB ' HD23 ' A' ' 469' ' ' LEU . 6.3 mt -84.61 -17.52 38.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.721 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 62.3 55.39 27.96 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.627 -2.533 . . . . 0.0 112.986 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.5 OUTLIER -104.2 -174.12 2.47 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 123.863 0.865 . . . . 0.0 109.642 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.673 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.6 p30 -106.03 -41.17 5.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 166.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -158.7 -78.25 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.009 160.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.698 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -62.61 70.45 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -169.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.407 ' HA2' HD11 ' A' ' 469' ' ' LEU . . . 38.09 40.82 0.9 Allowed Glycine 0 C--N 1.279 -2.631 0 CA-C-N 110.948 -2.842 . . . . 0.0 113.487 171.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.673 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 18.2 mm-40 -78.12 -52.37 8.83 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 122.631 1.205 . . . . 0.0 111.287 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.4 t 63.47 56.4 1.64 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.716 -2.493 . . . . 0.0 108.065 -171.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.721 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 CA-C-N 110.508 -3.042 . . . . 0.0 111.631 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.41 ' H ' HG11 ' A' ' 304' ' ' VAL . 1.6 p . . . . . 0 N--CA 1.424 -1.768 0 CA-C-O 121.309 0.576 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.76 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.8 mt -70.11 123.95 89.79 Favored Pre-proline 0 N--CA 1.425 -1.709 0 CA-C-O 121.862 0.839 . . . . 0.0 111.806 -175.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 308' ' ' GLN . 20.6 Cg_endo -71.77 -12.23 28.56 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 124.764 3.643 . . . . 0.0 111.23 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.68 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.2 tp 31.32 -64.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.217 0 C-N-CA 128.5 2.72 . . . . 0.0 116.046 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.613 ' HG2' HG23 ' A' ' 307' ' ' ILE . 38.9 mm-40 -57.79 -33.74 68.87 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.616 0.722 . . . . 0.0 110.163 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.501 ' HB3' HG13 ' A' ' 338' ' ' VAL . 6.8 t-160 -61.4 -48.82 79.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.682 173.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 307' ' ' ILE . 70.1 mt -61.32 -48.89 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 124.135 0.974 . . . . 0.0 112.799 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.68 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 2.0 mtp-105 -58.92 -30.87 68.16 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.242 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 36.9 t -69.82 -34.57 73.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.596 0.712 . . . . 0.0 109.641 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.1 -40.57 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.707 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.671 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.41 -36.28 26.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 122.912 1.339 . . . . 0.0 109.636 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.65 32.79 8.95 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.119 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.1 mt-10 53.42 167.47 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.142 0 C-N-CA 124.433 1.093 . . . . 0.0 113.869 -175.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.469 ' HB3' HD13 ' A' ' 324' ' ' ILE . 38.0 Cg_exo -44.03 146.61 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.766 2.977 . . . . 0.0 113.435 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.475 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 28.8 Cg_endo -93.44 -103.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.285 2.657 . . . . 0.0 112.068 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.416 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 12.9 mmm180 -91.77 -91.51 0.16 Allowed 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.117 0.484 . . . . 0.0 110.604 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.483 ' HB3' ' HG2' ' A' ' 322' ' ' ARG . 48.6 m-20 -95.05 164.81 18.36 Favored Pre-proline 0 N--CA 1.439 -0.978 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.14 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.0 -47.26 18.56 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 122.605 2.203 . . . . 0.0 110.249 167.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.483 ' HG2' ' HB3' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -55.67 -17.99 6.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.248 176.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 3.2 mt-10 -93.46 -23.42 18.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.963 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.694 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -52.15 -40.95 77.77 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.725 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.0 Cg_endo -48.97 -64.58 0.21 Allowed 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.96 2.44 . . . . 0.0 112.898 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.581 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -57.91 -39.0 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.878 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.671 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 61.8 t90 -56.43 -39.78 73.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.988 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.467 HD13 HG12 ' A' ' 351' ' ' ILE . 0.6 OUTLIER -67.35 -49.48 63.84 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.43 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -53.66 -23.71 22.17 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.888 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 3.4 mtm180 -73.2 -41.13 64.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.264 0.554 . . . . 0.0 111.137 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.527 ' HB2' HG23 ' A' ' 314' ' ' THR . 1.3 p30 -106.08 -15.78 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.558 ' HA ' HD13 ' A' ' 335' ' ' ILE . . . -40.35 -48.08 6.39 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.1 Cg_endo -61.75 -32.36 86.21 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.731 2.287 . . . . 0.0 111.989 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.496 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -74.58 -42.56 58.52 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.513 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.573 HG12 HG23 ' A' ' 310' ' ' ILE . 95.4 mt -56.73 -48.41 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.946 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -50.87 -21.81 1.89 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.73 -1.577 . . . . 0.0 112.764 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.7 -48.44 7.91 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.445 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 309' ' ' HIS . 88.6 t -60.05 -72.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 123.389 1.566 . . . . 0.0 110.087 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.76 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -88.05 122.67 69.84 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.251 -2.704 . . . . 0.0 111.758 -174.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.642 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 70.8 Cg_endo -73.41 -17.76 23.61 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 C-N-CA 123.742 2.961 . . . . 0.0 109.961 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.524 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.44 71.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.422 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.55 ' N ' HD11 ' A' ' 346' ' ' LEU . 45.1 p -85.52 11.34 10.77 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.042 -1.89 . . . . 0.0 113.049 -169.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.788 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.1 p -147.03 157.07 46.94 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 121.437 0.637 . . . . 0.0 109.968 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.466 ' HB3' HD12 ' A' ' 369' ' ' LEU . 73.3 Cg_exo -60.81 -36.85 82.17 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.643 3.562 . . . . 0.0 110.04 173.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.7 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.3 OUTLIER -51.84 -56.96 10.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.621 173.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.788 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.2 mt -56.72 -48.92 76.65 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.757 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 343' ' ' THR . 24.9 mmt180 -45.46 -52.14 10.62 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 125.295 1.622 . . . . 0.0 109.887 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.525 ' HA ' HD13 ' A' ' 351' ' ' ILE . 44.6 t -68.41 -50.87 49.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.825 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.639 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.9 mtp180 -61.06 -33.73 73.79 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.882 ' O ' HG12 ' A' ' 354' ' ' ILE . 18.5 mt -58.02 -53.22 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.205 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.586 ' O ' HD22 ' A' ' 355' ' ' LEU . 14.1 mt -59.35 -54.05 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.611 0.719 . . . . 0.0 111.254 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -38.06 85.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.039 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.473 ' HB2' HD11 ' A' ' 307' ' ' ILE . . . -70.94 -30.06 66.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.882 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.6 mm -56.62 -57.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 CA-C-O 122.922 1.344 . . . . 0.0 110.418 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.694 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -79.96 -27.47 39.73 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.195 -2.275 . . . . 0.0 109.897 -167.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.75 -76.93 0.21 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.936 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -101.52 38.55 3.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.866 -174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.671 HD21 ' HB2' ' A' ' 361' ' ' LEU . 18.3 p-10 -77.92 125.52 29.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.025 0.44 . . . . 0.0 110.424 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.561 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -48.56 -72.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.907 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -123.41 -1.7 9.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.304 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.671 ' HB2' HD21 ' A' ' 358' ' ' ASN . 2.5 mt -68.82 -6.0 24.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 122.193 0.997 . . . . 0.0 109.784 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 2.3 t -70.62 75.6 0.58 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.363 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.572 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.8 mm? -54.19 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.54 ' C ' ' H ' ' A' ' 366' ' ' GLY . 64.3 p -115.6 156.01 46.65 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.7 ' CB ' ' HA ' ' A' ' 345' ' ' ASP . 56.3 Cg_endo -71.91 22.19 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.11 1.874 . . . . 0.0 111.83 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -136.12 -2.55 2.68 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.726 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -104.54 -21.4 13.44 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.285 1.041 . . . . 0.0 109.308 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 63.1 m -85.29 21.84 1.63 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.58 -171.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.576 ' N ' HD11 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -55.94 -34.78 65.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.367 1.08 . . . . 0.0 110.112 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.04 159.96 31.37 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.697 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.531 ' O ' HG11 ' A' ' 375' ' ' VAL . 56.6 m95 -69.94 -35.77 74.78 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.64 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -57.35 -46.22 83.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.985 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 72.2 m -68.14 -42.14 80.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.072 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.605 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.14 -52.29 59.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.531 HG11 ' O ' ' A' ' 371' ' ' TRP . 13.6 m -57.23 -44.12 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.0 109.463 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.685 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.139 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.476 HG23 HD12 ' A' ' 363' ' ' LEU . 24.4 m -71.95 -37.56 69.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.371 -172.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -62.02 -34.21 75.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.674 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.725 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.9 t80 -73.46 -47.46 41.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.65 1.214 . . . . 0.0 109.125 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.09 -32.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 112.415 -2.175 . . . . 0.0 111.829 170.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.5 mpt_? -60.4 -40.76 92.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.482 0.658 . . . . 0.0 111.351 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 378' ' ' LEU . 31.6 p -100.25 -23.55 14.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.384 -166.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -110.39 23.03 14.79 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.89 20.99 21.77 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 123.308 0.38 . . . . 0.0 113.805 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.9 m 66.79 156.32 0.1 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 111.414 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.432 ' HZ ' ' HB3' ' A' ' 414' ' ' LEU . 0.1 OUTLIER -117.87 153.56 50.98 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.301 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -95.97 49.85 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.309 2.672 . . . . 0.0 111.348 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.61 ' HA ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.96 4.61 0.63 Allowed 'General case' 0 C--N 1.339 0.112 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -70.12 -47.1 63.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.241 0.544 . . . . 0.0 110.289 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.565 ' O ' HG21 ' A' ' 394' ' ' VAL . 97.3 mt-30 -73.84 -27.13 60.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.715 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -54.66 -31.84 58.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.128 0.877 . . . . 0.0 111.21 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.699 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.9 -55.06 30.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.087 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.45 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 7.6 m-20 -62.78 -36.52 83.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.559 0.695 . . . . 0.0 111.238 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 390' ' ' GLN . 52.6 t -54.95 -53.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.068 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.699 ' O ' HG21 ' A' ' 399' ' ' VAL . 4.6 mm -58.59 -45.93 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.177 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.699 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 40.2 mmtt -53.36 -41.07 65.44 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 124.0 0.813 . . . . 0.0 112.154 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.574 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -78.91 -44.54 9.96 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.394 -173.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.724 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.0 OUTLIER -69.51 -40.84 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 117.451 0.626 . . . . 0.0 111.4 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.699 HG21 ' O ' ' A' ' 395' ' ' ILE . 7.8 m -57.9 -41.43 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.908 0.861 . . . . 0.0 110.154 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.0 t70 -58.15 -41.88 84.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.88 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 75.3 mt-30 -81.62 -55.38 4.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.884 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -111.84 -30.3 7.35 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.001 0.905 . . . . 0.0 112.123 -170.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 119.24 177.32 16.44 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.601 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.606 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.68 -44.45 96.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.227 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.603 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -57.44 -50.74 72.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.573 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -66.0 -50.15 65.27 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 122.177 -0.327 . . . . 0.0 110.665 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.724 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -54.09 -41.9 68.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.546 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.2 t80 -56.24 -45.57 79.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.712 0.768 . . . . 0.0 109.212 175.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.83 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.7 m -59.29 -52.52 65.28 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.505 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.629 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.73 -49.54 77.08 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.051 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.49 -42.25 89.63 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.012 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.654 ' HE2' ' NE2' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.16 -31.98 66.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 122.702 -0.293 . . . . 0.0 111.227 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.83 ' HG3' ' O ' ' A' ' 409' ' ' THR . 61.1 mtm -70.31 -47.36 61.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.224 0.535 . . . . 0.0 109.912 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.685 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 16.6 mt -60.19 -39.92 88.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.665 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.755 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.6 OUTLIER -75.1 -14.3 60.56 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.427 -177.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 94.28 38.62 5.02 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.721 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.654 ' NE2' ' HE2' ' A' ' 412' ' ' MET . 4.9 mm-40 52.73 54.19 10.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.206 -0.997 . . . . 0.0 112.906 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.755 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -125.45 62.31 1.2 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 164.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.468 ' CE1' ' HB2' ' A' ' 452' ' ' ARG . 1.7 p90 -43.77 -33.92 1.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 111.408 -2.633 . . . . 0.0 112.976 -164.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.521 ' O ' ' HB3' ' A' ' 423' ' ' SER . 31.6 mt-30 -55.02 -44.55 74.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -165.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.547 ' CD2' ' ND2' ' A' ' 418' ' ' ASN . 2.3 pp -62.61 -47.85 82.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.047 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.553 HG21 ' N ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -61.36 -39.63 83.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 122.614 1.197 . . . . 0.0 108.947 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.553 ' N ' HG21 ' A' ' 422' ' ' VAL . 40.6 t -58.8 -46.09 88.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 112.434 -2.166 . . . . 0.0 111.478 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.97 -39.79 80.01 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.959 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.521 HD11 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.08 -40.49 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.506 0.669 . . . . 0.0 110.17 175.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.463 HD11 HG23 ' A' ' 395' ' ' ILE . 1.7 mm -58.66 -44.56 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 CA-C-N 114.274 -1.33 . . . . 0.0 113.131 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.614 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.3 OUTLIER -60.6 -29.23 69.09 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-O 122.784 1.278 . . . . 0.0 108.731 -174.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -15.75 76.9 Favored Glycine 0 C--N 1.3 -1.453 0 CA-C-N 112.394 -2.184 . . . . 0.0 112.674 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.651 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.7 m-85 -100.98 0.89 39.05 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.564 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.99 144.14 76.12 Favored Pre-proline 0 N--CA 1.41 -2.428 0 CA-C-O 123.723 1.725 . . . . 0.0 113.317 170.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.681 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 79.1 Cg_endo -72.23 -51.75 0.2 Allowed 'Trans proline' 0 C--N 1.311 -1.417 1 C-N-CA 126.065 4.51 . . . . 0.0 113.33 -173.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.533 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -122.88 142.34 14.54 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.417 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.621 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.24 -29.22 70.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.106 0.453 . . . . 0.0 111.627 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.83 78.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.674 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.9 t -59.02 -51.68 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.596 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.84 -54.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.259 179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 28.3 m -62.54 -55.88 23.19 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.809 -175.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.46 -44.74 80.81 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.615 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.842 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 40.6 mt -60.93 -55.01 38.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.835 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.673 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -49.93 -32.7 15.45 Favored 'General case' 0 N--CA 1.419 -1.999 0 O-C-N 124.429 1.081 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.39 -60.3 2.3 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 174.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -77.25 -52.22 9.59 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -170.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.842 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 1.5 pp -57.28 -24.25 53.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.331 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 28.5 t70 -71.53 -42.04 68.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.546 1.165 . . . . 0.0 110.019 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.0 mt-30 -71.39 -8.11 51.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.032 -1.895 . . . . 0.0 115.933 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 451' ' ' THR . 38.1 mm-40 -54.64 157.85 2.81 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 123.619 1.676 . . . . 0.0 115.022 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.434 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.7 mp -53.48 -33.14 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 110.445 -3.07 . . . . 0.0 115.101 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.642 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 29.9 m-20 -138.88 179.65 6.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.27 -52.1 50.89 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.95 -24.22 65.15 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 175.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.608 HG22 ' HB3' ' A' ' 446' ' ' GLU . 24.4 m -59.36 -40.75 87.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 171.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 39.0 mtt180 -60.75 -30.81 70.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.408 171.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.546 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -74.31 -32.81 63.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.712 0.768 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.8 -44.6 15.33 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.111 -171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.485 ' HG1' ' HG3' ' A' ' 446' ' ' GLU . 42.1 p -99.13 -4.96 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.893 -168.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.657 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.3 t80 -49.04 -51.0 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.664 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 24.5 mm -72.04 -27.57 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.519 ' O ' ' HB1' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -71.52 -42.92 67.36 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.597 ' O ' HG22 ' A' ' 463' ' ' VAL . 53.6 m-70 -66.99 -31.04 71.34 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.81 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.701 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.35 -53.89 36.96 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.116 0.96 . . . . 0.0 109.243 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.651 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.55 -31.91 72.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 113.329 -1.76 . . . . 0.0 110.137 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.73 -52.66 62.37 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.178 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.684 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 23.5 t -63.45 -33.73 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.186 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.2 m-30 -61.8 -15.04 38.36 Favored 'General case' 0 C--O 1.202 -1.447 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.984 169.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 50.0 mm-40 -90.37 -50.01 6.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.575 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.684 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -66.63 -38.89 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.121 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.48 ' HB2' ' HG ' ' A' ' 469' ' ' LEU . 6.5 mt -84.81 -15.64 44.14 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.741 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.59 49.02 66.89 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-N 111.822 -2.445 . . . . 0.0 113.213 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.9 OUTLIER -101.1 -179.1 3.94 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.094 0.958 . . . . 0.0 110.113 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.691 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.4 p30 -104.41 -40.65 6.0 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 167.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -158.42 -79.34 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.278 -2.237 . . . . 0.0 110.955 157.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.681 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -61.37 72.66 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -170.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 38.04 42.83 1.24 Allowed Glycine 0 C--N 1.275 -2.827 0 CA-C-N 110.602 -2.999 . . . . 0.0 113.431 171.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.691 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 15.2 mm-40 -79.04 -54.39 6.06 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 122.288 1.042 . . . . 0.0 111.469 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.6 t 65.75 46.18 2.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.066 -2.333 . . . . 0.0 108.763 -174.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.292 -1.898 0 CA-C-N 109.505 -3.498 . . . . 0.0 112.346 171.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 121.158 0.504 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.692 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -75.53 128.15 84.59 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 121.795 0.807 . . . . 0.0 112.187 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 308' ' ' GLN . 13.0 Cg_endo -70.38 -22.35 29.38 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 C-N-CA 124.54 3.493 . . . . 0.0 110.748 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.728 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.7 tp 38.0 -59.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 C-N-CA 128.244 2.618 . . . . 0.0 116.135 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.548 ' HG2' HG23 ' A' ' 307' ' ' ILE . 9.8 mm-40 -57.36 -39.5 76.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.833 0.825 . . . . 0.0 110.132 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.529 ' HB3' HG11 ' A' ' 338' ' ' VAL . 6.6 t-160 -58.87 -48.19 82.26 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.609 173.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.595 HG22 ' CG2' ' A' ' 350' ' ' ILE . 60.9 mt -58.92 -49.07 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.728 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 7.7 mtp180 -61.05 -30.16 70.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.889 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 47.9 t -70.06 -35.17 74.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.416 0.627 . . . . 0.0 109.59 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.566 HG11 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.71 -41.03 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.722 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.756 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.7 p -82.94 -36.69 25.0 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 122.914 1.34 . . . . 0.0 109.564 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.25 35.47 9.6 Favored Glycine 0 C--N 1.303 -1.252 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.596 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.472 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 51.29 173.24 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.298 0 C-N-CA 124.258 1.023 . . . . 0.0 113.153 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.561 ' HB3' HD12 ' A' ' 324' ' ' ILE . 37.3 Cg_exo -46.77 150.96 2.28 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.986 2.457 . . . . 0.0 113.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.45 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.2 Cg_endo -92.07 -104.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.656 2.904 . . . . 0.0 112.751 -172.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.409 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 12.1 mmm180 -92.29 -79.55 0.38 Allowed 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.538 0.685 . . . . 0.0 110.553 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.416 ' HB2' ' HG2' ' A' ' 323' ' ' GLU . 49.2 m-20 -103.9 161.45 22.91 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.955 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.484 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 45.2 Cg_exo -58.03 -50.37 10.29 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 122.656 2.237 . . . . 0.0 110.413 168.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.78 -27.32 4.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.662 175.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.416 ' HG2' ' HB2' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -80.52 -29.13 37.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.631 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -48.41 -45.53 67.76 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.715 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.0 Cg_endo -50.75 -61.29 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.742 2.295 . . . . 0.0 112.962 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.573 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -61.94 -36.26 72.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.01 179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.756 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.4 t90 -58.41 -36.65 73.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.257 -1.792 . . . . 0.0 111.305 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.02 -48.42 58.13 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.431 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.71 -23.2 20.49 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.774 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 330' ' ' ARG . 0.2 OUTLIER -74.97 -43.04 56.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.102 0.953 . . . . 0.0 110.552 174.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.56 ' HB3' HG22 ' A' ' 314' ' ' THR . 46.7 m-20 -95.07 -24.53 16.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.68 -1.6 . . . . 0.0 113.827 -169.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.553 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.23 -49.68 11.73 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 124.319 1.048 . . . . 0.0 113.777 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.4 Cg_endo -61.84 -32.57 85.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.522 2.148 . . . . 0.0 111.617 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.474 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -72.73 -43.64 62.69 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.673 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.573 HG12 HG23 ' A' ' 310' ' ' ILE . 89.3 mt -59.32 -48.78 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.67 173.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.71 -15.98 9.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.213 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -50.36 5.99 Favored Glycine 0 CA--C 1.509 -0.328 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 309' ' ' HIS . 70.5 t -54.62 -70.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 123.565 1.65 . . . . 0.0 110.094 169.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.801 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.7 OUTLIER -93.72 132.03 30.81 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.052 -2.795 . . . . 0.0 112.464 -171.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.801 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.1 Cg_endo -72.66 -19.48 24.29 Favored 'Trans proline' 0 CA--C 1.497 -1.357 0 C-N-CA 123.65 2.9 . . . . 0.0 111.084 173.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.6 p 32.45 69.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.472 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.568 ' N ' HD11 ' A' ' 346' ' ' LEU . 75.7 p -79.53 4.14 16.66 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.096 -1.866 . . . . 0.0 113.108 -170.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.767 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.7 p -142.7 156.15 63.04 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.636 0.732 . . . . 0.0 109.624 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 75.5 Cg_exo -60.5 -38.18 75.32 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 124.357 3.371 . . . . 0.0 109.601 172.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.637 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -51.9 -52.76 47.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.546 174.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.767 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.8 mt -56.96 -52.74 64.04 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.818 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.651 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 32.1 ttm105 -51.96 -43.89 63.74 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.255 -1.793 . . . . 0.0 110.442 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 368' ' ' CYS . 38.2 t -69.09 -48.73 61.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.341 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 72.7 mtt180 -57.74 -38.1 74.76 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.548 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.676 HG13 ' O ' ' A' ' 346' ' ' LEU . 52.5 mt -62.14 -54.51 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.941 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.489 ' HA ' HG13 ' A' ' 354' ' ' ILE . 18.2 mt -58.19 -53.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 122.197 0.998 . . . . 0.0 111.02 -168.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.48 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 44.4 m-20 -63.49 -34.55 78.02 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.17 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.462 ' HB1' HD12 ' A' ' 307' ' ' ILE . . . -69.28 -36.12 76.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.34 -53.9 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 122.873 1.32 . . . . 0.0 110.721 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.579 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -72.89 -25.65 61.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 111.805 -2.452 . . . . 0.0 109.104 -169.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.06 -78.19 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.975 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.33 52.57 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.705 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.611 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 29.5 p30 -74.51 160.32 31.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 122.35 0.26 . . . . 0.0 110.664 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.482 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.1 mp -56.98 -67.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 120.959 0.409 . . . . 0.0 111.337 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -144.98 12.88 1.9 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.896 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.611 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 7.0 mt -64.38 -2.37 2.2 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.48 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 38.7 t -62.3 84.28 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.224 0.535 . . . . 0.0 110.288 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.579 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 2.3 mm? -61.74 -172.75 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 70.5 p -126.73 155.94 74.35 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.574 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 21.5 Cg_exo -48.16 -38.42 32.78 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.531 1.488 . . . . 0.0 110.103 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 369' ' ' LEU . . . -81.7 1.51 85.85 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.107 -0.952 . . . . 0.0 114.661 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.473 ' HB2' HD11 ' A' ' 363' ' ' LEU . 26.2 m-20 -109.01 -21.76 12.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.236 1.017 . . . . 0.0 109.539 171.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.651 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 83.9 m -91.07 21.12 4.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.612 -171.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -62.45 -36.81 83.6 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.769 1.271 . . . . 0.0 108.579 -174.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.2 p -117.4 163.9 15.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.247 -2.251 . . . . 0.0 109.634 170.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.55 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.2 m95 -70.63 -34.24 71.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.598 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.42 -42.48 96.02 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.724 -170.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.6 m -71.33 -42.5 68.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.703 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.677 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.03 -52.17 66.13 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 371' ' ' TRP . 12.7 m -58.56 -44.36 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 109.512 -178.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.693 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.515 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 54.3 m -70.15 -41.04 74.36 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.825 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 1.8 mt -58.69 -34.45 71.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.562 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.715 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 45.6 t80 -73.52 -46.96 44.61 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.267 1.032 . . . . 0.0 109.766 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.515 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.19 -32.9 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.537 170.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -59.76 -43.1 94.46 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.412 0.625 . . . . 0.0 110.999 174.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 41.4 p -95.54 -23.37 17.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.214 -167.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -110.46 22.22 15.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.06 21.16 30.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 114.436 0.534 . . . . 0.0 114.436 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 64.81 158.13 0.09 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.441 0.639 . . . . 0.0 111.744 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.558 ' CE2' HD22 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.75 156.06 65.63 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -97.83 52.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.322 2.681 . . . . 0.0 111.266 166.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.622 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.8 6.09 0.42 Allowed 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -70.06 -48.29 58.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.215 0.531 . . . . 0.0 110.039 174.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.639 ' O ' HG12 ' A' ' 394' ' ' VAL . 59.0 mt-30 -75.84 -25.21 56.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.911 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -53.64 -31.11 46.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.488 1.04 . . . . 0.0 111.916 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 396' ' ' LYS . . . -55.24 -54.08 36.51 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.637 172.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 396' ' ' LYS . 17.7 m-20 -63.43 -38.71 92.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.336 0.654 . . . . 0.0 112.458 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.688 HG21 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -58.89 -46.17 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 120.795 0.331 . . . . 0.0 110.442 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.605 ' O ' HG21 ' A' ' 399' ' ' VAL . 5.5 mm -57.97 -46.83 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.311 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.531 ' HD2' ' OH ' ' A' ' 429' ' ' TYR . 8.1 mtmt -52.15 -46.28 65.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.768 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.55 -44.71 39.66 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.636 -1.268 . . . . 0.0 112.96 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.638 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.2 mt -69.93 -41.65 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 117.532 0.666 . . . . 0.0 111.684 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.717 HG22 ' CG ' ' A' ' 429' ' ' TYR . 5.7 m -57.42 -44.73 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.801 0.81 . . . . 0.0 110.369 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.478 ' N ' HG23 ' A' ' 399' ' ' VAL . 1.6 t70 -67.4 -32.61 73.62 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.919 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.43 -55.28 3.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.688 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.39 -28.12 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.901 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.12 162.16 11.6 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.608 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.616 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -41.34 92.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.586 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -57.75 -51.86 67.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.846 0.355 . . . . 0.0 111.863 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -64.04 -49.95 70.34 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.28 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.638 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -51.75 -43.03 62.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.585 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 34.5 t80 -56.18 -47.73 77.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.615 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.754 ' O ' ' HG3' ' A' ' 413' ' ' MET . 2.2 m -57.92 -51.77 68.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.608 HD12 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.56 -48.94 78.68 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.821 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.485 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.83 -43.59 87.14 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.397 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.58 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.2 OUTLIER -72.21 -31.67 66.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.887 0.343 . . . . 0.0 110.839 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.754 ' HG3' ' O ' ' A' ' 409' ' ' THR . 69.2 mtm -69.1 -48.57 62.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.291 0.567 . . . . 0.0 110.048 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.693 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 14.1 mt -59.13 -39.27 81.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.22 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.911 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 4.3 m -78.16 -13.6 59.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 95.92 32.25 6.92 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.33 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.58 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 69.92 37.63 1.74 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.357 0.663 . . . . 0.0 111.876 176.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.696 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.1 OUTLIER -120.52 81.24 1.73 Allowed 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 420' ' ' GLN . 8.5 p90 -63.15 -31.74 72.95 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.611 -161.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 423' ' ' SER . 25.8 mt-30 -54.3 -48.38 71.36 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 113.464 -164.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.664 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.4 pp -59.61 -51.36 70.16 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.416 0.626 . . . . 0.0 111.02 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.584 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -59.8 -38.44 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.891 1.329 . . . . 0.0 109.241 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 43.4 t -63.09 -47.12 84.22 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.025 -2.352 . . . . 0.0 111.873 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.66 -36.27 70.88 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.87 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.52 HD13 ' HA ' ' A' ' 422' ' ' VAL . 2.7 mt -72.01 -43.07 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.546 0.689 . . . . 0.0 109.944 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.488 HD11 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -56.09 -45.24 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.605 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.4 OUTLIER -61.45 -29.45 69.97 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 122.608 1.194 . . . . 0.0 108.959 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.06 -16.56 76.76 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.688 -2.051 . . . . 0.0 112.462 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.717 ' CG ' HG22 ' A' ' 399' ' ' VAL . 11.8 m-85 -100.68 2.69 41.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.578 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.74 143.6 75.82 Favored Pre-proline 0 N--CA 1.411 -2.414 0 CA-C-O 123.658 1.694 . . . . 0.0 113.687 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.673 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 72.9 Cg_endo -72.45 -55.09 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.102 1 C-N-CA 126.455 4.77 . . . . 0.0 113.263 -171.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.53 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -114.77 140.57 16.45 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.115 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.612 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.054 0.427 . . . . 0.0 111.522 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.4 -46.66 83.22 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.674 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.8 t -59.17 -51.37 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.553 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.21 -54.4 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.9 m -61.33 -56.64 18.18 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.12 -45.42 79.5 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.533 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.839 ' O ' HD23 ' A' ' 443' ' ' LEU . 43.9 mt -60.11 -53.29 59.5 Favored 'General case' 0 CA--C 1.481 -1.697 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.687 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.715 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 37.8 mm-40 -51.35 -35.15 37.05 Favored 'General case' 0 N--CA 1.415 -2.201 0 O-C-N 125.115 1.509 . . . . 0.0 110.437 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.673 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.64 -60.81 2.05 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 177.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.415 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -76.73 -50.63 13.13 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.84 -0.538 . . . . 0.0 112.3 -172.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.839 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.68 -24.28 61.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.767 0.794 . . . . 0.0 111.518 -178.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.733 ' N ' HD22 ' A' ' 443' ' ' LEU . 16.6 t70 -72.21 -42.87 65.28 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.688 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.673 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.26 -8.15 47.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.613 ' HB3' HG23 ' A' ' 451' ' ' THR . 55.9 mm-40 -51.32 157.8 0.93 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 123.683 1.706 . . . . 0.0 114.333 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.441 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -55.82 -32.81 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 CA-C-N 110.508 -3.042 . . . . 0.0 115.509 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.553 ' H ' ' HB ' ' A' ' 451' ' ' THR . 31.5 m-20 -140.04 179.11 6.8 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.437 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 7.3 m-20 -62.47 -56.77 14.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -65.18 -24.77 67.47 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 446' ' ' GLU . 21.1 m -59.55 -41.98 91.35 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 119.492 1.042 . . . . 0.0 109.928 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 52.7 mtt180 -61.32 -29.84 70.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.585 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.09 -31.84 61.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.141 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.8 mm-40 -79.8 -45.35 18.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.626 -172.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.502 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 43.5 p -101.79 -3.51 27.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.136 -167.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.65 ' CE1' HD22 ' A' ' 460' ' ' LEU . 7.7 t80 -48.75 -52.6 22.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 22.8 mm -71.45 -25.78 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.31 -43.4 64.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.613 ' O ' HG23 ' A' ' 463' ' ' VAL . 76.4 m-70 -66.82 -31.39 71.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.725 171.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.69 HD23 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.43 -53.87 36.78 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.117 0.961 . . . . 0.0 109.372 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.608 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.1 m-80 -62.0 -32.11 72.56 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.205 172.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.9 -52.02 64.71 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.026 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.676 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 23.1 t -63.37 -34.83 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 110.271 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.1 m-30 -61.24 -14.21 24.32 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.128 169.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 462' ' ' ALA . 63.5 mm-40 -91.53 -48.9 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.874 -1.141 . . . . 0.0 112.933 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.676 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -66.24 -39.77 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.881 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.466 HD12 HD13 ' A' ' 469' ' ' LEU . 6.2 mt -84.45 -16.44 42.58 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.789 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.97 51.17 55.61 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 111.674 -2.512 . . . . 0.0 113.348 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.4 OUTLIER -104.1 -179.52 3.97 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.918 0.887 . . . . 0.0 110.699 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.732 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 15.1 p30 -98.47 -41.28 7.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.421 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.83 -74.99 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.252 -2.249 . . . . 0.0 110.839 160.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.673 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -60.26 64.08 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 43.62 36.89 3.56 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.619 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.732 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 10.4 mm-40 -75.61 -53.39 8.67 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.346 1.069 . . . . 0.0 111.496 -170.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 26.9 t 66.18 59.1 0.69 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.267 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.789 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 111.247 -2.706 . . . . 0.0 111.635 175.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.426 -1.674 0 CA-C-O 121.324 0.583 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.696 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 20.2 mt -71.17 126.41 91.95 Favored Pre-proline 0 N--CA 1.426 -1.625 0 CA-C-O 121.997 0.903 . . . . 0.0 112.104 -174.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.464 ' HG2' HG12 ' A' ' 338' ' ' VAL . 24.4 Cg_endo -73.51 -8.96 22.41 Favored 'Trans proline' 0 CA--C 1.501 -1.136 0 C-N-CA 124.952 3.768 . . . . 0.0 111.382 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.689 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.7 tp 24.8 -64.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.315 0 C-N-CA 128.458 2.703 . . . . 0.0 116.195 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.543 ' H ' HG23 ' A' ' 307' ' ' ILE . 0.2 OUTLIER -57.7 -31.06 66.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.13 0.49 . . . . 0.0 111.337 177.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.467 ' HB3' HG13 ' A' ' 338' ' ' VAL . 7.2 t-160 -61.49 -49.05 78.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.498 170.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.652 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 55.1 mt -58.68 -48.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.605 174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.689 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 52.2 mtp180 -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 122.545 0.338 . . . . 0.0 111.52 176.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.9 m -69.84 -33.18 71.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.502 0.668 . . . . 0.0 110.056 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.576 HG11 ' N ' ' A' ' 314' ' ' THR . 0.6 OUTLIER -67.34 -42.32 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.51 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.753 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.3 p -83.21 -36.4 24.68 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.875 1.322 . . . . 0.0 110.44 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.91 33.91 10.53 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 112.248 -2.251 . . . . 0.0 110.834 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 49.44 176.22 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 124.424 1.09 . . . . 0.0 113.629 -174.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 316' ' ' GLU . 21.3 Cg_exo -45.6 141.49 8.0 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.913 2.409 . . . . 0.0 112.818 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.473 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 43.6 Cg_endo -87.84 -101.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.156 2.571 . . . . 0.0 112.318 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 8.8 mmm180 -94.22 -80.07 0.41 Allowed 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.484 0.659 . . . . 0.0 110.756 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.531 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 36.4 m-20 -105.87 162.78 18.66 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.811 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.498 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.3 Cg_exo -61.38 -52.37 3.32 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.671 2.247 . . . . 0.0 111.025 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.2 OUTLIER -52.48 -19.21 2.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.898 177.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.531 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.6 mm-40 -88.56 -26.91 21.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.519 0.199 . . . . 0.0 111.482 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.635 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.98 -44.13 45.96 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.698 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.22 -62.13 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.815 2.343 . . . . 0.0 113.044 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.575 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -62.29 -36.24 73.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 122.441 1.115 . . . . 0.0 110.027 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.753 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 50.1 t90 -57.84 -38.0 74.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.513 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.473 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.97 -48.19 59.28 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.447 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -53.53 -23.48 20.26 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.794 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -73.84 -43.17 59.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.322 1.058 . . . . 0.0 110.456 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.584 ' HB3' HG21 ' A' ' 314' ' ' THR . 51.8 m-20 -95.67 -24.73 16.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.478 -1.692 . . . . 0.0 113.711 -168.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.557 ' HA ' HD13 ' A' ' 335' ' ' ILE . . . -41.84 -50.56 10.19 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.1 Cg_endo -60.9 -33.88 91.91 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.623 2.215 . . . . 0.0 111.68 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.474 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -72.27 -44.46 62.76 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.774 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.585 HG12 HG21 ' A' ' 310' ' ' ILE . 87.7 mt -58.07 -48.21 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.635 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.07 -14.94 7.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.282 -1.781 . . . . 0.0 112.046 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.0 -48.7 5.64 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 309' ' ' HIS . 92.2 t -55.18 -70.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.617 1.675 . . . . 0.0 109.89 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.78 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.6 OUTLIER -91.67 131.19 36.53 Favored Pre-proline 0 N--CA 1.402 -2.847 0 CA-C-N 110.729 -2.941 . . . . 0.0 112.008 -173.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.78 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.4 Cg_endo -73.39 -18.42 23.09 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 123.634 2.889 . . . . 0.0 110.248 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.6 p 32.87 69.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 111.938 -2.392 . . . . 0.0 110.189 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.549 ' N ' HD12 ' A' ' 346' ' ' LEU . 40.9 p -79.93 3.61 19.41 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.119 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.784 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -140.85 156.1 68.84 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 109.509 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 68.7 Cg_exo -60.94 -38.57 68.12 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 124.263 3.308 . . . . 0.0 109.54 172.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.686 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.58 -53.08 41.94 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.364 -2.198 . . . . 0.0 110.566 173.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.784 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -56.68 -51.94 66.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.77 0.795 . . . . 0.0 110.311 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 10.5 ttm180 -50.62 -44.75 57.28 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.238 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 40.9 t -70.09 -49.34 51.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.738 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.686 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 77.8 mtt180 -57.93 -39.3 77.68 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.704 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.621 ' O ' HG12 ' A' ' 354' ' ' ILE . 37.0 mt -59.71 -54.04 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.689 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.475 ' HA ' HG13 ' A' ' 354' ' ' ILE . 15.9 mt -57.58 -53.34 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-O 122.133 0.968 . . . . 0.0 110.919 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -64.14 -34.79 78.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.149 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.469 ' HB3' HD13 ' A' ' 307' ' ' ILE . . . -69.27 -35.15 75.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.104 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.621 HG12 ' O ' ' A' ' 350' ' ' ILE 0.25 0.9 OUTLIER -57.9 -54.13 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 122.715 1.245 . . . . 0.0 110.616 174.421 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.604 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.3 OUTLIER -72.52 -27.32 62.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 111.758 -2.474 . . . . 0.0 109.037 -168.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 28.1 55.61 0.13 Allowed Glycine 0 CA--C 1.524 0.628 0 O-C-N 125.568 1.793 . . . . 0.0 115.357 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 135.96 45.85 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.667 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.612 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 30.1 p30 -98.3 163.31 12.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.173 0.189 . . . . 0.0 110.762 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.456 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -53.37 -60.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.23 0.538 . . . . 0.0 111.702 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -157.75 16.05 0.31 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.607 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.612 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 6.4 mt -64.46 -6.32 7.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 122.919 0.488 . . . . 0.0 111.649 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.515 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 22.9 t -61.43 85.2 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.22 0.533 . . . . 0.0 110.112 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.636 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.8 mm? -60.64 -172.74 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.652 0.739 . . . . 0.0 112.822 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.9 p -126.96 152.68 75.87 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 18.4 Cg_exo -46.55 -34.65 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.979 1.786 . . . . 0.0 111.265 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -86.26 -2.25 85.65 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.65 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.452 ' HB2' HD12 ' A' ' 363' ' ' LEU . 55.6 m-20 -105.48 -21.29 13.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.306 1.051 . . . . 0.0 109.124 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 77.0 m -86.8 22.94 1.82 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.382 -171.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 369' ' ' LEU . 0.2 OUTLIER -59.02 -35.98 74.18 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.62 1.2 . . . . 0.0 108.266 -173.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 29.8 p -118.83 163.48 16.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 112.839 -1.982 . . . . 0.0 110.361 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.593 ' O ' HG13 ' A' ' 375' ' ' VAL . 51.8 m95 -71.18 -34.1 70.61 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 167.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.587 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -62.92 -47.07 84.85 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.613 -173.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.3 t -65.86 -42.82 89.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.739 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.741 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.53 63.76 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 371' ' ' TRP . 10.4 m -58.84 -44.85 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.613 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.682 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.79 -43.46 98.08 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.949 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.505 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 24.1 m -70.47 -40.42 73.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.749 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.6 mt -59.18 -35.15 73.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.399 0.618 . . . . 0.0 110.439 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.698 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.0 t80 -71.12 -49.08 48.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.344 1.069 . . . . 0.0 109.412 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.92 -32.41 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.962 170.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -59.95 -33.02 71.35 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 123.241 0.616 . . . . 0.0 111.698 175.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 29.1 p -106.34 -23.24 12.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.771 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -110.34 22.61 15.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 52.87 21.38 9.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 114.336 0.494 . . . . 0.0 114.336 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.5 m 64.86 161.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.42 0.628 . . . . 0.0 111.022 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.571 ' CE2' HD23 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.5 157.01 63.37 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 389' ' ' HIS . 85.5 Cg_endo -97.67 54.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.361 2.708 . . . . 0.0 111.019 166.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.61 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 56.85 3.14 0.12 Allowed 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -174.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.3 t60 -69.91 -46.85 64.51 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.512 174.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.8 mt-30 -74.17 -26.72 60.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.955 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -54.69 -31.52 58.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.97 0.805 . . . . 0.0 111.492 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.659 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.72 -53.17 40.9 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.426 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.561 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.8 m-20 -64.88 -40.85 95.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.068 0.547 . . . . 0.0 112.17 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.42 -45.39 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 399' ' ' VAL . 6.8 mm -58.8 -48.45 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.513 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.3 mmtt -52.11 -42.15 63.06 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.893 0.746 . . . . 0.0 111.54 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.34 -45.09 11.71 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.186 -172.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.653 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.2 mt -69.75 -40.67 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 117.52 0.66 . . . . 0.0 111.25 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.733 HG21 ' CG ' ' A' ' 429' ' ' TYR . 5.8 m -58.35 -45.16 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.66 0.743 . . . . 0.0 110.194 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.479 ' N ' HG22 ' A' ' 399' ' ' VAL . 10.6 t70 -62.94 -35.94 81.78 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.879 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -86.59 -53.47 4.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.046 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -107.66 -29.49 9.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.469 -171.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 120.84 163.79 12.17 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.616 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -42.92 97.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -57.14 -51.21 70.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.917 0.389 . . . . 0.0 111.784 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.583 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.16 -50.77 66.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.508 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.653 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.65 -41.73 64.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.606 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.8 t80 -57.1 -46.18 82.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.661 0.743 . . . . 0.0 109.2 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.771 ' O ' ' HG3' ' A' ' 413' ' ' MET . 7.5 m -58.31 -51.85 68.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.642 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.577 HD11 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.87 -49.14 76.04 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.723 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.488 ' HA2' HD11 ' A' ' 414' ' ' LEU . . . -56.33 -42.14 88.46 Favored Glycine 0 C--N 1.315 -0.59 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.252 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.598 ' HE1' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.49 -32.01 65.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 116.764 0.282 . . . . 0.0 111.015 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.771 ' HG3' ' O ' ' A' ' 409' ' ' THR . 67.3 mtm -69.97 -48.03 59.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.378 0.609 . . . . 0.0 109.831 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.682 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 15.6 mt -59.48 -38.55 81.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.388 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.955 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.0 m -77.64 -15.04 59.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.39 28.57 7.96 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 119.936 -1.125 . . . . 0.0 111.526 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.598 ' HA ' ' HE1' ' A' ' 412' ' ' MET . 3.2 mm-40 63.12 46.42 4.65 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.022 0.929 . . . . 0.0 112.302 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.627 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.1 OUTLIER -122.69 66.99 0.95 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 165.412 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.485 ' HE1' ' O ' ' A' ' 449' ' ' ASP . 0.9 OUTLIER -47.53 -34.38 7.51 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 111.368 -2.651 . . . . 0.0 113.733 -165.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' A' ' 423' ' ' SER . 48.3 mt-30 -55.45 -44.41 76.33 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -164.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.68 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.56 -50.95 71.91 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.347 0.594 . . . . 0.0 110.624 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 412' ' ' MET . 0.7 OUTLIER -59.96 -38.76 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.428 1.109 . . . . 0.0 109.164 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 29.1 t -59.5 -47.85 83.91 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.648 -2.069 . . . . 0.0 112.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.82 73.09 Favored Glycine 0 C--N 1.317 -0.489 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.122 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -72.24 -42.2 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.546 0.688 . . . . 0.0 110.085 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -56.67 -44.32 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.94 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.642 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -62.7 -27.99 69.63 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 122.901 1.334 . . . . 0.0 108.991 -173.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.42 77.69 Favored Glycine 0 C--N 1.298 -1.537 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.503 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.733 ' CG ' HG21 ' A' ' 399' ' ' VAL . 14.5 m-85 -100.4 3.08 42.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.604 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.96 144.87 74.18 Favored Pre-proline 0 N--CA 1.413 -2.308 0 CA-C-O 123.615 1.674 . . . . 0.0 113.439 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.654 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.7 Cg_endo -72.98 -61.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 1 C-N-CA 126.118 4.545 . . . . 0.0 113.305 -174.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.37 142.69 16.33 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.63 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.27 -29.22 70.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.085 0.443 . . . . 0.0 111.184 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.26 -47.21 79.02 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.683 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.6 t -58.8 -51.83 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.663 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.08 -54.44 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.05 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 47.9 m -62.27 -55.77 25.02 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.476 -0.489 . . . . 0.0 112.073 -175.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.35 -45.65 80.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.715 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.84 ' O ' HD21 ' A' ' 443' ' ' LEU . 48.8 mt -60.39 -53.15 60.99 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.759 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.698 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -51.75 -34.16 38.06 Favored 'General case' 0 N--CA 1.416 -2.147 0 O-C-N 125.03 1.456 . . . . 0.0 110.644 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.705 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.65 -60.73 2.09 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.405 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.98 -51.43 11.14 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.963 -0.461 . . . . 0.0 112.243 -172.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.8 -23.85 60.95 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.869 0.842 . . . . 0.0 111.571 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.73 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.5 t70 -71.26 -41.41 70.1 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.666 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 45.1 mt-30 -72.68 -9.67 58.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -170.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.634 ' HB3' HG23 ' A' ' 451' ' ' THR . 5.8 mm-40 -56.48 154.0 9.19 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.79 1.281 . . . . 0.0 113.762 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.404 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -52.7 -33.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.09 -2.323 . . . . 0.0 116.249 -168.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.621 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 27.8 m-20 -135.69 -178.47 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.485 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.4 p-10 -64.07 -54.6 31.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.433 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.6 -24.16 65.45 Favored 'General case' 0 N--CA 1.403 -2.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.634 HG23 ' HB3' ' A' ' 446' ' ' GLU . 8.6 m -60.25 -44.05 95.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 119.696 1.134 . . . . 0.0 109.427 171.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.5 mtt180 -59.22 -29.98 67.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.172 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.606 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.59 -30.82 59.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.674 0.749 . . . . 0.0 109.627 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.91 -44.97 19.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.222 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.508 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -100.75 -4.19 28.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.723 -1.58 . . . . 0.0 111.818 -168.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.633 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.1 t80 -48.77 -52.5 23.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.809 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.563 HG21 ' HB1' ' A' ' 405' ' ' ALA . 23.8 mm -72.87 -25.24 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.586 ' O ' ' HB1' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.11 -43.28 64.99 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.648 ' O ' HG23 ' A' ' 463' ' ' VAL . 72.2 m-70 -67.81 -31.55 71.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.734 -1.576 . . . . 0.0 109.513 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.685 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.74 -53.84 40.88 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.165 0.983 . . . . 0.0 109.304 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.3 -30.6 71.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.619 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 458' ' ' GLN . . . -66.9 -48.81 67.57 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.708 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 22.0 t -65.24 -35.82 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.302 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.538 ' OH ' HG12 ' A' ' 404' ' ' VAL . 18.8 m-30 -61.47 -13.17 18.56 Favored 'General case' 0 C--O 1.204 -1.294 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.707 169.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 3.5 tp10 -95.23 -52.6 4.12 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.227 -0.921 . . . . 0.0 112.24 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.708 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -62.75 -41.08 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.317 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.477 HD13 HD12 ' A' ' 469' ' ' LEU . 7.3 mt -83.97 -16.44 44.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.781 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.27 47.57 78.78 Favored Glycine 0 C--O 1.215 -1.039 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.492 172.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.4 OUTLIER -102.31 178.88 4.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.069 0.948 . . . . 0.0 110.478 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.79 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 18.0 p30 -96.54 -40.75 8.9 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 167.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -163.48 -75.12 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.358 160.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.654 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 1.0 OUTLIER -61.61 68.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -171.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 39.55 41.97 1.82 Allowed Glycine 0 C--N 1.274 -2.901 0 CA-C-N 110.626 -2.988 . . . . 0.0 113.375 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.79 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 8.5 mm-40 -79.05 -56.62 4.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.2 1.0 . . . . 0.0 111.635 -171.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.8 t 68.9 54.46 0.47 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.283 -173.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.781 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.509 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.139 175.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.432 ' H ' HG11 ' A' ' 304' ' ' VAL . 1.9 p . . . . . 0 N--CA 1.426 -1.635 0 CA-C-O 121.54 0.686 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.693 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 17.2 mt -75.96 127.85 84.46 Favored Pre-proline 0 N--CA 1.424 -1.76 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.994 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.2 Cg_endo -72.88 -12.18 26.09 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.823 3.682 . . . . 0.0 111.253 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.688 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.9 tp 27.25 -61.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 C-N-CA 128.685 2.794 . . . . 0.0 116.145 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 306' ' ' PRO . 0.0 OUTLIER -58.81 -31.89 68.86 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.097 0.475 . . . . 0.0 110.305 178.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.503 ' HB3' HG12 ' A' ' 338' ' ' VAL . 7.0 t-160 -61.8 -48.58 79.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.615 171.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 60.0 mt -58.41 -48.9 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 C-N-CA 123.987 0.915 . . . . 0.0 112.638 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 15.1 mtp180 -60.62 -29.86 69.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 122.222 -0.299 . . . . 0.0 111.074 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 52.8 m -69.76 -34.96 74.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.38 0.609 . . . . 0.0 109.761 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.66 -41.12 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.741 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.676 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.2 p -83.52 -37.96 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.898 1.332 . . . . 0.0 109.882 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.58 35.52 6.87 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.003 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.489 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 39.6 mt-10 51.3 177.12 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 124.083 0.953 . . . . 0.0 113.051 -174.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.527 ' HB3' HD11 ' A' ' 324' ' ' ILE . 48.7 Cg_exo -48.59 152.56 4.05 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.633 2.222 . . . . 0.0 113.379 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.521 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 7.5 Cg_endo -98.93 -107.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.076 3.184 . . . . 0.0 112.624 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.479 ' HB2' ' CD ' ' A' ' 323' ' ' GLU . 8.6 mmm180 -89.19 -88.83 0.15 Allowed 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.013 0.911 . . . . 0.0 111.97 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.576 ' H ' ' HG2' ' A' ' 323' ' ' GLU . 2.2 m-20 -94.87 157.83 36.1 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.474 -170.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.404 ' HB3' HD13 ' A' ' 359' ' ' ILE . 38.2 Cg_exo -59.32 -50.75 7.76 Favored 'Trans proline' 0 CA--C 1.511 -0.675 0 C-N-CA 122.414 2.076 . . . . 0.0 110.399 166.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.48 23.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.791 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.576 ' HG2' ' H ' ' A' ' 320' ' ' ASN . 3.3 pt-20 -102.94 -20.47 14.23 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.622 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.648 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -44.05 -42.65 12.5 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.705 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.43 -61.44 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.565 HG13 ' HG ' ' A' ' 410' ' ' LEU . 0.8 OUTLIER -60.01 -34.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.153 178.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.676 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -58.8 -36.39 74.38 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.228 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.485 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.81 -49.13 55.67 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -54.01 -22.97 22.01 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.758 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.633 ' NH1' ' HB2' ' A' ' 402' ' ' GLU . 0.1 OUTLIER -72.11 -42.4 66.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.215 1.007 . . . . 0.0 110.105 174.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.57 ' HB3' HG21 ' A' ' 314' ' ' THR . 54.7 m-20 -99.79 -24.16 14.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.739 -1.573 . . . . 0.0 114.114 -168.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.545 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.31 -50.01 8.75 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.0 Cg_endo -60.73 -33.42 93.13 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.371 2.047 . . . . 0.0 111.529 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.484 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -72.36 -42.23 65.53 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.794 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.569 HG12 HG21 ' A' ' 310' ' ' ILE . 90.4 mt -59.91 -48.5 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.965 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -56.14 -16.54 5.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.24 5.68 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 309' ' ' HIS . 96.0 t -55.09 -70.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 123.665 1.698 . . . . 0.0 110.1 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.788 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.6 OUTLIER -92.75 131.28 34.13 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 110.798 -2.91 . . . . 0.0 111.94 -172.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.788 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 67.9 Cg_endo -72.3 -18.87 26.23 Favored 'Trans proline' 0 CA--C 1.495 -1.464 0 C-N-CA 123.562 2.841 . . . . 0.0 110.524 174.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 346' ' ' LEU . 2.5 p 32.75 69.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 112.107 -2.315 . . . . 0.0 110.32 -178.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.536 ' N ' HD11 ' A' ' 346' ' ' LEU . 46.4 p -80.6 4.46 18.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.034 -1.894 . . . . 0.0 113.206 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.812 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 33.4 p -142.89 157.27 61.57 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-O 121.699 0.761 . . . . 0.0 109.694 174.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 70.0 Cg_exo -60.63 -38.97 68.14 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 124.373 3.382 . . . . 0.0 109.413 172.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.605 ' HA ' ' HB3' ' A' ' 365' ' ' PRO . 11.5 t70 -45.75 -58.83 3.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 112.371 -2.195 . . . . 0.0 110.217 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.812 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.3 mt -56.17 -52.24 65.11 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.815 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.642 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 34.3 ttm105 -52.61 -42.99 65.08 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 48.6 t -69.49 -49.79 51.36 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 26.9 mtp180 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.667 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.674 ' O ' HG12 ' A' ' 354' ' ' ILE . 50.8 mt -62.23 -53.85 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.681 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.491 ' HA ' HG13 ' A' ' 354' ' ' ILE . 18.2 mt -58.19 -53.36 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.078 0.942 . . . . 0.0 111.143 -168.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.538 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -64.3 -35.08 79.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.171 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 307' ' ' ILE . . . -69.18 -32.92 72.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.674 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.36 -55.95 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 CA-C-O 122.925 1.345 . . . . 0.0 110.41 173.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.561 HD13 ' HB ' ' A' ' 354' ' ' ILE . 1.7 mp -72.94 -26.1 61.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 111.88 -2.418 . . . . 0.0 109.051 -169.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 37.44 59.18 1.29 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 113.694 -1.594 . . . . 0.0 114.609 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 121.02 48.92 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.688 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.638 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 26.7 p30 -87.94 162.61 16.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.479 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -53.69 -63.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 122.828 0.451 . . . . 0.0 111.448 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.11 9.31 0.96 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.512 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.638 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 4.8 mt -64.15 -5.38 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 122.955 0.502 . . . . 0.0 111.645 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.538 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 48.1 t -61.29 84.28 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.092 0.473 . . . . 0.0 110.546 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.692 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 2.2 mm? -62.71 -174.64 0.07 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.877 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 71.7 p -128.47 155.79 78.12 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.605 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 35.4 Cg_exo -45.14 -38.12 13.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.965 1.777 . . . . 0.0 111.23 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.595 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -78.47 -4.17 87.02 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.806 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 363' ' ' LEU . 9.4 m-20 -109.5 -20.02 13.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.835 0.826 . . . . 0.0 110.194 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 81.4 m -91.25 21.49 4.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.702 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.595 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.7 OUTLIER -60.48 -38.97 85.98 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.156 -172.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.47 162.39 21.8 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.015 170.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.557 ' O ' HG11 ' A' ' 375' ' ' VAL . 48.0 m95 -69.54 -35.78 75.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.584 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.64 -41.77 99.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.783 -174.231 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 66.5 p -67.91 -44.77 76.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.922 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.638 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.43 -52.61 62.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 371' ' ' TRP . 15.6 m -57.31 -45.23 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.598 0.714 . . . . 0.0 109.585 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.695 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -61.17 -44.79 96.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.052 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.538 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 34.5 m -67.37 -39.85 85.7 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.499 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -58.99 -34.9 72.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.445 0.566 . . . . 0.0 110.325 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.705 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 43.7 t80 -73.81 -46.0 48.0 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.309 1.052 . . . . 0.0 109.467 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.2 mp -51.52 -32.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.322 170.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -59.83 -36.59 77.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.185 0.594 . . . . 0.0 111.451 176.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 28.0 p -103.26 -22.63 13.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.72 -168.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -110.01 23.01 14.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.42 21.45 34.09 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.948 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 65.07 160.17 0.11 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.179 0.514 . . . . 0.0 110.788 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -124.92 157.62 65.87 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -101.64 54.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.867 3.045 . . . . 0.0 111.546 166.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.606 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.06 -0.26 0.24 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -70.17 -44.49 68.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.017 0.437 . . . . 0.0 110.906 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.613 ' O ' HG12 ' A' ' 394' ' ' VAL . 77.4 mt-30 -74.65 -27.01 60.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.903 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.41 -30.42 52.26 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.48 0.582 . . . . 0.0 111.638 -174.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.64 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.1 -53.05 39.52 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.795 173.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.559 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 12.3 m-20 -65.61 -39.24 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 391' ' ' LEU . 1.4 m -57.97 -45.37 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.052 0.453 . . . . 0.0 110.256 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 399' ' ' VAL . 6.3 mm -58.8 -48.11 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.1 mmtt -52.04 -41.26 62.15 Favored 'General case' 0 C--O 1.242 0.682 0 O-C-N 124.195 0.934 . . . . 0.0 111.418 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.63 12.78 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.352 -171.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.591 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.3 mt -70.61 -38.65 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 117.624 0.712 . . . . 0.0 112.002 -177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 395' ' ' ILE . 1.1 m -59.33 -42.33 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.999 0.904 . . . . 0.0 109.136 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -59.18 -44.34 92.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.807 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -83.88 -53.5 5.55 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.491 -172.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.665 ' HG2' HG22 ' A' ' 406' ' ' THR . 8.8 tp10 -112.34 -34.91 5.75 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -171.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 130.1 163.47 11.09 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.57 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.574 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.17 -41.28 91.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -56.18 -50.71 70.44 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.665 HG22 ' HG2' ' A' ' 402' ' ' GLU . 0.9 OUTLIER -65.55 -48.85 71.02 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.091 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.591 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.41 -44.81 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 112.008 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.0 t80 -55.66 -45.99 77.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.348 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.754 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.2 m -58.77 -52.58 65.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.758 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.596 HD12 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.47 -48.82 79.39 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.508 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 414' ' ' LEU . . . -55.72 -44.25 86.62 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.63 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.2 OUTLIER -72.7 -31.17 64.82 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.899 0.35 . . . . 0.0 110.923 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.754 ' HG3' ' O ' ' A' ' 409' ' ' THR . 68.4 mtm -68.61 -49.8 56.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.475 0.655 . . . . 0.0 109.988 172.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.695 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 17.5 mt -58.56 -39.11 79.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.986 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.903 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.7 m -77.93 -16.45 58.18 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.558 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.23 35.31 6.34 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.169 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.63 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 69.91 39.69 1.39 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.632 0.773 . . . . 0.0 112.571 176.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.742 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.1 OUTLIER -121.63 77.46 1.35 Allowed 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.491 -2.041 . . . . 0.0 105.491 164.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.52 ' O ' HG23 ' A' ' 422' ' ' VAL . 9.1 p90 -62.04 -31.32 71.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.627 -2.079 . . . . 0.0 110.515 -162.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.552 ' O ' ' HB3' ' A' ' 423' ' ' SER . 23.6 mt-30 -54.38 -48.08 71.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.086 -164.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.666 HD13 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.87 -49.69 76.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.717 0.77 . . . . 0.0 110.962 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 412' ' ' MET . 0.6 OUTLIER -60.31 -39.04 79.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.633 1.206 . . . . 0.0 109.251 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.552 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 38.8 t -60.54 -45.64 93.09 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.444 -2.162 . . . . 0.0 111.375 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.94 -39.31 78.24 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.358 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.534 HD13 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -72.26 -42.59 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.643 0.735 . . . . 0.0 109.976 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -55.46 -44.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.735 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.639 ' C ' ' HD3' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -60.85 -30.63 70.23 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-O 122.733 1.254 . . . . 0.0 108.987 -173.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.49 -18.24 76.89 Favored Glycine 0 C--N 1.299 -1.502 0 CA-C-N 112.561 -2.109 . . . . 0.0 111.921 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.711 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.35 1.27 44.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.591 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.91 141.99 79.84 Favored Pre-proline 0 N--CA 1.408 -2.557 0 CA-C-O 123.771 1.748 . . . . 0.0 112.848 170.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.73 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.7 Cg_endo -70.16 -60.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 1 C-N-CA 126.065 4.51 . . . . 0.0 112.977 -171.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.543 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -111.36 134.76 12.34 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.235 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.679 ' HA ' HG11 ' A' ' 436' ' ' VAL . 0.6 OUTLIER -49.26 -37.34 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -55.19 -48.33 73.96 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.658 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.9 t -58.13 -52.53 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.637 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 433' ' ' GLN . 1.6 m -51.81 -53.31 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 117.64 0.2 . . . . 0.0 110.492 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.452 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 59.4 m -68.71 -54.17 17.74 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.837 -174.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.44 -41.44 76.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.161 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.84 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.6 mt -63.37 -53.92 44.91 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.208 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.693 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.68 -33.79 35.46 Favored 'General case' 0 N--CA 1.419 -1.977 0 O-C-N 124.959 1.412 . . . . 0.0 110.279 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.69 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.48 -59.88 2.51 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 173.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.5 ptp180 -73.92 -53.55 9.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.838 0.745 . . . . 0.0 112.616 -172.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.44 -25.0 64.0 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.653 0.74 . . . . 0.0 111.786 -177.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.755 ' N ' HD21 ' A' ' 443' ' ' LEU . 6.3 t70 -72.69 -41.89 64.81 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.32 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.69 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.99 -7.74 43.32 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.631 ' HB3' HG21 ' A' ' 451' ' ' THR . 40.4 mm-40 -54.73 158.0 2.81 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 123.206 1.479 . . . . 0.0 114.171 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.443 ' HB ' HG22 ' A' ' 451' ' ' THR . 1.8 mp -54.19 -33.44 25.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 111.52 -2.582 . . . . 0.0 115.904 -170.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.552 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 38.8 m-20 -142.89 178.47 7.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.45 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.0 m-20 -61.48 -55.45 31.03 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.422 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -63.82 -27.58 69.27 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.631 HG21 ' HB3' ' A' ' 446' ' ' GLU . 6.5 m -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.636 1.107 . . . . 0.0 109.941 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 50.0 mtt180 -60.68 -29.46 69.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.583 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.96 -30.18 58.54 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.131 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -82.58 -46.49 13.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.273 1.035 . . . . 0.0 111.95 -172.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.524 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -100.54 -1.55 35.28 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.811 -1.54 . . . . 0.0 111.542 -168.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.634 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.8 -51.99 26.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.656 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 21.3 mm -72.68 -26.33 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.524 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.44 -42.61 64.85 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.626 ' O ' HG21 ' A' ' 463' ' ' VAL . 56.7 m-70 -67.49 -31.56 71.78 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.611 171.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.693 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.84 -53.84 40.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.172 0.987 . . . . 0.0 109.481 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.68 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.9 m-80 -62.68 -32.03 73.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.006 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.85 -53.03 61.41 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.857 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.76 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 21.4 t -63.05 -34.4 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.712 0.767 . . . . 0.0 110.398 177.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -62.17 -15.53 46.78 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.175 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 33.9 mm-40 -92.26 -49.7 6.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 112.475 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.76 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 4.8 pt -64.37 -40.82 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.559 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.49 ' HB3' HD22 ' A' ' 469' ' ' LEU . 6.9 mt -83.69 -16.67 44.1 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.712 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.5 51.88 50.84 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.123 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.5 OUTLIER -102.72 -178.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 123.766 0.826 . . . . 0.0 110.134 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.732 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 13.6 p30 -99.72 -42.98 6.62 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 165.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -159.61 -75.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.906 160.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.73 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -61.16 64.75 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -169.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 43.81 35.48 3.23 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 111.754 -2.475 . . . . 0.0 113.062 173.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.732 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 29.4 mm-40 -73.61 -57.19 4.16 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 122.093 0.949 . . . . 0.0 111.778 -172.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 68.53 49.34 0.76 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.271 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 109.887 -3.324 . . . . 0.0 111.565 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 304' ' ' VAL . 2.2 p . . . . . 0 N--CA 1.426 -1.666 0 CA-C-O 121.413 0.625 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.684 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 21.5 mt -77.33 126.19 85.32 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 308' ' ' GLN . 19.0 Cg_endo -71.4 -10.55 27.18 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.733 3.622 . . . . 0.0 111.111 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.569 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.6 tp 26.11 -61.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 128.72 2.808 . . . . 0.0 116.194 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.5 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.48 -32.04 68.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.231 0.539 . . . . 0.0 110.047 178.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.488 ' HB3' HG11 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.07 -49.4 76.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.913 172.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.582 HG22 HG12 ' A' ' 335' ' ' ILE . 54.7 mt -58.76 -49.31 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 123.95 0.9 . . . . 0.0 112.614 175.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 48.1 mtp180 -61.3 -29.61 69.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 123.38 0.672 . . . . 0.0 111.094 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 66.8 m -70.31 -34.03 72.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 110.251 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.575 HG11 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.73 -41.68 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.559 178.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.75 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -84.7 -37.69 20.64 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.748 1.261 . . . . 0.0 110.351 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.92 35.4 7.19 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.485 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 19.5 mt-10 50.34 176.39 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 355' ' ' LEU . 73.5 Cg_exo -51.22 129.76 29.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.825 2.35 . . . . 0.0 113.1 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.87 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 82.3 Cg_endo -84.79 -92.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.488 3.459 . . . . 0.0 113.913 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.499 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 5.8 mmm180 -89.54 -77.72 0.38 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.747 0.784 . . . . 0.0 112.355 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.581 ' H ' ' CG ' ' A' ' 323' ' ' GLU . 38.0 m-20 -123.55 175.31 2.86 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.738 -170.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -65.97 -56.96 0.26 Allowed 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 121.969 1.779 . . . . 0.0 111.572 167.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -50.68 -21.15 1.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.648 -1.615 . . . . 0.0 114.075 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.817 ' OE1' ' HG2' ' A' ' 318' ' ' PRO . 1.7 pp20? -99.24 -22.29 15.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.04 0.448 . . . . 0.0 111.629 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.667 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.62 -42.69 33.91 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.571 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.711 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -49.73 -59.61 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.815 2.344 . . . . 0.0 112.935 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.58 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -63.66 -35.95 74.7 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.953 -179.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.87 ' CD1' ' HG3' ' A' ' 318' ' ' PRO . 42.6 t90 -58.01 -37.33 74.1 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.289 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.486 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.6 OUTLIER -69.16 -48.14 63.09 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 413' ' ' MET . . . -53.77 -23.47 22.01 Favored Glycine 0 C--N 1.311 -0.858 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.794 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 1.4 mmm180 -74.46 -42.8 58.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.119 0.961 . . . . 0.0 110.66 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.564 ' HB3' HG22 ' A' ' 314' ' ' THR . 28.1 m-20 -97.15 -22.75 16.56 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.895 -169.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.553 ' HA ' HD13 ' A' ' 335' ' ' ILE . . . -42.17 -49.64 11.56 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 39.7 Cg_endo -61.31 -32.21 89.67 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.589 2.193 . . . . 0.0 111.7 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.479 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -73.41 -43.99 59.31 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.727 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.582 HG12 HG22 ' A' ' 310' ' ' ILE . 89.0 mt -57.57 -48.49 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.866 173.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.47 -15.71 7.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.166 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.55 -47.25 6.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.259 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 309' ' ' HIS . 99.1 t -57.51 -70.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 123.472 1.606 . . . . 0.0 110.128 169.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.761 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.6 OUTLIER -92.39 128.74 43.51 Favored Pre-proline 0 N--CA 1.401 -2.92 0 CA-C-N 111.008 -2.815 . . . . 0.0 112.039 -172.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.761 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.9 Cg_endo -73.96 -16.56 22.97 Favored 'Trans proline' 0 CA--C 1.494 -1.49 0 C-N-CA 123.752 2.968 . . . . 0.0 110.442 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.539 HG22 ' CB ' ' A' ' 346' ' ' LEU . 2.8 p 34.01 67.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.222 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.623 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.2 p -80.37 8.07 8.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.83 -1.986 . . . . 0.0 113.118 -170.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.781 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 11.3 p -142.13 161.97 47.98 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -63.27 -47.52 7.77 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.451 2.768 . . . . 0.0 108.487 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.759 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.3 OUTLIER -45.96 -45.88 15.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.002 -1.908 . . . . 0.0 111.081 176.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.781 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -58.82 -52.31 66.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.378 0.609 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.503 ' HG3' HG21 ' A' ' 341' ' ' VAL . 2.1 ttt180 -50.4 -48.82 55.91 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.199 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 1.048 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -69.67 -49.13 56.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.035 0.445 . . . . 0.0 111.522 -175.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.683 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.3 mtt180 -56.48 -41.73 77.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.492 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.609 ' O ' HG12 ' A' ' 354' ' ' ILE . 38.7 mt -57.72 -53.77 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.322 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.471 ' HA ' HG13 ' A' ' 354' ' ' ILE . 18.9 mt -58.15 -52.76 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.015 0.912 . . . . 0.0 111.018 -169.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.518 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 19.3 m-20 -63.39 -35.97 82.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.988 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.468 ' HB1' HD13 ' A' ' 307' ' ' ILE . . . -69.2 -34.76 75.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.615 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.39 -54.37 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 123.127 1.441 . . . . 0.0 110.21 173.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.615 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -73.83 -26.5 60.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.377 -2.647 . . . . 0.0 109.878 -167.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 17.24 75.72 0.01 OUTLIER Glycine 0 N--CA 1.468 0.816 0 O-C-N 125.706 1.879 . . . . 0.0 115.205 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 137.35 -8.2 3.73 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.086 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.678 HD21 ' HB2' ' A' ' 361' ' ' LEU . 22.1 p-10 -57.14 148.61 21.57 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.667 0.787 . . . . 0.0 111.703 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.467 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -56.05 -73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.477 0.711 . . . . 0.0 112.567 -175.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -136.9 11.16 3.93 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.678 ' HB2' HD21 ' A' ' 358' ' ' ASN . 4.6 mt -64.94 -4.68 4.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.87 0.468 . . . . 0.0 111.629 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.518 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.8 t -60.63 82.99 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.379 0.609 . . . . 0.0 110.334 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.442 HD22 ' CD2' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -62.42 173.78 1.13 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.664 0.745 . . . . 0.0 112.604 175.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 76.8 p -115.13 160.97 31.87 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 1.048 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.2 Cg_endo -61.06 -5.02 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.801 1.667 . . . . 0.0 112.26 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -105.84 -11.75 27.66 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -105.91 -20.89 13.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.569 1.184 . . . . 0.0 110.228 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.853 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 16.8 p -84.9 20.05 1.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.709 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.595 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.03 -34.18 67.95 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.986 0.898 . . . . 0.0 110.192 -165.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.41 166.1 20.24 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.176 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.541 ' O ' HG11 ' A' ' 375' ' ' VAL . 44.0 m95 -69.66 -36.01 75.66 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.6 p30 -63.36 -39.42 94.47 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.306 -173.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 m -71.37 -41.99 69.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.649 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -63.27 -52.34 62.47 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 371' ' ' TRP . 14.6 m -56.77 -44.6 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.554 0.692 . . . . 0.0 109.51 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.688 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.66 -45.53 93.77 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.056 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.525 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 30.7 m -66.96 -39.11 87.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.56 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.26 -33.5 73.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.317 0.508 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.711 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 48.9 t80 -74.77 -45.63 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.311 1.053 . . . . 0.0 109.075 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.1 mp -51.73 -33.27 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.346 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -60.25 -36.92 78.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 123.311 0.645 . . . . 0.0 111.732 177.026 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 32.5 p -102.77 -23.54 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.044 -167.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -109.83 23.06 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.86 21.24 51.25 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 114.073 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.408 HG23 HG13 ' A' ' 380' ' ' ILE . 2.8 m 64.11 163.74 0.13 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -129.09 150.52 75.6 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -97.35 59.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.251 2.634 . . . . 0.0 110.893 165.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.594 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.84 4.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.89 -48.82 51.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.635 ' O ' HG11 ' A' ' 394' ' ' VAL . 73.9 mt-30 -74.81 -27.74 60.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -169.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.944 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.4 mm? -54.76 -31.05 58.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.796 0.725 . . . . 0.0 111.892 -172.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.653 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.76 -52.67 44.39 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.438 173.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.544 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 3.5 m-20 -65.75 -39.94 91.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.826 0.45 . . . . 0.0 111.969 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -58.14 -45.06 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.667 ' O ' HG21 ' A' ' 399' ' ' VAL . 6.1 mm -58.51 -47.58 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.4 mmtt -52.23 -43.42 64.29 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.901 0.751 . . . . 0.0 111.486 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.69 -44.63 12.16 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.24 -172.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.65 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.7 mt -69.05 -41.13 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 117.436 0.618 . . . . 0.0 111.432 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.714 HG22 ' CG ' ' A' ' 429' ' ' TYR . 5.9 m -58.13 -45.62 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.706 0.765 . . . . 0.0 109.944 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.468 ' N ' HG23 ' A' ' 399' ' ' VAL . 7.7 t70 -60.88 -38.23 84.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -86.26 -53.25 5.14 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.793 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.599 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.2 OUTLIER -110.67 -30.01 7.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.035 -168.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.02 162.48 11.19 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.853 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.618 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.66 98.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.576 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -57.22 -50.31 73.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.572 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -63.61 -51.18 66.36 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.577 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.65 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.03 -41.88 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.513 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 44.4 t80 -58.42 -44.8 89.24 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.806 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.0 m -59.26 -53.08 62.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.407 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.607 ' O ' ' HG ' ' A' ' 414' ' ' LEU . 2.7 mm? -62.57 -49.08 76.67 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.686 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.502 ' HA2' HD13 ' A' ' 414' ' ' LEU . . . -56.1 -42.2 87.08 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.019 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.601 ' HE3' ' NE2' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.39 -32.44 66.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.68 0.24 . . . . 0.0 111.097 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.806 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.2 mtm -69.55 -46.29 66.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.172 0.511 . . . . 0.0 109.707 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.688 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.06 -40.75 90.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.524 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.944 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 9.2 m -78.12 8.0 5.45 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.744 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.38 31.73 56.47 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.601 ' NE2' ' HE3' ' A' ' 412' ' ' MET . 4.7 mm-40 63.87 44.98 4.56 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 123.942 0.897 . . . . 0.0 111.621 -178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.555 ' ND2' HD21 ' A' ' 421' ' ' LEU . 7.4 t30 -114.07 74.01 0.85 Allowed 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 164.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 412' ' ' MET . 0.5 OUTLIER -51.53 -35.41 40.5 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.32 -2.218 . . . . 0.0 111.288 -171.138 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.529 ' O ' ' HB3' ' A' ' 423' ' ' SER . 39.2 mt-30 -56.65 -50.57 71.69 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -166.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.736 HD12 ' OG ' ' A' ' 415' ' ' SER . 3.1 pp -59.53 -49.16 78.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.723 0.773 . . . . 0.0 110.564 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 412' ' ' MET . 0.7 OUTLIER -59.79 -40.27 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.421 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 48.5 t -59.83 -47.43 85.76 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.507 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.55 -39.51 74.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.961 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 422' ' ' VAL . 1.7 mt -71.92 -42.48 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.387 0.613 . . . . 0.0 110.142 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -57.07 -44.68 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.93 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.612 ' HA ' ' CD2' ' A' ' 430' ' ' LEU . 0.2 OUTLIER -63.51 -27.82 69.53 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-O 122.79 1.281 . . . . 0.0 108.846 -173.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -17.07 77.19 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 112.469 -2.15 . . . . 0.0 112.658 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.714 ' CG ' HG22 ' A' ' 399' ' ' VAL . 9.8 m-85 -99.71 2.43 44.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.612 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.31 144.82 76.75 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-O 123.645 1.688 . . . . 0.0 113.898 170.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.715 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.1 Cg_endo -72.36 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.083 1 C-N-CA 126.333 4.689 . . . . 0.0 113.584 -173.07 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.545 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.98 139.91 15.25 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.255 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.593 ' HA ' HG11 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.61 -29.49 70.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.078 0.439 . . . . 0.0 111.207 -177.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.85 -48.01 79.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.678 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.0 t -58.79 -51.66 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.644 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.62 -55.22 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 52.6 m -61.4 -55.92 26.08 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.246 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.17 -45.5 79.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.668 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.838 ' O ' HD23 ' A' ' 443' ' ' LEU . 43.1 mt -60.38 -53.31 59.12 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.684 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.714 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 32.5 mm-40 -51.58 -34.6 37.76 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 125.174 1.546 . . . . 0.0 110.563 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.637 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.67 -59.9 2.49 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 175.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.72 -51.98 10.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.735 -0.603 . . . . 0.0 112.43 -173.397 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.84 -23.25 60.36 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.043 0.925 . . . . 0.0 111.409 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.746 ' N ' HD22 ' A' ' 443' ' ' LEU . 12.6 t70 -72.23 -42.93 65.16 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.963 -1.472 . . . . 0.0 110.755 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.5 mt-30 -72.08 -8.29 53.76 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -172.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.623 ' HB3' HG21 ' A' ' 451' ' ' THR . 53.1 mm-40 -52.25 155.96 1.83 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 123.366 1.555 . . . . 0.0 114.659 -174.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 451' ' ' THR . 1.9 mp -53.32 -33.76 21.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 111.047 -2.797 . . . . 0.0 115.455 -170.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.563 ' H ' ' HB ' ' A' ' 451' ' ' THR . 15.7 m-20 -141.89 -179.21 6.07 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.929 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.466 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.2 p-10 -61.31 -55.55 30.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.28 -25.23 65.95 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 176.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 446' ' ' GLU . 8.8 m -59.81 -42.69 94.03 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 119.861 1.209 . . . . 0.0 109.705 171.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.513 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 55.7 mtt180 -59.67 -29.91 68.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.513 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.38 -31.26 60.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.797 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -83.88 -45.87 12.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.208 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.541 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 34.0 p -100.61 -2.76 31.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.551 -166.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.626 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.4 t80 -49.04 -52.3 26.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.667 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 23.7 mm -72.05 -25.72 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.35 -42.39 65.38 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.629 ' O ' HG23 ' A' ' 463' ' ' VAL . 52.5 m-70 -67.94 -31.47 71.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.686 -1.597 . . . . 0.0 109.718 172.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.679 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.27 -53.53 42.76 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.09 0.947 . . . . 0.0 109.33 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.637 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.77 -32.0 73.07 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.161 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.47 -52.47 63.38 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.709 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 21.8 t -62.57 -35.22 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 121.899 0.857 . . . . 0.0 110.344 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.3 m-30 -61.61 -14.51 31.18 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.155 170.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 61.5 mm-40 -93.06 -48.57 6.43 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.001 -1.062 . . . . 0.0 112.777 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.709 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.91 -39.0 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.109 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.453 ' HB2' ' CG ' ' A' ' 469' ' ' LEU . 6.5 mt -84.95 -17.12 38.68 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 170.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.727 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.27 53.45 39.54 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 111.698 -2.501 . . . . 0.0 113.161 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.5 OUTLIER -103.55 -170.29 1.76 Allowed 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 123.856 0.863 . . . . 0.0 110.268 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.661 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.8 p30 -109.86 -42.29 4.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.412 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -157.93 -76.41 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.081 158.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.715 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 4.1 mpt_? -62.15 66.74 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -170.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.403 ' HA2' HD11 ' A' ' 469' ' ' LEU . . . 41.05 39.5 2.06 Favored Glycine 0 C--N 1.278 -2.679 0 CA-C-N 111.554 -2.567 . . . . 0.0 113.65 170.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.661 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 10.1 mm-40 -77.76 -51.39 10.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.277 1.037 . . . . 0.0 111.398 -173.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.8 t 64.06 56.1 1.45 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.263 -171.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.727 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.444 0 CA-C-N 110.302 -3.135 . . . . 0.0 111.941 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.454 ' H ' HG11 ' A' ' 304' ' ' VAL . 1.8 p . . . . . 0 N--CA 1.425 -1.704 0 CA-C-O 120.962 0.411 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.68 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.5 mt -76.01 126.97 86.2 Favored Pre-proline 0 N--CA 1.422 -1.831 0 CA-C-O 121.77 0.795 . . . . 0.0 111.803 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -71.26 -15.45 31.63 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 124.708 3.606 . . . . 0.0 110.978 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.725 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.2 tp 30.62 -60.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 128.676 2.791 . . . . 0.0 116.279 172.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.562 ' HG2' HG23 ' A' ' 307' ' ' ILE . 7.1 mm-40 -56.64 -39.16 73.19 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.892 0.853 . . . . 0.0 109.958 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.493 ' HB3' HG11 ' A' ' 338' ' ' VAL . 7.4 t-160 -58.96 -48.51 81.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.866 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 60.1 mt -58.75 -48.52 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 123.96 0.904 . . . . 0.0 113.033 174.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.725 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.0 mtp180 -59.59 -29.83 68.24 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.726 0.41 . . . . 0.0 110.562 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.1 m -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.565 0.697 . . . . 0.0 109.911 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.585 HG13 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.91 -40.52 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.918 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.768 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.39 -36.18 26.98 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.691 1.234 . . . . 0.0 109.57 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.5 9.13 Favored Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.52 -2.127 . . . . 0.0 111.184 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 44.0 mt-10 51.62 173.18 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 124.302 1.041 . . . . 0.0 113.273 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 316' ' ' GLU . 22.6 Cg_exo -44.82 140.38 6.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.011 2.474 . . . . 0.0 112.821 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.512 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 40.3 Cg_endo -89.15 -100.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.42 2.747 . . . . 0.0 113.072 -171.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.497 ' HG2' ' HB2' ' A' ' 318' ' ' PRO . 5.1 mmt180 -98.23 -81.95 0.43 Allowed 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.381 0.61 . . . . 0.0 110.687 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.728 ' OD1' ' HG2' ' A' ' 322' ' ' ARG . 1.8 t30 -111.93 150.12 41.88 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.147 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.699 ' HD2' ' OD1' ' A' ' 320' ' ' ASN . 56.8 Cg_exo -49.14 -53.53 6.87 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.157 2.572 . . . . 0.0 111.692 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.728 ' HG2' ' OD1' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -63.24 -13.34 36.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.26 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.571 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 30.4 mt-10 -83.16 -28.01 29.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 171.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.641 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -48.39 -44.74 65.75 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.665 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.9 Cg_endo -50.21 -59.98 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.754 2.303 . . . . 0.0 112.965 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.588 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -64.75 -34.06 67.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.345 0 CA-C-O 122.9 1.333 . . . . 0.0 110.067 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.768 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 39.5 t90 -57.2 -38.62 73.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.073 -1.876 . . . . 0.0 110.718 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.469 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -67.71 -47.34 69.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-O 120.693 0.283 . . . . 0.0 111.688 -175.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.27 -23.05 16.37 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.88 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.653 ' HD3' ' OE1' ' A' ' 402' ' ' GLU . 3.2 mmm-85 -72.89 -43.9 61.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.735 0.779 . . . . 0.0 111.152 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.559 ' HB2' HG21 ' A' ' 314' ' ' THR . 1.5 p30 -103.02 -17.65 15.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.533 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.29 -49.75 6.51 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 174.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 43.0 Cg_endo -62.76 -32.34 78.16 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.566 2.177 . . . . 0.0 111.612 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.468 ' CB ' HG12 ' A' ' 313' ' ' VAL . . . -73.13 -42.83 62.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.314 -1.766 . . . . 0.0 109.839 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.584 HG12 HG22 ' A' ' 310' ' ' ILE . 89.7 mt -58.65 -48.66 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.362 173.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.87 -15.03 4.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.846 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.68 -50.16 5.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 309' ' ' HIS . 99.2 t -55.42 -71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 123.742 1.734 . . . . 0.0 109.796 169.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.758 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.8 OUTLIER -89.44 128.7 50.03 Favored Pre-proline 0 N--CA 1.397 -3.116 0 CA-C-N 110.537 -3.028 . . . . 0.0 111.9 -173.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.758 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.7 Cg_endo -72.92 -16.72 25.8 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 C-N-CA 123.548 2.832 . . . . 0.0 110.075 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.586 HG23 ' CB ' ' A' ' 346' ' ' LEU . 4.6 p 31.9 69.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.584 ' N ' HD13 ' A' ' 346' ' ' LEU . 39.6 p -79.2 6.33 10.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.671 -2.058 . . . . 0.0 113.408 -167.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.772 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -140.73 164.49 36.09 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.415 ' HB3' HD21 ' A' ' 369' ' ' LEU . 47.4 Cg_exo -64.32 -47.81 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.646 2.897 . . . . 0.0 108.655 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.604 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 1.0 OUTLIER -44.81 -48.84 11.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.076 177.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.772 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.5 mt -57.86 -50.97 71.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.902 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.445 ' HG2' HG22 ' A' ' 341' ' ' VAL . 55.0 mtt180 -48.4 -48.0 37.29 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.298 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.933 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -70.13 -48.39 57.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.728 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 84.0 mtt180 -57.4 -40.81 79.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.079 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.642 ' O ' HG12 ' A' ' 354' ' ' ILE . 48.0 mt -57.89 -53.13 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.497 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.515 ' HA ' HG13 ' A' ' 354' ' ' ILE . 26.0 mt -59.0 -52.5 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-O 122.117 0.96 . . . . 0.0 111.122 -170.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.576 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 13.6 m-20 -62.53 -35.95 81.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.938 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 307' ' ' ILE . . . -69.33 -34.75 75.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.244 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.642 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.66 -54.87 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-O 123.021 1.391 . . . . 0.0 110.515 173.162 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.601 HD12 ' HB ' ' A' ' 354' ' ' ILE . 1.1 mp -72.37 -25.7 61.62 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.777 -2.465 . . . . 0.0 109.1 -168.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 68.25 -76.74 0.25 Allowed Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 113.607 -1.633 . . . . 0.0 113.326 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -124.61 69.1 0.49 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.112 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.559 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 30.8 p30 -86.74 163.86 17.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.503 0.321 . . . . 0.0 110.994 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.473 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -53.43 -59.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 122.92 0.488 . . . . 0.0 111.494 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -160.51 16.08 0.19 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.624 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.564 ' HB3' HD13 ' A' ' 378' ' ' LEU . 3.1 mt -67.33 -3.74 8.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.307 0.643 . . . . 0.0 111.189 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.576 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.3 t -62.52 81.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.711 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.454 HD23 ' CG2' ' A' ' 377' ' ' THR . 0.6 OUTLIER -61.93 174.35 0.87 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.83 0.824 . . . . 0.0 113.019 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.4 p -117.52 157.96 46.29 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.151 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.842 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.4 Cg_endo -49.46 -30.23 20.36 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.556 1.504 . . . . 0.0 112.236 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.508 ' O ' HD12 ' A' ' 369' ' ' LEU . . . -96.36 0.53 61.8 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.811 1.085 . . . . 0.0 115.811 -170.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.417 ' HB2' HD13 ' A' ' 363' ' ' LEU . 6.4 m-20 -109.3 -18.37 13.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.686 1.243 . . . . 0.0 110.443 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.933 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 5.0 t -109.95 21.74 16.47 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.328 -165.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 366' ' ' GLY . 2.1 mt -60.04 -29.51 68.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.861 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 6.0 p -114.56 159.96 19.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.221 -1.809 . . . . 0.0 109.771 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.498 ' O ' HG11 ' A' ' 375' ' ' VAL . 31.0 m95 -70.28 -34.83 73.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.531 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -63.29 -44.84 93.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.887 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 t -68.44 -42.85 78.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.466 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.28 -53.13 60.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.531 HG23 ' HE1' ' A' ' 413' ' ' MET . 15.8 m -57.37 -44.96 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.759 0.79 . . . . 0.0 109.259 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.701 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -59.81 -45.75 91.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.634 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 29.5 m -66.76 -39.75 88.01 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.088 -172.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.595 ' O ' ' HB2' ' A' ' 381' ' ' ARG . 0.1 OUTLIER -60.16 -34.49 73.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.984 1.265 . . . . 0.0 109.832 177.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.665 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 62.1 t80 -72.1 -47.5 50.84 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.494 1.14 . . . . 0.0 109.288 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.631 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 112.469 -2.151 . . . . 0.0 111.407 171.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.5 OUTLIER -59.48 -36.19 75.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 123.219 0.608 . . . . 0.0 111.243 176.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 34.1 p -102.34 -22.09 14.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.799 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -109.49 23.1 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.25 16.22 26.29 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.448 -0.406 . . . . 0.0 114.034 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 64.68 158.23 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.996 0.518 . . . . 0.0 111.355 -175.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.444 ' HZ ' ' HB3' ' A' ' 414' ' ' LEU . 0.2 OUTLIER -124.65 154.05 70.07 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 389' ' ' HIS . 93.9 Cg_endo -100.07 59.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.703 2.935 . . . . 0.0 111.209 165.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.586 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.43 -1.24 0.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -175.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 387' ' ' PRO . 5.8 t60 -69.89 -48.31 59.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.892 176.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.63 ' O ' HG11 ' A' ' 394' ' ' VAL . 57.9 mt-30 -74.08 -25.43 59.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -169.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.793 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.86 -30.77 47.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.7 0.682 . . . . 0.0 111.657 -175.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.595 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.19 -49.69 62.4 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.549 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.582 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 29.9 m-20 -68.74 -39.88 80.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.774 0.43 . . . . 0.0 112.135 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.65 -44.89 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.619 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -57.76 -46.77 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.484 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.3 mmtt -52.23 -44.46 64.84 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.819 0.819 . . . . 0.0 111.365 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.05 17.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.191 -172.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.665 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 3.9 mt -68.93 -41.51 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 117.156 0.478 . . . . 0.0 111.379 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.731 HG23 ' CG ' ' A' ' 429' ' ' TYR . 5.5 m -57.85 -44.97 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.615 0.721 . . . . 0.0 110.032 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.47 ' N ' HG21 ' A' ' 399' ' ' VAL . 5.7 t70 -65.97 -37.75 86.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.412 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.67 -51.71 6.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.655 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.0 OUTLIER -108.95 -29.48 8.57 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.369 -170.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 125.7 160.56 10.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.598 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.619 ' HA ' HG11 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.24 -42.96 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -176.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HB1' HG22 ' A' ' 457' ' ' ILE . . . -57.04 -50.47 72.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.312 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -63.21 -51.3 66.85 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.665 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -41.97 65.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.544 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 55.0 t80 -59.24 -44.99 92.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.442 0.639 . . . . 0.0 109.524 176.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.757 ' O ' ' HG3' ' A' ' 413' ' ' MET . 4.6 m -60.45 -52.55 64.73 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.49 -178.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.613 HD11 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -61.69 -48.58 80.12 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.713 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.516 ' HA2' HD11 ' A' ' 414' ' ' LEU . . . -55.72 -43.75 86.58 Favored Glycine 0 C--N 1.313 -0.745 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.348 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.601 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.2 OUTLIER -72.3 -31.72 65.95 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.821 0.311 . . . . 0.0 110.975 179.067 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.757 ' HG3' ' O ' ' A' ' 409' ' ' THR . 65.2 mtm -69.12 -47.87 63.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.176 0.513 . . . . 0.0 109.915 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.701 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 14.6 mt -58.66 -39.83 81.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.159 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.793 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.4 OUTLIER -77.65 -14.54 59.6 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.741 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.8 32.37 7.63 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.135 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.601 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 71.35 38.53 1.03 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.54 0.736 . . . . 0.0 112.149 176.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.766 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.2 OUTLIER -119.99 77.99 1.3 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 165.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.497 ' O ' HG22 ' A' ' 422' ' ' VAL . 2.9 p90 -62.18 -32.6 73.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.416 -2.174 . . . . 0.0 110.501 -162.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.428 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 31.8 mt-30 -55.11 -46.98 75.61 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.171 0.989 . . . . 0.0 113.359 -164.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.732 HD12 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -60.06 -51.22 70.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.635 0.731 . . . . 0.0 110.777 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.589 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -59.83 -38.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 123.054 1.407 . . . . 0.0 108.893 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 419' ' ' TYR . 1.1 t -61.8 -46.79 88.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 111.891 -2.413 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.64 89.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.111 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.52 HD13 ' HA ' ' A' ' 422' ' ' VAL . 2.1 mt -71.25 -41.25 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.57 0.7 . . . . 0.0 109.672 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.484 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -56.77 -46.73 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.596 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.549 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.19 -30.18 68.01 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.518 1.151 . . . . 0.0 109.526 -175.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.43 -16.59 77.42 Favored Glycine 0 C--N 1.298 -1.57 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.595 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.731 ' CG ' HG23 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.96 0.03 40.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.549 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.65 145.05 71.37 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 123.626 1.679 . . . . 0.0 113.268 170.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.652 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.2 Cg_endo -71.24 -58.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 1 C-N-CA 126.22 4.613 . . . . 0.0 113.147 -173.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.534 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -110.97 139.35 15.5 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.407 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.607 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.23 -27.95 69.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.091 0.446 . . . . 0.0 111.286 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.44 -47.93 80.5 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.668 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.0 t -58.6 -51.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.676 177.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.94 -53.43 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.469 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 64.8 m -62.18 -56.33 19.82 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.914 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.11 -45.64 79.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.532 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.866 ' O ' HD21 ' A' ' 443' ' ' LEU . 42.7 mt -59.61 -53.77 54.26 Favored 'General case' 0 CA--C 1.481 -1.695 0 C-N-CA 120.276 -0.569 . . . . 0.0 110.619 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.79 -34.56 40.44 Favored 'General case' 0 N--CA 1.416 -2.143 0 O-C-N 125.073 1.483 . . . . 0.0 110.596 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.91 -60.99 1.97 Allowed 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 176.249 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.2 OUTLIER -76.3 -51.44 11.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.894 -0.504 . . . . 0.0 112.232 -172.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.866 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.62 -24.49 61.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.622 0.725 . . . . 0.0 111.735 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.721 ' N ' HD23 ' A' ' 443' ' ' LEU . 21.2 t70 -71.71 -42.76 66.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.662 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.4 mt-30 -69.48 -7.86 41.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.612 ' HB3' HG22 ' A' ' 451' ' ' THR . 43.5 mm-40 -51.7 160.08 0.7 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 123.721 1.724 . . . . 0.0 114.501 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.8 mp -56.32 -33.32 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 110.626 -2.988 . . . . 0.0 115.403 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.554 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 48.4 m-20 -142.78 -178.67 5.91 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -63.66 -56.59 14.62 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -25.11 67.87 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 176.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.612 HG22 ' HB3' ' A' ' 446' ' ' GLU . 17.8 m -59.34 -42.68 92.05 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 119.493 1.042 . . . . 0.0 109.889 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 53.0 mtt180 -61.34 -30.0 70.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.544 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -30.93 59.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.971 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -80.86 -45.17 17.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.416 1.103 . . . . 0.0 111.498 -172.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.488 ' HG1' ' HG3' ' A' ' 446' ' ' GLU . 43.7 p -101.36 -4.34 27.14 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.894 -167.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.647 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.5 t80 -49.01 -52.09 27.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.661 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.59 HG22 ' HB1' ' A' ' 405' ' ' ALA . 27.0 mm -70.95 -27.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.16 -42.73 65.58 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.639 ' O ' HG21 ' A' ' 463' ' ' VAL . 75.8 m-70 -67.03 -30.97 71.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.75 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.697 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -65.59 -53.7 38.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.207 1.003 . . . . 0.0 109.23 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.648 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.4 m-80 -61.94 -32.39 72.81 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.071 172.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.71 -52.73 62.11 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.002 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.713 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 21.9 t -62.78 -34.89 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 121.858 0.837 . . . . 0.0 110.32 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.7 m-30 -61.63 -15.13 36.81 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.014 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 45.7 mm-40 -91.16 -49.52 6.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.941 -1.099 . . . . 0.0 112.696 176.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.713 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.24 -39.77 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.997 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.453 HD11 HD11 ' A' ' 469' ' ' LEU . 6.6 mt -84.44 -16.61 42.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.784 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.88 50.02 60.32 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 111.855 -2.43 . . . . 0.0 113.599 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.3 OUTLIER -103.68 -179.28 3.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 123.877 0.871 . . . . 0.0 110.244 -179.156 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.691 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.0 p30 -102.1 -40.27 6.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 168.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -160.56 -76.51 0.06 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 112.524 -2.125 . . . . 0.0 111.052 158.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.652 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -60.07 69.26 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -171.139 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 37.39 40.37 0.63 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 110.738 -2.937 . . . . 0.0 113.654 174.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.691 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.3 mm-40 -77.67 -53.62 7.34 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.098 0.951 . . . . 0.0 111.784 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 67.9 55.08 0.59 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 112.084 -2.325 . . . . 0.0 108.833 -174.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.784 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 110.84 -2.891 . . . . 0.0 111.833 176.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.433 -1.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.691 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 22.6 mt -75.05 126.27 88.3 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-O 121.945 0.878 . . . . 0.0 112.698 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.57 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.0 Cg_endo -83.37 49.56 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.819 3.679 . . . . 0.0 109.522 167.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.767 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -42.49 -42.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.555 -2.111 . . . . 0.0 112.665 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.431 ' N ' HG21 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -65.25 -36.99 85.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.241 0.543 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.507 ' HB3' HG12 ' A' ' 338' ' ' VAL . 6.6 t-160 -62.7 -47.49 83.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.357 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.562 HG22 ' CG2' ' A' ' 350' ' ' ILE . 62.3 mt -58.74 -49.88 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.767 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.3 mtp180 -62.11 -29.95 70.68 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 110.683 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.0 m -69.71 -33.78 72.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.37 0.605 . . . . 0.0 110.072 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.24 -40.05 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.982 178.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.646 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.14 -36.93 26.94 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.74 1.257 . . . . 0.0 109.677 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.44 32.19 9.73 Favored Glycine 0 C--N 1.305 -1.14 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.803 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 25.5 mt-10 51.8 169.54 0.04 OUTLIER Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 124.626 1.17 . . . . 0.0 113.83 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.509 ' HB3' HD13 ' A' ' 324' ' ' ILE . 52.7 Cg_exo -46.19 148.53 3.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.469 2.779 . . . . 0.0 114.203 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.47 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 40.3 Cg_endo -91.86 -99.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.851 3.034 . . . . 0.0 112.746 -174.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 6.5 mmm180 -97.83 -83.09 0.41 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.154 0.502 . . . . 0.0 110.828 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.453 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 16.9 m-20 -102.67 163.57 17.34 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.467 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.4 Cg_exo -59.72 -47.41 16.12 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.708 2.272 . . . . 0.0 110.379 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.447 ' H ' ' HG3' ' A' ' 322' ' ' ARG . 81.2 mtt180 -48.65 -28.76 3.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.815 -1.993 . . . . 0.0 112.8 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.85 -23.16 22.87 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.801 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.699 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.2 OUTLIER -50.02 -42.39 70.44 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.708 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 7.5 Cg_endo -48.62 -61.52 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.848 2.365 . . . . 0.0 112.829 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.627 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -61.51 -36.79 75.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-O 122.667 1.222 . . . . 0.0 110.384 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.742 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 54.6 t90 -58.75 -40.72 84.68 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.48 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.467 ' HB3' HG13 ' A' ' 375' ' ' VAL . 0.5 OUTLIER -68.45 -50.12 54.86 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.559 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -53.46 -23.23 18.59 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.742 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 1.5 ttt-85 -72.77 -41.61 64.87 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 114.442 -0.879 . . . . 0.0 112.321 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.537 ' HB2' HG21 ' A' ' 314' ' ' THR . 1.4 p30 -106.74 -16.92 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.53 ' N ' ' HD2' ' A' ' 333' ' ' PRO . . . -40.17 -48.01 6.04 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 37.8 Cg_endo -60.49 -32.72 94.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.536 2.157 . . . . 0.0 111.555 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.495 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -72.7 -43.21 63.33 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.658 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.545 HG12 HG23 ' A' ' 310' ' ' ILE . 89.4 mt -58.37 -49.52 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.754 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.33 -14.57 7.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.044 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.66 6.43 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.364 175.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 306' ' ' PRO . 91.2 t -56.99 -70.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 123.698 1.713 . . . . 0.0 110.154 168.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.76 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.7 OUTLIER -92.43 130.6 36.85 Favored Pre-proline 0 N--CA 1.402 -2.864 0 CA-C-N 110.629 -2.987 . . . . 0.0 112.11 -173.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.76 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.7 Cg_endo -74.91 -17.42 19.79 Favored 'Trans proline' 0 CA--C 1.496 -1.394 0 C-N-CA 123.731 2.954 . . . . 0.0 110.631 174.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.496 HG22 ' CB ' ' A' ' 346' ' ' LEU . 2.6 p 34.08 67.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 112.216 -2.266 . . . . 0.0 110.107 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.602 ' N ' HD12 ' A' ' 346' ' ' LEU . 35.8 p -78.25 3.17 16.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 112.453 -2.158 . . . . 0.0 113.194 -170.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.781 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 10.2 p -137.93 164.13 43.06 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -63.8 -49.94 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.265 2.644 . . . . 0.0 108.329 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.724 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -43.6 -48.69 7.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.982 176.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.781 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.7 mt -56.18 -51.99 66.01 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.521 0.677 . . . . 0.0 110.166 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 2.1 ttm180 -54.9 -47.03 74.87 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.556 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 1.037 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.45 -48.16 61.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.179 0.514 . . . . 0.0 111.193 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.2 mtp180 -56.45 -41.1 75.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.244 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.669 ' O ' HG12 ' A' ' 354' ' ' ILE . 42.6 mt -58.63 -54.37 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.492 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.64 ' O ' HD23 ' A' ' 355' ' ' LEU . 20.8 mt -57.71 -54.04 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.952 0.882 . . . . 0.0 110.87 -168.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.473 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -63.95 -34.79 78.76 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.989 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.6 -34.42 74.08 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.336 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 350' ' ' ILE 0.252 1.0 OUTLIER -56.58 -55.32 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 CA-C-O 122.982 1.372 . . . . 0.0 110.523 175.289 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.699 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -73.06 -27.63 61.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.668 -2.514 . . . . 0.0 110.154 -169.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 39.41 75.35 0.1 Allowed Glycine 0 CA--C 1.524 0.63 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.851 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 112.85 25.08 4.66 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.86 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.756 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 3.9 p-10 -75.14 136.91 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.99 0.424 . . . . 0.0 111.365 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.535 ' N ' HD11 ' A' ' 359' ' ' ILE . 2.1 mp -71.77 98.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.999 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.76 -21.55 4.6 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.221 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.756 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 5.8 mt -61.59 -6.38 2.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 122.939 0.496 . . . . 0.0 112.195 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.473 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 20.7 t -61.06 81.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.217 0.532 . . . . 0.0 110.427 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.449 HD22 ' CD2' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -62.5 169.25 3.09 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.136 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 366' ' ' GLY . 69.5 p -111.75 161.4 25.8 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.329 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 1.037 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.2 Cg_endo -63.57 7.07 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.202 1.935 . . . . 0.0 112.747 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -117.23 -12.32 8.32 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.689 -0.687 . . . . 0.0 114.679 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.41 ' HB2' HD11 ' A' ' 363' ' ' LEU . 45.9 m-20 -105.67 -20.43 13.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.509 1.147 . . . . 0.0 109.804 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 7.6 p -82.91 20.04 1.26 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.431 -1.713 . . . . 0.0 112.805 -169.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.59 ' N ' HD11 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -58.03 -34.83 70.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 122.288 1.042 . . . . 0.0 110.067 -168.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.1 t -130.62 163.67 26.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.202 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.601 ' O ' HG12 ' A' ' 375' ' ' VAL . 55.4 m95 -70.36 -36.59 74.28 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.535 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.4 p30 -63.38 -39.37 94.34 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.439 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 48.1 t -66.36 -42.89 87.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.053 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -68.35 -51.81 40.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 371' ' ' TRP . 11.9 m -56.88 -45.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.144 0.497 . . . . 0.0 110.087 -178.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.672 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.09 -43.1 95.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.684 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.469 ' O ' ' HD3' ' A' ' 381' ' ' ARG . 40.2 m -68.5 -42.68 78.25 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.558 -173.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -58.74 -34.02 70.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.419 0.554 . . . . 0.0 110.671 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.708 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.6 t80 -73.68 -47.34 40.45 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.501 1.144 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.64 -32.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 CA-C-N 112.678 -2.055 . . . . 0.0 111.336 170.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.631 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -60.29 -41.99 94.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.682 175.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.3 p -97.4 -23.42 16.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.772 -168.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -110.5 22.91 14.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.75 21.73 23.49 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.315 0.486 . . . . 0.0 114.315 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.2 m 67.01 160.05 0.15 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.225 0.536 . . . . 0.0 111.328 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -125.31 156.17 70.4 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -97.94 54.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.415 2.743 . . . . 0.0 111.306 165.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.607 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.51 4.21 0.22 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.09 -47.45 61.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.014 0.435 . . . . 0.0 110.585 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.608 ' O ' HG12 ' A' ' 394' ' ' VAL . 75.7 mt-30 -71.47 -27.48 63.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -169.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.836 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.84 -31.18 59.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.59 0.632 . . . . 0.0 111.925 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.653 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -50.09 59.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.476 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.464 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.3 m-20 -68.58 -39.43 80.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.661 0.384 . . . . 0.0 112.002 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.55 -45.92 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.245 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.788 ' O ' HG22 ' A' ' 399' ' ' VAL . 5.9 mm -58.69 -47.27 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.615 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 34.8 mmtt -51.42 -42.61 61.61 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 124.077 0.861 . . . . 0.0 111.486 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.52 -44.11 13.78 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.921 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.68 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.8 mt -69.2 -40.73 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 117.5 0.65 . . . . 0.0 111.543 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 395' ' ' ILE . 0.8 OUTLIER -59.35 -42.81 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 109.506 -178.43 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.4 ' N ' HG21 ' A' ' 399' ' ' VAL . 17.1 t70 -63.63 -39.23 93.84 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.087 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -85.66 -53.41 5.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.281 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.547 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -110.64 -32.16 6.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.561 0.696 . . . . 0.0 111.747 -170.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.01 163.13 11.48 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.682 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.596 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -56.07 -49.81 72.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.164 0.507 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.644 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.76 -50.69 65.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.557 177.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.68 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.53 -44.18 65.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.514 ' HE1' ' OG ' ' A' ' 423' ' ' SER . 26.9 t80 -54.81 -46.44 74.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.779 0.799 . . . . 0.0 109.082 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.76 ' O ' ' HG3' ' A' ' 413' ' ' MET . 18.4 m -58.55 -52.02 67.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.958 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.627 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -61.99 -49.09 77.47 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.958 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.469 ' HA2' HD11 ' A' ' 414' ' ' LEU . . . -56.11 -43.28 88.59 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.805 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.555 ' HA ' HG12 ' A' ' 422' ' ' VAL . 0.1 OUTLIER -71.29 -32.94 69.25 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.728 0.264 . . . . 0.0 110.673 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.76 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.6 mtm -68.82 -46.2 69.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.923 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.672 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 18.5 mt -60.2 -43.35 96.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.292 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.836 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 1.9 m -80.63 7.15 10.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 70.81 46.78 43.59 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.857 171.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.534 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 62.3 42.12 9.61 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 123.87 0.868 . . . . 0.0 111.616 177.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.566 ' ND2' HD23 ' A' ' 421' ' ' LEU . 22.3 t30 -113.17 83.21 1.79 Allowed 'General case' 0 CA--C 1.476 -1.878 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 163.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.599 ' HD2' ' OG ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -57.09 -36.93 71.2 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.821 -174.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.431 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 41.6 mt-30 -57.29 -51.56 68.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -163.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.757 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 1.7 pt? -60.02 -49.23 78.48 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.392 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.757 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.77 -38.42 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.685 1.231 . . . . 0.0 108.894 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.599 ' OG ' ' HD2' ' A' ' 419' ' ' TYR . 43.6 m -65.31 -41.13 94.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.31 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.83 86.97 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.787 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 422' ' ' VAL . 1.7 mt -71.46 -40.71 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.597 0.713 . . . . 0.0 109.813 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -56.78 -44.67 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.58 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.511 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -57.4 -33.09 67.49 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 124.87 1.268 . . . . 0.0 109.245 -176.137 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.467 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.57 -15.01 77.52 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 112.992 -1.913 . . . . 0.0 112.448 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.75 ' CG ' HG23 ' A' ' 399' ' ' VAL . 9.0 m-85 -102.77 1.12 33.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.531 HD13 ' HD2' ' A' ' 431' ' ' PRO . 3.8 mm? -57.58 142.01 78.06 Favored Pre-proline 0 N--CA 1.41 -2.464 0 CA-C-O 123.645 1.688 . . . . 0.0 113.333 170.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.738 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 53.1 Cg_endo -68.95 -57.35 0.13 Allowed 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.564 4.843 . . . . 0.0 113.316 -169.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.577 ' O ' HG11 ' A' ' 436' ' ' VAL . . . -112.62 140.72 16.45 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.736 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.612 ' HA ' ' CG1' ' A' ' 436' ' ' VAL . 0.0 OUTLIER -59.44 -32.43 70.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.688 0.744 . . . . 0.0 111.651 -175.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -55.02 -48.43 73.39 Favored 'General case' 0 CA--C 1.509 -0.635 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.569 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.9 t -62.39 -36.76 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.337 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.612 ' CG1' ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -71.1 -45.98 69.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 45.4 m -72.27 -54.92 8.13 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.359 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.82 76.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.772 ' O ' HD22 ' A' ' 443' ' ' LEU . 20.1 mt -66.61 -54.49 22.91 Favored 'General case' 0 CA--C 1.465 -2.3 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.733 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.616 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.22 -33.54 28.29 Favored 'General case' 0 N--CA 1.405 -2.715 0 O-C-N 125.781 1.926 . . . . 0.0 109.944 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -72.95 -60.74 2.09 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -71.55 -48.73 46.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.126 0.488 . . . . 0.0 111.472 -171.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -60.22 -25.97 66.03 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.458 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.713 ' N ' HD21 ' A' ' 443' ' ' LEU . 12.0 t70 -73.09 -42.01 63.46 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.33 1.062 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -68.79 -8.31 42.14 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -171.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.598 ' HB3' HG22 ' A' ' 451' ' ' THR . 47.1 mm-40 -51.78 156.97 1.28 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.518 1.628 . . . . 0.0 115.058 -176.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.7 mp -52.92 -31.98 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 110.506 -3.043 . . . . 0.0 115.665 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.56 ' H ' ' HB ' ' A' ' 451' ' ' THR . 55.2 m-20 -140.81 178.9 7.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.407 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 7.6 p-10 -61.78 -56.3 20.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -67.49 -24.97 65.64 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 446' ' ' GLU . 19.2 m -57.78 -41.05 81.27 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.774 1.17 . . . . 0.0 109.932 171.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 62.5 mtt180 -60.97 -30.57 70.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 450' ' ' GLN . . . -76.09 -31.44 58.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.35 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.8 mm-40 -81.29 -45.68 15.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.474 1.13 . . . . 0.0 111.883 -172.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.469 ' HG1' ' HG3' ' A' ' 446' ' ' GLU . 47.2 p -98.95 -2.3 37.82 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.772 -167.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.63 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -48.89 -55.57 11.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.932 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 27.6 mm -70.23 -25.42 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.478 ' O ' ' HB1' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -73.0 -43.21 62.43 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.566 ' O ' HG22 ' A' ' 463' ' ' VAL . 65.9 m-70 -66.15 -32.19 73.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.261 171.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.703 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.18 -53.69 45.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.308 1.051 . . . . 0.0 109.34 -178.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.655 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.9 m-80 -62.6 -32.03 72.96 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.3 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.36 -52.55 63.16 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.035 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.745 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 34.5 t -63.26 -33.57 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-O 121.802 0.81 . . . . 0.0 110.56 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.4 m-30 -62.54 -15.26 49.8 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.309 168.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 22.4 mm-40 -92.25 -49.31 6.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.007 -1.058 . . . . 0.0 112.64 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.63 -40.16 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.67 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.483 ' HB3' HD21 ' A' ' 469' ' ' LEU . 5.3 mt -84.6 -16.67 41.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.747 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.75 51.79 50.91 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 111.681 -2.509 . . . . 0.0 113.171 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.4 OUTLIER -103.3 -178.12 3.57 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.723 0.809 . . . . 0.0 110.268 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.575 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 10.8 p30 -101.39 -41.95 6.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 167.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.92 -75.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.322 159.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.738 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 1.3 mpt_? -63.77 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -168.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 40.09 42.16 2.25 Favored Glycine 0 C--N 1.277 -2.72 0 CA-C-N 111.352 -2.658 . . . . 0.0 113.417 173.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.575 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 4.6 mm-40 -81.55 -49.64 10.32 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-O 122.306 1.05 . . . . 0.0 111.278 -172.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 46.8 t 62.1 57.69 1.99 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.346 -2.207 . . . . 0.0 108.433 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.747 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.322 0 CA-C-N 110.934 -2.848 . . . . 0.0 111.418 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.425 ' H ' HG12 ' A' ' 304' ' ' VAL . 1.5 p . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 121.175 0.512 . . . . 0.0 110.728 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.675 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -75.1 126.66 87.8 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-O 122.005 0.907 . . . . 0.0 111.731 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.5 ' HG2' HG12 ' A' ' 338' ' ' VAL . 18.6 Cg_endo -72.18 -10.84 26.39 Favored 'Trans proline' 0 CA--C 1.498 -1.307 0 C-N-CA 124.755 3.637 . . . . 0.0 111.298 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.701 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.8 tp 25.12 -61.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 O-C-N 127.13 2.769 . . . . 0.0 116.063 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 306' ' ' PRO . 0.0 OUTLIER -58.37 -32.78 68.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.196 0.522 . . . . 0.0 110.396 178.308 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.512 ' HB3' HG13 ' A' ' 338' ' ' VAL . 6.6 t-160 -62.27 -48.71 78.71 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.609 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 59.8 mt -58.32 -48.87 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 C-N-CA 123.982 0.913 . . . . 0.0 112.78 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.701 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 10.5 mtp180 -61.29 -30.48 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 122.141 -0.349 . . . . 0.0 110.827 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 53.1 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.62 0.724 . . . . 0.0 109.962 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.1 -40.89 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.748 178.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.729 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 32.3 p -82.67 -36.32 26.05 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.941 1.353 . . . . 0.0 109.531 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.64 33.54 8.42 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 112.183 -2.281 . . . . 0.0 110.938 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.1 mt-10 50.68 174.66 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 124.339 1.055 . . . . 0.0 113.029 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.524 ' HB3' HD11 ' A' ' 324' ' ' ILE . 42.6 Cg_exo -46.09 145.81 4.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.374 2.05 . . . . 0.0 112.467 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -87.65 -99.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.343 2.695 . . . . 0.0 112.451 -171.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -100.82 -76.57 0.56 Allowed 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.723 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.599 ' HB3' ' HG3' ' A' ' 323' ' ' GLU . 1.3 t30 -109.88 150.8 41.85 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.004 -173.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.597 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 47.7 Cg_exo -53.88 -52.83 7.53 Favored 'Trans proline' 0 CA--C 1.504 -1.024 0 C-N-CA 123.04 2.493 . . . . 0.0 111.52 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.53 ' HD2' ' HB ' ' A' ' 382' ' ' THR . 0.0 OUTLIER -59.18 -15.93 17.55 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.052 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.599 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 5.5 mt-10 -81.22 -25.85 36.35 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -48.58 -44.48 66.87 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.739 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -51.2 -61.9 0.47 Allowed 'Trans proline' 0 CA--C 1.518 -0.308 0 C-N-CA 122.697 2.265 . . . . 0.0 113.159 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.62 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.64 -35.59 60.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 122.919 1.343 . . . . 0.0 110.153 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.821 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 42.7 t90 -59.78 -38.5 82.05 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.88 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.5 OUTLIER -69.2 -50.6 45.94 Favored 'General case' 0 N--CA 1.407 -2.604 0 O-C-N 121.863 -0.523 . . . . 0.0 112.396 -175.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.551 ' HA3' ' HE2' ' A' ' 413' ' ' MET . . . -53.94 -22.87 21.16 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.821 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 10.7 ttp85 -71.76 -42.46 67.17 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 113.862 -1.169 . . . . 0.0 112.166 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.548 ' HB2' HG23 ' A' ' 314' ' ' THR . 0.8 OUTLIER -108.3 -15.44 14.47 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.099 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 333' ' ' PRO . . . -40.37 -47.97 6.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 32.1 Cg_endo -59.16 -34.94 98.61 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.557 175.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.495 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -71.94 -42.62 66.4 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.771 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.572 HG12 HG23 ' A' ' 310' ' ' ILE . 88.5 mt -58.87 -49.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.663 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.2 -16.87 5.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.895 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.2 -50.7 5.33 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.17 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.512 HG13 ' HB3' ' A' ' 309' ' ' HIS . 92.0 t -54.61 -69.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 123.541 1.639 . . . . 0.0 110.176 170.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.775 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.6 OUTLIER -94.51 129.39 36.79 Favored Pre-proline 0 N--CA 1.401 -2.923 0 CA-C-N 110.958 -2.837 . . . . 0.0 112.162 -172.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.775 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.3 Cg_endo -75.5 -16.0 19.38 Favored 'Trans proline' 0 CA--C 1.497 -1.367 0 C-N-CA 123.892 3.061 . . . . 0.0 110.503 174.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.478 HG21 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.43 68.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.943 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.63 ' N ' HD11 ' A' ' 346' ' ' LEU . 31.0 p -81.0 10.58 4.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.623 -2.08 . . . . 0.0 113.468 -169.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.776 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.3 p -143.71 162.52 41.09 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.42 -49.34 6.05 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.208 2.606 . . . . 0.0 108.214 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.755 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -46.02 -44.12 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.904 -1.953 . . . . 0.0 111.292 178.036 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.776 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.0 mt -58.59 -52.03 67.38 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.382 0.61 . . . . 0.0 110.746 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.67 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 32.6 ttm105 -53.92 -44.85 70.94 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.31 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.92 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.04 -47.4 65.47 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 111.086 -176.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.68 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 94.0 mtt180 -57.51 -41.76 81.46 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.036 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.666 ' O ' HG12 ' A' ' 354' ' ' ILE . 44.8 mt -58.0 -53.77 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.528 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.479 ' HA ' HG13 ' A' ' 354' ' ' ILE . 20.6 mt -58.69 -52.84 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.096 0.951 . . . . 0.0 110.815 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.531 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -63.36 -35.32 79.99 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.049 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 307' ' ' ILE . . . -69.23 -34.51 74.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 112.076 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.26 -55.09 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.833 1.302 . . . . 0.0 110.5 174.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.623 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -72.7 -26.79 61.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 111.693 -2.503 . . . . 0.0 109.297 -168.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 34.71 60.68 0.63 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.705 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 117.57 74.17 0.49 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.342 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.579 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 20.6 p30 -119.53 168.89 10.54 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 122.668 0.387 . . . . 0.0 110.432 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.498 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -52.84 -61.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 122.991 0.516 . . . . 0.0 111.517 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -156.44 14.05 0.36 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.05 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.579 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 5.1 mt -66.74 -4.81 9.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 122.934 0.494 . . . . 0.0 111.953 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.531 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 33.9 t -60.71 87.14 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 109.686 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.448 HD21 ' CD2' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -65.48 178.51 0.95 Allowed 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.249 174.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 43.0 p -122.06 161.13 44.27 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.92 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 8.7 Cg_endo -66.13 4.66 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.038 1.825 . . . . 0.0 112.365 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -110.53 -10.83 20.93 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.809 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -106.42 -21.76 12.99 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.081 0.943 . . . . 0.0 109.828 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.84 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 17.6 p -80.91 18.94 0.92 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.917 -170.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.62 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.32 -35.48 73.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 122.291 1.043 . . . . 0.0 109.671 -172.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.19 159.76 33.3 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.229 174.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.578 ' O ' HG11 ' A' ' 375' ' ' VAL . 59.5 m95 -70.29 -36.95 74.68 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.58 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.26 -40.02 84.69 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.483 -175.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 35.4 t -72.77 -42.59 63.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.649 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.32 -51.52 67.32 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.578 HG11 ' O ' ' A' ' 371' ' ' TRP . 11.2 m -58.52 -45.38 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.458 0.647 . . . . 0.0 109.824 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.66 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.09 -43.31 95.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.648 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.514 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 29.7 m -69.45 -39.21 77.92 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.836 -172.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.5 mt -60.75 -34.37 74.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.586 0.63 . . . . 0.0 110.516 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.739 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 38.0 t80 -73.58 -47.69 38.55 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 122.446 1.117 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -51.1 -32.42 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 112.661 -2.063 . . . . 0.0 111.706 170.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.596 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -59.8 -46.79 88.12 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.435 0.636 . . . . 0.0 111.042 174.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.53 ' HB ' ' HD2' ' A' ' 322' ' ' ARG . 43.8 p -93.22 -24.23 18.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.843 -169.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -110.84 23.14 14.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.05 20.75 15.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.6 m 66.27 163.52 0.17 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.279 0.561 . . . . 0.0 111.429 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.546 ' CE2' HD23 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -130.55 153.96 81.56 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.077 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -99.31 60.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.421 2.747 . . . . 0.0 111.015 164.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.631 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.4 6.32 0.38 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -174.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -70.24 -48.72 55.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.082 0.467 . . . . 0.0 110.629 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.64 ' O ' HG13 ' A' ' 394' ' ' VAL . 41.2 mt-30 -76.61 -27.37 55.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -169.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.713 ' O ' HG22 ' A' ' 394' ' ' VAL . 3.2 mm? -54.66 -31.45 57.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 -171.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.639 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.76 -53.29 40.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.924 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 14.2 m-20 -66.21 -37.92 86.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.1 -45.99 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.644 ' O ' HG21 ' A' ' 399' ' ' VAL . 7.0 mm -58.54 -47.59 87.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 34.0 mmtt -52.11 -42.81 63.58 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.354 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.26 -44.33 13.78 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.034 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.679 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.0 mt -68.97 -40.77 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 117.447 0.623 . . . . 0.0 111.233 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.734 HG22 ' CG ' ' A' ' 429' ' ' TYR . 4.8 m -58.25 -45.63 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.034 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.475 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.1 t70 -62.34 -37.43 85.61 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.948 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -83.47 -53.14 5.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.615 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.39 -28.6 8.86 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.521 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 119.6 165.89 13.15 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.444 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.616 ' HA ' HG11 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.56 -44.07 98.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.594 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -57.31 -51.07 70.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.635 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.43 -49.88 69.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.461 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.679 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.2 -43.62 67.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.484 ' HB3' HD13 ' A' ' 457' ' ' ILE . 28.6 t80 -55.67 -45.72 77.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.803 ' O ' ' HG3' ' A' ' 413' ' ' MET . 16.3 m -57.99 -52.07 67.06 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.702 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -62.89 -49.23 75.64 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.716 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 415' ' ' SER . . . -56.37 -41.81 88.22 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.776 -174.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.581 ' HE1' ' NE2' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.44 -32.15 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 122.245 0.218 . . . . 0.0 111.152 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.803 ' HG3' ' O ' ' A' ' 409' ' ' THR . 60.4 mtm -70.67 -46.56 62.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 109.831 173.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.66 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 16.4 mt -60.51 -38.68 85.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.352 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 411' ' ' GLY . 4.5 p -77.0 -2.9 36.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.326 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.63 29.12 36.63 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.581 ' NE2' ' HE1' ' A' ' 412' ' ' MET . 3.8 mm-40 68.43 45.55 1.15 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 122.253 1.025 . . . . 0.0 111.534 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.565 ' ND2' HD23 ' A' ' 421' ' ' LEU . 7.0 t30 -116.16 71.96 0.8 Allowed 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 164.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 422' ' ' VAL . 0.2 OUTLIER -48.05 -35.77 11.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.046 -2.343 . . . . 0.0 111.64 -172.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.543 ' O ' ' HB3' ' A' ' 423' ' ' SER . 33.3 mt-30 -57.29 -49.91 74.58 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -166.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.565 HD23 ' ND2' ' A' ' 418' ' ' ASN . 3.1 pp -59.53 -48.66 80.78 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.237 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.561 HG11 ' HA ' ' A' ' 412' ' ' MET . 0.7 OUTLIER -59.76 -39.8 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.643 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 44.0 t -59.81 -47.59 85.1 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.793 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.02 -37.38 70.93 Favored Glycine 0 C--N 1.32 -0.339 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.052 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -73.02 -42.69 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.548 0.689 . . . . 0.0 110.239 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.464 HD13 HG22 ' A' ' 395' ' ' ILE . 1.6 mm -55.94 -44.48 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.727 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.663 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.3 OUTLIER -59.74 -30.12 68.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-O 122.701 1.239 . . . . 0.0 109.236 -173.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.16 -16.82 77.0 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.429 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.734 ' CG ' HG22 ' A' ' 399' ' ' VAL . 15.3 m-85 -101.65 2.46 38.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.569 HD21 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.09 144.96 74.87 Favored Pre-proline 0 N--CA 1.416 -2.15 0 CA-C-O 123.501 1.62 . . . . 0.0 113.403 168.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.658 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.5 Cg_endo -72.6 -63.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 1 C-N-CA 126.126 4.551 . . . . 0.0 113.281 -173.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.549 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.06 140.23 15.22 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.181 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.61 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.74 -30.69 70.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.2 0.5 . . . . 0.0 111.204 -177.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -55.33 -48.16 74.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.695 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.0 t -58.61 -52.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.593 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.36 -54.66 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.109 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 53.2 m -62.76 -55.79 23.37 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.047 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.43 -45.13 80.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.642 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.833 ' O ' HD23 ' A' ' 443' ' ' LEU . 40.0 mt -60.06 -53.46 57.56 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.722 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.705 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.74 -34.15 37.94 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 125.124 1.515 . . . . 0.0 110.403 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.662 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.87 -60.62 2.14 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 174.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -75.64 -51.38 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.541 0.61 . . . . 0.0 112.006 -172.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.32 -24.83 63.65 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.636 -178.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.732 ' N ' HD22 ' A' ' 443' ' ' LEU . 12.1 t70 -73.06 -43.35 62.02 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.573 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.7 mt-30 -69.66 -8.95 52.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -172.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.596 ' HB3' HG23 ' A' ' 451' ' ' THR . 20.7 mm-40 -51.89 155.28 1.82 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 123.574 1.654 . . . . 0.0 114.825 -175.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -52.93 -33.32 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 110.752 -2.931 . . . . 0.0 115.335 -171.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.543 ' H ' ' HB ' ' A' ' 451' ' ' THR . 26.5 m-20 -141.73 177.04 8.44 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.94 -52.35 63.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.413 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.9 -25.2 67.05 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 174.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.596 HG23 ' HB3' ' A' ' 446' ' ' GLU . 12.6 m -60.89 -41.43 96.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 119.823 1.192 . . . . 0.0 109.756 172.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 71.8 mtt180 -60.42 -30.71 69.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.921 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.445 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.67 -30.33 59.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.835 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -82.05 -44.25 16.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.858 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.509 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -104.32 -0.74 27.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.383 -167.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.625 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.8 t80 -49.12 -54.31 16.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.349 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -71.39 -25.1 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.538 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -71.99 -43.98 64.22 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.634 ' O ' HG21 ' A' ' 463' ' ' VAL . 30.3 m80 -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.91 172.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.69 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.46 -53.77 43.09 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 122.263 1.03 . . . . 0.0 109.13 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -62.21 -30.65 71.23 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.341 -1.754 . . . . 0.0 110.869 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.7 -48.18 67.29 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.771 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.697 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 25.9 t -65.0 -35.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.352 174.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.53 -14.44 29.61 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.583 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.546 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 2.4 tp10 -92.56 -52.17 4.77 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.404 -0.81 . . . . 0.0 112.114 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.697 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -63.87 -41.15 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.424 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.455 HD13 HD11 ' A' ' 469' ' ' LEU . 7.1 mt -83.39 -16.85 44.32 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.9 50.8 56.37 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 111.565 -2.561 . . . . 0.0 112.977 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.4 OUTLIER -102.86 -178.9 3.8 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.694 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.0 p30 -101.02 -40.89 7.01 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -161.02 -75.79 0.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.114 159.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.658 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -61.48 70.57 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -171.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.42 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.77 46.54 0.61 Allowed Glycine 0 C--N 1.274 -2.862 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.398 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.694 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 22.9 mm-40 -83.89 -53.81 5.32 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 122.245 1.022 . . . . 0.0 111.245 -173.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.8 t 68.0 56.25 0.54 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.889 -174.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.803 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 110.547 -3.024 . . . . 0.0 111.845 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.431 -1.402 0 CA-C-O 121.136 0.493 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.682 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -74.82 127.54 86.86 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 121.765 0.793 . . . . 0.0 111.5 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -72.41 -12.27 27.18 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.881 3.72 . . . . 0.0 111.107 176.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.691 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.6 tp 26.95 -61.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.087 0 C-N-CA 128.704 2.801 . . . . 0.0 115.975 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 306' ' ' PRO . 0.0 OUTLIER -58.36 -32.08 68.22 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.273 0.559 . . . . 0.0 110.257 178.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.516 ' HB3' HG11 ' A' ' 338' ' ' VAL . 6.7 t-160 -62.08 -49.32 76.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.669 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.613 HG23 ' CG2' ' A' ' 350' ' ' ILE . 59.2 mt -58.88 -49.05 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 124.213 1.005 . . . . 0.0 113.08 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.691 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 4.3 mtp-105 -60.64 -30.57 69.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.864 0.364 . . . . 0.0 111.071 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.1 m -70.44 -33.28 71.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.572 0.701 . . . . 0.0 110.205 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.568 HG11 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.21 -40.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.8 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.768 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -82.45 -36.61 26.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.969 1.366 . . . . 0.0 109.759 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.98 35.44 8.22 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 112.117 -2.31 . . . . 0.0 111.135 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 42.8 mt-10 51.49 173.2 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.102 0 C-N-CA 124.196 0.998 . . . . 0.0 113.529 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.518 ' HB3' HD11 ' A' ' 324' ' ' ILE . 23.9 Cg_exo -45.2 142.18 6.16 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.015 2.477 . . . . 0.0 112.343 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.517 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 41.9 Cg_endo -89.71 -100.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.305 2.67 . . . . 0.0 112.896 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.479 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 12.3 mmm180 -94.01 -83.36 0.33 Allowed 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 123.149 0.58 . . . . 0.0 110.935 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.479 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 18.0 m-20 -103.29 163.18 18.0 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.769 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 35.2 Cg_exo -59.28 -51.59 6.25 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.499 2.133 . . . . 0.0 110.676 172.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.27 -14.82 1.95 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.203 -1.817 . . . . 0.0 113.142 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.3 mm-40 -91.64 -26.19 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.419 -0.175 . . . . 0.0 111.405 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.65 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.3 OUTLIER -46.44 -45.12 43.86 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.724 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.6 Cg_endo -47.47 -62.59 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.905 2.404 . . . . 0.0 113.25 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.605 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -63.42 -35.92 74.23 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 122.879 1.323 . . . . 0.0 110.141 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.768 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.6 t90 -57.51 -39.5 76.64 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.74 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.49 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.6 OUTLIER -67.62 -47.5 69.48 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 122.465 0.306 . . . . 0.0 111.716 -175.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.27 -22.96 16.04 Favored Glycine 0 C--N 1.311 -0.858 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.681 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -42.39 62.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.447 0.642 . . . . 0.0 111.31 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.56 ' HB2' HG23 ' A' ' 314' ' ' THR . 1.4 p30 -104.39 -17.61 14.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' A' ' 335' ' ' ILE . . . -40.72 -49.44 7.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.7 Cg_endo -61.81 -33.0 86.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.576 2.184 . . . . 0.0 111.466 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.501 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -71.9 -43.1 65.92 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.884 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.581 HG12 HG21 ' A' ' 310' ' ' ILE . 87.7 mt -58.79 -49.3 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.71 173.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.37 -14.5 4.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.921 175.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.12 -44.21 7.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.485 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 309' ' ' HIS . 92.1 t -60.74 -70.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 123.466 1.603 . . . . 0.0 109.79 169.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.778 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.7 OUTLIER -92.62 130.78 35.83 Favored Pre-proline 0 N--CA 1.403 -2.825 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.265 -173.089 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.778 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.2 Cg_endo -74.78 -16.85 20.6 Favored 'Trans proline' 0 CA--C 1.498 -1.323 0 C-N-CA 123.788 2.992 . . . . 0.0 110.862 173.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.49 HG21 ' CB ' ' A' ' 346' ' ' LEU . 3.1 p 33.4 67.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.342 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.595 ' N ' HD11 ' A' ' 346' ' ' LEU . 41.3 p -78.14 4.26 12.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 112.669 -2.06 . . . . 0.0 113.485 -169.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.789 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 13.5 p -139.86 163.35 45.2 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -63.31 -49.23 4.89 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.367 2.711 . . . . 0.0 108.103 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.735 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -44.32 -45.94 8.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.4 176.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.789 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.4 mt -59.22 -51.63 69.17 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 121.64 0.733 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 3.2 ttm180 -54.1 -45.85 71.96 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.262 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 1.053 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.89 -48.75 62.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 111.355 -177.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.66 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 62.9 mtt180 -56.01 -42.62 76.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 346' ' ' LEU . 39.9 mt -57.73 -54.13 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.523 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.505 ' HA ' HG13 ' A' ' 354' ' ' ILE . 19.8 mt -59.43 -52.57 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 122.162 0.982 . . . . 0.0 110.558 -170.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.527 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 17.4 m-20 -62.79 -35.18 79.01 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.272 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 307' ' ' ILE . . . -69.41 -36.0 76.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.58 -53.83 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 CA-C-O 123.107 1.432 . . . . 0.0 110.463 173.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.607 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -72.68 -25.71 61.36 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 111.716 -2.493 . . . . 0.0 109.412 -168.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 75.93 -74.71 1.57 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.895 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -151.39 56.94 0.45 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.332 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.57 HD21 ' HG ' ' A' ' 355' ' ' LEU . 81.7 m-20 -76.91 162.61 27.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.783 -0.245 . . . . 0.0 110.581 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.54 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -37.43 -59.73 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.252 1.021 . . . . 0.0 113.736 -166.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -153.9 16.56 0.62 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.511 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.545 ' HB3' HD23 ' A' ' 378' ' ' LEU . 6.3 mt -65.59 -3.87 5.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.942 0.497 . . . . 0.0 112.139 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.527 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.9 t -63.47 84.24 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.529 0.68 . . . . 0.0 110.309 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.463 HD21 ' CD2' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -62.63 170.53 2.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.773 0.796 . . . . 0.0 112.388 174.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 366' ' ' GLY . 65.4 p -111.31 156.33 41.32 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.952 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 1.053 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.8 Cg_endo -61.92 11.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.673 2.248 . . . . 0.0 113.794 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -128.53 -5.65 4.94 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.415 ' HB2' HD11 ' A' ' 363' ' ' LEU . 8.4 m-20 -109.57 -19.91 13.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.205 1.002 . . . . 0.0 110.298 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 15.4 p -88.56 16.27 6.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.595 -168.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 366' ' ' GLY . 1.0 OUTLIER -59.61 -40.84 88.86 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.524 -164.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.62 160.09 21.84 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.523 171.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.574 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.6 m95 -69.88 -35.89 75.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.577 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.44 -40.24 96.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.251 -175.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 36.8 t -68.69 -43.58 75.76 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.938 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.651 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.77 62.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 371' ' ' TRP . 15.1 m -57.22 -44.73 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.662 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.4 -44.75 95.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.019 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.521 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 55.5 m -68.79 -39.42 80.15 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.825 -172.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.1 mt -60.8 -33.22 72.66 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.849 -0.532 . . . . 0.0 110.57 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.724 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 49.8 t80 -75.0 -46.04 37.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.349 1.071 . . . . 0.0 109.161 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -51.54 -32.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.328 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.0 OUTLIER -59.85 -41.24 90.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 44.5 p -100.03 -23.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.36 -167.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -110.22 24.24 13.26 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.43 18.31 29.11 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 114.864 0.705 . . . . 0.0 114.864 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 66.17 159.37 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.286 0.565 . . . . 0.0 111.385 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.581 ' CE2' HD22 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -127.64 152.19 76.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -96.76 53.7 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.351 2.701 . . . . 0.0 111.211 166.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.618 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.17 7.87 0.71 Allowed 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -71.04 -48.59 51.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 0.0 110.389 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.644 ' O ' HG12 ' A' ' 394' ' ' VAL . 56.6 mt-30 -76.2 -26.15 55.86 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.689 ' O ' HG21 ' A' ' 394' ' ' VAL . 3.1 mm? -54.05 -31.36 51.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.332 0.969 . . . . 0.0 111.384 -173.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.56 -49.79 63.41 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.971 174.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.583 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 36.4 m-20 -69.34 -39.25 78.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 391' ' ' LEU . 1.9 m -57.46 -44.07 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.419 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.634 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.7 mm -58.24 -46.94 88.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.676 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.602 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 30.3 mmtt -52.4 -43.41 64.75 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.707 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.56 -44.34 16.5 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.1 -172.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.646 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.4 mt -69.31 -41.4 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 117.519 0.66 . . . . 0.0 111.552 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.688 HG23 ' CG ' ' A' ' 429' ' ' TYR . 6.4 m -57.64 -43.77 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.822 0.82 . . . . 0.0 109.955 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.468 ' N ' HG21 ' A' ' 399' ' ' VAL . 3.4 t70 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.064 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 70.1 mt-30 -83.78 -54.27 5.02 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.536 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -112.43 -30.46 7.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.796 -166.664 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.11 163.49 11.55 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.735 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.615 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.38 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.579 ' HB3' HG23 ' A' ' 457' ' ' ILE . . . -56.3 -50.51 71.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.1 0.476 . . . . 0.0 111.448 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.569 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -51.03 65.19 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.5 178.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.646 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.0 -41.85 65.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 31.6 t80 -57.08 -46.69 82.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.665 0.745 . . . . 0.0 109.086 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.812 ' O ' ' HG3' ' A' ' 413' ' ' MET . 8.5 m -58.69 -52.5 65.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.562 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.605 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.7 mm? -62.92 -49.01 76.46 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.737 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.626 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.95 -42.23 86.17 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.923 -174.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.573 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -32.64 66.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.66 0.23 . . . . 0.0 111.239 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.812 ' HG3' ' O ' ' A' ' 409' ' ' THR . 66.7 mtm -70.63 -46.98 62.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.383 0.611 . . . . 0.0 110.06 174.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.662 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 14.4 mt -59.23 -38.46 80.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.023 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.626 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.3 OUTLIER -77.45 -14.62 59.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.951 -176.066 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.67 27.03 8.71 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.178 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.573 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 3.9 mm-40 64.35 44.17 4.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.101 0.961 . . . . 0.0 112.292 177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.606 ' ND2' HD22 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -120.24 69.5 0.86 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 166.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.506 ' CZ ' ' HG2' ' A' ' 420' ' ' GLN . 0.8 OUTLIER -47.47 -35.25 8.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 111.568 -2.56 . . . . 0.0 113.477 -165.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 423' ' ' SER . 28.0 mt-30 -55.03 -47.74 74.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -163.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.606 HD22 ' ND2' ' A' ' 418' ' ' ASN . 1.9 pp -59.71 -48.99 79.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.384 0.612 . . . . 0.0 110.81 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.59 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.25 -38.87 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.574 1.178 . . . . 0.0 109.263 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 40.4 t -61.13 -46.53 90.19 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.905 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.77 72.93 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.019 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -72.26 -41.91 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.549 0.69 . . . . 0.0 110.162 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.481 HD13 HG21 ' A' ' 395' ' ' ILE . 1.6 mm -56.18 -44.8 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.604 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.38 -30.77 68.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.618 1.199 . . . . 0.0 109.376 -174.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.68 -14.33 77.93 Favored Glycine 0 C--N 1.299 -1.483 0 CA-C-N 112.845 -1.979 . . . . 0.0 112.503 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.688 ' CG ' HG23 ' A' ' 399' ' ' VAL . 16.5 m-85 -103.83 3.03 33.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.58 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.5 144.75 78.25 Favored Pre-proline 0 N--CA 1.411 -2.411 0 CA-C-O 123.541 1.639 . . . . 0.0 112.996 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.668 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.9 Cg_endo -72.94 -63.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 1 C-N-CA 126.074 4.516 . . . . 0.0 113.422 -173.056 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.554 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -104.58 141.86 15.37 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.622 ' HA ' HG11 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -65.68 -26.82 67.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.22 0.51 . . . . 0.0 111.216 -176.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.33 86.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.674 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.9 t -59.39 -52.04 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.629 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.36 -53.79 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.467 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 94.4 m -61.15 -56.6 18.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.96 -46.24 78.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.519 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.845 ' O ' HD22 ' A' ' 443' ' ' LEU . 54.9 mt -59.95 -53.5 57.08 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.64 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.675 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.5 mm-40 -51.77 -34.48 39.82 Favored 'General case' 0 N--CA 1.415 -2.19 0 O-C-N 124.956 1.41 . . . . 0.0 110.682 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.672 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.29 -61.81 1.69 Allowed 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 175.079 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.55 -50.17 14.59 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.85 -0.531 . . . . 0.0 112.205 -171.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.7 -25.35 62.8 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.34 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.731 ' N ' HD21 ' A' ' 443' ' ' LEU . 14.5 t70 -72.81 -42.74 63.54 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.701 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.672 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.8 mt-30 -68.97 -7.6 36.77 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -172.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.62 ' HB3' HG23 ' A' ' 451' ' ' THR . 4.9 mm-40 -51.66 156.22 1.42 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.516 1.627 . . . . 0.0 114.363 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.462 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.22 -32.37 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 110.719 -2.946 . . . . 0.0 115.38 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.547 ' H ' ' HB ' ' A' ' 451' ' ' THR . 19.1 m-20 -142.02 179.94 6.59 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.456 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 3.6 m-20 -62.65 -55.58 25.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.408 ' HA ' ' HB1' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.61 -25.2 67.86 Favored 'General case' 0 N--CA 1.403 -2.795 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.411 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.62 HG23 ' HB3' ' A' ' 446' ' ' GLU . 23.6 m -60.31 -41.91 94.45 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 119.793 1.179 . . . . 0.0 109.543 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.555 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 45.8 mtt180 -60.88 -30.32 70.08 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.851 172.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.536 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.65 -29.47 59.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.921 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.09 -44.66 17.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.788 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.561 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.1 p -106.24 0.39 25.16 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.184 -167.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.624 ' CE1' HD21 ' A' ' 460' ' ' LEU . 7.9 t80 -48.91 -53.83 17.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.03 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 405' ' ' ALA . 26.2 mm -71.06 -25.49 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.561 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.17 -43.42 64.61 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.632 ' O ' HG23 ' A' ' 463' ' ' VAL . 26.8 m80 -65.45 -32.03 73.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.722 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.675 HD22 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.14 -53.47 37.42 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.066 0.936 . . . . 0.0 109.512 -178.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.654 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 8.3 m-80 -62.37 -32.31 73.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.068 173.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.66 -53.36 57.23 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.893 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.715 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 20.9 t -62.7 -34.88 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.858 0 CA-C-O 121.818 0.818 . . . . 0.0 110.4 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.7 -14.7 33.95 Favored 'General case' 0 C--O 1.207 -1.155 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.32 170.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.654 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 43.4 mt-10 -92.99 -48.28 6.59 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.097 -1.002 . . . . 0.0 112.69 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.715 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.6 pt -66.27 -38.1 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.237 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.447 ' HB3' HD21 ' A' ' 469' ' ' LEU . 6.6 mt -85.27 -17.16 37.78 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.737 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 61.8 55.73 26.8 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.659 -2.518 . . . . 0.0 112.942 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.5 OUTLIER -105.02 -159.21 0.7 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 122.088 0.947 . . . . 0.0 109.644 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.608 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.3 p30 -124.76 -41.39 2.13 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.455 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -159.21 -79.59 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 112.251 -2.249 . . . . 0.0 110.619 156.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.668 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 1.3 mpt_? -59.06 68.13 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 33.47 53.58 0.6 Allowed Glycine 0 C--N 1.278 -2.689 0 CA-C-N 111.099 -2.773 . . . . 0.0 113.367 173.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.608 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 5.9 mm-40 -90.13 -49.07 6.78 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 122.4 1.095 . . . . 0.0 111.259 -173.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 27.2 t 62.0 62.58 1.21 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.119 -2.31 . . . . 0.0 108.561 -171.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.737 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.281 0 CA-C-N 110.932 -2.849 . . . . 0.0 112.115 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.428 -1.549 0 CA-C-O 120.857 0.36 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.696 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -74.73 125.43 89.56 Favored Pre-proline 0 N--CA 1.426 -1.65 0 CA-C-O 121.909 0.862 . . . . 0.0 111.852 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.512 ' HG2' HG11 ' A' ' 338' ' ' VAL . 17.6 Cg_endo -72.46 -11.32 26.37 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 124.929 3.752 . . . . 0.0 111.372 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.672 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.7 tp 25.66 -60.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 C-N-CA 128.677 2.791 . . . . 0.0 116.34 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 306' ' ' PRO . 0.0 OUTLIER -58.17 -32.44 68.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.355 0.598 . . . . 0.0 110.138 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.518 ' HB3' HG12 ' A' ' 338' ' ' VAL . 6.9 t-160 -62.4 -48.95 77.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.66 172.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.597 HG22 ' CG2' ' A' ' 350' ' ' ILE . 57.6 mt -58.59 -48.71 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 124.006 0.922 . . . . 0.0 113.172 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.4 mtp-105 -60.22 -30.11 69.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.14 -0.35 . . . . 0.0 111.41 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 46.9 m -69.6 -35.43 75.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.564 0.697 . . . . 0.0 109.845 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 314' ' ' THR . 0.6 OUTLIER -66.07 -40.9 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.717 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.815 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -83.35 -36.88 24.03 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.797 1.284 . . . . 0.0 110.235 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.66 36.67 7.8 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.245 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 38.8 mt-10 49.87 175.53 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 124.071 0.948 . . . . 0.0 113.261 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.532 ' HB3' HD12 ' A' ' 324' ' ' ILE . 90.8 Cg_exo -52.44 134.7 52.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.603 2.202 . . . . 0.0 112.48 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.74 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 95.1 Cg_endo -85.23 -90.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.487 2.792 . . . . 0.0 114.788 -174.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.458 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 6.4 mmm180 -93.76 -78.93 0.42 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.048 0.928 . . . . 0.0 113.033 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.586 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 65.1 m-20 -105.4 -159.93 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.756 -169.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 320' ' ' ASN . 58.6 Cg_endo -90.89 -32.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 121.647 1.565 . . . . 0.0 114.671 159.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 15.72 10.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -169.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.718 ' OE2' ' HG2' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -106.31 -35.83 7.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.671 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.615 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.4 OUTLIER -40.15 -46.15 5.22 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.345 1.458 . . . . 0.0 114.077 178.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.684 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.2 Cg_endo -47.01 -63.04 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.055 2.503 . . . . 0.0 112.814 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.581 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.8 OUTLIER -65.35 -35.53 75.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 123.054 1.407 . . . . 0.0 110.428 -179.047 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.815 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 32.7 t90 -58.34 -34.05 70.2 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.973 177.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.8 OUTLIER -70.45 -48.04 57.8 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.6 -23.13 19.31 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.793 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 0.5 OUTLIER -74.41 -42.94 58.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.247 1.023 . . . . 0.0 110.617 174.137 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.576 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.0 m-20 -95.67 -24.96 16.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.679 -168.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.529 ' HA ' HD11 ' A' ' 335' ' ' ILE . . . -42.1 -49.76 11.28 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 124.418 1.087 . . . . 0.0 113.749 177.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 49.3 Cg_endo -63.09 -31.27 75.92 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.544 2.163 . . . . 0.0 111.525 177.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.483 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -74.04 -44.11 55.47 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.689 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.567 HG12 HG23 ' A' ' 310' ' ' ILE . 88.7 mt -58.37 -48.69 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.584 173.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 19.4 t70 -57.09 -17.85 12.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.264 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -44.51 10.15 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.518 HG12 ' HB3' ' A' ' 309' ' ' HIS . 94.0 t -60.64 -68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 123.587 1.66 . . . . 0.0 110.242 169.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.76 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.7 OUTLIER -96.29 130.07 31.91 Favored Pre-proline 0 N--CA 1.403 -2.802 0 CA-C-N 110.791 -2.913 . . . . 0.0 112.787 -171.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.76 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -75.4 -16.36 19.39 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 123.89 3.06 . . . . 0.0 110.927 174.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.53 66.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 112.33 -2.214 . . . . 0.0 110.323 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.604 ' N ' HD12 ' A' ' 346' ' ' LEU . 34.8 p -77.88 2.71 16.48 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.681 -2.054 . . . . 0.0 113.225 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.789 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.1 p -138.06 161.36 60.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 41.1 Cg_exo -63.97 -46.53 8.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.419 2.746 . . . . 0.0 108.454 172.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.617 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -45.51 -44.2 12.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.425 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.789 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.3 mt -61.35 -52.01 66.43 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.696 0.76 . . . . 0.0 110.459 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 2.6 ttm180 -52.12 -47.32 65.38 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.627 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.969 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.5 OUTLIER -69.45 -48.24 61.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.734 -176.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 46.4 mtt180 -56.54 -42.1 77.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.232 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.625 ' O ' HG12 ' A' ' 354' ' ' ILE . 43.0 mt -57.24 -53.27 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.446 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.507 ' HA ' HG13 ' A' ' 354' ' ' ILE . 18.2 mt -59.4 -52.57 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 122.158 0.98 . . . . 0.0 110.986 -170.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.537 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 25.8 m-20 -63.42 -35.45 80.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.37 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 307' ' ' ILE . . . -68.8 -34.38 75.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -57.86 -54.31 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.052 1.406 . . . . 0.0 110.66 173.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.6 OUTLIER -72.12 -24.76 61.52 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.328 -169.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.5 -65.28 1.06 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.849 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -139.51 66.91 0.51 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.233 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.655 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 31.3 p30 -78.75 164.9 24.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.23 0.212 . . . . 0.0 111.283 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.469 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -56.52 -65.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 122.94 0.496 . . . . 0.0 111.289 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -148.55 10.9 1.12 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.565 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.655 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 3.7 mt -65.01 -5.85 7.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.723 0.409 . . . . 0.0 111.408 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.537 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 19.4 t -60.71 82.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.402 0.62 . . . . 0.0 110.596 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.456 HD23 ' CD2' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -64.55 170.67 3.8 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.953 0.882 . . . . 0.0 112.629 175.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 33.4 p -118.66 155.5 52.35 Favored Pre-proline 0 N--CA 1.436 -1.17 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.99 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.969 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.9 Cg_endo -54.8 -11.28 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.801 2.334 . . . . 0.0 113.419 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.567 ' O ' HD13 ' A' ' 369' ' ' LEU . . . -103.75 -6.31 43.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.139 -0.553 . . . . 0.0 114.471 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.407 ' HB2' HD13 ' A' ' 363' ' ' LEU . 1.3 m-20 -109.83 -18.83 13.33 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.075 0.941 . . . . 0.0 110.777 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.744 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 19.3 p -92.43 18.86 7.85 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.747 -167.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.567 HD13 ' O ' ' A' ' 366' ' ' GLY . 1.8 mt -62.15 -35.71 79.6 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.369 1.081 . . . . 0.0 110.242 -162.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.5 p -116.03 167.31 11.09 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.313 171.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.597 ' O ' HG11 ' A' ' 375' ' ' VAL . 43.1 m95 -70.39 -34.05 72.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.596 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.21 -43.56 94.65 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.559 0.695 . . . . 0.0 109.711 -173.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.7 p -66.24 -44.21 84.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.312 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.639 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.85 62.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 371' ' ' TRP . 12.0 m -58.13 -44.03 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.644 0.735 . . . . 0.0 109.568 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.704 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -62.63 -46.01 90.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.777 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.51 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 34.4 m -65.84 -40.74 92.02 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.445 -173.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.7 mt -60.16 -33.55 72.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.677 0.671 . . . . 0.0 110.369 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.684 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 65.8 t80 -73.36 -46.46 49.02 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 122.382 1.087 . . . . 0.0 109.567 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -51.83 -32.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 112.801 -1.999 . . . . 0.0 111.158 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.45 -38.13 83.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 176.399 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 37.2 p -98.25 -22.83 15.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.639 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . 0.434 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 26.6 m80 -110.08 22.19 15.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.91 21.0 28.85 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.4 m 65.98 158.17 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 111.906 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -126.65 155.35 75.05 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 389' ' ' HIS . 91.5 Cg_endo -101.61 58.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.912 3.075 . . . . 0.0 111.437 166.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.608 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.5 -2.08 0.09 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.4 t60 -69.64 -45.11 69.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.492 . . . . 0.0 110.847 176.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.618 ' O ' HG11 ' A' ' 394' ' ' VAL . 77.6 mt-30 -74.91 -26.71 59.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.92 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.2 -30.98 51.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.922 0.783 . . . . 0.0 111.787 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.607 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.99 -48.54 66.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.545 173.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.507 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 59.1 m-20 -68.47 -41.16 80.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.087 0.555 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.44 -44.93 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.257 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.4 mm -58.34 -47.39 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.459 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.3 mmtt -52.2 -43.17 64.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.936 0.772 . . . . 0.0 111.49 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.58 -44.11 17.06 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.15 -172.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.638 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 3.7 mt -69.12 -42.0 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 117.294 0.547 . . . . 0.0 111.596 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.727 HG23 ' CG ' ' A' ' 429' ' ' TYR . 5.4 m -58.71 -43.24 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.884 0.85 . . . . 0.0 109.872 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.419 ' N ' HG21 ' A' ' 399' ' ' VAL . 19.0 t70 -57.16 -44.5 83.51 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.328 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -86.66 -53.3 5.03 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.673 -1.149 . . . . 0.0 113.424 -170.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.538 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -109.04 -31.44 7.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.427 0.632 . . . . 0.0 111.549 -170.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.62 165.07 11.79 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.841 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.606 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -45.93 96.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.604 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -55.91 -50.14 71.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.591 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.511 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -50.82 66.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.369 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.638 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.54 -41.58 63.63 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 45.3 t80 -57.85 -46.51 84.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.572 0.701 . . . . 0.0 109.533 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.716 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.7 m -59.82 -52.71 64.28 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.816 -178.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.616 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -62.06 -49.03 77.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.875 177.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.78 -41.35 82.97 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.091 -175.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.581 ' HA ' HG12 ' A' ' 422' ' ' VAL . 0.3 OUTLIER -72.06 -33.73 68.18 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.643 0.222 . . . . 0.0 110.826 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.716 ' HG3' ' O ' ' A' ' 409' ' ' THR . 62.4 mtm -69.51 -46.63 66.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.042 174.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.704 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 15.9 mt -58.79 -40.13 83.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.924 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.92 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.5 m -78.84 -14.52 59.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.03 44.08 4.54 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.948 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.56 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 56.58 42.18 27.54 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 124.269 1.028 . . . . 0.0 113.323 178.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.747 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.1 OUTLIER -119.5 74.27 0.99 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.462 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 0.7 OUTLIER -49.65 -36.04 23.33 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 111.907 -2.406 . . . . 0.0 113.009 -167.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.5 mt-30 -54.83 -49.24 71.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -163.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.692 HD12 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.497 0.665 . . . . 0.0 111.184 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.583 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.648 1.213 . . . . 0.0 109.152 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 41.3 t -61.56 -46.9 87.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.467 -2.152 . . . . 0.0 112.023 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.21 -37.97 75.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.843 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 422' ' ' VAL . 2.4 mt -72.17 -41.47 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 110.048 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.499 HD12 HG22 ' A' ' 395' ' ' ILE . 1.5 mm -57.39 -45.05 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.003 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.618 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -61.69 -28.97 69.78 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 122.704 1.24 . . . . 0.0 108.963 -173.036 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.9 -17.86 77.21 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.374 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.727 ' CG ' HG23 ' A' ' 399' ' ' VAL . 11.3 m-85 -101.03 4.16 42.1 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.578 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.39 144.29 71.7 Favored Pre-proline 0 N--CA 1.41 -2.448 0 CA-C-O 123.722 1.725 . . . . 0.0 113.226 168.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.749 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.5 Cg_endo -71.37 -58.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.115 1 C-N-CA 126.308 4.672 . . . . 0.0 113.172 -170.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.22 142.38 17.15 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.105 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.6 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.48 -31.74 71.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.043 0.422 . . . . 0.0 111.28 -177.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.2 -46.47 79.44 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.647 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.4 t -59.44 -51.04 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.785 177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.6 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.64 -54.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 57.0 m -62.7 -56.44 17.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.48 -42.83 78.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.484 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.846 ' O ' HD21 ' A' ' 443' ' ' LEU . 54.1 mt -63.42 -53.25 55.34 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.204 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.653 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 35.0 mm-40 -51.31 -33.84 30.77 Favored 'General case' 0 N--CA 1.419 -2.014 0 O-C-N 124.959 1.412 . . . . 0.0 110.334 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.687 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.99 -60.96 1.99 Allowed 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 172.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.2 ptp180 -74.03 -53.6 9.67 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.613 -0.679 . . . . 0.0 112.536 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.846 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.24 -24.96 63.62 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.63 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.717 ' N ' HD23 ' A' ' 443' ' ' LEU . 8.3 t70 -73.17 -42.16 63.08 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.494 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 35.1 mt-30 -70.64 -7.98 48.35 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.625 ' HB3' HG22 ' A' ' 451' ' ' THR . 6.2 mm-40 -51.31 158.46 0.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 123.581 1.657 . . . . 0.0 114.623 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.9 mp -53.08 -32.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 110.543 -3.026 . . . . 0.0 115.33 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.555 ' H ' ' HB ' ' A' ' 451' ' ' THR . 13.6 m-20 -142.75 179.76 6.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.759 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.438 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 11.1 p-10 -61.68 -54.95 35.79 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -65.64 -26.51 67.84 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 446' ' ' GLU . 24.5 m -59.17 -41.19 87.86 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 119.905 1.229 . . . . 0.0 109.678 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 66.7 mtt180 -60.47 -29.57 69.13 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.935 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.493 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.61 -33.99 58.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.332 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.5 mm-40 -78.51 -44.63 23.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.941 -171.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.561 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 24.8 p -105.17 0.53 27.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.061 -167.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.541 ' HB2' ' O ' ' A' ' 452' ' ' ARG . 5.6 t80 -49.19 -54.87 14.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -70.44 -26.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.561 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.23 -42.97 68.19 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.633 ' O ' HG21 ' A' ' 463' ' ' VAL . 30.1 m80 -67.78 -31.89 72.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.745 172.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.707 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -63.48 -53.39 52.8 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.179 0.99 . . . . 0.0 109.292 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.4 m-80 -62.89 -31.8 72.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.525 173.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -63.96 -50.99 66.46 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.854 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.717 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 31.9 t -63.04 -34.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.906 0.86 . . . . 0.0 110.34 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.515 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.2 m-30 -61.18 -15.95 39.53 Favored 'General case' 0 C--O 1.205 -1.284 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.185 169.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 462' ' ' ALA . 33.5 mm-40 -90.34 -49.8 6.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 112.789 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.717 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.92 -39.42 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.86 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.477 ' HG ' HG12 ' A' ' 463' ' ' VAL . 6.9 mt -84.67 -16.04 43.27 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 171.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.746 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.31 52.02 50.21 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 111.741 -2.482 . . . . 0.0 113.1 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.3 OUTLIER -103.8 177.96 4.69 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 123.583 0.753 . . . . 0.0 109.892 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.637 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.4 p30 -96.55 -41.4 8.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 167.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -160.42 -74.37 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.356 -2.202 . . . . 0.0 111.19 158.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.749 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -63.15 68.91 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -169.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.454 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 40.09 40.03 1.66 Allowed Glycine 0 C--N 1.278 -2.677 0 CA-C-N 111.176 -2.738 . . . . 0.0 113.48 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.637 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 11.4 mm-40 -78.87 -51.62 9.44 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.142 0.972 . . . . 0.0 111.566 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.9 t 65.18 55.06 1.14 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.306 -173.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.746 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.467 0 CA-C-N 110.637 -2.983 . . . . 0.0 111.928 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.429 -1.516 0 CA-C-O 121.049 0.452 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.676 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.3 mt -73.83 125.85 90.01 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-O 121.716 0.769 . . . . 0.0 111.643 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 308' ' ' GLN . 23.3 Cg_endo -71.75 -15.98 29.95 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 124.555 3.503 . . . . 0.0 110.883 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.747 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.9 tp 30.38 -58.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 C-N-CA 128.673 2.789 . . . . 0.0 116.275 172.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 306' ' ' PRO . 3.3 mm-40 -56.17 -38.84 71.47 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.097 0.951 . . . . 0.0 109.811 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.487 ' HB3' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -59.85 -47.8 84.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.799 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' A' ' 339' ' ' PHE . 65.2 mt -60.2 -48.22 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 123.861 0.864 . . . . 0.0 113.036 174.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.747 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 5.5 mtp180 -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 O-C-N 122.032 -0.417 . . . . 0.0 110.461 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 23.2 t -70.03 -34.05 72.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.623 . . . . 0.0 109.6 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.558 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.38 -41.59 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.775 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.663 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 29.8 p -83.0 -36.66 24.85 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.765 1.269 . . . . 0.0 109.671 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.61 34.04 8.79 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.419 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 51.23 173.1 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.323 0 C-N-CA 124.419 1.087 . . . . 0.0 113.105 -173.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.551 ' HB3' HD11 ' A' ' 324' ' ' ILE . 28.2 Cg_exo -46.16 152.34 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.128 2.552 . . . . 0.0 113.586 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -89.52 -101.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.264 2.643 . . . . 0.0 111.991 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.431 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 13.3 mmt180 -104.38 -82.63 0.51 Allowed 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.126 0.489 . . . . 0.0 111.504 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.517 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 22.9 m-80 -98.33 163.14 19.76 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.861 -171.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.15 -51.67 6.26 Favored 'Trans proline' 0 CA--C 1.509 -0.756 0 C-N-CA 123.117 2.545 . . . . 0.0 110.971 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -13.56 2.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.492 -1.686 . . . . 0.0 113.29 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.2 mt-10 -92.86 -31.74 14.87 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.256 -0.177 . . . . 0.0 110.89 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -47.83 -45.03 60.46 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -177.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.716 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.5 Cg_endo -49.64 -61.91 0.5 Allowed 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.974 2.449 . . . . 0.0 112.849 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.558 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.25 -37.19 77.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.663 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 38.3 t90 -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.099 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.22 -48.18 58.17 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.426 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.58 -23.07 18.9 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.827 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -74.57 -43.06 57.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.259 1.028 . . . . 0.0 110.483 174.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.564 ' HB3' HG23 ' A' ' 314' ' ' THR . 48.3 m-20 -95.16 -24.18 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.444 -1.707 . . . . 0.0 113.601 -168.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.559 ' HA ' HD11 ' A' ' 335' ' ' ILE . . . -42.04 -50.32 10.87 Favored Pre-proline 0 C--N 1.306 -1.295 0 C-N-CA 124.223 1.009 . . . . 0.0 113.612 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.1 Cg_endo -62.08 -31.76 83.48 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.741 2.294 . . . . 0.0 111.828 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -73.59 -44.17 57.86 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.549 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 310' ' ' ILE . 91.0 mt -58.38 -48.42 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.855 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.67 -19.61 11.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.07 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.41 -48.07 9.74 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 309' ' ' HIS . 62.2 t -57.89 -72.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-O 123.445 1.593 . . . . 0.0 110.098 169.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.767 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.6 OUTLIER -92.39 129.56 40.53 Favored Pre-proline 0 N--CA 1.405 -2.686 0 CA-C-N 111.196 -2.729 . . . . 0.0 112.623 -171.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.767 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.7 Cg_endo -74.8 -16.47 20.73 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 123.981 3.12 . . . . 0.0 110.763 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.36 66.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 112.347 -2.206 . . . . 0.0 110.182 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.653 ' N ' HD12 ' A' ' 346' ' ' LEU . 37.4 p -79.37 8.66 5.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.945 -1.934 . . . . 0.0 113.586 -170.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.766 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.5 p -142.23 164.13 35.37 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.417 ' O ' ' SG ' ' A' ' 348' ' ' CYS . 44.6 Cg_exo -63.06 -50.02 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.154 2.569 . . . . 0.0 108.309 172.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.673 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.7 OUTLIER -42.7 -48.23 5.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.972 176.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.766 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.1 mt -56.43 -52.61 64.03 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.587 -177.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.683 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 39.1 ttm105 -54.72 -45.61 74.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.56 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 1.051 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.48 -48.38 60.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.067 0.461 . . . . 0.0 111.258 -176.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 49.7 mtp180 -55.96 -41.9 75.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.929 177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.685 HG13 ' O ' ' A' ' 346' ' ' LEU . 49.0 mt -58.72 -54.29 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.678 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.455 ' HA ' HG13 ' A' ' 354' ' ' ILE . 19.5 mt -57.85 -52.97 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.109 0.956 . . . . 0.0 110.777 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.2 m-20 -63.56 -34.98 79.01 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.911 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.499 ' HB1' HD12 ' A' ' 307' ' ' ILE . . . -69.16 -38.34 78.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.858 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.13 -52.82 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.001 1.382 . . . . 0.0 110.192 175.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.567 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.8 OUTLIER -72.96 -24.81 60.83 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 111.719 -2.491 . . . . 0.0 109.414 -170.157 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.82 -80.35 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 113.656 -1.611 . . . . 0.0 113.013 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.02 72.71 0.29 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.558 HD21 ' CD2' ' A' ' 355' ' ' LEU . 18.5 p30 -94.59 157.68 15.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 122.541 0.336 . . . . 0.0 111.32 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.588 ' N ' HD11 ' A' ' 359' ' ' ILE . 2.4 mp -81.28 89.34 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-O 121.11 0.481 . . . . 0.0 111.83 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.47 -16.97 15.64 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.552 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.546 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.4 mt -60.68 -4.68 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.484 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 25.1 t -63.69 81.98 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 110.353 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.431 HD21 ' CD2' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -61.96 172.46 1.35 Allowed 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.908 174.384 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.581 ' C ' ' H ' ' A' ' 366' ' ' GLY . 44.1 p -112.76 162.71 20.39 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.186 -174.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 1.051 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.0 Cg_endo -67.04 21.21 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.42 2.08 . . . . 0.0 112.583 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -131.66 -12.05 2.04 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.329 -0.85 . . . . 0.0 114.207 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -105.2 -20.49 13.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.715 1.245 . . . . 0.0 109.44 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.88 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 3.8 p -75.3 19.11 0.18 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.244 -172.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.73 -32.73 70.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.362 1.077 . . . . 0.0 109.814 -170.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.3 35.98 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.266 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.551 ' O ' HG12 ' A' ' 375' ' ' VAL . 65.4 m95 -69.66 -35.49 75.2 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.61 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.4 OUTLIER -60.81 -40.86 94.3 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.804 -175.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 53.9 m -68.92 -43.69 74.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.694 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.53 -52.71 62.38 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 371' ' ' TRP . 12.3 m -57.24 -45.73 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.395 0.617 . . . . 0.0 109.666 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.681 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -61.68 -45.57 93.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.889 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.524 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 31.7 m -67.56 -37.69 83.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.594 -172.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -60.95 -35.22 76.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.471 0.578 . . . . 0.0 110.434 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.716 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 55.6 t80 -72.51 -46.91 52.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.561 1.172 . . . . 0.0 109.175 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.647 HD11 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.07 -32.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.344 171.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.13 -46.58 89.16 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 123.193 0.597 . . . . 0.0 111.175 175.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.7 p -89.12 -23.98 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.531 -171.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . 0.447 ' HB3' HE22 ' A' ' 390' ' ' GLN . 27.2 m80 -111.28 23.22 14.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.0 21.56 24.63 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.745 0.658 . . . . 0.0 114.745 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 67.04 160.36 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.906 0.482 . . . . 0.0 111.413 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.561 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -125.45 158.48 64.25 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.475 ' C ' ' H ' ' A' ' 389' ' ' HIS . 90.6 Cg_endo -101.33 53.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.894 3.063 . . . . 0.0 111.466 166.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.638 ' HA ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.83 -14.99 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -175.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.475 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.1 t60 -57.52 -42.59 83.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.881 0.372 . . . . 0.0 110.648 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.7 mt-30 -75.2 -27.93 59.79 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -171.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.715 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -54.16 -31.27 52.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.972 0.806 . . . . 0.0 111.455 -176.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.643 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.37 -51.48 51.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.735 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 17.9 m-20 -68.97 -37.91 79.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -57.66 -46.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.044 0.449 . . . . 0.0 110.101 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.657 ' O ' HG21 ' A' ' 399' ' ' VAL . 21.8 mm -59.01 -45.87 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.967 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.682 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 37.2 mmtt -52.05 -42.78 63.41 Favored 'General case' 0 C--O 1.244 0.793 0 O-C-N 124.025 0.828 . . . . 0.0 111.531 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.35 -44.19 13.96 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.128 -172.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.638 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.5 mt -69.31 -40.81 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 117.429 0.615 . . . . 0.0 111.575 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.74 HG22 ' CG ' ' A' ' 429' ' ' TYR . 5.4 m -58.84 -43.94 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.823 0.821 . . . . 0.0 109.749 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 399' ' ' VAL . 16.2 t70 -59.19 -42.26 90.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.486 177.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 29.2 mm-40 -86.28 -53.1 5.22 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.331 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.475 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 1.1 mm-40 -109.56 -31.15 7.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.467 0.651 . . . . 0.0 111.622 -170.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.28 164.05 11.67 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.889 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.62 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -44.1 98.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 123.104 0.561 . . . . 0.0 112.417 -175.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -54.54 -52.27 62.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.57 0.7 . . . . 0.0 111.843 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.513 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.5 -49.69 68.07 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.348 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.638 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.31 -42.18 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.586 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 29.1 t80 -55.72 -48.65 74.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.589 0.709 . . . . 0.0 109.371 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.744 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.1 m -58.32 -52.16 66.75 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.752 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 414' ' ' LEU . 2.7 mm? -61.52 -48.72 79.78 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.604 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.471 ' HA2' HD11 ' A' ' 414' ' ' LEU . . . -56.25 -43.7 89.26 Favored Glycine 0 C--N 1.315 -0.603 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.392 -174.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.614 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -72.21 -31.22 65.67 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.795 0.298 . . . . 0.0 110.874 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.744 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.9 mtm -69.03 -48.97 61.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.35 0.595 . . . . 0.0 109.866 172.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.681 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.07 -39.35 81.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.113 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.766 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.4 OUTLIER -77.4 -14.3 59.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.684 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.84 4.88 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.866 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.614 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.0 OUTLIER 58.15 43.7 20.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.794 0.838 . . . . 0.0 113.228 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.766 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.2 OUTLIER -124.37 79.92 1.79 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.164 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.662 ' HD2' ' OG ' ' A' ' 423' ' ' SER . 7.5 p90 -62.27 -31.85 72.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.146 -163.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.406 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 47.4 mt-30 -53.79 -49.6 67.94 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.377 -164.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.702 HD12 ' OG ' ' A' ' 415' ' ' SER . 1.3 pp -59.18 -49.24 78.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.25 0.547 . . . . 0.0 110.671 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.616 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -60.61 -38.72 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 122.794 1.283 . . . . 0.0 108.917 -178.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.662 ' OG ' ' HD2' ' A' ' 419' ' ' TYR . 64.6 m -66.27 -42.19 88.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.507 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.62 -38.83 89.56 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.254 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 422' ' ' VAL . 4.3 mt -71.19 -42.07 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.515 0.674 . . . . 0.0 109.917 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.517 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -57.26 -44.47 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.334 -1.303 . . . . 0.0 112.606 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.633 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -61.28 -29.27 69.76 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 122.655 1.217 . . . . 0.0 109.143 -172.04 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.4 -20.24 78.14 Favored Glycine 0 C--N 1.298 -1.578 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.034 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.74 ' CG ' HG22 ' A' ' 399' ' ' VAL . 12.4 m-85 -97.04 0.6 48.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.563 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.84 143.31 77.17 Favored Pre-proline 0 N--CA 1.408 -2.529 0 CA-C-O 123.919 1.819 . . . . 0.0 113.267 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.737 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 51.0 Cg_endo -69.43 -60.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 1 C-N-CA 126.372 4.715 . . . . 0.0 112.973 -172.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.525 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.84 141.3 16.12 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.221 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.622 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.33 -26.98 68.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.133 0.467 . . . . 0.0 111.69 -177.07 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.29 80.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 169.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.684 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.8 t -58.22 -52.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.038 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.622 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.8 -52.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.461 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.6 m -62.55 -56.65 15.95 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.216 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.89 -46.01 78.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.485 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.831 ' O ' HD22 ' A' ' 443' ' ' LEU . 42.8 mt -59.56 -53.49 57.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.9 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.677 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.9 mm-40 -51.95 -34.74 43.35 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 124.932 1.395 . . . . 0.0 110.693 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -73.24 -60.87 2.04 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 175.599 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.4 -50.62 13.68 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.693 -0.63 . . . . 0.0 112.306 -172.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.831 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.58 -25.34 62.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.675 0.75 . . . . 0.0 111.487 -178.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.732 ' N ' HD21 ' A' ' 443' ' ' LEU . 11.5 t70 -72.6 -42.04 64.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.64 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -68.78 -7.95 38.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.598 ' HB3' HG21 ' A' ' 451' ' ' THR . 15.7 mm-40 -54.46 151.58 7.59 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 123.465 1.602 . . . . 0.0 114.436 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.74 -32.63 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.477 -3.056 . . . . 0.0 116.066 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.548 ' H ' ' HB ' ' A' ' 451' ' ' THR . 25.8 m-20 -135.49 175.77 9.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.464 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 5.8 m-20 -61.73 -56.89 14.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 172.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -62.9 -28.16 69.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 176.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.598 HG21 ' HB3' ' A' ' 446' ' ' GLU . 16.2 m -58.09 -43.18 86.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.803 1.183 . . . . 0.0 110.04 172.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 56.3 mtt180 -61.51 -29.75 70.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 172.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.586 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.24 -29.95 60.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.911 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.3 mm-40 -80.46 -45.74 17.08 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.286 1.041 . . . . 0.0 111.837 -173.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.54 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 25.7 p -103.28 -0.47 30.24 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.748 -167.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.599 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.3 t80 -49.22 -55.9 11.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.754 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 26.2 mm -69.04 -26.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.683 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.08 -43.95 64.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.599 ' O ' HG21 ' A' ' 463' ' ' VAL . 26.6 m80 -65.3 -31.09 72.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.707 171.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.653 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.45 -53.72 32.29 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.312 1.053 . . . . 0.0 109.181 -178.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.23 -30.18 71.37 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.19 -1.823 . . . . 0.0 110.188 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 458' ' ' GLN . . . -66.68 -49.24 66.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.017 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.684 ' CG1' ' HA ' ' A' ' 435' ' ' VAL . 33.6 t -65.61 -35.93 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.579 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.9 m-30 -61.27 -13.98 22.95 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.654 168.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 1.7 tp10 -93.09 -52.52 4.53 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.847 0.832 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.679 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.7 pt -63.79 -41.08 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.239 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.527 HD11 HD12 ' A' ' 469' ' ' LEU . 6.8 mt -83.8 -16.73 43.54 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.673 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 65.89 47.73 72.37 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.446 173.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 464' ' ' TYR . 1.2 mt -101.36 173.11 6.59 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.834 0.854 . . . . 0.0 111.733 -177.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.549 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.2 p30 -85.87 -44.9 12.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.63 -68.67 0.06 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.474 165.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.737 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 19.0 mmt180 -68.16 47.72 0.05 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -163.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.403 ' HA2' HD21 ' A' ' 469' ' ' LEU . . . 57.92 34.45 71.86 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.392 171.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.619 HE21 ' HB2' ' A' ' 472' ' ' ARG . 28.4 mm-40 -84.69 -51.45 6.81 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.972 0.892 . . . . 0.0 111.228 -173.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.673 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 45.4 t 68.99 53.59 0.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 112.506 -2.133 . . . . 0.0 109.118 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.289 -2.038 0 CA-C-N 109.474 -3.512 . . . . 0.0 112.61 169.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.427 ' H ' HG12 ' A' ' 304' ' ' VAL . 1.5 p . . . . . 0 N--CA 1.429 -1.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.706 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.1 mt -73.32 129.24 86.19 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 122.069 0.938 . . . . 0.0 113.048 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.535 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.0 Cg_endo -84.97 51.48 3.15 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.59 3.526 . . . . 0.0 109.093 165.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.682 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -46.63 -43.54 6.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 112.753 -2.021 . . . . 0.0 112.077 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.415 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -64.5 -35.6 81.47 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.055 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.492 ' HB3' HG13 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.45 -47.49 83.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.39 0.614 . . . . 0.0 109.695 172.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 339' ' ' PHE . 68.0 mt -59.0 -49.85 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 123.878 0.871 . . . . 0.0 113.197 175.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.682 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 33.1 mtp180 -62.25 -28.8 69.96 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.882 0.473 . . . . 0.0 111.013 177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 62.9 m -69.76 -34.65 74.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.326 0.584 . . . . 0.0 110.114 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.03 -41.73 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.723 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.711 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -83.42 -36.58 24.14 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.813 1.292 . . . . 0.0 110.087 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.84 34.86 8.68 Favored Glycine 0 C--N 1.304 -1.22 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.694 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.504 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 50.14 177.89 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.013 0 C-N-CA 124.296 1.038 . . . . 0.0 112.899 -174.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.56 ' HB3' HD11 ' A' ' 324' ' ' ILE . 46.2 Cg_exo -48.34 147.2 9.02 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.529 2.153 . . . . 0.0 112.786 -178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 51.1 Cg_endo -87.42 -99.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.341 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 10.3 mmm180 -100.45 -76.57 0.55 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.528 0.68 . . . . 0.0 110.555 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.6 m-20 -104.87 158.42 32.06 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.241 -174.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.438 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 36.6 Cg_exo -59.08 -50.13 9.52 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.824 2.349 . . . . 0.0 110.868 171.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.43 -23.64 2.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.224 -1.807 . . . . 0.0 112.547 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 2.3 mm-40 -87.42 -29.02 21.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.618 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -45.05 -46.8 30.71 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.643 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.692 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.94 -62.04 0.47 Allowed 'Trans proline' 0 CA--C 1.516 -0.399 0 C-N-CA 122.856 2.371 . . . . 0.0 112.997 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.561 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.56 -36.65 76.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.141 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.711 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 34.7 t90 -57.77 -35.07 70.26 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.096 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.44 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.8 OUTLIER -69.97 -49.17 54.34 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.101 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.51 -23.42 19.84 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.661 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -74.4 -42.5 59.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.132 0.968 . . . . 0.0 110.471 175.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.573 ' HB3' HG23 ' A' ' 314' ' ' THR . 43.4 m-20 -96.13 -23.47 16.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.918 -169.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' A' ' 335' ' ' ILE . . . -44.06 -49.38 22.3 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 113.681 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 52.2 Cg_endo -61.39 -33.0 89.58 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.551 2.168 . . . . 0.0 111.542 177.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 313' ' ' VAL . . . -72.3 -43.15 64.61 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 109.519 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 310' ' ' ILE . 91.6 mt -58.45 -49.4 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.734 173.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -55.42 -18.84 7.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.327 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.75 -46.68 8.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.145 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 309' ' ' HIS . 93.7 t -58.07 -72.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 123.4 1.572 . . . . 0.0 110.228 169.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.706 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 1.0 OUTLIER -91.14 131.7 36.18 Favored Pre-proline 0 N--CA 1.405 -2.717 0 CA-C-N 110.813 -2.903 . . . . 0.0 112.538 -170.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.541 ' HB2' HG22 ' A' ' 342' ' ' THR . 8.0 Cg_exo -75.01 -18.02 19.03 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.664 2.909 . . . . 0.0 110.652 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.534 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.5 p 33.09 72.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.648 -177.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.581 ' N ' HD13 ' A' ' 346' ' ' LEU . 60.0 p -81.38 5.83 16.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 112.778 -2.01 . . . . 0.0 113.463 -169.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.834 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.8 p -142.12 161.45 50.78 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.456 ' O ' ' SG ' ' A' ' 348' ' ' CYS . 51.2 Cg_exo -62.28 -48.25 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.262 2.641 . . . . 0.0 108.218 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.651 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.9 OUTLIER -41.76 -51.92 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 112.719 -2.037 . . . . 0.0 110.828 176.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.834 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.8 mt -57.09 -52.28 65.9 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.165 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 4.7 ttm180 -53.09 -42.96 66.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.318 -1.765 . . . . 0.0 110.696 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 1.042 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.8 m -70.19 -46.43 64.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 76.0 mtt180 -56.19 -42.83 77.77 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.232 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 346' ' ' LEU . 48.5 mt -58.17 -53.5 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 O-C-N 123.304 0.377 . . . . 0.0 111.426 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 348' ' ' CYS . 17.0 mt -57.66 -53.22 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 122.107 0.956 . . . . 0.0 110.841 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.495 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.1 m-20 -63.83 -35.14 79.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.956 -1.474 . . . . 0.0 109.982 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.29 -37.26 77.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.051 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 350' ' ' ILE 0.251 0.8 OUTLIER -57.26 -53.29 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.481 0 CA-C-O 123.069 1.414 . . . . 0.0 110.119 174.485 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.608 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -72.86 -25.29 61.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 111.559 -2.564 . . . . 0.0 109.338 -169.083 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.6 -79.01 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.586 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -119.62 57.4 0.56 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.6 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.591 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 31.5 p30 -76.13 161.74 28.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.254 0.222 . . . . 0.0 110.937 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.48 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -55.8 -66.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 122.947 0.499 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.41 15.16 1.1 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.514 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.591 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 5.9 mt -66.33 -2.99 5.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.698 0.399 . . . . 0.0 111.477 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.495 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 28.6 t -62.28 80.58 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 110.503 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.873 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.4 mm? -62.12 178.16 0.4 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.731 174.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 366' ' ' GLY . 44.5 p -116.77 157.39 46.31 Favored Pre-proline 0 CA--C 1.508 -0.669 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 1.042 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 19.5 Cg_endo -66.21 16.69 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.269 1.979 . . . . 0.0 113.528 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -135.43 6.22 4.23 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.26 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -109.76 -24.81 10.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.402 1.096 . . . . 0.0 109.954 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.873 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 6.5 m -93.97 19.77 8.63 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.076 -168.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -57.05 -39.79 75.57 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.433 -171.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.13 157.58 25.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.851 169.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.496 ' O ' HG13 ' A' ' 375' ' ' VAL . 86.3 m95 -70.14 -34.11 72.65 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.613 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 4.8 t0 -54.56 -48.83 71.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.695 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 28.0 t -69.15 -43.13 74.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.825 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.714 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.25 -51.57 67.21 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.548 HG22 ' CE ' ' A' ' 413' ' ' MET . 13.3 m -57.32 -44.5 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.603 0.716 . . . . 0.0 109.621 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.683 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -62.09 -45.86 91.65 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.005 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.516 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 48.8 m -68.55 -38.2 80.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.464 -171.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.21 -34.16 74.64 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.155 0.503 . . . . 0.0 110.411 176.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.692 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 67.5 t80 -73.13 -45.89 54.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.369 1.08 . . . . 0.0 109.4 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -52.3 -33.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.092 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.61 -39.21 87.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.653 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 50.2 p -98.83 -22.24 15.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.439 -167.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -108.97 22.83 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.642 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.37 19.15 39.1 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.847 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 65.09 159.77 0.11 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 111.694 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.438 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -126.27 151.88 72.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.289 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -98.96 55.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.535 2.824 . . . . 0.0 110.969 165.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.627 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.21 4.03 0.42 Allowed 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -173.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -71.13 -47.1 59.89 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.628 ' O ' HG11 ' A' ' 394' ' ' VAL . 99.5 mt-30 -74.74 -26.2 59.63 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.733 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.75 -31.3 47.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.004 0.82 . . . . 0.0 111.966 -173.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.405 ' HA2' ' CD1' ' A' ' 425' ' ' ILE . . . -54.57 -53.2 40.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.438 173.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.618 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 41.4 m-20 -64.99 -39.79 93.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.17 -46.21 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.42 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.62 ' O ' HG21 ' A' ' 399' ' ' VAL . 25.6 mm -58.94 -46.6 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.042 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.618 ' HG3' ' HA ' ' A' ' 393' ' ' ASN . 15.3 mmtt -52.84 -42.02 64.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.879 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.41 15.86 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.092 -173.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.654 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 3.0 mt -69.21 -41.45 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 117.133 0.466 . . . . 0.0 111.439 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.7 HG22 ' CG ' ' A' ' 429' ' ' TYR . 6.8 m -58.07 -44.54 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.609 0.719 . . . . 0.0 110.273 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.476 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.4 t70 -62.18 -39.03 91.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -84.88 -53.22 5.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.064 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.516 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -110.59 -30.74 7.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.508 -169.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.2 165.87 12.11 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.673 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.6 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.69 -44.83 98.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.58 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -54.55 -53.16 58.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.606 0.717 . . . . 0.0 111.87 -177.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -64.45 -49.77 70.16 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.273 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.654 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.26 -42.69 63.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 47.1 t80 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.616 0.722 . . . . 0.0 109.524 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.761 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.9 m -59.44 -52.55 65.14 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.613 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 414' ' ' LEU . 2.7 mm? -61.23 -48.67 80.4 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.645 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.496 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.85 -43.35 87.26 Favored Glycine 0 C--N 1.314 -0.655 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.546 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.596 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.56 -31.31 65.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.846 0.323 . . . . 0.0 111.02 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.761 ' HG3' ' O ' ' A' ' 409' ' ' THR . 53.2 mtm -70.08 -47.56 61.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.683 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 19.5 mt -58.55 -40.99 84.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.261 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.733 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -76.71 -12.62 60.02 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.729 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 88.36 43.73 5.48 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.659 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.596 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 0.8 OUTLIER 57.73 49.1 12.83 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.496 0.718 . . . . 0.0 112.471 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.717 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.2 OUTLIER -129.17 77.98 1.82 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 161.344 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 8.3 p90 -62.27 -31.47 72.06 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.341 -163.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.499 ' O ' ' HB3' ' A' ' 423' ' ' SER . 51.1 mt-30 -53.63 -48.03 69.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.312 -164.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.714 HD12 ' OG ' ' A' ' 415' ' ' SER . 1.1 pp -59.35 -50.62 73.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.955 0.407 . . . . 0.0 110.776 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.625 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -60.06 -38.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 123.021 1.391 . . . . 0.0 108.854 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.531 ' N ' HG23 ' A' ' 422' ' ' VAL . 42.4 t -62.56 -48.14 80.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.726 -2.488 . . . . 0.0 111.846 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.3 75.5 Favored Glycine 0 C--N 1.316 -0.568 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.402 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 422' ' ' VAL . 3.9 mt -72.1 -41.48 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.601 0.715 . . . . 0.0 110.025 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 427' ' ' ARG . 1.6 mm -57.57 -45.6 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.909 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.608 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -59.8 -29.15 68.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 122.646 1.212 . . . . 0.0 109.371 -173.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.8 -18.46 77.48 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.386 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.7 ' CG ' HG22 ' A' ' 399' ' ' VAL . 18.7 m-85 -100.0 3.17 44.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.565 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.02 145.89 70.82 Favored Pre-proline 0 N--CA 1.41 -2.452 0 CA-C-O 123.612 1.672 . . . . 0.0 113.308 168.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.697 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.7 Cg_endo -72.52 -62.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 1 C-N-CA 126.181 4.587 . . . . 0.0 113.378 -173.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.548 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -108.3 141.65 15.84 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.166 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.609 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.71 -29.88 71.0 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.903 0.351 . . . . 0.0 111.057 -177.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.43 81.48 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 172.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.672 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.1 t -59.27 -51.59 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.63 176.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -54.26 -54.85 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.474 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 61.4 m -61.61 -55.94 25.28 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.944 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.03 -46.17 78.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.81 ' O ' HD21 ' A' ' 443' ' ' LEU . 37.1 mt -59.37 -53.15 61.49 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.656 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.735 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 38.0 mm-40 -51.64 -35.09 40.71 Favored 'General case' 0 N--CA 1.419 -2.024 0 O-C-N 124.997 1.436 . . . . 0.0 110.447 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.74 -60.27 2.31 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 176.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -75.97 -50.86 13.72 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.743 -0.598 . . . . 0.0 112.002 -173.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.88 -24.08 61.76 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.719 0.771 . . . . 0.0 111.807 -179.001 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.735 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 11.1 t70 -72.18 -42.82 65.41 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.609 176.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.02 -7.99 45.55 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.609 ' HB3' HG21 ' A' ' 451' ' ' THR . 54.0 mm-40 -51.75 154.77 1.9 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 123.264 1.507 . . . . 0.0 114.43 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.471 ' HB ' HG22 ' A' ' 451' ' ' THR . 1.8 mp -53.36 -32.89 20.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 111.17 -2.741 . . . . 0.0 115.613 -172.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.557 ' H ' ' HB ' ' A' ' 451' ' ' THR . 48.1 m-20 -138.04 178.98 6.72 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.429 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.1 p-10 -64.88 -53.57 44.58 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -23.58 65.66 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 446' ' ' GLU . 19.2 m -59.04 -40.17 84.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 119.891 1.223 . . . . 0.0 109.453 171.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.597 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 72.6 mtp180 -61.23 -29.1 69.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.667 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.32 -34.01 59.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.204 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.405 ' HB2' HG21 ' A' ' 455' ' ' THR . 1.3 mm-40 -78.62 -44.92 22.79 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.903 -171.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.552 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 29.9 p -105.33 -1.23 25.42 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.298 -165.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.618 ' CE1' HD22 ' A' ' 460' ' ' LEU . 6.5 t80 -48.73 -51.49 28.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.716 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.58 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 24.3 mm -71.94 -26.59 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.634 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -71.51 -43.03 67.24 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.594 ' O ' HG22 ' A' ' 463' ' ' VAL . 53.7 m-70 -67.15 -30.34 70.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.178 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.674 HD23 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -66.66 -53.4 34.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.278 1.037 . . . . 0.0 109.126 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.652 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.6 m-80 -63.49 -31.29 72.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.682 173.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 458' ' ' GLN . . . -62.65 -53.53 53.17 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.192 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.706 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 26.1 t -62.36 -34.39 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.44 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.88 -15.39 42.2 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.125 169.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 10.9 mm-40 -89.95 -50.69 5.88 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.064 -1.023 . . . . 0.0 112.42 176.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.706 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -65.18 -39.82 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.904 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.47 HD13 HD11 ' A' ' 469' ' ' LEU . 7.0 mt -84.13 -17.1 41.21 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 66.05 49.56 57.44 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 112.106 -2.315 . . . . 0.0 113.591 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.8 OUTLIER -101.65 175.01 5.7 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.809 0.844 . . . . 0.0 111.064 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.719 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 13.0 p30 -92.58 -43.25 9.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 165.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -161.56 -73.89 0.06 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.475 162.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.697 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 2.0 mpt_? -63.63 67.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.64 40.24 2.04 Favored Glycine 0 C--N 1.277 -2.709 0 CA-C-N 111.369 -2.65 . . . . 0.0 113.33 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.719 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 27.4 mm-40 -80.3 -56.3 4.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.152 0.977 . . . . 0.0 111.449 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 38.2 t 67.87 44.36 1.57 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.281 -2.236 . . . . 0.0 108.219 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.294 -1.809 0 CA-C-N 109.149 -3.66 . . . . 0.0 112.684 170.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.459 ' H ' HG13 ' A' ' 304' ' ' VAL . 1.6 p . . . . . 0 N--CA 1.427 -1.576 0 CA-C-O 121.274 0.559 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.677 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 22.8 mt -74.45 127.01 88.26 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-O 121.844 0.831 . . . . 0.0 112.137 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' A' ' 308' ' ' GLN . 28.2 Cg_endo -74.8 -11.44 21.88 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 124.682 3.588 . . . . 0.0 111.466 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.687 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 6.1 tp 26.79 -64.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.298 0 C-N-CA 128.37 2.668 . . . . 0.0 115.877 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.556 ' H ' HG22 ' A' ' 307' ' ' ILE . 0.1 OUTLIER -57.66 -30.88 65.78 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.141 0.496 . . . . 0.0 111.246 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.497 ' HB3' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.73 -49.17 77.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.588 169.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 60.9 mt -58.55 -48.11 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.036 0.934 . . . . 0.0 112.705 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.7 mtp180 -59.9 -30.66 69.18 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 122.559 0.344 . . . . 0.0 111.108 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.2 m -70.03 -33.96 72.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.582 HG13 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.24 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.903 178.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.727 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.5 p -83.52 -37.19 23.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.83 1.3 . . . . 0.0 110.152 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.5 34.66 8.4 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.252 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.6 mt-10 51.68 172.25 0.03 OUTLIER Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -175.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.505 ' HB3' HD12 ' A' ' 324' ' ' ILE . 22.2 Cg_exo -45.27 143.56 5.15 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.374 2.716 . . . . 0.0 113.189 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.527 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.6 Cg_endo -91.41 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.614 2.876 . . . . 0.0 112.903 -172.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.434 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 7.9 mmm180 -89.29 -81.34 0.28 Allowed 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 123.449 0.699 . . . . 0.0 110.894 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.439 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 16.3 m-20 -112.71 164.94 14.14 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.846 -177.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.65 -50.4 9.43 Favored 'Trans proline' 0 CA--C 1.509 -0.735 0 C-N-CA 122.549 2.166 . . . . 0.0 110.483 171.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -48.74 -20.63 0.5 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.003 -1.908 . . . . 0.0 112.928 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.439 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.1 mt-10 -98.44 -23.46 15.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.7 0.286 . . . . 0.0 111.405 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.657 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.88 -44.34 45.79 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.695 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 6.4 Cg_endo -47.96 -62.76 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.008 2.472 . . . . 0.0 113.086 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.566 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.89 -36.32 75.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.031 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.168 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.727 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 47.5 t90 -57.63 -36.01 71.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.329 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.484 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.93 -48.15 59.62 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.585 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.491 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -53.55 -23.62 20.92 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.786 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -73.95 -42.17 60.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.22 1.01 . . . . 0.0 110.551 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.569 ' HB3' HG23 ' A' ' 314' ' ' THR . 47.1 m-20 -95.98 -24.82 16.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.599 -1.637 . . . . 0.0 113.854 -169.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.94 -50.29 13.6 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 124.296 1.038 . . . . 0.0 113.582 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 51.0 Cg_endo -61.09 -33.16 91.86 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.652 2.235 . . . . 0.0 111.729 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.492 ' CB ' HG12 ' A' ' 313' ' ' VAL . . . -72.57 -43.93 62.75 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.622 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.577 HG12 HG22 ' A' ' 310' ' ' ILE . 88.6 mt -57.99 -48.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.74 -17.87 6.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.233 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.92 -44.49 9.06 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 309' ' ' HIS . 98.6 t -61.29 -69.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 123.399 1.571 . . . . 0.0 110.222 169.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.774 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.7 OUTLIER -94.47 129.9 35.31 Favored Pre-proline 0 N--CA 1.403 -2.789 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.663 -171.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.774 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 68.0 Cg_endo -72.7 -18.86 24.84 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 123.887 3.058 . . . . 0.0 110.994 173.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.467 HG22 ' CB ' ' A' ' 346' ' ' LEU . 2.5 p 33.9 68.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.426 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.604 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.4 p -78.37 1.64 21.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.616 -170.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.785 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.4 p -137.59 164.09 43.85 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.403 ' O ' ' SG ' ' A' ' 348' ' ' CYS . 50.3 Cg_exo -62.45 -50.58 4.3 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.145 2.564 . . . . 0.0 108.043 172.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.711 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 4.6 t0 -42.81 -47.34 5.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.013 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.785 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 8.9 mt -56.99 -53.04 62.56 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.797 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.682 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 41.3 ttm105 -54.98 -45.81 75.02 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.603 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 1.034 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.78 -47.8 65.28 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.793 0.33 . . . . 0.0 111.216 -175.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.643 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 70.8 mtt180 -56.0 -42.41 76.36 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.079 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 346' ' ' LEU . 52.6 mt -57.73 -53.48 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.399 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.484 ' HA ' HG13 ' A' ' 354' ' ' ILE . 23.0 mt -58.47 -52.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 122.203 1.001 . . . . 0.0 110.715 -170.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.532 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 23.3 m-20 -63.0 -36.11 82.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.152 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.446 ' HB2' HD13 ' A' ' 307' ' ' ILE . . . -69.63 -34.72 74.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.081 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.62 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.72 -53.92 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 122.925 1.345 . . . . 0.0 110.256 173.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.616 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -71.95 -27.46 62.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.618 -2.537 . . . . 0.0 109.585 -167.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 63.25 -70.79 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.943 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.72 97.29 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.322 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.574 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 26.9 p30 -124.59 164.41 19.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 122.736 0.414 . . . . 0.0 110.447 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.477 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -51.42 -59.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.082 0.467 . . . . 0.0 111.804 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -162.63 20.39 0.17 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.54 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.574 ' HG ' ' HB2' ' A' ' 358' ' ' ASN . 6.9 mt -66.05 -5.28 9.21 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 122.835 0.454 . . . . 0.0 111.615 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.532 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 23.3 t -61.42 83.1 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.205 0.526 . . . . 0.0 110.62 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.437 HD21 ' CD2' ' A' ' 378' ' ' LEU . 0.9 OUTLIER -62.48 173.36 1.25 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.659 175.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.535 ' C ' ' H ' ' A' ' 366' ' ' GLY . 71.9 p -113.73 162.43 22.67 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.622 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 1.034 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 10.5 Cg_endo -68.63 25.92 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.121 1.881 . . . . 0.0 112.386 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -138.01 -6.28 1.5 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.759 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -105.65 -20.87 13.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.83 1.3 . . . . 0.0 109.129 176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.826 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 2.7 p -79.03 20.69 0.47 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.846 -172.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.582 ' N ' HD11 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -61.49 -30.58 70.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.707 1.241 . . . . 0.0 108.495 -172.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 24.9 p -125.73 163.9 21.83 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 112.393 -2.185 . . . . 0.0 109.933 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.552 ' O ' HG12 ' A' ' 375' ' ' VAL . 66.7 m95 -70.92 -33.91 70.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 167.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.519 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -61.24 -44.89 96.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.746 -172.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 29.1 t -69.15 -42.9 75.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.723 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.19 -52.15 66.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 371' ' ' TRP . 13.1 m -58.56 -43.86 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.585 0.707 . . . . 0.0 109.422 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.7 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -62.2 -46.19 90.0 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.095 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 37.3 m -66.41 -39.32 88.93 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.324 -173.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.723 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -59.69 -35.13 73.87 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.467 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.695 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 66.4 t80 -73.41 -45.96 51.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.491 1.139 . . . . 0.0 109.473 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.63 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -53.06 -32.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 112.625 -2.08 . . . . 0.0 111.314 171.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.3 OUTLIER -59.55 -38.69 81.75 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.442 0.697 . . . . 0.0 111.831 177.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 4.4 p -104.64 -20.91 13.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.62 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -108.34 24.46 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.87 21.12 29.0 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 114.587 0.595 . . . . 0.0 114.587 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 62.01 165.92 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.092 0.472 . . . . 0.0 110.976 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.511 ' CE2' HD23 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -130.52 154.21 81.59 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -94.56 47.75 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.386 2.724 . . . . 0.0 110.712 165.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.627 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.27 4.55 0.68 Allowed 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -173.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.08 -43.6 70.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.941 0.4 . . . . 0.0 110.569 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.651 ' O ' HG11 ' A' ' 394' ' ' VAL . 27.3 mt-30 -75.85 -25.4 56.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -170.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.905 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.11 -31.38 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.043 0.838 . . . . 0.0 112.024 -172.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 396' ' ' LYS . . . -54.86 -50.3 58.85 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.674 174.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.532 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.5 m-20 -69.84 -36.59 75.7 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.987 0.515 . . . . 0.0 111.814 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.657 HG21 ' O ' ' A' ' 391' ' ' LEU . 1.1 m -58.85 -48.51 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.574 ' O ' HG22 ' A' ' 399' ' ' VAL . 8.5 mm -58.37 -48.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.882 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 392' ' ' GLY . 0.2 OUTLIER -52.31 -46.32 65.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.312 -177.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -73.29 -44.13 35.85 Favored Glycine 0 C--N 1.31 -0.895 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.382 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.642 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 3.0 mt -69.15 -41.22 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 117.76 0.78 . . . . 0.0 111.582 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.648 HG23 ' CG ' ' A' ' 429' ' ' TYR . 6.5 m -57.93 -44.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.844 0.83 . . . . 0.0 109.552 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.401 ' N ' HG21 ' A' ' 399' ' ' VAL . 16.6 t70 -55.21 -46.05 75.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.328 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -85.3 -52.52 5.84 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.601 -170.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.562 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.7 OUTLIER -110.6 -30.39 7.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.52 0.676 . . . . 0.0 111.799 -170.254 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 124.84 166.16 12.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.705 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.599 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -62.95 -46.1 97.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.013 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.585 ' HB3' HG23 ' A' ' 457' ' ' ILE . . . -53.96 -52.54 60.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.617 0.722 . . . . 0.0 111.999 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.79 -49.91 68.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.308 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.642 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.23 -43.37 64.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.646 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.8 t80 -56.44 -46.72 80.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.524 0.678 . . . . 0.0 109.559 176.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.756 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.8 m -58.69 -52.26 66.47 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.65 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.584 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.7 -48.01 82.7 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.602 176.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' A' ' 414' ' ' LEU . . . -56.19 -43.24 89.03 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.598 ' HE1' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -72.2 -31.57 66.0 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.88 0.34 . . . . 0.0 110.69 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.756 ' HG3' ' O ' ' A' ' 409' ' ' THR . 62.5 mtm -70.18 -47.5 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 109.93 173.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.7 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 16.9 mt -59.18 -40.67 86.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.119 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.905 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.7 m -77.82 -12.76 60.01 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.964 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.61 44.13 4.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.206 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.598 ' HA ' ' HE1' ' A' ' 412' ' ' MET . 0.9 OUTLIER 58.46 39.99 24.52 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.762 0.825 . . . . 0.0 112.99 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.691 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.2 OUTLIER -123.46 79.55 1.7 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 165.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.513 ' O ' HG22 ' A' ' 422' ' ' VAL . 7.8 p90 -62.55 -31.12 71.85 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.8 -161.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.528 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.0 mt-30 -54.14 -47.76 71.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -164.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.696 HD12 ' OG ' ' A' ' 415' ' ' SER . 1.2 pp -59.21 -49.0 79.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.479 0.656 . . . . 0.0 110.974 177.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.622 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.7 -39.06 80.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.756 1.265 . . . . 0.0 109.208 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 30.0 t -60.8 -47.4 86.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.037 -2.347 . . . . 0.0 111.252 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.11 -38.19 75.4 Favored Glycine 0 C--N 1.315 -0.596 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 422' ' ' VAL . 1.7 mt -72.18 -43.99 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.583 0.706 . . . . 0.0 109.985 174.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.482 HD13 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -55.8 -44.28 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.73 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.628 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.3 OUTLIER -61.67 -30.26 70.61 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-O 122.586 1.184 . . . . 0.0 108.907 -173.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.39 -18.08 78.07 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.966 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.648 ' CG ' HG23 ' A' ' 399' ' ' VAL . 15.0 m-85 -100.65 3.77 42.73 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -177.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.58 HD21 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.77 145.4 70.82 Favored Pre-proline 0 N--CA 1.418 -2.069 0 CA-C-O 123.546 1.641 . . . . 0.0 113.721 167.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.66 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 59.2 Cg_endo -72.19 -61.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 1 C-N-CA 126.245 4.63 . . . . 0.0 113.127 -173.038 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.533 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.59 141.11 15.61 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.202 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.608 ' HA ' HG11 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.46 -30.69 71.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.107 0.454 . . . . 0.0 111.143 -177.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.67 79.52 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 171.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.653 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.7 t -59.66 -51.38 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.397 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.608 HG11 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.81 -54.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 51.8 m -62.73 -56.11 20.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.226 -175.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.24 -45.93 79.81 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.64 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.826 ' O ' HD23 ' A' ' 443' ' ' LEU . 39.0 mt -59.43 -53.73 54.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.806 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.701 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.2 mm-40 -52.23 -34.16 44.61 Favored 'General case' 0 N--CA 1.417 -2.108 0 O-C-N 125.09 1.494 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.658 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.18 -60.69 2.12 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.25 14.51 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.733 -0.605 . . . . 0.0 112.392 -172.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.826 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.08 62.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.596 0.712 . . . . 0.0 111.606 -179.102 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.742 ' N ' HD22 ' A' ' 443' ' ' LEU . 12.7 t70 -72.19 -41.11 67.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.484 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.658 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -70.29 -8.08 47.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.544 ' HB3' HG23 ' A' ' 451' ' ' THR . 14.0 mm-40 -56.6 161.27 2.81 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 123.221 1.486 . . . . 0.0 114.371 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.84 -34.28 25.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 111.216 -2.72 . . . . 0.0 115.78 -169.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.59 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 24.6 m-20 -142.32 -178.18 5.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.486 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 10.7 p-10 -63.83 -55.26 24.25 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -64.28 -27.12 68.82 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.084 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.547 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 8.8 m -58.6 -44.67 89.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.381 0.991 . . . . 0.0 109.864 172.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.0 mtt180 -61.0 -29.89 69.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.189 172.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.646 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.57 -31.47 63.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.91 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.1 mm-40 -78.11 -46.24 21.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.728 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.533 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 27.5 p -103.69 -0.9 28.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.481 -166.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.604 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -49.28 -55.34 13.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.828 177.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' A' ' 405' ' ' ALA . 26.8 mm -69.62 -26.7 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.665 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -71.27 -43.96 66.18 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.603 ' O ' HG21 ' A' ' 463' ' ' VAL . 25.4 m80 -65.53 -30.62 71.39 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.857 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.692 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.91 -53.25 33.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.206 1.003 . . . . 0.0 109.303 -178.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.643 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -63.6 -31.5 72.68 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.719 173.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 458' ' ' GLN . . . -62.98 -53.15 58.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.41 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.68 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 26.5 t -62.41 -33.88 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 121.836 0.827 . . . . 0.0 110.249 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 471' ' ' ALA . 21.9 m-30 -61.96 -15.15 41.35 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.157 169.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 48.0 mt-10 -91.77 -49.36 6.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.909 -1.119 . . . . 0.0 112.822 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.68 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -64.65 -40.43 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.902 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.455 ' CB ' HD21 ' A' ' 469' ' ' LEU . 7.3 mt -83.47 -16.58 45.12 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 172.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.61 51.14 54.6 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 111.68 -2.509 . . . . 0.0 113.028 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 475' ' ' SER . 0.9 OUTLIER -100.48 -156.93 0.58 Allowed 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 122.16 0.981 . . . . 0.0 109.381 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.72 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.7 p30 -130.01 -41.04 1.3 Allowed 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 171.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -155.76 -82.19 0.07 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.426 -2.17 . . . . 0.0 110.813 155.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.66 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -57.34 69.62 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -172.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.476 ' HA2' HD11 ' A' ' 469' ' ' LEU . . . 36.47 42.79 0.68 Allowed Glycine 0 C--N 1.276 -2.755 0 CA-C-N 111.163 -2.744 . . . . 0.0 113.323 172.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.72 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.1 mm-40 -77.4 -59.51 2.75 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 122.147 0.975 . . . . 0.0 111.421 -172.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.741 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 36.7 t 67.15 50.87 0.97 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.185 -2.279 . . . . 0.0 107.976 -173.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.638 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.5 OUTLIER . . . . . 0 C--N 1.291 -1.971 0 CA-C-N 109.196 -3.638 . . . . 0.0 112.507 170.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.427 -1.61 0 CA-C-O 120.973 0.416 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.713 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 36.2 mt -74.24 127.67 87.41 Favored Pre-proline 0 N--CA 1.425 -1.681 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.545 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.2 Cg_endo -84.96 50.21 2.8 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 125.011 3.807 . . . . 0.0 109.238 165.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.753 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.6 tp -45.41 -42.42 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.287 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' GLN . . . . . 0.585 ' HA ' ' HD3' ' A' ' 311' ' ' ARG . 26.4 mm-40 -60.86 -44.24 97.28 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.998 0.904 . . . . 0.0 111.653 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . 0.516 ' HB3' HG12 ' A' ' 338' ' ' VAL . 6.4 t-160 -58.97 -45.77 89.72 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.357 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.572 HG21 HG12 ' A' ' 335' ' ' ILE . 67.4 mt -59.22 -49.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.753 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 36.4 mtp180 -60.45 -31.28 70.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.523 -0.735 . . . . 0.0 110.987 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.6 m -69.76 -32.27 70.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.587 0.708 . . . . 0.0 109.881 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.56 -41.33 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.018 177.52 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.634 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.6 p -82.68 -36.7 25.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.728 1.251 . . . . 0.0 110.063 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.14 10.74 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 112.4 -2.182 . . . . 0.0 110.159 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.9 mt-10 49.12 173.57 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.126 0 C-N-CA 124.806 1.243 . . . . 0.0 113.254 -173.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.524 ' HB3' HD12 ' A' ' 324' ' ' ILE . 25.0 Cg_exo -45.1 154.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.038 2.492 . . . . 0.0 113.604 -176.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.402 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.6 Cg_endo -93.08 -109.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 123.29 2.66 . . . . 0.0 111.563 -175.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.432 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 14.4 mmm180 -97.2 -80.26 0.44 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.396 0.617 . . . . 0.0 111.058 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.485 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 46.0 m-20 -94.06 156.52 39.01 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.38 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 44.3 Cg_exo -58.53 -49.53 11.75 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.726 2.284 . . . . 0.0 110.483 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -21.94 2.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.194 -1.821 . . . . 0.0 112.665 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.485 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.0 mt-10 -85.0 -30.06 24.51 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.325 -0.234 . . . . 0.0 111.377 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.632 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -47.72 -45.05 59.25 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.697 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.0 Cg_endo -50.43 -62.65 0.37 Allowed 'Trans proline' 0 CA--C 1.517 -0.354 0 C-N-CA 122.802 2.335 . . . . 0.0 113.091 177.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.588 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.4 -35.43 69.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 122.664 1.221 . . . . 0.0 110.091 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . 0.634 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 49.7 t90 -58.46 -37.19 74.95 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.156 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.488 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.14 -47.81 60.13 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.435 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -53.67 -23.64 21.92 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.741 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.08 -43.27 58.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.407 1.098 . . . . 0.0 110.686 174.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.581 ' HB3' HG22 ' A' ' 314' ' ' THR . 52.6 m-20 -94.47 -25.03 17.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.407 -168.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ALA . . . . . 0.553 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.58 -50.3 9.5 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 124.453 1.101 . . . . 0.0 113.719 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.8 Cg_endo -62.78 -30.96 78.47 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.684 2.256 . . . . 0.0 111.801 177.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.498 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -73.52 -45.77 51.76 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.527 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.572 HG12 HG21 ' A' ' 310' ' ' ILE . 88.2 mt -57.17 -48.65 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.878 173.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.45 -16.37 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.769 -1.56 . . . . 0.0 112.14 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.8 -46.28 7.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.412 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.529 HG11 ' HG2' ' A' ' 306' ' ' PRO . 96.3 t -58.19 -70.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 123.499 1.619 . . . . 0.0 110.187 169.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.78 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.8 OUTLIER -92.64 131.81 33.05 Favored Pre-proline 0 N--CA 1.405 -2.679 0 CA-C-N 110.926 -2.852 . . . . 0.0 112.463 -172.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.78 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -73.25 -18.92 23.02 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 123.635 2.89 . . . . 0.0 110.737 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.487 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.7 p 33.26 70.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.54 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.556 ' N ' HD11 ' A' ' 346' ' ' LEU . 41.4 p -81.25 5.64 16.51 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.921 -1.945 . . . . 0.0 113.392 -169.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.773 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.9 p -143.14 158.02 59.31 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 121.517 0.675 . . . . 0.0 109.535 174.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 52.4 Cg_exo -62.08 -38.68 55.03 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 124.368 3.379 . . . . 0.0 109.435 172.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -52.36 -51.69 57.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 112.295 -2.229 . . . . 0.0 110.634 174.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.773 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.2 mt -58.4 -52.43 65.64 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.52 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 3.8 ttm180 -52.86 -41.48 64.34 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.116 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 45.7 t -69.71 -49.25 55.15 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.913 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.657 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.6 mtt180 -58.13 -40.01 80.2 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 346' ' ' LEU . 50.5 mt -58.68 -54.18 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.505 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.455 HD11 ' HB1' ' A' ' 374' ' ' ALA . 16.5 mt -57.56 -53.54 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 121.954 0.883 . . . . 0.0 111.055 -169.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . 0.441 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 52.0 m-20 -64.14 -34.26 77.64 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.079 -177.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 349' ' ' ARG . . . -69.77 -37.65 76.45 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.205 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.65 -51.61 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 122.875 1.322 . . . . 0.0 110.425 174.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.3 OUTLIER -72.29 -25.76 61.71 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.81 -2.45 . . . . 0.0 109.298 -170.271 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 66.69 -77.04 0.14 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.169 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.9 92.65 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.191 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.621 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 23.3 p30 -111.89 163.65 13.98 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 122.803 0.441 . . . . 0.0 110.751 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . 0.469 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -53.86 -64.87 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 C-N-CA 122.81 0.444 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -150.55 13.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.621 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 6.1 mt -64.37 -2.8 2.42 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.651 0.38 . . . . 0.0 111.909 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.441 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.1 t -61.75 84.61 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.26 0.552 . . . . 0.0 110.181 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.676 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 2.2 mm? -63.52 -174.96 0.1 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.672 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' THR . . . . . 0.455 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 48.6 p -125.61 157.7 67.45 Favored Pre-proline 0 CA--C 1.506 -0.738 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . 0.578 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 32.3 Cg_exo -46.75 -39.34 23.7 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.912 1.741 . . . . 0.0 110.942 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -83.46 2.67 86.86 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.38 -172.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.444 ' HB2' HD11 ' A' ' 363' ' ' LEU . 44.1 m-20 -108.81 -21.76 12.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.089 0.947 . . . . 0.0 109.778 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.676 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 57.8 m -95.38 20.3 9.58 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.383 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -61.34 -36.25 79.66 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.964 1.364 . . . . 0.0 108.375 -173.157 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 15.2 p -115.51 163.03 16.34 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 112.189 -2.278 . . . . 0.0 109.491 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' TRP . . . . . 0.574 ' O ' HG12 ' A' ' 375' ' ' VAL . 35.5 m95 -70.71 -33.51 70.94 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.578 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -64.33 -46.4 83.7 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.806 -170.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.0 t -68.22 -42.61 79.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.358 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.698 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.54 -52.54 64.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 371' ' ' TRP . 12.8 m -58.44 -44.4 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.627 0.727 . . . . 0.0 109.489 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.665 ' O ' HD13 ' A' ' 380' ' ' ILE . . . -61.24 -46.0 92.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.883 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.537 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 33.0 m -67.82 -38.72 83.62 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.517 -172.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 1.8 mt -59.47 -34.62 72.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.346 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . 0.697 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 59.2 t80 -73.53 -46.79 45.54 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.34 1.067 . . . . 0.0 109.263 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' ILE . . . . . 0.665 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -51.92 -32.45 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.279 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.4 mpt_? -59.7 -40.14 86.96 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.537 0.684 . . . . 0.0 111.369 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.9 p -96.79 -22.51 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.75 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -110.0 23.33 14.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.58 21.05 19.94 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.6 m 64.92 159.59 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.237 0.541 . . . . 0.0 111.285 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.539 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -123.83 155.45 66.8 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 389' ' ' HIS . 85.0 Cg_endo -101.2 56.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.027 3.152 . . . . 0.0 111.395 168.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.568 ' HE1' ' HA ' ' A' ' 415' ' ' SER . 5.3 mmt 62.44 -19.56 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -173.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.493 ' H ' ' C ' ' A' ' 387' ' ' PRO . 5.9 t60 -56.21 -44.25 79.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.065 0.459 . . . . 0.0 111.31 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.695 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.9 mt-30 -75.04 -28.66 60.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.665 ' O ' HG21 ' A' ' 394' ' ' VAL . 3.8 mm? -54.8 -31.53 59.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.313 0.961 . . . . 0.0 111.037 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.654 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.02 -51.58 52.78 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.617 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.536 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 50.4 m-20 -68.1 -39.86 82.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.96 0.504 . . . . 0.0 112.168 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.695 HG13 ' O ' ' A' ' 390' ' ' GLN . 1.9 m -56.82 -45.16 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.662 ' O ' HG21 ' A' ' 399' ' ' VAL . 12.9 mm -58.91 -47.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.832 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.6 mmtt -52.48 -43.13 64.81 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 123.987 0.804 . . . . 0.0 111.325 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.16 -44.63 13.15 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.236 -172.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.645 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.8 mt -69.05 -40.61 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 117.603 0.702 . . . . 0.0 111.34 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.706 HG22 ' CG ' ' A' ' 429' ' ' TYR . 5.5 m -58.35 -44.27 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.802 0.81 . . . . 0.0 109.904 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 399' ' ' VAL . 14.6 t70 -59.17 -43.49 92.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.261 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 30.8 mm-40 -83.52 -52.21 6.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.073 -171.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.552 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -111.13 -30.98 7.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.758 -170.16 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.81 165.84 12.04 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.678 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.61 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.47 -44.68 98.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.586 ' HB1' HG22 ' A' ' 457' ' ' ILE . . . -54.88 -52.45 62.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.464 0.649 . . . . 0.0 111.946 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.497 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.45 -49.57 68.65 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.17 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.645 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.61 -41.63 63.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.611 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 46.2 t80 -58.18 -46.65 85.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.471 0.653 . . . . 0.0 109.489 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.764 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.0 m -58.52 -52.58 65.06 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.674 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.62 ' O ' ' HG ' ' A' ' 414' ' ' LEU . 2.7 mm? -62.57 -48.77 78.02 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.568 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.82 -43.39 87.1 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.903 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.568 ' HE1' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.23 -32.29 66.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.798 0.299 . . . . 0.0 111.184 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.764 ' HG3' ' O ' ' A' ' 409' ' ' THR . 68.5 mtm -69.84 -47.17 63.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.396 0.617 . . . . 0.0 109.855 174.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.651 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 18.0 mt -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.937 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.612 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.6 OUTLIER -74.81 -16.89 60.69 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.864 -173.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 101.27 29.05 6.52 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.1 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.568 ' HA ' ' HE1' ' A' ' 412' ' ' MET . 4.7 mm-40 59.23 43.61 16.77 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.074 0.95 . . . . 0.0 112.279 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.637 ' ND2' HD22 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -119.09 66.78 0.78 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 167.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.454 ' HD2' ' HB2' ' A' ' 423' ' ' SER . 0.7 OUTLIER -46.1 -35.03 4.6 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 111.554 -2.566 . . . . 0.0 113.435 -164.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.1 mt-30 -54.54 -46.47 73.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.637 HD22 ' ND2' ' A' ' 418' ' ' ASN . 1.6 pp -60.3 -50.1 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.905 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.586 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -60.02 -39.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.632 1.206 . . . . 0.0 109.19 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.499 ' N ' HG23 ' A' ' 422' ' ' VAL . 17.2 t -60.15 -46.36 89.95 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.643 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.63 -38.63 82.73 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.746 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.544 HD11 ' HA ' ' A' ' 422' ' ' VAL . 2.4 mt -71.79 -41.98 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.507 0.67 . . . . 0.0 109.932 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.489 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -57.86 -45.71 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.407 -1.269 . . . . 0.0 112.726 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.567 ' HA ' ' CD2' ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.52 -29.92 68.23 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.608 1.194 . . . . 0.0 109.325 -174.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.48 -15.18 77.34 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.625 175.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.706 ' CG ' HG22 ' A' ' 399' ' ' VAL . 13.9 m-85 -102.49 2.62 36.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.567 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.68 145.07 78.81 Favored Pre-proline 0 N--CA 1.409 -2.479 0 CA-C-O 123.717 1.722 . . . . 0.0 113.516 168.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.69 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 71.9 Cg_endo -72.12 -55.68 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.426 1 C-N-CA 126.289 4.659 . . . . 0.0 113.618 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.69 140.59 16.31 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.4 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.605 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.23 -27.31 68.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.155 0.478 . . . . 0.0 111.29 -177.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.13 -48.22 79.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 170.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.679 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.3 t -57.71 -51.7 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.788 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -55.02 -53.05 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 91.8 m -61.52 -56.49 19.48 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.401 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.11 -45.34 79.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.519 -177.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.812 ' O ' HD21 ' A' ' 443' ' ' LEU . 41.9 mt -59.57 -53.13 61.59 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.706 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.77 -35.52 44.0 Favored 'General case' 0 N--CA 1.421 -1.905 0 O-C-N 124.844 1.34 . . . . 0.0 110.429 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.663 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.69 -59.83 2.53 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 177.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.76 13.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.416 0.553 . . . . 0.0 112.151 -173.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.812 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.75 -24.32 61.42 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.629 0.728 . . . . 0.0 111.776 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.708 ' N ' HD23 ' A' ' 443' ' ' LEU . 15.9 t70 -71.72 -42.73 66.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.564 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 37.9 mt-30 -69.34 -9.36 52.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -171.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 451' ' ' THR . 58.7 mm-40 -52.03 153.65 2.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.377 1.56 . . . . 0.0 114.322 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.463 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.8 mp -53.1 -32.81 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.985 -2.825 . . . . 0.0 115.483 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.558 ' H ' ' HB ' ' A' ' 451' ' ' THR . 40.2 m-20 -139.13 178.74 6.95 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 452' ' ' ARG . 7.9 p-10 -64.42 -51.59 62.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.414 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -66.79 -25.55 66.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 174.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.608 HG22 ' HB3' ' A' ' 446' ' ' GLU . 13.6 m -59.43 -42.08 91.04 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 119.798 1.181 . . . . 0.0 109.631 171.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 54.7 mtt180 -59.89 -30.98 69.38 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.338 171.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.611 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.46 -29.63 59.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.042 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -82.82 -47.18 12.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.094 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.607 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -101.95 -1.53 31.73 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.338 -165.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.583 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.72 -51.72 27.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.586 HG22 ' HB1' ' A' ' 405' ' ' ALA . 24.1 mm -71.85 -27.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . 0.671 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -70.77 -42.55 70.25 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.629 ' O ' HG22 ' A' ' 463' ' ' VAL . 51.5 m-70 -66.92 -30.72 70.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.169 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.678 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -67.06 -53.27 32.69 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.192 0.996 . . . . 0.0 109.052 -179.2 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.636 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.98 -32.19 73.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.665 173.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 458' ' ' GLN . . . -61.82 -54.41 42.63 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.105 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.701 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 22.1 t -62.21 -34.42 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 CA-C-O 121.684 0.754 . . . . 0.0 110.589 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.4 m-30 -61.8 -15.08 38.69 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.219 170.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 46.3 mm-40 -91.89 -49.56 6.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.954 . . . . 0.0 112.732 176.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.701 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -65.14 -40.06 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.456 ' HB2' ' HG ' ' A' ' 469' ' ' LEU . 6.9 mt -84.11 -16.64 42.9 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.73 50.56 58.02 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.28 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 475' ' ' SER . 0.9 OUTLIER -100.26 -178.64 3.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.71 0.804 . . . . 0.0 110.364 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.758 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 15.7 p30 -101.11 -43.39 6.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.39 -76.69 0.07 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.273 158.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.69 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -60.23 71.22 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -172.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.479 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 36.69 45.84 1.06 Allowed Glycine 0 C--N 1.276 -2.772 0 CA-C-N 110.589 -3.005 . . . . 0.0 113.577 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.758 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 27.5 mm-40 -82.54 -57.83 3.18 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.012 0.911 . . . . 0.0 111.466 -173.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 39.0 t 66.94 42.78 2.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.493 -2.139 . . . . 0.0 108.155 -173.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-N 109.246 -3.616 . . . . 0.0 112.623 170.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.478 0.579 0 N-CA-C 110.512 -0.611 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.9 mp -76.71 122.49 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.146 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 106.02 -94.91 1.0 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.587 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 83.0 m -156.84 122.12 4.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.362 0.601 . . . . 0.0 110.915 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 304' ' ' VAL . 2.8 p -64.66 130.67 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.538 172.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.724 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 27.8 mt -77.96 122.27 85.24 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-O 121.989 0.9 . . . . 0.0 111.851 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 308' ' ' GLN . 25.4 Cg_endo -72.62 -14.02 27.32 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 124.887 3.725 . . . . 0.0 111.417 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.696 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 3.5 tp 34.71 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 C-N-CA 128.296 2.638 . . . . 0.0 116.088 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.63 ' HG2' HG21 ' A' ' 307' ' ' ILE . 61.6 mm-40 -58.71 -34.4 71.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.643 0.777 . . . . 0.0 110.41 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.492 ' HB3' HG12 ' A' ' 338' ' ' VAL . 7.6 t-160 -60.93 -47.41 86.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.583 173.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 307' ' ' ILE . 67.7 mt -61.76 -48.41 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 124.157 0.983 . . . . 0.0 112.68 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.696 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 9.5 mtp-105 -58.5 -31.56 67.99 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.655 0.382 . . . . 0.0 111.258 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 38.5 t -69.67 -32.78 71.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.56 0.695 . . . . 0.0 109.66 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.599 HG11 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.22 -41.23 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.942 177.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.663 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 33.6 p -82.33 -36.18 27.16 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.939 1.352 . . . . 0.0 109.807 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.66 32.73 8.39 Favored Glycine 0 N--CA 1.432 -1.576 0 CA-C-N 112.203 -2.271 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 46.9 mt-10 55.75 165.35 0.06 OUTLIER Pre-proline 0 N--CA 1.437 -1.085 0 C-N-CA 124.062 0.945 . . . . 0.0 113.429 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.454 ' HB3' HD12 ' A' ' 324' ' ' ILE . 33.1 Cg_exo -44.27 146.73 1.78 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.547 2.831 . . . . 0.0 113.095 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.426 ' HD2' HD11 ' A' ' 324' ' ' ILE . 68.9 Cg_endo -88.09 -102.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.739 2.292 . . . . 0.0 111.171 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.404 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 11.2 mmm180 -102.36 -79.94 0.52 Allowed 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.284 0.564 . . . . 0.0 111.188 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.531 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 8.6 m-20 -94.75 164.17 20.38 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.51 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.73 -48.11 9.67 Favored 'Trans proline' 0 CA--C 1.512 -0.577 0 C-N-CA 122.975 2.45 . . . . 0.0 110.613 168.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -25.91 6.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.218 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 63.7 mt-10 -81.73 -33.5 31.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 0.0 111.226 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.719 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -48.38 -42.37 52.96 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -173.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.677 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.97 -63.23 0.31 Allowed 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 123.089 2.526 . . . . 0.0 113.019 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.548 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -61.23 -37.25 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.246 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.663 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -57.63 -36.53 71.94 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.569 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.486 HD12 HG12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -70.59 -49.49 47.17 Favored 'General case' 0 N--CA 1.401 -2.916 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.457 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.75 -24.11 24.4 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.887 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -74.48 -42.14 59.52 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.994 0.902 . . . . 0.0 110.882 173.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.565 ' HB3' HG22 ' A' ' 314' ' ' THR . 49.2 m-20 -94.24 -23.63 17.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.522 -168.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.58 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.66 -50.29 9.75 Favored Pre-proline 0 C--N 1.308 -1.239 0 C-N-CA 124.523 1.129 . . . . 0.0 113.829 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 53.3 Cg_endo -63.19 -31.48 74.68 Favored 'Trans proline' 0 CA--C 1.51 -0.693 0 C-N-CA 122.473 2.115 . . . . 0.0 111.557 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.483 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -74.38 -42.44 59.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.501 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 332' ' ' ALA . 95.5 mt -58.27 -48.01 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.947 174.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.39 -17.96 2.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.496 -1.684 . . . . 0.0 112.368 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.09 -52.8 5.52 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.03 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' ' 309' ' ' HIS . 96.8 t -57.78 -71.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 123.506 1.622 . . . . 0.0 110.238 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.724 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.6 123.46 72.6 Favored Pre-proline 0 N--CA 1.403 -2.82 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.588 -174.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.697 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 74.1 Cg_endo -72.7 -17.22 26.25 Favored 'Trans proline' 0 CA--C 1.495 -1.454 0 C-N-CA 123.947 3.098 . . . . 0.0 110.267 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.442 ' O ' HG21 ' A' ' 341' ' ' VAL . 2.6 p 32.62 66.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 111.683 -2.508 . . . . 0.0 110.103 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.547 ' N ' HD13 ' A' ' 346' ' ' LEU . 46.6 p -79.08 4.11 15.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.738 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.807 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.2 p -140.74 159.5 62.34 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.546 ' HB3' HD12 ' A' ' 369' ' ' LEU . 70.5 Cg_exo -60.33 -46.21 19.18 Favored 'Trans proline' 0 CA--C 1.498 -1.296 0 C-N-CA 123.571 2.847 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.628 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -41.33 -56.52 2.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.4 175.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.807 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.9 mt -55.85 -51.24 68.22 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.051 -1.432 . . . . 0.0 111.0 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.503 ' HA ' HD12 ' A' ' 350' ' ' ILE . 4.7 ttm180 -49.83 -48.06 51.2 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.959 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 1.08 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.7 m -68.88 -47.1 66.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.949 -177.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.56 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.0 mtp180 -62.37 -34.3 76.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.857 ' O ' HG12 ' A' ' 354' ' ' ILE . 28.1 mt -58.24 -53.04 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.753 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.613 ' O ' HD23 ' A' ' 355' ' ' LEU . 19.7 mt -57.81 -53.89 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 121.922 0.868 . . . . 0.0 111.201 -170.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.538 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 13.5 m-20 -63.89 -35.68 81.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.133 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 307' ' ' ILE . . . -70.56 -29.91 66.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.68 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.857 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.03 -58.85 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 122.945 1.355 . . . . 0.0 110.118 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.719 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.13 -27.95 57.27 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.182 -167.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.74 -72.56 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.341 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -106.63 52.15 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.562 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.649 HD21 ' HB2' ' A' ' 361' ' ' LEU . 12.7 p-10 -89.88 129.45 36.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 122.861 0.464 . . . . 0.0 109.911 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.555 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -48.24 -71.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.881 -170.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.37 6.68 5.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.523 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.649 ' HB2' HD21 ' A' ' 358' ' ' ASN . 3.5 mt -70.96 -6.19 36.76 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.582 0.706 . . . . 0.0 109.962 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.538 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 19.5 t -63.7 78.89 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.413 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.749 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.9 mm? -61.14 -179.69 0.16 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.184 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 366' ' ' GLY . 49.2 p -119.76 157.71 51.57 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.436 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 1.08 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 57.7 Cg_endo -69.79 25.32 0.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.115 1.876 . . . . 0.0 113.254 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -134.32 -4.0 2.97 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.647 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.88 -21.21 13.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.119 0.961 . . . . 0.0 110.451 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.911 ' HB2' ' SG ' ' A' ' 348' ' ' CYS . 3.8 m -94.41 24.16 4.7 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.638 -168.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.598 ' N ' HD11 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -54.9 -35.89 64.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.332 1.063 . . . . 0.0 109.356 -172.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.06 159.48 23.15 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.304 172.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.608 ' O ' HG12 ' A' ' 375' ' ' VAL . 58.7 m95 -69.63 -35.48 75.28 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.575 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.32 -41.96 98.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.969 -175.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 92.0 p -67.47 -44.48 78.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.906 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.553 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -63.43 -52.83 59.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 371' ' ' TRP . 15.3 m -56.11 -45.03 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.453 0.645 . . . . 0.0 109.559 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.672 ' O ' HD13 ' A' ' 380' ' ' ILE . . . -59.05 -45.66 90.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.999 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.512 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 24.0 m -68.05 -37.24 81.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.289 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -61.73 -34.83 76.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.677 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 68.1 t80 -73.38 -45.15 56.51 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.461 1.124 . . . . 0.0 109.097 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.6 -33.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 112.647 -2.07 . . . . 0.0 111.167 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.41 -44.39 95.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.538 0.685 . . . . 0.0 111.068 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.415 HG21 ' O ' ' A' ' 378' ' ' LEU . 32.7 p -93.73 -23.68 18.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.82 -167.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 30.6 m80 -109.55 23.75 14.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.57 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.91 36.15 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 114.223 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m 66.27 159.54 0.13 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 111.494 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.582 ' CE2' HD23 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -129.47 151.22 77.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -96.32 54.1 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 110.906 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.629 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.02 8.16 0.72 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -70.69 -45.65 64.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.102 0.477 . . . . 0.0 110.479 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.648 ' O ' HG12 ' A' ' 394' ' ' VAL . 75.6 mt-30 -75.26 -28.17 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -170.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.698 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.34 -31.61 45.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.025 0.829 . . . . 0.0 112.115 -170.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.617 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -53.18 41.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.925 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.511 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 18.2 m-20 -67.48 -37.48 82.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.3 m -58.5 -45.75 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 110.616 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 399' ' ' VAL . 9.5 mm -58.25 -47.16 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.855 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 34.0 mmtt -52.42 -39.86 61.48 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 124.205 0.94 . . . . 0.0 111.893 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -77.39 -44.62 12.75 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.68 -1.247 . . . . 0.0 113.146 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.709 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.4 mt -69.39 -42.72 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 111.749 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 395' ' ' ILE . 4.2 m -57.09 -43.96 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.562 0.696 . . . . 0.0 110.226 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.496 ' N ' HG22 ' A' ' 399' ' ' VAL . 6.1 t70 -58.47 -39.76 80.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.861 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 47.7 mt-30 -86.38 -53.62 4.9 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.28 -173.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.51 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.6 OUTLIER -113.19 -30.85 6.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.107 -166.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.29 165.83 12.09 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.856 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.593 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.1 -43.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -56.32 -50.57 71.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.92 0.391 . . . . 0.0 111.871 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.557 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.54 -51.42 62.93 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.705 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.709 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.33 -41.41 65.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.567 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 48.0 t80 -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.635 0.731 . . . . 0.0 109.366 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.786 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.3 m -59.91 -53.42 58.1 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.808 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.623 HD12 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 117.887 0.312 . . . . 0.0 110.681 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.28 -45.24 83.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.405 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.617 ' HE3' ' HA ' ' A' ' 417' ' ' GLN . 0.4 OUTLIER -70.41 -32.21 69.74 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.645 0.723 . . . . 0.0 111.075 177.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.786 ' HG3' ' O ' ' A' ' 409' ' ' THR . 49.7 mtm -68.65 -48.04 65.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.53 0.681 . . . . 0.0 109.521 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.654 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 15.3 mt -59.66 -40.14 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.653 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.792 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -78.32 -17.23 56.85 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.803 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 86.78 47.05 4.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.839 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.617 ' HA ' ' HE3' ' A' ' 412' ' ' MET . 0.8 OUTLIER 57.96 47.54 14.81 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.792 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -125.89 74.36 1.42 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.612 1.673 . . . . 0.0 106.953 161.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.473 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 2.1 p90 -58.57 -33.49 70.0 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.165 -2.288 . . . . 0.0 110.826 -160.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -55.11 -43.45 74.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.495 -165.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.579 HD21 ' ND2' ' A' ' 418' ' ' ASN . 2.0 pp -63.42 -49.63 72.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.242 0.544 . . . . 0.0 110.721 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.544 HG21 ' N ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -60.71 -39.45 81.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.834 1.302 . . . . 0.0 109.207 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.544 ' N ' HG21 ' A' ' 422' ' ' VAL . 41.2 t -61.91 -44.36 96.95 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.076 -2.329 . . . . 0.0 111.723 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.98 -40.74 82.97 Favored Glycine 0 C--N 1.316 -0.557 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.713 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -71.4 -41.92 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.623 0.725 . . . . 0.0 110.167 175.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.4 mm -55.13 -42.74 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.483 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.695 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 3.3 tmm_? -58.86 -36.05 73.96 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 123.201 1.477 . . . . 0.0 109.383 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.08 -8.34 69.18 Favored Glycine 0 C--N 1.283 -2.397 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.224 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.617 ' CD1' HG21 ' A' ' 399' ' ' VAL . 11.1 m-85 -105.6 -0.55 25.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.55 142.84 82.29 Favored Pre-proline 0 N--CA 1.406 -2.637 0 CA-C-O 123.585 1.66 . . . . 0.0 113.017 170.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.694 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 67.6 Cg_endo -70.75 -55.25 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.386 1 C-N-CA 126.164 4.576 . . . . 0.0 113.212 -172.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.535 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -118.79 143.5 17.48 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.372 -178.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.608 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.31 -26.77 68.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.992 0.396 . . . . 0.0 111.268 -177.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.46 79.32 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.701 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.5 t -58.25 -51.54 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.807 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -55.29 -53.33 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 99.9 m -61.85 -56.67 16.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.169 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.19 -45.93 79.59 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.57 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.817 ' O ' HD23 ' A' ' 443' ' ' LEU . 41.8 mt -59.66 -53.15 61.41 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.651 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.711 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 39.8 mm-40 -51.51 -35.44 40.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 O-C-N 124.882 1.364 . . . . 0.0 110.683 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.39 -60.59 2.17 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -76.09 -50.29 15.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.77 -0.581 . . . . 0.0 111.901 -172.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.88 63.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.384 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.711 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 8.2 t70 -73.95 -41.85 61.4 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.129 0.966 . . . . 0.0 110.747 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.18 -8.15 43.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.601 ' HB3' HG22 ' A' ' 451' ' ' THR . 51.5 mm-40 -51.77 157.16 1.24 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.377 1.561 . . . . 0.0 114.186 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.402 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.7 mp -53.87 -32.92 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.841 -2.89 . . . . 0.0 115.191 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.562 ' H ' ' HB ' ' A' ' 451' ' ' THR . 68.9 m-20 -135.18 178.22 7.2 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.432 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.8 p-10 -66.54 -51.48 56.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -22.98 63.62 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.601 HG22 ' HB3' ' A' ' 446' ' ' GLU . 31.1 m -57.79 -39.5 77.67 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 119.888 1.222 . . . . 0.0 109.398 170.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.604 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 75.7 mtt180 -60.72 -30.42 69.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.356 172.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.567 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.84 -35.36 59.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.164 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.93 -43.16 25.3 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.654 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.437 ' HG1' ' HG3' ' A' ' 446' ' ' GLU . 40.2 p -101.46 -2.09 31.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.295 -169.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.608 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.2 t80 -49.04 -54.58 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.827 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 26.3 mm -69.97 -26.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.499 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.72 -42.96 63.59 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.612 ' O ' HG22 ' A' ' 463' ' ' VAL . 39.7 m-70 -67.3 -31.04 71.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.562 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.677 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -64.37 -53.89 41.53 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.174 0.987 . . . . 0.0 109.093 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.45 -30.69 71.42 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.799 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 458' ' ' GLN . . . -66.94 -48.67 67.9 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.463 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.716 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 34.2 t -65.35 -36.24 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.471 175.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.5 m-30 -60.17 -13.9 14.54 Favored 'General case' 0 C--O 1.202 -1.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.625 168.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.3 tp10 -95.52 -51.93 4.34 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.213 -0.929 . . . . 0.0 112.467 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.716 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -62.62 -41.36 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.374 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.504 ' CD1' HG21 ' A' ' 435' ' ' VAL . 6.7 mt -83.94 -17.51 40.4 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.804 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.31 49.67 60.1 Favored Glycine 0 C--O 1.211 -1.294 0 CA-C-N 111.481 -2.599 . . . . 0.0 113.239 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.5 OUTLIER -102.86 172.91 6.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 123.951 0.9 . . . . 0.0 110.149 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.722 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.6 p30 -92.64 -39.59 11.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -161.96 -75.57 0.05 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.197 159.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.694 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -66.26 71.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.064 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.47 42.0 2.46 Favored Glycine 0 C--N 1.275 -2.817 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.217 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.722 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.6 mm-40 -80.24 -54.83 5.38 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.472 1.13 . . . . 0.0 111.102 -174.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.1 t 68.91 61.16 0.33 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.372 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.804 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -57.2 -47.66 83.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 111.023 -2.808 . . . . 0.0 111.893 174.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -54.86 142.07 30.81 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.968 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.6 mt -49.26 -55.61 12.09 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.533 -174.34 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 N--CA 1.479 0.623 0 N-CA-C 110.567 -0.59 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.3 mp -80.32 -51.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 140.43 -118.75 1.47 Allowed Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.01 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 26.5 m -130.77 134.81 47.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 0.0 110.707 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.5 t -75.11 123.98 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.636 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.758 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.7 mt -77.2 123.66 87.12 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 122.026 0.917 . . . . 0.0 112.657 -174.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 308' ' ' GLN . 37.4 Cg_endo -73.55 -20.04 20.99 Favored 'Trans proline' 0 CA--C 1.502 -1.106 0 C-N-CA 124.881 3.721 . . . . 0.0 111.116 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 3.6 tp 41.03 -63.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 127.833 2.453 . . . . 0.0 115.584 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.614 ' HG2' HG23 ' A' ' 307' ' ' ILE . 69.7 mm-40 -59.35 -33.67 71.43 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 123.409 0.684 . . . . 0.0 110.631 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.497 ' HB3' HG13 ' A' ' 338' ' ' VAL . 8.7 t-160 -60.5 -47.79 84.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.514 172.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.592 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 64.9 mt -60.28 -48.66 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 123.875 0.87 . . . . 0.0 112.091 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.69 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 14.1 mtp180 -57.5 -30.45 65.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 122.852 0.461 . . . . 0.0 111.798 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -34.17 74.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.462 0.648 . . . . 0.0 109.957 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.595 HG11 ' N ' ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.92 -40.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.515 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.727 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 36.3 p -81.91 -36.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.827 1.298 . . . . 0.0 109.793 -176.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 85.93 36.03 10.66 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 112.315 -2.221 . . . . 0.0 111.064 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 53.97 168.21 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.402 ' HB3' HD13 ' A' ' 324' ' ' ILE . 63.7 Cg_exo -47.13 147.13 5.63 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.674 2.916 . . . . 0.0 113.55 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.512 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 18.0 Cg_endo -96.94 -105.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.769 2.979 . . . . 0.0 113.378 -170.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.459 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 15.5 mmt180 -86.52 -86.26 0.15 Allowed 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 123.207 0.603 . . . . 0.0 110.687 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.459 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 22.6 m-20 -102.9 166.36 12.04 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.036 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.501 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 34.5 Cg_exo -58.35 -50.35 9.94 Favored 'Trans proline' 0 CA--C 1.511 -0.631 0 C-N-CA 122.536 2.158 . . . . 0.0 110.571 169.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -60.32 -11.72 7.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.295 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -92.19 -22.52 19.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.257 . . . . 0.0 111.591 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.674 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -49.71 -40.88 56.4 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.692 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 7.9 Cg_endo -49.61 -62.56 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.916 2.411 . . . . 0.0 113.05 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.641 ' O ' ' HG3' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -60.46 -37.2 73.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 122.329 1.062 . . . . 0.0 110.303 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.727 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 63.1 t90 -58.56 -38.05 77.02 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.741 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.504 HD12 HG12 ' A' ' 351' ' ' ILE . 0.6 OUTLIER -70.85 -50.59 33.62 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.453 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -54.36 -24.05 28.73 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.554 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.641 ' HG3' ' O ' ' A' ' 326' ' ' ILE . 21.4 mtp180 -75.21 -40.59 59.08 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 122.271 1.034 . . . . 0.0 112.0 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.542 ' HB3' HG23 ' A' ' 314' ' ' THR . 43.0 m-20 -94.27 -24.41 17.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.511 -1.677 . . . . 0.0 113.195 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.563 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.67 -49.28 13.3 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 124.635 1.174 . . . . 0.0 113.803 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.5 Cg_endo -60.78 -34.41 91.64 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 122.464 2.109 . . . . 0.0 111.488 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.505 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -74.06 -43.39 57.93 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.544 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 332' ' ' ALA . 94.1 mt -58.26 -47.08 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.013 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -13.8 2.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.995 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.86 -51.18 4.62 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.26 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 309' ' ' HIS . 94.6 t -57.81 -70.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 123.128 1.442 . . . . 0.0 109.846 170.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.758 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -87.4 125.68 64.79 Favored Pre-proline 0 N--CA 1.408 -2.526 0 CA-C-N 111.644 -2.526 . . . . 0.0 111.885 -175.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.658 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.1 Cg_endo -70.83 -19.71 30.68 Favored 'Trans proline' 0 CA--C 1.493 -1.566 0 C-N-CA 123.736 2.957 . . . . 0.0 110.283 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.404 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.6 p 33.24 70.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.54 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.571 ' N ' HD11 ' A' ' 346' ' ' LEU . 68.7 p -79.96 2.65 22.77 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.684 -2.053 . . . . 0.0 112.821 -170.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.813 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 18.0 p -143.22 161.65 46.8 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-O 121.457 0.646 . . . . 0.0 109.753 177.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.1 -40.67 32.26 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 124.403 3.402 . . . . 0.0 109.8 172.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -47.86 -55.11 10.56 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.625 -2.079 . . . . 0.0 110.298 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.813 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.7 mt -57.64 -51.38 69.76 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.817 -175.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 10.1 ttm180 -52.92 -42.06 65.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.934 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.53 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 42.0 t -68.26 -49.95 57.13 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.972 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.657 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 60.3 mtp180 -61.14 -37.64 83.57 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.476 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.868 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -57.44 -52.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 O-C-N 123.371 0.419 . . . . 0.0 111.006 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.604 ' O ' HD23 ' A' ' 355' ' ' LEU . 18.3 mt -58.38 -54.19 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 122.098 0.952 . . . . 0.0 110.964 -172.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 21.8 m-20 -63.96 -35.62 81.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.004 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.447 ' HB3' HD13 ' A' ' 307' ' ' ILE . . . -70.77 -29.22 65.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.876 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.868 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.8 mm -56.67 -59.49 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 CA-C-O 122.794 1.283 . . . . 0.0 110.161 174.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.664 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.87 -26.3 54.07 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 111.977 -2.374 . . . . 0.0 109.772 -167.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.58 -71.68 1.56 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.065 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -115.85 33.07 5.37 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.949 -176.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.662 HD21 ' HB2' ' A' ' 361' ' ' LEU . 22.6 p-10 -58.32 134.32 56.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.572 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -47.77 -72.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 C-N-CA 124.237 1.015 . . . . 0.0 112.854 -170.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -131.62 7.6 5.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.758 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 358' ' ' ASN . 2.6 mt -70.89 -4.59 25.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.669 0.747 . . . . 0.0 109.942 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.556 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 8.7 t -63.62 80.31 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.994 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.704 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.7 mm? -60.35 -170.82 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 30.5 p -124.77 157.49 65.88 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.598 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 53.0 Cg_exo -46.65 -37.73 21.05 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.09 1.86 . . . . 0.0 111.491 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 369' ' ' LEU . . . -86.05 2.96 87.62 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.693 -0.685 . . . . 0.0 114.594 -172.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.409 ' HB2' HD11 ' A' ' 363' ' ' LEU . 24.2 m-20 -109.21 -22.15 12.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.916 0.865 . . . . 0.0 110.083 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 62.7 m -94.3 19.74 9.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.67 -169.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -58.74 -41.27 86.06 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.897 -170.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.9 157.25 27.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 113.276 -1.783 . . . . 0.0 109.373 170.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.635 ' O ' HG12 ' A' ' 375' ' ' VAL . 51.5 m95 -69.59 -35.89 75.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.442 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.95 -38.56 91.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.352 -174.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 37.1 t -70.25 -44.0 69.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.11 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 351' ' ' ILE . . . -63.33 -52.17 62.98 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 371' ' ' TRP . 14.9 m -55.63 -46.35 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.494 0.664 . . . . 0.0 110.192 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.646 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -58.52 -37.5 75.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.848 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.47 HG22 HD12 ' A' ' 363' ' ' LEU . 39.0 m -75.29 -41.75 56.37 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.931 -171.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 381' ' ' ARG . 0.1 OUTLIER -58.82 -34.42 71.5 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.821 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.692 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 30.0 t80 -70.99 -49.1 48.96 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.49 1.138 . . . . 0.0 109.627 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.03 -32.12 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.976 170.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -60.0 -34.4 73.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.878 0.471 . . . . 0.0 111.451 175.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 26.1 p -103.83 -23.34 13.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.956 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -110.12 22.94 14.96 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.15 17.04 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 114.359 0.504 . . . . 0.0 114.359 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m 66.64 154.79 0.09 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.386 0.613 . . . . 0.0 111.236 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -119.12 154.57 53.52 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 389' ' ' HIS . 83.2 Cg_endo -96.09 54.55 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.36 2.707 . . . . 0.0 111.207 167.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.603 ' HA ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.0 -7.44 0.07 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 387' ' ' PRO . 7.8 t60 -69.21 -43.79 73.4 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.659 0.266 . . . . 0.0 111.235 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.645 ' O ' HG12 ' A' ' 394' ' ' VAL . 75.2 mt-30 -69.38 -26.24 64.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.687 ' O ' HG23 ' A' ' 394' ' ' VAL . 3.8 mm? -54.03 -29.82 45.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.354 0.525 . . . . 0.0 110.976 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.24 -53.29 38.61 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.683 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.531 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 34.4 m-20 -64.36 -41.38 96.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.861 0.464 . . . . 0.0 111.947 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.72 -45.2 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.249 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.689 ' O ' HG21 ' A' ' 399' ' ' VAL . 6.8 mm -58.05 -47.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.161 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 27.3 mmtt -52.78 -42.62 65.19 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.027 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -75.7 -44.91 18.96 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.494 -1.336 . . . . 0.0 112.637 -173.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.712 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.1 mt -69.87 -41.46 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 117.16 0.48 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 395' ' ' ILE . 4.3 m -57.35 -43.57 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.54 0.686 . . . . 0.0 110.381 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.47 ' N ' HG23 ' A' ' 399' ' ' VAL . 2.7 t70 -65.66 -37.43 86.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.975 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 74.4 mt-30 -82.56 -52.63 6.66 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.458 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.56 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -115.14 -30.39 6.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.031 -167.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 128.33 164.69 11.63 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.043 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.606 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -63.75 -43.01 97.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 122.653 0.381 . . . . 0.0 111.783 -176.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.574 ' HB2' HG21 ' A' ' 457' ' ' ILE . . . -57.26 -50.41 72.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.294 0.568 . . . . 0.0 111.246 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.492 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -63.37 -52.04 63.35 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 179.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.712 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.74 -40.41 66.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 176.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 32.9 t80 -58.4 -43.53 88.61 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.765 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.4 m -62.84 -53.18 58.11 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.624 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.599 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.7 mm? -60.14 -49.49 77.42 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.249 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.14 -42.34 87.59 Favored Glycine 0 C--N 1.314 -0.649 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.255 -174.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.582 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.17 -31.84 66.29 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 116.686 0.243 . . . . 0.0 110.956 179.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.765 ' HG3' ' O ' ' A' ' 409' ' ' THR . 50.8 mtm -69.51 -47.98 62.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 109.742 173.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.646 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 16.1 mt -59.02 -40.58 85.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.453 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.646 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.2 OUTLIER -77.08 -8.82 58.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.394 -177.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.42 33.54 7.97 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.952 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.582 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 4.2 mm-40 57.26 48.46 15.03 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.054 -1.073 . . . . 0.0 112.814 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.601 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -120.17 63.53 0.83 Allowed 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 165.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.482 ' HE1' ' O ' ' A' ' 449' ' ' ASP . 1.0 OUTLIER -44.59 -35.02 2.37 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.426 -2.624 . . . . 0.0 112.871 -163.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 423' ' ' SER . 39.5 mt-30 -55.71 -43.01 76.08 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -165.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.62 HD11 ' HG ' ' A' ' 415' ' ' SER . 1.9 pp -63.39 -48.4 78.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 412' ' ' MET . 0.7 OUTLIER -60.54 -38.99 79.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.579 1.181 . . . . 0.0 109.059 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.502 ' N ' HG22 ' A' ' 422' ' ' VAL . 35.9 t -59.62 -46.34 89.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.356 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.9 -39.03 76.97 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.207 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.1 -40.56 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.582 0.706 . . . . 0.0 110.24 174.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.446 HD12 HG22 ' A' ' 395' ' ' ILE . 1.8 mm -58.13 -45.21 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.023 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.635 ' C ' ' HD3' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -59.72 -29.53 68.19 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.76 1.267 . . . . 0.0 108.746 -174.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.17 -15.37 74.52 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 112.71 -2.041 . . . . 0.0 112.562 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.568 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 10.2 m-85 -101.17 -0.33 36.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.27 142.9 80.6 Favored Pre-proline 0 N--CA 1.414 -2.263 0 CA-C-O 123.653 1.692 . . . . 0.0 113.626 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.641 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 66.9 Cg_endo -71.71 -61.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.227 4.618 . . . . 0.0 113.603 -172.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.559 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.15 142.17 17.04 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.147 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.6 ' HA ' ' CG1' ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.96 -27.47 68.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.316 0.558 . . . . 0.0 111.701 -176.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.22 -48.89 77.66 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.612 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.2 t -61.61 -37.66 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.485 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.6 ' CG1' ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.13 -44.19 65.48 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.261 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 67.1 m -71.9 -54.94 8.47 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.433 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.0 -46.11 78.84 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.414 0.446 . . . . 0.0 111.168 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.773 ' O ' HD21 ' A' ' 443' ' ' LEU . 21.1 mt -60.11 -54.11 49.8 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.47 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.752 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.26 -33.59 29.03 Favored 'General case' 0 N--CA 1.405 -2.69 0 O-C-N 125.487 1.742 . . . . 0.0 111.108 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.1 -59.81 2.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -75.76 -50.19 15.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.978 0.354 . . . . 0.0 111.895 -173.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.773 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -59.0 -24.7 63.01 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.623 -178.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.752 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 7.2 t70 -73.32 -41.05 63.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.882 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -72.31 -8.16 53.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -172.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.507 ' HB3' HG22 ' A' ' 451' ' ' THR . 6.1 mm-40 -56.85 162.76 2.23 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.176 1.465 . . . . 0.0 114.317 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.82 -33.52 34.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 111.31 -2.677 . . . . 0.0 115.974 -168.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.539 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.9 m-20 -145.03 -175.73 4.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.482 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.7 m-20 -65.11 -56.81 10.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.414 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.58 -25.21 67.31 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 177.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.539 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 17.0 m -56.85 -44.02 81.74 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.708 1.14 . . . . 0.0 109.47 170.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.713 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 27.6 mtm-85 -62.13 -29.45 70.35 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.774 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.591 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.25 -28.67 62.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.032 0.92 . . . . 0.0 109.449 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -86.21 -43.73 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.22 -171.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.8 p -103.44 -3.99 24.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.932 -169.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.669 ' HB2' ' O ' ' A' ' 452' ' ' ARG . 8.8 t80 -49.12 -53.58 20.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.668 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.574 HG21 ' HB2' ' A' ' 405' ' ' ALA . 21.4 mm -71.17 -25.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.521 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.97 -43.54 62.13 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.578 ' O ' HG21 ' A' ' 463' ' ' VAL . 80.1 m-70 -67.92 -31.1 70.63 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.215 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.673 HD22 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.8 -53.98 42.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.165 0.984 . . . . 0.0 109.177 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -61.61 -30.41 70.67 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.785 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -69.06 -47.57 64.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.585 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.712 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 45.6 t -66.06 -35.78 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.314 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.0 m-30 -61.12 -14.09 21.98 Favored 'General case' 0 C--O 1.2 -1.504 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.647 168.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 6.3 tp10 -93.36 -52.03 4.71 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.444 -0.785 . . . . 0.0 112.323 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.712 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -62.98 -41.31 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.421 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.47 ' CD1' HG23 ' A' ' 435' ' ' VAL . 5.7 mt -84.33 -17.12 40.53 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.734 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 66.1 49.35 58.5 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 111.633 -2.53 . . . . 0.0 113.336 173.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.6 OUTLIER -101.81 -176.59 3.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.056 0.943 . . . . 0.0 110.04 -179.21 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.731 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.8 p30 -105.11 -40.63 5.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 167.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.435 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -159.06 -79.38 0.06 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.335 -2.211 . . . . 0.0 110.91 158.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.641 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.5 OUTLIER -61.41 73.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -170.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.482 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.73 44.69 0.71 Allowed Glycine 0 C--N 1.274 -2.864 0 CA-C-N 110.462 -3.063 . . . . 0.0 113.227 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.731 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.1 mm-40 -79.66 -55.19 5.19 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.273 1.035 . . . . 0.0 111.223 -173.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.7 t 65.69 47.81 2.07 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.912 -2.403 . . . . 0.0 108.095 -173.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.734 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -43.42 -47.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 109.808 -3.36 . . . . 0.0 112.303 176.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -47.48 137.63 8.58 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.266 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.72 -27.56 66.58 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.651 0.78 . . . . 0.0 112.434 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.251 1.167 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.593 176.631 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.476 0.467 0 N-CA-C 110.44 -0.639 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.424 ' N ' HD13 ' A' ' 301' ' ' ILE . 3.0 mp -111.89 106.18 20.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -88.35 153.86 24.67 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.762 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 52.9 m -91.97 136.76 32.91 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.392 0.615 . . . . 0.0 111.353 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.8 t -83.51 121.25 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.157 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.771 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 47.6 mt -71.11 121.19 83.46 Favored Pre-proline 0 N--CA 1.426 -1.665 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 57.8 Cg_endo -82.09 58.21 6.56 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 124.92 3.746 . . . . 0.0 109.592 170.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.658 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 1.7 tp -45.52 -47.38 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 112.12 -2.309 . . . . 0.0 113.347 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.618 ' HA ' ' OE1' ' A' ' 308' ' ' GLN . 16.7 mm-40 -65.63 -35.65 81.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.327 0.584 . . . . 0.0 111.282 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.508 ' HB3' HG13 ' A' ' 338' ' ' VAL . 6.3 t-160 -61.89 -47.41 85.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.615 173.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.544 ' O ' HG22 ' A' ' 314' ' ' THR . 67.5 mt -61.25 -49.62 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.058 0.943 . . . . 0.0 113.043 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 28.1 mtp180 -59.93 -29.57 68.47 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.05 0.54 . . . . 0.0 111.602 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 69.4 m -69.67 -33.26 72.31 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.606 0.717 . . . . 0.0 110.266 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.593 HG11 ' N ' ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.27 -40.86 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.936 177.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.644 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 34.4 p -82.13 -36.47 27.43 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.805 1.288 . . . . 0.0 109.928 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.23 34.42 9.67 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 112.323 -2.217 . . . . 0.0 110.813 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 33.2 mt-10 52.46 170.24 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.445 ' HB3' HD13 ' A' ' 324' ' ' ILE . 93.7 Cg_exo -49.63 150.67 8.53 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.213 2.609 . . . . 0.0 113.246 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.451 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 42.4 Cg_endo -93.37 -104.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.444 2.763 . . . . 0.0 112.11 -174.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.43 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 20.0 mmt180 -95.17 -84.58 0.33 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.515 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 12.1 m-20 -96.07 163.47 20.86 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.876 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.473 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.75 -48.64 12.19 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.732 2.288 . . . . 0.0 110.434 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.425 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -56.36 -17.14 6.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.509 -1.678 . . . . 0.0 113.562 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 39.7 mt-10 -87.38 -27.97 22.46 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.368 -0.208 . . . . 0.0 110.993 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.647 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.09 -43.69 69.31 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.675 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 3.5 Cg_endo -46.64 -65.35 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.098 2.532 . . . . 0.0 112.997 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.555 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.61 -37.62 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.317 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.644 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.5 t90 -57.68 -34.05 69.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.114 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.533 HD13 HG12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -70.58 -50.23 39.46 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.38 -23.73 27.73 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.903 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.511 ' HD2' HG23 ' A' ' 406' ' ' THR . 2.4 mtm-85 -73.23 -40.78 64.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.317 1.056 . . . . 0.0 110.369 175.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.552 ' HB3' HG23 ' A' ' 314' ' ' THR . 56.6 m-20 -97.75 -24.91 15.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.716 -1.584 . . . . 0.0 114.004 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.549 ' HA ' HD11 ' A' ' 335' ' ' ILE . . . -42.66 -49.72 13.07 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.4 Cg_endo -61.13 -32.93 91.68 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.495 2.13 . . . . 0.0 111.528 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.501 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -73.97 -43.51 57.89 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.483 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 332' ' ' ALA . 92.9 mt -57.44 -47.24 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.942 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 36.9 t70 -55.93 -14.78 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.202 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.82 -47.37 6.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.429 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 309' ' ' HIS . 92.2 t -63.49 -72.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.296 1.522 . . . . 0.0 109.946 169.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.771 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -84.05 122.48 75.93 Favored Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.665 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.7 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.2 Cg_endo -72.23 -17.25 27.86 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.094 3.196 . . . . 0.0 110.159 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.42 ' O ' HG21 ' A' ' 341' ' ' VAL . 2.4 p 33.89 67.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.068 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.541 ' N ' HD11 ' A' ' 346' ' ' LEU . 41.5 p -78.35 0.7 24.5 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.775 -2.012 . . . . 0.0 112.572 -170.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.822 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -138.06 159.09 69.78 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.463 ' HB3' HD13 ' A' ' 369' ' ' LEU . 68.1 Cg_exo -60.53 -44.94 24.0 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 123.583 2.855 . . . . 0.0 108.797 172.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.619 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -44.99 -52.43 8.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.722 -2.035 . . . . 0.0 110.776 176.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.822 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.0 mt -56.94 -52.3 65.73 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.518 ' HA ' HD13 ' A' ' 350' ' ' ILE . 25.3 ttm180 -49.94 -46.23 51.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.603 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.945 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 8.2 m -68.12 -50.86 52.12 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.146 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.69 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 35.2 mtt180 -61.23 -34.82 75.75 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.409 0.443 . . . . 0.0 111.105 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.861 ' O ' HG12 ' A' ' 354' ' ' ILE . 32.7 mt -56.22 -51.5 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.898 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.576 ' O ' HD21 ' A' ' 355' ' ' LEU . 21.7 mt -60.38 -53.84 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 123.832 0.707 . . . . 0.0 111.744 -172.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.69 ' OD1' ' HA ' ' A' ' 349' ' ' ARG . 0.0 OUTLIER -60.41 -36.13 77.42 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.822 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.465 ' HB2' HD12 ' A' ' 307' ' ' ILE . . . -71.19 -29.79 65.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.861 HG12 ' O ' ' A' ' 350' ' ' ILE . 4.3 mm -58.03 -59.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 CA-C-O 123.082 1.42 . . . . 0.0 110.493 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.647 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -78.62 -26.96 45.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.26 -167.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.85 -78.7 0.2 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.903 -1.499 . . . . 0.0 113.023 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -102.4 36.31 4.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.415 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.658 HD21 ' HB2' ' A' ' 361' ' ' LEU . 22.0 p-10 -70.63 131.46 43.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.069 0.461 . . . . 0.0 110.649 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.552 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -49.62 -72.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -169.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.9 2.94 6.91 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.885 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.658 ' HB2' HD21 ' A' ' 358' ' ' ASN . 2.2 mt -72.46 -4.62 31.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.943 0.877 . . . . 0.0 109.953 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 8.2 t -69.18 70.55 0.24 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.378 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 367' ' ' ASP . 1.5 mm? -55.03 172.31 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.5 p -120.27 159.4 47.74 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.325 -175.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.831 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.1 Cg_endo -53.3 -9.98 1.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.156 2.57 . . . . 0.0 113.215 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -103.49 -17.99 15.8 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.261 0.864 . . . . 0.0 115.261 -174.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.469 ' HB2' HD11 ' A' ' 363' ' ' LEU . 4.9 m-20 -105.72 -23.61 12.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.617 1.208 . . . . 0.0 110.649 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.945 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 8.6 t -96.18 25.24 5.02 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.653 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 369' ' ' LEU . 0.2 OUTLIER -54.39 -37.01 64.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.635 0.731 . . . . 0.0 110.467 -170.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.26 161.2 20.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.514 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.55 ' O ' HG11 ' A' ' 375' ' ' VAL . 30.3 m95 -69.41 -36.67 76.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.544 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.5 OUTLIER -64.31 -40.47 95.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.531 -174.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.1 t -69.08 -43.11 75.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.44 -53.44 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 371' ' ' TRP . 15.6 m -57.55 -43.02 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.624 0.726 . . . . 0.0 109.731 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.701 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -64.13 -42.75 96.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.272 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.498 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 22.8 m -69.32 -37.93 77.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.768 -173.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -61.33 -34.61 75.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.58 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.675 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 56.9 t80 -75.33 -43.98 47.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.161 0.982 . . . . 0.0 109.414 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.1 mp -52.08 -33.01 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.245 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.604 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.42 -34.63 74.23 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 123.141 0.576 . . . . 0.0 111.956 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.8 p -111.05 -23.53 10.87 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -165.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -109.98 25.6 11.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.63 50.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.959 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 64.12 164.39 0.13 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.023 0.439 . . . . 0.0 111.269 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.561 ' CE2' HD23 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -130.41 153.67 81.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 389' ' ' HIS . 85.8 Cg_endo -99.37 54.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.571 2.847 . . . . 0.0 111.248 165.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.645 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.5 -0.53 0.18 Allowed 'General case' 0 C--O 1.231 0.1 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.4 t60 -69.13 -44.51 72.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.951 0.405 . . . . 0.0 110.571 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.564 ' O ' HG23 ' A' ' 394' ' ' VAL . 27.6 mt-30 -75.01 -26.03 59.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.687 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.2 mm? -53.62 -31.71 48.31 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.28 0.945 . . . . 0.0 111.515 -174.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.676 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.45 -56.26 24.42 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.701 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.479 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 51.6 t30 -64.56 -34.47 78.32 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 110.717 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 390' ' ' GLN . 44.9 t -53.55 -53.64 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.645 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.752 ' O ' HG21 ' A' ' 399' ' ' VAL . 7.0 mm -59.15 -48.26 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 175.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 39.9 mmtt -52.71 -38.47 60.77 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 124.185 0.928 . . . . 0.0 112.056 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.57 -45.26 8.73 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.607 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.687 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.1 mt -70.33 -40.68 78.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 117.762 0.781 . . . . 0.0 111.271 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.752 HG21 ' O ' ' A' ' 395' ' ' ILE . 5.4 m -57.75 -44.0 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.575 0.702 . . . . 0.0 110.028 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.499 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.2 t70 -60.38 -36.62 78.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.576 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -91.19 -55.56 3.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.645 ' HG2' ' CG2' ' A' ' 406' ' ' THR . 3.0 tp10 -106.42 -34.42 7.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.245 0.545 . . . . 0.0 112.289 -172.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 129.97 167.29 12.03 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.511 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.587 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.55 -43.16 96.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -174.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.57 ' HB3' HG22 ' A' ' 457' ' ' ILE . . . -56.62 -51.0 70.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.645 ' CG2' ' HG2' ' A' ' 402' ' ' GLU . 0.9 OUTLIER -66.03 -48.79 69.96 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.756 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.687 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.96 -39.68 66.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 41.1 t80 -57.06 -47.2 81.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.676 0.75 . . . . 0.0 109.189 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.774 ' O ' ' HG3' ' A' ' 413' ' ' MET . 15.6 m -59.62 -53.0 63.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.008 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.597 HD11 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.49 -49.12 78.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.784 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.2 -42.47 88.19 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.18 -174.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.555 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.944 0.372 . . . . 0.0 110.746 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.774 ' HG3' ' O ' ' A' ' 409' ' ' THR . 65.5 mtm -69.57 -48.31 60.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.418 0.628 . . . . 0.0 110.047 175.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.701 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 17.0 mt -59.61 -37.56 78.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.376 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.79 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -77.76 -16.22 58.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.722 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.95 4.02 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.179 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.555 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 50.19 48.49 22.05 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 124.49 1.116 . . . . 0.0 113.91 -177.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.79 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -121.1 65.06 0.86 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 123.419 1.581 . . . . 0.0 107.294 166.01 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.485 ' HD2' ' HB2' ' A' ' 423' ' ' SER . 0.4 OUTLIER -44.17 -35.06 2.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.52 -2.582 . . . . 0.0 112.984 -164.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 423' ' ' SER . 53.5 mt-30 -54.66 -45.62 73.89 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -165.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.572 HD22 ' ND2' ' A' ' 418' ' ' ASN . 2.2 pp -62.75 -48.82 77.52 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.02 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.537 HG21 ' N ' ' A' ' 423' ' ' SER . 0.6 OUTLIER -61.28 -39.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 122.7 1.238 . . . . 0.0 109.04 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.537 ' N ' HG21 ' A' ' 422' ' ' VAL . 31.3 t -60.27 -46.58 89.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.405 -2.18 . . . . 0.0 111.718 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.85 -38.7 75.04 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.656 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 422' ' ' VAL . 2.3 mt -71.96 -40.97 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.441 0.638 . . . . 0.0 110.285 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 395' ' ' ILE . 1.6 mm -57.94 -44.09 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.618 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.517 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -58.23 -31.95 67.86 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 124.826 1.25 . . . . 0.0 109.046 -175.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.45 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -71.98 -13.36 75.82 Favored Glycine 0 C--N 1.301 -1.409 0 CA-C-N 113.0 -1.909 . . . . 0.0 112.595 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.625 ' CD1' HG22 ' A' ' 399' ' ' VAL . 11.0 m-85 -102.52 0.15 33.14 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.67 138.76 86.25 Favored Pre-proline 0 N--CA 1.408 -2.574 0 CA-C-O 123.752 1.739 . . . . 0.0 113.126 171.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.643 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 57.7 Cg_endo -68.58 -58.13 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.285 1 C-N-CA 126.34 4.694 . . . . 0.0 113.556 -170.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.544 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.51 143.46 18.1 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.96 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.609 ' HA ' ' CG1' ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -27.53 69.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.433 0.617 . . . . 0.0 111.857 -173.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.72 78.3 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.61 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.4 t -61.17 -36.9 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.617 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.609 ' CG1' ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -73.19 -43.16 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -175.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 24.0 m -71.6 -55.61 7.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.923 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.8 83.51 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.81 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.788 ' O ' HD21 ' A' ' 443' ' ' LEU . 29.2 mt -65.02 -54.24 33.47 Favored 'General case' 0 CA--C 1.477 -1.836 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.244 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.678 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.2 mp0 -52.18 -33.4 40.49 Favored 'General case' 0 N--CA 1.409 -2.515 0 O-C-N 125.21 1.569 . . . . 0.0 110.372 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.678 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -60.07 2.41 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 172.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -75.1 -49.47 19.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.839 -0.538 . . . . 0.0 112.116 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.788 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.81 -24.35 64.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.629 0.728 . . . . 0.0 111.774 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.697 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.1 t70 -72.8 -43.4 62.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.528 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.7 mt-30 -69.67 -8.35 46.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.621 ' HB3' HG22 ' A' ' 451' ' ' THR . 55.6 mm-40 -51.68 154.96 1.77 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 123.148 1.451 . . . . 0.0 114.267 -176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.519 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.8 mp -52.68 -32.48 17.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 111.444 -2.616 . . . . 0.0 115.409 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.559 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.5 m-20 -141.88 178.79 7.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.997 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 452' ' ' ARG . 6.0 p-10 -63.01 -51.15 67.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -23.71 62.46 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.621 HG22 ' HB3' ' A' ' 446' ' ' GLU . 19.2 m -59.58 -40.35 87.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 120.011 1.278 . . . . 0.0 109.264 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 61.8 mtt180 -60.19 -31.25 69.95 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.36 171.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.521 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.36 -28.99 57.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.079 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.4 -43.84 13.29 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.047 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.507 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -103.06 -1.36 29.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.352 -168.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 452' ' ' ARG . 5.6 t80 -48.88 -55.33 12.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.633 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.57 HG22 ' HB3' ' A' ' 405' ' ' ALA . 25.9 mm -70.32 -25.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.56 -43.28 63.65 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.556 ' O ' HG21 ' A' ' 463' ' ' VAL . 49.4 m-70 -67.71 -32.06 72.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.541 172.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.677 HD22 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.12 -53.39 54.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 122.172 0.987 . . . . 0.0 108.895 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -61.99 -31.1 71.44 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.629 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 458' ' ' GLN . . . -67.18 -49.5 64.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.503 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.769 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 38.5 t -65.95 -34.38 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.8 m-30 -63.1 -14.6 50.42 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.617 169.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 7.4 tp10 -94.44 -52.29 4.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.889 0.852 . . . . 0.0 111.601 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.769 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.0 pt -63.33 -41.47 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.278 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 463' ' ' VAL . 7.2 mt -83.94 -17.78 39.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.763 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.41 50.13 57.24 Favored Glycine 0 C--O 1.218 -0.882 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.159 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.6 OUTLIER -100.9 172.78 6.83 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.036 0.934 . . . . 0.0 110.275 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.774 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 16.0 p30 -88.7 -44.16 10.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 166.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -162.18 -72.92 0.05 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.776 162.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.643 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -61.33 68.87 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.486 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.47 43.92 0.57 Allowed Glycine 0 C--N 1.275 -2.824 0 CA-C-N 110.715 -2.948 . . . . 0.0 113.564 173.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.774 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 30.3 mm-40 -82.25 -55.62 4.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 122.578 1.18 . . . . 0.0 111.054 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 44.2 t 69.12 55.04 0.42 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.368 -2.651 . . . . 0.0 108.307 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.763 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -49.33 -46.9 19.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 110.584 -3.007 . . . . 0.0 111.544 174.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 28.9 mmm-85 -60.97 152.44 27.77 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.448 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 59.8 mt -60.48 154.32 21.05 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.721 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.434 -1.265 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.523 -178.058 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.478 0.596 0 N-CA-C 111.095 -0.387 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.405 HD11 ' N ' ' A' ' 301' ' ' ILE . 2.7 mp -91.76 125.54 44.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.197 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 100.28 -107.6 3.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.911 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 86.4 m -157.07 127.0 6.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.586 0.708 . . . . 0.0 110.976 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.432 ' H ' HG11 ' A' ' 304' ' ' VAL . 1.5 p -70.21 121.62 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.323 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.814 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 54.4 mt -72.86 124.65 90.98 Favored Pre-proline 0 N--CA 1.423 -1.794 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.317 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.501 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 60.5 Cg_endo -83.0 53.78 4.52 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 124.969 3.779 . . . . 0.0 109.797 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.776 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 2.8 tp -43.06 -46.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 112.237 -2.256 . . . . 0.0 113.672 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.533 ' HG2' HG21 ' A' ' 307' ' ' ILE . 54.4 mm-40 -65.59 -36.29 83.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.692 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.468 ' HB3' HG12 ' A' ' 338' ' ' VAL . 7.4 t-160 -61.09 -46.21 91.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.315 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' A' ' 307' ' ' ILE . 68.6 mt -62.84 -49.61 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 124.263 1.025 . . . . 0.0 113.254 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.776 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 22.9 mtp180 -59.27 -30.3 68.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 121.888 -0.507 . . . . 0.0 111.259 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 59.5 m -69.59 -32.72 71.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.557 0.694 . . . . 0.0 110.01 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.21 -40.58 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.022 177.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.609 ' N ' HG12 ' A' ' 313' ' ' VAL . 35.9 p -82.56 -37.53 25.0 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.788 1.28 . . . . 0.0 109.976 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.04 34.09 7.83 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.817 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 35.7 mt-10 53.52 169.42 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 316' ' ' GLU . 25.4 Cg_exo -44.06 151.39 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.795 2.997 . . . . 0.0 113.621 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 17.2 Cg_endo -97.97 -108.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.356 2.704 . . . . 0.0 112.601 -174.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.452 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 9.6 mmm180 -92.47 -82.02 0.33 Allowed 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.592 0.71 . . . . 0.0 111.277 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.473 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 28.3 m-20 -102.63 158.63 31.39 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.133 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.445 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.1 Cg_exo -59.4 -49.67 10.1 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.654 2.236 . . . . 0.0 110.685 172.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -22.56 12.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.224 -1.807 . . . . 0.0 113.035 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.473 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -85.97 -24.37 26.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.672 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.0 OUTLIER -51.21 -40.95 71.95 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.684 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.4 Cg_endo -49.8 -62.22 0.45 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.903 2.402 . . . . 0.0 112.773 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.575 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.09 -37.18 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.236 177.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.644 ' CH2' HG21 ' A' ' 354' ' ' ILE . 55.5 t90 -58.35 -36.46 73.48 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.007 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.503 HD13 HG12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -69.85 -49.99 46.97 Favored 'General case' 0 N--CA 1.396 -3.125 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.523 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.08 -24.04 26.63 Favored Glycine 0 C--N 1.311 -0.824 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.151 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.3 mtt180 -73.99 -41.68 61.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.042 0.925 . . . . 0.0 110.576 174.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.562 ' HB3' HG23 ' A' ' 314' ' ' THR . 56.9 m-20 -95.68 -23.6 16.93 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.82 -169.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.541 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -43.5 -48.89 18.5 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.365 1.066 . . . . 0.0 113.727 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.1 Cg_endo -60.03 -34.56 94.73 Favored 'Trans proline' 0 CA--C 1.508 -0.796 0 C-N-CA 122.548 2.166 . . . . 0.0 111.539 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.506 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -73.4 -43.56 60.26 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.476 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 332' ' ' ALA . 97.1 mt -57.95 -48.24 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.872 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 31.8 t70 -54.27 -15.48 1.6 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.199 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.43 -51.65 4.83 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.508 HG23 HG21 ' A' ' 313' ' ' VAL . 91.1 t -59.17 -72.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.255 1.502 . . . . 0.0 109.998 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.814 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.4 OUTLIER -87.98 121.07 70.87 Favored Pre-proline 0 N--CA 1.405 -2.69 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.685 -176.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.594 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.3 Cg_endo -72.92 -20.76 21.81 Favored 'Trans proline' 0 CA--C 1.496 -1.422 0 C-N-CA 123.736 2.957 . . . . 0.0 110.362 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.623 HG22 ' CD2' ' A' ' 339' ' ' PHE . 2.7 t 46.07 61.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 111.715 -2.493 . . . . 0.0 109.92 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.596 ' N ' HD11 ' A' ' 346' ' ' LEU . 35.9 p -75.85 5.56 6.24 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.914 -172.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.764 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -141.89 159.28 59.98 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 347' ' ' ARG . 56.2 Cg_exo -61.81 -44.3 21.7 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 123.924 3.083 . . . . 0.0 108.994 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.675 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -50.07 -44.17 51.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.037 -1.892 . . . . 0.0 111.523 175.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.769 ' O ' HG13 ' A' ' 350' ' ' ILE . 14.9 mt -59.21 -52.25 66.47 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 344' ' ' PRO . 11.5 mmt180 -45.3 -52.44 9.71 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 125.249 1.593 . . . . 0.0 110.66 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.979 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -65.66 -49.2 69.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.713 -175.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.669 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.7 mtt180 -61.56 -39.31 90.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.872 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.6 mt -57.31 -55.43 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.788 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.351 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.652 ' O ' HD21 ' A' ' 355' ' ' LEU . 20.1 mt -57.65 -53.34 45.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 O-C-N 124.764 1.29 . . . . 0.0 110.736 -170.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.588 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 11.7 m-20 -63.14 -36.46 83.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.211 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.46 ' HB3' HD13 ' A' ' 307' ' ' ILE . . . -71.46 -30.61 66.21 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.173 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.872 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.2 mm -56.04 -58.09 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 CA-C-O 122.797 1.284 . . . . 0.0 110.312 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.672 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.99 -26.77 54.27 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.086 -2.325 . . . . 0.0 109.726 -168.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 73.69 -71.47 1.34 Allowed Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.93 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -113.21 37.88 3.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.941 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.633 HD21 ' HB2' ' A' ' 361' ' ' LEU . 20.2 p-10 -66.99 133.61 50.3 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.042 0.448 . . . . 0.0 110.563 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.562 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.1 mp -51.01 -77.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 124.409 1.084 . . . . 0.0 112.871 -169.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -124.92 7.0 8.26 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.492 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.633 ' HB2' HD21 ' A' ' 358' ' ' ASN . 2.6 mt -72.39 -4.63 31.19 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.67 0.748 . . . . 0.0 109.655 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.588 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 23.1 t -63.84 76.95 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.332 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.47 HD21 ' CD2' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -62.55 173.48 1.24 Allowed 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.7 p -122.05 156.39 59.89 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.896 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.979 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 6.7 Cg_endo -56.76 -3.54 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.856 2.37 . . . . 0.0 114.286 -172.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.502 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -104.59 -12.05 29.42 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.409 ' HB2' HD13 ' A' ' 363' ' ' LEU . 16.1 m-20 -109.25 -20.39 12.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.023 0.916 . . . . 0.0 110.853 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 17.1 p -96.75 15.21 22.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.117 -164.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.502 HD11 ' O ' ' A' ' 366' ' ' GLY . 1.3 mt -58.75 -40.98 85.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.879 -161.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.88 163.15 16.98 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.223 170.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.512 ' O ' HG13 ' A' ' 375' ' ' VAL . 41.3 m95 -68.81 -35.74 77.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.554 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.2 p30 -62.73 -40.2 96.45 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.875 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.7 m -71.39 -41.04 70.14 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.066 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.508 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -66.53 -52.19 48.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.544 HG21 ' HE1' ' A' ' 413' ' ' MET . 15.8 m -56.38 -45.36 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.377 0.608 . . . . 0.0 109.86 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.635 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -59.93 -42.37 93.81 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.105 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.506 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 19.6 m -70.81 -36.86 73.15 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.232 -172.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -62.99 -33.32 75.15 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.425 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.684 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.1 t80 -75.6 -44.5 42.63 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.433 1.111 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.512 HD11 ' O ' ' A' ' 376' ' ' ALA . 1.1 mp -52.45 -33.22 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.503 169.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.67 -41.69 95.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.168 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 378' ' ' LEU . 28.7 p -99.91 -22.99 15.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.123 -168.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.519 ' HB3' HE22 ' A' ' 390' ' ' GLN . 36.6 m80 -111.14 22.64 15.01 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.21 20.9 16.97 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.7 m 66.96 159.87 0.14 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.265 0.533 . . . . 0.0 111.519 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.418 ' HZ ' ' HB3' ' A' ' 414' ' ' LEU . 0.2 OUTLIER -127.93 156.06 76.65 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 389' ' ' HIS . 77.0 Cg_endo -97.95 54.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.46 2.773 . . . . 0.0 111.643 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.606 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.28 -1.27 0.14 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.1 t60 -69.79 -46.12 66.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.143 0.497 . . . . 0.0 110.938 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.623 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.6 mt-30 -74.7 -25.59 59.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.749 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.87 -30.62 46.55 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.772 0.715 . . . . 0.0 111.283 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.638 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.47 -50.23 57.64 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.509 174.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.516 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 5.7 m-20 -67.89 -40.56 83.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.852 0.461 . . . . 0.0 111.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.681 HG21 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.14 -44.12 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.003 0.43 . . . . 0.0 110.438 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -58.35 -47.12 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.18 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.652 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 32.3 mmtt -53.07 -41.39 64.83 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.097 0.873 . . . . 0.0 111.897 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -76.75 -44.64 14.66 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.025 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.745 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -69.96 -40.81 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 117.302 0.551 . . . . 0.0 111.767 -178.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 395' ' ' ILE . 5.0 m -57.75 -43.47 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.745 0.783 . . . . 0.0 109.721 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.439 ' N ' HG21 ' A' ' 399' ' ' VAL . 17.6 t70 -56.15 -43.7 78.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.252 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 33.1 mm-40 -84.1 -54.27 4.95 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.47 -172.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -110.58 -29.34 8.09 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.516 0.674 . . . . 0.0 112.535 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.78 171.38 14.04 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.688 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.586 ' HA ' HG11 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.3 -44.42 97.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -57.18 -51.05 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.927 0.394 . . . . 0.0 112.005 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.586 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.2 m -64.18 -51.2 64.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.553 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.745 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.55 -43.15 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.574 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 30.3 t80 -55.58 -46.32 77.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.686 0.755 . . . . 0.0 109.197 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.816 ' O ' ' HG3' ' A' ' 413' ' ' MET . 13.0 m -57.92 -52.68 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.353 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.594 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.66 -48.74 80.45 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.32 -42.62 89.13 Favored Glycine 0 C--N 1.313 -0.724 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.003 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.606 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -72.71 -32.52 65.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.823 0.311 . . . . 0.0 110.833 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.816 ' HG3' ' O ' ' A' ' 409' ' ' THR . 62.5 mtm -69.36 -46.6 66.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.09 174.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.635 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.16 -39.17 85.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.74 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.762 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -77.1 -16.87 59.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.057 -178.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.84 47.01 3.78 Favored Glycine 0 C--N 1.308 -1.018 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.024 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.606 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 49.71 48.69 21.24 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.521 1.128 . . . . 0.0 113.892 -177.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.762 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -123.57 66.0 1.01 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.481 ' HB3' ' CE ' ' A' ' 412' ' ' MET . 14.4 p90 -51.48 -31.84 25.02 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.701 -161.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.476 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 34.1 mt-30 -53.89 -43.25 69.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.596 -165.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.623 HD21 ' ND2' ' A' ' 418' ' ' ASN . 2.0 pp -63.06 -48.1 80.1 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.329 0.585 . . . . 0.0 110.855 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.541 ' HA ' HD13 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -62.31 -38.97 82.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.588 1.185 . . . . 0.0 109.101 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.527 ' N ' HG22 ' A' ' 422' ' ' VAL . 30.7 t -59.64 -45.95 90.45 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.301 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.47 87.27 Favored Glycine 0 C--N 1.316 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.844 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 422' ' ' VAL . 2.1 mt -71.09 -41.31 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -56.43 -43.98 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.285 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.687 ' HD2' ' O ' ' A' ' 427' ' ' ARG . 1.8 tmm_? -56.97 -35.38 69.08 Favored 'General case' 0 N--CA 1.406 -2.647 0 C-N-CA 124.962 1.305 . . . . 0.0 109.837 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.74 -13.12 74.93 Favored Glycine 0 C--N 1.29 -1.985 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.948 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.652 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.5 m-85 -100.08 -3.64 31.49 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.508 ' CB ' HG11 ' A' ' 436' ' ' VAL . 3.9 mm? -59.24 142.96 85.71 Favored Pre-proline 0 N--CA 1.412 -2.329 0 CA-C-O 123.438 1.59 . . . . 0.0 112.875 173.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.684 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 88.5 Cg_endo -72.23 -53.25 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.083 4.522 . . . . 0.0 113.338 -170.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -120.94 140.33 14.08 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.615 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -63.19 -26.53 68.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.164 0.482 . . . . 0.0 111.776 -175.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.2 -48.46 78.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.687 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.4 t -58.44 -51.89 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.705 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.8 OUTLIER -54.87 -51.43 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 118.096 0.407 . . . . 0.0 109.945 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.447 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 86.4 m -62.67 -57.33 11.39 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.14 -44.76 79.54 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.368 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.851 ' O ' HD23 ' A' ' 443' ' ' LEU . 40.0 mt -59.72 -53.71 54.83 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.73 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.706 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 39.1 mm-40 -51.5 -35.14 39.05 Favored 'General case' 0 N--CA 1.417 -2.123 0 O-C-N 124.899 1.374 . . . . 0.0 110.669 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.32 -60.37 2.28 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 176.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.74 -51.71 10.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.378 0.535 . . . . 0.0 112.385 -172.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.851 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.74 -25.46 63.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.522 0.677 . . . . 0.0 111.575 -177.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.747 ' N ' HD22 ' A' ' 443' ' ' LEU . 10.7 t70 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.657 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 34.6 mt-30 -71.56 -6.85 43.8 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.612 ' HB3' HG23 ' A' ' 451' ' ' THR . 25.2 mm-40 -51.86 161.25 0.58 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 123.662 1.696 . . . . 0.0 114.614 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.457 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -56.99 -33.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 110.443 -3.071 . . . . 0.0 115.199 -172.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.576 ' H ' ' HB ' ' A' ' 451' ' ' THR . 66.4 m-20 -138.96 179.99 6.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.457 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 8.9 p-10 -64.43 -55.32 21.67 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -23.52 64.77 Favored 'General case' 0 N--CA 1.402 -2.868 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 446' ' ' GLU . 25.4 m -58.82 -41.51 87.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.756 1.162 . . . . 0.0 109.677 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.548 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 48.2 mtt180 -60.16 -30.0 69.04 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.201 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.574 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.03 -33.64 59.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 109.877 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.02 -42.83 31.23 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.333 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.532 ' HG1' ' HG3' ' A' ' 446' ' ' GLU . 38.3 p -101.34 -4.18 27.46 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.375 -169.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.641 ' CE1' HD22 ' A' ' 460' ' ' LEU . 7.4 t80 -49.25 -52.82 24.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.846 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 22.9 mm -71.75 -27.01 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.519 ' O ' ' HB1' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.56 -42.45 64.65 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 463' ' ' VAL . 25.9 m80 -67.6 -31.17 71.03 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.473 -1.694 . . . . 0.0 109.96 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.695 HD23 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.41 -54.05 34.32 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 122.188 0.994 . . . . 0.0 109.165 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.724 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -62.26 -32.31 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.034 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.68 -53.27 58.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.922 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.693 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 25.9 t -63.45 -34.27 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-O 121.806 0.812 . . . . 0.0 110.287 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.2 m-30 -60.93 -14.39 22.22 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.191 169.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.724 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 45.0 mt-10 -93.81 -48.37 6.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.824 -1.173 . . . . 0.0 112.652 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.693 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.4 pt -64.6 -39.94 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.049 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.475 ' HB2' ' HG ' ' A' ' 469' ' ' LEU . 7.3 mt -84.46 -16.84 41.11 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.788 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.02 51.05 56.49 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 111.73 -2.486 . . . . 0.0 113.219 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.8 OUTLIER -101.28 177.4 4.94 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.13 0.972 . . . . 0.0 109.88 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.675 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.5 p30 -96.46 -44.11 7.33 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.474 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -157.39 -74.61 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.457 -2.156 . . . . 0.0 110.351 160.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.684 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -59.01 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -172.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.556 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.96 42.69 0.37 Allowed Glycine 0 C--N 1.275 -2.854 0 CA-C-N 111.423 -2.626 . . . . 0.0 113.613 173.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.675 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 31.2 mm-40 -81.32 -51.99 7.78 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 122.79 1.281 . . . . 0.0 111.453 -172.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.4 t 68.91 61.47 0.33 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.171 -2.74 . . . . 0.0 109.037 -173.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.788 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -53.44 -48.36 57.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 110.923 -2.853 . . . . 0.0 111.463 175.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -55.31 132.97 49.21 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.009 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.524 ' H ' ' CD2' ' A' ' 478' ' ' LEU . 2.9 mm? -61.86 -28.9 69.82 Favored 'General case' 0 N--CA 1.418 -2.054 0 C-N-CA 124.515 1.126 . . . . 0.0 112.557 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 . . . . . 0 N--CA 1.436 -1.161 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.169 -179.8 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo . . . . . 0 N--CA 1.479 0.665 0 N-CA-C 110.309 -0.689 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.6 mp -85.08 -56.99 4.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.863 0.363 . . . . 0.0 110.171 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -140.03 55.17 0.64 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.559 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 28.5 m 73.3 116.18 0.05 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.364 1.078 . . . . 0.0 111.926 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.69 131.25 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.043 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.742 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 31.9 mt -78.74 125.56 84.02 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 121.89 0.852 . . . . 0.0 111.878 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 308' ' ' GLN . 26.0 Cg_endo -74.97 -12.04 21.57 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.99 3.793 . . . . 0.0 111.663 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.707 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.1 tp 30.31 -64.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 O-C-N 126.973 2.671 . . . . 0.0 115.996 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.627 ' HG2' HG21 ' A' ' 307' ' ' ILE . 66.6 mm-40 -58.24 -33.24 69.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.466 0.65 . . . . 0.0 110.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.52 ' HB3' HG11 ' A' ' 338' ' ' VAL . 5.7 t-160 -61.42 -48.83 79.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.646 172.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 307' ' ' ILE . 64.2 mt -59.06 -48.38 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 124.111 0.965 . . . . 0.0 112.51 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.5 mtp-105 -58.33 -30.83 67.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 122.613 0.365 . . . . 0.0 111.456 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.7 m -69.92 -33.22 71.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.573 0.701 . . . . 0.0 109.882 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.15 -40.49 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.785 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.651 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.22 -36.7 26.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.646 1.212 . . . . 0.0 110.024 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.26 34.72 7.91 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.107 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 45.9 mt-10 56.77 165.81 0.07 OUTLIER Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.447 ' HB3' HD13 ' A' ' 324' ' ' ILE . 43.0 Cg_exo -44.97 147.31 2.03 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.517 2.812 . . . . 0.0 113.032 175.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.462 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 39.6 Cg_endo -93.16 -104.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.358 2.705 . . . . 0.0 112.169 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.421 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 10.8 mmt180 -95.92 -85.21 0.33 Allowed 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 121.259 0.552 . . . . 0.0 111.113 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.508 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 16.5 m-20 -97.37 164.46 17.64 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.733 -175.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 -49.39 10.92 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.655 2.237 . . . . 0.0 110.546 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.55 -13.96 2.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.309 -1.768 . . . . 0.0 113.401 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.508 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 14.9 mt-10 -90.52 -29.2 18.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.374 -0.204 . . . . 0.0 111.201 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.681 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.7 -42.87 70.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.696 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.8 Cg_endo -47.65 -63.74 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.097 2.531 . . . . 0.0 113.05 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.556 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.97 -36.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.428 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.651 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 44.7 t90 -57.82 -36.08 71.74 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.83 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.524 HD13 HG12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -70.55 -49.74 44.83 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.433 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.78 -23.74 23.17 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.804 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.35 -42.19 59.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.947 0.88 . . . . 0.0 110.948 173.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.558 ' HB3' HG21 ' A' ' 314' ' ' THR . 52.6 m-20 -94.78 -24.05 17.26 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.492 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.544 ' HA ' HD11 ' A' ' 335' ' ' ILE . . . -42.43 -49.65 12.38 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.8 Cg_endo -61.66 -32.9 87.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.564 2.176 . . . . 0.0 111.662 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.489 ' CB ' HG12 ' A' ' 313' ' ' VAL . . . -73.75 -44.43 56.22 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.305 -1.77 . . . . 0.0 109.547 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.544 HD11 ' HA ' ' A' ' 332' ' ' ALA . 93.6 mt -56.11 -47.74 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.934 173.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.0 -13.96 2.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.6 -1.636 . . . . 0.0 112.327 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.59 -51.15 4.7 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.529 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.52 HG11 ' HB3' ' A' ' 309' ' ' HIS . 83.2 t -58.68 -71.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 123.351 1.548 . . . . 0.0 109.743 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.742 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.29 123.64 72.88 Favored Pre-proline 0 N--CA 1.402 -2.853 0 CA-C-N 111.261 -2.7 . . . . 0.0 111.953 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.718 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.5 Cg_endo -72.36 -17.1 27.52 Favored 'Trans proline' 0 CA--C 1.494 -1.485 0 C-N-CA 124.163 3.242 . . . . 0.0 110.543 175.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 2.5 p 33.29 69.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 111.907 -2.406 . . . . 0.0 110.088 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.558 ' N ' HD12 ' A' ' 346' ' ' LEU . 62.4 p -80.72 6.06 13.92 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.844 -170.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.787 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 14.7 p -143.06 160.71 51.62 Favored Pre-proline 0 N--CA 1.434 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.491 ' HB3' HD12 ' A' ' 369' ' ' LEU . 50.6 Cg_exo -62.62 -45.05 15.11 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.591 2.861 . . . . 0.0 108.739 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.661 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -44.78 -52.24 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.784 175.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.787 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.6 mt -56.72 -51.55 68.41 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 17.7 ttm-85 -49.79 -47.84 50.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.595 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 1.077 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -68.15 -48.07 66.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.472 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 53.7 mtt180 -60.25 -37.77 81.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.113 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.862 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -56.87 -52.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.572 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.608 ' O ' HD22 ' A' ' 355' ' ' LEU . 21.1 mt -58.56 -53.38 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.905 0.86 . . . . 0.0 111.248 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 18.6 m-20 -63.13 -36.2 82.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.987 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.463 ' HB1' HD13 ' A' ' 307' ' ' ILE . . . -70.89 -29.5 65.61 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.79 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.862 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.14 -60.13 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.052 1.406 . . . . 0.0 110.067 173.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.681 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -74.55 -27.53 60.56 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 111.961 -2.381 . . . . 0.0 109.883 -167.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.98 -71.68 0.29 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.941 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -111.68 54.05 0.56 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.644 HD21 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -84.93 133.28 34.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.564 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -47.84 -73.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 124.042 0.937 . . . . 0.0 112.664 -170.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.27 5.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.192 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.644 ' HB2' HD21 ' A' ' 358' ' ' ASN . 3.6 mt -69.98 -5.08 23.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.587 0.708 . . . . 0.0 110.127 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.55 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 25.2 t -59.12 82.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.393 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -65.55 178.38 1.0 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.791 177.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.7 p -122.02 153.94 61.09 Favored Pre-proline 0 N--CA 1.437 -1.088 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.867 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 3.2 Cg_exo -53.94 -11.14 2.26 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.007 2.472 . . . . 0.0 113.107 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -111.29 -2.19 27.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.442 ' HB2' HD13 ' A' ' 363' ' ' LEU . 19.4 m-20 -106.32 -21.62 13.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.741 1.27 . . . . 0.0 110.542 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 1.077 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 34.8 t -98.24 25.29 6.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.597 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.595 ' N ' HD11 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -54.57 -34.3 61.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.127 0.965 . . . . 0.0 109.806 -173.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.42 159.04 24.99 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.869 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.592 ' O ' HG11 ' A' ' 375' ' ' VAL . 46.4 m95 -68.91 -35.71 77.15 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.612 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -59.54 -46.85 87.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.126 -176.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 62.4 m -67.29 -41.9 84.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.111 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.616 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.48 63.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.592 HG11 ' O ' ' A' ' 371' ' ' TRP . 14.4 m -57.87 -44.43 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.588 0.709 . . . . 0.0 109.603 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.697 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -61.46 -41.08 96.68 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.102 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.501 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 22.4 m -71.47 -39.14 71.12 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.619 -173.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.9 mt -61.58 -33.45 73.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.31 0.576 . . . . 0.0 110.328 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.696 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 41.6 t80 -73.08 -47.16 46.97 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.211 1.005 . . . . 0.0 109.489 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.501 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.45 -32.77 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 113.14 -1.845 . . . . 0.0 111.796 169.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.26 -32.72 71.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 123.014 0.525 . . . . 0.0 111.564 175.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.0 p -109.01 -23.65 11.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.388 -167.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -110.52 22.51 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.23 17.91 33.15 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 114.47 0.548 . . . . 0.0 114.47 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.0 m 66.2 160.41 0.14 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.232 0.539 . . . . 0.0 111.374 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -128.2 155.67 77.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -101.88 63.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.972 3.115 . . . . 0.0 111.216 164.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.563 ' HA ' HD21 ' A' ' 391' ' ' LEU . 3.4 mmt 53.01 5.55 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -70.32 -48.2 57.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.247 0.546 . . . . 0.0 111.173 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.617 ' O ' HG11 ' A' ' 394' ' ' VAL . 78.1 mt-30 -75.61 -28.69 58.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.889 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -54.62 -31.28 57.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.61 0.641 . . . . 0.0 112.157 -170.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.635 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.42 -51.93 48.22 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.862 -1.161 . . . . 0.0 110.543 173.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.53 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 8.8 m-20 -68.56 -38.21 80.57 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 122.95 0.5 . . . . 0.0 112.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.657 ' O ' HG13 ' A' ' 398' ' ' ILE . 1.6 m -58.16 -44.72 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.711 ' O ' HG21 ' A' ' 399' ' ' VAL . 9.5 mm -58.47 -48.35 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.214 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.2 mmtt -52.8 -40.27 63.11 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 124.051 0.845 . . . . 0.0 112.031 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.94 -44.88 13.0 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.926 -173.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.717 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.3 mt -69.65 -41.9 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 117.33 0.565 . . . . 0.0 111.686 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.711 HG21 ' O ' ' A' ' 395' ' ' ILE . 4.3 m -57.28 -45.21 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.609 0.719 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.9 t70 -60.85 -37.16 81.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.193 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 27.1 mt-30 -88.31 -52.67 5.08 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.555 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -113.26 -30.67 6.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.963 -167.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.69 164.5 11.65 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.754 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.592 ' HA ' HG11 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -64.04 -42.54 96.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -175.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.556 ' HB3' HG23 ' A' ' 457' ' ' ILE . . . -58.12 -50.32 73.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.791 0.329 . . . . 0.0 111.511 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -62.31 -52.41 63.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.717 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -42.67 66.18 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.489 ' HB3' HD13 ' A' ' 457' ' ' ILE . 39.1 t80 -56.15 -47.08 78.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.567 0.699 . . . . 0.0 109.226 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.805 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.3 m -58.86 -53.01 63.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.743 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.617 HD12 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.67 -49.23 78.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.783 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.488 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.08 -43.05 88.47 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.042 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.536 ' HE3' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.03 -31.37 66.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.773 0.287 . . . . 0.0 111.158 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.805 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.2 mtm -70.92 -46.53 62.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.669 0.747 . . . . 0.0 109.599 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.697 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.78 -42.0 92.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.066 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.889 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 74.8 m -78.76 2.48 19.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.34 53.86 9.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.363 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.536 ' HA ' ' HE3' ' A' ' 412' ' ' MET . 1.4 mp0 46.01 56.98 5.55 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.85 0.86 . . . . 0.0 112.926 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.572 ' O ' HD23 ' A' ' 421' ' ' LEU . 48.1 t30 -122.47 65.63 0.94 Allowed 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 162.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.472 ' O ' HG23 ' A' ' 422' ' ' VAL . 0.3 OUTLIER -48.79 -36.28 16.27 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.594 -173.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 423' ' ' SER . 45.0 mt-30 -57.08 -50.58 72.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -168.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.765 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 0.2 OUTLIER -59.37 -50.43 73.98 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.365 -178.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.765 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.35 -38.27 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 122.675 1.226 . . . . 0.0 109.233 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.564 ' N ' HG23 ' A' ' 422' ' ' VAL . 19.2 t -59.94 -49.63 76.94 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.299 -2.228 . . . . 0.0 111.585 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.69 -36.13 77.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.375 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.537 HD13 ' HA ' ' A' ' 422' ' ' VAL . 4.3 mt -72.51 -39.72 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.627 0.727 . . . . 0.0 110.112 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.449 HD11 ' HB1' ' A' ' 407' ' ' ALA . 1.7 mm -62.76 -41.63 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.569 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -57.18 -34.4 68.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 125.916 1.686 . . . . 0.0 108.64 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.457 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -73.01 -11.57 78.92 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.725 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.607 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.9 m-85 -105.52 -0.27 26.0 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.536 HD12 HG12 ' A' ' 435' ' ' VAL . 3.7 mm? -58.01 141.35 81.35 Favored Pre-proline 0 N--CA 1.412 -2.328 0 CA-C-O 123.566 1.65 . . . . 0.0 113.411 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.693 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 57.6 Cg_endo -70.04 -60.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 1 C-N-CA 126.444 4.763 . . . . 0.0 113.43 -170.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.593 ' O ' HG13 ' A' ' 436' ' ' VAL . . . -110.09 141.45 16.23 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.606 ' HA ' ' CG1' ' A' ' 436' ' ' VAL . 0.0 OUTLIER -59.58 -30.07 68.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.361 0.58 . . . . 0.0 111.831 -174.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.05 -48.96 77.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.58 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.6 t -62.86 -35.6 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.524 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.606 ' CG1' ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.14 -46.63 57.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 38.4 m -72.65 -54.21 9.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.337 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.53 -46.16 80.76 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.342 0.401 . . . . 0.0 111.348 -174.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.774 ' O ' HD22 ' A' ' 443' ' ' LEU . 17.7 mt -60.92 -54.2 47.97 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.71 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.672 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.77 -33.6 35.94 Favored 'General case' 0 N--CA 1.407 -2.596 0 O-C-N 125.709 1.881 . . . . 0.0 110.64 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.664 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -59.86 2.52 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -47.53 27.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.581 0.628 . . . . 0.0 111.66 -173.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -59.23 -25.24 63.85 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 111.427 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.744 ' N ' HD21 ' A' ' 443' ' ' LEU . 13.4 t70 -73.94 -42.2 60.9 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.795 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.664 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 40.9 mt-30 -70.65 -9.74 57.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -172.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.634 ' HB3' HG23 ' A' ' 451' ' ' THR . 38.4 mm-40 -50.28 157.73 0.65 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 123.361 1.553 . . . . 0.0 115.094 -174.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.514 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.27 -32.41 19.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 110.937 -2.847 . . . . 0.0 115.408 -170.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.551 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 9.2 m-20 -140.93 178.64 7.22 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.424 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 2.3 m-20 -62.56 -54.51 38.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -24.27 66.17 Favored 'General case' 0 N--CA 1.404 -2.736 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.634 HG23 ' HB3' ' A' ' 446' ' ' GLU . 19.5 m -59.45 -40.96 88.55 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 119.992 1.269 . . . . 0.0 109.388 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.572 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 67.0 mtt180 -61.82 -29.29 70.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.304 172.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.476 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -31.73 60.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.041 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.05 -42.98 13.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.47 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.507 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.4 p -101.88 -0.94 33.19 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.723 -170.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.64 ' CE1' HD22 ' A' ' 460' ' ' LEU . 7.1 t80 -49.29 -55.96 11.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.003 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.556 HG23 ' HB3' ' A' ' 405' ' ' ALA . 24.6 mm -70.05 -24.73 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.72 -44.66 61.42 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.566 ' O ' HD23 ' A' ' 439' ' ' LEU . 47.3 m-70 -65.49 -32.02 73.4 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.15 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.672 HD23 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.54 -53.82 41.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.209 1.004 . . . . 0.0 109.263 -178.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -61.96 -30.42 70.91 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.187 -1.824 . . . . 0.0 110.74 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.556 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.76 -48.48 66.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.722 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 42.2 t -66.76 -34.71 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.489 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.547 ' OH ' HG11 ' A' ' 404' ' ' VAL . 19.2 m-30 -62.21 -13.96 33.09 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.617 167.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.8 tp10 -93.41 -52.94 4.28 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.414 -0.804 . . . . 0.0 112.242 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.722 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.3 pt -62.07 -41.73 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.132 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 469' ' ' LEU . 5.4 mt -84.14 -17.34 40.39 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.73 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.63 49.87 57.51 Favored Glycine 0 C--O 1.219 -0.801 0 CA-C-N 111.515 -2.584 . . . . 0.0 113.223 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.8 OUTLIER -102.68 -179.17 3.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 123.861 0.864 . . . . 0.0 110.402 -178.302 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.631 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.0 p30 -100.82 -40.6 7.23 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -160.73 -76.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.121 160.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.693 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -64.32 67.81 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.41 ' HA2' HD13 ' A' ' 469' ' ' LEU . . . 41.04 39.84 2.16 Favored Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.425 -2.625 . . . . 0.0 113.361 173.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.631 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 9.9 mm-40 -79.19 -51.87 8.92 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.529 1.157 . . . . 0.0 111.324 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.6 t 64.7 61.44 0.82 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 111.806 -2.452 . . . . 0.0 109.24 -172.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.6 OUTLIER -56.08 -49.77 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 110.391 -3.095 . . . . 0.0 111.49 171.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.551 ' HB2' HD13 ' A' ' 476' ' ' ILE . 0.0 OUTLIER -78.1 -153.62 0.06 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.083 -1.872 . . . . 0.0 112.935 -170.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 53.5 mt -55.1 163.87 0.98 Allowed 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.57 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 N--CA 1.435 -1.213 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.381 177.465 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 110.286 -0.698 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.45 HD11 ' N ' ' A' ' 301' ' ' ILE . 3.2 mp -80.88 -63.73 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -129.92 -89.25 0.54 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.979 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 63.6 m -154.91 118.48 4.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.663 0.744 . . . . 0.0 110.922 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.0 p -65.98 125.63 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.582 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.786 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 33.4 mt -74.1 125.57 89.99 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-O 122.222 1.011 . . . . 0.0 112.221 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 308' ' ' GLN . 29.4 Cg_endo -74.58 -16.99 21.07 Favored 'Trans proline' 0 CA--C 1.503 -1.042 0 C-N-CA 124.954 3.77 . . . . 0.0 111.193 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.636 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.3 tp 36.82 -64.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 C-N-CA 128.225 2.61 . . . . 0.0 115.881 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.635 ' HG2' HG21 ' A' ' 307' ' ' ILE . 62.1 mm-40 -58.58 -34.03 70.62 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.561 0.696 . . . . 0.0 110.344 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.492 ' HB3' HG12 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.04 -47.99 83.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.927 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 307' ' ' ILE . 67.6 mt -61.75 -49.22 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 124.253 1.021 . . . . 0.0 112.624 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.636 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 0.9 OUTLIER -58.26 -31.4 67.39 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 122.697 0.399 . . . . 0.0 111.369 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 27.5 t -69.88 -33.34 72.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.533 0.682 . . . . 0.0 109.664 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.82 -41.02 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.659 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.704 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 35.5 p -82.91 -35.89 25.75 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.733 1.254 . . . . 0.0 110.206 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.27 32.06 12.85 Favored Glycine 0 C--N 1.302 -1.342 0 CA-C-N 112.305 -2.225 . . . . 0.0 110.696 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.4 mt-10 51.79 172.86 0.03 OUTLIER Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.488 ' HB3' HD13 ' A' ' 324' ' ' ILE . 71.8 Cg_exo -48.15 149.46 6.05 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.994 2.462 . . . . 0.0 113.687 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.491 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 16.3 Cg_endo -97.62 -106.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.992 3.128 . . . . 0.0 113.183 -171.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.455 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 2.9 mmm180 -88.91 -78.37 0.35 Allowed 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 123.239 0.616 . . . . 0.0 110.506 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.491 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.9 m-20 -108.88 160.69 26.44 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.067 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.3 Cg_exo -60.13 -48.17 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 122.544 2.163 . . . . 0.0 110.107 168.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -46.83 -26.19 0.92 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.851 -1.977 . . . . 0.0 112.743 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.491 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -93.52 -22.0 19.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.683 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -47.71 -42.48 45.4 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.726 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.3 Cg_endo -46.38 -64.8 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.185 2.59 . . . . 0.0 113.009 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.567 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.21 -37.02 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.209 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.704 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 54.5 t90 -58.55 -36.44 73.92 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.139 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.5 HD11 HG12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -69.94 -49.96 46.73 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.22 -23.65 26.2 Favored Glycine 0 C--N 1.311 -0.817 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.156 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.577 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.7 mtt180 -73.6 -41.73 62.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.128 0.966 . . . . 0.0 110.598 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.569 ' HB3' HG21 ' A' ' 314' ' ' THR . 55.9 m-20 -97.57 -22.7 16.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.023 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.558 ' HA ' HD13 ' A' ' 335' ' ' ILE . . . -43.3 -48.65 16.83 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.2 Cg_endo -61.02 -33.67 91.67 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 122.584 2.19 . . . . 0.0 111.606 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.487 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -73.26 -42.73 62.17 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.559 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 332' ' ' ALA . 98.6 mt -57.79 -49.3 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.055 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 27.3 t70 -53.43 -17.57 2.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.501 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.24 5.75 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.024 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' ' 309' ' ' HIS . 85.3 t -58.24 -71.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-O 123.354 1.55 . . . . 0.0 110.205 170.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.786 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -87.63 124.43 67.62 Favored Pre-proline 0 N--CA 1.406 -2.675 0 CA-C-N 111.288 -2.687 . . . . 0.0 111.863 -175.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.688 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.5 Cg_endo -72.57 -19.24 24.88 Favored 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 123.809 3.006 . . . . 0.0 110.41 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.405 HG21 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 33.35 70.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.233 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.544 ' N ' HD11 ' A' ' 346' ' ' LEU . 63.4 p -80.83 3.78 21.39 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.749 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.794 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 28.2 p -141.78 154.54 65.9 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -60.15 -36.79 87.47 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 124.323 3.349 . . . . 0.0 109.563 171.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.641 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.7 -53.41 39.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.602 172.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.794 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.8 mt -56.73 -54.76 42.49 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.027 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.611 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 33.3 ttm105 -50.26 -41.17 49.99 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 125.511 1.757 . . . . 0.0 110.61 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.521 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 52.1 t -67.76 -48.94 64.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.666 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.641 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.6 mtt180 -61.11 -38.3 85.85 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.598 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.873 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.1 mt -57.14 -54.63 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.254 -0.579 . . . . 0.0 111.528 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.633 ' O ' HD21 ' A' ' 355' ' ' LEU . 14.9 mt -56.98 -54.39 30.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 124.566 1.166 . . . . 0.0 110.812 -171.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.585 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 37.0 m-20 -64.66 -34.57 78.6 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.288 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.457 ' HB1' HD12 ' A' ' 307' ' ' ILE . . . -70.99 -31.12 67.56 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.94 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.873 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.5 mm -56.7 -58.35 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-O 122.821 1.296 . . . . 0.0 110.539 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.683 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.35 -26.71 55.98 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.007 -2.36 . . . . 0.0 109.871 -168.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.28 -68.84 0.68 Allowed Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.611 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -114.92 35.62 4.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.932 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.669 HD21 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -66.95 127.61 33.22 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.047 0.451 . . . . 0.0 110.794 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.552 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -49.0 -70.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.985 -169.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.67 5.17 7.05 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.443 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.669 ' HB2' HD21 ' A' ' 358' ' ' ASN . 4.4 mt -72.68 -3.59 25.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.557 0.694 . . . . 0.0 110.199 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.585 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 11.3 t -62.29 83.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.843 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.56 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.7 mm? -62.7 -174.24 0.06 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.905 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 63.8 p -125.11 157.41 67.21 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 23.4 Cg_exo -49.14 -31.63 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.839 1.693 . . . . 0.0 111.072 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -87.4 -3.78 81.27 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.961 -172.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.443 ' HB2' HD13 ' A' ' 363' ' ' LEU . 37.4 m-20 -104.88 -21.0 13.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.223 1.011 . . . . 0.0 109.274 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.611 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 65.1 m -86.14 23.69 1.48 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.402 -171.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.86 -36.29 72.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.045 0.926 . . . . 0.0 109.835 -174.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.88 162.43 26.72 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.392 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.539 ' O ' HG12 ' A' ' 375' ' ' VAL . 41.8 m95 -70.62 -36.65 73.59 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.595 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.15 -39.93 83.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.911 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 75.3 p -73.41 -43.69 59.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.641 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.29 -52.38 63.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.549 HG22 ' HE1' ' A' ' 413' ' ' MET . 14.0 m -57.28 -44.08 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.611 0.719 . . . . 0.0 109.548 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.663 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -61.08 -44.14 97.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.041 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.504 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 29.3 m -69.34 -38.19 78.04 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.168 -172.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 3.0 mt -61.05 -33.71 73.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 110.473 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.726 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.5 t80 -75.76 -45.01 38.7 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.308 1.052 . . . . 0.0 109.233 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.1 mp -52.12 -33.25 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.147 170.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.552 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.9 OUTLIER -60.78 -47.1 87.85 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.734 0.778 . . . . 0.0 110.899 176.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 378' ' ' LEU . 37.8 p -93.93 -23.36 18.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.998 -166.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.406 ' HB3' HE22 ' A' ' 390' ' ' GLN . 52.7 m80 -111.22 23.08 14.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.22 20.84 30.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.639 0.616 . . . . 0.0 114.639 173.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.407 HG23 HG13 ' A' ' 380' ' ' ILE . 2.9 m 64.13 157.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -175.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.81 157.52 57.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 389' ' ' HIS . 87.2 Cg_endo -96.5 52.54 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.481 2.787 . . . . 0.0 111.783 168.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.583 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.02 -8.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -177.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 387' ' ' PRO . 7.7 t60 -69.56 -42.81 74.03 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.042 -0.411 . . . . 0.0 110.943 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.687 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.2 mt-30 -68.32 -27.11 66.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.676 ' O ' HG23 ' A' ' 394' ' ' VAL . 3.7 mm? -53.5 -30.16 39.9 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.342 0.519 . . . . 0.0 111.015 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 396' ' ' LYS . . . -54.81 -51.88 50.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.676 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.569 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.1 m-20 -69.73 -37.0 76.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.982 0.513 . . . . 0.0 112.085 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.694 ' O ' HG13 ' A' ' 398' ' ' ILE . 1.4 m -58.3 -47.72 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.588 ' O ' HG21 ' A' ' 399' ' ' VAL . 4.3 mm -57.99 -48.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 173.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.569 ' HE3' ' HA ' ' A' ' 393' ' ' ASN . 0.2 OUTLIER -52.43 -46.32 66.34 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.836 -177.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.91 50.19 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.018 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.731 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -70.59 -41.49 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 117.143 0.472 . . . . 0.0 111.7 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 404' ' ' VAL . 6.5 m -56.45 -41.91 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.809 0.814 . . . . 0.0 110.181 -177.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.495 ' N ' HG23 ' A' ' 399' ' ' VAL . 0.8 OUTLIER -67.49 -34.61 77.48 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.07 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -85.47 -54.67 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -107.8 -30.77 8.34 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.692 0.758 . . . . 0.0 112.329 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.38 170.71 14.01 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.532 -175.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.603 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.82 -45.11 95.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -172.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.581 ' HB3' HG23 ' A' ' 457' ' ' ILE . . . -57.32 -50.57 72.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.604 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.1 m -63.06 -51.15 67.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.731 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.7 -43.93 69.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.484 ' HB3' HD13 ' A' ' 457' ' ' ILE . 34.0 t80 -54.7 -45.23 73.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.735 0.779 . . . . 0.0 109.157 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.825 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.2 m -59.33 -52.65 64.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.502 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.42 -49.35 77.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.081 176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.511 ' HA2' HD13 ' A' ' 414' ' ' LEU . . . -56.12 -42.83 88.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.906 -173.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.62 ' HE1' ' NE2' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -31.6 65.56 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.541 0.17 . . . . 0.0 111.121 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.825 ' HG3' ' O ' ' A' ' 409' ' ' THR . 57.7 mtm -70.97 -45.58 63.86 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.381 0.61 . . . . 0.0 109.655 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.663 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 19.3 mt -60.28 -39.44 86.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.481 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.553 ' HB2' HD21 ' A' ' 421' ' ' LEU . 6.6 p -76.44 -2.57 32.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.766 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 79.78 31.04 41.36 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.62 ' NE2' ' HE1' ' A' ' 412' ' ' MET . 4.0 mm-40 68.12 52.63 0.66 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.134 -1.033 . . . . 0.0 111.668 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.64 ' O ' HD22 ' A' ' 421' ' ' LEU . 22.9 t30 -117.41 74.9 0.95 Allowed 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 160.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.505 ' O ' HG22 ' A' ' 422' ' ' VAL . 0.3 OUTLIER -53.98 -35.95 62.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.143 -173.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' A' ' 423' ' ' SER . 25.2 mt-30 -57.61 -49.77 75.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -168.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.749 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 0.2 OUTLIER -59.59 -50.43 73.91 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.34 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.749 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.28 -38.2 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.738 1.256 . . . . 0.0 109.269 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 427' ' ' ARG . 24.5 t -59.59 -50.46 73.81 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 112.271 -2.24 . . . . 0.0 111.473 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.99 71.39 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.302 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.51 HD13 ' HA ' ' A' ' 422' ' ' VAL . 6.1 mt -73.15 -40.91 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.72 0.772 . . . . 0.0 110.484 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 395' ' ' ILE . 1.5 mm -63.42 -42.75 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.228 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.57 ' HA ' ' CD2' ' A' ' 430' ' ' LEU . 0.1 OUTLIER -59.77 -31.17 69.41 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.714 -176.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.432 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.46 -20.12 79.25 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.108 174.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.498 ' CG ' HG22 ' A' ' 399' ' ' VAL . 10.0 m-85 -98.45 1.96 47.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -176.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.57 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.44 145.64 67.27 Favored Pre-proline 0 N--CA 1.417 -2.09 0 CA-C-O 123.647 1.689 . . . . 0.0 113.83 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.698 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 60.1 Cg_endo -71.53 -64.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 1 C-N-CA 126.099 4.533 . . . . 0.0 113.063 -172.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.57 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.49 140.2 15.28 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.133 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.584 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.16 -27.17 68.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.948 0.374 . . . . 0.0 111.8 -176.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -59.92 -47.24 86.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.685 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.9 t -60.42 -51.7 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.232 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.88 ' O ' ' HG2' ' A' ' 440' ' ' GLN . 0.7 OUTLIER -51.76 -59.52 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 66.5 m -61.21 -55.52 31.14 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.252 -173.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.66 -44.36 81.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.894 -176.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.777 ' O ' HD23 ' A' ' 443' ' ' LEU . 17.3 mt -59.7 -55.0 39.8 Favored 'General case' 0 CA--C 1.469 -2.155 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.248 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.88 ' HG2' ' O ' ' A' ' 436' ' ' VAL . 5.4 mm100 -53.57 -34.34 57.97 Favored 'General case' 0 N--CA 1.409 -2.52 0 O-C-N 125.627 1.829 . . . . 0.0 109.787 -177.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -71.33 -60.04 2.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 176.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -47.77 27.65 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 121.585 -0.697 . . . . 0.0 111.742 -173.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.25 -25.7 64.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.708 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.738 ' N ' HD22 ' A' ' 443' ' ' LEU . 9.2 t70 -73.74 -41.42 62.54 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.418 1.104 . . . . 0.0 110.738 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -69.57 -6.6 32.11 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -173.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.6 ' HB3' HG21 ' A' ' 451' ' ' THR . 38.2 mm-40 -49.63 161.46 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.707 1.718 . . . . 0.0 114.435 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.521 ' HB ' HG22 ' A' ' 451' ' ' THR . 1.8 mp -57.18 -31.73 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 110.525 -3.034 . . . . 0.0 114.938 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.554 ' H ' ' HB ' ' A' ' 451' ' ' THR . 9.1 m-20 -143.85 -179.22 6.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.654 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 8.5 p-10 -64.42 -53.54 46.84 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 175.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.6 HG21 ' HB3' ' A' ' 446' ' ' GLU . 24.3 m -58.53 -39.21 79.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.553 171.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.666 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 30.7 mtm-85 -63.52 -29.57 70.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.425 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.93 -31.97 63.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.853 0.835 . . . . 0.0 109.643 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.46 -43.86 13.23 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.436 -1.257 . . . . 0.0 112.435 -170.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.531 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 35.6 p -102.34 -1.41 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.011 -168.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.644 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.4 t80 -49.05 -53.28 20.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.581 HG23 ' HB3' ' A' ' 405' ' ' ALA . 24.9 mm -71.2 -25.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.14 -43.31 64.86 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.569 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.3 m-70 -66.7 -31.15 71.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.615 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.695 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.5 -53.92 35.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.181 0.991 . . . . 0.0 109.293 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.658 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.14 -32.06 72.61 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.136 173.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.608 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.93 -53.24 57.16 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.685 ' CG1' ' HA ' ' A' ' 435' ' ' VAL . 26.0 t -63.23 -33.84 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.345 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.8 m-30 -61.28 -15.3 33.81 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.136 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 16.9 mm-40 -91.14 -49.18 6.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.141 -0.974 . . . . 0.0 112.753 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.683 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -65.8 -39.3 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.027 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.442 ' CB ' HD23 ' A' ' 469' ' ' LEU . 6.3 mt -84.61 -17.52 38.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.721 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 62.3 55.39 27.96 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.627 -2.533 . . . . 0.0 112.986 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.5 OUTLIER -104.2 -174.12 2.47 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 123.863 0.865 . . . . 0.0 109.642 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.673 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.6 p30 -106.03 -41.17 5.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 166.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -158.7 -78.25 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.009 160.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.698 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -62.61 70.45 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -169.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.407 ' HA2' HD11 ' A' ' 469' ' ' LEU . . . 38.09 40.82 0.9 Allowed Glycine 0 C--N 1.279 -2.631 0 CA-C-N 110.948 -2.842 . . . . 0.0 113.487 171.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.673 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 18.2 mm-40 -78.12 -52.37 8.83 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 122.631 1.205 . . . . 0.0 111.287 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.4 t 63.47 56.4 1.64 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.716 -2.493 . . . . 0.0 108.065 -171.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.721 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -46.05 -52.65 2.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 110.508 -3.042 . . . . 0.0 111.631 176.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.655 ' C ' ' HD2' ' A' ' 477' ' ' ARG . 0.3 OUTLIER -72.18 153.54 41.56 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.789 177.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 40.4 mt -75.53 149.64 38.33 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.417 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.459 ' HA ' ' NH1' ' A' ' 477' ' ' ARG . 43.0 mt-10 . . . . . 0 N--CA 1.432 -1.355 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.541 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.478 0.598 0 N-CA-C 111.194 -0.349 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 301' ' ' ILE . 3.1 mp 64.55 -82.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 123.335 0.654 . . . . 0.0 110.948 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -140.08 26.17 2.61 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 28.1 m 72.18 114.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 122.17 0.986 . . . . 0.0 110.972 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.41 ' H ' HG11 ' A' ' 304' ' ' VAL . 1.6 p -85.12 124.07 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.506 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.76 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.8 mt -70.11 123.95 89.79 Favored Pre-proline 0 N--CA 1.425 -1.709 0 CA-C-O 121.862 0.839 . . . . 0.0 111.806 -175.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 308' ' ' GLN . 20.6 Cg_endo -71.77 -12.23 28.56 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 124.764 3.643 . . . . 0.0 111.23 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.68 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.2 tp 31.32 -64.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.217 0 C-N-CA 128.5 2.72 . . . . 0.0 116.046 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.613 ' HG2' HG23 ' A' ' 307' ' ' ILE . 38.9 mm-40 -57.79 -33.74 68.87 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.616 0.722 . . . . 0.0 110.163 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.501 ' HB3' HG13 ' A' ' 338' ' ' VAL . 6.8 t-160 -61.4 -48.82 79.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.682 173.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 307' ' ' ILE . 70.1 mt -61.32 -48.89 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 124.135 0.974 . . . . 0.0 112.799 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.68 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 2.0 mtp-105 -58.92 -30.87 68.16 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.242 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 36.9 t -69.82 -34.57 73.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.596 0.712 . . . . 0.0 109.641 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.1 -40.57 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.707 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.671 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.41 -36.28 26.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 122.912 1.339 . . . . 0.0 109.636 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.65 32.79 8.95 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.119 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.1 mt-10 53.42 167.47 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.142 0 C-N-CA 124.433 1.093 . . . . 0.0 113.869 -175.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.469 ' HB3' HD13 ' A' ' 324' ' ' ILE . 38.0 Cg_exo -44.03 146.61 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.766 2.977 . . . . 0.0 113.435 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.475 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 28.8 Cg_endo -93.44 -103.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.285 2.657 . . . . 0.0 112.068 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.416 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 12.9 mmm180 -91.77 -91.51 0.16 Allowed 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.117 0.484 . . . . 0.0 110.604 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.483 ' HB3' ' HG2' ' A' ' 322' ' ' ARG . 48.6 m-20 -95.05 164.81 18.36 Favored Pre-proline 0 N--CA 1.439 -0.978 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.14 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.0 -47.26 18.56 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 122.605 2.203 . . . . 0.0 110.249 167.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.483 ' HG2' ' HB3' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -55.67 -17.99 6.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.248 176.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 3.2 mt-10 -93.46 -23.42 18.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.963 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.694 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -52.15 -40.95 77.77 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.725 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.0 Cg_endo -48.97 -64.58 0.21 Allowed 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.96 2.44 . . . . 0.0 112.898 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.581 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -57.91 -39.0 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.878 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.671 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 61.8 t90 -56.43 -39.78 73.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.988 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.467 HD13 HG12 ' A' ' 351' ' ' ILE . 0.6 OUTLIER -67.35 -49.48 63.84 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.43 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -53.66 -23.71 22.17 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.888 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 3.4 mtm180 -73.2 -41.13 64.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.264 0.554 . . . . 0.0 111.137 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.527 ' HB2' HG23 ' A' ' 314' ' ' THR . 1.3 p30 -106.08 -15.78 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.558 ' HA ' HD13 ' A' ' 335' ' ' ILE . . . -40.35 -48.08 6.39 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.1 Cg_endo -61.75 -32.36 86.21 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.731 2.287 . . . . 0.0 111.989 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.496 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -74.58 -42.56 58.52 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.513 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.573 HG12 HG23 ' A' ' 310' ' ' ILE . 95.4 mt -56.73 -48.41 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.946 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -50.87 -21.81 1.89 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.73 -1.577 . . . . 0.0 112.764 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.7 -48.44 7.91 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.445 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 309' ' ' HIS . 88.6 t -60.05 -72.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 123.389 1.566 . . . . 0.0 110.087 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.76 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -88.05 122.67 69.84 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.251 -2.704 . . . . 0.0 111.758 -174.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.642 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 70.8 Cg_endo -73.41 -17.76 23.61 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 C-N-CA 123.742 2.961 . . . . 0.0 109.961 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.524 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.44 71.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.422 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.55 ' N ' HD11 ' A' ' 346' ' ' LEU . 45.1 p -85.52 11.34 10.77 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.042 -1.89 . . . . 0.0 113.049 -169.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.788 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.1 p -147.03 157.07 46.94 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 121.437 0.637 . . . . 0.0 109.968 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.466 ' HB3' HD12 ' A' ' 369' ' ' LEU . 73.3 Cg_exo -60.81 -36.85 82.17 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.643 3.562 . . . . 0.0 110.04 173.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.7 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.3 OUTLIER -51.84 -56.96 10.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.621 173.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.788 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.2 mt -56.72 -48.92 76.65 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.757 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 343' ' ' THR . 24.9 mmt180 -45.46 -52.14 10.62 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 125.295 1.622 . . . . 0.0 109.887 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.525 ' HA ' HD13 ' A' ' 351' ' ' ILE . 44.6 t -68.41 -50.87 49.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.825 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.639 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.9 mtp180 -61.06 -33.73 73.79 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.882 ' O ' HG12 ' A' ' 354' ' ' ILE . 18.5 mt -58.02 -53.22 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.205 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.586 ' O ' HD22 ' A' ' 355' ' ' LEU . 14.1 mt -59.35 -54.05 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.611 0.719 . . . . 0.0 111.254 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -38.06 85.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.039 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.473 ' HB2' HD11 ' A' ' 307' ' ' ILE . . . -70.94 -30.06 66.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.882 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.6 mm -56.62 -57.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 CA-C-O 122.922 1.344 . . . . 0.0 110.418 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.694 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -79.96 -27.47 39.73 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.195 -2.275 . . . . 0.0 109.897 -167.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.75 -76.93 0.21 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.936 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -101.52 38.55 3.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.866 -174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.671 HD21 ' HB2' ' A' ' 361' ' ' LEU . 18.3 p-10 -77.92 125.52 29.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.025 0.44 . . . . 0.0 110.424 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.561 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -48.56 -72.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.907 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -123.41 -1.7 9.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.304 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.671 ' HB2' HD21 ' A' ' 358' ' ' ASN . 2.5 mt -68.82 -6.0 24.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 122.193 0.997 . . . . 0.0 109.784 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 2.3 t -70.62 75.6 0.58 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.363 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.572 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.8 mm? -54.19 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.54 ' C ' ' H ' ' A' ' 366' ' ' GLY . 64.3 p -115.6 156.01 46.65 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.7 ' CB ' ' HA ' ' A' ' 345' ' ' ASP . 56.3 Cg_endo -71.91 22.19 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.11 1.874 . . . . 0.0 111.83 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -136.12 -2.55 2.68 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.726 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -104.54 -21.4 13.44 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.285 1.041 . . . . 0.0 109.308 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 63.1 m -85.29 21.84 1.63 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.58 -171.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.576 ' N ' HD11 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -55.94 -34.78 65.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.367 1.08 . . . . 0.0 110.112 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.04 159.96 31.37 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.697 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.531 ' O ' HG11 ' A' ' 375' ' ' VAL . 56.6 m95 -69.94 -35.77 74.78 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.64 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -57.35 -46.22 83.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.985 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 72.2 m -68.14 -42.14 80.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.072 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.605 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.14 -52.29 59.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.531 HG11 ' O ' ' A' ' 371' ' ' TRP . 13.6 m -57.23 -44.12 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.0 109.463 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.685 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.139 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.476 HG23 HD12 ' A' ' 363' ' ' LEU . 24.4 m -71.95 -37.56 69.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.371 -172.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -62.02 -34.21 75.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.674 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.725 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.9 t80 -73.46 -47.46 41.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.65 1.214 . . . . 0.0 109.125 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.09 -32.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 112.415 -2.175 . . . . 0.0 111.829 170.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.5 mpt_? -60.4 -40.76 92.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.482 0.658 . . . . 0.0 111.351 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 378' ' ' LEU . 31.6 p -100.25 -23.55 14.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.384 -166.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -110.39 23.03 14.79 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.89 20.99 21.77 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 123.308 0.38 . . . . 0.0 113.805 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.9 m 66.79 156.32 0.1 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 111.414 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.432 ' HZ ' ' HB3' ' A' ' 414' ' ' LEU . 0.1 OUTLIER -117.87 153.56 50.98 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.301 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -95.97 49.85 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.309 2.672 . . . . 0.0 111.348 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.61 ' HA ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.96 4.61 0.63 Allowed 'General case' 0 C--N 1.339 0.112 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -70.12 -47.1 63.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.241 0.544 . . . . 0.0 110.289 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.565 ' O ' HG21 ' A' ' 394' ' ' VAL . 97.3 mt-30 -73.84 -27.13 60.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.715 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -54.66 -31.84 58.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.128 0.877 . . . . 0.0 111.21 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.699 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.9 -55.06 30.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.087 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.45 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 7.6 m-20 -62.78 -36.52 83.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.559 0.695 . . . . 0.0 111.238 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 390' ' ' GLN . 52.6 t -54.95 -53.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.068 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.699 ' O ' HG21 ' A' ' 399' ' ' VAL . 4.6 mm -58.59 -45.93 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.177 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.699 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 40.2 mmtt -53.36 -41.07 65.44 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 124.0 0.813 . . . . 0.0 112.154 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.574 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -78.91 -44.54 9.96 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.394 -173.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.724 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.0 OUTLIER -69.51 -40.84 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 117.451 0.626 . . . . 0.0 111.4 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.699 HG21 ' O ' ' A' ' 395' ' ' ILE . 7.8 m -57.9 -41.43 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.908 0.861 . . . . 0.0 110.154 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.0 t70 -58.15 -41.88 84.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.88 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 75.3 mt-30 -81.62 -55.38 4.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.884 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -111.84 -30.3 7.35 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.001 0.905 . . . . 0.0 112.123 -170.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 119.24 177.32 16.44 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.601 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.606 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.68 -44.45 96.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.227 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.603 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -57.44 -50.74 72.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.573 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -66.0 -50.15 65.27 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 122.177 -0.327 . . . . 0.0 110.665 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.724 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -54.09 -41.9 68.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.546 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.2 t80 -56.24 -45.57 79.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.712 0.768 . . . . 0.0 109.212 175.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.83 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.7 m -59.29 -52.52 65.28 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.505 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.629 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.73 -49.54 77.08 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.051 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.49 -42.25 89.63 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.012 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.654 ' HE2' ' NE2' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.16 -31.98 66.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 122.702 -0.293 . . . . 0.0 111.227 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.83 ' HG3' ' O ' ' A' ' 409' ' ' THR . 61.1 mtm -70.31 -47.36 61.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.224 0.535 . . . . 0.0 109.912 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.685 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 16.6 mt -60.19 -39.92 88.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.665 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.755 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.6 OUTLIER -75.1 -14.3 60.56 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.427 -177.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 94.28 38.62 5.02 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.721 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.654 ' NE2' ' HE2' ' A' ' 412' ' ' MET . 4.9 mm-40 52.73 54.19 10.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.206 -0.997 . . . . 0.0 112.906 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.755 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -125.45 62.31 1.2 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 164.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.468 ' CE1' ' HB2' ' A' ' 452' ' ' ARG . 1.7 p90 -43.77 -33.92 1.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 111.408 -2.633 . . . . 0.0 112.976 -164.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.521 ' O ' ' HB3' ' A' ' 423' ' ' SER . 31.6 mt-30 -55.02 -44.55 74.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -165.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.547 ' CD2' ' ND2' ' A' ' 418' ' ' ASN . 2.3 pp -62.61 -47.85 82.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.047 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.553 HG21 ' N ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -61.36 -39.63 83.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 122.614 1.197 . . . . 0.0 108.947 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.553 ' N ' HG21 ' A' ' 422' ' ' VAL . 40.6 t -58.8 -46.09 88.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 112.434 -2.166 . . . . 0.0 111.478 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.97 -39.79 80.01 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.959 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.521 HD11 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.08 -40.49 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.506 0.669 . . . . 0.0 110.17 175.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.463 HD11 HG23 ' A' ' 395' ' ' ILE . 1.7 mm -58.66 -44.56 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 CA-C-N 114.274 -1.33 . . . . 0.0 113.131 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.614 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.3 OUTLIER -60.6 -29.23 69.09 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-O 122.784 1.278 . . . . 0.0 108.731 -174.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -15.75 76.9 Favored Glycine 0 C--N 1.3 -1.453 0 CA-C-N 112.394 -2.184 . . . . 0.0 112.674 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.651 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.7 m-85 -100.98 0.89 39.05 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.564 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.99 144.14 76.12 Favored Pre-proline 0 N--CA 1.41 -2.428 0 CA-C-O 123.723 1.725 . . . . 0.0 113.317 170.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.681 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 79.1 Cg_endo -72.23 -51.75 0.2 Allowed 'Trans proline' 0 C--N 1.311 -1.417 1 C-N-CA 126.065 4.51 . . . . 0.0 113.33 -173.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.533 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -122.88 142.34 14.54 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.417 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.621 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.24 -29.22 70.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.106 0.453 . . . . 0.0 111.627 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.83 78.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.674 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.9 t -59.02 -51.68 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.596 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.84 -54.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.259 179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 28.3 m -62.54 -55.88 23.19 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.809 -175.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.46 -44.74 80.81 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.615 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.842 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 40.6 mt -60.93 -55.01 38.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.835 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.673 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -49.93 -32.7 15.45 Favored 'General case' 0 N--CA 1.419 -1.999 0 O-C-N 124.429 1.081 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.39 -60.3 2.3 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 174.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -77.25 -52.22 9.59 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -170.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.842 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 1.5 pp -57.28 -24.25 53.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.331 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 28.5 t70 -71.53 -42.04 68.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.546 1.165 . . . . 0.0 110.019 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.0 mt-30 -71.39 -8.11 51.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.032 -1.895 . . . . 0.0 115.933 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 451' ' ' THR . 38.1 mm-40 -54.64 157.85 2.81 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 123.619 1.676 . . . . 0.0 115.022 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.434 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.7 mp -53.48 -33.14 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 110.445 -3.07 . . . . 0.0 115.101 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.642 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 29.9 m-20 -138.88 179.65 6.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.27 -52.1 50.89 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.95 -24.22 65.15 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 175.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.608 HG22 ' HB3' ' A' ' 446' ' ' GLU . 24.4 m -59.36 -40.75 87.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 171.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 39.0 mtt180 -60.75 -30.81 70.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.408 171.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.546 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -74.31 -32.81 63.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.712 0.768 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.8 -44.6 15.33 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.111 -171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.485 ' HG1' ' HG3' ' A' ' 446' ' ' GLU . 42.1 p -99.13 -4.96 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.893 -168.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.657 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.3 t80 -49.04 -51.0 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.664 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 24.5 mm -72.04 -27.57 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.519 ' O ' ' HB1' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -71.52 -42.92 67.36 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.597 ' O ' HG22 ' A' ' 463' ' ' VAL . 53.6 m-70 -66.99 -31.04 71.34 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.81 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.701 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.35 -53.89 36.96 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.116 0.96 . . . . 0.0 109.243 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.651 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.55 -31.91 72.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 113.329 -1.76 . . . . 0.0 110.137 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.73 -52.66 62.37 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.178 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.684 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 23.5 t -63.45 -33.73 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.186 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.2 m-30 -61.8 -15.04 38.36 Favored 'General case' 0 C--O 1.202 -1.447 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.984 169.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 50.0 mm-40 -90.37 -50.01 6.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.575 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.684 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -66.63 -38.89 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.121 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.48 ' HB2' ' HG ' ' A' ' 469' ' ' LEU . 6.5 mt -84.81 -15.64 44.14 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.741 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.59 49.02 66.89 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-N 111.822 -2.445 . . . . 0.0 113.213 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.9 OUTLIER -101.1 -179.1 3.94 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.094 0.958 . . . . 0.0 110.113 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.691 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.4 p30 -104.41 -40.65 6.0 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 167.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -158.42 -79.34 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.278 -2.237 . . . . 0.0 110.955 157.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.681 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -61.37 72.66 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -170.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 38.04 42.83 1.24 Allowed Glycine 0 C--N 1.275 -2.827 0 CA-C-N 110.602 -2.999 . . . . 0.0 113.431 171.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.691 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 15.2 mm-40 -79.04 -54.39 6.06 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 122.288 1.042 . . . . 0.0 111.469 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.6 t 65.75 46.18 2.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.066 -2.333 . . . . 0.0 108.763 -174.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.7 OUTLIER -46.45 -47.71 6.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 109.505 -3.498 . . . . 0.0 112.346 171.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.546 ' HD2' HD12 ' A' ' 476' ' ' ILE . 0.0 OUTLIER -77.38 -162.65 0.31 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.652 -1.613 . . . . 0.0 113.509 -169.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 72.5 mt -55.24 -59.36 4.89 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.45 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.599 -178.652 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.48 0.703 0 N-CA-C 110.424 -0.645 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.6 mp -86.65 -38.68 12.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.085 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -107.62 136.21 13.28 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.55 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 27.4 m -63.49 123.32 18.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.351 0.596 . . . . 0.0 111.357 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.1 125.19 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.349 171.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.692 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -75.53 128.15 84.59 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 121.795 0.807 . . . . 0.0 112.187 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 308' ' ' GLN . 13.0 Cg_endo -70.38 -22.35 29.38 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 C-N-CA 124.54 3.493 . . . . 0.0 110.748 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.728 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.7 tp 38.0 -59.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 C-N-CA 128.244 2.618 . . . . 0.0 116.135 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.548 ' HG2' HG23 ' A' ' 307' ' ' ILE . 9.8 mm-40 -57.36 -39.5 76.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.833 0.825 . . . . 0.0 110.132 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.529 ' HB3' HG11 ' A' ' 338' ' ' VAL . 6.6 t-160 -58.87 -48.19 82.26 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.609 173.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.595 HG22 ' CG2' ' A' ' 350' ' ' ILE . 60.9 mt -58.92 -49.07 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.728 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 7.7 mtp180 -61.05 -30.16 70.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.889 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 47.9 t -70.06 -35.17 74.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.416 0.627 . . . . 0.0 109.59 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.566 HG11 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.71 -41.03 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.722 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.756 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.7 p -82.94 -36.69 25.0 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 122.914 1.34 . . . . 0.0 109.564 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.25 35.47 9.6 Favored Glycine 0 C--N 1.303 -1.252 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.596 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.472 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 51.29 173.24 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.298 0 C-N-CA 124.258 1.023 . . . . 0.0 113.153 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.561 ' HB3' HD12 ' A' ' 324' ' ' ILE . 37.3 Cg_exo -46.77 150.96 2.28 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.986 2.457 . . . . 0.0 113.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.45 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.2 Cg_endo -92.07 -104.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.656 2.904 . . . . 0.0 112.751 -172.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.409 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 12.1 mmm180 -92.29 -79.55 0.38 Allowed 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.538 0.685 . . . . 0.0 110.553 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.416 ' HB2' ' HG2' ' A' ' 323' ' ' GLU . 49.2 m-20 -103.9 161.45 22.91 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.955 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.484 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 45.2 Cg_exo -58.03 -50.37 10.29 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 122.656 2.237 . . . . 0.0 110.413 168.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.78 -27.32 4.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.662 175.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.416 ' HG2' ' HB2' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -80.52 -29.13 37.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.631 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -48.41 -45.53 67.76 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.715 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.0 Cg_endo -50.75 -61.29 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.742 2.295 . . . . 0.0 112.962 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.573 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -61.94 -36.26 72.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.01 179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.756 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.4 t90 -58.41 -36.65 73.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.257 -1.792 . . . . 0.0 111.305 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.02 -48.42 58.13 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.431 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.71 -23.2 20.49 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.774 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 330' ' ' ARG . 0.2 OUTLIER -74.97 -43.04 56.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.102 0.953 . . . . 0.0 110.552 174.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.56 ' HB3' HG22 ' A' ' 314' ' ' THR . 46.7 m-20 -95.07 -24.53 16.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.68 -1.6 . . . . 0.0 113.827 -169.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.553 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.23 -49.68 11.73 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 124.319 1.048 . . . . 0.0 113.777 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.4 Cg_endo -61.84 -32.57 85.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.522 2.148 . . . . 0.0 111.617 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.474 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -72.73 -43.64 62.69 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.673 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.573 HG12 HG23 ' A' ' 310' ' ' ILE . 89.3 mt -59.32 -48.78 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.67 173.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.71 -15.98 9.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.213 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -50.36 5.99 Favored Glycine 0 CA--C 1.509 -0.328 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 309' ' ' HIS . 70.5 t -54.62 -70.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 123.565 1.65 . . . . 0.0 110.094 169.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.801 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.7 OUTLIER -93.72 132.03 30.81 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.052 -2.795 . . . . 0.0 112.464 -171.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.801 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.1 Cg_endo -72.66 -19.48 24.29 Favored 'Trans proline' 0 CA--C 1.497 -1.357 0 C-N-CA 123.65 2.9 . . . . 0.0 111.084 173.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.6 p 32.45 69.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.472 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.568 ' N ' HD11 ' A' ' 346' ' ' LEU . 75.7 p -79.53 4.14 16.66 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.096 -1.866 . . . . 0.0 113.108 -170.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.767 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.7 p -142.7 156.15 63.04 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.636 0.732 . . . . 0.0 109.624 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 75.5 Cg_exo -60.5 -38.18 75.32 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 124.357 3.371 . . . . 0.0 109.601 172.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.637 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -51.9 -52.76 47.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.546 174.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.767 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.8 mt -56.96 -52.74 64.04 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.818 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.651 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 32.1 ttm105 -51.96 -43.89 63.74 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.255 -1.793 . . . . 0.0 110.442 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 368' ' ' CYS . 38.2 t -69.09 -48.73 61.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.341 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 72.7 mtt180 -57.74 -38.1 74.76 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.548 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.676 HG13 ' O ' ' A' ' 346' ' ' LEU . 52.5 mt -62.14 -54.51 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.941 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.489 ' HA ' HG13 ' A' ' 354' ' ' ILE . 18.2 mt -58.19 -53.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 122.197 0.998 . . . . 0.0 111.02 -168.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.48 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 44.4 m-20 -63.49 -34.55 78.02 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.17 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.462 ' HB1' HD12 ' A' ' 307' ' ' ILE . . . -69.28 -36.12 76.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.34 -53.9 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 122.873 1.32 . . . . 0.0 110.721 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.579 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -72.89 -25.65 61.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 111.805 -2.452 . . . . 0.0 109.104 -169.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.06 -78.19 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.975 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.33 52.57 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.705 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.611 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 29.5 p30 -74.51 160.32 31.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 122.35 0.26 . . . . 0.0 110.664 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.482 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.1 mp -56.98 -67.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 120.959 0.409 . . . . 0.0 111.337 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -144.98 12.88 1.9 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.896 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.611 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 7.0 mt -64.38 -2.37 2.2 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.48 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 38.7 t -62.3 84.28 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.224 0.535 . . . . 0.0 110.288 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.579 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 2.3 mm? -61.74 -172.75 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 70.5 p -126.73 155.94 74.35 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.574 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 21.5 Cg_exo -48.16 -38.42 32.78 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.531 1.488 . . . . 0.0 110.103 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 369' ' ' LEU . . . -81.7 1.51 85.85 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.107 -0.952 . . . . 0.0 114.661 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.473 ' HB2' HD11 ' A' ' 363' ' ' LEU . 26.2 m-20 -109.01 -21.76 12.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.236 1.017 . . . . 0.0 109.539 171.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.651 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 83.9 m -91.07 21.12 4.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.612 -171.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -62.45 -36.81 83.6 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.769 1.271 . . . . 0.0 108.579 -174.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.2 p -117.4 163.9 15.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.247 -2.251 . . . . 0.0 109.634 170.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.55 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.2 m95 -70.63 -34.24 71.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.598 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.42 -42.48 96.02 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.724 -170.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.6 m -71.33 -42.5 68.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.703 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.677 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.03 -52.17 66.13 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 371' ' ' TRP . 12.7 m -58.56 -44.36 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 109.512 -178.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.693 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.515 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 54.3 m -70.15 -41.04 74.36 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.825 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 1.8 mt -58.69 -34.45 71.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.562 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.715 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 45.6 t80 -73.52 -46.96 44.61 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.267 1.032 . . . . 0.0 109.766 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.515 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.19 -32.9 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.537 170.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -59.76 -43.1 94.46 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.412 0.625 . . . . 0.0 110.999 174.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 41.4 p -95.54 -23.37 17.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.214 -167.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -110.46 22.22 15.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.06 21.16 30.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 114.436 0.534 . . . . 0.0 114.436 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 64.81 158.13 0.09 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.441 0.639 . . . . 0.0 111.744 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.558 ' CE2' HD22 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.75 156.06 65.63 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -97.83 52.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.322 2.681 . . . . 0.0 111.266 166.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.622 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.8 6.09 0.42 Allowed 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -70.06 -48.29 58.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.215 0.531 . . . . 0.0 110.039 174.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.639 ' O ' HG12 ' A' ' 394' ' ' VAL . 59.0 mt-30 -75.84 -25.21 56.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.911 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -53.64 -31.11 46.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.488 1.04 . . . . 0.0 111.916 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 396' ' ' LYS . . . -55.24 -54.08 36.51 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.637 172.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 396' ' ' LYS . 17.7 m-20 -63.43 -38.71 92.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.336 0.654 . . . . 0.0 112.458 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.688 HG21 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -58.89 -46.17 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 120.795 0.331 . . . . 0.0 110.442 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.605 ' O ' HG21 ' A' ' 399' ' ' VAL . 5.5 mm -57.97 -46.83 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.311 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.531 ' HD2' ' OH ' ' A' ' 429' ' ' TYR . 8.1 mtmt -52.15 -46.28 65.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.768 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.55 -44.71 39.66 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.636 -1.268 . . . . 0.0 112.96 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.638 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.2 mt -69.93 -41.65 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 117.532 0.666 . . . . 0.0 111.684 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.717 HG22 ' CG ' ' A' ' 429' ' ' TYR . 5.7 m -57.42 -44.73 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.801 0.81 . . . . 0.0 110.369 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.478 ' N ' HG23 ' A' ' 399' ' ' VAL . 1.6 t70 -67.4 -32.61 73.62 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.919 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.43 -55.28 3.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.688 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.39 -28.12 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.901 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.12 162.16 11.6 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.608 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.616 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -41.34 92.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.586 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -57.75 -51.86 67.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.846 0.355 . . . . 0.0 111.863 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -64.04 -49.95 70.34 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.28 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.638 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -51.75 -43.03 62.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.585 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 34.5 t80 -56.18 -47.73 77.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.615 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.754 ' O ' ' HG3' ' A' ' 413' ' ' MET . 2.2 m -57.92 -51.77 68.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.608 HD12 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.56 -48.94 78.68 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.821 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.485 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.83 -43.59 87.14 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.397 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.58 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.2 OUTLIER -72.21 -31.67 66.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.887 0.343 . . . . 0.0 110.839 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.754 ' HG3' ' O ' ' A' ' 409' ' ' THR . 69.2 mtm -69.1 -48.57 62.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.291 0.567 . . . . 0.0 110.048 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.693 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 14.1 mt -59.13 -39.27 81.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.22 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.911 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 4.3 m -78.16 -13.6 59.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 95.92 32.25 6.92 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.33 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.58 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 69.92 37.63 1.74 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.357 0.663 . . . . 0.0 111.876 176.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.696 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.1 OUTLIER -120.52 81.24 1.73 Allowed 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 420' ' ' GLN . 8.5 p90 -63.15 -31.74 72.95 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.611 -161.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 423' ' ' SER . 25.8 mt-30 -54.3 -48.38 71.36 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 113.464 -164.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.664 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.4 pp -59.61 -51.36 70.16 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.416 0.626 . . . . 0.0 111.02 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.584 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -59.8 -38.44 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.891 1.329 . . . . 0.0 109.241 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 43.4 t -63.09 -47.12 84.22 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.025 -2.352 . . . . 0.0 111.873 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.66 -36.27 70.88 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.87 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.52 HD13 ' HA ' ' A' ' 422' ' ' VAL . 2.7 mt -72.01 -43.07 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.546 0.689 . . . . 0.0 109.944 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.488 HD11 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -56.09 -45.24 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.605 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.4 OUTLIER -61.45 -29.45 69.97 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 122.608 1.194 . . . . 0.0 108.959 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.06 -16.56 76.76 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.688 -2.051 . . . . 0.0 112.462 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.717 ' CG ' HG22 ' A' ' 399' ' ' VAL . 11.8 m-85 -100.68 2.69 41.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.578 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.74 143.6 75.82 Favored Pre-proline 0 N--CA 1.411 -2.414 0 CA-C-O 123.658 1.694 . . . . 0.0 113.687 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.673 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 72.9 Cg_endo -72.45 -55.09 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.102 1 C-N-CA 126.455 4.77 . . . . 0.0 113.263 -171.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.53 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -114.77 140.57 16.45 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.115 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.612 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.054 0.427 . . . . 0.0 111.522 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.4 -46.66 83.22 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.674 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.8 t -59.17 -51.37 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.553 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.21 -54.4 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.9 m -61.33 -56.64 18.18 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.12 -45.42 79.5 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.533 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.839 ' O ' HD23 ' A' ' 443' ' ' LEU . 43.9 mt -60.11 -53.29 59.5 Favored 'General case' 0 CA--C 1.481 -1.697 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.687 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.715 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 37.8 mm-40 -51.35 -35.15 37.05 Favored 'General case' 0 N--CA 1.415 -2.201 0 O-C-N 125.115 1.509 . . . . 0.0 110.437 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.673 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.64 -60.81 2.05 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 177.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.415 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -76.73 -50.63 13.13 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.84 -0.538 . . . . 0.0 112.3 -172.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.839 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.68 -24.28 61.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.767 0.794 . . . . 0.0 111.518 -178.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.733 ' N ' HD22 ' A' ' 443' ' ' LEU . 16.6 t70 -72.21 -42.87 65.28 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.688 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.673 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.26 -8.15 47.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.613 ' HB3' HG23 ' A' ' 451' ' ' THR . 55.9 mm-40 -51.32 157.8 0.93 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 123.683 1.706 . . . . 0.0 114.333 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.441 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -55.82 -32.81 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 CA-C-N 110.508 -3.042 . . . . 0.0 115.509 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.553 ' H ' ' HB ' ' A' ' 451' ' ' THR . 31.5 m-20 -140.04 179.11 6.8 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.437 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 7.3 m-20 -62.47 -56.77 14.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -65.18 -24.77 67.47 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 446' ' ' GLU . 21.1 m -59.55 -41.98 91.35 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 119.492 1.042 . . . . 0.0 109.928 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 52.7 mtt180 -61.32 -29.84 70.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.585 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.09 -31.84 61.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.141 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.8 mm-40 -79.8 -45.35 18.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.626 -172.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.502 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 43.5 p -101.79 -3.51 27.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.136 -167.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.65 ' CE1' HD22 ' A' ' 460' ' ' LEU . 7.7 t80 -48.75 -52.6 22.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 22.8 mm -71.45 -25.78 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.31 -43.4 64.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.613 ' O ' HG23 ' A' ' 463' ' ' VAL . 76.4 m-70 -66.82 -31.39 71.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.725 171.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.69 HD23 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.43 -53.87 36.78 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.117 0.961 . . . . 0.0 109.372 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.608 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.1 m-80 -62.0 -32.11 72.56 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.205 172.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.9 -52.02 64.71 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.026 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.676 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 23.1 t -63.37 -34.83 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 110.271 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.1 m-30 -61.24 -14.21 24.32 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.128 169.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 462' ' ' ALA . 63.5 mm-40 -91.53 -48.9 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.874 -1.141 . . . . 0.0 112.933 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.676 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -66.24 -39.77 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.881 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.466 HD12 HD13 ' A' ' 469' ' ' LEU . 6.2 mt -84.45 -16.44 42.58 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.789 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.97 51.17 55.61 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 111.674 -2.512 . . . . 0.0 113.348 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.4 OUTLIER -104.1 -179.52 3.97 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.918 0.887 . . . . 0.0 110.699 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.732 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 15.1 p30 -98.47 -41.28 7.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.421 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.83 -74.99 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.252 -2.249 . . . . 0.0 110.839 160.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.673 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -60.26 64.08 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 43.62 36.89 3.56 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.619 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.732 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 10.4 mm-40 -75.61 -53.39 8.67 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.346 1.069 . . . . 0.0 111.496 -170.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 26.9 t 66.18 59.1 0.69 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.267 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.789 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -52.42 -46.84 47.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 111.247 -2.706 . . . . 0.0 111.635 175.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -50.54 145.96 6.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.118 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 62.0 mt -55.4 152.42 8.68 Favored 'General case' 0 N--CA 1.42 -1.952 0 C-N-CA 123.377 0.671 . . . . 0.0 112.105 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 . . . . . 0 N--CA 1.435 -1.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.101 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.48 0.677 0 N-CA-C 111.073 -0.395 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.454 HD11 ' N ' ' A' ' 301' ' ' ILE . 3.2 mp -82.76 -54.66 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.488 . . . . 0.0 110.152 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -149.87 -95.05 0.13 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.874 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 57.9 m -158.88 116.87 2.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.362 0.601 . . . . 0.0 110.515 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.9 p -62.72 120.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.272 173.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.696 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 20.2 mt -71.17 126.41 91.95 Favored Pre-proline 0 N--CA 1.426 -1.625 0 CA-C-O 121.997 0.903 . . . . 0.0 112.104 -174.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.464 ' HG2' HG12 ' A' ' 338' ' ' VAL . 24.4 Cg_endo -73.51 -8.96 22.41 Favored 'Trans proline' 0 CA--C 1.501 -1.136 0 C-N-CA 124.952 3.768 . . . . 0.0 111.382 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.689 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.7 tp 24.8 -64.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.315 0 C-N-CA 128.458 2.703 . . . . 0.0 116.195 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.543 ' H ' HG23 ' A' ' 307' ' ' ILE . 0.2 OUTLIER -57.7 -31.06 66.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.13 0.49 . . . . 0.0 111.337 177.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.467 ' HB3' HG13 ' A' ' 338' ' ' VAL . 7.2 t-160 -61.49 -49.05 78.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.498 170.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.652 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 55.1 mt -58.68 -48.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.605 174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.689 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 52.2 mtp180 -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 122.545 0.338 . . . . 0.0 111.52 176.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.9 m -69.84 -33.18 71.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.502 0.668 . . . . 0.0 110.056 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.576 HG11 ' N ' ' A' ' 314' ' ' THR . 0.6 OUTLIER -67.34 -42.32 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.51 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.753 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.3 p -83.21 -36.4 24.68 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.875 1.322 . . . . 0.0 110.44 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.91 33.91 10.53 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 112.248 -2.251 . . . . 0.0 110.834 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 49.44 176.22 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 124.424 1.09 . . . . 0.0 113.629 -174.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 316' ' ' GLU . 21.3 Cg_exo -45.6 141.49 8.0 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.913 2.409 . . . . 0.0 112.818 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.473 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 43.6 Cg_endo -87.84 -101.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.156 2.571 . . . . 0.0 112.318 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 8.8 mmm180 -94.22 -80.07 0.41 Allowed 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.484 0.659 . . . . 0.0 110.756 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.531 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 36.4 m-20 -105.87 162.78 18.66 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.811 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.498 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.3 Cg_exo -61.38 -52.37 3.32 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.671 2.247 . . . . 0.0 111.025 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.2 OUTLIER -52.48 -19.21 2.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.898 177.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.531 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.6 mm-40 -88.56 -26.91 21.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.519 0.199 . . . . 0.0 111.482 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.635 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.98 -44.13 45.96 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.698 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.22 -62.13 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.815 2.343 . . . . 0.0 113.044 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.575 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -62.29 -36.24 73.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 122.441 1.115 . . . . 0.0 110.027 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.753 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 50.1 t90 -57.84 -38.0 74.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.513 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.473 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.97 -48.19 59.28 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.447 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -53.53 -23.48 20.26 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.794 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -73.84 -43.17 59.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.322 1.058 . . . . 0.0 110.456 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.584 ' HB3' HG21 ' A' ' 314' ' ' THR . 51.8 m-20 -95.67 -24.73 16.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.478 -1.692 . . . . 0.0 113.711 -168.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.557 ' HA ' HD13 ' A' ' 335' ' ' ILE . . . -41.84 -50.56 10.19 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.1 Cg_endo -60.9 -33.88 91.91 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.623 2.215 . . . . 0.0 111.68 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.474 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -72.27 -44.46 62.76 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.774 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.585 HG12 HG21 ' A' ' 310' ' ' ILE . 87.7 mt -58.07 -48.21 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.635 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.07 -14.94 7.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.282 -1.781 . . . . 0.0 112.046 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.0 -48.7 5.64 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 309' ' ' HIS . 92.2 t -55.18 -70.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.617 1.675 . . . . 0.0 109.89 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.78 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.6 OUTLIER -91.67 131.19 36.53 Favored Pre-proline 0 N--CA 1.402 -2.847 0 CA-C-N 110.729 -2.941 . . . . 0.0 112.008 -173.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.78 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.4 Cg_endo -73.39 -18.42 23.09 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 123.634 2.889 . . . . 0.0 110.248 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.6 p 32.87 69.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 111.938 -2.392 . . . . 0.0 110.189 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.549 ' N ' HD12 ' A' ' 346' ' ' LEU . 40.9 p -79.93 3.61 19.41 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.119 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.784 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -140.85 156.1 68.84 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 109.509 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 68.7 Cg_exo -60.94 -38.57 68.12 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 124.263 3.308 . . . . 0.0 109.54 172.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.686 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.58 -53.08 41.94 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.364 -2.198 . . . . 0.0 110.566 173.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.784 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -56.68 -51.94 66.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.77 0.795 . . . . 0.0 110.311 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 10.5 ttm180 -50.62 -44.75 57.28 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.238 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 40.9 t -70.09 -49.34 51.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.738 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.686 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 77.8 mtt180 -57.93 -39.3 77.68 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.704 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.621 ' O ' HG12 ' A' ' 354' ' ' ILE . 37.0 mt -59.71 -54.04 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.689 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.475 ' HA ' HG13 ' A' ' 354' ' ' ILE . 15.9 mt -57.58 -53.34 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-O 122.133 0.968 . . . . 0.0 110.919 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -64.14 -34.79 78.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.149 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.469 ' HB3' HD13 ' A' ' 307' ' ' ILE . . . -69.27 -35.15 75.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.104 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.621 HG12 ' O ' ' A' ' 350' ' ' ILE 0.25 0.9 OUTLIER -57.9 -54.13 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 122.715 1.245 . . . . 0.0 110.616 174.421 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.604 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.3 OUTLIER -72.52 -27.32 62.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 111.758 -2.474 . . . . 0.0 109.037 -168.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 28.1 55.61 0.13 Allowed Glycine 0 CA--C 1.524 0.628 0 O-C-N 125.568 1.793 . . . . 0.0 115.357 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 135.96 45.85 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.667 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.612 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 30.1 p30 -98.3 163.31 12.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.173 0.189 . . . . 0.0 110.762 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.456 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -53.37 -60.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.23 0.538 . . . . 0.0 111.702 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -157.75 16.05 0.31 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.607 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.612 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 6.4 mt -64.46 -6.32 7.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 122.919 0.488 . . . . 0.0 111.649 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.515 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 22.9 t -61.43 85.2 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.22 0.533 . . . . 0.0 110.112 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.636 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.8 mm? -60.64 -172.74 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.652 0.739 . . . . 0.0 112.822 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.9 p -126.96 152.68 75.87 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 18.4 Cg_exo -46.55 -34.65 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.979 1.786 . . . . 0.0 111.265 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -86.26 -2.25 85.65 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.65 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.452 ' HB2' HD12 ' A' ' 363' ' ' LEU . 55.6 m-20 -105.48 -21.29 13.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.306 1.051 . . . . 0.0 109.124 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 77.0 m -86.8 22.94 1.82 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.382 -171.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 369' ' ' LEU . 0.2 OUTLIER -59.02 -35.98 74.18 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.62 1.2 . . . . 0.0 108.266 -173.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 29.8 p -118.83 163.48 16.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 112.839 -1.982 . . . . 0.0 110.361 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.593 ' O ' HG13 ' A' ' 375' ' ' VAL . 51.8 m95 -71.18 -34.1 70.61 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 167.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.587 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -62.92 -47.07 84.85 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.613 -173.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.3 t -65.86 -42.82 89.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.739 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.741 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.53 63.76 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 371' ' ' TRP . 10.4 m -58.84 -44.85 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.613 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.682 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.79 -43.46 98.08 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.949 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.505 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 24.1 m -70.47 -40.42 73.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.749 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.6 mt -59.18 -35.15 73.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.399 0.618 . . . . 0.0 110.439 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.698 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.0 t80 -71.12 -49.08 48.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.344 1.069 . . . . 0.0 109.412 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.92 -32.41 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.962 170.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -59.95 -33.02 71.35 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 123.241 0.616 . . . . 0.0 111.698 175.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 29.1 p -106.34 -23.24 12.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.771 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -110.34 22.61 15.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 52.87 21.38 9.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 114.336 0.494 . . . . 0.0 114.336 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.5 m 64.86 161.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.42 0.628 . . . . 0.0 111.022 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.571 ' CE2' HD23 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.5 157.01 63.37 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 389' ' ' HIS . 85.5 Cg_endo -97.67 54.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.361 2.708 . . . . 0.0 111.019 166.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.61 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 56.85 3.14 0.12 Allowed 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -174.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.3 t60 -69.91 -46.85 64.51 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.512 174.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.8 mt-30 -74.17 -26.72 60.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.955 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -54.69 -31.52 58.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.97 0.805 . . . . 0.0 111.492 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.659 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.72 -53.17 40.9 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.426 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.561 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.8 m-20 -64.88 -40.85 95.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.068 0.547 . . . . 0.0 112.17 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.42 -45.39 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 399' ' ' VAL . 6.8 mm -58.8 -48.45 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.513 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.3 mmtt -52.11 -42.15 63.06 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.893 0.746 . . . . 0.0 111.54 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.34 -45.09 11.71 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.186 -172.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.653 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.2 mt -69.75 -40.67 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 117.52 0.66 . . . . 0.0 111.25 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.733 HG21 ' CG ' ' A' ' 429' ' ' TYR . 5.8 m -58.35 -45.16 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.66 0.743 . . . . 0.0 110.194 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.479 ' N ' HG22 ' A' ' 399' ' ' VAL . 10.6 t70 -62.94 -35.94 81.78 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.879 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -86.59 -53.47 4.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.046 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -107.66 -29.49 9.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.469 -171.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 120.84 163.79 12.17 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.616 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -42.92 97.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -57.14 -51.21 70.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.917 0.389 . . . . 0.0 111.784 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.583 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.16 -50.77 66.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.508 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.653 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.65 -41.73 64.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.606 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.8 t80 -57.1 -46.18 82.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.661 0.743 . . . . 0.0 109.2 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.771 ' O ' ' HG3' ' A' ' 413' ' ' MET . 7.5 m -58.31 -51.85 68.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.642 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.577 HD11 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.87 -49.14 76.04 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.723 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.488 ' HA2' HD11 ' A' ' 414' ' ' LEU . . . -56.33 -42.14 88.46 Favored Glycine 0 C--N 1.315 -0.59 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.252 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.598 ' HE1' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.49 -32.01 65.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 116.764 0.282 . . . . 0.0 111.015 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.771 ' HG3' ' O ' ' A' ' 409' ' ' THR . 67.3 mtm -69.97 -48.03 59.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.378 0.609 . . . . 0.0 109.831 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.682 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 15.6 mt -59.48 -38.55 81.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.388 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.955 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.0 m -77.64 -15.04 59.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.39 28.57 7.96 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 119.936 -1.125 . . . . 0.0 111.526 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.598 ' HA ' ' HE1' ' A' ' 412' ' ' MET . 3.2 mm-40 63.12 46.42 4.65 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.022 0.929 . . . . 0.0 112.302 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.627 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.1 OUTLIER -122.69 66.99 0.95 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 165.412 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.485 ' HE1' ' O ' ' A' ' 449' ' ' ASP . 0.9 OUTLIER -47.53 -34.38 7.51 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 111.368 -2.651 . . . . 0.0 113.733 -165.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' A' ' 423' ' ' SER . 48.3 mt-30 -55.45 -44.41 76.33 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -164.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.68 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.56 -50.95 71.91 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.347 0.594 . . . . 0.0 110.624 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 412' ' ' MET . 0.7 OUTLIER -59.96 -38.76 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.428 1.109 . . . . 0.0 109.164 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 29.1 t -59.5 -47.85 83.91 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.648 -2.069 . . . . 0.0 112.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.82 73.09 Favored Glycine 0 C--N 1.317 -0.489 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.122 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -72.24 -42.2 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.546 0.688 . . . . 0.0 110.085 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -56.67 -44.32 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.94 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.642 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -62.7 -27.99 69.63 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 122.901 1.334 . . . . 0.0 108.991 -173.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.42 77.69 Favored Glycine 0 C--N 1.298 -1.537 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.503 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.733 ' CG ' HG21 ' A' ' 399' ' ' VAL . 14.5 m-85 -100.4 3.08 42.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.604 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.96 144.87 74.18 Favored Pre-proline 0 N--CA 1.413 -2.308 0 CA-C-O 123.615 1.674 . . . . 0.0 113.439 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.654 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.7 Cg_endo -72.98 -61.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 1 C-N-CA 126.118 4.545 . . . . 0.0 113.305 -174.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.37 142.69 16.33 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.63 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.27 -29.22 70.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.085 0.443 . . . . 0.0 111.184 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.26 -47.21 79.02 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.683 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.6 t -58.8 -51.83 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.663 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.08 -54.44 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.05 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 47.9 m -62.27 -55.77 25.02 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.476 -0.489 . . . . 0.0 112.073 -175.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.35 -45.65 80.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.715 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.84 ' O ' HD21 ' A' ' 443' ' ' LEU . 48.8 mt -60.39 -53.15 60.99 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.759 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.698 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -51.75 -34.16 38.06 Favored 'General case' 0 N--CA 1.416 -2.147 0 O-C-N 125.03 1.456 . . . . 0.0 110.644 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.705 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.65 -60.73 2.09 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.405 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.98 -51.43 11.14 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.963 -0.461 . . . . 0.0 112.243 -172.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.8 -23.85 60.95 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.869 0.842 . . . . 0.0 111.571 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.73 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.5 t70 -71.26 -41.41 70.1 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.666 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 45.1 mt-30 -72.68 -9.67 58.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -170.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.634 ' HB3' HG23 ' A' ' 451' ' ' THR . 5.8 mm-40 -56.48 154.0 9.19 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.79 1.281 . . . . 0.0 113.762 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.404 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -52.7 -33.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.09 -2.323 . . . . 0.0 116.249 -168.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.621 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 27.8 m-20 -135.69 -178.47 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.485 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.4 p-10 -64.07 -54.6 31.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.433 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.6 -24.16 65.45 Favored 'General case' 0 N--CA 1.403 -2.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.634 HG23 ' HB3' ' A' ' 446' ' ' GLU . 8.6 m -60.25 -44.05 95.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 119.696 1.134 . . . . 0.0 109.427 171.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.5 mtt180 -59.22 -29.98 67.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.172 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.606 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.59 -30.82 59.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.674 0.749 . . . . 0.0 109.627 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.91 -44.97 19.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.222 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.508 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -100.75 -4.19 28.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.723 -1.58 . . . . 0.0 111.818 -168.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.633 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.1 t80 -48.77 -52.5 23.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.809 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.563 HG21 ' HB1' ' A' ' 405' ' ' ALA . 23.8 mm -72.87 -25.24 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.586 ' O ' ' HB1' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.11 -43.28 64.99 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.648 ' O ' HG23 ' A' ' 463' ' ' VAL . 72.2 m-70 -67.81 -31.55 71.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.734 -1.576 . . . . 0.0 109.513 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.685 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.74 -53.84 40.88 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.165 0.983 . . . . 0.0 109.304 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.3 -30.6 71.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.619 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 458' ' ' GLN . . . -66.9 -48.81 67.57 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.708 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 22.0 t -65.24 -35.82 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.302 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.538 ' OH ' HG12 ' A' ' 404' ' ' VAL . 18.8 m-30 -61.47 -13.17 18.56 Favored 'General case' 0 C--O 1.204 -1.294 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.707 169.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 3.5 tp10 -95.23 -52.6 4.12 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.227 -0.921 . . . . 0.0 112.24 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.708 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -62.75 -41.08 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.317 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.477 HD13 HD12 ' A' ' 469' ' ' LEU . 7.3 mt -83.97 -16.44 44.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.781 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.27 47.57 78.78 Favored Glycine 0 C--O 1.215 -1.039 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.492 172.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.4 OUTLIER -102.31 178.88 4.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.069 0.948 . . . . 0.0 110.478 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.79 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 18.0 p30 -96.54 -40.75 8.9 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 167.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -163.48 -75.12 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.358 160.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.654 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 1.0 OUTLIER -61.61 68.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -171.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 39.55 41.97 1.82 Allowed Glycine 0 C--N 1.274 -2.901 0 CA-C-N 110.626 -2.988 . . . . 0.0 113.375 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.79 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 8.5 mm-40 -79.05 -56.62 4.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.2 1.0 . . . . 0.0 111.635 -171.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.8 t 68.9 54.46 0.47 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.283 -173.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.781 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -51.32 -48.01 33.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.139 175.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -50.86 139.59 16.71 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.315 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.97 -26.42 66.0 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.517 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.437 -1.077 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.089 179.496 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.473 0.296 0 N-CA-C 111.063 -0.399 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.05 123.35 44.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 110.61 -154.05 16.8 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.879 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 94.8 m -153.13 120.37 5.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.432 ' H ' HG11 ' A' ' 304' ' ' VAL . 1.9 p -55.76 119.51 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.252 176.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.693 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 17.2 mt -75.96 127.85 84.46 Favored Pre-proline 0 N--CA 1.424 -1.76 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.994 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.2 Cg_endo -72.88 -12.18 26.09 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.823 3.682 . . . . 0.0 111.253 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.688 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.9 tp 27.25 -61.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 C-N-CA 128.685 2.794 . . . . 0.0 116.145 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 306' ' ' PRO . 0.0 OUTLIER -58.81 -31.89 68.86 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.097 0.475 . . . . 0.0 110.305 178.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.503 ' HB3' HG12 ' A' ' 338' ' ' VAL . 7.0 t-160 -61.8 -48.58 79.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.615 171.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 60.0 mt -58.41 -48.9 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 C-N-CA 123.987 0.915 . . . . 0.0 112.638 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 15.1 mtp180 -60.62 -29.86 69.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 122.222 -0.299 . . . . 0.0 111.074 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 52.8 m -69.76 -34.96 74.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.38 0.609 . . . . 0.0 109.761 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.66 -41.12 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.741 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.676 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.2 p -83.52 -37.96 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.898 1.332 . . . . 0.0 109.882 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.58 35.52 6.87 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.003 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.489 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 39.6 mt-10 51.3 177.12 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 124.083 0.953 . . . . 0.0 113.051 -174.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.527 ' HB3' HD11 ' A' ' 324' ' ' ILE . 48.7 Cg_exo -48.59 152.56 4.05 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.633 2.222 . . . . 0.0 113.379 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.521 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 7.5 Cg_endo -98.93 -107.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.076 3.184 . . . . 0.0 112.624 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.479 ' HB2' ' CD ' ' A' ' 323' ' ' GLU . 8.6 mmm180 -89.19 -88.83 0.15 Allowed 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.013 0.911 . . . . 0.0 111.97 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.576 ' H ' ' HG2' ' A' ' 323' ' ' GLU . 2.2 m-20 -94.87 157.83 36.1 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.474 -170.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.404 ' HB3' HD13 ' A' ' 359' ' ' ILE . 38.2 Cg_exo -59.32 -50.75 7.76 Favored 'Trans proline' 0 CA--C 1.511 -0.675 0 C-N-CA 122.414 2.076 . . . . 0.0 110.399 166.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.48 23.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.791 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.576 ' HG2' ' H ' ' A' ' 320' ' ' ASN . 3.3 pt-20 -102.94 -20.47 14.23 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.622 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.648 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -44.05 -42.65 12.5 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.705 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.43 -61.44 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.565 HG13 ' HG ' ' A' ' 410' ' ' LEU . 0.8 OUTLIER -60.01 -34.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.153 178.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.676 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -58.8 -36.39 74.38 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.228 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.485 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.81 -49.13 55.67 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -54.01 -22.97 22.01 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.758 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.633 ' NH1' ' HB2' ' A' ' 402' ' ' GLU . 0.1 OUTLIER -72.11 -42.4 66.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.215 1.007 . . . . 0.0 110.105 174.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.57 ' HB3' HG21 ' A' ' 314' ' ' THR . 54.7 m-20 -99.79 -24.16 14.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.739 -1.573 . . . . 0.0 114.114 -168.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.545 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.31 -50.01 8.75 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.0 Cg_endo -60.73 -33.42 93.13 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.371 2.047 . . . . 0.0 111.529 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.484 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -72.36 -42.23 65.53 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.794 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.569 HG12 HG21 ' A' ' 310' ' ' ILE . 90.4 mt -59.91 -48.5 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.965 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -56.14 -16.54 5.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.24 5.68 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 309' ' ' HIS . 96.0 t -55.09 -70.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 123.665 1.698 . . . . 0.0 110.1 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.788 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.6 OUTLIER -92.75 131.28 34.13 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 110.798 -2.91 . . . . 0.0 111.94 -172.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.788 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 67.9 Cg_endo -72.3 -18.87 26.23 Favored 'Trans proline' 0 CA--C 1.495 -1.464 0 C-N-CA 123.562 2.841 . . . . 0.0 110.524 174.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 346' ' ' LEU . 2.5 p 32.75 69.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 112.107 -2.315 . . . . 0.0 110.32 -178.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.536 ' N ' HD11 ' A' ' 346' ' ' LEU . 46.4 p -80.6 4.46 18.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.034 -1.894 . . . . 0.0 113.206 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.812 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 33.4 p -142.89 157.27 61.57 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-O 121.699 0.761 . . . . 0.0 109.694 174.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 70.0 Cg_exo -60.63 -38.97 68.14 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 124.373 3.382 . . . . 0.0 109.413 172.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.605 ' HA ' ' HB3' ' A' ' 365' ' ' PRO . 11.5 t70 -45.75 -58.83 3.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 112.371 -2.195 . . . . 0.0 110.217 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.812 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.3 mt -56.17 -52.24 65.11 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.815 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.642 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 34.3 ttm105 -52.61 -42.99 65.08 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 48.6 t -69.49 -49.79 51.36 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 26.9 mtp180 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.667 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.674 ' O ' HG12 ' A' ' 354' ' ' ILE . 50.8 mt -62.23 -53.85 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.681 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.491 ' HA ' HG13 ' A' ' 354' ' ' ILE . 18.2 mt -58.19 -53.36 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.078 0.942 . . . . 0.0 111.143 -168.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.538 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -64.3 -35.08 79.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.171 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 307' ' ' ILE . . . -69.18 -32.92 72.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.674 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.36 -55.95 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 CA-C-O 122.925 1.345 . . . . 0.0 110.41 173.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.561 HD13 ' HB ' ' A' ' 354' ' ' ILE . 1.7 mp -72.94 -26.1 61.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 111.88 -2.418 . . . . 0.0 109.051 -169.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 37.44 59.18 1.29 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 113.694 -1.594 . . . . 0.0 114.609 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 121.02 48.92 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.688 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.638 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 26.7 p30 -87.94 162.61 16.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.479 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -53.69 -63.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 122.828 0.451 . . . . 0.0 111.448 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.11 9.31 0.96 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.512 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.638 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 4.8 mt -64.15 -5.38 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 122.955 0.502 . . . . 0.0 111.645 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.538 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 48.1 t -61.29 84.28 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.092 0.473 . . . . 0.0 110.546 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.692 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 2.2 mm? -62.71 -174.64 0.07 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.877 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 71.7 p -128.47 155.79 78.12 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.605 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 35.4 Cg_exo -45.14 -38.12 13.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.965 1.777 . . . . 0.0 111.23 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.595 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -78.47 -4.17 87.02 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.806 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 363' ' ' LEU . 9.4 m-20 -109.5 -20.02 13.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.835 0.826 . . . . 0.0 110.194 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 81.4 m -91.25 21.49 4.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.702 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.595 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.7 OUTLIER -60.48 -38.97 85.98 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.156 -172.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.47 162.39 21.8 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.015 170.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.557 ' O ' HG11 ' A' ' 375' ' ' VAL . 48.0 m95 -69.54 -35.78 75.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.584 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.64 -41.77 99.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.783 -174.231 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 66.5 p -67.91 -44.77 76.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.922 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.638 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.43 -52.61 62.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 371' ' ' TRP . 15.6 m -57.31 -45.23 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.598 0.714 . . . . 0.0 109.585 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.695 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -61.17 -44.79 96.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.052 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.538 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 34.5 m -67.37 -39.85 85.7 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.499 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -58.99 -34.9 72.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.445 0.566 . . . . 0.0 110.325 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.705 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 43.7 t80 -73.81 -46.0 48.0 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.309 1.052 . . . . 0.0 109.467 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.2 mp -51.52 -32.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.322 170.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -59.83 -36.59 77.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.185 0.594 . . . . 0.0 111.451 176.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 28.0 p -103.26 -22.63 13.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.72 -168.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -110.01 23.01 14.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.42 21.45 34.09 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.948 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 65.07 160.17 0.11 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.179 0.514 . . . . 0.0 110.788 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -124.92 157.62 65.87 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -101.64 54.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.867 3.045 . . . . 0.0 111.546 166.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.606 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.06 -0.26 0.24 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -70.17 -44.49 68.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.017 0.437 . . . . 0.0 110.906 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.613 ' O ' HG12 ' A' ' 394' ' ' VAL . 77.4 mt-30 -74.65 -27.01 60.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.903 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.41 -30.42 52.26 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.48 0.582 . . . . 0.0 111.638 -174.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.64 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.1 -53.05 39.52 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.795 173.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.559 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 12.3 m-20 -65.61 -39.24 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 391' ' ' LEU . 1.4 m -57.97 -45.37 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.052 0.453 . . . . 0.0 110.256 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 399' ' ' VAL . 6.3 mm -58.8 -48.11 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.1 mmtt -52.04 -41.26 62.15 Favored 'General case' 0 C--O 1.242 0.682 0 O-C-N 124.195 0.934 . . . . 0.0 111.418 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.63 12.78 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.352 -171.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.591 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.3 mt -70.61 -38.65 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 117.624 0.712 . . . . 0.0 112.002 -177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 395' ' ' ILE . 1.1 m -59.33 -42.33 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.999 0.904 . . . . 0.0 109.136 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -59.18 -44.34 92.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.807 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -83.88 -53.5 5.55 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.491 -172.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.665 ' HG2' HG22 ' A' ' 406' ' ' THR . 8.8 tp10 -112.34 -34.91 5.75 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -171.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 130.1 163.47 11.09 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.57 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.574 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.17 -41.28 91.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -56.18 -50.71 70.44 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.665 HG22 ' HG2' ' A' ' 402' ' ' GLU . 0.9 OUTLIER -65.55 -48.85 71.02 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.091 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.591 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.41 -44.81 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 112.008 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.0 t80 -55.66 -45.99 77.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.348 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.754 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.2 m -58.77 -52.58 65.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.758 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.596 HD12 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.47 -48.82 79.39 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.508 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 414' ' ' LEU . . . -55.72 -44.25 86.62 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.63 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.2 OUTLIER -72.7 -31.17 64.82 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.899 0.35 . . . . 0.0 110.923 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.754 ' HG3' ' O ' ' A' ' 409' ' ' THR . 68.4 mtm -68.61 -49.8 56.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.475 0.655 . . . . 0.0 109.988 172.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.695 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 17.5 mt -58.56 -39.11 79.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.986 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.903 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.7 m -77.93 -16.45 58.18 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.558 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.23 35.31 6.34 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.169 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.63 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 69.91 39.69 1.39 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.632 0.773 . . . . 0.0 112.571 176.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.742 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.1 OUTLIER -121.63 77.46 1.35 Allowed 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.491 -2.041 . . . . 0.0 105.491 164.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.52 ' O ' HG23 ' A' ' 422' ' ' VAL . 9.1 p90 -62.04 -31.32 71.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.627 -2.079 . . . . 0.0 110.515 -162.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.552 ' O ' ' HB3' ' A' ' 423' ' ' SER . 23.6 mt-30 -54.38 -48.08 71.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.086 -164.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.666 HD13 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.87 -49.69 76.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.717 0.77 . . . . 0.0 110.962 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 412' ' ' MET . 0.6 OUTLIER -60.31 -39.04 79.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.633 1.206 . . . . 0.0 109.251 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.552 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 38.8 t -60.54 -45.64 93.09 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.444 -2.162 . . . . 0.0 111.375 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.94 -39.31 78.24 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.358 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.534 HD13 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -72.26 -42.59 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.643 0.735 . . . . 0.0 109.976 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -55.46 -44.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.735 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.639 ' C ' ' HD3' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -60.85 -30.63 70.23 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-O 122.733 1.254 . . . . 0.0 108.987 -173.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.49 -18.24 76.89 Favored Glycine 0 C--N 1.299 -1.502 0 CA-C-N 112.561 -2.109 . . . . 0.0 111.921 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.711 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.35 1.27 44.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.591 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.91 141.99 79.84 Favored Pre-proline 0 N--CA 1.408 -2.557 0 CA-C-O 123.771 1.748 . . . . 0.0 112.848 170.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.73 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.7 Cg_endo -70.16 -60.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 1 C-N-CA 126.065 4.51 . . . . 0.0 112.977 -171.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.543 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -111.36 134.76 12.34 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.235 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.679 ' HA ' HG11 ' A' ' 436' ' ' VAL . 0.6 OUTLIER -49.26 -37.34 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -55.19 -48.33 73.96 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.658 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.9 t -58.13 -52.53 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.637 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 433' ' ' GLN . 1.6 m -51.81 -53.31 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 117.64 0.2 . . . . 0.0 110.492 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.452 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 59.4 m -68.71 -54.17 17.74 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.837 -174.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.44 -41.44 76.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.161 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.84 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.6 mt -63.37 -53.92 44.91 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.208 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.693 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.68 -33.79 35.46 Favored 'General case' 0 N--CA 1.419 -1.977 0 O-C-N 124.959 1.412 . . . . 0.0 110.279 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.69 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.48 -59.88 2.51 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 173.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.5 ptp180 -73.92 -53.55 9.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.838 0.745 . . . . 0.0 112.616 -172.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.44 -25.0 64.0 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.653 0.74 . . . . 0.0 111.786 -177.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.755 ' N ' HD21 ' A' ' 443' ' ' LEU . 6.3 t70 -72.69 -41.89 64.81 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.32 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.69 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.99 -7.74 43.32 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.631 ' HB3' HG21 ' A' ' 451' ' ' THR . 40.4 mm-40 -54.73 158.0 2.81 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 123.206 1.479 . . . . 0.0 114.171 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.443 ' HB ' HG22 ' A' ' 451' ' ' THR . 1.8 mp -54.19 -33.44 25.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 111.52 -2.582 . . . . 0.0 115.904 -170.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.552 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 38.8 m-20 -142.89 178.47 7.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.45 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.0 m-20 -61.48 -55.45 31.03 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.422 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -63.82 -27.58 69.27 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.631 HG21 ' HB3' ' A' ' 446' ' ' GLU . 6.5 m -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.636 1.107 . . . . 0.0 109.941 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 50.0 mtt180 -60.68 -29.46 69.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.583 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.96 -30.18 58.54 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.131 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -82.58 -46.49 13.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.273 1.035 . . . . 0.0 111.95 -172.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.524 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -100.54 -1.55 35.28 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.811 -1.54 . . . . 0.0 111.542 -168.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.634 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.8 -51.99 26.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.656 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 21.3 mm -72.68 -26.33 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.524 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.44 -42.61 64.85 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.626 ' O ' HG21 ' A' ' 463' ' ' VAL . 56.7 m-70 -67.49 -31.56 71.78 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.611 171.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.693 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.84 -53.84 40.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.172 0.987 . . . . 0.0 109.481 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.68 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.9 m-80 -62.68 -32.03 73.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.006 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.85 -53.03 61.41 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.857 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.76 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 21.4 t -63.05 -34.4 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.712 0.767 . . . . 0.0 110.398 177.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -62.17 -15.53 46.78 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.175 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 33.9 mm-40 -92.26 -49.7 6.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 112.475 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.76 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 4.8 pt -64.37 -40.82 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.559 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.49 ' HB3' HD22 ' A' ' 469' ' ' LEU . 6.9 mt -83.69 -16.67 44.1 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.712 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.5 51.88 50.84 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.123 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.5 OUTLIER -102.72 -178.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 123.766 0.826 . . . . 0.0 110.134 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.732 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 13.6 p30 -99.72 -42.98 6.62 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 165.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -159.61 -75.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.906 160.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.73 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -61.16 64.75 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -169.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 43.81 35.48 3.23 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 111.754 -2.475 . . . . 0.0 113.062 173.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.732 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 29.4 mm-40 -73.61 -57.19 4.16 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 122.093 0.949 . . . . 0.0 111.778 -172.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 68.53 49.34 0.76 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.271 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER -42.59 -50.46 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 109.887 -3.324 . . . . 0.0 111.565 173.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.508 ' C ' ' HD2' ' A' ' 477' ' ' ARG . 0.0 OUTLIER -92.17 141.53 28.48 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.85 175.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 40.0 mt -59.6 139.82 56.87 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 123.042 0.537 . . . . 0.0 111.985 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.435 -1.184 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.575 -178.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.475 0.401 0 N-CA-C 110.525 -0.606 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.0 mp -94.05 113.52 28.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -93.51 1.43 69.21 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.441 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 26.9 m 75.6 117.46 0.06 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 122.259 1.028 . . . . 0.0 111.22 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 304' ' ' VAL . 2.2 p -71.84 124.61 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.318 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.684 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 21.5 mt -77.33 126.19 85.32 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 308' ' ' GLN . 19.0 Cg_endo -71.4 -10.55 27.18 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.733 3.622 . . . . 0.0 111.111 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.569 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.6 tp 26.11 -61.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 128.72 2.808 . . . . 0.0 116.194 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.5 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.48 -32.04 68.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.231 0.539 . . . . 0.0 110.047 178.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.488 ' HB3' HG11 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.07 -49.4 76.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.913 172.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.582 HG22 HG12 ' A' ' 335' ' ' ILE . 54.7 mt -58.76 -49.31 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 123.95 0.9 . . . . 0.0 112.614 175.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 48.1 mtp180 -61.3 -29.61 69.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 123.38 0.672 . . . . 0.0 111.094 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 66.8 m -70.31 -34.03 72.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 110.251 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.575 HG11 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.73 -41.68 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.559 178.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.75 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -84.7 -37.69 20.64 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.748 1.261 . . . . 0.0 110.351 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.92 35.4 7.19 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.485 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 19.5 mt-10 50.34 176.39 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 355' ' ' LEU . 73.5 Cg_exo -51.22 129.76 29.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.825 2.35 . . . . 0.0 113.1 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.87 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 82.3 Cg_endo -84.79 -92.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.488 3.459 . . . . 0.0 113.913 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.499 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 5.8 mmm180 -89.54 -77.72 0.38 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.747 0.784 . . . . 0.0 112.355 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.581 ' H ' ' CG ' ' A' ' 323' ' ' GLU . 38.0 m-20 -123.55 175.31 2.86 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.738 -170.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -65.97 -56.96 0.26 Allowed 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 121.969 1.779 . . . . 0.0 111.572 167.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -50.68 -21.15 1.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.648 -1.615 . . . . 0.0 114.075 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.817 ' OE1' ' HG2' ' A' ' 318' ' ' PRO . 1.7 pp20? -99.24 -22.29 15.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.04 0.448 . . . . 0.0 111.629 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.667 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.62 -42.69 33.91 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.571 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.711 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -49.73 -59.61 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.815 2.344 . . . . 0.0 112.935 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.58 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -63.66 -35.95 74.7 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.953 -179.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.87 ' CD1' ' HG3' ' A' ' 318' ' ' PRO . 42.6 t90 -58.01 -37.33 74.1 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.289 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.486 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.6 OUTLIER -69.16 -48.14 63.09 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 413' ' ' MET . . . -53.77 -23.47 22.01 Favored Glycine 0 C--N 1.311 -0.858 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.794 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 1.4 mmm180 -74.46 -42.8 58.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.119 0.961 . . . . 0.0 110.66 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.564 ' HB3' HG22 ' A' ' 314' ' ' THR . 28.1 m-20 -97.15 -22.75 16.56 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.895 -169.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.553 ' HA ' HD13 ' A' ' 335' ' ' ILE . . . -42.17 -49.64 11.56 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 39.7 Cg_endo -61.31 -32.21 89.67 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.589 2.193 . . . . 0.0 111.7 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.479 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -73.41 -43.99 59.31 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.727 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.582 HG12 HG22 ' A' ' 310' ' ' ILE . 89.0 mt -57.57 -48.49 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.866 173.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.47 -15.71 7.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.166 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.55 -47.25 6.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.259 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 309' ' ' HIS . 99.1 t -57.51 -70.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 123.472 1.606 . . . . 0.0 110.128 169.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.761 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.6 OUTLIER -92.39 128.74 43.51 Favored Pre-proline 0 N--CA 1.401 -2.92 0 CA-C-N 111.008 -2.815 . . . . 0.0 112.039 -172.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.761 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.9 Cg_endo -73.96 -16.56 22.97 Favored 'Trans proline' 0 CA--C 1.494 -1.49 0 C-N-CA 123.752 2.968 . . . . 0.0 110.442 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.539 HG22 ' CB ' ' A' ' 346' ' ' LEU . 2.8 p 34.01 67.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.222 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.623 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.2 p -80.37 8.07 8.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.83 -1.986 . . . . 0.0 113.118 -170.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.781 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 11.3 p -142.13 161.97 47.98 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -63.27 -47.52 7.77 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.451 2.768 . . . . 0.0 108.487 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.759 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.3 OUTLIER -45.96 -45.88 15.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.002 -1.908 . . . . 0.0 111.081 176.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.781 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -58.82 -52.31 66.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.378 0.609 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.503 ' HG3' HG21 ' A' ' 341' ' ' VAL . 2.1 ttt180 -50.4 -48.82 55.91 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.199 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 1.048 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -69.67 -49.13 56.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.035 0.445 . . . . 0.0 111.522 -175.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.683 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.3 mtt180 -56.48 -41.73 77.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.492 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.609 ' O ' HG12 ' A' ' 354' ' ' ILE . 38.7 mt -57.72 -53.77 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.322 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.471 ' HA ' HG13 ' A' ' 354' ' ' ILE . 18.9 mt -58.15 -52.76 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.015 0.912 . . . . 0.0 111.018 -169.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.518 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 19.3 m-20 -63.39 -35.97 82.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.988 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.468 ' HB1' HD13 ' A' ' 307' ' ' ILE . . . -69.2 -34.76 75.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.615 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.39 -54.37 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 123.127 1.441 . . . . 0.0 110.21 173.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.615 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -73.83 -26.5 60.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.377 -2.647 . . . . 0.0 109.878 -167.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 17.24 75.72 0.01 OUTLIER Glycine 0 N--CA 1.468 0.816 0 O-C-N 125.706 1.879 . . . . 0.0 115.205 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 137.35 -8.2 3.73 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.086 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.678 HD21 ' HB2' ' A' ' 361' ' ' LEU . 22.1 p-10 -57.14 148.61 21.57 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.667 0.787 . . . . 0.0 111.703 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.467 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -56.05 -73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.477 0.711 . . . . 0.0 112.567 -175.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -136.9 11.16 3.93 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.678 ' HB2' HD21 ' A' ' 358' ' ' ASN . 4.6 mt -64.94 -4.68 4.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.87 0.468 . . . . 0.0 111.629 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.518 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.8 t -60.63 82.99 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.379 0.609 . . . . 0.0 110.334 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.442 HD22 ' CD2' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -62.42 173.78 1.13 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.664 0.745 . . . . 0.0 112.604 175.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 76.8 p -115.13 160.97 31.87 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 1.048 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.2 Cg_endo -61.06 -5.02 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.801 1.667 . . . . 0.0 112.26 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -105.84 -11.75 27.66 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -105.91 -20.89 13.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.569 1.184 . . . . 0.0 110.228 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.853 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 16.8 p -84.9 20.05 1.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.709 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.595 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.03 -34.18 67.95 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.986 0.898 . . . . 0.0 110.192 -165.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.41 166.1 20.24 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.176 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.541 ' O ' HG11 ' A' ' 375' ' ' VAL . 44.0 m95 -69.66 -36.01 75.66 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.6 p30 -63.36 -39.42 94.47 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.306 -173.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 m -71.37 -41.99 69.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.649 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -63.27 -52.34 62.47 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 371' ' ' TRP . 14.6 m -56.77 -44.6 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.554 0.692 . . . . 0.0 109.51 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.688 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.66 -45.53 93.77 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.056 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.525 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 30.7 m -66.96 -39.11 87.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.56 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.26 -33.5 73.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.317 0.508 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.711 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 48.9 t80 -74.77 -45.63 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.311 1.053 . . . . 0.0 109.075 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.1 mp -51.73 -33.27 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.346 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -60.25 -36.92 78.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 123.311 0.645 . . . . 0.0 111.732 177.026 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 32.5 p -102.77 -23.54 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.044 -167.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -109.83 23.06 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.86 21.24 51.25 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 114.073 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.408 HG23 HG13 ' A' ' 380' ' ' ILE . 2.8 m 64.11 163.74 0.13 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -129.09 150.52 75.6 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -97.35 59.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.251 2.634 . . . . 0.0 110.893 165.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.594 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.84 4.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.89 -48.82 51.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.635 ' O ' HG11 ' A' ' 394' ' ' VAL . 73.9 mt-30 -74.81 -27.74 60.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -169.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.944 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.4 mm? -54.76 -31.05 58.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.796 0.725 . . . . 0.0 111.892 -172.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.653 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.76 -52.67 44.39 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.438 173.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.544 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 3.5 m-20 -65.75 -39.94 91.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.826 0.45 . . . . 0.0 111.969 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -58.14 -45.06 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.667 ' O ' HG21 ' A' ' 399' ' ' VAL . 6.1 mm -58.51 -47.58 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.4 mmtt -52.23 -43.42 64.29 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.901 0.751 . . . . 0.0 111.486 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.69 -44.63 12.16 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.24 -172.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.65 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.7 mt -69.05 -41.13 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 117.436 0.618 . . . . 0.0 111.432 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.714 HG22 ' CG ' ' A' ' 429' ' ' TYR . 5.9 m -58.13 -45.62 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.706 0.765 . . . . 0.0 109.944 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.468 ' N ' HG23 ' A' ' 399' ' ' VAL . 7.7 t70 -60.88 -38.23 84.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -86.26 -53.25 5.14 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.793 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.599 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.2 OUTLIER -110.67 -30.01 7.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.035 -168.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.02 162.48 11.19 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.853 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.618 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.66 98.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.576 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -57.22 -50.31 73.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.572 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -63.61 -51.18 66.36 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.577 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.65 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.03 -41.88 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.513 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 44.4 t80 -58.42 -44.8 89.24 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.806 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.0 m -59.26 -53.08 62.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.407 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.607 ' O ' ' HG ' ' A' ' 414' ' ' LEU . 2.7 mm? -62.57 -49.08 76.67 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.686 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.502 ' HA2' HD13 ' A' ' 414' ' ' LEU . . . -56.1 -42.2 87.08 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.019 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.601 ' HE3' ' NE2' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.39 -32.44 66.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.68 0.24 . . . . 0.0 111.097 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.806 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.2 mtm -69.55 -46.29 66.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.172 0.511 . . . . 0.0 109.707 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.688 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.06 -40.75 90.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.524 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.944 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 9.2 m -78.12 8.0 5.45 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.744 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.38 31.73 56.47 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.601 ' NE2' ' HE3' ' A' ' 412' ' ' MET . 4.7 mm-40 63.87 44.98 4.56 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 123.942 0.897 . . . . 0.0 111.621 -178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.555 ' ND2' HD21 ' A' ' 421' ' ' LEU . 7.4 t30 -114.07 74.01 0.85 Allowed 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 164.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 412' ' ' MET . 0.5 OUTLIER -51.53 -35.41 40.5 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.32 -2.218 . . . . 0.0 111.288 -171.138 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.529 ' O ' ' HB3' ' A' ' 423' ' ' SER . 39.2 mt-30 -56.65 -50.57 71.69 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -166.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.736 HD12 ' OG ' ' A' ' 415' ' ' SER . 3.1 pp -59.53 -49.16 78.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.723 0.773 . . . . 0.0 110.564 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 412' ' ' MET . 0.7 OUTLIER -59.79 -40.27 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.421 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 48.5 t -59.83 -47.43 85.76 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.507 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.55 -39.51 74.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.961 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 422' ' ' VAL . 1.7 mt -71.92 -42.48 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.387 0.613 . . . . 0.0 110.142 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -57.07 -44.68 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.93 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.612 ' HA ' ' CD2' ' A' ' 430' ' ' LEU . 0.2 OUTLIER -63.51 -27.82 69.53 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-O 122.79 1.281 . . . . 0.0 108.846 -173.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -17.07 77.19 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 112.469 -2.15 . . . . 0.0 112.658 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.714 ' CG ' HG22 ' A' ' 399' ' ' VAL . 9.8 m-85 -99.71 2.43 44.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.612 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.31 144.82 76.75 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-O 123.645 1.688 . . . . 0.0 113.898 170.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.715 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.1 Cg_endo -72.36 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.083 1 C-N-CA 126.333 4.689 . . . . 0.0 113.584 -173.07 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.545 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.98 139.91 15.25 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.255 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.593 ' HA ' HG11 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.61 -29.49 70.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.078 0.439 . . . . 0.0 111.207 -177.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.85 -48.01 79.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.678 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.0 t -58.79 -51.66 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.644 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.62 -55.22 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 52.6 m -61.4 -55.92 26.08 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.246 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.17 -45.5 79.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.668 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.838 ' O ' HD23 ' A' ' 443' ' ' LEU . 43.1 mt -60.38 -53.31 59.12 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.684 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.714 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 32.5 mm-40 -51.58 -34.6 37.76 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 125.174 1.546 . . . . 0.0 110.563 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.637 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.67 -59.9 2.49 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 175.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.72 -51.98 10.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.735 -0.603 . . . . 0.0 112.43 -173.397 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.84 -23.25 60.36 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.043 0.925 . . . . 0.0 111.409 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.746 ' N ' HD22 ' A' ' 443' ' ' LEU . 12.6 t70 -72.23 -42.93 65.16 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.963 -1.472 . . . . 0.0 110.755 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.5 mt-30 -72.08 -8.29 53.76 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -172.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.623 ' HB3' HG21 ' A' ' 451' ' ' THR . 53.1 mm-40 -52.25 155.96 1.83 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 123.366 1.555 . . . . 0.0 114.659 -174.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 451' ' ' THR . 1.9 mp -53.32 -33.76 21.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 111.047 -2.797 . . . . 0.0 115.455 -170.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.563 ' H ' ' HB ' ' A' ' 451' ' ' THR . 15.7 m-20 -141.89 -179.21 6.07 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.929 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.466 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.2 p-10 -61.31 -55.55 30.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.28 -25.23 65.95 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 176.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 446' ' ' GLU . 8.8 m -59.81 -42.69 94.03 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 119.861 1.209 . . . . 0.0 109.705 171.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.513 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 55.7 mtt180 -59.67 -29.91 68.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.513 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.38 -31.26 60.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.797 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -83.88 -45.87 12.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.208 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.541 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 34.0 p -100.61 -2.76 31.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.551 -166.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.626 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.4 t80 -49.04 -52.3 26.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.667 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 23.7 mm -72.05 -25.72 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.35 -42.39 65.38 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.629 ' O ' HG23 ' A' ' 463' ' ' VAL . 52.5 m-70 -67.94 -31.47 71.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.686 -1.597 . . . . 0.0 109.718 172.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.679 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.27 -53.53 42.76 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.09 0.947 . . . . 0.0 109.33 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.637 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.77 -32.0 73.07 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.161 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.47 -52.47 63.38 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.709 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 21.8 t -62.57 -35.22 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 121.899 0.857 . . . . 0.0 110.344 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.3 m-30 -61.61 -14.51 31.18 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.155 170.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 61.5 mm-40 -93.06 -48.57 6.43 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.001 -1.062 . . . . 0.0 112.777 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.709 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.91 -39.0 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.109 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.453 ' HB2' ' CG ' ' A' ' 469' ' ' LEU . 6.5 mt -84.95 -17.12 38.68 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 170.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.727 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.27 53.45 39.54 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 111.698 -2.501 . . . . 0.0 113.161 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.5 OUTLIER -103.55 -170.29 1.76 Allowed 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 123.856 0.863 . . . . 0.0 110.268 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.661 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.8 p30 -109.86 -42.29 4.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.412 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -157.93 -76.41 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.081 158.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.715 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 4.1 mpt_? -62.15 66.74 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -170.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.403 ' HA2' HD11 ' A' ' 469' ' ' LEU . . . 41.05 39.5 2.06 Favored Glycine 0 C--N 1.278 -2.679 0 CA-C-N 111.554 -2.567 . . . . 0.0 113.65 170.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.661 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 10.1 mm-40 -77.76 -51.39 10.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.277 1.037 . . . . 0.0 111.398 -173.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.8 t 64.06 56.1 1.45 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.263 -171.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.727 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -45.17 -53.82 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 110.302 -3.135 . . . . 0.0 111.941 177.18 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.543 ' C ' ' HD2' ' A' ' 477' ' ' ARG . 0.0 OUTLIER -74.3 143.05 45.14 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.842 179.124 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 22.9 tp -49.49 -50.13 42.8 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -167.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.404 ' HB2' ' NE ' ' A' ' 477' ' ' ARG . 42.3 mt-10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.704 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.478 0.587 0 N-CA-C 110.426 -0.644 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.456 HD11 ' N ' ' A' ' 301' ' ' ILE . 3.0 mp -90.94 130.09 40.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.761 0.315 . . . . 0.0 110.19 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.37 -92.18 1.77 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 90.5 m -154.32 127.5 8.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.495 0.664 . . . . 0.0 109.714 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.454 ' H ' HG11 ' A' ' 304' ' ' VAL . 1.8 p -75.92 127.71 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.165 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.68 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.5 mt -76.01 126.97 86.2 Favored Pre-proline 0 N--CA 1.422 -1.831 0 CA-C-O 121.77 0.795 . . . . 0.0 111.803 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -71.26 -15.45 31.63 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 124.708 3.606 . . . . 0.0 110.978 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.725 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.2 tp 30.62 -60.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 128.676 2.791 . . . . 0.0 116.279 172.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.562 ' HG2' HG23 ' A' ' 307' ' ' ILE . 7.1 mm-40 -56.64 -39.16 73.19 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.892 0.853 . . . . 0.0 109.958 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.493 ' HB3' HG11 ' A' ' 338' ' ' VAL . 7.4 t-160 -58.96 -48.51 81.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.866 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 60.1 mt -58.75 -48.52 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 123.96 0.904 . . . . 0.0 113.033 174.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.725 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.0 mtp180 -59.59 -29.83 68.24 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.726 0.41 . . . . 0.0 110.562 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.1 m -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.565 0.697 . . . . 0.0 109.911 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.585 HG13 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.91 -40.52 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.918 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.768 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.39 -36.18 26.98 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.691 1.234 . . . . 0.0 109.57 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.5 9.13 Favored Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.52 -2.127 . . . . 0.0 111.184 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 44.0 mt-10 51.62 173.18 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 124.302 1.041 . . . . 0.0 113.273 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 316' ' ' GLU . 22.6 Cg_exo -44.82 140.38 6.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.011 2.474 . . . . 0.0 112.821 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.512 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 40.3 Cg_endo -89.15 -100.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.42 2.747 . . . . 0.0 113.072 -171.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.497 ' HG2' ' HB2' ' A' ' 318' ' ' PRO . 5.1 mmt180 -98.23 -81.95 0.43 Allowed 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.381 0.61 . . . . 0.0 110.687 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.728 ' OD1' ' HG2' ' A' ' 322' ' ' ARG . 1.8 t30 -111.93 150.12 41.88 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.147 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.699 ' HD2' ' OD1' ' A' ' 320' ' ' ASN . 56.8 Cg_exo -49.14 -53.53 6.87 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.157 2.572 . . . . 0.0 111.692 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.728 ' HG2' ' OD1' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -63.24 -13.34 36.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.26 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.571 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 30.4 mt-10 -83.16 -28.01 29.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 171.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.641 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -48.39 -44.74 65.75 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.665 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.9 Cg_endo -50.21 -59.98 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.754 2.303 . . . . 0.0 112.965 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.588 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -64.75 -34.06 67.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.345 0 CA-C-O 122.9 1.333 . . . . 0.0 110.067 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.768 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 39.5 t90 -57.2 -38.62 73.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.073 -1.876 . . . . 0.0 110.718 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.469 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -67.71 -47.34 69.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-O 120.693 0.283 . . . . 0.0 111.688 -175.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.27 -23.05 16.37 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.88 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.653 ' HD3' ' OE1' ' A' ' 402' ' ' GLU . 3.2 mmm-85 -72.89 -43.9 61.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.735 0.779 . . . . 0.0 111.152 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.559 ' HB2' HG21 ' A' ' 314' ' ' THR . 1.5 p30 -103.02 -17.65 15.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.533 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.29 -49.75 6.51 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 174.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 43.0 Cg_endo -62.76 -32.34 78.16 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.566 2.177 . . . . 0.0 111.612 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.468 ' CB ' HG12 ' A' ' 313' ' ' VAL . . . -73.13 -42.83 62.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.314 -1.766 . . . . 0.0 109.839 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.584 HG12 HG22 ' A' ' 310' ' ' ILE . 89.7 mt -58.65 -48.66 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.362 173.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.87 -15.03 4.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.846 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.68 -50.16 5.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 309' ' ' HIS . 99.2 t -55.42 -71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 123.742 1.734 . . . . 0.0 109.796 169.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.758 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.8 OUTLIER -89.44 128.7 50.03 Favored Pre-proline 0 N--CA 1.397 -3.116 0 CA-C-N 110.537 -3.028 . . . . 0.0 111.9 -173.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.758 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.7 Cg_endo -72.92 -16.72 25.8 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 C-N-CA 123.548 2.832 . . . . 0.0 110.075 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.586 HG23 ' CB ' ' A' ' 346' ' ' LEU . 4.6 p 31.9 69.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.584 ' N ' HD13 ' A' ' 346' ' ' LEU . 39.6 p -79.2 6.33 10.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.671 -2.058 . . . . 0.0 113.408 -167.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.772 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -140.73 164.49 36.09 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.415 ' HB3' HD21 ' A' ' 369' ' ' LEU . 47.4 Cg_exo -64.32 -47.81 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.646 2.897 . . . . 0.0 108.655 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.604 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 1.0 OUTLIER -44.81 -48.84 11.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.076 177.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.772 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.5 mt -57.86 -50.97 71.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.902 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.445 ' HG2' HG22 ' A' ' 341' ' ' VAL . 55.0 mtt180 -48.4 -48.0 37.29 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.298 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.933 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -70.13 -48.39 57.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.728 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 84.0 mtt180 -57.4 -40.81 79.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.079 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.642 ' O ' HG12 ' A' ' 354' ' ' ILE . 48.0 mt -57.89 -53.13 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.497 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.515 ' HA ' HG13 ' A' ' 354' ' ' ILE . 26.0 mt -59.0 -52.5 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-O 122.117 0.96 . . . . 0.0 111.122 -170.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.576 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 13.6 m-20 -62.53 -35.95 81.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.938 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 307' ' ' ILE . . . -69.33 -34.75 75.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.244 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.642 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.66 -54.87 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-O 123.021 1.391 . . . . 0.0 110.515 173.162 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.601 HD12 ' HB ' ' A' ' 354' ' ' ILE . 1.1 mp -72.37 -25.7 61.62 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.777 -2.465 . . . . 0.0 109.1 -168.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 68.25 -76.74 0.25 Allowed Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 113.607 -1.633 . . . . 0.0 113.326 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -124.61 69.1 0.49 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.112 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.559 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 30.8 p30 -86.74 163.86 17.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.503 0.321 . . . . 0.0 110.994 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.473 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -53.43 -59.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 122.92 0.488 . . . . 0.0 111.494 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -160.51 16.08 0.19 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.624 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.564 ' HB3' HD13 ' A' ' 378' ' ' LEU . 3.1 mt -67.33 -3.74 8.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.307 0.643 . . . . 0.0 111.189 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.576 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.3 t -62.52 81.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.711 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.454 HD23 ' CG2' ' A' ' 377' ' ' THR . 0.6 OUTLIER -61.93 174.35 0.87 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.83 0.824 . . . . 0.0 113.019 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.4 p -117.52 157.96 46.29 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.151 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.842 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.4 Cg_endo -49.46 -30.23 20.36 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.556 1.504 . . . . 0.0 112.236 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.508 ' O ' HD12 ' A' ' 369' ' ' LEU . . . -96.36 0.53 61.8 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.811 1.085 . . . . 0.0 115.811 -170.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.417 ' HB2' HD13 ' A' ' 363' ' ' LEU . 6.4 m-20 -109.3 -18.37 13.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.686 1.243 . . . . 0.0 110.443 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.933 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 5.0 t -109.95 21.74 16.47 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.328 -165.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 366' ' ' GLY . 2.1 mt -60.04 -29.51 68.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.861 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 6.0 p -114.56 159.96 19.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.221 -1.809 . . . . 0.0 109.771 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.498 ' O ' HG11 ' A' ' 375' ' ' VAL . 31.0 m95 -70.28 -34.83 73.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.531 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -63.29 -44.84 93.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.887 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 t -68.44 -42.85 78.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.466 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.28 -53.13 60.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.531 HG23 ' HE1' ' A' ' 413' ' ' MET . 15.8 m -57.37 -44.96 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.759 0.79 . . . . 0.0 109.259 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.701 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -59.81 -45.75 91.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.634 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 29.5 m -66.76 -39.75 88.01 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.088 -172.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.595 ' O ' ' HB2' ' A' ' 381' ' ' ARG . 0.1 OUTLIER -60.16 -34.49 73.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.984 1.265 . . . . 0.0 109.832 177.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.665 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 62.1 t80 -72.1 -47.5 50.84 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.494 1.14 . . . . 0.0 109.288 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.631 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 112.469 -2.151 . . . . 0.0 111.407 171.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.5 OUTLIER -59.48 -36.19 75.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 123.219 0.608 . . . . 0.0 111.243 176.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 34.1 p -102.34 -22.09 14.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.799 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -109.49 23.1 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.25 16.22 26.29 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.448 -0.406 . . . . 0.0 114.034 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 64.68 158.23 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.996 0.518 . . . . 0.0 111.355 -175.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.444 ' HZ ' ' HB3' ' A' ' 414' ' ' LEU . 0.2 OUTLIER -124.65 154.05 70.07 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 389' ' ' HIS . 93.9 Cg_endo -100.07 59.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.703 2.935 . . . . 0.0 111.209 165.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.586 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.43 -1.24 0.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -175.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 387' ' ' PRO . 5.8 t60 -69.89 -48.31 59.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.892 176.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.63 ' O ' HG11 ' A' ' 394' ' ' VAL . 57.9 mt-30 -74.08 -25.43 59.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -169.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.793 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.86 -30.77 47.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.7 0.682 . . . . 0.0 111.657 -175.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.595 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.19 -49.69 62.4 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.549 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.582 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 29.9 m-20 -68.74 -39.88 80.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.774 0.43 . . . . 0.0 112.135 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.65 -44.89 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.619 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -57.76 -46.77 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.484 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.3 mmtt -52.23 -44.46 64.84 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.819 0.819 . . . . 0.0 111.365 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.05 17.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.191 -172.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.665 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 3.9 mt -68.93 -41.51 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 117.156 0.478 . . . . 0.0 111.379 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.731 HG23 ' CG ' ' A' ' 429' ' ' TYR . 5.5 m -57.85 -44.97 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.615 0.721 . . . . 0.0 110.032 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.47 ' N ' HG21 ' A' ' 399' ' ' VAL . 5.7 t70 -65.97 -37.75 86.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.412 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.67 -51.71 6.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.655 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.0 OUTLIER -108.95 -29.48 8.57 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.369 -170.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 125.7 160.56 10.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.598 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.619 ' HA ' HG11 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.24 -42.96 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -176.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HB1' HG22 ' A' ' 457' ' ' ILE . . . -57.04 -50.47 72.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.312 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -63.21 -51.3 66.85 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.665 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -41.97 65.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.544 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 55.0 t80 -59.24 -44.99 92.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.442 0.639 . . . . 0.0 109.524 176.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.757 ' O ' ' HG3' ' A' ' 413' ' ' MET . 4.6 m -60.45 -52.55 64.73 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.49 -178.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.613 HD11 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -61.69 -48.58 80.12 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.713 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.516 ' HA2' HD11 ' A' ' 414' ' ' LEU . . . -55.72 -43.75 86.58 Favored Glycine 0 C--N 1.313 -0.745 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.348 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.601 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.2 OUTLIER -72.3 -31.72 65.95 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.821 0.311 . . . . 0.0 110.975 179.067 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.757 ' HG3' ' O ' ' A' ' 409' ' ' THR . 65.2 mtm -69.12 -47.87 63.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.176 0.513 . . . . 0.0 109.915 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.701 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 14.6 mt -58.66 -39.83 81.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.159 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.793 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.4 OUTLIER -77.65 -14.54 59.6 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.741 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.8 32.37 7.63 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.135 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.601 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 71.35 38.53 1.03 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.54 0.736 . . . . 0.0 112.149 176.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.766 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.2 OUTLIER -119.99 77.99 1.3 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 165.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.497 ' O ' HG22 ' A' ' 422' ' ' VAL . 2.9 p90 -62.18 -32.6 73.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.416 -2.174 . . . . 0.0 110.501 -162.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.428 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 31.8 mt-30 -55.11 -46.98 75.61 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.171 0.989 . . . . 0.0 113.359 -164.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.732 HD12 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -60.06 -51.22 70.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.635 0.731 . . . . 0.0 110.777 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.589 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -59.83 -38.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 123.054 1.407 . . . . 0.0 108.893 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 419' ' ' TYR . 1.1 t -61.8 -46.79 88.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 111.891 -2.413 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.64 89.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.111 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.52 HD13 ' HA ' ' A' ' 422' ' ' VAL . 2.1 mt -71.25 -41.25 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.57 0.7 . . . . 0.0 109.672 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.484 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -56.77 -46.73 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.596 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.549 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.19 -30.18 68.01 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.518 1.151 . . . . 0.0 109.526 -175.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.43 -16.59 77.42 Favored Glycine 0 C--N 1.298 -1.57 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.595 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.731 ' CG ' HG23 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.96 0.03 40.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.549 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.65 145.05 71.37 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 123.626 1.679 . . . . 0.0 113.268 170.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.652 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.2 Cg_endo -71.24 -58.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 1 C-N-CA 126.22 4.613 . . . . 0.0 113.147 -173.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.534 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -110.97 139.35 15.5 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.407 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.607 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.23 -27.95 69.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.091 0.446 . . . . 0.0 111.286 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.44 -47.93 80.5 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.668 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.0 t -58.6 -51.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.676 177.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.94 -53.43 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.469 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 64.8 m -62.18 -56.33 19.82 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.914 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.11 -45.64 79.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.532 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.866 ' O ' HD21 ' A' ' 443' ' ' LEU . 42.7 mt -59.61 -53.77 54.26 Favored 'General case' 0 CA--C 1.481 -1.695 0 C-N-CA 120.276 -0.569 . . . . 0.0 110.619 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.79 -34.56 40.44 Favored 'General case' 0 N--CA 1.416 -2.143 0 O-C-N 125.073 1.483 . . . . 0.0 110.596 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.91 -60.99 1.97 Allowed 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 176.249 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.2 OUTLIER -76.3 -51.44 11.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.894 -0.504 . . . . 0.0 112.232 -172.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.866 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.62 -24.49 61.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.622 0.725 . . . . 0.0 111.735 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.721 ' N ' HD23 ' A' ' 443' ' ' LEU . 21.2 t70 -71.71 -42.76 66.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.662 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.4 mt-30 -69.48 -7.86 41.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.612 ' HB3' HG22 ' A' ' 451' ' ' THR . 43.5 mm-40 -51.7 160.08 0.7 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 123.721 1.724 . . . . 0.0 114.501 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.8 mp -56.32 -33.32 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 110.626 -2.988 . . . . 0.0 115.403 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.554 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 48.4 m-20 -142.78 -178.67 5.91 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -63.66 -56.59 14.62 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -25.11 67.87 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 176.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.612 HG22 ' HB3' ' A' ' 446' ' ' GLU . 17.8 m -59.34 -42.68 92.05 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 119.493 1.042 . . . . 0.0 109.889 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 53.0 mtt180 -61.34 -30.0 70.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.544 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -30.93 59.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.971 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -80.86 -45.17 17.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.416 1.103 . . . . 0.0 111.498 -172.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.488 ' HG1' ' HG3' ' A' ' 446' ' ' GLU . 43.7 p -101.36 -4.34 27.14 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.894 -167.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.647 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.5 t80 -49.01 -52.09 27.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.661 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.59 HG22 ' HB1' ' A' ' 405' ' ' ALA . 27.0 mm -70.95 -27.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.16 -42.73 65.58 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.639 ' O ' HG21 ' A' ' 463' ' ' VAL . 75.8 m-70 -67.03 -30.97 71.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.75 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.697 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -65.59 -53.7 38.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.207 1.003 . . . . 0.0 109.23 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.648 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.4 m-80 -61.94 -32.39 72.81 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.071 172.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.71 -52.73 62.11 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.002 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.713 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 21.9 t -62.78 -34.89 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 121.858 0.837 . . . . 0.0 110.32 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.7 m-30 -61.63 -15.13 36.81 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.014 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 45.7 mm-40 -91.16 -49.52 6.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.941 -1.099 . . . . 0.0 112.696 176.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.713 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.24 -39.77 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.997 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.453 HD11 HD11 ' A' ' 469' ' ' LEU . 6.6 mt -84.44 -16.61 42.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.784 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.88 50.02 60.32 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 111.855 -2.43 . . . . 0.0 113.599 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.3 OUTLIER -103.68 -179.28 3.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 123.877 0.871 . . . . 0.0 110.244 -179.156 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.691 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.0 p30 -102.1 -40.27 6.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 168.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -160.56 -76.51 0.06 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 112.524 -2.125 . . . . 0.0 111.052 158.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.652 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -60.07 69.26 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -171.139 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 37.39 40.37 0.63 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 110.738 -2.937 . . . . 0.0 113.654 174.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.691 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.3 mm-40 -77.67 -53.62 7.34 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.098 0.951 . . . . 0.0 111.784 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 67.9 55.08 0.59 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 112.084 -2.325 . . . . 0.0 108.833 -174.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.784 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -51.25 -49.67 29.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 110.84 -2.891 . . . . 0.0 111.833 176.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -50.89 136.12 23.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.434 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.43 -27.82 67.78 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.627 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.434 -1.272 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.07 176.216 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo . . . . . 0 N--CA 1.477 0.545 0 N-CA-C 110.143 -0.753 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.5 mp -86.63 -52.66 11.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -142.11 54.27 0.61 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.653 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 41.5 m 71.89 117.72 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 122.181 0.991 . . . . 0.0 112.155 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.95 129.86 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.381 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.691 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 22.6 mt -75.05 126.27 88.3 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-O 121.945 0.878 . . . . 0.0 112.698 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.57 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.0 Cg_endo -83.37 49.56 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.819 3.679 . . . . 0.0 109.522 167.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.767 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -42.49 -42.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.555 -2.111 . . . . 0.0 112.665 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.431 ' N ' HG21 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -65.25 -36.99 85.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.241 0.543 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.507 ' HB3' HG12 ' A' ' 338' ' ' VAL . 6.6 t-160 -62.7 -47.49 83.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.357 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.562 HG22 ' CG2' ' A' ' 350' ' ' ILE . 62.3 mt -58.74 -49.88 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.767 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.3 mtp180 -62.11 -29.95 70.68 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 110.683 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.0 m -69.71 -33.78 72.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.37 0.605 . . . . 0.0 110.072 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.24 -40.05 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.982 178.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.646 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.14 -36.93 26.94 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.74 1.257 . . . . 0.0 109.677 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.44 32.19 9.73 Favored Glycine 0 C--N 1.305 -1.14 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.803 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 25.5 mt-10 51.8 169.54 0.04 OUTLIER Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 124.626 1.17 . . . . 0.0 113.83 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.509 ' HB3' HD13 ' A' ' 324' ' ' ILE . 52.7 Cg_exo -46.19 148.53 3.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.469 2.779 . . . . 0.0 114.203 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.47 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 40.3 Cg_endo -91.86 -99.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.851 3.034 . . . . 0.0 112.746 -174.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 6.5 mmm180 -97.83 -83.09 0.41 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.154 0.502 . . . . 0.0 110.828 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.453 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 16.9 m-20 -102.67 163.57 17.34 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.467 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.4 Cg_exo -59.72 -47.41 16.12 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.708 2.272 . . . . 0.0 110.379 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.447 ' H ' ' HG3' ' A' ' 322' ' ' ARG . 81.2 mtt180 -48.65 -28.76 3.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.815 -1.993 . . . . 0.0 112.8 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.85 -23.16 22.87 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.801 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.699 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.2 OUTLIER -50.02 -42.39 70.44 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.708 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 7.5 Cg_endo -48.62 -61.52 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.848 2.365 . . . . 0.0 112.829 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.627 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -61.51 -36.79 75.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-O 122.667 1.222 . . . . 0.0 110.384 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.742 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 54.6 t90 -58.75 -40.72 84.68 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.48 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.467 ' HB3' HG13 ' A' ' 375' ' ' VAL . 0.5 OUTLIER -68.45 -50.12 54.86 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.559 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -53.46 -23.23 18.59 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.742 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 1.5 ttt-85 -72.77 -41.61 64.87 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 114.442 -0.879 . . . . 0.0 112.321 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.537 ' HB2' HG21 ' A' ' 314' ' ' THR . 1.4 p30 -106.74 -16.92 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.53 ' N ' ' HD2' ' A' ' 333' ' ' PRO . . . -40.17 -48.01 6.04 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 37.8 Cg_endo -60.49 -32.72 94.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.536 2.157 . . . . 0.0 111.555 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.495 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -72.7 -43.21 63.33 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.658 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.545 HG12 HG23 ' A' ' 310' ' ' ILE . 89.4 mt -58.37 -49.52 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.754 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.33 -14.57 7.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.044 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.66 6.43 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.364 175.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 306' ' ' PRO . 91.2 t -56.99 -70.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 123.698 1.713 . . . . 0.0 110.154 168.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.76 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.7 OUTLIER -92.43 130.6 36.85 Favored Pre-proline 0 N--CA 1.402 -2.864 0 CA-C-N 110.629 -2.987 . . . . 0.0 112.11 -173.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.76 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.7 Cg_endo -74.91 -17.42 19.79 Favored 'Trans proline' 0 CA--C 1.496 -1.394 0 C-N-CA 123.731 2.954 . . . . 0.0 110.631 174.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.496 HG22 ' CB ' ' A' ' 346' ' ' LEU . 2.6 p 34.08 67.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 112.216 -2.266 . . . . 0.0 110.107 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.602 ' N ' HD12 ' A' ' 346' ' ' LEU . 35.8 p -78.25 3.17 16.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 112.453 -2.158 . . . . 0.0 113.194 -170.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.781 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 10.2 p -137.93 164.13 43.06 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -63.8 -49.94 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.265 2.644 . . . . 0.0 108.329 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.724 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -43.6 -48.69 7.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.982 176.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.781 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.7 mt -56.18 -51.99 66.01 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.521 0.677 . . . . 0.0 110.166 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 2.1 ttm180 -54.9 -47.03 74.87 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.556 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 1.037 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.45 -48.16 61.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.179 0.514 . . . . 0.0 111.193 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.2 mtp180 -56.45 -41.1 75.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.244 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.669 ' O ' HG12 ' A' ' 354' ' ' ILE . 42.6 mt -58.63 -54.37 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.492 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.64 ' O ' HD23 ' A' ' 355' ' ' LEU . 20.8 mt -57.71 -54.04 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.952 0.882 . . . . 0.0 110.87 -168.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.473 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -63.95 -34.79 78.76 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.989 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.6 -34.42 74.08 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.336 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 350' ' ' ILE 0.252 1.0 OUTLIER -56.58 -55.32 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 CA-C-O 122.982 1.372 . . . . 0.0 110.523 175.289 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.699 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -73.06 -27.63 61.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.668 -2.514 . . . . 0.0 110.154 -169.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 39.41 75.35 0.1 Allowed Glycine 0 CA--C 1.524 0.63 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.851 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 112.85 25.08 4.66 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.86 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.756 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 3.9 p-10 -75.14 136.91 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.99 0.424 . . . . 0.0 111.365 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.535 ' N ' HD11 ' A' ' 359' ' ' ILE . 2.1 mp -71.77 98.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.999 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.76 -21.55 4.6 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.221 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.756 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 5.8 mt -61.59 -6.38 2.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 122.939 0.496 . . . . 0.0 112.195 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.473 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 20.7 t -61.06 81.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.217 0.532 . . . . 0.0 110.427 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.449 HD22 ' CD2' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -62.5 169.25 3.09 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.136 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 366' ' ' GLY . 69.5 p -111.75 161.4 25.8 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.329 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 1.037 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.2 Cg_endo -63.57 7.07 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.202 1.935 . . . . 0.0 112.747 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -117.23 -12.32 8.32 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.689 -0.687 . . . . 0.0 114.679 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.41 ' HB2' HD11 ' A' ' 363' ' ' LEU . 45.9 m-20 -105.67 -20.43 13.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.509 1.147 . . . . 0.0 109.804 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 7.6 p -82.91 20.04 1.26 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.431 -1.713 . . . . 0.0 112.805 -169.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.59 ' N ' HD11 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -58.03 -34.83 70.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 122.288 1.042 . . . . 0.0 110.067 -168.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.1 t -130.62 163.67 26.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.202 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.601 ' O ' HG12 ' A' ' 375' ' ' VAL . 55.4 m95 -70.36 -36.59 74.28 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.535 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.4 p30 -63.38 -39.37 94.34 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.439 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 48.1 t -66.36 -42.89 87.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.053 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -68.35 -51.81 40.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 371' ' ' TRP . 11.9 m -56.88 -45.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.144 0.497 . . . . 0.0 110.087 -178.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.672 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.09 -43.1 95.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.684 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.469 ' O ' ' HD3' ' A' ' 381' ' ' ARG . 40.2 m -68.5 -42.68 78.25 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.558 -173.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -58.74 -34.02 70.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.419 0.554 . . . . 0.0 110.671 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.708 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.6 t80 -73.68 -47.34 40.45 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.501 1.144 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.64 -32.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 CA-C-N 112.678 -2.055 . . . . 0.0 111.336 170.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.631 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -60.29 -41.99 94.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.682 175.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.3 p -97.4 -23.42 16.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.772 -168.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -110.5 22.91 14.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.75 21.73 23.49 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.315 0.486 . . . . 0.0 114.315 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.2 m 67.01 160.05 0.15 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.225 0.536 . . . . 0.0 111.328 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -125.31 156.17 70.4 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -97.94 54.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.415 2.743 . . . . 0.0 111.306 165.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.607 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.51 4.21 0.22 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.09 -47.45 61.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.014 0.435 . . . . 0.0 110.585 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.608 ' O ' HG12 ' A' ' 394' ' ' VAL . 75.7 mt-30 -71.47 -27.48 63.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -169.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.836 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.84 -31.18 59.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.59 0.632 . . . . 0.0 111.925 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.653 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -50.09 59.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.476 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.464 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.3 m-20 -68.58 -39.43 80.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.661 0.384 . . . . 0.0 112.002 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.55 -45.92 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.245 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.788 ' O ' HG22 ' A' ' 399' ' ' VAL . 5.9 mm -58.69 -47.27 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.615 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 34.8 mmtt -51.42 -42.61 61.61 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 124.077 0.861 . . . . 0.0 111.486 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.52 -44.11 13.78 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.921 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.68 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 1.8 mt -69.2 -40.73 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 117.5 0.65 . . . . 0.0 111.543 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 395' ' ' ILE . 0.8 OUTLIER -59.35 -42.81 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 109.506 -178.43 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.4 ' N ' HG21 ' A' ' 399' ' ' VAL . 17.1 t70 -63.63 -39.23 93.84 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.087 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -85.66 -53.41 5.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.281 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.547 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -110.64 -32.16 6.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.561 0.696 . . . . 0.0 111.747 -170.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.01 163.13 11.48 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.682 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.596 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -56.07 -49.81 72.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.164 0.507 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.644 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.76 -50.69 65.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.557 177.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.68 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.53 -44.18 65.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.514 ' HE1' ' OG ' ' A' ' 423' ' ' SER . 26.9 t80 -54.81 -46.44 74.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.779 0.799 . . . . 0.0 109.082 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.76 ' O ' ' HG3' ' A' ' 413' ' ' MET . 18.4 m -58.55 -52.02 67.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.958 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.627 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -61.99 -49.09 77.47 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.958 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.469 ' HA2' HD11 ' A' ' 414' ' ' LEU . . . -56.11 -43.28 88.59 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.805 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.555 ' HA ' HG12 ' A' ' 422' ' ' VAL . 0.1 OUTLIER -71.29 -32.94 69.25 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.728 0.264 . . . . 0.0 110.673 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.76 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.6 mtm -68.82 -46.2 69.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.923 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.672 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 18.5 mt -60.2 -43.35 96.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.292 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.836 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 1.9 m -80.63 7.15 10.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 70.81 46.78 43.59 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.857 171.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.534 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 62.3 42.12 9.61 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 123.87 0.868 . . . . 0.0 111.616 177.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.566 ' ND2' HD23 ' A' ' 421' ' ' LEU . 22.3 t30 -113.17 83.21 1.79 Allowed 'General case' 0 CA--C 1.476 -1.878 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 163.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.599 ' HD2' ' OG ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -57.09 -36.93 71.2 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.821 -174.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.431 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 41.6 mt-30 -57.29 -51.56 68.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -163.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.757 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 1.7 pt? -60.02 -49.23 78.48 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.392 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.757 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.77 -38.42 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.685 1.231 . . . . 0.0 108.894 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.599 ' OG ' ' HD2' ' A' ' 419' ' ' TYR . 43.6 m -65.31 -41.13 94.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.31 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.83 86.97 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.787 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 422' ' ' VAL . 1.7 mt -71.46 -40.71 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.597 0.713 . . . . 0.0 109.813 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -56.78 -44.67 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.58 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.511 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -57.4 -33.09 67.49 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 124.87 1.268 . . . . 0.0 109.245 -176.137 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.467 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.57 -15.01 77.52 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 112.992 -1.913 . . . . 0.0 112.448 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.75 ' CG ' HG23 ' A' ' 399' ' ' VAL . 9.0 m-85 -102.77 1.12 33.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.531 HD13 ' HD2' ' A' ' 431' ' ' PRO . 3.8 mm? -57.58 142.01 78.06 Favored Pre-proline 0 N--CA 1.41 -2.464 0 CA-C-O 123.645 1.688 . . . . 0.0 113.333 170.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.738 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 53.1 Cg_endo -68.95 -57.35 0.13 Allowed 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.564 4.843 . . . . 0.0 113.316 -169.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.577 ' O ' HG11 ' A' ' 436' ' ' VAL . . . -112.62 140.72 16.45 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.736 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.612 ' HA ' ' CG1' ' A' ' 436' ' ' VAL . 0.0 OUTLIER -59.44 -32.43 70.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.688 0.744 . . . . 0.0 111.651 -175.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -55.02 -48.43 73.39 Favored 'General case' 0 CA--C 1.509 -0.635 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.569 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.9 t -62.39 -36.76 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.337 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.612 ' CG1' ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -71.1 -45.98 69.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 45.4 m -72.27 -54.92 8.13 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.359 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.82 76.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.772 ' O ' HD22 ' A' ' 443' ' ' LEU . 20.1 mt -66.61 -54.49 22.91 Favored 'General case' 0 CA--C 1.465 -2.3 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.733 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.616 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.22 -33.54 28.29 Favored 'General case' 0 N--CA 1.405 -2.715 0 O-C-N 125.781 1.926 . . . . 0.0 109.944 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -72.95 -60.74 2.09 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -71.55 -48.73 46.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.126 0.488 . . . . 0.0 111.472 -171.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -60.22 -25.97 66.03 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.458 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.713 ' N ' HD21 ' A' ' 443' ' ' LEU . 12.0 t70 -73.09 -42.01 63.46 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.33 1.062 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -68.79 -8.31 42.14 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -171.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.598 ' HB3' HG22 ' A' ' 451' ' ' THR . 47.1 mm-40 -51.78 156.97 1.28 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.518 1.628 . . . . 0.0 115.058 -176.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.7 mp -52.92 -31.98 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 110.506 -3.043 . . . . 0.0 115.665 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.56 ' H ' ' HB ' ' A' ' 451' ' ' THR . 55.2 m-20 -140.81 178.9 7.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.407 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 7.6 p-10 -61.78 -56.3 20.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -67.49 -24.97 65.64 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 446' ' ' GLU . 19.2 m -57.78 -41.05 81.27 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.774 1.17 . . . . 0.0 109.932 171.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 62.5 mtt180 -60.97 -30.57 70.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 450' ' ' GLN . . . -76.09 -31.44 58.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.35 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.8 mm-40 -81.29 -45.68 15.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.474 1.13 . . . . 0.0 111.883 -172.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.469 ' HG1' ' HG3' ' A' ' 446' ' ' GLU . 47.2 p -98.95 -2.3 37.82 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.772 -167.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.63 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -48.89 -55.57 11.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.932 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 27.6 mm -70.23 -25.42 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.478 ' O ' ' HB1' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -73.0 -43.21 62.43 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.566 ' O ' HG22 ' A' ' 463' ' ' VAL . 65.9 m-70 -66.15 -32.19 73.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.261 171.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.703 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.18 -53.69 45.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.308 1.051 . . . . 0.0 109.34 -178.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.655 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.9 m-80 -62.6 -32.03 72.96 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.3 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.36 -52.55 63.16 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.035 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.745 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 34.5 t -63.26 -33.57 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-O 121.802 0.81 . . . . 0.0 110.56 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.4 m-30 -62.54 -15.26 49.8 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.309 168.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 22.4 mm-40 -92.25 -49.31 6.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.007 -1.058 . . . . 0.0 112.64 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.63 -40.16 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.67 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.483 ' HB3' HD21 ' A' ' 469' ' ' LEU . 5.3 mt -84.6 -16.67 41.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.747 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.75 51.79 50.91 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 111.681 -2.509 . . . . 0.0 113.171 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.4 OUTLIER -103.3 -178.12 3.57 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.723 0.809 . . . . 0.0 110.268 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.575 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 10.8 p30 -101.39 -41.95 6.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 167.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.92 -75.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.322 159.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.738 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 1.3 mpt_? -63.77 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -168.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 40.09 42.16 2.25 Favored Glycine 0 C--N 1.277 -2.72 0 CA-C-N 111.352 -2.658 . . . . 0.0 113.417 173.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.575 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 4.6 mm-40 -81.55 -49.64 10.32 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-O 122.306 1.05 . . . . 0.0 111.278 -172.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 46.8 t 62.1 57.69 1.99 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.346 -2.207 . . . . 0.0 108.433 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.747 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.2 OUTLIER -49.98 -47.1 23.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 110.934 -2.848 . . . . 0.0 111.418 175.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -55.49 133.24 50.0 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.092 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.7 -26.04 67.79 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.514 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.437 -1.089 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.869 179.377 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.477 0.512 0 N-CA-C 110.656 -0.555 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 301' ' ' ILE . 2.4 mp -84.78 115.31 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 141.23 172.42 13.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.864 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 43.6 m -80.2 118.64 22.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.648 0.737 . . . . 0.0 111.239 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.425 ' H ' HG12 ' A' ' 304' ' ' VAL . 1.5 p -69.0 125.87 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.728 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.675 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -75.1 126.66 87.8 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-O 122.005 0.907 . . . . 0.0 111.731 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.5 ' HG2' HG12 ' A' ' 338' ' ' VAL . 18.6 Cg_endo -72.18 -10.84 26.39 Favored 'Trans proline' 0 CA--C 1.498 -1.307 0 C-N-CA 124.755 3.637 . . . . 0.0 111.298 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.701 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.8 tp 25.12 -61.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 O-C-N 127.13 2.769 . . . . 0.0 116.063 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 306' ' ' PRO . 0.0 OUTLIER -58.37 -32.78 68.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.196 0.522 . . . . 0.0 110.396 178.308 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.512 ' HB3' HG13 ' A' ' 338' ' ' VAL . 6.6 t-160 -62.27 -48.71 78.71 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.609 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 59.8 mt -58.32 -48.87 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 C-N-CA 123.982 0.913 . . . . 0.0 112.78 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.701 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 10.5 mtp180 -61.29 -30.48 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 122.141 -0.349 . . . . 0.0 110.827 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 53.1 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.62 0.724 . . . . 0.0 109.962 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.1 -40.89 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.748 178.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.729 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 32.3 p -82.67 -36.32 26.05 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.941 1.353 . . . . 0.0 109.531 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.64 33.54 8.42 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 112.183 -2.281 . . . . 0.0 110.938 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.1 mt-10 50.68 174.66 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 124.339 1.055 . . . . 0.0 113.029 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.524 ' HB3' HD11 ' A' ' 324' ' ' ILE . 42.6 Cg_exo -46.09 145.81 4.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.374 2.05 . . . . 0.0 112.467 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -87.65 -99.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.343 2.695 . . . . 0.0 112.451 -171.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -100.82 -76.57 0.56 Allowed 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.723 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.599 ' HB3' ' HG3' ' A' ' 323' ' ' GLU . 1.3 t30 -109.88 150.8 41.85 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.004 -173.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.597 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 47.7 Cg_exo -53.88 -52.83 7.53 Favored 'Trans proline' 0 CA--C 1.504 -1.024 0 C-N-CA 123.04 2.493 . . . . 0.0 111.52 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.53 ' HD2' ' HB ' ' A' ' 382' ' ' THR . 0.0 OUTLIER -59.18 -15.93 17.55 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.052 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.599 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 5.5 mt-10 -81.22 -25.85 36.35 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -48.58 -44.48 66.87 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.739 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -51.2 -61.9 0.47 Allowed 'Trans proline' 0 CA--C 1.518 -0.308 0 C-N-CA 122.697 2.265 . . . . 0.0 113.159 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.62 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.64 -35.59 60.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 122.919 1.343 . . . . 0.0 110.153 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.821 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 42.7 t90 -59.78 -38.5 82.05 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.88 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.5 OUTLIER -69.2 -50.6 45.94 Favored 'General case' 0 N--CA 1.407 -2.604 0 O-C-N 121.863 -0.523 . . . . 0.0 112.396 -175.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.551 ' HA3' ' HE2' ' A' ' 413' ' ' MET . . . -53.94 -22.87 21.16 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.821 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 10.7 ttp85 -71.76 -42.46 67.17 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 113.862 -1.169 . . . . 0.0 112.166 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.548 ' HB2' HG23 ' A' ' 314' ' ' THR . 0.8 OUTLIER -108.3 -15.44 14.47 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.099 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 333' ' ' PRO . . . -40.37 -47.97 6.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 32.1 Cg_endo -59.16 -34.94 98.61 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.557 175.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.495 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -71.94 -42.62 66.4 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.771 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.572 HG12 HG23 ' A' ' 310' ' ' ILE . 88.5 mt -58.87 -49.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.663 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.2 -16.87 5.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.895 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.2 -50.7 5.33 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.17 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.512 HG13 ' HB3' ' A' ' 309' ' ' HIS . 92.0 t -54.61 -69.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 123.541 1.639 . . . . 0.0 110.176 170.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.775 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.6 OUTLIER -94.51 129.39 36.79 Favored Pre-proline 0 N--CA 1.401 -2.923 0 CA-C-N 110.958 -2.837 . . . . 0.0 112.162 -172.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.775 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.3 Cg_endo -75.5 -16.0 19.38 Favored 'Trans proline' 0 CA--C 1.497 -1.367 0 C-N-CA 123.892 3.061 . . . . 0.0 110.503 174.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.478 HG21 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.43 68.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.943 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.63 ' N ' HD11 ' A' ' 346' ' ' LEU . 31.0 p -81.0 10.58 4.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.623 -2.08 . . . . 0.0 113.468 -169.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.776 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.3 p -143.71 162.52 41.09 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.42 -49.34 6.05 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.208 2.606 . . . . 0.0 108.214 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.755 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -46.02 -44.12 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.904 -1.953 . . . . 0.0 111.292 178.036 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.776 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.0 mt -58.59 -52.03 67.38 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.382 0.61 . . . . 0.0 110.746 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.67 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 32.6 ttm105 -53.92 -44.85 70.94 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.31 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.92 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.04 -47.4 65.47 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 111.086 -176.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.68 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 94.0 mtt180 -57.51 -41.76 81.46 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.036 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.666 ' O ' HG12 ' A' ' 354' ' ' ILE . 44.8 mt -58.0 -53.77 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.528 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.479 ' HA ' HG13 ' A' ' 354' ' ' ILE . 20.6 mt -58.69 -52.84 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.096 0.951 . . . . 0.0 110.815 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.531 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -63.36 -35.32 79.99 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.049 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 307' ' ' ILE . . . -69.23 -34.51 74.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 112.076 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.26 -55.09 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.833 1.302 . . . . 0.0 110.5 174.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.623 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -72.7 -26.79 61.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 111.693 -2.503 . . . . 0.0 109.297 -168.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 34.71 60.68 0.63 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.705 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 117.57 74.17 0.49 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.342 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.579 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 20.6 p30 -119.53 168.89 10.54 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 122.668 0.387 . . . . 0.0 110.432 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.498 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -52.84 -61.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 122.991 0.516 . . . . 0.0 111.517 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -156.44 14.05 0.36 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.05 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.579 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 5.1 mt -66.74 -4.81 9.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 122.934 0.494 . . . . 0.0 111.953 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.531 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 33.9 t -60.71 87.14 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 109.686 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.448 HD21 ' CD2' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -65.48 178.51 0.95 Allowed 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.249 174.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 43.0 p -122.06 161.13 44.27 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.92 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 8.7 Cg_endo -66.13 4.66 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.038 1.825 . . . . 0.0 112.365 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -110.53 -10.83 20.93 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.809 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -106.42 -21.76 12.99 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.081 0.943 . . . . 0.0 109.828 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.84 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 17.6 p -80.91 18.94 0.92 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.917 -170.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.62 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.32 -35.48 73.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 122.291 1.043 . . . . 0.0 109.671 -172.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.19 159.76 33.3 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.229 174.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.578 ' O ' HG11 ' A' ' 375' ' ' VAL . 59.5 m95 -70.29 -36.95 74.68 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.58 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.26 -40.02 84.69 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.483 -175.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 35.4 t -72.77 -42.59 63.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.649 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.32 -51.52 67.32 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.578 HG11 ' O ' ' A' ' 371' ' ' TRP . 11.2 m -58.52 -45.38 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.458 0.647 . . . . 0.0 109.824 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.66 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.09 -43.31 95.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.648 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.514 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 29.7 m -69.45 -39.21 77.92 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.836 -172.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.5 mt -60.75 -34.37 74.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.586 0.63 . . . . 0.0 110.516 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.739 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 38.0 t80 -73.58 -47.69 38.55 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 122.446 1.117 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -51.1 -32.42 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 112.661 -2.063 . . . . 0.0 111.706 170.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.596 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -59.8 -46.79 88.12 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.435 0.636 . . . . 0.0 111.042 174.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.53 ' HB ' ' HD2' ' A' ' 322' ' ' ARG . 43.8 p -93.22 -24.23 18.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.843 -169.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -110.84 23.14 14.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.05 20.75 15.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.6 m 66.27 163.52 0.17 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.279 0.561 . . . . 0.0 111.429 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.546 ' CE2' HD23 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -130.55 153.96 81.56 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.077 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -99.31 60.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.421 2.747 . . . . 0.0 111.015 164.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.631 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.4 6.32 0.38 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -174.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -70.24 -48.72 55.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.082 0.467 . . . . 0.0 110.629 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.64 ' O ' HG13 ' A' ' 394' ' ' VAL . 41.2 mt-30 -76.61 -27.37 55.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -169.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.713 ' O ' HG22 ' A' ' 394' ' ' VAL . 3.2 mm? -54.66 -31.45 57.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 -171.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.639 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.76 -53.29 40.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.924 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 14.2 m-20 -66.21 -37.92 86.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.1 -45.99 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.644 ' O ' HG21 ' A' ' 399' ' ' VAL . 7.0 mm -58.54 -47.59 87.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 34.0 mmtt -52.11 -42.81 63.58 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.354 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.26 -44.33 13.78 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.034 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.679 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.0 mt -68.97 -40.77 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 117.447 0.623 . . . . 0.0 111.233 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.734 HG22 ' CG ' ' A' ' 429' ' ' TYR . 4.8 m -58.25 -45.63 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.034 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.475 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.1 t70 -62.34 -37.43 85.61 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.948 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -83.47 -53.14 5.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.615 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.39 -28.6 8.86 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.521 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 119.6 165.89 13.15 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.444 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.616 ' HA ' HG11 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.56 -44.07 98.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.594 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -57.31 -51.07 70.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.635 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.43 -49.88 69.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.461 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.679 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.2 -43.62 67.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.484 ' HB3' HD13 ' A' ' 457' ' ' ILE . 28.6 t80 -55.67 -45.72 77.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.803 ' O ' ' HG3' ' A' ' 413' ' ' MET . 16.3 m -57.99 -52.07 67.06 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.702 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -62.89 -49.23 75.64 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.716 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 415' ' ' SER . . . -56.37 -41.81 88.22 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.776 -174.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.581 ' HE1' ' NE2' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.44 -32.15 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 122.245 0.218 . . . . 0.0 111.152 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.803 ' HG3' ' O ' ' A' ' 409' ' ' THR . 60.4 mtm -70.67 -46.56 62.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 109.831 173.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.66 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 16.4 mt -60.51 -38.68 85.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.352 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 411' ' ' GLY . 4.5 p -77.0 -2.9 36.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.326 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.63 29.12 36.63 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.581 ' NE2' ' HE1' ' A' ' 412' ' ' MET . 3.8 mm-40 68.43 45.55 1.15 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 122.253 1.025 . . . . 0.0 111.534 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.565 ' ND2' HD23 ' A' ' 421' ' ' LEU . 7.0 t30 -116.16 71.96 0.8 Allowed 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 164.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 422' ' ' VAL . 0.2 OUTLIER -48.05 -35.77 11.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.046 -2.343 . . . . 0.0 111.64 -172.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.543 ' O ' ' HB3' ' A' ' 423' ' ' SER . 33.3 mt-30 -57.29 -49.91 74.58 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -166.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.565 HD23 ' ND2' ' A' ' 418' ' ' ASN . 3.1 pp -59.53 -48.66 80.78 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.237 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.561 HG11 ' HA ' ' A' ' 412' ' ' MET . 0.7 OUTLIER -59.76 -39.8 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.643 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 44.0 t -59.81 -47.59 85.1 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.793 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.02 -37.38 70.93 Favored Glycine 0 C--N 1.32 -0.339 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.052 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -73.02 -42.69 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.548 0.689 . . . . 0.0 110.239 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.464 HD13 HG22 ' A' ' 395' ' ' ILE . 1.6 mm -55.94 -44.48 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.727 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.663 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.3 OUTLIER -59.74 -30.12 68.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-O 122.701 1.239 . . . . 0.0 109.236 -173.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.16 -16.82 77.0 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.429 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.734 ' CG ' HG22 ' A' ' 399' ' ' VAL . 15.3 m-85 -101.65 2.46 38.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.569 HD21 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.09 144.96 74.87 Favored Pre-proline 0 N--CA 1.416 -2.15 0 CA-C-O 123.501 1.62 . . . . 0.0 113.403 168.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.658 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.5 Cg_endo -72.6 -63.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 1 C-N-CA 126.126 4.551 . . . . 0.0 113.281 -173.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.549 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.06 140.23 15.22 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.181 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.61 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.74 -30.69 70.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.2 0.5 . . . . 0.0 111.204 -177.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -55.33 -48.16 74.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.695 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.0 t -58.61 -52.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.593 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.36 -54.66 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.109 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 53.2 m -62.76 -55.79 23.37 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.047 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.43 -45.13 80.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.642 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.833 ' O ' HD23 ' A' ' 443' ' ' LEU . 40.0 mt -60.06 -53.46 57.56 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.722 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.705 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.74 -34.15 37.94 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 125.124 1.515 . . . . 0.0 110.403 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.662 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.87 -60.62 2.14 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 174.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -75.64 -51.38 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.541 0.61 . . . . 0.0 112.006 -172.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.32 -24.83 63.65 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.636 -178.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.732 ' N ' HD22 ' A' ' 443' ' ' LEU . 12.1 t70 -73.06 -43.35 62.02 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.573 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.7 mt-30 -69.66 -8.95 52.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -172.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.596 ' HB3' HG23 ' A' ' 451' ' ' THR . 20.7 mm-40 -51.89 155.28 1.82 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 123.574 1.654 . . . . 0.0 114.825 -175.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -52.93 -33.32 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 110.752 -2.931 . . . . 0.0 115.335 -171.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.543 ' H ' ' HB ' ' A' ' 451' ' ' THR . 26.5 m-20 -141.73 177.04 8.44 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.94 -52.35 63.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.413 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.9 -25.2 67.05 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 174.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.596 HG23 ' HB3' ' A' ' 446' ' ' GLU . 12.6 m -60.89 -41.43 96.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 119.823 1.192 . . . . 0.0 109.756 172.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 71.8 mtt180 -60.42 -30.71 69.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.921 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.445 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.67 -30.33 59.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.835 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -82.05 -44.25 16.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.858 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.509 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -104.32 -0.74 27.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.383 -167.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.625 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.8 t80 -49.12 -54.31 16.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.349 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -71.39 -25.1 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.538 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -71.99 -43.98 64.22 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.634 ' O ' HG21 ' A' ' 463' ' ' VAL . 30.3 m80 -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.91 172.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.69 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.46 -53.77 43.09 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 122.263 1.03 . . . . 0.0 109.13 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -62.21 -30.65 71.23 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.341 -1.754 . . . . 0.0 110.869 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.7 -48.18 67.29 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.771 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.697 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 25.9 t -65.0 -35.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.352 174.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.53 -14.44 29.61 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.583 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.546 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 2.4 tp10 -92.56 -52.17 4.77 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.404 -0.81 . . . . 0.0 112.114 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.697 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -63.87 -41.15 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.424 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.455 HD13 HD11 ' A' ' 469' ' ' LEU . 7.1 mt -83.39 -16.85 44.32 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.9 50.8 56.37 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 111.565 -2.561 . . . . 0.0 112.977 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.4 OUTLIER -102.86 -178.9 3.8 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.694 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.0 p30 -101.02 -40.89 7.01 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -161.02 -75.79 0.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.114 159.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.658 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -61.48 70.57 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -171.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.42 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.77 46.54 0.61 Allowed Glycine 0 C--N 1.274 -2.862 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.398 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.694 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 22.9 mm-40 -83.89 -53.81 5.32 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 122.245 1.022 . . . . 0.0 111.245 -173.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.8 t 68.0 56.25 0.54 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.889 -174.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.803 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -50.85 -48.37 28.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 110.547 -3.024 . . . . 0.0 111.845 175.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -48.85 134.33 16.72 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.213 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 79.9 mt -56.91 -28.09 61.6 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 123.977 0.911 . . . . 0.0 113.381 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.838 178.56 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.421 ' O ' ' HB ' ' A' ' 301' ' ' ILE . 1.1 Cg_endo . . . . . 0 N--CA 1.478 0.562 0 N-CA-C 111.077 -0.394 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 300' ' ' PRO . 1.8 mp 73.82 -51.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.032 0.533 . . . . 0.0 111.725 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 109.3 -146.81 16.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.906 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.46 ' HB ' HD12 ' A' ' 346' ' ' LEU . 95.8 m -155.94 125.97 6.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 0.0 109.729 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.24 121.9 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.286 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.682 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -74.82 127.54 86.86 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 121.765 0.793 . . . . 0.0 111.5 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -72.41 -12.27 27.18 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.881 3.72 . . . . 0.0 111.107 176.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.691 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.6 tp 26.95 -61.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.087 0 C-N-CA 128.704 2.801 . . . . 0.0 115.975 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 306' ' ' PRO . 0.0 OUTLIER -58.36 -32.08 68.22 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.273 0.559 . . . . 0.0 110.257 178.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.516 ' HB3' HG11 ' A' ' 338' ' ' VAL . 6.7 t-160 -62.08 -49.32 76.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.669 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.613 HG23 ' CG2' ' A' ' 350' ' ' ILE . 59.2 mt -58.88 -49.05 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 124.213 1.005 . . . . 0.0 113.08 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.691 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 4.3 mtp-105 -60.64 -30.57 69.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.864 0.364 . . . . 0.0 111.071 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.1 m -70.44 -33.28 71.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.572 0.701 . . . . 0.0 110.205 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.568 HG11 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.21 -40.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.8 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.768 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -82.45 -36.61 26.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.969 1.366 . . . . 0.0 109.759 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.98 35.44 8.22 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 112.117 -2.31 . . . . 0.0 111.135 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 42.8 mt-10 51.49 173.2 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.102 0 C-N-CA 124.196 0.998 . . . . 0.0 113.529 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.518 ' HB3' HD11 ' A' ' 324' ' ' ILE . 23.9 Cg_exo -45.2 142.18 6.16 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.015 2.477 . . . . 0.0 112.343 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.517 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 41.9 Cg_endo -89.71 -100.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.305 2.67 . . . . 0.0 112.896 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.479 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 12.3 mmm180 -94.01 -83.36 0.33 Allowed 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 123.149 0.58 . . . . 0.0 110.935 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.479 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 18.0 m-20 -103.29 163.18 18.0 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.769 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 35.2 Cg_exo -59.28 -51.59 6.25 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.499 2.133 . . . . 0.0 110.676 172.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.27 -14.82 1.95 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.203 -1.817 . . . . 0.0 113.142 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.3 mm-40 -91.64 -26.19 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.419 -0.175 . . . . 0.0 111.405 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.65 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.3 OUTLIER -46.44 -45.12 43.86 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.724 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.6 Cg_endo -47.47 -62.59 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.905 2.404 . . . . 0.0 113.25 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.605 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -63.42 -35.92 74.23 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 122.879 1.323 . . . . 0.0 110.141 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.768 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.6 t90 -57.51 -39.5 76.64 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.74 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.49 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.6 OUTLIER -67.62 -47.5 69.48 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 122.465 0.306 . . . . 0.0 111.716 -175.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.27 -22.96 16.04 Favored Glycine 0 C--N 1.311 -0.858 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.681 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -42.39 62.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.447 0.642 . . . . 0.0 111.31 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.56 ' HB2' HG23 ' A' ' 314' ' ' THR . 1.4 p30 -104.39 -17.61 14.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' A' ' 335' ' ' ILE . . . -40.72 -49.44 7.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.7 Cg_endo -61.81 -33.0 86.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.576 2.184 . . . . 0.0 111.466 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.501 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -71.9 -43.1 65.92 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.884 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.581 HG12 HG21 ' A' ' 310' ' ' ILE . 87.7 mt -58.79 -49.3 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.71 173.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.37 -14.5 4.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.921 175.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.12 -44.21 7.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.485 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 309' ' ' HIS . 92.1 t -60.74 -70.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 123.466 1.603 . . . . 0.0 109.79 169.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.778 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.7 OUTLIER -92.62 130.78 35.83 Favored Pre-proline 0 N--CA 1.403 -2.825 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.265 -173.089 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.778 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.2 Cg_endo -74.78 -16.85 20.6 Favored 'Trans proline' 0 CA--C 1.498 -1.323 0 C-N-CA 123.788 2.992 . . . . 0.0 110.862 173.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.49 HG21 ' CB ' ' A' ' 346' ' ' LEU . 3.1 p 33.4 67.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.342 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.595 ' N ' HD11 ' A' ' 346' ' ' LEU . 41.3 p -78.14 4.26 12.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 112.669 -2.06 . . . . 0.0 113.485 -169.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.789 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 13.5 p -139.86 163.35 45.2 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -63.31 -49.23 4.89 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.367 2.711 . . . . 0.0 108.103 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.735 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -44.32 -45.94 8.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.4 176.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.789 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.4 mt -59.22 -51.63 69.17 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 121.64 0.733 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 3.2 ttm180 -54.1 -45.85 71.96 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.262 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 1.053 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.89 -48.75 62.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 111.355 -177.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.66 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 62.9 mtt180 -56.01 -42.62 76.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 346' ' ' LEU . 39.9 mt -57.73 -54.13 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.523 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.505 ' HA ' HG13 ' A' ' 354' ' ' ILE . 19.8 mt -59.43 -52.57 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 122.162 0.982 . . . . 0.0 110.558 -170.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.527 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 17.4 m-20 -62.79 -35.18 79.01 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.272 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 307' ' ' ILE . . . -69.41 -36.0 76.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.58 -53.83 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 CA-C-O 123.107 1.432 . . . . 0.0 110.463 173.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.607 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -72.68 -25.71 61.36 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 111.716 -2.493 . . . . 0.0 109.412 -168.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 75.93 -74.71 1.57 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.895 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -151.39 56.94 0.45 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.332 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.57 HD21 ' HG ' ' A' ' 355' ' ' LEU . 81.7 m-20 -76.91 162.61 27.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.783 -0.245 . . . . 0.0 110.581 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.54 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -37.43 -59.73 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.252 1.021 . . . . 0.0 113.736 -166.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -153.9 16.56 0.62 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.511 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.545 ' HB3' HD23 ' A' ' 378' ' ' LEU . 6.3 mt -65.59 -3.87 5.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.942 0.497 . . . . 0.0 112.139 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.527 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.9 t -63.47 84.24 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.529 0.68 . . . . 0.0 110.309 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.463 HD21 ' CD2' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -62.63 170.53 2.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.773 0.796 . . . . 0.0 112.388 174.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 366' ' ' GLY . 65.4 p -111.31 156.33 41.32 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.952 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 1.053 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.8 Cg_endo -61.92 11.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.673 2.248 . . . . 0.0 113.794 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -128.53 -5.65 4.94 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.415 ' HB2' HD11 ' A' ' 363' ' ' LEU . 8.4 m-20 -109.57 -19.91 13.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.205 1.002 . . . . 0.0 110.298 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 15.4 p -88.56 16.27 6.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.595 -168.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 366' ' ' GLY . 1.0 OUTLIER -59.61 -40.84 88.86 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.524 -164.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.62 160.09 21.84 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.523 171.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.574 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.6 m95 -69.88 -35.89 75.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.577 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.44 -40.24 96.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.251 -175.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 36.8 t -68.69 -43.58 75.76 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.938 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.651 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.77 62.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 371' ' ' TRP . 15.1 m -57.22 -44.73 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.662 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -60.4 -44.75 95.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.019 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.521 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 55.5 m -68.79 -39.42 80.15 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.825 -172.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.1 mt -60.8 -33.22 72.66 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.849 -0.532 . . . . 0.0 110.57 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.724 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 49.8 t80 -75.0 -46.04 37.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.349 1.071 . . . . 0.0 109.161 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -51.54 -32.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.328 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.0 OUTLIER -59.85 -41.24 90.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 44.5 p -100.03 -23.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.36 -167.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -110.22 24.24 13.26 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.43 18.31 29.11 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 114.864 0.705 . . . . 0.0 114.864 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 66.17 159.37 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.286 0.565 . . . . 0.0 111.385 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.581 ' CE2' HD22 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -127.64 152.19 76.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -96.76 53.7 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.351 2.701 . . . . 0.0 111.211 166.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.618 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.17 7.87 0.71 Allowed 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -71.04 -48.59 51.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 0.0 110.389 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.644 ' O ' HG12 ' A' ' 394' ' ' VAL . 56.6 mt-30 -76.2 -26.15 55.86 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.689 ' O ' HG21 ' A' ' 394' ' ' VAL . 3.1 mm? -54.05 -31.36 51.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.332 0.969 . . . . 0.0 111.384 -173.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.56 -49.79 63.41 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.971 174.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.583 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 36.4 m-20 -69.34 -39.25 78.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 391' ' ' LEU . 1.9 m -57.46 -44.07 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.419 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.634 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.7 mm -58.24 -46.94 88.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.676 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.602 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 30.3 mmtt -52.4 -43.41 64.75 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.707 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.56 -44.34 16.5 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.1 -172.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.646 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.4 mt -69.31 -41.4 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 117.519 0.66 . . . . 0.0 111.552 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.688 HG23 ' CG ' ' A' ' 429' ' ' TYR . 6.4 m -57.64 -43.77 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.822 0.82 . . . . 0.0 109.955 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.468 ' N ' HG21 ' A' ' 399' ' ' VAL . 3.4 t70 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.064 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 70.1 mt-30 -83.78 -54.27 5.02 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.536 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -112.43 -30.46 7.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.796 -166.664 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.11 163.49 11.55 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.735 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.615 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.38 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.579 ' HB3' HG23 ' A' ' 457' ' ' ILE . . . -56.3 -50.51 71.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.1 0.476 . . . . 0.0 111.448 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.569 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -51.03 65.19 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.5 178.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.646 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.0 -41.85 65.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 31.6 t80 -57.08 -46.69 82.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.665 0.745 . . . . 0.0 109.086 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.812 ' O ' ' HG3' ' A' ' 413' ' ' MET . 8.5 m -58.69 -52.5 65.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.562 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.605 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.7 mm? -62.92 -49.01 76.46 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.737 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.626 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.95 -42.23 86.17 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.923 -174.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.573 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -32.64 66.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.66 0.23 . . . . 0.0 111.239 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.812 ' HG3' ' O ' ' A' ' 409' ' ' THR . 66.7 mtm -70.63 -46.98 62.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.383 0.611 . . . . 0.0 110.06 174.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.662 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 14.4 mt -59.23 -38.46 80.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.023 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.626 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.3 OUTLIER -77.45 -14.62 59.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.951 -176.066 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.67 27.03 8.71 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.178 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.573 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 3.9 mm-40 64.35 44.17 4.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.101 0.961 . . . . 0.0 112.292 177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.606 ' ND2' HD22 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -120.24 69.5 0.86 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 166.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.506 ' CZ ' ' HG2' ' A' ' 420' ' ' GLN . 0.8 OUTLIER -47.47 -35.25 8.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 111.568 -2.56 . . . . 0.0 113.477 -165.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 423' ' ' SER . 28.0 mt-30 -55.03 -47.74 74.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -163.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.606 HD22 ' ND2' ' A' ' 418' ' ' ASN . 1.9 pp -59.71 -48.99 79.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.384 0.612 . . . . 0.0 110.81 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.59 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.25 -38.87 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.574 1.178 . . . . 0.0 109.263 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 40.4 t -61.13 -46.53 90.19 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.905 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.77 72.93 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.019 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -72.26 -41.91 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.549 0.69 . . . . 0.0 110.162 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.481 HD13 HG21 ' A' ' 395' ' ' ILE . 1.6 mm -56.18 -44.8 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.604 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.38 -30.77 68.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.618 1.199 . . . . 0.0 109.376 -174.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.68 -14.33 77.93 Favored Glycine 0 C--N 1.299 -1.483 0 CA-C-N 112.845 -1.979 . . . . 0.0 112.503 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.688 ' CG ' HG23 ' A' ' 399' ' ' VAL . 16.5 m-85 -103.83 3.03 33.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.58 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.5 144.75 78.25 Favored Pre-proline 0 N--CA 1.411 -2.411 0 CA-C-O 123.541 1.639 . . . . 0.0 112.996 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.668 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.9 Cg_endo -72.94 -63.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 1 C-N-CA 126.074 4.516 . . . . 0.0 113.422 -173.056 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.554 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -104.58 141.86 15.37 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.622 ' HA ' HG11 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -65.68 -26.82 67.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.22 0.51 . . . . 0.0 111.216 -176.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.33 86.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.674 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.9 t -59.39 -52.04 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.629 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.36 -53.79 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.467 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 94.4 m -61.15 -56.6 18.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.96 -46.24 78.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.519 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.845 ' O ' HD22 ' A' ' 443' ' ' LEU . 54.9 mt -59.95 -53.5 57.08 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.64 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.675 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.5 mm-40 -51.77 -34.48 39.82 Favored 'General case' 0 N--CA 1.415 -2.19 0 O-C-N 124.956 1.41 . . . . 0.0 110.682 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.672 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.29 -61.81 1.69 Allowed 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 175.079 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.55 -50.17 14.59 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.85 -0.531 . . . . 0.0 112.205 -171.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.7 -25.35 62.8 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.34 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.731 ' N ' HD21 ' A' ' 443' ' ' LEU . 14.5 t70 -72.81 -42.74 63.54 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.701 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.672 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.8 mt-30 -68.97 -7.6 36.77 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -172.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.62 ' HB3' HG23 ' A' ' 451' ' ' THR . 4.9 mm-40 -51.66 156.22 1.42 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.516 1.627 . . . . 0.0 114.363 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.462 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.22 -32.37 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 110.719 -2.946 . . . . 0.0 115.38 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.547 ' H ' ' HB ' ' A' ' 451' ' ' THR . 19.1 m-20 -142.02 179.94 6.59 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.456 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 3.6 m-20 -62.65 -55.58 25.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.408 ' HA ' ' HB1' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.61 -25.2 67.86 Favored 'General case' 0 N--CA 1.403 -2.795 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.411 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.62 HG23 ' HB3' ' A' ' 446' ' ' GLU . 23.6 m -60.31 -41.91 94.45 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 119.793 1.179 . . . . 0.0 109.543 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.555 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 45.8 mtt180 -60.88 -30.32 70.08 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.851 172.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.536 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.65 -29.47 59.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.921 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.09 -44.66 17.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.788 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.561 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.1 p -106.24 0.39 25.16 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.184 -167.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.624 ' CE1' HD21 ' A' ' 460' ' ' LEU . 7.9 t80 -48.91 -53.83 17.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.03 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 405' ' ' ALA . 26.2 mm -71.06 -25.49 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.561 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.17 -43.42 64.61 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.632 ' O ' HG23 ' A' ' 463' ' ' VAL . 26.8 m80 -65.45 -32.03 73.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.722 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.675 HD22 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.14 -53.47 37.42 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.066 0.936 . . . . 0.0 109.512 -178.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.654 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 8.3 m-80 -62.37 -32.31 73.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.068 173.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.66 -53.36 57.23 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.893 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.715 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 20.9 t -62.7 -34.88 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.858 0 CA-C-O 121.818 0.818 . . . . 0.0 110.4 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.7 -14.7 33.95 Favored 'General case' 0 C--O 1.207 -1.155 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.32 170.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.654 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 43.4 mt-10 -92.99 -48.28 6.59 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.097 -1.002 . . . . 0.0 112.69 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.715 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.6 pt -66.27 -38.1 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.237 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.447 ' HB3' HD21 ' A' ' 469' ' ' LEU . 6.6 mt -85.27 -17.16 37.78 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.737 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 61.8 55.73 26.8 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.659 -2.518 . . . . 0.0 112.942 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.5 OUTLIER -105.02 -159.21 0.7 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 122.088 0.947 . . . . 0.0 109.644 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.608 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.3 p30 -124.76 -41.39 2.13 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.455 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -159.21 -79.59 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 112.251 -2.249 . . . . 0.0 110.619 156.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.668 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 1.3 mpt_? -59.06 68.13 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 33.47 53.58 0.6 Allowed Glycine 0 C--N 1.278 -2.689 0 CA-C-N 111.099 -2.773 . . . . 0.0 113.367 173.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.608 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 5.9 mm-40 -90.13 -49.07 6.78 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 122.4 1.095 . . . . 0.0 111.259 -173.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 27.2 t 62.0 62.58 1.21 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.119 -2.31 . . . . 0.0 108.561 -171.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.737 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -50.71 -50.36 23.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 110.932 -2.849 . . . . 0.0 112.115 177.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.666 ' HD2' ' N ' ' A' ' 478' ' ' LEU . 0.1 OUTLIER -75.4 -176.16 3.05 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.154 178.387 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.666 ' N ' ' HD2' ' A' ' 477' ' ' ARG . 84.9 mt -53.17 -175.18 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-N 113.891 -1.504 . . . . 0.0 112.67 -178.333 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 N--CA 1.482 0.813 0 N-CA-C 111.425 -0.26 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.35 -62.35 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.82 0.343 . . . . 0.0 110.661 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -123.82 73.23 0.41 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.252 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 25.0 m 72.35 118.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.352 1.072 . . . . 0.0 112.222 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.1 p -79.3 130.07 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.335 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.696 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -74.73 125.43 89.56 Favored Pre-proline 0 N--CA 1.426 -1.65 0 CA-C-O 121.909 0.862 . . . . 0.0 111.852 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.512 ' HG2' HG11 ' A' ' 338' ' ' VAL . 17.6 Cg_endo -72.46 -11.32 26.37 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 124.929 3.752 . . . . 0.0 111.372 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.672 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.7 tp 25.66 -60.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 C-N-CA 128.677 2.791 . . . . 0.0 116.34 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 306' ' ' PRO . 0.0 OUTLIER -58.17 -32.44 68.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.355 0.598 . . . . 0.0 110.138 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.518 ' HB3' HG12 ' A' ' 338' ' ' VAL . 6.9 t-160 -62.4 -48.95 77.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.66 172.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.597 HG22 ' CG2' ' A' ' 350' ' ' ILE . 57.6 mt -58.59 -48.71 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 124.006 0.922 . . . . 0.0 113.172 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.4 mtp-105 -60.22 -30.11 69.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.14 -0.35 . . . . 0.0 111.41 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 46.9 m -69.6 -35.43 75.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.564 0.697 . . . . 0.0 109.845 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 314' ' ' THR . 0.6 OUTLIER -66.07 -40.9 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.717 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.815 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -83.35 -36.88 24.03 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.797 1.284 . . . . 0.0 110.235 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.66 36.67 7.8 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.245 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 38.8 mt-10 49.87 175.53 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 124.071 0.948 . . . . 0.0 113.261 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.532 ' HB3' HD12 ' A' ' 324' ' ' ILE . 90.8 Cg_exo -52.44 134.7 52.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.603 2.202 . . . . 0.0 112.48 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.74 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 95.1 Cg_endo -85.23 -90.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.487 2.792 . . . . 0.0 114.788 -174.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.458 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 6.4 mmm180 -93.76 -78.93 0.42 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.048 0.928 . . . . 0.0 113.033 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.586 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 65.1 m-20 -105.4 -159.93 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.756 -169.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 320' ' ' ASN . 58.6 Cg_endo -90.89 -32.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 121.647 1.565 . . . . 0.0 114.671 159.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 15.72 10.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -169.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.718 ' OE2' ' HG2' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -106.31 -35.83 7.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.671 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.615 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.4 OUTLIER -40.15 -46.15 5.22 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.345 1.458 . . . . 0.0 114.077 178.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.684 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.2 Cg_endo -47.01 -63.04 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.055 2.503 . . . . 0.0 112.814 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.581 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.8 OUTLIER -65.35 -35.53 75.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 123.054 1.407 . . . . 0.0 110.428 -179.047 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.815 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 32.7 t90 -58.34 -34.05 70.2 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.973 177.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.8 OUTLIER -70.45 -48.04 57.8 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.6 -23.13 19.31 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.793 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 0.5 OUTLIER -74.41 -42.94 58.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.247 1.023 . . . . 0.0 110.617 174.137 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.576 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.0 m-20 -95.67 -24.96 16.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.679 -168.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.529 ' HA ' HD11 ' A' ' 335' ' ' ILE . . . -42.1 -49.76 11.28 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 124.418 1.087 . . . . 0.0 113.749 177.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 49.3 Cg_endo -63.09 -31.27 75.92 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.544 2.163 . . . . 0.0 111.525 177.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.483 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -74.04 -44.11 55.47 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.689 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.567 HG12 HG23 ' A' ' 310' ' ' ILE . 88.7 mt -58.37 -48.69 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.584 173.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 19.4 t70 -57.09 -17.85 12.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.264 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -44.51 10.15 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.518 HG12 ' HB3' ' A' ' 309' ' ' HIS . 94.0 t -60.64 -68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 123.587 1.66 . . . . 0.0 110.242 169.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.76 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.7 OUTLIER -96.29 130.07 31.91 Favored Pre-proline 0 N--CA 1.403 -2.802 0 CA-C-N 110.791 -2.913 . . . . 0.0 112.787 -171.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.76 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -75.4 -16.36 19.39 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 123.89 3.06 . . . . 0.0 110.927 174.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.53 66.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 112.33 -2.214 . . . . 0.0 110.323 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.604 ' N ' HD12 ' A' ' 346' ' ' LEU . 34.8 p -77.88 2.71 16.48 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.681 -2.054 . . . . 0.0 113.225 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.789 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.1 p -138.06 161.36 60.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 41.1 Cg_exo -63.97 -46.53 8.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.419 2.746 . . . . 0.0 108.454 172.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.617 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -45.51 -44.2 12.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.425 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.789 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.3 mt -61.35 -52.01 66.43 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.696 0.76 . . . . 0.0 110.459 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 2.6 ttm180 -52.12 -47.32 65.38 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.627 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.969 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.5 OUTLIER -69.45 -48.24 61.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.734 -176.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 46.4 mtt180 -56.54 -42.1 77.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.232 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.625 ' O ' HG12 ' A' ' 354' ' ' ILE . 43.0 mt -57.24 -53.27 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.446 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.507 ' HA ' HG13 ' A' ' 354' ' ' ILE . 18.2 mt -59.4 -52.57 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 122.158 0.98 . . . . 0.0 110.986 -170.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.537 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 25.8 m-20 -63.42 -35.45 80.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.37 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 307' ' ' ILE . . . -68.8 -34.38 75.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -57.86 -54.31 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.052 1.406 . . . . 0.0 110.66 173.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.6 OUTLIER -72.12 -24.76 61.52 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.328 -169.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.5 -65.28 1.06 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.849 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -139.51 66.91 0.51 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.233 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.655 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 31.3 p30 -78.75 164.9 24.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.23 0.212 . . . . 0.0 111.283 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.469 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -56.52 -65.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 122.94 0.496 . . . . 0.0 111.289 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -148.55 10.9 1.12 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.565 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.655 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 3.7 mt -65.01 -5.85 7.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.723 0.409 . . . . 0.0 111.408 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.537 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 19.4 t -60.71 82.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.402 0.62 . . . . 0.0 110.596 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.456 HD23 ' CD2' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -64.55 170.67 3.8 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.953 0.882 . . . . 0.0 112.629 175.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 33.4 p -118.66 155.5 52.35 Favored Pre-proline 0 N--CA 1.436 -1.17 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.99 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.969 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.9 Cg_endo -54.8 -11.28 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.801 2.334 . . . . 0.0 113.419 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.567 ' O ' HD13 ' A' ' 369' ' ' LEU . . . -103.75 -6.31 43.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.139 -0.553 . . . . 0.0 114.471 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.407 ' HB2' HD13 ' A' ' 363' ' ' LEU . 1.3 m-20 -109.83 -18.83 13.33 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.075 0.941 . . . . 0.0 110.777 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.744 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 19.3 p -92.43 18.86 7.85 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.747 -167.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.567 HD13 ' O ' ' A' ' 366' ' ' GLY . 1.8 mt -62.15 -35.71 79.6 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.369 1.081 . . . . 0.0 110.242 -162.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.5 p -116.03 167.31 11.09 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.313 171.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.597 ' O ' HG11 ' A' ' 375' ' ' VAL . 43.1 m95 -70.39 -34.05 72.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.596 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.21 -43.56 94.65 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.559 0.695 . . . . 0.0 109.711 -173.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.7 p -66.24 -44.21 84.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.312 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.639 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.85 62.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 371' ' ' TRP . 12.0 m -58.13 -44.03 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.644 0.735 . . . . 0.0 109.568 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.704 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -62.63 -46.01 90.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.777 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.51 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 34.4 m -65.84 -40.74 92.02 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.445 -173.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.7 mt -60.16 -33.55 72.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.677 0.671 . . . . 0.0 110.369 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.684 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 65.8 t80 -73.36 -46.46 49.02 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 122.382 1.087 . . . . 0.0 109.567 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -51.83 -32.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 112.801 -1.999 . . . . 0.0 111.158 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.45 -38.13 83.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 176.399 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 37.2 p -98.25 -22.83 15.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.639 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.434 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 26.6 m80 -110.08 22.19 15.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.91 21.0 28.85 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.4 m 65.98 158.17 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 111.906 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -126.65 155.35 75.05 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 389' ' ' HIS . 91.5 Cg_endo -101.61 58.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.912 3.075 . . . . 0.0 111.437 166.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.608 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.5 -2.08 0.09 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.4 t60 -69.64 -45.11 69.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.492 . . . . 0.0 110.847 176.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.618 ' O ' HG11 ' A' ' 394' ' ' VAL . 77.6 mt-30 -74.91 -26.71 59.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.92 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.2 -30.98 51.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.922 0.783 . . . . 0.0 111.787 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.607 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.99 -48.54 66.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.545 173.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.507 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 59.1 m-20 -68.47 -41.16 80.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.087 0.555 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.44 -44.93 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.257 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.4 mm -58.34 -47.39 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.459 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.3 mmtt -52.2 -43.17 64.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.936 0.772 . . . . 0.0 111.49 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.58 -44.11 17.06 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.15 -172.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.638 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 3.7 mt -69.12 -42.0 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 117.294 0.547 . . . . 0.0 111.596 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.727 HG23 ' CG ' ' A' ' 429' ' ' TYR . 5.4 m -58.71 -43.24 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.884 0.85 . . . . 0.0 109.872 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.419 ' N ' HG21 ' A' ' 399' ' ' VAL . 19.0 t70 -57.16 -44.5 83.51 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.328 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -86.66 -53.3 5.03 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.673 -1.149 . . . . 0.0 113.424 -170.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.538 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -109.04 -31.44 7.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.427 0.632 . . . . 0.0 111.549 -170.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.62 165.07 11.79 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.841 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.606 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -45.93 96.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.604 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -55.91 -50.14 71.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.591 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.511 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -50.82 66.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.369 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.638 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.54 -41.58 63.63 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 45.3 t80 -57.85 -46.51 84.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.572 0.701 . . . . 0.0 109.533 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.716 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.7 m -59.82 -52.71 64.28 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.816 -178.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.616 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -62.06 -49.03 77.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.875 177.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.78 -41.35 82.97 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.091 -175.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.581 ' HA ' HG12 ' A' ' 422' ' ' VAL . 0.3 OUTLIER -72.06 -33.73 68.18 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.643 0.222 . . . . 0.0 110.826 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.716 ' HG3' ' O ' ' A' ' 409' ' ' THR . 62.4 mtm -69.51 -46.63 66.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.042 174.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.704 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 15.9 mt -58.79 -40.13 83.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.924 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.92 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.5 m -78.84 -14.52 59.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.03 44.08 4.54 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.948 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.56 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 56.58 42.18 27.54 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 124.269 1.028 . . . . 0.0 113.323 178.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.747 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.1 OUTLIER -119.5 74.27 0.99 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.462 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 0.7 OUTLIER -49.65 -36.04 23.33 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 111.907 -2.406 . . . . 0.0 113.009 -167.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.5 mt-30 -54.83 -49.24 71.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -163.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.692 HD12 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.497 0.665 . . . . 0.0 111.184 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.583 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.648 1.213 . . . . 0.0 109.152 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 41.3 t -61.56 -46.9 87.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.467 -2.152 . . . . 0.0 112.023 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.21 -37.97 75.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.843 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 422' ' ' VAL . 2.4 mt -72.17 -41.47 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 110.048 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.499 HD12 HG22 ' A' ' 395' ' ' ILE . 1.5 mm -57.39 -45.05 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.003 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.618 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -61.69 -28.97 69.78 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 122.704 1.24 . . . . 0.0 108.963 -173.036 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.9 -17.86 77.21 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.374 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.727 ' CG ' HG23 ' A' ' 399' ' ' VAL . 11.3 m-85 -101.03 4.16 42.1 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.578 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.39 144.29 71.7 Favored Pre-proline 0 N--CA 1.41 -2.448 0 CA-C-O 123.722 1.725 . . . . 0.0 113.226 168.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.749 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.5 Cg_endo -71.37 -58.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.115 1 C-N-CA 126.308 4.672 . . . . 0.0 113.172 -170.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.22 142.38 17.15 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.105 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.6 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.48 -31.74 71.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.043 0.422 . . . . 0.0 111.28 -177.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.2 -46.47 79.44 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.647 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.4 t -59.44 -51.04 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.785 177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.6 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.64 -54.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 57.0 m -62.7 -56.44 17.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.48 -42.83 78.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.484 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.846 ' O ' HD21 ' A' ' 443' ' ' LEU . 54.1 mt -63.42 -53.25 55.34 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.204 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.653 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 35.0 mm-40 -51.31 -33.84 30.77 Favored 'General case' 0 N--CA 1.419 -2.014 0 O-C-N 124.959 1.412 . . . . 0.0 110.334 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.687 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.99 -60.96 1.99 Allowed 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 172.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.2 ptp180 -74.03 -53.6 9.67 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.613 -0.679 . . . . 0.0 112.536 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.846 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.24 -24.96 63.62 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.63 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.717 ' N ' HD23 ' A' ' 443' ' ' LEU . 8.3 t70 -73.17 -42.16 63.08 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.494 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 35.1 mt-30 -70.64 -7.98 48.35 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.625 ' HB3' HG22 ' A' ' 451' ' ' THR . 6.2 mm-40 -51.31 158.46 0.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 123.581 1.657 . . . . 0.0 114.623 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.9 mp -53.08 -32.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 110.543 -3.026 . . . . 0.0 115.33 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.555 ' H ' ' HB ' ' A' ' 451' ' ' THR . 13.6 m-20 -142.75 179.76 6.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.759 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.438 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 11.1 p-10 -61.68 -54.95 35.79 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -65.64 -26.51 67.84 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 446' ' ' GLU . 24.5 m -59.17 -41.19 87.86 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 119.905 1.229 . . . . 0.0 109.678 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 66.7 mtt180 -60.47 -29.57 69.13 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.935 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.493 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.61 -33.99 58.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.332 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.5 mm-40 -78.51 -44.63 23.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.941 -171.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.561 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 24.8 p -105.17 0.53 27.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.061 -167.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.541 ' HB2' ' O ' ' A' ' 452' ' ' ARG . 5.6 t80 -49.19 -54.87 14.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -70.44 -26.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.561 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.23 -42.97 68.19 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.633 ' O ' HG21 ' A' ' 463' ' ' VAL . 30.1 m80 -67.78 -31.89 72.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.745 172.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.707 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -63.48 -53.39 52.8 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.179 0.99 . . . . 0.0 109.292 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.4 m-80 -62.89 -31.8 72.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.525 173.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -63.96 -50.99 66.46 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.854 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.717 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 31.9 t -63.04 -34.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.906 0.86 . . . . 0.0 110.34 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.515 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.2 m-30 -61.18 -15.95 39.53 Favored 'General case' 0 C--O 1.205 -1.284 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.185 169.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 462' ' ' ALA . 33.5 mm-40 -90.34 -49.8 6.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 112.789 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.717 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.92 -39.42 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.86 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.477 ' HG ' HG12 ' A' ' 463' ' ' VAL . 6.9 mt -84.67 -16.04 43.27 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 171.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.746 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.31 52.02 50.21 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 111.741 -2.482 . . . . 0.0 113.1 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.3 OUTLIER -103.8 177.96 4.69 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 123.583 0.753 . . . . 0.0 109.892 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.637 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.4 p30 -96.55 -41.4 8.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 167.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -160.42 -74.37 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.356 -2.202 . . . . 0.0 111.19 158.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.749 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -63.15 68.91 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -169.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.454 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 40.09 40.03 1.66 Allowed Glycine 0 C--N 1.278 -2.677 0 CA-C-N 111.176 -2.738 . . . . 0.0 113.48 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.637 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 11.4 mm-40 -78.87 -51.62 9.44 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.142 0.972 . . . . 0.0 111.566 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.9 t 65.18 55.06 1.14 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.306 -173.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.746 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -53.6 -47.26 61.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 110.637 -2.983 . . . . 0.0 111.928 176.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 477' ' ' ARG . 8.3 mmm-85 -51.49 145.68 8.41 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.943 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.1 -25.79 68.53 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.351 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.439 -1.014 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.146 178.103 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.476 0.478 0 N-CA-C 110.571 -0.588 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 2.3 mp 71.33 -59.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.185 0.594 . . . . 0.0 111.096 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 167.94 -19.27 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 58.6 m 76.97 113.7 0.07 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.183 0.992 . . . . 0.0 111.69 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.0 p -66.54 127.32 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.725 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.676 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.3 mt -73.83 125.85 90.01 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-O 121.716 0.769 . . . . 0.0 111.643 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 308' ' ' GLN . 23.3 Cg_endo -71.75 -15.98 29.95 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 124.555 3.503 . . . . 0.0 110.883 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.747 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.9 tp 30.38 -58.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 C-N-CA 128.673 2.789 . . . . 0.0 116.275 172.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 306' ' ' PRO . 3.3 mm-40 -56.17 -38.84 71.47 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.097 0.951 . . . . 0.0 109.811 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.487 ' HB3' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -59.85 -47.8 84.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.799 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' A' ' 339' ' ' PHE . 65.2 mt -60.2 -48.22 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 123.861 0.864 . . . . 0.0 113.036 174.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.747 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 5.5 mtp180 -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 O-C-N 122.032 -0.417 . . . . 0.0 110.461 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 23.2 t -70.03 -34.05 72.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.623 . . . . 0.0 109.6 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.558 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.38 -41.59 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.775 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.663 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 29.8 p -83.0 -36.66 24.85 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.765 1.269 . . . . 0.0 109.671 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.61 34.04 8.79 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.419 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 51.23 173.1 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.323 0 C-N-CA 124.419 1.087 . . . . 0.0 113.105 -173.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.551 ' HB3' HD11 ' A' ' 324' ' ' ILE . 28.2 Cg_exo -46.16 152.34 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.128 2.552 . . . . 0.0 113.586 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -89.52 -101.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.264 2.643 . . . . 0.0 111.991 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.431 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 13.3 mmt180 -104.38 -82.63 0.51 Allowed 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.126 0.489 . . . . 0.0 111.504 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.517 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 22.9 m-80 -98.33 163.14 19.76 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.861 -171.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.15 -51.67 6.26 Favored 'Trans proline' 0 CA--C 1.509 -0.756 0 C-N-CA 123.117 2.545 . . . . 0.0 110.971 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -13.56 2.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.492 -1.686 . . . . 0.0 113.29 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.2 mt-10 -92.86 -31.74 14.87 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.256 -0.177 . . . . 0.0 110.89 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -47.83 -45.03 60.46 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -177.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.716 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.5 Cg_endo -49.64 -61.91 0.5 Allowed 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.974 2.449 . . . . 0.0 112.849 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.558 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.25 -37.19 77.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.663 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 38.3 t90 -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.099 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.22 -48.18 58.17 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.426 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.58 -23.07 18.9 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.827 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -74.57 -43.06 57.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.259 1.028 . . . . 0.0 110.483 174.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.564 ' HB3' HG23 ' A' ' 314' ' ' THR . 48.3 m-20 -95.16 -24.18 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.444 -1.707 . . . . 0.0 113.601 -168.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.559 ' HA ' HD11 ' A' ' 335' ' ' ILE . . . -42.04 -50.32 10.87 Favored Pre-proline 0 C--N 1.306 -1.295 0 C-N-CA 124.223 1.009 . . . . 0.0 113.612 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.1 Cg_endo -62.08 -31.76 83.48 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.741 2.294 . . . . 0.0 111.828 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -73.59 -44.17 57.86 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.549 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 310' ' ' ILE . 91.0 mt -58.38 -48.42 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.855 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.67 -19.61 11.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.07 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.41 -48.07 9.74 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 309' ' ' HIS . 62.2 t -57.89 -72.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-O 123.445 1.593 . . . . 0.0 110.098 169.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.767 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.6 OUTLIER -92.39 129.56 40.53 Favored Pre-proline 0 N--CA 1.405 -2.686 0 CA-C-N 111.196 -2.729 . . . . 0.0 112.623 -171.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.767 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.7 Cg_endo -74.8 -16.47 20.73 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 123.981 3.12 . . . . 0.0 110.763 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.36 66.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 112.347 -2.206 . . . . 0.0 110.182 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.653 ' N ' HD12 ' A' ' 346' ' ' LEU . 37.4 p -79.37 8.66 5.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.945 -1.934 . . . . 0.0 113.586 -170.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.766 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.5 p -142.23 164.13 35.37 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.417 ' O ' ' SG ' ' A' ' 348' ' ' CYS . 44.6 Cg_exo -63.06 -50.02 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.154 2.569 . . . . 0.0 108.309 172.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.673 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.7 OUTLIER -42.7 -48.23 5.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.972 176.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.766 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.1 mt -56.43 -52.61 64.03 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.587 -177.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.683 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 39.1 ttm105 -54.72 -45.61 74.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.56 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 1.051 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.48 -48.38 60.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.067 0.461 . . . . 0.0 111.258 -176.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 49.7 mtp180 -55.96 -41.9 75.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.929 177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.685 HG13 ' O ' ' A' ' 346' ' ' LEU . 49.0 mt -58.72 -54.29 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.678 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.455 ' HA ' HG13 ' A' ' 354' ' ' ILE . 19.5 mt -57.85 -52.97 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.109 0.956 . . . . 0.0 110.777 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.2 m-20 -63.56 -34.98 79.01 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.911 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.499 ' HB1' HD12 ' A' ' 307' ' ' ILE . . . -69.16 -38.34 78.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.858 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.13 -52.82 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.001 1.382 . . . . 0.0 110.192 175.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.567 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.8 OUTLIER -72.96 -24.81 60.83 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 111.719 -2.491 . . . . 0.0 109.414 -170.157 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.82 -80.35 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 113.656 -1.611 . . . . 0.0 113.013 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.02 72.71 0.29 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.558 HD21 ' CD2' ' A' ' 355' ' ' LEU . 18.5 p30 -94.59 157.68 15.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 122.541 0.336 . . . . 0.0 111.32 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.588 ' N ' HD11 ' A' ' 359' ' ' ILE . 2.4 mp -81.28 89.34 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-O 121.11 0.481 . . . . 0.0 111.83 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.47 -16.97 15.64 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.552 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.546 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.4 mt -60.68 -4.68 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.484 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 25.1 t -63.69 81.98 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 110.353 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.431 HD21 ' CD2' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -61.96 172.46 1.35 Allowed 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.908 174.384 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.581 ' C ' ' H ' ' A' ' 366' ' ' GLY . 44.1 p -112.76 162.71 20.39 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.186 -174.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 1.051 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.0 Cg_endo -67.04 21.21 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.42 2.08 . . . . 0.0 112.583 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -131.66 -12.05 2.04 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.329 -0.85 . . . . 0.0 114.207 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -105.2 -20.49 13.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.715 1.245 . . . . 0.0 109.44 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.88 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 3.8 p -75.3 19.11 0.18 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.244 -172.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.73 -32.73 70.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.362 1.077 . . . . 0.0 109.814 -170.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.3 35.98 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.266 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.551 ' O ' HG12 ' A' ' 375' ' ' VAL . 65.4 m95 -69.66 -35.49 75.2 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.61 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.4 OUTLIER -60.81 -40.86 94.3 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.804 -175.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 53.9 m -68.92 -43.69 74.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.694 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.53 -52.71 62.38 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 371' ' ' TRP . 12.3 m -57.24 -45.73 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.395 0.617 . . . . 0.0 109.666 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.681 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -61.68 -45.57 93.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.889 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.524 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 31.7 m -67.56 -37.69 83.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.594 -172.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -60.95 -35.22 76.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.471 0.578 . . . . 0.0 110.434 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.716 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 55.6 t80 -72.51 -46.91 52.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.561 1.172 . . . . 0.0 109.175 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.647 HD11 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.07 -32.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.344 171.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.13 -46.58 89.16 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 123.193 0.597 . . . . 0.0 111.175 175.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.7 p -89.12 -23.98 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.531 -171.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.447 ' HB3' HE22 ' A' ' 390' ' ' GLN . 27.2 m80 -111.28 23.22 14.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.0 21.56 24.63 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.745 0.658 . . . . 0.0 114.745 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 67.04 160.36 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.906 0.482 . . . . 0.0 111.413 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.561 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -125.45 158.48 64.25 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.475 ' C ' ' H ' ' A' ' 389' ' ' HIS . 90.6 Cg_endo -101.33 53.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.894 3.063 . . . . 0.0 111.466 166.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.638 ' HA ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.83 -14.99 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -175.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.475 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.1 t60 -57.52 -42.59 83.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.881 0.372 . . . . 0.0 110.648 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.7 mt-30 -75.2 -27.93 59.79 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -171.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.715 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -54.16 -31.27 52.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.972 0.806 . . . . 0.0 111.455 -176.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.643 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.37 -51.48 51.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.735 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 17.9 m-20 -68.97 -37.91 79.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -57.66 -46.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.044 0.449 . . . . 0.0 110.101 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.657 ' O ' HG21 ' A' ' 399' ' ' VAL . 21.8 mm -59.01 -45.87 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.967 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.682 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 37.2 mmtt -52.05 -42.78 63.41 Favored 'General case' 0 C--O 1.244 0.793 0 O-C-N 124.025 0.828 . . . . 0.0 111.531 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.35 -44.19 13.96 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.128 -172.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.638 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.5 mt -69.31 -40.81 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 117.429 0.615 . . . . 0.0 111.575 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.74 HG22 ' CG ' ' A' ' 429' ' ' TYR . 5.4 m -58.84 -43.94 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.823 0.821 . . . . 0.0 109.749 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 399' ' ' VAL . 16.2 t70 -59.19 -42.26 90.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.486 177.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 29.2 mm-40 -86.28 -53.1 5.22 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.331 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.475 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 1.1 mm-40 -109.56 -31.15 7.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.467 0.651 . . . . 0.0 111.622 -170.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.28 164.05 11.67 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.889 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.62 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -44.1 98.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 123.104 0.561 . . . . 0.0 112.417 -175.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -54.54 -52.27 62.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.57 0.7 . . . . 0.0 111.843 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.513 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.5 -49.69 68.07 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.348 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.638 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.31 -42.18 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.586 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 29.1 t80 -55.72 -48.65 74.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.589 0.709 . . . . 0.0 109.371 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.744 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.1 m -58.32 -52.16 66.75 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.752 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 414' ' ' LEU . 2.7 mm? -61.52 -48.72 79.78 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.604 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.471 ' HA2' HD11 ' A' ' 414' ' ' LEU . . . -56.25 -43.7 89.26 Favored Glycine 0 C--N 1.315 -0.603 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.392 -174.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.614 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -72.21 -31.22 65.67 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.795 0.298 . . . . 0.0 110.874 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.744 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.9 mtm -69.03 -48.97 61.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.35 0.595 . . . . 0.0 109.866 172.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.681 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.07 -39.35 81.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.113 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.766 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.4 OUTLIER -77.4 -14.3 59.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.684 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.84 4.88 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.866 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.614 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.0 OUTLIER 58.15 43.7 20.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.794 0.838 . . . . 0.0 113.228 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.766 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.2 OUTLIER -124.37 79.92 1.79 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.164 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.662 ' HD2' ' OG ' ' A' ' 423' ' ' SER . 7.5 p90 -62.27 -31.85 72.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.146 -163.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.406 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 47.4 mt-30 -53.79 -49.6 67.94 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.377 -164.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.702 HD12 ' OG ' ' A' ' 415' ' ' SER . 1.3 pp -59.18 -49.24 78.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.25 0.547 . . . . 0.0 110.671 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.616 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -60.61 -38.72 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 122.794 1.283 . . . . 0.0 108.917 -178.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.662 ' OG ' ' HD2' ' A' ' 419' ' ' TYR . 64.6 m -66.27 -42.19 88.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.507 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.62 -38.83 89.56 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.254 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 422' ' ' VAL . 4.3 mt -71.19 -42.07 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.515 0.674 . . . . 0.0 109.917 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.517 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -57.26 -44.47 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.334 -1.303 . . . . 0.0 112.606 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.633 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -61.28 -29.27 69.76 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 122.655 1.217 . . . . 0.0 109.143 -172.04 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.4 -20.24 78.14 Favored Glycine 0 C--N 1.298 -1.578 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.034 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.74 ' CG ' HG22 ' A' ' 399' ' ' VAL . 12.4 m-85 -97.04 0.6 48.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.563 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.84 143.31 77.17 Favored Pre-proline 0 N--CA 1.408 -2.529 0 CA-C-O 123.919 1.819 . . . . 0.0 113.267 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.737 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 51.0 Cg_endo -69.43 -60.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 1 C-N-CA 126.372 4.715 . . . . 0.0 112.973 -172.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.525 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.84 141.3 16.12 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.221 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.622 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.33 -26.98 68.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.133 0.467 . . . . 0.0 111.69 -177.07 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.29 80.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 169.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.684 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.8 t -58.22 -52.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.038 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.622 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.8 -52.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.461 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.6 m -62.55 -56.65 15.95 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.216 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.89 -46.01 78.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.485 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.831 ' O ' HD22 ' A' ' 443' ' ' LEU . 42.8 mt -59.56 -53.49 57.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.9 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.677 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.9 mm-40 -51.95 -34.74 43.35 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 124.932 1.395 . . . . 0.0 110.693 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -73.24 -60.87 2.04 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 175.599 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.4 -50.62 13.68 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.693 -0.63 . . . . 0.0 112.306 -172.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.831 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.58 -25.34 62.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.675 0.75 . . . . 0.0 111.487 -178.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.732 ' N ' HD21 ' A' ' 443' ' ' LEU . 11.5 t70 -72.6 -42.04 64.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.64 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -68.78 -7.95 38.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.598 ' HB3' HG21 ' A' ' 451' ' ' THR . 15.7 mm-40 -54.46 151.58 7.59 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 123.465 1.602 . . . . 0.0 114.436 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.74 -32.63 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.477 -3.056 . . . . 0.0 116.066 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.548 ' H ' ' HB ' ' A' ' 451' ' ' THR . 25.8 m-20 -135.49 175.77 9.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.464 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 5.8 m-20 -61.73 -56.89 14.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 172.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -62.9 -28.16 69.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 176.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.598 HG21 ' HB3' ' A' ' 446' ' ' GLU . 16.2 m -58.09 -43.18 86.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.803 1.183 . . . . 0.0 110.04 172.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 56.3 mtt180 -61.51 -29.75 70.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 172.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.586 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.24 -29.95 60.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.911 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.3 mm-40 -80.46 -45.74 17.08 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.286 1.041 . . . . 0.0 111.837 -173.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.54 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 25.7 p -103.28 -0.47 30.24 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.748 -167.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.599 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.3 t80 -49.22 -55.9 11.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.754 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 26.2 mm -69.04 -26.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.683 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -72.08 -43.95 64.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.599 ' O ' HG21 ' A' ' 463' ' ' VAL . 26.6 m80 -65.3 -31.09 72.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.707 171.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.653 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.45 -53.72 32.29 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.312 1.053 . . . . 0.0 109.181 -178.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.23 -30.18 71.37 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.19 -1.823 . . . . 0.0 110.188 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 458' ' ' GLN . . . -66.68 -49.24 66.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.017 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.684 ' CG1' ' HA ' ' A' ' 435' ' ' VAL . 33.6 t -65.61 -35.93 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.579 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.9 m-30 -61.27 -13.98 22.95 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.654 168.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 1.7 tp10 -93.09 -52.52 4.53 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.847 0.832 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.679 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.7 pt -63.79 -41.08 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.239 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.527 HD11 HD12 ' A' ' 469' ' ' LEU . 6.8 mt -83.8 -16.73 43.54 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.673 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 65.89 47.73 72.37 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.446 173.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 464' ' ' TYR . 1.2 mt -101.36 173.11 6.59 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.834 0.854 . . . . 0.0 111.733 -177.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.549 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.2 p30 -85.87 -44.9 12.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.63 -68.67 0.06 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.474 165.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.737 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 19.0 mmt180 -68.16 47.72 0.05 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -163.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.403 ' HA2' HD21 ' A' ' 469' ' ' LEU . . . 57.92 34.45 71.86 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.392 171.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.619 HE21 ' HB2' ' A' ' 472' ' ' ARG . 28.4 mm-40 -84.69 -51.45 6.81 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.972 0.892 . . . . 0.0 111.228 -173.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.673 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 45.4 t 68.99 53.59 0.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 112.506 -2.133 . . . . 0.0 109.118 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -39.79 -44.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 109.474 -3.512 . . . . 0.0 112.61 169.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 13.7 mmm-85 -46.47 138.47 5.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.559 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 67.7 mt -58.33 158.82 6.81 Favored 'General case' 0 N--CA 1.422 -1.858 0 C-N-CA 123.996 0.918 . . . . 0.0 112.914 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.435 -1.195 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.136 177.113 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.474 0.341 0 N-CA-C 111.756 -0.132 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.403 ' N ' HD11 ' A' ' 301' ' ' ILE . 3.5 mp 61.21 84.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.475 0.655 . . . . 0.0 109.88 -176.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 111.05 -173.9 16.39 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.038 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.414 ' HB ' HD11 ' A' ' 346' ' ' LEU . 54.0 m -81.35 116.17 21.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.608 0.718 . . . . 0.0 111.358 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.427 ' H ' HG12 ' A' ' 304' ' ' VAL . 1.5 p -64.57 122.9 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.702 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.706 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.1 mt -73.32 129.24 86.19 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 122.069 0.938 . . . . 0.0 113.048 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.535 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.0 Cg_endo -84.97 51.48 3.15 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.59 3.526 . . . . 0.0 109.093 165.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.682 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -46.63 -43.54 6.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 112.753 -2.021 . . . . 0.0 112.077 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.415 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -64.5 -35.6 81.47 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.055 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.492 ' HB3' HG13 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.45 -47.49 83.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.39 0.614 . . . . 0.0 109.695 172.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 339' ' ' PHE . 68.0 mt -59.0 -49.85 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 123.878 0.871 . . . . 0.0 113.197 175.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.682 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 33.1 mtp180 -62.25 -28.8 69.96 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.882 0.473 . . . . 0.0 111.013 177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 62.9 m -69.76 -34.65 74.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.326 0.584 . . . . 0.0 110.114 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.03 -41.73 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.723 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.711 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -83.42 -36.58 24.14 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.813 1.292 . . . . 0.0 110.087 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.84 34.86 8.68 Favored Glycine 0 C--N 1.304 -1.22 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.694 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.504 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 50.14 177.89 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.013 0 C-N-CA 124.296 1.038 . . . . 0.0 112.899 -174.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.56 ' HB3' HD11 ' A' ' 324' ' ' ILE . 46.2 Cg_exo -48.34 147.2 9.02 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.529 2.153 . . . . 0.0 112.786 -178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 51.1 Cg_endo -87.42 -99.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.341 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 10.3 mmm180 -100.45 -76.57 0.55 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.528 0.68 . . . . 0.0 110.555 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.6 m-20 -104.87 158.42 32.06 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.241 -174.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.438 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 36.6 Cg_exo -59.08 -50.13 9.52 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.824 2.349 . . . . 0.0 110.868 171.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.43 -23.64 2.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.224 -1.807 . . . . 0.0 112.547 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 2.3 mm-40 -87.42 -29.02 21.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.618 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -45.05 -46.8 30.71 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.643 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.692 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.94 -62.04 0.47 Allowed 'Trans proline' 0 CA--C 1.516 -0.399 0 C-N-CA 122.856 2.371 . . . . 0.0 112.997 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.561 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.56 -36.65 76.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.141 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.711 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 34.7 t90 -57.77 -35.07 70.26 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.096 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.44 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.8 OUTLIER -69.97 -49.17 54.34 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.101 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.51 -23.42 19.84 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.661 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -74.4 -42.5 59.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.132 0.968 . . . . 0.0 110.471 175.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.573 ' HB3' HG23 ' A' ' 314' ' ' THR . 43.4 m-20 -96.13 -23.47 16.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.918 -169.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' A' ' 335' ' ' ILE . . . -44.06 -49.38 22.3 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 113.681 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 52.2 Cg_endo -61.39 -33.0 89.58 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.551 2.168 . . . . 0.0 111.542 177.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 313' ' ' VAL . . . -72.3 -43.15 64.61 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 109.519 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 310' ' ' ILE . 91.6 mt -58.45 -49.4 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.734 173.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -55.42 -18.84 7.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.327 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.75 -46.68 8.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.145 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 309' ' ' HIS . 93.7 t -58.07 -72.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 123.4 1.572 . . . . 0.0 110.228 169.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.706 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 1.0 OUTLIER -91.14 131.7 36.18 Favored Pre-proline 0 N--CA 1.405 -2.717 0 CA-C-N 110.813 -2.903 . . . . 0.0 112.538 -170.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.541 ' HB2' HG22 ' A' ' 342' ' ' THR . 8.0 Cg_exo -75.01 -18.02 19.03 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.664 2.909 . . . . 0.0 110.652 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.534 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.5 p 33.09 72.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.648 -177.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.581 ' N ' HD13 ' A' ' 346' ' ' LEU . 60.0 p -81.38 5.83 16.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 112.778 -2.01 . . . . 0.0 113.463 -169.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.834 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.8 p -142.12 161.45 50.78 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.456 ' O ' ' SG ' ' A' ' 348' ' ' CYS . 51.2 Cg_exo -62.28 -48.25 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.262 2.641 . . . . 0.0 108.218 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.651 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.9 OUTLIER -41.76 -51.92 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 112.719 -2.037 . . . . 0.0 110.828 176.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.834 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.8 mt -57.09 -52.28 65.9 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.165 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 4.7 ttm180 -53.09 -42.96 66.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.318 -1.765 . . . . 0.0 110.696 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 1.042 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.8 m -70.19 -46.43 64.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 76.0 mtt180 -56.19 -42.83 77.77 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.232 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 346' ' ' LEU . 48.5 mt -58.17 -53.5 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 O-C-N 123.304 0.377 . . . . 0.0 111.426 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 348' ' ' CYS . 17.0 mt -57.66 -53.22 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 122.107 0.956 . . . . 0.0 110.841 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.495 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.1 m-20 -63.83 -35.14 79.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.956 -1.474 . . . . 0.0 109.982 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.29 -37.26 77.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.051 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 350' ' ' ILE 0.251 0.8 OUTLIER -57.26 -53.29 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.481 0 CA-C-O 123.069 1.414 . . . . 0.0 110.119 174.485 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.608 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -72.86 -25.29 61.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 111.559 -2.564 . . . . 0.0 109.338 -169.083 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.6 -79.01 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.586 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -119.62 57.4 0.56 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.6 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.591 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 31.5 p30 -76.13 161.74 28.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.254 0.222 . . . . 0.0 110.937 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.48 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -55.8 -66.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 122.947 0.499 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.41 15.16 1.1 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.514 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.591 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 5.9 mt -66.33 -2.99 5.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.698 0.399 . . . . 0.0 111.477 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.495 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 28.6 t -62.28 80.58 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 110.503 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.873 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.4 mm? -62.12 178.16 0.4 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.731 174.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 366' ' ' GLY . 44.5 p -116.77 157.39 46.31 Favored Pre-proline 0 CA--C 1.508 -0.669 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 1.042 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 19.5 Cg_endo -66.21 16.69 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.269 1.979 . . . . 0.0 113.528 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -135.43 6.22 4.23 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.26 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -109.76 -24.81 10.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.402 1.096 . . . . 0.0 109.954 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.873 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 6.5 m -93.97 19.77 8.63 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.076 -168.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -57.05 -39.79 75.57 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.433 -171.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.13 157.58 25.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.851 169.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.496 ' O ' HG13 ' A' ' 375' ' ' VAL . 86.3 m95 -70.14 -34.11 72.65 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.613 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 4.8 t0 -54.56 -48.83 71.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.695 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 28.0 t -69.15 -43.13 74.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.825 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.714 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.25 -51.57 67.21 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.548 HG22 ' CE ' ' A' ' 413' ' ' MET . 13.3 m -57.32 -44.5 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.603 0.716 . . . . 0.0 109.621 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.683 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -62.09 -45.86 91.65 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.005 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.516 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 48.8 m -68.55 -38.2 80.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.464 -171.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.21 -34.16 74.64 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.155 0.503 . . . . 0.0 110.411 176.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.692 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 67.5 t80 -73.13 -45.89 54.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.369 1.08 . . . . 0.0 109.4 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -52.3 -33.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.092 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.61 -39.21 87.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.653 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 50.2 p -98.83 -22.24 15.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.439 -167.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -108.97 22.83 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.642 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.37 19.15 39.1 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.847 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 65.09 159.77 0.11 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 111.694 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.438 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -126.27 151.88 72.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.289 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -98.96 55.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.535 2.824 . . . . 0.0 110.969 165.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.627 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.21 4.03 0.42 Allowed 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -173.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -71.13 -47.1 59.89 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.628 ' O ' HG11 ' A' ' 394' ' ' VAL . 99.5 mt-30 -74.74 -26.2 59.63 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.733 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.75 -31.3 47.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.004 0.82 . . . . 0.0 111.966 -173.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.405 ' HA2' ' CD1' ' A' ' 425' ' ' ILE . . . -54.57 -53.2 40.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.438 173.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.618 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 41.4 m-20 -64.99 -39.79 93.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.17 -46.21 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.42 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.62 ' O ' HG21 ' A' ' 399' ' ' VAL . 25.6 mm -58.94 -46.6 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.042 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.618 ' HG3' ' HA ' ' A' ' 393' ' ' ASN . 15.3 mmtt -52.84 -42.02 64.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.879 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.41 15.86 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.092 -173.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.654 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 3.0 mt -69.21 -41.45 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 117.133 0.466 . . . . 0.0 111.439 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.7 HG22 ' CG ' ' A' ' 429' ' ' TYR . 6.8 m -58.07 -44.54 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.609 0.719 . . . . 0.0 110.273 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.476 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.4 t70 -62.18 -39.03 91.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -84.88 -53.22 5.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.064 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.516 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -110.59 -30.74 7.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.508 -169.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.2 165.87 12.11 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.673 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.6 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.69 -44.83 98.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.58 ' HA ' ' CD1' ' A' ' 457' ' ' ILE . . . -54.55 -53.16 58.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.606 0.717 . . . . 0.0 111.87 -177.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -64.45 -49.77 70.16 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.273 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.654 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.26 -42.69 63.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 47.1 t80 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.616 0.722 . . . . 0.0 109.524 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.761 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.9 m -59.44 -52.55 65.14 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.613 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 414' ' ' LEU . 2.7 mm? -61.23 -48.67 80.4 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.645 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.496 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.85 -43.35 87.26 Favored Glycine 0 C--N 1.314 -0.655 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.546 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.596 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.56 -31.31 65.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.846 0.323 . . . . 0.0 111.02 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.761 ' HG3' ' O ' ' A' ' 409' ' ' THR . 53.2 mtm -70.08 -47.56 61.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.683 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 19.5 mt -58.55 -40.99 84.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.261 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.733 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -76.71 -12.62 60.02 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.729 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 88.36 43.73 5.48 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.659 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.596 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 0.8 OUTLIER 57.73 49.1 12.83 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.496 0.718 . . . . 0.0 112.471 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.717 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.2 OUTLIER -129.17 77.98 1.82 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 161.344 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 8.3 p90 -62.27 -31.47 72.06 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.341 -163.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.499 ' O ' ' HB3' ' A' ' 423' ' ' SER . 51.1 mt-30 -53.63 -48.03 69.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.312 -164.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.714 HD12 ' OG ' ' A' ' 415' ' ' SER . 1.1 pp -59.35 -50.62 73.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.955 0.407 . . . . 0.0 110.776 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.625 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -60.06 -38.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 123.021 1.391 . . . . 0.0 108.854 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.531 ' N ' HG23 ' A' ' 422' ' ' VAL . 42.4 t -62.56 -48.14 80.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.726 -2.488 . . . . 0.0 111.846 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.3 75.5 Favored Glycine 0 C--N 1.316 -0.568 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.402 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 422' ' ' VAL . 3.9 mt -72.1 -41.48 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.601 0.715 . . . . 0.0 110.025 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 427' ' ' ARG . 1.6 mm -57.57 -45.6 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.909 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.608 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -59.8 -29.15 68.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 122.646 1.212 . . . . 0.0 109.371 -173.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.8 -18.46 77.48 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.386 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.7 ' CG ' HG22 ' A' ' 399' ' ' VAL . 18.7 m-85 -100.0 3.17 44.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.565 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.02 145.89 70.82 Favored Pre-proline 0 N--CA 1.41 -2.452 0 CA-C-O 123.612 1.672 . . . . 0.0 113.308 168.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.697 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.7 Cg_endo -72.52 -62.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 1 C-N-CA 126.181 4.587 . . . . 0.0 113.378 -173.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.548 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -108.3 141.65 15.84 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.166 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.609 ' HA ' HG12 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.71 -29.88 71.0 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.903 0.351 . . . . 0.0 111.057 -177.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.43 81.48 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 172.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.672 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.1 t -59.27 -51.59 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.63 176.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -54.26 -54.85 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.474 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 61.4 m -61.61 -55.94 25.28 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.944 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.03 -46.17 78.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.81 ' O ' HD21 ' A' ' 443' ' ' LEU . 37.1 mt -59.37 -53.15 61.49 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.656 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.735 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 38.0 mm-40 -51.64 -35.09 40.71 Favored 'General case' 0 N--CA 1.419 -2.024 0 O-C-N 124.997 1.436 . . . . 0.0 110.447 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.74 -60.27 2.31 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 176.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -75.97 -50.86 13.72 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.743 -0.598 . . . . 0.0 112.002 -173.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.88 -24.08 61.76 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.719 0.771 . . . . 0.0 111.807 -179.001 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.735 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 11.1 t70 -72.18 -42.82 65.41 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.609 176.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.02 -7.99 45.55 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.609 ' HB3' HG21 ' A' ' 451' ' ' THR . 54.0 mm-40 -51.75 154.77 1.9 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 123.264 1.507 . . . . 0.0 114.43 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.471 ' HB ' HG22 ' A' ' 451' ' ' THR . 1.8 mp -53.36 -32.89 20.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 111.17 -2.741 . . . . 0.0 115.613 -172.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.557 ' H ' ' HB ' ' A' ' 451' ' ' THR . 48.1 m-20 -138.04 178.98 6.72 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.429 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.1 p-10 -64.88 -53.57 44.58 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -23.58 65.66 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 446' ' ' GLU . 19.2 m -59.04 -40.17 84.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 119.891 1.223 . . . . 0.0 109.453 171.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.597 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 72.6 mtp180 -61.23 -29.1 69.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.667 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.32 -34.01 59.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.204 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.405 ' HB2' HG21 ' A' ' 455' ' ' THR . 1.3 mm-40 -78.62 -44.92 22.79 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.903 -171.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.552 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 29.9 p -105.33 -1.23 25.42 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.298 -165.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.618 ' CE1' HD22 ' A' ' 460' ' ' LEU . 6.5 t80 -48.73 -51.49 28.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.716 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.58 ' CD1' ' HA ' ' A' ' 405' ' ' ALA . 24.3 mm -71.94 -26.59 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.634 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -71.51 -43.03 67.24 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.594 ' O ' HG22 ' A' ' 463' ' ' VAL . 53.7 m-70 -67.15 -30.34 70.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.178 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.674 HD23 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -66.66 -53.4 34.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.278 1.037 . . . . 0.0 109.126 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.652 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.6 m-80 -63.49 -31.29 72.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.682 173.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 458' ' ' GLN . . . -62.65 -53.53 53.17 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.192 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.706 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 26.1 t -62.36 -34.39 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.44 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.88 -15.39 42.2 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.125 169.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 10.9 mm-40 -89.95 -50.69 5.88 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.064 -1.023 . . . . 0.0 112.42 176.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.706 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -65.18 -39.82 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.904 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.47 HD13 HD11 ' A' ' 469' ' ' LEU . 7.0 mt -84.13 -17.1 41.21 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 66.05 49.56 57.44 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 112.106 -2.315 . . . . 0.0 113.591 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 464' ' ' TYR . 0.8 OUTLIER -101.65 175.01 5.7 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.809 0.844 . . . . 0.0 111.064 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.719 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 13.0 p30 -92.58 -43.25 9.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 165.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -161.56 -73.89 0.06 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.475 162.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.697 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 2.0 mpt_? -63.63 67.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.64 40.24 2.04 Favored Glycine 0 C--N 1.277 -2.709 0 CA-C-N 111.369 -2.65 . . . . 0.0 113.33 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.719 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 27.4 mm-40 -80.3 -56.3 4.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.152 0.977 . . . . 0.0 111.449 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 38.2 t 67.87 44.36 1.57 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.281 -2.236 . . . . 0.0 108.219 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER -37.51 -44.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 109.149 -3.66 . . . . 0.0 112.684 170.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.414 ' HG2' HD11 ' A' ' 476' ' ' ILE . 15.7 mmm180 -48.63 128.92 15.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.155 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.5 mt -71.55 -36.75 71.05 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.021 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 . . . . . 0 N--CA 1.432 -1.374 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.446 179.147 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.475 0.396 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.8 mp 60.13 78.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.998 0.904 . . . . 0.0 109.795 -175.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 83.51 -177.17 52.66 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.26 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 81.7 m -73.77 128.73 36.31 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.494 0.664 . . . . 0.0 111.254 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.459 ' H ' HG13 ' A' ' 304' ' ' VAL . 1.6 p -64.46 122.28 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.413 173.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.677 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 22.8 mt -74.45 127.01 88.26 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-O 121.844 0.831 . . . . 0.0 112.137 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' A' ' 308' ' ' GLN . 28.2 Cg_endo -74.8 -11.44 21.88 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 124.682 3.588 . . . . 0.0 111.466 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.687 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 6.1 tp 26.79 -64.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.298 0 C-N-CA 128.37 2.668 . . . . 0.0 115.877 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.556 ' H ' HG22 ' A' ' 307' ' ' ILE . 0.1 OUTLIER -57.66 -30.88 65.78 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.141 0.496 . . . . 0.0 111.246 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.497 ' HB3' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.73 -49.17 77.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.588 169.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 307' ' ' ILE . 60.9 mt -58.55 -48.11 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.036 0.934 . . . . 0.0 112.705 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.7 mtp180 -59.9 -30.66 69.18 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 122.559 0.344 . . . . 0.0 111.108 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.2 m -70.03 -33.96 72.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.582 HG13 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.24 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.903 178.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.727 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.5 p -83.52 -37.19 23.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.83 1.3 . . . . 0.0 110.152 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.5 34.66 8.4 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.252 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.6 mt-10 51.68 172.25 0.03 OUTLIER Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -175.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.505 ' HB3' HD12 ' A' ' 324' ' ' ILE . 22.2 Cg_exo -45.27 143.56 5.15 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.374 2.716 . . . . 0.0 113.189 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.527 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.6 Cg_endo -91.41 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.614 2.876 . . . . 0.0 112.903 -172.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.434 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 7.9 mmm180 -89.29 -81.34 0.28 Allowed 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 123.449 0.699 . . . . 0.0 110.894 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.439 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 16.3 m-20 -112.71 164.94 14.14 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.846 -177.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.65 -50.4 9.43 Favored 'Trans proline' 0 CA--C 1.509 -0.735 0 C-N-CA 122.549 2.166 . . . . 0.0 110.483 171.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -48.74 -20.63 0.5 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.003 -1.908 . . . . 0.0 112.928 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.439 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.1 mt-10 -98.44 -23.46 15.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.7 0.286 . . . . 0.0 111.405 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.657 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.88 -44.34 45.79 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.695 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 6.4 Cg_endo -47.96 -62.76 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.008 2.472 . . . . 0.0 113.086 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.566 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.89 -36.32 75.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.031 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.168 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.727 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 47.5 t90 -57.63 -36.01 71.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.329 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.484 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.93 -48.15 59.62 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.585 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.491 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -53.55 -23.62 20.92 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.786 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -73.95 -42.17 60.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.22 1.01 . . . . 0.0 110.551 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.569 ' HB3' HG23 ' A' ' 314' ' ' THR . 47.1 m-20 -95.98 -24.82 16.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.599 -1.637 . . . . 0.0 113.854 -169.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.94 -50.29 13.6 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 124.296 1.038 . . . . 0.0 113.582 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 51.0 Cg_endo -61.09 -33.16 91.86 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.652 2.235 . . . . 0.0 111.729 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.492 ' CB ' HG12 ' A' ' 313' ' ' VAL . . . -72.57 -43.93 62.75 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.622 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.577 HG12 HG22 ' A' ' 310' ' ' ILE . 88.6 mt -57.99 -48.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.74 -17.87 6.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.233 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.92 -44.49 9.06 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 309' ' ' HIS . 98.6 t -61.29 -69.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 123.399 1.571 . . . . 0.0 110.222 169.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.774 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.7 OUTLIER -94.47 129.9 35.31 Favored Pre-proline 0 N--CA 1.403 -2.789 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.663 -171.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.774 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 68.0 Cg_endo -72.7 -18.86 24.84 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 123.887 3.058 . . . . 0.0 110.994 173.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.467 HG22 ' CB ' ' A' ' 346' ' ' LEU . 2.5 p 33.9 68.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.426 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.604 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.4 p -78.37 1.64 21.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.616 -170.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.785 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.4 p -137.59 164.09 43.85 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.403 ' O ' ' SG ' ' A' ' 348' ' ' CYS . 50.3 Cg_exo -62.45 -50.58 4.3 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.145 2.564 . . . . 0.0 108.043 172.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.711 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 4.6 t0 -42.81 -47.34 5.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.013 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.785 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 8.9 mt -56.99 -53.04 62.56 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.797 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.682 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 41.3 ttm105 -54.98 -45.81 75.02 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.603 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 1.034 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.78 -47.8 65.28 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.793 0.33 . . . . 0.0 111.216 -175.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.643 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 70.8 mtt180 -56.0 -42.41 76.36 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.079 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 346' ' ' LEU . 52.6 mt -57.73 -53.48 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.399 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.484 ' HA ' HG13 ' A' ' 354' ' ' ILE . 23.0 mt -58.47 -52.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 122.203 1.001 . . . . 0.0 110.715 -170.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.532 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 23.3 m-20 -63.0 -36.11 82.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.152 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.446 ' HB2' HD13 ' A' ' 307' ' ' ILE . . . -69.63 -34.72 74.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.081 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.62 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.72 -53.92 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 122.925 1.345 . . . . 0.0 110.256 173.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.616 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -71.95 -27.46 62.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.618 -2.537 . . . . 0.0 109.585 -167.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 63.25 -70.79 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.943 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.72 97.29 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.322 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.574 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 26.9 p30 -124.59 164.41 19.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 122.736 0.414 . . . . 0.0 110.447 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.477 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -51.42 -59.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.082 0.467 . . . . 0.0 111.804 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -162.63 20.39 0.17 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.54 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.574 ' HG ' ' HB2' ' A' ' 358' ' ' ASN . 6.9 mt -66.05 -5.28 9.21 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 122.835 0.454 . . . . 0.0 111.615 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.532 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 23.3 t -61.42 83.1 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.205 0.526 . . . . 0.0 110.62 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.437 HD21 ' CD2' ' A' ' 378' ' ' LEU . 0.9 OUTLIER -62.48 173.36 1.25 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.659 175.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.535 ' C ' ' H ' ' A' ' 366' ' ' GLY . 71.9 p -113.73 162.43 22.67 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.622 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 1.034 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 10.5 Cg_endo -68.63 25.92 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.121 1.881 . . . . 0.0 112.386 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -138.01 -6.28 1.5 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.759 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -105.65 -20.87 13.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.83 1.3 . . . . 0.0 109.129 176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.826 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 2.7 p -79.03 20.69 0.47 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.846 -172.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.582 ' N ' HD11 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -61.49 -30.58 70.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.707 1.241 . . . . 0.0 108.495 -172.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 24.9 p -125.73 163.9 21.83 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 112.393 -2.185 . . . . 0.0 109.933 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.552 ' O ' HG12 ' A' ' 375' ' ' VAL . 66.7 m95 -70.92 -33.91 70.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 167.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.519 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -61.24 -44.89 96.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.746 -172.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 29.1 t -69.15 -42.9 75.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.723 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.19 -52.15 66.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 371' ' ' TRP . 13.1 m -58.56 -43.86 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.585 0.707 . . . . 0.0 109.422 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.7 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . . . -62.2 -46.19 90.0 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.095 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 37.3 m -66.41 -39.32 88.93 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.324 -173.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.723 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -59.69 -35.13 73.87 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.467 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.695 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 66.4 t80 -73.41 -45.96 51.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.491 1.139 . . . . 0.0 109.473 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.63 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -53.06 -32.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 112.625 -2.08 . . . . 0.0 111.314 171.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.3 OUTLIER -59.55 -38.69 81.75 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.442 0.697 . . . . 0.0 111.831 177.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 4.4 p -104.64 -20.91 13.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.62 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -108.34 24.46 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.87 21.12 29.0 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 114.587 0.595 . . . . 0.0 114.587 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 62.01 165.92 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.092 0.472 . . . . 0.0 110.976 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.511 ' CE2' HD23 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -130.52 154.21 81.59 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -94.56 47.75 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.386 2.724 . . . . 0.0 110.712 165.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.627 ' HA ' HD21 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.27 4.55 0.68 Allowed 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -173.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.08 -43.6 70.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.941 0.4 . . . . 0.0 110.569 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.651 ' O ' HG11 ' A' ' 394' ' ' VAL . 27.3 mt-30 -75.85 -25.4 56.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -170.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.905 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.11 -31.38 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.043 0.838 . . . . 0.0 112.024 -172.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 396' ' ' LYS . . . -54.86 -50.3 58.85 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.674 174.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.532 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.5 m-20 -69.84 -36.59 75.7 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.987 0.515 . . . . 0.0 111.814 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.657 HG21 ' O ' ' A' ' 391' ' ' LEU . 1.1 m -58.85 -48.51 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.574 ' O ' HG22 ' A' ' 399' ' ' VAL . 8.5 mm -58.37 -48.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.882 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 392' ' ' GLY . 0.2 OUTLIER -52.31 -46.32 65.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.312 -177.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -73.29 -44.13 35.85 Favored Glycine 0 C--N 1.31 -0.895 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.382 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.642 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 3.0 mt -69.15 -41.22 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 117.76 0.78 . . . . 0.0 111.582 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.648 HG23 ' CG ' ' A' ' 429' ' ' TYR . 6.5 m -57.93 -44.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.844 0.83 . . . . 0.0 109.552 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.401 ' N ' HG21 ' A' ' 399' ' ' VAL . 16.6 t70 -55.21 -46.05 75.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.328 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -85.3 -52.52 5.84 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.601 -170.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.562 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.7 OUTLIER -110.6 -30.39 7.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.52 0.676 . . . . 0.0 111.799 -170.254 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 124.84 166.16 12.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.705 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.599 ' HA ' HG13 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -62.95 -46.1 97.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.013 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.585 ' HB3' HG23 ' A' ' 457' ' ' ILE . . . -53.96 -52.54 60.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.617 0.722 . . . . 0.0 111.999 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.79 -49.91 68.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.308 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.642 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.23 -43.37 64.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.646 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.8 t80 -56.44 -46.72 80.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.524 0.678 . . . . 0.0 109.559 176.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.756 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.8 m -58.69 -52.26 66.47 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.65 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.584 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.7 -48.01 82.7 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.602 176.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' A' ' 414' ' ' LEU . . . -56.19 -43.24 89.03 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.598 ' HE1' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -72.2 -31.57 66.0 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.88 0.34 . . . . 0.0 110.69 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.756 ' HG3' ' O ' ' A' ' 409' ' ' THR . 62.5 mtm -70.18 -47.5 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 109.93 173.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.7 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 16.9 mt -59.18 -40.67 86.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.119 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.905 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.7 m -77.82 -12.76 60.01 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.964 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.61 44.13 4.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.206 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.598 ' HA ' ' HE1' ' A' ' 412' ' ' MET . 0.9 OUTLIER 58.46 39.99 24.52 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.762 0.825 . . . . 0.0 112.99 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.691 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.2 OUTLIER -123.46 79.55 1.7 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 165.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.513 ' O ' HG22 ' A' ' 422' ' ' VAL . 7.8 p90 -62.55 -31.12 71.85 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.8 -161.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.528 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.0 mt-30 -54.14 -47.76 71.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -164.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.696 HD12 ' OG ' ' A' ' 415' ' ' SER . 1.2 pp -59.21 -49.0 79.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.479 0.656 . . . . 0.0 110.974 177.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.622 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.7 -39.06 80.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.756 1.265 . . . . 0.0 109.208 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 30.0 t -60.8 -47.4 86.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.037 -2.347 . . . . 0.0 111.252 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.11 -38.19 75.4 Favored Glycine 0 C--N 1.315 -0.596 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 422' ' ' VAL . 1.7 mt -72.18 -43.99 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.583 0.706 . . . . 0.0 109.985 174.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.482 HD13 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -55.8 -44.28 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.73 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.628 ' HD2' ' C ' ' A' ' 427' ' ' ARG . 0.3 OUTLIER -61.67 -30.26 70.61 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-O 122.586 1.184 . . . . 0.0 108.907 -173.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.39 -18.08 78.07 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.966 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.648 ' CG ' HG23 ' A' ' 399' ' ' VAL . 15.0 m-85 -100.65 3.77 42.73 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -177.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.58 HD21 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.77 145.4 70.82 Favored Pre-proline 0 N--CA 1.418 -2.069 0 CA-C-O 123.546 1.641 . . . . 0.0 113.721 167.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.66 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 59.2 Cg_endo -72.19 -61.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 1 C-N-CA 126.245 4.63 . . . . 0.0 113.127 -173.038 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.533 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.59 141.11 15.61 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.202 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.608 ' HA ' HG11 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.46 -30.69 71.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.107 0.454 . . . . 0.0 111.143 -177.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.67 79.52 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 171.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.653 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 2.7 t -59.66 -51.38 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.397 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.608 HG11 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.81 -54.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 51.8 m -62.73 -56.11 20.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.226 -175.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.24 -45.93 79.81 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.64 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.826 ' O ' HD23 ' A' ' 443' ' ' LEU . 39.0 mt -59.43 -53.73 54.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.806 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.701 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.2 mm-40 -52.23 -34.16 44.61 Favored 'General case' 0 N--CA 1.417 -2.108 0 O-C-N 125.09 1.494 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.658 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.18 -60.69 2.12 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.25 14.51 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.733 -0.605 . . . . 0.0 112.392 -172.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.826 HD23 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.08 62.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.596 0.712 . . . . 0.0 111.606 -179.102 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.742 ' N ' HD22 ' A' ' 443' ' ' LEU . 12.7 t70 -72.19 -41.11 67.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.484 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.658 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -70.29 -8.08 47.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.544 ' HB3' HG23 ' A' ' 451' ' ' THR . 14.0 mm-40 -56.6 161.27 2.81 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 123.221 1.486 . . . . 0.0 114.371 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.84 -34.28 25.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 111.216 -2.72 . . . . 0.0 115.78 -169.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.59 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 24.6 m-20 -142.32 -178.18 5.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.486 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 10.7 p-10 -63.83 -55.26 24.25 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -64.28 -27.12 68.82 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.084 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.547 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 8.8 m -58.6 -44.67 89.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.381 0.991 . . . . 0.0 109.864 172.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.0 mtt180 -61.0 -29.89 69.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.189 172.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.646 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.57 -31.47 63.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.91 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.1 mm-40 -78.11 -46.24 21.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.728 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.533 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 27.5 p -103.69 -0.9 28.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.481 -166.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.604 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -49.28 -55.34 13.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.828 177.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' A' ' 405' ' ' ALA . 26.8 mm -69.62 -26.7 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.665 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -71.27 -43.96 66.18 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.603 ' O ' HG21 ' A' ' 463' ' ' VAL . 25.4 m80 -65.53 -30.62 71.39 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.857 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.692 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.91 -53.25 33.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.206 1.003 . . . . 0.0 109.303 -178.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.643 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -63.6 -31.5 72.68 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.719 173.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 458' ' ' GLN . . . -62.98 -53.15 58.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.41 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.68 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 26.5 t -62.41 -33.88 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 121.836 0.827 . . . . 0.0 110.249 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 471' ' ' ALA . 21.9 m-30 -61.96 -15.15 41.35 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.157 169.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 48.0 mt-10 -91.77 -49.36 6.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.909 -1.119 . . . . 0.0 112.822 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.68 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -64.65 -40.43 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.902 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.455 ' CB ' HD21 ' A' ' 469' ' ' LEU . 7.3 mt -83.47 -16.58 45.12 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 172.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.61 51.14 54.6 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 111.68 -2.509 . . . . 0.0 113.028 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 475' ' ' SER . 0.9 OUTLIER -100.48 -156.93 0.58 Allowed 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 122.16 0.981 . . . . 0.0 109.381 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.72 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.7 p30 -130.01 -41.04 1.3 Allowed 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 171.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -155.76 -82.19 0.07 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.426 -2.17 . . . . 0.0 110.813 155.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.66 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -57.34 69.62 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -172.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.476 ' HA2' HD11 ' A' ' 469' ' ' LEU . . . 36.47 42.79 0.68 Allowed Glycine 0 C--N 1.276 -2.755 0 CA-C-N 111.163 -2.744 . . . . 0.0 113.323 172.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.72 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.1 mm-40 -77.4 -59.51 2.75 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 122.147 0.975 . . . . 0.0 111.421 -172.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.741 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 36.7 t 67.15 50.87 0.97 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.185 -2.279 . . . . 0.0 107.976 -173.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.638 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.5 OUTLIER -38.37 -41.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 109.196 -3.638 . . . . 0.0 112.507 170.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.457 ' HG3' ' HA3' ' A' ' 468' ' ' GLY . 8.9 mmt180 -45.45 146.45 1.01 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.279 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.33 -15.51 36.57 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 . . . . . 0 C--O 1.251 1.165 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.322 179.231 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 110.076 -0.779 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.3 mp -64.89 -47.48 88.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -70.18 158.79 53.51 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.304 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 29.0 m -70.36 119.19 14.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.461 0.648 . . . . 0.0 111.282 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.71 125.09 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.203 173.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.713 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 36.2 mt -74.24 127.67 87.41 Favored Pre-proline 0 N--CA 1.425 -1.681 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.545 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.2 Cg_endo -84.96 50.21 2.8 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 125.011 3.807 . . . . 0.0 109.238 165.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.753 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.6 tp -45.41 -42.42 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.287 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' GLN . . . . . 0.585 ' HA ' ' HD3' ' A' ' 311' ' ' ARG . 26.4 mm-40 -60.86 -44.24 97.28 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.998 0.904 . . . . 0.0 111.653 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . 0.516 ' HB3' HG12 ' A' ' 338' ' ' VAL . 6.4 t-160 -58.97 -45.77 89.72 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.357 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.572 HG21 HG12 ' A' ' 335' ' ' ILE . 67.4 mt -59.22 -49.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.753 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 36.4 mtp180 -60.45 -31.28 70.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.523 -0.735 . . . . 0.0 110.987 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.6 m -69.76 -32.27 70.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.587 0.708 . . . . 0.0 109.881 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.56 -41.33 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.018 177.52 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.634 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.6 p -82.68 -36.7 25.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.728 1.251 . . . . 0.0 110.063 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.14 10.74 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 112.4 -2.182 . . . . 0.0 110.159 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.9 mt-10 49.12 173.57 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.126 0 C-N-CA 124.806 1.243 . . . . 0.0 113.254 -173.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.524 ' HB3' HD12 ' A' ' 324' ' ' ILE . 25.0 Cg_exo -45.1 154.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.038 2.492 . . . . 0.0 113.604 -176.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.402 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.6 Cg_endo -93.08 -109.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 123.29 2.66 . . . . 0.0 111.563 -175.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.432 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 14.4 mmm180 -97.2 -80.26 0.44 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.396 0.617 . . . . 0.0 111.058 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.485 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 46.0 m-20 -94.06 156.52 39.01 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.38 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 44.3 Cg_exo -58.53 -49.53 11.75 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.726 2.284 . . . . 0.0 110.483 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -21.94 2.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.194 -1.821 . . . . 0.0 112.665 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.485 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.0 mt-10 -85.0 -30.06 24.51 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.325 -0.234 . . . . 0.0 111.377 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.632 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -47.72 -45.05 59.25 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.697 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.0 Cg_endo -50.43 -62.65 0.37 Allowed 'Trans proline' 0 CA--C 1.517 -0.354 0 C-N-CA 122.802 2.335 . . . . 0.0 113.091 177.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.588 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.4 -35.43 69.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 122.664 1.221 . . . . 0.0 110.091 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . 0.634 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 49.7 t90 -58.46 -37.19 74.95 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.156 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.488 ' HB3' ' CG1' ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.14 -47.81 60.13 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.435 ' HA3' ' HE3' ' A' ' 413' ' ' MET . . . -53.67 -23.64 21.92 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.741 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.08 -43.27 58.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.407 1.098 . . . . 0.0 110.686 174.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.581 ' HB3' HG22 ' A' ' 314' ' ' THR . 52.6 m-20 -94.47 -25.03 17.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.407 -168.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ALA . . . . . 0.553 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.58 -50.3 9.5 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 124.453 1.101 . . . . 0.0 113.719 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.8 Cg_endo -62.78 -30.96 78.47 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.684 2.256 . . . . 0.0 111.801 177.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.498 ' CB ' HG11 ' A' ' 313' ' ' VAL . . . -73.52 -45.77 51.76 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.527 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.572 HG12 HG21 ' A' ' 310' ' ' ILE . 88.2 mt -57.17 -48.65 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.878 173.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.45 -16.37 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.769 -1.56 . . . . 0.0 112.14 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.8 -46.28 7.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.412 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.529 HG11 ' HG2' ' A' ' 306' ' ' PRO . 96.3 t -58.19 -70.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 123.499 1.619 . . . . 0.0 110.187 169.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.78 ' CD1' ' HD2' ' A' ' 340' ' ' PRO . 0.8 OUTLIER -92.64 131.81 33.05 Favored Pre-proline 0 N--CA 1.405 -2.679 0 CA-C-N 110.926 -2.852 . . . . 0.0 112.463 -172.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.78 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -73.25 -18.92 23.02 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 123.635 2.89 . . . . 0.0 110.737 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.487 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.7 p 33.26 70.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.54 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.556 ' N ' HD11 ' A' ' 346' ' ' LEU . 41.4 p -81.25 5.64 16.51 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.921 -1.945 . . . . 0.0 113.392 -169.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.773 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.9 p -143.14 158.02 59.31 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 121.517 0.675 . . . . 0.0 109.535 174.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 52.4 Cg_exo -62.08 -38.68 55.03 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 124.368 3.379 . . . . 0.0 109.435 172.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -52.36 -51.69 57.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 112.295 -2.229 . . . . 0.0 110.634 174.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.773 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.2 mt -58.4 -52.43 65.64 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.52 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 3.8 ttm180 -52.86 -41.48 64.34 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.116 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 45.7 t -69.71 -49.25 55.15 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.913 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.657 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.6 mtt180 -58.13 -40.01 80.2 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 346' ' ' LEU . 50.5 mt -58.68 -54.18 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.505 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.455 HD11 ' HB1' ' A' ' 374' ' ' ALA . 16.5 mt -57.56 -53.54 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 121.954 0.883 . . . . 0.0 111.055 -169.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . 0.441 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 52.0 m-20 -64.14 -34.26 77.64 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.079 -177.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 349' ' ' ARG . . . -69.77 -37.65 76.45 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.205 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.65 -51.61 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 122.875 1.322 . . . . 0.0 110.425 174.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 354' ' ' ILE . 0.3 OUTLIER -72.29 -25.76 61.71 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.81 -2.45 . . . . 0.0 109.298 -170.271 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 66.69 -77.04 0.14 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.169 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.9 92.65 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.191 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.621 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 23.3 p30 -111.89 163.65 13.98 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 122.803 0.441 . . . . 0.0 110.751 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . 0.469 ' H ' ' CD1' ' A' ' 359' ' ' ILE . 2.0 mp -53.86 -64.87 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 C-N-CA 122.81 0.444 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -150.55 13.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.621 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 6.1 mt -64.37 -2.8 2.42 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.651 0.38 . . . . 0.0 111.909 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.441 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.1 t -61.75 84.61 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.26 0.552 . . . . 0.0 110.181 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.676 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 2.2 mm? -63.52 -174.96 0.1 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.672 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' THR . . . . . 0.455 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 48.6 p -125.61 157.7 67.45 Favored Pre-proline 0 CA--C 1.506 -0.738 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . 0.578 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 32.3 Cg_exo -46.75 -39.34 23.7 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.912 1.741 . . . . 0.0 110.942 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.509 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -83.46 2.67 86.86 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.38 -172.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.444 ' HB2' HD11 ' A' ' 363' ' ' LEU . 44.1 m-20 -108.81 -21.76 12.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.089 0.947 . . . . 0.0 109.778 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.676 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 57.8 m -95.38 20.3 9.58 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.383 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -61.34 -36.25 79.66 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.964 1.364 . . . . 0.0 108.375 -173.157 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 15.2 p -115.51 163.03 16.34 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 112.189 -2.278 . . . . 0.0 109.491 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' TRP . . . . . 0.574 ' O ' HG12 ' A' ' 375' ' ' VAL . 35.5 m95 -70.71 -33.51 70.94 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.578 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -64.33 -46.4 83.7 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.806 -170.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.0 t -68.22 -42.61 79.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.358 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.698 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.54 -52.54 64.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 371' ' ' TRP . 12.8 m -58.44 -44.4 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.627 0.727 . . . . 0.0 109.489 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.665 ' O ' HD13 ' A' ' 380' ' ' ILE . . . -61.24 -46.0 92.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.883 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.537 ' HA ' ' HB ' ' A' ' 380' ' ' ILE . 33.0 m -67.82 -38.72 83.62 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.517 -172.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 1.8 mt -59.47 -34.62 72.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.346 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.697 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 59.2 t80 -73.53 -46.79 45.54 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.34 1.067 . . . . 0.0 109.263 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ILE . . . . . 0.665 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -51.92 -32.45 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.279 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.4 mpt_? -59.7 -40.14 86.96 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.537 0.684 . . . . 0.0 111.369 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.9 p -96.79 -22.51 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.75 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -110.0 23.33 14.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.58 21.05 19.94 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.6 m 64.92 159.59 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.237 0.541 . . . . 0.0 111.285 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.539 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -123.83 155.45 66.8 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 389' ' ' HIS . 85.0 Cg_endo -101.2 56.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.027 3.152 . . . . 0.0 111.395 168.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.568 ' HE1' ' HA ' ' A' ' 415' ' ' SER . 5.3 mmt 62.44 -19.56 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -173.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.493 ' H ' ' C ' ' A' ' 387' ' ' PRO . 5.9 t60 -56.21 -44.25 79.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.065 0.459 . . . . 0.0 111.31 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.695 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.9 mt-30 -75.04 -28.66 60.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.665 ' O ' HG21 ' A' ' 394' ' ' VAL . 3.8 mm? -54.8 -31.53 59.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.313 0.961 . . . . 0.0 111.037 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.654 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.02 -51.58 52.78 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.617 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.536 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 50.4 m-20 -68.1 -39.86 82.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.96 0.504 . . . . 0.0 112.168 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.695 HG13 ' O ' ' A' ' 390' ' ' GLN . 1.9 m -56.82 -45.16 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.662 ' O ' HG21 ' A' ' 399' ' ' VAL . 12.9 mm -58.91 -47.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.832 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.6 mmtt -52.48 -43.13 64.81 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 123.987 0.804 . . . . 0.0 111.325 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.16 -44.63 13.15 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.236 -172.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.645 ' HB ' ' CB ' ' A' ' 407' ' ' ALA . 2.8 mt -69.05 -40.61 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 117.603 0.702 . . . . 0.0 111.34 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.706 HG22 ' CG ' ' A' ' 429' ' ' TYR . 5.5 m -58.35 -44.27 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.802 0.81 . . . . 0.0 109.904 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 399' ' ' VAL . 14.6 t70 -59.17 -43.49 92.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.261 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 30.8 mm-40 -83.52 -52.21 6.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.073 -171.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.552 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -111.13 -30.98 7.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.758 -170.16 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.81 165.84 12.04 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.678 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.61 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.47 -44.68 98.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.586 ' HB1' HG22 ' A' ' 457' ' ' ILE . . . -54.88 -52.45 62.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.464 0.649 . . . . 0.0 111.946 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.497 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.45 -49.57 68.65 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.17 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.645 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.61 -41.63 63.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.611 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 46.2 t80 -58.18 -46.65 85.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.471 0.653 . . . . 0.0 109.489 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.764 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.0 m -58.52 -52.58 65.06 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.674 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.62 ' O ' ' HG ' ' A' ' 414' ' ' LEU . 2.7 mm? -62.57 -48.77 78.02 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.568 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.82 -43.39 87.1 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.903 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.568 ' HE1' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.23 -32.29 66.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.798 0.299 . . . . 0.0 111.184 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.764 ' HG3' ' O ' ' A' ' 409' ' ' THR . 68.5 mtm -69.84 -47.17 63.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.396 0.617 . . . . 0.0 109.855 174.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.651 ' CD2' ' HA ' ' A' ' 376' ' ' ALA . 18.0 mt -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.937 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.612 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.6 OUTLIER -74.81 -16.89 60.69 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.864 -173.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 101.27 29.05 6.52 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.1 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.568 ' HA ' ' HE1' ' A' ' 412' ' ' MET . 4.7 mm-40 59.23 43.61 16.77 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.074 0.95 . . . . 0.0 112.279 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.637 ' ND2' HD22 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -119.09 66.78 0.78 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 167.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.454 ' HD2' ' HB2' ' A' ' 423' ' ' SER . 0.7 OUTLIER -46.1 -35.03 4.6 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 111.554 -2.566 . . . . 0.0 113.435 -164.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.1 mt-30 -54.54 -46.47 73.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.637 HD22 ' ND2' ' A' ' 418' ' ' ASN . 1.6 pp -60.3 -50.1 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.905 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.586 ' H ' ' HG ' ' A' ' 421' ' ' LEU . 0.6 OUTLIER -60.02 -39.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.632 1.206 . . . . 0.0 109.19 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.499 ' N ' HG23 ' A' ' 422' ' ' VAL . 17.2 t -60.15 -46.36 89.95 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.643 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.63 -38.63 82.73 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.746 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.544 HD11 ' HA ' ' A' ' 422' ' ' VAL . 2.4 mt -71.79 -41.98 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.507 0.67 . . . . 0.0 109.932 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.489 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -57.86 -45.71 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.407 -1.269 . . . . 0.0 112.726 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.567 ' HA ' ' CD2' ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.52 -29.92 68.23 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.608 1.194 . . . . 0.0 109.325 -174.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.48 -15.18 77.34 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.625 175.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.706 ' CG ' HG22 ' A' ' 399' ' ' VAL . 13.9 m-85 -102.49 2.62 36.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.567 ' CD2' ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.68 145.07 78.81 Favored Pre-proline 0 N--CA 1.409 -2.479 0 CA-C-O 123.717 1.722 . . . . 0.0 113.516 168.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.69 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 71.9 Cg_endo -72.12 -55.68 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.426 1 C-N-CA 126.289 4.659 . . . . 0.0 113.618 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.69 140.59 16.31 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.4 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.605 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.23 -27.31 68.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.155 0.478 . . . . 0.0 111.29 -177.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -57.13 -48.22 79.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 170.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.679 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 3.3 t -57.71 -51.7 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.788 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -55.02 -53.05 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 91.8 m -61.52 -56.49 19.48 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.401 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.11 -45.34 79.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.519 -177.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.812 ' O ' HD21 ' A' ' 443' ' ' LEU . 41.9 mt -59.57 -53.13 61.59 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.706 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.77 -35.52 44.0 Favored 'General case' 0 N--CA 1.421 -1.905 0 O-C-N 124.844 1.34 . . . . 0.0 110.429 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.663 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.69 -59.83 2.53 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 177.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.76 13.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.416 0.553 . . . . 0.0 112.151 -173.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.812 HD21 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.75 -24.32 61.42 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.629 0.728 . . . . 0.0 111.776 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.708 ' N ' HD23 ' A' ' 443' ' ' LEU . 15.9 t70 -71.72 -42.73 66.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.564 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 37.9 mt-30 -69.34 -9.36 52.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -171.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 451' ' ' THR . 58.7 mm-40 -52.03 153.65 2.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.377 1.56 . . . . 0.0 114.322 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.463 ' HB ' HG23 ' A' ' 451' ' ' THR . 1.8 mp -53.1 -32.81 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.985 -2.825 . . . . 0.0 115.483 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.558 ' H ' ' HB ' ' A' ' 451' ' ' THR . 40.2 m-20 -139.13 178.74 6.95 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 452' ' ' ARG . 7.9 p-10 -64.42 -51.59 62.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.414 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -66.79 -25.55 66.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 174.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.608 HG22 ' HB3' ' A' ' 446' ' ' GLU . 13.6 m -59.43 -42.08 91.04 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 119.798 1.181 . . . . 0.0 109.631 171.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 54.7 mtt180 -59.89 -30.98 69.38 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.338 171.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.611 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.46 -29.63 59.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.042 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -82.82 -47.18 12.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.094 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.607 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -101.95 -1.53 31.73 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.338 -165.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.583 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.72 -51.72 27.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.586 HG22 ' HB1' ' A' ' 405' ' ' ALA . 24.1 mm -71.85 -27.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . 0.671 ' O ' ' HB2' ' A' ' 462' ' ' ALA . 0.0 OUTLIER -70.77 -42.55 70.25 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.629 ' O ' HG22 ' A' ' 463' ' ' VAL . 51.5 m-70 -66.92 -30.72 70.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.169 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.678 HD21 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -67.06 -53.27 32.69 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.192 0.996 . . . . 0.0 109.052 -179.2 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.636 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.98 -32.19 73.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.665 173.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 458' ' ' GLN . . . -61.82 -54.41 42.63 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.105 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.701 ' HA ' ' CD1' ' A' ' 466' ' ' ILE . 22.1 t -62.21 -34.42 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 CA-C-O 121.684 0.754 . . . . 0.0 110.589 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.4 m-30 -61.8 -15.08 38.69 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.219 170.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 46.3 mm-40 -91.89 -49.56 6.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.954 . . . . 0.0 112.732 176.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.701 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -65.14 -40.06 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.456 ' HB2' ' HG ' ' A' ' 469' ' ' LEU . 6.9 mt -84.11 -16.64 42.9 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.73 50.56 58.02 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.28 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 475' ' ' SER . 0.9 OUTLIER -100.26 -178.64 3.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.71 0.804 . . . . 0.0 110.364 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.758 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 15.7 p30 -101.11 -43.39 6.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.39 -76.69 0.07 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.273 158.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.69 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -60.23 71.22 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -172.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.479 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 36.69 45.84 1.06 Allowed Glycine 0 C--N 1.276 -2.772 0 CA-C-N 110.589 -3.005 . . . . 0.0 113.577 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.758 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 27.5 mm-40 -82.54 -57.83 3.18 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.012 0.911 . . . . 0.0 111.466 -173.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 39.0 t 66.94 42.78 2.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.493 -2.139 . . . . 0.0 108.155 -173.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER -36.53 -44.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 109.246 -3.616 . . . . 0.0 112.623 170.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 477' ' ' ARG . 11.4 mmm-85 -44.56 131.56 6.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.974 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.75 -26.82 67.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.931 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.457 -179.412 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.43 -1.462 0 CA-C-O 120.96 0.41 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.753 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 27.8 mt -77.96 122.27 85.24 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-O 121.989 0.9 . . . . 0.0 111.851 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 308' ' ' GLN . 25.4 Cg_endo -72.62 -14.02 27.32 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 124.887 3.725 . . . . 0.0 111.417 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.719 HG23 ' HG2' ' A' ' 308' ' ' GLN . 3.5 tp 34.71 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 C-N-CA 128.296 2.638 . . . . 0.0 116.088 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.719 ' HG2' HG23 ' A' ' 307' ' ' ILE . 61.6 mm-40 -58.71 -34.4 71.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.643 0.777 . . . . 0.0 110.41 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.582 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.6 t-160 -60.93 -47.41 86.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.583 173.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 307' ' ' ILE . 67.7 mt -61.76 -48.41 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 124.157 0.983 . . . . 0.0 112.68 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.694 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 9.5 mtp-105 -58.5 -31.56 67.99 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.655 0.382 . . . . 0.0 111.258 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 38.5 t -69.67 -32.78 71.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.56 0.695 . . . . 0.0 109.66 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.529 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.22 -41.23 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.942 177.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.702 HG22 ' HB3' ' A' ' 331' ' ' ASN . 33.6 p -82.33 -36.18 27.16 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.939 1.352 . . . . 0.0 109.807 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.66 32.73 8.39 Favored Glycine 0 N--CA 1.432 -1.576 0 CA-C-N 112.203 -2.271 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.448 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 46.9 mt-10 55.75 165.35 0.06 OUTLIER Pre-proline 0 N--CA 1.437 -1.085 0 C-N-CA 124.062 0.945 . . . . 0.0 113.429 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' A' ' 355' ' ' LEU . 33.1 Cg_exo -44.27 146.73 1.78 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.547 2.831 . . . . 0.0 113.095 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.09 -102.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.739 2.292 . . . . 0.0 111.171 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.46 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 11.2 mmm180 -102.36 -79.94 0.52 Allowed 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.284 0.564 . . . . 0.0 111.188 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 8.6 m-20 -94.75 164.17 20.38 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.51 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.418 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 37.4 Cg_exo -61.73 -48.11 9.67 Favored 'Trans proline' 0 CA--C 1.512 -0.577 0 C-N-CA 122.975 2.45 . . . . 0.0 110.613 168.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -51.29 -25.91 6.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.218 177.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 63.7 mt-10 -81.73 -33.5 31.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 0.0 111.226 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.733 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -48.38 -42.37 52.96 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -173.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.699 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.97 -63.23 0.31 Allowed 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 123.089 2.526 . . . . 0.0 113.019 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.592 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -61.23 -37.25 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.246 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.671 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -57.63 -36.53 71.94 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.569 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.827 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.59 -49.49 47.17 Favored 'General case' 0 N--CA 1.401 -2.916 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.75 -24.11 24.4 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.887 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.552 ' HD2' HG21 ' A' ' 406' ' ' THR . 1.0 OUTLIER -74.48 -42.14 59.52 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.994 0.902 . . . . 0.0 110.882 173.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.702 ' HB3' HG22 ' A' ' 314' ' ' THR . 49.2 m-20 -94.24 -23.63 17.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.522 -168.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.613 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.66 -50.29 9.75 Favored Pre-proline 0 C--N 1.308 -1.239 0 C-N-CA 124.523 1.129 . . . . 0.0 113.829 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 53.3 Cg_endo -63.19 -31.48 74.68 Favored 'Trans proline' 0 CA--C 1.51 -0.693 0 C-N-CA 122.473 2.115 . . . . 0.0 111.557 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.38 -42.44 59.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.501 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.618 HG23 HG23 ' A' ' 310' ' ' ILE . 95.5 mt -58.27 -48.01 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.947 174.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.39 -17.96 2.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.496 -1.684 . . . . 0.0 112.368 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.09 -52.8 5.52 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.03 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.628 HG11 HG13 ' A' ' 310' ' ' ILE . 96.8 t -57.78 -71.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 123.506 1.622 . . . . 0.0 110.238 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.753 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.6 123.46 72.6 Favored Pre-proline 0 N--CA 1.403 -2.82 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.588 -174.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.705 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 74.1 Cg_endo -72.7 -17.22 26.25 Favored 'Trans proline' 0 CA--C 1.495 -1.454 0 C-N-CA 123.947 3.098 . . . . 0.0 110.267 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 32.62 66.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 111.683 -2.508 . . . . 0.0 110.103 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.563 ' N ' HD12 ' A' ' 346' ' ' LEU . 46.6 p -79.08 4.11 15.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.738 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.803 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.2 p -140.74 159.5 62.34 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.697 ' HB3' HD12 ' A' ' 369' ' ' LEU . 70.5 Cg_exo -60.33 -46.21 19.18 Favored 'Trans proline' 0 CA--C 1.498 -1.296 0 C-N-CA 123.571 2.847 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.638 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -41.33 -56.52 2.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.4 175.456 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.803 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.9 mt -55.85 -51.24 68.22 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.051 -1.432 . . . . 0.0 111.0 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.834 ' HA ' HD12 ' A' ' 350' ' ' ILE . 4.7 ttm180 -49.83 -48.06 51.2 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.959 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 1.117 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.7 m -68.88 -47.1 66.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.949 -177.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.587 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.0 mtp180 -62.37 -34.3 76.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.88 ' O ' HG12 ' A' ' 354' ' ' ILE . 28.1 mt -58.24 -53.04 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.753 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.627 ' O ' HD22 ' A' ' 355' ' ' LEU . 19.7 mt -57.81 -53.89 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 121.922 0.868 . . . . 0.0 111.201 -170.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.566 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 13.5 m-20 -63.89 -35.68 81.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.133 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ALA . . . . . 0.566 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.56 -29.91 66.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.68 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.88 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.03 -58.85 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 122.945 1.355 . . . . 0.0 110.118 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.733 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.13 -27.95 57.27 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.182 -167.403 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.74 -72.56 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.341 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -106.63 52.15 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.562 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.732 HD22 ' HB2' ' A' ' 361' ' ' LEU . 12.7 p-10 -89.88 129.45 36.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 122.861 0.464 . . . . 0.0 109.911 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.662 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -48.24 -71.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.881 -170.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.37 6.68 5.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.523 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.732 ' HB2' HD22 ' A' ' 358' ' ' ASN . 3.5 mt -70.96 -6.19 36.76 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.582 0.706 . . . . 0.0 109.962 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.566 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 19.5 t -63.7 78.89 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.413 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.772 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.9 mm? -61.14 -179.69 0.16 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.184 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 366' ' ' GLY . 49.2 p -119.76 157.71 51.57 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.436 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 1.117 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 57.7 Cg_endo -69.79 25.32 0.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.115 1.876 . . . . 0.0 113.254 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -134.32 -4.0 2.97 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.647 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.563 ' HB2' HD12 ' A' ' 363' ' ' LEU . 1.5 m-20 -106.88 -21.21 13.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.119 0.961 . . . . 0.0 110.451 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.887 ' HB2' ' SG ' ' A' ' 348' ' ' CYS . 3.8 m -94.41 24.16 4.7 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.638 -168.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.9 -35.89 64.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.332 1.063 . . . . 0.0 109.356 -172.176 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.06 159.48 23.15 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.304 172.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.643 ' O ' HG13 ' A' ' 375' ' ' VAL . 58.7 m95 -69.63 -35.48 75.28 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.562 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.32 -41.96 98.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.969 -175.211 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 92.0 p -67.47 -44.48 78.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.906 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.586 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -63.43 -52.83 59.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.827 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.3 m -56.11 -45.03 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.453 0.645 . . . . 0.0 109.559 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.04 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.05 -45.66 90.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.999 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.63 HG21 HD11 ' A' ' 363' ' ' LEU . 24.0 m -68.05 -37.24 81.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.289 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -61.73 -34.83 76.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.699 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 68.1 t80 -73.38 -45.15 56.51 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.461 1.124 . . . . 0.0 109.097 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.6 -33.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 112.647 -2.07 . . . . 0.0 111.167 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.41 -44.39 95.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.538 0.685 . . . . 0.0 111.068 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 32.7 p -93.73 -23.68 18.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.82 -167.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' HIS . . . . . 0.464 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 30.6 m80 -109.55 23.75 14.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.57 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.91 36.15 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 114.223 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m 66.27 159.54 0.13 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 111.494 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -129.47 151.22 77.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -96.32 54.1 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 110.906 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.688 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.02 8.16 0.72 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -70.69 -45.65 64.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.102 0.477 . . . . 0.0 110.479 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.657 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.6 mt-30 -75.26 -28.17 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -170.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.695 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.34 -31.61 45.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.025 0.829 . . . . 0.0 112.115 -170.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.644 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -53.18 41.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.925 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 18.2 m-20 -67.48 -37.48 82.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.3 m -58.5 -45.75 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 110.616 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 399' ' ' VAL . 9.5 mm -58.25 -47.16 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.855 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.65 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.0 mmtt -52.42 -39.86 61.48 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 124.205 0.94 . . . . 0.0 111.893 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -77.39 -44.62 12.75 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.68 -1.247 . . . . 0.0 113.146 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.4 mt -69.39 -42.72 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 111.749 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.2 m -57.09 -43.96 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.562 0.696 . . . . 0.0 110.226 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 399' ' ' VAL . 6.1 t70 -58.47 -39.76 80.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.861 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 47.7 mt-30 -86.38 -53.62 4.9 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.28 -173.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.515 ' HG3' HG22 ' A' ' 398' ' ' ILE . 0.6 OUTLIER -113.19 -30.85 6.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.107 -166.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.29 165.83 12.09 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.856 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.939 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.1 -43.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.32 -50.57 71.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.92 0.391 . . . . 0.0 111.871 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.566 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.54 -51.42 62.93 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.705 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.878 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.33 -41.41 65.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.582 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 48.0 t80 -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.635 0.731 . . . . 0.0 109.366 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.799 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.3 m -59.91 -53.42 58.1 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.808 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.71 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 117.887 0.312 . . . . 0.0 110.681 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.28 -45.24 83.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.405 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.735 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.4 OUTLIER -70.41 -32.21 69.74 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.645 0.723 . . . . 0.0 111.075 177.318 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.799 ' HG3' ' O ' ' A' ' 409' ' ' THR . 49.7 mtm -68.65 -48.04 65.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.53 0.681 . . . . 0.0 109.521 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.04 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.3 mt -59.66 -40.14 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.653 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.695 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -78.32 -17.23 56.85 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.803 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 86.78 47.05 4.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.839 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.623 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 57.96 47.54 14.81 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.643 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 12.6 p30 -125.89 74.36 1.42 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.612 1.673 . . . . 0.0 106.953 161.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.735 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 2.1 p90 -58.57 -33.49 70.0 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.165 -2.288 . . . . 0.0 110.826 -160.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -55.11 -43.45 74.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.495 -165.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.497 ' HG ' ' H ' ' A' ' 422' ' ' VAL . 2.0 pp -63.42 -49.63 72.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.242 0.544 . . . . 0.0 110.721 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.68 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.71 -39.45 81.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.834 1.302 . . . . 0.0 109.207 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.556 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 41.2 t -61.91 -44.36 96.95 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.076 -2.329 . . . . 0.0 111.723 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.98 -40.74 82.97 Favored Glycine 0 C--N 1.316 -0.557 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.713 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -71.4 -41.92 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.623 0.725 . . . . 0.0 110.167 175.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.4 mm -55.13 -42.74 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.483 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.676 ' HA ' HD23 ' A' ' 430' ' ' LEU . 3.3 tmm_? -58.86 -36.05 73.96 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 123.201 1.477 . . . . 0.0 109.383 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.08 -8.34 69.18 Favored Glycine 0 C--N 1.283 -2.397 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.224 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.1 m-85 -105.6 -0.55 25.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.55 142.84 82.29 Favored Pre-proline 0 N--CA 1.406 -2.637 0 CA-C-O 123.585 1.66 . . . . 0.0 113.017 170.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.754 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 67.6 Cg_endo -70.75 -55.25 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.386 1 C-N-CA 126.164 4.576 . . . . 0.0 113.212 -172.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -118.79 143.5 17.48 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.372 -178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.867 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.31 -26.77 68.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.992 0.396 . . . . 0.0 111.268 -177.097 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.58 -48.46 79.32 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.985 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.5 t -58.25 -51.54 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.807 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.867 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -55.29 -53.33 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.402 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 99.9 m -61.85 -56.67 16.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.169 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.19 -45.93 79.59 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.57 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.811 ' O ' HD22 ' A' ' 443' ' ' LEU . 41.8 mt -59.66 -53.15 61.41 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.651 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.716 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 39.8 mm-40 -51.51 -35.44 40.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 O-C-N 124.882 1.364 . . . . 0.0 110.683 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.39 -60.59 2.17 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -76.09 -50.29 15.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.77 -0.581 . . . . 0.0 111.901 -172.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.811 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.88 63.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.384 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.747 ' N ' HD23 ' A' ' 443' ' ' LEU . 8.2 t70 -73.95 -41.85 61.4 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.129 0.966 . . . . 0.0 110.747 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.18 -8.15 43.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.514 ' HB3' ' CG2' ' A' ' 451' ' ' THR . 51.5 mm-40 -51.77 157.16 1.24 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.377 1.561 . . . . 0.0 114.186 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.431 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -53.87 -32.92 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.841 -2.89 . . . . 0.0 115.191 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.665 ' H ' ' HB ' ' A' ' 451' ' ' THR . 68.9 m-20 -135.18 178.22 7.2 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.417 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.8 p-10 -66.54 -51.48 56.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -69.43 -22.98 63.62 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.388 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 31.1 m -57.79 -39.5 77.67 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 119.888 1.222 . . . . 0.0 109.398 170.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.617 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 75.7 mtt180 -60.72 -30.42 69.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.356 172.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.582 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.84 -35.36 59.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.164 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.93 -43.16 25.3 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.654 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 40.2 p -101.46 -2.09 31.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.295 -169.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.685 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.2 t80 -49.04 -54.58 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.827 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.3 mm -69.97 -26.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -42.96 63.59 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 463' ' ' VAL . 39.7 m-70 -67.3 -31.04 71.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.562 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.724 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -64.37 -53.89 41.53 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.174 0.987 . . . . 0.0 109.093 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.45 -30.69 71.42 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.799 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -66.94 -48.67 67.9 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.463 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.985 HG11 ' HA ' ' A' ' 435' ' ' VAL . 34.2 t -65.35 -36.24 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.471 175.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.5 m-30 -60.17 -13.9 14.54 Favored 'General case' 0 C--O 1.202 -1.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.625 168.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.3 tp10 -95.52 -51.93 4.34 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.213 -0.929 . . . . 0.0 112.467 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -62.62 -41.36 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.374 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.805 HD12 HD11 ' A' ' 469' ' ' LEU . 6.7 mt -83.94 -17.51 40.4 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.822 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.31 49.67 60.1 Favored Glycine 0 C--O 1.211 -1.294 0 CA-C-N 111.481 -2.599 . . . . 0.0 113.239 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.805 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -102.86 172.91 6.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 123.951 0.9 . . . . 0.0 110.149 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.585 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.5 p-10 -92.64 -39.59 11.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -161.96 -75.57 0.05 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.197 159.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.754 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -66.26 71.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.064 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.47 42.0 2.46 Favored Glycine 0 C--N 1.275 -2.817 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.217 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.585 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 3.3 mm100 -80.24 -54.83 5.38 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.472 1.13 . . . . 0.0 111.102 -174.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.1 t 68.91 61.16 0.33 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.372 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.822 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.401 0 CA-C-N 111.023 -2.808 . . . . 0.0 111.893 174.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.431 -1.396 0 CA-C-O 120.824 0.345 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.786 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.7 mt -77.2 123.66 87.12 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 122.026 0.917 . . . . 0.0 112.657 -174.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 308' ' ' GLN . 37.4 Cg_endo -73.55 -20.04 20.99 Favored 'Trans proline' 0 CA--C 1.502 -1.106 0 C-N-CA 124.881 3.721 . . . . 0.0 111.116 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.711 HG23 ' HG2' ' A' ' 308' ' ' GLN . 3.6 tp 41.03 -63.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 127.833 2.453 . . . . 0.0 115.584 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.711 ' HG2' HG23 ' A' ' 307' ' ' ILE . 69.7 mm-40 -59.35 -33.67 71.43 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 123.409 0.684 . . . . 0.0 110.631 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.518 ' CG ' HG13 ' A' ' 338' ' ' VAL . 8.7 t-160 -60.5 -47.79 84.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.514 172.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.654 HG13 HG11 ' A' ' 338' ' ' VAL . 64.9 mt -60.28 -48.66 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 123.875 0.87 . . . . 0.0 112.091 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.692 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 14.1 mtp180 -57.5 -30.45 65.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 122.852 0.461 . . . . 0.0 111.798 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -34.17 74.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.462 0.648 . . . . 0.0 109.957 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.504 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.92 -40.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.515 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.743 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 36.3 p -81.91 -36.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.827 1.298 . . . . 0.0 109.793 -176.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 85.93 36.03 10.66 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 112.315 -2.221 . . . . 0.0 111.064 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 34.3 mt-10 53.97 168.21 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.585 ' HG3' HD12 ' A' ' 355' ' ' LEU . 63.7 Cg_exo -47.13 147.13 5.63 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.674 2.916 . . . . 0.0 113.55 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 18.0 Cg_endo -96.94 -105.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.769 2.979 . . . . 0.0 113.378 -170.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.432 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 15.5 mmt180 -86.52 -86.26 0.15 Allowed 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 123.207 0.603 . . . . 0.0 110.687 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 22.6 m-20 -102.9 166.36 12.04 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.036 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.518 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 34.5 Cg_exo -58.35 -50.35 9.94 Favored 'Trans proline' 0 CA--C 1.511 -0.631 0 C-N-CA 122.536 2.158 . . . . 0.0 110.571 169.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.474 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -60.32 -11.72 7.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.295 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 320' ' ' ASN . 1.6 mm-40 -92.19 -22.52 19.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.257 . . . . 0.0 111.591 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.765 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.71 -40.88 56.4 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.74 ' HA ' HD23 ' A' ' 378' ' ' LEU . 7.9 Cg_endo -49.61 -62.56 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.916 2.411 . . . . 0.0 113.05 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.67 ' O ' ' HG3' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -60.46 -37.2 73.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 122.329 1.062 . . . . 0.0 110.303 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.743 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 63.1 t90 -58.56 -38.05 77.02 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.741 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.831 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -70.85 -50.59 33.62 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -54.36 -24.05 28.73 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.554 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 326' ' ' ILE . 21.4 mtp180 -75.21 -40.59 59.08 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 122.271 1.034 . . . . 0.0 112.0 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.618 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.0 m-20 -94.27 -24.41 17.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.511 -1.677 . . . . 0.0 113.195 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.57 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.67 -49.28 13.3 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 124.635 1.174 . . . . 0.0 113.803 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.5 Cg_endo -60.78 -34.41 91.64 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 122.464 2.109 . . . . 0.0 111.488 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -74.06 -43.39 57.93 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.544 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.621 HG23 HG23 ' A' ' 310' ' ' ILE . 94.1 mt -58.26 -47.08 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.013 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -13.8 2.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.995 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.86 -51.18 4.62 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.26 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.654 HG11 HG13 ' A' ' 310' ' ' ILE . 94.6 t -57.81 -70.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 123.128 1.442 . . . . 0.0 109.846 170.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.811 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.5 OUTLIER -87.4 125.68 64.79 Favored Pre-proline 0 N--CA 1.408 -2.526 0 CA-C-N 111.644 -2.526 . . . . 0.0 111.885 -175.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.671 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.1 Cg_endo -70.83 -19.71 30.68 Favored 'Trans proline' 0 CA--C 1.493 -1.566 0 C-N-CA 123.736 2.957 . . . . 0.0 110.283 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 33.24 70.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.54 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.569 ' N ' HD12 ' A' ' 346' ' ' LEU . 68.7 p -79.96 2.65 22.77 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.684 -2.053 . . . . 0.0 112.821 -170.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.81 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 18.0 p -143.22 161.65 46.8 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-O 121.457 0.646 . . . . 0.0 109.753 177.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.1 -40.67 32.26 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 124.403 3.402 . . . . 0.0 109.8 172.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -47.86 -55.11 10.56 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.625 -2.079 . . . . 0.0 110.298 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.81 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.7 mt -57.64 -51.38 69.76 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.817 -175.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.791 ' HA ' HD12 ' A' ' 350' ' ' ILE . 10.1 ttm180 -52.92 -42.06 65.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.934 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.509 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 42.0 t -68.26 -49.95 57.13 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.972 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.657 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 60.3 mtp180 -61.14 -37.64 83.57 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.476 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.894 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -57.44 -52.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 O-C-N 123.371 0.419 . . . . 0.0 111.006 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.613 ' O ' HD22 ' A' ' 355' ' ' LEU . 18.3 mt -58.38 -54.19 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 122.098 0.952 . . . . 0.0 110.964 -172.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.573 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 21.8 m-20 -63.96 -35.62 81.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.004 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ALA . . . . . 0.565 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.77 -29.22 65.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.876 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.894 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.8 mm -56.67 -59.49 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 CA-C-O 122.794 1.283 . . . . 0.0 110.161 174.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.765 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.87 -26.3 54.07 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 111.977 -2.374 . . . . 0.0 109.772 -167.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.58 -71.68 1.56 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.065 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -115.85 33.07 5.37 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.949 -176.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.63 HD21 ' N ' ' A' ' 358' ' ' ASN . 0.0 OUTLIER -58.32 134.32 56.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 175.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.707 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -47.77 -72.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 C-N-CA 124.237 1.015 . . . . 0.0 112.854 -170.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -131.62 7.6 5.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.758 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.586 ' HB3' HD12 ' A' ' 378' ' ' LEU . 2.6 mt -70.89 -4.59 25.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.669 0.747 . . . . 0.0 109.942 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.573 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 8.7 t -63.62 80.31 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.994 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.861 HD11 HG21 ' A' ' 377' ' ' THR . 1.7 mm? -60.35 -170.82 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 30.5 p -124.77 157.49 65.88 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.613 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 53.0 Cg_exo -46.65 -37.73 21.05 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.09 1.86 . . . . 0.0 111.491 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.528 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -86.05 2.96 87.62 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.693 -0.685 . . . . 0.0 114.594 -172.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.698 ' HB2' HD12 ' A' ' 363' ' ' LEU . 24.2 m-20 -109.21 -22.15 12.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.916 0.865 . . . . 0.0 110.083 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.732 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 62.7 m -94.3 19.74 9.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.67 -169.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.528 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -58.74 -41.27 86.06 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.897 -170.166 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.9 157.25 27.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 113.276 -1.783 . . . . 0.0 109.373 170.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.641 ' O ' HG13 ' A' ' 375' ' ' VAL . 51.5 m95 -69.59 -35.89 75.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.433 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.95 -38.56 91.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.352 -174.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 37.1 t -70.25 -44.0 69.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.11 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.551 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -63.33 -52.17 62.98 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.831 HG12 ' HB3' ' A' ' 328' ' ' LEU . 14.9 m -55.63 -46.35 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.494 0.664 . . . . 0.0 110.192 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.089 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -58.52 -37.5 75.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.848 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.861 HG21 HD11 ' A' ' 363' ' ' LEU . 39.0 m -75.29 -41.75 56.37 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.931 -171.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.74 HD23 ' HA ' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -58.82 -34.42 71.5 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.821 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.712 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 30.0 t80 -70.99 -49.1 48.96 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.49 1.138 . . . . 0.0 109.627 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.03 -32.12 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.976 170.519 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -60.0 -34.4 73.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.878 0.471 . . . . 0.0 111.451 175.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 26.1 p -103.83 -23.34 13.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.956 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -110.12 22.94 14.96 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.15 17.04 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 114.359 0.504 . . . . 0.0 114.359 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.427 HG23 HG13 ' A' ' 380' ' ' ILE . 1.1 m 66.64 154.79 0.09 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.386 0.613 . . . . 0.0 111.236 -175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -119.12 154.57 53.52 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 389' ' ' HIS . 83.2 Cg_endo -96.09 54.55 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.36 2.707 . . . . 0.0 111.207 167.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.783 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.0 -7.44 0.07 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.404 ' H ' ' C ' ' A' ' 387' ' ' PRO . 45.4 t-80 -69.21 -43.79 73.4 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.659 0.266 . . . . 0.0 111.235 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.2 mt-30 -69.38 -26.24 64.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.783 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.8 mm? -54.03 -29.82 45.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.354 0.525 . . . . 0.0 110.976 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.653 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.24 -53.29 38.61 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.683 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.589 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 34.4 m-20 -64.36 -41.38 96.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.861 0.464 . . . . 0.0 111.947 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.72 -45.2 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.249 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.701 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.8 mm -58.05 -47.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.161 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 27.3 mmtt -52.78 -42.62 65.19 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.027 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -75.7 -44.91 18.96 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.494 -1.336 . . . . 0.0 112.637 -173.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.904 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.1 mt -69.87 -41.46 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 117.16 0.48 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.3 m -57.35 -43.57 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.54 0.686 . . . . 0.0 110.381 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 399' ' ' VAL . 2.7 t70 -65.66 -37.43 86.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.975 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 74.4 mt-30 -82.56 -52.63 6.66 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.458 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.563 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -115.14 -30.39 6.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.031 -167.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 128.33 164.69 11.63 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.043 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.937 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -63.75 -43.01 97.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 122.653 0.381 . . . . 0.0 111.783 -176.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.638 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -57.26 -50.41 72.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.294 0.568 . . . . 0.0 111.246 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.563 HG21 ' HD2' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -63.37 -52.04 63.35 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 179.294 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.904 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.74 -40.41 66.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 176.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.604 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 32.9 t80 -58.4 -43.53 88.61 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.791 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.4 m -62.84 -53.18 58.11 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.624 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.659 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.14 -49.49 77.42 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.249 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.14 -42.34 87.59 Favored Glycine 0 C--N 1.314 -0.649 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.255 -174.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.75 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.17 -31.84 66.29 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 116.686 0.243 . . . . 0.0 110.956 179.085 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.791 ' HG3' ' O ' ' A' ' 409' ' ' THR . 50.8 mtm -69.51 -47.98 62.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 109.742 173.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.089 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.1 mt -59.02 -40.58 85.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.453 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.674 ' HG ' ' HG ' ' A' ' 391' ' ' LEU . 0.2 OUTLIER -77.08 -8.82 58.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.394 -177.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.42 33.54 7.97 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.952 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.75 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.3 mm100 57.26 48.46 15.03 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.054 -1.073 . . . . 0.0 112.814 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.485 ' OD1' HD21 ' A' ' 421' ' ' LEU . 12.9 p30 -120.17 63.53 0.83 Allowed 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 165.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.732 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 1.0 OUTLIER -44.59 -35.02 2.37 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.426 -2.624 . . . . 0.0 112.871 -163.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 39.5 mt-30 -55.71 -43.01 76.08 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -165.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.486 ' HG ' ' H ' ' A' ' 422' ' ' VAL . 1.9 pp -63.39 -48.4 78.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.54 -38.99 79.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.579 1.181 . . . . 0.0 109.059 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.51 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 35.9 t -59.62 -46.34 89.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.356 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.9 -39.03 76.97 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.207 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.1 -40.56 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.582 0.706 . . . . 0.0 110.24 174.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 404' ' ' VAL . 1.8 mm -58.13 -45.21 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.023 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.665 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.72 -29.53 68.19 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.76 1.267 . . . . 0.0 108.746 -174.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.17 -15.37 74.52 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 112.71 -2.041 . . . . 0.0 112.562 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.604 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 10.2 m-85 -101.17 -0.33 36.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.27 142.9 80.6 Favored Pre-proline 0 N--CA 1.414 -2.263 0 CA-C-O 123.653 1.692 . . . . 0.0 113.626 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.747 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 66.9 Cg_endo -71.71 -61.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.227 4.618 . . . . 0.0 113.603 -172.19 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.561 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.15 142.17 17.04 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.147 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.918 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.96 -27.47 68.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.316 0.558 . . . . 0.0 111.701 -176.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.809 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.22 -48.89 77.66 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.048 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.2 t -61.61 -37.66 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.485 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.918 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.13 -44.19 65.48 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.261 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 67.1 m -71.9 -54.94 8.47 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.433 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.0 -46.11 78.84 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.414 0.446 . . . . 0.0 111.168 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 460' ' ' LEU . 21.1 mt -60.11 -54.11 49.8 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.47 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.765 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 2.5 mp0 -51.26 -33.59 29.03 Favored 'General case' 0 N--CA 1.405 -2.69 0 O-C-N 125.487 1.742 . . . . 0.0 111.108 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.1 -59.81 2.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.518 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -75.76 -50.19 15.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.978 0.354 . . . . 0.0 111.895 -173.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.768 HD23 ' N ' ' A' ' 444' ' ' ASP . 0.1 OUTLIER -59.0 -24.7 63.01 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.623 -178.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.768 ' N ' HD23 ' A' ' 443' ' ' LEU . 7.2 t70 -73.32 -41.05 63.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.882 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -72.31 -8.16 53.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -172.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.484 ' HB3' HG22 ' A' ' 451' ' ' THR . 6.1 mm-40 -56.85 162.76 2.23 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.176 1.465 . . . . 0.0 114.317 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.771 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -55.82 -33.52 34.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 111.31 -2.677 . . . . 0.0 115.974 -168.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.64 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.9 m-20 -145.03 -175.73 4.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.464 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.7 m-20 -65.11 -56.81 10.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.58 -25.21 67.31 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 177.321 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.771 HG21 ' HB ' ' A' ' 447' ' ' ILE . 17.0 m -56.85 -44.02 81.74 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.708 1.14 . . . . 0.0 109.47 170.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.728 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 27.6 mtm-85 -62.13 -29.45 70.35 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.774 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.604 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.25 -28.67 62.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.032 0.92 . . . . 0.0 109.449 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -86.21 -43.73 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.22 -171.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.8 p -103.44 -3.99 24.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.932 -169.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.686 ' HB2' ' O ' ' A' ' 452' ' ' ARG . 8.8 t80 -49.12 -53.58 20.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.668 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.638 HG23 ' HB1' ' A' ' 405' ' ' ALA . 21.4 mm -71.17 -25.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.433 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.97 -43.54 62.13 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.559 ' O ' HG23 ' A' ' 463' ' ' VAL . 80.1 m-70 -67.92 -31.1 70.63 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.215 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.812 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.8 -53.98 42.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.165 0.984 . . . . 0.0 109.177 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -61.61 -30.41 70.67 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.785 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -69.06 -47.57 64.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.585 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.048 HG11 ' HA ' ' A' ' 435' ' ' VAL . 45.6 t -66.06 -35.78 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.314 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.535 ' OH ' HG13 ' A' ' 404' ' ' VAL . 20.0 m-30 -61.12 -14.09 21.98 Favored 'General case' 0 C--O 1.2 -1.504 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.647 168.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.569 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 6.3 tp10 -93.36 -52.03 4.71 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.444 -0.785 . . . . 0.0 112.323 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -62.98 -41.31 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.421 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.809 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.7 mt -84.33 -17.12 40.53 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.741 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 66.1 49.35 58.5 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 111.633 -2.53 . . . . 0.0 113.336 173.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.739 HD11 HD12 ' A' ' 467' ' ' LEU . 0.6 OUTLIER -101.81 -176.59 3.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.056 0.943 . . . . 0.0 110.04 -179.21 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.594 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.4 p-10 -105.11 -40.63 5.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 167.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.452 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -159.06 -79.38 0.06 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.335 -2.211 . . . . 0.0 110.91 158.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.747 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.5 OUTLIER -61.41 73.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -170.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.493 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.73 44.69 0.71 Allowed Glycine 0 C--N 1.274 -2.864 0 CA-C-N 110.462 -3.063 . . . . 0.0 113.227 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.594 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 2.8 mm100 -79.66 -55.19 5.19 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.273 1.035 . . . . 0.0 111.223 -173.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.7 t 65.69 47.81 2.07 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.912 -2.403 . . . . 0.0 108.095 -173.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.605 0 CA-C-N 109.808 -3.36 . . . . 0.0 112.303 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.432 -1.331 0 CA-C-O 120.816 0.341 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.801 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 47.6 mt -71.11 121.19 83.46 Favored Pre-proline 0 N--CA 1.426 -1.665 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.585 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 57.8 Cg_endo -82.09 58.21 6.56 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 124.92 3.746 . . . . 0.0 109.592 170.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.671 HG12 ' HB1' ' A' ' 353' ' ' ALA . 1.7 tp -45.52 -47.38 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 112.12 -2.309 . . . . 0.0 113.347 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.628 ' HG2' HG23 ' A' ' 307' ' ' ILE . 16.7 mm-40 -65.63 -35.65 81.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.327 0.584 . . . . 0.0 111.282 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.429 ' HB3' HG11 ' A' ' 338' ' ' VAL . 1.4 t-80 -61.89 -47.41 85.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.615 173.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.624 HG23 HG23 ' A' ' 335' ' ' ILE . 67.5 mt -61.25 -49.62 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.058 0.943 . . . . 0.0 113.043 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 28.1 mtp180 -59.93 -29.57 68.47 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.05 0.54 . . . . 0.0 111.602 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 69.4 m -69.67 -33.26 72.31 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.606 0.717 . . . . 0.0 110.266 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.502 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.27 -40.86 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.936 177.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.664 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 34.4 p -82.13 -36.47 27.43 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.805 1.288 . . . . 0.0 109.928 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.23 34.42 9.67 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 112.323 -2.217 . . . . 0.0 110.813 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 33.2 mt-10 52.46 170.24 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.67 ' HG3' HD12 ' A' ' 355' ' ' LEU . 93.7 Cg_exo -49.63 150.67 8.53 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.213 2.609 . . . . 0.0 113.246 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 42.4 Cg_endo -93.37 -104.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.444 2.763 . . . . 0.0 112.11 -174.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.415 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 20.0 mmt180 -95.17 -84.58 0.33 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 12.1 m-20 -96.07 163.47 20.86 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.876 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.491 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.75 -48.64 12.19 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.732 2.288 . . . . 0.0 110.434 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.46 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -56.36 -17.14 6.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.509 -1.678 . . . . 0.0 113.562 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.528 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 39.7 mt-10 -87.38 -27.97 22.46 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.368 -0.208 . . . . 0.0 110.993 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.719 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.09 -43.69 69.31 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.698 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 3.5 Cg_endo -46.64 -65.35 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.098 2.532 . . . . 0.0 112.997 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.597 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.61 -37.62 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.317 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.664 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.5 t90 -57.68 -34.05 69.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.114 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.832 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.58 -50.23 39.46 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.38 -23.73 27.73 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.903 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.534 ' HD2' HG21 ' A' ' 406' ' ' THR . 2.4 mtm-85 -73.23 -40.78 64.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.317 1.056 . . . . 0.0 110.369 175.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.654 ' HB3' HG22 ' A' ' 314' ' ' THR . 56.6 m-20 -97.75 -24.91 15.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.716 -1.584 . . . . 0.0 114.004 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.63 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.66 -49.72 13.07 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.4 Cg_endo -61.13 -32.93 91.68 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.495 2.13 . . . . 0.0 111.528 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.97 -43.51 57.89 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.483 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 332' ' ' ALA . 92.9 mt -57.44 -47.24 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.942 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 36.9 t70 -55.93 -14.78 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.202 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.82 -47.37 6.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.429 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.555 HG11 HG13 ' A' ' 310' ' ' ILE . 92.2 t -63.49 -72.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.296 1.522 . . . . 0.0 109.946 169.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.801 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -84.05 122.48 75.93 Favored Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.665 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.704 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.2 Cg_endo -72.23 -17.25 27.86 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.094 3.196 . . . . 0.0 110.159 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.4 p 33.89 67.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.068 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.559 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.5 p -78.35 0.7 24.5 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.775 -2.012 . . . . 0.0 112.572 -170.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.817 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -138.06 159.09 69.78 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.697 ' HB3' HD12 ' A' ' 369' ' ' LEU . 68.1 Cg_exo -60.53 -44.94 24.0 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 123.583 2.855 . . . . 0.0 108.797 172.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.616 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -44.99 -52.43 8.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.722 -2.035 . . . . 0.0 110.776 176.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.817 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.0 mt -56.94 -52.3 65.73 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.845 ' HA ' HD12 ' A' ' 350' ' ' ILE . 25.3 ttm180 -49.94 -46.23 51.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.603 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.941 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 8.2 m -68.12 -50.86 52.12 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.146 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.694 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 35.2 mtt180 -61.23 -34.82 75.75 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.409 0.443 . . . . 0.0 111.105 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.888 ' O ' HG12 ' A' ' 354' ' ' ILE . 32.7 mt -56.22 -51.5 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.898 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 328' ' ' LEU . 21.7 mt -60.38 -53.84 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 123.832 0.707 . . . . 0.0 111.744 -172.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.694 ' OD1' ' HA ' ' A' ' 349' ' ' ARG . 0.0 OUTLIER -60.41 -36.13 77.42 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.822 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ALA . . . . . 0.671 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -71.19 -29.79 65.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.888 HG12 ' O ' ' A' ' 350' ' ' ILE . 4.3 mm -58.03 -59.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 CA-C-O 123.082 1.42 . . . . 0.0 110.493 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.719 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -78.62 -26.96 45.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.26 -167.041 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.85 -78.7 0.2 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.903 -1.499 . . . . 0.0 113.023 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -102.4 36.31 4.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.415 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.742 HD22 ' HB2' ' A' ' 361' ' ' LEU . 22.0 p-10 -70.63 131.46 43.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.069 0.461 . . . . 0.0 110.649 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.662 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -49.62 -72.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -169.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.9 2.94 6.91 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.885 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.742 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.2 mt -72.46 -4.62 31.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.943 0.877 . . . . 0.0 109.953 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 8.2 t -69.18 70.55 0.24 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.378 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 367' ' ' ASP . 1.5 mm? -55.03 172.31 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.5 p -120.27 159.4 47.74 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.325 -175.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.888 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.1 Cg_endo -53.3 -9.98 1.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.156 2.57 . . . . 0.0 113.215 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -103.49 -17.99 15.8 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.261 0.864 . . . . 0.0 115.261 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.732 ' HB2' HD12 ' A' ' 363' ' ' LEU . 4.9 m-20 -105.72 -23.61 12.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.617 1.208 . . . . 0.0 110.649 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.941 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 8.6 t -96.18 25.24 5.02 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.653 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.39 -37.01 64.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.635 0.731 . . . . 0.0 110.467 -170.486 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.26 161.2 20.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.514 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.584 ' O ' HG13 ' A' ' 375' ' ' VAL . 30.3 m95 -69.41 -36.67 76.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.535 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.5 OUTLIER -64.31 -40.47 95.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.531 -174.195 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.1 t -69.08 -43.11 75.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.65 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.44 -53.44 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.832 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.6 m -57.55 -43.02 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.624 0.726 . . . . 0.0 109.731 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 0.994 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -64.13 -42.75 96.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.272 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.622 ' CG2' HD21 ' A' ' 363' ' ' LEU . 22.8 m -69.32 -37.93 77.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.768 -173.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.664 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -61.33 -34.61 75.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.58 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.698 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 56.9 t80 -75.33 -43.98 47.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.161 0.982 . . . . 0.0 109.414 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.08 -33.01 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.245 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.6 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.42 -34.63 74.23 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 123.141 0.576 . . . . 0.0 111.956 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.8 p -111.05 -23.53 10.87 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -165.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -109.98 25.6 11.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.63 50.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.959 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 64.12 164.39 0.13 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.023 0.439 . . . . 0.0 111.269 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.513 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -130.41 153.67 81.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -99.37 54.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.571 2.847 . . . . 0.0 111.248 165.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.715 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.5 -0.53 0.18 Allowed 'General case' 0 C--O 1.231 0.1 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.715 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -69.13 -44.51 72.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.951 0.405 . . . . 0.0 110.571 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 394' ' ' VAL . 93.5 mt-30 -75.01 -26.03 59.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.2 mm? -53.62 -31.71 48.31 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.28 0.945 . . . . 0.0 111.515 -174.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.707 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.45 -56.26 24.42 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.701 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.516 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 51.6 t30 -64.56 -34.47 78.32 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 110.717 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 391' ' ' LEU . 44.9 t -53.55 -53.64 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.645 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.762 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.0 mm -59.15 -48.26 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 175.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.707 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 39.9 mmtt -52.71 -38.47 60.77 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 124.185 0.928 . . . . 0.0 112.056 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.57 -45.26 8.73 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.607 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.959 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.1 mt -70.33 -40.68 78.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 117.762 0.781 . . . . 0.0 111.271 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -57.75 -44.0 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.575 0.702 . . . . 0.0 110.028 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.2 t70 -60.38 -36.62 78.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.576 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -91.19 -55.56 3.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.693 ' HG2' HG21 ' A' ' 406' ' ' THR . 3.0 tp10 -106.42 -34.42 7.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.245 0.545 . . . . 0.0 112.289 -172.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 129.97 167.29 12.03 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.511 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.954 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.55 -43.16 96.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -174.23 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.62 -51.0 70.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.693 HG21 ' HG2' ' A' ' 402' ' ' GLU . 0.9 OUTLIER -66.03 -48.79 69.96 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.756 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.959 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.96 -39.68 66.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 41.1 t80 -57.06 -47.2 81.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.676 0.75 . . . . 0.0 109.189 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.79 ' O ' ' HG3' ' A' ' 413' ' ' MET . 15.6 m -59.62 -53.0 63.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.008 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.673 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.49 -49.12 78.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.784 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.2 -42.47 88.19 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.18 -174.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.572 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.944 0.372 . . . . 0.0 110.746 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.804 ' HE3' HG21 ' A' ' 375' ' ' VAL . 65.5 mtm -69.57 -48.31 60.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.418 0.628 . . . . 0.0 110.047 175.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.994 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.0 mt -59.61 -37.56 78.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.376 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.682 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -77.76 -16.22 58.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.722 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.95 4.02 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.179 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.663 HE22 ' HA ' ' A' ' 413' ' ' MET . 0.1 OUTLIER 50.19 48.49 22.05 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 124.49 1.116 . . . . 0.0 113.91 -177.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.647 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 16.0 p30 -121.1 65.06 0.86 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 123.419 1.581 . . . . 0.0 107.294 166.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' A' ' 423' ' ' SER . 0.4 OUTLIER -44.17 -35.06 2.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.52 -2.582 . . . . 0.0 112.984 -164.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 423' ' ' SER . 53.5 mt-30 -54.66 -45.62 73.89 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -165.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 422' ' ' VAL . 2.2 pp -62.75 -48.82 77.52 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.02 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.684 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -61.28 -39.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 122.7 1.238 . . . . 0.0 109.04 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.544 ' HB2' ' HD2' ' A' ' 419' ' ' TYR . 31.3 t -60.27 -46.58 89.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.405 -2.18 . . . . 0.0 111.718 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.85 -38.7 75.04 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.656 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.3 mt -71.96 -40.97 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.441 0.638 . . . . 0.0 110.285 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.531 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -57.94 -44.09 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.618 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.662 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -58.23 -31.95 67.86 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 124.826 1.25 . . . . 0.0 109.046 -175.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.427 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -71.98 -13.36 75.82 Favored Glycine 0 C--N 1.301 -1.409 0 CA-C-N 113.0 -1.909 . . . . 0.0 112.595 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.639 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.0 m-85 -102.52 0.15 33.14 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.67 138.76 86.25 Favored Pre-proline 0 N--CA 1.408 -2.574 0 CA-C-O 123.752 1.739 . . . . 0.0 113.126 171.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.736 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 57.7 Cg_endo -68.58 -58.13 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.285 1 C-N-CA 126.34 4.694 . . . . 0.0 113.556 -170.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.538 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.51 143.46 18.1 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.96 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.937 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -27.53 69.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.433 0.617 . . . . 0.0 111.857 -173.371 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.36 -48.72 78.3 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.048 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.4 t -61.17 -36.9 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.617 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.937 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -73.19 -43.16 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -175.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 24.0 m -71.6 -55.61 7.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.923 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.8 83.51 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.81 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.841 HD13 HD22 ' A' ' 460' ' ' LEU . 29.2 mt -65.02 -54.24 33.47 Favored 'General case' 0 CA--C 1.477 -1.836 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.244 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.686 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 2.3 mp0 -52.18 -33.4 40.49 Favored 'General case' 0 N--CA 1.409 -2.515 0 O-C-N 125.21 1.569 . . . . 0.0 110.372 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.683 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -60.07 2.41 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 172.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -75.1 -49.47 19.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.839 -0.538 . . . . 0.0 112.116 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.81 -24.35 64.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.629 0.728 . . . . 0.0 111.774 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.741 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.1 t70 -72.8 -43.4 62.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.528 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.683 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.7 mt-30 -69.67 -8.35 46.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 55.6 mm-40 -51.68 154.96 1.77 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 123.148 1.451 . . . . 0.0 114.267 -176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.562 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -52.68 -32.48 17.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 111.444 -2.616 . . . . 0.0 115.409 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.661 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.5 m-20 -141.88 178.79 7.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.997 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.01 -51.15 67.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -70.77 -23.71 62.46 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 175.05 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.661 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -59.58 -40.35 87.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 120.011 1.278 . . . . 0.0 109.264 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.602 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 61.8 mtt180 -60.19 -31.25 69.95 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.36 171.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.536 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.36 -28.99 57.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.079 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.4 -43.84 13.29 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.047 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.499 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -103.06 -1.36 29.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.352 -168.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.724 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.6 t80 -48.88 -55.33 12.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.633 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.9 mm -70.32 -25.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.499 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.56 -43.28 63.65 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.543 ' O ' HG23 ' A' ' 463' ' ' VAL . 49.4 m-70 -67.71 -32.06 72.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.541 172.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.841 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.12 -53.39 54.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 122.172 0.987 . . . . 0.0 108.895 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -61.99 -31.1 71.44 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.629 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -67.18 -49.5 64.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.503 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.048 HG11 ' HA ' ' A' ' 435' ' ' VAL . 38.5 t -65.95 -34.38 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.8 m-30 -63.1 -14.6 50.42 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.617 169.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 7.4 tp10 -94.44 -52.29 4.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.889 0.852 . . . . 0.0 111.601 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.78 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.0 pt -63.33 -41.47 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.278 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 469' ' ' LEU . 7.2 mt -83.94 -17.78 39.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.779 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.41 50.13 57.24 Favored Glycine 0 C--O 1.218 -0.882 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.159 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 467' ' ' LEU . 0.6 OUTLIER -100.9 172.78 6.83 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.036 0.934 . . . . 0.0 110.275 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.644 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 0.9 OUTLIER -88.7 -44.16 10.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 166.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -162.18 -72.92 0.05 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.776 162.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.736 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -61.33 68.87 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.47 43.92 0.57 Allowed Glycine 0 C--N 1.275 -2.824 0 CA-C-N 110.715 -2.948 . . . . 0.0 113.564 173.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.644 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 3.4 mm100 -82.25 -55.62 4.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 122.578 1.18 . . . . 0.0 111.054 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 44.2 t 69.12 55.04 0.42 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.368 -2.651 . . . . 0.0 108.307 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 110.584 -3.007 . . . . 0.0 111.544 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.428 -1.538 0 CA-C-O 121.423 0.63 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.841 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 54.4 mt -72.86 124.65 90.98 Favored Pre-proline 0 N--CA 1.423 -1.794 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.317 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 60.5 Cg_endo -83.0 53.78 4.52 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 124.969 3.779 . . . . 0.0 109.797 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.77 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 2.8 tp -43.06 -46.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 112.237 -2.256 . . . . 0.0 113.672 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.619 ' HG2' HG23 ' A' ' 307' ' ' ILE . 54.4 mm-40 -65.59 -36.29 83.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.692 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.4 t-160 -61.09 -46.21 91.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.315 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 335' ' ' ILE . 68.6 mt -62.84 -49.61 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 124.263 1.025 . . . . 0.0 113.254 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.77 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 22.9 mtp180 -59.27 -30.3 68.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 121.888 -0.507 . . . . 0.0 111.259 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 59.5 m -69.59 -32.72 71.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.557 0.694 . . . . 0.0 110.01 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.552 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.21 -40.58 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.022 177.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 331' ' ' ASN . 35.9 p -82.56 -37.53 25.0 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.788 1.28 . . . . 0.0 109.976 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.04 34.09 7.83 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.817 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 35.7 mt-10 53.52 169.42 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.61 ' HG3' HD12 ' A' ' 355' ' ' LEU . 25.4 Cg_exo -44.06 151.39 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.795 2.997 . . . . 0.0 113.621 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.459 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 17.2 Cg_endo -97.97 -108.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.356 2.704 . . . . 0.0 112.601 -174.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.421 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 9.6 mmm180 -92.47 -82.02 0.33 Allowed 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.592 0.71 . . . . 0.0 111.277 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.473 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 28.3 m-20 -102.63 158.63 31.39 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.133 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.468 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.1 Cg_exo -59.4 -49.67 10.1 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.654 2.236 . . . . 0.0 110.685 172.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -22.56 12.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.224 -1.807 . . . . 0.0 113.035 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.473 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -85.97 -24.37 26.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.718 HG12 HD11 ' A' ' 355' ' ' LEU . 0.0 OUTLIER -51.21 -40.95 71.95 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.286 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.706 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.4 Cg_endo -49.8 -62.22 0.45 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.903 2.402 . . . . 0.0 112.773 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.593 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.09 -37.18 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.236 177.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.668 ' CH2' HG21 ' A' ' 354' ' ' ILE . 55.5 t90 -58.35 -36.46 73.48 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.007 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.81 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.85 -49.99 46.97 Favored 'General case' 0 N--CA 1.396 -3.125 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.535 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.08 -24.04 26.63 Favored Glycine 0 C--N 1.311 -0.824 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.151 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.6 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.3 mtt180 -73.99 -41.68 61.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.042 0.925 . . . . 0.0 110.576 174.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.693 ' HB3' HG22 ' A' ' 314' ' ' THR . 56.9 m-20 -95.68 -23.6 16.93 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.82 -169.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.544 ' N ' ' HD2' ' A' ' 333' ' ' PRO . . . -43.5 -48.89 18.5 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.365 1.066 . . . . 0.0 113.727 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.1 Cg_endo -60.03 -34.56 94.73 Favored 'Trans proline' 0 CA--C 1.508 -0.796 0 C-N-CA 122.548 2.166 . . . . 0.0 111.539 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.4 -43.56 60.26 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.476 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 310' ' ' ILE . 97.1 mt -57.95 -48.24 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.872 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.56 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 31.8 t70 -54.27 -15.48 1.6 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.199 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.43 -51.65 4.83 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 310' ' ' ILE . 91.1 t -59.17 -72.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.255 1.502 . . . . 0.0 109.998 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.841 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.4 OUTLIER -87.98 121.07 70.87 Favored Pre-proline 0 N--CA 1.405 -2.69 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.685 -176.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.605 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.3 Cg_endo -72.92 -20.76 21.81 Favored 'Trans proline' 0 CA--C 1.496 -1.422 0 C-N-CA 123.736 2.957 . . . . 0.0 110.362 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.629 HG22 ' CD2' ' A' ' 339' ' ' PHE . 2.7 t 46.07 61.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 111.715 -2.493 . . . . 0.0 109.92 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.626 ' N ' HD12 ' A' ' 346' ' ' LEU . 35.9 p -75.85 5.56 6.24 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.914 -172.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.758 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -141.89 159.28 59.98 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.538 ' O ' ' HB2' ' A' ' 347' ' ' ARG . 56.2 Cg_exo -61.81 -44.3 21.7 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 123.924 3.083 . . . . 0.0 108.994 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.692 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -50.07 -44.17 51.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.037 -1.892 . . . . 0.0 111.523 175.307 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.819 ' O ' HG13 ' A' ' 350' ' ' ILE . 14.9 mt -59.21 -52.25 66.47 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.546 ' HD3' HG11 ' A' ' 341' ' ' VAL . 11.5 mmt180 -45.3 -52.44 9.71 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 125.249 1.593 . . . . 0.0 110.66 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.928 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -65.66 -49.2 69.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.713 -175.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.672 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 69.7 mtt180 -61.56 -39.31 90.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.888 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.6 mt -57.31 -55.43 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.788 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.351 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.659 ' O ' HD22 ' A' ' 355' ' ' LEU . 20.1 mt -57.65 -53.34 45.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 O-C-N 124.764 1.29 . . . . 0.0 110.736 -170.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 11.7 m-20 -63.14 -36.46 83.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.211 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ALA . . . . . 0.658 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -71.46 -30.61 66.21 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.173 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.888 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.2 mm -56.04 -58.09 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 CA-C-O 122.797 1.284 . . . . 0.0 110.312 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.718 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.99 -26.77 54.27 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.086 -2.325 . . . . 0.0 109.726 -168.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 73.69 -71.47 1.34 Allowed Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.93 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -113.21 37.88 3.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.941 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.724 HD22 ' HB2' ' A' ' 361' ' ' LEU . 20.2 p-10 -66.99 133.61 50.3 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.042 0.448 . . . . 0.0 110.563 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.663 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.1 mp -51.01 -77.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 124.409 1.084 . . . . 0.0 112.871 -169.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -124.92 7.0 8.26 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.492 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.724 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.6 mt -72.39 -4.63 31.19 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.67 0.748 . . . . 0.0 109.655 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.601 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 23.1 t -63.84 76.95 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.332 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.739 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -62.55 173.48 1.24 Allowed 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.7 p -122.05 156.39 59.89 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.896 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.928 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 6.7 Cg_endo -56.76 -3.54 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.856 2.37 . . . . 0.0 114.286 -172.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.477 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -104.59 -12.05 29.42 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.739 ' HB2' HD12 ' A' ' 363' ' ' LEU . 16.1 m-20 -109.25 -20.39 12.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.023 0.916 . . . . 0.0 110.853 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 17.1 p -96.75 15.21 22.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.117 -164.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' A' ' 344' ' ' PRO . 1.3 mt -58.75 -40.98 85.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.879 -161.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.88 163.15 16.98 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.223 170.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.573 ' O ' HG13 ' A' ' 375' ' ' VAL . 41.3 m95 -68.81 -35.74 77.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.547 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.2 p30 -62.73 -40.2 96.45 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.875 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.7 m -71.39 -41.04 70.14 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.066 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.568 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -66.53 -52.19 48.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.81 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.8 m -56.38 -45.36 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.377 0.608 . . . . 0.0 109.86 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.043 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.93 -42.37 93.81 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.105 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.632 ' CG2' HD21 ' A' ' 363' ' ' LEU . 19.6 m -70.81 -36.86 73.15 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.232 -172.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -62.99 -33.32 75.15 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.425 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.706 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.1 t80 -75.6 -44.5 42.63 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.433 1.111 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.45 -33.22 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.503 169.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.67 -41.69 95.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.168 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 28.7 p -99.91 -22.99 15.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.123 -168.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -111.14 22.64 15.01 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.21 20.9 16.97 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.422 HG23 HG13 ' A' ' 380' ' ' ILE . 2.7 m 66.96 159.87 0.14 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.265 0.533 . . . . 0.0 111.519 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -127.93 156.06 76.65 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -97.95 54.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.46 2.773 . . . . 0.0 111.643 168.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.756 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.28 -1.27 0.14 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -69.79 -46.12 66.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.143 0.497 . . . . 0.0 110.938 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.633 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.8 mt-30 -74.7 -25.59 59.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -53.87 -30.62 46.55 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.772 0.715 . . . . 0.0 111.283 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.667 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.47 -50.23 57.64 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.509 174.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.565 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 5.7 m-20 -67.89 -40.56 83.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.852 0.461 . . . . 0.0 111.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.14 -44.12 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.003 0.43 . . . . 0.0 110.438 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.703 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -58.35 -47.12 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.18 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.684 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 32.3 mmtt -53.07 -41.39 64.83 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.097 0.873 . . . . 0.0 111.897 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -76.75 -44.64 14.66 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.025 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.879 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -69.96 -40.81 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 117.302 0.551 . . . . 0.0 111.767 -178.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.871 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.0 m -57.75 -43.47 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.745 0.783 . . . . 0.0 109.721 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.48 ' N ' HG23 ' A' ' 399' ' ' VAL . 17.6 t70 -56.15 -43.7 78.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.252 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 33.1 mm-40 -84.1 -54.27 4.95 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.47 -172.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -110.58 -29.34 8.09 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.516 0.674 . . . . 0.0 112.535 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.78 171.38 14.04 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.688 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.871 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.3 -44.42 97.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.13 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.672 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.18 -51.05 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.927 0.394 . . . . 0.0 112.005 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.595 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.2 m -64.18 -51.2 64.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.553 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.879 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.55 -43.15 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 30.3 t80 -55.58 -46.32 77.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.686 0.755 . . . . 0.0 109.197 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.831 ' O ' ' HG3' ' A' ' 413' ' ' MET . 13.0 m -57.92 -52.68 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.353 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.674 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.66 -48.74 80.45 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.537 ' HA3' HD11 ' A' ' 395' ' ' ILE . . . -56.32 -42.62 89.13 Favored Glycine 0 C--N 1.313 -0.724 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.003 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.708 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -72.71 -32.52 65.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.823 0.311 . . . . 0.0 110.833 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.831 ' HG3' ' O ' ' A' ' 409' ' ' THR . 62.5 mtm -69.36 -46.6 66.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.09 174.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.043 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.16 -39.17 85.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.74 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.751 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -77.1 -16.87 59.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.057 -178.162 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.84 47.01 3.78 Favored Glycine 0 C--N 1.308 -1.018 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.024 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.623 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 49.71 48.69 21.24 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.521 1.128 . . . . 0.0 113.892 -177.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.615 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 12.5 p30 -123.57 66.0 1.01 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.708 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 14.4 p90 -51.48 -31.84 25.02 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.701 -161.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 34.1 mt-30 -53.89 -43.25 69.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.596 -165.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.507 HD21 ' OD1' ' A' ' 418' ' ' ASN . 2.0 pp -63.06 -48.1 80.1 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.329 0.585 . . . . 0.0 110.855 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.754 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -62.31 -38.97 82.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.588 1.185 . . . . 0.0 109.101 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 30.7 t -59.64 -45.95 90.45 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.301 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.47 87.27 Favored Glycine 0 C--N 1.316 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.844 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.1 mt -71.09 -41.31 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.501 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -56.43 -43.98 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.285 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.676 ' HD2' ' O ' ' A' ' 427' ' ' ARG . 1.8 tmm_? -56.97 -35.38 69.08 Favored 'General case' 0 N--CA 1.406 -2.647 0 C-N-CA 124.962 1.305 . . . . 0.0 109.837 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.74 -13.12 74.93 Favored Glycine 0 C--N 1.29 -1.985 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.948 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.5 m-85 -100.08 -3.64 31.49 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -59.24 142.96 85.71 Favored Pre-proline 0 N--CA 1.412 -2.329 0 CA-C-O 123.438 1.59 . . . . 0.0 112.875 173.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.781 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 88.5 Cg_endo -72.23 -53.25 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.083 4.522 . . . . 0.0 113.338 -170.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -120.94 140.33 14.08 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.894 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -63.19 -26.53 68.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.164 0.482 . . . . 0.0 111.776 -175.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.683 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.2 -48.46 78.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.018 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.4 t -58.44 -51.89 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.705 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.8 OUTLIER -54.87 -51.43 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 118.096 0.407 . . . . 0.0 109.945 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.447 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 86.4 m -62.67 -57.33 11.39 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.14 -44.76 79.54 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.368 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.85 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.0 mt -59.72 -53.71 54.83 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.73 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.708 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 21.1 mm100 -51.5 -35.14 39.05 Favored 'General case' 0 N--CA 1.417 -2.123 0 O-C-N 124.899 1.374 . . . . 0.0 110.669 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.624 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.32 -60.37 2.28 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 176.567 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.74 -51.71 10.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.378 0.535 . . . . 0.0 112.385 -172.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.74 -25.46 63.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.522 0.677 . . . . 0.0 111.575 -177.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.777 ' N ' HD23 ' A' ' 443' ' ' LEU . 10.7 t70 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.657 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 34.6 mt-30 -71.56 -6.85 43.8 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.471 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 25.2 mm-40 -51.86 161.25 0.58 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 123.662 1.696 . . . . 0.0 114.614 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.516 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -56.99 -33.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 110.443 -3.071 . . . . 0.0 115.199 -172.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.683 ' H ' ' HB ' ' A' ' 451' ' ' THR . 66.4 m-20 -138.96 179.99 6.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.441 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 8.9 p-10 -64.43 -55.32 21.67 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -68.28 -23.52 64.77 Favored 'General case' 0 N--CA 1.402 -2.868 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 176.368 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.683 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 25.4 m -58.82 -41.51 87.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.756 1.162 . . . . 0.0 109.677 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 48.2 mtt180 -60.16 -30.0 69.04 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.201 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.591 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.03 -33.64 59.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 109.877 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.02 -42.83 31.23 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.333 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 38.3 p -101.34 -4.18 27.46 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.375 -169.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.705 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.4 t80 -49.25 -52.82 24.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.846 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 405' ' ' ALA . 22.9 mm -71.75 -27.01 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -72.56 -42.45 64.65 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.583 ' O ' HG23 ' A' ' 463' ' ' VAL . 25.9 m80 -67.6 -31.17 71.03 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.473 -1.694 . . . . 0.0 109.96 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.77 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.41 -54.05 34.32 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 122.188 0.994 . . . . 0.0 109.165 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.733 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -62.26 -32.31 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.034 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.68 -53.27 58.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.922 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.018 HG11 ' HA ' ' A' ' 435' ' ' VAL . 25.9 t -63.45 -34.27 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-O 121.806 0.812 . . . . 0.0 110.287 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.607 ' HD1' HD12 ' A' ' 469' ' ' LEU . 20.2 m-30 -60.93 -14.39 22.22 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.191 169.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.733 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 45.0 mt-10 -93.81 -48.37 6.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.824 -1.173 . . . . 0.0 112.652 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.712 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.4 pt -64.6 -39.94 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.049 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.841 HD12 HD11 ' A' ' 469' ' ' LEU . 7.3 mt -84.46 -16.84 41.11 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.802 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.02 51.05 56.49 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 111.73 -2.486 . . . . 0.0 113.219 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.841 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -101.28 177.4 4.94 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.13 0.972 . . . . 0.0 109.88 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.553 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.6 p-10 -96.46 -44.11 7.33 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -157.39 -74.61 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.457 -2.156 . . . . 0.0 110.351 160.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.781 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -59.01 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -172.599 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.96 42.69 0.37 Allowed Glycine 0 C--N 1.275 -2.854 0 CA-C-N 111.423 -2.626 . . . . 0.0 113.613 173.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.553 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 3.5 mm100 -81.32 -51.99 7.78 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 122.79 1.281 . . . . 0.0 111.453 -172.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.4 t 68.91 61.47 0.33 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.171 -2.74 . . . . 0.0 109.037 -173.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.802 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 110.923 -2.853 . . . . 0.0 111.463 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.43 -1.472 0 CA-C-O 121.032 0.444 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.768 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 31.9 mt -78.74 125.56 84.02 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 121.89 0.852 . . . . 0.0 111.878 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 308' ' ' GLN . 26.0 Cg_endo -74.97 -12.04 21.57 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.99 3.793 . . . . 0.0 111.663 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.71 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.1 tp 30.31 -64.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 O-C-N 126.973 2.671 . . . . 0.0 115.996 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.709 ' HG2' HG23 ' A' ' 307' ' ' ILE . 66.6 mm-40 -58.24 -33.24 69.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.466 0.65 . . . . 0.0 110.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.443 ' HB3' HG11 ' A' ' 338' ' ' VAL . 1.5 t-80 -61.42 -48.83 79.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.646 172.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 307' ' ' ILE . 64.2 mt -59.06 -48.38 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 124.111 0.965 . . . . 0.0 112.51 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.5 mtp-105 -58.33 -30.83 67.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 122.613 0.365 . . . . 0.0 111.456 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.7 m -69.92 -33.22 71.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.573 0.701 . . . . 0.0 109.882 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.51 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.15 -40.49 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.785 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.659 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.22 -36.7 26.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.646 1.212 . . . . 0.0 110.024 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.26 34.72 7.91 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.107 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 45.9 mt-10 56.77 165.81 0.07 OUTLIER Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.666 ' HG3' HD12 ' A' ' 355' ' ' LEU . 43.0 Cg_exo -44.97 147.31 2.03 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.517 2.812 . . . . 0.0 113.032 175.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 39.6 Cg_endo -93.16 -104.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.358 2.705 . . . . 0.0 112.169 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.413 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 10.8 mmt180 -95.92 -85.21 0.33 Allowed 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 121.259 0.552 . . . . 0.0 111.113 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 16.5 m-20 -97.37 164.46 17.64 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.733 -175.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 -49.39 10.92 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.655 2.237 . . . . 0.0 110.546 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.411 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -56.55 -13.96 2.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.309 -1.768 . . . . 0.0 113.401 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 14.9 mt-10 -90.52 -29.2 18.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.374 -0.204 . . . . 0.0 111.201 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.746 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.7 -42.87 70.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.214 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.715 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.8 Cg_endo -47.65 -63.74 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.097 2.531 . . . . 0.0 113.05 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.599 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.97 -36.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.428 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.659 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 44.7 t90 -57.82 -36.08 71.74 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.83 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.822 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.55 -49.74 44.83 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.435 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.78 -23.74 23.17 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.804 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.595 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -74.35 -42.19 59.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.947 0.88 . . . . 0.0 110.948 173.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.658 ' HB3' HG22 ' A' ' 314' ' ' THR . 52.6 m-20 -94.78 -24.05 17.26 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.492 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.43 -49.65 12.38 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.8 Cg_endo -61.66 -32.9 87.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.564 2.176 . . . . 0.0 111.662 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.75 -44.43 56.22 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.305 -1.77 . . . . 0.0 109.547 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 332' ' ' ALA . 93.6 mt -56.11 -47.74 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.934 173.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.0 -13.96 2.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.6 -1.636 . . . . 0.0 112.327 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.59 -51.15 4.7 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.529 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.587 HG11 HG13 ' A' ' 310' ' ' ILE . 83.2 t -58.68 -71.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 123.351 1.548 . . . . 0.0 109.743 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.768 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.29 123.64 72.88 Favored Pre-proline 0 N--CA 1.402 -2.853 0 CA-C-N 111.261 -2.7 . . . . 0.0 111.953 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.726 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.5 Cg_endo -72.36 -17.1 27.52 Favored 'Trans proline' 0 CA--C 1.494 -1.485 0 C-N-CA 124.163 3.242 . . . . 0.0 110.543 175.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.5 p 33.29 69.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 111.907 -2.406 . . . . 0.0 110.088 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.585 ' N ' HD12 ' A' ' 346' ' ' LEU . 62.4 p -80.72 6.06 13.92 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.844 -170.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.787 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 14.7 p -143.06 160.71 51.62 Favored Pre-proline 0 N--CA 1.434 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.68 ' HB3' HD12 ' A' ' 369' ' ' LEU . 50.6 Cg_exo -62.62 -45.05 15.11 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.591 2.861 . . . . 0.0 108.739 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.653 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -44.78 -52.24 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.784 175.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.787 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.6 mt -56.72 -51.55 68.41 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.852 ' HA ' HD12 ' A' ' 350' ' ' ILE . 17.7 ttm-85 -49.79 -47.84 50.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.595 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 1.084 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -68.15 -48.07 66.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.472 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.653 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 53.7 mtt180 -60.25 -37.77 81.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.113 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.883 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -56.87 -52.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.572 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.655 HG12 HD11 ' A' ' 328' ' ' LEU . 21.1 mt -58.56 -53.38 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.905 0.86 . . . . 0.0 111.248 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.564 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 18.6 m-20 -63.13 -36.2 82.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.987 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.89 -29.5 65.61 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.79 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.883 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.14 -60.13 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.052 1.406 . . . . 0.0 110.067 173.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.746 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -74.55 -27.53 60.56 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 111.961 -2.381 . . . . 0.0 109.883 -167.057 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.98 -71.68 0.29 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.941 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -111.68 54.05 0.56 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.731 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -84.93 133.28 34.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -47.84 -73.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 124.042 0.937 . . . . 0.0 112.664 -170.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.27 5.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.192 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.731 ' HB2' HD22 ' A' ' 358' ' ' ASN . 3.6 mt -69.98 -5.08 23.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.587 0.708 . . . . 0.0 110.127 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.564 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 25.2 t -59.12 82.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.393 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.749 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.8 OUTLIER -65.55 178.38 1.0 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.791 177.114 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.7 p -122.02 153.94 61.09 Favored Pre-proline 0 N--CA 1.437 -1.088 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.926 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 3.2 Cg_exo -53.94 -11.14 2.26 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.007 2.472 . . . . 0.0 113.107 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -111.29 -2.19 27.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.749 ' HB2' HD12 ' A' ' 363' ' ' LEU . 19.4 m-20 -106.32 -21.62 13.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.741 1.27 . . . . 0.0 110.542 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 1.084 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 34.8 t -98.24 25.29 6.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.597 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.57 -34.3 61.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.127 0.965 . . . . 0.0 109.806 -173.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.42 159.04 24.99 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.869 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.636 ' O ' HG13 ' A' ' 375' ' ' VAL . 46.4 m95 -68.91 -35.71 77.15 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.602 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -59.54 -46.85 87.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.126 -176.323 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 62.4 m -67.29 -41.9 84.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.111 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.607 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.48 63.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.822 HG12 ' HB3' ' A' ' 328' ' ' LEU . 14.4 m -57.87 -44.43 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.588 0.709 . . . . 0.0 109.603 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.0 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.46 -41.08 96.68 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.102 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.671 HG21 HD11 ' A' ' 363' ' ' LEU . 22.4 m -71.47 -39.14 71.12 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.619 -173.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -61.58 -33.45 73.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.31 0.576 . . . . 0.0 110.328 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.715 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 41.6 t80 -73.08 -47.16 46.97 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.211 1.005 . . . . 0.0 109.489 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.45 -32.77 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 113.14 -1.845 . . . . 0.0 111.796 169.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.26 -32.72 71.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 123.014 0.525 . . . . 0.0 111.564 175.133 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.0 p -109.01 -23.65 11.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.388 -167.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -110.52 22.51 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.23 17.91 33.15 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 114.47 0.548 . . . . 0.0 114.47 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.444 HG23 HG13 ' A' ' 380' ' ' ILE . 2.0 m 66.2 160.41 0.14 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.232 0.539 . . . . 0.0 111.374 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.557 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -128.2 155.67 77.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.149 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -101.88 63.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.972 3.115 . . . . 0.0 111.216 164.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.73 ' HA ' HD23 ' A' ' 391' ' ' LEU . 3.4 mmt 53.01 5.55 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -70.32 -48.2 57.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.247 0.546 . . . . 0.0 111.173 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.614 ' O ' HG13 ' A' ' 394' ' ' VAL . 78.1 mt-30 -75.61 -28.69 58.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.872 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -54.62 -31.28 57.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.61 0.641 . . . . 0.0 112.157 -170.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.894 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.42 -51.93 48.22 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.862 -1.161 . . . . 0.0 110.543 173.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.585 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 8.8 m-20 -68.56 -38.21 80.57 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 122.95 0.5 . . . . 0.0 112.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 398' ' ' ILE . 1.6 m -58.16 -44.72 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 399' ' ' VAL . 9.5 mm -58.47 -48.35 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.214 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.2 mmtt -52.8 -40.27 63.11 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 124.051 0.845 . . . . 0.0 112.031 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.94 -44.88 13.0 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.926 -173.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.872 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.3 mt -69.65 -41.9 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 117.33 0.565 . . . . 0.0 111.686 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.899 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.3 m -57.28 -45.21 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.609 0.719 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.9 t70 -60.85 -37.16 81.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.193 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 92.0 mt-30 -88.31 -52.67 5.08 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.557 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -113.26 -30.67 6.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.963 -167.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.69 164.5 11.65 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.754 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.899 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -64.04 -42.54 96.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -175.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.602 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -58.12 -50.32 73.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.791 0.329 . . . . 0.0 111.511 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.595 HG21 ' HD2' ' A' ' 330' ' ' ARG . 0.9 OUTLIER -62.31 -52.41 63.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.872 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -42.67 66.18 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.568 ' HB3' HD11 ' A' ' 457' ' ' ILE . 39.1 t80 -56.15 -47.08 78.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.567 0.699 . . . . 0.0 109.226 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.823 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.3 m -58.86 -53.01 63.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.743 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.695 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.67 -49.23 78.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.783 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.08 -43.05 88.47 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.042 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.63 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.03 -31.37 66.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.773 0.287 . . . . 0.0 111.158 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.823 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.2 mtm -70.92 -46.53 62.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.669 0.747 . . . . 0.0 109.599 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.0 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.78 -42.0 92.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.066 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.872 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 74.8 m -78.76 2.48 19.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.34 53.86 9.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.363 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.63 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.0 mp0 46.01 56.98 5.55 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.85 0.86 . . . . 0.0 112.926 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.758 ' O ' HD23 ' A' ' 421' ' ' LEU . 5.4 t-20 -122.47 65.63 0.94 Allowed 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 162.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.579 ' O ' HG22 ' A' ' 422' ' ' VAL . 0.3 OUTLIER -48.79 -36.28 16.27 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.594 -173.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' A' ' 423' ' ' SER . 45.0 mt-30 -57.08 -50.58 72.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -168.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.811 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 0.2 OUTLIER -59.37 -50.43 73.98 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.365 -178.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.811 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.35 -38.27 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 122.675 1.226 . . . . 0.0 109.233 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 19.2 t -59.94 -49.63 76.94 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.299 -2.228 . . . . 0.0 111.585 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.69 -36.13 77.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.375 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.894 HD13 ' HA2' ' A' ' 392' ' ' GLY . 4.3 mt -72.51 -39.72 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.627 0.727 . . . . 0.0 110.112 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 404' ' ' VAL . 1.7 mm -62.76 -41.63 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.569 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.615 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -57.18 -34.4 68.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 125.916 1.686 . . . . 0.0 108.64 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -73.01 -11.57 78.92 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.725 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.638 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.9 m-85 -105.52 -0.27 26.0 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.7 mm? -58.01 141.35 81.35 Favored Pre-proline 0 N--CA 1.412 -2.328 0 CA-C-O 123.566 1.65 . . . . 0.0 113.411 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.755 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 57.6 Cg_endo -70.04 -60.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 1 C-N-CA 126.444 4.763 . . . . 0.0 113.43 -170.474 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -110.09 141.45 16.23 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.897 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -59.58 -30.07 68.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.361 0.58 . . . . 0.0 111.831 -174.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.824 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.05 -48.96 77.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.009 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.6 t -62.86 -35.6 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.524 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.897 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.14 -46.63 57.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 38.4 m -72.65 -54.21 9.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.337 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.53 -46.16 80.76 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.342 0.401 . . . . 0.0 111.348 -174.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.818 HD13 HD22 ' A' ' 460' ' ' LEU . 17.7 mt -60.92 -54.2 47.97 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.71 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.684 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 2.3 mp0 -51.77 -33.6 35.94 Favored 'General case' 0 N--CA 1.407 -2.596 0 O-C-N 125.709 1.881 . . . . 0.0 110.64 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.66 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -59.86 2.52 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -47.53 27.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.581 0.628 . . . . 0.0 111.66 -173.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 444' ' ' ASP . 0.1 OUTLIER -59.23 -25.24 63.85 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 111.427 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.773 ' N ' HD23 ' A' ' 443' ' ' LEU . 13.4 t70 -73.94 -42.2 60.9 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.795 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.66 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 45.6 mt-30 -70.65 -9.74 57.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -172.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.59 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 38.4 mm-40 -50.28 157.73 0.65 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 123.361 1.553 . . . . 0.0 115.094 -174.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.589 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.27 -32.41 19.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 110.937 -2.847 . . . . 0.0 115.408 -170.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.652 ' H ' ' HB ' ' A' ' 451' ' ' THR . 9.2 m-20 -140.93 178.64 7.22 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.4 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 2.3 m-20 -62.56 -54.51 38.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -66.78 -24.27 66.17 Favored 'General case' 0 N--CA 1.404 -2.736 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 176.714 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.652 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.5 m -59.45 -40.96 88.55 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 119.992 1.269 . . . . 0.0 109.388 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.59 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 67.0 mtt180 -61.82 -29.29 70.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.304 172.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.492 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -31.73 60.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.041 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.05 -42.98 13.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.47 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.502 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.4 p -101.88 -0.94 33.19 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.723 -170.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.652 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.1 t80 -49.29 -55.96 11.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.003 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.621 ' HA ' ' HB2' ' A' ' 460' ' ' LEU . 24.6 mm -70.05 -24.73 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.502 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.72 -44.66 61.42 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.542 ' O ' HG23 ' A' ' 463' ' ' VAL . 47.3 m-70 -65.49 -32.02 73.4 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.15 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.818 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.54 -53.82 41.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.209 1.004 . . . . 0.0 109.263 -178.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -61.96 -30.42 70.91 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.187 -1.824 . . . . 0.0 110.74 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.76 -48.48 66.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.009 HG11 ' HA ' ' A' ' 435' ' ' VAL . 42.2 t -66.76 -34.71 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.489 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.546 ' OH ' HG13 ' A' ' 404' ' ' VAL . 19.2 m-30 -62.21 -13.96 33.09 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.617 167.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.573 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.8 tp10 -93.41 -52.94 4.28 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.414 -0.804 . . . . 0.0 112.242 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.739 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.3 pt -62.07 -41.73 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.132 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.4 mt -84.14 -17.34 40.39 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.732 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.63 49.87 57.51 Favored Glycine 0 C--O 1.219 -0.801 0 CA-C-N 111.515 -2.584 . . . . 0.0 113.223 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -102.68 -179.17 3.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 123.861 0.864 . . . . 0.0 110.402 -178.302 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.493 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.7 p-10 -100.82 -40.6 7.23 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -160.73 -76.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.121 160.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.755 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -64.32 67.81 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 41.04 39.84 2.16 Favored Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.425 -2.625 . . . . 0.0 113.361 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.493 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 1.1 mm100 -79.19 -51.87 8.92 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.529 1.157 . . . . 0.0 111.324 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.6 t 64.7 61.44 0.82 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 111.806 -2.452 . . . . 0.0 109.24 -172.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-N 110.391 -3.095 . . . . 0.0 111.49 171.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.429 -1.504 0 CA-C-O 121.118 0.485 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.81 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 33.4 mt -74.1 125.57 89.99 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-O 122.222 1.011 . . . . 0.0 112.221 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 308' ' ' GLN . 29.4 Cg_endo -74.58 -16.99 21.07 Favored 'Trans proline' 0 CA--C 1.503 -1.042 0 C-N-CA 124.954 3.77 . . . . 0.0 111.193 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.736 HG23 ' HG2' ' A' ' 308' ' ' GLN . 4.3 tp 36.82 -64.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 C-N-CA 128.225 2.61 . . . . 0.0 115.881 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.736 ' HG2' HG23 ' A' ' 307' ' ' ILE . 62.1 mm-40 -58.58 -34.03 70.62 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.561 0.696 . . . . 0.0 110.344 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.566 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.04 -47.99 83.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.927 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 335' ' ' ILE . 67.6 mt -61.75 -49.22 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 124.253 1.021 . . . . 0.0 112.624 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 0.9 OUTLIER -58.26 -31.4 67.39 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 122.697 0.399 . . . . 0.0 111.369 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 27.5 t -69.88 -33.34 72.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.533 0.682 . . . . 0.0 109.664 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.563 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.82 -41.02 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.659 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 331' ' ' ASN . 35.5 p -82.91 -35.89 25.75 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.733 1.254 . . . . 0.0 110.206 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.27 32.06 12.85 Favored Glycine 0 C--N 1.302 -1.342 0 CA-C-N 112.305 -2.225 . . . . 0.0 110.696 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.4 mt-10 51.79 172.86 0.03 OUTLIER Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 324' ' ' ILE . 71.8 Cg_exo -48.15 149.46 6.05 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.994 2.462 . . . . 0.0 113.687 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.48 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 16.3 Cg_endo -97.62 -106.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.992 3.128 . . . . 0.0 113.183 -171.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.466 ' H ' ' HG2' ' A' ' 319' ' ' ARG . 2.9 mmm180 -88.91 -78.37 0.35 Allowed 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 123.239 0.616 . . . . 0.0 110.506 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.493 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.9 m-20 -108.88 160.69 26.44 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.067 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.3 Cg_exo -60.13 -48.17 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 122.544 2.163 . . . . 0.0 110.107 168.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.457 ' HA ' HG21 ' A' ' 382' ' ' THR . 1.9 mmt180 -46.83 -26.19 0.92 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.851 -1.977 . . . . 0.0 112.743 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.493 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -93.52 -22.0 19.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.701 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -47.71 -42.48 45.4 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.748 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.3 Cg_endo -46.38 -64.8 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.185 2.59 . . . . 0.0 113.009 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.606 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.21 -37.02 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.209 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.72 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 54.5 t90 -58.55 -36.44 73.92 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.139 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.815 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.94 -49.96 46.73 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.512 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.22 -23.65 26.2 Favored Glycine 0 C--N 1.311 -0.817 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.156 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.7 mtt180 -73.6 -41.73 62.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.128 0.966 . . . . 0.0 110.598 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.725 ' HB3' HG22 ' A' ' 314' ' ' THR . 55.9 m-20 -97.57 -22.7 16.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.023 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.566 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -43.3 -48.65 16.83 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.2 Cg_endo -61.02 -33.67 91.67 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 122.584 2.19 . . . . 0.0 111.606 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.406 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -73.26 -42.73 62.17 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.559 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 310' ' ' ILE . 98.6 mt -57.79 -49.3 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.055 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 27.3 t70 -53.43 -17.57 2.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.501 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.24 5.75 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.024 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.66 HG11 HG13 ' A' ' 310' ' ' ILE . 85.3 t -58.24 -71.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-O 123.354 1.55 . . . . 0.0 110.205 170.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.81 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -87.63 124.43 67.62 Favored Pre-proline 0 N--CA 1.406 -2.675 0 CA-C-N 111.288 -2.687 . . . . 0.0 111.863 -175.044 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.695 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.5 Cg_endo -72.57 -19.24 24.88 Favored 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 123.809 3.006 . . . . 0.0 110.41 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.4 p 33.35 70.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.233 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 346' ' ' LEU . 63.4 p -80.83 3.78 21.39 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.749 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.789 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 28.2 p -141.78 154.54 65.9 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -60.15 -36.79 87.47 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 124.323 3.349 . . . . 0.0 109.563 171.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.634 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.7 -53.41 39.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.602 172.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.789 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.8 mt -56.73 -54.76 42.49 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.027 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.617 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 33.3 ttm105 -50.26 -41.17 49.99 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 125.511 1.757 . . . . 0.0 110.61 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.513 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 52.1 t -67.76 -48.94 64.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.666 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.6 mtt180 -61.11 -38.3 85.85 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.598 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.901 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.1 mt -57.14 -54.63 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.254 -0.579 . . . . 0.0 111.528 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.642 ' O ' HD22 ' A' ' 355' ' ' LEU . 14.9 mt -56.98 -54.39 30.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 124.566 1.166 . . . . 0.0 110.812 -171.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.589 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 37.0 m-20 -64.66 -34.57 78.6 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.288 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.12 67.56 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.94 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.901 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.5 mm -56.7 -58.35 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-O 122.821 1.296 . . . . 0.0 110.539 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.701 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.35 -26.71 55.98 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.007 -2.36 . . . . 0.0 109.871 -168.034 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.28 -68.84 0.68 Allowed Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.611 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -114.92 35.62 4.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.932 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.767 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -66.95 127.61 33.22 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.047 0.451 . . . . 0.0 110.794 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.668 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -49.0 -70.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.985 -169.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.67 5.17 7.05 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.443 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.767 ' HB2' HD22 ' A' ' 358' ' ' ASN . 4.4 mt -72.68 -3.59 25.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.557 0.694 . . . . 0.0 110.199 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.589 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 11.3 t -62.29 83.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.843 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.819 HD11 HG21 ' A' ' 377' ' ' THR . 1.7 mm? -62.7 -174.24 0.06 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.905 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 63.8 p -125.11 157.41 67.21 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 23.4 Cg_exo -49.14 -31.63 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.839 1.693 . . . . 0.0 111.072 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -87.4 -3.78 81.27 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.961 -172.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.754 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.4 m-20 -104.88 -21.0 13.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.223 1.011 . . . . 0.0 109.274 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 65.1 m -86.14 23.69 1.48 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.402 -171.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.86 -36.29 72.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.045 0.926 . . . . 0.0 109.835 -174.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.88 162.43 26.72 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.392 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.612 ' O ' HG13 ' A' ' 375' ' ' VAL . 41.8 m95 -70.62 -36.65 73.59 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.588 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.15 -39.93 83.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.911 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 75.3 p -73.41 -43.69 59.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.29 -52.38 63.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.836 HG21 ' HE3' ' A' ' 413' ' ' MET . 14.0 m -57.28 -44.08 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.611 0.719 . . . . 0.0 109.548 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 0.998 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.08 -44.14 97.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.041 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.819 HG21 HD11 ' A' ' 363' ' ' LEU . 29.3 m -69.34 -38.19 78.04 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.168 -172.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 3.0 mt -61.05 -33.71 73.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 110.473 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.748 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.5 t80 -75.76 -45.01 38.7 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.308 1.052 . . . . 0.0 109.233 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.12 -33.25 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.147 170.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.9 OUTLIER -60.78 -47.1 87.85 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.734 0.778 . . . . 0.0 110.899 176.336 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 322' ' ' ARG . 37.8 p -93.93 -23.36 18.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.998 -166.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -111.22 23.08 14.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.22 20.84 30.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.639 0.616 . . . . 0.0 114.639 173.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.457 HG23 HG13 ' A' ' 380' ' ' ILE . 2.9 m 64.13 157.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -175.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.498 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.1 OUTLIER -121.81 157.52 57.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.068 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -96.5 52.54 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.481 2.787 . . . . 0.0 111.783 168.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.754 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.02 -8.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -177.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -69.56 -42.81 74.03 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.042 -0.411 . . . . 0.0 110.943 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.691 ' O ' HG13 ' A' ' 394' ' ' VAL . 78.4 mt-30 -68.32 -27.11 66.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.754 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -53.5 -30.16 39.9 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.342 0.519 . . . . 0.0 111.015 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.86 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.81 -51.88 50.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.676 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.569 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.1 m-20 -69.73 -37.0 76.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.982 0.513 . . . . 0.0 112.085 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 390' ' ' GLN . 1.4 m -58.3 -47.72 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.58 ' O ' HG22 ' A' ' 399' ' ' VAL . 4.3 mm -57.99 -48.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 173.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.569 ' HE3' ' HA ' ' A' ' 393' ' ' ASN . 0.2 OUTLIER -52.43 -46.32 66.34 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.836 -177.136 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.91 50.19 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.018 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.871 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -70.59 -41.49 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 117.143 0.472 . . . . 0.0 111.7 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.5 m -56.45 -41.91 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.809 0.814 . . . . 0.0 110.181 -177.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.471 ' N ' HG23 ' A' ' 399' ' ' VAL . 0.8 OUTLIER -67.49 -34.61 77.48 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.07 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -85.47 -54.67 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -107.8 -30.77 8.34 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.692 0.758 . . . . 0.0 112.329 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.38 170.71 14.01 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.532 -175.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.789 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.82 -45.11 95.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -172.645 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.32 -50.57 72.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.612 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.1 m -63.06 -51.15 67.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.871 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.7 -43.93 69.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.544 ' HB3' HD11 ' A' ' 457' ' ' ILE . 34.0 t80 -54.7 -45.23 73.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.735 0.779 . . . . 0.0 109.157 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.841 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.2 m -59.33 -52.65 64.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.502 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.698 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.42 -49.35 77.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.081 176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.592 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.12 -42.83 88.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.906 -173.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.815 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -31.6 65.56 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.541 0.17 . . . . 0.0 111.121 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.841 ' HG3' ' O ' ' A' ' 409' ' ' THR . 57.7 mtm -70.97 -45.58 63.86 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.381 0.61 . . . . 0.0 109.655 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.998 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.3 mt -60.28 -39.44 86.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.481 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.648 ' HB2' HD21 ' A' ' 421' ' ' LEU . 6.6 p -76.44 -2.57 32.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.766 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 79.78 31.04 41.36 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.815 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.2 mm100 68.12 52.63 0.66 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.134 -1.033 . . . . 0.0 111.668 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.722 ' O ' HD23 ' A' ' 421' ' ' LEU . 2.7 t-20 -117.41 74.9 0.95 Allowed 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 160.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.593 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.3 OUTLIER -53.98 -35.95 62.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.143 -173.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.545 ' O ' ' HB3' ' A' ' 423' ' ' SER . 25.2 mt-30 -57.61 -49.77 75.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -168.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.779 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 0.2 OUTLIER -59.59 -50.43 73.91 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.34 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.779 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.28 -38.2 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.738 1.256 . . . . 0.0 109.269 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.545 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 24.5 t -59.59 -50.46 73.81 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 112.271 -2.24 . . . . 0.0 111.473 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.99 71.39 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.302 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.86 HD13 ' HA2' ' A' ' 392' ' ' GLY . 6.1 mt -73.15 -40.91 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.72 0.772 . . . . 0.0 110.484 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.597 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -63.42 -42.75 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.228 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.703 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.1 OUTLIER -59.77 -31.17 69.41 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.714 -176.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.46 -20.12 79.25 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.108 174.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.499 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.0 m-85 -98.45 1.96 47.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -176.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.44 145.64 67.27 Favored Pre-proline 0 N--CA 1.417 -2.09 0 CA-C-O 123.647 1.689 . . . . 0.0 113.83 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.768 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 60.1 Cg_endo -71.53 -64.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 1 C-N-CA 126.099 4.533 . . . . 0.0 113.063 -172.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.566 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.49 140.2 15.28 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.133 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.829 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.16 -27.17 68.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.948 0.374 . . . . 0.0 111.8 -176.276 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.761 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -59.92 -47.24 86.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.067 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -60.42 -51.7 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.232 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.909 ' O ' ' HG2' ' A' ' 440' ' ' GLN . 0.7 OUTLIER -51.76 -59.52 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 66.5 m -61.21 -55.52 31.14 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.252 -173.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.66 -44.36 81.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.894 -176.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.82 HD21 ' HA ' ' A' ' 460' ' ' LEU . 17.3 mt -59.7 -55.0 39.8 Favored 'General case' 0 CA--C 1.469 -2.155 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.248 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.909 ' HG2' ' O ' ' A' ' 436' ' ' VAL . 27.5 mm-40 -53.57 -34.34 57.97 Favored 'General case' 0 N--CA 1.409 -2.52 0 O-C-N 125.627 1.829 . . . . 0.0 109.787 -177.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -71.33 -60.04 2.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 176.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -74.97 -47.77 27.65 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 121.585 -0.697 . . . . 0.0 111.742 -173.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.25 -25.7 64.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.708 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.768 ' N ' HD23 ' A' ' 443' ' ' LEU . 9.2 t70 -73.74 -41.42 62.54 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.418 1.104 . . . . 0.0 110.738 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -69.57 -6.6 32.11 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -173.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 452' ' ' ARG . 38.2 mm-40 -49.63 161.46 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.707 1.718 . . . . 0.0 114.435 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.544 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -57.18 -31.73 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 110.525 -3.034 . . . . 0.0 114.938 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.656 ' H ' ' HB ' ' A' ' 451' ' ' THR . 9.1 m-20 -143.85 -179.22 6.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.654 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.485 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 8.5 p-10 -64.42 -53.54 46.84 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 175.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.656 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.3 m -58.53 -39.21 79.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.553 171.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.677 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 30.7 mtm-85 -63.52 -29.57 70.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 450' ' ' GLN . . . -73.93 -31.97 63.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.853 0.835 . . . . 0.0 109.643 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.46 -43.86 13.23 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.436 -1.257 . . . . 0.0 112.435 -170.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.529 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 35.6 p -102.34 -1.41 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.011 -168.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.4 t80 -49.05 -53.28 20.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.9 mm -71.2 -25.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.529 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.14 -43.31 64.86 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.566 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.3 m-70 -66.7 -31.15 71.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.615 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.82 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.5 -53.92 35.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.181 0.991 . . . . 0.0 109.293 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.664 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.14 -32.06 72.61 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.136 173.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.93 -53.24 57.16 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.067 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.0 t -63.23 -33.84 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.345 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.8 m-30 -61.28 -15.3 33.81 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.136 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 16.9 mm-40 -91.14 -49.18 6.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.141 -0.974 . . . . 0.0 112.753 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.7 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -65.8 -39.3 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.027 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.3 mt -84.61 -17.52 38.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.733 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 62.3 55.39 27.96 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.627 -2.533 . . . . 0.0 112.986 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.746 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -104.2 -174.12 2.47 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 123.863 0.865 . . . . 0.0 109.642 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.54 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.9 p-10 -106.03 -41.17 5.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 166.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -158.7 -78.25 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.009 160.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.768 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -62.61 70.45 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -169.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 38.09 40.82 0.9 Allowed Glycine 0 C--N 1.279 -2.631 0 CA-C-N 110.948 -2.842 . . . . 0.0 113.487 171.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.54 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 2.0 mm100 -78.12 -52.37 8.83 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 122.631 1.205 . . . . 0.0 111.287 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.4 t 63.47 56.4 1.64 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.716 -2.493 . . . . 0.0 108.065 -171.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.733 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 CA-C-N 110.508 -3.042 . . . . 0.0 111.631 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.424 -1.768 0 CA-C-O 121.309 0.576 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.785 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.8 mt -70.11 123.95 89.79 Favored Pre-proline 0 N--CA 1.425 -1.709 0 CA-C-O 121.862 0.839 . . . . 0.0 111.806 -175.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 308' ' ' GLN . 20.6 Cg_endo -71.77 -12.23 28.56 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 124.764 3.643 . . . . 0.0 111.23 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 308' ' ' GLN . 4.2 tp 31.32 -64.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.217 0 C-N-CA 128.5 2.72 . . . . 0.0 116.046 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.673 ' HG2' HG23 ' A' ' 307' ' ' ILE . 38.9 mm-40 -57.79 -33.74 68.87 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.616 0.722 . . . . 0.0 110.163 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.495 ' CD2' HG13 ' A' ' 338' ' ' VAL . 1.3 t-80 -61.4 -48.82 79.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.682 173.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.639 HG13 HG11 ' A' ' 338' ' ' VAL . 70.1 mt -61.32 -48.89 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 124.135 0.974 . . . . 0.0 112.799 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.667 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 2.0 mtp-105 -58.92 -30.87 68.16 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.242 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 36.9 t -69.82 -34.57 73.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.596 0.712 . . . . 0.0 109.641 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.501 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.1 -40.57 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.707 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.689 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.41 -36.28 26.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 122.912 1.339 . . . . 0.0 109.636 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.65 32.79 8.95 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.119 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.1 mt-10 53.42 167.47 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.142 0 C-N-CA 124.433 1.093 . . . . 0.0 113.869 -175.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.683 ' HG3' HD12 ' A' ' 355' ' ' LEU . 38.0 Cg_exo -44.03 146.61 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.766 2.977 . . . . 0.0 113.435 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.463 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 28.8 Cg_endo -93.44 -103.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.285 2.657 . . . . 0.0 112.068 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.46 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 12.9 mmm180 -91.77 -91.51 0.16 Allowed 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.117 0.484 . . . . 0.0 110.604 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.533 ' HB3' ' HG2' ' A' ' 322' ' ' ARG . 48.6 m-20 -95.05 164.81 18.36 Favored Pre-proline 0 N--CA 1.439 -0.978 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.14 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.461 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.0 -47.26 18.56 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 122.605 2.203 . . . . 0.0 110.249 167.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.533 ' HG2' ' HB3' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -55.67 -17.99 6.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.248 176.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 3.2 mt-10 -93.46 -23.42 18.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.963 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.712 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -52.15 -40.95 77.77 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.745 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.0 Cg_endo -48.97 -64.58 0.21 Allowed 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.96 2.44 . . . . 0.0 112.898 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.594 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -57.91 -39.0 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.878 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.689 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 61.8 t90 -56.43 -39.78 73.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.988 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.805 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -67.35 -49.48 63.84 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.407 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -53.66 -23.71 22.17 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.888 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 3.4 mtm180 -73.2 -41.13 64.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.264 0.554 . . . . 0.0 111.137 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.574 ' HB2' HG22 ' A' ' 314' ' ' THR . 1.3 p30 -106.08 -15.78 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.712 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.35 -48.08 6.39 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.1 Cg_endo -61.75 -32.36 86.21 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.731 2.287 . . . . 0.0 111.989 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.58 -42.56 58.52 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.513 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 332' ' ' ALA . 95.4 mt -56.73 -48.41 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.946 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 15.2 t70 -50.87 -21.81 1.89 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.73 -1.577 . . . . 0.0 112.764 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.7 -48.44 7.91 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.445 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.639 HG11 HG13 ' A' ' 310' ' ' ILE . 88.6 t -60.05 -72.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 123.389 1.566 . . . . 0.0 110.087 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.785 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -88.05 122.67 69.84 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.251 -2.704 . . . . 0.0 111.758 -174.257 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.644 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 70.8 Cg_endo -73.41 -17.76 23.61 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 C-N-CA 123.742 2.961 . . . . 0.0 109.961 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.495 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.44 71.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.422 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.543 ' N ' HD12 ' A' ' 346' ' ' LEU . 45.1 p -85.52 11.34 10.77 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.042 -1.89 . . . . 0.0 113.049 -169.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.78 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.1 p -147.03 157.07 46.94 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 121.437 0.637 . . . . 0.0 109.968 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.533 ' HB3' HD12 ' A' ' 369' ' ' LEU . 73.3 Cg_exo -60.81 -36.85 82.17 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.643 3.562 . . . . 0.0 110.04 173.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.715 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.3 OUTLIER -51.84 -56.96 10.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.621 173.335 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.78 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.2 mt -56.72 -48.92 76.65 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.757 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.527 ' HA ' HD12 ' A' ' 350' ' ' ILE . 24.9 mmt180 -45.46 -52.14 10.62 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 125.295 1.622 . . . . 0.0 109.887 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.543 ' HA ' HD12 ' A' ' 351' ' ' ILE . 44.6 t -68.41 -50.87 49.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.825 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.666 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.9 mtp180 -61.06 -33.73 73.79 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.907 ' O ' HG12 ' A' ' 354' ' ' ILE . 18.5 mt -58.02 -53.22 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.205 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.594 ' O ' HD22 ' A' ' 355' ' ' LEU . 14.1 mt -59.35 -54.05 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.611 0.719 . . . . 0.0 111.254 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.402 ' HB3' ' OG ' ' A' ' 362' ' ' SER . 0.1 OUTLIER -61.12 -38.06 85.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.039 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ALA . . . . . 0.496 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.94 -30.06 66.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.907 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.6 mm -56.62 -57.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 CA-C-O 122.922 1.344 . . . . 0.0 110.418 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.712 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -79.96 -27.47 39.73 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.195 -2.275 . . . . 0.0 109.897 -167.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.75 -76.93 0.21 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.936 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -101.52 38.55 3.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.866 -174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.756 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.3 p-10 -77.92 125.52 29.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.025 0.44 . . . . 0.0 110.424 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -48.56 -72.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.907 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -123.41 -1.7 9.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.304 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.756 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.5 mt -68.82 -6.0 24.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 122.193 0.997 . . . . 0.0 109.784 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 352' ' ' ASN . 2.3 t -70.62 75.6 0.58 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.363 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.738 HD11 HG21 ' A' ' 377' ' ' THR . 1.8 mm? -54.19 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.497 ' C ' ' H ' ' A' ' 366' ' ' GLY . 64.3 p -115.6 156.01 46.65 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.715 ' CB ' ' HA ' ' A' ' 345' ' ' ASP . 56.3 Cg_endo -71.91 22.19 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.11 1.874 . . . . 0.0 111.83 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -136.12 -2.55 2.68 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.726 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.589 ' HB2' HD12 ' A' ' 363' ' ' LEU . 45.5 m-20 -104.54 -21.4 13.44 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.285 1.041 . . . . 0.0 109.308 173.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 63.1 m -85.29 21.84 1.63 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.58 -171.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -55.94 -34.78 65.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.367 1.08 . . . . 0.0 110.112 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.04 159.96 31.37 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.697 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.615 ' O ' HG13 ' A' ' 375' ' ' VAL . 56.6 m95 -69.94 -35.77 74.78 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.634 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -57.35 -46.22 83.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.985 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 72.2 m -68.14 -42.14 80.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.072 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.604 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.14 -52.29 59.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.6 m -57.23 -44.12 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.0 109.463 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.053 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.139 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.738 HG21 HD11 ' A' ' 363' ' ' LEU . 24.4 m -71.95 -37.56 69.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.371 -172.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -62.02 -34.21 75.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.674 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.745 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.9 t80 -73.46 -47.46 41.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.65 1.214 . . . . 0.0 109.125 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.09 -32.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 112.415 -2.175 . . . . 0.0 111.829 170.093 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.5 mpt_? -60.4 -40.76 92.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.482 0.658 . . . . 0.0 111.351 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.424 HG21 ' HA ' ' A' ' 322' ' ' ARG . 31.6 p -100.25 -23.55 14.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.384 -166.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -110.39 23.03 14.79 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.89 20.99 21.77 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 123.308 0.38 . . . . 0.0 113.805 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 380' ' ' ILE . 1.9 m 66.79 156.32 0.1 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 111.414 -175.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.493 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.1 OUTLIER -117.87 153.56 50.98 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.301 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -95.97 49.85 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.309 2.672 . . . . 0.0 111.348 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.728 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.96 4.61 0.63 Allowed 'General case' 0 C--N 1.339 0.112 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -70.12 -47.1 63.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.241 0.544 . . . . 0.0 110.289 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.566 ' O ' HG23 ' A' ' 394' ' ' VAL . 97.3 mt-30 -73.84 -27.13 60.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -54.66 -31.84 58.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.128 0.877 . . . . 0.0 111.21 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.729 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.9 -55.06 30.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.087 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.495 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 7.6 m-20 -62.78 -36.52 83.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.559 0.695 . . . . 0.0 111.238 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.574 HG11 ' CD1' ' A' ' 414' ' ' LEU . 52.6 t -54.95 -53.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.068 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.702 ' O ' HG22 ' A' ' 399' ' ' VAL . 4.6 mm -58.59 -45.93 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.177 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 40.2 mmtt -53.36 -41.07 65.44 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 124.0 0.813 . . . . 0.0 112.154 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.566 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -78.91 -44.54 9.96 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.394 -173.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.899 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.0 OUTLIER -69.51 -40.84 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 117.451 0.626 . . . . 0.0 111.4 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.861 HG12 ' HA ' ' A' ' 404' ' ' VAL . 7.8 m -57.9 -41.43 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.908 0.861 . . . . 0.0 110.154 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.0 t70 -58.15 -41.88 84.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.88 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 75.3 mt-30 -81.62 -55.38 4.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.884 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.493 ' HG3' ' HD2' ' A' ' 330' ' ' ARG . 18.5 mm-40 -111.84 -30.3 7.35 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.001 0.905 . . . . 0.0 112.123 -170.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.4 ' C ' ' HA ' ' A' ' 399' ' ' VAL . . . 119.24 177.32 16.44 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.601 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.861 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.68 -44.45 96.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.227 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.44 -50.74 72.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -66.0 -50.15 65.27 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 122.177 -0.327 . . . . 0.0 110.665 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.899 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -54.09 -41.9 68.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.559 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.2 t80 -56.24 -45.57 79.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.712 0.768 . . . . 0.0 109.212 175.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.843 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.7 m -59.29 -52.52 65.28 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.505 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.713 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.73 -49.54 77.08 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.051 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.544 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.49 -42.25 89.63 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.012 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.724 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.0 OUTLIER -72.16 -31.98 66.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 122.702 -0.293 . . . . 0.0 111.227 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.843 ' HG3' ' O ' ' A' ' 409' ' ' THR . 61.1 mtm -70.31 -47.36 61.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.224 0.535 . . . . 0.0 109.912 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.053 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.6 mt -60.19 -39.92 88.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.665 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.717 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.6 OUTLIER -75.1 -14.3 60.56 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.427 -177.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 94.28 38.62 5.02 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.721 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.719 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.8 mm100 52.73 54.19 10.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.206 -0.997 . . . . 0.0 112.906 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.61 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 13.1 p30 -125.45 62.31 1.2 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 164.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.724 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 1.7 p90 -43.77 -33.92 1.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 111.408 -2.633 . . . . 0.0 112.976 -164.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 423' ' ' SER . 31.6 mt-30 -55.02 -44.55 74.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -165.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 422' ' ' VAL . 2.3 pp -62.61 -47.85 82.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.047 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.694 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -61.36 -39.63 83.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 122.614 1.197 . . . . 0.0 108.947 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.594 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 40.6 t -58.8 -46.09 88.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 112.434 -2.166 . . . . 0.0 111.478 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.97 -39.79 80.01 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.959 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.08 -40.49 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.506 0.669 . . . . 0.0 110.17 175.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.594 HG23 HG23 ' A' ' 404' ' ' VAL . 1.7 mm -58.66 -44.56 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 CA-C-N 114.274 -1.33 . . . . 0.0 113.131 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.706 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -60.6 -29.23 69.09 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-O 122.784 1.278 . . . . 0.0 108.731 -174.222 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -15.75 76.9 Favored Glycine 0 C--N 1.3 -1.453 0 CA-C-N 112.394 -2.184 . . . . 0.0 112.674 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.7 m-85 -100.98 0.89 39.05 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.99 144.14 76.12 Favored Pre-proline 0 N--CA 1.41 -2.428 0 CA-C-O 123.723 1.725 . . . . 0.0 113.317 170.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.762 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 79.1 Cg_endo -72.23 -51.75 0.2 Allowed 'Trans proline' 0 C--N 1.311 -1.417 1 C-N-CA 126.065 4.51 . . . . 0.0 113.33 -173.026 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.508 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -122.88 142.34 14.54 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.417 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.883 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.24 -29.22 70.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.106 0.453 . . . . 0.0 111.627 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.741 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.51 -47.83 78.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.007 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -59.02 -51.68 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.596 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.883 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.84 -54.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.259 179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 28.3 m -62.54 -55.88 23.19 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.809 -175.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.46 -44.74 80.81 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.615 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.855 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 40.6 mt -60.93 -55.01 38.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.835 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.671 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -49.93 -32.7 15.45 Favored 'General case' 0 N--CA 1.419 -1.999 0 O-C-N 124.429 1.081 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.39 -60.3 2.3 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 174.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -77.25 -52.22 9.59 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -170.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 1.5 pp -57.28 -24.25 53.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.331 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.671 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 28.5 t70 -71.53 -42.04 68.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.546 1.165 . . . . 0.0 110.019 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.0 mt-30 -71.39 -8.11 51.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.032 -1.895 . . . . 0.0 115.933 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 38.1 mm-40 -54.64 157.85 2.81 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 123.619 1.676 . . . . 0.0 115.022 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -53.48 -33.14 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 110.445 -3.07 . . . . 0.0 115.101 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.664 ' H ' ' HB ' ' A' ' 451' ' ' THR . 29.9 m-20 -138.88 179.65 6.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.27 -52.1 50.89 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.95 -24.22 65.15 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 175.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.664 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.4 m -59.36 -40.75 87.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 171.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 39.0 mtt180 -60.75 -30.81 70.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.408 171.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.559 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -74.31 -32.81 63.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.712 0.768 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.8 -44.6 15.33 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.111 -171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.471 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 42.1 p -99.13 -4.96 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.893 -168.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.724 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.3 t80 -49.04 -51.0 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.664 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.5 mm -72.04 -27.57 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.432 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.52 -42.92 67.36 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 463' ' ' VAL . 53.6 m-70 -66.99 -31.04 71.34 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.81 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.775 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.35 -53.89 36.96 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.116 0.96 . . . . 0.0 109.243 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.55 -31.91 72.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 113.329 -1.76 . . . . 0.0 110.137 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.73 -52.66 62.37 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.178 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.007 HG11 ' HA ' ' A' ' 435' ' ' VAL . 23.5 t -63.45 -33.73 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.186 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.2 m-30 -61.8 -15.04 38.36 Favored 'General case' 0 C--O 1.202 -1.447 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.984 169.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 50.0 mm-40 -90.37 -50.01 6.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.575 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.702 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -66.63 -38.89 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.121 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 469' ' ' LEU . 6.5 mt -84.81 -15.64 44.14 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.59 49.02 66.89 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-N 111.822 -2.445 . . . . 0.0 113.213 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.764 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -101.1 -179.1 3.94 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.094 0.958 . . . . 0.0 110.113 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.555 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.5 p-10 -104.41 -40.65 6.0 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 167.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -158.42 -79.34 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.278 -2.237 . . . . 0.0 110.955 157.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.762 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -61.37 72.66 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -170.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 38.04 42.83 1.24 Allowed Glycine 0 C--N 1.275 -2.827 0 CA-C-N 110.602 -2.999 . . . . 0.0 113.431 171.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.555 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 1.5 mm100 -79.04 -54.39 6.06 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 122.288 1.042 . . . . 0.0 111.469 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.6 t 65.75 46.18 2.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.066 -2.333 . . . . 0.0 108.763 -174.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.74 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.292 -1.898 0 CA-C-N 109.505 -3.498 . . . . 0.0 112.346 171.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 121.158 0.504 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.717 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -75.53 128.15 84.59 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 121.795 0.807 . . . . 0.0 112.187 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 308' ' ' GLN . 13.0 Cg_endo -70.38 -22.35 29.38 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 C-N-CA 124.54 3.493 . . . . 0.0 110.748 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.728 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.7 tp 38.0 -59.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 C-N-CA 128.244 2.618 . . . . 0.0 116.135 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.598 ' HG2' HG23 ' A' ' 307' ' ' ILE . 9.8 mm-40 -57.36 -39.5 76.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.833 0.825 . . . . 0.0 110.132 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.519 ' CD2' HG13 ' A' ' 338' ' ' VAL . 1.3 t-80 -58.87 -48.19 82.26 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.609 173.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.9 mt -58.92 -49.07 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.728 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 7.7 mtp180 -61.05 -30.16 70.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.889 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 47.9 t -70.06 -35.17 74.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.416 0.627 . . . . 0.0 109.59 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.55 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.71 -41.03 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.722 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.782 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.7 p -82.94 -36.69 25.0 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 122.914 1.34 . . . . 0.0 109.564 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.25 35.47 9.6 Favored Glycine 0 C--N 1.303 -1.252 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.596 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 51.29 173.24 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.298 0 C-N-CA 124.258 1.023 . . . . 0.0 113.153 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.798 ' HB3' HD11 ' A' ' 324' ' ' ILE . 37.3 Cg_exo -46.77 150.96 2.28 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.986 2.457 . . . . 0.0 113.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.2 Cg_endo -92.07 -104.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.656 2.904 . . . . 0.0 112.751 -172.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -92.29 -79.55 0.38 Allowed 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.538 0.685 . . . . 0.0 110.553 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 323' ' ' GLU . 49.2 m-20 -103.9 161.45 22.91 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.955 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.5 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 45.2 Cg_exo -58.03 -50.37 10.29 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 122.656 2.237 . . . . 0.0 110.413 168.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.1 OUTLIER -49.78 -27.32 4.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.662 175.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -80.52 -29.13 37.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -48.41 -45.53 67.76 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.736 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.0 Cg_endo -50.75 -61.29 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.742 2.295 . . . . 0.0 112.962 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.625 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -61.94 -36.26 72.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.01 179.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.782 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.4 t90 -58.41 -36.65 73.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.257 -1.792 . . . . 0.0 111.305 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.834 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.02 -48.42 58.13 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.71 -23.2 20.49 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.774 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.52 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.2 OUTLIER -74.97 -43.04 56.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.102 0.953 . . . . 0.0 110.552 174.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.728 ' HB3' HG22 ' A' ' 314' ' ' THR . 46.7 m-20 -95.07 -24.53 16.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.68 -1.6 . . . . 0.0 113.827 -169.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.23 -49.68 11.73 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 124.319 1.048 . . . . 0.0 113.777 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.4 Cg_endo -61.84 -32.57 85.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.522 2.148 . . . . 0.0 111.617 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.64 62.69 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.673 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.641 HG23 HG23 ' A' ' 310' ' ' ILE . 89.3 mt -59.32 -48.78 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.67 173.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.71 -15.98 9.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.213 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -50.36 5.99 Favored Glycine 0 CA--C 1.509 -0.328 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.657 HG11 HG13 ' A' ' 310' ' ' ILE . 70.5 t -54.62 -70.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 123.565 1.65 . . . . 0.0 110.094 169.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.858 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -93.72 132.03 30.81 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.052 -2.795 . . . . 0.0 112.464 -171.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.807 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.1 Cg_endo -72.66 -19.48 24.29 Favored 'Trans proline' 0 CA--C 1.497 -1.357 0 C-N-CA 123.65 2.9 . . . . 0.0 111.084 173.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.6 p 32.45 69.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.472 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.618 ' N ' HD12 ' A' ' 346' ' ' LEU . 75.7 p -79.53 4.14 16.66 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.096 -1.866 . . . . 0.0 113.108 -170.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.7 p -142.7 156.15 63.04 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.636 0.732 . . . . 0.0 109.624 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 75.5 Cg_exo -60.5 -38.18 75.32 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 124.357 3.371 . . . . 0.0 109.601 172.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.632 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -51.9 -52.76 47.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.546 174.021 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.8 mt -56.96 -52.74 64.04 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.818 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.719 ' HA ' HD12 ' A' ' 350' ' ' ILE . 32.1 ttm105 -51.96 -43.89 63.74 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.255 -1.793 . . . . 0.0 110.442 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 368' ' ' CYS . 38.2 t -69.09 -48.73 61.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.341 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 72.7 mtt180 -57.74 -38.1 74.76 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.548 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.858 HD11 ' CD2' ' A' ' 339' ' ' PHE . 52.5 mt -62.14 -54.51 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.941 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.569 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -58.19 -53.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 122.197 0.998 . . . . 0.0 111.02 -168.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 44.4 m-20 -63.49 -34.55 78.02 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.17 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.12 76.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.34 -53.9 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 122.873 1.32 . . . . 0.0 110.721 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -72.89 -25.65 61.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 111.805 -2.452 . . . . 0.0 109.104 -169.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.06 -78.19 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.975 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.33 52.57 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.705 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.573 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.2 OUTLIER -74.51 160.32 31.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 122.35 0.26 . . . . 0.0 110.664 177.157 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.1 mp -56.98 -67.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 120.959 0.409 . . . . 0.0 111.337 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -144.98 12.88 1.9 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.896 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.694 ' HB3' HD22 ' A' ' 378' ' ' LEU . 7.0 mt -64.38 -2.37 2.2 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.487 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 38.7 t -62.3 84.28 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.224 0.535 . . . . 0.0 110.288 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.91 HD11 HG21 ' A' ' 377' ' ' THR . 2.3 mm? -61.74 -172.75 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 70.5 p -126.73 155.94 74.35 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 21.5 Cg_exo -48.16 -38.42 32.78 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.531 1.488 . . . . 0.0 110.103 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -81.7 1.51 85.85 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.107 -0.952 . . . . 0.0 114.661 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.738 ' HB2' HD12 ' A' ' 363' ' ' LEU . 26.2 m-20 -109.01 -21.76 12.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.236 1.017 . . . . 0.0 109.539 171.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.654 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 83.9 m -91.07 21.12 4.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.612 -171.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -62.45 -36.81 83.6 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.769 1.271 . . . . 0.0 108.579 -174.601 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.2 p -117.4 163.9 15.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.247 -2.251 . . . . 0.0 109.634 170.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.633 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.2 m95 -70.63 -34.24 71.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.59 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.42 -42.48 96.02 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.724 -170.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.6 m -71.33 -42.5 68.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.703 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.03 -52.17 66.13 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.921 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.7 m -58.56 -44.36 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 109.512 -178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.077 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.91 HG21 HD11 ' A' ' 363' ' ' LEU . 54.3 m -70.15 -41.04 74.36 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.825 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.694 HD22 ' HB3' ' A' ' 361' ' ' LEU . 1.8 mt -58.69 -34.45 71.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.562 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.736 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 45.6 t80 -73.52 -46.96 44.61 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.267 1.032 . . . . 0.0 109.766 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.574 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.19 -32.9 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.537 170.213 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.619 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -59.76 -43.1 94.46 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.412 0.625 . . . . 0.0 110.999 174.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 41.4 p -95.54 -23.37 17.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.214 -167.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -110.46 22.22 15.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.06 21.16 30.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 114.436 0.534 . . . . 0.0 114.436 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.414 HG23 HG13 ' A' ' 380' ' ' ILE . 1.8 m 64.81 158.13 0.09 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.441 0.639 . . . . 0.0 111.744 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.468 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.75 156.06 65.63 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -97.83 52.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.322 2.681 . . . . 0.0 111.266 166.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.688 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.8 6.09 0.42 Allowed 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -70.06 -48.29 58.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.215 0.531 . . . . 0.0 110.039 174.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.642 ' O ' HG13 ' A' ' 394' ' ' VAL . 59.0 mt-30 -75.84 -25.21 56.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.902 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -53.64 -31.11 46.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.488 1.04 . . . . 0.0 111.916 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.72 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.24 -54.08 36.51 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.637 172.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 396' ' ' LYS . 17.7 m-20 -63.43 -38.71 92.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.336 0.654 . . . . 0.0 112.458 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -58.89 -46.17 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 120.795 0.331 . . . . 0.0 110.442 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 399' ' ' VAL . 5.5 mm -57.97 -46.83 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.311 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.568 ' HD2' ' OH ' ' A' ' 429' ' ' TYR . 8.1 mtmt -52.15 -46.28 65.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.768 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.55 -44.71 39.66 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.636 -1.268 . . . . 0.0 112.96 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.2 mt -69.93 -41.65 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 117.532 0.666 . . . . 0.0 111.684 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.7 m -57.42 -44.73 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.801 0.81 . . . . 0.0 110.369 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.479 ' N ' HG23 ' A' ' 399' ' ' VAL . 1.6 t70 -67.4 -32.61 73.62 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.919 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.43 -55.28 3.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.688 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.39 -28.12 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.901 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.408 ' HA2' ' NH1' ' A' ' 472' ' ' ARG . . . 121.12 162.16 11.6 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.608 -175.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.903 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -41.34 92.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.667 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.75 -51.86 67.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.846 0.355 . . . . 0.0 111.863 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 330' ' ' ARG . 0.8 OUTLIER -64.04 -49.95 70.34 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.28 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.683 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -51.75 -43.03 62.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.6 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 34.5 t80 -56.18 -47.73 77.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.615 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.769 ' O ' ' HG3' ' A' ' 413' ' ' MET . 2.2 m -57.92 -51.77 68.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.705 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.56 -48.94 78.68 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.821 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.83 -43.59 87.14 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.397 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.689 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.21 -31.67 66.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.887 0.343 . . . . 0.0 110.839 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.921 ' HE3' HG21 ' A' ' 375' ' ' VAL . 69.2 mtm -69.1 -48.57 62.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.291 0.567 . . . . 0.0 110.048 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.077 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.1 mt -59.13 -39.27 81.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.22 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.902 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 4.3 m -78.16 -13.6 59.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 95.92 32.25 6.92 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.33 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.601 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.7 OUTLIER 69.92 37.63 1.74 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.357 0.663 . . . . 0.0 111.876 176.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.61 ' OD1' HD21 ' A' ' 421' ' ' LEU . 0.3 OUTLIER -120.52 81.24 1.73 Allowed 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.689 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 8.5 p90 -63.15 -31.74 72.95 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.611 -161.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 25.8 mt-30 -54.3 -48.38 71.36 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 113.464 -164.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.672 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.4 pp -59.61 -51.36 70.16 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.416 0.626 . . . . 0.0 111.02 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -59.8 -38.44 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.891 1.329 . . . . 0.0 109.241 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 43.4 t -63.09 -47.12 84.22 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.025 -2.352 . . . . 0.0 111.873 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.66 -36.27 70.88 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.87 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.72 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.7 mt -72.01 -43.07 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.546 0.689 . . . . 0.0 109.944 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.583 HD13 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -56.09 -45.24 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.718 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.4 OUTLIER -61.45 -29.45 69.97 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 122.608 1.194 . . . . 0.0 108.959 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.06 -16.56 76.76 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.688 -2.051 . . . . 0.0 112.462 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.712 ' CG ' HG21 ' A' ' 399' ' ' VAL . 11.8 m-85 -100.68 2.69 41.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.74 143.6 75.82 Favored Pre-proline 0 N--CA 1.411 -2.414 0 CA-C-O 123.658 1.694 . . . . 0.0 113.687 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.76 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 72.9 Cg_endo -72.45 -55.09 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.102 1 C-N-CA 126.455 4.77 . . . . 0.0 113.263 -171.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -114.77 140.57 16.45 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.115 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.892 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.054 0.427 . . . . 0.0 111.522 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.789 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.4 -46.66 83.22 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.01 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.8 t -59.17 -51.37 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.553 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.21 -54.4 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.9 m -61.33 -56.64 18.18 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.12 -45.42 79.5 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.533 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.841 ' O ' HD22 ' A' ' 443' ' ' LEU . 43.9 mt -60.11 -53.29 59.5 Favored 'General case' 0 CA--C 1.481 -1.697 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.687 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.716 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 19.9 mm100 -51.35 -35.15 37.05 Favored 'General case' 0 N--CA 1.415 -2.201 0 O-C-N 125.115 1.509 . . . . 0.0 110.437 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.64 -60.81 2.05 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 177.042 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.415 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -76.73 -50.63 13.13 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.84 -0.538 . . . . 0.0 112.3 -172.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.841 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.68 -24.28 61.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.767 0.794 . . . . 0.0 111.518 -178.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.752 ' N ' HD23 ' A' ' 443' ' ' LEU . 16.6 t70 -72.21 -42.87 65.28 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.688 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.26 -8.15 47.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.525 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 55.9 mm-40 -51.32 157.8 0.93 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 123.683 1.706 . . . . 0.0 114.333 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.485 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -55.82 -32.81 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 CA-C-N 110.508 -3.042 . . . . 0.0 115.509 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.664 ' H ' ' HB ' ' A' ' 451' ' ' THR . 31.5 m-20 -140.04 179.11 6.8 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.422 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 7.3 m-20 -62.47 -56.77 14.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.18 -24.77 67.47 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.118 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.664 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 21.1 m -59.55 -41.98 91.35 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 119.492 1.042 . . . . 0.0 109.928 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 52.7 mtt180 -61.32 -29.84 70.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -75.09 -31.84 61.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.141 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.8 mm-40 -79.8 -45.35 18.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.626 -172.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.505 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 43.5 p -101.79 -3.51 27.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.136 -167.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.697 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.7 t80 -48.75 -52.6 22.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 405' ' ' ALA . 22.8 mm -71.45 -25.78 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.505 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.31 -43.4 64.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.621 ' O ' HG23 ' A' ' 463' ' ' VAL . 76.4 m-70 -66.82 -31.39 71.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.725 171.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.762 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.43 -53.87 36.78 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.117 0.961 . . . . 0.0 109.372 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.607 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.1 m-80 -62.0 -32.11 72.56 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.205 172.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.9 -52.02 64.71 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.026 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 435' ' ' VAL . 23.1 t -63.37 -34.83 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 110.271 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.1 m-30 -61.24 -14.21 24.32 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.128 169.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 63.5 mm-40 -91.53 -48.9 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.874 -1.141 . . . . 0.0 112.933 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.694 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -66.24 -39.77 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.881 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.2 mt -84.45 -16.44 42.58 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.806 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.97 51.17 55.61 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 111.674 -2.512 . . . . 0.0 113.348 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.697 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -104.1 -179.52 3.97 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.918 0.887 . . . . 0.0 110.699 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.593 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.0 OUTLIER -98.47 -41.28 7.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.405 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.83 -74.99 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.252 -2.249 . . . . 0.0 110.839 160.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.76 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -60.26 64.08 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.159 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 43.62 36.89 3.56 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.619 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.593 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 10.4 mm-40 -75.61 -53.39 8.67 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.346 1.069 . . . . 0.0 111.496 -170.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 26.9 t 66.18 59.1 0.69 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.267 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.806 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 111.247 -2.706 . . . . 0.0 111.635 175.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.426 -1.674 0 CA-C-O 121.324 0.583 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.72 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 20.2 mt -71.17 126.41 91.95 Favored Pre-proline 0 N--CA 1.426 -1.625 0 CA-C-O 121.997 0.903 . . . . 0.0 112.104 -174.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 308' ' ' GLN . 24.4 Cg_endo -73.51 -8.96 22.41 Favored 'Trans proline' 0 CA--C 1.501 -1.136 0 C-N-CA 124.952 3.768 . . . . 0.0 111.382 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.707 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.7 tp 24.8 -64.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.315 0 C-N-CA 128.458 2.703 . . . . 0.0 116.195 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.645 ' H ' HG23 ' A' ' 307' ' ' ILE . 0.2 OUTLIER -57.7 -31.06 66.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.13 0.49 . . . . 0.0 111.337 177.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.544 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.2 t-160 -61.49 -49.05 78.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.498 170.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.671 HG13 HG11 ' A' ' 338' ' ' VAL . 55.1 mt -58.68 -48.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.605 174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.695 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 52.2 mtp180 -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 122.545 0.338 . . . . 0.0 111.52 176.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.9 m -69.84 -33.18 71.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.502 0.668 . . . . 0.0 110.056 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.586 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -67.34 -42.32 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.51 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.774 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.3 p -83.21 -36.4 24.68 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.875 1.322 . . . . 0.0 110.44 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.91 33.91 10.53 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 112.248 -2.251 . . . . 0.0 110.834 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 49.44 176.22 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 124.424 1.09 . . . . 0.0 113.629 -174.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.632 ' HB3' HD11 ' A' ' 324' ' ' ILE . 21.3 Cg_exo -45.6 141.49 8.0 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.913 2.409 . . . . 0.0 112.818 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.469 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 43.6 Cg_endo -87.84 -101.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.156 2.571 . . . . 0.0 112.318 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 8.8 mmm180 -94.22 -80.07 0.41 Allowed 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.484 0.659 . . . . 0.0 110.756 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.534 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 36.4 m-20 -105.87 162.78 18.66 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.811 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.516 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.3 Cg_exo -61.38 -52.37 3.32 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.671 2.247 . . . . 0.0 111.025 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.48 -19.21 2.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.898 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.534 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.6 mm-40 -88.56 -26.91 21.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.519 0.199 . . . . 0.0 111.482 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.98 -44.13 45.96 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.717 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.22 -62.13 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.815 2.343 . . . . 0.0 113.044 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.647 HG21 HG12 ' A' ' 398' ' ' ILE . 1.1 mp -62.29 -36.24 73.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 122.441 1.115 . . . . 0.0 110.027 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.774 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 50.1 t90 -57.84 -38.0 74.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.513 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.833 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.97 -48.19 59.28 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.53 -23.48 20.26 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.794 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.538 ' HD2' HG21 ' A' ' 406' ' ' THR . 1.5 mtm-85 -73.84 -43.17 59.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.322 1.058 . . . . 0.0 110.456 174.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.748 ' HB3' HG22 ' A' ' 314' ' ' THR . 51.8 m-20 -95.67 -24.73 16.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.478 -1.692 . . . . 0.0 113.711 -168.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.84 -50.56 10.19 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.1 Cg_endo -60.9 -33.88 91.91 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.623 2.215 . . . . 0.0 111.68 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.27 -44.46 62.76 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.774 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.621 HG23 HG23 ' A' ' 310' ' ' ILE . 87.7 mt -58.07 -48.21 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.635 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.07 -14.94 7.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.282 -1.781 . . . . 0.0 112.046 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.0 -48.7 5.64 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.671 HG11 HG13 ' A' ' 310' ' ' ILE . 92.2 t -55.18 -70.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.617 1.675 . . . . 0.0 109.89 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.846 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -91.67 131.19 36.53 Favored Pre-proline 0 N--CA 1.402 -2.847 0 CA-C-N 110.729 -2.941 . . . . 0.0 112.008 -173.139 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.789 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.4 Cg_endo -73.39 -18.42 23.09 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 123.634 2.889 . . . . 0.0 110.248 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 32.87 69.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 111.938 -2.392 . . . . 0.0 110.189 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.592 ' N ' HD12 ' A' ' 346' ' ' LEU . 40.9 p -79.93 3.61 19.41 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.119 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.79 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -140.85 156.1 68.84 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 109.509 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.511 ' HB3' HD12 ' A' ' 369' ' ' LEU . 68.7 Cg_exo -60.94 -38.57 68.12 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 124.263 3.308 . . . . 0.0 109.54 172.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.678 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.58 -53.08 41.94 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.364 -2.198 . . . . 0.0 110.566 173.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.79 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -56.68 -51.94 66.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.77 0.795 . . . . 0.0 110.311 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 350' ' ' ILE . 10.5 ttm180 -50.62 -44.75 57.28 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.238 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 40.9 t -70.09 -49.34 51.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.738 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 77.8 mtt180 -57.93 -39.3 77.68 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.704 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.846 HD11 ' CD2' ' A' ' 339' ' ' PHE . 37.0 mt -59.71 -54.04 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.689 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.589 HD13 ' HB1' ' A' ' 374' ' ' ALA . 15.9 mt -57.58 -53.34 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-O 122.133 0.968 . . . . 0.0 110.919 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.529 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -64.14 -34.79 78.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.149 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.27 -35.15 75.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.104 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.67 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.25 0.9 OUTLIER -57.9 -54.13 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 122.715 1.245 . . . . 0.0 110.616 174.421 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.67 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.3 OUTLIER -72.52 -27.32 62.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 111.758 -2.474 . . . . 0.0 109.037 -168.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 28.1 55.61 0.13 Allowed Glycine 0 CA--C 1.524 0.628 0 O-C-N 125.568 1.793 . . . . 0.0 115.357 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 135.96 45.85 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.667 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.571 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -98.3 163.31 12.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.173 0.189 . . . . 0.0 110.762 178.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.37 -60.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.23 0.538 . . . . 0.0 111.702 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -157.75 16.05 0.31 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.607 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.674 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.4 mt -64.46 -6.32 7.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 122.919 0.488 . . . . 0.0 111.649 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.529 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.9 t -61.43 85.2 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.22 0.533 . . . . 0.0 110.112 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.814 HD11 HG21 ' A' ' 377' ' ' THR . 1.8 mm? -60.64 -172.74 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.652 0.739 . . . . 0.0 112.822 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.9 p -126.96 152.68 75.87 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 18.4 Cg_exo -46.55 -34.65 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.979 1.786 . . . . 0.0 111.265 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -86.26 -2.25 85.65 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.65 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.675 ' HB2' HD12 ' A' ' 363' ' ' LEU . 55.6 m-20 -105.48 -21.29 13.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.306 1.051 . . . . 0.0 109.124 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 77.0 m -86.8 22.94 1.82 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.382 -171.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -59.02 -35.98 74.18 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.62 1.2 . . . . 0.0 108.266 -173.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 29.8 p -118.83 163.48 16.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 112.839 -1.982 . . . . 0.0 110.361 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.655 ' O ' HG13 ' A' ' 375' ' ' VAL . 51.8 m95 -71.18 -34.1 70.61 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 167.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.585 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -62.92 -47.07 84.85 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.613 -173.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.3 t -65.86 -42.82 89.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.739 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.745 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.53 63.76 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.909 HG21 ' HE3' ' A' ' 413' ' ' MET . 10.4 m -58.84 -44.85 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.613 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.088 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.79 -43.46 98.08 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.949 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.814 HG21 HD11 ' A' ' 363' ' ' LEU . 24.1 m -70.47 -40.42 73.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.749 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.6 mt -59.18 -35.15 73.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.399 0.618 . . . . 0.0 110.439 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.717 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.0 t80 -71.12 -49.08 48.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.344 1.069 . . . . 0.0 109.412 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.554 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.92 -32.41 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.962 170.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.609 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -59.95 -33.02 71.35 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 123.241 0.616 . . . . 0.0 111.698 175.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 29.1 p -106.34 -23.24 12.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.771 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -110.34 22.61 15.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 52.87 21.38 9.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 114.336 0.494 . . . . 0.0 114.336 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.5 m 64.86 161.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.42 0.628 . . . . 0.0 111.022 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.502 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.5 157.01 63.37 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -97.67 54.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.361 2.708 . . . . 0.0 111.019 166.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.682 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 56.85 3.14 0.12 Allowed 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -174.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -69.91 -46.85 64.51 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.512 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.659 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.8 mt-30 -74.17 -26.72 60.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.95 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -54.69 -31.52 58.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.97 0.805 . . . . 0.0 111.492 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.688 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.72 -53.17 40.9 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.426 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.62 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.8 m-20 -64.88 -40.85 95.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.068 0.547 . . . . 0.0 112.17 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.42 -45.39 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.687 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.8 mm -58.8 -48.45 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.513 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.3 mmtt -52.11 -42.15 63.06 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.893 0.746 . . . . 0.0 111.54 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.34 -45.09 11.71 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.186 -172.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.2 mt -69.75 -40.67 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 117.52 0.66 . . . . 0.0 111.25 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.9 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.8 m -58.35 -45.16 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.66 0.743 . . . . 0.0 110.194 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.481 ' N ' HG23 ' A' ' 399' ' ' VAL . 10.6 t70 -62.94 -35.94 81.78 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.879 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -86.59 -53.47 4.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.046 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -107.66 -29.49 9.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.469 -171.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 120.84 163.79 12.17 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.9 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -42.92 97.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.624 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.14 -51.21 70.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.917 0.389 . . . . 0.0 111.784 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.587 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.16 -50.77 66.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.508 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.692 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.65 -41.73 64.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.618 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.8 t80 -57.1 -46.18 82.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.661 0.743 . . . . 0.0 109.2 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.783 ' O ' ' HG3' ' A' ' 413' ' ' MET . 7.5 m -58.31 -51.85 68.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.642 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.678 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.87 -49.14 76.04 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.723 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.562 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.33 -42.14 88.46 Favored Glycine 0 C--N 1.315 -0.59 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.252 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.68 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.49 -32.01 65.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 116.764 0.282 . . . . 0.0 111.015 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.909 ' HE3' HG21 ' A' ' 375' ' ' VAL . 67.3 mtm -69.97 -48.03 59.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.378 0.609 . . . . 0.0 109.831 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.088 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.6 mt -59.48 -38.55 81.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.388 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.95 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.0 m -77.64 -15.04 59.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.39 28.57 7.96 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 119.936 -1.125 . . . . 0.0 111.526 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.68 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.8 mm100 63.12 46.42 4.65 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.022 0.929 . . . . 0.0 112.302 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.574 ' OD1' HD21 ' A' ' 421' ' ' LEU . 0.4 OUTLIER -122.69 66.99 0.95 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 165.412 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.622 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.9 OUTLIER -47.53 -34.38 7.51 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 111.368 -2.651 . . . . 0.0 113.733 -165.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 423' ' ' SER . 48.3 mt-30 -55.45 -44.41 76.33 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -164.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.686 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.56 -50.95 71.91 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.347 0.594 . . . . 0.0 110.624 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.611 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.96 -38.76 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.428 1.109 . . . . 0.0 109.164 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 29.1 t -59.5 -47.85 83.91 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.648 -2.069 . . . . 0.0 112.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.82 73.09 Favored Glycine 0 C--N 1.317 -0.489 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.122 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.681 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.24 -42.2 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.546 0.688 . . . . 0.0 110.085 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.607 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.67 -44.32 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.94 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.724 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.1 OUTLIER -62.7 -27.99 69.63 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 122.901 1.334 . . . . 0.0 108.991 -173.302 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.42 77.69 Favored Glycine 0 C--N 1.298 -1.537 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.503 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 14.5 m-85 -100.4 3.08 42.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.96 144.87 74.18 Favored Pre-proline 0 N--CA 1.413 -2.308 0 CA-C-O 123.615 1.674 . . . . 0.0 113.439 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.723 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.7 Cg_endo -72.98 -61.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 1 C-N-CA 126.118 4.545 . . . . 0.0 113.305 -174.139 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.546 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.37 142.69 16.33 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.879 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.27 -29.22 70.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.085 0.443 . . . . 0.0 111.184 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.748 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.26 -47.21 79.02 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.004 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.6 t -58.8 -51.83 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.663 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.879 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.08 -54.44 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.05 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 47.9 m -62.27 -55.77 25.02 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.476 -0.489 . . . . 0.0 112.073 -175.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.35 -45.65 80.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.715 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.838 ' O ' HD22 ' A' ' 443' ' ' LEU . 48.8 mt -60.39 -53.15 60.99 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.759 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.705 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -51.75 -34.16 38.06 Favored 'General case' 0 N--CA 1.416 -2.147 0 O-C-N 125.03 1.456 . . . . 0.0 110.644 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.716 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.65 -60.73 2.09 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.405 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.98 -51.43 11.14 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.963 -0.461 . . . . 0.0 112.243 -172.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.838 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.8 -23.85 60.95 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.869 0.842 . . . . 0.0 111.571 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.756 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.5 t70 -71.26 -41.41 70.1 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.666 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.716 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 45.1 mt-30 -72.68 -9.67 58.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -170.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.492 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 5.8 mm-40 -56.48 154.0 9.19 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.79 1.281 . . . . 0.0 113.762 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.496 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -52.7 -33.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.09 -2.323 . . . . 0.0 116.249 -168.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.622 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 27.8 m-20 -135.69 -178.47 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.475 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.4 p-10 -64.07 -54.6 31.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.501 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.1 OUTLIER -67.6 -24.16 65.45 Favored 'General case' 0 N--CA 1.403 -2.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.609 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 8.6 m -60.25 -44.05 95.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 119.696 1.134 . . . . 0.0 109.427 171.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.5 mtt180 -59.22 -29.98 67.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.172 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.618 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.59 -30.82 59.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.674 0.749 . . . . 0.0 109.627 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.91 -44.97 19.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.222 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.506 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -100.75 -4.19 28.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.723 -1.58 . . . . 0.0 111.818 -168.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.673 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.1 t80 -48.77 -52.5 23.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.809 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 405' ' ' ALA . 23.8 mm -72.87 -25.24 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.11 -43.28 64.99 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 463' ' ' VAL . 72.2 m-70 -67.81 -31.55 71.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.734 -1.576 . . . . 0.0 109.513 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.744 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.74 -53.84 40.88 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.165 0.983 . . . . 0.0 109.304 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.3 -30.6 71.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.619 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -66.9 -48.81 67.57 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.004 HG11 ' HA ' ' A' ' 435' ' ' VAL . 22.0 t -65.24 -35.82 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.302 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.538 ' OH ' HG13 ' A' ' 404' ' ' VAL . 18.8 m-30 -61.47 -13.17 18.56 Favored 'General case' 0 C--O 1.204 -1.294 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.707 169.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 3.5 tp10 -95.23 -52.6 4.12 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.227 -0.921 . . . . 0.0 112.24 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.724 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -62.75 -41.08 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.317 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.748 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.3 mt -83.97 -16.44 44.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.796 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.27 47.57 78.78 Favored Glycine 0 C--O 1.215 -1.039 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.492 172.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -102.31 178.88 4.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.069 0.948 . . . . 0.0 110.478 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.654 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 0.7 OUTLIER -96.54 -40.75 8.9 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 167.314 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -163.48 -75.12 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.358 160.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.723 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 1.0 OUTLIER -61.61 68.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -171.275 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 39.55 41.97 1.82 Allowed Glycine 0 C--N 1.274 -2.901 0 CA-C-N 110.626 -2.988 . . . . 0.0 113.375 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.654 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 0.0 OUTLIER -79.05 -56.62 4.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.2 1.0 . . . . 0.0 111.635 -171.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.8 t 68.9 54.46 0.47 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.283 -173.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.796 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.509 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.139 175.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.426 -1.635 0 CA-C-O 121.54 0.686 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.718 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 17.2 mt -75.96 127.85 84.46 Favored Pre-proline 0 N--CA 1.424 -1.76 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.994 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.2 Cg_endo -72.88 -12.18 26.09 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.823 3.682 . . . . 0.0 111.253 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.709 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.9 tp 27.25 -61.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 C-N-CA 128.685 2.794 . . . . 0.0 116.145 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.569 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.81 -31.89 68.86 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.097 0.475 . . . . 0.0 110.305 178.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.559 ' CD2' HG13 ' A' ' 338' ' ' VAL . 1.2 t-80 -61.8 -48.58 79.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.615 171.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.0 mt -58.41 -48.9 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 C-N-CA 123.987 0.915 . . . . 0.0 112.638 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.69 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 15.1 mtp180 -60.62 -29.86 69.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 122.222 -0.299 . . . . 0.0 111.074 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 52.8 m -69.76 -34.96 74.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.38 0.609 . . . . 0.0 109.761 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.578 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.66 -41.12 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.741 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.772 HG22 ' HB3' ' A' ' 331' ' ' ASN . 30.2 p -83.52 -37.96 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.898 1.332 . . . . 0.0 109.882 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.58 35.52 6.87 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.003 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 39.6 mt-10 51.3 177.12 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 124.083 0.953 . . . . 0.0 113.051 -174.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.634 ' HB3' HD11 ' A' ' 324' ' ' ILE . 48.7 Cg_exo -48.59 152.56 4.05 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.633 2.222 . . . . 0.0 113.379 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.522 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 7.5 Cg_endo -98.93 -107.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.076 3.184 . . . . 0.0 112.624 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.466 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 8.6 mmm180 -89.19 -88.83 0.15 Allowed 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.013 0.911 . . . . 0.0 111.97 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.688 ' H ' ' HG2' ' A' ' 323' ' ' GLU . 2.2 m-20 -94.87 157.83 36.1 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.474 -170.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.504 ' HB3' HD13 ' A' ' 359' ' ' ILE . 38.2 Cg_exo -59.32 -50.75 7.76 Favored 'Trans proline' 0 CA--C 1.511 -0.675 0 C-N-CA 122.414 2.076 . . . . 0.0 110.399 166.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.48 23.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.791 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.688 ' HG2' ' H ' ' A' ' 320' ' ' ASN . 3.3 pt-20 -102.94 -20.47 14.23 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.622 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -44.05 -42.65 12.5 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.019 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.726 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.43 -61.44 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.757 HG21 HG12 ' A' ' 398' ' ' ILE . 0.8 OUTLIER -60.01 -34.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.153 178.032 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.693 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -58.8 -36.39 74.38 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.228 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.853 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.81 -49.13 55.67 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.425 ' HA3' HD11 ' A' ' 410' ' ' LEU . . . -54.01 -22.97 22.01 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.758 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.66 ' HD3' HG21 ' A' ' 406' ' ' THR . 0.1 OUTLIER -72.11 -42.4 66.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.215 1.007 . . . . 0.0 110.105 174.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.772 ' HB3' HG22 ' A' ' 314' ' ' THR . 54.7 m-20 -99.79 -24.16 14.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.739 -1.573 . . . . 0.0 114.114 -168.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.626 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.31 -50.01 8.75 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.0 Cg_endo -60.73 -33.42 93.13 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.371 2.047 . . . . 0.0 111.529 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.36 -42.23 65.53 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.794 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.633 HG23 HG23 ' A' ' 310' ' ' ILE . 90.4 mt -59.91 -48.5 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.965 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -56.14 -16.54 5.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.24 5.68 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.66 HG11 HG13 ' A' ' 310' ' ' ILE . 96.0 t -55.09 -70.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 123.665 1.698 . . . . 0.0 110.1 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.927 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.75 131.28 34.13 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 110.798 -2.91 . . . . 0.0 111.94 -172.642 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.798 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 67.9 Cg_endo -72.3 -18.87 26.23 Favored 'Trans proline' 0 CA--C 1.495 -1.464 0 C-N-CA 123.562 2.841 . . . . 0.0 110.524 174.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.5 p 32.75 69.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 112.107 -2.315 . . . . 0.0 110.32 -178.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.617 ' H ' HD12 ' A' ' 346' ' ' LEU . 46.4 p -80.6 4.46 18.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.034 -1.894 . . . . 0.0 113.206 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.815 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 33.4 p -142.89 157.27 61.57 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-O 121.699 0.761 . . . . 0.0 109.694 174.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 70.0 Cg_exo -60.63 -38.97 68.14 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 124.373 3.382 . . . . 0.0 109.413 172.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.619 ' HA ' ' HB3' ' A' ' 365' ' ' PRO . 11.5 t70 -45.75 -58.83 3.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 112.371 -2.195 . . . . 0.0 110.217 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.815 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.3 mt -56.17 -52.24 65.11 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.815 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.735 ' HA ' HD12 ' A' ' 350' ' ' ILE . 34.3 ttm105 -52.61 -42.99 65.08 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 48.6 t -69.49 -49.79 51.36 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 26.9 mtp180 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.667 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.927 HD11 ' HD2' ' A' ' 339' ' ' PHE . 50.8 mt -62.23 -53.85 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.681 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.584 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -58.19 -53.36 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.078 0.942 . . . . 0.0 111.143 -168.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.548 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -64.3 -35.08 79.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.171 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.18 -32.92 72.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.706 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.36 -55.95 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 CA-C-O 122.925 1.345 . . . . 0.0 110.41 173.253 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 354' ' ' ILE . 1.7 mp -72.94 -26.1 61.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 111.88 -2.418 . . . . 0.0 109.051 -169.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 37.44 59.18 1.29 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 113.694 -1.594 . . . . 0.0 114.609 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 121.02 48.92 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.688 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.545 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -87.94 162.61 16.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.69 -63.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 122.828 0.451 . . . . 0.0 111.448 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.11 9.31 0.96 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.512 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.663 ' HB3' HD22 ' A' ' 378' ' ' LEU . 4.8 mt -64.15 -5.38 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 122.955 0.502 . . . . 0.0 111.645 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 48.1 t -61.29 84.28 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.092 0.473 . . . . 0.0 110.546 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.833 HD11 HG21 ' A' ' 377' ' ' THR . 2.2 mm? -62.71 -174.64 0.07 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.877 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 71.7 p -128.47 155.79 78.12 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.619 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 35.4 Cg_exo -45.14 -38.12 13.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.965 1.777 . . . . 0.0 111.23 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.571 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -78.47 -4.17 87.02 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.806 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 363' ' ' LEU . 9.4 m-20 -109.5 -20.02 13.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.835 0.826 . . . . 0.0 110.194 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 81.4 m -91.25 21.49 4.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.702 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.571 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.7 OUTLIER -60.48 -38.97 85.98 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.156 -172.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.47 162.39 21.8 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.015 170.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.616 ' O ' HG13 ' A' ' 375' ' ' VAL . 48.0 m95 -69.54 -35.78 75.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.571 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.64 -41.77 99.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.783 -174.231 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 66.5 p -67.91 -44.77 76.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.922 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.43 -52.61 62.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.905 HG21 ' HE3' ' A' ' 413' ' ' MET . 15.6 m -57.31 -45.23 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.598 0.714 . . . . 0.0 109.585 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.021 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.17 -44.79 96.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.052 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.833 HG21 HD11 ' A' ' 363' ' ' LEU . 34.5 m -67.37 -39.85 85.7 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.499 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 325' ' ' PRO . 2.4 mt -58.99 -34.9 72.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.445 0.566 . . . . 0.0 110.325 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.726 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 43.7 t80 -73.81 -46.0 48.0 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.309 1.052 . . . . 0.0 109.467 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.591 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.2 mp -51.52 -32.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.322 170.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.624 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -59.83 -36.59 77.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.185 0.594 . . . . 0.0 111.451 176.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 28.0 p -103.26 -22.63 13.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.72 -168.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' HIS . . . . . 0.404 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 14.0 m80 -110.01 23.01 14.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.42 21.45 34.09 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.948 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.456 HG23 HG13 ' A' ' 380' ' ' ILE . 1.7 m 65.07 160.17 0.11 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.179 0.514 . . . . 0.0 110.788 -174.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.505 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -124.92 157.62 65.87 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -101.64 54.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.867 3.045 . . . . 0.0 111.546 166.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.771 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.06 -0.26 0.24 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.603 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -70.17 -44.49 68.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.017 0.437 . . . . 0.0 110.906 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.622 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.4 mt-30 -74.65 -27.01 60.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.901 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.41 -30.42 52.26 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.48 0.582 . . . . 0.0 111.638 -174.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.666 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.1 -53.05 39.52 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.795 173.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.614 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 12.3 m-20 -65.61 -39.24 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.4 m -57.97 -45.37 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.052 0.453 . . . . 0.0 110.256 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.764 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.3 mm -58.8 -48.11 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.1 mmtt -52.04 -41.26 62.15 Favored 'General case' 0 C--O 1.242 0.682 0 O-C-N 124.195 0.934 . . . . 0.0 111.418 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.63 12.78 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.352 -171.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.757 HG12 HG21 ' A' ' 326' ' ' ILE . 1.3 mt -70.61 -38.65 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 117.624 0.712 . . . . 0.0 112.002 -177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.881 HG12 ' HA ' ' A' ' 404' ' ' VAL . 1.1 m -59.33 -42.33 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.999 0.904 . . . . 0.0 109.136 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -59.18 -44.34 92.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.807 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -83.88 -53.5 5.55 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.491 -172.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.648 ' HB2' ' NH1' ' A' ' 330' ' ' ARG . 8.8 tp10 -112.34 -34.91 5.75 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -171.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 130.1 163.47 11.09 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.57 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.881 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.17 -41.28 91.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.107 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.18 -50.71 70.44 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.66 HG21 ' HD3' ' A' ' 330' ' ' ARG . 0.9 OUTLIER -65.55 -48.85 71.02 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.091 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.687 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.41 -44.81 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 112.008 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.0 t80 -55.66 -45.99 77.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.348 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.77 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.2 m -58.77 -52.58 65.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.758 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.69 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.47 -48.82 79.39 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.508 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.523 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.72 -44.25 86.62 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.685 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.7 -31.17 64.82 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.899 0.35 . . . . 0.0 110.923 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.905 ' HE3' HG21 ' A' ' 375' ' ' VAL . 68.4 mtm -68.61 -49.8 56.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.475 0.655 . . . . 0.0 109.988 172.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.021 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.5 mt -58.56 -39.11 79.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.986 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.901 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.7 m -77.93 -16.45 58.18 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.558 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.23 35.31 6.34 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.169 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.643 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 69.91 39.69 1.39 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.632 0.773 . . . . 0.0 112.571 176.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.611 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 0.3 OUTLIER -121.63 77.46 1.35 Allowed 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.491 -2.041 . . . . 0.0 105.491 164.363 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.685 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 9.1 p90 -62.04 -31.32 71.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.627 -2.079 . . . . 0.0 110.515 -162.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.553 ' O ' ' HB3' ' A' ' 423' ' ' SER . 23.6 mt-30 -54.38 -48.08 71.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.086 -164.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.672 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.87 -49.69 76.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.717 0.77 . . . . 0.0 110.962 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.616 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.31 -39.04 79.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.633 1.206 . . . . 0.0 109.251 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 38.8 t -60.54 -45.64 93.09 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.444 -2.162 . . . . 0.0 111.375 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -55.94 -39.31 78.24 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.358 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.657 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.26 -42.59 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.643 0.735 . . . . 0.0 109.976 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.58 HD13 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -55.46 -44.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.735 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -60.85 -30.63 70.23 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-O 122.733 1.254 . . . . 0.0 108.987 -173.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.49 -18.24 76.89 Favored Glycine 0 C--N 1.299 -1.502 0 CA-C-N 112.561 -2.109 . . . . 0.0 111.921 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.711 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.35 1.27 44.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.91 141.99 79.84 Favored Pre-proline 0 N--CA 1.408 -2.557 0 CA-C-O 123.771 1.748 . . . . 0.0 112.848 170.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.808 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.7 Cg_endo -70.16 -60.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 1 C-N-CA 126.065 4.51 . . . . 0.0 112.977 -171.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -111.36 134.76 12.34 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.235 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.845 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -49.26 -37.34 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.19 -48.33 73.96 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.039 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -58.13 -52.53 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.637 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.845 HG13 ' HA ' ' A' ' 433' ' ' GLN . 1.6 m -51.81 -53.31 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 117.64 0.2 . . . . 0.0 110.492 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.452 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 59.4 m -68.71 -54.17 17.74 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.837 -174.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.44 -41.44 76.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.161 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.842 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.6 mt -63.37 -53.92 44.91 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.208 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.7 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.68 -33.79 35.46 Favored 'General case' 0 N--CA 1.419 -1.977 0 O-C-N 124.959 1.412 . . . . 0.0 110.279 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.686 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.48 -59.88 2.51 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 173.011 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.5 ptp180 -73.92 -53.55 9.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.838 0.745 . . . . 0.0 112.616 -172.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.44 -25.0 64.0 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.653 0.74 . . . . 0.0 111.786 -177.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.777 ' N ' HD23 ' A' ' 443' ' ' LEU . 6.3 t70 -72.69 -41.89 64.81 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.32 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.99 -7.74 43.32 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.573 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 40.4 mm-40 -54.73 158.0 2.81 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 123.206 1.479 . . . . 0.0 114.171 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.607 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -54.19 -33.44 25.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 111.52 -2.582 . . . . 0.0 115.904 -170.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.65 ' H ' ' HB ' ' A' ' 451' ' ' THR . 38.8 m-20 -142.89 178.47 7.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.426 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.0 m-20 -61.48 -55.45 31.03 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -63.82 -27.58 69.27 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.65 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 6.5 m -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.636 1.107 . . . . 0.0 109.941 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.611 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 50.0 mtt180 -60.68 -29.46 69.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.598 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.96 -30.18 58.54 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.131 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 2.9 mm-40 -82.58 -46.49 13.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.273 1.035 . . . . 0.0 111.95 -172.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.523 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -100.54 -1.55 35.28 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.811 -1.54 . . . . 0.0 111.542 -168.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.669 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.8 -51.99 26.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.656 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 405' ' ' ALA . 21.3 mm -72.68 -26.33 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.523 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.44 -42.61 64.85 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.629 ' O ' HG23 ' A' ' 463' ' ' VAL . 56.7 m-70 -67.49 -31.56 71.78 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.611 171.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.758 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.84 -53.84 40.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.172 0.987 . . . . 0.0 109.481 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.68 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.9 m-80 -62.68 -32.03 73.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.006 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.85 -53.03 61.41 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.857 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.039 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.4 t -63.05 -34.4 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.712 0.767 . . . . 0.0 110.398 177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -62.17 -15.53 46.78 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.175 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 33.9 mm-40 -92.26 -49.7 6.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 112.475 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.777 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 4.8 pt -64.37 -40.82 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.559 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -83.69 -16.67 44.1 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.719 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.5 51.88 50.84 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.123 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.72 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -102.72 -178.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 123.766 0.826 . . . . 0.0 110.134 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.596 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.2 p-10 -99.72 -42.98 6.62 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 165.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.61 -75.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.906 160.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.808 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -61.16 64.75 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -169.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 43.81 35.48 3.23 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 111.754 -2.475 . . . . 0.0 113.062 173.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.596 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 3.3 mm100 -73.61 -57.19 4.16 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 122.093 0.949 . . . . 0.0 111.778 -172.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 68.53 49.34 0.76 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.271 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.719 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 109.887 -3.324 . . . . 0.0 111.565 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.426 -1.666 0 CA-C-O 121.413 0.625 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.708 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 21.5 mt -77.33 126.19 85.32 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 308' ' ' GLN . 19.0 Cg_endo -71.4 -10.55 27.18 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.733 3.622 . . . . 0.0 111.111 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.688 ' H ' HG22 ' A' ' 305' ' ' ILE . 4.6 tp 26.11 -61.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 128.72 2.808 . . . . 0.0 116.194 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.571 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.48 -32.04 68.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.231 0.539 . . . . 0.0 110.047 178.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.569 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.07 -49.4 76.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.913 172.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.674 HG13 HG11 ' A' ' 338' ' ' VAL . 54.7 mt -58.76 -49.31 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 123.95 0.9 . . . . 0.0 112.614 175.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 48.1 mtp180 -61.3 -29.61 69.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 123.38 0.672 . . . . 0.0 111.094 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 66.8 m -70.31 -34.03 72.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 110.251 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.643 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.73 -41.68 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.559 178.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.778 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -84.7 -37.69 20.64 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.748 1.261 . . . . 0.0 110.351 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.92 35.4 7.19 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.485 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 19.5 mt-10 50.34 176.39 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.62 ' HG3' ' HA ' ' A' ' 355' ' ' LEU . 73.5 Cg_exo -51.22 129.76 29.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.825 2.35 . . . . 0.0 113.1 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.88 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 82.3 Cg_endo -84.79 -92.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.488 3.459 . . . . 0.0 113.913 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.497 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 5.8 mmm180 -89.54 -77.72 0.38 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.747 0.784 . . . . 0.0 112.355 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.647 ' H ' ' CG ' ' A' ' 323' ' ' GLU . 38.0 m-20 -123.55 175.31 2.86 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.738 -170.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.459 ' HB3' HD13 ' A' ' 359' ' ' ILE . 27.2 Cg_exo -65.97 -56.96 0.26 Allowed 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 121.969 1.779 . . . . 0.0 111.572 167.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -50.68 -21.15 1.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.648 -1.615 . . . . 0.0 114.075 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.823 ' OE1' ' HG2' ' A' ' 318' ' ' PRO . 1.7 pp20? -99.24 -22.29 15.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.04 0.448 . . . . 0.0 111.629 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.67 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.62 -42.69 33.91 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.571 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.73 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -49.73 -59.61 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.815 2.344 . . . . 0.0 112.935 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.627 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -63.66 -35.95 74.7 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.953 -179.297 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.88 ' CD1' ' HG3' ' A' ' 318' ' ' PRO . 42.6 t90 -58.01 -37.33 74.1 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.289 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.837 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -69.16 -48.14 63.09 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.77 -23.47 22.01 Favored Glycine 0 C--N 1.311 -0.858 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.794 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.478 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 1.4 mmm180 -74.46 -42.8 58.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.119 0.961 . . . . 0.0 110.66 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.751 ' HB3' HG22 ' A' ' 314' ' ' THR . 28.1 m-20 -97.15 -22.75 16.56 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.895 -169.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.671 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.17 -49.64 11.56 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 39.7 Cg_endo -61.31 -32.21 89.67 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.589 2.193 . . . . 0.0 111.7 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.41 -43.99 59.31 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.727 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.0 mt -57.57 -48.49 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.866 173.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.47 -15.71 7.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.166 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.55 -47.25 6.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.259 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.674 HG11 HG13 ' A' ' 310' ' ' ILE . 99.1 t -57.51 -70.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 123.472 1.606 . . . . 0.0 110.128 169.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.887 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.39 128.74 43.51 Favored Pre-proline 0 N--CA 1.401 -2.92 0 CA-C-N 111.008 -2.815 . . . . 0.0 112.039 -172.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.768 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.9 Cg_endo -73.96 -16.56 22.97 Favored 'Trans proline' 0 CA--C 1.494 -1.49 0 C-N-CA 123.752 2.968 . . . . 0.0 110.442 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.621 HG21 ' HG3' ' A' ' 347' ' ' ARG . 2.8 p 34.01 67.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.222 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.649 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.2 p -80.37 8.07 8.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.83 -1.986 . . . . 0.0 113.118 -170.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.782 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 11.3 p -142.13 161.97 47.98 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -63.27 -47.52 7.77 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.451 2.768 . . . . 0.0 108.487 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.765 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.3 OUTLIER -45.96 -45.88 15.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.002 -1.908 . . . . 0.0 111.081 176.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.782 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -58.82 -52.31 66.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.378 0.609 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.621 ' HG3' HG21 ' A' ' 341' ' ' VAL . 2.1 ttt180 -50.4 -48.82 55.91 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.199 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 1.005 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -69.67 -49.13 56.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.035 0.445 . . . . 0.0 111.522 -175.428 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.664 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.3 mtt180 -56.48 -41.73 77.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.492 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.887 HD11 ' HD2' ' A' ' 339' ' ' PHE . 38.7 mt -57.72 -53.77 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.322 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.591 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.9 mt -58.15 -52.76 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.015 0.912 . . . . 0.0 111.018 -169.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.53 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 19.3 m-20 -63.39 -35.97 82.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.988 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.76 75.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.668 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.39 -54.37 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 123.127 1.441 . . . . 0.0 110.21 173.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.668 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -73.83 -26.5 60.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.377 -2.647 . . . . 0.0 109.878 -167.079 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 17.24 75.72 0.01 OUTLIER Glycine 0 N--CA 1.468 0.816 0 O-C-N 125.706 1.879 . . . . 0.0 115.205 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 137.35 -8.2 3.73 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.086 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.681 HD21 ' N ' ' A' ' 358' ' ' ASN . 0.0 OUTLIER -57.14 148.61 21.57 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.667 0.787 . . . . 0.0 111.703 175.654 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -56.05 -73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.477 0.711 . . . . 0.0 112.567 -175.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -136.9 11.16 3.93 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.644 ' HB3' HD22 ' A' ' 378' ' ' LEU . 4.6 mt -64.94 -4.68 4.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.87 0.468 . . . . 0.0 111.629 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.53 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.8 t -60.63 82.99 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.379 0.609 . . . . 0.0 110.334 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.799 HD11 HG21 ' A' ' 377' ' ' THR . 0.7 OUTLIER -62.42 173.78 1.13 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.664 0.745 . . . . 0.0 112.604 175.379 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 76.8 p -115.13 160.97 31.87 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 1.005 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.2 Cg_endo -61.06 -5.02 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.801 1.667 . . . . 0.0 112.26 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -105.84 -11.75 27.66 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' A' ' 363' ' ' LEU . 30.7 m-20 -105.91 -20.89 13.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.569 1.184 . . . . 0.0 110.228 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.853 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 16.8 p -84.9 20.05 1.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.709 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.03 -34.18 67.95 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.986 0.898 . . . . 0.0 110.192 -165.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.41 166.1 20.24 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.176 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.573 ' O ' HG13 ' A' ' 375' ' ' VAL . 44.0 m95 -69.66 -36.01 75.66 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.6 p30 -63.36 -39.42 94.47 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.306 -173.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 m -71.37 -41.99 69.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -63.27 -52.34 62.47 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.871 HG21 ' HE3' ' A' ' 413' ' ' MET . 14.6 m -56.77 -44.6 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.554 0.692 . . . . 0.0 109.51 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.041 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.66 -45.53 93.77 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.056 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.799 HG21 HD11 ' A' ' 363' ' ' LEU . 30.7 m -66.96 -39.11 87.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.56 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.26 -33.5 73.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.317 0.508 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.73 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 48.9 t80 -74.77 -45.63 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.311 1.053 . . . . 0.0 109.075 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -51.73 -33.27 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.346 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -60.25 -36.92 78.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 123.311 0.645 . . . . 0.0 111.732 177.026 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 32.5 p -102.77 -23.54 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.044 -167.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -109.83 23.06 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.86 21.24 51.25 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 114.073 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.462 HG23 HG13 ' A' ' 380' ' ' ILE . 2.8 m 64.11 163.74 0.13 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.588 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -129.09 150.52 75.6 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -97.35 59.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.251 2.634 . . . . 0.0 110.893 165.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.679 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.84 4.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.793 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -70.89 -48.82 51.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.635 ' O ' HG13 ' A' ' 394' ' ' VAL . 73.9 mt-30 -74.81 -27.74 60.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -169.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.941 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.4 mm? -54.76 -31.05 58.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.796 0.725 . . . . 0.0 111.892 -172.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.682 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.76 -52.67 44.39 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.438 173.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.599 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 3.5 m-20 -65.75 -39.94 91.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.826 0.45 . . . . 0.0 111.969 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -58.14 -45.06 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.1 mm -58.51 -47.58 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.682 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.4 mmtt -52.23 -43.42 64.29 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.901 0.751 . . . . 0.0 111.486 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.69 -44.63 12.16 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.24 -172.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.7 mt -69.05 -41.13 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 117.436 0.618 . . . . 0.0 111.432 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.9 m -58.13 -45.62 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.706 0.765 . . . . 0.0 109.944 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.475 ' N ' HG23 ' A' ' 399' ' ' VAL . 7.7 t70 -60.88 -38.23 84.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -86.26 -53.25 5.14 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.793 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.612 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.2 OUTLIER -110.67 -30.01 7.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.035 -168.549 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.02 162.48 11.19 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.853 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.94 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.66 98.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.037 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.654 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.22 -50.31 73.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.579 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -63.61 -51.18 66.36 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.577 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.678 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.03 -41.88 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.567 ' HB3' HD11 ' A' ' 457' ' ' ILE . 44.4 t80 -58.42 -44.8 89.24 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.827 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.0 m -59.26 -53.08 62.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.407 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.686 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.57 -49.08 76.67 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.686 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.607 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.1 -42.2 87.08 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.019 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.734 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.39 -32.44 66.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.68 0.24 . . . . 0.0 111.097 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.871 ' HE3' HG21 ' A' ' 375' ' ' VAL . 63.2 mtm -69.55 -46.29 66.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.172 0.511 . . . . 0.0 109.707 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.041 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.06 -40.75 90.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.524 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.941 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 9.2 m -78.12 8.0 5.45 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.744 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.38 31.73 56.47 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.734 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.8 mm100 63.87 44.98 4.56 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 123.942 0.897 . . . . 0.0 111.621 -178.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.684 ' OD1' HD23 ' A' ' 421' ' ' LEU . 24.5 t-20 -114.07 74.01 0.85 Allowed 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 164.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.676 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.5 OUTLIER -51.53 -35.41 40.5 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.32 -2.218 . . . . 0.0 111.288 -171.138 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.532 ' O ' ' HB3' ' A' ' 423' ' ' SER . 39.2 mt-30 -56.65 -50.57 71.69 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -166.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.733 HD11 ' OG ' ' A' ' 415' ' ' SER . 3.1 pp -59.53 -49.16 78.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.723 0.773 . . . . 0.0 110.564 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.63 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.79 -40.27 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.421 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 48.5 t -59.83 -47.43 85.76 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.507 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.55 -39.51 74.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.961 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.665 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.7 mt -71.92 -42.48 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.387 0.613 . . . . 0.0 110.142 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.58 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -57.07 -44.68 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.93 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.2 OUTLIER -63.51 -27.82 69.53 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-O 122.79 1.281 . . . . 0.0 108.846 -173.439 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -17.07 77.19 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 112.469 -2.15 . . . . 0.0 112.658 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.707 ' CG ' HG21 ' A' ' 399' ' ' VAL . 9.8 m-85 -99.71 2.43 44.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.31 144.82 76.75 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-O 123.645 1.688 . . . . 0.0 113.898 170.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.787 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.1 Cg_endo -72.36 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.083 1 C-N-CA 126.333 4.689 . . . . 0.0 113.584 -173.07 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.98 139.91 15.25 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.255 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.819 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.1 OUTLIER -61.61 -29.49 70.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.078 0.439 . . . . 0.0 111.207 -177.419 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.8 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.85 -48.01 79.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.01 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.79 -51.66 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.644 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.62 -55.22 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 52.6 m -61.4 -55.92 26.08 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.246 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.17 -45.5 79.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.668 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.844 ' O ' HD22 ' A' ' 443' ' ' LEU . 43.1 mt -60.38 -53.31 59.12 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.684 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.718 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 32.5 mm-40 -51.58 -34.6 37.76 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 125.174 1.546 . . . . 0.0 110.563 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.633 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.67 -59.9 2.49 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 175.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.72 -51.98 10.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.735 -0.603 . . . . 0.0 112.43 -173.397 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.84 -23.25 60.36 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.043 0.925 . . . . 0.0 111.409 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.756 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.6 t70 -72.23 -42.93 65.16 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.963 -1.472 . . . . 0.0 110.755 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.5 mt-30 -72.08 -8.29 53.76 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -172.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.529 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 53.1 mm-40 -52.25 155.96 1.83 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 123.366 1.555 . . . . 0.0 114.659 -174.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.601 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.32 -33.76 21.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 111.047 -2.797 . . . . 0.0 115.455 -170.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.653 ' H ' ' HB ' ' A' ' 451' ' ' THR . 15.7 m-20 -141.89 -179.21 6.07 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.929 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.442 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.2 p-10 -61.31 -55.55 30.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.485 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.28 -25.23 65.95 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 176.618 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.653 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 8.8 m -59.81 -42.69 94.03 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 119.861 1.209 . . . . 0.0 109.705 171.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.529 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 55.7 mtt180 -59.67 -29.91 68.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.525 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.38 -31.26 60.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.797 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -83.88 -45.87 12.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.208 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.542 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 34.0 p -100.61 -2.76 31.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.551 -166.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.694 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.4 t80 -49.04 -52.3 26.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.667 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 405' ' ' ALA . 23.7 mm -72.05 -25.72 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.542 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.35 -42.39 65.38 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.64 ' O ' HG23 ' A' ' 463' ' ' VAL . 52.5 m-70 -67.94 -31.47 71.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.686 -1.597 . . . . 0.0 109.718 172.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.733 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.27 -53.53 42.76 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.09 0.947 . . . . 0.0 109.33 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.634 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.77 -32.0 73.07 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.161 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.47 -52.47 63.38 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.8 t -62.57 -35.22 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 121.899 0.857 . . . . 0.0 110.344 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.3 m-30 -61.61 -14.51 31.18 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.155 170.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 61.5 mm-40 -93.06 -48.57 6.43 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.001 -1.062 . . . . 0.0 112.777 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.727 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.91 -39.0 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.109 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.5 mt -84.95 -17.12 38.68 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 170.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.738 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.27 53.45 39.54 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 111.698 -2.501 . . . . 0.0 113.161 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.739 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -103.55 -170.29 1.76 Allowed 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 123.856 0.863 . . . . 0.0 110.268 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.523 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.8 p-10 -109.86 -42.29 4.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -157.93 -76.41 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.081 158.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.787 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 4.1 mpt_? -62.15 66.74 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -170.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 41.05 39.5 2.06 Favored Glycine 0 C--N 1.278 -2.679 0 CA-C-N 111.554 -2.567 . . . . 0.0 113.65 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.523 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 10.1 mm-40 -77.76 -51.39 10.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.277 1.037 . . . . 0.0 111.398 -173.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.8 t 64.06 56.1 1.45 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.263 -171.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.738 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.444 0 CA-C-N 110.302 -3.135 . . . . 0.0 111.941 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.425 -1.704 0 CA-C-O 120.962 0.411 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.703 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.5 mt -76.01 126.97 86.2 Favored Pre-proline 0 N--CA 1.422 -1.831 0 CA-C-O 121.77 0.795 . . . . 0.0 111.803 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -71.26 -15.45 31.63 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 124.708 3.606 . . . . 0.0 110.978 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.723 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.2 tp 30.62 -60.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 128.676 2.791 . . . . 0.0 116.279 172.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.615 ' HG2' HG23 ' A' ' 307' ' ' ILE . 7.1 mm-40 -56.64 -39.16 73.19 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.892 0.853 . . . . 0.0 109.958 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.531 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.4 t-160 -58.96 -48.51 81.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.866 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.1 mt -58.75 -48.52 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 123.96 0.904 . . . . 0.0 113.033 174.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.723 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.0 mtp180 -59.59 -29.83 68.24 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.726 0.41 . . . . 0.0 110.562 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.1 m -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.565 0.697 . . . . 0.0 109.911 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 338' ' ' VAL . 0.5 OUTLIER -67.91 -40.52 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.918 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.795 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.39 -36.18 26.98 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.691 1.234 . . . . 0.0 109.57 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.5 9.13 Favored Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.52 -2.127 . . . . 0.0 111.184 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 44.0 mt-10 51.62 173.18 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 124.302 1.041 . . . . 0.0 113.273 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.537 ' HB3' HD11 ' A' ' 324' ' ' ILE . 22.6 Cg_exo -44.82 140.38 6.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.011 2.474 . . . . 0.0 112.821 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 319' ' ' ARG . 40.3 Cg_endo -89.15 -100.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.42 2.747 . . . . 0.0 113.072 -171.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.509 ' HG2' ' HB2' ' A' ' 318' ' ' PRO . 5.1 mmt180 -98.23 -81.95 0.43 Allowed 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.381 0.61 . . . . 0.0 110.687 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.741 ' OD1' ' HG2' ' A' ' 322' ' ' ARG . 1.8 t30 -111.93 150.12 41.88 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.147 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.697 ' HD2' ' OD1' ' A' ' 320' ' ' ASN . 56.8 Cg_exo -49.14 -53.53 6.87 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.157 2.572 . . . . 0.0 111.692 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.741 ' HG2' ' OD1' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -63.24 -13.34 36.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.26 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.584 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 30.4 mt-10 -83.16 -28.01 29.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 171.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -48.39 -44.74 65.75 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 378' ' ' LEU . 8.9 Cg_endo -50.21 -59.98 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.754 2.303 . . . . 0.0 112.965 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.641 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -64.75 -34.06 67.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.345 0 CA-C-O 122.9 1.333 . . . . 0.0 110.067 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.795 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 39.5 t90 -57.2 -38.62 73.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.073 -1.876 . . . . 0.0 110.718 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.84 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -67.71 -47.34 69.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-O 120.693 0.283 . . . . 0.0 111.688 -175.456 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.27 -23.05 16.37 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.88 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.663 ' HD3' ' OE1' ' A' ' 402' ' ' GLU . 3.2 mmm-85 -72.89 -43.9 61.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.735 0.779 . . . . 0.0 111.152 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.621 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.5 p30 -103.02 -17.65 15.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.29 -49.75 6.51 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 174.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 43.0 Cg_endo -62.76 -32.34 78.16 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.566 2.177 . . . . 0.0 111.612 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.13 -42.83 62.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.314 -1.766 . . . . 0.0 109.839 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.7 mt -58.65 -48.66 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.362 173.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.87 -15.03 4.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.846 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.68 -50.16 5.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.624 HG11 HG13 ' A' ' 310' ' ' ILE . 99.2 t -55.42 -71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 123.742 1.734 . . . . 0.0 109.796 169.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.824 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.8 OUTLIER -89.44 128.7 50.03 Favored Pre-proline 0 N--CA 1.397 -3.116 0 CA-C-N 110.537 -3.028 . . . . 0.0 111.9 -173.339 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.762 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.7 Cg_endo -72.92 -16.72 25.8 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 C-N-CA 123.548 2.832 . . . . 0.0 110.075 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.56 HG21 ' HG2' ' A' ' 347' ' ' ARG . 4.6 p 31.9 69.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.603 ' N ' HD12 ' A' ' 346' ' ' LEU . 39.6 p -79.2 6.33 10.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.671 -2.058 . . . . 0.0 113.408 -167.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -140.73 164.49 36.09 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.659 ' HB3' HD23 ' A' ' 369' ' ' LEU . 47.4 Cg_exo -64.32 -47.81 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.646 2.897 . . . . 0.0 108.655 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.598 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 1.0 OUTLIER -44.81 -48.84 11.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.076 177.297 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.5 mt -57.86 -50.97 71.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.902 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.584 ' HA ' HD12 ' A' ' 350' ' ' ILE . 55.0 mtt180 -48.4 -48.0 37.29 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.298 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.926 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -70.13 -48.39 57.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.728 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 84.0 mtt180 -57.4 -40.81 79.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.079 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.824 HD11 ' CD2' ' A' ' 339' ' ' PHE . 48.0 mt -57.89 -53.13 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.497 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.581 HG12 HD11 ' A' ' 328' ' ' LEU . 26.0 mt -59.0 -52.5 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-O 122.117 0.96 . . . . 0.0 111.122 -170.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.598 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 13.6 m-20 -62.53 -35.95 81.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.938 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.75 75.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.244 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.674 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.66 -54.87 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-O 123.021 1.391 . . . . 0.0 110.515 173.162 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.663 HD13 ' HB ' ' A' ' 354' ' ' ILE . 1.1 mp -72.37 -25.7 61.62 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.777 -2.465 . . . . 0.0 109.1 -168.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 68.25 -76.74 0.25 Allowed Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 113.607 -1.633 . . . . 0.0 113.326 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -124.61 69.1 0.49 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.112 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.572 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -86.74 163.86 17.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.503 0.321 . . . . 0.0 110.994 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.43 -59.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 122.92 0.488 . . . . 0.0 111.494 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -160.51 16.08 0.19 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.624 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.613 ' HB3' HD12 ' A' ' 378' ' ' LEU . 3.1 mt -67.33 -3.74 8.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.307 0.643 . . . . 0.0 111.189 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.598 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.3 t -62.52 81.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.711 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -61.93 174.35 0.87 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.83 0.824 . . . . 0.0 113.019 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.4 p -117.52 157.96 46.29 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.151 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.879 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.4 Cg_endo -49.46 -30.23 20.36 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.556 1.504 . . . . 0.0 112.236 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.65 ' HA2' HD21 ' A' ' 369' ' ' LEU . . . -96.36 0.53 61.8 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.811 1.085 . . . . 0.0 115.811 -170.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.677 ' HB2' HD12 ' A' ' 363' ' ' LEU . 6.4 m-20 -109.3 -18.37 13.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.686 1.243 . . . . 0.0 110.443 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.926 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 5.0 t -109.95 21.74 16.47 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.328 -165.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 344' ' ' PRO . 2.1 mt -60.04 -29.51 68.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.861 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 6.0 p -114.56 159.96 19.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.221 -1.809 . . . . 0.0 109.771 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.596 ' O ' HG13 ' A' ' 375' ' ' VAL . 31.0 m95 -70.28 -34.83 73.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.538 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -63.29 -44.84 93.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.887 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 t -68.44 -42.85 78.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.466 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.627 ' O ' HD22 ' A' ' 378' ' ' LEU . . . -61.28 -53.13 60.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.847 HG21 ' HE3' ' A' ' 413' ' ' MET . 15.8 m -57.37 -44.96 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.759 0.79 . . . . 0.0 109.259 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 0.999 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.81 -45.75 91.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.634 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.677 HG21 HD11 ' A' ' 363' ' ' LEU . 29.5 m -66.76 -39.75 88.01 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.088 -172.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -60.16 -34.49 73.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.984 1.265 . . . . 0.0 109.832 177.106 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.687 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 62.1 t80 -72.1 -47.5 50.84 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.494 1.14 . . . . 0.0 109.288 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 112.469 -2.151 . . . . 0.0 111.407 171.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.5 OUTLIER -59.48 -36.19 75.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 123.219 0.608 . . . . 0.0 111.243 176.583 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 322' ' ' ARG . 34.1 p -102.34 -22.09 14.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.799 -169.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -109.49 23.1 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.25 16.22 26.29 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.448 -0.406 . . . . 0.0 114.034 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.41 HG23 HG13 ' A' ' 380' ' ' ILE . 0.7 OUTLIER 64.68 158.23 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.996 0.518 . . . . 0.0 111.355 -175.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.509 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -124.65 154.05 70.07 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -100.07 59.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.703 2.935 . . . . 0.0 111.209 165.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.742 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.43 -1.24 0.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -175.558 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -69.89 -48.31 59.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.892 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.637 ' O ' HG13 ' A' ' 394' ' ' VAL . 57.9 mt-30 -74.08 -25.43 59.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -169.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.798 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.86 -30.77 47.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.7 0.682 . . . . 0.0 111.657 -175.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.787 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.19 -49.69 62.4 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.549 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.639 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 29.9 m-20 -68.74 -39.88 80.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.774 0.43 . . . . 0.0 112.135 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.65 -44.89 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.626 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -57.76 -46.77 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.484 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.639 ' HG3' ' HA ' ' A' ' 393' ' ' ASN . 30.3 mmtt -52.23 -44.46 64.84 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.819 0.819 . . . . 0.0 111.365 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.05 17.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.191 -172.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.696 HG23 ' HG3' ' A' ' 402' ' ' GLU . 3.9 mt -68.93 -41.51 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 117.156 0.478 . . . . 0.0 111.379 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.5 m -57.85 -44.97 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.615 0.721 . . . . 0.0 110.032 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.476 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.7 t70 -65.97 -37.75 86.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.412 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.67 -51.71 6.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.696 ' HG3' HG23 ' A' ' 398' ' ' ILE . 0.0 OUTLIER -108.95 -29.48 8.57 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.369 -170.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 125.7 160.56 10.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.598 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.804 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.24 -42.96 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -176.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.67 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -57.04 -50.47 72.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.312 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -63.21 -51.3 66.85 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.27 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.658 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -41.97 65.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 55.0 t80 -59.24 -44.99 92.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.442 0.639 . . . . 0.0 109.524 176.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.774 ' O ' ' HG3' ' A' ' 413' ' ' MET . 4.6 m -60.45 -52.55 64.73 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.49 -178.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.707 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -61.69 -48.58 80.12 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.713 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.638 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.72 -43.75 86.58 Favored Glycine 0 C--N 1.313 -0.745 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.348 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.626 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.3 -31.72 65.95 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.821 0.311 . . . . 0.0 110.975 179.067 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.847 ' HE3' HG21 ' A' ' 375' ' ' VAL . 65.2 mtm -69.12 -47.87 63.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.176 0.513 . . . . 0.0 109.915 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.999 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.6 mt -58.66 -39.83 81.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.159 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.798 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.4 OUTLIER -77.65 -14.54 59.6 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.741 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.8 32.37 7.63 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.135 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.617 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 71.35 38.53 1.03 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.54 0.736 . . . . 0.0 112.149 176.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.618 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 0.3 OUTLIER -119.99 77.99 1.3 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 165.079 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.626 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 2.9 p90 -62.18 -32.6 73.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.416 -2.174 . . . . 0.0 110.501 -162.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 31.8 mt-30 -55.11 -46.98 75.61 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.171 0.989 . . . . 0.0 113.359 -164.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.736 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -60.06 -51.22 70.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.635 0.731 . . . . 0.0 110.777 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.617 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -59.83 -38.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 123.054 1.407 . . . . 0.0 108.893 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 419' ' ' TYR . 1.1 t -61.8 -46.79 88.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 111.891 -2.413 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.64 89.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.111 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.787 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.1 mt -71.25 -41.25 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.57 0.7 . . . . 0.0 109.672 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.77 -46.73 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.596 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.719 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.19 -30.18 68.01 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.518 1.151 . . . . 0.0 109.526 -175.128 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.409 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.43 -16.59 77.42 Favored Glycine 0 C--N 1.298 -1.57 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.595 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.96 0.03 40.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.65 145.05 71.37 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 123.626 1.679 . . . . 0.0 113.268 170.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.719 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.2 Cg_endo -71.24 -58.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 1 C-N-CA 126.22 4.613 . . . . 0.0 113.147 -173.106 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.524 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -110.97 139.35 15.5 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.407 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.886 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.23 -27.95 69.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.091 0.446 . . . . 0.0 111.286 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.774 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.44 -47.93 80.5 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.021 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.6 -51.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.676 177.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.886 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.94 -53.43 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.469 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 64.8 m -62.18 -56.33 19.82 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.914 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.11 -45.64 79.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.532 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.863 ' O ' HD22 ' A' ' 443' ' ' LEU . 42.7 mt -59.61 -53.77 54.26 Favored 'General case' 0 CA--C 1.481 -1.695 0 C-N-CA 120.276 -0.569 . . . . 0.0 110.619 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.682 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.79 -34.56 40.44 Favored 'General case' 0 N--CA 1.416 -2.143 0 O-C-N 125.073 1.483 . . . . 0.0 110.596 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.91 -60.99 1.97 Allowed 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 176.249 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.2 OUTLIER -76.3 -51.44 11.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.894 -0.504 . . . . 0.0 112.232 -172.473 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.62 -24.49 61.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.622 0.725 . . . . 0.0 111.735 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.749 ' N ' HD23 ' A' ' 443' ' ' LEU . 21.2 t70 -71.71 -42.76 66.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.662 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.4 mt-30 -69.48 -7.86 41.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 43.5 mm-40 -51.7 160.08 0.7 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 123.721 1.724 . . . . 0.0 114.501 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.502 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -56.32 -33.32 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 110.626 -2.988 . . . . 0.0 115.403 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.647 ' H ' ' HB ' ' A' ' 451' ' ' THR . 48.4 m-20 -142.78 -178.67 5.91 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -63.66 -56.59 14.62 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.42 -25.11 67.87 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 176.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.647 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 17.8 m -59.34 -42.68 92.05 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 119.493 1.042 . . . . 0.0 109.889 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 53.0 mtt180 -61.34 -30.0 70.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.557 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -30.93 59.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.971 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 2.5 mm-40 -80.86 -45.17 17.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.416 1.103 . . . . 0.0 111.498 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 43.7 p -101.36 -4.34 27.14 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.894 -167.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.736 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.5 t80 -49.01 -52.09 27.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.661 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.67 HG23 ' HB1' ' A' ' 405' ' ' ALA . 27.0 mm -70.95 -27.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.429 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.16 -42.73 65.58 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 463' ' ' VAL . 75.8 m-70 -67.03 -30.97 71.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.75 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.782 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -65.59 -53.7 38.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.207 1.003 . . . . 0.0 109.23 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.652 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.4 m-80 -61.94 -32.39 72.81 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.071 172.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.71 -52.73 62.11 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.002 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.021 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.9 t -62.78 -34.89 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 121.858 0.837 . . . . 0.0 110.32 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.7 m-30 -61.63 -15.13 36.81 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.014 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 45.7 mm-40 -91.16 -49.52 6.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.941 -1.099 . . . . 0.0 112.696 176.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.73 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.24 -39.77 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.997 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.774 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.6 mt -84.44 -16.61 42.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.801 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.88 50.02 60.32 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 111.855 -2.43 . . . . 0.0 113.599 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.715 HD11 HD12 ' A' ' 467' ' ' LEU . 0.3 OUTLIER -103.68 -179.28 3.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 123.877 0.871 . . . . 0.0 110.244 -179.156 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.564 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.6 p-10 -102.1 -40.27 6.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 168.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -160.56 -76.51 0.06 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 112.524 -2.125 . . . . 0.0 111.052 158.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.719 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -60.07 69.26 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -171.139 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 37.39 40.37 0.63 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 110.738 -2.937 . . . . 0.0 113.654 174.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.564 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 2.7 mm100 -77.67 -53.62 7.34 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.098 0.951 . . . . 0.0 111.784 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 67.9 55.08 0.59 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 112.084 -2.325 . . . . 0.0 108.833 -174.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.801 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 110.84 -2.891 . . . . 0.0 111.833 176.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.433 -1.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.715 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 22.6 mt -75.05 126.27 88.3 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-O 121.945 0.878 . . . . 0.0 112.698 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.602 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.0 Cg_endo -83.37 49.56 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.819 3.679 . . . . 0.0 109.522 167.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.761 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -42.49 -42.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.555 -2.111 . . . . 0.0 112.665 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -65.25 -36.99 85.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.241 0.543 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.59 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.6 t-160 -62.7 -47.49 83.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.357 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.637 HG13 HG11 ' A' ' 338' ' ' VAL . 62.3 mt -58.74 -49.88 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.761 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.3 mtp180 -62.11 -29.95 70.68 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 110.683 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.0 m -69.71 -33.78 72.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.37 0.605 . . . . 0.0 110.072 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.545 HG21 HG23 ' A' ' 338' ' ' VAL . 0.5 OUTLIER -66.24 -40.05 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.982 178.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.654 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.14 -36.93 26.94 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.74 1.257 . . . . 0.0 109.677 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.44 32.19 9.73 Favored Glycine 0 C--N 1.305 -1.14 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.803 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 25.5 mt-10 51.8 169.54 0.04 OUTLIER Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 124.626 1.17 . . . . 0.0 113.83 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.643 ' HB3' HD11 ' A' ' 324' ' ' ILE . 52.7 Cg_exo -46.19 148.53 3.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.469 2.779 . . . . 0.0 114.203 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.475 ' HG2' ' H ' ' A' ' 319' ' ' ARG . 40.3 Cg_endo -91.86 -99.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.851 3.034 . . . . 0.0 112.746 -174.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 6.5 mmm180 -97.83 -83.09 0.41 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.154 0.502 . . . . 0.0 110.828 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.405 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 16.9 m-20 -102.67 163.57 17.34 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.479 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.4 Cg_exo -59.72 -47.41 16.12 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.708 2.272 . . . . 0.0 110.379 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.452 ' HA ' HG21 ' A' ' 382' ' ' THR . 81.2 mtt180 -48.65 -28.76 3.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.815 -1.993 . . . . 0.0 112.8 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.85 -23.16 22.87 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.801 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.716 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.2 OUTLIER -50.02 -42.39 70.44 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.728 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 7.5 Cg_endo -48.62 -61.52 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.848 2.365 . . . . 0.0 112.829 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.723 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -61.51 -36.79 75.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-O 122.667 1.222 . . . . 0.0 110.384 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.758 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 54.6 t90 -58.75 -40.72 84.68 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.48 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.803 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.5 OUTLIER -68.45 -50.12 54.86 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.46 -23.23 18.59 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.758 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 1.5 ttt-85 -72.77 -41.61 64.87 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 114.442 -0.879 . . . . 0.0 112.321 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.575 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.4 p30 -106.74 -16.92 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.17 -48.01 6.04 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 37.8 Cg_endo -60.49 -32.72 94.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.536 2.157 . . . . 0.0 111.555 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -72.7 -43.21 63.33 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.658 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.4 mt -58.37 -49.52 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.754 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 28.1 t70 -58.33 -14.57 7.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.044 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.66 6.43 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.364 175.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.637 HG11 HG13 ' A' ' 310' ' ' ILE . 91.2 t -56.99 -70.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 123.698 1.713 . . . . 0.0 110.154 168.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.864 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -92.43 130.6 36.85 Favored Pre-proline 0 N--CA 1.402 -2.864 0 CA-C-N 110.629 -2.987 . . . . 0.0 112.11 -173.313 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.775 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.7 Cg_endo -74.91 -17.42 19.79 Favored 'Trans proline' 0 CA--C 1.496 -1.394 0 C-N-CA 123.731 2.954 . . . . 0.0 110.631 174.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.465 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.6 p 34.08 67.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 112.216 -2.266 . . . . 0.0 110.107 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.63 ' N ' HD12 ' A' ' 346' ' ' LEU . 35.8 p -78.25 3.17 16.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 112.453 -2.158 . . . . 0.0 113.194 -170.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.79 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 10.2 p -137.93 164.13 43.06 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 343' ' ' THR . 42.2 Cg_exo -63.8 -49.94 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.265 2.644 . . . . 0.0 108.329 172.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.73 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -43.6 -48.69 7.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.982 176.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.79 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.7 mt -56.18 -51.99 66.01 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.521 0.677 . . . . 0.0 110.166 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.712 ' HA ' HD12 ' A' ' 350' ' ' ILE . 2.1 ttm180 -54.9 -47.03 74.87 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.556 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 1.088 ' HG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.45 -48.16 61.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.179 0.514 . . . . 0.0 111.193 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.2 mtp180 -56.45 -41.1 75.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.244 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.864 HD11 ' CD2' ' A' ' 339' ' ' PHE . 42.6 mt -58.63 -54.37 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.492 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.652 ' O ' HD22 ' A' ' 355' ' ' LEU . 20.8 mt -57.71 -54.04 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.952 0.882 . . . . 0.0 110.87 -168.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.489 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -63.95 -34.79 78.76 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.989 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.6 -34.42 74.08 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.336 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.727 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.252 1.0 OUTLIER -56.58 -55.32 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 CA-C-O 122.982 1.372 . . . . 0.0 110.523 175.289 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.727 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.0 OUTLIER -73.06 -27.63 61.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.668 -2.514 . . . . 0.0 110.154 -169.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 39.41 75.35 0.1 Allowed Glycine 0 CA--C 1.524 0.63 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.851 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 112.85 25.08 4.66 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.86 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.788 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 3.9 p-10 -75.14 136.91 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.99 0.424 . . . . 0.0 111.365 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.627 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.1 mp -71.77 98.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.999 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.76 -21.55 4.6 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.221 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.788 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 5.8 mt -61.59 -6.38 2.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 122.939 0.496 . . . . 0.0 112.195 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.489 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 20.7 t -61.06 81.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.217 0.532 . . . . 0.0 110.427 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -62.5 169.25 3.09 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.136 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 366' ' ' GLY . 69.5 p -111.75 161.4 25.8 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.329 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 1.088 ' HA ' ' HG ' ' A' ' 348' ' ' CYS . 2.2 Cg_endo -63.57 7.07 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.202 1.935 . . . . 0.0 112.747 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -117.23 -12.32 8.32 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.689 -0.687 . . . . 0.0 114.679 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.751 ' HB2' HD12 ' A' ' 363' ' ' LEU . 45.9 m-20 -105.67 -20.43 13.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.509 1.147 . . . . 0.0 109.804 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 7.6 p -82.91 20.04 1.26 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.431 -1.713 . . . . 0.0 112.805 -169.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -58.03 -34.83 70.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 122.288 1.042 . . . . 0.0 110.067 -168.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.1 t -130.62 163.67 26.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.202 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.608 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.4 m95 -70.36 -36.59 74.28 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.535 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.4 p30 -63.38 -39.37 94.34 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.439 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 48.1 t -66.36 -42.89 87.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.053 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.65 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -68.35 -51.81 40.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 328' ' ' LEU . 11.9 m -56.88 -45.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.144 0.497 . . . . 0.0 110.087 -178.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.006 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.09 -43.1 95.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.684 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.722 HG21 HD11 ' A' ' 363' ' ' LEU . 40.2 m -68.5 -42.68 78.25 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.558 -173.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -58.74 -34.02 70.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.419 0.554 . . . . 0.0 110.671 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.728 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.6 t80 -73.68 -47.34 40.45 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.501 1.144 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.64 -32.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 CA-C-N 112.678 -2.055 . . . . 0.0 111.336 170.553 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.63 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -60.29 -41.99 94.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.682 175.066 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 322' ' ' ARG . 30.3 p -97.4 -23.42 16.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.772 -168.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -110.5 22.91 14.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.75 21.73 23.49 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.315 0.486 . . . . 0.0 114.315 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.2 m 67.01 160.05 0.15 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.225 0.536 . . . . 0.0 111.328 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.518 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -125.31 156.17 70.4 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.087 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -97.94 54.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.415 2.743 . . . . 0.0 111.306 165.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.79 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.51 4.21 0.22 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.147 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -70.09 -47.45 61.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.014 0.435 . . . . 0.0 110.585 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.616 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.7 mt-30 -71.47 -27.48 63.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -169.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.839 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.84 -31.18 59.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.59 0.632 . . . . 0.0 111.925 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.682 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -50.09 59.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.476 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.516 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.3 m-20 -68.58 -39.43 80.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.661 0.384 . . . . 0.0 112.002 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.55 -45.92 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.245 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.796 ' O ' HG22 ' A' ' 399' ' ' VAL . 5.9 mm -58.69 -47.27 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.615 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.693 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.8 mmtt -51.42 -42.61 61.61 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 124.077 0.861 . . . . 0.0 111.486 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.52 -44.11 13.78 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.921 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.723 HG12 HG21 ' A' ' 326' ' ' ILE . 1.8 mt -69.2 -40.73 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 117.5 0.65 . . . . 0.0 111.543 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.873 HG12 ' HA ' ' A' ' 404' ' ' VAL . 0.8 OUTLIER -59.35 -42.81 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 109.506 -178.43 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.63 -39.23 93.84 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.087 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -85.66 -53.41 5.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.281 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.554 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -110.64 -32.16 6.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.561 0.696 . . . . 0.0 111.747 -170.064 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.01 163.13 11.48 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.682 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.873 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.07 -49.81 72.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.164 0.507 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.645 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.76 -50.69 65.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.557 177.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.677 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.53 -44.18 65.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.518 ' HB3' HD11 ' A' ' 457' ' ' ILE . 26.9 t80 -54.81 -46.44 74.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.779 0.799 . . . . 0.0 109.082 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.778 ' O ' ' HG3' ' A' ' 413' ' ' MET . 18.4 m -58.55 -52.02 67.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.958 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.68 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -61.99 -49.09 77.47 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.958 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.538 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.11 -43.28 88.59 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.805 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.631 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -71.29 -32.94 69.25 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.728 0.264 . . . . 0.0 110.673 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.778 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.6 mtm -68.82 -46.2 69.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.923 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.006 HD23 ' HA ' ' A' ' 376' ' ' ALA . 18.5 mt -60.2 -43.35 96.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.292 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.839 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 1.9 m -80.63 7.15 10.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 70.81 46.78 43.59 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.857 171.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.631 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 0.0 OUTLIER 62.3 42.12 9.61 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 123.87 0.868 . . . . 0.0 111.616 177.534 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.741 ' ND2' HD22 ' A' ' 421' ' ' LEU . 22.3 t30 -113.17 83.21 1.79 Allowed 'General case' 0 CA--C 1.476 -1.878 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 163.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.786 ' HD2' ' HG ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -57.09 -36.93 71.2 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.821 -174.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 41.6 mt-30 -57.29 -51.56 68.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -163.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.803 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 1.7 pt? -60.02 -49.23 78.48 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.392 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.803 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.77 -38.42 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.685 1.231 . . . . 0.0 108.894 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.786 ' HG ' ' HD2' ' A' ' 419' ' ' TYR . 43.6 m -65.31 -41.13 94.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.31 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.83 86.97 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.787 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.625 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.7 mt -71.46 -40.71 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.597 0.713 . . . . 0.0 109.813 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -56.78 -44.67 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.58 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.642 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -57.4 -33.09 67.49 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 124.87 1.268 . . . . 0.0 109.245 -176.137 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.443 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.57 -15.01 77.52 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 112.992 -1.913 . . . . 0.0 112.448 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.75 ' CG ' HG21 ' A' ' 399' ' ' VAL . 9.0 m-85 -102.77 1.12 33.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -57.58 142.01 78.06 Favored Pre-proline 0 N--CA 1.41 -2.464 0 CA-C-O 123.645 1.688 . . . . 0.0 113.333 170.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.807 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 53.1 Cg_endo -68.95 -57.35 0.13 Allowed 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.564 4.843 . . . . 0.0 113.316 -169.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.497 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.62 140.72 16.45 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.736 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.933 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.1 OUTLIER -59.44 -32.43 70.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.688 0.744 . . . . 0.0 111.651 -175.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.857 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.02 -48.43 73.39 Favored 'General case' 0 CA--C 1.509 -0.635 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.045 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -62.39 -36.76 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.337 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.933 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -71.1 -45.98 69.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.184 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 45.4 m -72.27 -54.92 8.13 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.359 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.82 76.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.842 HD13 HD22 ' A' ' 460' ' ' LEU . 20.1 mt -66.61 -54.49 22.91 Favored 'General case' 0 CA--C 1.465 -2.3 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.733 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 2.3 mp0 -51.22 -33.54 28.29 Favored 'General case' 0 N--CA 1.405 -2.715 0 O-C-N 125.781 1.926 . . . . 0.0 109.944 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -72.95 -60.74 2.09 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.845 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -71.55 -48.73 46.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.126 0.488 . . . . 0.0 111.472 -171.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -60.22 -25.97 66.03 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.458 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.744 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.0 t70 -73.09 -42.01 63.46 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.33 1.062 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -68.79 -8.31 42.14 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -171.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 47.1 mm-40 -51.78 156.97 1.28 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.518 1.628 . . . . 0.0 115.058 -176.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.5 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -52.92 -31.98 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 110.506 -3.043 . . . . 0.0 115.665 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.651 ' H ' ' HB ' ' A' ' 451' ' ' THR . 55.2 m-20 -140.81 178.9 7.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.78 -56.3 20.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.1 OUTLIER -67.49 -24.97 65.64 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.627 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.651 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -57.78 -41.05 81.27 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.774 1.17 . . . . 0.0 109.932 171.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 62.5 mtt180 -60.97 -30.57 70.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.565 ' HB2' ' HD1' ' A' ' 419' ' ' TYR . . . -76.09 -31.44 58.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.35 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.8 mm-40 -81.29 -45.68 15.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.474 1.13 . . . . 0.0 111.883 -172.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.464 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 47.2 p -98.95 -2.3 37.82 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.772 -167.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.645 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -48.89 -55.57 11.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.932 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 405' ' ' ALA . 27.6 mm -70.23 -25.42 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -73.0 -43.21 62.43 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.585 ' O ' HG23 ' A' ' 463' ' ' VAL . 65.9 m-70 -66.15 -32.19 73.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.261 171.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.18 -53.69 45.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.308 1.051 . . . . 0.0 109.34 -178.603 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.662 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.9 m-80 -62.6 -32.03 72.96 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.3 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.36 -52.55 63.16 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.035 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.045 HG11 ' HA ' ' A' ' 435' ' ' VAL . 34.5 t -63.26 -33.57 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-O 121.802 0.81 . . . . 0.0 110.56 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.4 m-30 -62.54 -15.26 49.8 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.309 168.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 22.4 mm-40 -92.25 -49.31 6.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.007 -1.058 . . . . 0.0 112.64 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.762 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.63 -40.16 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.67 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.857 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.3 mt -84.6 -16.67 41.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.759 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.75 51.79 50.91 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 111.681 -2.509 . . . . 0.0 113.171 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.667 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -103.3 -178.12 3.57 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.723 0.809 . . . . 0.0 110.268 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.435 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.7 p-10 -101.39 -41.95 6.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 167.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.92 -75.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.322 159.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.807 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 1.3 mpt_? -63.77 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -168.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 40.09 42.16 2.25 Favored Glycine 0 C--N 1.277 -2.72 0 CA-C-N 111.352 -2.658 . . . . 0.0 113.417 173.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.435 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 0.3 OUTLIER -81.55 -49.64 10.32 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-O 122.306 1.05 . . . . 0.0 111.278 -172.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 46.8 t 62.1 57.69 1.99 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.346 -2.207 . . . . 0.0 108.433 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.759 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.322 0 CA-C-N 110.934 -2.848 . . . . 0.0 111.418 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 121.175 0.512 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.698 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -75.1 126.66 87.8 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-O 122.005 0.907 . . . . 0.0 111.731 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.6 Cg_endo -72.18 -10.84 26.39 Favored 'Trans proline' 0 CA--C 1.498 -1.307 0 C-N-CA 124.755 3.637 . . . . 0.0 111.298 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.7 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.8 tp 25.12 -61.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 O-C-N 127.13 2.769 . . . . 0.0 116.063 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.565 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.37 -32.78 68.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.196 0.522 . . . . 0.0 110.396 178.308 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.51 ' CG ' HG13 ' A' ' 338' ' ' VAL . 1.4 t-80 -62.27 -48.71 78.71 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.609 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 307' ' ' ILE . 59.8 mt -58.32 -48.87 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 C-N-CA 123.982 0.913 . . . . 0.0 112.78 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 10.5 mtp180 -61.29 -30.48 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 122.141 -0.349 . . . . 0.0 110.827 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 53.1 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.62 0.724 . . . . 0.0 109.962 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.542 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.1 -40.89 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.748 178.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.742 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 32.3 p -82.67 -36.32 26.05 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.941 1.353 . . . . 0.0 109.531 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.64 33.54 8.42 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 112.183 -2.281 . . . . 0.0 110.938 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.539 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.1 mt-10 50.68 174.66 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 124.339 1.055 . . . . 0.0 113.029 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.658 ' HB3' HD11 ' A' ' 324' ' ' ILE . 42.6 Cg_exo -46.09 145.81 4.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.374 2.05 . . . . 0.0 112.467 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 319' ' ' ARG . 48.6 Cg_endo -87.65 -99.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.343 2.695 . . . . 0.0 112.451 -171.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.401 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 4.0 mmm180 -100.82 -76.57 0.56 Allowed 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.723 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.755 HD22 ' HG2' ' A' ' 322' ' ' ARG . 1.2 t-20 -109.88 150.8 41.85 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.004 -173.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.715 ' HD2' ' ND2' ' A' ' 320' ' ' ASN . 47.7 Cg_exo -53.88 -52.83 7.53 Favored 'Trans proline' 0 CA--C 1.504 -1.024 0 C-N-CA 123.04 2.493 . . . . 0.0 111.52 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.755 ' HG2' HD22 ' A' ' 320' ' ' ASN . 0.0 OUTLIER -59.18 -15.93 17.55 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.052 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.614 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 5.5 mt-10 -81.22 -25.85 36.35 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.658 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -48.58 -44.48 66.87 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.759 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -51.2 -61.9 0.47 Allowed 'Trans proline' 0 CA--C 1.518 -0.308 0 C-N-CA 122.697 2.265 . . . . 0.0 113.159 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.733 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.64 -35.59 60.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 122.919 1.343 . . . . 0.0 110.153 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.842 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 42.7 t90 -59.78 -38.5 82.05 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.88 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.867 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.5 OUTLIER -69.2 -50.6 45.94 Favored 'General case' 0 N--CA 1.407 -2.604 0 O-C-N 121.863 -0.523 . . . . 0.0 112.396 -175.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.94 -22.87 21.16 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.842 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 10.7 ttp85 -71.76 -42.46 67.17 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 113.862 -1.169 . . . . 0.0 112.166 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.573 ' HB2' HG22 ' A' ' 314' ' ' THR . 0.8 OUTLIER -108.3 -15.44 14.47 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.099 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.37 -47.97 6.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 32.1 Cg_endo -59.16 -34.94 98.61 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.557 175.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -71.94 -42.62 66.4 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.771 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 332' ' ' ALA . 88.5 mt -58.87 -49.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.663 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.2 -16.87 5.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.895 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.2 -50.7 5.33 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.17 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.673 HG11 HG13 ' A' ' 310' ' ' ILE . 92.0 t -54.61 -69.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 123.541 1.639 . . . . 0.0 110.176 170.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.838 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -94.51 129.39 36.79 Favored Pre-proline 0 N--CA 1.401 -2.923 0 CA-C-N 110.958 -2.837 . . . . 0.0 112.162 -172.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.782 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.3 Cg_endo -75.5 -16.0 19.38 Favored 'Trans proline' 0 CA--C 1.497 -1.367 0 C-N-CA 123.892 3.061 . . . . 0.0 110.503 174.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.464 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.43 68.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.943 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.655 ' N ' HD12 ' A' ' 346' ' ' LEU . 31.0 p -81.0 10.58 4.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.623 -2.08 . . . . 0.0 113.468 -169.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.78 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.3 p -143.71 162.52 41.09 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.42 -49.34 6.05 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.208 2.606 . . . . 0.0 108.214 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.763 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -46.02 -44.12 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.904 -1.953 . . . . 0.0 111.292 178.036 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.78 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.0 mt -58.59 -52.03 67.38 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.382 0.61 . . . . 0.0 110.746 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.735 ' HA ' HD12 ' A' ' 350' ' ' ILE . 32.6 ttm105 -53.92 -44.85 70.94 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.31 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.867 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.04 -47.4 65.47 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 111.086 -176.693 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 94.0 mtt180 -57.51 -41.76 81.46 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.036 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.838 HD11 ' CD2' ' A' ' 339' ' ' PHE . 44.8 mt -58.0 -53.77 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.528 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 328' ' ' LEU . 20.6 mt -58.69 -52.84 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.096 0.951 . . . . 0.0 110.815 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -63.36 -35.32 79.99 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.049 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.23 -34.51 74.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 112.076 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.698 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.26 -55.09 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.833 1.302 . . . . 0.0 110.5 174.427 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.693 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -72.7 -26.79 61.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 111.693 -2.503 . . . . 0.0 109.297 -168.497 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 34.71 60.68 0.63 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.705 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 117.57 74.17 0.49 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.342 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.59 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -119.53 168.89 10.54 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 122.668 0.387 . . . . 0.0 110.432 -179.265 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.536 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -52.84 -61.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 122.991 0.516 . . . . 0.0 111.517 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.411 ' C ' ' HG2' ' A' ' 381' ' ' ARG . . . -156.44 14.05 0.36 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.05 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.68 ' HB3' HD22 ' A' ' 378' ' ' LEU . 5.1 mt -66.74 -4.81 9.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 122.934 0.494 . . . . 0.0 111.953 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.529 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 33.9 t -60.71 87.14 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 109.686 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.812 HD11 HG21 ' A' ' 377' ' ' THR . 0.7 OUTLIER -65.48 178.51 0.95 Allowed 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.249 174.586 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 43.0 p -122.06 161.13 44.27 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.867 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 8.7 Cg_endo -66.13 4.66 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.038 1.825 . . . . 0.0 112.365 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -110.53 -10.83 20.93 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.809 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.748 ' HB2' HD12 ' A' ' 363' ' ' LEU . 36.7 m-20 -106.42 -21.76 12.99 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.081 0.943 . . . . 0.0 109.828 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.83 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 17.6 p -80.91 18.94 0.92 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.917 -170.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.32 -35.48 73.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 122.291 1.043 . . . . 0.0 109.671 -172.576 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.19 159.76 33.3 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.229 174.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.628 ' O ' HG13 ' A' ' 375' ' ' VAL . 59.5 m95 -70.29 -36.95 74.68 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.576 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.26 -40.02 84.69 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.483 -175.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 35.4 t -72.77 -42.59 63.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.657 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.32 -51.52 67.32 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.867 HG12 ' HB3' ' A' ' 328' ' ' LEU . 11.2 m -58.52 -45.38 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.458 0.647 . . . . 0.0 109.824 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.039 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.09 -43.31 95.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.648 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.812 HG21 HD11 ' A' ' 363' ' ' LEU . 29.7 m -69.45 -39.21 77.92 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.836 -172.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.69 HD11 HD12 ' A' ' 328' ' ' LEU . 2.5 mt -60.75 -34.37 74.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.586 0.63 . . . . 0.0 110.516 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.759 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 38.0 t80 -73.58 -47.69 38.55 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 122.446 1.117 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -51.1 -32.42 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 112.661 -2.063 . . . . 0.0 111.706 170.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -59.8 -46.79 88.12 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.435 0.636 . . . . 0.0 111.042 174.026 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.572 ' HB ' ' HD2' ' A' ' 322' ' ' ARG . 43.8 p -93.22 -24.23 18.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.843 -169.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -110.84 23.14 14.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.05 20.75 15.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.415 HG23 HG13 ' A' ' 380' ' ' ILE . 2.6 m 66.27 163.52 0.17 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.279 0.561 . . . . 0.0 111.429 -176.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.537 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -130.55 153.96 81.56 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.077 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -99.31 60.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.421 2.747 . . . . 0.0 111.015 164.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.667 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.4 6.32 0.38 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -174.15 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -70.24 -48.72 55.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.082 0.467 . . . . 0.0 110.629 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.649 ' O ' HG13 ' A' ' 394' ' ' VAL . 41.2 mt-30 -76.61 -27.37 55.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -169.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.711 ' O ' HG22 ' A' ' 394' ' ' VAL . 3.2 mm? -54.66 -31.45 57.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 -171.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.7 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.76 -53.29 40.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.924 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.611 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 14.2 m-20 -66.21 -37.92 86.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.1 -45.99 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.648 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.0 mm -58.54 -47.59 87.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 34.0 mmtt -52.11 -42.81 63.58 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.354 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.26 -44.33 13.78 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.034 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 326' ' ' ILE . 2.0 mt -68.97 -40.77 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 117.447 0.623 . . . . 0.0 111.233 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.882 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.8 m -58.25 -45.63 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.034 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.474 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.1 t70 -62.34 -37.43 85.61 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.948 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -83.47 -53.14 5.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.615 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.39 -28.6 8.86 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.521 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 119.6 165.89 13.15 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.444 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.882 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.56 -44.07 98.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.31 -51.07 70.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.644 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.43 -49.88 69.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.461 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.678 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.2 -43.62 67.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.547 ' HB3' HD11 ' A' ' 457' ' ' ILE . 28.6 t80 -55.67 -45.72 77.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.816 ' O ' ' HG3' ' A' ' 413' ' ' MET . 16.3 m -57.99 -52.07 67.06 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.702 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.671 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -62.89 -49.23 75.64 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.716 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.57 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.37 -41.81 88.22 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.776 -174.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.709 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.44 -32.15 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 122.245 0.218 . . . . 0.0 111.152 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.816 ' HG3' ' O ' ' A' ' 409' ' ' THR . 60.4 mtm -70.67 -46.56 62.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 109.831 173.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.039 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.4 mt -60.51 -38.68 85.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.352 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 411' ' ' GLY . 4.5 p -77.0 -2.9 36.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.326 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.63 29.12 36.63 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.709 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.2 mm100 68.43 45.55 1.15 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 122.253 1.025 . . . . 0.0 111.534 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.669 ' OD1' HD23 ' A' ' 421' ' ' LEU . 25.1 t-20 -116.16 71.96 0.8 Allowed 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 164.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.617 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.2 OUTLIER -48.05 -35.77 11.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.046 -2.343 . . . . 0.0 111.64 -172.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 423' ' ' SER . 33.3 mt-30 -57.29 -49.91 74.58 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -166.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.669 HD23 ' OD1' ' A' ' 418' ' ' ASN . 3.1 pp -59.53 -48.66 80.78 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.237 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.76 -39.8 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.643 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.547 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 44.0 t -59.81 -47.59 85.1 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.793 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -56.02 -37.38 70.93 Favored Glycine 0 C--N 1.32 -0.339 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.052 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.7 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.9 mt -73.02 -42.69 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.548 0.689 . . . . 0.0 110.239 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.6 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -55.94 -44.48 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.727 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.71 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -59.74 -30.12 68.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-O 122.701 1.239 . . . . 0.0 109.236 -173.343 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.16 -16.82 77.0 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.429 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 15.3 m-85 -101.65 2.46 38.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.09 144.96 74.87 Favored Pre-proline 0 N--CA 1.416 -2.15 0 CA-C-O 123.501 1.62 . . . . 0.0 113.403 168.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.736 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.5 Cg_endo -72.6 -63.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 1 C-N-CA 126.126 4.551 . . . . 0.0 113.281 -173.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.552 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.06 140.23 15.22 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.181 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.83 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.74 -30.69 70.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.2 0.5 . . . . 0.0 111.204 -177.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.752 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.33 -48.16 74.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.005 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.61 -52.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.593 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.83 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.36 -54.66 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.109 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 53.2 m -62.76 -55.79 23.37 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.047 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.43 -45.13 80.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.642 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.0 mt -60.06 -53.46 57.56 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.722 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.704 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.74 -34.15 37.94 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 125.124 1.515 . . . . 0.0 110.403 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.663 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.87 -60.62 2.14 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 174.924 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -75.64 -51.38 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.541 0.61 . . . . 0.0 112.006 -172.486 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.32 -24.83 63.65 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.636 -178.442 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.757 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.1 t70 -73.06 -43.35 62.02 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.573 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.7 mt-30 -69.66 -8.95 52.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -172.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.436 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 20.7 mm-40 -51.89 155.28 1.82 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 123.574 1.654 . . . . 0.0 114.825 -175.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -52.93 -33.32 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 110.752 -2.931 . . . . 0.0 115.335 -171.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.643 ' H ' ' HB ' ' A' ' 451' ' ' THR . 26.5 m-20 -141.73 177.04 8.44 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.94 -52.35 63.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.1 OUTLIER -65.9 -25.2 67.05 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 174.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.643 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 12.6 m -60.89 -41.43 96.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 119.823 1.192 . . . . 0.0 109.756 172.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 71.8 mtt180 -60.42 -30.71 69.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.921 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 450' ' ' GLN . . . -75.67 -30.33 59.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.835 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -82.05 -44.25 16.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.858 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.506 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -104.32 -0.74 27.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.383 -167.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.676 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.8 t80 -49.12 -54.31 16.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.349 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -71.39 -25.1 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.99 -43.98 64.22 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.632 ' O ' HG23 ' A' ' 463' ' ' VAL . 78.8 m-70 -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.91 172.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.77 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.46 -53.77 43.09 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 122.263 1.03 . . . . 0.0 109.13 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -62.21 -30.65 71.23 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.341 -1.754 . . . . 0.0 110.869 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.7 -48.18 67.29 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.771 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.005 HG11 ' HA ' ' A' ' 435' ' ' VAL . 25.9 t -65.0 -35.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.352 174.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.53 -14.44 29.61 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.583 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 2.4 tp10 -92.56 -52.17 4.77 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.404 -0.81 . . . . 0.0 112.114 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.714 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -63.87 -41.15 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.424 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.1 mt -83.39 -16.85 44.32 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.817 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.9 50.8 56.37 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 111.565 -2.561 . . . . 0.0 112.977 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -102.86 -178.9 3.8 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.562 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.6 p-10 -101.02 -40.89 7.01 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.509 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -161.02 -75.79 0.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.114 159.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.736 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -61.48 70.57 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -171.15 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.77 46.54 0.61 Allowed Glycine 0 C--N 1.274 -2.862 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.398 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.562 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 2.3 mm100 -83.89 -53.81 5.32 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 122.245 1.022 . . . . 0.0 111.245 -173.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.8 t 68.0 56.25 0.54 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.889 -174.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.817 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 110.547 -3.024 . . . . 0.0 111.845 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.431 -1.402 0 CA-C-O 121.136 0.493 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.705 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -74.82 127.54 86.86 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 121.765 0.793 . . . . 0.0 111.5 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -72.41 -12.27 27.18 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.881 3.72 . . . . 0.0 111.107 176.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.696 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.6 tp 26.95 -61.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.087 0 C-N-CA 128.704 2.801 . . . . 0.0 115.975 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.36 -32.08 68.22 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.273 0.559 . . . . 0.0 110.257 178.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.517 ' CG ' HG13 ' A' ' 338' ' ' VAL . 6.7 t-160 -62.08 -49.32 76.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.669 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' A' ' 307' ' ' ILE . 59.2 mt -58.88 -49.05 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 124.213 1.005 . . . . 0.0 113.08 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 4.3 mtp-105 -60.64 -30.57 69.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.864 0.364 . . . . 0.0 111.071 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.1 m -70.44 -33.28 71.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.572 0.701 . . . . 0.0 110.205 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.21 -40.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.8 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.788 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -82.45 -36.61 26.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.969 1.366 . . . . 0.0 109.759 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.98 35.44 8.22 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 112.117 -2.31 . . . . 0.0 111.135 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.531 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 42.8 mt-10 51.49 173.2 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.102 0 C-N-CA 124.196 0.998 . . . . 0.0 113.529 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.609 ' HB3' HD11 ' A' ' 324' ' ' ILE . 23.9 Cg_exo -45.2 142.18 6.16 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.015 2.477 . . . . 0.0 112.343 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.507 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 41.9 Cg_endo -89.71 -100.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.305 2.67 . . . . 0.0 112.896 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.448 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 12.3 mmm180 -94.01 -83.36 0.33 Allowed 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 123.149 0.58 . . . . 0.0 110.935 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 18.0 m-20 -103.29 163.18 18.0 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.769 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 35.2 Cg_exo -59.28 -51.59 6.25 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.499 2.133 . . . . 0.0 110.676 172.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -55.27 -14.82 1.95 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.203 -1.817 . . . . 0.0 113.142 177.232 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.3 mm-40 -91.64 -26.19 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.419 -0.175 . . . . 0.0 111.405 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.646 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.3 OUTLIER -46.44 -45.12 43.86 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.745 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.6 Cg_endo -47.47 -62.59 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.905 2.404 . . . . 0.0 113.25 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.65 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -63.42 -35.92 74.23 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 122.879 1.323 . . . . 0.0 110.141 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.788 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.6 t90 -57.51 -39.5 76.64 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.74 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.849 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -67.62 -47.5 69.48 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 122.465 0.306 . . . . 0.0 111.716 -175.403 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.408 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.27 -22.96 16.04 Favored Glycine 0 C--N 1.311 -0.858 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.681 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.441 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -73.16 -42.39 62.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.447 0.642 . . . . 0.0 111.31 175.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.656 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.4 p30 -104.39 -17.61 14.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.698 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.72 -49.44 7.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.7 Cg_endo -61.81 -33.0 86.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.576 2.184 . . . . 0.0 111.466 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -71.9 -43.1 65.92 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.884 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 332' ' ' ALA . 87.7 mt -58.79 -49.3 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.71 173.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.37 -14.5 4.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.921 175.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.12 -44.21 7.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.485 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.647 HG11 HG13 ' A' ' 310' ' ' ILE . 92.1 t -60.74 -70.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 123.466 1.603 . . . . 0.0 109.79 169.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -92.62 130.78 35.83 Favored Pre-proline 0 N--CA 1.403 -2.825 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.265 -173.089 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.789 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.2 Cg_endo -74.78 -16.85 20.6 Favored 'Trans proline' 0 CA--C 1.498 -1.323 0 C-N-CA 123.788 2.992 . . . . 0.0 110.862 173.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 346' ' ' LEU . 3.1 p 33.4 67.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.342 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.652 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.3 p -78.14 4.26 12.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 112.669 -2.06 . . . . 0.0 113.485 -169.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.797 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 13.5 p -139.86 163.35 45.2 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -63.31 -49.23 4.89 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.367 2.711 . . . . 0.0 108.103 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.747 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -44.32 -45.94 8.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.4 176.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.797 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.4 mt -59.22 -51.63 69.17 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 121.64 0.733 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.674 ' HA ' HD12 ' A' ' 350' ' ' ILE . 3.2 ttm180 -54.1 -45.85 71.96 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.262 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 1.006 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.89 -48.75 62.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 111.355 -177.794 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.646 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 62.9 mtt180 -56.01 -42.62 76.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 339' ' ' PHE . 39.9 mt -57.73 -54.13 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.523 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.55 HD13 ' HB1' ' A' ' 374' ' ' ALA . 19.8 mt -59.43 -52.57 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 122.162 0.982 . . . . 0.0 110.558 -170.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 17.4 m-20 -62.79 -35.18 79.01 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.272 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.41 -36.0 76.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.683 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.58 -53.83 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 CA-C-O 123.107 1.432 . . . . 0.0 110.463 173.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.683 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -72.68 -25.71 61.36 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 111.716 -2.493 . . . . 0.0 109.412 -168.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 75.93 -74.71 1.57 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.895 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -151.39 56.94 0.45 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.332 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -76.91 162.61 27.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.783 -0.245 . . . . 0.0 110.581 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.659 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -37.43 -59.73 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.252 1.021 . . . . 0.0 113.736 -166.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -153.9 16.56 0.62 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.511 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.725 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.3 mt -65.59 -3.87 5.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.942 0.497 . . . . 0.0 112.139 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.541 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.9 t -63.47 84.24 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.529 0.68 . . . . 0.0 110.309 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.82 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -62.63 170.53 2.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.773 0.796 . . . . 0.0 112.388 174.215 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 366' ' ' GLY . 65.4 p -111.31 156.33 41.32 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.952 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 1.006 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.8 Cg_endo -61.92 11.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.673 2.248 . . . . 0.0 113.794 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.518 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -128.53 -5.65 4.94 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.728 ' HB2' HD12 ' A' ' 363' ' ' LEU . 8.4 m-20 -109.57 -19.91 13.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.205 1.002 . . . . 0.0 110.298 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 15.4 p -88.56 16.27 6.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.595 -168.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.518 HD11 ' O ' ' A' ' 366' ' ' GLY . 1.0 OUTLIER -59.61 -40.84 88.86 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.524 -164.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.62 160.09 21.84 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.523 171.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.626 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.6 m95 -69.88 -35.89 75.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.58 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.44 -40.24 96.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.251 -175.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 36.8 t -68.69 -43.58 75.76 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.938 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.661 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.77 62.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.849 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.1 m -57.22 -44.73 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.057 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.4 -44.75 95.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.019 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.82 HG21 HD11 ' A' ' 363' ' ' LEU . 55.5 m -68.79 -39.42 80.15 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.825 -172.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.725 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.1 mt -60.8 -33.22 72.66 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.849 -0.532 . . . . 0.0 110.57 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.745 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 49.8 t80 -75.0 -46.04 37.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.349 1.071 . . . . 0.0 109.161 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -51.54 -32.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.328 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.0 OUTLIER -59.85 -41.24 90.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.071 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 44.5 p -100.03 -23.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.36 -167.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' HIS . . . . . 0.422 ' HB3' HE22 ' A' ' 390' ' ' GLN . 29.5 m80 -110.22 24.24 13.26 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.43 18.31 29.11 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 114.864 0.705 . . . . 0.0 114.864 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.419 HG23 HG13 ' A' ' 380' ' ' ILE . 1.7 m 66.17 159.37 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.286 0.565 . . . . 0.0 111.385 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.472 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -127.64 152.19 76.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -96.76 53.7 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.351 2.701 . . . . 0.0 111.211 166.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.681 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.17 7.87 0.71 Allowed 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -71.04 -48.59 51.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 0.0 110.389 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.655 ' O ' HG13 ' A' ' 394' ' ' VAL . 56.6 mt-30 -76.2 -26.15 55.86 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.694 ' O ' HG22 ' A' ' 394' ' ' VAL . 3.1 mm? -54.05 -31.36 51.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.332 0.969 . . . . 0.0 111.384 -173.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.709 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.56 -49.79 63.41 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.971 174.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.642 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 36.4 m-20 -69.34 -39.25 78.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.9 m -57.46 -44.07 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.419 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.625 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.7 mm -58.24 -46.94 88.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.676 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.648 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 30.3 mmtt -52.4 -43.41 64.75 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.707 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.562 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.56 -44.34 16.5 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.1 -172.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.4 mt -69.31 -41.4 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 117.519 0.66 . . . . 0.0 111.552 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.4 m -57.64 -43.77 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.822 0.82 . . . . 0.0 109.955 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 399' ' ' VAL . 3.4 t70 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.064 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 70.1 mt-30 -83.78 -54.27 5.02 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.547 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -112.43 -30.46 7.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.796 -166.664 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.11 163.49 11.55 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.735 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.86 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.38 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.654 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.3 -50.51 71.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.1 0.476 . . . . 0.0 111.448 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.576 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -51.03 65.19 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.5 178.39 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.674 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.0 -41.85 65.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.548 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 31.6 t80 -57.08 -46.69 82.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.665 0.745 . . . . 0.0 109.086 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.821 ' O ' ' HG3' ' A' ' 413' ' ' MET . 8.5 m -58.69 -52.5 65.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.562 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.682 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.92 -49.01 76.46 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.737 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.95 -42.23 86.17 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.923 -174.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.759 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -32.64 66.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.66 0.23 . . . . 0.0 111.239 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.821 ' HG3' ' O ' ' A' ' 409' ' ' THR . 66.7 mtm -70.63 -46.98 62.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.383 0.611 . . . . 0.0 110.06 174.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.057 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.4 mt -59.23 -38.46 80.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.023 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.635 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.3 OUTLIER -77.45 -14.62 59.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.951 -176.066 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.67 27.03 8.71 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.178 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.759 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.3 mm100 64.35 44.17 4.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.101 0.961 . . . . 0.0 112.292 177.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.543 ' OD1' HD21 ' A' ' 421' ' ' LEU . 0.5 OUTLIER -120.24 69.5 0.86 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 166.37 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.667 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.8 OUTLIER -47.47 -35.25 8.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 111.568 -2.56 . . . . 0.0 113.477 -165.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' A' ' 423' ' ' SER . 28.0 mt-30 -55.03 -47.74 74.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -163.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.58 ' HG ' ' H ' ' A' ' 422' ' ' VAL . 1.9 pp -59.71 -48.99 79.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.384 0.612 . . . . 0.0 110.81 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.629 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.25 -38.87 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.574 1.178 . . . . 0.0 109.263 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.65 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 40.4 t -61.13 -46.53 90.19 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.905 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.77 72.93 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.019 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.709 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.26 -41.91 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.549 0.69 . . . . 0.0 110.162 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.58 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.18 -44.8 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.604 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.755 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.38 -30.77 68.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.618 1.199 . . . . 0.0 109.376 -174.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.68 -14.33 77.93 Favored Glycine 0 C--N 1.299 -1.483 0 CA-C-N 112.845 -1.979 . . . . 0.0 112.503 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.67 ' CG ' HG21 ' A' ' 399' ' ' VAL . 16.5 m-85 -103.83 3.03 33.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.5 144.75 78.25 Favored Pre-proline 0 N--CA 1.411 -2.411 0 CA-C-O 123.541 1.639 . . . . 0.0 112.996 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.746 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 60.9 Cg_endo -72.94 -63.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 1 C-N-CA 126.074 4.516 . . . . 0.0 113.422 -173.056 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.559 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -104.58 141.86 15.37 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.899 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -65.68 -26.82 67.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.22 0.51 . . . . 0.0 111.216 -176.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.778 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -58.5 -46.33 86.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.029 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -59.39 -52.04 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.629 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.899 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.36 -53.79 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.467 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 94.4 m -61.15 -56.6 18.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.96 -46.24 78.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.519 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.842 ' O ' HD22 ' A' ' 443' ' ' LEU . 54.9 mt -59.95 -53.5 57.08 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.64 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.674 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.5 mm-40 -51.77 -34.48 39.82 Favored 'General case' 0 N--CA 1.415 -2.19 0 O-C-N 124.956 1.41 . . . . 0.0 110.682 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.674 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.29 -61.81 1.69 Allowed 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 175.079 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.55 -50.17 14.59 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.85 -0.531 . . . . 0.0 112.205 -171.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.7 -25.35 62.8 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.34 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.752 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.5 t70 -72.81 -42.74 63.54 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.701 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.8 mt-30 -68.97 -7.6 36.77 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -172.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 4.9 mm-40 -51.66 156.22 1.42 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.516 1.627 . . . . 0.0 114.363 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.487 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.22 -32.37 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 110.719 -2.946 . . . . 0.0 115.38 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.663 ' H ' ' HB ' ' A' ' 451' ' ' THR . 19.1 m-20 -142.02 179.94 6.59 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.442 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 3.6 m-20 -62.65 -55.58 25.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.1 OUTLIER -64.61 -25.2 67.86 Favored 'General case' 0 N--CA 1.403 -2.795 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.411 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.663 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 23.6 m -60.31 -41.91 94.45 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 119.793 1.179 . . . . 0.0 109.543 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 45.8 mtt180 -60.88 -30.32 70.08 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.851 172.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.548 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.65 -29.47 59.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.921 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.09 -44.66 17.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.788 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.562 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.1 p -106.24 0.39 25.16 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.184 -167.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.9 t80 -48.91 -53.83 17.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.03 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.2 mm -71.06 -25.49 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.562 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.17 -43.42 64.61 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.643 ' O ' HG23 ' A' ' 463' ' ' VAL . 72.1 m-70 -65.45 -32.03 73.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.722 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.717 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.14 -53.47 37.42 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.066 0.936 . . . . 0.0 109.512 -178.562 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.666 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 8.3 m-80 -62.37 -32.31 73.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.068 173.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -61.66 -53.36 57.23 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.893 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.029 HG11 ' HA ' ' A' ' 435' ' ' VAL . 20.9 t -62.7 -34.88 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.858 0 CA-C-O 121.818 0.818 . . . . 0.0 110.4 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.7 -14.7 33.95 Favored 'General case' 0 C--O 1.207 -1.155 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.32 170.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.666 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 43.4 mt-10 -92.99 -48.28 6.59 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.097 -1.002 . . . . 0.0 112.69 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.734 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.6 pt -66.27 -38.1 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.237 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.6 mt -85.27 -17.16 37.78 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.753 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 61.8 55.73 26.8 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.659 -2.518 . . . . 0.0 112.942 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -105.02 -159.21 0.7 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 122.088 0.947 . . . . 0.0 109.644 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.474 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.6 p-10 -124.76 -41.39 2.13 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -159.21 -79.59 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 112.251 -2.249 . . . . 0.0 110.619 156.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.746 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 1.3 mpt_? -59.06 68.13 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 33.47 53.58 0.6 Allowed Glycine 0 C--N 1.278 -2.689 0 CA-C-N 111.099 -2.773 . . . . 0.0 113.367 173.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.474 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 0.4 OUTLIER -90.13 -49.07 6.78 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 122.4 1.095 . . . . 0.0 111.259 -173.378 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 27.2 t 62.0 62.58 1.21 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.119 -2.31 . . . . 0.0 108.561 -171.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.753 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.281 0 CA-C-N 110.932 -2.849 . . . . 0.0 112.115 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.428 -1.549 0 CA-C-O 120.857 0.36 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.72 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -74.73 125.43 89.56 Favored Pre-proline 0 N--CA 1.426 -1.65 0 CA-C-O 121.909 0.862 . . . . 0.0 111.852 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 308' ' ' GLN . 17.6 Cg_endo -72.46 -11.32 26.37 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 124.929 3.752 . . . . 0.0 111.372 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.7 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.7 tp 25.66 -60.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 C-N-CA 128.677 2.791 . . . . 0.0 116.34 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.558 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.17 -32.44 68.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.355 0.598 . . . . 0.0 110.138 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.9 t-160 -62.4 -48.95 77.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.66 172.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 307' ' ' ILE . 57.6 mt -58.59 -48.71 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 124.006 0.922 . . . . 0.0 113.172 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.671 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.4 mtp-105 -60.22 -30.11 69.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.14 -0.35 . . . . 0.0 111.41 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 46.9 m -69.6 -35.43 75.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.564 0.697 . . . . 0.0 109.845 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.547 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -66.07 -40.9 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.717 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.846 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -83.35 -36.88 24.03 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.797 1.284 . . . . 0.0 110.235 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.66 36.67 7.8 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.245 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 38.8 mt-10 49.87 175.53 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 124.071 0.948 . . . . 0.0 113.261 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.628 ' HB3' HD11 ' A' ' 324' ' ' ILE . 90.8 Cg_exo -52.44 134.7 52.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.603 2.202 . . . . 0.0 112.48 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.737 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 95.1 Cg_endo -85.23 -90.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.487 2.792 . . . . 0.0 114.788 -174.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.462 ' HG2' ' HB2' ' A' ' 318' ' ' PRO . 6.4 mmm180 -93.76 -78.93 0.42 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.048 0.928 . . . . 0.0 113.033 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.667 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 65.1 m-20 -105.4 -159.93 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.756 -169.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 320' ' ' ASN . 58.6 Cg_endo -90.89 -32.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 121.647 1.565 . . . . 0.0 114.671 159.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 15.72 10.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -169.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.725 ' OE2' ' HG2' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -106.31 -35.83 7.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.671 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.633 ' HA ' ' HB3' ' A' ' 327' ' ' TRP . 0.4 OUTLIER -40.15 -46.15 5.22 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.345 1.458 . . . . 0.0 114.077 178.059 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.706 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.2 Cg_endo -47.01 -63.04 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.055 2.503 . . . . 0.0 112.814 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.621 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.8 OUTLIER -65.35 -35.53 75.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 123.054 1.407 . . . . 0.0 110.428 -179.047 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.846 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 32.7 t90 -58.34 -34.05 70.2 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.973 177.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.889 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.8 OUTLIER -70.45 -48.04 57.8 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.303 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.6 -23.13 19.31 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.793 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.498 ' CD ' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -74.41 -42.94 58.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.247 1.023 . . . . 0.0 110.617 174.137 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.675 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.0 m-20 -95.67 -24.96 16.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.679 -168.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.569 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.1 -49.76 11.28 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 124.418 1.087 . . . . 0.0 113.749 177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 49.3 Cg_endo -63.09 -31.27 75.92 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.544 2.163 . . . . 0.0 111.525 177.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.04 -44.11 55.47 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.689 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.6 HG12 HG23 ' A' ' 310' ' ' ILE . 88.7 mt -58.37 -48.69 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.584 173.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 19.4 t70 -57.09 -17.85 12.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.264 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -44.51 10.15 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.68 HG11 HG13 ' A' ' 310' ' ' ILE . 94.0 t -60.64 -68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 123.587 1.66 . . . . 0.0 110.242 169.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.825 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -96.29 130.07 31.91 Favored Pre-proline 0 N--CA 1.403 -2.802 0 CA-C-N 110.791 -2.913 . . . . 0.0 112.787 -171.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.772 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -75.4 -16.36 19.39 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 123.89 3.06 . . . . 0.0 110.927 174.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.462 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.53 66.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 112.33 -2.214 . . . . 0.0 110.323 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.632 ' N ' HD12 ' A' ' 346' ' ' LEU . 34.8 p -77.88 2.71 16.48 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.681 -2.054 . . . . 0.0 113.225 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.798 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.1 p -138.06 161.36 60.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -63.97 -46.53 8.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.419 2.746 . . . . 0.0 108.454 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.637 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -45.51 -44.2 12.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.425 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.798 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.3 mt -61.35 -52.01 66.43 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.696 0.76 . . . . 0.0 110.459 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.641 ' HA ' HD12 ' A' ' 350' ' ' ILE . 2.6 ttm180 -52.12 -47.32 65.38 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.627 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 1.058 ' HG ' ' HA ' ' A' ' 365' ' ' PRO . 0.5 OUTLIER -69.45 -48.24 61.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.734 -176.111 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 46.4 mtt180 -56.54 -42.1 77.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.232 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.825 HD11 ' CD2' ' A' ' 339' ' ' PHE . 43.0 mt -57.24 -53.27 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.446 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.61 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -59.4 -52.57 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 122.158 0.98 . . . . 0.0 110.986 -170.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.553 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 25.8 m-20 -63.42 -35.45 80.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.37 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.38 75.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.656 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -57.86 -54.31 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.052 1.406 . . . . 0.0 110.66 173.328 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.633 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.6 OUTLIER -72.12 -24.76 61.52 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.328 -169.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.5 -65.28 1.06 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.849 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -139.51 66.91 0.51 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.233 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.569 HD21 ' C ' ' A' ' 358' ' ' ASN . 0.2 OUTLIER -78.75 164.9 24.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.23 0.212 . . . . 0.0 111.283 178.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.558 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -56.52 -65.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 122.94 0.496 . . . . 0.0 111.289 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -148.55 10.9 1.12 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.565 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.663 ' HB3' HD22 ' A' ' 378' ' ' LEU . 3.7 mt -65.01 -5.85 7.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.723 0.409 . . . . 0.0 111.408 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.553 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 19.4 t -60.71 82.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.402 0.62 . . . . 0.0 110.596 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.699 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -64.55 170.67 3.8 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.953 0.882 . . . . 0.0 112.629 175.787 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 33.4 p -118.66 155.5 52.35 Favored Pre-proline 0 N--CA 1.436 -1.17 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.99 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 1.058 ' HA ' ' HG ' ' A' ' 348' ' ' CYS . 1.9 Cg_endo -54.8 -11.28 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.801 2.334 . . . . 0.0 113.419 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.542 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -103.75 -6.31 43.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.139 -0.553 . . . . 0.0 114.471 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.678 ' HB2' HD12 ' A' ' 363' ' ' LEU . 1.3 m-20 -109.83 -18.83 13.33 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.075 0.941 . . . . 0.0 110.777 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.744 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 19.3 p -92.43 18.86 7.85 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.747 -167.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.542 HD11 ' O ' ' A' ' 366' ' ' GLY . 1.8 mt -62.15 -35.71 79.6 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.369 1.081 . . . . 0.0 110.242 -162.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.5 p -116.03 167.31 11.09 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.313 171.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.683 ' O ' HG13 ' A' ' 375' ' ' VAL . 43.1 m95 -70.39 -34.05 72.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.21 -43.56 94.65 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.559 0.695 . . . . 0.0 109.711 -173.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.7 p -66.24 -44.21 84.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.312 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.85 62.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.902 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.0 m -58.13 -44.03 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.644 0.735 . . . . 0.0 109.568 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.033 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.63 -46.01 90.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.777 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.699 HG21 HD11 ' A' ' 363' ' ' LEU . 34.4 m -65.84 -40.74 92.02 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.445 -173.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.7 mt -60.16 -33.55 72.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.677 0.671 . . . . 0.0 110.369 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.706 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 65.8 t80 -73.36 -46.46 49.02 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 122.382 1.087 . . . . 0.0 109.567 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -51.83 -32.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 112.801 -1.999 . . . . 0.0 111.158 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.45 -38.13 83.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 176.399 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 37.2 p -98.25 -22.83 15.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.639 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' HIS . . . . . 0.442 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 26.6 m80 -110.08 22.19 15.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.91 21.0 28.85 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.4 m 65.98 158.17 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 111.906 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.488 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -126.65 155.35 75.05 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 386' ' ' PHE . 91.5 Cg_endo -101.61 58.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.912 3.075 . . . . 0.0 111.437 166.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.773 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.5 -2.08 0.09 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -69.64 -45.11 69.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.492 . . . . 0.0 110.847 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.626 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.6 mt-30 -74.91 -26.71 59.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.919 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.2 -30.98 51.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.922 0.783 . . . . 0.0 111.787 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.71 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.99 -48.54 66.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.545 173.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 59.1 m-20 -68.47 -41.16 80.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.087 0.555 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.44 -44.93 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.257 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.678 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.4 mm -58.34 -47.39 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.459 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.637 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.3 mmtt -52.2 -43.17 64.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.936 0.772 . . . . 0.0 111.49 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.58 -44.11 17.06 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.15 -172.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.7 mt -69.12 -42.0 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 117.294 0.547 . . . . 0.0 111.596 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -58.71 -43.24 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.884 0.85 . . . . 0.0 109.872 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 399' ' ' VAL . 19.0 t70 -57.16 -44.5 83.51 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.328 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -86.66 -53.3 5.03 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.673 -1.149 . . . . 0.0 113.424 -170.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.579 ' HG3' HG23 ' A' ' 398' ' ' ILE . 0.1 OUTLIER -109.04 -31.44 7.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.427 0.632 . . . . 0.0 111.549 -170.456 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.62 165.07 11.79 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.841 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.903 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -45.93 96.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.113 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -55.91 -50.14 71.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.591 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.515 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -50.82 66.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.369 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.673 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.54 -41.58 63.63 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.561 ' HB3' HD11 ' A' ' 457' ' ' ILE . 45.3 t80 -57.85 -46.51 84.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.572 0.701 . . . . 0.0 109.533 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.744 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.7 m -59.82 -52.71 64.28 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.816 -178.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.715 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -62.06 -49.03 77.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.875 177.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.627 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.78 -41.35 82.97 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.091 -175.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.582 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.3 OUTLIER -72.06 -33.73 68.18 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.643 0.222 . . . . 0.0 110.826 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.902 ' HE3' HG21 ' A' ' 375' ' ' VAL . 62.4 mtm -69.51 -46.63 66.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.042 174.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.033 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.9 mt -58.79 -40.13 83.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.924 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.919 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.5 m -78.84 -14.52 59.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.03 44.08 4.54 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.948 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.87 HE22 ' HA ' ' A' ' 413' ' ' MET . 0.2 OUTLIER 56.58 42.18 27.54 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 124.269 1.028 . . . . 0.0 113.323 178.18 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.621 ' OD1' HD21 ' A' ' 421' ' ' LEU . 0.4 OUTLIER -119.5 74.27 0.99 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.295 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.554 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 0.7 OUTLIER -49.65 -36.04 23.33 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 111.907 -2.406 . . . . 0.0 113.009 -167.384 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.5 mt-30 -54.83 -49.24 71.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -163.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.696 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.497 0.665 . . . . 0.0 111.184 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.587 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.648 1.213 . . . . 0.0 109.152 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.564 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 41.3 t -61.56 -46.9 87.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.467 -2.152 . . . . 0.0 112.023 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.21 -37.97 75.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.843 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.71 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.4 mt -72.17 -41.47 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 110.048 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.623 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -57.39 -45.05 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.003 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.709 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -61.69 -28.97 69.78 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 122.704 1.24 . . . . 0.0 108.963 -173.036 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.9 -17.86 77.21 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.374 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.73 ' CG ' HG21 ' A' ' 399' ' ' VAL . 11.3 m-85 -101.03 4.16 42.1 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.39 144.29 71.7 Favored Pre-proline 0 N--CA 1.41 -2.448 0 CA-C-O 123.722 1.725 . . . . 0.0 113.226 168.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.823 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.5 Cg_endo -71.37 -58.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.115 1 C-N-CA 126.308 4.672 . . . . 0.0 113.172 -170.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.22 142.38 17.15 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.105 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.827 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.48 -31.74 71.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.043 0.422 . . . . 0.0 111.28 -177.108 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.757 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.2 -46.47 79.44 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.026 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.4 t -59.44 -51.04 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.785 177.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.827 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.64 -54.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 57.0 m -62.7 -56.44 17.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.551 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.48 -42.83 78.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.484 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.836 ' O ' HD22 ' A' ' 443' ' ' LEU . 54.1 mt -63.42 -53.25 55.34 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.204 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 19.3 mm100 -51.31 -33.84 30.77 Favored 'General case' 0 N--CA 1.419 -2.014 0 O-C-N 124.959 1.412 . . . . 0.0 110.334 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.687 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.99 -60.96 1.99 Allowed 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 172.782 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.2 ptp180 -74.03 -53.6 9.67 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.613 -0.679 . . . . 0.0 112.536 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.24 -24.96 63.62 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.63 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.749 ' N ' HD23 ' A' ' 443' ' ' LEU . 8.3 t70 -73.17 -42.16 63.08 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.494 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 35.1 mt-30 -70.64 -7.98 48.35 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.554 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 6.2 mm-40 -51.31 158.46 0.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 123.581 1.657 . . . . 0.0 114.623 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.539 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.08 -32.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 110.543 -3.026 . . . . 0.0 115.33 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.663 ' H ' ' HB ' ' A' ' 451' ' ' THR . 13.6 m-20 -142.75 179.76 6.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.759 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.426 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 11.1 p-10 -61.68 -54.95 35.79 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -65.64 -26.51 67.84 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.663 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.5 m -59.17 -41.19 87.86 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 119.905 1.229 . . . . 0.0 109.678 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 66.7 mtt180 -60.47 -29.57 69.13 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.935 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.554 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -76.61 -33.99 58.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.332 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.5 mm-40 -78.51 -44.63 23.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.941 -171.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.56 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 24.8 p -105.17 0.53 27.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.061 -167.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.703 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.6 t80 -49.19 -54.87 14.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -70.44 -26.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.56 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.23 -42.97 68.19 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 463' ' ' VAL . 30.1 m80 -67.78 -31.89 72.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.745 172.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.74 HD22 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -63.48 -53.39 52.8 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.179 0.99 . . . . 0.0 109.292 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.591 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.4 m-80 -62.89 -31.8 72.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.525 173.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -63.96 -50.99 66.46 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.854 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.026 HG11 ' HA ' ' A' ' 435' ' ' VAL . 31.9 t -63.04 -34.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.906 0.86 . . . . 0.0 110.34 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.534 ' HD1' HD12 ' A' ' 469' ' ' LEU . 19.2 m-30 -61.18 -15.95 39.53 Favored 'General case' 0 C--O 1.205 -1.284 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.185 169.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 462' ' ' ALA . 33.5 mm-40 -90.34 -49.8 6.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 112.789 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.736 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.92 -39.42 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.86 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -84.67 -16.04 43.27 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 171.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.761 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.31 52.02 50.21 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 111.741 -2.482 . . . . 0.0 113.1 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.731 HD11 HD12 ' A' ' 467' ' ' LEU . 0.3 OUTLIER -103.8 177.96 4.69 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 123.583 0.753 . . . . 0.0 109.892 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.5 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.7 p-10 -96.55 -41.4 8.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 167.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.416 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -160.42 -74.37 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.356 -2.202 . . . . 0.0 111.19 158.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.823 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -63.15 68.91 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -169.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.476 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 40.09 40.03 1.66 Allowed Glycine 0 C--N 1.278 -2.677 0 CA-C-N 111.176 -2.738 . . . . 0.0 113.48 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.5 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 1.2 mm100 -78.87 -51.62 9.44 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.142 0.972 . . . . 0.0 111.566 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.9 t 65.18 55.06 1.14 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.306 -173.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.761 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.467 0 CA-C-N 110.637 -2.983 . . . . 0.0 111.928 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.429 -1.516 0 CA-C-O 121.049 0.452 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.702 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.3 mt -73.83 125.85 90.01 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-O 121.716 0.769 . . . . 0.0 111.643 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 308' ' ' GLN . 23.3 Cg_endo -71.75 -15.98 29.95 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 124.555 3.503 . . . . 0.0 110.883 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.744 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.9 tp 30.38 -58.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 C-N-CA 128.673 2.789 . . . . 0.0 116.275 172.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 306' ' ' PRO . 3.3 mm-40 -56.17 -38.84 71.47 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.097 0.951 . . . . 0.0 109.811 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.535 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -59.85 -47.8 84.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.799 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 307' ' ' ILE . 65.2 mt -60.2 -48.22 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 123.861 0.864 . . . . 0.0 113.036 174.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.744 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 5.5 mtp180 -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 O-C-N 122.032 -0.417 . . . . 0.0 110.461 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 23.2 t -70.03 -34.05 72.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.623 . . . . 0.0 109.6 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.568 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.38 -41.59 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.775 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 331' ' ' ASN . 29.8 p -83.0 -36.66 24.85 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.765 1.269 . . . . 0.0 109.671 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.61 34.04 8.79 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.419 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.543 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 51.23 173.1 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.323 0 C-N-CA 124.419 1.087 . . . . 0.0 113.105 -173.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.774 ' HB3' HD11 ' A' ' 324' ' ' ILE . 28.2 Cg_exo -46.16 152.34 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.128 2.552 . . . . 0.0 113.586 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -89.52 -101.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.264 2.643 . . . . 0.0 111.991 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.473 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 13.3 mmt180 -104.38 -82.63 0.51 Allowed 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.126 0.489 . . . . 0.0 111.504 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 14.5 m120 -98.33 163.14 19.76 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.861 -171.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.15 -51.67 6.26 Favored 'Trans proline' 0 CA--C 1.509 -0.756 0 C-N-CA 123.117 2.545 . . . . 0.0 110.971 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -13.56 2.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.492 -1.686 . . . . 0.0 113.29 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.2 mt-10 -92.86 -31.74 14.87 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.256 -0.177 . . . . 0.0 110.89 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -47.83 -45.03 60.46 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -177.643 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.738 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.5 Cg_endo -49.64 -61.91 0.5 Allowed 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.974 2.449 . . . . 0.0 112.849 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.677 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.25 -37.19 77.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.686 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 38.3 t90 -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.099 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.848 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.22 -48.18 58.17 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.58 -23.07 18.9 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.827 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.469 ' CD ' HG21 ' A' ' 406' ' ' THR . 1.2 mmm180 -74.57 -43.06 57.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.259 1.028 . . . . 0.0 110.483 174.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.729 ' HB3' HG22 ' A' ' 314' ' ' THR . 48.3 m-20 -95.16 -24.18 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.444 -1.707 . . . . 0.0 113.601 -168.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.04 -50.32 10.87 Favored Pre-proline 0 C--N 1.306 -1.295 0 C-N-CA 124.223 1.009 . . . . 0.0 113.612 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.1 Cg_endo -62.08 -31.76 83.48 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.741 2.294 . . . . 0.0 111.828 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.59 -44.17 57.86 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.549 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.619 HG23 HG23 ' A' ' 310' ' ' ILE . 91.0 mt -58.38 -48.42 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.855 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 19.2 t70 -55.67 -19.61 11.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.07 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.41 -48.07 9.74 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 310' ' ' ILE . 62.2 t -57.89 -72.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-O 123.445 1.593 . . . . 0.0 110.098 169.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.875 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.39 129.56 40.53 Favored Pre-proline 0 N--CA 1.405 -2.686 0 CA-C-N 111.196 -2.729 . . . . 0.0 112.623 -171.319 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.774 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.7 Cg_endo -74.8 -16.47 20.73 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 123.981 3.12 . . . . 0.0 110.763 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.465 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.36 66.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 112.347 -2.206 . . . . 0.0 110.182 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.688 ' N ' HD12 ' A' ' 346' ' ' LEU . 37.4 p -79.37 8.66 5.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.945 -1.934 . . . . 0.0 113.586 -170.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.5 p -142.23 164.13 35.37 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.417 ' O ' ' SG ' ' A' ' 348' ' ' CYS . 44.6 Cg_exo -63.06 -50.02 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.154 2.569 . . . . 0.0 108.309 172.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.68 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.7 OUTLIER -42.7 -48.23 5.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.972 176.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.1 mt -56.43 -52.61 64.03 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.587 -177.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.718 ' HA ' HD12 ' A' ' 350' ' ' ILE . 39.1 ttm105 -54.72 -45.61 74.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.56 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 1.019 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.48 -48.38 60.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.067 0.461 . . . . 0.0 111.258 -176.103 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 49.7 mtp180 -55.96 -41.9 75.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.929 177.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.875 HD11 ' CD2' ' A' ' 339' ' ' PHE . 49.0 mt -58.72 -54.29 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.678 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.571 HG23 HD11 ' A' ' 328' ' ' LEU . 19.5 mt -57.85 -52.97 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.109 0.956 . . . . 0.0 110.777 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.499 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.2 m-20 -63.56 -34.98 79.01 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.911 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.16 -38.34 78.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.858 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.13 -52.82 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.001 1.382 . . . . 0.0 110.192 175.137 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.608 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.8 OUTLIER -72.96 -24.81 60.83 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 111.719 -2.491 . . . . 0.0 109.414 -170.157 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.82 -80.35 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 113.656 -1.611 . . . . 0.0 113.013 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.02 72.71 0.29 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.519 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.2 OUTLIER -94.59 157.68 15.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 122.541 0.336 . . . . 0.0 111.32 -177.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.4 mp -81.28 89.34 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-O 121.11 0.481 . . . . 0.0 111.83 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.47 -16.97 15.64 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.552 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.726 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.4 mt -60.68 -4.68 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 25.1 t -63.69 81.98 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 110.353 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -61.96 172.46 1.35 Allowed 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.908 174.384 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.557 ' C ' ' H ' ' A' ' 366' ' ' GLY . 44.1 p -112.76 162.71 20.39 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.186 -174.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 1.019 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.0 Cg_endo -67.04 21.21 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.42 2.08 . . . . 0.0 112.583 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -131.66 -12.05 2.04 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.329 -0.85 . . . . 0.0 114.207 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.708 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.5 m-20 -105.2 -20.49 13.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.715 1.245 . . . . 0.0 109.44 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 3.8 p -75.3 19.11 0.18 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.244 -172.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.73 -32.73 70.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.362 1.077 . . . . 0.0 109.814 -170.722 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.3 35.98 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.266 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.588 ' O ' HG13 ' A' ' 375' ' ' VAL . 65.4 m95 -69.66 -35.49 75.2 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.61 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.4 OUTLIER -60.81 -40.86 94.3 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.804 -175.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 53.9 m -68.92 -43.69 74.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.702 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.53 -52.71 62.38 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.887 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.3 m -57.24 -45.73 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.395 0.617 . . . . 0.0 109.666 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.003 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.68 -45.57 93.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.889 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 363' ' ' LEU . 31.7 m -67.56 -37.69 83.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.594 -172.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -60.95 -35.22 76.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.471 0.578 . . . . 0.0 110.434 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.738 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 55.6 t80 -72.51 -46.91 52.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.561 1.172 . . . . 0.0 109.175 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.07 -32.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.344 171.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.13 -46.58 89.16 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 123.193 0.597 . . . . 0.0 111.175 175.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.7 p -89.12 -23.98 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.531 -171.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -111.28 23.22 14.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.0 21.56 24.63 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.745 0.658 . . . . 0.0 114.745 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 67.04 160.36 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.906 0.482 . . . . 0.0 111.413 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -125.45 158.48 64.25 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 389' ' ' HIS . 90.6 Cg_endo -101.33 53.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.894 3.063 . . . . 0.0 111.466 166.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.742 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.83 -14.99 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -175.468 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.441 ' H ' ' C ' ' A' ' 387' ' ' PRO . 34.6 t-80 -57.52 -42.59 83.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.881 0.372 . . . . 0.0 110.648 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.664 ' O ' HG13 ' A' ' 394' ' ' VAL . 78.3 mt-30 -75.2 -27.93 59.79 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -171.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.1 mm? -54.16 -31.27 52.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.972 0.806 . . . . 0.0 111.455 -176.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.744 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.37 -51.48 51.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.735 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.605 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 17.9 m-20 -68.97 -37.91 79.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -57.66 -46.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.044 0.449 . . . . 0.0 110.101 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 399' ' ' VAL . 21.8 mm -59.01 -45.87 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.967 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.726 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 37.2 mmtt -52.05 -42.78 63.41 Favored 'General case' 0 C--O 1.244 0.793 0 O-C-N 124.025 0.828 . . . . 0.0 111.531 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.35 -44.19 13.96 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.128 -172.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.677 HG12 HG21 ' A' ' 326' ' ' ILE . 2.5 mt -69.31 -40.81 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 117.429 0.615 . . . . 0.0 111.575 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -58.84 -43.94 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.823 0.821 . . . . 0.0 109.749 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.46 ' N ' HG23 ' A' ' 399' ' ' VAL . 16.2 t70 -59.19 -42.26 90.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.486 177.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 29.2 mm-40 -86.28 -53.1 5.22 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.331 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 398' ' ' ILE . 1.1 mm-40 -109.56 -31.15 7.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.467 0.651 . . . . 0.0 111.622 -170.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.28 164.05 11.67 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.889 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -44.1 98.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 123.104 0.561 . . . . 0.0 112.417 -175.564 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.667 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.54 -52.27 62.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.57 0.7 . . . . 0.0 111.843 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.515 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.5 -49.69 68.07 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.348 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.671 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.31 -42.18 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 29.1 t80 -55.72 -48.65 74.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.589 0.709 . . . . 0.0 109.371 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.767 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.1 m -58.32 -52.16 66.75 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.752 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.696 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.52 -48.72 79.78 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.604 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.25 -43.7 89.26 Favored Glycine 0 C--N 1.315 -0.603 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.392 -174.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.589 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -72.21 -31.22 65.67 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.795 0.298 . . . . 0.0 110.874 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.887 ' HE3' HG21 ' A' ' 375' ' ' VAL . 63.9 mtm -69.03 -48.97 61.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.35 0.595 . . . . 0.0 109.866 172.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.07 -39.35 81.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.113 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.716 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.4 OUTLIER -77.4 -14.3 59.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.684 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.84 4.88 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.866 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.589 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 1.0 OUTLIER 58.15 43.7 20.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.794 0.838 . . . . 0.0 113.228 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 0.5 OUTLIER -124.37 79.92 1.79 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.164 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.759 ' HD2' ' HG ' ' A' ' 423' ' ' SER . 7.5 p90 -62.27 -31.85 72.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.146 -163.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 47.4 mt-30 -53.79 -49.6 67.94 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.377 -164.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.697 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.3 pp -59.18 -49.24 78.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.25 0.547 . . . . 0.0 110.671 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.669 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.61 -38.72 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 122.794 1.283 . . . . 0.0 108.917 -178.199 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.759 ' HG ' ' HD2' ' A' ' 419' ' ' TYR . 64.6 m -66.27 -42.19 88.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.507 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.62 -38.83 89.56 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.254 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.744 HD13 ' HA2' ' A' ' 392' ' ' GLY . 4.3 mt -71.19 -42.07 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.515 0.674 . . . . 0.0 109.917 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -57.26 -44.47 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.334 -1.303 . . . . 0.0 112.606 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.715 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -61.28 -29.27 69.76 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 122.655 1.217 . . . . 0.0 109.143 -172.04 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.4 -20.24 78.14 Favored Glycine 0 C--N 1.298 -1.578 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.034 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.739 ' CG ' HG21 ' A' ' 399' ' ' VAL . 12.4 m-85 -97.04 0.6 48.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.84 143.31 77.17 Favored Pre-proline 0 N--CA 1.408 -2.529 0 CA-C-O 123.919 1.819 . . . . 0.0 113.267 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.828 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 51.0 Cg_endo -69.43 -60.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 1 C-N-CA 126.372 4.715 . . . . 0.0 112.973 -172.457 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.522 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.84 141.3 16.12 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.221 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.917 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.33 -26.98 68.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.133 0.467 . . . . 0.0 111.69 -177.07 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.82 -48.29 80.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 169.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.994 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.8 t -58.22 -52.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.038 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.8 -52.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.461 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.6 m -62.55 -56.65 15.95 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.216 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.89 -46.01 78.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.485 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 42.8 mt -59.56 -53.49 57.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.9 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.679 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 19.0 mm100 -51.95 -34.74 43.35 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 124.932 1.395 . . . . 0.0 110.693 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.668 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -73.24 -60.87 2.04 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 175.599 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.4 -50.62 13.68 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.693 -0.63 . . . . 0.0 112.306 -172.394 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.58 -25.34 62.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.675 0.75 . . . . 0.0 111.487 -178.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.76 ' N ' HD23 ' A' ' 443' ' ' LEU . 11.5 t70 -72.6 -42.04 64.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.64 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.668 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -68.78 -7.95 38.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.572 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 15.7 mm-40 -54.46 151.58 7.59 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 123.465 1.602 . . . . 0.0 114.436 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.74 -32.63 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.477 -3.056 . . . . 0.0 116.066 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.654 ' H ' ' HB ' ' A' ' 451' ' ' THR . 25.8 m-20 -135.49 175.77 9.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.449 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 5.8 m-20 -61.73 -56.89 14.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 172.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -62.9 -28.16 69.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 176.292 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.654 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 16.2 m -58.09 -43.18 86.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.803 1.183 . . . . 0.0 110.04 172.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 56.3 mtt180 -61.51 -29.75 70.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 172.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.602 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -75.24 -29.95 60.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.911 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.3 mm-40 -80.46 -45.74 17.08 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.286 1.041 . . . . 0.0 111.837 -173.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.534 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 25.7 p -103.28 -0.47 30.24 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.748 -167.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.649 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.3 t80 -49.22 -55.9 11.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.754 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.2 mm -69.04 -26.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.534 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.08 -43.95 64.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.601 ' O ' HG23 ' A' ' 463' ' ' VAL . 72.3 m-70 -65.3 -31.09 72.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.707 171.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.762 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.45 -53.72 32.29 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.312 1.053 . . . . 0.0 109.181 -178.631 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.23 -30.18 71.37 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.19 -1.823 . . . . 0.0 110.188 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -66.68 -49.24 66.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.017 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.994 HG11 ' HA ' ' A' ' 435' ' ' VAL . 33.6 t -65.61 -35.93 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.579 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.9 m-30 -61.27 -13.98 22.95 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.654 168.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 1.7 tp10 -93.09 -52.52 4.53 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.847 0.832 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.696 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.7 pt -63.79 -41.08 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.239 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.767 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.8 mt -83.8 -16.73 43.54 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 65.89 47.73 72.37 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.446 173.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 467' ' ' LEU . 1.2 mt -101.36 173.11 6.59 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.834 0.854 . . . . 0.0 111.733 -177.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.425 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.4 p-10 -85.87 -44.9 12.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.411 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.63 -68.67 0.06 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.474 165.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.828 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 19.0 mmt180 -68.16 47.72 0.05 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -163.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 57.92 34.45 71.86 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.392 171.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 475' ' ' SER . 3.9 mm100 -84.69 -51.45 6.81 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.972 0.892 . . . . 0.0 111.228 -173.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.687 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 45.4 t 68.99 53.59 0.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 112.506 -2.133 . . . . 0.0 109.118 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.289 -2.038 0 CA-C-N 109.474 -3.512 . . . . 0.0 112.61 169.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.429 -1.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.731 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.1 mt -73.32 129.24 86.19 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 122.069 0.938 . . . . 0.0 113.048 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.566 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.0 Cg_endo -84.97 51.48 3.15 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.59 3.526 . . . . 0.0 109.093 165.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.665 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -46.63 -43.54 6.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 112.753 -2.021 . . . . 0.0 112.077 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.477 ' HG2' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -64.5 -35.6 81.47 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.055 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.556 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.45 -47.49 83.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.39 0.614 . . . . 0.0 109.695 172.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.646 HG13 HG11 ' A' ' 338' ' ' VAL . 68.0 mt -59.0 -49.85 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 123.878 0.871 . . . . 0.0 113.197 175.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 33.1 mtp180 -62.25 -28.8 69.96 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.882 0.473 . . . . 0.0 111.013 177.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 62.9 m -69.76 -34.65 74.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.326 0.584 . . . . 0.0 110.114 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.602 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.03 -41.73 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.723 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.754 HG22 ' HB3' ' A' ' 331' ' ' ASN . 31.1 p -83.42 -36.58 24.14 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.813 1.292 . . . . 0.0 110.087 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.84 34.86 8.68 Favored Glycine 0 C--N 1.304 -1.22 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.694 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 50.14 177.89 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.013 0 C-N-CA 124.296 1.038 . . . . 0.0 112.899 -174.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.695 ' HB3' HD11 ' A' ' 324' ' ' ILE . 46.2 Cg_exo -48.34 147.2 9.02 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.529 2.153 . . . . 0.0 112.786 -178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.428 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 51.1 Cg_endo -87.42 -99.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.341 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.41 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 10.3 mmm180 -100.45 -76.57 0.55 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.528 0.68 . . . . 0.0 110.555 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.6 m-20 -104.87 158.42 32.06 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.241 -174.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.454 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 36.6 Cg_exo -59.08 -50.13 9.52 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.824 2.349 . . . . 0.0 110.868 171.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.43 -23.64 2.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.224 -1.807 . . . . 0.0 112.547 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 2.3 mm-40 -87.42 -29.02 21.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.2 OUTLIER -45.05 -46.8 30.71 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.643 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.713 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.94 -62.04 0.47 Allowed 'Trans proline' 0 CA--C 1.516 -0.399 0 C-N-CA 122.856 2.371 . . . . 0.0 112.997 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.643 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.56 -36.65 76.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.141 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.738 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 34.7 t90 -57.77 -35.07 70.26 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.096 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.861 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.8 OUTLIER -69.97 -49.17 54.34 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.101 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.51 -23.42 19.84 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.661 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 1.0 OUTLIER -74.4 -42.5 59.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.132 0.968 . . . . 0.0 110.471 175.069 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.754 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.4 m-20 -96.13 -23.47 16.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.918 -169.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.607 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -44.06 -49.38 22.3 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 113.681 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 52.2 Cg_endo -61.39 -33.0 89.58 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.551 2.168 . . . . 0.0 111.542 177.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.3 -43.15 64.61 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 109.519 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.637 HG23 HG23 ' A' ' 310' ' ' ILE . 91.6 mt -58.45 -49.4 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.734 173.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -55.42 -18.84 7.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.327 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.75 -46.68 8.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.145 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.646 HG11 HG13 ' A' ' 310' ' ' ILE . 93.7 t -58.07 -72.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 123.4 1.572 . . . . 0.0 110.228 169.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.83 ' CD2' HD11 ' A' ' 350' ' ' ILE . 1.0 OUTLIER -91.14 131.7 36.18 Favored Pre-proline 0 N--CA 1.405 -2.717 0 CA-C-N 110.813 -2.903 . . . . 0.0 112.538 -170.572 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.606 ' HB2' HG23 ' A' ' 342' ' ' THR . 8.0 Cg_exo -75.01 -18.02 19.03 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.664 2.909 . . . . 0.0 110.652 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.5 p 33.09 72.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.648 -177.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.606 HG23 ' HB2' ' A' ' 340' ' ' PRO . 60.0 p -81.38 5.83 16.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 112.778 -2.01 . . . . 0.0 113.463 -169.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.843 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.8 p -142.12 161.45 50.78 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.459 ' HB3' HD23 ' A' ' 369' ' ' LEU . 51.2 Cg_exo -62.28 -48.25 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.262 2.641 . . . . 0.0 108.218 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.645 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.9 OUTLIER -41.76 -51.92 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 112.719 -2.037 . . . . 0.0 110.828 176.695 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.843 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.8 mt -57.09 -52.28 65.9 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.165 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.687 ' HA ' HD12 ' A' ' 350' ' ' ILE . 4.7 ttm180 -53.09 -42.96 66.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.318 -1.765 . . . . 0.0 110.696 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 1.072 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.8 m -70.19 -46.43 64.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 76.0 mtt180 -56.19 -42.83 77.77 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.232 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.83 HD11 ' CD2' ' A' ' 339' ' ' PHE . 48.5 mt -58.17 -53.5 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 O-C-N 123.304 0.377 . . . . 0.0 111.426 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.548 HD13 ' HB1' ' A' ' 374' ' ' ALA . 17.0 mt -57.66 -53.22 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 122.107 0.956 . . . . 0.0 110.841 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.511 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.1 m-20 -63.83 -35.14 79.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.956 -1.474 . . . . 0.0 109.982 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.29 -37.26 77.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.051 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.665 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.251 0.8 OUTLIER -57.26 -53.29 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.481 0 CA-C-O 123.069 1.414 . . . . 0.0 110.119 174.485 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.665 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -72.86 -25.29 61.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 111.559 -2.564 . . . . 0.0 109.338 -169.083 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.6 -79.01 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.586 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -119.62 57.4 0.56 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.6 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.563 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.2 OUTLIER -76.13 161.74 28.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.254 0.222 . . . . 0.0 110.937 178.033 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -55.8 -66.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 122.947 0.499 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.41 15.16 1.1 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.514 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.701 ' HB3' HD22 ' A' ' 378' ' ' LEU . 5.9 mt -66.33 -2.99 5.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.698 0.399 . . . . 0.0 111.477 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.511 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 28.6 t -62.28 80.58 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 110.503 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.901 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.4 mm? -62.12 178.16 0.4 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.731 174.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 44.5 p -116.77 157.39 46.31 Favored Pre-proline 0 CA--C 1.508 -0.669 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 1.072 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 19.5 Cg_endo -66.21 16.69 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.269 1.979 . . . . 0.0 113.528 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.486 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -135.43 6.22 4.23 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.26 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.66 ' HB2' HD12 ' A' ' 363' ' ' LEU . 72.7 m-20 -109.76 -24.81 10.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.402 1.096 . . . . 0.0 109.954 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.901 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 6.5 m -93.97 19.77 8.63 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.076 -168.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -57.05 -39.79 75.57 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.433 -171.077 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.13 157.58 25.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.851 169.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.699 ' O ' HG13 ' A' ' 375' ' ' VAL . 86.3 m95 -70.14 -34.11 72.65 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 4.8 t0 -54.56 -48.83 71.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.695 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 28.0 t -69.15 -43.13 74.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.825 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.722 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.25 -51.57 67.21 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.861 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.3 m -57.32 -44.5 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.603 0.716 . . . . 0.0 109.621 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 0.98 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.09 -45.86 91.65 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.005 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.779 HG21 HD11 ' A' ' 363' ' ' LEU . 48.8 m -68.55 -38.2 80.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.464 -171.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.21 -34.16 74.64 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.155 0.503 . . . . 0.0 110.411 176.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.713 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 67.5 t80 -73.13 -45.89 54.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.369 1.08 . . . . 0.0 109.4 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.659 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -52.3 -33.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.092 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.61 -39.21 87.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.653 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 50.2 p -98.83 -22.24 15.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.439 -167.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -108.97 22.83 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.642 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.37 19.15 39.1 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.847 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 65.09 159.77 0.11 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 111.694 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -126.27 151.88 72.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.289 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -98.96 55.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.535 2.824 . . . . 0.0 110.969 165.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.702 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.21 4.03 0.42 Allowed 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -173.513 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -71.13 -47.1 59.89 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.638 ' O ' HG13 ' A' ' 394' ' ' VAL . 99.5 mt-30 -74.74 -26.2 59.63 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.733 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.75 -31.3 47.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.004 0.82 . . . . 0.0 111.966 -173.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.775 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.57 -53.2 40.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.438 173.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.691 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 41.4 m-20 -64.99 -39.79 93.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.17 -46.21 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.42 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.624 ' O ' HG22 ' A' ' 399' ' ' VAL . 25.6 mm -58.94 -46.6 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.042 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.691 ' HG3' ' HA ' ' A' ' 393' ' ' ASN . 15.3 mmtt -52.84 -42.02 64.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.879 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.41 15.86 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.092 -173.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.0 mt -69.21 -41.45 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 117.133 0.466 . . . . 0.0 111.439 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.88 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.8 m -58.07 -44.54 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.609 0.719 . . . . 0.0 110.273 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.4 t70 -62.18 -39.03 91.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -84.88 -53.22 5.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.064 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.523 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -110.59 -30.74 7.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.508 -169.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.2 165.87 12.11 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.673 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.88 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.69 -44.83 98.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.042 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.55 -53.16 58.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.606 0.717 . . . . 0.0 111.87 -177.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -64.45 -49.77 70.16 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.273 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.68 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.26 -42.69 63.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.682 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 47.1 t80 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.616 0.722 . . . . 0.0 109.524 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.792 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.9 m -59.44 -52.55 65.14 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.613 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.694 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.23 -48.67 80.4 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.645 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.61 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.85 -43.35 87.26 Favored Glycine 0 C--N 1.314 -0.655 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.546 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.673 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.0 OUTLIER -72.56 -31.31 65.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.846 0.323 . . . . 0.0 111.02 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.792 ' HG3' ' O ' ' A' ' 409' ' ' THR . 53.2 mtm -70.08 -47.56 61.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.98 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.5 mt -58.55 -40.99 84.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.261 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.733 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -76.71 -12.62 60.02 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.729 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 88.36 43.73 5.48 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.659 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.578 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 57.73 49.1 12.83 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.496 0.718 . . . . 0.0 112.471 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -129.17 77.98 1.82 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 161.344 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.675 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 8.3 p90 -62.27 -31.47 72.06 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.341 -163.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 423' ' ' SER . 51.1 mt-30 -53.63 -48.03 69.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.312 -164.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.709 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.1 pp -59.35 -50.62 73.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.955 0.407 . . . . 0.0 110.776 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.706 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.06 -38.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 123.021 1.391 . . . . 0.0 108.854 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 42.4 t -62.56 -48.14 80.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.726 -2.488 . . . . 0.0 111.846 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.3 75.5 Favored Glycine 0 C--N 1.316 -0.568 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.402 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.775 HD13 ' HA2' ' A' ' 392' ' ' GLY . 3.9 mt -72.1 -41.48 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.601 0.715 . . . . 0.0 110.025 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.6 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -57.57 -45.6 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.909 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.708 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.8 -29.15 68.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 122.646 1.212 . . . . 0.0 109.371 -173.074 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.8 -18.46 77.48 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.386 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.698 ' CG ' HG21 ' A' ' 399' ' ' VAL . 18.7 m-85 -100.0 3.17 44.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.02 145.89 70.82 Favored Pre-proline 0 N--CA 1.41 -2.452 0 CA-C-O 123.612 1.672 . . . . 0.0 113.308 168.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.77 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.7 Cg_endo -72.52 -62.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 1 C-N-CA 126.181 4.587 . . . . 0.0 113.378 -173.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.549 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -108.3 141.65 15.84 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.166 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.846 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.71 -29.88 71.0 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.903 0.351 . . . . 0.0 111.057 -177.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.77 -46.43 81.48 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 172.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.999 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.1 t -59.27 -51.59 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.63 176.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.846 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -54.26 -54.85 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.474 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 61.4 m -61.61 -55.94 25.28 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.944 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.03 -46.17 78.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.806 ' O ' HD22 ' A' ' 443' ' ' LEU . 37.1 mt -59.37 -53.15 61.49 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.656 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.743 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 38.0 mm-40 -51.64 -35.09 40.71 Favored 'General case' 0 N--CA 1.419 -2.024 0 O-C-N 124.997 1.436 . . . . 0.0 110.447 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.634 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.74 -60.27 2.31 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 176.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -75.97 -50.86 13.72 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.743 -0.598 . . . . 0.0 112.002 -173.067 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.88 -24.08 61.76 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.719 0.771 . . . . 0.0 111.807 -179.001 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.746 ' N ' HD23 ' A' ' 443' ' ' LEU . 11.1 t70 -72.18 -42.82 65.41 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.609 176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.02 -7.99 45.55 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.53 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 54.0 mm-40 -51.75 154.77 1.9 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 123.264 1.507 . . . . 0.0 114.43 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.509 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.36 -32.89 20.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 111.17 -2.741 . . . . 0.0 115.613 -172.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.665 ' H ' ' HB ' ' A' ' 451' ' ' THR . 48.1 m-20 -138.04 178.98 6.72 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.418 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.1 p-10 -64.88 -53.57 44.58 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.1 OUTLIER -67.31 -23.58 65.66 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -59.04 -40.17 84.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 119.891 1.223 . . . . 0.0 109.453 171.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.614 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 72.6 mtp180 -61.23 -29.1 69.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.682 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.32 -34.01 59.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.204 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 455' ' ' THR . 1.3 mm-40 -78.62 -44.92 22.79 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.903 -171.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.556 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 29.9 p -105.33 -1.23 25.42 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.298 -165.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.675 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.5 t80 -48.73 -51.49 28.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.716 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.3 mm -71.94 -26.59 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.556 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.51 -43.03 67.24 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 463' ' ' VAL . 53.7 m-70 -67.15 -30.34 70.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.178 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.784 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -66.66 -53.4 34.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.278 1.037 . . . . 0.0 109.126 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.658 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.6 m-80 -63.49 -31.29 72.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.682 173.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.65 -53.53 53.17 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.192 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.999 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.1 t -62.36 -34.39 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.44 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.88 -15.39 42.2 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.125 169.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 10.9 mm-40 -89.95 -50.69 5.88 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.064 -1.023 . . . . 0.0 112.42 176.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.724 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -65.18 -39.82 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.904 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 469' ' ' LEU . 7.0 mt -84.13 -17.1 41.21 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 66.05 49.56 57.44 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 112.106 -2.315 . . . . 0.0 113.591 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -101.65 175.01 5.7 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.809 0.844 . . . . 0.0 111.064 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.583 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.1 p-10 -92.58 -43.25 9.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 165.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -161.56 -73.89 0.06 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.475 162.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.77 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 2.0 mpt_? -63.63 67.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.64 40.24 2.04 Favored Glycine 0 C--N 1.277 -2.709 0 CA-C-N 111.369 -2.65 . . . . 0.0 113.33 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.583 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 27.4 mm-40 -80.3 -56.3 4.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.152 0.977 . . . . 0.0 111.449 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 38.2 t 67.87 44.36 1.57 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.281 -2.236 . . . . 0.0 108.219 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.294 -1.809 0 CA-C-N 109.149 -3.66 . . . . 0.0 112.684 170.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.427 -1.576 0 CA-C-O 121.274 0.559 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 307' ' ' ILE . 22.8 mt -74.45 127.01 88.26 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-O 121.844 0.831 . . . . 0.0 112.137 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' A' ' 308' ' ' GLN . 28.2 Cg_endo -74.8 -11.44 21.88 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 124.682 3.588 . . . . 0.0 111.466 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.754 ' H ' HG22 ' A' ' 305' ' ' ILE . 6.1 tp 26.79 -64.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.298 0 C-N-CA 128.37 2.668 . . . . 0.0 115.877 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.657 ' H ' HG23 ' A' ' 307' ' ' ILE . 0.1 OUTLIER -57.66 -30.88 65.78 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.141 0.496 . . . . 0.0 111.246 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.543 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.73 -49.17 77.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.588 169.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.715 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.9 mt -58.55 -48.11 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.036 0.934 . . . . 0.0 112.705 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.682 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.7 mtp180 -59.9 -30.66 69.18 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 122.559 0.344 . . . . 0.0 111.108 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.2 m -70.03 -33.96 72.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.56 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.24 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.903 178.721 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.75 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.5 p -83.52 -37.19 23.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.83 1.3 . . . . 0.0 110.152 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.5 34.66 8.4 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.252 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.6 mt-10 51.68 172.25 0.03 OUTLIER Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -175.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.584 ' HB3' HD11 ' A' ' 324' ' ' ILE . 22.2 Cg_exo -45.27 143.56 5.15 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.374 2.716 . . . . 0.0 113.189 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.52 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.6 Cg_endo -91.41 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.614 2.876 . . . . 0.0 112.903 -172.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.465 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 7.9 mmm180 -89.29 -81.34 0.28 Allowed 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 123.449 0.699 . . . . 0.0 110.894 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.465 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 16.3 m-20 -112.71 164.94 14.14 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.846 -177.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.414 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 38.6 Cg_exo -58.65 -50.4 9.43 Favored 'Trans proline' 0 CA--C 1.509 -0.735 0 C-N-CA 122.549 2.166 . . . . 0.0 110.483 171.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.403 ' HG2' ' H ' ' A' ' 322' ' ' ARG . 5.1 mmt180 -48.74 -20.63 0.5 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.003 -1.908 . . . . 0.0 112.928 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.1 mt-10 -98.44 -23.46 15.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.7 0.286 . . . . 0.0 111.405 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.655 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.88 -44.34 45.79 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.717 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 6.4 Cg_endo -47.96 -62.76 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.008 2.472 . . . . 0.0 113.086 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.659 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.89 -36.32 75.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.031 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.168 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.75 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 47.5 t90 -57.63 -36.01 71.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.329 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.872 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.93 -48.15 59.62 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.585 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.55 -23.62 20.92 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.786 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.433 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 2.8 mmm180 -73.95 -42.17 60.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.22 1.01 . . . . 0.0 110.551 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.722 ' HB3' HG22 ' A' ' 314' ' ' THR . 47.1 m-20 -95.98 -24.82 16.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.599 -1.637 . . . . 0.0 113.854 -169.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.608 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.94 -50.29 13.6 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 124.296 1.038 . . . . 0.0 113.582 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 51.0 Cg_endo -61.09 -33.16 91.86 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.652 2.235 . . . . 0.0 111.729 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.57 -43.93 62.75 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.622 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.611 HG12 HG23 ' A' ' 310' ' ' ILE . 88.6 mt -57.99 -48.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.74 -17.87 6.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.233 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.92 -44.49 9.06 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.684 HG11 HG13 ' A' ' 310' ' ' ILE . 98.6 t -61.29 -69.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 123.399 1.571 . . . . 0.0 110.222 169.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.854 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -94.47 129.9 35.31 Favored Pre-proline 0 N--CA 1.403 -2.789 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.663 -171.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.774 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 68.0 Cg_endo -72.7 -18.86 24.84 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 123.887 3.058 . . . . 0.0 110.994 173.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.45 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.5 p 33.9 68.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.426 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.4 p -78.37 1.64 21.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.616 -170.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.795 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.4 p -137.59 164.09 43.85 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 343' ' ' THR . 50.3 Cg_exo -62.45 -50.58 4.3 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.145 2.564 . . . . 0.0 108.043 172.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.708 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 4.6 t0 -42.81 -47.34 5.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.013 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.795 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 8.9 mt -56.99 -53.04 62.56 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.797 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.74 ' HA ' HD12 ' A' ' 350' ' ' ILE . 41.3 ttm105 -54.98 -45.81 75.02 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.603 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.991 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.78 -47.8 65.28 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.793 0.33 . . . . 0.0 111.216 -175.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 70.8 mtt180 -56.0 -42.41 76.36 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.079 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.854 HD11 ' CD2' ' A' ' 339' ' ' PHE . 52.6 mt -57.73 -53.48 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.399 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.565 HG12 HD11 ' A' ' 328' ' ' LEU . 23.0 mt -58.47 -52.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 122.203 1.001 . . . . 0.0 110.715 -170.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.549 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 23.3 m-20 -63.0 -36.11 82.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.152 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.63 -34.72 74.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.081 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.679 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.72 -53.92 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 122.925 1.345 . . . . 0.0 110.256 173.249 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.679 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -71.95 -27.46 62.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.618 -2.537 . . . . 0.0 109.585 -167.367 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 63.25 -70.79 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.943 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.72 97.29 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.322 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.59 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -124.59 164.41 19.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 122.736 0.414 . . . . 0.0 110.447 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.522 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -51.42 -59.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.082 0.467 . . . . 0.0 111.804 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -162.63 20.39 0.17 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.54 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.694 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.9 mt -66.05 -5.28 9.21 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 122.835 0.454 . . . . 0.0 111.615 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.549 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 23.3 t -61.42 83.1 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.205 0.526 . . . . 0.0 110.62 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.751 HD11 HG21 ' A' ' 377' ' ' THR . 0.9 OUTLIER -62.48 173.36 1.25 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.659 175.061 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 366' ' ' GLY . 71.9 p -113.73 162.43 22.67 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.622 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.991 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 10.5 Cg_endo -68.63 25.92 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.121 1.881 . . . . 0.0 112.386 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -138.01 -6.28 1.5 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.759 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.686 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.1 m-20 -105.65 -20.87 13.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.83 1.3 . . . . 0.0 109.129 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.826 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 2.7 p -79.03 20.69 0.47 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.846 -172.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -61.49 -30.58 70.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.707 1.241 . . . . 0.0 108.495 -172.513 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 24.9 p -125.73 163.9 21.83 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 112.393 -2.185 . . . . 0.0 109.933 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.619 ' O ' HG13 ' A' ' 375' ' ' VAL . 66.7 m95 -70.92 -33.91 70.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 167.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.51 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -61.24 -44.89 96.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.746 -172.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 29.1 t -69.15 -42.9 75.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.733 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.19 -52.15 66.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.872 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.1 m -58.56 -43.86 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.585 0.707 . . . . 0.0 109.422 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.01 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.2 -46.19 90.0 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.095 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.751 HG21 HD11 ' A' ' 363' ' ' LEU . 37.3 m -66.41 -39.32 88.93 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.324 -173.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -59.69 -35.13 73.87 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.467 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.717 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 66.4 t80 -73.41 -45.96 51.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.491 1.139 . . . . 0.0 109.473 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -53.06 -32.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 112.625 -2.08 . . . . 0.0 111.314 171.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.3 OUTLIER -59.55 -38.69 81.75 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.442 0.697 . . . . 0.0 111.831 177.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 4.4 p -104.64 -20.91 13.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.62 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -108.34 24.46 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.87 21.12 29.0 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 114.587 0.595 . . . . 0.0 114.587 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 62.01 165.92 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.092 0.472 . . . . 0.0 110.976 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -130.52 154.21 81.59 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -94.56 47.75 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.386 2.724 . . . . 0.0 110.712 165.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.693 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.27 4.55 0.68 Allowed 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -173.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.08 -43.6 70.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.941 0.4 . . . . 0.0 110.569 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.636 ' O ' HG13 ' A' ' 394' ' ' VAL . 98.1 mt-30 -75.85 -25.4 56.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -170.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.889 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.11 -31.38 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.043 0.838 . . . . 0.0 112.024 -172.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.565 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.86 -50.3 58.85 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.674 174.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.523 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.5 m-20 -69.84 -36.59 75.7 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.987 0.515 . . . . 0.0 111.814 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.1 m -58.85 -48.51 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 399' ' ' VAL . 8.5 mm -58.37 -48.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.882 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 392' ' ' GLY . 0.2 OUTLIER -52.31 -46.32 65.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.312 -177.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -73.29 -44.13 35.85 Favored Glycine 0 C--N 1.31 -0.895 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.382 -176.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.0 mt -69.15 -41.22 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 117.76 0.78 . . . . 0.0 111.582 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.5 m -57.93 -44.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.844 0.83 . . . . 0.0 109.552 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.431 ' N ' HG23 ' A' ' 399' ' ' VAL . 16.6 t70 -55.21 -46.05 75.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.328 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 29.2 mm-40 -85.3 -52.52 5.84 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.601 -170.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.575 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.7 OUTLIER -110.6 -30.39 7.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.52 0.676 . . . . 0.0 111.799 -170.254 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 124.84 166.16 12.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.705 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.875 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -62.95 -46.1 97.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.013 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -53.96 -52.54 60.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.617 0.722 . . . . 0.0 111.999 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.79 -49.91 68.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.308 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.672 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.23 -43.37 64.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.66 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.8 t80 -56.44 -46.72 80.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.524 0.678 . . . . 0.0 109.559 176.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.776 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.8 m -58.69 -52.26 66.47 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.65 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.684 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.7 -48.01 82.7 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.602 176.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.58 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.19 -43.24 89.03 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.664 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -72.2 -31.57 66.0 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.88 0.34 . . . . 0.0 110.69 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.858 ' HE3' HG21 ' A' ' 375' ' ' VAL . 62.5 mtm -70.18 -47.5 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 109.93 173.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.01 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.9 mt -59.18 -40.67 86.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.119 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.889 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.7 m -77.82 -12.76 60.01 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.964 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.61 44.13 4.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.206 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.599 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 58.46 39.99 24.52 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.762 0.825 . . . . 0.0 112.99 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 0.5 OUTLIER -123.46 79.55 1.7 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 165.402 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.664 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 7.8 p90 -62.55 -31.12 71.85 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.8 -161.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.529 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.0 mt-30 -54.14 -47.76 71.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -164.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.716 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.2 pp -59.21 -49.0 79.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.479 0.656 . . . . 0.0 110.974 177.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.732 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.7 -39.06 80.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.756 1.265 . . . . 0.0 109.208 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 30.0 t -60.8 -47.4 86.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.037 -2.347 . . . . 0.0 111.252 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.11 -38.19 75.4 Favored Glycine 0 C--N 1.315 -0.596 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.7 mt -72.18 -43.99 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.583 0.706 . . . . 0.0 109.985 174.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.615 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -55.8 -44.28 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.73 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.717 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -61.67 -30.26 70.61 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-O 122.586 1.184 . . . . 0.0 108.907 -173.208 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.39 -18.08 78.07 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.966 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.665 ' CG ' HG21 ' A' ' 399' ' ' VAL . 15.0 m-85 -100.65 3.77 42.73 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -177.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.77 145.4 70.82 Favored Pre-proline 0 N--CA 1.418 -2.069 0 CA-C-O 123.546 1.641 . . . . 0.0 113.721 167.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.755 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 59.2 Cg_endo -72.19 -61.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 1 C-N-CA 126.245 4.63 . . . . 0.0 113.127 -173.038 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.53 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.59 141.11 15.61 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.202 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.868 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.1 OUTLIER -62.46 -30.69 71.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.107 0.454 . . . . 0.0 111.143 -177.44 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.77 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.25 -46.67 79.52 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 171.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.061 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.7 t -59.66 -51.38 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.397 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.868 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.81 -54.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 51.8 m -62.73 -56.11 20.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.226 -175.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.24 -45.93 79.81 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.64 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 39.0 mt -59.43 -53.73 54.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.806 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.711 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.2 mm-40 -52.23 -34.16 44.61 Favored 'General case' 0 N--CA 1.417 -2.108 0 O-C-N 125.09 1.494 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.656 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.18 -60.69 2.12 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.25 14.51 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.733 -0.605 . . . . 0.0 112.392 -172.702 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.08 62.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.596 0.712 . . . . 0.0 111.606 -179.102 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.767 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.7 t70 -72.19 -41.11 67.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.484 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.656 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -70.29 -8.08 47.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 14.0 mm-40 -56.6 161.27 2.81 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 123.221 1.486 . . . . 0.0 114.371 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.693 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.84 -34.28 25.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 111.216 -2.72 . . . . 0.0 115.78 -169.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.635 ' H ' ' HB ' ' A' ' 451' ' ' THR . 24.6 m-20 -142.32 -178.18 5.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.464 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 10.7 p-10 -63.83 -55.26 24.25 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.528 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.28 -27.12 68.82 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.084 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.693 HG21 ' HB ' ' A' ' 447' ' ' ILE . 8.8 m -58.6 -44.67 89.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.381 0.991 . . . . 0.0 109.864 172.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.0 mtt180 -61.0 -29.89 69.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.189 172.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.66 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.57 -31.47 63.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.91 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.1 mm-40 -78.11 -46.24 21.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.728 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.531 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 27.5 p -103.69 -0.9 28.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.481 -166.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -49.28 -55.34 13.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.828 177.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.8 mm -69.62 -26.7 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.531 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.27 -43.96 66.18 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.616 ' O ' HG23 ' A' ' 463' ' ' VAL . 71.0 m-70 -65.53 -30.62 71.39 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.857 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.737 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.91 -53.25 33.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.206 1.003 . . . . 0.0 109.303 -178.607 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.661 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -63.6 -31.5 72.68 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.719 173.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -62.98 -53.15 58.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.41 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.061 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.5 t -62.41 -33.88 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 121.836 0.827 . . . . 0.0 110.249 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.647 ' HD1' HD12 ' A' ' 469' ' ' LEU . 21.9 m-30 -61.96 -15.15 41.35 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.157 169.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 48.0 mt-10 -91.77 -49.36 6.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.909 -1.119 . . . . 0.0 112.822 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.7 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -64.65 -40.43 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.902 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.77 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.3 mt -83.47 -16.58 45.12 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 172.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.61 51.14 54.6 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 111.68 -2.509 . . . . 0.0 113.028 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.732 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -100.48 -156.93 0.58 Allowed 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 122.16 0.981 . . . . 0.0 109.381 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.583 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.2 p-10 -130.01 -41.04 1.3 Allowed 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 171.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.535 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -155.76 -82.19 0.07 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.426 -2.17 . . . . 0.0 110.813 155.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.755 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -57.34 69.62 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -172.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.482 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 36.47 42.79 0.68 Allowed Glycine 0 C--N 1.276 -2.755 0 CA-C-N 111.163 -2.744 . . . . 0.0 113.323 172.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.583 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 2.7 mm100 -77.4 -59.51 2.75 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 122.147 0.975 . . . . 0.0 111.421 -172.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 36.7 t 67.15 50.87 0.97 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.185 -2.279 . . . . 0.0 107.976 -173.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.5 OUTLIER . . . . . 0 C--N 1.291 -1.971 0 CA-C-N 109.196 -3.638 . . . . 0.0 112.507 170.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.427 -1.61 0 CA-C-O 120.973 0.416 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.737 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 36.2 mt -74.24 127.67 87.41 Favored Pre-proline 0 N--CA 1.425 -1.681 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.576 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.2 Cg_endo -84.96 50.21 2.8 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 125.011 3.807 . . . . 0.0 109.238 165.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.749 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.6 tp -45.41 -42.42 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.287 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' GLN . . . . . 0.616 ' HA ' ' HD3' ' A' ' 311' ' ' ARG . 26.4 mm-40 -60.86 -44.24 97.28 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.998 0.904 . . . . 0.0 111.653 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' HIS . . . . . 0.475 ' CG ' HG13 ' A' ' 338' ' ' VAL . 1.4 t-80 -58.97 -45.77 89.72 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.357 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 335' ' ' ILE . 67.4 mt -59.22 -49.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.749 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 36.4 mtp180 -60.45 -31.28 70.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.523 -0.735 . . . . 0.0 110.987 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.6 m -69.76 -32.27 70.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.587 0.708 . . . . 0.0 109.881 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.544 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.56 -41.33 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.018 177.52 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.751 HG22 ' HB3' ' A' ' 331' ' ' ASN . 31.6 p -82.68 -36.7 25.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.728 1.251 . . . . 0.0 110.063 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.14 10.74 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 112.4 -2.182 . . . . 0.0 110.159 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.9 mt-10 49.12 173.57 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.126 0 C-N-CA 124.806 1.243 . . . . 0.0 113.254 -173.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 324' ' ' ILE . 25.0 Cg_exo -45.1 154.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.038 2.492 . . . . 0.0 113.604 -176.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 317' ' ' PRO . 32.6 Cg_endo -93.08 -109.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 123.29 2.66 . . . . 0.0 111.563 -175.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.469 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 14.4 mmm180 -97.2 -80.26 0.44 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.396 0.617 . . . . 0.0 111.058 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.504 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 46.0 m-20 -94.06 156.52 39.01 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.38 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 44.3 Cg_exo -58.53 -49.53 11.75 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.726 2.284 . . . . 0.0 110.483 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.421 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.1 OUTLIER -51.61 -21.94 2.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.194 -1.821 . . . . 0.0 112.665 175.296 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.0 mt-10 -85.0 -30.06 24.51 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.325 -0.234 . . . . 0.0 111.377 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -47.72 -45.05 59.25 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.718 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.0 Cg_endo -50.43 -62.65 0.37 Allowed 'Trans proline' 0 CA--C 1.517 -0.354 0 C-N-CA 122.802 2.335 . . . . 0.0 113.091 177.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.635 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.4 -35.43 69.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 122.664 1.221 . . . . 0.0 110.091 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 327' ' ' TRP . . . . . 0.651 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 49.7 t90 -58.46 -37.19 74.95 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.156 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.848 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.14 -47.81 60.13 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.349 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.67 -23.64 21.92 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.741 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.495 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.9 OUTLIER -74.08 -43.27 58.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.407 1.098 . . . . 0.0 110.686 174.252 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.751 ' HB3' HG22 ' A' ' 314' ' ' THR . 52.6 m-20 -94.47 -25.03 17.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.407 -168.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ALA . . . . . 0.546 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.58 -50.3 9.5 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 124.453 1.101 . . . . 0.0 113.719 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.8 Cg_endo -62.78 -30.96 78.47 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.684 2.256 . . . . 0.0 111.801 177.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -73.52 -45.77 51.76 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.527 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 310' ' ' ILE . 88.2 mt -57.17 -48.65 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.878 173.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.45 -16.37 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.769 -1.56 . . . . 0.0 112.14 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.8 -46.28 7.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.412 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.623 HG11 HG13 ' A' ' 310' ' ' ILE . 96.3 t -58.19 -70.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 123.499 1.619 . . . . 0.0 110.187 169.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.855 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.8 OUTLIER -92.64 131.81 33.05 Favored Pre-proline 0 N--CA 1.405 -2.679 0 CA-C-N 110.926 -2.852 . . . . 0.0 112.463 -172.287 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.779 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -73.25 -18.92 23.02 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 123.635 2.89 . . . . 0.0 110.737 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.7 p 33.26 70.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.54 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.583 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.4 p -81.25 5.64 16.51 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.921 -1.945 . . . . 0.0 113.392 -169.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.781 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.9 p -143.14 158.02 59.31 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 121.517 0.675 . . . . 0.0 109.535 174.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 52.4 Cg_exo -62.08 -38.68 55.03 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 124.368 3.379 . . . . 0.0 109.435 172.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.655 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -52.36 -51.69 57.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 112.295 -2.229 . . . . 0.0 110.634 174.336 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.781 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.2 mt -58.4 -52.43 65.64 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.52 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.658 ' HA ' HD12 ' A' ' 350' ' ' ILE . 3.8 ttm180 -52.86 -41.48 64.34 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.116 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' CYS . . . . . 0.452 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 45.7 t -69.71 -49.25 55.15 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.913 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.6 mtt180 -58.13 -40.01 80.2 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.855 HD11 ' CD2' ' A' ' 339' ' ' PHE . 50.5 mt -58.68 -54.18 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.505 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.606 HD13 ' HB1' ' A' ' 374' ' ' ALA . 16.5 mt -57.56 -53.54 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 121.954 0.883 . . . . 0.0 111.055 -169.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.456 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 52.0 m-20 -64.14 -34.26 77.64 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.079 -177.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.65 76.45 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.205 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.65 -51.61 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 122.875 1.322 . . . . 0.0 110.425 174.647 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.582 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.3 OUTLIER -72.29 -25.76 61.71 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.81 -2.45 . . . . 0.0 109.298 -170.271 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 66.69 -77.04 0.14 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.169 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.9 92.65 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.191 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.601 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -111.89 163.65 13.98 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 122.803 0.441 . . . . 0.0 110.751 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.86 -64.87 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 C-N-CA 122.81 0.444 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -150.55 13.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.687 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.1 mt -64.37 -2.8 2.42 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.651 0.38 . . . . 0.0 111.909 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.456 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.1 t -61.75 84.61 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.26 0.552 . . . . 0.0 110.181 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.9 HD11 HG21 ' A' ' 377' ' ' THR . 2.2 mm? -63.52 -174.96 0.1 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.672 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 48.6 p -125.61 157.7 67.45 Favored Pre-proline 0 CA--C 1.506 -0.738 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 32.3 Cg_exo -46.75 -39.34 23.7 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.912 1.741 . . . . 0.0 110.942 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' GLY . . . . . 0.505 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -83.46 2.67 86.86 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.38 -172.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.69 ' CB ' HD12 ' A' ' 363' ' ' LEU . 44.1 m-20 -108.81 -21.76 12.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.089 0.947 . . . . 0.0 109.778 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 57.8 m -95.38 20.3 9.58 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.383 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.505 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -61.34 -36.25 79.66 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.964 1.364 . . . . 0.0 108.375 -173.157 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 15.2 p -115.51 163.03 16.34 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 112.189 -2.278 . . . . 0.0 109.491 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 375' ' ' VAL . 35.5 m95 -70.71 -33.51 70.94 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.575 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -64.33 -46.4 83.7 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.806 -170.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.0 t -68.22 -42.61 79.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.358 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.705 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.54 -52.54 64.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.918 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.8 m -58.44 -44.4 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.627 0.727 . . . . 0.0 109.489 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 1.023 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.24 -46.0 92.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.883 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.9 HG21 HD11 ' A' ' 363' ' ' LEU . 33.0 m -67.82 -38.72 83.62 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.517 -172.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 1.8 mt -59.47 -34.62 72.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.346 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.718 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 59.2 t80 -73.53 -46.79 45.54 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.34 1.067 . . . . 0.0 109.263 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -51.92 -32.45 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.279 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.4 mpt_? -59.7 -40.14 86.96 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.537 0.684 . . . . 0.0 111.369 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.9 p -96.79 -22.51 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.75 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -110.0 23.33 14.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.58 21.05 19.94 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.6 m 64.92 159.59 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.237 0.541 . . . . 0.0 111.285 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.543 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -123.83 155.45 66.8 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.682 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 389' ' ' HIS . 85.0 Cg_endo -101.2 56.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.027 3.152 . . . . 0.0 111.395 168.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.73 ' HA ' HD23 ' A' ' 391' ' ' LEU . 5.3 mmt 62.44 -19.56 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -173.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.461 ' H ' ' C ' ' A' ' 387' ' ' PRO . 5.9 t60 -56.21 -44.25 79.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.065 0.459 . . . . 0.0 111.31 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.707 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.9 mt-30 -75.04 -28.66 60.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.8 mm? -54.8 -31.53 59.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.313 0.961 . . . . 0.0 111.037 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.689 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.02 -51.58 52.78 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.617 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.595 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 50.4 m-20 -68.1 -39.86 82.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.96 0.504 . . . . 0.0 112.168 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 390' ' ' GLN . 1.9 m -56.82 -45.16 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 399' ' ' VAL . 12.9 mm -58.91 -47.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.832 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.691 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 30.6 mmtt -52.48 -43.13 64.81 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 123.987 0.804 . . . . 0.0 111.325 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.16 -44.63 13.15 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.236 -172.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.8 mt -69.05 -40.61 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 117.603 0.702 . . . . 0.0 111.34 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.5 m -58.35 -44.27 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.802 0.81 . . . . 0.0 109.904 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 399' ' ' VAL . 14.6 t70 -59.17 -43.49 92.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.261 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 30.8 mm-40 -83.52 -52.21 6.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.073 -171.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.561 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -111.13 -30.98 7.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.758 -170.16 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.81 165.84 12.04 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.678 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.902 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.47 -44.68 98.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.257 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.88 -52.45 62.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.464 0.649 . . . . 0.0 111.946 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.504 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.45 -49.57 68.65 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.17 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.668 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.61 -41.63 63.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.623 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 46.2 t80 -58.18 -46.65 85.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.471 0.653 . . . . 0.0 109.489 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.773 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.0 m -58.52 -52.58 65.06 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.674 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.677 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.57 -48.77 78.02 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.568 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.63 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.82 -43.39 87.1 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.903 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.737 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.23 -32.29 66.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.798 0.299 . . . . 0.0 111.184 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.918 ' HE3' HG21 ' A' ' 375' ' ' VAL . 68.5 mtm -69.84 -47.17 63.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.396 0.617 . . . . 0.0 109.855 174.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 1.023 HD23 ' HA ' ' A' ' 376' ' ' ALA . 18.0 mt -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.937 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.623 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.6 OUTLIER -74.81 -16.89 60.69 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.864 -173.532 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 101.27 29.05 6.52 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.1 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.737 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.7 mm100 59.23 43.61 16.77 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.074 0.95 . . . . 0.0 112.279 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.51 ' OD1' HD21 ' A' ' 421' ' ' LEU . 0.5 OUTLIER -119.09 66.78 0.78 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 167.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.666 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.7 OUTLIER -46.1 -35.03 4.6 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 111.554 -2.566 . . . . 0.0 113.435 -164.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.1 mt-30 -54.54 -46.47 73.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.597 HD21 ' HG ' ' A' ' 415' ' ' SER . 1.6 pp -60.3 -50.1 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.905 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.805 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.02 -39.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.632 1.206 . . . . 0.0 109.19 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.512 ' HB2' ' HD2' ' A' ' 419' ' ' TYR . 17.2 t -60.15 -46.36 89.95 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.643 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.63 -38.63 82.73 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.746 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.4 mt -71.79 -41.98 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.507 0.67 . . . . 0.0 109.932 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.59 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -57.86 -45.71 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.407 -1.269 . . . . 0.0 112.726 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.751 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.52 -29.92 68.23 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.608 1.194 . . . . 0.0 109.325 -174.096 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 428' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.48 -15.18 77.34 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.625 175.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.704 ' CG ' HG21 ' A' ' 399' ' ' VAL . 13.9 m-85 -102.49 2.62 36.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.68 145.07 78.81 Favored Pre-proline 0 N--CA 1.409 -2.479 0 CA-C-O 123.717 1.722 . . . . 0.0 113.516 168.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.769 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 71.9 Cg_endo -72.12 -55.68 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.426 1 C-N-CA 126.289 4.659 . . . . 0.0 113.618 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.513 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.69 140.59 16.31 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.4 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.875 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.23 -27.31 68.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.155 0.478 . . . . 0.0 111.29 -177.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.13 -48.22 79.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 170.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 1.014 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.3 t -57.71 -51.7 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.788 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.875 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -55.02 -53.05 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 91.8 m -61.52 -56.49 19.48 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.11 -45.34 79.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.519 -177.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.811 ' O ' HD22 ' A' ' 443' ' ' LEU . 41.9 mt -59.57 -53.13 61.59 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.71 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.77 -35.52 44.0 Favored 'General case' 0 N--CA 1.421 -1.905 0 O-C-N 124.844 1.34 . . . . 0.0 110.429 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.662 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.69 -59.83 2.53 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 177.104 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.76 13.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.416 0.553 . . . . 0.0 112.151 -173.646 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.811 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.75 -24.32 61.42 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.629 0.728 . . . . 0.0 111.776 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.738 ' N ' HD23 ' A' ' 443' ' ' LEU . 15.9 t70 -71.72 -42.73 66.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.564 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 37.9 mt-30 -69.34 -9.36 52.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -171.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 58.7 mm-40 -52.03 153.65 2.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.377 1.56 . . . . 0.0 114.322 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.503 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.1 -32.81 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.985 -2.825 . . . . 0.0 115.483 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.652 ' H ' ' HB ' ' A' ' 451' ' ' THR . 40.2 m-20 -139.13 178.74 6.95 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 452' ' ' ARG . 7.9 p-10 -64.42 -51.59 62.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.1 OUTLIER -66.79 -25.55 66.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 174.533 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.652 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 13.6 m -59.43 -42.08 91.04 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 119.798 1.181 . . . . 0.0 109.631 171.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.555 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 54.7 mtt180 -59.89 -30.98 69.38 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.338 171.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.623 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.46 -29.63 59.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.042 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.429 ' HB2' HG23 ' A' ' 455' ' ' THR . 2.7 mm-40 -82.82 -47.18 12.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.094 -172.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.605 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -101.95 -1.53 31.73 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.338 -165.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.666 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.72 -51.72 27.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.1 mm -71.85 -27.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' GLN . . . . . 0.605 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -70.77 -42.55 70.25 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.636 ' O ' HG23 ' A' ' 463' ' ' VAL . 51.5 m-70 -66.92 -30.72 70.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.169 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.722 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -67.06 -53.27 32.69 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.192 0.996 . . . . 0.0 109.052 -179.2 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.636 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.98 -32.19 73.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.665 173.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -61.82 -54.41 42.63 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.105 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 1.014 HG11 ' HA ' ' A' ' 435' ' ' VAL . 22.1 t -62.21 -34.42 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 CA-C-O 121.684 0.754 . . . . 0.0 110.589 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.544 ' HD1' HD12 ' A' ' 469' ' ' LEU . 20.4 m-30 -61.8 -15.08 38.69 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.219 170.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 46.3 mm-40 -91.89 -49.56 6.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.954 . . . . 0.0 112.732 176.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.717 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -65.14 -40.06 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -84.11 -16.64 42.9 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.73 50.56 58.02 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.28 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.732 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -100.26 -178.64 3.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.71 0.804 . . . . 0.0 110.364 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.629 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 0.8 OUTLIER -101.11 -43.39 6.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.528 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.39 -76.69 0.07 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.273 158.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.769 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -60.23 71.22 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -172.702 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 36.69 45.84 1.06 Allowed Glycine 0 C--N 1.276 -2.772 0 CA-C-N 110.589 -3.005 . . . . 0.0 113.577 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.629 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 27.5 mm-40 -82.54 -57.83 3.18 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.012 0.911 . . . . 0.0 111.466 -173.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 39.0 t 66.94 42.78 2.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.493 -2.139 . . . . 0.0 108.155 -173.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-N 109.246 -3.616 . . . . 0.0 112.623 170.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.478 0.579 0 N-CA-C 110.512 -0.611 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 301' ' ' ILE . 2.9 mp -76.71 122.49 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.146 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 106.02 -94.91 1.0 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.587 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 83.0 m -156.84 122.12 4.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.362 0.601 . . . . 0.0 110.915 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 304' ' ' VAL . 2.8 p -64.66 130.67 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.538 172.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.753 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 27.8 mt -77.96 122.27 85.24 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-O 121.989 0.9 . . . . 0.0 111.851 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 308' ' ' GLN . 25.4 Cg_endo -72.62 -14.02 27.32 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 124.887 3.725 . . . . 0.0 111.417 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.719 HG23 ' HG2' ' A' ' 308' ' ' GLN . 3.5 tp 34.71 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 C-N-CA 128.296 2.638 . . . . 0.0 116.088 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.719 ' HG2' HG23 ' A' ' 307' ' ' ILE . 61.6 mm-40 -58.71 -34.4 71.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.643 0.777 . . . . 0.0 110.41 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.582 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.6 t-160 -60.93 -47.41 86.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.583 173.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 307' ' ' ILE . 67.7 mt -61.76 -48.41 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 124.157 0.983 . . . . 0.0 112.68 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.694 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 9.5 mtp-105 -58.5 -31.56 67.99 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.655 0.382 . . . . 0.0 111.258 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 38.5 t -69.67 -32.78 71.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.56 0.695 . . . . 0.0 109.66 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.529 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.22 -41.23 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.942 177.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.702 HG22 ' HB3' ' A' ' 331' ' ' ASN . 33.6 p -82.33 -36.18 27.16 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.939 1.352 . . . . 0.0 109.807 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.66 32.73 8.39 Favored Glycine 0 N--CA 1.432 -1.576 0 CA-C-N 112.203 -2.271 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.448 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 46.9 mt-10 55.75 165.35 0.06 OUTLIER Pre-proline 0 N--CA 1.437 -1.085 0 C-N-CA 124.062 0.945 . . . . 0.0 113.429 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' A' ' 355' ' ' LEU . 33.1 Cg_exo -44.27 146.73 1.78 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.547 2.831 . . . . 0.0 113.095 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.09 -102.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.739 2.292 . . . . 0.0 111.171 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.46 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 11.2 mmm180 -102.36 -79.94 0.52 Allowed 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.284 0.564 . . . . 0.0 111.188 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 8.6 m-20 -94.75 164.17 20.38 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.51 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.418 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 37.4 Cg_exo -61.73 -48.11 9.67 Favored 'Trans proline' 0 CA--C 1.512 -0.577 0 C-N-CA 122.975 2.45 . . . . 0.0 110.613 168.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -51.29 -25.91 6.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.218 177.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 63.7 mt-10 -81.73 -33.5 31.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 0.0 111.226 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.733 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -48.38 -42.37 52.96 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -173.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.699 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.97 -63.23 0.31 Allowed 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 123.089 2.526 . . . . 0.0 113.019 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.592 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -61.23 -37.25 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.246 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.671 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -57.63 -36.53 71.94 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.569 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.827 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.59 -49.49 47.17 Favored 'General case' 0 N--CA 1.401 -2.916 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.75 -24.11 24.4 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.887 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.552 ' HD2' HG21 ' A' ' 406' ' ' THR . 1.0 OUTLIER -74.48 -42.14 59.52 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.994 0.902 . . . . 0.0 110.882 173.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.702 ' HB3' HG22 ' A' ' 314' ' ' THR . 49.2 m-20 -94.24 -23.63 17.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.522 -168.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.613 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.66 -50.29 9.75 Favored Pre-proline 0 C--N 1.308 -1.239 0 C-N-CA 124.523 1.129 . . . . 0.0 113.829 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 53.3 Cg_endo -63.19 -31.48 74.68 Favored 'Trans proline' 0 CA--C 1.51 -0.693 0 C-N-CA 122.473 2.115 . . . . 0.0 111.557 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.38 -42.44 59.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.501 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.618 HG23 HG23 ' A' ' 310' ' ' ILE . 95.5 mt -58.27 -48.01 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.947 174.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.39 -17.96 2.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.496 -1.684 . . . . 0.0 112.368 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.09 -52.8 5.52 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.03 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.628 HG11 HG13 ' A' ' 310' ' ' ILE . 96.8 t -57.78 -71.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 123.506 1.622 . . . . 0.0 110.238 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.753 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.6 123.46 72.6 Favored Pre-proline 0 N--CA 1.403 -2.82 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.588 -174.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.705 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 74.1 Cg_endo -72.7 -17.22 26.25 Favored 'Trans proline' 0 CA--C 1.495 -1.454 0 C-N-CA 123.947 3.098 . . . . 0.0 110.267 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 32.62 66.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 111.683 -2.508 . . . . 0.0 110.103 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.563 ' N ' HD12 ' A' ' 346' ' ' LEU . 46.6 p -79.08 4.11 15.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.738 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.803 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.2 p -140.74 159.5 62.34 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.697 ' HB3' HD12 ' A' ' 369' ' ' LEU . 70.5 Cg_exo -60.33 -46.21 19.18 Favored 'Trans proline' 0 CA--C 1.498 -1.296 0 C-N-CA 123.571 2.847 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.638 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -41.33 -56.52 2.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.4 175.456 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.803 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.9 mt -55.85 -51.24 68.22 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.051 -1.432 . . . . 0.0 111.0 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.834 ' HA ' HD12 ' A' ' 350' ' ' ILE . 4.7 ttm180 -49.83 -48.06 51.2 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.959 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 1.117 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.7 m -68.88 -47.1 66.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.949 -177.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.587 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.0 mtp180 -62.37 -34.3 76.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.88 ' O ' HG12 ' A' ' 354' ' ' ILE . 28.1 mt -58.24 -53.04 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.753 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.627 ' O ' HD22 ' A' ' 355' ' ' LEU . 19.7 mt -57.81 -53.89 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 121.922 0.868 . . . . 0.0 111.201 -170.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.566 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 13.5 m-20 -63.89 -35.68 81.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.133 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ALA . . . . . 0.566 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.56 -29.91 66.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.68 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.88 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.03 -58.85 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 122.945 1.355 . . . . 0.0 110.118 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.733 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.13 -27.95 57.27 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.182 -167.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.74 -72.56 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.341 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -106.63 52.15 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.562 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.732 HD22 ' HB2' ' A' ' 361' ' ' LEU . 12.7 p-10 -89.88 129.45 36.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 122.861 0.464 . . . . 0.0 109.911 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.662 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -48.24 -71.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.881 -170.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.37 6.68 5.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.523 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.732 ' HB2' HD22 ' A' ' 358' ' ' ASN . 3.5 mt -70.96 -6.19 36.76 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.582 0.706 . . . . 0.0 109.962 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.566 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 19.5 t -63.7 78.89 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.413 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.772 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.9 mm? -61.14 -179.69 0.16 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.184 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 366' ' ' GLY . 49.2 p -119.76 157.71 51.57 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.436 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 1.117 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 57.7 Cg_endo -69.79 25.32 0.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.115 1.876 . . . . 0.0 113.254 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -134.32 -4.0 2.97 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.647 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.563 ' HB2' HD12 ' A' ' 363' ' ' LEU . 1.5 m-20 -106.88 -21.21 13.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.119 0.961 . . . . 0.0 110.451 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.887 ' HB2' ' SG ' ' A' ' 348' ' ' CYS . 3.8 m -94.41 24.16 4.7 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.638 -168.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.9 -35.89 64.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.332 1.063 . . . . 0.0 109.356 -172.176 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.06 159.48 23.15 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.304 172.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.643 ' O ' HG13 ' A' ' 375' ' ' VAL . 58.7 m95 -69.63 -35.48 75.28 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.562 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.32 -41.96 98.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.969 -175.211 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 92.0 p -67.47 -44.48 78.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.906 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.586 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -63.43 -52.83 59.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.827 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.3 m -56.11 -45.03 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.453 0.645 . . . . 0.0 109.559 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.04 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.05 -45.66 90.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.999 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.63 HG21 HD11 ' A' ' 363' ' ' LEU . 24.0 m -68.05 -37.24 81.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.289 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -61.73 -34.83 76.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.699 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 68.1 t80 -73.38 -45.15 56.51 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.461 1.124 . . . . 0.0 109.097 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.6 -33.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 112.647 -2.07 . . . . 0.0 111.167 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.41 -44.39 95.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.538 0.685 . . . . 0.0 111.068 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 32.7 p -93.73 -23.68 18.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.82 -167.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.464 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 30.6 m80 -109.55 23.75 14.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.57 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.91 36.15 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 114.223 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m 66.27 159.54 0.13 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 111.494 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -129.47 151.22 77.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -96.32 54.1 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 110.906 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.688 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.02 8.16 0.72 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -70.69 -45.65 64.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.102 0.477 . . . . 0.0 110.479 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.657 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.6 mt-30 -75.26 -28.17 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -170.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.695 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.34 -31.61 45.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.025 0.829 . . . . 0.0 112.115 -170.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.644 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -53.18 41.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.925 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 18.2 m-20 -67.48 -37.48 82.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.3 m -58.5 -45.75 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 110.616 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 399' ' ' VAL . 9.5 mm -58.25 -47.16 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.855 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.65 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.0 mmtt -52.42 -39.86 61.48 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 124.205 0.94 . . . . 0.0 111.893 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -77.39 -44.62 12.75 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.68 -1.247 . . . . 0.0 113.146 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.4 mt -69.39 -42.72 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 111.749 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.2 m -57.09 -43.96 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.562 0.696 . . . . 0.0 110.226 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 399' ' ' VAL . 6.1 t70 -58.47 -39.76 80.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.861 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 47.7 mt-30 -86.38 -53.62 4.9 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.28 -173.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.515 ' HG3' HG22 ' A' ' 398' ' ' ILE . 0.6 OUTLIER -113.19 -30.85 6.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.107 -166.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.29 165.83 12.09 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.856 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.939 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.1 -43.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.32 -50.57 71.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.92 0.391 . . . . 0.0 111.871 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.566 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.54 -51.42 62.93 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.705 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.878 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.33 -41.41 65.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.582 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 48.0 t80 -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.635 0.731 . . . . 0.0 109.366 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.799 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.3 m -59.91 -53.42 58.1 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.808 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.71 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 117.887 0.312 . . . . 0.0 110.681 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.28 -45.24 83.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.405 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.735 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.4 OUTLIER -70.41 -32.21 69.74 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.645 0.723 . . . . 0.0 111.075 177.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.799 ' HG3' ' O ' ' A' ' 409' ' ' THR . 49.7 mtm -68.65 -48.04 65.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.53 0.681 . . . . 0.0 109.521 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.04 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.3 mt -59.66 -40.14 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.653 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.695 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -78.32 -17.23 56.85 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.803 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 86.78 47.05 4.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.839 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.623 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 57.96 47.54 14.81 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.643 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 12.6 p30 -125.89 74.36 1.42 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.612 1.673 . . . . 0.0 106.953 161.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.735 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 2.1 p90 -58.57 -33.49 70.0 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.165 -2.288 . . . . 0.0 110.826 -160.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -55.11 -43.45 74.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.495 -165.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.497 ' HG ' ' H ' ' A' ' 422' ' ' VAL . 2.0 pp -63.42 -49.63 72.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.242 0.544 . . . . 0.0 110.721 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.68 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.71 -39.45 81.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.834 1.302 . . . . 0.0 109.207 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.556 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 41.2 t -61.91 -44.36 96.95 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.076 -2.329 . . . . 0.0 111.723 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.98 -40.74 82.97 Favored Glycine 0 C--N 1.316 -0.557 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.713 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -71.4 -41.92 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.623 0.725 . . . . 0.0 110.167 175.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.4 mm -55.13 -42.74 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.483 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.676 ' HA ' HD23 ' A' ' 430' ' ' LEU . 3.3 tmm_? -58.86 -36.05 73.96 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 123.201 1.477 . . . . 0.0 109.383 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.08 -8.34 69.18 Favored Glycine 0 C--N 1.283 -2.397 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.224 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.1 m-85 -105.6 -0.55 25.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.55 142.84 82.29 Favored Pre-proline 0 N--CA 1.406 -2.637 0 CA-C-O 123.585 1.66 . . . . 0.0 113.017 170.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.754 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 67.6 Cg_endo -70.75 -55.25 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.386 1 C-N-CA 126.164 4.576 . . . . 0.0 113.212 -172.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -118.79 143.5 17.48 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.372 -178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.867 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.31 -26.77 68.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.992 0.396 . . . . 0.0 111.268 -177.097 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.58 -48.46 79.32 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.985 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.5 t -58.25 -51.54 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.807 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.867 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -55.29 -53.33 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.402 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 99.9 m -61.85 -56.67 16.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.169 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.19 -45.93 79.59 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.57 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.811 ' O ' HD22 ' A' ' 443' ' ' LEU . 41.8 mt -59.66 -53.15 61.41 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.651 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.716 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 39.8 mm-40 -51.51 -35.44 40.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 O-C-N 124.882 1.364 . . . . 0.0 110.683 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.39 -60.59 2.17 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -76.09 -50.29 15.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.77 -0.581 . . . . 0.0 111.901 -172.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.811 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.88 63.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.384 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.747 ' N ' HD23 ' A' ' 443' ' ' LEU . 8.2 t70 -73.95 -41.85 61.4 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.129 0.966 . . . . 0.0 110.747 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.18 -8.15 43.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.514 ' HB3' ' CG2' ' A' ' 451' ' ' THR . 51.5 mm-40 -51.77 157.16 1.24 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.377 1.561 . . . . 0.0 114.186 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.431 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -53.87 -32.92 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.841 -2.89 . . . . 0.0 115.191 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.665 ' H ' ' HB ' ' A' ' 451' ' ' THR . 68.9 m-20 -135.18 178.22 7.2 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.417 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.8 p-10 -66.54 -51.48 56.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -69.43 -22.98 63.62 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 31.1 m -57.79 -39.5 77.67 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 119.888 1.222 . . . . 0.0 109.398 170.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.617 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 75.7 mtt180 -60.72 -30.42 69.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.356 172.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.582 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.84 -35.36 59.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.164 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.93 -43.16 25.3 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.654 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 40.2 p -101.46 -2.09 31.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.295 -169.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.685 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.2 t80 -49.04 -54.58 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.827 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.3 mm -69.97 -26.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -42.96 63.59 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 463' ' ' VAL . 39.7 m-70 -67.3 -31.04 71.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.562 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.724 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -64.37 -53.89 41.53 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.174 0.987 . . . . 0.0 109.093 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.45 -30.69 71.42 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.799 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -66.94 -48.67 67.9 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.463 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.985 HG11 ' HA ' ' A' ' 435' ' ' VAL . 34.2 t -65.35 -36.24 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.471 175.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.5 m-30 -60.17 -13.9 14.54 Favored 'General case' 0 C--O 1.202 -1.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.625 168.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.3 tp10 -95.52 -51.93 4.34 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.213 -0.929 . . . . 0.0 112.467 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -62.62 -41.36 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.374 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.805 HD12 HD11 ' A' ' 469' ' ' LEU . 6.7 mt -83.94 -17.51 40.4 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.822 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.31 49.67 60.1 Favored Glycine 0 C--O 1.211 -1.294 0 CA-C-N 111.481 -2.599 . . . . 0.0 113.239 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.805 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -102.86 172.91 6.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 123.951 0.9 . . . . 0.0 110.149 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.585 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.5 p-10 -92.64 -39.59 11.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -161.96 -75.57 0.05 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.197 159.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.754 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -66.26 71.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.064 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.47 42.0 2.46 Favored Glycine 0 C--N 1.275 -2.817 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.217 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.585 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 3.3 mm100 -80.24 -54.83 5.38 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.472 1.13 . . . . 0.0 111.102 -174.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.1 t 68.91 61.16 0.33 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.372 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.822 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -57.2 -47.66 83.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 111.023 -2.808 . . . . 0.0 111.893 174.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 477' ' ' ARG . 17.7 mmt180 -54.86 142.07 30.81 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.968 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.6 mt -49.26 -55.61 12.09 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.533 -174.34 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 N--CA 1.479 0.623 0 N-CA-C 110.567 -0.59 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.3 mp -80.32 -51.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 140.43 -118.75 1.47 Allowed Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.01 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 26.5 m -130.77 134.81 47.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 0.0 110.707 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.5 t -75.11 123.98 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.636 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.786 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.7 mt -77.2 123.66 87.12 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 122.026 0.917 . . . . 0.0 112.657 -174.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 308' ' ' GLN . 37.4 Cg_endo -73.55 -20.04 20.99 Favored 'Trans proline' 0 CA--C 1.502 -1.106 0 C-N-CA 124.881 3.721 . . . . 0.0 111.116 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.711 HG23 ' HG2' ' A' ' 308' ' ' GLN . 3.6 tp 41.03 -63.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 127.833 2.453 . . . . 0.0 115.584 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.711 ' HG2' HG23 ' A' ' 307' ' ' ILE . 69.7 mm-40 -59.35 -33.67 71.43 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 123.409 0.684 . . . . 0.0 110.631 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.518 ' CG ' HG13 ' A' ' 338' ' ' VAL . 8.7 t-160 -60.5 -47.79 84.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.514 172.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.654 HG13 HG11 ' A' ' 338' ' ' VAL . 64.9 mt -60.28 -48.66 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 123.875 0.87 . . . . 0.0 112.091 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.692 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 14.1 mtp180 -57.5 -30.45 65.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 122.852 0.461 . . . . 0.0 111.798 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -34.17 74.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.462 0.648 . . . . 0.0 109.957 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.504 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.92 -40.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.515 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.743 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 36.3 p -81.91 -36.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.827 1.298 . . . . 0.0 109.793 -176.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 85.93 36.03 10.66 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 112.315 -2.221 . . . . 0.0 111.064 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 34.3 mt-10 53.97 168.21 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.585 ' HG3' HD12 ' A' ' 355' ' ' LEU . 63.7 Cg_exo -47.13 147.13 5.63 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.674 2.916 . . . . 0.0 113.55 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 18.0 Cg_endo -96.94 -105.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.769 2.979 . . . . 0.0 113.378 -170.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.432 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 15.5 mmt180 -86.52 -86.26 0.15 Allowed 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 123.207 0.603 . . . . 0.0 110.687 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 22.6 m-20 -102.9 166.36 12.04 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.036 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.518 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 34.5 Cg_exo -58.35 -50.35 9.94 Favored 'Trans proline' 0 CA--C 1.511 -0.631 0 C-N-CA 122.536 2.158 . . . . 0.0 110.571 169.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.474 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -60.32 -11.72 7.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.295 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 320' ' ' ASN . 1.6 mm-40 -92.19 -22.52 19.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.257 . . . . 0.0 111.591 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.765 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.71 -40.88 56.4 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.74 ' HA ' HD23 ' A' ' 378' ' ' LEU . 7.9 Cg_endo -49.61 -62.56 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.916 2.411 . . . . 0.0 113.05 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.67 ' O ' ' HG3' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -60.46 -37.2 73.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 122.329 1.062 . . . . 0.0 110.303 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.743 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 63.1 t90 -58.56 -38.05 77.02 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.741 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.831 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -70.85 -50.59 33.62 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -54.36 -24.05 28.73 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.554 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 326' ' ' ILE . 21.4 mtp180 -75.21 -40.59 59.08 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 122.271 1.034 . . . . 0.0 112.0 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.618 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.0 m-20 -94.27 -24.41 17.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.511 -1.677 . . . . 0.0 113.195 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.57 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.67 -49.28 13.3 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 124.635 1.174 . . . . 0.0 113.803 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.5 Cg_endo -60.78 -34.41 91.64 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 122.464 2.109 . . . . 0.0 111.488 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -74.06 -43.39 57.93 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.544 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.621 HG23 HG23 ' A' ' 310' ' ' ILE . 94.1 mt -58.26 -47.08 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.013 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -13.8 2.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.995 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.86 -51.18 4.62 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.26 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.654 HG11 HG13 ' A' ' 310' ' ' ILE . 94.6 t -57.81 -70.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 123.128 1.442 . . . . 0.0 109.846 170.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.811 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.5 OUTLIER -87.4 125.68 64.79 Favored Pre-proline 0 N--CA 1.408 -2.526 0 CA-C-N 111.644 -2.526 . . . . 0.0 111.885 -175.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.671 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.1 Cg_endo -70.83 -19.71 30.68 Favored 'Trans proline' 0 CA--C 1.493 -1.566 0 C-N-CA 123.736 2.957 . . . . 0.0 110.283 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 33.24 70.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.54 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.569 ' N ' HD12 ' A' ' 346' ' ' LEU . 68.7 p -79.96 2.65 22.77 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.684 -2.053 . . . . 0.0 112.821 -170.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.81 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 18.0 p -143.22 161.65 46.8 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-O 121.457 0.646 . . . . 0.0 109.753 177.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.1 -40.67 32.26 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 124.403 3.402 . . . . 0.0 109.8 172.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -47.86 -55.11 10.56 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.625 -2.079 . . . . 0.0 110.298 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.81 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.7 mt -57.64 -51.38 69.76 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.817 -175.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.791 ' HA ' HD12 ' A' ' 350' ' ' ILE . 10.1 ttm180 -52.92 -42.06 65.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.934 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.509 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 42.0 t -68.26 -49.95 57.13 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.972 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.657 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 60.3 mtp180 -61.14 -37.64 83.57 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.476 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.894 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -57.44 -52.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 O-C-N 123.371 0.419 . . . . 0.0 111.006 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.613 ' O ' HD22 ' A' ' 355' ' ' LEU . 18.3 mt -58.38 -54.19 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 122.098 0.952 . . . . 0.0 110.964 -172.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.573 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 21.8 m-20 -63.96 -35.62 81.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.004 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ALA . . . . . 0.565 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.77 -29.22 65.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.876 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.894 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.8 mm -56.67 -59.49 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 CA-C-O 122.794 1.283 . . . . 0.0 110.161 174.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.765 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.87 -26.3 54.07 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 111.977 -2.374 . . . . 0.0 109.772 -167.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.58 -71.68 1.56 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.065 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -115.85 33.07 5.37 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.949 -176.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.63 HD21 ' N ' ' A' ' 358' ' ' ASN . 0.0 OUTLIER -58.32 134.32 56.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 175.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.707 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -47.77 -72.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 C-N-CA 124.237 1.015 . . . . 0.0 112.854 -170.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -131.62 7.6 5.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.758 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.586 ' HB3' HD12 ' A' ' 378' ' ' LEU . 2.6 mt -70.89 -4.59 25.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.669 0.747 . . . . 0.0 109.942 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.573 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 8.7 t -63.62 80.31 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.994 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.861 HD11 HG21 ' A' ' 377' ' ' THR . 1.7 mm? -60.35 -170.82 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 30.5 p -124.77 157.49 65.88 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.613 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 53.0 Cg_exo -46.65 -37.73 21.05 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.09 1.86 . . . . 0.0 111.491 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.528 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -86.05 2.96 87.62 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.693 -0.685 . . . . 0.0 114.594 -172.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.698 ' HB2' HD12 ' A' ' 363' ' ' LEU . 24.2 m-20 -109.21 -22.15 12.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.916 0.865 . . . . 0.0 110.083 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.732 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 62.7 m -94.3 19.74 9.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.67 -169.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.528 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -58.74 -41.27 86.06 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.897 -170.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.9 157.25 27.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 113.276 -1.783 . . . . 0.0 109.373 170.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.641 ' O ' HG13 ' A' ' 375' ' ' VAL . 51.5 m95 -69.59 -35.89 75.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.433 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.95 -38.56 91.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.352 -174.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 37.1 t -70.25 -44.0 69.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.11 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.551 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -63.33 -52.17 62.98 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.831 HG12 ' HB3' ' A' ' 328' ' ' LEU . 14.9 m -55.63 -46.35 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.494 0.664 . . . . 0.0 110.192 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.089 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -58.52 -37.5 75.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.848 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.861 HG21 HD11 ' A' ' 363' ' ' LEU . 39.0 m -75.29 -41.75 56.37 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.931 -171.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.74 HD23 ' HA ' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -58.82 -34.42 71.5 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.821 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.712 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 30.0 t80 -70.99 -49.1 48.96 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.49 1.138 . . . . 0.0 109.627 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.03 -32.12 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.976 170.519 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -60.0 -34.4 73.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.878 0.471 . . . . 0.0 111.451 175.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 26.1 p -103.83 -23.34 13.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.956 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -110.12 22.94 14.96 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.15 17.04 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 114.359 0.504 . . . . 0.0 114.359 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.427 HG23 HG13 ' A' ' 380' ' ' ILE . 1.1 m 66.64 154.79 0.09 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.386 0.613 . . . . 0.0 111.236 -175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -119.12 154.57 53.52 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 389' ' ' HIS . 83.2 Cg_endo -96.09 54.55 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.36 2.707 . . . . 0.0 111.207 167.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.783 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.0 -7.44 0.07 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.404 ' H ' ' C ' ' A' ' 387' ' ' PRO . 45.4 t-80 -69.21 -43.79 73.4 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.659 0.266 . . . . 0.0 111.235 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.2 mt-30 -69.38 -26.24 64.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.783 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.8 mm? -54.03 -29.82 45.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.354 0.525 . . . . 0.0 110.976 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.653 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.24 -53.29 38.61 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.683 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.589 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 34.4 m-20 -64.36 -41.38 96.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.861 0.464 . . . . 0.0 111.947 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.72 -45.2 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.249 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.701 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.8 mm -58.05 -47.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.161 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 27.3 mmtt -52.78 -42.62 65.19 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.027 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -75.7 -44.91 18.96 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.494 -1.336 . . . . 0.0 112.637 -173.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.904 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.1 mt -69.87 -41.46 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 117.16 0.48 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.3 m -57.35 -43.57 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.54 0.686 . . . . 0.0 110.381 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 399' ' ' VAL . 2.7 t70 -65.66 -37.43 86.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.975 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 74.4 mt-30 -82.56 -52.63 6.66 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.458 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.563 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -115.14 -30.39 6.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.031 -167.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 128.33 164.69 11.63 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.043 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.937 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -63.75 -43.01 97.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 122.653 0.381 . . . . 0.0 111.783 -176.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.638 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -57.26 -50.41 72.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.294 0.568 . . . . 0.0 111.246 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.563 HG21 ' HD2' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -63.37 -52.04 63.35 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 179.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.904 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.74 -40.41 66.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 176.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.604 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 32.9 t80 -58.4 -43.53 88.61 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.791 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.4 m -62.84 -53.18 58.11 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.624 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.659 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.14 -49.49 77.42 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.249 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.14 -42.34 87.59 Favored Glycine 0 C--N 1.314 -0.649 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.255 -174.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.75 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.17 -31.84 66.29 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 116.686 0.243 . . . . 0.0 110.956 179.085 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.791 ' HG3' ' O ' ' A' ' 409' ' ' THR . 50.8 mtm -69.51 -47.98 62.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 109.742 173.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.089 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.1 mt -59.02 -40.58 85.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.453 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.674 ' HG ' ' HG ' ' A' ' 391' ' ' LEU . 0.2 OUTLIER -77.08 -8.82 58.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.394 -177.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.42 33.54 7.97 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.952 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.75 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.3 mm100 57.26 48.46 15.03 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.054 -1.073 . . . . 0.0 112.814 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.485 ' OD1' HD21 ' A' ' 421' ' ' LEU . 12.9 p30 -120.17 63.53 0.83 Allowed 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 165.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.732 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 1.0 OUTLIER -44.59 -35.02 2.37 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.426 -2.624 . . . . 0.0 112.871 -163.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 39.5 mt-30 -55.71 -43.01 76.08 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -165.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.486 ' HG ' ' H ' ' A' ' 422' ' ' VAL . 1.9 pp -63.39 -48.4 78.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.54 -38.99 79.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.579 1.181 . . . . 0.0 109.059 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.51 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 35.9 t -59.62 -46.34 89.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.356 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.9 -39.03 76.97 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.207 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.1 -40.56 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.582 0.706 . . . . 0.0 110.24 174.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 404' ' ' VAL . 1.8 mm -58.13 -45.21 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.023 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.665 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.72 -29.53 68.19 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.76 1.267 . . . . 0.0 108.746 -174.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.17 -15.37 74.52 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 112.71 -2.041 . . . . 0.0 112.562 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.604 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 10.2 m-85 -101.17 -0.33 36.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.27 142.9 80.6 Favored Pre-proline 0 N--CA 1.414 -2.263 0 CA-C-O 123.653 1.692 . . . . 0.0 113.626 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.747 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 66.9 Cg_endo -71.71 -61.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.227 4.618 . . . . 0.0 113.603 -172.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.561 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.15 142.17 17.04 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.147 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.918 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.96 -27.47 68.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.316 0.558 . . . . 0.0 111.701 -176.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.809 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.22 -48.89 77.66 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.048 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.2 t -61.61 -37.66 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.485 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.918 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.13 -44.19 65.48 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.261 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 67.1 m -71.9 -54.94 8.47 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.433 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.0 -46.11 78.84 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.414 0.446 . . . . 0.0 111.168 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 460' ' ' LEU . 21.1 mt -60.11 -54.11 49.8 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.47 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.765 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 2.5 mp0 -51.26 -33.59 29.03 Favored 'General case' 0 N--CA 1.405 -2.69 0 O-C-N 125.487 1.742 . . . . 0.0 111.108 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.1 -59.81 2.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.518 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -75.76 -50.19 15.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.978 0.354 . . . . 0.0 111.895 -173.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.768 HD23 ' N ' ' A' ' 444' ' ' ASP . 0.1 OUTLIER -59.0 -24.7 63.01 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.623 -178.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.768 ' N ' HD23 ' A' ' 443' ' ' LEU . 7.2 t70 -73.32 -41.05 63.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.882 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -72.31 -8.16 53.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -172.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.484 ' HB3' HG22 ' A' ' 451' ' ' THR . 6.1 mm-40 -56.85 162.76 2.23 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.176 1.465 . . . . 0.0 114.317 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.771 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -55.82 -33.52 34.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 111.31 -2.677 . . . . 0.0 115.974 -168.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.64 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.9 m-20 -145.03 -175.73 4.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.464 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.7 m-20 -65.11 -56.81 10.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.58 -25.21 67.31 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 177.321 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.771 HG21 ' HB ' ' A' ' 447' ' ' ILE . 17.0 m -56.85 -44.02 81.74 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.708 1.14 . . . . 0.0 109.47 170.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.728 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 27.6 mtm-85 -62.13 -29.45 70.35 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.774 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.604 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.25 -28.67 62.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.032 0.92 . . . . 0.0 109.449 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -86.21 -43.73 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.22 -171.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.8 p -103.44 -3.99 24.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.932 -169.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.686 ' HB2' ' O ' ' A' ' 452' ' ' ARG . 8.8 t80 -49.12 -53.58 20.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.668 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.638 HG23 ' HB1' ' A' ' 405' ' ' ALA . 21.4 mm -71.17 -25.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.433 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.97 -43.54 62.13 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.559 ' O ' HG23 ' A' ' 463' ' ' VAL . 80.1 m-70 -67.92 -31.1 70.63 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.215 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.812 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.8 -53.98 42.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.165 0.984 . . . . 0.0 109.177 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -61.61 -30.41 70.67 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.785 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -69.06 -47.57 64.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.585 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.048 HG11 ' HA ' ' A' ' 435' ' ' VAL . 45.6 t -66.06 -35.78 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.314 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.535 ' OH ' HG13 ' A' ' 404' ' ' VAL . 20.0 m-30 -61.12 -14.09 21.98 Favored 'General case' 0 C--O 1.2 -1.504 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.647 168.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.569 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 6.3 tp10 -93.36 -52.03 4.71 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.444 -0.785 . . . . 0.0 112.323 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -62.98 -41.31 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.421 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.809 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.7 mt -84.33 -17.12 40.53 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.741 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 66.1 49.35 58.5 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 111.633 -2.53 . . . . 0.0 113.336 173.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.739 HD11 HD12 ' A' ' 467' ' ' LEU . 0.6 OUTLIER -101.81 -176.59 3.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.056 0.943 . . . . 0.0 110.04 -179.21 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.594 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.4 p-10 -105.11 -40.63 5.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 167.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.452 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -159.06 -79.38 0.06 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.335 -2.211 . . . . 0.0 110.91 158.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.747 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.5 OUTLIER -61.41 73.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -170.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.493 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.73 44.69 0.71 Allowed Glycine 0 C--N 1.274 -2.864 0 CA-C-N 110.462 -3.063 . . . . 0.0 113.227 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.594 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 2.8 mm100 -79.66 -55.19 5.19 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.273 1.035 . . . . 0.0 111.223 -173.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.7 t 65.69 47.81 2.07 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.912 -2.403 . . . . 0.0 108.095 -173.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -43.42 -47.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 109.808 -3.36 . . . . 0.0 112.303 176.328 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 477' ' ' ARG . 12.7 mmt180 -47.48 137.63 8.58 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.266 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.72 -27.56 66.58 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.651 0.78 . . . . 0.0 112.434 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.251 1.167 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.593 176.631 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.476 0.467 0 N-CA-C 110.44 -0.639 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.0 mp -111.89 106.18 20.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -88.35 153.86 24.67 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.762 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.412 ' HB ' HD11 ' A' ' 346' ' ' LEU . 52.9 m -91.97 136.76 32.91 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.392 0.615 . . . . 0.0 111.353 -176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.8 t -83.51 121.25 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.157 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.801 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 47.6 mt -71.11 121.19 83.46 Favored Pre-proline 0 N--CA 1.426 -1.665 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.585 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 57.8 Cg_endo -82.09 58.21 6.56 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 124.92 3.746 . . . . 0.0 109.592 170.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.671 HG12 ' HB1' ' A' ' 353' ' ' ALA . 1.7 tp -45.52 -47.38 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 112.12 -2.309 . . . . 0.0 113.347 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.628 ' HG2' HG23 ' A' ' 307' ' ' ILE . 16.7 mm-40 -65.63 -35.65 81.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.327 0.584 . . . . 0.0 111.282 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.429 ' HB3' HG11 ' A' ' 338' ' ' VAL . 1.4 t-80 -61.89 -47.41 85.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.615 173.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.624 HG23 HG23 ' A' ' 335' ' ' ILE . 67.5 mt -61.25 -49.62 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.058 0.943 . . . . 0.0 113.043 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 28.1 mtp180 -59.93 -29.57 68.47 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.05 0.54 . . . . 0.0 111.602 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 69.4 m -69.67 -33.26 72.31 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.606 0.717 . . . . 0.0 110.266 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.502 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.27 -40.86 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.936 177.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.664 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 34.4 p -82.13 -36.47 27.43 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.805 1.288 . . . . 0.0 109.928 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.23 34.42 9.67 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 112.323 -2.217 . . . . 0.0 110.813 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 33.2 mt-10 52.46 170.24 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.67 ' HG3' HD12 ' A' ' 355' ' ' LEU . 93.7 Cg_exo -49.63 150.67 8.53 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.213 2.609 . . . . 0.0 113.246 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 42.4 Cg_endo -93.37 -104.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.444 2.763 . . . . 0.0 112.11 -174.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.415 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 20.0 mmt180 -95.17 -84.58 0.33 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 12.1 m-20 -96.07 163.47 20.86 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.876 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.491 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.75 -48.64 12.19 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.732 2.288 . . . . 0.0 110.434 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.46 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -56.36 -17.14 6.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.509 -1.678 . . . . 0.0 113.562 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.528 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 39.7 mt-10 -87.38 -27.97 22.46 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.368 -0.208 . . . . 0.0 110.993 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.719 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.09 -43.69 69.31 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.698 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 3.5 Cg_endo -46.64 -65.35 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.098 2.532 . . . . 0.0 112.997 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.597 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.61 -37.62 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.317 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.664 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.5 t90 -57.68 -34.05 69.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.114 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.832 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.58 -50.23 39.46 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.38 -23.73 27.73 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.903 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.534 ' HD2' HG21 ' A' ' 406' ' ' THR . 2.4 mtm-85 -73.23 -40.78 64.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.317 1.056 . . . . 0.0 110.369 175.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.654 ' HB3' HG22 ' A' ' 314' ' ' THR . 56.6 m-20 -97.75 -24.91 15.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.716 -1.584 . . . . 0.0 114.004 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.63 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.66 -49.72 13.07 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.4 Cg_endo -61.13 -32.93 91.68 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.495 2.13 . . . . 0.0 111.528 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.97 -43.51 57.89 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.483 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 332' ' ' ALA . 92.9 mt -57.44 -47.24 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.942 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 36.9 t70 -55.93 -14.78 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.202 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.82 -47.37 6.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.429 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.555 HG11 HG13 ' A' ' 310' ' ' ILE . 92.2 t -63.49 -72.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.296 1.522 . . . . 0.0 109.946 169.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.801 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -84.05 122.48 75.93 Favored Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.665 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.704 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.2 Cg_endo -72.23 -17.25 27.86 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.094 3.196 . . . . 0.0 110.159 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.4 p 33.89 67.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.068 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.559 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.5 p -78.35 0.7 24.5 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.775 -2.012 . . . . 0.0 112.572 -170.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.817 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -138.06 159.09 69.78 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.697 ' HB3' HD12 ' A' ' 369' ' ' LEU . 68.1 Cg_exo -60.53 -44.94 24.0 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 123.583 2.855 . . . . 0.0 108.797 172.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.616 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -44.99 -52.43 8.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.722 -2.035 . . . . 0.0 110.776 176.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.817 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.0 mt -56.94 -52.3 65.73 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.845 ' HA ' HD12 ' A' ' 350' ' ' ILE . 25.3 ttm180 -49.94 -46.23 51.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.603 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.941 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 8.2 m -68.12 -50.86 52.12 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.146 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.694 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 35.2 mtt180 -61.23 -34.82 75.75 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.409 0.443 . . . . 0.0 111.105 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.888 ' O ' HG12 ' A' ' 354' ' ' ILE . 32.7 mt -56.22 -51.5 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.898 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 328' ' ' LEU . 21.7 mt -60.38 -53.84 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 123.832 0.707 . . . . 0.0 111.744 -172.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.694 ' OD1' ' HA ' ' A' ' 349' ' ' ARG . 0.0 OUTLIER -60.41 -36.13 77.42 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.822 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ALA . . . . . 0.671 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -71.19 -29.79 65.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.888 HG12 ' O ' ' A' ' 350' ' ' ILE . 4.3 mm -58.03 -59.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 CA-C-O 123.082 1.42 . . . . 0.0 110.493 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.719 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -78.62 -26.96 45.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.26 -167.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.85 -78.7 0.2 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.903 -1.499 . . . . 0.0 113.023 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -102.4 36.31 4.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.415 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.742 HD22 ' HB2' ' A' ' 361' ' ' LEU . 22.0 p-10 -70.63 131.46 43.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.069 0.461 . . . . 0.0 110.649 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.662 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -49.62 -72.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -169.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.9 2.94 6.91 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.885 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.742 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.2 mt -72.46 -4.62 31.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.943 0.877 . . . . 0.0 109.953 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 8.2 t -69.18 70.55 0.24 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.378 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 367' ' ' ASP . 1.5 mm? -55.03 172.31 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.5 p -120.27 159.4 47.74 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.325 -175.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.888 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.1 Cg_endo -53.3 -9.98 1.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.156 2.57 . . . . 0.0 113.215 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -103.49 -17.99 15.8 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.261 0.864 . . . . 0.0 115.261 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.732 ' HB2' HD12 ' A' ' 363' ' ' LEU . 4.9 m-20 -105.72 -23.61 12.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.617 1.208 . . . . 0.0 110.649 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.941 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 8.6 t -96.18 25.24 5.02 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.653 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.39 -37.01 64.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.635 0.731 . . . . 0.0 110.467 -170.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.26 161.2 20.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.514 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.584 ' O ' HG13 ' A' ' 375' ' ' VAL . 30.3 m95 -69.41 -36.67 76.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.535 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.5 OUTLIER -64.31 -40.47 95.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.531 -174.195 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.1 t -69.08 -43.11 75.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.65 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.44 -53.44 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.832 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.6 m -57.55 -43.02 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.624 0.726 . . . . 0.0 109.731 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 0.994 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -64.13 -42.75 96.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.272 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.622 ' CG2' HD21 ' A' ' 363' ' ' LEU . 22.8 m -69.32 -37.93 77.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.768 -173.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.664 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -61.33 -34.61 75.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.58 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.698 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 56.9 t80 -75.33 -43.98 47.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.161 0.982 . . . . 0.0 109.414 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.08 -33.01 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.245 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.6 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.42 -34.63 74.23 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 123.141 0.576 . . . . 0.0 111.956 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.8 p -111.05 -23.53 10.87 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -165.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -109.98 25.6 11.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.63 50.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.959 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 64.12 164.39 0.13 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.023 0.439 . . . . 0.0 111.269 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.513 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -130.41 153.67 81.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -99.37 54.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.571 2.847 . . . . 0.0 111.248 165.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.715 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.5 -0.53 0.18 Allowed 'General case' 0 C--O 1.231 0.1 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.715 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -69.13 -44.51 72.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.951 0.405 . . . . 0.0 110.571 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 394' ' ' VAL . 93.5 mt-30 -75.01 -26.03 59.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.2 mm? -53.62 -31.71 48.31 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.28 0.945 . . . . 0.0 111.515 -174.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.707 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.45 -56.26 24.42 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.701 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.516 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 51.6 t30 -64.56 -34.47 78.32 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 110.717 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 391' ' ' LEU . 44.9 t -53.55 -53.64 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.645 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.762 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.0 mm -59.15 -48.26 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 175.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.707 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 39.9 mmtt -52.71 -38.47 60.77 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 124.185 0.928 . . . . 0.0 112.056 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.57 -45.26 8.73 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.607 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.959 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.1 mt -70.33 -40.68 78.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 117.762 0.781 . . . . 0.0 111.271 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -57.75 -44.0 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.575 0.702 . . . . 0.0 110.028 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.2 t70 -60.38 -36.62 78.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.576 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -91.19 -55.56 3.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.693 ' HG2' HG21 ' A' ' 406' ' ' THR . 3.0 tp10 -106.42 -34.42 7.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.245 0.545 . . . . 0.0 112.289 -172.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 129.97 167.29 12.03 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.511 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.954 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.55 -43.16 96.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -174.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.62 -51.0 70.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.693 HG21 ' HG2' ' A' ' 402' ' ' GLU . 0.9 OUTLIER -66.03 -48.79 69.96 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.756 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.959 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.96 -39.68 66.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 41.1 t80 -57.06 -47.2 81.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.676 0.75 . . . . 0.0 109.189 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.79 ' O ' ' HG3' ' A' ' 413' ' ' MET . 15.6 m -59.62 -53.0 63.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.008 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.673 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.49 -49.12 78.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.784 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.2 -42.47 88.19 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.18 -174.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.572 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.944 0.372 . . . . 0.0 110.746 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.804 ' HE3' HG21 ' A' ' 375' ' ' VAL . 65.5 mtm -69.57 -48.31 60.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.418 0.628 . . . . 0.0 110.047 175.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.994 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.0 mt -59.61 -37.56 78.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.376 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.682 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -77.76 -16.22 58.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.722 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.95 4.02 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.179 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.663 HE22 ' HA ' ' A' ' 413' ' ' MET . 0.1 OUTLIER 50.19 48.49 22.05 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 124.49 1.116 . . . . 0.0 113.91 -177.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.647 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 16.0 p30 -121.1 65.06 0.86 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 123.419 1.581 . . . . 0.0 107.294 166.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' A' ' 423' ' ' SER . 0.4 OUTLIER -44.17 -35.06 2.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.52 -2.582 . . . . 0.0 112.984 -164.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 423' ' ' SER . 53.5 mt-30 -54.66 -45.62 73.89 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -165.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 422' ' ' VAL . 2.2 pp -62.75 -48.82 77.52 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.02 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.684 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -61.28 -39.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 122.7 1.238 . . . . 0.0 109.04 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.544 ' HB2' ' HD2' ' A' ' 419' ' ' TYR . 31.3 t -60.27 -46.58 89.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.405 -2.18 . . . . 0.0 111.718 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.85 -38.7 75.04 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.656 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.3 mt -71.96 -40.97 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.441 0.638 . . . . 0.0 110.285 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.531 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -57.94 -44.09 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.618 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.662 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -58.23 -31.95 67.86 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 124.826 1.25 . . . . 0.0 109.046 -175.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.427 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -71.98 -13.36 75.82 Favored Glycine 0 C--N 1.301 -1.409 0 CA-C-N 113.0 -1.909 . . . . 0.0 112.595 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.639 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.0 m-85 -102.52 0.15 33.14 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.67 138.76 86.25 Favored Pre-proline 0 N--CA 1.408 -2.574 0 CA-C-O 123.752 1.739 . . . . 0.0 113.126 171.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.736 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 57.7 Cg_endo -68.58 -58.13 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.285 1 C-N-CA 126.34 4.694 . . . . 0.0 113.556 -170.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.538 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.51 143.46 18.1 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.96 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.937 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -27.53 69.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.433 0.617 . . . . 0.0 111.857 -173.371 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.36 -48.72 78.3 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.048 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.4 t -61.17 -36.9 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.617 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.937 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -73.19 -43.16 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -175.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 24.0 m -71.6 -55.61 7.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.923 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.8 83.51 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.81 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.841 HD13 HD22 ' A' ' 460' ' ' LEU . 29.2 mt -65.02 -54.24 33.47 Favored 'General case' 0 CA--C 1.477 -1.836 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.244 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.686 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 2.3 mp0 -52.18 -33.4 40.49 Favored 'General case' 0 N--CA 1.409 -2.515 0 O-C-N 125.21 1.569 . . . . 0.0 110.372 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.683 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -60.07 2.41 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 172.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -75.1 -49.47 19.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.839 -0.538 . . . . 0.0 112.116 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.81 -24.35 64.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.629 0.728 . . . . 0.0 111.774 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.741 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.1 t70 -72.8 -43.4 62.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.528 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.683 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.7 mt-30 -69.67 -8.35 46.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 55.6 mm-40 -51.68 154.96 1.77 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 123.148 1.451 . . . . 0.0 114.267 -176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.562 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -52.68 -32.48 17.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 111.444 -2.616 . . . . 0.0 115.409 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.661 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.5 m-20 -141.88 178.79 7.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.997 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.01 -51.15 67.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -70.77 -23.71 62.46 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 175.05 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.661 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -59.58 -40.35 87.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 120.011 1.278 . . . . 0.0 109.264 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.602 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 61.8 mtt180 -60.19 -31.25 69.95 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.36 171.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.536 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.36 -28.99 57.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.079 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.4 -43.84 13.29 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.047 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.499 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -103.06 -1.36 29.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.352 -168.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.724 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.6 t80 -48.88 -55.33 12.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.633 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.9 mm -70.32 -25.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.499 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.56 -43.28 63.65 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.543 ' O ' HG23 ' A' ' 463' ' ' VAL . 49.4 m-70 -67.71 -32.06 72.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.541 172.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.841 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.12 -53.39 54.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 122.172 0.987 . . . . 0.0 108.895 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -61.99 -31.1 71.44 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.629 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -67.18 -49.5 64.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.503 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.048 HG11 ' HA ' ' A' ' 435' ' ' VAL . 38.5 t -65.95 -34.38 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.8 m-30 -63.1 -14.6 50.42 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.617 169.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 7.4 tp10 -94.44 -52.29 4.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.889 0.852 . . . . 0.0 111.601 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.78 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.0 pt -63.33 -41.47 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.278 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 469' ' ' LEU . 7.2 mt -83.94 -17.78 39.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.779 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.41 50.13 57.24 Favored Glycine 0 C--O 1.218 -0.882 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.159 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 467' ' ' LEU . 0.6 OUTLIER -100.9 172.78 6.83 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.036 0.934 . . . . 0.0 110.275 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.644 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 0.9 OUTLIER -88.7 -44.16 10.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 166.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -162.18 -72.92 0.05 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.776 162.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.736 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -61.33 68.87 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.47 43.92 0.57 Allowed Glycine 0 C--N 1.275 -2.824 0 CA-C-N 110.715 -2.948 . . . . 0.0 113.564 173.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.644 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 3.4 mm100 -82.25 -55.62 4.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 122.578 1.18 . . . . 0.0 111.054 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 44.2 t 69.12 55.04 0.42 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.368 -2.651 . . . . 0.0 108.307 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -49.33 -46.9 19.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 110.584 -3.007 . . . . 0.0 111.544 174.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.518 ' HG2' HD12 ' A' ' 476' ' ' ILE . 28.9 mmm-85 -60.97 152.44 27.77 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.448 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 59.8 mt -60.48 154.32 21.05 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.721 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.434 -1.265 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.523 -178.058 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.478 0.596 0 N-CA-C 111.095 -0.387 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.7 mp -91.76 125.54 44.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.197 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 100.28 -107.6 3.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.911 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 86.4 m -157.07 127.0 6.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.586 0.708 . . . . 0.0 110.976 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 304' ' ' VAL . 1.5 p -70.21 121.62 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.323 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.841 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 54.4 mt -72.86 124.65 90.98 Favored Pre-proline 0 N--CA 1.423 -1.794 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.317 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 60.5 Cg_endo -83.0 53.78 4.52 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 124.969 3.779 . . . . 0.0 109.797 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.77 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 2.8 tp -43.06 -46.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 112.237 -2.256 . . . . 0.0 113.672 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.619 ' HG2' HG23 ' A' ' 307' ' ' ILE . 54.4 mm-40 -65.59 -36.29 83.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.692 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.4 t-160 -61.09 -46.21 91.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.315 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 335' ' ' ILE . 68.6 mt -62.84 -49.61 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 124.263 1.025 . . . . 0.0 113.254 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.77 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 22.9 mtp180 -59.27 -30.3 68.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 121.888 -0.507 . . . . 0.0 111.259 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 59.5 m -69.59 -32.72 71.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.557 0.694 . . . . 0.0 110.01 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.552 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.21 -40.58 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.022 177.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 331' ' ' ASN . 35.9 p -82.56 -37.53 25.0 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.788 1.28 . . . . 0.0 109.976 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.04 34.09 7.83 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.817 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 35.7 mt-10 53.52 169.42 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.61 ' HG3' HD12 ' A' ' 355' ' ' LEU . 25.4 Cg_exo -44.06 151.39 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.795 2.997 . . . . 0.0 113.621 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.459 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 17.2 Cg_endo -97.97 -108.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.356 2.704 . . . . 0.0 112.601 -174.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.421 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 9.6 mmm180 -92.47 -82.02 0.33 Allowed 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.592 0.71 . . . . 0.0 111.277 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.473 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 28.3 m-20 -102.63 158.63 31.39 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.133 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.468 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.1 Cg_exo -59.4 -49.67 10.1 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.654 2.236 . . . . 0.0 110.685 172.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -22.56 12.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.224 -1.807 . . . . 0.0 113.035 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.473 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -85.97 -24.37 26.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.718 HG12 HD11 ' A' ' 355' ' ' LEU . 0.0 OUTLIER -51.21 -40.95 71.95 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.706 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.4 Cg_endo -49.8 -62.22 0.45 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.903 2.402 . . . . 0.0 112.773 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.593 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.09 -37.18 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.236 177.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.668 ' CH2' HG21 ' A' ' 354' ' ' ILE . 55.5 t90 -58.35 -36.46 73.48 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.007 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.81 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.85 -49.99 46.97 Favored 'General case' 0 N--CA 1.396 -3.125 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.535 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.08 -24.04 26.63 Favored Glycine 0 C--N 1.311 -0.824 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.151 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.6 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.3 mtt180 -73.99 -41.68 61.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.042 0.925 . . . . 0.0 110.576 174.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.693 ' HB3' HG22 ' A' ' 314' ' ' THR . 56.9 m-20 -95.68 -23.6 16.93 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.82 -169.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.544 ' N ' ' HD2' ' A' ' 333' ' ' PRO . . . -43.5 -48.89 18.5 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.365 1.066 . . . . 0.0 113.727 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.1 Cg_endo -60.03 -34.56 94.73 Favored 'Trans proline' 0 CA--C 1.508 -0.796 0 C-N-CA 122.548 2.166 . . . . 0.0 111.539 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.4 -43.56 60.26 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.476 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 310' ' ' ILE . 97.1 mt -57.95 -48.24 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.872 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.56 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 31.8 t70 -54.27 -15.48 1.6 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.199 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.43 -51.65 4.83 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 310' ' ' ILE . 91.1 t -59.17 -72.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.255 1.502 . . . . 0.0 109.998 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.841 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.4 OUTLIER -87.98 121.07 70.87 Favored Pre-proline 0 N--CA 1.405 -2.69 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.685 -176.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.605 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.3 Cg_endo -72.92 -20.76 21.81 Favored 'Trans proline' 0 CA--C 1.496 -1.422 0 C-N-CA 123.736 2.957 . . . . 0.0 110.362 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.629 HG22 ' CD2' ' A' ' 339' ' ' PHE . 2.7 t 46.07 61.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 111.715 -2.493 . . . . 0.0 109.92 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.626 ' N ' HD12 ' A' ' 346' ' ' LEU . 35.9 p -75.85 5.56 6.24 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.914 -172.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.758 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -141.89 159.28 59.98 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.538 ' O ' ' HB2' ' A' ' 347' ' ' ARG . 56.2 Cg_exo -61.81 -44.3 21.7 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 123.924 3.083 . . . . 0.0 108.994 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.692 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -50.07 -44.17 51.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.037 -1.892 . . . . 0.0 111.523 175.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.819 ' O ' HG13 ' A' ' 350' ' ' ILE . 14.9 mt -59.21 -52.25 66.47 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.546 ' HD3' HG11 ' A' ' 341' ' ' VAL . 11.5 mmt180 -45.3 -52.44 9.71 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 125.249 1.593 . . . . 0.0 110.66 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.928 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -65.66 -49.2 69.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.713 -175.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.672 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 69.7 mtt180 -61.56 -39.31 90.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.888 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.6 mt -57.31 -55.43 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.788 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.351 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.659 ' O ' HD22 ' A' ' 355' ' ' LEU . 20.1 mt -57.65 -53.34 45.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 O-C-N 124.764 1.29 . . . . 0.0 110.736 -170.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 11.7 m-20 -63.14 -36.46 83.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.211 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ALA . . . . . 0.658 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -71.46 -30.61 66.21 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.173 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.888 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.2 mm -56.04 -58.09 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 CA-C-O 122.797 1.284 . . . . 0.0 110.312 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.718 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.99 -26.77 54.27 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.086 -2.325 . . . . 0.0 109.726 -168.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 73.69 -71.47 1.34 Allowed Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.93 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -113.21 37.88 3.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.941 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.724 HD22 ' HB2' ' A' ' 361' ' ' LEU . 20.2 p-10 -66.99 133.61 50.3 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.042 0.448 . . . . 0.0 110.563 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.663 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.1 mp -51.01 -77.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 124.409 1.084 . . . . 0.0 112.871 -169.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -124.92 7.0 8.26 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.492 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.724 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.6 mt -72.39 -4.63 31.19 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.67 0.748 . . . . 0.0 109.655 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.601 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 23.1 t -63.84 76.95 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.332 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.739 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -62.55 173.48 1.24 Allowed 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.7 p -122.05 156.39 59.89 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.896 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.928 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 6.7 Cg_endo -56.76 -3.54 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.856 2.37 . . . . 0.0 114.286 -172.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.477 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -104.59 -12.05 29.42 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.739 ' HB2' HD12 ' A' ' 363' ' ' LEU . 16.1 m-20 -109.25 -20.39 12.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.023 0.916 . . . . 0.0 110.853 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 17.1 p -96.75 15.21 22.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.117 -164.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' A' ' 344' ' ' PRO . 1.3 mt -58.75 -40.98 85.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.879 -161.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.88 163.15 16.98 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.223 170.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.573 ' O ' HG13 ' A' ' 375' ' ' VAL . 41.3 m95 -68.81 -35.74 77.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.547 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.2 p30 -62.73 -40.2 96.45 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.875 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.7 m -71.39 -41.04 70.14 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.066 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.568 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -66.53 -52.19 48.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.81 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.8 m -56.38 -45.36 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.377 0.608 . . . . 0.0 109.86 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.043 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.93 -42.37 93.81 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.105 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.632 ' CG2' HD21 ' A' ' 363' ' ' LEU . 19.6 m -70.81 -36.86 73.15 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.232 -172.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -62.99 -33.32 75.15 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.425 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.706 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.1 t80 -75.6 -44.5 42.63 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.433 1.111 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.45 -33.22 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.503 169.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.67 -41.69 95.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.168 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 28.7 p -99.91 -22.99 15.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.123 -168.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -111.14 22.64 15.01 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.21 20.9 16.97 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.422 HG23 HG13 ' A' ' 380' ' ' ILE . 2.7 m 66.96 159.87 0.14 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.265 0.533 . . . . 0.0 111.519 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -127.93 156.06 76.65 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -97.95 54.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.46 2.773 . . . . 0.0 111.643 168.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.756 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.28 -1.27 0.14 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -69.79 -46.12 66.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.143 0.497 . . . . 0.0 110.938 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.633 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.8 mt-30 -74.7 -25.59 59.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -53.87 -30.62 46.55 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.772 0.715 . . . . 0.0 111.283 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.667 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.47 -50.23 57.64 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.509 174.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.565 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 5.7 m-20 -67.89 -40.56 83.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.852 0.461 . . . . 0.0 111.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.14 -44.12 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.003 0.43 . . . . 0.0 110.438 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.703 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -58.35 -47.12 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.18 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.684 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 32.3 mmtt -53.07 -41.39 64.83 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.097 0.873 . . . . 0.0 111.897 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -76.75 -44.64 14.66 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.025 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.879 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -69.96 -40.81 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 117.302 0.551 . . . . 0.0 111.767 -178.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.871 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.0 m -57.75 -43.47 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.745 0.783 . . . . 0.0 109.721 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.48 ' N ' HG23 ' A' ' 399' ' ' VAL . 17.6 t70 -56.15 -43.7 78.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.252 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 33.1 mm-40 -84.1 -54.27 4.95 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.47 -172.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -110.58 -29.34 8.09 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.516 0.674 . . . . 0.0 112.535 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.78 171.38 14.04 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.688 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.871 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.3 -44.42 97.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.13 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.672 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.18 -51.05 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.927 0.394 . . . . 0.0 112.005 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.595 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.2 m -64.18 -51.2 64.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.553 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.879 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.55 -43.15 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 30.3 t80 -55.58 -46.32 77.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.686 0.755 . . . . 0.0 109.197 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.831 ' O ' ' HG3' ' A' ' 413' ' ' MET . 13.0 m -57.92 -52.68 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.353 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.674 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.66 -48.74 80.45 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.537 ' HA3' HD11 ' A' ' 395' ' ' ILE . . . -56.32 -42.62 89.13 Favored Glycine 0 C--N 1.313 -0.724 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.003 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.708 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -72.71 -32.52 65.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.823 0.311 . . . . 0.0 110.833 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.831 ' HG3' ' O ' ' A' ' 409' ' ' THR . 62.5 mtm -69.36 -46.6 66.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.09 174.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.043 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.16 -39.17 85.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.74 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.751 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -77.1 -16.87 59.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.057 -178.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.84 47.01 3.78 Favored Glycine 0 C--N 1.308 -1.018 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.024 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.623 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 49.71 48.69 21.24 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.521 1.128 . . . . 0.0 113.892 -177.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.615 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 12.5 p30 -123.57 66.0 1.01 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.708 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 14.4 p90 -51.48 -31.84 25.02 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.701 -161.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 34.1 mt-30 -53.89 -43.25 69.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.596 -165.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.507 HD21 ' OD1' ' A' ' 418' ' ' ASN . 2.0 pp -63.06 -48.1 80.1 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.329 0.585 . . . . 0.0 110.855 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.754 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -62.31 -38.97 82.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.588 1.185 . . . . 0.0 109.101 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 30.7 t -59.64 -45.95 90.45 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.301 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.47 87.27 Favored Glycine 0 C--N 1.316 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.844 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.1 mt -71.09 -41.31 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.501 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -56.43 -43.98 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.285 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.676 ' HD2' ' O ' ' A' ' 427' ' ' ARG . 1.8 tmm_? -56.97 -35.38 69.08 Favored 'General case' 0 N--CA 1.406 -2.647 0 C-N-CA 124.962 1.305 . . . . 0.0 109.837 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.74 -13.12 74.93 Favored Glycine 0 C--N 1.29 -1.985 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.948 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.5 m-85 -100.08 -3.64 31.49 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -59.24 142.96 85.71 Favored Pre-proline 0 N--CA 1.412 -2.329 0 CA-C-O 123.438 1.59 . . . . 0.0 112.875 173.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.781 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 88.5 Cg_endo -72.23 -53.25 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.083 4.522 . . . . 0.0 113.338 -170.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -120.94 140.33 14.08 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.894 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -63.19 -26.53 68.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.164 0.482 . . . . 0.0 111.776 -175.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.683 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.2 -48.46 78.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.018 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.4 t -58.44 -51.89 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.705 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.8 OUTLIER -54.87 -51.43 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 118.096 0.407 . . . . 0.0 109.945 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.447 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 86.4 m -62.67 -57.33 11.39 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.14 -44.76 79.54 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.368 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.85 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.0 mt -59.72 -53.71 54.83 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.73 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.708 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 21.1 mm100 -51.5 -35.14 39.05 Favored 'General case' 0 N--CA 1.417 -2.123 0 O-C-N 124.899 1.374 . . . . 0.0 110.669 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.624 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.32 -60.37 2.28 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 176.567 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.74 -51.71 10.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.378 0.535 . . . . 0.0 112.385 -172.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.74 -25.46 63.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.522 0.677 . . . . 0.0 111.575 -177.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.777 ' N ' HD23 ' A' ' 443' ' ' LEU . 10.7 t70 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.657 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 34.6 mt-30 -71.56 -6.85 43.8 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.471 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 25.2 mm-40 -51.86 161.25 0.58 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 123.662 1.696 . . . . 0.0 114.614 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.516 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -56.99 -33.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 110.443 -3.071 . . . . 0.0 115.199 -172.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.683 ' H ' ' HB ' ' A' ' 451' ' ' THR . 66.4 m-20 -138.96 179.99 6.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.441 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 8.9 p-10 -64.43 -55.32 21.67 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -68.28 -23.52 64.77 Favored 'General case' 0 N--CA 1.402 -2.868 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 176.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.683 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 25.4 m -58.82 -41.51 87.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.756 1.162 . . . . 0.0 109.677 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 48.2 mtt180 -60.16 -30.0 69.04 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.201 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.591 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.03 -33.64 59.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 109.877 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.02 -42.83 31.23 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.333 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 38.3 p -101.34 -4.18 27.46 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.375 -169.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.705 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.4 t80 -49.25 -52.82 24.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.846 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 405' ' ' ALA . 22.9 mm -71.75 -27.01 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -72.56 -42.45 64.65 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.583 ' O ' HG23 ' A' ' 463' ' ' VAL . 25.9 m80 -67.6 -31.17 71.03 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.473 -1.694 . . . . 0.0 109.96 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.77 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.41 -54.05 34.32 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 122.188 0.994 . . . . 0.0 109.165 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.733 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -62.26 -32.31 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.034 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.68 -53.27 58.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.922 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.018 HG11 ' HA ' ' A' ' 435' ' ' VAL . 25.9 t -63.45 -34.27 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-O 121.806 0.812 . . . . 0.0 110.287 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.607 ' HD1' HD12 ' A' ' 469' ' ' LEU . 20.2 m-30 -60.93 -14.39 22.22 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.191 169.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.733 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 45.0 mt-10 -93.81 -48.37 6.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.824 -1.173 . . . . 0.0 112.652 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.712 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.4 pt -64.6 -39.94 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.049 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.841 HD12 HD11 ' A' ' 469' ' ' LEU . 7.3 mt -84.46 -16.84 41.11 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.802 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.02 51.05 56.49 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 111.73 -2.486 . . . . 0.0 113.219 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.841 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -101.28 177.4 4.94 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.13 0.972 . . . . 0.0 109.88 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.553 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.6 p-10 -96.46 -44.11 7.33 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -157.39 -74.61 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.457 -2.156 . . . . 0.0 110.351 160.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.781 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -59.01 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -172.599 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.96 42.69 0.37 Allowed Glycine 0 C--N 1.275 -2.854 0 CA-C-N 111.423 -2.626 . . . . 0.0 113.613 173.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.553 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 3.5 mm100 -81.32 -51.99 7.78 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 122.79 1.281 . . . . 0.0 111.453 -172.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.4 t 68.91 61.47 0.33 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.171 -2.74 . . . . 0.0 109.037 -173.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.802 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -53.44 -48.36 57.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 110.923 -2.853 . . . . 0.0 111.463 175.345 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -55.31 132.97 49.21 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.009 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.593 HD22 ' H ' ' A' ' 478' ' ' LEU . 2.9 mm? -61.86 -28.9 69.82 Favored 'General case' 0 N--CA 1.418 -2.054 0 C-N-CA 124.515 1.126 . . . . 0.0 112.557 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 . . . . . 0 N--CA 1.436 -1.161 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.169 -179.8 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo . . . . . 0 N--CA 1.479 0.665 0 N-CA-C 110.309 -0.689 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.6 mp -85.08 -56.99 4.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.863 0.363 . . . . 0.0 110.171 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -140.03 55.17 0.64 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.559 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.553 ' HB ' HD11 ' A' ' 346' ' ' LEU . 28.5 m 73.3 116.18 0.05 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.364 1.078 . . . . 0.0 111.926 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.2 p -75.69 131.25 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.043 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.768 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 31.9 mt -78.74 125.56 84.02 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 121.89 0.852 . . . . 0.0 111.878 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 308' ' ' GLN . 26.0 Cg_endo -74.97 -12.04 21.57 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.99 3.793 . . . . 0.0 111.663 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.71 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.1 tp 30.31 -64.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 O-C-N 126.973 2.671 . . . . 0.0 115.996 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.709 ' HG2' HG23 ' A' ' 307' ' ' ILE . 66.6 mm-40 -58.24 -33.24 69.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.466 0.65 . . . . 0.0 110.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.443 ' HB3' HG11 ' A' ' 338' ' ' VAL . 1.5 t-80 -61.42 -48.83 79.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.646 172.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 307' ' ' ILE . 64.2 mt -59.06 -48.38 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 124.111 0.965 . . . . 0.0 112.51 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.5 mtp-105 -58.33 -30.83 67.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 122.613 0.365 . . . . 0.0 111.456 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.7 m -69.92 -33.22 71.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.573 0.701 . . . . 0.0 109.882 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.51 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.15 -40.49 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.785 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.659 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.22 -36.7 26.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.646 1.212 . . . . 0.0 110.024 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.26 34.72 7.91 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.107 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 45.9 mt-10 56.77 165.81 0.07 OUTLIER Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.666 ' HG3' HD12 ' A' ' 355' ' ' LEU . 43.0 Cg_exo -44.97 147.31 2.03 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.517 2.812 . . . . 0.0 113.032 175.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 39.6 Cg_endo -93.16 -104.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.358 2.705 . . . . 0.0 112.169 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.413 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 10.8 mmt180 -95.92 -85.21 0.33 Allowed 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 121.259 0.552 . . . . 0.0 111.113 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 16.5 m-20 -97.37 164.46 17.64 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.733 -175.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 -49.39 10.92 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.655 2.237 . . . . 0.0 110.546 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.411 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -56.55 -13.96 2.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.309 -1.768 . . . . 0.0 113.401 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 14.9 mt-10 -90.52 -29.2 18.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.374 -0.204 . . . . 0.0 111.201 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.746 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.7 -42.87 70.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.214 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.715 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.8 Cg_endo -47.65 -63.74 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.097 2.531 . . . . 0.0 113.05 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.599 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.97 -36.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.428 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.659 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 44.7 t90 -57.82 -36.08 71.74 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.83 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.822 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.55 -49.74 44.83 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.435 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.78 -23.74 23.17 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.804 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.595 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -74.35 -42.19 59.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.947 0.88 . . . . 0.0 110.948 173.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.658 ' HB3' HG22 ' A' ' 314' ' ' THR . 52.6 m-20 -94.78 -24.05 17.26 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.492 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.43 -49.65 12.38 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.8 Cg_endo -61.66 -32.9 87.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.564 2.176 . . . . 0.0 111.662 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.75 -44.43 56.22 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.305 -1.77 . . . . 0.0 109.547 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 332' ' ' ALA . 93.6 mt -56.11 -47.74 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.934 173.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.0 -13.96 2.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.6 -1.636 . . . . 0.0 112.327 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.59 -51.15 4.7 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.529 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.587 HG11 HG13 ' A' ' 310' ' ' ILE . 83.2 t -58.68 -71.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 123.351 1.548 . . . . 0.0 109.743 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.768 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.29 123.64 72.88 Favored Pre-proline 0 N--CA 1.402 -2.853 0 CA-C-N 111.261 -2.7 . . . . 0.0 111.953 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.726 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.5 Cg_endo -72.36 -17.1 27.52 Favored 'Trans proline' 0 CA--C 1.494 -1.485 0 C-N-CA 124.163 3.242 . . . . 0.0 110.543 175.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.5 p 33.29 69.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 111.907 -2.406 . . . . 0.0 110.088 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.585 ' N ' HD12 ' A' ' 346' ' ' LEU . 62.4 p -80.72 6.06 13.92 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.844 -170.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.787 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 14.7 p -143.06 160.71 51.62 Favored Pre-proline 0 N--CA 1.434 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.68 ' HB3' HD12 ' A' ' 369' ' ' LEU . 50.6 Cg_exo -62.62 -45.05 15.11 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.591 2.861 . . . . 0.0 108.739 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.653 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -44.78 -52.24 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.784 175.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.787 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.6 mt -56.72 -51.55 68.41 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.852 ' HA ' HD12 ' A' ' 350' ' ' ILE . 17.7 ttm-85 -49.79 -47.84 50.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.595 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 1.084 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -68.15 -48.07 66.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.472 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.653 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 53.7 mtt180 -60.25 -37.77 81.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.113 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.883 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -56.87 -52.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.572 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.655 HG12 HD11 ' A' ' 328' ' ' LEU . 21.1 mt -58.56 -53.38 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.905 0.86 . . . . 0.0 111.248 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.564 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 18.6 m-20 -63.13 -36.2 82.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.987 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.89 -29.5 65.61 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.79 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.883 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.14 -60.13 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.052 1.406 . . . . 0.0 110.067 173.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.746 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -74.55 -27.53 60.56 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 111.961 -2.381 . . . . 0.0 109.883 -167.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.98 -71.68 0.29 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.941 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -111.68 54.05 0.56 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.731 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -84.93 133.28 34.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -47.84 -73.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 124.042 0.937 . . . . 0.0 112.664 -170.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.27 5.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.192 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.731 ' HB2' HD22 ' A' ' 358' ' ' ASN . 3.6 mt -69.98 -5.08 23.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.587 0.708 . . . . 0.0 110.127 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.564 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 25.2 t -59.12 82.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.393 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.749 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.8 OUTLIER -65.55 178.38 1.0 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.791 177.114 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.7 p -122.02 153.94 61.09 Favored Pre-proline 0 N--CA 1.437 -1.088 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.926 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 3.2 Cg_exo -53.94 -11.14 2.26 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.007 2.472 . . . . 0.0 113.107 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -111.29 -2.19 27.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.749 ' HB2' HD12 ' A' ' 363' ' ' LEU . 19.4 m-20 -106.32 -21.62 13.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.741 1.27 . . . . 0.0 110.542 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 1.084 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 34.8 t -98.24 25.29 6.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.597 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.57 -34.3 61.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.127 0.965 . . . . 0.0 109.806 -173.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.42 159.04 24.99 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.869 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.636 ' O ' HG13 ' A' ' 375' ' ' VAL . 46.4 m95 -68.91 -35.71 77.15 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.602 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -59.54 -46.85 87.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.126 -176.323 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 62.4 m -67.29 -41.9 84.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.111 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.607 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.48 63.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.822 HG12 ' HB3' ' A' ' 328' ' ' LEU . 14.4 m -57.87 -44.43 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.588 0.709 . . . . 0.0 109.603 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.0 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.46 -41.08 96.68 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.102 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.671 HG21 HD11 ' A' ' 363' ' ' LEU . 22.4 m -71.47 -39.14 71.12 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.619 -173.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -61.58 -33.45 73.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.31 0.576 . . . . 0.0 110.328 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.715 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 41.6 t80 -73.08 -47.16 46.97 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.211 1.005 . . . . 0.0 109.489 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.45 -32.77 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 113.14 -1.845 . . . . 0.0 111.796 169.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.26 -32.72 71.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 123.014 0.525 . . . . 0.0 111.564 175.133 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.0 p -109.01 -23.65 11.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.388 -167.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -110.52 22.51 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.23 17.91 33.15 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 114.47 0.548 . . . . 0.0 114.47 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.444 HG23 HG13 ' A' ' 380' ' ' ILE . 2.0 m 66.2 160.41 0.14 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.232 0.539 . . . . 0.0 111.374 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.557 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -128.2 155.67 77.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.149 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -101.88 63.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.972 3.115 . . . . 0.0 111.216 164.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.73 ' HA ' HD23 ' A' ' 391' ' ' LEU . 3.4 mmt 53.01 5.55 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -70.32 -48.2 57.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.247 0.546 . . . . 0.0 111.173 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.614 ' O ' HG13 ' A' ' 394' ' ' VAL . 78.1 mt-30 -75.61 -28.69 58.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.872 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -54.62 -31.28 57.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.61 0.641 . . . . 0.0 112.157 -170.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.894 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.42 -51.93 48.22 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.862 -1.161 . . . . 0.0 110.543 173.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.585 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 8.8 m-20 -68.56 -38.21 80.57 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 122.95 0.5 . . . . 0.0 112.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 398' ' ' ILE . 1.6 m -58.16 -44.72 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 399' ' ' VAL . 9.5 mm -58.47 -48.35 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.214 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.2 mmtt -52.8 -40.27 63.11 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 124.051 0.845 . . . . 0.0 112.031 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.94 -44.88 13.0 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.926 -173.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.872 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.3 mt -69.65 -41.9 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 117.33 0.565 . . . . 0.0 111.686 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.899 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.3 m -57.28 -45.21 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.609 0.719 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.9 t70 -60.85 -37.16 81.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.193 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 92.0 mt-30 -88.31 -52.67 5.08 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.557 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -113.26 -30.67 6.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.963 -167.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.69 164.5 11.65 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.754 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.899 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -64.04 -42.54 96.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -175.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.602 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -58.12 -50.32 73.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.791 0.329 . . . . 0.0 111.511 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.595 HG21 ' HD2' ' A' ' 330' ' ' ARG . 0.9 OUTLIER -62.31 -52.41 63.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.872 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -42.67 66.18 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.568 ' HB3' HD11 ' A' ' 457' ' ' ILE . 39.1 t80 -56.15 -47.08 78.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.567 0.699 . . . . 0.0 109.226 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.823 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.3 m -58.86 -53.01 63.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.743 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.695 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.67 -49.23 78.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.783 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.08 -43.05 88.47 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.042 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.63 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.03 -31.37 66.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.773 0.287 . . . . 0.0 111.158 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.823 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.2 mtm -70.92 -46.53 62.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.669 0.747 . . . . 0.0 109.599 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.0 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.78 -42.0 92.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.066 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.872 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 74.8 m -78.76 2.48 19.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.34 53.86 9.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.363 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.63 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.0 mp0 46.01 56.98 5.55 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.85 0.86 . . . . 0.0 112.926 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.758 ' O ' HD23 ' A' ' 421' ' ' LEU . 5.4 t-20 -122.47 65.63 0.94 Allowed 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 162.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.579 ' O ' HG22 ' A' ' 422' ' ' VAL . 0.3 OUTLIER -48.79 -36.28 16.27 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.594 -173.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' A' ' 423' ' ' SER . 45.0 mt-30 -57.08 -50.58 72.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -168.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.811 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 0.2 OUTLIER -59.37 -50.43 73.98 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.365 -178.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.811 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.35 -38.27 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 122.675 1.226 . . . . 0.0 109.233 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 19.2 t -59.94 -49.63 76.94 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.299 -2.228 . . . . 0.0 111.585 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.69 -36.13 77.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.375 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.894 HD13 ' HA2' ' A' ' 392' ' ' GLY . 4.3 mt -72.51 -39.72 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.627 0.727 . . . . 0.0 110.112 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 404' ' ' VAL . 1.7 mm -62.76 -41.63 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.569 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.615 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -57.18 -34.4 68.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 125.916 1.686 . . . . 0.0 108.64 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -73.01 -11.57 78.92 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.725 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.638 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.9 m-85 -105.52 -0.27 26.0 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.7 mm? -58.01 141.35 81.35 Favored Pre-proline 0 N--CA 1.412 -2.328 0 CA-C-O 123.566 1.65 . . . . 0.0 113.411 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.755 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 57.6 Cg_endo -70.04 -60.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 1 C-N-CA 126.444 4.763 . . . . 0.0 113.43 -170.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -110.09 141.45 16.23 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.897 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -59.58 -30.07 68.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.361 0.58 . . . . 0.0 111.831 -174.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.824 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.05 -48.96 77.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.009 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.6 t -62.86 -35.6 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.524 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.897 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.14 -46.63 57.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 38.4 m -72.65 -54.21 9.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.337 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.53 -46.16 80.76 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.342 0.401 . . . . 0.0 111.348 -174.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.818 HD13 HD22 ' A' ' 460' ' ' LEU . 17.7 mt -60.92 -54.2 47.97 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.71 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.684 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 2.3 mp0 -51.77 -33.6 35.94 Favored 'General case' 0 N--CA 1.407 -2.596 0 O-C-N 125.709 1.881 . . . . 0.0 110.64 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.66 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -59.86 2.52 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -47.53 27.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.581 0.628 . . . . 0.0 111.66 -173.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 444' ' ' ASP . 0.1 OUTLIER -59.23 -25.24 63.85 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 111.427 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.773 ' N ' HD23 ' A' ' 443' ' ' LEU . 13.4 t70 -73.94 -42.2 60.9 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.795 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.66 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 45.6 mt-30 -70.65 -9.74 57.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -172.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.59 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 38.4 mm-40 -50.28 157.73 0.65 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 123.361 1.553 . . . . 0.0 115.094 -174.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.589 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.27 -32.41 19.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 110.937 -2.847 . . . . 0.0 115.408 -170.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.652 ' H ' ' HB ' ' A' ' 451' ' ' THR . 9.2 m-20 -140.93 178.64 7.22 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.4 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 2.3 m-20 -62.56 -54.51 38.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -66.78 -24.27 66.17 Favored 'General case' 0 N--CA 1.404 -2.736 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 176.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.652 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.5 m -59.45 -40.96 88.55 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 119.992 1.269 . . . . 0.0 109.388 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.59 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 67.0 mtt180 -61.82 -29.29 70.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.304 172.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.492 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -31.73 60.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.041 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.05 -42.98 13.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.47 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.502 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.4 p -101.88 -0.94 33.19 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.723 -170.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.652 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.1 t80 -49.29 -55.96 11.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.003 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.621 ' HA ' ' HB2' ' A' ' 460' ' ' LEU . 24.6 mm -70.05 -24.73 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.502 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.72 -44.66 61.42 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.542 ' O ' HG23 ' A' ' 463' ' ' VAL . 47.3 m-70 -65.49 -32.02 73.4 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.15 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.818 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.54 -53.82 41.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.209 1.004 . . . . 0.0 109.263 -178.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -61.96 -30.42 70.91 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.187 -1.824 . . . . 0.0 110.74 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.76 -48.48 66.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.009 HG11 ' HA ' ' A' ' 435' ' ' VAL . 42.2 t -66.76 -34.71 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.489 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.546 ' OH ' HG13 ' A' ' 404' ' ' VAL . 19.2 m-30 -62.21 -13.96 33.09 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.617 167.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.573 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.8 tp10 -93.41 -52.94 4.28 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.414 -0.804 . . . . 0.0 112.242 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.739 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.3 pt -62.07 -41.73 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.132 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.4 mt -84.14 -17.34 40.39 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.732 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.63 49.87 57.51 Favored Glycine 0 C--O 1.219 -0.801 0 CA-C-N 111.515 -2.584 . . . . 0.0 113.223 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -102.68 -179.17 3.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 123.861 0.864 . . . . 0.0 110.402 -178.302 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.493 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.7 p-10 -100.82 -40.6 7.23 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -160.73 -76.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.121 160.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.755 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -64.32 67.81 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 41.04 39.84 2.16 Favored Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.425 -2.625 . . . . 0.0 113.361 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.493 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 1.1 mm100 -79.19 -51.87 8.92 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.529 1.157 . . . . 0.0 111.324 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.6 t 64.7 61.44 0.82 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 111.806 -2.452 . . . . 0.0 109.24 -172.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.6 OUTLIER -56.08 -49.77 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 110.391 -3.095 . . . . 0.0 111.49 171.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.564 ' HB2' HD12 ' A' ' 476' ' ' ILE . 0.0 OUTLIER -78.1 -153.62 0.06 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.083 -1.872 . . . . 0.0 112.935 -170.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 53.5 mt -55.1 163.87 0.98 Allowed 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.57 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 N--CA 1.435 -1.213 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.381 177.465 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 110.286 -0.698 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.2 mp -80.88 -63.73 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -129.92 -89.25 0.54 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.979 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.531 ' HB ' HD11 ' A' ' 346' ' ' LEU . 63.6 m -154.91 118.48 4.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.663 0.744 . . . . 0.0 110.922 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.0 p -65.98 125.63 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.582 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.81 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 33.4 mt -74.1 125.57 89.99 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-O 122.222 1.011 . . . . 0.0 112.221 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 308' ' ' GLN . 29.4 Cg_endo -74.58 -16.99 21.07 Favored 'Trans proline' 0 CA--C 1.503 -1.042 0 C-N-CA 124.954 3.77 . . . . 0.0 111.193 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.736 HG23 ' HG2' ' A' ' 308' ' ' GLN . 4.3 tp 36.82 -64.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 C-N-CA 128.225 2.61 . . . . 0.0 115.881 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.736 ' HG2' HG23 ' A' ' 307' ' ' ILE . 62.1 mm-40 -58.58 -34.03 70.62 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.561 0.696 . . . . 0.0 110.344 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.566 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.04 -47.99 83.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.927 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 335' ' ' ILE . 67.6 mt -61.75 -49.22 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 124.253 1.021 . . . . 0.0 112.624 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 0.9 OUTLIER -58.26 -31.4 67.39 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 122.697 0.399 . . . . 0.0 111.369 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 27.5 t -69.88 -33.34 72.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.533 0.682 . . . . 0.0 109.664 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.563 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.82 -41.02 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.659 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 331' ' ' ASN . 35.5 p -82.91 -35.89 25.75 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.733 1.254 . . . . 0.0 110.206 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.27 32.06 12.85 Favored Glycine 0 C--N 1.302 -1.342 0 CA-C-N 112.305 -2.225 . . . . 0.0 110.696 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.4 mt-10 51.79 172.86 0.03 OUTLIER Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 324' ' ' ILE . 71.8 Cg_exo -48.15 149.46 6.05 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.994 2.462 . . . . 0.0 113.687 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.48 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 16.3 Cg_endo -97.62 -106.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.992 3.128 . . . . 0.0 113.183 -171.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.466 ' H ' ' HG2' ' A' ' 319' ' ' ARG . 2.9 mmm180 -88.91 -78.37 0.35 Allowed 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 123.239 0.616 . . . . 0.0 110.506 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.493 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.9 m-20 -108.88 160.69 26.44 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.067 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.3 Cg_exo -60.13 -48.17 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 122.544 2.163 . . . . 0.0 110.107 168.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.457 ' HA ' HG21 ' A' ' 382' ' ' THR . 1.9 mmt180 -46.83 -26.19 0.92 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.851 -1.977 . . . . 0.0 112.743 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.493 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -93.52 -22.0 19.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.701 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -47.71 -42.48 45.4 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.748 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.3 Cg_endo -46.38 -64.8 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.185 2.59 . . . . 0.0 113.009 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.606 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.21 -37.02 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.209 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.72 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 54.5 t90 -58.55 -36.44 73.92 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.139 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.815 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.94 -49.96 46.73 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.512 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.22 -23.65 26.2 Favored Glycine 0 C--N 1.311 -0.817 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.156 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.7 mtt180 -73.6 -41.73 62.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.128 0.966 . . . . 0.0 110.598 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.725 ' HB3' HG22 ' A' ' 314' ' ' THR . 55.9 m-20 -97.57 -22.7 16.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.023 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.566 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -43.3 -48.65 16.83 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.2 Cg_endo -61.02 -33.67 91.67 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 122.584 2.19 . . . . 0.0 111.606 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.406 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -73.26 -42.73 62.17 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.559 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 310' ' ' ILE . 98.6 mt -57.79 -49.3 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.055 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 27.3 t70 -53.43 -17.57 2.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.501 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.24 5.75 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.024 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.66 HG11 HG13 ' A' ' 310' ' ' ILE . 85.3 t -58.24 -71.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-O 123.354 1.55 . . . . 0.0 110.205 170.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.81 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -87.63 124.43 67.62 Favored Pre-proline 0 N--CA 1.406 -2.675 0 CA-C-N 111.288 -2.687 . . . . 0.0 111.863 -175.044 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.695 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.5 Cg_endo -72.57 -19.24 24.88 Favored 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 123.809 3.006 . . . . 0.0 110.41 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.4 p 33.35 70.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.233 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 346' ' ' LEU . 63.4 p -80.83 3.78 21.39 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.749 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.789 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 28.2 p -141.78 154.54 65.9 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -60.15 -36.79 87.47 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 124.323 3.349 . . . . 0.0 109.563 171.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.634 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.7 -53.41 39.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.602 172.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.789 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.8 mt -56.73 -54.76 42.49 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.027 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.617 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 33.3 ttm105 -50.26 -41.17 49.99 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 125.511 1.757 . . . . 0.0 110.61 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.513 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 52.1 t -67.76 -48.94 64.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.666 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.6 mtt180 -61.11 -38.3 85.85 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.598 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.901 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.1 mt -57.14 -54.63 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.254 -0.579 . . . . 0.0 111.528 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.642 ' O ' HD22 ' A' ' 355' ' ' LEU . 14.9 mt -56.98 -54.39 30.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 124.566 1.166 . . . . 0.0 110.812 -171.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.589 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 37.0 m-20 -64.66 -34.57 78.6 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.288 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.12 67.56 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.94 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.901 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.5 mm -56.7 -58.35 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-O 122.821 1.296 . . . . 0.0 110.539 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.701 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.35 -26.71 55.98 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.007 -2.36 . . . . 0.0 109.871 -168.034 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.28 -68.84 0.68 Allowed Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.611 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -114.92 35.62 4.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.932 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.767 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -66.95 127.61 33.22 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.047 0.451 . . . . 0.0 110.794 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.668 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -49.0 -70.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.985 -169.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.67 5.17 7.05 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.443 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.767 ' HB2' HD22 ' A' ' 358' ' ' ASN . 4.4 mt -72.68 -3.59 25.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.557 0.694 . . . . 0.0 110.199 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.589 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 11.3 t -62.29 83.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.843 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.819 HD11 HG21 ' A' ' 377' ' ' THR . 1.7 mm? -62.7 -174.24 0.06 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.905 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 63.8 p -125.11 157.41 67.21 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 23.4 Cg_exo -49.14 -31.63 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.839 1.693 . . . . 0.0 111.072 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -87.4 -3.78 81.27 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.961 -172.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.754 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.4 m-20 -104.88 -21.0 13.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.223 1.011 . . . . 0.0 109.274 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 65.1 m -86.14 23.69 1.48 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.402 -171.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.86 -36.29 72.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.045 0.926 . . . . 0.0 109.835 -174.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.88 162.43 26.72 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.392 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.612 ' O ' HG13 ' A' ' 375' ' ' VAL . 41.8 m95 -70.62 -36.65 73.59 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.588 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.15 -39.93 83.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.911 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 75.3 p -73.41 -43.69 59.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.29 -52.38 63.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.836 HG21 ' HE3' ' A' ' 413' ' ' MET . 14.0 m -57.28 -44.08 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.611 0.719 . . . . 0.0 109.548 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 0.998 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.08 -44.14 97.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.041 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.819 HG21 HD11 ' A' ' 363' ' ' LEU . 29.3 m -69.34 -38.19 78.04 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.168 -172.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 3.0 mt -61.05 -33.71 73.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 110.473 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.748 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.5 t80 -75.76 -45.01 38.7 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.308 1.052 . . . . 0.0 109.233 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.12 -33.25 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.147 170.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.9 OUTLIER -60.78 -47.1 87.85 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.734 0.778 . . . . 0.0 110.899 176.336 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 322' ' ' ARG . 37.8 p -93.93 -23.36 18.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.998 -166.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -111.22 23.08 14.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.22 20.84 30.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.639 0.616 . . . . 0.0 114.639 173.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.457 HG23 HG13 ' A' ' 380' ' ' ILE . 2.9 m 64.13 157.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -175.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.498 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.1 OUTLIER -121.81 157.52 57.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.068 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -96.5 52.54 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.481 2.787 . . . . 0.0 111.783 168.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.754 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.02 -8.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -177.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -69.56 -42.81 74.03 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.042 -0.411 . . . . 0.0 110.943 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.691 ' O ' HG13 ' A' ' 394' ' ' VAL . 78.4 mt-30 -68.32 -27.11 66.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.754 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -53.5 -30.16 39.9 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.342 0.519 . . . . 0.0 111.015 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.86 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.81 -51.88 50.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.676 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.569 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.1 m-20 -69.73 -37.0 76.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.982 0.513 . . . . 0.0 112.085 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 390' ' ' GLN . 1.4 m -58.3 -47.72 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.58 ' O ' HG22 ' A' ' 399' ' ' VAL . 4.3 mm -57.99 -48.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 173.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.569 ' HE3' ' HA ' ' A' ' 393' ' ' ASN . 0.2 OUTLIER -52.43 -46.32 66.34 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.836 -177.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.91 50.19 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.018 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.871 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -70.59 -41.49 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 117.143 0.472 . . . . 0.0 111.7 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.5 m -56.45 -41.91 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.809 0.814 . . . . 0.0 110.181 -177.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.471 ' N ' HG23 ' A' ' 399' ' ' VAL . 0.8 OUTLIER -67.49 -34.61 77.48 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.07 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -85.47 -54.67 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -107.8 -30.77 8.34 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.692 0.758 . . . . 0.0 112.329 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.38 170.71 14.01 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.532 -175.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.789 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.82 -45.11 95.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -172.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.32 -50.57 72.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.612 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.1 m -63.06 -51.15 67.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.871 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.7 -43.93 69.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.544 ' HB3' HD11 ' A' ' 457' ' ' ILE . 34.0 t80 -54.7 -45.23 73.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.735 0.779 . . . . 0.0 109.157 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.841 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.2 m -59.33 -52.65 64.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.502 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.698 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.42 -49.35 77.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.081 176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.592 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.12 -42.83 88.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.906 -173.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.815 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -31.6 65.56 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.541 0.17 . . . . 0.0 111.121 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.841 ' HG3' ' O ' ' A' ' 409' ' ' THR . 57.7 mtm -70.97 -45.58 63.86 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.381 0.61 . . . . 0.0 109.655 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.998 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.3 mt -60.28 -39.44 86.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.481 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.648 ' HB2' HD21 ' A' ' 421' ' ' LEU . 6.6 p -76.44 -2.57 32.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.766 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 79.78 31.04 41.36 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.815 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.2 mm100 68.12 52.63 0.66 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.134 -1.033 . . . . 0.0 111.668 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.722 ' O ' HD23 ' A' ' 421' ' ' LEU . 2.7 t-20 -117.41 74.9 0.95 Allowed 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 160.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.593 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.3 OUTLIER -53.98 -35.95 62.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.143 -173.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.545 ' O ' ' HB3' ' A' ' 423' ' ' SER . 25.2 mt-30 -57.61 -49.77 75.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -168.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.779 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 0.2 OUTLIER -59.59 -50.43 73.91 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.34 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.779 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.28 -38.2 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.738 1.256 . . . . 0.0 109.269 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.545 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 24.5 t -59.59 -50.46 73.81 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 112.271 -2.24 . . . . 0.0 111.473 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.99 71.39 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.302 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.86 HD13 ' HA2' ' A' ' 392' ' ' GLY . 6.1 mt -73.15 -40.91 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.72 0.772 . . . . 0.0 110.484 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.597 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -63.42 -42.75 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.228 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.703 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.1 OUTLIER -59.77 -31.17 69.41 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.714 -176.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.46 -20.12 79.25 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.108 174.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.499 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.0 m-85 -98.45 1.96 47.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -176.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.44 145.64 67.27 Favored Pre-proline 0 N--CA 1.417 -2.09 0 CA-C-O 123.647 1.689 . . . . 0.0 113.83 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.768 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 60.1 Cg_endo -71.53 -64.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 1 C-N-CA 126.099 4.533 . . . . 0.0 113.063 -172.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.566 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.49 140.2 15.28 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.133 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.829 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.16 -27.17 68.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.948 0.374 . . . . 0.0 111.8 -176.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.761 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -59.92 -47.24 86.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.067 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -60.42 -51.7 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.232 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.909 ' O ' ' HG2' ' A' ' 440' ' ' GLN . 0.7 OUTLIER -51.76 -59.52 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 66.5 m -61.21 -55.52 31.14 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.252 -173.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.66 -44.36 81.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.894 -176.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.82 HD21 ' HA ' ' A' ' 460' ' ' LEU . 17.3 mt -59.7 -55.0 39.8 Favored 'General case' 0 CA--C 1.469 -2.155 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.248 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.909 ' HG2' ' O ' ' A' ' 436' ' ' VAL . 27.5 mm-40 -53.57 -34.34 57.97 Favored 'General case' 0 N--CA 1.409 -2.52 0 O-C-N 125.627 1.829 . . . . 0.0 109.787 -177.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -71.33 -60.04 2.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 176.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -74.97 -47.77 27.65 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 121.585 -0.697 . . . . 0.0 111.742 -173.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.25 -25.7 64.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.708 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.768 ' N ' HD23 ' A' ' 443' ' ' LEU . 9.2 t70 -73.74 -41.42 62.54 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.418 1.104 . . . . 0.0 110.738 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -69.57 -6.6 32.11 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -173.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 452' ' ' ARG . 38.2 mm-40 -49.63 161.46 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.707 1.718 . . . . 0.0 114.435 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.544 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -57.18 -31.73 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 110.525 -3.034 . . . . 0.0 114.938 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.656 ' H ' ' HB ' ' A' ' 451' ' ' THR . 9.1 m-20 -143.85 -179.22 6.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.654 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.485 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 8.5 p-10 -64.42 -53.54 46.84 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 175.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.656 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.3 m -58.53 -39.21 79.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.553 171.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.677 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 30.7 mtm-85 -63.52 -29.57 70.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 450' ' ' GLN . . . -73.93 -31.97 63.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.853 0.835 . . . . 0.0 109.643 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.46 -43.86 13.23 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.436 -1.257 . . . . 0.0 112.435 -170.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.529 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 35.6 p -102.34 -1.41 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.011 -168.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.4 t80 -49.05 -53.28 20.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.9 mm -71.2 -25.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.529 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.14 -43.31 64.86 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.566 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.3 m-70 -66.7 -31.15 71.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.615 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.82 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.5 -53.92 35.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.181 0.991 . . . . 0.0 109.293 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.664 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.14 -32.06 72.61 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.136 173.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.93 -53.24 57.16 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.067 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.0 t -63.23 -33.84 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.345 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.8 m-30 -61.28 -15.3 33.81 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.136 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 16.9 mm-40 -91.14 -49.18 6.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.141 -0.974 . . . . 0.0 112.753 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.7 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -65.8 -39.3 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.027 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.3 mt -84.61 -17.52 38.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.733 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 62.3 55.39 27.96 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.627 -2.533 . . . . 0.0 112.986 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.746 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -104.2 -174.12 2.47 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 123.863 0.865 . . . . 0.0 109.642 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.54 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.9 p-10 -106.03 -41.17 5.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 166.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -158.7 -78.25 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.009 160.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.768 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -62.61 70.45 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -169.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 38.09 40.82 0.9 Allowed Glycine 0 C--N 1.279 -2.631 0 CA-C-N 110.948 -2.842 . . . . 0.0 113.487 171.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.54 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 2.0 mm100 -78.12 -52.37 8.83 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 122.631 1.205 . . . . 0.0 111.287 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.4 t 63.47 56.4 1.64 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.716 -2.493 . . . . 0.0 108.065 -171.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.733 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -46.05 -52.65 2.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 110.508 -3.042 . . . . 0.0 111.631 176.177 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.607 ' C ' ' HD2' ' A' ' 477' ' ' ARG . 0.3 OUTLIER -72.18 153.54 41.56 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.789 177.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 40.4 mt -75.53 149.64 38.33 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.417 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.486 ' HA ' ' NH1' ' A' ' 477' ' ' ARG . 43.0 mt-10 . . . . . 0 N--CA 1.432 -1.355 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.541 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.478 0.598 0 N-CA-C 111.194 -0.349 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.1 mp 64.55 -82.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 123.335 0.654 . . . . 0.0 110.948 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -140.08 26.17 2.61 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.477 ' HB ' HD11 ' A' ' 346' ' ' LEU . 28.1 m 72.18 114.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 122.17 0.986 . . . . 0.0 110.972 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.457 ' H ' HG12 ' A' ' 304' ' ' VAL . 1.6 p -85.12 124.07 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.506 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.785 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.8 mt -70.11 123.95 89.79 Favored Pre-proline 0 N--CA 1.425 -1.709 0 CA-C-O 121.862 0.839 . . . . 0.0 111.806 -175.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 308' ' ' GLN . 20.6 Cg_endo -71.77 -12.23 28.56 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 124.764 3.643 . . . . 0.0 111.23 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 308' ' ' GLN . 4.2 tp 31.32 -64.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.217 0 C-N-CA 128.5 2.72 . . . . 0.0 116.046 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.673 ' HG2' HG23 ' A' ' 307' ' ' ILE . 38.9 mm-40 -57.79 -33.74 68.87 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.616 0.722 . . . . 0.0 110.163 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.495 ' CD2' HG13 ' A' ' 338' ' ' VAL . 1.3 t-80 -61.4 -48.82 79.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.682 173.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.639 HG13 HG11 ' A' ' 338' ' ' VAL . 70.1 mt -61.32 -48.89 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 124.135 0.974 . . . . 0.0 112.799 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.667 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 2.0 mtp-105 -58.92 -30.87 68.16 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.242 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 36.9 t -69.82 -34.57 73.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.596 0.712 . . . . 0.0 109.641 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.501 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.1 -40.57 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.707 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.689 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.41 -36.28 26.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 122.912 1.339 . . . . 0.0 109.636 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.65 32.79 8.95 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.119 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.1 mt-10 53.42 167.47 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.142 0 C-N-CA 124.433 1.093 . . . . 0.0 113.869 -175.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.683 ' HG3' HD12 ' A' ' 355' ' ' LEU . 38.0 Cg_exo -44.03 146.61 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.766 2.977 . . . . 0.0 113.435 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.463 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 28.8 Cg_endo -93.44 -103.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.285 2.657 . . . . 0.0 112.068 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.46 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 12.9 mmm180 -91.77 -91.51 0.16 Allowed 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.117 0.484 . . . . 0.0 110.604 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.533 ' HB3' ' HG2' ' A' ' 322' ' ' ARG . 48.6 m-20 -95.05 164.81 18.36 Favored Pre-proline 0 N--CA 1.439 -0.978 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.14 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.461 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.0 -47.26 18.56 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 122.605 2.203 . . . . 0.0 110.249 167.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.533 ' HG2' ' HB3' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -55.67 -17.99 6.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.248 176.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 3.2 mt-10 -93.46 -23.42 18.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.963 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.712 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -52.15 -40.95 77.77 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.745 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.0 Cg_endo -48.97 -64.58 0.21 Allowed 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.96 2.44 . . . . 0.0 112.898 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.594 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -57.91 -39.0 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.878 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.689 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 61.8 t90 -56.43 -39.78 73.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.988 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.805 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -67.35 -49.48 63.84 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.407 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -53.66 -23.71 22.17 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.888 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 3.4 mtm180 -73.2 -41.13 64.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.264 0.554 . . . . 0.0 111.137 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.574 ' HB2' HG22 ' A' ' 314' ' ' THR . 1.3 p30 -106.08 -15.78 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.712 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.35 -48.08 6.39 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.1 Cg_endo -61.75 -32.36 86.21 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.731 2.287 . . . . 0.0 111.989 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.58 -42.56 58.52 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.513 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 332' ' ' ALA . 95.4 mt -56.73 -48.41 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.946 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 15.2 t70 -50.87 -21.81 1.89 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.73 -1.577 . . . . 0.0 112.764 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.7 -48.44 7.91 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.445 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.639 HG11 HG13 ' A' ' 310' ' ' ILE . 88.6 t -60.05 -72.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 123.389 1.566 . . . . 0.0 110.087 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.785 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -88.05 122.67 69.84 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.251 -2.704 . . . . 0.0 111.758 -174.257 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.644 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 70.8 Cg_endo -73.41 -17.76 23.61 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 C-N-CA 123.742 2.961 . . . . 0.0 109.961 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.495 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.44 71.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.422 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.543 ' N ' HD12 ' A' ' 346' ' ' LEU . 45.1 p -85.52 11.34 10.77 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.042 -1.89 . . . . 0.0 113.049 -169.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.78 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.1 p -147.03 157.07 46.94 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 121.437 0.637 . . . . 0.0 109.968 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.533 ' HB3' HD12 ' A' ' 369' ' ' LEU . 73.3 Cg_exo -60.81 -36.85 82.17 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.643 3.562 . . . . 0.0 110.04 173.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.715 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.3 OUTLIER -51.84 -56.96 10.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.621 173.335 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.78 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.2 mt -56.72 -48.92 76.65 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.757 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.527 ' HA ' HD12 ' A' ' 350' ' ' ILE . 24.9 mmt180 -45.46 -52.14 10.62 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 125.295 1.622 . . . . 0.0 109.887 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.543 ' HA ' HD12 ' A' ' 351' ' ' ILE . 44.6 t -68.41 -50.87 49.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.825 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.666 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.9 mtp180 -61.06 -33.73 73.79 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.907 ' O ' HG12 ' A' ' 354' ' ' ILE . 18.5 mt -58.02 -53.22 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.205 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.594 ' O ' HD22 ' A' ' 355' ' ' LEU . 14.1 mt -59.35 -54.05 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.611 0.719 . . . . 0.0 111.254 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.402 ' HB3' ' OG ' ' A' ' 362' ' ' SER . 0.1 OUTLIER -61.12 -38.06 85.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.039 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ALA . . . . . 0.496 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.94 -30.06 66.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.907 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.6 mm -56.62 -57.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 CA-C-O 122.922 1.344 . . . . 0.0 110.418 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.712 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -79.96 -27.47 39.73 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.195 -2.275 . . . . 0.0 109.897 -167.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.75 -76.93 0.21 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.936 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -101.52 38.55 3.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.866 -174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.756 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.3 p-10 -77.92 125.52 29.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.025 0.44 . . . . 0.0 110.424 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -48.56 -72.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.907 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -123.41 -1.7 9.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.304 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.756 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.5 mt -68.82 -6.0 24.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 122.193 0.997 . . . . 0.0 109.784 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 352' ' ' ASN . 2.3 t -70.62 75.6 0.58 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.363 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.738 HD11 HG21 ' A' ' 377' ' ' THR . 1.8 mm? -54.19 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.497 ' C ' ' H ' ' A' ' 366' ' ' GLY . 64.3 p -115.6 156.01 46.65 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.715 ' CB ' ' HA ' ' A' ' 345' ' ' ASP . 56.3 Cg_endo -71.91 22.19 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.11 1.874 . . . . 0.0 111.83 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -136.12 -2.55 2.68 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.726 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.589 ' HB2' HD12 ' A' ' 363' ' ' LEU . 45.5 m-20 -104.54 -21.4 13.44 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.285 1.041 . . . . 0.0 109.308 173.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 63.1 m -85.29 21.84 1.63 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.58 -171.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -55.94 -34.78 65.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.367 1.08 . . . . 0.0 110.112 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.04 159.96 31.37 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.697 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.615 ' O ' HG13 ' A' ' 375' ' ' VAL . 56.6 m95 -69.94 -35.77 74.78 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.634 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -57.35 -46.22 83.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.985 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 72.2 m -68.14 -42.14 80.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.072 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.604 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.14 -52.29 59.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.6 m -57.23 -44.12 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.0 109.463 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.053 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.139 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.738 HG21 HD11 ' A' ' 363' ' ' LEU . 24.4 m -71.95 -37.56 69.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.371 -172.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -62.02 -34.21 75.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.674 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.745 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.9 t80 -73.46 -47.46 41.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.65 1.214 . . . . 0.0 109.125 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.09 -32.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 112.415 -2.175 . . . . 0.0 111.829 170.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.5 mpt_? -60.4 -40.76 92.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.482 0.658 . . . . 0.0 111.351 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.424 HG21 ' HA ' ' A' ' 322' ' ' ARG . 31.6 p -100.25 -23.55 14.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.384 -166.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -110.39 23.03 14.79 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.89 20.99 21.77 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 123.308 0.38 . . . . 0.0 113.805 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 380' ' ' ILE . 1.9 m 66.79 156.32 0.1 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 111.414 -175.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.493 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.1 OUTLIER -117.87 153.56 50.98 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.301 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -95.97 49.85 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.309 2.672 . . . . 0.0 111.348 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.728 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.96 4.61 0.63 Allowed 'General case' 0 C--N 1.339 0.112 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -70.12 -47.1 63.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.241 0.544 . . . . 0.0 110.289 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.566 ' O ' HG23 ' A' ' 394' ' ' VAL . 97.3 mt-30 -73.84 -27.13 60.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -54.66 -31.84 58.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.128 0.877 . . . . 0.0 111.21 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.729 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.9 -55.06 30.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.087 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.495 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 7.6 m-20 -62.78 -36.52 83.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.559 0.695 . . . . 0.0 111.238 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.574 HG11 ' CD1' ' A' ' 414' ' ' LEU . 52.6 t -54.95 -53.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.068 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.702 ' O ' HG22 ' A' ' 399' ' ' VAL . 4.6 mm -58.59 -45.93 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.177 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 40.2 mmtt -53.36 -41.07 65.44 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 124.0 0.813 . . . . 0.0 112.154 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.566 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -78.91 -44.54 9.96 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.394 -173.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.899 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.0 OUTLIER -69.51 -40.84 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 117.451 0.626 . . . . 0.0 111.4 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.861 HG12 ' HA ' ' A' ' 404' ' ' VAL . 7.8 m -57.9 -41.43 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.908 0.861 . . . . 0.0 110.154 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.0 t70 -58.15 -41.88 84.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.88 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 75.3 mt-30 -81.62 -55.38 4.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.884 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.493 ' HG3' ' HD2' ' A' ' 330' ' ' ARG . 18.5 mm-40 -111.84 -30.3 7.35 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.001 0.905 . . . . 0.0 112.123 -170.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.4 ' C ' ' HA ' ' A' ' 399' ' ' VAL . . . 119.24 177.32 16.44 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.601 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.861 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.68 -44.45 96.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.227 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.44 -50.74 72.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -66.0 -50.15 65.27 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 122.177 -0.327 . . . . 0.0 110.665 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.899 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -54.09 -41.9 68.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.559 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.2 t80 -56.24 -45.57 79.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.712 0.768 . . . . 0.0 109.212 175.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.843 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.7 m -59.29 -52.52 65.28 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.505 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.713 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.73 -49.54 77.08 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.051 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.544 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.49 -42.25 89.63 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.012 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.724 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.0 OUTLIER -72.16 -31.98 66.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 122.702 -0.293 . . . . 0.0 111.227 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.843 ' HG3' ' O ' ' A' ' 409' ' ' THR . 61.1 mtm -70.31 -47.36 61.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.224 0.535 . . . . 0.0 109.912 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.053 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.6 mt -60.19 -39.92 88.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.665 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.717 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.6 OUTLIER -75.1 -14.3 60.56 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.427 -177.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 94.28 38.62 5.02 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.721 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.719 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.8 mm100 52.73 54.19 10.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.206 -0.997 . . . . 0.0 112.906 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.61 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 13.1 p30 -125.45 62.31 1.2 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 164.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.724 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 1.7 p90 -43.77 -33.92 1.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 111.408 -2.633 . . . . 0.0 112.976 -164.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 423' ' ' SER . 31.6 mt-30 -55.02 -44.55 74.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -165.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 422' ' ' VAL . 2.3 pp -62.61 -47.85 82.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.047 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.694 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -61.36 -39.63 83.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 122.614 1.197 . . . . 0.0 108.947 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.594 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 40.6 t -58.8 -46.09 88.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 112.434 -2.166 . . . . 0.0 111.478 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.97 -39.79 80.01 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.959 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.08 -40.49 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.506 0.669 . . . . 0.0 110.17 175.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.594 HG23 HG23 ' A' ' 404' ' ' VAL . 1.7 mm -58.66 -44.56 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 CA-C-N 114.274 -1.33 . . . . 0.0 113.131 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.706 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -60.6 -29.23 69.09 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-O 122.784 1.278 . . . . 0.0 108.731 -174.222 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -15.75 76.9 Favored Glycine 0 C--N 1.3 -1.453 0 CA-C-N 112.394 -2.184 . . . . 0.0 112.674 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.7 m-85 -100.98 0.89 39.05 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.99 144.14 76.12 Favored Pre-proline 0 N--CA 1.41 -2.428 0 CA-C-O 123.723 1.725 . . . . 0.0 113.317 170.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.762 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 79.1 Cg_endo -72.23 -51.75 0.2 Allowed 'Trans proline' 0 C--N 1.311 -1.417 1 C-N-CA 126.065 4.51 . . . . 0.0 113.33 -173.026 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.508 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -122.88 142.34 14.54 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.417 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.883 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.24 -29.22 70.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.106 0.453 . . . . 0.0 111.627 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.741 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.51 -47.83 78.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.007 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -59.02 -51.68 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.596 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.883 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.84 -54.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.259 179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 28.3 m -62.54 -55.88 23.19 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.809 -175.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.46 -44.74 80.81 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.615 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.855 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 40.6 mt -60.93 -55.01 38.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.835 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.671 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -49.93 -32.7 15.45 Favored 'General case' 0 N--CA 1.419 -1.999 0 O-C-N 124.429 1.081 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.39 -60.3 2.3 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 174.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -77.25 -52.22 9.59 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -170.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 1.5 pp -57.28 -24.25 53.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.331 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.671 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 28.5 t70 -71.53 -42.04 68.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.546 1.165 . . . . 0.0 110.019 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.0 mt-30 -71.39 -8.11 51.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.032 -1.895 . . . . 0.0 115.933 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 38.1 mm-40 -54.64 157.85 2.81 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 123.619 1.676 . . . . 0.0 115.022 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -53.48 -33.14 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 110.445 -3.07 . . . . 0.0 115.101 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.664 ' H ' ' HB ' ' A' ' 451' ' ' THR . 29.9 m-20 -138.88 179.65 6.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.27 -52.1 50.89 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.95 -24.22 65.15 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 175.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.664 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.4 m -59.36 -40.75 87.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 171.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 39.0 mtt180 -60.75 -30.81 70.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.408 171.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.559 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -74.31 -32.81 63.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.712 0.768 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.8 -44.6 15.33 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.111 -171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.471 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 42.1 p -99.13 -4.96 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.893 -168.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.724 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.3 t80 -49.04 -51.0 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.664 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.5 mm -72.04 -27.57 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.432 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.52 -42.92 67.36 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 463' ' ' VAL . 53.6 m-70 -66.99 -31.04 71.34 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.81 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.775 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.35 -53.89 36.96 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.116 0.96 . . . . 0.0 109.243 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.55 -31.91 72.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 113.329 -1.76 . . . . 0.0 110.137 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.73 -52.66 62.37 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.178 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.007 HG11 ' HA ' ' A' ' 435' ' ' VAL . 23.5 t -63.45 -33.73 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.186 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.2 m-30 -61.8 -15.04 38.36 Favored 'General case' 0 C--O 1.202 -1.447 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.984 169.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 50.0 mm-40 -90.37 -50.01 6.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.575 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.702 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -66.63 -38.89 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.121 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 469' ' ' LEU . 6.5 mt -84.81 -15.64 44.14 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.59 49.02 66.89 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-N 111.822 -2.445 . . . . 0.0 113.213 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.764 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -101.1 -179.1 3.94 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.094 0.958 . . . . 0.0 110.113 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.555 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.5 p-10 -104.41 -40.65 6.0 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 167.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -158.42 -79.34 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.278 -2.237 . . . . 0.0 110.955 157.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.762 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -61.37 72.66 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -170.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 38.04 42.83 1.24 Allowed Glycine 0 C--N 1.275 -2.827 0 CA-C-N 110.602 -2.999 . . . . 0.0 113.431 171.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.555 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 1.5 mm100 -79.04 -54.39 6.06 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 122.288 1.042 . . . . 0.0 111.469 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.6 t 65.75 46.18 2.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.066 -2.333 . . . . 0.0 108.763 -174.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.74 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.7 OUTLIER -46.45 -47.71 6.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 109.505 -3.498 . . . . 0.0 112.346 171.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.537 ' HB2' HD12 ' A' ' 476' ' ' ILE . 0.0 OUTLIER -77.38 -162.65 0.31 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.652 -1.613 . . . . 0.0 113.509 -169.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 72.5 mt -55.24 -59.36 4.89 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.45 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.599 -178.652 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.48 0.703 0 N-CA-C 110.424 -0.645 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.6 mp -86.65 -38.68 12.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.085 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -107.62 136.21 13.28 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.55 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 27.4 m -63.49 123.32 18.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.351 0.596 . . . . 0.0 111.357 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 304' ' ' VAL . 2.3 p -65.1 125.19 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.349 171.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.717 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -75.53 128.15 84.59 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 121.795 0.807 . . . . 0.0 112.187 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 308' ' ' GLN . 13.0 Cg_endo -70.38 -22.35 29.38 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 C-N-CA 124.54 3.493 . . . . 0.0 110.748 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.728 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.7 tp 38.0 -59.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 C-N-CA 128.244 2.618 . . . . 0.0 116.135 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.598 ' HG2' HG23 ' A' ' 307' ' ' ILE . 9.8 mm-40 -57.36 -39.5 76.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.833 0.825 . . . . 0.0 110.132 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.519 ' CD2' HG13 ' A' ' 338' ' ' VAL . 1.3 t-80 -58.87 -48.19 82.26 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.609 173.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.9 mt -58.92 -49.07 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.728 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 7.7 mtp180 -61.05 -30.16 70.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.889 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 47.9 t -70.06 -35.17 74.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.416 0.627 . . . . 0.0 109.59 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.55 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.71 -41.03 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.722 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.782 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.7 p -82.94 -36.69 25.0 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 122.914 1.34 . . . . 0.0 109.564 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.25 35.47 9.6 Favored Glycine 0 C--N 1.303 -1.252 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.596 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 51.29 173.24 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.298 0 C-N-CA 124.258 1.023 . . . . 0.0 113.153 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.798 ' HB3' HD11 ' A' ' 324' ' ' ILE . 37.3 Cg_exo -46.77 150.96 2.28 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.986 2.457 . . . . 0.0 113.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.2 Cg_endo -92.07 -104.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.656 2.904 . . . . 0.0 112.751 -172.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -92.29 -79.55 0.38 Allowed 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.538 0.685 . . . . 0.0 110.553 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 323' ' ' GLU . 49.2 m-20 -103.9 161.45 22.91 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.955 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.5 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 45.2 Cg_exo -58.03 -50.37 10.29 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 122.656 2.237 . . . . 0.0 110.413 168.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.1 OUTLIER -49.78 -27.32 4.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.662 175.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -80.52 -29.13 37.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -48.41 -45.53 67.76 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.736 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.0 Cg_endo -50.75 -61.29 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.742 2.295 . . . . 0.0 112.962 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.625 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -61.94 -36.26 72.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.01 179.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.782 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.4 t90 -58.41 -36.65 73.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.257 -1.792 . . . . 0.0 111.305 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.834 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.02 -48.42 58.13 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.71 -23.2 20.49 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.774 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.52 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.2 OUTLIER -74.97 -43.04 56.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.102 0.953 . . . . 0.0 110.552 174.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.728 ' HB3' HG22 ' A' ' 314' ' ' THR . 46.7 m-20 -95.07 -24.53 16.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.68 -1.6 . . . . 0.0 113.827 -169.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.23 -49.68 11.73 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 124.319 1.048 . . . . 0.0 113.777 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.4 Cg_endo -61.84 -32.57 85.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.522 2.148 . . . . 0.0 111.617 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.64 62.69 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.673 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.641 HG23 HG23 ' A' ' 310' ' ' ILE . 89.3 mt -59.32 -48.78 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.67 173.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.71 -15.98 9.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.213 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -50.36 5.99 Favored Glycine 0 CA--C 1.509 -0.328 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.657 HG11 HG13 ' A' ' 310' ' ' ILE . 70.5 t -54.62 -70.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 123.565 1.65 . . . . 0.0 110.094 169.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.858 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -93.72 132.03 30.81 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.052 -2.795 . . . . 0.0 112.464 -171.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.807 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.1 Cg_endo -72.66 -19.48 24.29 Favored 'Trans proline' 0 CA--C 1.497 -1.357 0 C-N-CA 123.65 2.9 . . . . 0.0 111.084 173.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.6 p 32.45 69.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.472 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.618 ' N ' HD12 ' A' ' 346' ' ' LEU . 75.7 p -79.53 4.14 16.66 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.096 -1.866 . . . . 0.0 113.108 -170.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.7 p -142.7 156.15 63.04 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.636 0.732 . . . . 0.0 109.624 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 75.5 Cg_exo -60.5 -38.18 75.32 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 124.357 3.371 . . . . 0.0 109.601 172.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.632 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -51.9 -52.76 47.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.546 174.021 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.8 mt -56.96 -52.74 64.04 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.818 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.719 ' HA ' HD12 ' A' ' 350' ' ' ILE . 32.1 ttm105 -51.96 -43.89 63.74 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.255 -1.793 . . . . 0.0 110.442 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 368' ' ' CYS . 38.2 t -69.09 -48.73 61.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.341 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 72.7 mtt180 -57.74 -38.1 74.76 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.548 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.858 HD11 ' CD2' ' A' ' 339' ' ' PHE . 52.5 mt -62.14 -54.51 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.941 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.569 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -58.19 -53.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 122.197 0.998 . . . . 0.0 111.02 -168.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 44.4 m-20 -63.49 -34.55 78.02 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.17 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.12 76.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.34 -53.9 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 122.873 1.32 . . . . 0.0 110.721 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -72.89 -25.65 61.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 111.805 -2.452 . . . . 0.0 109.104 -169.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.06 -78.19 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.975 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.33 52.57 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.705 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.573 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.2 OUTLIER -74.51 160.32 31.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 122.35 0.26 . . . . 0.0 110.664 177.157 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.1 mp -56.98 -67.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 120.959 0.409 . . . . 0.0 111.337 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -144.98 12.88 1.9 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.896 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.694 ' HB3' HD22 ' A' ' 378' ' ' LEU . 7.0 mt -64.38 -2.37 2.2 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.487 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 38.7 t -62.3 84.28 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.224 0.535 . . . . 0.0 110.288 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.91 HD11 HG21 ' A' ' 377' ' ' THR . 2.3 mm? -61.74 -172.75 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 70.5 p -126.73 155.94 74.35 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 21.5 Cg_exo -48.16 -38.42 32.78 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.531 1.488 . . . . 0.0 110.103 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -81.7 1.51 85.85 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.107 -0.952 . . . . 0.0 114.661 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.738 ' HB2' HD12 ' A' ' 363' ' ' LEU . 26.2 m-20 -109.01 -21.76 12.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.236 1.017 . . . . 0.0 109.539 171.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.654 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 83.9 m -91.07 21.12 4.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.612 -171.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -62.45 -36.81 83.6 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.769 1.271 . . . . 0.0 108.579 -174.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.2 p -117.4 163.9 15.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.247 -2.251 . . . . 0.0 109.634 170.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.633 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.2 m95 -70.63 -34.24 71.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.59 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.42 -42.48 96.02 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.724 -170.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.6 m -71.33 -42.5 68.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.703 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.03 -52.17 66.13 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.921 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.7 m -58.56 -44.36 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 109.512 -178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.077 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.91 HG21 HD11 ' A' ' 363' ' ' LEU . 54.3 m -70.15 -41.04 74.36 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.825 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.694 HD22 ' HB3' ' A' ' 361' ' ' LEU . 1.8 mt -58.69 -34.45 71.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.562 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.736 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 45.6 t80 -73.52 -46.96 44.61 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.267 1.032 . . . . 0.0 109.766 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.574 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.19 -32.9 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.537 170.213 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.619 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -59.76 -43.1 94.46 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.412 0.625 . . . . 0.0 110.999 174.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 41.4 p -95.54 -23.37 17.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.214 -167.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -110.46 22.22 15.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.06 21.16 30.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 114.436 0.534 . . . . 0.0 114.436 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.414 HG23 HG13 ' A' ' 380' ' ' ILE . 1.8 m 64.81 158.13 0.09 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.441 0.639 . . . . 0.0 111.744 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.468 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.75 156.06 65.63 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -97.83 52.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.322 2.681 . . . . 0.0 111.266 166.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.688 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.8 6.09 0.42 Allowed 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -70.06 -48.29 58.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.215 0.531 . . . . 0.0 110.039 174.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.642 ' O ' HG13 ' A' ' 394' ' ' VAL . 59.0 mt-30 -75.84 -25.21 56.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.902 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -53.64 -31.11 46.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.488 1.04 . . . . 0.0 111.916 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.72 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.24 -54.08 36.51 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.637 172.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 396' ' ' LYS . 17.7 m-20 -63.43 -38.71 92.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.336 0.654 . . . . 0.0 112.458 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -58.89 -46.17 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 120.795 0.331 . . . . 0.0 110.442 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 399' ' ' VAL . 5.5 mm -57.97 -46.83 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.311 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.568 ' HD2' ' OH ' ' A' ' 429' ' ' TYR . 8.1 mtmt -52.15 -46.28 65.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.768 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.55 -44.71 39.66 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.636 -1.268 . . . . 0.0 112.96 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.2 mt -69.93 -41.65 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 117.532 0.666 . . . . 0.0 111.684 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.7 m -57.42 -44.73 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.801 0.81 . . . . 0.0 110.369 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.479 ' N ' HG23 ' A' ' 399' ' ' VAL . 1.6 t70 -67.4 -32.61 73.62 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.919 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.43 -55.28 3.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.688 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.39 -28.12 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.901 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.408 ' HA2' ' NH1' ' A' ' 472' ' ' ARG . . . 121.12 162.16 11.6 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.608 -175.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.903 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -41.34 92.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.667 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.75 -51.86 67.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.846 0.355 . . . . 0.0 111.863 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 330' ' ' ARG . 0.8 OUTLIER -64.04 -49.95 70.34 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.28 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.683 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -51.75 -43.03 62.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.6 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 34.5 t80 -56.18 -47.73 77.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.615 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.769 ' O ' ' HG3' ' A' ' 413' ' ' MET . 2.2 m -57.92 -51.77 68.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.705 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.56 -48.94 78.68 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.821 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.83 -43.59 87.14 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.397 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.689 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.21 -31.67 66.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.887 0.343 . . . . 0.0 110.839 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.921 ' HE3' HG21 ' A' ' 375' ' ' VAL . 69.2 mtm -69.1 -48.57 62.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.291 0.567 . . . . 0.0 110.048 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.077 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.1 mt -59.13 -39.27 81.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.22 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.902 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 4.3 m -78.16 -13.6 59.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 95.92 32.25 6.92 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.33 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.601 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.7 OUTLIER 69.92 37.63 1.74 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.357 0.663 . . . . 0.0 111.876 176.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.61 ' OD1' HD21 ' A' ' 421' ' ' LEU . 0.3 OUTLIER -120.52 81.24 1.73 Allowed 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.689 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 8.5 p90 -63.15 -31.74 72.95 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.611 -161.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 25.8 mt-30 -54.3 -48.38 71.36 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 113.464 -164.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.672 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.4 pp -59.61 -51.36 70.16 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.416 0.626 . . . . 0.0 111.02 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -59.8 -38.44 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.891 1.329 . . . . 0.0 109.241 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 43.4 t -63.09 -47.12 84.22 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.025 -2.352 . . . . 0.0 111.873 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.66 -36.27 70.88 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.87 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.72 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.7 mt -72.01 -43.07 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.546 0.689 . . . . 0.0 109.944 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.583 HD13 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -56.09 -45.24 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.718 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.4 OUTLIER -61.45 -29.45 69.97 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 122.608 1.194 . . . . 0.0 108.959 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.06 -16.56 76.76 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.688 -2.051 . . . . 0.0 112.462 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.712 ' CG ' HG21 ' A' ' 399' ' ' VAL . 11.8 m-85 -100.68 2.69 41.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.74 143.6 75.82 Favored Pre-proline 0 N--CA 1.411 -2.414 0 CA-C-O 123.658 1.694 . . . . 0.0 113.687 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.76 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 72.9 Cg_endo -72.45 -55.09 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.102 1 C-N-CA 126.455 4.77 . . . . 0.0 113.263 -171.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -114.77 140.57 16.45 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.115 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.892 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.054 0.427 . . . . 0.0 111.522 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.789 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.4 -46.66 83.22 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.01 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.8 t -59.17 -51.37 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.553 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.21 -54.4 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.9 m -61.33 -56.64 18.18 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.12 -45.42 79.5 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.533 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.841 ' O ' HD22 ' A' ' 443' ' ' LEU . 43.9 mt -60.11 -53.29 59.5 Favored 'General case' 0 CA--C 1.481 -1.697 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.687 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.716 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 19.9 mm100 -51.35 -35.15 37.05 Favored 'General case' 0 N--CA 1.415 -2.201 0 O-C-N 125.115 1.509 . . . . 0.0 110.437 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.64 -60.81 2.05 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 177.042 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.415 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -76.73 -50.63 13.13 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.84 -0.538 . . . . 0.0 112.3 -172.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.841 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.68 -24.28 61.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.767 0.794 . . . . 0.0 111.518 -178.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.752 ' N ' HD23 ' A' ' 443' ' ' LEU . 16.6 t70 -72.21 -42.87 65.28 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.688 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.26 -8.15 47.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.525 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 55.9 mm-40 -51.32 157.8 0.93 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 123.683 1.706 . . . . 0.0 114.333 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.485 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -55.82 -32.81 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 CA-C-N 110.508 -3.042 . . . . 0.0 115.509 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.664 ' H ' ' HB ' ' A' ' 451' ' ' THR . 31.5 m-20 -140.04 179.11 6.8 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.422 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 7.3 m-20 -62.47 -56.77 14.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.18 -24.77 67.47 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.118 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.664 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 21.1 m -59.55 -41.98 91.35 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 119.492 1.042 . . . . 0.0 109.928 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 52.7 mtt180 -61.32 -29.84 70.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -75.09 -31.84 61.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.141 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.8 mm-40 -79.8 -45.35 18.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.626 -172.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.505 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 43.5 p -101.79 -3.51 27.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.136 -167.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.697 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.7 t80 -48.75 -52.6 22.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 405' ' ' ALA . 22.8 mm -71.45 -25.78 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.505 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.31 -43.4 64.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.621 ' O ' HG23 ' A' ' 463' ' ' VAL . 76.4 m-70 -66.82 -31.39 71.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.725 171.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.762 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.43 -53.87 36.78 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.117 0.961 . . . . 0.0 109.372 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.607 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.1 m-80 -62.0 -32.11 72.56 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.205 172.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.9 -52.02 64.71 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.026 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 435' ' ' VAL . 23.1 t -63.37 -34.83 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 110.271 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.1 m-30 -61.24 -14.21 24.32 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.128 169.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 63.5 mm-40 -91.53 -48.9 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.874 -1.141 . . . . 0.0 112.933 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.694 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -66.24 -39.77 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.881 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.2 mt -84.45 -16.44 42.58 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.806 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.97 51.17 55.61 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 111.674 -2.512 . . . . 0.0 113.348 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.697 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -104.1 -179.52 3.97 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.918 0.887 . . . . 0.0 110.699 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.593 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.0 OUTLIER -98.47 -41.28 7.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.405 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.83 -74.99 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.252 -2.249 . . . . 0.0 110.839 160.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.76 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -60.26 64.08 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.159 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 43.62 36.89 3.56 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.619 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.593 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 10.4 mm-40 -75.61 -53.39 8.67 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.346 1.069 . . . . 0.0 111.496 -170.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 26.9 t 66.18 59.1 0.69 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.267 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.806 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -52.42 -46.84 47.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 111.247 -2.706 . . . . 0.0 111.635 175.189 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -50.54 145.96 6.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.118 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 62.0 mt -55.4 152.42 8.68 Favored 'General case' 0 N--CA 1.42 -1.952 0 C-N-CA 123.377 0.671 . . . . 0.0 112.105 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 . . . . . 0 N--CA 1.435 -1.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.101 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.48 0.677 0 N-CA-C 111.073 -0.395 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.2 mp -82.76 -54.66 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.488 . . . . 0.0 110.152 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -149.87 -95.05 0.13 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.874 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 57.9 m -158.88 116.87 2.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.362 0.601 . . . . 0.0 110.515 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 304' ' ' VAL . 1.9 p -62.72 120.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.272 173.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.72 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 20.2 mt -71.17 126.41 91.95 Favored Pre-proline 0 N--CA 1.426 -1.625 0 CA-C-O 121.997 0.903 . . . . 0.0 112.104 -174.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 308' ' ' GLN . 24.4 Cg_endo -73.51 -8.96 22.41 Favored 'Trans proline' 0 CA--C 1.501 -1.136 0 C-N-CA 124.952 3.768 . . . . 0.0 111.382 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.707 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.7 tp 24.8 -64.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.315 0 C-N-CA 128.458 2.703 . . . . 0.0 116.195 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.645 ' H ' HG23 ' A' ' 307' ' ' ILE . 0.2 OUTLIER -57.7 -31.06 66.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.13 0.49 . . . . 0.0 111.337 177.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.544 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.2 t-160 -61.49 -49.05 78.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.498 170.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.671 HG13 HG11 ' A' ' 338' ' ' VAL . 55.1 mt -58.68 -48.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.605 174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.695 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 52.2 mtp180 -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 122.545 0.338 . . . . 0.0 111.52 176.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.9 m -69.84 -33.18 71.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.502 0.668 . . . . 0.0 110.056 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.586 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -67.34 -42.32 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.51 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.774 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.3 p -83.21 -36.4 24.68 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.875 1.322 . . . . 0.0 110.44 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.91 33.91 10.53 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 112.248 -2.251 . . . . 0.0 110.834 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 49.44 176.22 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 124.424 1.09 . . . . 0.0 113.629 -174.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.632 ' HB3' HD11 ' A' ' 324' ' ' ILE . 21.3 Cg_exo -45.6 141.49 8.0 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.913 2.409 . . . . 0.0 112.818 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.469 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 43.6 Cg_endo -87.84 -101.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.156 2.571 . . . . 0.0 112.318 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 8.8 mmm180 -94.22 -80.07 0.41 Allowed 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.484 0.659 . . . . 0.0 110.756 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.534 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 36.4 m-20 -105.87 162.78 18.66 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.811 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.516 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.3 Cg_exo -61.38 -52.37 3.32 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.671 2.247 . . . . 0.0 111.025 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.48 -19.21 2.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.898 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.534 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.6 mm-40 -88.56 -26.91 21.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.519 0.199 . . . . 0.0 111.482 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.98 -44.13 45.96 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.717 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.22 -62.13 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.815 2.343 . . . . 0.0 113.044 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.647 HG21 HG12 ' A' ' 398' ' ' ILE . 1.1 mp -62.29 -36.24 73.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 122.441 1.115 . . . . 0.0 110.027 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.774 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 50.1 t90 -57.84 -38.0 74.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.513 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.833 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.97 -48.19 59.28 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.53 -23.48 20.26 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.794 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.538 ' HD2' HG21 ' A' ' 406' ' ' THR . 1.5 mtm-85 -73.84 -43.17 59.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.322 1.058 . . . . 0.0 110.456 174.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.748 ' HB3' HG22 ' A' ' 314' ' ' THR . 51.8 m-20 -95.67 -24.73 16.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.478 -1.692 . . . . 0.0 113.711 -168.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.84 -50.56 10.19 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.1 Cg_endo -60.9 -33.88 91.91 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.623 2.215 . . . . 0.0 111.68 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.27 -44.46 62.76 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.774 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.621 HG23 HG23 ' A' ' 310' ' ' ILE . 87.7 mt -58.07 -48.21 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.635 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.07 -14.94 7.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.282 -1.781 . . . . 0.0 112.046 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.0 -48.7 5.64 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.671 HG11 HG13 ' A' ' 310' ' ' ILE . 92.2 t -55.18 -70.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.617 1.675 . . . . 0.0 109.89 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.846 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -91.67 131.19 36.53 Favored Pre-proline 0 N--CA 1.402 -2.847 0 CA-C-N 110.729 -2.941 . . . . 0.0 112.008 -173.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.789 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.4 Cg_endo -73.39 -18.42 23.09 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 123.634 2.889 . . . . 0.0 110.248 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 32.87 69.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 111.938 -2.392 . . . . 0.0 110.189 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.592 ' N ' HD12 ' A' ' 346' ' ' LEU . 40.9 p -79.93 3.61 19.41 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.119 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.79 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -140.85 156.1 68.84 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 109.509 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.511 ' HB3' HD12 ' A' ' 369' ' ' LEU . 68.7 Cg_exo -60.94 -38.57 68.12 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 124.263 3.308 . . . . 0.0 109.54 172.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.678 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.58 -53.08 41.94 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.364 -2.198 . . . . 0.0 110.566 173.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.79 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -56.68 -51.94 66.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.77 0.795 . . . . 0.0 110.311 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 350' ' ' ILE . 10.5 ttm180 -50.62 -44.75 57.28 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.238 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 40.9 t -70.09 -49.34 51.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.738 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 77.8 mtt180 -57.93 -39.3 77.68 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.704 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.846 HD11 ' CD2' ' A' ' 339' ' ' PHE . 37.0 mt -59.71 -54.04 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.689 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.589 HD13 ' HB1' ' A' ' 374' ' ' ALA . 15.9 mt -57.58 -53.34 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-O 122.133 0.968 . . . . 0.0 110.919 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.529 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -64.14 -34.79 78.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.149 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.27 -35.15 75.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.104 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.67 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.25 0.9 OUTLIER -57.9 -54.13 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 122.715 1.245 . . . . 0.0 110.616 174.421 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.67 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.3 OUTLIER -72.52 -27.32 62.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 111.758 -2.474 . . . . 0.0 109.037 -168.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 28.1 55.61 0.13 Allowed Glycine 0 CA--C 1.524 0.628 0 O-C-N 125.568 1.793 . . . . 0.0 115.357 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 135.96 45.85 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.667 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.571 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -98.3 163.31 12.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.173 0.189 . . . . 0.0 110.762 178.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.37 -60.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.23 0.538 . . . . 0.0 111.702 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -157.75 16.05 0.31 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.607 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.674 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.4 mt -64.46 -6.32 7.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 122.919 0.488 . . . . 0.0 111.649 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.529 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.9 t -61.43 85.2 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.22 0.533 . . . . 0.0 110.112 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.814 HD11 HG21 ' A' ' 377' ' ' THR . 1.8 mm? -60.64 -172.74 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.652 0.739 . . . . 0.0 112.822 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.9 p -126.96 152.68 75.87 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 18.4 Cg_exo -46.55 -34.65 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.979 1.786 . . . . 0.0 111.265 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -86.26 -2.25 85.65 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.65 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.675 ' HB2' HD12 ' A' ' 363' ' ' LEU . 55.6 m-20 -105.48 -21.29 13.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.306 1.051 . . . . 0.0 109.124 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 77.0 m -86.8 22.94 1.82 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.382 -171.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -59.02 -35.98 74.18 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.62 1.2 . . . . 0.0 108.266 -173.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 29.8 p -118.83 163.48 16.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 112.839 -1.982 . . . . 0.0 110.361 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.655 ' O ' HG13 ' A' ' 375' ' ' VAL . 51.8 m95 -71.18 -34.1 70.61 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 167.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.585 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -62.92 -47.07 84.85 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.613 -173.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.3 t -65.86 -42.82 89.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.739 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.745 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.53 63.76 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.909 HG21 ' HE3' ' A' ' 413' ' ' MET . 10.4 m -58.84 -44.85 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.613 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.088 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.79 -43.46 98.08 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.949 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.814 HG21 HD11 ' A' ' 363' ' ' LEU . 24.1 m -70.47 -40.42 73.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.749 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.6 mt -59.18 -35.15 73.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.399 0.618 . . . . 0.0 110.439 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.717 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.0 t80 -71.12 -49.08 48.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.344 1.069 . . . . 0.0 109.412 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.554 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.92 -32.41 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.962 170.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.609 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -59.95 -33.02 71.35 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 123.241 0.616 . . . . 0.0 111.698 175.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 29.1 p -106.34 -23.24 12.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.771 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -110.34 22.61 15.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 52.87 21.38 9.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 114.336 0.494 . . . . 0.0 114.336 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.5 m 64.86 161.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.42 0.628 . . . . 0.0 111.022 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.502 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.5 157.01 63.37 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -97.67 54.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.361 2.708 . . . . 0.0 111.019 166.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.682 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 56.85 3.14 0.12 Allowed 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -174.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -69.91 -46.85 64.51 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.512 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.659 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.8 mt-30 -74.17 -26.72 60.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.95 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -54.69 -31.52 58.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.97 0.805 . . . . 0.0 111.492 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.688 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.72 -53.17 40.9 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.426 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.62 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.8 m-20 -64.88 -40.85 95.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.068 0.547 . . . . 0.0 112.17 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.42 -45.39 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.687 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.8 mm -58.8 -48.45 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.513 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.3 mmtt -52.11 -42.15 63.06 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.893 0.746 . . . . 0.0 111.54 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.34 -45.09 11.71 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.186 -172.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.2 mt -69.75 -40.67 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 117.52 0.66 . . . . 0.0 111.25 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.9 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.8 m -58.35 -45.16 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.66 0.743 . . . . 0.0 110.194 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.481 ' N ' HG23 ' A' ' 399' ' ' VAL . 10.6 t70 -62.94 -35.94 81.78 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.879 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -86.59 -53.47 4.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.046 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -107.66 -29.49 9.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.469 -171.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 120.84 163.79 12.17 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.9 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -42.92 97.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.624 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.14 -51.21 70.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.917 0.389 . . . . 0.0 111.784 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.587 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.16 -50.77 66.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.508 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.692 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.65 -41.73 64.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.618 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.8 t80 -57.1 -46.18 82.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.661 0.743 . . . . 0.0 109.2 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.783 ' O ' ' HG3' ' A' ' 413' ' ' MET . 7.5 m -58.31 -51.85 68.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.642 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.678 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.87 -49.14 76.04 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.723 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.562 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.33 -42.14 88.46 Favored Glycine 0 C--N 1.315 -0.59 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.252 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.68 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.49 -32.01 65.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 116.764 0.282 . . . . 0.0 111.015 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.909 ' HE3' HG21 ' A' ' 375' ' ' VAL . 67.3 mtm -69.97 -48.03 59.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.378 0.609 . . . . 0.0 109.831 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.088 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.6 mt -59.48 -38.55 81.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.388 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.95 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.0 m -77.64 -15.04 59.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.39 28.57 7.96 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 119.936 -1.125 . . . . 0.0 111.526 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.68 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.8 mm100 63.12 46.42 4.65 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.022 0.929 . . . . 0.0 112.302 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.574 ' OD1' HD21 ' A' ' 421' ' ' LEU . 0.4 OUTLIER -122.69 66.99 0.95 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 165.412 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.622 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.9 OUTLIER -47.53 -34.38 7.51 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 111.368 -2.651 . . . . 0.0 113.733 -165.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 423' ' ' SER . 48.3 mt-30 -55.45 -44.41 76.33 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -164.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.686 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.56 -50.95 71.91 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.347 0.594 . . . . 0.0 110.624 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.611 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.96 -38.76 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.428 1.109 . . . . 0.0 109.164 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 29.1 t -59.5 -47.85 83.91 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.648 -2.069 . . . . 0.0 112.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.82 73.09 Favored Glycine 0 C--N 1.317 -0.489 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.122 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.681 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.24 -42.2 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.546 0.688 . . . . 0.0 110.085 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.607 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.67 -44.32 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.94 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.724 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.1 OUTLIER -62.7 -27.99 69.63 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 122.901 1.334 . . . . 0.0 108.991 -173.302 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.42 77.69 Favored Glycine 0 C--N 1.298 -1.537 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.503 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 14.5 m-85 -100.4 3.08 42.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.96 144.87 74.18 Favored Pre-proline 0 N--CA 1.413 -2.308 0 CA-C-O 123.615 1.674 . . . . 0.0 113.439 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.723 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.7 Cg_endo -72.98 -61.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 1 C-N-CA 126.118 4.545 . . . . 0.0 113.305 -174.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.546 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.37 142.69 16.33 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.879 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.27 -29.22 70.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.085 0.443 . . . . 0.0 111.184 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.748 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.26 -47.21 79.02 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.004 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.6 t -58.8 -51.83 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.663 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.879 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.08 -54.44 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.05 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 47.9 m -62.27 -55.77 25.02 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.476 -0.489 . . . . 0.0 112.073 -175.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.35 -45.65 80.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.715 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.838 ' O ' HD22 ' A' ' 443' ' ' LEU . 48.8 mt -60.39 -53.15 60.99 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.759 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.705 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -51.75 -34.16 38.06 Favored 'General case' 0 N--CA 1.416 -2.147 0 O-C-N 125.03 1.456 . . . . 0.0 110.644 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.716 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.65 -60.73 2.09 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.405 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.98 -51.43 11.14 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.963 -0.461 . . . . 0.0 112.243 -172.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.838 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.8 -23.85 60.95 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.869 0.842 . . . . 0.0 111.571 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.756 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.5 t70 -71.26 -41.41 70.1 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.666 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.716 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 45.1 mt-30 -72.68 -9.67 58.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -170.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.492 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 5.8 mm-40 -56.48 154.0 9.19 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.79 1.281 . . . . 0.0 113.762 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.496 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -52.7 -33.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.09 -2.323 . . . . 0.0 116.249 -168.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.622 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 27.8 m-20 -135.69 -178.47 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.475 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.4 p-10 -64.07 -54.6 31.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.501 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.1 OUTLIER -67.6 -24.16 65.45 Favored 'General case' 0 N--CA 1.403 -2.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.609 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 8.6 m -60.25 -44.05 95.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 119.696 1.134 . . . . 0.0 109.427 171.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.5 mtt180 -59.22 -29.98 67.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.172 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.618 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.59 -30.82 59.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.674 0.749 . . . . 0.0 109.627 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.91 -44.97 19.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.222 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.506 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -100.75 -4.19 28.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.723 -1.58 . . . . 0.0 111.818 -168.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.673 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.1 t80 -48.77 -52.5 23.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.809 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 405' ' ' ALA . 23.8 mm -72.87 -25.24 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.11 -43.28 64.99 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 463' ' ' VAL . 72.2 m-70 -67.81 -31.55 71.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.734 -1.576 . . . . 0.0 109.513 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.744 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.74 -53.84 40.88 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.165 0.983 . . . . 0.0 109.304 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.3 -30.6 71.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.619 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -66.9 -48.81 67.57 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.004 HG11 ' HA ' ' A' ' 435' ' ' VAL . 22.0 t -65.24 -35.82 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.302 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.538 ' OH ' HG13 ' A' ' 404' ' ' VAL . 18.8 m-30 -61.47 -13.17 18.56 Favored 'General case' 0 C--O 1.204 -1.294 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.707 169.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 3.5 tp10 -95.23 -52.6 4.12 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.227 -0.921 . . . . 0.0 112.24 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.724 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -62.75 -41.08 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.317 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.748 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.3 mt -83.97 -16.44 44.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.796 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.27 47.57 78.78 Favored Glycine 0 C--O 1.215 -1.039 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.492 172.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -102.31 178.88 4.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.069 0.948 . . . . 0.0 110.478 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.654 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 0.7 OUTLIER -96.54 -40.75 8.9 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 167.314 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -163.48 -75.12 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.358 160.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.723 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 1.0 OUTLIER -61.61 68.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -171.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 39.55 41.97 1.82 Allowed Glycine 0 C--N 1.274 -2.901 0 CA-C-N 110.626 -2.988 . . . . 0.0 113.375 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.654 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 0.0 OUTLIER -79.05 -56.62 4.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.2 1.0 . . . . 0.0 111.635 -171.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.8 t 68.9 54.46 0.47 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.283 -173.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.796 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -51.32 -48.01 33.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.139 175.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -50.86 139.59 16.71 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.315 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.97 -26.42 66.0 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.517 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.437 -1.077 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.089 179.496 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.473 0.296 0 N-CA-C 111.063 -0.399 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.05 123.35 44.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 110.61 -154.05 16.8 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.879 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.512 ' HB ' HD11 ' A' ' 346' ' ' LEU . 94.8 m -153.13 120.37 5.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 -177.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.9 p -55.76 119.51 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.252 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.718 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 17.2 mt -75.96 127.85 84.46 Favored Pre-proline 0 N--CA 1.424 -1.76 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.994 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.2 Cg_endo -72.88 -12.18 26.09 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.823 3.682 . . . . 0.0 111.253 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.709 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.9 tp 27.25 -61.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 C-N-CA 128.685 2.794 . . . . 0.0 116.145 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.569 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.81 -31.89 68.86 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.097 0.475 . . . . 0.0 110.305 178.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.559 ' CD2' HG13 ' A' ' 338' ' ' VAL . 1.2 t-80 -61.8 -48.58 79.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.615 171.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.0 mt -58.41 -48.9 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 C-N-CA 123.987 0.915 . . . . 0.0 112.638 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.69 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 15.1 mtp180 -60.62 -29.86 69.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 122.222 -0.299 . . . . 0.0 111.074 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 52.8 m -69.76 -34.96 74.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.38 0.609 . . . . 0.0 109.761 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.578 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.66 -41.12 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.741 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.772 HG22 ' HB3' ' A' ' 331' ' ' ASN . 30.2 p -83.52 -37.96 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.898 1.332 . . . . 0.0 109.882 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.58 35.52 6.87 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.003 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 39.6 mt-10 51.3 177.12 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 124.083 0.953 . . . . 0.0 113.051 -174.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.634 ' HB3' HD11 ' A' ' 324' ' ' ILE . 48.7 Cg_exo -48.59 152.56 4.05 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.633 2.222 . . . . 0.0 113.379 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.522 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 7.5 Cg_endo -98.93 -107.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.076 3.184 . . . . 0.0 112.624 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.466 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 8.6 mmm180 -89.19 -88.83 0.15 Allowed 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.013 0.911 . . . . 0.0 111.97 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.688 ' H ' ' HG2' ' A' ' 323' ' ' GLU . 2.2 m-20 -94.87 157.83 36.1 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.474 -170.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.504 ' HB3' HD13 ' A' ' 359' ' ' ILE . 38.2 Cg_exo -59.32 -50.75 7.76 Favored 'Trans proline' 0 CA--C 1.511 -0.675 0 C-N-CA 122.414 2.076 . . . . 0.0 110.399 166.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.48 23.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.791 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.688 ' HG2' ' H ' ' A' ' 320' ' ' ASN . 3.3 pt-20 -102.94 -20.47 14.23 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.622 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -44.05 -42.65 12.5 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.019 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.726 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.43 -61.44 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.757 HG21 HG12 ' A' ' 398' ' ' ILE . 0.8 OUTLIER -60.01 -34.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.153 178.032 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.693 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -58.8 -36.39 74.38 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.228 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.853 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.81 -49.13 55.67 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.425 ' HA3' HD11 ' A' ' 410' ' ' LEU . . . -54.01 -22.97 22.01 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.758 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.66 ' HD3' HG21 ' A' ' 406' ' ' THR . 0.1 OUTLIER -72.11 -42.4 66.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.215 1.007 . . . . 0.0 110.105 174.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.772 ' HB3' HG22 ' A' ' 314' ' ' THR . 54.7 m-20 -99.79 -24.16 14.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.739 -1.573 . . . . 0.0 114.114 -168.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.626 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.31 -50.01 8.75 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.0 Cg_endo -60.73 -33.42 93.13 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.371 2.047 . . . . 0.0 111.529 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.36 -42.23 65.53 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.794 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.633 HG23 HG23 ' A' ' 310' ' ' ILE . 90.4 mt -59.91 -48.5 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.965 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -56.14 -16.54 5.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.24 5.68 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.66 HG11 HG13 ' A' ' 310' ' ' ILE . 96.0 t -55.09 -70.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 123.665 1.698 . . . . 0.0 110.1 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.927 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.75 131.28 34.13 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 110.798 -2.91 . . . . 0.0 111.94 -172.642 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.798 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 67.9 Cg_endo -72.3 -18.87 26.23 Favored 'Trans proline' 0 CA--C 1.495 -1.464 0 C-N-CA 123.562 2.841 . . . . 0.0 110.524 174.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.5 p 32.75 69.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 112.107 -2.315 . . . . 0.0 110.32 -178.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.617 ' H ' HD12 ' A' ' 346' ' ' LEU . 46.4 p -80.6 4.46 18.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.034 -1.894 . . . . 0.0 113.206 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.815 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 33.4 p -142.89 157.27 61.57 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-O 121.699 0.761 . . . . 0.0 109.694 174.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 70.0 Cg_exo -60.63 -38.97 68.14 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 124.373 3.382 . . . . 0.0 109.413 172.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.619 ' HA ' ' HB3' ' A' ' 365' ' ' PRO . 11.5 t70 -45.75 -58.83 3.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 112.371 -2.195 . . . . 0.0 110.217 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.815 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.3 mt -56.17 -52.24 65.11 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.815 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.735 ' HA ' HD12 ' A' ' 350' ' ' ILE . 34.3 ttm105 -52.61 -42.99 65.08 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 48.6 t -69.49 -49.79 51.36 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 26.9 mtp180 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.667 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.927 HD11 ' HD2' ' A' ' 339' ' ' PHE . 50.8 mt -62.23 -53.85 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.681 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.584 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -58.19 -53.36 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.078 0.942 . . . . 0.0 111.143 -168.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.548 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -64.3 -35.08 79.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.171 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.18 -32.92 72.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.706 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.36 -55.95 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 CA-C-O 122.925 1.345 . . . . 0.0 110.41 173.253 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 354' ' ' ILE . 1.7 mp -72.94 -26.1 61.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 111.88 -2.418 . . . . 0.0 109.051 -169.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 37.44 59.18 1.29 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 113.694 -1.594 . . . . 0.0 114.609 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 121.02 48.92 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.688 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.545 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -87.94 162.61 16.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.69 -63.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 122.828 0.451 . . . . 0.0 111.448 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.11 9.31 0.96 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.512 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.663 ' HB3' HD22 ' A' ' 378' ' ' LEU . 4.8 mt -64.15 -5.38 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 122.955 0.502 . . . . 0.0 111.645 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 48.1 t -61.29 84.28 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.092 0.473 . . . . 0.0 110.546 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.833 HD11 HG21 ' A' ' 377' ' ' THR . 2.2 mm? -62.71 -174.64 0.07 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.877 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 71.7 p -128.47 155.79 78.12 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.619 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 35.4 Cg_exo -45.14 -38.12 13.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.965 1.777 . . . . 0.0 111.23 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.571 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -78.47 -4.17 87.02 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.806 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 363' ' ' LEU . 9.4 m-20 -109.5 -20.02 13.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.835 0.826 . . . . 0.0 110.194 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 81.4 m -91.25 21.49 4.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.702 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.571 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.7 OUTLIER -60.48 -38.97 85.98 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.156 -172.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.47 162.39 21.8 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.015 170.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.616 ' O ' HG13 ' A' ' 375' ' ' VAL . 48.0 m95 -69.54 -35.78 75.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.571 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.64 -41.77 99.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.783 -174.231 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 66.5 p -67.91 -44.77 76.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.922 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.43 -52.61 62.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.905 HG21 ' HE3' ' A' ' 413' ' ' MET . 15.6 m -57.31 -45.23 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.598 0.714 . . . . 0.0 109.585 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.021 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.17 -44.79 96.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.052 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.833 HG21 HD11 ' A' ' 363' ' ' LEU . 34.5 m -67.37 -39.85 85.7 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.499 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 325' ' ' PRO . 2.4 mt -58.99 -34.9 72.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.445 0.566 . . . . 0.0 110.325 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.726 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 43.7 t80 -73.81 -46.0 48.0 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.309 1.052 . . . . 0.0 109.467 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.591 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.2 mp -51.52 -32.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.322 170.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.624 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -59.83 -36.59 77.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.185 0.594 . . . . 0.0 111.451 176.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 28.0 p -103.26 -22.63 13.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.72 -168.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.404 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 14.0 m80 -110.01 23.01 14.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.42 21.45 34.09 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.948 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.456 HG23 HG13 ' A' ' 380' ' ' ILE . 1.7 m 65.07 160.17 0.11 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.179 0.514 . . . . 0.0 110.788 -174.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.505 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -124.92 157.62 65.87 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -101.64 54.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.867 3.045 . . . . 0.0 111.546 166.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.771 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.06 -0.26 0.24 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.603 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -70.17 -44.49 68.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.017 0.437 . . . . 0.0 110.906 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.622 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.4 mt-30 -74.65 -27.01 60.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.901 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.41 -30.42 52.26 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.48 0.582 . . . . 0.0 111.638 -174.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.666 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.1 -53.05 39.52 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.795 173.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.614 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 12.3 m-20 -65.61 -39.24 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.4 m -57.97 -45.37 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.052 0.453 . . . . 0.0 110.256 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.764 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.3 mm -58.8 -48.11 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.1 mmtt -52.04 -41.26 62.15 Favored 'General case' 0 C--O 1.242 0.682 0 O-C-N 124.195 0.934 . . . . 0.0 111.418 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.63 12.78 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.352 -171.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.757 HG12 HG21 ' A' ' 326' ' ' ILE . 1.3 mt -70.61 -38.65 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 117.624 0.712 . . . . 0.0 112.002 -177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.881 HG12 ' HA ' ' A' ' 404' ' ' VAL . 1.1 m -59.33 -42.33 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.999 0.904 . . . . 0.0 109.136 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -59.18 -44.34 92.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.807 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -83.88 -53.5 5.55 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.491 -172.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.648 ' HB2' ' NH1' ' A' ' 330' ' ' ARG . 8.8 tp10 -112.34 -34.91 5.75 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -171.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 130.1 163.47 11.09 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.57 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.881 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.17 -41.28 91.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.107 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.18 -50.71 70.44 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.66 HG21 ' HD3' ' A' ' 330' ' ' ARG . 0.9 OUTLIER -65.55 -48.85 71.02 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.091 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.687 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.41 -44.81 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 112.008 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.0 t80 -55.66 -45.99 77.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.348 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.77 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.2 m -58.77 -52.58 65.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.758 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.69 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.47 -48.82 79.39 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.508 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.523 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.72 -44.25 86.62 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.685 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.7 -31.17 64.82 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.899 0.35 . . . . 0.0 110.923 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.905 ' HE3' HG21 ' A' ' 375' ' ' VAL . 68.4 mtm -68.61 -49.8 56.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.475 0.655 . . . . 0.0 109.988 172.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.021 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.5 mt -58.56 -39.11 79.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.986 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.901 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.7 m -77.93 -16.45 58.18 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.558 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.23 35.31 6.34 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.169 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.643 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 69.91 39.69 1.39 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.632 0.773 . . . . 0.0 112.571 176.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.611 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 0.3 OUTLIER -121.63 77.46 1.35 Allowed 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.491 -2.041 . . . . 0.0 105.491 164.363 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.685 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 9.1 p90 -62.04 -31.32 71.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.627 -2.079 . . . . 0.0 110.515 -162.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.553 ' O ' ' HB3' ' A' ' 423' ' ' SER . 23.6 mt-30 -54.38 -48.08 71.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.086 -164.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.672 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.87 -49.69 76.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.717 0.77 . . . . 0.0 110.962 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.616 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.31 -39.04 79.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.633 1.206 . . . . 0.0 109.251 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 38.8 t -60.54 -45.64 93.09 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.444 -2.162 . . . . 0.0 111.375 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -55.94 -39.31 78.24 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.358 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.657 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.26 -42.59 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.643 0.735 . . . . 0.0 109.976 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.58 HD13 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -55.46 -44.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.735 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -60.85 -30.63 70.23 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-O 122.733 1.254 . . . . 0.0 108.987 -173.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.49 -18.24 76.89 Favored Glycine 0 C--N 1.299 -1.502 0 CA-C-N 112.561 -2.109 . . . . 0.0 111.921 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.711 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.35 1.27 44.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.91 141.99 79.84 Favored Pre-proline 0 N--CA 1.408 -2.557 0 CA-C-O 123.771 1.748 . . . . 0.0 112.848 170.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.808 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.7 Cg_endo -70.16 -60.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 1 C-N-CA 126.065 4.51 . . . . 0.0 112.977 -171.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -111.36 134.76 12.34 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.235 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.845 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -49.26 -37.34 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.19 -48.33 73.96 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.039 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -58.13 -52.53 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.637 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.845 HG13 ' HA ' ' A' ' 433' ' ' GLN . 1.6 m -51.81 -53.31 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 117.64 0.2 . . . . 0.0 110.492 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.452 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 59.4 m -68.71 -54.17 17.74 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.837 -174.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.44 -41.44 76.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.161 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.842 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.6 mt -63.37 -53.92 44.91 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.208 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.7 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.68 -33.79 35.46 Favored 'General case' 0 N--CA 1.419 -1.977 0 O-C-N 124.959 1.412 . . . . 0.0 110.279 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.686 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.48 -59.88 2.51 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 173.011 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.5 ptp180 -73.92 -53.55 9.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.838 0.745 . . . . 0.0 112.616 -172.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.44 -25.0 64.0 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.653 0.74 . . . . 0.0 111.786 -177.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.777 ' N ' HD23 ' A' ' 443' ' ' LEU . 6.3 t70 -72.69 -41.89 64.81 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.32 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.99 -7.74 43.32 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.573 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 40.4 mm-40 -54.73 158.0 2.81 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 123.206 1.479 . . . . 0.0 114.171 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.607 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -54.19 -33.44 25.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 111.52 -2.582 . . . . 0.0 115.904 -170.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.65 ' H ' ' HB ' ' A' ' 451' ' ' THR . 38.8 m-20 -142.89 178.47 7.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.426 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.0 m-20 -61.48 -55.45 31.03 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -63.82 -27.58 69.27 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.65 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 6.5 m -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.636 1.107 . . . . 0.0 109.941 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.611 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 50.0 mtt180 -60.68 -29.46 69.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.598 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.96 -30.18 58.54 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.131 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 2.9 mm-40 -82.58 -46.49 13.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.273 1.035 . . . . 0.0 111.95 -172.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.523 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -100.54 -1.55 35.28 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.811 -1.54 . . . . 0.0 111.542 -168.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.669 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.8 -51.99 26.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.656 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 405' ' ' ALA . 21.3 mm -72.68 -26.33 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.523 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.44 -42.61 64.85 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.629 ' O ' HG23 ' A' ' 463' ' ' VAL . 56.7 m-70 -67.49 -31.56 71.78 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.611 171.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.758 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.84 -53.84 40.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.172 0.987 . . . . 0.0 109.481 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.68 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.9 m-80 -62.68 -32.03 73.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.006 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.85 -53.03 61.41 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.857 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.039 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.4 t -63.05 -34.4 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.712 0.767 . . . . 0.0 110.398 177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -62.17 -15.53 46.78 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.175 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 33.9 mm-40 -92.26 -49.7 6.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 112.475 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.777 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 4.8 pt -64.37 -40.82 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.559 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -83.69 -16.67 44.1 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.719 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.5 51.88 50.84 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.123 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.72 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -102.72 -178.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 123.766 0.826 . . . . 0.0 110.134 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.596 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.2 p-10 -99.72 -42.98 6.62 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 165.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.61 -75.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.906 160.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.808 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -61.16 64.75 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -169.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 43.81 35.48 3.23 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 111.754 -2.475 . . . . 0.0 113.062 173.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.596 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 3.3 mm100 -73.61 -57.19 4.16 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 122.093 0.949 . . . . 0.0 111.778 -172.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 68.53 49.34 0.76 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.271 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.719 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER -42.59 -50.46 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 109.887 -3.324 . . . . 0.0 111.565 173.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.446 ' C ' ' HD2' ' A' ' 477' ' ' ARG . 0.0 OUTLIER -92.17 141.53 28.48 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.85 175.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 40.0 mt -59.6 139.82 56.87 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 123.042 0.537 . . . . 0.0 111.985 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.435 -1.184 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.575 -178.862 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.475 0.401 0 N-CA-C 110.525 -0.606 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.0 mp -94.05 113.52 28.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.462 ' O ' HD21 ' A' ' 346' ' ' LEU . . . -93.51 1.43 69.21 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.441 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.479 ' HB ' HD11 ' A' ' 346' ' ' LEU . 26.9 m 75.6 117.46 0.06 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 122.259 1.028 . . . . 0.0 111.22 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.2 p -71.84 124.61 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.318 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.708 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 21.5 mt -77.33 126.19 85.32 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 308' ' ' GLN . 19.0 Cg_endo -71.4 -10.55 27.18 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.733 3.622 . . . . 0.0 111.111 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.688 ' H ' HG22 ' A' ' 305' ' ' ILE . 4.6 tp 26.11 -61.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 128.72 2.808 . . . . 0.0 116.194 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.571 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.48 -32.04 68.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.231 0.539 . . . . 0.0 110.047 178.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.569 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.07 -49.4 76.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.913 172.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.674 HG13 HG11 ' A' ' 338' ' ' VAL . 54.7 mt -58.76 -49.31 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 123.95 0.9 . . . . 0.0 112.614 175.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 48.1 mtp180 -61.3 -29.61 69.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 123.38 0.672 . . . . 0.0 111.094 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 66.8 m -70.31 -34.03 72.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 110.251 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.643 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.73 -41.68 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.559 178.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.778 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -84.7 -37.69 20.64 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.748 1.261 . . . . 0.0 110.351 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.92 35.4 7.19 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.485 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 19.5 mt-10 50.34 176.39 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.62 ' HG3' ' HA ' ' A' ' 355' ' ' LEU . 73.5 Cg_exo -51.22 129.76 29.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.825 2.35 . . . . 0.0 113.1 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.88 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 82.3 Cg_endo -84.79 -92.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.488 3.459 . . . . 0.0 113.913 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.497 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 5.8 mmm180 -89.54 -77.72 0.38 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.747 0.784 . . . . 0.0 112.355 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.647 ' H ' ' CG ' ' A' ' 323' ' ' GLU . 38.0 m-20 -123.55 175.31 2.86 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.738 -170.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.459 ' HB3' HD13 ' A' ' 359' ' ' ILE . 27.2 Cg_exo -65.97 -56.96 0.26 Allowed 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 121.969 1.779 . . . . 0.0 111.572 167.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -50.68 -21.15 1.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.648 -1.615 . . . . 0.0 114.075 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.823 ' OE1' ' HG2' ' A' ' 318' ' ' PRO . 1.7 pp20? -99.24 -22.29 15.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.04 0.448 . . . . 0.0 111.629 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.67 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.62 -42.69 33.91 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.571 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.73 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -49.73 -59.61 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.815 2.344 . . . . 0.0 112.935 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.627 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -63.66 -35.95 74.7 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.953 -179.297 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.88 ' CD1' ' HG3' ' A' ' 318' ' ' PRO . 42.6 t90 -58.01 -37.33 74.1 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.289 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.837 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -69.16 -48.14 63.09 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.77 -23.47 22.01 Favored Glycine 0 C--N 1.311 -0.858 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.794 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.478 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 1.4 mmm180 -74.46 -42.8 58.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.119 0.961 . . . . 0.0 110.66 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.751 ' HB3' HG22 ' A' ' 314' ' ' THR . 28.1 m-20 -97.15 -22.75 16.56 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.895 -169.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.671 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.17 -49.64 11.56 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 39.7 Cg_endo -61.31 -32.21 89.67 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.589 2.193 . . . . 0.0 111.7 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.41 -43.99 59.31 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.727 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.0 mt -57.57 -48.49 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.866 173.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.47 -15.71 7.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.166 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.55 -47.25 6.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.259 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.674 HG11 HG13 ' A' ' 310' ' ' ILE . 99.1 t -57.51 -70.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 123.472 1.606 . . . . 0.0 110.128 169.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.887 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.39 128.74 43.51 Favored Pre-proline 0 N--CA 1.401 -2.92 0 CA-C-N 111.008 -2.815 . . . . 0.0 112.039 -172.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.768 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.9 Cg_endo -73.96 -16.56 22.97 Favored 'Trans proline' 0 CA--C 1.494 -1.49 0 C-N-CA 123.752 2.968 . . . . 0.0 110.442 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.621 HG21 ' HG3' ' A' ' 347' ' ' ARG . 2.8 p 34.01 67.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.222 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.649 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.2 p -80.37 8.07 8.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.83 -1.986 . . . . 0.0 113.118 -170.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.782 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 11.3 p -142.13 161.97 47.98 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -63.27 -47.52 7.77 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.451 2.768 . . . . 0.0 108.487 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.765 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.3 OUTLIER -45.96 -45.88 15.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.002 -1.908 . . . . 0.0 111.081 176.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.782 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -58.82 -52.31 66.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.378 0.609 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.621 ' HG3' HG21 ' A' ' 341' ' ' VAL . 2.1 ttt180 -50.4 -48.82 55.91 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.199 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 1.005 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -69.67 -49.13 56.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.035 0.445 . . . . 0.0 111.522 -175.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.664 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.3 mtt180 -56.48 -41.73 77.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.492 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.887 HD11 ' HD2' ' A' ' 339' ' ' PHE . 38.7 mt -57.72 -53.77 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.322 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.591 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.9 mt -58.15 -52.76 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.015 0.912 . . . . 0.0 111.018 -169.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.53 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 19.3 m-20 -63.39 -35.97 82.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.988 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.76 75.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.668 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.39 -54.37 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 123.127 1.441 . . . . 0.0 110.21 173.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.668 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -73.83 -26.5 60.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.377 -2.647 . . . . 0.0 109.878 -167.079 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 17.24 75.72 0.01 OUTLIER Glycine 0 N--CA 1.468 0.816 0 O-C-N 125.706 1.879 . . . . 0.0 115.205 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 137.35 -8.2 3.73 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.086 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.681 HD21 ' N ' ' A' ' 358' ' ' ASN . 0.0 OUTLIER -57.14 148.61 21.57 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.667 0.787 . . . . 0.0 111.703 175.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -56.05 -73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.477 0.711 . . . . 0.0 112.567 -175.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -136.9 11.16 3.93 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.644 ' HB3' HD22 ' A' ' 378' ' ' LEU . 4.6 mt -64.94 -4.68 4.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.87 0.468 . . . . 0.0 111.629 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.53 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.8 t -60.63 82.99 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.379 0.609 . . . . 0.0 110.334 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.799 HD11 HG21 ' A' ' 377' ' ' THR . 0.7 OUTLIER -62.42 173.78 1.13 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.664 0.745 . . . . 0.0 112.604 175.379 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 76.8 p -115.13 160.97 31.87 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 1.005 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.2 Cg_endo -61.06 -5.02 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.801 1.667 . . . . 0.0 112.26 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -105.84 -11.75 27.66 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' A' ' 363' ' ' LEU . 30.7 m-20 -105.91 -20.89 13.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.569 1.184 . . . . 0.0 110.228 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.853 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 16.8 p -84.9 20.05 1.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.709 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.03 -34.18 67.95 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.986 0.898 . . . . 0.0 110.192 -165.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.41 166.1 20.24 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.176 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.573 ' O ' HG13 ' A' ' 375' ' ' VAL . 44.0 m95 -69.66 -36.01 75.66 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.6 p30 -63.36 -39.42 94.47 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.306 -173.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 m -71.37 -41.99 69.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -63.27 -52.34 62.47 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.871 HG21 ' HE3' ' A' ' 413' ' ' MET . 14.6 m -56.77 -44.6 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.554 0.692 . . . . 0.0 109.51 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.041 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.66 -45.53 93.77 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.056 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.799 HG21 HD11 ' A' ' 363' ' ' LEU . 30.7 m -66.96 -39.11 87.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.56 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.26 -33.5 73.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.317 0.508 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.73 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 48.9 t80 -74.77 -45.63 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.311 1.053 . . . . 0.0 109.075 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -51.73 -33.27 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.346 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -60.25 -36.92 78.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 123.311 0.645 . . . . 0.0 111.732 177.026 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 32.5 p -102.77 -23.54 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.044 -167.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -109.83 23.06 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.86 21.24 51.25 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 114.073 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.462 HG23 HG13 ' A' ' 380' ' ' ILE . 2.8 m 64.11 163.74 0.13 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.588 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -129.09 150.52 75.6 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -97.35 59.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.251 2.634 . . . . 0.0 110.893 165.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.679 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.84 4.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.793 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -70.89 -48.82 51.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.635 ' O ' HG13 ' A' ' 394' ' ' VAL . 73.9 mt-30 -74.81 -27.74 60.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -169.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.941 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.4 mm? -54.76 -31.05 58.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.796 0.725 . . . . 0.0 111.892 -172.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.682 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.76 -52.67 44.39 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.438 173.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.599 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 3.5 m-20 -65.75 -39.94 91.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.826 0.45 . . . . 0.0 111.969 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -58.14 -45.06 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.1 mm -58.51 -47.58 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.682 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.4 mmtt -52.23 -43.42 64.29 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.901 0.751 . . . . 0.0 111.486 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.69 -44.63 12.16 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.24 -172.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.7 mt -69.05 -41.13 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 117.436 0.618 . . . . 0.0 111.432 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.9 m -58.13 -45.62 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.706 0.765 . . . . 0.0 109.944 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.475 ' N ' HG23 ' A' ' 399' ' ' VAL . 7.7 t70 -60.88 -38.23 84.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -86.26 -53.25 5.14 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.793 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.612 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.2 OUTLIER -110.67 -30.01 7.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.035 -168.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.02 162.48 11.19 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.853 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.94 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.66 98.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.037 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.654 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.22 -50.31 73.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.579 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -63.61 -51.18 66.36 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.577 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.678 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.03 -41.88 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.567 ' HB3' HD11 ' A' ' 457' ' ' ILE . 44.4 t80 -58.42 -44.8 89.24 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.827 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.0 m -59.26 -53.08 62.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.407 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.686 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.57 -49.08 76.67 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.686 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.607 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.1 -42.2 87.08 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.019 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.734 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.39 -32.44 66.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.68 0.24 . . . . 0.0 111.097 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.871 ' HE3' HG21 ' A' ' 375' ' ' VAL . 63.2 mtm -69.55 -46.29 66.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.172 0.511 . . . . 0.0 109.707 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.041 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.06 -40.75 90.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.524 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.941 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 9.2 m -78.12 8.0 5.45 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.744 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.38 31.73 56.47 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.734 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.8 mm100 63.87 44.98 4.56 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 123.942 0.897 . . . . 0.0 111.621 -178.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.684 ' OD1' HD23 ' A' ' 421' ' ' LEU . 24.5 t-20 -114.07 74.01 0.85 Allowed 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 164.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.676 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.5 OUTLIER -51.53 -35.41 40.5 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.32 -2.218 . . . . 0.0 111.288 -171.138 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.532 ' O ' ' HB3' ' A' ' 423' ' ' SER . 39.2 mt-30 -56.65 -50.57 71.69 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -166.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.733 HD11 ' OG ' ' A' ' 415' ' ' SER . 3.1 pp -59.53 -49.16 78.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.723 0.773 . . . . 0.0 110.564 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.63 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.79 -40.27 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.421 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 48.5 t -59.83 -47.43 85.76 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.507 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.55 -39.51 74.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.961 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.665 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.7 mt -71.92 -42.48 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.387 0.613 . . . . 0.0 110.142 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.58 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -57.07 -44.68 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.93 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.2 OUTLIER -63.51 -27.82 69.53 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-O 122.79 1.281 . . . . 0.0 108.846 -173.439 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -17.07 77.19 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 112.469 -2.15 . . . . 0.0 112.658 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.707 ' CG ' HG21 ' A' ' 399' ' ' VAL . 9.8 m-85 -99.71 2.43 44.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.31 144.82 76.75 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-O 123.645 1.688 . . . . 0.0 113.898 170.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.787 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.1 Cg_endo -72.36 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.083 1 C-N-CA 126.333 4.689 . . . . 0.0 113.584 -173.07 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.98 139.91 15.25 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.255 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.819 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.1 OUTLIER -61.61 -29.49 70.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.078 0.439 . . . . 0.0 111.207 -177.419 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.8 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.85 -48.01 79.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.01 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.79 -51.66 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.644 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.62 -55.22 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 52.6 m -61.4 -55.92 26.08 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.246 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.17 -45.5 79.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.668 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.844 ' O ' HD22 ' A' ' 443' ' ' LEU . 43.1 mt -60.38 -53.31 59.12 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.684 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.718 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 32.5 mm-40 -51.58 -34.6 37.76 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 125.174 1.546 . . . . 0.0 110.563 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.633 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.67 -59.9 2.49 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 175.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.72 -51.98 10.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.735 -0.603 . . . . 0.0 112.43 -173.397 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.84 -23.25 60.36 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.043 0.925 . . . . 0.0 111.409 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.756 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.6 t70 -72.23 -42.93 65.16 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.963 -1.472 . . . . 0.0 110.755 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.5 mt-30 -72.08 -8.29 53.76 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -172.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.529 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 53.1 mm-40 -52.25 155.96 1.83 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 123.366 1.555 . . . . 0.0 114.659 -174.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.601 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.32 -33.76 21.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 111.047 -2.797 . . . . 0.0 115.455 -170.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.653 ' H ' ' HB ' ' A' ' 451' ' ' THR . 15.7 m-20 -141.89 -179.21 6.07 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.929 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.442 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.2 p-10 -61.31 -55.55 30.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.485 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.28 -25.23 65.95 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 176.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.653 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 8.8 m -59.81 -42.69 94.03 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 119.861 1.209 . . . . 0.0 109.705 171.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.529 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 55.7 mtt180 -59.67 -29.91 68.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.525 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.38 -31.26 60.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.797 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -83.88 -45.87 12.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.208 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.542 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 34.0 p -100.61 -2.76 31.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.551 -166.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.694 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.4 t80 -49.04 -52.3 26.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.667 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 405' ' ' ALA . 23.7 mm -72.05 -25.72 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.542 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.35 -42.39 65.38 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.64 ' O ' HG23 ' A' ' 463' ' ' VAL . 52.5 m-70 -67.94 -31.47 71.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.686 -1.597 . . . . 0.0 109.718 172.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.733 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.27 -53.53 42.76 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.09 0.947 . . . . 0.0 109.33 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.634 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.77 -32.0 73.07 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.161 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.47 -52.47 63.38 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.8 t -62.57 -35.22 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 121.899 0.857 . . . . 0.0 110.344 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.3 m-30 -61.61 -14.51 31.18 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.155 170.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 61.5 mm-40 -93.06 -48.57 6.43 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.001 -1.062 . . . . 0.0 112.777 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.727 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.91 -39.0 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.109 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.5 mt -84.95 -17.12 38.68 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 170.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.738 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.27 53.45 39.54 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 111.698 -2.501 . . . . 0.0 113.161 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.739 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -103.55 -170.29 1.76 Allowed 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 123.856 0.863 . . . . 0.0 110.268 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.523 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.8 p-10 -109.86 -42.29 4.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -157.93 -76.41 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.081 158.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.787 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 4.1 mpt_? -62.15 66.74 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -170.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 41.05 39.5 2.06 Favored Glycine 0 C--N 1.278 -2.679 0 CA-C-N 111.554 -2.567 . . . . 0.0 113.65 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.523 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 10.1 mm-40 -77.76 -51.39 10.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.277 1.037 . . . . 0.0 111.398 -173.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.8 t 64.06 56.1 1.45 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.263 -171.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.738 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -45.17 -53.82 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 110.302 -3.135 . . . . 0.0 111.941 177.18 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.494 ' C ' ' HD2' ' A' ' 477' ' ' ARG . 0.0 OUTLIER -74.3 143.05 45.14 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.842 179.124 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 22.9 tp -49.49 -50.13 42.8 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -167.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.415 ' HB2' ' NE ' ' A' ' 477' ' ' ARG . 42.3 mt-10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.704 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.478 0.587 0 N-CA-C 110.426 -0.644 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.0 mp -90.94 130.09 40.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.761 0.315 . . . . 0.0 110.19 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.37 -92.18 1.77 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.478 ' HB ' HD11 ' A' ' 346' ' ' LEU . 90.5 m -154.32 127.5 8.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.495 0.664 . . . . 0.0 109.714 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 304' ' ' VAL . 1.8 p -75.92 127.71 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.165 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.703 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.5 mt -76.01 126.97 86.2 Favored Pre-proline 0 N--CA 1.422 -1.831 0 CA-C-O 121.77 0.795 . . . . 0.0 111.803 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -71.26 -15.45 31.63 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 124.708 3.606 . . . . 0.0 110.978 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.723 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.2 tp 30.62 -60.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 128.676 2.791 . . . . 0.0 116.279 172.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.615 ' HG2' HG23 ' A' ' 307' ' ' ILE . 7.1 mm-40 -56.64 -39.16 73.19 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.892 0.853 . . . . 0.0 109.958 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.531 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.4 t-160 -58.96 -48.51 81.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.866 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.1 mt -58.75 -48.52 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 123.96 0.904 . . . . 0.0 113.033 174.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.723 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.0 mtp180 -59.59 -29.83 68.24 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.726 0.41 . . . . 0.0 110.562 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.1 m -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.565 0.697 . . . . 0.0 109.911 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 338' ' ' VAL . 0.5 OUTLIER -67.91 -40.52 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.918 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.795 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.39 -36.18 26.98 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.691 1.234 . . . . 0.0 109.57 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.5 9.13 Favored Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.52 -2.127 . . . . 0.0 111.184 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 44.0 mt-10 51.62 173.18 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 124.302 1.041 . . . . 0.0 113.273 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.537 ' HB3' HD11 ' A' ' 324' ' ' ILE . 22.6 Cg_exo -44.82 140.38 6.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.011 2.474 . . . . 0.0 112.821 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 319' ' ' ARG . 40.3 Cg_endo -89.15 -100.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.42 2.747 . . . . 0.0 113.072 -171.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.509 ' HG2' ' HB2' ' A' ' 318' ' ' PRO . 5.1 mmt180 -98.23 -81.95 0.43 Allowed 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.381 0.61 . . . . 0.0 110.687 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.741 ' OD1' ' HG2' ' A' ' 322' ' ' ARG . 1.8 t30 -111.93 150.12 41.88 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.147 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.697 ' HD2' ' OD1' ' A' ' 320' ' ' ASN . 56.8 Cg_exo -49.14 -53.53 6.87 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.157 2.572 . . . . 0.0 111.692 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.741 ' HG2' ' OD1' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -63.24 -13.34 36.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.26 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.584 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 30.4 mt-10 -83.16 -28.01 29.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 171.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -48.39 -44.74 65.75 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 378' ' ' LEU . 8.9 Cg_endo -50.21 -59.98 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.754 2.303 . . . . 0.0 112.965 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.641 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -64.75 -34.06 67.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.345 0 CA-C-O 122.9 1.333 . . . . 0.0 110.067 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.795 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 39.5 t90 -57.2 -38.62 73.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.073 -1.876 . . . . 0.0 110.718 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.84 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -67.71 -47.34 69.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-O 120.693 0.283 . . . . 0.0 111.688 -175.456 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.27 -23.05 16.37 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.88 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.663 ' HD3' ' OE1' ' A' ' 402' ' ' GLU . 3.2 mmm-85 -72.89 -43.9 61.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.735 0.779 . . . . 0.0 111.152 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.621 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.5 p30 -103.02 -17.65 15.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.29 -49.75 6.51 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 174.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 43.0 Cg_endo -62.76 -32.34 78.16 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.566 2.177 . . . . 0.0 111.612 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.13 -42.83 62.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.314 -1.766 . . . . 0.0 109.839 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.7 mt -58.65 -48.66 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.362 173.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.87 -15.03 4.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.846 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.68 -50.16 5.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.624 HG11 HG13 ' A' ' 310' ' ' ILE . 99.2 t -55.42 -71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 123.742 1.734 . . . . 0.0 109.796 169.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.824 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.8 OUTLIER -89.44 128.7 50.03 Favored Pre-proline 0 N--CA 1.397 -3.116 0 CA-C-N 110.537 -3.028 . . . . 0.0 111.9 -173.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.762 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.7 Cg_endo -72.92 -16.72 25.8 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 C-N-CA 123.548 2.832 . . . . 0.0 110.075 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.56 HG21 ' HG2' ' A' ' 347' ' ' ARG . 4.6 p 31.9 69.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.603 ' N ' HD12 ' A' ' 346' ' ' LEU . 39.6 p -79.2 6.33 10.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.671 -2.058 . . . . 0.0 113.408 -167.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -140.73 164.49 36.09 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.659 ' HB3' HD23 ' A' ' 369' ' ' LEU . 47.4 Cg_exo -64.32 -47.81 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.646 2.897 . . . . 0.0 108.655 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.598 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 1.0 OUTLIER -44.81 -48.84 11.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.076 177.297 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.5 mt -57.86 -50.97 71.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.902 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.584 ' HA ' HD12 ' A' ' 350' ' ' ILE . 55.0 mtt180 -48.4 -48.0 37.29 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.298 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.926 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -70.13 -48.39 57.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.728 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 84.0 mtt180 -57.4 -40.81 79.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.079 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.824 HD11 ' CD2' ' A' ' 339' ' ' PHE . 48.0 mt -57.89 -53.13 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.497 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.581 HG12 HD11 ' A' ' 328' ' ' LEU . 26.0 mt -59.0 -52.5 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-O 122.117 0.96 . . . . 0.0 111.122 -170.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.598 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 13.6 m-20 -62.53 -35.95 81.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.938 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.75 75.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.244 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.674 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.66 -54.87 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-O 123.021 1.391 . . . . 0.0 110.515 173.162 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.663 HD13 ' HB ' ' A' ' 354' ' ' ILE . 1.1 mp -72.37 -25.7 61.62 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.777 -2.465 . . . . 0.0 109.1 -168.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 68.25 -76.74 0.25 Allowed Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 113.607 -1.633 . . . . 0.0 113.326 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -124.61 69.1 0.49 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.112 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.572 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -86.74 163.86 17.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.503 0.321 . . . . 0.0 110.994 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.43 -59.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 122.92 0.488 . . . . 0.0 111.494 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -160.51 16.08 0.19 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.624 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.613 ' HB3' HD12 ' A' ' 378' ' ' LEU . 3.1 mt -67.33 -3.74 8.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.307 0.643 . . . . 0.0 111.189 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.598 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.3 t -62.52 81.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.711 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -61.93 174.35 0.87 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.83 0.824 . . . . 0.0 113.019 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.4 p -117.52 157.96 46.29 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.151 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.879 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.4 Cg_endo -49.46 -30.23 20.36 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.556 1.504 . . . . 0.0 112.236 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.65 ' HA2' HD21 ' A' ' 369' ' ' LEU . . . -96.36 0.53 61.8 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.811 1.085 . . . . 0.0 115.811 -170.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.677 ' HB2' HD12 ' A' ' 363' ' ' LEU . 6.4 m-20 -109.3 -18.37 13.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.686 1.243 . . . . 0.0 110.443 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.926 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 5.0 t -109.95 21.74 16.47 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.328 -165.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 344' ' ' PRO . 2.1 mt -60.04 -29.51 68.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.861 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 6.0 p -114.56 159.96 19.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.221 -1.809 . . . . 0.0 109.771 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.596 ' O ' HG13 ' A' ' 375' ' ' VAL . 31.0 m95 -70.28 -34.83 73.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.538 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -63.29 -44.84 93.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.887 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 t -68.44 -42.85 78.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.466 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.627 ' O ' HD22 ' A' ' 378' ' ' LEU . . . -61.28 -53.13 60.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.847 HG21 ' HE3' ' A' ' 413' ' ' MET . 15.8 m -57.37 -44.96 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.759 0.79 . . . . 0.0 109.259 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 0.999 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.81 -45.75 91.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.634 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.677 HG21 HD11 ' A' ' 363' ' ' LEU . 29.5 m -66.76 -39.75 88.01 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.088 -172.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -60.16 -34.49 73.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.984 1.265 . . . . 0.0 109.832 177.106 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.687 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 62.1 t80 -72.1 -47.5 50.84 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.494 1.14 . . . . 0.0 109.288 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 112.469 -2.151 . . . . 0.0 111.407 171.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.5 OUTLIER -59.48 -36.19 75.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 123.219 0.608 . . . . 0.0 111.243 176.583 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 322' ' ' ARG . 34.1 p -102.34 -22.09 14.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.799 -169.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -109.49 23.1 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.25 16.22 26.29 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.448 -0.406 . . . . 0.0 114.034 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.41 HG23 HG13 ' A' ' 380' ' ' ILE . 0.7 OUTLIER 64.68 158.23 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.996 0.518 . . . . 0.0 111.355 -175.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.509 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -124.65 154.05 70.07 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -100.07 59.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.703 2.935 . . . . 0.0 111.209 165.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.742 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.43 -1.24 0.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -175.558 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -69.89 -48.31 59.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.892 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.637 ' O ' HG13 ' A' ' 394' ' ' VAL . 57.9 mt-30 -74.08 -25.43 59.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -169.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.798 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.86 -30.77 47.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.7 0.682 . . . . 0.0 111.657 -175.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.787 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.19 -49.69 62.4 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.549 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.639 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 29.9 m-20 -68.74 -39.88 80.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.774 0.43 . . . . 0.0 112.135 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.65 -44.89 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.626 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -57.76 -46.77 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.484 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.639 ' HG3' ' HA ' ' A' ' 393' ' ' ASN . 30.3 mmtt -52.23 -44.46 64.84 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.819 0.819 . . . . 0.0 111.365 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.05 17.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.191 -172.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.696 HG23 ' HG3' ' A' ' 402' ' ' GLU . 3.9 mt -68.93 -41.51 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 117.156 0.478 . . . . 0.0 111.379 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.5 m -57.85 -44.97 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.615 0.721 . . . . 0.0 110.032 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.476 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.7 t70 -65.97 -37.75 86.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.412 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.67 -51.71 6.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.696 ' HG3' HG23 ' A' ' 398' ' ' ILE . 0.0 OUTLIER -108.95 -29.48 8.57 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.369 -170.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 125.7 160.56 10.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.598 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.804 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.24 -42.96 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -176.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.67 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -57.04 -50.47 72.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.312 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -63.21 -51.3 66.85 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.27 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.658 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -41.97 65.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 55.0 t80 -59.24 -44.99 92.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.442 0.639 . . . . 0.0 109.524 176.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.774 ' O ' ' HG3' ' A' ' 413' ' ' MET . 4.6 m -60.45 -52.55 64.73 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.49 -178.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.707 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -61.69 -48.58 80.12 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.713 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.638 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.72 -43.75 86.58 Favored Glycine 0 C--N 1.313 -0.745 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.348 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.626 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.3 -31.72 65.95 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.821 0.311 . . . . 0.0 110.975 179.067 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.847 ' HE3' HG21 ' A' ' 375' ' ' VAL . 65.2 mtm -69.12 -47.87 63.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.176 0.513 . . . . 0.0 109.915 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.999 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.6 mt -58.66 -39.83 81.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.159 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.798 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.4 OUTLIER -77.65 -14.54 59.6 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.741 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.8 32.37 7.63 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.135 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.617 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 71.35 38.53 1.03 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.54 0.736 . . . . 0.0 112.149 176.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.618 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 0.3 OUTLIER -119.99 77.99 1.3 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 165.079 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.626 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 2.9 p90 -62.18 -32.6 73.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.416 -2.174 . . . . 0.0 110.501 -162.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 31.8 mt-30 -55.11 -46.98 75.61 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.171 0.989 . . . . 0.0 113.359 -164.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.736 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -60.06 -51.22 70.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.635 0.731 . . . . 0.0 110.777 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.617 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -59.83 -38.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 123.054 1.407 . . . . 0.0 108.893 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 419' ' ' TYR . 1.1 t -61.8 -46.79 88.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 111.891 -2.413 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.64 89.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.111 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.787 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.1 mt -71.25 -41.25 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.57 0.7 . . . . 0.0 109.672 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.77 -46.73 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.596 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.719 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.19 -30.18 68.01 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.518 1.151 . . . . 0.0 109.526 -175.128 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.409 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.43 -16.59 77.42 Favored Glycine 0 C--N 1.298 -1.57 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.595 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.96 0.03 40.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.65 145.05 71.37 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 123.626 1.679 . . . . 0.0 113.268 170.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.719 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.2 Cg_endo -71.24 -58.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 1 C-N-CA 126.22 4.613 . . . . 0.0 113.147 -173.106 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.524 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -110.97 139.35 15.5 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.407 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.886 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.23 -27.95 69.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.091 0.446 . . . . 0.0 111.286 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.774 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.44 -47.93 80.5 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.021 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.6 -51.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.676 177.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.886 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.94 -53.43 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.469 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 64.8 m -62.18 -56.33 19.82 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.914 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.11 -45.64 79.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.532 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.863 ' O ' HD22 ' A' ' 443' ' ' LEU . 42.7 mt -59.61 -53.77 54.26 Favored 'General case' 0 CA--C 1.481 -1.695 0 C-N-CA 120.276 -0.569 . . . . 0.0 110.619 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.682 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.79 -34.56 40.44 Favored 'General case' 0 N--CA 1.416 -2.143 0 O-C-N 125.073 1.483 . . . . 0.0 110.596 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.91 -60.99 1.97 Allowed 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 176.249 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.2 OUTLIER -76.3 -51.44 11.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.894 -0.504 . . . . 0.0 112.232 -172.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.62 -24.49 61.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.622 0.725 . . . . 0.0 111.735 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.749 ' N ' HD23 ' A' ' 443' ' ' LEU . 21.2 t70 -71.71 -42.76 66.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.662 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.4 mt-30 -69.48 -7.86 41.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 43.5 mm-40 -51.7 160.08 0.7 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 123.721 1.724 . . . . 0.0 114.501 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.502 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -56.32 -33.32 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 110.626 -2.988 . . . . 0.0 115.403 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.647 ' H ' ' HB ' ' A' ' 451' ' ' THR . 48.4 m-20 -142.78 -178.67 5.91 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -63.66 -56.59 14.62 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.42 -25.11 67.87 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 176.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.647 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 17.8 m -59.34 -42.68 92.05 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 119.493 1.042 . . . . 0.0 109.889 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 53.0 mtt180 -61.34 -30.0 70.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.557 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -30.93 59.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.971 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 2.5 mm-40 -80.86 -45.17 17.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.416 1.103 . . . . 0.0 111.498 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 43.7 p -101.36 -4.34 27.14 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.894 -167.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.736 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.5 t80 -49.01 -52.09 27.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.661 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.67 HG23 ' HB1' ' A' ' 405' ' ' ALA . 27.0 mm -70.95 -27.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.429 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.16 -42.73 65.58 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 463' ' ' VAL . 75.8 m-70 -67.03 -30.97 71.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.75 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.782 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -65.59 -53.7 38.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.207 1.003 . . . . 0.0 109.23 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.652 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.4 m-80 -61.94 -32.39 72.81 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.071 172.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.71 -52.73 62.11 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.002 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.021 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.9 t -62.78 -34.89 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 121.858 0.837 . . . . 0.0 110.32 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.7 m-30 -61.63 -15.13 36.81 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.014 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 45.7 mm-40 -91.16 -49.52 6.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.941 -1.099 . . . . 0.0 112.696 176.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.73 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.24 -39.77 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.997 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.774 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.6 mt -84.44 -16.61 42.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.801 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.88 50.02 60.32 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 111.855 -2.43 . . . . 0.0 113.599 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.715 HD11 HD12 ' A' ' 467' ' ' LEU . 0.3 OUTLIER -103.68 -179.28 3.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 123.877 0.871 . . . . 0.0 110.244 -179.156 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.564 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.6 p-10 -102.1 -40.27 6.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 168.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -160.56 -76.51 0.06 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 112.524 -2.125 . . . . 0.0 111.052 158.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.719 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -60.07 69.26 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -171.139 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 37.39 40.37 0.63 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 110.738 -2.937 . . . . 0.0 113.654 174.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.564 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 2.7 mm100 -77.67 -53.62 7.34 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.098 0.951 . . . . 0.0 111.784 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 67.9 55.08 0.59 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 112.084 -2.325 . . . . 0.0 108.833 -174.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.801 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -51.25 -49.67 29.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 110.84 -2.891 . . . . 0.0 111.833 176.004 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -50.89 136.12 23.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.434 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.43 -27.82 67.78 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.627 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.434 -1.272 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.07 176.216 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo . . . . . 0 N--CA 1.477 0.545 0 N-CA-C 110.143 -0.753 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.5 mp -86.63 -52.66 11.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -142.11 54.27 0.61 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.653 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 41.5 m 71.89 117.72 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 122.181 0.991 . . . . 0.0 112.155 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.2 p -78.95 129.86 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.381 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.715 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 22.6 mt -75.05 126.27 88.3 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-O 121.945 0.878 . . . . 0.0 112.698 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.602 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.0 Cg_endo -83.37 49.56 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.819 3.679 . . . . 0.0 109.522 167.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.761 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -42.49 -42.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.555 -2.111 . . . . 0.0 112.665 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -65.25 -36.99 85.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.241 0.543 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.59 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.6 t-160 -62.7 -47.49 83.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.357 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.637 HG13 HG11 ' A' ' 338' ' ' VAL . 62.3 mt -58.74 -49.88 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.761 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.3 mtp180 -62.11 -29.95 70.68 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 110.683 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.0 m -69.71 -33.78 72.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.37 0.605 . . . . 0.0 110.072 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.545 HG21 HG23 ' A' ' 338' ' ' VAL . 0.5 OUTLIER -66.24 -40.05 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.982 178.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.654 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.14 -36.93 26.94 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.74 1.257 . . . . 0.0 109.677 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.44 32.19 9.73 Favored Glycine 0 C--N 1.305 -1.14 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.803 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 25.5 mt-10 51.8 169.54 0.04 OUTLIER Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 124.626 1.17 . . . . 0.0 113.83 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.643 ' HB3' HD11 ' A' ' 324' ' ' ILE . 52.7 Cg_exo -46.19 148.53 3.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.469 2.779 . . . . 0.0 114.203 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.475 ' HG2' ' H ' ' A' ' 319' ' ' ARG . 40.3 Cg_endo -91.86 -99.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.851 3.034 . . . . 0.0 112.746 -174.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 6.5 mmm180 -97.83 -83.09 0.41 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.154 0.502 . . . . 0.0 110.828 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.405 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 16.9 m-20 -102.67 163.57 17.34 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.479 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.4 Cg_exo -59.72 -47.41 16.12 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.708 2.272 . . . . 0.0 110.379 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.452 ' HA ' HG21 ' A' ' 382' ' ' THR . 81.2 mtt180 -48.65 -28.76 3.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.815 -1.993 . . . . 0.0 112.8 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.85 -23.16 22.87 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.801 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.716 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.2 OUTLIER -50.02 -42.39 70.44 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.728 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 7.5 Cg_endo -48.62 -61.52 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.848 2.365 . . . . 0.0 112.829 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.723 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -61.51 -36.79 75.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-O 122.667 1.222 . . . . 0.0 110.384 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.758 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 54.6 t90 -58.75 -40.72 84.68 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.48 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.803 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.5 OUTLIER -68.45 -50.12 54.86 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.46 -23.23 18.59 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.758 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 1.5 ttt-85 -72.77 -41.61 64.87 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 114.442 -0.879 . . . . 0.0 112.321 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.575 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.4 p30 -106.74 -16.92 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.17 -48.01 6.04 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 37.8 Cg_endo -60.49 -32.72 94.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.536 2.157 . . . . 0.0 111.555 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -72.7 -43.21 63.33 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.658 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.4 mt -58.37 -49.52 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.754 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 28.1 t70 -58.33 -14.57 7.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.044 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.66 6.43 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.364 175.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.637 HG11 HG13 ' A' ' 310' ' ' ILE . 91.2 t -56.99 -70.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 123.698 1.713 . . . . 0.0 110.154 168.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.864 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -92.43 130.6 36.85 Favored Pre-proline 0 N--CA 1.402 -2.864 0 CA-C-N 110.629 -2.987 . . . . 0.0 112.11 -173.313 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.775 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.7 Cg_endo -74.91 -17.42 19.79 Favored 'Trans proline' 0 CA--C 1.496 -1.394 0 C-N-CA 123.731 2.954 . . . . 0.0 110.631 174.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.465 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.6 p 34.08 67.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 112.216 -2.266 . . . . 0.0 110.107 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.63 ' N ' HD12 ' A' ' 346' ' ' LEU . 35.8 p -78.25 3.17 16.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 112.453 -2.158 . . . . 0.0 113.194 -170.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.79 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 10.2 p -137.93 164.13 43.06 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 343' ' ' THR . 42.2 Cg_exo -63.8 -49.94 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.265 2.644 . . . . 0.0 108.329 172.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.73 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -43.6 -48.69 7.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.982 176.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.79 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.7 mt -56.18 -51.99 66.01 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.521 0.677 . . . . 0.0 110.166 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.712 ' HA ' HD12 ' A' ' 350' ' ' ILE . 2.1 ttm180 -54.9 -47.03 74.87 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.556 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 1.088 ' HG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.45 -48.16 61.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.179 0.514 . . . . 0.0 111.193 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.2 mtp180 -56.45 -41.1 75.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.244 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.864 HD11 ' CD2' ' A' ' 339' ' ' PHE . 42.6 mt -58.63 -54.37 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.492 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.652 ' O ' HD22 ' A' ' 355' ' ' LEU . 20.8 mt -57.71 -54.04 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.952 0.882 . . . . 0.0 110.87 -168.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.489 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -63.95 -34.79 78.76 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.989 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.6 -34.42 74.08 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.336 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.727 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.252 1.0 OUTLIER -56.58 -55.32 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 CA-C-O 122.982 1.372 . . . . 0.0 110.523 175.289 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.727 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.0 OUTLIER -73.06 -27.63 61.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.668 -2.514 . . . . 0.0 110.154 -169.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 39.41 75.35 0.1 Allowed Glycine 0 CA--C 1.524 0.63 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.851 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 112.85 25.08 4.66 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.86 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.788 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 3.9 p-10 -75.14 136.91 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.99 0.424 . . . . 0.0 111.365 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.627 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.1 mp -71.77 98.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.999 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.76 -21.55 4.6 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.221 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.788 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 5.8 mt -61.59 -6.38 2.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 122.939 0.496 . . . . 0.0 112.195 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.489 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 20.7 t -61.06 81.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.217 0.532 . . . . 0.0 110.427 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -62.5 169.25 3.09 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.136 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 366' ' ' GLY . 69.5 p -111.75 161.4 25.8 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.329 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 1.088 ' HA ' ' HG ' ' A' ' 348' ' ' CYS . 2.2 Cg_endo -63.57 7.07 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.202 1.935 . . . . 0.0 112.747 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -117.23 -12.32 8.32 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.689 -0.687 . . . . 0.0 114.679 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.751 ' HB2' HD12 ' A' ' 363' ' ' LEU . 45.9 m-20 -105.67 -20.43 13.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.509 1.147 . . . . 0.0 109.804 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 7.6 p -82.91 20.04 1.26 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.431 -1.713 . . . . 0.0 112.805 -169.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -58.03 -34.83 70.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 122.288 1.042 . . . . 0.0 110.067 -168.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.1 t -130.62 163.67 26.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.202 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.608 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.4 m95 -70.36 -36.59 74.28 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.535 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.4 p30 -63.38 -39.37 94.34 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.439 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 48.1 t -66.36 -42.89 87.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.053 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.65 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -68.35 -51.81 40.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 328' ' ' LEU . 11.9 m -56.88 -45.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.144 0.497 . . . . 0.0 110.087 -178.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.006 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.09 -43.1 95.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.684 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.722 HG21 HD11 ' A' ' 363' ' ' LEU . 40.2 m -68.5 -42.68 78.25 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.558 -173.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -58.74 -34.02 70.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.419 0.554 . . . . 0.0 110.671 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.728 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.6 t80 -73.68 -47.34 40.45 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.501 1.144 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.64 -32.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 CA-C-N 112.678 -2.055 . . . . 0.0 111.336 170.553 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.63 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -60.29 -41.99 94.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.682 175.066 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 322' ' ' ARG . 30.3 p -97.4 -23.42 16.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.772 -168.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -110.5 22.91 14.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.75 21.73 23.49 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.315 0.486 . . . . 0.0 114.315 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.2 m 67.01 160.05 0.15 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.225 0.536 . . . . 0.0 111.328 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.518 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -125.31 156.17 70.4 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.087 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -97.94 54.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.415 2.743 . . . . 0.0 111.306 165.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.79 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.51 4.21 0.22 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.147 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -70.09 -47.45 61.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.014 0.435 . . . . 0.0 110.585 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.616 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.7 mt-30 -71.47 -27.48 63.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -169.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.839 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.84 -31.18 59.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.59 0.632 . . . . 0.0 111.925 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.682 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -50.09 59.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.476 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.516 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.3 m-20 -68.58 -39.43 80.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.661 0.384 . . . . 0.0 112.002 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.55 -45.92 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.245 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.796 ' O ' HG22 ' A' ' 399' ' ' VAL . 5.9 mm -58.69 -47.27 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.615 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.693 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.8 mmtt -51.42 -42.61 61.61 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 124.077 0.861 . . . . 0.0 111.486 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.52 -44.11 13.78 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.921 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.723 HG12 HG21 ' A' ' 326' ' ' ILE . 1.8 mt -69.2 -40.73 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 117.5 0.65 . . . . 0.0 111.543 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.873 HG12 ' HA ' ' A' ' 404' ' ' VAL . 0.8 OUTLIER -59.35 -42.81 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 109.506 -178.43 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.63 -39.23 93.84 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.087 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -85.66 -53.41 5.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.281 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.554 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -110.64 -32.16 6.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.561 0.696 . . . . 0.0 111.747 -170.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.01 163.13 11.48 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.682 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.873 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.07 -49.81 72.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.164 0.507 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.645 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.76 -50.69 65.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.557 177.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.677 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.53 -44.18 65.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.518 ' HB3' HD11 ' A' ' 457' ' ' ILE . 26.9 t80 -54.81 -46.44 74.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.779 0.799 . . . . 0.0 109.082 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.778 ' O ' ' HG3' ' A' ' 413' ' ' MET . 18.4 m -58.55 -52.02 67.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.958 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.68 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -61.99 -49.09 77.47 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.958 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.538 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.11 -43.28 88.59 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.805 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.631 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -71.29 -32.94 69.25 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.728 0.264 . . . . 0.0 110.673 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.778 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.6 mtm -68.82 -46.2 69.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.923 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.006 HD23 ' HA ' ' A' ' 376' ' ' ALA . 18.5 mt -60.2 -43.35 96.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.292 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.839 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 1.9 m -80.63 7.15 10.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 70.81 46.78 43.59 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.857 171.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.631 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 0.0 OUTLIER 62.3 42.12 9.61 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 123.87 0.868 . . . . 0.0 111.616 177.534 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.741 ' ND2' HD22 ' A' ' 421' ' ' LEU . 22.3 t30 -113.17 83.21 1.79 Allowed 'General case' 0 CA--C 1.476 -1.878 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 163.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.786 ' HD2' ' HG ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -57.09 -36.93 71.2 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.821 -174.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 41.6 mt-30 -57.29 -51.56 68.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -163.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.803 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 1.7 pt? -60.02 -49.23 78.48 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.392 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.803 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.77 -38.42 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.685 1.231 . . . . 0.0 108.894 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.786 ' HG ' ' HD2' ' A' ' 419' ' ' TYR . 43.6 m -65.31 -41.13 94.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.31 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.83 86.97 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.787 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.625 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.7 mt -71.46 -40.71 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.597 0.713 . . . . 0.0 109.813 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -56.78 -44.67 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.58 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.642 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -57.4 -33.09 67.49 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 124.87 1.268 . . . . 0.0 109.245 -176.137 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.443 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.57 -15.01 77.52 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 112.992 -1.913 . . . . 0.0 112.448 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.75 ' CG ' HG21 ' A' ' 399' ' ' VAL . 9.0 m-85 -102.77 1.12 33.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -57.58 142.01 78.06 Favored Pre-proline 0 N--CA 1.41 -2.464 0 CA-C-O 123.645 1.688 . . . . 0.0 113.333 170.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.807 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 53.1 Cg_endo -68.95 -57.35 0.13 Allowed 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.564 4.843 . . . . 0.0 113.316 -169.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.497 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.62 140.72 16.45 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.736 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.933 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.1 OUTLIER -59.44 -32.43 70.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.688 0.744 . . . . 0.0 111.651 -175.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.857 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.02 -48.43 73.39 Favored 'General case' 0 CA--C 1.509 -0.635 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.045 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -62.39 -36.76 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.337 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.933 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -71.1 -45.98 69.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.184 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 45.4 m -72.27 -54.92 8.13 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.359 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.82 76.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.842 HD13 HD22 ' A' ' 460' ' ' LEU . 20.1 mt -66.61 -54.49 22.91 Favored 'General case' 0 CA--C 1.465 -2.3 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.733 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 2.3 mp0 -51.22 -33.54 28.29 Favored 'General case' 0 N--CA 1.405 -2.715 0 O-C-N 125.781 1.926 . . . . 0.0 109.944 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -72.95 -60.74 2.09 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -71.55 -48.73 46.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.126 0.488 . . . . 0.0 111.472 -171.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -60.22 -25.97 66.03 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.458 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.744 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.0 t70 -73.09 -42.01 63.46 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.33 1.062 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -68.79 -8.31 42.14 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -171.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 47.1 mm-40 -51.78 156.97 1.28 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.518 1.628 . . . . 0.0 115.058 -176.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.5 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -52.92 -31.98 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 110.506 -3.043 . . . . 0.0 115.665 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.651 ' H ' ' HB ' ' A' ' 451' ' ' THR . 55.2 m-20 -140.81 178.9 7.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.78 -56.3 20.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.1 OUTLIER -67.49 -24.97 65.64 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.627 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.651 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -57.78 -41.05 81.27 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.774 1.17 . . . . 0.0 109.932 171.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 62.5 mtt180 -60.97 -30.57 70.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.565 ' HB2' ' HD1' ' A' ' 419' ' ' TYR . . . -76.09 -31.44 58.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.35 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.8 mm-40 -81.29 -45.68 15.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.474 1.13 . . . . 0.0 111.883 -172.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.464 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 47.2 p -98.95 -2.3 37.82 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.772 -167.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.645 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -48.89 -55.57 11.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.932 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 405' ' ' ALA . 27.6 mm -70.23 -25.42 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -73.0 -43.21 62.43 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.585 ' O ' HG23 ' A' ' 463' ' ' VAL . 65.9 m-70 -66.15 -32.19 73.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.261 171.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.18 -53.69 45.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.308 1.051 . . . . 0.0 109.34 -178.603 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.662 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.9 m-80 -62.6 -32.03 72.96 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.3 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.36 -52.55 63.16 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.035 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.045 HG11 ' HA ' ' A' ' 435' ' ' VAL . 34.5 t -63.26 -33.57 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-O 121.802 0.81 . . . . 0.0 110.56 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.4 m-30 -62.54 -15.26 49.8 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.309 168.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 22.4 mm-40 -92.25 -49.31 6.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.007 -1.058 . . . . 0.0 112.64 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.762 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.63 -40.16 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.67 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.857 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.3 mt -84.6 -16.67 41.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.759 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.75 51.79 50.91 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 111.681 -2.509 . . . . 0.0 113.171 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.667 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -103.3 -178.12 3.57 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.723 0.809 . . . . 0.0 110.268 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.435 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.7 p-10 -101.39 -41.95 6.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 167.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.92 -75.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.322 159.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.807 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 1.3 mpt_? -63.77 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -168.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 40.09 42.16 2.25 Favored Glycine 0 C--N 1.277 -2.72 0 CA-C-N 111.352 -2.658 . . . . 0.0 113.417 173.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.435 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 0.3 OUTLIER -81.55 -49.64 10.32 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-O 122.306 1.05 . . . . 0.0 111.278 -172.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 46.8 t 62.1 57.69 1.99 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.346 -2.207 . . . . 0.0 108.433 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.759 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.2 OUTLIER -49.98 -47.1 23.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 110.934 -2.848 . . . . 0.0 111.418 175.469 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.409 ' HG2' HD12 ' A' ' 476' ' ' ILE . 14.1 mmm-85 -55.49 133.24 50.0 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.092 177.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.7 -26.04 67.79 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.514 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.437 -1.089 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.869 179.377 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.477 0.512 0 N-CA-C 110.656 -0.555 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.4 mp -84.78 115.31 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 141.23 172.42 13.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.864 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.507 ' HB ' HD11 ' A' ' 346' ' ' LEU . 43.6 m -80.2 118.64 22.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.648 0.737 . . . . 0.0 111.239 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.471 ' H ' HG12 ' A' ' 304' ' ' VAL . 1.5 p -69.0 125.87 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.728 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.698 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -75.1 126.66 87.8 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-O 122.005 0.907 . . . . 0.0 111.731 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.6 Cg_endo -72.18 -10.84 26.39 Favored 'Trans proline' 0 CA--C 1.498 -1.307 0 C-N-CA 124.755 3.637 . . . . 0.0 111.298 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.7 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.8 tp 25.12 -61.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 O-C-N 127.13 2.769 . . . . 0.0 116.063 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.565 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.37 -32.78 68.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.196 0.522 . . . . 0.0 110.396 178.308 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.51 ' CG ' HG13 ' A' ' 338' ' ' VAL . 1.4 t-80 -62.27 -48.71 78.71 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.609 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 307' ' ' ILE . 59.8 mt -58.32 -48.87 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 C-N-CA 123.982 0.913 . . . . 0.0 112.78 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 10.5 mtp180 -61.29 -30.48 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 122.141 -0.349 . . . . 0.0 110.827 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 53.1 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.62 0.724 . . . . 0.0 109.962 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.542 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.1 -40.89 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.748 178.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.742 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 32.3 p -82.67 -36.32 26.05 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.941 1.353 . . . . 0.0 109.531 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.64 33.54 8.42 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 112.183 -2.281 . . . . 0.0 110.938 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.539 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.1 mt-10 50.68 174.66 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 124.339 1.055 . . . . 0.0 113.029 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.658 ' HB3' HD11 ' A' ' 324' ' ' ILE . 42.6 Cg_exo -46.09 145.81 4.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.374 2.05 . . . . 0.0 112.467 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 319' ' ' ARG . 48.6 Cg_endo -87.65 -99.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.343 2.695 . . . . 0.0 112.451 -171.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.401 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 4.0 mmm180 -100.82 -76.57 0.56 Allowed 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.723 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.755 HD22 ' HG2' ' A' ' 322' ' ' ARG . 1.2 t-20 -109.88 150.8 41.85 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.004 -173.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.715 ' HD2' ' ND2' ' A' ' 320' ' ' ASN . 47.7 Cg_exo -53.88 -52.83 7.53 Favored 'Trans proline' 0 CA--C 1.504 -1.024 0 C-N-CA 123.04 2.493 . . . . 0.0 111.52 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.755 ' HG2' HD22 ' A' ' 320' ' ' ASN . 0.0 OUTLIER -59.18 -15.93 17.55 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.052 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.614 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 5.5 mt-10 -81.22 -25.85 36.35 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.658 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -48.58 -44.48 66.87 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.759 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -51.2 -61.9 0.47 Allowed 'Trans proline' 0 CA--C 1.518 -0.308 0 C-N-CA 122.697 2.265 . . . . 0.0 113.159 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.733 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.64 -35.59 60.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 122.919 1.343 . . . . 0.0 110.153 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.842 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 42.7 t90 -59.78 -38.5 82.05 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.88 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.867 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.5 OUTLIER -69.2 -50.6 45.94 Favored 'General case' 0 N--CA 1.407 -2.604 0 O-C-N 121.863 -0.523 . . . . 0.0 112.396 -175.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.94 -22.87 21.16 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.842 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 10.7 ttp85 -71.76 -42.46 67.17 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 113.862 -1.169 . . . . 0.0 112.166 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.573 ' HB2' HG22 ' A' ' 314' ' ' THR . 0.8 OUTLIER -108.3 -15.44 14.47 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.099 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.37 -47.97 6.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 32.1 Cg_endo -59.16 -34.94 98.61 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.557 175.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -71.94 -42.62 66.4 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.771 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 332' ' ' ALA . 88.5 mt -58.87 -49.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.663 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.2 -16.87 5.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.895 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.2 -50.7 5.33 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.17 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.673 HG11 HG13 ' A' ' 310' ' ' ILE . 92.0 t -54.61 -69.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 123.541 1.639 . . . . 0.0 110.176 170.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.838 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -94.51 129.39 36.79 Favored Pre-proline 0 N--CA 1.401 -2.923 0 CA-C-N 110.958 -2.837 . . . . 0.0 112.162 -172.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.782 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.3 Cg_endo -75.5 -16.0 19.38 Favored 'Trans proline' 0 CA--C 1.497 -1.367 0 C-N-CA 123.892 3.061 . . . . 0.0 110.503 174.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.464 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.43 68.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.943 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.655 ' N ' HD12 ' A' ' 346' ' ' LEU . 31.0 p -81.0 10.58 4.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.623 -2.08 . . . . 0.0 113.468 -169.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.78 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.3 p -143.71 162.52 41.09 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.42 -49.34 6.05 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.208 2.606 . . . . 0.0 108.214 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.763 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -46.02 -44.12 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.904 -1.953 . . . . 0.0 111.292 178.036 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.78 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.0 mt -58.59 -52.03 67.38 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.382 0.61 . . . . 0.0 110.746 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.735 ' HA ' HD12 ' A' ' 350' ' ' ILE . 32.6 ttm105 -53.92 -44.85 70.94 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.31 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.867 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.04 -47.4 65.47 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 111.086 -176.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 94.0 mtt180 -57.51 -41.76 81.46 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.036 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.838 HD11 ' CD2' ' A' ' 339' ' ' PHE . 44.8 mt -58.0 -53.77 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.528 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 328' ' ' LEU . 20.6 mt -58.69 -52.84 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.096 0.951 . . . . 0.0 110.815 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -63.36 -35.32 79.99 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.049 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.23 -34.51 74.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 112.076 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.698 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.26 -55.09 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.833 1.302 . . . . 0.0 110.5 174.427 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.693 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -72.7 -26.79 61.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 111.693 -2.503 . . . . 0.0 109.297 -168.497 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 34.71 60.68 0.63 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.705 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 117.57 74.17 0.49 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.342 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.59 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -119.53 168.89 10.54 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 122.668 0.387 . . . . 0.0 110.432 -179.265 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.536 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -52.84 -61.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 122.991 0.516 . . . . 0.0 111.517 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.411 ' C ' ' HG2' ' A' ' 381' ' ' ARG . . . -156.44 14.05 0.36 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.05 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.68 ' HB3' HD22 ' A' ' 378' ' ' LEU . 5.1 mt -66.74 -4.81 9.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 122.934 0.494 . . . . 0.0 111.953 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.529 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 33.9 t -60.71 87.14 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 109.686 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.812 HD11 HG21 ' A' ' 377' ' ' THR . 0.7 OUTLIER -65.48 178.51 0.95 Allowed 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.249 174.586 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 43.0 p -122.06 161.13 44.27 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.867 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 8.7 Cg_endo -66.13 4.66 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.038 1.825 . . . . 0.0 112.365 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -110.53 -10.83 20.93 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.809 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.748 ' HB2' HD12 ' A' ' 363' ' ' LEU . 36.7 m-20 -106.42 -21.76 12.99 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.081 0.943 . . . . 0.0 109.828 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.748 ' HG ' ' HA ' ' A' ' 365' ' ' PRO . 17.6 p -80.91 18.94 0.92 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.917 -170.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.32 -35.48 73.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 122.291 1.043 . . . . 0.0 109.671 -172.576 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.19 159.76 33.3 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.229 174.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.628 ' O ' HG13 ' A' ' 375' ' ' VAL . 59.5 m95 -70.29 -36.95 74.68 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.576 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.26 -40.02 84.69 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.483 -175.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 35.4 t -72.77 -42.59 63.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.657 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.32 -51.52 67.32 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.867 HG12 ' HB3' ' A' ' 328' ' ' LEU . 11.2 m -58.52 -45.38 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.458 0.647 . . . . 0.0 109.824 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.039 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.09 -43.31 95.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.648 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.812 HG21 HD11 ' A' ' 363' ' ' LEU . 29.7 m -69.45 -39.21 77.92 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.836 -172.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.69 HD11 HD12 ' A' ' 328' ' ' LEU . 2.5 mt -60.75 -34.37 74.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.586 0.63 . . . . 0.0 110.516 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.759 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 38.0 t80 -73.58 -47.69 38.55 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 122.446 1.117 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -51.1 -32.42 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 112.661 -2.063 . . . . 0.0 111.706 170.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -59.8 -46.79 88.12 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.435 0.636 . . . . 0.0 111.042 174.026 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.572 ' HB ' ' HD2' ' A' ' 322' ' ' ARG . 43.8 p -93.22 -24.23 18.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.843 -169.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -110.84 23.14 14.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.05 20.75 15.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.415 HG23 HG13 ' A' ' 380' ' ' ILE . 2.6 m 66.27 163.52 0.17 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.279 0.561 . . . . 0.0 111.429 -176.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.537 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -130.55 153.96 81.56 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.077 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -99.31 60.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.421 2.747 . . . . 0.0 111.015 164.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.667 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.4 6.32 0.38 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -174.15 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -70.24 -48.72 55.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.082 0.467 . . . . 0.0 110.629 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.649 ' O ' HG13 ' A' ' 394' ' ' VAL . 41.2 mt-30 -76.61 -27.37 55.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -169.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.711 ' O ' HG22 ' A' ' 394' ' ' VAL . 3.2 mm? -54.66 -31.45 57.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 -171.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.7 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.76 -53.29 40.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.924 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.611 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 14.2 m-20 -66.21 -37.92 86.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.1 -45.99 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.648 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.0 mm -58.54 -47.59 87.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 34.0 mmtt -52.11 -42.81 63.58 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.354 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.26 -44.33 13.78 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.034 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 326' ' ' ILE . 2.0 mt -68.97 -40.77 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 117.447 0.623 . . . . 0.0 111.233 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.882 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.8 m -58.25 -45.63 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.034 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.474 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.1 t70 -62.34 -37.43 85.61 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.948 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -83.47 -53.14 5.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.615 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.39 -28.6 8.86 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.521 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 119.6 165.89 13.15 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.444 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.882 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.56 -44.07 98.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.31 -51.07 70.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.644 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.43 -49.88 69.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.461 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.678 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.2 -43.62 67.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.547 ' HB3' HD11 ' A' ' 457' ' ' ILE . 28.6 t80 -55.67 -45.72 77.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.816 ' O ' ' HG3' ' A' ' 413' ' ' MET . 16.3 m -57.99 -52.07 67.06 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.702 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.671 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -62.89 -49.23 75.64 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.716 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.57 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.37 -41.81 88.22 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.776 -174.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.709 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.44 -32.15 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 122.245 0.218 . . . . 0.0 111.152 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.816 ' HG3' ' O ' ' A' ' 409' ' ' THR . 60.4 mtm -70.67 -46.56 62.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 109.831 173.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.039 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.4 mt -60.51 -38.68 85.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.352 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 411' ' ' GLY . 4.5 p -77.0 -2.9 36.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.326 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.63 29.12 36.63 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.709 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.2 mm100 68.43 45.55 1.15 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 122.253 1.025 . . . . 0.0 111.534 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.669 ' OD1' HD23 ' A' ' 421' ' ' LEU . 25.1 t-20 -116.16 71.96 0.8 Allowed 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 164.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.617 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.2 OUTLIER -48.05 -35.77 11.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.046 -2.343 . . . . 0.0 111.64 -172.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 423' ' ' SER . 33.3 mt-30 -57.29 -49.91 74.58 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -166.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.669 HD23 ' OD1' ' A' ' 418' ' ' ASN . 3.1 pp -59.53 -48.66 80.78 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.237 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.76 -39.8 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.643 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.547 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 44.0 t -59.81 -47.59 85.1 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.793 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -56.02 -37.38 70.93 Favored Glycine 0 C--N 1.32 -0.339 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.052 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.7 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.9 mt -73.02 -42.69 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.548 0.689 . . . . 0.0 110.239 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.6 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -55.94 -44.48 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.727 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.71 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -59.74 -30.12 68.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-O 122.701 1.239 . . . . 0.0 109.236 -173.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.16 -16.82 77.0 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.429 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 15.3 m-85 -101.65 2.46 38.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.09 144.96 74.87 Favored Pre-proline 0 N--CA 1.416 -2.15 0 CA-C-O 123.501 1.62 . . . . 0.0 113.403 168.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.736 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.5 Cg_endo -72.6 -63.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 1 C-N-CA 126.126 4.551 . . . . 0.0 113.281 -173.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.552 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.06 140.23 15.22 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.181 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.83 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.74 -30.69 70.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.2 0.5 . . . . 0.0 111.204 -177.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.752 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.33 -48.16 74.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.005 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.61 -52.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.593 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.83 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.36 -54.66 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.109 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 53.2 m -62.76 -55.79 23.37 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.047 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.43 -45.13 80.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.642 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.0 mt -60.06 -53.46 57.56 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.722 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.704 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.74 -34.15 37.94 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 125.124 1.515 . . . . 0.0 110.403 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.663 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.87 -60.62 2.14 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 174.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -75.64 -51.38 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.541 0.61 . . . . 0.0 112.006 -172.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.32 -24.83 63.65 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.636 -178.442 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.757 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.1 t70 -73.06 -43.35 62.02 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.573 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.7 mt-30 -69.66 -8.95 52.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -172.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.436 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 20.7 mm-40 -51.89 155.28 1.82 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 123.574 1.654 . . . . 0.0 114.825 -175.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -52.93 -33.32 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 110.752 -2.931 . . . . 0.0 115.335 -171.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.643 ' H ' ' HB ' ' A' ' 451' ' ' THR . 26.5 m-20 -141.73 177.04 8.44 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.94 -52.35 63.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.1 OUTLIER -65.9 -25.2 67.05 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 174.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.643 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 12.6 m -60.89 -41.43 96.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 119.823 1.192 . . . . 0.0 109.756 172.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 71.8 mtt180 -60.42 -30.71 69.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.921 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 450' ' ' GLN . . . -75.67 -30.33 59.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.835 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -82.05 -44.25 16.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.858 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.506 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -104.32 -0.74 27.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.383 -167.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.676 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.8 t80 -49.12 -54.31 16.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.349 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -71.39 -25.1 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.99 -43.98 64.22 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.632 ' O ' HG23 ' A' ' 463' ' ' VAL . 78.8 m-70 -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.91 172.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.77 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.46 -53.77 43.09 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 122.263 1.03 . . . . 0.0 109.13 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -62.21 -30.65 71.23 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.341 -1.754 . . . . 0.0 110.869 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.7 -48.18 67.29 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.771 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.005 HG11 ' HA ' ' A' ' 435' ' ' VAL . 25.9 t -65.0 -35.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.352 174.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.53 -14.44 29.61 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.583 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 2.4 tp10 -92.56 -52.17 4.77 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.404 -0.81 . . . . 0.0 112.114 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.714 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -63.87 -41.15 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.424 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.1 mt -83.39 -16.85 44.32 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.817 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.9 50.8 56.37 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 111.565 -2.561 . . . . 0.0 112.977 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -102.86 -178.9 3.8 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.562 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.6 p-10 -101.02 -40.89 7.01 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.509 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -161.02 -75.79 0.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.114 159.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.736 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -61.48 70.57 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -171.15 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.77 46.54 0.61 Allowed Glycine 0 C--N 1.274 -2.862 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.398 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.562 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 2.3 mm100 -83.89 -53.81 5.32 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 122.245 1.022 . . . . 0.0 111.245 -173.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.8 t 68.0 56.25 0.54 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.889 -174.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.817 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -50.85 -48.37 28.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 110.547 -3.024 . . . . 0.0 111.845 175.069 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -48.85 134.33 16.72 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.213 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 79.9 mt -56.91 -28.09 61.6 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 123.977 0.911 . . . . 0.0 113.381 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.838 178.56 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 301' ' ' ILE . 1.1 Cg_endo . . . . . 0 N--CA 1.478 0.562 0 N-CA-C 111.077 -0.394 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 300' ' ' PRO . 1.8 mp 73.82 -51.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.032 0.533 . . . . 0.0 111.725 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 109.3 -146.81 16.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.906 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.675 ' HB ' HD11 ' A' ' 346' ' ' LEU . 95.8 m -155.94 125.97 6.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 0.0 109.729 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.24 121.9 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.286 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.705 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -74.82 127.54 86.86 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 121.765 0.793 . . . . 0.0 111.5 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -72.41 -12.27 27.18 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.881 3.72 . . . . 0.0 111.107 176.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.696 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.6 tp 26.95 -61.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.087 0 C-N-CA 128.704 2.801 . . . . 0.0 115.975 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.36 -32.08 68.22 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.273 0.559 . . . . 0.0 110.257 178.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.517 ' CG ' HG13 ' A' ' 338' ' ' VAL . 6.7 t-160 -62.08 -49.32 76.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.669 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' A' ' 307' ' ' ILE . 59.2 mt -58.88 -49.05 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 124.213 1.005 . . . . 0.0 113.08 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 4.3 mtp-105 -60.64 -30.57 69.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.864 0.364 . . . . 0.0 111.071 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.1 m -70.44 -33.28 71.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.572 0.701 . . . . 0.0 110.205 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.21 -40.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.8 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.788 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -82.45 -36.61 26.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.969 1.366 . . . . 0.0 109.759 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.98 35.44 8.22 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 112.117 -2.31 . . . . 0.0 111.135 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.531 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 42.8 mt-10 51.49 173.2 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.102 0 C-N-CA 124.196 0.998 . . . . 0.0 113.529 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.609 ' HB3' HD11 ' A' ' 324' ' ' ILE . 23.9 Cg_exo -45.2 142.18 6.16 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.015 2.477 . . . . 0.0 112.343 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.507 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 41.9 Cg_endo -89.71 -100.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.305 2.67 . . . . 0.0 112.896 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.448 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 12.3 mmm180 -94.01 -83.36 0.33 Allowed 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 123.149 0.58 . . . . 0.0 110.935 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 18.0 m-20 -103.29 163.18 18.0 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.769 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 35.2 Cg_exo -59.28 -51.59 6.25 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.499 2.133 . . . . 0.0 110.676 172.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -55.27 -14.82 1.95 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.203 -1.817 . . . . 0.0 113.142 177.232 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.3 mm-40 -91.64 -26.19 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.419 -0.175 . . . . 0.0 111.405 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.646 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.3 OUTLIER -46.44 -45.12 43.86 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.745 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.6 Cg_endo -47.47 -62.59 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.905 2.404 . . . . 0.0 113.25 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.65 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -63.42 -35.92 74.23 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 122.879 1.323 . . . . 0.0 110.141 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.788 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.6 t90 -57.51 -39.5 76.64 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.74 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.849 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -67.62 -47.5 69.48 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 122.465 0.306 . . . . 0.0 111.716 -175.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.408 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.27 -22.96 16.04 Favored Glycine 0 C--N 1.311 -0.858 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.681 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.441 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -73.16 -42.39 62.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.447 0.642 . . . . 0.0 111.31 175.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.656 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.4 p30 -104.39 -17.61 14.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.698 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.72 -49.44 7.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.7 Cg_endo -61.81 -33.0 86.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.576 2.184 . . . . 0.0 111.466 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -71.9 -43.1 65.92 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.884 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 332' ' ' ALA . 87.7 mt -58.79 -49.3 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.71 173.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.37 -14.5 4.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.921 175.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.12 -44.21 7.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.485 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.647 HG11 HG13 ' A' ' 310' ' ' ILE . 92.1 t -60.74 -70.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 123.466 1.603 . . . . 0.0 109.79 169.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -92.62 130.78 35.83 Favored Pre-proline 0 N--CA 1.403 -2.825 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.265 -173.089 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.789 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.2 Cg_endo -74.78 -16.85 20.6 Favored 'Trans proline' 0 CA--C 1.498 -1.323 0 C-N-CA 123.788 2.992 . . . . 0.0 110.862 173.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 346' ' ' LEU . 3.1 p 33.4 67.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.342 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.652 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.3 p -78.14 4.26 12.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 112.669 -2.06 . . . . 0.0 113.485 -169.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.797 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 13.5 p -139.86 163.35 45.2 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -63.31 -49.23 4.89 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.367 2.711 . . . . 0.0 108.103 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.747 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -44.32 -45.94 8.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.4 176.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.797 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.4 mt -59.22 -51.63 69.17 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 121.64 0.733 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.674 ' HA ' HD12 ' A' ' 350' ' ' ILE . 3.2 ttm180 -54.1 -45.85 71.96 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.262 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 1.006 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.89 -48.75 62.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 111.355 -177.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.646 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 62.9 mtt180 -56.01 -42.62 76.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 339' ' ' PHE . 39.9 mt -57.73 -54.13 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.523 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.55 HD13 ' HB1' ' A' ' 374' ' ' ALA . 19.8 mt -59.43 -52.57 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 122.162 0.982 . . . . 0.0 110.558 -170.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 17.4 m-20 -62.79 -35.18 79.01 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.272 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.41 -36.0 76.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.683 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.58 -53.83 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 CA-C-O 123.107 1.432 . . . . 0.0 110.463 173.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.683 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -72.68 -25.71 61.36 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 111.716 -2.493 . . . . 0.0 109.412 -168.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 75.93 -74.71 1.57 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.895 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -151.39 56.94 0.45 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.332 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -76.91 162.61 27.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.783 -0.245 . . . . 0.0 110.581 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.659 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -37.43 -59.73 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.252 1.021 . . . . 0.0 113.736 -166.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -153.9 16.56 0.62 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.511 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.725 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.3 mt -65.59 -3.87 5.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.942 0.497 . . . . 0.0 112.139 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.541 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.9 t -63.47 84.24 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.529 0.68 . . . . 0.0 110.309 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.82 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -62.63 170.53 2.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.773 0.796 . . . . 0.0 112.388 174.215 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 366' ' ' GLY . 65.4 p -111.31 156.33 41.32 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.952 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 1.006 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.8 Cg_endo -61.92 11.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.673 2.248 . . . . 0.0 113.794 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.518 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -128.53 -5.65 4.94 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.728 ' HB2' HD12 ' A' ' 363' ' ' LEU . 8.4 m-20 -109.57 -19.91 13.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.205 1.002 . . . . 0.0 110.298 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 15.4 p -88.56 16.27 6.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.595 -168.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.518 HD11 ' O ' ' A' ' 366' ' ' GLY . 1.0 OUTLIER -59.61 -40.84 88.86 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.524 -164.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.62 160.09 21.84 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.523 171.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.626 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.6 m95 -69.88 -35.89 75.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.58 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.44 -40.24 96.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.251 -175.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 36.8 t -68.69 -43.58 75.76 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.938 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.661 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.77 62.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.849 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.1 m -57.22 -44.73 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.057 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.4 -44.75 95.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.019 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.82 HG21 HD11 ' A' ' 363' ' ' LEU . 55.5 m -68.79 -39.42 80.15 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.825 -172.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.725 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.1 mt -60.8 -33.22 72.66 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.849 -0.532 . . . . 0.0 110.57 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.745 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 49.8 t80 -75.0 -46.04 37.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.349 1.071 . . . . 0.0 109.161 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -51.54 -32.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.328 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.0 OUTLIER -59.85 -41.24 90.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.071 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 44.5 p -100.03 -23.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.36 -167.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.422 ' HB3' HE22 ' A' ' 390' ' ' GLN . 29.5 m80 -110.22 24.24 13.26 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.43 18.31 29.11 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 114.864 0.705 . . . . 0.0 114.864 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.419 HG23 HG13 ' A' ' 380' ' ' ILE . 1.7 m 66.17 159.37 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.286 0.565 . . . . 0.0 111.385 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.472 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -127.64 152.19 76.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -96.76 53.7 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.351 2.701 . . . . 0.0 111.211 166.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.681 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.17 7.87 0.71 Allowed 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -71.04 -48.59 51.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 0.0 110.389 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.655 ' O ' HG13 ' A' ' 394' ' ' VAL . 56.6 mt-30 -76.2 -26.15 55.86 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.694 ' O ' HG22 ' A' ' 394' ' ' VAL . 3.1 mm? -54.05 -31.36 51.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.332 0.969 . . . . 0.0 111.384 -173.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.709 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.56 -49.79 63.41 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.971 174.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.642 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 36.4 m-20 -69.34 -39.25 78.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.9 m -57.46 -44.07 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.419 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.625 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.7 mm -58.24 -46.94 88.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.676 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.648 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 30.3 mmtt -52.4 -43.41 64.75 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.707 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.562 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.56 -44.34 16.5 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.1 -172.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.4 mt -69.31 -41.4 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 117.519 0.66 . . . . 0.0 111.552 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.4 m -57.64 -43.77 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.822 0.82 . . . . 0.0 109.955 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 399' ' ' VAL . 3.4 t70 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.064 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 70.1 mt-30 -83.78 -54.27 5.02 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.547 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -112.43 -30.46 7.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.796 -166.664 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.11 163.49 11.55 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.735 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.86 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.38 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.654 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.3 -50.51 71.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.1 0.476 . . . . 0.0 111.448 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.576 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -51.03 65.19 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.5 178.39 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.674 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.0 -41.85 65.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.548 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 31.6 t80 -57.08 -46.69 82.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.665 0.745 . . . . 0.0 109.086 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.821 ' O ' ' HG3' ' A' ' 413' ' ' MET . 8.5 m -58.69 -52.5 65.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.562 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.682 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.92 -49.01 76.46 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.737 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.95 -42.23 86.17 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.923 -174.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.759 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -32.64 66.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.66 0.23 . . . . 0.0 111.239 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.821 ' HG3' ' O ' ' A' ' 409' ' ' THR . 66.7 mtm -70.63 -46.98 62.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.383 0.611 . . . . 0.0 110.06 174.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.057 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.4 mt -59.23 -38.46 80.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.023 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.635 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.3 OUTLIER -77.45 -14.62 59.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.951 -176.066 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.67 27.03 8.71 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.178 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.759 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.3 mm100 64.35 44.17 4.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.101 0.961 . . . . 0.0 112.292 177.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.543 ' OD1' HD21 ' A' ' 421' ' ' LEU . 0.5 OUTLIER -120.24 69.5 0.86 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 166.37 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.667 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.8 OUTLIER -47.47 -35.25 8.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 111.568 -2.56 . . . . 0.0 113.477 -165.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' A' ' 423' ' ' SER . 28.0 mt-30 -55.03 -47.74 74.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -163.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.58 ' HG ' ' H ' ' A' ' 422' ' ' VAL . 1.9 pp -59.71 -48.99 79.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.384 0.612 . . . . 0.0 110.81 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.629 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.25 -38.87 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.574 1.178 . . . . 0.0 109.263 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.65 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 40.4 t -61.13 -46.53 90.19 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.905 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.77 72.93 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.019 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.709 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.26 -41.91 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.549 0.69 . . . . 0.0 110.162 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.58 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.18 -44.8 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.604 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.755 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.38 -30.77 68.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.618 1.199 . . . . 0.0 109.376 -174.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.68 -14.33 77.93 Favored Glycine 0 C--N 1.299 -1.483 0 CA-C-N 112.845 -1.979 . . . . 0.0 112.503 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.67 ' CG ' HG21 ' A' ' 399' ' ' VAL . 16.5 m-85 -103.83 3.03 33.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.5 144.75 78.25 Favored Pre-proline 0 N--CA 1.411 -2.411 0 CA-C-O 123.541 1.639 . . . . 0.0 112.996 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.746 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 60.9 Cg_endo -72.94 -63.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 1 C-N-CA 126.074 4.516 . . . . 0.0 113.422 -173.056 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.559 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -104.58 141.86 15.37 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.899 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -65.68 -26.82 67.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.22 0.51 . . . . 0.0 111.216 -176.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.778 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -58.5 -46.33 86.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.029 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -59.39 -52.04 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.629 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.899 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.36 -53.79 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.467 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 94.4 m -61.15 -56.6 18.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.96 -46.24 78.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.519 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.842 ' O ' HD22 ' A' ' 443' ' ' LEU . 54.9 mt -59.95 -53.5 57.08 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.64 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.674 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.5 mm-40 -51.77 -34.48 39.82 Favored 'General case' 0 N--CA 1.415 -2.19 0 O-C-N 124.956 1.41 . . . . 0.0 110.682 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.674 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.29 -61.81 1.69 Allowed 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 175.079 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.55 -50.17 14.59 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.85 -0.531 . . . . 0.0 112.205 -171.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.7 -25.35 62.8 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.34 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.752 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.5 t70 -72.81 -42.74 63.54 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.701 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.8 mt-30 -68.97 -7.6 36.77 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -172.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 4.9 mm-40 -51.66 156.22 1.42 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.516 1.627 . . . . 0.0 114.363 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.487 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.22 -32.37 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 110.719 -2.946 . . . . 0.0 115.38 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.663 ' H ' ' HB ' ' A' ' 451' ' ' THR . 19.1 m-20 -142.02 179.94 6.59 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.442 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 3.6 m-20 -62.65 -55.58 25.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.1 OUTLIER -64.61 -25.2 67.86 Favored 'General case' 0 N--CA 1.403 -2.795 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.411 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.663 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 23.6 m -60.31 -41.91 94.45 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 119.793 1.179 . . . . 0.0 109.543 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 45.8 mtt180 -60.88 -30.32 70.08 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.851 172.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.548 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.65 -29.47 59.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.921 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.09 -44.66 17.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.788 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.562 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.1 p -106.24 0.39 25.16 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.184 -167.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.9 t80 -48.91 -53.83 17.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.03 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.2 mm -71.06 -25.49 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.562 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.17 -43.42 64.61 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.643 ' O ' HG23 ' A' ' 463' ' ' VAL . 72.1 m-70 -65.45 -32.03 73.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.722 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.717 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.14 -53.47 37.42 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.066 0.936 . . . . 0.0 109.512 -178.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.666 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 8.3 m-80 -62.37 -32.31 73.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.068 173.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -61.66 -53.36 57.23 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.893 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.029 HG11 ' HA ' ' A' ' 435' ' ' VAL . 20.9 t -62.7 -34.88 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.858 0 CA-C-O 121.818 0.818 . . . . 0.0 110.4 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.7 -14.7 33.95 Favored 'General case' 0 C--O 1.207 -1.155 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.32 170.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.666 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 43.4 mt-10 -92.99 -48.28 6.59 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.097 -1.002 . . . . 0.0 112.69 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.734 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.6 pt -66.27 -38.1 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.237 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.6 mt -85.27 -17.16 37.78 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.753 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 61.8 55.73 26.8 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.659 -2.518 . . . . 0.0 112.942 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -105.02 -159.21 0.7 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 122.088 0.947 . . . . 0.0 109.644 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.474 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.6 p-10 -124.76 -41.39 2.13 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -159.21 -79.59 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 112.251 -2.249 . . . . 0.0 110.619 156.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.746 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 1.3 mpt_? -59.06 68.13 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 33.47 53.58 0.6 Allowed Glycine 0 C--N 1.278 -2.689 0 CA-C-N 111.099 -2.773 . . . . 0.0 113.367 173.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.474 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 0.4 OUTLIER -90.13 -49.07 6.78 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 122.4 1.095 . . . . 0.0 111.259 -173.378 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 27.2 t 62.0 62.58 1.21 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.119 -2.31 . . . . 0.0 108.561 -171.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.753 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -50.71 -50.36 23.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 110.932 -2.849 . . . . 0.0 112.115 177.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.651 ' HD2' ' N ' ' A' ' 478' ' ' LEU . 0.1 OUTLIER -75.4 -176.16 3.05 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.154 178.387 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.651 ' N ' ' HD2' ' A' ' 477' ' ' ARG . 84.9 mt -53.17 -175.18 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-N 113.891 -1.504 . . . . 0.0 112.67 -178.333 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.465 ' HB2' HD12 ' A' ' 301' ' ' ILE . 51.7 Cg_exo . . . . . 0 N--CA 1.482 0.813 0 N-CA-C 111.425 -0.26 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 300' ' ' PRO . 2.6 mp -99.35 -62.35 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.82 0.343 . . . . 0.0 110.661 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -123.82 73.23 0.41 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.252 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.467 ' HB ' HD11 ' A' ' 346' ' ' LEU . 25.0 m 72.35 118.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.352 1.072 . . . . 0.0 112.222 177.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.1 p -79.3 130.07 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.335 176.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.72 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -74.73 125.43 89.56 Favored Pre-proline 0 N--CA 1.426 -1.65 0 CA-C-O 121.909 0.862 . . . . 0.0 111.852 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 308' ' ' GLN . 17.6 Cg_endo -72.46 -11.32 26.37 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 124.929 3.752 . . . . 0.0 111.372 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.7 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.7 tp 25.66 -60.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 C-N-CA 128.677 2.791 . . . . 0.0 116.34 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.558 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.17 -32.44 68.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.355 0.598 . . . . 0.0 110.138 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.9 t-160 -62.4 -48.95 77.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.66 172.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 307' ' ' ILE . 57.6 mt -58.59 -48.71 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 124.006 0.922 . . . . 0.0 113.172 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.671 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.4 mtp-105 -60.22 -30.11 69.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.14 -0.35 . . . . 0.0 111.41 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 46.9 m -69.6 -35.43 75.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.564 0.697 . . . . 0.0 109.845 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.547 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -66.07 -40.9 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.717 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.846 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -83.35 -36.88 24.03 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.797 1.284 . . . . 0.0 110.235 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.66 36.67 7.8 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.245 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 38.8 mt-10 49.87 175.53 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 124.071 0.948 . . . . 0.0 113.261 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.628 ' HB3' HD11 ' A' ' 324' ' ' ILE . 90.8 Cg_exo -52.44 134.7 52.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.603 2.202 . . . . 0.0 112.48 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.737 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 95.1 Cg_endo -85.23 -90.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.487 2.792 . . . . 0.0 114.788 -174.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.462 ' HG2' ' HB2' ' A' ' 318' ' ' PRO . 6.4 mmm180 -93.76 -78.93 0.42 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.048 0.928 . . . . 0.0 113.033 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.667 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 65.1 m-20 -105.4 -159.93 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.756 -169.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 320' ' ' ASN . 58.6 Cg_endo -90.89 -32.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 121.647 1.565 . . . . 0.0 114.671 159.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 15.72 10.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -169.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.725 ' OE2' ' HG2' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -106.31 -35.83 7.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.671 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.633 ' HA ' ' HB3' ' A' ' 327' ' ' TRP . 0.4 OUTLIER -40.15 -46.15 5.22 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.345 1.458 . . . . 0.0 114.077 178.059 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.706 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.2 Cg_endo -47.01 -63.04 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.055 2.503 . . . . 0.0 112.814 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.621 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.8 OUTLIER -65.35 -35.53 75.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 123.054 1.407 . . . . 0.0 110.428 -179.047 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.846 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 32.7 t90 -58.34 -34.05 70.2 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.973 177.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.889 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.8 OUTLIER -70.45 -48.04 57.8 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.303 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.6 -23.13 19.31 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.793 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.498 ' CD ' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -74.41 -42.94 58.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.247 1.023 . . . . 0.0 110.617 174.137 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.675 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.0 m-20 -95.67 -24.96 16.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.679 -168.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.569 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.1 -49.76 11.28 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 124.418 1.087 . . . . 0.0 113.749 177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 49.3 Cg_endo -63.09 -31.27 75.92 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.544 2.163 . . . . 0.0 111.525 177.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.04 -44.11 55.47 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.689 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.6 HG12 HG23 ' A' ' 310' ' ' ILE . 88.7 mt -58.37 -48.69 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.584 173.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 19.4 t70 -57.09 -17.85 12.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.264 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -44.51 10.15 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.68 HG11 HG13 ' A' ' 310' ' ' ILE . 94.0 t -60.64 -68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 123.587 1.66 . . . . 0.0 110.242 169.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.825 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -96.29 130.07 31.91 Favored Pre-proline 0 N--CA 1.403 -2.802 0 CA-C-N 110.791 -2.913 . . . . 0.0 112.787 -171.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.772 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -75.4 -16.36 19.39 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 123.89 3.06 . . . . 0.0 110.927 174.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.462 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.53 66.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 112.33 -2.214 . . . . 0.0 110.323 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.632 ' N ' HD12 ' A' ' 346' ' ' LEU . 34.8 p -77.88 2.71 16.48 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.681 -2.054 . . . . 0.0 113.225 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.798 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.1 p -138.06 161.36 60.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -63.97 -46.53 8.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.419 2.746 . . . . 0.0 108.454 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.637 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -45.51 -44.2 12.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.425 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.798 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.3 mt -61.35 -52.01 66.43 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.696 0.76 . . . . 0.0 110.459 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.641 ' HA ' HD12 ' A' ' 350' ' ' ILE . 2.6 ttm180 -52.12 -47.32 65.38 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.627 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 1.058 ' HG ' ' HA ' ' A' ' 365' ' ' PRO . 0.5 OUTLIER -69.45 -48.24 61.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.734 -176.111 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 46.4 mtt180 -56.54 -42.1 77.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.232 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.825 HD11 ' CD2' ' A' ' 339' ' ' PHE . 43.0 mt -57.24 -53.27 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.446 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.61 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -59.4 -52.57 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 122.158 0.98 . . . . 0.0 110.986 -170.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.553 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 25.8 m-20 -63.42 -35.45 80.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.37 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.38 75.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.656 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -57.86 -54.31 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.052 1.406 . . . . 0.0 110.66 173.328 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.633 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.6 OUTLIER -72.12 -24.76 61.52 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.328 -169.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.5 -65.28 1.06 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.849 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -139.51 66.91 0.51 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.233 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.569 HD21 ' C ' ' A' ' 358' ' ' ASN . 0.2 OUTLIER -78.75 164.9 24.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.23 0.212 . . . . 0.0 111.283 178.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.558 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -56.52 -65.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 122.94 0.496 . . . . 0.0 111.289 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -148.55 10.9 1.12 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.565 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.663 ' HB3' HD22 ' A' ' 378' ' ' LEU . 3.7 mt -65.01 -5.85 7.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.723 0.409 . . . . 0.0 111.408 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.553 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 19.4 t -60.71 82.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.402 0.62 . . . . 0.0 110.596 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.699 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -64.55 170.67 3.8 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.953 0.882 . . . . 0.0 112.629 175.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 33.4 p -118.66 155.5 52.35 Favored Pre-proline 0 N--CA 1.436 -1.17 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.99 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 1.058 ' HA ' ' HG ' ' A' ' 348' ' ' CYS . 1.9 Cg_endo -54.8 -11.28 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.801 2.334 . . . . 0.0 113.419 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.542 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -103.75 -6.31 43.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.139 -0.553 . . . . 0.0 114.471 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.678 ' HB2' HD12 ' A' ' 363' ' ' LEU . 1.3 m-20 -109.83 -18.83 13.33 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.075 0.941 . . . . 0.0 110.777 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.744 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 19.3 p -92.43 18.86 7.85 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.747 -167.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.542 HD11 ' O ' ' A' ' 366' ' ' GLY . 1.8 mt -62.15 -35.71 79.6 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.369 1.081 . . . . 0.0 110.242 -162.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.5 p -116.03 167.31 11.09 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.313 171.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.683 ' O ' HG13 ' A' ' 375' ' ' VAL . 43.1 m95 -70.39 -34.05 72.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.21 -43.56 94.65 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.559 0.695 . . . . 0.0 109.711 -173.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.7 p -66.24 -44.21 84.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.312 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.85 62.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.902 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.0 m -58.13 -44.03 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.644 0.735 . . . . 0.0 109.568 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.033 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.63 -46.01 90.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.777 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.699 HG21 HD11 ' A' ' 363' ' ' LEU . 34.4 m -65.84 -40.74 92.02 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.445 -173.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.7 mt -60.16 -33.55 72.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.677 0.671 . . . . 0.0 110.369 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.706 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 65.8 t80 -73.36 -46.46 49.02 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 122.382 1.087 . . . . 0.0 109.567 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -51.83 -32.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 112.801 -1.999 . . . . 0.0 111.158 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.45 -38.13 83.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 176.399 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 37.2 p -98.25 -22.83 15.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.639 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.442 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 26.6 m80 -110.08 22.19 15.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.91 21.0 28.85 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.4 m 65.98 158.17 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 111.906 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.488 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -126.65 155.35 75.05 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 386' ' ' PHE . 91.5 Cg_endo -101.61 58.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.912 3.075 . . . . 0.0 111.437 166.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.773 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.5 -2.08 0.09 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -69.64 -45.11 69.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.492 . . . . 0.0 110.847 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.626 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.6 mt-30 -74.91 -26.71 59.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.919 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.2 -30.98 51.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.922 0.783 . . . . 0.0 111.787 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.71 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.99 -48.54 66.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.545 173.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 59.1 m-20 -68.47 -41.16 80.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.087 0.555 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.44 -44.93 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.257 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.678 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.4 mm -58.34 -47.39 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.459 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.637 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.3 mmtt -52.2 -43.17 64.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.936 0.772 . . . . 0.0 111.49 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.58 -44.11 17.06 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.15 -172.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.7 mt -69.12 -42.0 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 117.294 0.547 . . . . 0.0 111.596 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -58.71 -43.24 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.884 0.85 . . . . 0.0 109.872 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 399' ' ' VAL . 19.0 t70 -57.16 -44.5 83.51 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.328 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -86.66 -53.3 5.03 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.673 -1.149 . . . . 0.0 113.424 -170.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.579 ' HG3' HG23 ' A' ' 398' ' ' ILE . 0.1 OUTLIER -109.04 -31.44 7.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.427 0.632 . . . . 0.0 111.549 -170.456 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.62 165.07 11.79 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.841 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.903 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -45.93 96.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.113 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -55.91 -50.14 71.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.591 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.515 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -50.82 66.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.369 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.673 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.54 -41.58 63.63 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.561 ' HB3' HD11 ' A' ' 457' ' ' ILE . 45.3 t80 -57.85 -46.51 84.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.572 0.701 . . . . 0.0 109.533 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.744 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.7 m -59.82 -52.71 64.28 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.816 -178.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.715 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -62.06 -49.03 77.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.875 177.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.627 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.78 -41.35 82.97 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.091 -175.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.582 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.3 OUTLIER -72.06 -33.73 68.18 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.643 0.222 . . . . 0.0 110.826 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.902 ' HE3' HG21 ' A' ' 375' ' ' VAL . 62.4 mtm -69.51 -46.63 66.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.042 174.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.033 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.9 mt -58.79 -40.13 83.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.924 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.919 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.5 m -78.84 -14.52 59.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.03 44.08 4.54 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.948 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.87 HE22 ' HA ' ' A' ' 413' ' ' MET . 0.2 OUTLIER 56.58 42.18 27.54 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 124.269 1.028 . . . . 0.0 113.323 178.18 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.621 ' OD1' HD21 ' A' ' 421' ' ' LEU . 0.4 OUTLIER -119.5 74.27 0.99 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.295 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.554 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 0.7 OUTLIER -49.65 -36.04 23.33 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 111.907 -2.406 . . . . 0.0 113.009 -167.384 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.5 mt-30 -54.83 -49.24 71.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -163.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.696 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.6 pp -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.497 0.665 . . . . 0.0 111.184 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.587 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.648 1.213 . . . . 0.0 109.152 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.564 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 41.3 t -61.56 -46.9 87.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.467 -2.152 . . . . 0.0 112.023 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.21 -37.97 75.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.843 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.71 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.4 mt -72.17 -41.47 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 110.048 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.623 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -57.39 -45.05 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.003 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.709 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -61.69 -28.97 69.78 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 122.704 1.24 . . . . 0.0 108.963 -173.036 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.9 -17.86 77.21 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.374 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.73 ' CG ' HG21 ' A' ' 399' ' ' VAL . 11.3 m-85 -101.03 4.16 42.1 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.39 144.29 71.7 Favored Pre-proline 0 N--CA 1.41 -2.448 0 CA-C-O 123.722 1.725 . . . . 0.0 113.226 168.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.823 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.5 Cg_endo -71.37 -58.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.115 1 C-N-CA 126.308 4.672 . . . . 0.0 113.172 -170.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.22 142.38 17.15 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.105 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.827 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.48 -31.74 71.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.043 0.422 . . . . 0.0 111.28 -177.108 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.757 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.2 -46.47 79.44 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.026 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.4 t -59.44 -51.04 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.785 177.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.827 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.64 -54.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 57.0 m -62.7 -56.44 17.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.551 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.48 -42.83 78.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.484 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.836 ' O ' HD22 ' A' ' 443' ' ' LEU . 54.1 mt -63.42 -53.25 55.34 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.204 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 19.3 mm100 -51.31 -33.84 30.77 Favored 'General case' 0 N--CA 1.419 -2.014 0 O-C-N 124.959 1.412 . . . . 0.0 110.334 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.687 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.99 -60.96 1.99 Allowed 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 172.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.2 ptp180 -74.03 -53.6 9.67 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.613 -0.679 . . . . 0.0 112.536 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.24 -24.96 63.62 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.63 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.749 ' N ' HD23 ' A' ' 443' ' ' LEU . 8.3 t70 -73.17 -42.16 63.08 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.494 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 35.1 mt-30 -70.64 -7.98 48.35 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.554 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 6.2 mm-40 -51.31 158.46 0.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 123.581 1.657 . . . . 0.0 114.623 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.539 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.08 -32.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 110.543 -3.026 . . . . 0.0 115.33 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.663 ' H ' ' HB ' ' A' ' 451' ' ' THR . 13.6 m-20 -142.75 179.76 6.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.759 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.426 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 11.1 p-10 -61.68 -54.95 35.79 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -65.64 -26.51 67.84 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.663 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.5 m -59.17 -41.19 87.86 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 119.905 1.229 . . . . 0.0 109.678 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 66.7 mtt180 -60.47 -29.57 69.13 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.935 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.554 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -76.61 -33.99 58.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.332 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.5 mm-40 -78.51 -44.63 23.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.941 -171.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.56 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 24.8 p -105.17 0.53 27.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.061 -167.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.703 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.6 t80 -49.19 -54.87 14.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -70.44 -26.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.56 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.23 -42.97 68.19 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 463' ' ' VAL . 30.1 m80 -67.78 -31.89 72.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.745 172.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.74 HD22 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -63.48 -53.39 52.8 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.179 0.99 . . . . 0.0 109.292 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.591 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.4 m-80 -62.89 -31.8 72.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.525 173.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -63.96 -50.99 66.46 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.854 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.026 HG11 ' HA ' ' A' ' 435' ' ' VAL . 31.9 t -63.04 -34.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.906 0.86 . . . . 0.0 110.34 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.534 ' HD1' HD12 ' A' ' 469' ' ' LEU . 19.2 m-30 -61.18 -15.95 39.53 Favored 'General case' 0 C--O 1.205 -1.284 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.185 169.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 462' ' ' ALA . 33.5 mm-40 -90.34 -49.8 6.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 112.789 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.736 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.92 -39.42 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.86 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -84.67 -16.04 43.27 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 171.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.761 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.31 52.02 50.21 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 111.741 -2.482 . . . . 0.0 113.1 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.731 HD11 HD12 ' A' ' 467' ' ' LEU . 0.3 OUTLIER -103.8 177.96 4.69 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 123.583 0.753 . . . . 0.0 109.892 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.5 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.7 p-10 -96.55 -41.4 8.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 167.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.416 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -160.42 -74.37 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.356 -2.202 . . . . 0.0 111.19 158.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.823 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -63.15 68.91 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -169.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.476 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 40.09 40.03 1.66 Allowed Glycine 0 C--N 1.278 -2.677 0 CA-C-N 111.176 -2.738 . . . . 0.0 113.48 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.5 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 1.2 mm100 -78.87 -51.62 9.44 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.142 0.972 . . . . 0.0 111.566 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.9 t 65.18 55.06 1.14 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.306 -173.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.761 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -53.6 -47.26 61.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 110.637 -2.983 . . . . 0.0 111.928 176.361 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 477' ' ' ARG . 8.3 mmm-85 -51.49 145.68 8.41 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.943 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.1 -25.79 68.53 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.351 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.439 -1.014 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.146 178.103 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.408 ' O ' ' HB ' ' A' ' 301' ' ' ILE . 5.1 Cg_exo . . . . . 0 N--CA 1.476 0.478 0 N-CA-C 110.571 -0.588 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 300' ' ' PRO . 2.3 mp 71.33 -59.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.185 0.594 . . . . 0.0 111.096 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 346' ' ' LEU . . . 167.94 -19.27 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 58.6 m 76.97 113.7 0.07 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.183 0.992 . . . . 0.0 111.69 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.0 p -66.54 127.32 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.725 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.702 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.3 mt -73.83 125.85 90.01 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-O 121.716 0.769 . . . . 0.0 111.643 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 308' ' ' GLN . 23.3 Cg_endo -71.75 -15.98 29.95 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 124.555 3.503 . . . . 0.0 110.883 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.744 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.9 tp 30.38 -58.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 C-N-CA 128.673 2.789 . . . . 0.0 116.275 172.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 306' ' ' PRO . 3.3 mm-40 -56.17 -38.84 71.47 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.097 0.951 . . . . 0.0 109.811 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.535 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -59.85 -47.8 84.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.799 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 307' ' ' ILE . 65.2 mt -60.2 -48.22 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 123.861 0.864 . . . . 0.0 113.036 174.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.744 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 5.5 mtp180 -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 O-C-N 122.032 -0.417 . . . . 0.0 110.461 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 23.2 t -70.03 -34.05 72.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.623 . . . . 0.0 109.6 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.568 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.38 -41.59 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.775 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 331' ' ' ASN . 29.8 p -83.0 -36.66 24.85 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.765 1.269 . . . . 0.0 109.671 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.61 34.04 8.79 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.419 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.543 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 51.23 173.1 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.323 0 C-N-CA 124.419 1.087 . . . . 0.0 113.105 -173.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.774 ' HB3' HD11 ' A' ' 324' ' ' ILE . 28.2 Cg_exo -46.16 152.34 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.128 2.552 . . . . 0.0 113.586 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -89.52 -101.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.264 2.643 . . . . 0.0 111.991 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.473 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 13.3 mmt180 -104.38 -82.63 0.51 Allowed 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.126 0.489 . . . . 0.0 111.504 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 14.5 m120 -98.33 163.14 19.76 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.861 -171.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.15 -51.67 6.26 Favored 'Trans proline' 0 CA--C 1.509 -0.756 0 C-N-CA 123.117 2.545 . . . . 0.0 110.971 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -13.56 2.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.492 -1.686 . . . . 0.0 113.29 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.2 mt-10 -92.86 -31.74 14.87 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.256 -0.177 . . . . 0.0 110.89 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -47.83 -45.03 60.46 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -177.643 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.738 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.5 Cg_endo -49.64 -61.91 0.5 Allowed 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.974 2.449 . . . . 0.0 112.849 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.677 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.25 -37.19 77.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.686 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 38.3 t90 -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.099 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.848 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.22 -48.18 58.17 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.58 -23.07 18.9 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.827 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.469 ' CD ' HG21 ' A' ' 406' ' ' THR . 1.2 mmm180 -74.57 -43.06 57.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.259 1.028 . . . . 0.0 110.483 174.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.729 ' HB3' HG22 ' A' ' 314' ' ' THR . 48.3 m-20 -95.16 -24.18 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.444 -1.707 . . . . 0.0 113.601 -168.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.04 -50.32 10.87 Favored Pre-proline 0 C--N 1.306 -1.295 0 C-N-CA 124.223 1.009 . . . . 0.0 113.612 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.1 Cg_endo -62.08 -31.76 83.48 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.741 2.294 . . . . 0.0 111.828 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.59 -44.17 57.86 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.549 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.619 HG23 HG23 ' A' ' 310' ' ' ILE . 91.0 mt -58.38 -48.42 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.855 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 19.2 t70 -55.67 -19.61 11.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.07 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.41 -48.07 9.74 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 310' ' ' ILE . 62.2 t -57.89 -72.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-O 123.445 1.593 . . . . 0.0 110.098 169.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.875 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.39 129.56 40.53 Favored Pre-proline 0 N--CA 1.405 -2.686 0 CA-C-N 111.196 -2.729 . . . . 0.0 112.623 -171.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.774 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.7 Cg_endo -74.8 -16.47 20.73 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 123.981 3.12 . . . . 0.0 110.763 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.465 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.36 66.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 112.347 -2.206 . . . . 0.0 110.182 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.688 ' N ' HD12 ' A' ' 346' ' ' LEU . 37.4 p -79.37 8.66 5.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.945 -1.934 . . . . 0.0 113.586 -170.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.5 p -142.23 164.13 35.37 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.417 ' O ' ' SG ' ' A' ' 348' ' ' CYS . 44.6 Cg_exo -63.06 -50.02 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.154 2.569 . . . . 0.0 108.309 172.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.68 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.7 OUTLIER -42.7 -48.23 5.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.972 176.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.1 mt -56.43 -52.61 64.03 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.587 -177.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.718 ' HA ' HD12 ' A' ' 350' ' ' ILE . 39.1 ttm105 -54.72 -45.61 74.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.56 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 1.019 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.48 -48.38 60.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.067 0.461 . . . . 0.0 111.258 -176.103 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 49.7 mtp180 -55.96 -41.9 75.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.929 177.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.875 HD11 ' CD2' ' A' ' 339' ' ' PHE . 49.0 mt -58.72 -54.29 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.678 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.571 HG23 HD11 ' A' ' 328' ' ' LEU . 19.5 mt -57.85 -52.97 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.109 0.956 . . . . 0.0 110.777 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.499 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.2 m-20 -63.56 -34.98 79.01 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.911 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.16 -38.34 78.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.858 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.13 -52.82 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.001 1.382 . . . . 0.0 110.192 175.137 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.608 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.8 OUTLIER -72.96 -24.81 60.83 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 111.719 -2.491 . . . . 0.0 109.414 -170.157 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.82 -80.35 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 113.656 -1.611 . . . . 0.0 113.013 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.02 72.71 0.29 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.519 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.2 OUTLIER -94.59 157.68 15.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 122.541 0.336 . . . . 0.0 111.32 -177.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.4 mp -81.28 89.34 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-O 121.11 0.481 . . . . 0.0 111.83 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.47 -16.97 15.64 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.552 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.726 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.4 mt -60.68 -4.68 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 25.1 t -63.69 81.98 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 110.353 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -61.96 172.46 1.35 Allowed 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.908 174.384 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.557 ' C ' ' H ' ' A' ' 366' ' ' GLY . 44.1 p -112.76 162.71 20.39 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.186 -174.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 1.019 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.0 Cg_endo -67.04 21.21 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.42 2.08 . . . . 0.0 112.583 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -131.66 -12.05 2.04 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.329 -0.85 . . . . 0.0 114.207 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.708 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.5 m-20 -105.2 -20.49 13.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.715 1.245 . . . . 0.0 109.44 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 3.8 p -75.3 19.11 0.18 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.244 -172.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.73 -32.73 70.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.362 1.077 . . . . 0.0 109.814 -170.722 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.3 35.98 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.266 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.588 ' O ' HG13 ' A' ' 375' ' ' VAL . 65.4 m95 -69.66 -35.49 75.2 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.61 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.4 OUTLIER -60.81 -40.86 94.3 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.804 -175.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 53.9 m -68.92 -43.69 74.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.702 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.53 -52.71 62.38 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.887 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.3 m -57.24 -45.73 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.395 0.617 . . . . 0.0 109.666 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.003 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.68 -45.57 93.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.889 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 363' ' ' LEU . 31.7 m -67.56 -37.69 83.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.594 -172.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -60.95 -35.22 76.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.471 0.578 . . . . 0.0 110.434 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.738 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 55.6 t80 -72.51 -46.91 52.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.561 1.172 . . . . 0.0 109.175 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.07 -32.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.344 171.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.13 -46.58 89.16 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 123.193 0.597 . . . . 0.0 111.175 175.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.7 p -89.12 -23.98 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.531 -171.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -111.28 23.22 14.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.0 21.56 24.63 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.745 0.658 . . . . 0.0 114.745 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 67.04 160.36 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.906 0.482 . . . . 0.0 111.413 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -125.45 158.48 64.25 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 389' ' ' HIS . 90.6 Cg_endo -101.33 53.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.894 3.063 . . . . 0.0 111.466 166.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.742 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.83 -14.99 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -175.468 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.441 ' H ' ' C ' ' A' ' 387' ' ' PRO . 34.6 t-80 -57.52 -42.59 83.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.881 0.372 . . . . 0.0 110.648 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.664 ' O ' HG13 ' A' ' 394' ' ' VAL . 78.3 mt-30 -75.2 -27.93 59.79 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -171.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.1 mm? -54.16 -31.27 52.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.972 0.806 . . . . 0.0 111.455 -176.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.744 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.37 -51.48 51.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.735 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.605 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 17.9 m-20 -68.97 -37.91 79.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -57.66 -46.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.044 0.449 . . . . 0.0 110.101 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 399' ' ' VAL . 21.8 mm -59.01 -45.87 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.967 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.726 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 37.2 mmtt -52.05 -42.78 63.41 Favored 'General case' 0 C--O 1.244 0.793 0 O-C-N 124.025 0.828 . . . . 0.0 111.531 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.35 -44.19 13.96 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.128 -172.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.677 HG12 HG21 ' A' ' 326' ' ' ILE . 2.5 mt -69.31 -40.81 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 117.429 0.615 . . . . 0.0 111.575 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -58.84 -43.94 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.823 0.821 . . . . 0.0 109.749 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.46 ' N ' HG23 ' A' ' 399' ' ' VAL . 16.2 t70 -59.19 -42.26 90.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.486 177.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 29.2 mm-40 -86.28 -53.1 5.22 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.331 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 398' ' ' ILE . 1.1 mm-40 -109.56 -31.15 7.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.467 0.651 . . . . 0.0 111.622 -170.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.28 164.05 11.67 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.889 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -44.1 98.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 123.104 0.561 . . . . 0.0 112.417 -175.564 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.667 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.54 -52.27 62.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.57 0.7 . . . . 0.0 111.843 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.515 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.5 -49.69 68.07 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.348 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.671 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.31 -42.18 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 29.1 t80 -55.72 -48.65 74.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.589 0.709 . . . . 0.0 109.371 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.767 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.1 m -58.32 -52.16 66.75 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.752 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.696 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.52 -48.72 79.78 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.604 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.25 -43.7 89.26 Favored Glycine 0 C--N 1.315 -0.603 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.392 -174.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.589 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -72.21 -31.22 65.67 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.795 0.298 . . . . 0.0 110.874 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.887 ' HE3' HG21 ' A' ' 375' ' ' VAL . 63.9 mtm -69.03 -48.97 61.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.35 0.595 . . . . 0.0 109.866 172.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.07 -39.35 81.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.113 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.716 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.4 OUTLIER -77.4 -14.3 59.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.684 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.84 4.88 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.866 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.589 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 1.0 OUTLIER 58.15 43.7 20.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.794 0.838 . . . . 0.0 113.228 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 0.5 OUTLIER -124.37 79.92 1.79 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.164 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.759 ' HD2' ' HG ' ' A' ' 423' ' ' SER . 7.5 p90 -62.27 -31.85 72.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.146 -163.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 47.4 mt-30 -53.79 -49.6 67.94 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.377 -164.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.697 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.3 pp -59.18 -49.24 78.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.25 0.547 . . . . 0.0 110.671 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.669 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.61 -38.72 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 122.794 1.283 . . . . 0.0 108.917 -178.199 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.759 ' HG ' ' HD2' ' A' ' 419' ' ' TYR . 64.6 m -66.27 -42.19 88.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.507 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.62 -38.83 89.56 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.254 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.744 HD13 ' HA2' ' A' ' 392' ' ' GLY . 4.3 mt -71.19 -42.07 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.515 0.674 . . . . 0.0 109.917 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -57.26 -44.47 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.334 -1.303 . . . . 0.0 112.606 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.715 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -61.28 -29.27 69.76 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 122.655 1.217 . . . . 0.0 109.143 -172.04 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.4 -20.24 78.14 Favored Glycine 0 C--N 1.298 -1.578 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.034 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.739 ' CG ' HG21 ' A' ' 399' ' ' VAL . 12.4 m-85 -97.04 0.6 48.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.84 143.31 77.17 Favored Pre-proline 0 N--CA 1.408 -2.529 0 CA-C-O 123.919 1.819 . . . . 0.0 113.267 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.828 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 51.0 Cg_endo -69.43 -60.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 1 C-N-CA 126.372 4.715 . . . . 0.0 112.973 -172.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.522 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.84 141.3 16.12 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.221 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.917 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.33 -26.98 68.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.133 0.467 . . . . 0.0 111.69 -177.07 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.82 -48.29 80.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 169.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.994 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.8 t -58.22 -52.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.038 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.8 -52.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.461 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.6 m -62.55 -56.65 15.95 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.216 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.89 -46.01 78.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.485 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 42.8 mt -59.56 -53.49 57.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.9 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.679 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 19.0 mm100 -51.95 -34.74 43.35 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 124.932 1.395 . . . . 0.0 110.693 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.668 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -73.24 -60.87 2.04 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 175.599 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.4 -50.62 13.68 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.693 -0.63 . . . . 0.0 112.306 -172.394 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.58 -25.34 62.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.675 0.75 . . . . 0.0 111.487 -178.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.76 ' N ' HD23 ' A' ' 443' ' ' LEU . 11.5 t70 -72.6 -42.04 64.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.64 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.668 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -68.78 -7.95 38.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.572 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 15.7 mm-40 -54.46 151.58 7.59 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 123.465 1.602 . . . . 0.0 114.436 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.74 -32.63 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.477 -3.056 . . . . 0.0 116.066 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.654 ' H ' ' HB ' ' A' ' 451' ' ' THR . 25.8 m-20 -135.49 175.77 9.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.449 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 5.8 m-20 -61.73 -56.89 14.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 172.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -62.9 -28.16 69.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 176.292 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.654 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 16.2 m -58.09 -43.18 86.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.803 1.183 . . . . 0.0 110.04 172.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 56.3 mtt180 -61.51 -29.75 70.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 172.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.602 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -75.24 -29.95 60.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.911 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.3 mm-40 -80.46 -45.74 17.08 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.286 1.041 . . . . 0.0 111.837 -173.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.534 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 25.7 p -103.28 -0.47 30.24 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.748 -167.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.649 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.3 t80 -49.22 -55.9 11.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.754 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.2 mm -69.04 -26.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.534 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.08 -43.95 64.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.601 ' O ' HG23 ' A' ' 463' ' ' VAL . 72.3 m-70 -65.3 -31.09 72.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.707 171.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.762 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.45 -53.72 32.29 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.312 1.053 . . . . 0.0 109.181 -178.631 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.23 -30.18 71.37 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.19 -1.823 . . . . 0.0 110.188 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -66.68 -49.24 66.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.017 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.994 HG11 ' HA ' ' A' ' 435' ' ' VAL . 33.6 t -65.61 -35.93 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.579 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.9 m-30 -61.27 -13.98 22.95 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.654 168.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 1.7 tp10 -93.09 -52.52 4.53 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.847 0.832 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.696 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.7 pt -63.79 -41.08 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.239 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.767 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.8 mt -83.8 -16.73 43.54 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 65.89 47.73 72.37 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.446 173.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 467' ' ' LEU . 1.2 mt -101.36 173.11 6.59 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.834 0.854 . . . . 0.0 111.733 -177.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.425 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.4 p-10 -85.87 -44.9 12.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.411 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.63 -68.67 0.06 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.474 165.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.828 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 19.0 mmt180 -68.16 47.72 0.05 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -163.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 57.92 34.45 71.86 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.392 171.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 475' ' ' SER . 3.9 mm100 -84.69 -51.45 6.81 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.972 0.892 . . . . 0.0 111.228 -173.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.687 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 45.4 t 68.99 53.59 0.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 112.506 -2.133 . . . . 0.0 109.118 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.633 HD12 ' HG2' ' A' ' 477' ' ' ARG . 0.3 OUTLIER -39.79 -44.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 109.474 -3.512 . . . . 0.0 112.61 169.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.633 ' HG2' HD12 ' A' ' 476' ' ' ILE . 13.7 mmm-85 -46.47 138.47 5.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.559 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 67.7 mt -58.33 158.82 6.81 Favored 'General case' 0 N--CA 1.422 -1.858 0 C-N-CA 123.996 0.918 . . . . 0.0 112.914 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.435 -1.195 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.136 177.113 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.474 0.341 0 N-CA-C 111.756 -0.132 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 301' ' ' ILE . 3.5 mp 61.21 84.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.475 0.655 . . . . 0.0 109.88 -176.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 111.05 -173.9 16.39 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.038 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.477 ' HB ' HD11 ' A' ' 346' ' ' LEU . 54.0 m -81.35 116.17 21.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.608 0.718 . . . . 0.0 111.358 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 304' ' ' VAL . 1.5 p -64.57 122.9 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.702 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.731 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.1 mt -73.32 129.24 86.19 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 122.069 0.938 . . . . 0.0 113.048 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.566 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.0 Cg_endo -84.97 51.48 3.15 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.59 3.526 . . . . 0.0 109.093 165.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.665 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -46.63 -43.54 6.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 112.753 -2.021 . . . . 0.0 112.077 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.477 ' HG2' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -64.5 -35.6 81.47 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.055 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.556 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.45 -47.49 83.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.39 0.614 . . . . 0.0 109.695 172.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.646 HG13 HG11 ' A' ' 338' ' ' VAL . 68.0 mt -59.0 -49.85 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 123.878 0.871 . . . . 0.0 113.197 175.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 33.1 mtp180 -62.25 -28.8 69.96 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.882 0.473 . . . . 0.0 111.013 177.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 62.9 m -69.76 -34.65 74.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.326 0.584 . . . . 0.0 110.114 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.602 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.03 -41.73 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.723 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.754 HG22 ' HB3' ' A' ' 331' ' ' ASN . 31.1 p -83.42 -36.58 24.14 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.813 1.292 . . . . 0.0 110.087 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.84 34.86 8.68 Favored Glycine 0 C--N 1.304 -1.22 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.694 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 50.14 177.89 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.013 0 C-N-CA 124.296 1.038 . . . . 0.0 112.899 -174.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.695 ' HB3' HD11 ' A' ' 324' ' ' ILE . 46.2 Cg_exo -48.34 147.2 9.02 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.529 2.153 . . . . 0.0 112.786 -178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.428 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 51.1 Cg_endo -87.42 -99.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.341 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.41 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 10.3 mmm180 -100.45 -76.57 0.55 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.528 0.68 . . . . 0.0 110.555 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.6 m-20 -104.87 158.42 32.06 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.241 -174.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.454 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 36.6 Cg_exo -59.08 -50.13 9.52 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.824 2.349 . . . . 0.0 110.868 171.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.43 -23.64 2.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.224 -1.807 . . . . 0.0 112.547 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 2.3 mm-40 -87.42 -29.02 21.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.2 OUTLIER -45.05 -46.8 30.71 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.643 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.713 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.94 -62.04 0.47 Allowed 'Trans proline' 0 CA--C 1.516 -0.399 0 C-N-CA 122.856 2.371 . . . . 0.0 112.997 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.643 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.56 -36.65 76.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.141 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.738 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 34.7 t90 -57.77 -35.07 70.26 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.096 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.861 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.8 OUTLIER -69.97 -49.17 54.34 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.101 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.51 -23.42 19.84 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.661 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 1.0 OUTLIER -74.4 -42.5 59.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.132 0.968 . . . . 0.0 110.471 175.069 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.754 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.4 m-20 -96.13 -23.47 16.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.918 -169.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.607 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -44.06 -49.38 22.3 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 113.681 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 52.2 Cg_endo -61.39 -33.0 89.58 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.551 2.168 . . . . 0.0 111.542 177.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.3 -43.15 64.61 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 109.519 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.637 HG23 HG23 ' A' ' 310' ' ' ILE . 91.6 mt -58.45 -49.4 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.734 173.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -55.42 -18.84 7.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.327 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.75 -46.68 8.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.145 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.646 HG11 HG13 ' A' ' 310' ' ' ILE . 93.7 t -58.07 -72.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 123.4 1.572 . . . . 0.0 110.228 169.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.83 ' CD2' HD11 ' A' ' 350' ' ' ILE . 1.0 OUTLIER -91.14 131.7 36.18 Favored Pre-proline 0 N--CA 1.405 -2.717 0 CA-C-N 110.813 -2.903 . . . . 0.0 112.538 -170.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.606 ' HB2' HG23 ' A' ' 342' ' ' THR . 8.0 Cg_exo -75.01 -18.02 19.03 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.664 2.909 . . . . 0.0 110.652 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.5 p 33.09 72.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.648 -177.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.606 HG23 ' HB2' ' A' ' 340' ' ' PRO . 60.0 p -81.38 5.83 16.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 112.778 -2.01 . . . . 0.0 113.463 -169.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.843 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.8 p -142.12 161.45 50.78 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.459 ' HB3' HD23 ' A' ' 369' ' ' LEU . 51.2 Cg_exo -62.28 -48.25 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.262 2.641 . . . . 0.0 108.218 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.645 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.9 OUTLIER -41.76 -51.92 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 112.719 -2.037 . . . . 0.0 110.828 176.695 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.843 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.8 mt -57.09 -52.28 65.9 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.165 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.687 ' HA ' HD12 ' A' ' 350' ' ' ILE . 4.7 ttm180 -53.09 -42.96 66.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.318 -1.765 . . . . 0.0 110.696 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 1.072 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.8 m -70.19 -46.43 64.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 76.0 mtt180 -56.19 -42.83 77.77 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.232 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.83 HD11 ' CD2' ' A' ' 339' ' ' PHE . 48.5 mt -58.17 -53.5 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 O-C-N 123.304 0.377 . . . . 0.0 111.426 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.548 HD13 ' HB1' ' A' ' 374' ' ' ALA . 17.0 mt -57.66 -53.22 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 122.107 0.956 . . . . 0.0 110.841 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.511 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.1 m-20 -63.83 -35.14 79.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.956 -1.474 . . . . 0.0 109.982 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.29 -37.26 77.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.051 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.665 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.251 0.8 OUTLIER -57.26 -53.29 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.481 0 CA-C-O 123.069 1.414 . . . . 0.0 110.119 174.485 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.665 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -72.86 -25.29 61.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 111.559 -2.564 . . . . 0.0 109.338 -169.083 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.6 -79.01 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.586 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -119.62 57.4 0.56 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.6 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.563 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.2 OUTLIER -76.13 161.74 28.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.254 0.222 . . . . 0.0 110.937 178.033 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -55.8 -66.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 122.947 0.499 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.41 15.16 1.1 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.514 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.701 ' HB3' HD22 ' A' ' 378' ' ' LEU . 5.9 mt -66.33 -2.99 5.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.698 0.399 . . . . 0.0 111.477 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.511 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 28.6 t -62.28 80.58 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 110.503 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.901 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.4 mm? -62.12 178.16 0.4 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.731 174.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 44.5 p -116.77 157.39 46.31 Favored Pre-proline 0 CA--C 1.508 -0.669 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 1.072 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 19.5 Cg_endo -66.21 16.69 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.269 1.979 . . . . 0.0 113.528 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.486 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -135.43 6.22 4.23 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.26 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.66 ' HB2' HD12 ' A' ' 363' ' ' LEU . 72.7 m-20 -109.76 -24.81 10.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.402 1.096 . . . . 0.0 109.954 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.901 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 6.5 m -93.97 19.77 8.63 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.076 -168.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -57.05 -39.79 75.57 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.433 -171.077 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.13 157.58 25.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.851 169.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.699 ' O ' HG13 ' A' ' 375' ' ' VAL . 86.3 m95 -70.14 -34.11 72.65 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 4.8 t0 -54.56 -48.83 71.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.695 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 28.0 t -69.15 -43.13 74.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.825 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.722 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.25 -51.57 67.21 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.861 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.3 m -57.32 -44.5 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.603 0.716 . . . . 0.0 109.621 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 0.98 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.09 -45.86 91.65 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.005 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.779 HG21 HD11 ' A' ' 363' ' ' LEU . 48.8 m -68.55 -38.2 80.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.464 -171.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.21 -34.16 74.64 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.155 0.503 . . . . 0.0 110.411 176.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.713 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 67.5 t80 -73.13 -45.89 54.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.369 1.08 . . . . 0.0 109.4 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.659 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -52.3 -33.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.092 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.61 -39.21 87.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.653 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 50.2 p -98.83 -22.24 15.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.439 -167.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -108.97 22.83 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.642 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.37 19.15 39.1 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.847 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 65.09 159.77 0.11 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 111.694 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -126.27 151.88 72.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.289 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -98.96 55.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.535 2.824 . . . . 0.0 110.969 165.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.702 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.21 4.03 0.42 Allowed 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -173.513 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -71.13 -47.1 59.89 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.638 ' O ' HG13 ' A' ' 394' ' ' VAL . 99.5 mt-30 -74.74 -26.2 59.63 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.733 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.75 -31.3 47.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.004 0.82 . . . . 0.0 111.966 -173.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.775 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.57 -53.2 40.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.438 173.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.691 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 41.4 m-20 -64.99 -39.79 93.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.17 -46.21 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.42 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.624 ' O ' HG22 ' A' ' 399' ' ' VAL . 25.6 mm -58.94 -46.6 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.042 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.691 ' HG3' ' HA ' ' A' ' 393' ' ' ASN . 15.3 mmtt -52.84 -42.02 64.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.879 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.41 15.86 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.092 -173.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.0 mt -69.21 -41.45 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 117.133 0.466 . . . . 0.0 111.439 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.88 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.8 m -58.07 -44.54 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.609 0.719 . . . . 0.0 110.273 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.4 t70 -62.18 -39.03 91.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -84.88 -53.22 5.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.064 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.523 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -110.59 -30.74 7.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.508 -169.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.2 165.87 12.11 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.673 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.88 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.69 -44.83 98.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.042 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.55 -53.16 58.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.606 0.717 . . . . 0.0 111.87 -177.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -64.45 -49.77 70.16 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.273 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.68 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.26 -42.69 63.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.682 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 47.1 t80 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.616 0.722 . . . . 0.0 109.524 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.792 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.9 m -59.44 -52.55 65.14 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.613 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.694 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.23 -48.67 80.4 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.645 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.61 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.85 -43.35 87.26 Favored Glycine 0 C--N 1.314 -0.655 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.546 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.673 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.0 OUTLIER -72.56 -31.31 65.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.846 0.323 . . . . 0.0 111.02 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.792 ' HG3' ' O ' ' A' ' 409' ' ' THR . 53.2 mtm -70.08 -47.56 61.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.98 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.5 mt -58.55 -40.99 84.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.261 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.733 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -76.71 -12.62 60.02 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.729 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 88.36 43.73 5.48 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.659 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.578 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 57.73 49.1 12.83 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.496 0.718 . . . . 0.0 112.471 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -129.17 77.98 1.82 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 161.344 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.675 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 8.3 p90 -62.27 -31.47 72.06 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.341 -163.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 423' ' ' SER . 51.1 mt-30 -53.63 -48.03 69.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.312 -164.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.709 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.1 pp -59.35 -50.62 73.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.955 0.407 . . . . 0.0 110.776 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.706 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.06 -38.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 123.021 1.391 . . . . 0.0 108.854 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 42.4 t -62.56 -48.14 80.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.726 -2.488 . . . . 0.0 111.846 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.3 75.5 Favored Glycine 0 C--N 1.316 -0.568 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.402 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.775 HD13 ' HA2' ' A' ' 392' ' ' GLY . 3.9 mt -72.1 -41.48 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.601 0.715 . . . . 0.0 110.025 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.6 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -57.57 -45.6 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.909 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.708 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.8 -29.15 68.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 122.646 1.212 . . . . 0.0 109.371 -173.074 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.8 -18.46 77.48 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.386 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.698 ' CG ' HG21 ' A' ' 399' ' ' VAL . 18.7 m-85 -100.0 3.17 44.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.02 145.89 70.82 Favored Pre-proline 0 N--CA 1.41 -2.452 0 CA-C-O 123.612 1.672 . . . . 0.0 113.308 168.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.77 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.7 Cg_endo -72.52 -62.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 1 C-N-CA 126.181 4.587 . . . . 0.0 113.378 -173.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.549 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -108.3 141.65 15.84 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.166 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.846 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.71 -29.88 71.0 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.903 0.351 . . . . 0.0 111.057 -177.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.77 -46.43 81.48 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 172.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.999 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.1 t -59.27 -51.59 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.63 176.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.846 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -54.26 -54.85 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.474 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 61.4 m -61.61 -55.94 25.28 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.944 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.03 -46.17 78.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.806 ' O ' HD22 ' A' ' 443' ' ' LEU . 37.1 mt -59.37 -53.15 61.49 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.656 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.743 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 38.0 mm-40 -51.64 -35.09 40.71 Favored 'General case' 0 N--CA 1.419 -2.024 0 O-C-N 124.997 1.436 . . . . 0.0 110.447 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.634 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.74 -60.27 2.31 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 176.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -75.97 -50.86 13.72 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.743 -0.598 . . . . 0.0 112.002 -173.067 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.88 -24.08 61.76 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.719 0.771 . . . . 0.0 111.807 -179.001 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.746 ' N ' HD23 ' A' ' 443' ' ' LEU . 11.1 t70 -72.18 -42.82 65.41 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.609 176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.02 -7.99 45.55 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.53 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 54.0 mm-40 -51.75 154.77 1.9 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 123.264 1.507 . . . . 0.0 114.43 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.509 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.36 -32.89 20.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 111.17 -2.741 . . . . 0.0 115.613 -172.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.665 ' H ' ' HB ' ' A' ' 451' ' ' THR . 48.1 m-20 -138.04 178.98 6.72 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.418 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.1 p-10 -64.88 -53.57 44.58 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.1 OUTLIER -67.31 -23.58 65.66 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -59.04 -40.17 84.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 119.891 1.223 . . . . 0.0 109.453 171.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.614 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 72.6 mtp180 -61.23 -29.1 69.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.682 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.32 -34.01 59.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.204 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 455' ' ' THR . 1.3 mm-40 -78.62 -44.92 22.79 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.903 -171.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.556 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 29.9 p -105.33 -1.23 25.42 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.298 -165.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.675 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.5 t80 -48.73 -51.49 28.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.716 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.3 mm -71.94 -26.59 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.556 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.51 -43.03 67.24 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 463' ' ' VAL . 53.7 m-70 -67.15 -30.34 70.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.178 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.784 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -66.66 -53.4 34.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.278 1.037 . . . . 0.0 109.126 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.658 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.6 m-80 -63.49 -31.29 72.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.682 173.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.65 -53.53 53.17 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.192 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.999 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.1 t -62.36 -34.39 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.44 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.88 -15.39 42.2 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.125 169.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 10.9 mm-40 -89.95 -50.69 5.88 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.064 -1.023 . . . . 0.0 112.42 176.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.724 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -65.18 -39.82 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.904 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 469' ' ' LEU . 7.0 mt -84.13 -17.1 41.21 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 66.05 49.56 57.44 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 112.106 -2.315 . . . . 0.0 113.591 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -101.65 175.01 5.7 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.809 0.844 . . . . 0.0 111.064 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.583 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.1 p-10 -92.58 -43.25 9.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 165.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -161.56 -73.89 0.06 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.475 162.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.77 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 2.0 mpt_? -63.63 67.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.64 40.24 2.04 Favored Glycine 0 C--N 1.277 -2.709 0 CA-C-N 111.369 -2.65 . . . . 0.0 113.33 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.583 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 27.4 mm-40 -80.3 -56.3 4.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.152 0.977 . . . . 0.0 111.449 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 38.2 t 67.87 44.36 1.57 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.281 -2.236 . . . . 0.0 108.219 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.663 HD12 ' HG2' ' A' ' 477' ' ' ARG . 0.4 OUTLIER -37.51 -44.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 109.149 -3.66 . . . . 0.0 112.684 170.325 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.663 ' HG2' HD12 ' A' ' 476' ' ' ILE . 15.7 mmm180 -48.63 128.92 15.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.155 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.5 mt -71.55 -36.75 71.05 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.021 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 . . . . . 0 N--CA 1.432 -1.374 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.446 179.147 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.475 0.396 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.8 mp 60.13 78.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.998 0.904 . . . . 0.0 109.795 -175.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 83.51 -177.17 52.66 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.26 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 81.7 m -73.77 128.73 36.31 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.494 0.664 . . . . 0.0 111.254 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.6 p -64.46 122.28 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.413 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 307' ' ' ILE . 22.8 mt -74.45 127.01 88.26 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-O 121.844 0.831 . . . . 0.0 112.137 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' A' ' 308' ' ' GLN . 28.2 Cg_endo -74.8 -11.44 21.88 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 124.682 3.588 . . . . 0.0 111.466 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.754 ' H ' HG22 ' A' ' 305' ' ' ILE . 6.1 tp 26.79 -64.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.298 0 C-N-CA 128.37 2.668 . . . . 0.0 115.877 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.657 ' H ' HG23 ' A' ' 307' ' ' ILE . 0.1 OUTLIER -57.66 -30.88 65.78 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.141 0.496 . . . . 0.0 111.246 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.543 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.73 -49.17 77.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.588 169.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.715 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.9 mt -58.55 -48.11 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.036 0.934 . . . . 0.0 112.705 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.682 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.7 mtp180 -59.9 -30.66 69.18 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 122.559 0.344 . . . . 0.0 111.108 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.2 m -70.03 -33.96 72.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.56 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.24 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.903 178.721 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.75 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.5 p -83.52 -37.19 23.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.83 1.3 . . . . 0.0 110.152 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.5 34.66 8.4 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.252 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.6 mt-10 51.68 172.25 0.03 OUTLIER Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -175.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.584 ' HB3' HD11 ' A' ' 324' ' ' ILE . 22.2 Cg_exo -45.27 143.56 5.15 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.374 2.716 . . . . 0.0 113.189 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.52 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.6 Cg_endo -91.41 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.614 2.876 . . . . 0.0 112.903 -172.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.465 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 7.9 mmm180 -89.29 -81.34 0.28 Allowed 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 123.449 0.699 . . . . 0.0 110.894 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.465 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 16.3 m-20 -112.71 164.94 14.14 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.846 -177.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.414 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 38.6 Cg_exo -58.65 -50.4 9.43 Favored 'Trans proline' 0 CA--C 1.509 -0.735 0 C-N-CA 122.549 2.166 . . . . 0.0 110.483 171.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.403 ' HG2' ' H ' ' A' ' 322' ' ' ARG . 5.1 mmt180 -48.74 -20.63 0.5 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.003 -1.908 . . . . 0.0 112.928 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.1 mt-10 -98.44 -23.46 15.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.7 0.286 . . . . 0.0 111.405 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.655 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.88 -44.34 45.79 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.717 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 6.4 Cg_endo -47.96 -62.76 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.008 2.472 . . . . 0.0 113.086 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.659 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.89 -36.32 75.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.031 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.168 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.75 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 47.5 t90 -57.63 -36.01 71.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.329 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.872 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.93 -48.15 59.62 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.585 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.55 -23.62 20.92 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.786 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.433 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 2.8 mmm180 -73.95 -42.17 60.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.22 1.01 . . . . 0.0 110.551 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.722 ' HB3' HG22 ' A' ' 314' ' ' THR . 47.1 m-20 -95.98 -24.82 16.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.599 -1.637 . . . . 0.0 113.854 -169.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.608 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.94 -50.29 13.6 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 124.296 1.038 . . . . 0.0 113.582 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 51.0 Cg_endo -61.09 -33.16 91.86 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.652 2.235 . . . . 0.0 111.729 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.57 -43.93 62.75 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.622 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.611 HG12 HG23 ' A' ' 310' ' ' ILE . 88.6 mt -57.99 -48.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.74 -17.87 6.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.233 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.92 -44.49 9.06 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.684 HG11 HG13 ' A' ' 310' ' ' ILE . 98.6 t -61.29 -69.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 123.399 1.571 . . . . 0.0 110.222 169.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.854 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -94.47 129.9 35.31 Favored Pre-proline 0 N--CA 1.403 -2.789 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.663 -171.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.774 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 68.0 Cg_endo -72.7 -18.86 24.84 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 123.887 3.058 . . . . 0.0 110.994 173.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.45 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.5 p 33.9 68.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.426 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.4 p -78.37 1.64 21.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.616 -170.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.795 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.4 p -137.59 164.09 43.85 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 343' ' ' THR . 50.3 Cg_exo -62.45 -50.58 4.3 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.145 2.564 . . . . 0.0 108.043 172.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.708 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 4.6 t0 -42.81 -47.34 5.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.013 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.795 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 8.9 mt -56.99 -53.04 62.56 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.797 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.74 ' HA ' HD12 ' A' ' 350' ' ' ILE . 41.3 ttm105 -54.98 -45.81 75.02 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.603 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.991 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.78 -47.8 65.28 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.793 0.33 . . . . 0.0 111.216 -175.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 70.8 mtt180 -56.0 -42.41 76.36 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.079 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.854 HD11 ' CD2' ' A' ' 339' ' ' PHE . 52.6 mt -57.73 -53.48 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.399 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.565 HG12 HD11 ' A' ' 328' ' ' LEU . 23.0 mt -58.47 -52.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 122.203 1.001 . . . . 0.0 110.715 -170.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.549 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 23.3 m-20 -63.0 -36.11 82.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.152 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.63 -34.72 74.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.081 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.679 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.72 -53.92 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 122.925 1.345 . . . . 0.0 110.256 173.249 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.679 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -71.95 -27.46 62.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.618 -2.537 . . . . 0.0 109.585 -167.367 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 63.25 -70.79 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.943 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.72 97.29 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.322 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.59 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -124.59 164.41 19.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 122.736 0.414 . . . . 0.0 110.447 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.522 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -51.42 -59.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.082 0.467 . . . . 0.0 111.804 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -162.63 20.39 0.17 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.54 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.694 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.9 mt -66.05 -5.28 9.21 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 122.835 0.454 . . . . 0.0 111.615 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.549 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 23.3 t -61.42 83.1 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.205 0.526 . . . . 0.0 110.62 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.751 HD11 HG21 ' A' ' 377' ' ' THR . 0.9 OUTLIER -62.48 173.36 1.25 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.659 175.061 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 366' ' ' GLY . 71.9 p -113.73 162.43 22.67 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.622 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.991 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 10.5 Cg_endo -68.63 25.92 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.121 1.881 . . . . 0.0 112.386 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -138.01 -6.28 1.5 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.759 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.686 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.1 m-20 -105.65 -20.87 13.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.83 1.3 . . . . 0.0 109.129 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.826 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 2.7 p -79.03 20.69 0.47 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.846 -172.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -61.49 -30.58 70.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.707 1.241 . . . . 0.0 108.495 -172.513 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 24.9 p -125.73 163.9 21.83 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 112.393 -2.185 . . . . 0.0 109.933 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.619 ' O ' HG13 ' A' ' 375' ' ' VAL . 66.7 m95 -70.92 -33.91 70.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 167.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.51 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -61.24 -44.89 96.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.746 -172.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 29.1 t -69.15 -42.9 75.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.733 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.19 -52.15 66.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.872 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.1 m -58.56 -43.86 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.585 0.707 . . . . 0.0 109.422 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.01 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.2 -46.19 90.0 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.095 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.751 HG21 HD11 ' A' ' 363' ' ' LEU . 37.3 m -66.41 -39.32 88.93 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.324 -173.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -59.69 -35.13 73.87 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.467 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.717 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 66.4 t80 -73.41 -45.96 51.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.491 1.139 . . . . 0.0 109.473 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -53.06 -32.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 112.625 -2.08 . . . . 0.0 111.314 171.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.3 OUTLIER -59.55 -38.69 81.75 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.442 0.697 . . . . 0.0 111.831 177.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 4.4 p -104.64 -20.91 13.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.62 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -108.34 24.46 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.87 21.12 29.0 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 114.587 0.595 . . . . 0.0 114.587 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 62.01 165.92 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.092 0.472 . . . . 0.0 110.976 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -130.52 154.21 81.59 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -94.56 47.75 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.386 2.724 . . . . 0.0 110.712 165.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.693 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.27 4.55 0.68 Allowed 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -173.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.08 -43.6 70.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.941 0.4 . . . . 0.0 110.569 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.636 ' O ' HG13 ' A' ' 394' ' ' VAL . 98.1 mt-30 -75.85 -25.4 56.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -170.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.889 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.11 -31.38 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.043 0.838 . . . . 0.0 112.024 -172.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.565 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.86 -50.3 58.85 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.674 174.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.523 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.5 m-20 -69.84 -36.59 75.7 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.987 0.515 . . . . 0.0 111.814 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.1 m -58.85 -48.51 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 399' ' ' VAL . 8.5 mm -58.37 -48.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.882 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 392' ' ' GLY . 0.2 OUTLIER -52.31 -46.32 65.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.312 -177.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -73.29 -44.13 35.85 Favored Glycine 0 C--N 1.31 -0.895 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.382 -176.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.0 mt -69.15 -41.22 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 117.76 0.78 . . . . 0.0 111.582 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.5 m -57.93 -44.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.844 0.83 . . . . 0.0 109.552 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.431 ' N ' HG23 ' A' ' 399' ' ' VAL . 16.6 t70 -55.21 -46.05 75.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.328 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 29.2 mm-40 -85.3 -52.52 5.84 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.601 -170.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.575 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.7 OUTLIER -110.6 -30.39 7.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.52 0.676 . . . . 0.0 111.799 -170.254 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 124.84 166.16 12.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.705 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.875 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -62.95 -46.1 97.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.013 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -53.96 -52.54 60.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.617 0.722 . . . . 0.0 111.999 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.79 -49.91 68.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.308 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.672 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.23 -43.37 64.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.66 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.8 t80 -56.44 -46.72 80.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.524 0.678 . . . . 0.0 109.559 176.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.776 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.8 m -58.69 -52.26 66.47 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.65 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.684 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.7 -48.01 82.7 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.602 176.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.58 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.19 -43.24 89.03 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.664 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -72.2 -31.57 66.0 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.88 0.34 . . . . 0.0 110.69 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.858 ' HE3' HG21 ' A' ' 375' ' ' VAL . 62.5 mtm -70.18 -47.5 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 109.93 173.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.01 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.9 mt -59.18 -40.67 86.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.119 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.889 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.7 m -77.82 -12.76 60.01 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.964 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.61 44.13 4.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.206 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.599 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 58.46 39.99 24.52 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.762 0.825 . . . . 0.0 112.99 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 415' ' ' SER . 0.5 OUTLIER -123.46 79.55 1.7 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 165.402 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.664 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 7.8 p90 -62.55 -31.12 71.85 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.8 -161.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.529 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.0 mt-30 -54.14 -47.76 71.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -164.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.716 HD11 ' OG ' ' A' ' 415' ' ' SER . 1.2 pp -59.21 -49.0 79.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.479 0.656 . . . . 0.0 110.974 177.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.732 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.7 -39.06 80.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.756 1.265 . . . . 0.0 109.208 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 30.0 t -60.8 -47.4 86.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.037 -2.347 . . . . 0.0 111.252 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.11 -38.19 75.4 Favored Glycine 0 C--N 1.315 -0.596 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.7 mt -72.18 -43.99 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.583 0.706 . . . . 0.0 109.985 174.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.615 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -55.8 -44.28 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.73 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.717 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -61.67 -30.26 70.61 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-O 122.586 1.184 . . . . 0.0 108.907 -173.208 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.39 -18.08 78.07 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.966 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.665 ' CG ' HG21 ' A' ' 399' ' ' VAL . 15.0 m-85 -100.65 3.77 42.73 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -177.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.77 145.4 70.82 Favored Pre-proline 0 N--CA 1.418 -2.069 0 CA-C-O 123.546 1.641 . . . . 0.0 113.721 167.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.755 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 59.2 Cg_endo -72.19 -61.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 1 C-N-CA 126.245 4.63 . . . . 0.0 113.127 -173.038 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.53 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.59 141.11 15.61 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.202 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.868 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.1 OUTLIER -62.46 -30.69 71.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.107 0.454 . . . . 0.0 111.143 -177.44 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.77 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.25 -46.67 79.52 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 171.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.061 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.7 t -59.66 -51.38 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.397 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.868 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.81 -54.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 51.8 m -62.73 -56.11 20.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.226 -175.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.24 -45.93 79.81 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.64 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 39.0 mt -59.43 -53.73 54.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.806 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.711 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.2 mm-40 -52.23 -34.16 44.61 Favored 'General case' 0 N--CA 1.417 -2.108 0 O-C-N 125.09 1.494 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.656 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.18 -60.69 2.12 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.25 14.51 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.733 -0.605 . . . . 0.0 112.392 -172.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.08 62.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.596 0.712 . . . . 0.0 111.606 -179.102 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.767 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.7 t70 -72.19 -41.11 67.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.484 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.656 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -70.29 -8.08 47.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 14.0 mm-40 -56.6 161.27 2.81 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 123.221 1.486 . . . . 0.0 114.371 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.693 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.84 -34.28 25.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 111.216 -2.72 . . . . 0.0 115.78 -169.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.635 ' H ' ' HB ' ' A' ' 451' ' ' THR . 24.6 m-20 -142.32 -178.18 5.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.464 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 10.7 p-10 -63.83 -55.26 24.25 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.528 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.28 -27.12 68.82 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.084 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.693 HG21 ' HB ' ' A' ' 447' ' ' ILE . 8.8 m -58.6 -44.67 89.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.381 0.991 . . . . 0.0 109.864 172.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.0 mtt180 -61.0 -29.89 69.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.189 172.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.66 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.57 -31.47 63.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.91 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.1 mm-40 -78.11 -46.24 21.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.728 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.531 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 27.5 p -103.69 -0.9 28.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.481 -166.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -49.28 -55.34 13.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.828 177.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.8 mm -69.62 -26.7 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.531 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.27 -43.96 66.18 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.616 ' O ' HG23 ' A' ' 463' ' ' VAL . 71.0 m-70 -65.53 -30.62 71.39 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.857 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.737 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.91 -53.25 33.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.206 1.003 . . . . 0.0 109.303 -178.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.661 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -63.6 -31.5 72.68 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.719 173.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -62.98 -53.15 58.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.41 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.061 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.5 t -62.41 -33.88 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 121.836 0.827 . . . . 0.0 110.249 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.647 ' HD1' HD12 ' A' ' 469' ' ' LEU . 21.9 m-30 -61.96 -15.15 41.35 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.157 169.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 48.0 mt-10 -91.77 -49.36 6.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.909 -1.119 . . . . 0.0 112.822 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.7 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -64.65 -40.43 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.902 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.77 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.3 mt -83.47 -16.58 45.12 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 172.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.61 51.14 54.6 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 111.68 -2.509 . . . . 0.0 113.028 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.732 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -100.48 -156.93 0.58 Allowed 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 122.16 0.981 . . . . 0.0 109.381 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.583 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 1.2 p-10 -130.01 -41.04 1.3 Allowed 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 171.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.535 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -155.76 -82.19 0.07 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.426 -2.17 . . . . 0.0 110.813 155.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.755 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -57.34 69.62 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -172.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.482 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 36.47 42.79 0.68 Allowed Glycine 0 C--N 1.276 -2.755 0 CA-C-N 111.163 -2.744 . . . . 0.0 113.323 172.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.583 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 2.7 mm100 -77.4 -59.51 2.75 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 122.147 0.975 . . . . 0.0 111.421 -172.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 36.7 t 67.15 50.87 0.97 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.185 -2.279 . . . . 0.0 107.976 -173.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.5 OUTLIER -38.37 -41.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 109.196 -3.638 . . . . 0.0 112.507 170.323 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.526 ' HG3' ' HA3' ' A' ' 468' ' ' GLY . 8.9 mmt180 -45.45 146.45 1.01 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.279 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.33 -15.51 36.57 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 . . . . . 0 C--O 1.251 1.165 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.322 179.231 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 110.076 -0.779 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.3 mp -64.89 -47.48 88.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -70.18 158.79 53.51 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.304 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.458 ' HB ' HD11 ' A' ' 346' ' ' LEU . 29.0 m -70.36 119.19 14.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.461 0.648 . . . . 0.0 111.282 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.1 p -67.71 125.09 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.203 173.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.737 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 36.2 mt -74.24 127.67 87.41 Favored Pre-proline 0 N--CA 1.425 -1.681 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.576 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.2 Cg_endo -84.96 50.21 2.8 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 125.011 3.807 . . . . 0.0 109.238 165.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.749 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.6 tp -45.41 -42.42 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.287 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' GLN . . . . . 0.616 ' HA ' ' HD3' ' A' ' 311' ' ' ARG . 26.4 mm-40 -60.86 -44.24 97.28 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.998 0.904 . . . . 0.0 111.653 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' HIS . . . . . 0.475 ' CG ' HG13 ' A' ' 338' ' ' VAL . 1.4 t-80 -58.97 -45.77 89.72 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.357 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 335' ' ' ILE . 67.4 mt -59.22 -49.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.749 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 36.4 mtp180 -60.45 -31.28 70.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.523 -0.735 . . . . 0.0 110.987 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.6 m -69.76 -32.27 70.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.587 0.708 . . . . 0.0 109.881 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.544 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.56 -41.33 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.018 177.52 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.751 HG22 ' HB3' ' A' ' 331' ' ' ASN . 31.6 p -82.68 -36.7 25.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.728 1.251 . . . . 0.0 110.063 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.14 10.74 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 112.4 -2.182 . . . . 0.0 110.159 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.9 mt-10 49.12 173.57 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.126 0 C-N-CA 124.806 1.243 . . . . 0.0 113.254 -173.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 324' ' ' ILE . 25.0 Cg_exo -45.1 154.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.038 2.492 . . . . 0.0 113.604 -176.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 317' ' ' PRO . 32.6 Cg_endo -93.08 -109.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 123.29 2.66 . . . . 0.0 111.563 -175.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.469 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 14.4 mmm180 -97.2 -80.26 0.44 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.396 0.617 . . . . 0.0 111.058 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.504 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 46.0 m-20 -94.06 156.52 39.01 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.38 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 44.3 Cg_exo -58.53 -49.53 11.75 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.726 2.284 . . . . 0.0 110.483 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.421 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.1 OUTLIER -51.61 -21.94 2.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.194 -1.821 . . . . 0.0 112.665 175.296 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.0 mt-10 -85.0 -30.06 24.51 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.325 -0.234 . . . . 0.0 111.377 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -47.72 -45.05 59.25 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.718 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.0 Cg_endo -50.43 -62.65 0.37 Allowed 'Trans proline' 0 CA--C 1.517 -0.354 0 C-N-CA 122.802 2.335 . . . . 0.0 113.091 177.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.635 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.4 -35.43 69.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 122.664 1.221 . . . . 0.0 110.091 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 327' ' ' TRP . . . . . 0.651 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 49.7 t90 -58.46 -37.19 74.95 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.156 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.848 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.14 -47.81 60.13 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.349 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.67 -23.64 21.92 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.741 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.495 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.9 OUTLIER -74.08 -43.27 58.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.407 1.098 . . . . 0.0 110.686 174.252 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.751 ' HB3' HG22 ' A' ' 314' ' ' THR . 52.6 m-20 -94.47 -25.03 17.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.407 -168.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ALA . . . . . 0.546 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.58 -50.3 9.5 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 124.453 1.101 . . . . 0.0 113.719 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.8 Cg_endo -62.78 -30.96 78.47 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.684 2.256 . . . . 0.0 111.801 177.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -73.52 -45.77 51.76 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.527 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 310' ' ' ILE . 88.2 mt -57.17 -48.65 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.878 173.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.45 -16.37 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.769 -1.56 . . . . 0.0 112.14 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.8 -46.28 7.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.412 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.623 HG11 HG13 ' A' ' 310' ' ' ILE . 96.3 t -58.19 -70.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 123.499 1.619 . . . . 0.0 110.187 169.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.855 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.8 OUTLIER -92.64 131.81 33.05 Favored Pre-proline 0 N--CA 1.405 -2.679 0 CA-C-N 110.926 -2.852 . . . . 0.0 112.463 -172.287 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.779 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -73.25 -18.92 23.02 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 123.635 2.89 . . . . 0.0 110.737 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.7 p 33.26 70.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.54 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.583 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.4 p -81.25 5.64 16.51 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.921 -1.945 . . . . 0.0 113.392 -169.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.781 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.9 p -143.14 158.02 59.31 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 121.517 0.675 . . . . 0.0 109.535 174.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 52.4 Cg_exo -62.08 -38.68 55.03 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 124.368 3.379 . . . . 0.0 109.435 172.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.655 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -52.36 -51.69 57.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 112.295 -2.229 . . . . 0.0 110.634 174.336 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.781 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.2 mt -58.4 -52.43 65.64 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.52 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.658 ' HA ' HD12 ' A' ' 350' ' ' ILE . 3.8 ttm180 -52.86 -41.48 64.34 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.116 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' CYS . . . . . 0.452 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 45.7 t -69.71 -49.25 55.15 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.913 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.6 mtt180 -58.13 -40.01 80.2 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.855 HD11 ' CD2' ' A' ' 339' ' ' PHE . 50.5 mt -58.68 -54.18 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.505 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.606 HD13 ' HB1' ' A' ' 374' ' ' ALA . 16.5 mt -57.56 -53.54 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 121.954 0.883 . . . . 0.0 111.055 -169.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.456 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 52.0 m-20 -64.14 -34.26 77.64 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.079 -177.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.65 76.45 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.205 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.65 -51.61 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 122.875 1.322 . . . . 0.0 110.425 174.647 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.582 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.3 OUTLIER -72.29 -25.76 61.71 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.81 -2.45 . . . . 0.0 109.298 -170.271 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 66.69 -77.04 0.14 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.169 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.9 92.65 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.191 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.601 ' HB2' ' HG ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -111.89 163.65 13.98 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 122.803 0.441 . . . . 0.0 110.751 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.86 -64.87 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 C-N-CA 122.81 0.444 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -150.55 13.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.687 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.1 mt -64.37 -2.8 2.42 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.651 0.38 . . . . 0.0 111.909 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.456 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.1 t -61.75 84.61 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.26 0.552 . . . . 0.0 110.181 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.9 HD11 HG21 ' A' ' 377' ' ' THR . 2.2 mm? -63.52 -174.96 0.1 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.672 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 48.6 p -125.61 157.7 67.45 Favored Pre-proline 0 CA--C 1.506 -0.738 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 32.3 Cg_exo -46.75 -39.34 23.7 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.912 1.741 . . . . 0.0 110.942 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.505 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -83.46 2.67 86.86 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.38 -172.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.69 ' CB ' HD12 ' A' ' 363' ' ' LEU . 44.1 m-20 -108.81 -21.76 12.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.089 0.947 . . . . 0.0 109.778 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 57.8 m -95.38 20.3 9.58 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.383 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.505 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -61.34 -36.25 79.66 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.964 1.364 . . . . 0.0 108.375 -173.157 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 15.2 p -115.51 163.03 16.34 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 112.189 -2.278 . . . . 0.0 109.491 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 375' ' ' VAL . 35.5 m95 -70.71 -33.51 70.94 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.575 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -64.33 -46.4 83.7 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.806 -170.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.0 t -68.22 -42.61 79.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.358 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.705 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.54 -52.54 64.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.918 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.8 m -58.44 -44.4 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.627 0.727 . . . . 0.0 109.489 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 1.023 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.24 -46.0 92.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.883 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.9 HG21 HD11 ' A' ' 363' ' ' LEU . 33.0 m -67.82 -38.72 83.62 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.517 -172.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 1.8 mt -59.47 -34.62 72.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.346 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.718 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 59.2 t80 -73.53 -46.79 45.54 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.34 1.067 . . . . 0.0 109.263 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -51.92 -32.45 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.279 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.4 mpt_? -59.7 -40.14 86.96 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.537 0.684 . . . . 0.0 111.369 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.9 p -96.79 -22.51 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.75 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -110.0 23.33 14.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.58 21.05 19.94 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.6 m 64.92 159.59 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.237 0.541 . . . . 0.0 111.285 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.543 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -123.83 155.45 66.8 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.682 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 389' ' ' HIS . 85.0 Cg_endo -101.2 56.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.027 3.152 . . . . 0.0 111.395 168.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.73 ' HA ' HD23 ' A' ' 391' ' ' LEU . 5.3 mmt 62.44 -19.56 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -173.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.461 ' H ' ' C ' ' A' ' 387' ' ' PRO . 5.9 t60 -56.21 -44.25 79.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.065 0.459 . . . . 0.0 111.31 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.707 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.9 mt-30 -75.04 -28.66 60.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.8 mm? -54.8 -31.53 59.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.313 0.961 . . . . 0.0 111.037 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.689 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.02 -51.58 52.78 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.617 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.595 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 50.4 m-20 -68.1 -39.86 82.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.96 0.504 . . . . 0.0 112.168 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 390' ' ' GLN . 1.9 m -56.82 -45.16 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 399' ' ' VAL . 12.9 mm -58.91 -47.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.832 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.691 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 30.6 mmtt -52.48 -43.13 64.81 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 123.987 0.804 . . . . 0.0 111.325 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.16 -44.63 13.15 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.236 -172.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.8 mt -69.05 -40.61 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 117.603 0.702 . . . . 0.0 111.34 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.5 m -58.35 -44.27 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.802 0.81 . . . . 0.0 109.904 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 399' ' ' VAL . 14.6 t70 -59.17 -43.49 92.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.261 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 30.8 mm-40 -83.52 -52.21 6.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.073 -171.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.561 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -111.13 -30.98 7.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.758 -170.16 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.81 165.84 12.04 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.678 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.902 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.47 -44.68 98.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.257 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.88 -52.45 62.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.464 0.649 . . . . 0.0 111.946 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.504 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.45 -49.57 68.65 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.17 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.668 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.61 -41.63 63.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.623 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 46.2 t80 -58.18 -46.65 85.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.471 0.653 . . . . 0.0 109.489 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.773 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.0 m -58.52 -52.58 65.06 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.674 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.677 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.57 -48.77 78.02 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.568 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.63 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.82 -43.39 87.1 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.903 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.737 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.23 -32.29 66.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.798 0.299 . . . . 0.0 111.184 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.918 ' HE3' HG21 ' A' ' 375' ' ' VAL . 68.5 mtm -69.84 -47.17 63.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.396 0.617 . . . . 0.0 109.855 174.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 1.023 HD23 ' HA ' ' A' ' 376' ' ' ALA . 18.0 mt -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.937 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.623 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.6 OUTLIER -74.81 -16.89 60.69 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.864 -173.532 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 101.27 29.05 6.52 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.1 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.737 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 2.7 mm100 59.23 43.61 16.77 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.074 0.95 . . . . 0.0 112.279 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.51 ' OD1' HD21 ' A' ' 421' ' ' LEU . 0.5 OUTLIER -119.09 66.78 0.78 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 167.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.666 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.7 OUTLIER -46.1 -35.03 4.6 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 111.554 -2.566 . . . . 0.0 113.435 -164.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.1 mt-30 -54.54 -46.47 73.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.597 HD21 ' HG ' ' A' ' 415' ' ' SER . 1.6 pp -60.3 -50.1 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.905 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.805 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.02 -39.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.632 1.206 . . . . 0.0 109.19 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.512 ' HB2' ' HD2' ' A' ' 419' ' ' TYR . 17.2 t -60.15 -46.36 89.95 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.643 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.63 -38.63 82.73 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.746 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.4 mt -71.79 -41.98 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.507 0.67 . . . . 0.0 109.932 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.59 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -57.86 -45.71 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.407 -1.269 . . . . 0.0 112.726 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.751 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.52 -29.92 68.23 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.608 1.194 . . . . 0.0 109.325 -174.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.48 -15.18 77.34 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.625 175.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.704 ' CG ' HG21 ' A' ' 399' ' ' VAL . 13.9 m-85 -102.49 2.62 36.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.68 145.07 78.81 Favored Pre-proline 0 N--CA 1.409 -2.479 0 CA-C-O 123.717 1.722 . . . . 0.0 113.516 168.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.769 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 71.9 Cg_endo -72.12 -55.68 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.426 1 C-N-CA 126.289 4.659 . . . . 0.0 113.618 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.513 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.69 140.59 16.31 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.4 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.875 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.23 -27.31 68.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.155 0.478 . . . . 0.0 111.29 -177.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.13 -48.22 79.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 170.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 1.014 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.3 t -57.71 -51.7 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.788 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.875 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -55.02 -53.05 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 91.8 m -61.52 -56.49 19.48 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.11 -45.34 79.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.519 -177.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.811 ' O ' HD22 ' A' ' 443' ' ' LEU . 41.9 mt -59.57 -53.13 61.59 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.71 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.77 -35.52 44.0 Favored 'General case' 0 N--CA 1.421 -1.905 0 O-C-N 124.844 1.34 . . . . 0.0 110.429 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.662 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.69 -59.83 2.53 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 177.104 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.76 13.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.416 0.553 . . . . 0.0 112.151 -173.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.811 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.75 -24.32 61.42 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.629 0.728 . . . . 0.0 111.776 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.738 ' N ' HD23 ' A' ' 443' ' ' LEU . 15.9 t70 -71.72 -42.73 66.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.564 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 37.9 mt-30 -69.34 -9.36 52.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -171.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 58.7 mm-40 -52.03 153.65 2.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.377 1.56 . . . . 0.0 114.322 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.503 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.1 -32.81 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.985 -2.825 . . . . 0.0 115.483 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.652 ' H ' ' HB ' ' A' ' 451' ' ' THR . 40.2 m-20 -139.13 178.74 6.95 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 452' ' ' ARG . 7.9 p-10 -64.42 -51.59 62.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.1 OUTLIER -66.79 -25.55 66.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 174.533 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.652 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 13.6 m -59.43 -42.08 91.04 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 119.798 1.181 . . . . 0.0 109.631 171.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.555 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 54.7 mtt180 -59.89 -30.98 69.38 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.338 171.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.623 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.46 -29.63 59.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.042 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.429 ' HB2' HG23 ' A' ' 455' ' ' THR . 2.7 mm-40 -82.82 -47.18 12.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.094 -172.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.605 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -101.95 -1.53 31.73 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.338 -165.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.666 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.72 -51.72 27.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.1 mm -71.85 -27.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' GLN . . . . . 0.605 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -70.77 -42.55 70.25 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.636 ' O ' HG23 ' A' ' 463' ' ' VAL . 51.5 m-70 -66.92 -30.72 70.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.169 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.722 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -67.06 -53.27 32.69 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.192 0.996 . . . . 0.0 109.052 -179.2 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.636 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.98 -32.19 73.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.665 173.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -61.82 -54.41 42.63 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.105 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 1.014 HG11 ' HA ' ' A' ' 435' ' ' VAL . 22.1 t -62.21 -34.42 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 CA-C-O 121.684 0.754 . . . . 0.0 110.589 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.544 ' HD1' HD12 ' A' ' 469' ' ' LEU . 20.4 m-30 -61.8 -15.08 38.69 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.219 170.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 46.3 mm-40 -91.89 -49.56 6.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.954 . . . . 0.0 112.732 176.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.717 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -65.14 -40.06 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -84.11 -16.64 42.9 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.73 50.56 58.02 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.28 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.732 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -100.26 -178.64 3.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.71 0.804 . . . . 0.0 110.364 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.629 ' OD1' ' HG3' ' A' ' 474' ' ' GLN . 0.8 OUTLIER -101.11 -43.39 6.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.528 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.39 -76.69 0.07 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.273 158.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.769 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -60.23 71.22 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -172.702 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 36.69 45.84 1.06 Allowed Glycine 0 C--N 1.276 -2.772 0 CA-C-N 110.589 -3.005 . . . . 0.0 113.577 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.629 ' HG3' ' OD1' ' A' ' 470' ' ' ASN . 27.5 mm-40 -82.54 -57.83 3.18 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.012 0.911 . . . . 0.0 111.466 -173.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 39.0 t 66.94 42.78 2.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.493 -2.139 . . . . 0.0 108.155 -173.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.654 HD12 ' HG2' ' A' ' 477' ' ' ARG . 0.4 OUTLIER -36.53 -44.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 109.246 -3.616 . . . . 0.0 112.623 170.493 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.654 ' HG2' HD12 ' A' ' 476' ' ' ILE . 11.4 mmm-85 -44.56 131.56 6.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.974 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.75 -26.82 67.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.931 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.457 -179.412 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.43 -1.462 0 CA-C-O 120.96 0.41 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.753 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 27.8 mt -77.96 122.27 85.24 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-O 121.989 0.9 . . . . 0.0 111.851 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 308' ' ' GLN . 25.4 Cg_endo -72.62 -14.02 27.32 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 124.887 3.725 . . . . 0.0 111.417 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.719 HG23 ' HG2' ' A' ' 308' ' ' GLN . 3.5 tp 34.71 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 C-N-CA 128.296 2.638 . . . . 0.0 116.088 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.719 ' HG2' HG23 ' A' ' 307' ' ' ILE . 61.6 mm-40 -58.71 -34.4 71.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.643 0.777 . . . . 0.0 110.41 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.582 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.6 t-160 -60.93 -47.41 86.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.583 173.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 307' ' ' ILE . 67.7 mt -61.76 -48.41 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 124.157 0.983 . . . . 0.0 112.68 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.694 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 9.5 mtp-105 -58.5 -31.56 67.99 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.655 0.382 . . . . 0.0 111.258 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 38.5 t -69.67 -32.78 71.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.56 0.695 . . . . 0.0 109.66 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.529 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.22 -41.23 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.942 177.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.702 HG22 ' HB3' ' A' ' 331' ' ' ASN . 33.6 p -82.33 -36.18 27.16 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.939 1.352 . . . . 0.0 109.807 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.66 32.73 8.39 Favored Glycine 0 N--CA 1.432 -1.576 0 CA-C-N 112.203 -2.271 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.448 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 46.9 mt-10 55.75 165.35 0.06 OUTLIER Pre-proline 0 N--CA 1.437 -1.085 0 C-N-CA 124.062 0.945 . . . . 0.0 113.429 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' A' ' 355' ' ' LEU . 33.1 Cg_exo -44.27 146.73 1.78 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.547 2.831 . . . . 0.0 113.095 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.09 -102.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.739 2.292 . . . . 0.0 111.171 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.46 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 11.2 mmm180 -102.36 -79.94 0.52 Allowed 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.284 0.564 . . . . 0.0 111.188 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 8.6 m-20 -94.75 164.17 20.38 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.51 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.418 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 37.4 Cg_exo -61.73 -48.11 9.67 Favored 'Trans proline' 0 CA--C 1.512 -0.577 0 C-N-CA 122.975 2.45 . . . . 0.0 110.613 168.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -51.29 -25.91 6.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.218 177.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 63.7 mt-10 -81.73 -33.5 31.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 0.0 111.226 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.733 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -48.38 -42.37 52.96 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -173.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.699 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.97 -63.23 0.31 Allowed 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 123.089 2.526 . . . . 0.0 113.019 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.592 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -61.23 -37.25 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.246 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.671 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -57.63 -36.53 71.94 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.569 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.827 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.59 -49.49 47.17 Favored 'General case' 0 N--CA 1.401 -2.916 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.75 -24.11 24.4 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.887 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.552 ' HD2' HG21 ' A' ' 406' ' ' THR . 1.0 OUTLIER -74.48 -42.14 59.52 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.994 0.902 . . . . 0.0 110.882 173.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.702 ' HB3' HG22 ' A' ' 314' ' ' THR . 49.2 m-20 -94.24 -23.63 17.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.522 -168.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.613 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.66 -50.29 9.75 Favored Pre-proline 0 C--N 1.308 -1.239 0 C-N-CA 124.523 1.129 . . . . 0.0 113.829 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 53.3 Cg_endo -63.19 -31.48 74.68 Favored 'Trans proline' 0 CA--C 1.51 -0.693 0 C-N-CA 122.473 2.115 . . . . 0.0 111.557 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.38 -42.44 59.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.501 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.618 HG23 HG23 ' A' ' 310' ' ' ILE . 95.5 mt -58.27 -48.01 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.947 174.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.39 -17.96 2.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.496 -1.684 . . . . 0.0 112.368 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.09 -52.8 5.52 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.03 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.628 HG11 HG13 ' A' ' 310' ' ' ILE . 96.8 t -57.78 -71.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 123.506 1.622 . . . . 0.0 110.238 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.753 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.6 123.46 72.6 Favored Pre-proline 0 N--CA 1.403 -2.82 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.588 -174.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.705 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 74.1 Cg_endo -72.7 -17.22 26.25 Favored 'Trans proline' 0 CA--C 1.495 -1.454 0 C-N-CA 123.947 3.098 . . . . 0.0 110.267 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 32.62 66.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 111.683 -2.508 . . . . 0.0 110.103 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.563 ' N ' HD12 ' A' ' 346' ' ' LEU . 46.6 p -79.08 4.11 15.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.738 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.803 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.2 p -140.74 159.5 62.34 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.697 ' HB3' HD12 ' A' ' 369' ' ' LEU . 70.5 Cg_exo -60.33 -46.21 19.18 Favored 'Trans proline' 0 CA--C 1.498 -1.296 0 C-N-CA 123.571 2.847 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.638 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -41.33 -56.52 2.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.4 175.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.803 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.9 mt -55.85 -51.24 68.22 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.051 -1.432 . . . . 0.0 111.0 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.834 ' HA ' HD12 ' A' ' 350' ' ' ILE . 4.7 ttm180 -49.83 -48.06 51.2 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.959 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 1.117 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.7 m -68.88 -47.1 66.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.949 -177.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.587 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.0 mtp180 -62.37 -34.3 76.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.88 ' O ' HG12 ' A' ' 354' ' ' ILE . 28.1 mt -58.24 -53.04 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.753 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.627 ' O ' HD22 ' A' ' 355' ' ' LEU . 19.7 mt -57.81 -53.89 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 121.922 0.868 . . . . 0.0 111.201 -170.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.566 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 13.5 m-20 -63.89 -35.68 81.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.133 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . 0.566 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.56 -29.91 66.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.68 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.88 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.03 -58.85 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 122.945 1.355 . . . . 0.0 110.118 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.733 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.13 -27.95 57.27 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.182 -167.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.74 -72.56 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.341 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -106.63 52.15 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.562 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.732 HD22 ' HB2' ' A' ' 361' ' ' LEU . 12.7 p-10 -89.88 129.45 36.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 122.861 0.464 . . . . 0.0 109.911 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.662 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -48.24 -71.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.881 -170.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.37 6.68 5.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.523 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.732 ' HB2' HD22 ' A' ' 358' ' ' ASN . 3.5 mt -70.96 -6.19 36.76 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.582 0.706 . . . . 0.0 109.962 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.566 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 19.5 t -63.7 78.89 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.413 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.772 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.9 mm? -61.14 -179.69 0.16 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.184 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 366' ' ' GLY . 49.2 p -119.76 157.71 51.57 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.436 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 1.117 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 57.7 Cg_endo -69.79 25.32 0.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.115 1.876 . . . . 0.0 113.254 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -134.32 -4.0 2.97 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.647 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.563 ' HB2' HD12 ' A' ' 363' ' ' LEU . 1.5 m-20 -106.88 -21.21 13.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.119 0.961 . . . . 0.0 110.451 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.887 ' HB2' ' SG ' ' A' ' 348' ' ' CYS . 3.8 m -94.41 24.16 4.7 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.638 -168.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.9 -35.89 64.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.332 1.063 . . . . 0.0 109.356 -172.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.06 159.48 23.15 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.304 172.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.643 ' O ' HG13 ' A' ' 375' ' ' VAL . 58.7 m95 -69.63 -35.48 75.28 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.562 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.32 -41.96 98.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.969 -175.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 92.0 p -67.47 -44.48 78.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.906 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.586 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -63.43 -52.83 59.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.827 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.3 m -56.11 -45.03 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.453 0.645 . . . . 0.0 109.559 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.04 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.05 -45.66 90.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.999 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.63 HG21 HD11 ' A' ' 363' ' ' LEU . 24.0 m -68.05 -37.24 81.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.289 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -61.73 -34.83 76.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.699 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 68.1 t80 -73.38 -45.15 56.51 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.461 1.124 . . . . 0.0 109.097 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.6 -33.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 112.647 -2.07 . . . . 0.0 111.167 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.41 -44.39 95.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.538 0.685 . . . . 0.0 111.068 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 32.7 p -93.73 -23.68 18.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.82 -167.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . 0.464 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 30.6 m80 -109.55 23.75 14.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.57 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.91 36.15 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 114.223 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m 66.27 159.54 0.13 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 111.494 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -129.47 151.22 77.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -96.32 54.1 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 110.906 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.688 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.02 8.16 0.72 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -70.69 -45.65 64.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.102 0.477 . . . . 0.0 110.479 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.657 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.6 mt-30 -75.26 -28.17 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -170.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.695 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.34 -31.61 45.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.025 0.829 . . . . 0.0 112.115 -170.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.644 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -53.18 41.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.925 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 18.2 m-20 -67.48 -37.48 82.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.3 m -58.5 -45.75 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 110.616 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 399' ' ' VAL . 9.5 mm -58.25 -47.16 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.855 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.65 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.0 mmtt -52.42 -39.86 61.48 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 124.205 0.94 . . . . 0.0 111.893 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -77.39 -44.62 12.75 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.68 -1.247 . . . . 0.0 113.146 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.4 mt -69.39 -42.72 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 111.749 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.2 m -57.09 -43.96 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.562 0.696 . . . . 0.0 110.226 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 399' ' ' VAL . 6.1 t70 -58.47 -39.76 80.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.861 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 47.7 mt-30 -86.38 -53.62 4.9 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.28 -173.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.515 ' HG3' HG22 ' A' ' 398' ' ' ILE . 0.6 OUTLIER -113.19 -30.85 6.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.107 -166.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.29 165.83 12.09 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.856 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.939 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.1 -43.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.32 -50.57 71.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.92 0.391 . . . . 0.0 111.871 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.566 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.54 -51.42 62.93 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.705 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.878 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.33 -41.41 65.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.582 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 48.0 t80 -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.635 0.731 . . . . 0.0 109.366 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.799 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.3 m -59.91 -53.42 58.1 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.808 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.71 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 117.887 0.312 . . . . 0.0 110.681 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.28 -45.24 83.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.405 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.735 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.4 OUTLIER -70.41 -32.21 69.74 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.645 0.723 . . . . 0.0 111.075 177.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.799 ' HG3' ' O ' ' A' ' 409' ' ' THR . 49.7 mtm -68.65 -48.04 65.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.53 0.681 . . . . 0.0 109.521 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.04 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.3 mt -59.66 -40.14 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.653 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.793 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -78.32 -17.23 56.85 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.803 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 86.78 47.05 4.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.839 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.623 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 57.96 47.54 14.81 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.793 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -125.89 74.36 1.42 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.612 1.673 . . . . 0.0 106.953 161.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.735 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 2.1 p90 -58.57 -33.49 70.0 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.165 -2.288 . . . . 0.0 110.826 -160.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -55.11 -43.45 74.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.495 -165.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.635 HD21 ' ND2' ' A' ' 418' ' ' ASN . 2.0 pp -63.42 -49.63 72.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.242 0.544 . . . . 0.0 110.721 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.68 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.71 -39.45 81.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.834 1.302 . . . . 0.0 109.207 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.556 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 41.2 t -61.91 -44.36 96.95 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.076 -2.329 . . . . 0.0 111.723 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.98 -40.74 82.97 Favored Glycine 0 C--N 1.316 -0.557 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.713 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -71.4 -41.92 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.623 0.725 . . . . 0.0 110.167 175.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.4 mm -55.13 -42.74 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.483 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.676 ' HA ' HD23 ' A' ' 430' ' ' LEU . 3.3 tmm_? -58.86 -36.05 73.96 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 123.201 1.477 . . . . 0.0 109.383 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.08 -8.34 69.18 Favored Glycine 0 C--N 1.283 -2.397 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.224 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.1 m-85 -105.6 -0.55 25.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.55 142.84 82.29 Favored Pre-proline 0 N--CA 1.406 -2.637 0 CA-C-O 123.585 1.66 . . . . 0.0 113.017 170.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.754 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 67.6 Cg_endo -70.75 -55.25 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.386 1 C-N-CA 126.164 4.576 . . . . 0.0 113.212 -172.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -118.79 143.5 17.48 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.372 -178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.867 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.31 -26.77 68.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.992 0.396 . . . . 0.0 111.268 -177.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.58 -48.46 79.32 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.985 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.5 t -58.25 -51.54 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.807 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.867 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -55.29 -53.33 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 99.9 m -61.85 -56.67 16.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.169 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.19 -45.93 79.59 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.57 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.811 ' O ' HD22 ' A' ' 443' ' ' LEU . 41.8 mt -59.66 -53.15 61.41 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.651 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.716 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 39.8 mm-40 -51.51 -35.44 40.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 O-C-N 124.882 1.364 . . . . 0.0 110.683 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.39 -60.59 2.17 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -76.09 -50.29 15.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.77 -0.581 . . . . 0.0 111.901 -172.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.811 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.88 63.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.384 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.747 ' N ' HD23 ' A' ' 443' ' ' LEU . 8.2 t70 -73.95 -41.85 61.4 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.129 0.966 . . . . 0.0 110.747 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.18 -8.15 43.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.514 ' HB3' ' CG2' ' A' ' 451' ' ' THR . 51.5 mm-40 -51.77 157.16 1.24 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.377 1.561 . . . . 0.0 114.186 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.431 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -53.87 -32.92 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.841 -2.89 . . . . 0.0 115.191 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.665 ' H ' ' HB ' ' A' ' 451' ' ' THR . 68.9 m-20 -135.18 178.22 7.2 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.417 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.8 p-10 -66.54 -51.48 56.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -69.43 -22.98 63.62 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 31.1 m -57.79 -39.5 77.67 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 119.888 1.222 . . . . 0.0 109.398 170.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.617 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 75.7 mtt180 -60.72 -30.42 69.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.356 172.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.582 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.84 -35.36 59.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.164 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.93 -43.16 25.3 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.654 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 40.2 p -101.46 -2.09 31.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.295 -169.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.685 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.2 t80 -49.04 -54.58 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.827 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.3 mm -69.97 -26.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -42.96 63.59 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 463' ' ' VAL . 39.7 m-70 -67.3 -31.04 71.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.562 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.724 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -64.37 -53.89 41.53 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.174 0.987 . . . . 0.0 109.093 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.45 -30.69 71.42 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.799 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -66.94 -48.67 67.9 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.463 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.985 HG11 ' HA ' ' A' ' 435' ' ' VAL . 34.2 t -65.35 -36.24 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.471 175.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.5 m-30 -60.17 -13.9 14.54 Favored 'General case' 0 C--O 1.202 -1.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.625 168.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.3 tp10 -95.52 -51.93 4.34 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.213 -0.929 . . . . 0.0 112.467 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -62.62 -41.36 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.374 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.805 HD12 HD11 ' A' ' 469' ' ' LEU . 6.7 mt -83.94 -17.51 40.4 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.822 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.31 49.67 60.1 Favored Glycine 0 C--O 1.211 -1.294 0 CA-C-N 111.481 -2.599 . . . . 0.0 113.239 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.805 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -102.86 172.91 6.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 123.951 0.9 . . . . 0.0 110.149 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.735 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.6 p30 -92.64 -39.59 11.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -161.96 -75.57 0.05 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.197 159.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.754 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -66.26 71.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.064 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.47 42.0 2.46 Favored Glycine 0 C--N 1.275 -2.817 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.217 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.735 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.6 mm-40 -80.24 -54.83 5.38 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.472 1.13 . . . . 0.0 111.102 -174.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.1 t 68.91 61.16 0.33 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.372 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.822 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.401 0 CA-C-N 111.023 -2.808 . . . . 0.0 111.893 174.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.431 -1.396 0 CA-C-O 120.824 0.345 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.786 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.7 mt -77.2 123.66 87.12 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 122.026 0.917 . . . . 0.0 112.657 -174.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 308' ' ' GLN . 37.4 Cg_endo -73.55 -20.04 20.99 Favored 'Trans proline' 0 CA--C 1.502 -1.106 0 C-N-CA 124.881 3.721 . . . . 0.0 111.116 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.711 HG23 ' HG2' ' A' ' 308' ' ' GLN . 3.6 tp 41.03 -63.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 127.833 2.453 . . . . 0.0 115.584 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.711 ' HG2' HG23 ' A' ' 307' ' ' ILE . 69.7 mm-40 -59.35 -33.67 71.43 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 123.409 0.684 . . . . 0.0 110.631 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.518 ' CG ' HG13 ' A' ' 338' ' ' VAL . 8.7 t-160 -60.5 -47.79 84.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.514 172.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.654 HG13 HG11 ' A' ' 338' ' ' VAL . 64.9 mt -60.28 -48.66 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 123.875 0.87 . . . . 0.0 112.091 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.692 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 14.1 mtp180 -57.5 -30.45 65.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 122.852 0.461 . . . . 0.0 111.798 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -34.17 74.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.462 0.648 . . . . 0.0 109.957 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.504 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.92 -40.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.515 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.743 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 36.3 p -81.91 -36.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.827 1.298 . . . . 0.0 109.793 -176.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 85.93 36.03 10.66 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 112.315 -2.221 . . . . 0.0 111.064 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 34.3 mt-10 53.97 168.21 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.585 ' HG3' HD12 ' A' ' 355' ' ' LEU . 63.7 Cg_exo -47.13 147.13 5.63 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.674 2.916 . . . . 0.0 113.55 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 18.0 Cg_endo -96.94 -105.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.769 2.979 . . . . 0.0 113.378 -170.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.432 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 15.5 mmt180 -86.52 -86.26 0.15 Allowed 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 123.207 0.603 . . . . 0.0 110.687 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 22.6 m-20 -102.9 166.36 12.04 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.036 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.518 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 34.5 Cg_exo -58.35 -50.35 9.94 Favored 'Trans proline' 0 CA--C 1.511 -0.631 0 C-N-CA 122.536 2.158 . . . . 0.0 110.571 169.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.474 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -60.32 -11.72 7.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.295 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 320' ' ' ASN . 1.6 mm-40 -92.19 -22.52 19.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.257 . . . . 0.0 111.591 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.765 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.71 -40.88 56.4 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.74 ' HA ' HD23 ' A' ' 378' ' ' LEU . 7.9 Cg_endo -49.61 -62.56 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.916 2.411 . . . . 0.0 113.05 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.67 ' O ' ' HG3' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -60.46 -37.2 73.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 122.329 1.062 . . . . 0.0 110.303 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.743 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 63.1 t90 -58.56 -38.05 77.02 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.741 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.831 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -70.85 -50.59 33.62 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -54.36 -24.05 28.73 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.554 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 326' ' ' ILE . 21.4 mtp180 -75.21 -40.59 59.08 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 122.271 1.034 . . . . 0.0 112.0 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.618 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.0 m-20 -94.27 -24.41 17.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.511 -1.677 . . . . 0.0 113.195 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.57 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.67 -49.28 13.3 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 124.635 1.174 . . . . 0.0 113.803 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.5 Cg_endo -60.78 -34.41 91.64 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 122.464 2.109 . . . . 0.0 111.488 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -74.06 -43.39 57.93 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.544 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.621 HG23 HG23 ' A' ' 310' ' ' ILE . 94.1 mt -58.26 -47.08 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.013 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -13.8 2.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.995 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.86 -51.18 4.62 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.26 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.654 HG11 HG13 ' A' ' 310' ' ' ILE . 94.6 t -57.81 -70.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 123.128 1.442 . . . . 0.0 109.846 170.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.811 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.5 OUTLIER -87.4 125.68 64.79 Favored Pre-proline 0 N--CA 1.408 -2.526 0 CA-C-N 111.644 -2.526 . . . . 0.0 111.885 -175.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.671 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.1 Cg_endo -70.83 -19.71 30.68 Favored 'Trans proline' 0 CA--C 1.493 -1.566 0 C-N-CA 123.736 2.957 . . . . 0.0 110.283 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 33.24 70.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.54 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.569 ' N ' HD12 ' A' ' 346' ' ' LEU . 68.7 p -79.96 2.65 22.77 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.684 -2.053 . . . . 0.0 112.821 -170.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.81 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 18.0 p -143.22 161.65 46.8 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-O 121.457 0.646 . . . . 0.0 109.753 177.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.1 -40.67 32.26 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 124.403 3.402 . . . . 0.0 109.8 172.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -47.86 -55.11 10.56 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.625 -2.079 . . . . 0.0 110.298 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.81 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.7 mt -57.64 -51.38 69.76 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.817 -175.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.791 ' HA ' HD12 ' A' ' 350' ' ' ILE . 10.1 ttm180 -52.92 -42.06 65.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.934 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.509 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 42.0 t -68.26 -49.95 57.13 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.972 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.657 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 60.3 mtp180 -61.14 -37.64 83.57 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.476 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.894 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -57.44 -52.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 O-C-N 123.371 0.419 . . . . 0.0 111.006 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.613 ' O ' HD22 ' A' ' 355' ' ' LEU . 18.3 mt -58.38 -54.19 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 122.098 0.952 . . . . 0.0 110.964 -172.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.573 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 21.8 m-20 -63.96 -35.62 81.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.004 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . 0.565 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.77 -29.22 65.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.876 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.894 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.8 mm -56.67 -59.49 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 CA-C-O 122.794 1.283 . . . . 0.0 110.161 174.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.765 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.87 -26.3 54.07 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 111.977 -2.374 . . . . 0.0 109.772 -167.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.58 -71.68 1.56 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.065 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -115.85 33.07 5.37 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.949 -176.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.754 HD22 ' HB2' ' A' ' 361' ' ' LEU . 22.6 p-10 -58.32 134.32 56.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.707 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -47.77 -72.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 C-N-CA 124.237 1.015 . . . . 0.0 112.854 -170.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -131.62 7.6 5.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.758 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.754 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.6 mt -70.89 -4.59 25.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.669 0.747 . . . . 0.0 109.942 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.573 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 8.7 t -63.62 80.31 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.994 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.861 HD11 HG21 ' A' ' 377' ' ' THR . 1.7 mm? -60.35 -170.82 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 30.5 p -124.77 157.49 65.88 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.613 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 53.0 Cg_exo -46.65 -37.73 21.05 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.09 1.86 . . . . 0.0 111.491 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.528 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -86.05 2.96 87.62 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.693 -0.685 . . . . 0.0 114.594 -172.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.698 ' HB2' HD12 ' A' ' 363' ' ' LEU . 24.2 m-20 -109.21 -22.15 12.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.916 0.865 . . . . 0.0 110.083 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.732 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 62.7 m -94.3 19.74 9.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.67 -169.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.528 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -58.74 -41.27 86.06 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.897 -170.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.9 157.25 27.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 113.276 -1.783 . . . . 0.0 109.373 170.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.641 ' O ' HG13 ' A' ' 375' ' ' VAL . 51.5 m95 -69.59 -35.89 75.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.433 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.95 -38.56 91.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.352 -174.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 37.1 t -70.25 -44.0 69.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.11 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.551 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -63.33 -52.17 62.98 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.831 HG12 ' HB3' ' A' ' 328' ' ' LEU . 14.9 m -55.63 -46.35 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.494 0.664 . . . . 0.0 110.192 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.089 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -58.52 -37.5 75.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.848 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.861 HG21 HD11 ' A' ' 363' ' ' LEU . 39.0 m -75.29 -41.75 56.37 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.931 -171.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.74 HD23 ' HA ' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -58.82 -34.42 71.5 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.821 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.712 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 30.0 t80 -70.99 -49.1 48.96 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.49 1.138 . . . . 0.0 109.627 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.03 -32.12 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.976 170.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -60.0 -34.4 73.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.878 0.471 . . . . 0.0 111.451 175.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 26.1 p -103.83 -23.34 13.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.956 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -110.12 22.94 14.96 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.15 17.04 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 114.359 0.504 . . . . 0.0 114.359 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.427 HG23 HG13 ' A' ' 380' ' ' ILE . 1.1 m 66.64 154.79 0.09 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.386 0.613 . . . . 0.0 111.236 -175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -119.12 154.57 53.52 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 389' ' ' HIS . 83.2 Cg_endo -96.09 54.55 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.36 2.707 . . . . 0.0 111.207 167.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.783 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.0 -7.44 0.07 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.404 ' H ' ' C ' ' A' ' 387' ' ' PRO . 7.8 t60 -69.21 -43.79 73.4 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.659 0.266 . . . . 0.0 111.235 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.2 mt-30 -69.38 -26.24 64.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.783 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.8 mm? -54.03 -29.82 45.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.354 0.525 . . . . 0.0 110.976 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.653 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.24 -53.29 38.61 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.683 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.589 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 34.4 m-20 -64.36 -41.38 96.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.861 0.464 . . . . 0.0 111.947 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.72 -45.2 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.249 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.701 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.8 mm -58.05 -47.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.161 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 27.3 mmtt -52.78 -42.62 65.19 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.027 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -75.7 -44.91 18.96 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.494 -1.336 . . . . 0.0 112.637 -173.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.904 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.1 mt -69.87 -41.46 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 117.16 0.48 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.3 m -57.35 -43.57 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.54 0.686 . . . . 0.0 110.381 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 399' ' ' VAL . 2.7 t70 -65.66 -37.43 86.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.975 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 74.4 mt-30 -82.56 -52.63 6.66 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.458 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.563 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -115.14 -30.39 6.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.031 -167.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 128.33 164.69 11.63 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.043 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.937 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -63.75 -43.01 97.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 122.653 0.381 . . . . 0.0 111.783 -176.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.638 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -57.26 -50.41 72.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.294 0.568 . . . . 0.0 111.246 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.563 HG21 ' HD2' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -63.37 -52.04 63.35 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 179.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.904 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.74 -40.41 66.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 176.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.604 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 32.9 t80 -58.4 -43.53 88.61 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.791 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.4 m -62.84 -53.18 58.11 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.624 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.659 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.14 -49.49 77.42 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.249 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.14 -42.34 87.59 Favored Glycine 0 C--N 1.314 -0.649 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.255 -174.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.802 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.17 -31.84 66.29 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 116.686 0.243 . . . . 0.0 110.956 179.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.791 ' HG3' ' O ' ' A' ' 409' ' ' THR . 50.8 mtm -69.51 -47.98 62.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 109.742 173.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.089 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.1 mt -59.02 -40.58 85.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.453 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.674 ' HG ' ' HG ' ' A' ' 391' ' ' LEU . 0.2 OUTLIER -77.08 -8.82 58.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.394 -177.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.42 33.54 7.97 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.952 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.802 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 4.2 mm-40 57.26 48.46 15.03 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.054 -1.073 . . . . 0.0 112.814 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.64 ' ND2' HD21 ' A' ' 421' ' ' LEU . 0.4 OUTLIER -120.17 63.53 0.83 Allowed 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 165.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.792 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 1.0 OUTLIER -44.59 -35.02 2.37 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.426 -2.624 . . . . 0.0 112.871 -163.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 39.5 mt-30 -55.71 -43.01 76.08 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -165.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.64 HD21 ' ND2' ' A' ' 418' ' ' ASN . 1.9 pp -63.39 -48.4 78.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.54 -38.99 79.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.579 1.181 . . . . 0.0 109.059 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.51 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 35.9 t -59.62 -46.34 89.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.356 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.9 -39.03 76.97 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.207 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.1 -40.56 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.582 0.706 . . . . 0.0 110.24 174.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 404' ' ' VAL . 1.8 mm -58.13 -45.21 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.023 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.665 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.72 -29.53 68.19 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.76 1.267 . . . . 0.0 108.746 -174.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.17 -15.37 74.52 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 112.71 -2.041 . . . . 0.0 112.562 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.604 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 10.2 m-85 -101.17 -0.33 36.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.27 142.9 80.6 Favored Pre-proline 0 N--CA 1.414 -2.263 0 CA-C-O 123.653 1.692 . . . . 0.0 113.626 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.747 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 66.9 Cg_endo -71.71 -61.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.227 4.618 . . . . 0.0 113.603 -172.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.561 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.15 142.17 17.04 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.147 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.918 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.96 -27.47 68.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.316 0.558 . . . . 0.0 111.701 -176.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.809 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.22 -48.89 77.66 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.048 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.2 t -61.61 -37.66 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.485 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.918 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.13 -44.19 65.48 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.261 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 67.1 m -71.9 -54.94 8.47 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.433 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.0 -46.11 78.84 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.414 0.446 . . . . 0.0 111.168 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 460' ' ' LEU . 21.1 mt -60.11 -54.11 49.8 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.47 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.765 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.26 -33.59 29.03 Favored 'General case' 0 N--CA 1.405 -2.69 0 O-C-N 125.487 1.742 . . . . 0.0 111.108 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.1 -59.81 2.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -75.76 -50.19 15.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.978 0.354 . . . . 0.0 111.895 -173.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.768 HD23 ' N ' ' A' ' 444' ' ' ASP . 0.1 OUTLIER -59.0 -24.7 63.01 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.623 -178.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.768 ' N ' HD23 ' A' ' 443' ' ' LEU . 7.2 t70 -73.32 -41.05 63.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.882 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -72.31 -8.16 53.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -172.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.484 ' HB3' HG22 ' A' ' 451' ' ' THR . 6.1 mm-40 -56.85 162.76 2.23 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.176 1.465 . . . . 0.0 114.317 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.771 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -55.82 -33.52 34.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 111.31 -2.677 . . . . 0.0 115.974 -168.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.64 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.9 m-20 -145.03 -175.73 4.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.464 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.7 m-20 -65.11 -56.81 10.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.58 -25.21 67.31 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 177.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.771 HG21 ' HB ' ' A' ' 447' ' ' ILE . 17.0 m -56.85 -44.02 81.74 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.708 1.14 . . . . 0.0 109.47 170.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.728 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 27.6 mtm-85 -62.13 -29.45 70.35 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.774 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.604 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.25 -28.67 62.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.032 0.92 . . . . 0.0 109.449 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -86.21 -43.73 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.22 -171.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.8 p -103.44 -3.99 24.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.932 -169.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.686 ' HB2' ' O ' ' A' ' 452' ' ' ARG . 8.8 t80 -49.12 -53.58 20.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.668 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.638 HG23 ' HB1' ' A' ' 405' ' ' ALA . 21.4 mm -71.17 -25.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.433 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.97 -43.54 62.13 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.559 ' O ' HG23 ' A' ' 463' ' ' VAL . 80.1 m-70 -67.92 -31.1 70.63 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.215 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.812 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.8 -53.98 42.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.165 0.984 . . . . 0.0 109.177 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -61.61 -30.41 70.67 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.785 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -69.06 -47.57 64.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.585 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.048 HG11 ' HA ' ' A' ' 435' ' ' VAL . 45.6 t -66.06 -35.78 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.314 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.535 ' OH ' HG13 ' A' ' 404' ' ' VAL . 20.0 m-30 -61.12 -14.09 21.98 Favored 'General case' 0 C--O 1.2 -1.504 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.647 168.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.569 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 6.3 tp10 -93.36 -52.03 4.71 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.444 -0.785 . . . . 0.0 112.323 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -62.98 -41.31 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.421 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.809 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.7 mt -84.33 -17.12 40.53 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.741 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 66.1 49.35 58.5 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 111.633 -2.53 . . . . 0.0 113.336 173.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.739 HD11 HD12 ' A' ' 467' ' ' LEU . 0.6 OUTLIER -101.81 -176.59 3.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.056 0.943 . . . . 0.0 110.04 -179.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.744 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.8 p30 -105.11 -40.63 5.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 167.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.452 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -159.06 -79.38 0.06 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.335 -2.211 . . . . 0.0 110.91 158.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.747 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.5 OUTLIER -61.41 73.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -170.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.493 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.73 44.69 0.71 Allowed Glycine 0 C--N 1.274 -2.864 0 CA-C-N 110.462 -3.063 . . . . 0.0 113.227 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.744 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.1 mm-40 -79.66 -55.19 5.19 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.273 1.035 . . . . 0.0 111.223 -173.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.7 t 65.69 47.81 2.07 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.912 -2.403 . . . . 0.0 108.095 -173.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.605 0 CA-C-N 109.808 -3.36 . . . . 0.0 112.303 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.432 -1.331 0 CA-C-O 120.816 0.341 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.801 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 47.6 mt -71.11 121.19 83.46 Favored Pre-proline 0 N--CA 1.426 -1.665 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.585 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 57.8 Cg_endo -82.09 58.21 6.56 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 124.92 3.746 . . . . 0.0 109.592 170.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.671 HG12 ' HB1' ' A' ' 353' ' ' ALA . 1.7 tp -45.52 -47.38 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 112.12 -2.309 . . . . 0.0 113.347 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.628 ' HG2' HG23 ' A' ' 307' ' ' ILE . 16.7 mm-40 -65.63 -35.65 81.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.327 0.584 . . . . 0.0 111.282 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.6 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.3 t-160 -61.89 -47.41 85.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.615 173.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.624 HG23 HG23 ' A' ' 335' ' ' ILE . 67.5 mt -61.25 -49.62 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.058 0.943 . . . . 0.0 113.043 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 28.1 mtp180 -59.93 -29.57 68.47 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.05 0.54 . . . . 0.0 111.602 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 69.4 m -69.67 -33.26 72.31 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.606 0.717 . . . . 0.0 110.266 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.502 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.27 -40.86 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.936 177.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.664 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 34.4 p -82.13 -36.47 27.43 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.805 1.288 . . . . 0.0 109.928 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.23 34.42 9.67 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 112.323 -2.217 . . . . 0.0 110.813 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 33.2 mt-10 52.46 170.24 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.67 ' HG3' HD12 ' A' ' 355' ' ' LEU . 93.7 Cg_exo -49.63 150.67 8.53 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.213 2.609 . . . . 0.0 113.246 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 42.4 Cg_endo -93.37 -104.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.444 2.763 . . . . 0.0 112.11 -174.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.415 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 20.0 mmt180 -95.17 -84.58 0.33 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 12.1 m-20 -96.07 163.47 20.86 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.876 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.491 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.75 -48.64 12.19 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.732 2.288 . . . . 0.0 110.434 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.46 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -56.36 -17.14 6.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.509 -1.678 . . . . 0.0 113.562 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.528 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 39.7 mt-10 -87.38 -27.97 22.46 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.368 -0.208 . . . . 0.0 110.993 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.719 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.09 -43.69 69.31 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.698 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 3.5 Cg_endo -46.64 -65.35 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.098 2.532 . . . . 0.0 112.997 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.597 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.61 -37.62 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.317 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.664 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.5 t90 -57.68 -34.05 69.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.114 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.832 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.58 -50.23 39.46 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.38 -23.73 27.73 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.903 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.534 ' HD2' HG21 ' A' ' 406' ' ' THR . 2.4 mtm-85 -73.23 -40.78 64.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.317 1.056 . . . . 0.0 110.369 175.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.654 ' HB3' HG22 ' A' ' 314' ' ' THR . 56.6 m-20 -97.75 -24.91 15.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.716 -1.584 . . . . 0.0 114.004 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.63 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.66 -49.72 13.07 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.4 Cg_endo -61.13 -32.93 91.68 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.495 2.13 . . . . 0.0 111.528 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.97 -43.51 57.89 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.483 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 332' ' ' ALA . 92.9 mt -57.44 -47.24 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.942 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 36.9 t70 -55.93 -14.78 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.202 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.82 -47.37 6.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.429 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.6 HG22 ' CD2' ' A' ' 309' ' ' HIS . 92.2 t -63.49 -72.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.296 1.522 . . . . 0.0 109.946 169.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.801 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -84.05 122.48 75.93 Favored Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.665 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.704 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.2 Cg_endo -72.23 -17.25 27.86 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.094 3.196 . . . . 0.0 110.159 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.4 p 33.89 67.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.068 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.559 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.5 p -78.35 0.7 24.5 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.775 -2.012 . . . . 0.0 112.572 -170.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.817 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -138.06 159.09 69.78 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.697 ' HB3' HD12 ' A' ' 369' ' ' LEU . 68.1 Cg_exo -60.53 -44.94 24.0 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 123.583 2.855 . . . . 0.0 108.797 172.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.616 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -44.99 -52.43 8.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.722 -2.035 . . . . 0.0 110.776 176.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.817 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.0 mt -56.94 -52.3 65.73 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.845 ' HA ' HD12 ' A' ' 350' ' ' ILE . 25.3 ttm180 -49.94 -46.23 51.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.603 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.941 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 8.2 m -68.12 -50.86 52.12 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.146 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.694 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 35.2 mtt180 -61.23 -34.82 75.75 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.409 0.443 . . . . 0.0 111.105 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.888 ' O ' HG12 ' A' ' 354' ' ' ILE . 32.7 mt -56.22 -51.5 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.898 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 328' ' ' LEU . 21.7 mt -60.38 -53.84 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 123.832 0.707 . . . . 0.0 111.744 -172.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.694 ' OD1' ' HA ' ' A' ' 349' ' ' ARG . 0.0 OUTLIER -60.41 -36.13 77.42 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.822 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . 0.671 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -71.19 -29.79 65.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.888 HG12 ' O ' ' A' ' 350' ' ' ILE . 4.3 mm -58.03 -59.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 CA-C-O 123.082 1.42 . . . . 0.0 110.493 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.719 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -78.62 -26.96 45.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.26 -167.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.85 -78.7 0.2 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.903 -1.499 . . . . 0.0 113.023 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -102.4 36.31 4.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.415 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.742 HD22 ' HB2' ' A' ' 361' ' ' LEU . 22.0 p-10 -70.63 131.46 43.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.069 0.461 . . . . 0.0 110.649 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.662 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -49.62 -72.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -169.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.9 2.94 6.91 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.885 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.742 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.2 mt -72.46 -4.62 31.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.943 0.877 . . . . 0.0 109.953 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 8.2 t -69.18 70.55 0.24 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.378 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 367' ' ' ASP . 1.5 mm? -55.03 172.31 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.5 p -120.27 159.4 47.74 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.325 -175.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.888 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.1 Cg_endo -53.3 -9.98 1.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.156 2.57 . . . . 0.0 113.215 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -103.49 -17.99 15.8 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.261 0.864 . . . . 0.0 115.261 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.732 ' HB2' HD12 ' A' ' 363' ' ' LEU . 4.9 m-20 -105.72 -23.61 12.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.617 1.208 . . . . 0.0 110.649 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.941 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 8.6 t -96.18 25.24 5.02 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.653 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.39 -37.01 64.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.635 0.731 . . . . 0.0 110.467 -170.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.26 161.2 20.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.514 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.584 ' O ' HG13 ' A' ' 375' ' ' VAL . 30.3 m95 -69.41 -36.67 76.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.535 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.5 OUTLIER -64.31 -40.47 95.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.531 -174.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.1 t -69.08 -43.11 75.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.65 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.44 -53.44 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.832 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.6 m -57.55 -43.02 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.624 0.726 . . . . 0.0 109.731 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 0.994 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -64.13 -42.75 96.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.272 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.622 ' CG2' HD21 ' A' ' 363' ' ' LEU . 22.8 m -69.32 -37.93 77.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.768 -173.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.664 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -61.33 -34.61 75.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.58 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.698 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 56.9 t80 -75.33 -43.98 47.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.161 0.982 . . . . 0.0 109.414 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.08 -33.01 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.245 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.6 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.42 -34.63 74.23 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 123.141 0.576 . . . . 0.0 111.956 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.8 p -111.05 -23.53 10.87 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -165.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -109.98 25.6 11.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.63 50.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.959 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 64.12 164.39 0.13 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.023 0.439 . . . . 0.0 111.269 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.513 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -130.41 153.67 81.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -99.37 54.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.571 2.847 . . . . 0.0 111.248 165.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.715 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.5 -0.53 0.18 Allowed 'General case' 0 C--O 1.231 0.1 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -69.13 -44.51 72.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.951 0.405 . . . . 0.0 110.571 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 394' ' ' VAL . 27.6 mt-30 -75.01 -26.03 59.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.2 mm? -53.62 -31.71 48.31 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.28 0.945 . . . . 0.0 111.515 -174.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.707 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.45 -56.26 24.42 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.701 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.516 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 51.6 t30 -64.56 -34.47 78.32 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 110.717 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 391' ' ' LEU . 44.9 t -53.55 -53.64 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.645 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.762 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.0 mm -59.15 -48.26 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 175.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.707 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 39.9 mmtt -52.71 -38.47 60.77 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 124.185 0.928 . . . . 0.0 112.056 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.57 -45.26 8.73 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.607 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.959 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.1 mt -70.33 -40.68 78.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 117.762 0.781 . . . . 0.0 111.271 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -57.75 -44.0 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.575 0.702 . . . . 0.0 110.028 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.2 t70 -60.38 -36.62 78.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.576 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -91.19 -55.56 3.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.693 ' HG2' HG21 ' A' ' 406' ' ' THR . 3.0 tp10 -106.42 -34.42 7.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.245 0.545 . . . . 0.0 112.289 -172.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 129.97 167.29 12.03 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.511 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.954 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.55 -43.16 96.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -174.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.62 -51.0 70.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.693 HG21 ' HG2' ' A' ' 402' ' ' GLU . 0.9 OUTLIER -66.03 -48.79 69.96 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.756 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.959 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.96 -39.68 66.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 41.1 t80 -57.06 -47.2 81.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.676 0.75 . . . . 0.0 109.189 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.79 ' O ' ' HG3' ' A' ' 413' ' ' MET . 15.6 m -59.62 -53.0 63.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.008 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.673 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.49 -49.12 78.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.784 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.2 -42.47 88.19 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.18 -174.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.647 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.0 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.944 0.372 . . . . 0.0 110.746 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.804 ' HE3' HG21 ' A' ' 375' ' ' VAL . 65.5 mtm -69.57 -48.31 60.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.418 0.628 . . . . 0.0 110.047 175.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.994 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.0 mt -59.61 -37.56 78.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.376 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.797 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -77.76 -16.22 58.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.722 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.95 4.02 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.179 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.572 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 50.19 48.49 22.05 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 124.49 1.116 . . . . 0.0 113.91 -177.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.797 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -121.1 65.06 0.86 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 123.419 1.581 . . . . 0.0 107.294 166.01 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.647 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.4 OUTLIER -44.17 -35.06 2.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.52 -2.582 . . . . 0.0 112.984 -164.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 423' ' ' SER . 53.5 mt-30 -54.66 -45.62 73.89 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -165.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.647 HD21 HD21 ' A' ' 418' ' ' ASN . 2.2 pp -62.75 -48.82 77.52 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.02 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.684 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -61.28 -39.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 122.7 1.238 . . . . 0.0 109.04 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.544 ' HB2' ' HD2' ' A' ' 419' ' ' TYR . 31.3 t -60.27 -46.58 89.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.405 -2.18 . . . . 0.0 111.718 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.85 -38.7 75.04 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.656 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.3 mt -71.96 -40.97 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.441 0.638 . . . . 0.0 110.285 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.531 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -57.94 -44.09 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.618 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.662 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -58.23 -31.95 67.86 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 124.826 1.25 . . . . 0.0 109.046 -175.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.427 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -71.98 -13.36 75.82 Favored Glycine 0 C--N 1.301 -1.409 0 CA-C-N 113.0 -1.909 . . . . 0.0 112.595 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.639 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.0 m-85 -102.52 0.15 33.14 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.67 138.76 86.25 Favored Pre-proline 0 N--CA 1.408 -2.574 0 CA-C-O 123.752 1.739 . . . . 0.0 113.126 171.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.736 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 57.7 Cg_endo -68.58 -58.13 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.285 1 C-N-CA 126.34 4.694 . . . . 0.0 113.556 -170.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.538 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.51 143.46 18.1 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.96 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.937 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -27.53 69.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.433 0.617 . . . . 0.0 111.857 -173.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.36 -48.72 78.3 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.048 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.4 t -61.17 -36.9 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.617 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.937 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -73.19 -43.16 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -175.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 24.0 m -71.6 -55.61 7.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.923 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.8 83.51 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.81 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.841 HD13 HD22 ' A' ' 460' ' ' LEU . 29.2 mt -65.02 -54.24 33.47 Favored 'General case' 0 CA--C 1.477 -1.836 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.244 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.686 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.2 mp0 -52.18 -33.4 40.49 Favored 'General case' 0 N--CA 1.409 -2.515 0 O-C-N 125.21 1.569 . . . . 0.0 110.372 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.683 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -60.07 2.41 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 172.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -75.1 -49.47 19.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.839 -0.538 . . . . 0.0 112.116 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.81 -24.35 64.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.629 0.728 . . . . 0.0 111.774 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.741 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.1 t70 -72.8 -43.4 62.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.528 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.683 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.7 mt-30 -69.67 -8.35 46.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 55.6 mm-40 -51.68 154.96 1.77 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 123.148 1.451 . . . . 0.0 114.267 -176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.562 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -52.68 -32.48 17.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 111.444 -2.616 . . . . 0.0 115.409 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.661 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.5 m-20 -141.88 178.79 7.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.997 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.01 -51.15 67.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -70.77 -23.71 62.46 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 175.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.661 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -59.58 -40.35 87.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 120.011 1.278 . . . . 0.0 109.264 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.602 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 61.8 mtt180 -60.19 -31.25 69.95 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.36 171.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.536 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.36 -28.99 57.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.079 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.4 -43.84 13.29 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.047 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.499 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -103.06 -1.36 29.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.352 -168.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.724 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.6 t80 -48.88 -55.33 12.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.633 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.9 mm -70.32 -25.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.499 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.56 -43.28 63.65 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.543 ' O ' HG23 ' A' ' 463' ' ' VAL . 49.4 m-70 -67.71 -32.06 72.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.541 172.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.841 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.12 -53.39 54.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 122.172 0.987 . . . . 0.0 108.895 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -61.99 -31.1 71.44 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.629 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -67.18 -49.5 64.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.503 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.048 HG11 ' HA ' ' A' ' 435' ' ' VAL . 38.5 t -65.95 -34.38 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.8 m-30 -63.1 -14.6 50.42 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.617 169.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 7.4 tp10 -94.44 -52.29 4.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.889 0.852 . . . . 0.0 111.601 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.78 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.0 pt -63.33 -41.47 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.278 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 469' ' ' LEU . 7.2 mt -83.94 -17.78 39.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.779 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.41 50.13 57.24 Favored Glycine 0 C--O 1.218 -0.882 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.159 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 467' ' ' LEU . 0.6 OUTLIER -100.9 172.78 6.83 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.036 0.934 . . . . 0.0 110.275 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.794 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 16.0 p30 -88.7 -44.16 10.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 166.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -162.18 -72.92 0.05 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.776 162.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.736 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -61.33 68.87 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.47 43.92 0.57 Allowed Glycine 0 C--N 1.275 -2.824 0 CA-C-N 110.715 -2.948 . . . . 0.0 113.564 173.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.794 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 30.3 mm-40 -82.25 -55.62 4.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 122.578 1.18 . . . . 0.0 111.054 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 44.2 t 69.12 55.04 0.42 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.368 -2.651 . . . . 0.0 108.307 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 110.584 -3.007 . . . . 0.0 111.544 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.428 -1.538 0 CA-C-O 121.423 0.63 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.841 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 54.4 mt -72.86 124.65 90.98 Favored Pre-proline 0 N--CA 1.423 -1.794 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.317 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 60.5 Cg_endo -83.0 53.78 4.52 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 124.969 3.779 . . . . 0.0 109.797 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.77 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 2.8 tp -43.06 -46.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 112.237 -2.256 . . . . 0.0 113.672 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.619 ' HG2' HG23 ' A' ' 307' ' ' ILE . 54.4 mm-40 -65.59 -36.29 83.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.692 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.4 t-160 -61.09 -46.21 91.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.315 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 335' ' ' ILE . 68.6 mt -62.84 -49.61 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 124.263 1.025 . . . . 0.0 113.254 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.77 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 22.9 mtp180 -59.27 -30.3 68.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 121.888 -0.507 . . . . 0.0 111.259 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 59.5 m -69.59 -32.72 71.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.557 0.694 . . . . 0.0 110.01 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.552 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.21 -40.58 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.022 177.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 331' ' ' ASN . 35.9 p -82.56 -37.53 25.0 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.788 1.28 . . . . 0.0 109.976 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.04 34.09 7.83 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.817 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 35.7 mt-10 53.52 169.42 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.61 ' HG3' HD12 ' A' ' 355' ' ' LEU . 25.4 Cg_exo -44.06 151.39 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.795 2.997 . . . . 0.0 113.621 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.459 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 17.2 Cg_endo -97.97 -108.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.356 2.704 . . . . 0.0 112.601 -174.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.421 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 9.6 mmm180 -92.47 -82.02 0.33 Allowed 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.592 0.71 . . . . 0.0 111.277 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.473 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 28.3 m-20 -102.63 158.63 31.39 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.133 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.468 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.1 Cg_exo -59.4 -49.67 10.1 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.654 2.236 . . . . 0.0 110.685 172.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -22.56 12.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.224 -1.807 . . . . 0.0 113.035 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.473 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -85.97 -24.37 26.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.718 HG12 HD11 ' A' ' 355' ' ' LEU . 0.0 OUTLIER -51.21 -40.95 71.95 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.706 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.4 Cg_endo -49.8 -62.22 0.45 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.903 2.402 . . . . 0.0 112.773 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.593 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.09 -37.18 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.236 177.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.668 ' CH2' HG21 ' A' ' 354' ' ' ILE . 55.5 t90 -58.35 -36.46 73.48 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.007 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.81 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.85 -49.99 46.97 Favored 'General case' 0 N--CA 1.396 -3.125 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.535 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.08 -24.04 26.63 Favored Glycine 0 C--N 1.311 -0.824 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.151 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.6 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.3 mtt180 -73.99 -41.68 61.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.042 0.925 . . . . 0.0 110.576 174.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.693 ' HB3' HG22 ' A' ' 314' ' ' THR . 56.9 m-20 -95.68 -23.6 16.93 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.82 -169.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.544 ' N ' ' HD2' ' A' ' 333' ' ' PRO . . . -43.5 -48.89 18.5 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.365 1.066 . . . . 0.0 113.727 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.1 Cg_endo -60.03 -34.56 94.73 Favored 'Trans proline' 0 CA--C 1.508 -0.796 0 C-N-CA 122.548 2.166 . . . . 0.0 111.539 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.4 -43.56 60.26 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.476 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 310' ' ' ILE . 97.1 mt -57.95 -48.24 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.872 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.56 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 31.8 t70 -54.27 -15.48 1.6 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.199 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.43 -51.65 4.83 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 310' ' ' ILE . 91.1 t -59.17 -72.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.255 1.502 . . . . 0.0 109.998 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.841 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.4 OUTLIER -87.98 121.07 70.87 Favored Pre-proline 0 N--CA 1.405 -2.69 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.685 -176.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.605 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.3 Cg_endo -72.92 -20.76 21.81 Favored 'Trans proline' 0 CA--C 1.496 -1.422 0 C-N-CA 123.736 2.957 . . . . 0.0 110.362 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.629 HG22 ' CD2' ' A' ' 339' ' ' PHE . 2.7 t 46.07 61.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 111.715 -2.493 . . . . 0.0 109.92 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.626 ' N ' HD12 ' A' ' 346' ' ' LEU . 35.9 p -75.85 5.56 6.24 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.914 -172.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.758 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -141.89 159.28 59.98 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.538 ' O ' ' HB2' ' A' ' 347' ' ' ARG . 56.2 Cg_exo -61.81 -44.3 21.7 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 123.924 3.083 . . . . 0.0 108.994 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.692 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -50.07 -44.17 51.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.037 -1.892 . . . . 0.0 111.523 175.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.819 ' O ' HG13 ' A' ' 350' ' ' ILE . 14.9 mt -59.21 -52.25 66.47 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.546 ' HD3' HG11 ' A' ' 341' ' ' VAL . 11.5 mmt180 -45.3 -52.44 9.71 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 125.249 1.593 . . . . 0.0 110.66 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.928 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -65.66 -49.2 69.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.713 -175.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.672 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 69.7 mtt180 -61.56 -39.31 90.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.888 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.6 mt -57.31 -55.43 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.788 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.351 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.659 ' O ' HD22 ' A' ' 355' ' ' LEU . 20.1 mt -57.65 -53.34 45.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 O-C-N 124.764 1.29 . . . . 0.0 110.736 -170.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 11.7 m-20 -63.14 -36.46 83.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.211 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . 0.658 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -71.46 -30.61 66.21 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.173 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.888 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.2 mm -56.04 -58.09 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 CA-C-O 122.797 1.284 . . . . 0.0 110.312 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.718 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.99 -26.77 54.27 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.086 -2.325 . . . . 0.0 109.726 -168.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 73.69 -71.47 1.34 Allowed Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.93 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -113.21 37.88 3.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.941 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.724 HD22 ' HB2' ' A' ' 361' ' ' LEU . 20.2 p-10 -66.99 133.61 50.3 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.042 0.448 . . . . 0.0 110.563 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.663 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.1 mp -51.01 -77.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 124.409 1.084 . . . . 0.0 112.871 -169.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -124.92 7.0 8.26 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.492 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.724 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.6 mt -72.39 -4.63 31.19 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.67 0.748 . . . . 0.0 109.655 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.601 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 23.1 t -63.84 76.95 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.332 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.739 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -62.55 173.48 1.24 Allowed 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.7 p -122.05 156.39 59.89 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.896 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.928 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 6.7 Cg_endo -56.76 -3.54 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.856 2.37 . . . . 0.0 114.286 -172.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.477 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -104.59 -12.05 29.42 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.739 ' HB2' HD12 ' A' ' 363' ' ' LEU . 16.1 m-20 -109.25 -20.39 12.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.023 0.916 . . . . 0.0 110.853 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 17.1 p -96.75 15.21 22.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.117 -164.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' A' ' 344' ' ' PRO . 1.3 mt -58.75 -40.98 85.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.879 -161.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.88 163.15 16.98 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.223 170.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.573 ' O ' HG13 ' A' ' 375' ' ' VAL . 41.3 m95 -68.81 -35.74 77.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.547 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.2 p30 -62.73 -40.2 96.45 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.875 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.7 m -71.39 -41.04 70.14 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.066 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.568 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -66.53 -52.19 48.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.81 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.8 m -56.38 -45.36 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.377 0.608 . . . . 0.0 109.86 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.043 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.93 -42.37 93.81 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.105 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.632 ' CG2' HD21 ' A' ' 363' ' ' LEU . 19.6 m -70.81 -36.86 73.15 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.232 -172.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -62.99 -33.32 75.15 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.425 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.706 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.1 t80 -75.6 -44.5 42.63 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.433 1.111 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.45 -33.22 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.503 169.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.67 -41.69 95.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.168 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 28.7 p -99.91 -22.99 15.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.123 -168.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . 0.591 ' HB3' HE22 ' A' ' 390' ' ' GLN . 36.6 m80 -111.14 22.64 15.01 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.21 20.9 16.97 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.422 HG23 HG13 ' A' ' 380' ' ' ILE . 2.7 m 66.96 159.87 0.14 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.265 0.533 . . . . 0.0 111.519 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -127.93 156.06 76.65 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -97.95 54.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.46 2.773 . . . . 0.0 111.643 168.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.756 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.28 -1.27 0.14 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -69.79 -46.12 66.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.143 0.497 . . . . 0.0 110.938 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.633 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.6 mt-30 -74.7 -25.59 59.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -53.87 -30.62 46.55 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.772 0.715 . . . . 0.0 111.283 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.667 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.47 -50.23 57.64 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.509 174.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.565 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 5.7 m-20 -67.89 -40.56 83.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.852 0.461 . . . . 0.0 111.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.14 -44.12 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.003 0.43 . . . . 0.0 110.438 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.703 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -58.35 -47.12 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.18 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.684 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 32.3 mmtt -53.07 -41.39 64.83 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.097 0.873 . . . . 0.0 111.897 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -76.75 -44.64 14.66 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.025 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.879 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -69.96 -40.81 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 117.302 0.551 . . . . 0.0 111.767 -178.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.871 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.0 m -57.75 -43.47 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.745 0.783 . . . . 0.0 109.721 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.48 ' N ' HG23 ' A' ' 399' ' ' VAL . 17.6 t70 -56.15 -43.7 78.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.252 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 33.1 mm-40 -84.1 -54.27 4.95 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.47 -172.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -110.58 -29.34 8.09 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.516 0.674 . . . . 0.0 112.535 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.78 171.38 14.04 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.688 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.871 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.3 -44.42 97.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.672 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.18 -51.05 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.927 0.394 . . . . 0.0 112.005 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.595 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.2 m -64.18 -51.2 64.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.553 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.879 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.55 -43.15 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 30.3 t80 -55.58 -46.32 77.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.686 0.755 . . . . 0.0 109.197 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.831 ' O ' ' HG3' ' A' ' 413' ' ' MET . 13.0 m -57.92 -52.68 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.353 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.674 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.66 -48.74 80.45 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.537 ' HA3' HD11 ' A' ' 395' ' ' ILE . . . -56.32 -42.62 89.13 Favored Glycine 0 C--N 1.313 -0.724 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.003 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.861 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -72.71 -32.52 65.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.823 0.311 . . . . 0.0 110.833 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.831 ' HG3' ' O ' ' A' ' 409' ' ' THR . 62.5 mtm -69.36 -46.6 66.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.09 174.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.043 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.16 -39.17 85.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.74 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.765 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -77.1 -16.87 59.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.057 -178.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.84 47.01 3.78 Favored Glycine 0 C--N 1.308 -1.018 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.024 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.687 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 0.0 OUTLIER 49.71 48.69 21.24 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.521 1.128 . . . . 0.0 113.892 -177.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.765 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -123.57 66.0 1.01 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.861 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 14.4 p90 -51.48 -31.84 25.02 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.701 -161.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 34.1 mt-30 -53.89 -43.25 69.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.596 -165.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.657 HD21 ' ND2' ' A' ' 418' ' ' ASN . 2.0 pp -63.06 -48.1 80.1 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.329 0.585 . . . . 0.0 110.855 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.754 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -62.31 -38.97 82.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.588 1.185 . . . . 0.0 109.101 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 30.7 t -59.64 -45.95 90.45 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.301 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.47 87.27 Favored Glycine 0 C--N 1.316 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.844 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.1 mt -71.09 -41.31 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.501 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -56.43 -43.98 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.285 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.676 ' HD2' ' O ' ' A' ' 427' ' ' ARG . 1.8 tmm_? -56.97 -35.38 69.08 Favored 'General case' 0 N--CA 1.406 -2.647 0 C-N-CA 124.962 1.305 . . . . 0.0 109.837 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.74 -13.12 74.93 Favored Glycine 0 C--N 1.29 -1.985 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.948 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.5 m-85 -100.08 -3.64 31.49 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -59.24 142.96 85.71 Favored Pre-proline 0 N--CA 1.412 -2.329 0 CA-C-O 123.438 1.59 . . . . 0.0 112.875 173.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.781 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 88.5 Cg_endo -72.23 -53.25 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.083 4.522 . . . . 0.0 113.338 -170.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -120.94 140.33 14.08 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.894 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -63.19 -26.53 68.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.164 0.482 . . . . 0.0 111.776 -175.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.683 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.2 -48.46 78.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.018 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.4 t -58.44 -51.89 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.705 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.8 OUTLIER -54.87 -51.43 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 118.096 0.407 . . . . 0.0 109.945 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.447 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 86.4 m -62.67 -57.33 11.39 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.14 -44.76 79.54 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.368 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.85 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.0 mt -59.72 -53.71 54.83 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.73 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.708 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 39.1 mm-40 -51.5 -35.14 39.05 Favored 'General case' 0 N--CA 1.417 -2.123 0 O-C-N 124.899 1.374 . . . . 0.0 110.669 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.624 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.32 -60.37 2.28 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 176.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.74 -51.71 10.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.378 0.535 . . . . 0.0 112.385 -172.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.74 -25.46 63.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.522 0.677 . . . . 0.0 111.575 -177.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.777 ' N ' HD23 ' A' ' 443' ' ' LEU . 10.7 t70 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.657 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 34.6 mt-30 -71.56 -6.85 43.8 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.471 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 25.2 mm-40 -51.86 161.25 0.58 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 123.662 1.696 . . . . 0.0 114.614 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.516 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -56.99 -33.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 110.443 -3.071 . . . . 0.0 115.199 -172.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.683 ' H ' ' HB ' ' A' ' 451' ' ' THR . 66.4 m-20 -138.96 179.99 6.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.441 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 8.9 p-10 -64.43 -55.32 21.67 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -68.28 -23.52 64.77 Favored 'General case' 0 N--CA 1.402 -2.868 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 176.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.683 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 25.4 m -58.82 -41.51 87.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.756 1.162 . . . . 0.0 109.677 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 48.2 mtt180 -60.16 -30.0 69.04 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.201 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.591 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.03 -33.64 59.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 109.877 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.02 -42.83 31.23 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.333 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 38.3 p -101.34 -4.18 27.46 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.375 -169.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.705 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.4 t80 -49.25 -52.82 24.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.846 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 405' ' ' ALA . 22.9 mm -71.75 -27.01 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -72.56 -42.45 64.65 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.583 ' O ' HG23 ' A' ' 463' ' ' VAL . 25.9 m80 -67.6 -31.17 71.03 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.473 -1.694 . . . . 0.0 109.96 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.77 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.41 -54.05 34.32 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 122.188 0.994 . . . . 0.0 109.165 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.733 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -62.26 -32.31 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.034 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.68 -53.27 58.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.922 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.018 HG11 ' HA ' ' A' ' 435' ' ' VAL . 25.9 t -63.45 -34.27 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-O 121.806 0.812 . . . . 0.0 110.287 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.607 ' HD1' HD12 ' A' ' 469' ' ' LEU . 20.2 m-30 -60.93 -14.39 22.22 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.191 169.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.733 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 45.0 mt-10 -93.81 -48.37 6.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.824 -1.173 . . . . 0.0 112.652 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.712 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.4 pt -64.6 -39.94 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.049 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.841 HD12 HD11 ' A' ' 469' ' ' LEU . 7.3 mt -84.46 -16.84 41.11 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.802 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.02 51.05 56.49 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 111.73 -2.486 . . . . 0.0 113.219 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.841 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -101.28 177.4 4.94 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.13 0.972 . . . . 0.0 109.88 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.694 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.5 p30 -96.46 -44.11 7.33 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -157.39 -74.61 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.457 -2.156 . . . . 0.0 110.351 160.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.781 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -59.01 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -172.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.96 42.69 0.37 Allowed Glycine 0 C--N 1.275 -2.854 0 CA-C-N 111.423 -2.626 . . . . 0.0 113.613 173.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.694 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 31.2 mm-40 -81.32 -51.99 7.78 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 122.79 1.281 . . . . 0.0 111.453 -172.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.4 t 68.91 61.47 0.33 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.171 -2.74 . . . . 0.0 109.037 -173.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.802 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 110.923 -2.853 . . . . 0.0 111.463 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.43 -1.472 0 CA-C-O 121.032 0.444 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.768 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 31.9 mt -78.74 125.56 84.02 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 121.89 0.852 . . . . 0.0 111.878 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 308' ' ' GLN . 26.0 Cg_endo -74.97 -12.04 21.57 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.99 3.793 . . . . 0.0 111.663 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.71 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.1 tp 30.31 -64.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 O-C-N 126.973 2.671 . . . . 0.0 115.996 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.709 ' HG2' HG23 ' A' ' 307' ' ' ILE . 66.6 mm-40 -58.24 -33.24 69.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.466 0.65 . . . . 0.0 110.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.543 ' CD2' HG22 ' A' ' 338' ' ' VAL . 5.7 t-160 -61.42 -48.83 79.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.646 172.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 307' ' ' ILE . 64.2 mt -59.06 -48.38 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 124.111 0.965 . . . . 0.0 112.51 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.5 mtp-105 -58.33 -30.83 67.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 122.613 0.365 . . . . 0.0 111.456 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.7 m -69.92 -33.22 71.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.573 0.701 . . . . 0.0 109.882 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.51 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.15 -40.49 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.785 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.659 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.22 -36.7 26.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.646 1.212 . . . . 0.0 110.024 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.26 34.72 7.91 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.107 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 45.9 mt-10 56.77 165.81 0.07 OUTLIER Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.666 ' HG3' HD12 ' A' ' 355' ' ' LEU . 43.0 Cg_exo -44.97 147.31 2.03 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.517 2.812 . . . . 0.0 113.032 175.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 39.6 Cg_endo -93.16 -104.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.358 2.705 . . . . 0.0 112.169 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.413 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 10.8 mmt180 -95.92 -85.21 0.33 Allowed 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 121.259 0.552 . . . . 0.0 111.113 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 16.5 m-20 -97.37 164.46 17.64 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.733 -175.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 -49.39 10.92 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.655 2.237 . . . . 0.0 110.546 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.411 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -56.55 -13.96 2.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.309 -1.768 . . . . 0.0 113.401 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 14.9 mt-10 -90.52 -29.2 18.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.374 -0.204 . . . . 0.0 111.201 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.746 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.7 -42.87 70.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.715 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.8 Cg_endo -47.65 -63.74 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.097 2.531 . . . . 0.0 113.05 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.599 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.97 -36.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.428 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.659 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 44.7 t90 -57.82 -36.08 71.74 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.83 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.822 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.55 -49.74 44.83 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.435 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.78 -23.74 23.17 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.804 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.595 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -74.35 -42.19 59.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.947 0.88 . . . . 0.0 110.948 173.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.658 ' HB3' HG22 ' A' ' 314' ' ' THR . 52.6 m-20 -94.78 -24.05 17.26 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.492 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.43 -49.65 12.38 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.8 Cg_endo -61.66 -32.9 87.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.564 2.176 . . . . 0.0 111.662 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.75 -44.43 56.22 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.305 -1.77 . . . . 0.0 109.547 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 332' ' ' ALA . 93.6 mt -56.11 -47.74 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.934 173.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.0 -13.96 2.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.6 -1.636 . . . . 0.0 112.327 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.59 -51.15 4.7 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.529 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.587 HG11 HG13 ' A' ' 310' ' ' ILE . 83.2 t -58.68 -71.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 123.351 1.548 . . . . 0.0 109.743 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.768 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.29 123.64 72.88 Favored Pre-proline 0 N--CA 1.402 -2.853 0 CA-C-N 111.261 -2.7 . . . . 0.0 111.953 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.726 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.5 Cg_endo -72.36 -17.1 27.52 Favored 'Trans proline' 0 CA--C 1.494 -1.485 0 C-N-CA 124.163 3.242 . . . . 0.0 110.543 175.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.5 p 33.29 69.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 111.907 -2.406 . . . . 0.0 110.088 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.585 ' N ' HD12 ' A' ' 346' ' ' LEU . 62.4 p -80.72 6.06 13.92 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.844 -170.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.787 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 14.7 p -143.06 160.71 51.62 Favored Pre-proline 0 N--CA 1.434 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.68 ' HB3' HD12 ' A' ' 369' ' ' LEU . 50.6 Cg_exo -62.62 -45.05 15.11 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.591 2.861 . . . . 0.0 108.739 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.653 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -44.78 -52.24 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.784 175.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.787 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.6 mt -56.72 -51.55 68.41 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.852 ' HA ' HD12 ' A' ' 350' ' ' ILE . 17.7 ttm-85 -49.79 -47.84 50.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.595 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 1.084 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -68.15 -48.07 66.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.472 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.653 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 53.7 mtt180 -60.25 -37.77 81.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.113 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.883 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -56.87 -52.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.572 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.655 HG12 HD11 ' A' ' 328' ' ' LEU . 21.1 mt -58.56 -53.38 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.905 0.86 . . . . 0.0 111.248 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.564 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 18.6 m-20 -63.13 -36.2 82.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.987 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.89 -29.5 65.61 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.79 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.883 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.14 -60.13 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.052 1.406 . . . . 0.0 110.067 173.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.746 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -74.55 -27.53 60.56 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 111.961 -2.381 . . . . 0.0 109.883 -167.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.98 -71.68 0.29 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.941 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -111.68 54.05 0.56 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.731 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -84.93 133.28 34.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -47.84 -73.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 124.042 0.937 . . . . 0.0 112.664 -170.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.27 5.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.192 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.731 ' HB2' HD22 ' A' ' 358' ' ' ASN . 3.6 mt -69.98 -5.08 23.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.587 0.708 . . . . 0.0 110.127 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.564 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 25.2 t -59.12 82.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.393 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.749 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.8 OUTLIER -65.55 178.38 1.0 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.791 177.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.7 p -122.02 153.94 61.09 Favored Pre-proline 0 N--CA 1.437 -1.088 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.926 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 3.2 Cg_exo -53.94 -11.14 2.26 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.007 2.472 . . . . 0.0 113.107 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -111.29 -2.19 27.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.749 ' HB2' HD12 ' A' ' 363' ' ' LEU . 19.4 m-20 -106.32 -21.62 13.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.741 1.27 . . . . 0.0 110.542 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 1.084 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 34.8 t -98.24 25.29 6.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.597 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.57 -34.3 61.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.127 0.965 . . . . 0.0 109.806 -173.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.42 159.04 24.99 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.869 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.636 ' O ' HG13 ' A' ' 375' ' ' VAL . 46.4 m95 -68.91 -35.71 77.15 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.602 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -59.54 -46.85 87.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.126 -176.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 62.4 m -67.29 -41.9 84.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.111 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.607 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.48 63.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.822 HG12 ' HB3' ' A' ' 328' ' ' LEU . 14.4 m -57.87 -44.43 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.588 0.709 . . . . 0.0 109.603 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.0 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.46 -41.08 96.68 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.102 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.671 HG21 HD11 ' A' ' 363' ' ' LEU . 22.4 m -71.47 -39.14 71.12 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.619 -173.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -61.58 -33.45 73.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.31 0.576 . . . . 0.0 110.328 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.715 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 41.6 t80 -73.08 -47.16 46.97 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.211 1.005 . . . . 0.0 109.489 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.45 -32.77 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 113.14 -1.845 . . . . 0.0 111.796 169.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.26 -32.72 71.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 123.014 0.525 . . . . 0.0 111.564 175.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.0 p -109.01 -23.65 11.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.388 -167.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -110.52 22.51 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.23 17.91 33.15 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 114.47 0.548 . . . . 0.0 114.47 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.444 HG23 HG13 ' A' ' 380' ' ' ILE . 2.0 m 66.2 160.41 0.14 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.232 0.539 . . . . 0.0 111.374 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.557 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -128.2 155.67 77.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -101.88 63.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.972 3.115 . . . . 0.0 111.216 164.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.73 ' HA ' HD23 ' A' ' 391' ' ' LEU . 3.4 mmt 53.01 5.55 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -70.32 -48.2 57.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.247 0.546 . . . . 0.0 111.173 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.614 ' O ' HG13 ' A' ' 394' ' ' VAL . 78.1 mt-30 -75.61 -28.69 58.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.872 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -54.62 -31.28 57.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.61 0.641 . . . . 0.0 112.157 -170.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.894 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.42 -51.93 48.22 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.862 -1.161 . . . . 0.0 110.543 173.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.585 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 8.8 m-20 -68.56 -38.21 80.57 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 122.95 0.5 . . . . 0.0 112.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 398' ' ' ILE . 1.6 m -58.16 -44.72 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 399' ' ' VAL . 9.5 mm -58.47 -48.35 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.214 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.2 mmtt -52.8 -40.27 63.11 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 124.051 0.845 . . . . 0.0 112.031 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.94 -44.88 13.0 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.926 -173.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.872 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.3 mt -69.65 -41.9 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 117.33 0.565 . . . . 0.0 111.686 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.899 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.3 m -57.28 -45.21 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.609 0.719 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.9 t70 -60.85 -37.16 81.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.193 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 27.1 mt-30 -88.31 -52.67 5.08 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.557 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -113.26 -30.67 6.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.963 -167.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.69 164.5 11.65 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.754 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.899 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -64.04 -42.54 96.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -175.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.602 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -58.12 -50.32 73.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.791 0.329 . . . . 0.0 111.511 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.595 HG21 ' HD2' ' A' ' 330' ' ' ARG . 0.9 OUTLIER -62.31 -52.41 63.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.872 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -42.67 66.18 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.568 ' HB3' HD11 ' A' ' 457' ' ' ILE . 39.1 t80 -56.15 -47.08 78.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.567 0.699 . . . . 0.0 109.226 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.823 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.3 m -58.86 -53.01 63.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.743 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.695 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.67 -49.23 78.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.783 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.08 -43.05 88.47 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.042 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.63 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.03 -31.37 66.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.773 0.287 . . . . 0.0 111.158 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.823 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.2 mtm -70.92 -46.53 62.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.669 0.747 . . . . 0.0 109.599 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.0 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.78 -42.0 92.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.066 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.872 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 74.8 m -78.76 2.48 19.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.34 53.86 9.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.363 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.63 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.4 mp0 46.01 56.98 5.55 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.85 0.86 . . . . 0.0 112.926 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.854 HD22 HD22 ' A' ' 421' ' ' LEU . 48.1 t30 -122.47 65.63 0.94 Allowed 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 162.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.579 ' O ' HG22 ' A' ' 422' ' ' VAL . 0.3 OUTLIER -48.79 -36.28 16.27 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.594 -173.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' A' ' 423' ' ' SER . 45.0 mt-30 -57.08 -50.58 72.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -168.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.854 HD22 HD22 ' A' ' 418' ' ' ASN . 0.2 OUTLIER -59.37 -50.43 73.98 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.365 -178.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.811 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.35 -38.27 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 122.675 1.226 . . . . 0.0 109.233 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 19.2 t -59.94 -49.63 76.94 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.299 -2.228 . . . . 0.0 111.585 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.69 -36.13 77.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.375 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.894 HD13 ' HA2' ' A' ' 392' ' ' GLY . 4.3 mt -72.51 -39.72 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.627 0.727 . . . . 0.0 110.112 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 404' ' ' VAL . 1.7 mm -62.76 -41.63 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.569 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.615 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -57.18 -34.4 68.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 125.916 1.686 . . . . 0.0 108.64 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -73.01 -11.57 78.92 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.725 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.638 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.9 m-85 -105.52 -0.27 26.0 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.7 mm? -58.01 141.35 81.35 Favored Pre-proline 0 N--CA 1.412 -2.328 0 CA-C-O 123.566 1.65 . . . . 0.0 113.411 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.755 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 57.6 Cg_endo -70.04 -60.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 1 C-N-CA 126.444 4.763 . . . . 0.0 113.43 -170.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -110.09 141.45 16.23 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.897 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -59.58 -30.07 68.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.361 0.58 . . . . 0.0 111.831 -174.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.824 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.05 -48.96 77.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.009 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.6 t -62.86 -35.6 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.524 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.897 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.14 -46.63 57.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 38.4 m -72.65 -54.21 9.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.337 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.53 -46.16 80.76 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.342 0.401 . . . . 0.0 111.348 -174.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.818 HD13 HD22 ' A' ' 460' ' ' LEU . 17.7 mt -60.92 -54.2 47.97 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.71 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.684 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.77 -33.6 35.94 Favored 'General case' 0 N--CA 1.407 -2.596 0 O-C-N 125.709 1.881 . . . . 0.0 110.64 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.66 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -59.86 2.52 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -47.53 27.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.581 0.628 . . . . 0.0 111.66 -173.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 444' ' ' ASP . 0.1 OUTLIER -59.23 -25.24 63.85 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 111.427 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.773 ' N ' HD23 ' A' ' 443' ' ' LEU . 13.4 t70 -73.94 -42.2 60.9 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.795 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.66 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 40.9 mt-30 -70.65 -9.74 57.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -172.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.59 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 38.4 mm-40 -50.28 157.73 0.65 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 123.361 1.553 . . . . 0.0 115.094 -174.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.589 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.27 -32.41 19.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 110.937 -2.847 . . . . 0.0 115.408 -170.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.652 ' H ' ' HB ' ' A' ' 451' ' ' THR . 9.2 m-20 -140.93 178.64 7.22 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.4 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 2.3 m-20 -62.56 -54.51 38.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -66.78 -24.27 66.17 Favored 'General case' 0 N--CA 1.404 -2.736 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 176.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.652 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.5 m -59.45 -40.96 88.55 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 119.992 1.269 . . . . 0.0 109.388 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.59 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 67.0 mtt180 -61.82 -29.29 70.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.304 172.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.492 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -31.73 60.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.041 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.05 -42.98 13.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.47 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.502 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.4 p -101.88 -0.94 33.19 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.723 -170.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.652 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.1 t80 -49.29 -55.96 11.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.003 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.621 ' HA ' ' HB2' ' A' ' 460' ' ' LEU . 24.6 mm -70.05 -24.73 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.502 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.72 -44.66 61.42 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.542 ' O ' HG23 ' A' ' 463' ' ' VAL . 47.3 m-70 -65.49 -32.02 73.4 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.15 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.818 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.54 -53.82 41.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.209 1.004 . . . . 0.0 109.263 -178.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -61.96 -30.42 70.91 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.187 -1.824 . . . . 0.0 110.74 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.76 -48.48 66.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.009 HG11 ' HA ' ' A' ' 435' ' ' VAL . 42.2 t -66.76 -34.71 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.489 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.546 ' OH ' HG13 ' A' ' 404' ' ' VAL . 19.2 m-30 -62.21 -13.96 33.09 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.617 167.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.573 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.8 tp10 -93.41 -52.94 4.28 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.414 -0.804 . . . . 0.0 112.242 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.739 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.3 pt -62.07 -41.73 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.132 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.4 mt -84.14 -17.34 40.39 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.732 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.63 49.87 57.51 Favored Glycine 0 C--O 1.219 -0.801 0 CA-C-N 111.515 -2.584 . . . . 0.0 113.223 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -102.68 -179.17 3.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 123.861 0.864 . . . . 0.0 110.402 -178.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.643 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.0 p30 -100.82 -40.6 7.23 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -160.73 -76.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.121 160.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.755 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -64.32 67.81 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 41.04 39.84 2.16 Favored Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.425 -2.625 . . . . 0.0 113.361 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.643 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 9.9 mm-40 -79.19 -51.87 8.92 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.529 1.157 . . . . 0.0 111.324 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.6 t 64.7 61.44 0.82 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 111.806 -2.452 . . . . 0.0 109.24 -172.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-N 110.391 -3.095 . . . . 0.0 111.49 171.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.429 -1.504 0 CA-C-O 121.118 0.485 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.81 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 33.4 mt -74.1 125.57 89.99 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-O 122.222 1.011 . . . . 0.0 112.221 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 308' ' ' GLN . 29.4 Cg_endo -74.58 -16.99 21.07 Favored 'Trans proline' 0 CA--C 1.503 -1.042 0 C-N-CA 124.954 3.77 . . . . 0.0 111.193 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.736 HG23 ' HG2' ' A' ' 308' ' ' GLN . 4.3 tp 36.82 -64.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 C-N-CA 128.225 2.61 . . . . 0.0 115.881 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.736 ' HG2' HG23 ' A' ' 307' ' ' ILE . 62.1 mm-40 -58.58 -34.03 70.62 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.561 0.696 . . . . 0.0 110.344 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.566 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.04 -47.99 83.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.927 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 335' ' ' ILE . 67.6 mt -61.75 -49.22 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 124.253 1.021 . . . . 0.0 112.624 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 0.9 OUTLIER -58.26 -31.4 67.39 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 122.697 0.399 . . . . 0.0 111.369 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 27.5 t -69.88 -33.34 72.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.533 0.682 . . . . 0.0 109.664 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.563 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.82 -41.02 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.659 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 331' ' ' ASN . 35.5 p -82.91 -35.89 25.75 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.733 1.254 . . . . 0.0 110.206 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.27 32.06 12.85 Favored Glycine 0 C--N 1.302 -1.342 0 CA-C-N 112.305 -2.225 . . . . 0.0 110.696 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.4 mt-10 51.79 172.86 0.03 OUTLIER Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 324' ' ' ILE . 71.8 Cg_exo -48.15 149.46 6.05 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.994 2.462 . . . . 0.0 113.687 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.48 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 16.3 Cg_endo -97.62 -106.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.992 3.128 . . . . 0.0 113.183 -171.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.466 ' H ' ' HG2' ' A' ' 319' ' ' ARG . 2.9 mmm180 -88.91 -78.37 0.35 Allowed 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 123.239 0.616 . . . . 0.0 110.506 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.493 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.9 m-20 -108.88 160.69 26.44 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.067 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.3 Cg_exo -60.13 -48.17 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 122.544 2.163 . . . . 0.0 110.107 168.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.457 ' HA ' HG21 ' A' ' 382' ' ' THR . 1.9 mmt180 -46.83 -26.19 0.92 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.851 -1.977 . . . . 0.0 112.743 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.493 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -93.52 -22.0 19.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.701 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -47.71 -42.48 45.4 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.748 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.3 Cg_endo -46.38 -64.8 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.185 2.59 . . . . 0.0 113.009 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.606 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.21 -37.02 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.209 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.72 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 54.5 t90 -58.55 -36.44 73.92 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.139 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.815 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.94 -49.96 46.73 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.512 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.22 -23.65 26.2 Favored Glycine 0 C--N 1.311 -0.817 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.156 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.7 mtt180 -73.6 -41.73 62.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.128 0.966 . . . . 0.0 110.598 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.725 ' HB3' HG22 ' A' ' 314' ' ' THR . 55.9 m-20 -97.57 -22.7 16.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.023 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.566 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -43.3 -48.65 16.83 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.2 Cg_endo -61.02 -33.67 91.67 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 122.584 2.19 . . . . 0.0 111.606 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.406 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -73.26 -42.73 62.17 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.559 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 310' ' ' ILE . 98.6 mt -57.79 -49.3 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.055 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 27.3 t70 -53.43 -17.57 2.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.501 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.24 5.75 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.024 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.66 HG11 HG13 ' A' ' 310' ' ' ILE . 85.3 t -58.24 -71.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-O 123.354 1.55 . . . . 0.0 110.205 170.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.81 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -87.63 124.43 67.62 Favored Pre-proline 0 N--CA 1.406 -2.675 0 CA-C-N 111.288 -2.687 . . . . 0.0 111.863 -175.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.695 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.5 Cg_endo -72.57 -19.24 24.88 Favored 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 123.809 3.006 . . . . 0.0 110.41 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.4 p 33.35 70.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.233 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 346' ' ' LEU . 63.4 p -80.83 3.78 21.39 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.749 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.789 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 28.2 p -141.78 154.54 65.9 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -60.15 -36.79 87.47 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 124.323 3.349 . . . . 0.0 109.563 171.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.634 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.7 -53.41 39.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.602 172.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.789 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.8 mt -56.73 -54.76 42.49 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.027 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.617 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 33.3 ttm105 -50.26 -41.17 49.99 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 125.511 1.757 . . . . 0.0 110.61 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.513 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 52.1 t -67.76 -48.94 64.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.666 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.6 mtt180 -61.11 -38.3 85.85 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.598 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.901 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.1 mt -57.14 -54.63 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.254 -0.579 . . . . 0.0 111.528 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.642 ' O ' HD22 ' A' ' 355' ' ' LEU . 14.9 mt -56.98 -54.39 30.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 124.566 1.166 . . . . 0.0 110.812 -171.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.589 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 37.0 m-20 -64.66 -34.57 78.6 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.288 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.12 67.56 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.94 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.901 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.5 mm -56.7 -58.35 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-O 122.821 1.296 . . . . 0.0 110.539 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.701 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.35 -26.71 55.98 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.007 -2.36 . . . . 0.0 109.871 -168.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.28 -68.84 0.68 Allowed Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.611 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -114.92 35.62 4.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.932 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.767 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -66.95 127.61 33.22 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.047 0.451 . . . . 0.0 110.794 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.668 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -49.0 -70.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.985 -169.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.67 5.17 7.05 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.443 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.767 ' HB2' HD22 ' A' ' 358' ' ' ASN . 4.4 mt -72.68 -3.59 25.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.557 0.694 . . . . 0.0 110.199 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.589 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 11.3 t -62.29 83.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.843 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.819 HD11 HG21 ' A' ' 377' ' ' THR . 1.7 mm? -62.7 -174.24 0.06 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.905 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 63.8 p -125.11 157.41 67.21 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 23.4 Cg_exo -49.14 -31.63 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.839 1.693 . . . . 0.0 111.072 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -87.4 -3.78 81.27 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.961 -172.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.754 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.4 m-20 -104.88 -21.0 13.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.223 1.011 . . . . 0.0 109.274 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 65.1 m -86.14 23.69 1.48 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.402 -171.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.86 -36.29 72.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.045 0.926 . . . . 0.0 109.835 -174.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.88 162.43 26.72 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.392 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.612 ' O ' HG13 ' A' ' 375' ' ' VAL . 41.8 m95 -70.62 -36.65 73.59 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.588 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.15 -39.93 83.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.911 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 75.3 p -73.41 -43.69 59.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.29 -52.38 63.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.836 HG21 ' HE3' ' A' ' 413' ' ' MET . 14.0 m -57.28 -44.08 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.611 0.719 . . . . 0.0 109.548 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 0.998 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.08 -44.14 97.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.041 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.819 HG21 HD11 ' A' ' 363' ' ' LEU . 29.3 m -69.34 -38.19 78.04 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.168 -172.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 3.0 mt -61.05 -33.71 73.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 110.473 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.748 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.5 t80 -75.76 -45.01 38.7 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.308 1.052 . . . . 0.0 109.233 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.12 -33.25 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.147 170.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.9 OUTLIER -60.78 -47.1 87.85 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.734 0.778 . . . . 0.0 110.899 176.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 322' ' ' ARG . 37.8 p -93.93 -23.36 18.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.998 -166.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . 0.478 ' HB3' HE22 ' A' ' 390' ' ' GLN . 52.7 m80 -111.22 23.08 14.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.22 20.84 30.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.639 0.616 . . . . 0.0 114.639 173.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.457 HG23 HG13 ' A' ' 380' ' ' ILE . 2.9 m 64.13 157.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -175.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.498 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.1 OUTLIER -121.81 157.52 57.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.068 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -96.5 52.54 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.481 2.787 . . . . 0.0 111.783 168.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.754 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.02 -8.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -177.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -69.56 -42.81 74.03 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.042 -0.411 . . . . 0.0 110.943 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.691 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.2 mt-30 -68.32 -27.11 66.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.754 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -53.5 -30.16 39.9 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.342 0.519 . . . . 0.0 111.015 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.86 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.81 -51.88 50.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.676 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.569 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.1 m-20 -69.73 -37.0 76.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.982 0.513 . . . . 0.0 112.085 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 390' ' ' GLN . 1.4 m -58.3 -47.72 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.58 ' O ' HG22 ' A' ' 399' ' ' VAL . 4.3 mm -57.99 -48.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 173.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.569 ' HE3' ' HA ' ' A' ' 393' ' ' ASN . 0.2 OUTLIER -52.43 -46.32 66.34 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.836 -177.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.91 50.19 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.018 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.871 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -70.59 -41.49 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 117.143 0.472 . . . . 0.0 111.7 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.5 m -56.45 -41.91 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.809 0.814 . . . . 0.0 110.181 -177.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.471 ' N ' HG23 ' A' ' 399' ' ' VAL . 0.8 OUTLIER -67.49 -34.61 77.48 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.07 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -85.47 -54.67 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -107.8 -30.77 8.34 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.692 0.758 . . . . 0.0 112.329 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.38 170.71 14.01 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.532 -175.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.789 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.82 -45.11 95.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -172.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.32 -50.57 72.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.612 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.1 m -63.06 -51.15 67.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.871 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.7 -43.93 69.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.544 ' HB3' HD11 ' A' ' 457' ' ' ILE . 34.0 t80 -54.7 -45.23 73.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.735 0.779 . . . . 0.0 109.157 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.841 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.2 m -59.33 -52.65 64.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.502 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.698 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.42 -49.35 77.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.081 176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.592 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.12 -42.83 88.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.906 -173.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.771 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -31.6 65.56 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.541 0.17 . . . . 0.0 111.121 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.841 ' HG3' ' O ' ' A' ' 409' ' ' THR . 57.7 mtm -70.97 -45.58 63.86 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.381 0.61 . . . . 0.0 109.655 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.998 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.3 mt -60.28 -39.44 86.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.481 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.648 ' HB2' HD21 ' A' ' 421' ' ' LEU . 6.6 p -76.44 -2.57 32.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.766 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 79.78 31.04 41.36 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.771 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 4.0 mm-40 68.12 52.63 0.66 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.134 -1.033 . . . . 0.0 111.668 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.722 ' O ' HD23 ' A' ' 421' ' ' LEU . 22.9 t30 -117.41 74.9 0.95 Allowed 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 160.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.712 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.3 OUTLIER -53.98 -35.95 62.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.143 -173.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.545 ' O ' ' HB3' ' A' ' 423' ' ' SER . 25.2 mt-30 -57.61 -49.77 75.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -168.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.779 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 0.2 OUTLIER -59.59 -50.43 73.91 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.34 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.779 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.28 -38.2 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.738 1.256 . . . . 0.0 109.269 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.545 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 24.5 t -59.59 -50.46 73.81 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 112.271 -2.24 . . . . 0.0 111.473 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.99 71.39 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.302 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.86 HD13 ' HA2' ' A' ' 392' ' ' GLY . 6.1 mt -73.15 -40.91 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.72 0.772 . . . . 0.0 110.484 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.597 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -63.42 -42.75 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.228 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.703 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.1 OUTLIER -59.77 -31.17 69.41 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.714 -176.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.46 -20.12 79.25 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.108 174.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.499 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.0 m-85 -98.45 1.96 47.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -176.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.44 145.64 67.27 Favored Pre-proline 0 N--CA 1.417 -2.09 0 CA-C-O 123.647 1.689 . . . . 0.0 113.83 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.768 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 60.1 Cg_endo -71.53 -64.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 1 C-N-CA 126.099 4.533 . . . . 0.0 113.063 -172.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.566 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.49 140.2 15.28 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.133 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.829 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.16 -27.17 68.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.948 0.374 . . . . 0.0 111.8 -176.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.761 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -59.92 -47.24 86.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.067 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -60.42 -51.7 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.232 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.909 ' O ' ' HG2' ' A' ' 440' ' ' GLN . 0.7 OUTLIER -51.76 -59.52 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 66.5 m -61.21 -55.52 31.14 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.252 -173.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.66 -44.36 81.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.894 -176.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.82 HD21 ' HA ' ' A' ' 460' ' ' LEU . 17.3 mt -59.7 -55.0 39.8 Favored 'General case' 0 CA--C 1.469 -2.155 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.248 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.909 ' HG2' ' O ' ' A' ' 436' ' ' VAL . 5.4 mm100 -53.57 -34.34 57.97 Favored 'General case' 0 N--CA 1.409 -2.52 0 O-C-N 125.627 1.829 . . . . 0.0 109.787 -177.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -71.33 -60.04 2.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 176.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -74.97 -47.77 27.65 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 121.585 -0.697 . . . . 0.0 111.742 -173.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.25 -25.7 64.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.708 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.768 ' N ' HD23 ' A' ' 443' ' ' LEU . 9.2 t70 -73.74 -41.42 62.54 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.418 1.104 . . . . 0.0 110.738 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -69.57 -6.6 32.11 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -173.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 452' ' ' ARG . 38.2 mm-40 -49.63 161.46 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.707 1.718 . . . . 0.0 114.435 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.544 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -57.18 -31.73 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 110.525 -3.034 . . . . 0.0 114.938 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.656 ' H ' ' HB ' ' A' ' 451' ' ' THR . 9.1 m-20 -143.85 -179.22 6.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.654 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.485 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 8.5 p-10 -64.42 -53.54 46.84 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 175.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.656 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.3 m -58.53 -39.21 79.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.553 171.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.677 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 30.7 mtm-85 -63.52 -29.57 70.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 450' ' ' GLN . . . -73.93 -31.97 63.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.853 0.835 . . . . 0.0 109.643 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.46 -43.86 13.23 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.436 -1.257 . . . . 0.0 112.435 -170.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.529 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 35.6 p -102.34 -1.41 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.011 -168.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.4 t80 -49.05 -53.28 20.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.9 mm -71.2 -25.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.529 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.14 -43.31 64.86 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.566 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.3 m-70 -66.7 -31.15 71.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.615 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.82 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.5 -53.92 35.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.181 0.991 . . . . 0.0 109.293 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.664 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.14 -32.06 72.61 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.136 173.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.93 -53.24 57.16 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.067 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.0 t -63.23 -33.84 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.345 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.8 m-30 -61.28 -15.3 33.81 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.136 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 16.9 mm-40 -91.14 -49.18 6.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.141 -0.974 . . . . 0.0 112.753 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.7 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -65.8 -39.3 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.027 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.3 mt -84.61 -17.52 38.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.733 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 62.3 55.39 27.96 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.627 -2.533 . . . . 0.0 112.986 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.746 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -104.2 -174.12 2.47 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 123.863 0.865 . . . . 0.0 109.642 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.689 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.6 p30 -106.03 -41.17 5.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 166.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -158.7 -78.25 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.009 160.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.768 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -62.61 70.45 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -169.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 38.09 40.82 0.9 Allowed Glycine 0 C--N 1.279 -2.631 0 CA-C-N 110.948 -2.842 . . . . 0.0 113.487 171.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.689 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 18.2 mm-40 -78.12 -52.37 8.83 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 122.631 1.205 . . . . 0.0 111.287 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.4 t 63.47 56.4 1.64 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.716 -2.493 . . . . 0.0 108.065 -171.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.733 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 CA-C-N 110.508 -3.042 . . . . 0.0 111.631 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.424 -1.768 0 CA-C-O 121.309 0.576 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.785 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.8 mt -70.11 123.95 89.79 Favored Pre-proline 0 N--CA 1.425 -1.709 0 CA-C-O 121.862 0.839 . . . . 0.0 111.806 -175.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 308' ' ' GLN . 20.6 Cg_endo -71.77 -12.23 28.56 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 124.764 3.643 . . . . 0.0 111.23 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 308' ' ' GLN . 4.2 tp 31.32 -64.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.217 0 C-N-CA 128.5 2.72 . . . . 0.0 116.046 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.673 ' HG2' HG23 ' A' ' 307' ' ' ILE . 38.9 mm-40 -57.79 -33.74 68.87 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.616 0.722 . . . . 0.0 110.163 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.588 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.8 t-160 -61.4 -48.82 79.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.682 173.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.639 HG13 HG11 ' A' ' 338' ' ' VAL . 70.1 mt -61.32 -48.89 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 124.135 0.974 . . . . 0.0 112.799 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.667 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 2.0 mtp-105 -58.92 -30.87 68.16 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.242 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 36.9 t -69.82 -34.57 73.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.596 0.712 . . . . 0.0 109.641 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.501 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.1 -40.57 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.707 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.689 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.41 -36.28 26.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 122.912 1.339 . . . . 0.0 109.636 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.65 32.79 8.95 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.119 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.1 mt-10 53.42 167.47 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.142 0 C-N-CA 124.433 1.093 . . . . 0.0 113.869 -175.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.683 ' HG3' HD12 ' A' ' 355' ' ' LEU . 38.0 Cg_exo -44.03 146.61 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.766 2.977 . . . . 0.0 113.435 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.463 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 28.8 Cg_endo -93.44 -103.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.285 2.657 . . . . 0.0 112.068 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.46 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 12.9 mmm180 -91.77 -91.51 0.16 Allowed 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.117 0.484 . . . . 0.0 110.604 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.533 ' HB3' ' HG2' ' A' ' 322' ' ' ARG . 48.6 m-20 -95.05 164.81 18.36 Favored Pre-proline 0 N--CA 1.439 -0.978 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.14 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.461 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.0 -47.26 18.56 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 122.605 2.203 . . . . 0.0 110.249 167.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.533 ' HG2' ' HB3' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -55.67 -17.99 6.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.248 176.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 3.2 mt-10 -93.46 -23.42 18.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.963 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.712 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -52.15 -40.95 77.77 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.745 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.0 Cg_endo -48.97 -64.58 0.21 Allowed 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.96 2.44 . . . . 0.0 112.898 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.594 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -57.91 -39.0 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.878 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.689 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 61.8 t90 -56.43 -39.78 73.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.988 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.805 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -67.35 -49.48 63.84 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.407 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -53.66 -23.71 22.17 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.888 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 3.4 mtm180 -73.2 -41.13 64.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.264 0.554 . . . . 0.0 111.137 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.574 ' HB2' HG22 ' A' ' 314' ' ' THR . 1.3 p30 -106.08 -15.78 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.712 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.35 -48.08 6.39 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.1 Cg_endo -61.75 -32.36 86.21 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.731 2.287 . . . . 0.0 111.989 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.58 -42.56 58.52 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.513 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 332' ' ' ALA . 95.4 mt -56.73 -48.41 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.946 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 15.2 t70 -50.87 -21.81 1.89 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.73 -1.577 . . . . 0.0 112.764 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.7 -48.44 7.91 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.445 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.639 HG11 HG13 ' A' ' 310' ' ' ILE . 88.6 t -60.05 -72.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 123.389 1.566 . . . . 0.0 110.087 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.785 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -88.05 122.67 69.84 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.251 -2.704 . . . . 0.0 111.758 -174.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.644 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 70.8 Cg_endo -73.41 -17.76 23.61 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 C-N-CA 123.742 2.961 . . . . 0.0 109.961 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.495 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.44 71.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.422 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.543 ' N ' HD12 ' A' ' 346' ' ' LEU . 45.1 p -85.52 11.34 10.77 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.042 -1.89 . . . . 0.0 113.049 -169.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.78 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.1 p -147.03 157.07 46.94 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 121.437 0.637 . . . . 0.0 109.968 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.533 ' HB3' HD12 ' A' ' 369' ' ' LEU . 73.3 Cg_exo -60.81 -36.85 82.17 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.643 3.562 . . . . 0.0 110.04 173.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.715 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.3 OUTLIER -51.84 -56.96 10.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.621 173.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.78 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.2 mt -56.72 -48.92 76.65 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.757 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.527 ' HA ' HD12 ' A' ' 350' ' ' ILE . 24.9 mmt180 -45.46 -52.14 10.62 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 125.295 1.622 . . . . 0.0 109.887 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.556 ' CB ' ' HG ' ' A' ' 368' ' ' CYS . 44.6 t -68.41 -50.87 49.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.825 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.666 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.9 mtp180 -61.06 -33.73 73.79 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.907 ' O ' HG12 ' A' ' 354' ' ' ILE . 18.5 mt -58.02 -53.22 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.205 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.594 ' O ' HD22 ' A' ' 355' ' ' LEU . 14.1 mt -59.35 -54.05 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.611 0.719 . . . . 0.0 111.254 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.402 ' HB3' ' OG ' ' A' ' 362' ' ' SER . 0.0 OUTLIER -61.12 -38.06 85.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.039 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . 0.496 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.94 -30.06 66.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.907 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.6 mm -56.62 -57.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 CA-C-O 122.922 1.344 . . . . 0.0 110.418 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.712 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -79.96 -27.47 39.73 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.195 -2.275 . . . . 0.0 109.897 -167.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.75 -76.93 0.21 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.936 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -101.52 38.55 3.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.866 -174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.756 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.3 p-10 -77.92 125.52 29.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.025 0.44 . . . . 0.0 110.424 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -48.56 -72.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.907 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -123.41 -1.7 9.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.304 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.756 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.5 mt -68.82 -6.0 24.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 122.193 0.997 . . . . 0.0 109.784 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 352' ' ' ASN . 2.3 t -70.62 75.6 0.58 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.363 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.738 HD11 HG21 ' A' ' 377' ' ' THR . 1.8 mm? -54.19 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.497 ' C ' ' H ' ' A' ' 366' ' ' GLY . 64.3 p -115.6 156.01 46.65 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.715 ' CB ' ' HA ' ' A' ' 345' ' ' ASP . 56.3 Cg_endo -71.91 22.19 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.11 1.874 . . . . 0.0 111.83 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -136.12 -2.55 2.68 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.726 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.589 ' HB2' HD12 ' A' ' 363' ' ' LEU . 45.5 m-20 -104.54 -21.4 13.44 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.285 1.041 . . . . 0.0 109.308 173.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 63.1 m -85.29 21.84 1.63 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.58 -171.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -55.94 -34.78 65.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.367 1.08 . . . . 0.0 110.112 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.04 159.96 31.37 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.697 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.615 ' O ' HG13 ' A' ' 375' ' ' VAL . 56.6 m95 -69.94 -35.77 74.78 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.634 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -57.35 -46.22 83.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.985 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 72.2 m -68.14 -42.14 80.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.072 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.604 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.14 -52.29 59.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.6 m -57.23 -44.12 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.0 109.463 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.053 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.139 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.738 HG21 HD11 ' A' ' 363' ' ' LEU . 24.4 m -71.95 -37.56 69.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.371 -172.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -62.02 -34.21 75.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.674 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.745 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.9 t80 -73.46 -47.46 41.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.65 1.214 . . . . 0.0 109.125 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.09 -32.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 112.415 -2.175 . . . . 0.0 111.829 170.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.5 mpt_? -60.4 -40.76 92.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.482 0.658 . . . . 0.0 111.351 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.424 HG21 ' HA ' ' A' ' 322' ' ' ARG . 31.6 p -100.25 -23.55 14.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.384 -166.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -110.39 23.03 14.79 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.89 20.99 21.77 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 123.308 0.38 . . . . 0.0 113.805 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 380' ' ' ILE . 1.9 m 66.79 156.32 0.1 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 111.414 -175.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.493 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.1 OUTLIER -117.87 153.56 50.98 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -95.97 49.85 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.309 2.672 . . . . 0.0 111.348 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.728 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.96 4.61 0.63 Allowed 'General case' 0 C--N 1.339 0.112 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -70.12 -47.1 63.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.241 0.544 . . . . 0.0 110.289 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.566 ' O ' HG23 ' A' ' 394' ' ' VAL . 97.3 mt-30 -73.84 -27.13 60.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -54.66 -31.84 58.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.128 0.877 . . . . 0.0 111.21 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.729 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.9 -55.06 30.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.087 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.495 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 7.6 m-20 -62.78 -36.52 83.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.559 0.695 . . . . 0.0 111.238 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.574 HG11 ' CD1' ' A' ' 414' ' ' LEU . 52.6 t -54.95 -53.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.068 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.702 ' O ' HG22 ' A' ' 399' ' ' VAL . 4.6 mm -58.59 -45.93 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.177 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 40.2 mmtt -53.36 -41.07 65.44 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 124.0 0.813 . . . . 0.0 112.154 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.566 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -78.91 -44.54 9.96 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.394 -173.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.899 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.0 OUTLIER -69.51 -40.84 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 117.451 0.626 . . . . 0.0 111.4 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.861 HG12 ' HA ' ' A' ' 404' ' ' VAL . 7.8 m -57.9 -41.43 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.908 0.861 . . . . 0.0 110.154 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.0 t70 -58.15 -41.88 84.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.88 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 75.3 mt-30 -81.62 -55.38 4.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.884 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.493 ' HG3' ' HD2' ' A' ' 330' ' ' ARG . 18.5 mm-40 -111.84 -30.3 7.35 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.001 0.905 . . . . 0.0 112.123 -170.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.4 ' C ' ' HA ' ' A' ' 399' ' ' VAL . . . 119.24 177.32 16.44 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.601 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.861 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.68 -44.45 96.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.227 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.44 -50.74 72.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -66.0 -50.15 65.27 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 122.177 -0.327 . . . . 0.0 110.665 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.899 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -54.09 -41.9 68.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.559 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.2 t80 -56.24 -45.57 79.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.712 0.768 . . . . 0.0 109.212 175.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.843 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.7 m -59.29 -52.52 65.28 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.505 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.713 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.73 -49.54 77.08 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.051 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.544 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.49 -42.25 89.63 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.012 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.727 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.16 -31.98 66.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 122.702 -0.293 . . . . 0.0 111.227 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.843 ' HG3' ' O ' ' A' ' 409' ' ' THR . 61.1 mtm -70.31 -47.36 61.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.224 0.535 . . . . 0.0 109.912 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.053 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.6 mt -60.19 -39.92 88.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.665 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.76 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.6 OUTLIER -75.1 -14.3 60.56 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.427 -177.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 94.28 38.62 5.02 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.721 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.727 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 4.9 mm-40 52.73 54.19 10.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.206 -0.997 . . . . 0.0 112.906 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.76 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -125.45 62.31 1.2 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 164.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.726 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 1.7 p90 -43.77 -33.92 1.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 111.408 -2.633 . . . . 0.0 112.976 -164.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 423' ' ' SER . 31.6 mt-30 -55.02 -44.55 74.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -165.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.608 HD21 HD21 ' A' ' 418' ' ' ASN . 2.3 pp -62.61 -47.85 82.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.047 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.694 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -61.36 -39.63 83.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 122.614 1.197 . . . . 0.0 108.947 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.594 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 40.6 t -58.8 -46.09 88.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 112.434 -2.166 . . . . 0.0 111.478 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.97 -39.79 80.01 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.959 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.08 -40.49 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.506 0.669 . . . . 0.0 110.17 175.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.594 HG23 HG23 ' A' ' 404' ' ' VAL . 1.7 mm -58.66 -44.56 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 CA-C-N 114.274 -1.33 . . . . 0.0 113.131 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.706 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -60.6 -29.23 69.09 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-O 122.784 1.278 . . . . 0.0 108.731 -174.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -15.75 76.9 Favored Glycine 0 C--N 1.3 -1.453 0 CA-C-N 112.394 -2.184 . . . . 0.0 112.674 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.7 m-85 -100.98 0.89 39.05 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.99 144.14 76.12 Favored Pre-proline 0 N--CA 1.41 -2.428 0 CA-C-O 123.723 1.725 . . . . 0.0 113.317 170.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.762 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 79.1 Cg_endo -72.23 -51.75 0.2 Allowed 'Trans proline' 0 C--N 1.311 -1.417 1 C-N-CA 126.065 4.51 . . . . 0.0 113.33 -173.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.508 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -122.88 142.34 14.54 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.417 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.883 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.24 -29.22 70.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.106 0.453 . . . . 0.0 111.627 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.741 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.51 -47.83 78.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.007 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -59.02 -51.68 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.596 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.883 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.84 -54.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.259 179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 28.3 m -62.54 -55.88 23.19 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.809 -175.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.46 -44.74 80.81 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.615 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.855 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 40.6 mt -60.93 -55.01 38.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.835 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.671 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -49.93 -32.7 15.45 Favored 'General case' 0 N--CA 1.419 -1.999 0 O-C-N 124.429 1.081 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.39 -60.3 2.3 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 174.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -77.25 -52.22 9.59 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -170.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 1.5 pp -57.28 -24.25 53.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.331 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.671 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 28.5 t70 -71.53 -42.04 68.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.546 1.165 . . . . 0.0 110.019 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.0 mt-30 -71.39 -8.11 51.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.032 -1.895 . . . . 0.0 115.933 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 38.1 mm-40 -54.64 157.85 2.81 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 123.619 1.676 . . . . 0.0 115.022 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -53.48 -33.14 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 110.445 -3.07 . . . . 0.0 115.101 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.664 ' H ' ' HB ' ' A' ' 451' ' ' THR . 29.9 m-20 -138.88 179.65 6.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.27 -52.1 50.89 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.95 -24.22 65.15 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 175.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.664 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.4 m -59.36 -40.75 87.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 171.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 39.0 mtt180 -60.75 -30.81 70.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.408 171.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.559 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -74.31 -32.81 63.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.712 0.768 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.8 -44.6 15.33 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.111 -171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.471 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 42.1 p -99.13 -4.96 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.893 -168.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.724 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.3 t80 -49.04 -51.0 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.664 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.5 mm -72.04 -27.57 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.432 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.52 -42.92 67.36 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 463' ' ' VAL . 53.6 m-70 -66.99 -31.04 71.34 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.81 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.775 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.35 -53.89 36.96 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.116 0.96 . . . . 0.0 109.243 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.55 -31.91 72.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 113.329 -1.76 . . . . 0.0 110.137 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.73 -52.66 62.37 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.178 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.007 HG11 ' HA ' ' A' ' 435' ' ' VAL . 23.5 t -63.45 -33.73 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.186 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.2 m-30 -61.8 -15.04 38.36 Favored 'General case' 0 C--O 1.202 -1.447 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.984 169.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 50.0 mm-40 -90.37 -50.01 6.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.575 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.702 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -66.63 -38.89 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.121 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 469' ' ' LEU . 6.5 mt -84.81 -15.64 44.14 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.59 49.02 66.89 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-N 111.822 -2.445 . . . . 0.0 113.213 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.764 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -101.1 -179.1 3.94 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.094 0.958 . . . . 0.0 110.113 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.699 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.4 p30 -104.41 -40.65 6.0 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 167.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -158.42 -79.34 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.278 -2.237 . . . . 0.0 110.955 157.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.762 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -61.37 72.66 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -170.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 38.04 42.83 1.24 Allowed Glycine 0 C--N 1.275 -2.827 0 CA-C-N 110.602 -2.999 . . . . 0.0 113.431 171.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.699 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 15.2 mm-40 -79.04 -54.39 6.06 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 122.288 1.042 . . . . 0.0 111.469 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.6 t 65.75 46.18 2.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.066 -2.333 . . . . 0.0 108.763 -174.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.74 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.292 -1.898 0 CA-C-N 109.505 -3.498 . . . . 0.0 112.346 171.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 121.158 0.504 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.717 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -75.53 128.15 84.59 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 121.795 0.807 . . . . 0.0 112.187 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 308' ' ' GLN . 13.0 Cg_endo -70.38 -22.35 29.38 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 C-N-CA 124.54 3.493 . . . . 0.0 110.748 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.728 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.7 tp 38.0 -59.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 C-N-CA 128.244 2.618 . . . . 0.0 116.135 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.598 ' HG2' HG23 ' A' ' 307' ' ' ILE . 9.8 mm-40 -57.36 -39.5 76.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.833 0.825 . . . . 0.0 110.132 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.551 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.6 t-160 -58.87 -48.19 82.26 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.609 173.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.9 mt -58.92 -49.07 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.728 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 7.7 mtp180 -61.05 -30.16 70.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.889 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 47.9 t -70.06 -35.17 74.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.416 0.627 . . . . 0.0 109.59 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.55 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.71 -41.03 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.722 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.782 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.7 p -82.94 -36.69 25.0 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 122.914 1.34 . . . . 0.0 109.564 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.25 35.47 9.6 Favored Glycine 0 C--N 1.303 -1.252 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.596 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 51.29 173.24 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.298 0 C-N-CA 124.258 1.023 . . . . 0.0 113.153 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.798 ' HB3' HD11 ' A' ' 324' ' ' ILE . 37.3 Cg_exo -46.77 150.96 2.28 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.986 2.457 . . . . 0.0 113.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.2 Cg_endo -92.07 -104.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.656 2.904 . . . . 0.0 112.751 -172.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -92.29 -79.55 0.38 Allowed 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.538 0.685 . . . . 0.0 110.553 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 323' ' ' GLU . 49.2 m-20 -103.9 161.45 22.91 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.955 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.5 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 45.2 Cg_exo -58.03 -50.37 10.29 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 122.656 2.237 . . . . 0.0 110.413 168.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.1 OUTLIER -49.78 -27.32 4.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.662 175.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -80.52 -29.13 37.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -48.41 -45.53 67.76 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.736 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.0 Cg_endo -50.75 -61.29 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.742 2.295 . . . . 0.0 112.962 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.625 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -61.94 -36.26 72.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.01 179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.782 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.4 t90 -58.41 -36.65 73.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.257 -1.792 . . . . 0.0 111.305 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.834 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.02 -48.42 58.13 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.71 -23.2 20.49 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.774 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.52 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.2 OUTLIER -74.97 -43.04 56.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.102 0.953 . . . . 0.0 110.552 174.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.728 ' HB3' HG22 ' A' ' 314' ' ' THR . 46.7 m-20 -95.07 -24.53 16.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.68 -1.6 . . . . 0.0 113.827 -169.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.23 -49.68 11.73 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 124.319 1.048 . . . . 0.0 113.777 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.4 Cg_endo -61.84 -32.57 85.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.522 2.148 . . . . 0.0 111.617 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.64 62.69 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.673 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.641 HG23 HG23 ' A' ' 310' ' ' ILE . 89.3 mt -59.32 -48.78 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.67 173.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.71 -15.98 9.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.213 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -50.36 5.99 Favored Glycine 0 CA--C 1.509 -0.328 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.657 HG11 HG13 ' A' ' 310' ' ' ILE . 70.5 t -54.62 -70.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 123.565 1.65 . . . . 0.0 110.094 169.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.858 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -93.72 132.03 30.81 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.052 -2.795 . . . . 0.0 112.464 -171.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.807 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.1 Cg_endo -72.66 -19.48 24.29 Favored 'Trans proline' 0 CA--C 1.497 -1.357 0 C-N-CA 123.65 2.9 . . . . 0.0 111.084 173.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.6 p 32.45 69.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.472 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.618 ' N ' HD12 ' A' ' 346' ' ' LEU . 75.7 p -79.53 4.14 16.66 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.096 -1.866 . . . . 0.0 113.108 -170.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.7 p -142.7 156.15 63.04 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.636 0.732 . . . . 0.0 109.624 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 75.5 Cg_exo -60.5 -38.18 75.32 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 124.357 3.371 . . . . 0.0 109.601 172.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.632 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -51.9 -52.76 47.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.546 174.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.8 mt -56.96 -52.74 64.04 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.818 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.719 ' HA ' HD12 ' A' ' 350' ' ' ILE . 32.1 ttm105 -51.96 -43.89 63.74 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.255 -1.793 . . . . 0.0 110.442 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 368' ' ' CYS . 38.2 t -69.09 -48.73 61.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.341 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 72.7 mtt180 -57.74 -38.1 74.76 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.548 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.858 HD11 ' CD2' ' A' ' 339' ' ' PHE . 52.5 mt -62.14 -54.51 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.941 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.569 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -58.19 -53.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 122.197 0.998 . . . . 0.0 111.02 -168.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 44.4 m-20 -63.49 -34.55 78.02 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.17 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.12 76.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.34 -53.9 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 122.873 1.32 . . . . 0.0 110.721 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.764 HD23 HD22 ' A' ' 358' ' ' ASN . 0.4 OUTLIER -72.89 -25.65 61.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 111.805 -2.452 . . . . 0.0 109.104 -169.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.06 -78.19 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.975 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.33 52.57 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.705 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.764 HD22 HD23 ' A' ' 355' ' ' LEU . 29.5 p30 -74.51 160.32 31.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 122.35 0.26 . . . . 0.0 110.664 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.1 mp -56.98 -67.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 120.959 0.409 . . . . 0.0 111.337 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -144.98 12.88 1.9 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.896 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.694 ' HB3' HD22 ' A' ' 378' ' ' LEU . 7.0 mt -64.38 -2.37 2.2 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.487 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 38.7 t -62.3 84.28 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.224 0.535 . . . . 0.0 110.288 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.91 HD11 HG21 ' A' ' 377' ' ' THR . 2.3 mm? -61.74 -172.75 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 70.5 p -126.73 155.94 74.35 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 21.5 Cg_exo -48.16 -38.42 32.78 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.531 1.488 . . . . 0.0 110.103 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -81.7 1.51 85.85 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.107 -0.952 . . . . 0.0 114.661 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.738 ' HB2' HD12 ' A' ' 363' ' ' LEU . 26.2 m-20 -109.01 -21.76 12.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.236 1.017 . . . . 0.0 109.539 171.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.654 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 83.9 m -91.07 21.12 4.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.612 -171.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -62.45 -36.81 83.6 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.769 1.271 . . . . 0.0 108.579 -174.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.2 p -117.4 163.9 15.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.247 -2.251 . . . . 0.0 109.634 170.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.633 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.2 m95 -70.63 -34.24 71.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.59 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.42 -42.48 96.02 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.724 -170.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.6 m -71.33 -42.5 68.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.703 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.03 -52.17 66.13 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.921 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.7 m -58.56 -44.36 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 109.512 -178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.077 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.91 HG21 HD11 ' A' ' 363' ' ' LEU . 54.3 m -70.15 -41.04 74.36 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.825 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.694 HD22 ' HB3' ' A' ' 361' ' ' LEU . 1.8 mt -58.69 -34.45 71.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.562 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.736 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 45.6 t80 -73.52 -46.96 44.61 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.267 1.032 . . . . 0.0 109.766 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.574 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.19 -32.9 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.537 170.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.619 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -59.76 -43.1 94.46 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.412 0.625 . . . . 0.0 110.999 174.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 41.4 p -95.54 -23.37 17.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.214 -167.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -110.46 22.22 15.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.06 21.16 30.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 114.436 0.534 . . . . 0.0 114.436 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.414 HG23 HG13 ' A' ' 380' ' ' ILE . 1.8 m 64.81 158.13 0.09 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.441 0.639 . . . . 0.0 111.744 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.468 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.75 156.06 65.63 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -97.83 52.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.322 2.681 . . . . 0.0 111.266 166.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.688 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.8 6.09 0.42 Allowed 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -70.06 -48.29 58.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.215 0.531 . . . . 0.0 110.039 174.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.642 ' O ' HG13 ' A' ' 394' ' ' VAL . 59.0 mt-30 -75.84 -25.21 56.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.902 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -53.64 -31.11 46.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.488 1.04 . . . . 0.0 111.916 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.72 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.24 -54.08 36.51 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.637 172.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 396' ' ' LYS . 17.7 m-20 -63.43 -38.71 92.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.336 0.654 . . . . 0.0 112.458 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -58.89 -46.17 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 120.795 0.331 . . . . 0.0 110.442 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 399' ' ' VAL . 5.5 mm -57.97 -46.83 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.311 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.568 ' HD2' ' OH ' ' A' ' 429' ' ' TYR . 8.1 mtmt -52.15 -46.28 65.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.768 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.55 -44.71 39.66 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.636 -1.268 . . . . 0.0 112.96 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.2 mt -69.93 -41.65 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 117.532 0.666 . . . . 0.0 111.684 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.7 m -57.42 -44.73 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.801 0.81 . . . . 0.0 110.369 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.479 ' N ' HG23 ' A' ' 399' ' ' VAL . 1.6 t70 -67.4 -32.61 73.62 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.919 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.43 -55.28 3.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.688 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.39 -28.12 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.901 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.408 ' HA2' ' NH1' ' A' ' 472' ' ' ARG . . . 121.12 162.16 11.6 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.608 -175.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.903 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -41.34 92.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.667 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.75 -51.86 67.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.846 0.355 . . . . 0.0 111.863 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 330' ' ' ARG . 0.8 OUTLIER -64.04 -49.95 70.34 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.28 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.683 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -51.75 -43.03 62.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.6 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 34.5 t80 -56.18 -47.73 77.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.615 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.769 ' O ' ' HG3' ' A' ' 413' ' ' MET . 2.2 m -57.92 -51.77 68.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.705 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.56 -48.94 78.68 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.821 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.83 -43.59 87.14 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.397 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.689 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.21 -31.67 66.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.887 0.343 . . . . 0.0 110.839 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.921 ' HE3' HG21 ' A' ' 375' ' ' VAL . 69.2 mtm -69.1 -48.57 62.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.291 0.567 . . . . 0.0 110.048 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.077 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.1 mt -59.13 -39.27 81.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.22 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.902 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 4.3 m -78.16 -13.6 59.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 95.92 32.25 6.92 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.33 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.601 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 69.92 37.63 1.74 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.357 0.663 . . . . 0.0 111.876 176.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.87 HD22 HD21 ' A' ' 421' ' ' LEU . 0.1 OUTLIER -120.52 81.24 1.73 Allowed 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.689 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 8.5 p90 -63.15 -31.74 72.95 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.611 -161.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 25.8 mt-30 -54.3 -48.38 71.36 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 113.464 -164.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.87 HD21 HD22 ' A' ' 418' ' ' ASN . 1.4 pp -59.61 -51.36 70.16 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.416 0.626 . . . . 0.0 111.02 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -59.8 -38.44 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.891 1.329 . . . . 0.0 109.241 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 43.4 t -63.09 -47.12 84.22 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.025 -2.352 . . . . 0.0 111.873 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.66 -36.27 70.88 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.87 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.72 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.7 mt -72.01 -43.07 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.546 0.689 . . . . 0.0 109.944 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.583 HD13 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -56.09 -45.24 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.718 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.4 OUTLIER -61.45 -29.45 69.97 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 122.608 1.194 . . . . 0.0 108.959 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.06 -16.56 76.76 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.688 -2.051 . . . . 0.0 112.462 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.712 ' CG ' HG21 ' A' ' 399' ' ' VAL . 11.8 m-85 -100.68 2.69 41.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.74 143.6 75.82 Favored Pre-proline 0 N--CA 1.411 -2.414 0 CA-C-O 123.658 1.694 . . . . 0.0 113.687 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.76 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 72.9 Cg_endo -72.45 -55.09 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.102 1 C-N-CA 126.455 4.77 . . . . 0.0 113.263 -171.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -114.77 140.57 16.45 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.115 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.892 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.054 0.427 . . . . 0.0 111.522 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.789 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.4 -46.66 83.22 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.01 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.8 t -59.17 -51.37 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.553 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.21 -54.4 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.9 m -61.33 -56.64 18.18 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.12 -45.42 79.5 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.533 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.841 ' O ' HD22 ' A' ' 443' ' ' LEU . 43.9 mt -60.11 -53.29 59.5 Favored 'General case' 0 CA--C 1.481 -1.697 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.687 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.716 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 37.8 mm-40 -51.35 -35.15 37.05 Favored 'General case' 0 N--CA 1.415 -2.201 0 O-C-N 125.115 1.509 . . . . 0.0 110.437 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.64 -60.81 2.05 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 177.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.415 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -76.73 -50.63 13.13 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.84 -0.538 . . . . 0.0 112.3 -172.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.841 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.68 -24.28 61.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.767 0.794 . . . . 0.0 111.518 -178.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.752 ' N ' HD23 ' A' ' 443' ' ' LEU . 16.6 t70 -72.21 -42.87 65.28 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.688 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.26 -8.15 47.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.525 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 55.9 mm-40 -51.32 157.8 0.93 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 123.683 1.706 . . . . 0.0 114.333 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.485 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -55.82 -32.81 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 CA-C-N 110.508 -3.042 . . . . 0.0 115.509 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.664 ' H ' ' HB ' ' A' ' 451' ' ' THR . 31.5 m-20 -140.04 179.11 6.8 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.422 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 7.3 m-20 -62.47 -56.77 14.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.18 -24.77 67.47 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.664 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 21.1 m -59.55 -41.98 91.35 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 119.492 1.042 . . . . 0.0 109.928 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 52.7 mtt180 -61.32 -29.84 70.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -75.09 -31.84 61.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.141 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.8 mm-40 -79.8 -45.35 18.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.626 -172.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.505 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 43.5 p -101.79 -3.51 27.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.136 -167.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.697 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.7 t80 -48.75 -52.6 22.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 405' ' ' ALA . 22.8 mm -71.45 -25.78 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.505 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.31 -43.4 64.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.621 ' O ' HG23 ' A' ' 463' ' ' VAL . 76.4 m-70 -66.82 -31.39 71.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.725 171.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.762 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.43 -53.87 36.78 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.117 0.961 . . . . 0.0 109.372 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.607 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.1 m-80 -62.0 -32.11 72.56 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.205 172.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.9 -52.02 64.71 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.026 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 435' ' ' VAL . 23.1 t -63.37 -34.83 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 110.271 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.1 m-30 -61.24 -14.21 24.32 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.128 169.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 63.5 mm-40 -91.53 -48.9 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.874 -1.141 . . . . 0.0 112.933 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.694 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -66.24 -39.77 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.881 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.2 mt -84.45 -16.44 42.58 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.806 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.97 51.17 55.61 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 111.674 -2.512 . . . . 0.0 113.348 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.697 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -104.1 -179.52 3.97 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.918 0.887 . . . . 0.0 110.699 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.743 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 15.1 p30 -98.47 -41.28 7.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.83 -74.99 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.252 -2.249 . . . . 0.0 110.839 160.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.76 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -60.26 64.08 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.159 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 43.62 36.89 3.56 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.619 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.743 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 10.4 mm-40 -75.61 -53.39 8.67 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.346 1.069 . . . . 0.0 111.496 -170.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 26.9 t 66.18 59.1 0.69 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.267 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.806 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 111.247 -2.706 . . . . 0.0 111.635 175.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.426 -1.674 0 CA-C-O 121.324 0.583 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.72 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 20.2 mt -71.17 126.41 91.95 Favored Pre-proline 0 N--CA 1.426 -1.625 0 CA-C-O 121.997 0.903 . . . . 0.0 112.104 -174.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 308' ' ' GLN . 24.4 Cg_endo -73.51 -8.96 22.41 Favored 'Trans proline' 0 CA--C 1.501 -1.136 0 C-N-CA 124.952 3.768 . . . . 0.0 111.382 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.707 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.7 tp 24.8 -64.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.315 0 C-N-CA 128.458 2.703 . . . . 0.0 116.195 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.645 ' H ' HG23 ' A' ' 307' ' ' ILE . 0.2 OUTLIER -57.7 -31.06 66.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.13 0.49 . . . . 0.0 111.337 177.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.544 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.2 t-160 -61.49 -49.05 78.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.498 170.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.671 HG13 HG11 ' A' ' 338' ' ' VAL . 55.1 mt -58.68 -48.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.605 174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.695 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 52.2 mtp180 -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 122.545 0.338 . . . . 0.0 111.52 176.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.9 m -69.84 -33.18 71.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.502 0.668 . . . . 0.0 110.056 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.586 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -67.34 -42.32 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.51 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.774 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.3 p -83.21 -36.4 24.68 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.875 1.322 . . . . 0.0 110.44 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.91 33.91 10.53 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 112.248 -2.251 . . . . 0.0 110.834 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 49.44 176.22 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 124.424 1.09 . . . . 0.0 113.629 -174.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.632 ' HB3' HD11 ' A' ' 324' ' ' ILE . 21.3 Cg_exo -45.6 141.49 8.0 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.913 2.409 . . . . 0.0 112.818 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.469 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 43.6 Cg_endo -87.84 -101.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.156 2.571 . . . . 0.0 112.318 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 8.8 mmm180 -94.22 -80.07 0.41 Allowed 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.484 0.659 . . . . 0.0 110.756 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.534 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 36.4 m-20 -105.87 162.78 18.66 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.811 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.516 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.3 Cg_exo -61.38 -52.37 3.32 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.671 2.247 . . . . 0.0 111.025 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.48 -19.21 2.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.898 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.534 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.6 mm-40 -88.56 -26.91 21.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.519 0.199 . . . . 0.0 111.482 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.98 -44.13 45.96 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.717 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.22 -62.13 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.815 2.343 . . . . 0.0 113.044 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.647 HG21 HG12 ' A' ' 398' ' ' ILE . 1.1 mp -62.29 -36.24 73.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 122.441 1.115 . . . . 0.0 110.027 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.774 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 50.1 t90 -57.84 -38.0 74.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.513 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.833 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.97 -48.19 59.28 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.53 -23.48 20.26 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.794 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.538 ' HD2' HG21 ' A' ' 406' ' ' THR . 1.5 mtm-85 -73.84 -43.17 59.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.322 1.058 . . . . 0.0 110.456 174.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.748 ' HB3' HG22 ' A' ' 314' ' ' THR . 51.8 m-20 -95.67 -24.73 16.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.478 -1.692 . . . . 0.0 113.711 -168.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.84 -50.56 10.19 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.1 Cg_endo -60.9 -33.88 91.91 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.623 2.215 . . . . 0.0 111.68 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.27 -44.46 62.76 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.774 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.621 HG23 HG23 ' A' ' 310' ' ' ILE . 87.7 mt -58.07 -48.21 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.635 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.07 -14.94 7.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.282 -1.781 . . . . 0.0 112.046 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.0 -48.7 5.64 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.671 HG11 HG13 ' A' ' 310' ' ' ILE . 92.2 t -55.18 -70.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.617 1.675 . . . . 0.0 109.89 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.846 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -91.67 131.19 36.53 Favored Pre-proline 0 N--CA 1.402 -2.847 0 CA-C-N 110.729 -2.941 . . . . 0.0 112.008 -173.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.789 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.4 Cg_endo -73.39 -18.42 23.09 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 123.634 2.889 . . . . 0.0 110.248 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 32.87 69.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 111.938 -2.392 . . . . 0.0 110.189 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.592 ' N ' HD12 ' A' ' 346' ' ' LEU . 40.9 p -79.93 3.61 19.41 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.119 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.79 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -140.85 156.1 68.84 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 109.509 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.511 ' HB3' HD12 ' A' ' 369' ' ' LEU . 68.7 Cg_exo -60.94 -38.57 68.12 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 124.263 3.308 . . . . 0.0 109.54 172.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.678 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.58 -53.08 41.94 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.364 -2.198 . . . . 0.0 110.566 173.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.79 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -56.68 -51.94 66.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.77 0.795 . . . . 0.0 110.311 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 350' ' ' ILE . 10.5 ttm180 -50.62 -44.75 57.28 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.238 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 40.9 t -70.09 -49.34 51.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.738 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 77.8 mtt180 -57.93 -39.3 77.68 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.704 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.846 HD11 ' CD2' ' A' ' 339' ' ' PHE . 37.0 mt -59.71 -54.04 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.689 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.589 HD13 ' HB1' ' A' ' 374' ' ' ALA . 15.9 mt -57.58 -53.34 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-O 122.133 0.968 . . . . 0.0 110.919 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.529 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -64.14 -34.79 78.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.149 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.27 -35.15 75.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.104 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.67 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.25 0.9 OUTLIER -57.9 -54.13 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 122.715 1.245 . . . . 0.0 110.616 174.421 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.736 HD23 HD22 ' A' ' 358' ' ' ASN . 0.3 OUTLIER -72.52 -27.32 62.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 111.758 -2.474 . . . . 0.0 109.037 -168.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 28.1 55.61 0.13 Allowed Glycine 0 CA--C 1.524 0.628 0 O-C-N 125.568 1.793 . . . . 0.0 115.357 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 135.96 45.85 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.667 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.736 HD22 HD23 ' A' ' 355' ' ' LEU . 30.1 p30 -98.3 163.31 12.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.173 0.189 . . . . 0.0 110.762 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.37 -60.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.23 0.538 . . . . 0.0 111.702 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -157.75 16.05 0.31 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.607 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.674 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.4 mt -64.46 -6.32 7.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 122.919 0.488 . . . . 0.0 111.649 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.529 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.9 t -61.43 85.2 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.22 0.533 . . . . 0.0 110.112 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.814 HD11 HG21 ' A' ' 377' ' ' THR . 1.8 mm? -60.64 -172.74 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.652 0.739 . . . . 0.0 112.822 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.9 p -126.96 152.68 75.87 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 18.4 Cg_exo -46.55 -34.65 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.979 1.786 . . . . 0.0 111.265 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -86.26 -2.25 85.65 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.65 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.675 ' HB2' HD12 ' A' ' 363' ' ' LEU . 55.6 m-20 -105.48 -21.29 13.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.306 1.051 . . . . 0.0 109.124 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 77.0 m -86.8 22.94 1.82 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.382 -171.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -59.02 -35.98 74.18 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.62 1.2 . . . . 0.0 108.266 -173.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 29.8 p -118.83 163.48 16.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 112.839 -1.982 . . . . 0.0 110.361 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.655 ' O ' HG13 ' A' ' 375' ' ' VAL . 51.8 m95 -71.18 -34.1 70.61 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 167.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.585 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -62.92 -47.07 84.85 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.613 -173.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.3 t -65.86 -42.82 89.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.739 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.745 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.53 63.76 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.909 HG21 ' HE3' ' A' ' 413' ' ' MET . 10.4 m -58.84 -44.85 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.613 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.088 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.79 -43.46 98.08 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.949 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.814 HG21 HD11 ' A' ' 363' ' ' LEU . 24.1 m -70.47 -40.42 73.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.749 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.6 mt -59.18 -35.15 73.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.399 0.618 . . . . 0.0 110.439 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.717 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.0 t80 -71.12 -49.08 48.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.344 1.069 . . . . 0.0 109.412 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.554 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.92 -32.41 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.962 170.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.609 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -59.95 -33.02 71.35 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 123.241 0.616 . . . . 0.0 111.698 175.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 29.1 p -106.34 -23.24 12.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.771 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -110.34 22.61 15.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 52.87 21.38 9.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 114.336 0.494 . . . . 0.0 114.336 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.5 m 64.86 161.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.42 0.628 . . . . 0.0 111.022 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.502 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.5 157.01 63.37 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -97.67 54.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.361 2.708 . . . . 0.0 111.019 166.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.682 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 56.85 3.14 0.12 Allowed 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -174.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -69.91 -46.85 64.51 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.512 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.659 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.8 mt-30 -74.17 -26.72 60.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.95 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -54.69 -31.52 58.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.97 0.805 . . . . 0.0 111.492 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.688 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.72 -53.17 40.9 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.426 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.62 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.8 m-20 -64.88 -40.85 95.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.068 0.547 . . . . 0.0 112.17 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.42 -45.39 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.687 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.8 mm -58.8 -48.45 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.513 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.3 mmtt -52.11 -42.15 63.06 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.893 0.746 . . . . 0.0 111.54 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.34 -45.09 11.71 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.186 -172.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.2 mt -69.75 -40.67 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 117.52 0.66 . . . . 0.0 111.25 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.9 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.8 m -58.35 -45.16 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.66 0.743 . . . . 0.0 110.194 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.481 ' N ' HG23 ' A' ' 399' ' ' VAL . 10.6 t70 -62.94 -35.94 81.78 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.879 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -86.59 -53.47 4.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.046 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -107.66 -29.49 9.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.469 -171.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 120.84 163.79 12.17 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.9 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -42.92 97.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.624 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.14 -51.21 70.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.917 0.389 . . . . 0.0 111.784 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.587 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.16 -50.77 66.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.508 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.692 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.65 -41.73 64.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.618 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.8 t80 -57.1 -46.18 82.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.661 0.743 . . . . 0.0 109.2 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.783 ' O ' ' HG3' ' A' ' 413' ' ' MET . 7.5 m -58.31 -51.85 68.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.642 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.678 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.87 -49.14 76.04 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.723 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.562 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.33 -42.14 88.46 Favored Glycine 0 C--N 1.315 -0.59 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.252 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.744 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.49 -32.01 65.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 116.764 0.282 . . . . 0.0 111.015 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.909 ' HE3' HG21 ' A' ' 375' ' ' VAL . 67.3 mtm -69.97 -48.03 59.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.378 0.609 . . . . 0.0 109.831 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.088 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.6 mt -59.48 -38.55 81.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.388 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.95 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.0 m -77.64 -15.04 59.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.39 28.57 7.96 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 119.936 -1.125 . . . . 0.0 111.526 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.744 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 3.2 mm-40 63.12 46.42 4.65 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.022 0.929 . . . . 0.0 112.302 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.812 HD22 HD21 ' A' ' 421' ' ' LEU . 0.1 OUTLIER -122.69 66.99 0.95 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 165.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.699 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.9 OUTLIER -47.53 -34.38 7.51 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 111.368 -2.651 . . . . 0.0 113.733 -165.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 423' ' ' SER . 48.3 mt-30 -55.45 -44.41 76.33 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -164.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.812 HD21 HD22 ' A' ' 418' ' ' ASN . 1.6 pp -59.56 -50.95 71.91 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.347 0.594 . . . . 0.0 110.624 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.611 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.96 -38.76 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.428 1.109 . . . . 0.0 109.164 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 29.1 t -59.5 -47.85 83.91 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.648 -2.069 . . . . 0.0 112.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.82 73.09 Favored Glycine 0 C--N 1.317 -0.489 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.122 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.681 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.24 -42.2 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.546 0.688 . . . . 0.0 110.085 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.607 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.67 -44.32 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.94 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.724 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.1 OUTLIER -62.7 -27.99 69.63 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 122.901 1.334 . . . . 0.0 108.991 -173.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.42 77.69 Favored Glycine 0 C--N 1.298 -1.537 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.503 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 14.5 m-85 -100.4 3.08 42.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.96 144.87 74.18 Favored Pre-proline 0 N--CA 1.413 -2.308 0 CA-C-O 123.615 1.674 . . . . 0.0 113.439 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.723 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.7 Cg_endo -72.98 -61.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 1 C-N-CA 126.118 4.545 . . . . 0.0 113.305 -174.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.546 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.37 142.69 16.33 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.879 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.27 -29.22 70.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.085 0.443 . . . . 0.0 111.184 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.748 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.26 -47.21 79.02 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.004 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.6 t -58.8 -51.83 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.663 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.879 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.08 -54.44 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.05 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 47.9 m -62.27 -55.77 25.02 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.476 -0.489 . . . . 0.0 112.073 -175.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.35 -45.65 80.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.715 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.838 ' O ' HD22 ' A' ' 443' ' ' LEU . 48.8 mt -60.39 -53.15 60.99 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.759 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.705 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -51.75 -34.16 38.06 Favored 'General case' 0 N--CA 1.416 -2.147 0 O-C-N 125.03 1.456 . . . . 0.0 110.644 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.716 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.65 -60.73 2.09 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.405 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.98 -51.43 11.14 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.963 -0.461 . . . . 0.0 112.243 -172.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.838 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.8 -23.85 60.95 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.869 0.842 . . . . 0.0 111.571 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.756 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.5 t70 -71.26 -41.41 70.1 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.666 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.716 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 45.1 mt-30 -72.68 -9.67 58.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -170.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.492 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 5.8 mm-40 -56.48 154.0 9.19 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.79 1.281 . . . . 0.0 113.762 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.496 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -52.7 -33.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.09 -2.323 . . . . 0.0 116.249 -168.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.622 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 27.8 m-20 -135.69 -178.47 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.475 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.4 p-10 -64.07 -54.6 31.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.501 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.6 -24.16 65.45 Favored 'General case' 0 N--CA 1.403 -2.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.609 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 8.6 m -60.25 -44.05 95.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 119.696 1.134 . . . . 0.0 109.427 171.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.5 mtt180 -59.22 -29.98 67.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.172 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.618 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.59 -30.82 59.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.674 0.749 . . . . 0.0 109.627 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.91 -44.97 19.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.222 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.506 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -100.75 -4.19 28.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.723 -1.58 . . . . 0.0 111.818 -168.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.673 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.1 t80 -48.77 -52.5 23.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.809 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 405' ' ' ALA . 23.8 mm -72.87 -25.24 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.11 -43.28 64.99 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 463' ' ' VAL . 72.2 m-70 -67.81 -31.55 71.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.734 -1.576 . . . . 0.0 109.513 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.744 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.74 -53.84 40.88 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.165 0.983 . . . . 0.0 109.304 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.3 -30.6 71.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.619 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -66.9 -48.81 67.57 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.004 HG11 ' HA ' ' A' ' 435' ' ' VAL . 22.0 t -65.24 -35.82 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.302 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.538 ' OH ' HG13 ' A' ' 404' ' ' VAL . 18.8 m-30 -61.47 -13.17 18.56 Favored 'General case' 0 C--O 1.204 -1.294 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.707 169.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 3.5 tp10 -95.23 -52.6 4.12 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.227 -0.921 . . . . 0.0 112.24 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.724 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -62.75 -41.08 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.317 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.748 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.3 mt -83.97 -16.44 44.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.796 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.27 47.57 78.78 Favored Glycine 0 C--O 1.215 -1.039 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.492 172.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -102.31 178.88 4.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.069 0.948 . . . . 0.0 110.478 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.804 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 18.0 p30 -96.54 -40.75 8.9 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 167.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -163.48 -75.12 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.358 160.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.723 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 1.0 OUTLIER -61.61 68.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -171.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 39.55 41.97 1.82 Allowed Glycine 0 C--N 1.274 -2.901 0 CA-C-N 110.626 -2.988 . . . . 0.0 113.375 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.804 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 8.5 mm-40 -79.05 -56.62 4.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.2 1.0 . . . . 0.0 111.635 -171.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.8 t 68.9 54.46 0.47 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.283 -173.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.796 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.509 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.139 175.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.426 -1.635 0 CA-C-O 121.54 0.686 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.718 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 17.2 mt -75.96 127.85 84.46 Favored Pre-proline 0 N--CA 1.424 -1.76 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.994 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.2 Cg_endo -72.88 -12.18 26.09 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.823 3.682 . . . . 0.0 111.253 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.709 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.9 tp 27.25 -61.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 C-N-CA 128.685 2.794 . . . . 0.0 116.145 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.569 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.81 -31.89 68.86 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.097 0.475 . . . . 0.0 110.305 178.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.559 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.0 t-160 -61.8 -48.58 79.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.615 171.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.0 mt -58.41 -48.9 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 C-N-CA 123.987 0.915 . . . . 0.0 112.638 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.69 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 15.1 mtp180 -60.62 -29.86 69.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 122.222 -0.299 . . . . 0.0 111.074 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 52.8 m -69.76 -34.96 74.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.38 0.609 . . . . 0.0 109.761 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.578 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.66 -41.12 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.741 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.772 HG22 ' HB3' ' A' ' 331' ' ' ASN . 30.2 p -83.52 -37.96 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.898 1.332 . . . . 0.0 109.882 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.58 35.52 6.87 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.003 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 39.6 mt-10 51.3 177.12 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 124.083 0.953 . . . . 0.0 113.051 -174.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.634 ' HB3' HD11 ' A' ' 324' ' ' ILE . 48.7 Cg_exo -48.59 152.56 4.05 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.633 2.222 . . . . 0.0 113.379 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.522 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 7.5 Cg_endo -98.93 -107.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.076 3.184 . . . . 0.0 112.624 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.466 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 8.6 mmm180 -89.19 -88.83 0.15 Allowed 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.013 0.911 . . . . 0.0 111.97 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.688 ' H ' ' HG2' ' A' ' 323' ' ' GLU . 2.2 m-20 -94.87 157.83 36.1 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.474 -170.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.504 ' HB3' HD13 ' A' ' 359' ' ' ILE . 38.2 Cg_exo -59.32 -50.75 7.76 Favored 'Trans proline' 0 CA--C 1.511 -0.675 0 C-N-CA 122.414 2.076 . . . . 0.0 110.399 166.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.48 23.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.791 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.688 ' HG2' ' H ' ' A' ' 320' ' ' ASN . 3.3 pt-20 -102.94 -20.47 14.23 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.622 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -44.05 -42.65 12.5 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.726 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.43 -61.44 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.757 HG21 HG12 ' A' ' 398' ' ' ILE . 0.8 OUTLIER -60.01 -34.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.153 178.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.693 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -58.8 -36.39 74.38 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.228 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.853 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.81 -49.13 55.67 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.425 ' HA3' HD11 ' A' ' 410' ' ' LEU . . . -54.01 -22.97 22.01 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.758 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.66 ' HD3' HG21 ' A' ' 406' ' ' THR . 0.1 OUTLIER -72.11 -42.4 66.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.215 1.007 . . . . 0.0 110.105 174.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.772 ' HB3' HG22 ' A' ' 314' ' ' THR . 54.7 m-20 -99.79 -24.16 14.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.739 -1.573 . . . . 0.0 114.114 -168.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.626 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.31 -50.01 8.75 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.0 Cg_endo -60.73 -33.42 93.13 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.371 2.047 . . . . 0.0 111.529 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.36 -42.23 65.53 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.794 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.633 HG23 HG23 ' A' ' 310' ' ' ILE . 90.4 mt -59.91 -48.5 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.965 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -56.14 -16.54 5.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.24 5.68 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.66 HG11 HG13 ' A' ' 310' ' ' ILE . 96.0 t -55.09 -70.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 123.665 1.698 . . . . 0.0 110.1 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.927 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.75 131.28 34.13 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 110.798 -2.91 . . . . 0.0 111.94 -172.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.798 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 67.9 Cg_endo -72.3 -18.87 26.23 Favored 'Trans proline' 0 CA--C 1.495 -1.464 0 C-N-CA 123.562 2.841 . . . . 0.0 110.524 174.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.5 p 32.75 69.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 112.107 -2.315 . . . . 0.0 110.32 -178.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.617 ' H ' HD12 ' A' ' 346' ' ' LEU . 46.4 p -80.6 4.46 18.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.034 -1.894 . . . . 0.0 113.206 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.815 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 33.4 p -142.89 157.27 61.57 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-O 121.699 0.761 . . . . 0.0 109.694 174.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 70.0 Cg_exo -60.63 -38.97 68.14 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 124.373 3.382 . . . . 0.0 109.413 172.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.619 ' HA ' ' HB3' ' A' ' 365' ' ' PRO . 11.5 t70 -45.75 -58.83 3.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 112.371 -2.195 . . . . 0.0 110.217 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.815 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.3 mt -56.17 -52.24 65.11 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.815 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.735 ' HA ' HD12 ' A' ' 350' ' ' ILE . 34.3 ttm105 -52.61 -42.99 65.08 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 48.6 t -69.49 -49.79 51.36 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 26.9 mtp180 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.667 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.927 HD11 ' HD2' ' A' ' 339' ' ' PHE . 50.8 mt -62.23 -53.85 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.681 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.584 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -58.19 -53.36 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.078 0.942 . . . . 0.0 111.143 -168.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.548 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -64.3 -35.08 79.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.171 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.18 -32.92 72.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.706 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.36 -55.95 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 CA-C-O 122.925 1.345 . . . . 0.0 110.41 173.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.751 HD23 HD22 ' A' ' 358' ' ' ASN . 1.7 mp -72.94 -26.1 61.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 111.88 -2.418 . . . . 0.0 109.051 -169.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 37.44 59.18 1.29 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 113.694 -1.594 . . . . 0.0 114.609 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 121.02 48.92 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.688 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.751 HD22 HD23 ' A' ' 355' ' ' LEU . 26.7 p30 -87.94 162.61 16.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.69 -63.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 122.828 0.451 . . . . 0.0 111.448 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.11 9.31 0.96 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.512 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.663 ' HB3' HD22 ' A' ' 378' ' ' LEU . 4.8 mt -64.15 -5.38 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 122.955 0.502 . . . . 0.0 111.645 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 48.1 t -61.29 84.28 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.092 0.473 . . . . 0.0 110.546 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.833 HD11 HG21 ' A' ' 377' ' ' THR . 2.2 mm? -62.71 -174.64 0.07 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.877 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 71.7 p -128.47 155.79 78.12 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.619 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 35.4 Cg_exo -45.14 -38.12 13.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.965 1.777 . . . . 0.0 111.23 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.571 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -78.47 -4.17 87.02 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.806 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 363' ' ' LEU . 9.4 m-20 -109.5 -20.02 13.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.835 0.826 . . . . 0.0 110.194 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 81.4 m -91.25 21.49 4.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.702 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.571 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.7 OUTLIER -60.48 -38.97 85.98 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.156 -172.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.47 162.39 21.8 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.015 170.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.616 ' O ' HG13 ' A' ' 375' ' ' VAL . 48.0 m95 -69.54 -35.78 75.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.571 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.64 -41.77 99.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.783 -174.231 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 66.5 p -67.91 -44.77 76.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.922 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.43 -52.61 62.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.905 HG21 ' HE3' ' A' ' 413' ' ' MET . 15.6 m -57.31 -45.23 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.598 0.714 . . . . 0.0 109.585 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.021 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.17 -44.79 96.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.052 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.833 HG21 HD11 ' A' ' 363' ' ' LEU . 34.5 m -67.37 -39.85 85.7 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.499 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 325' ' ' PRO . 2.4 mt -58.99 -34.9 72.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.445 0.566 . . . . 0.0 110.325 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.726 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 43.7 t80 -73.81 -46.0 48.0 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.309 1.052 . . . . 0.0 109.467 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.591 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.2 mp -51.52 -32.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.322 170.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.624 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -59.83 -36.59 77.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.185 0.594 . . . . 0.0 111.451 176.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 28.0 p -103.26 -22.63 13.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.72 -168.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . 0.404 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 14.0 m80 -110.01 23.01 14.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.42 21.45 34.09 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.948 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.456 HG23 HG13 ' A' ' 380' ' ' ILE . 1.7 m 65.07 160.17 0.11 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.179 0.514 . . . . 0.0 110.788 -174.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.505 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -124.92 157.62 65.87 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -101.64 54.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.867 3.045 . . . . 0.0 111.546 166.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.771 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.06 -0.26 0.24 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -70.17 -44.49 68.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.017 0.437 . . . . 0.0 110.906 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.622 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.4 mt-30 -74.65 -27.01 60.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.901 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.41 -30.42 52.26 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.48 0.582 . . . . 0.0 111.638 -174.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.666 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.1 -53.05 39.52 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.795 173.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.614 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 12.3 m-20 -65.61 -39.24 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.4 m -57.97 -45.37 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.052 0.453 . . . . 0.0 110.256 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.764 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.3 mm -58.8 -48.11 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.1 mmtt -52.04 -41.26 62.15 Favored 'General case' 0 C--O 1.242 0.682 0 O-C-N 124.195 0.934 . . . . 0.0 111.418 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.63 12.78 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.352 -171.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.757 HG12 HG21 ' A' ' 326' ' ' ILE . 1.3 mt -70.61 -38.65 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 117.624 0.712 . . . . 0.0 112.002 -177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.881 HG12 ' HA ' ' A' ' 404' ' ' VAL . 1.1 m -59.33 -42.33 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.999 0.904 . . . . 0.0 109.136 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -59.18 -44.34 92.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.807 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -83.88 -53.5 5.55 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.491 -172.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.648 ' HB2' ' NH1' ' A' ' 330' ' ' ARG . 8.8 tp10 -112.34 -34.91 5.75 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -171.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 130.1 163.47 11.09 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.57 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.881 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.17 -41.28 91.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.18 -50.71 70.44 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.66 HG21 ' HD3' ' A' ' 330' ' ' ARG . 0.9 OUTLIER -65.55 -48.85 71.02 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.091 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.687 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.41 -44.81 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 112.008 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.0 t80 -55.66 -45.99 77.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.348 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.77 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.2 m -58.77 -52.58 65.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.758 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.69 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.47 -48.82 79.39 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.508 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.523 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.72 -44.25 86.62 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.685 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.7 -31.17 64.82 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.899 0.35 . . . . 0.0 110.923 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.905 ' HE3' HG21 ' A' ' 375' ' ' VAL . 68.4 mtm -68.61 -49.8 56.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.475 0.655 . . . . 0.0 109.988 172.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.021 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.5 mt -58.56 -39.11 79.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.986 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.901 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.7 m -77.93 -16.45 58.18 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.558 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.23 35.31 6.34 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.169 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.643 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 69.91 39.69 1.39 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.632 0.773 . . . . 0.0 112.571 176.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.899 HD22 HD21 ' A' ' 421' ' ' LEU . 0.1 OUTLIER -121.63 77.46 1.35 Allowed 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.491 -2.041 . . . . 0.0 105.491 164.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.685 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 9.1 p90 -62.04 -31.32 71.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.627 -2.079 . . . . 0.0 110.515 -162.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.553 ' O ' ' HB3' ' A' ' 423' ' ' SER . 23.6 mt-30 -54.38 -48.08 71.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.086 -164.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.899 HD21 HD22 ' A' ' 418' ' ' ASN . 1.6 pp -59.87 -49.69 76.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.717 0.77 . . . . 0.0 110.962 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.616 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.31 -39.04 79.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.633 1.206 . . . . 0.0 109.251 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 38.8 t -60.54 -45.64 93.09 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.444 -2.162 . . . . 0.0 111.375 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -55.94 -39.31 78.24 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.358 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.657 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.26 -42.59 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.643 0.735 . . . . 0.0 109.976 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.58 HD13 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -55.46 -44.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.735 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -60.85 -30.63 70.23 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-O 122.733 1.254 . . . . 0.0 108.987 -173.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.49 -18.24 76.89 Favored Glycine 0 C--N 1.299 -1.502 0 CA-C-N 112.561 -2.109 . . . . 0.0 111.921 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.711 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.35 1.27 44.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.91 141.99 79.84 Favored Pre-proline 0 N--CA 1.408 -2.557 0 CA-C-O 123.771 1.748 . . . . 0.0 112.848 170.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.808 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.7 Cg_endo -70.16 -60.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 1 C-N-CA 126.065 4.51 . . . . 0.0 112.977 -171.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -111.36 134.76 12.34 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.235 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.845 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.6 OUTLIER -49.26 -37.34 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.19 -48.33 73.96 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.039 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -58.13 -52.53 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.637 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.845 HG13 ' HA ' ' A' ' 433' ' ' GLN . 1.6 m -51.81 -53.31 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 117.64 0.2 . . . . 0.0 110.492 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.452 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 59.4 m -68.71 -54.17 17.74 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.837 -174.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.44 -41.44 76.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.161 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.842 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.6 mt -63.37 -53.92 44.91 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.208 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.7 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.68 -33.79 35.46 Favored 'General case' 0 N--CA 1.419 -1.977 0 O-C-N 124.959 1.412 . . . . 0.0 110.279 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.686 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.48 -59.88 2.51 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 173.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.5 ptp180 -73.92 -53.55 9.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.838 0.745 . . . . 0.0 112.616 -172.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.44 -25.0 64.0 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.653 0.74 . . . . 0.0 111.786 -177.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.777 ' N ' HD23 ' A' ' 443' ' ' LEU . 6.3 t70 -72.69 -41.89 64.81 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.32 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.99 -7.74 43.32 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.573 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 40.4 mm-40 -54.73 158.0 2.81 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 123.206 1.479 . . . . 0.0 114.171 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.607 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -54.19 -33.44 25.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 111.52 -2.582 . . . . 0.0 115.904 -170.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.65 ' H ' ' HB ' ' A' ' 451' ' ' THR . 38.8 m-20 -142.89 178.47 7.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.426 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.0 m-20 -61.48 -55.45 31.03 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -63.82 -27.58 69.27 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.65 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 6.5 m -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.636 1.107 . . . . 0.0 109.941 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.611 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 50.0 mtt180 -60.68 -29.46 69.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.598 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.96 -30.18 58.54 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.131 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 2.9 mm-40 -82.58 -46.49 13.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.273 1.035 . . . . 0.0 111.95 -172.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.523 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -100.54 -1.55 35.28 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.811 -1.54 . . . . 0.0 111.542 -168.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.669 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.8 -51.99 26.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.656 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 405' ' ' ALA . 21.3 mm -72.68 -26.33 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.523 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.44 -42.61 64.85 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.629 ' O ' HG23 ' A' ' 463' ' ' VAL . 56.7 m-70 -67.49 -31.56 71.78 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.611 171.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.758 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.84 -53.84 40.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.172 0.987 . . . . 0.0 109.481 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.68 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.9 m-80 -62.68 -32.03 73.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.006 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.85 -53.03 61.41 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.857 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.039 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.4 t -63.05 -34.4 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.712 0.767 . . . . 0.0 110.398 177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -62.17 -15.53 46.78 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.175 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 33.9 mm-40 -92.26 -49.7 6.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 112.475 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.777 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 4.8 pt -64.37 -40.82 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.559 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -83.69 -16.67 44.1 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.719 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.5 51.88 50.84 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.123 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.72 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -102.72 -178.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 123.766 0.826 . . . . 0.0 110.134 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.746 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 13.6 p30 -99.72 -42.98 6.62 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 165.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.61 -75.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.906 160.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.808 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -61.16 64.75 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -169.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 43.81 35.48 3.23 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 111.754 -2.475 . . . . 0.0 113.062 173.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.746 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 29.4 mm-40 -73.61 -57.19 4.16 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 122.093 0.949 . . . . 0.0 111.778 -172.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 68.53 49.34 0.76 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.271 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.719 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 109.887 -3.324 . . . . 0.0 111.565 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.426 -1.666 0 CA-C-O 121.413 0.625 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.708 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 21.5 mt -77.33 126.19 85.32 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 308' ' ' GLN . 19.0 Cg_endo -71.4 -10.55 27.18 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.733 3.622 . . . . 0.0 111.111 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.688 ' H ' HG22 ' A' ' 305' ' ' ILE . 4.6 tp 26.11 -61.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 128.72 2.808 . . . . 0.0 116.194 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.571 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.48 -32.04 68.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.231 0.539 . . . . 0.0 110.047 178.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.569 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.07 -49.4 76.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.913 172.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.674 HG13 HG11 ' A' ' 338' ' ' VAL . 54.7 mt -58.76 -49.31 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 123.95 0.9 . . . . 0.0 112.614 175.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 48.1 mtp180 -61.3 -29.61 69.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 123.38 0.672 . . . . 0.0 111.094 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 66.8 m -70.31 -34.03 72.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 110.251 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.643 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.73 -41.68 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.559 178.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.778 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -84.7 -37.69 20.64 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.748 1.261 . . . . 0.0 110.351 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.92 35.4 7.19 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.485 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 19.5 mt-10 50.34 176.39 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.62 ' HG3' ' HA ' ' A' ' 355' ' ' LEU . 73.5 Cg_exo -51.22 129.76 29.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.825 2.35 . . . . 0.0 113.1 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.88 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 82.3 Cg_endo -84.79 -92.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.488 3.459 . . . . 0.0 113.913 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.497 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 5.8 mmm180 -89.54 -77.72 0.38 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.747 0.784 . . . . 0.0 112.355 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.647 ' H ' ' CG ' ' A' ' 323' ' ' GLU . 38.0 m-20 -123.55 175.31 2.86 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.738 -170.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.459 ' HB3' HD13 ' A' ' 359' ' ' ILE . 27.2 Cg_exo -65.97 -56.96 0.26 Allowed 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 121.969 1.779 . . . . 0.0 111.572 167.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -50.68 -21.15 1.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.648 -1.615 . . . . 0.0 114.075 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.823 ' OE1' ' HG2' ' A' ' 318' ' ' PRO . 1.7 pp20? -99.24 -22.29 15.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.04 0.448 . . . . 0.0 111.629 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.67 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.62 -42.69 33.91 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.571 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.73 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -49.73 -59.61 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.815 2.344 . . . . 0.0 112.935 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.627 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -63.66 -35.95 74.7 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.953 -179.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.88 ' CD1' ' HG3' ' A' ' 318' ' ' PRO . 42.6 t90 -58.01 -37.33 74.1 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.289 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.837 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -69.16 -48.14 63.09 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.77 -23.47 22.01 Favored Glycine 0 C--N 1.311 -0.858 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.794 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.478 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 1.4 mmm180 -74.46 -42.8 58.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.119 0.961 . . . . 0.0 110.66 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.751 ' HB3' HG22 ' A' ' 314' ' ' THR . 28.1 m-20 -97.15 -22.75 16.56 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.895 -169.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.671 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.17 -49.64 11.56 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 39.7 Cg_endo -61.31 -32.21 89.67 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.589 2.193 . . . . 0.0 111.7 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.41 -43.99 59.31 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.727 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.0 mt -57.57 -48.49 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.866 173.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.47 -15.71 7.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.166 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.55 -47.25 6.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.259 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.674 HG11 HG13 ' A' ' 310' ' ' ILE . 99.1 t -57.51 -70.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 123.472 1.606 . . . . 0.0 110.128 169.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.887 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.39 128.74 43.51 Favored Pre-proline 0 N--CA 1.401 -2.92 0 CA-C-N 111.008 -2.815 . . . . 0.0 112.039 -172.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.768 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.9 Cg_endo -73.96 -16.56 22.97 Favored 'Trans proline' 0 CA--C 1.494 -1.49 0 C-N-CA 123.752 2.968 . . . . 0.0 110.442 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.621 HG21 ' HG3' ' A' ' 347' ' ' ARG . 2.8 p 34.01 67.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.222 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.649 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.2 p -80.37 8.07 8.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.83 -1.986 . . . . 0.0 113.118 -170.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.782 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 11.3 p -142.13 161.97 47.98 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -63.27 -47.52 7.77 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.451 2.768 . . . . 0.0 108.487 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.765 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.3 OUTLIER -45.96 -45.88 15.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.002 -1.908 . . . . 0.0 111.081 176.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.782 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -58.82 -52.31 66.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.378 0.609 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.621 ' HG3' HG21 ' A' ' 341' ' ' VAL . 2.1 ttt180 -50.4 -48.82 55.91 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.199 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 1.005 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -69.67 -49.13 56.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.035 0.445 . . . . 0.0 111.522 -175.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.664 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.3 mtt180 -56.48 -41.73 77.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.492 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.887 HD11 ' HD2' ' A' ' 339' ' ' PHE . 38.7 mt -57.72 -53.77 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.322 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.591 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.9 mt -58.15 -52.76 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.015 0.912 . . . . 0.0 111.018 -169.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.53 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 19.3 m-20 -63.39 -35.97 82.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.988 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.76 75.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.668 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.39 -54.37 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 123.127 1.441 . . . . 0.0 110.21 173.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.668 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -73.83 -26.5 60.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.377 -2.647 . . . . 0.0 109.878 -167.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 17.24 75.72 0.01 OUTLIER Glycine 0 N--CA 1.468 0.816 0 O-C-N 125.706 1.879 . . . . 0.0 115.205 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 137.35 -8.2 3.73 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.086 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.783 HD22 ' HB2' ' A' ' 361' ' ' LEU . 22.1 p-10 -57.14 148.61 21.57 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.667 0.787 . . . . 0.0 111.703 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -56.05 -73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.477 0.711 . . . . 0.0 112.567 -175.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -136.9 11.16 3.93 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.783 ' HB2' HD22 ' A' ' 358' ' ' ASN . 4.6 mt -64.94 -4.68 4.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.87 0.468 . . . . 0.0 111.629 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.53 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.8 t -60.63 82.99 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.379 0.609 . . . . 0.0 110.334 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.799 HD11 HG21 ' A' ' 377' ' ' THR . 0.7 OUTLIER -62.42 173.78 1.13 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.664 0.745 . . . . 0.0 112.604 175.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 76.8 p -115.13 160.97 31.87 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 1.005 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.2 Cg_endo -61.06 -5.02 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.801 1.667 . . . . 0.0 112.26 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -105.84 -11.75 27.66 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' A' ' 363' ' ' LEU . 30.7 m-20 -105.91 -20.89 13.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.569 1.184 . . . . 0.0 110.228 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.853 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 16.8 p -84.9 20.05 1.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.709 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.03 -34.18 67.95 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.986 0.898 . . . . 0.0 110.192 -165.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.41 166.1 20.24 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.176 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.573 ' O ' HG13 ' A' ' 375' ' ' VAL . 44.0 m95 -69.66 -36.01 75.66 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.6 p30 -63.36 -39.42 94.47 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.306 -173.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 m -71.37 -41.99 69.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -63.27 -52.34 62.47 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.871 HG21 ' HE3' ' A' ' 413' ' ' MET . 14.6 m -56.77 -44.6 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.554 0.692 . . . . 0.0 109.51 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.041 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.66 -45.53 93.77 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.056 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.799 HG21 HD11 ' A' ' 363' ' ' LEU . 30.7 m -66.96 -39.11 87.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.56 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.26 -33.5 73.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.317 0.508 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.73 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 48.9 t80 -74.77 -45.63 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.311 1.053 . . . . 0.0 109.075 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -51.73 -33.27 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.346 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -60.25 -36.92 78.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 123.311 0.645 . . . . 0.0 111.732 177.026 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 32.5 p -102.77 -23.54 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.044 -167.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -109.83 23.06 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.86 21.24 51.25 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 114.073 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.462 HG23 HG13 ' A' ' 380' ' ' ILE . 2.8 m 64.11 163.74 0.13 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.588 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -129.09 150.52 75.6 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -97.35 59.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.251 2.634 . . . . 0.0 110.893 165.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.679 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.84 4.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.89 -48.82 51.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.635 ' O ' HG13 ' A' ' 394' ' ' VAL . 73.9 mt-30 -74.81 -27.74 60.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -169.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.941 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.4 mm? -54.76 -31.05 58.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.796 0.725 . . . . 0.0 111.892 -172.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.682 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.76 -52.67 44.39 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.438 173.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.599 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 3.5 m-20 -65.75 -39.94 91.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.826 0.45 . . . . 0.0 111.969 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -58.14 -45.06 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.1 mm -58.51 -47.58 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.682 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.4 mmtt -52.23 -43.42 64.29 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.901 0.751 . . . . 0.0 111.486 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.69 -44.63 12.16 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.24 -172.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.7 mt -69.05 -41.13 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 117.436 0.618 . . . . 0.0 111.432 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.9 m -58.13 -45.62 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.706 0.765 . . . . 0.0 109.944 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.475 ' N ' HG23 ' A' ' 399' ' ' VAL . 7.7 t70 -60.88 -38.23 84.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -86.26 -53.25 5.14 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.793 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.612 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.2 OUTLIER -110.67 -30.01 7.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.035 -168.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.02 162.48 11.19 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.853 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.94 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.66 98.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.654 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.22 -50.31 73.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.579 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -63.61 -51.18 66.36 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.577 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.678 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.03 -41.88 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.567 ' HB3' HD11 ' A' ' 457' ' ' ILE . 44.4 t80 -58.42 -44.8 89.24 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.827 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.0 m -59.26 -53.08 62.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.407 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.686 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.57 -49.08 76.67 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.686 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.607 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.1 -42.2 87.08 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.019 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.792 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.39 -32.44 66.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.68 0.24 . . . . 0.0 111.097 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.871 ' HE3' HG21 ' A' ' 375' ' ' VAL . 63.2 mtm -69.55 -46.29 66.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.172 0.511 . . . . 0.0 109.707 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.041 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.06 -40.75 90.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.524 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.941 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 9.2 m -78.12 8.0 5.45 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.744 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.38 31.73 56.47 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.792 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 4.7 mm-40 63.87 44.98 4.56 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 123.942 0.897 . . . . 0.0 111.621 -178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.841 ' ND2' HD23 ' A' ' 421' ' ' LEU . 7.4 t30 -114.07 74.01 0.85 Allowed 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 164.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.693 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.5 OUTLIER -51.53 -35.41 40.5 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.32 -2.218 . . . . 0.0 111.288 -171.138 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.532 ' O ' ' HB3' ' A' ' 423' ' ' SER . 39.2 mt-30 -56.65 -50.57 71.69 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -166.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.841 HD23 ' ND2' ' A' ' 418' ' ' ASN . 3.1 pp -59.53 -49.16 78.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.723 0.773 . . . . 0.0 110.564 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.63 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.79 -40.27 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.421 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 48.5 t -59.83 -47.43 85.76 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.507 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.55 -39.51 74.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.961 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.665 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.7 mt -71.92 -42.48 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.387 0.613 . . . . 0.0 110.142 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.58 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -57.07 -44.68 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.93 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.2 OUTLIER -63.51 -27.82 69.53 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-O 122.79 1.281 . . . . 0.0 108.846 -173.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -17.07 77.19 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 112.469 -2.15 . . . . 0.0 112.658 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.707 ' CG ' HG21 ' A' ' 399' ' ' VAL . 9.8 m-85 -99.71 2.43 44.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.31 144.82 76.75 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-O 123.645 1.688 . . . . 0.0 113.898 170.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.787 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.1 Cg_endo -72.36 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.083 1 C-N-CA 126.333 4.689 . . . . 0.0 113.584 -173.07 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.98 139.91 15.25 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.255 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.819 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.61 -29.49 70.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.078 0.439 . . . . 0.0 111.207 -177.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.8 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.85 -48.01 79.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.01 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.79 -51.66 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.644 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.62 -55.22 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 52.6 m -61.4 -55.92 26.08 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.246 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.17 -45.5 79.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.668 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.844 ' O ' HD22 ' A' ' 443' ' ' LEU . 43.1 mt -60.38 -53.31 59.12 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.684 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.718 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 32.5 mm-40 -51.58 -34.6 37.76 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 125.174 1.546 . . . . 0.0 110.563 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.633 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.67 -59.9 2.49 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 175.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.72 -51.98 10.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.735 -0.603 . . . . 0.0 112.43 -173.397 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.84 -23.25 60.36 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.043 0.925 . . . . 0.0 111.409 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.756 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.6 t70 -72.23 -42.93 65.16 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.963 -1.472 . . . . 0.0 110.755 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.5 mt-30 -72.08 -8.29 53.76 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -172.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.529 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 53.1 mm-40 -52.25 155.96 1.83 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 123.366 1.555 . . . . 0.0 114.659 -174.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.601 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.32 -33.76 21.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 111.047 -2.797 . . . . 0.0 115.455 -170.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.653 ' H ' ' HB ' ' A' ' 451' ' ' THR . 15.7 m-20 -141.89 -179.21 6.07 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.929 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.442 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.2 p-10 -61.31 -55.55 30.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.485 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.28 -25.23 65.95 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 176.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.653 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 8.8 m -59.81 -42.69 94.03 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 119.861 1.209 . . . . 0.0 109.705 171.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.529 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 55.7 mtt180 -59.67 -29.91 68.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.525 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.38 -31.26 60.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.797 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -83.88 -45.87 12.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.208 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.542 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 34.0 p -100.61 -2.76 31.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.551 -166.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.694 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.4 t80 -49.04 -52.3 26.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.667 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 405' ' ' ALA . 23.7 mm -72.05 -25.72 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.542 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.35 -42.39 65.38 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.64 ' O ' HG23 ' A' ' 463' ' ' VAL . 52.5 m-70 -67.94 -31.47 71.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.686 -1.597 . . . . 0.0 109.718 172.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.733 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.27 -53.53 42.76 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.09 0.947 . . . . 0.0 109.33 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.634 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.77 -32.0 73.07 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.161 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.47 -52.47 63.38 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.8 t -62.57 -35.22 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 121.899 0.857 . . . . 0.0 110.344 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.3 m-30 -61.61 -14.51 31.18 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.155 170.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 61.5 mm-40 -93.06 -48.57 6.43 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.001 -1.062 . . . . 0.0 112.777 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.727 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.91 -39.0 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.109 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.5 mt -84.95 -17.12 38.68 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 170.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.738 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.27 53.45 39.54 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 111.698 -2.501 . . . . 0.0 113.161 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.739 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -103.55 -170.29 1.76 Allowed 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 123.856 0.863 . . . . 0.0 110.268 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.673 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.8 p30 -109.86 -42.29 4.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -157.93 -76.41 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.081 158.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.787 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 4.1 mpt_? -62.15 66.74 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -170.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 41.05 39.5 2.06 Favored Glycine 0 C--N 1.278 -2.679 0 CA-C-N 111.554 -2.567 . . . . 0.0 113.65 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.673 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 10.1 mm-40 -77.76 -51.39 10.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.277 1.037 . . . . 0.0 111.398 -173.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.8 t 64.06 56.1 1.45 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.263 -171.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.738 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.444 0 CA-C-N 110.302 -3.135 . . . . 0.0 111.941 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.425 -1.704 0 CA-C-O 120.962 0.411 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.703 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.5 mt -76.01 126.97 86.2 Favored Pre-proline 0 N--CA 1.422 -1.831 0 CA-C-O 121.77 0.795 . . . . 0.0 111.803 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -71.26 -15.45 31.63 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 124.708 3.606 . . . . 0.0 110.978 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.723 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.2 tp 30.62 -60.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 128.676 2.791 . . . . 0.0 116.279 172.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.615 ' HG2' HG23 ' A' ' 307' ' ' ILE . 7.1 mm-40 -56.64 -39.16 73.19 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.892 0.853 . . . . 0.0 109.958 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.531 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.4 t-160 -58.96 -48.51 81.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.866 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.1 mt -58.75 -48.52 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 123.96 0.904 . . . . 0.0 113.033 174.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.723 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.0 mtp180 -59.59 -29.83 68.24 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.726 0.41 . . . . 0.0 110.562 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.1 m -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.565 0.697 . . . . 0.0 109.911 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 338' ' ' VAL . 0.5 OUTLIER -67.91 -40.52 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.918 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.795 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.39 -36.18 26.98 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.691 1.234 . . . . 0.0 109.57 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.5 9.13 Favored Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.52 -2.127 . . . . 0.0 111.184 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 44.0 mt-10 51.62 173.18 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 124.302 1.041 . . . . 0.0 113.273 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.537 ' HB3' HD11 ' A' ' 324' ' ' ILE . 22.6 Cg_exo -44.82 140.38 6.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.011 2.474 . . . . 0.0 112.821 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 319' ' ' ARG . 40.3 Cg_endo -89.15 -100.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.42 2.747 . . . . 0.0 113.072 -171.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.509 ' HG2' ' HB2' ' A' ' 318' ' ' PRO . 5.1 mmt180 -98.23 -81.95 0.43 Allowed 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.381 0.61 . . . . 0.0 110.687 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.741 ' OD1' ' HG2' ' A' ' 322' ' ' ARG . 1.8 t30 -111.93 150.12 41.88 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.147 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.697 ' HD2' ' OD1' ' A' ' 320' ' ' ASN . 56.8 Cg_exo -49.14 -53.53 6.87 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.157 2.572 . . . . 0.0 111.692 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.741 ' HG2' ' OD1' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -63.24 -13.34 36.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.26 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.584 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 30.4 mt-10 -83.16 -28.01 29.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 171.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -48.39 -44.74 65.75 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 378' ' ' LEU . 8.9 Cg_endo -50.21 -59.98 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.754 2.303 . . . . 0.0 112.965 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.641 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -64.75 -34.06 67.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.345 0 CA-C-O 122.9 1.333 . . . . 0.0 110.067 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.795 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 39.5 t90 -57.2 -38.62 73.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.073 -1.876 . . . . 0.0 110.718 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.84 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -67.71 -47.34 69.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-O 120.693 0.283 . . . . 0.0 111.688 -175.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.27 -23.05 16.37 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.88 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.663 ' HD3' ' OE1' ' A' ' 402' ' ' GLU . 3.2 mmm-85 -72.89 -43.9 61.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.735 0.779 . . . . 0.0 111.152 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.621 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.5 p30 -103.02 -17.65 15.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.29 -49.75 6.51 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 174.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 43.0 Cg_endo -62.76 -32.34 78.16 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.566 2.177 . . . . 0.0 111.612 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.13 -42.83 62.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.314 -1.766 . . . . 0.0 109.839 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.7 mt -58.65 -48.66 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.362 173.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.87 -15.03 4.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.846 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.68 -50.16 5.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.624 HG11 HG13 ' A' ' 310' ' ' ILE . 99.2 t -55.42 -71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 123.742 1.734 . . . . 0.0 109.796 169.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.824 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.8 OUTLIER -89.44 128.7 50.03 Favored Pre-proline 0 N--CA 1.397 -3.116 0 CA-C-N 110.537 -3.028 . . . . 0.0 111.9 -173.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.762 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.7 Cg_endo -72.92 -16.72 25.8 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 C-N-CA 123.548 2.832 . . . . 0.0 110.075 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.56 HG21 ' HG2' ' A' ' 347' ' ' ARG . 4.6 p 31.9 69.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.603 ' N ' HD12 ' A' ' 346' ' ' LEU . 39.6 p -79.2 6.33 10.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.671 -2.058 . . . . 0.0 113.408 -167.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -140.73 164.49 36.09 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.659 ' HB3' HD23 ' A' ' 369' ' ' LEU . 47.4 Cg_exo -64.32 -47.81 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.646 2.897 . . . . 0.0 108.655 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.598 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 1.0 OUTLIER -44.81 -48.84 11.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.076 177.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.5 mt -57.86 -50.97 71.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.902 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.584 ' HA ' HD12 ' A' ' 350' ' ' ILE . 55.0 mtt180 -48.4 -48.0 37.29 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.298 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.926 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -70.13 -48.39 57.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.728 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 84.0 mtt180 -57.4 -40.81 79.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.079 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.824 HD11 ' CD2' ' A' ' 339' ' ' PHE . 48.0 mt -57.89 -53.13 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.497 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.581 HG12 HD11 ' A' ' 328' ' ' LEU . 26.0 mt -59.0 -52.5 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-O 122.117 0.96 . . . . 0.0 111.122 -170.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.598 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 13.6 m-20 -62.53 -35.95 81.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.938 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.75 75.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.244 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.674 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.66 -54.87 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-O 123.021 1.391 . . . . 0.0 110.515 173.162 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.721 HD23 HD22 ' A' ' 358' ' ' ASN . 1.1 mp -72.37 -25.7 61.62 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.777 -2.465 . . . . 0.0 109.1 -168.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 68.25 -76.74 0.25 Allowed Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 113.607 -1.633 . . . . 0.0 113.326 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -124.61 69.1 0.49 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.112 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.721 HD22 HD23 ' A' ' 355' ' ' LEU . 30.8 p30 -86.74 163.86 17.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.503 0.321 . . . . 0.0 110.994 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.43 -59.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 122.92 0.488 . . . . 0.0 111.494 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -160.51 16.08 0.19 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.624 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.613 ' HB3' HD12 ' A' ' 378' ' ' LEU . 3.1 mt -67.33 -3.74 8.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.307 0.643 . . . . 0.0 111.189 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.598 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.3 t -62.52 81.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.711 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -61.93 174.35 0.87 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.83 0.824 . . . . 0.0 113.019 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.4 p -117.52 157.96 46.29 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.151 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.879 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.4 Cg_endo -49.46 -30.23 20.36 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.556 1.504 . . . . 0.0 112.236 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.65 ' HA2' HD21 ' A' ' 369' ' ' LEU . . . -96.36 0.53 61.8 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.811 1.085 . . . . 0.0 115.811 -170.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.677 ' HB2' HD12 ' A' ' 363' ' ' LEU . 6.4 m-20 -109.3 -18.37 13.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.686 1.243 . . . . 0.0 110.443 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.926 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 5.0 t -109.95 21.74 16.47 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.328 -165.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 344' ' ' PRO . 2.1 mt -60.04 -29.51 68.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.861 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 6.0 p -114.56 159.96 19.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.221 -1.809 . . . . 0.0 109.771 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.596 ' O ' HG13 ' A' ' 375' ' ' VAL . 31.0 m95 -70.28 -34.83 73.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.538 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -63.29 -44.84 93.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.887 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 t -68.44 -42.85 78.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.466 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.627 ' O ' HD22 ' A' ' 378' ' ' LEU . . . -61.28 -53.13 60.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.847 HG21 ' HE3' ' A' ' 413' ' ' MET . 15.8 m -57.37 -44.96 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.759 0.79 . . . . 0.0 109.259 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 0.999 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.81 -45.75 91.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.634 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.677 HG21 HD11 ' A' ' 363' ' ' LEU . 29.5 m -66.76 -39.75 88.01 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.088 -172.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -60.16 -34.49 73.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.984 1.265 . . . . 0.0 109.832 177.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.687 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 62.1 t80 -72.1 -47.5 50.84 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.494 1.14 . . . . 0.0 109.288 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 112.469 -2.151 . . . . 0.0 111.407 171.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.5 OUTLIER -59.48 -36.19 75.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 123.219 0.608 . . . . 0.0 111.243 176.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 322' ' ' ARG . 34.1 p -102.34 -22.09 14.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.799 -169.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -109.49 23.1 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.25 16.22 26.29 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.448 -0.406 . . . . 0.0 114.034 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.41 HG23 HG13 ' A' ' 380' ' ' ILE . 0.7 OUTLIER 64.68 158.23 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.996 0.518 . . . . 0.0 111.355 -175.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.509 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -124.65 154.05 70.07 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -100.07 59.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.703 2.935 . . . . 0.0 111.209 165.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.742 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.43 -1.24 0.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -175.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -69.89 -48.31 59.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.892 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.637 ' O ' HG13 ' A' ' 394' ' ' VAL . 57.9 mt-30 -74.08 -25.43 59.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -169.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.798 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.86 -30.77 47.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.7 0.682 . . . . 0.0 111.657 -175.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.787 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.19 -49.69 62.4 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.549 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.639 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 29.9 m-20 -68.74 -39.88 80.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.774 0.43 . . . . 0.0 112.135 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.65 -44.89 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.626 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -57.76 -46.77 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.484 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.639 ' HG3' ' HA ' ' A' ' 393' ' ' ASN . 30.3 mmtt -52.23 -44.46 64.84 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.819 0.819 . . . . 0.0 111.365 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.05 17.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.191 -172.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.696 HG23 ' HG3' ' A' ' 402' ' ' GLU . 3.9 mt -68.93 -41.51 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 117.156 0.478 . . . . 0.0 111.379 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.5 m -57.85 -44.97 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.615 0.721 . . . . 0.0 110.032 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.476 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.7 t70 -65.97 -37.75 86.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.412 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.67 -51.71 6.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.696 ' HG3' HG23 ' A' ' 398' ' ' ILE . 0.0 OUTLIER -108.95 -29.48 8.57 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.369 -170.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 125.7 160.56 10.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.598 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.804 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.24 -42.96 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -176.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.67 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -57.04 -50.47 72.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.312 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -63.21 -51.3 66.85 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.658 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -41.97 65.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 55.0 t80 -59.24 -44.99 92.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.442 0.639 . . . . 0.0 109.524 176.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.774 ' O ' ' HG3' ' A' ' 413' ' ' MET . 4.6 m -60.45 -52.55 64.73 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.49 -178.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.707 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -61.69 -48.58 80.12 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.713 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.638 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.72 -43.75 86.58 Favored Glycine 0 C--N 1.313 -0.745 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.348 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.626 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.3 -31.72 65.95 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.821 0.311 . . . . 0.0 110.975 179.067 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.847 ' HE3' HG21 ' A' ' 375' ' ' VAL . 65.2 mtm -69.12 -47.87 63.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.176 0.513 . . . . 0.0 109.915 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.999 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.6 mt -58.66 -39.83 81.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.159 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.798 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.4 OUTLIER -77.65 -14.54 59.6 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.741 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.8 32.37 7.63 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.135 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.617 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 71.35 38.53 1.03 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.54 0.736 . . . . 0.0 112.149 176.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.877 HD22 HD21 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -119.99 77.99 1.3 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 165.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.626 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 2.9 p90 -62.18 -32.6 73.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.416 -2.174 . . . . 0.0 110.501 -162.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 31.8 mt-30 -55.11 -46.98 75.61 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.171 0.989 . . . . 0.0 113.359 -164.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.877 HD21 HD22 ' A' ' 418' ' ' ASN . 1.6 pp -60.06 -51.22 70.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.635 0.731 . . . . 0.0 110.777 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.617 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -59.83 -38.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 123.054 1.407 . . . . 0.0 108.893 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 419' ' ' TYR . 1.1 t -61.8 -46.79 88.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 111.891 -2.413 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.64 89.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.111 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.787 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.1 mt -71.25 -41.25 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.57 0.7 . . . . 0.0 109.672 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.77 -46.73 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.596 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.719 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.19 -30.18 68.01 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.518 1.151 . . . . 0.0 109.526 -175.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.409 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.43 -16.59 77.42 Favored Glycine 0 C--N 1.298 -1.57 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.595 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.96 0.03 40.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.65 145.05 71.37 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 123.626 1.679 . . . . 0.0 113.268 170.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.719 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.2 Cg_endo -71.24 -58.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 1 C-N-CA 126.22 4.613 . . . . 0.0 113.147 -173.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.524 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -110.97 139.35 15.5 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.407 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.886 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.23 -27.95 69.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.091 0.446 . . . . 0.0 111.286 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.774 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.44 -47.93 80.5 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.021 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.6 -51.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.676 177.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.886 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.94 -53.43 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.469 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 64.8 m -62.18 -56.33 19.82 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.914 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.11 -45.64 79.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.532 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.863 ' O ' HD22 ' A' ' 443' ' ' LEU . 42.7 mt -59.61 -53.77 54.26 Favored 'General case' 0 CA--C 1.481 -1.695 0 C-N-CA 120.276 -0.569 . . . . 0.0 110.619 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.682 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.79 -34.56 40.44 Favored 'General case' 0 N--CA 1.416 -2.143 0 O-C-N 125.073 1.483 . . . . 0.0 110.596 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.91 -60.99 1.97 Allowed 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 176.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.2 OUTLIER -76.3 -51.44 11.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.894 -0.504 . . . . 0.0 112.232 -172.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.62 -24.49 61.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.622 0.725 . . . . 0.0 111.735 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.749 ' N ' HD23 ' A' ' 443' ' ' LEU . 21.2 t70 -71.71 -42.76 66.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.662 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.4 mt-30 -69.48 -7.86 41.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 43.5 mm-40 -51.7 160.08 0.7 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 123.721 1.724 . . . . 0.0 114.501 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.502 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -56.32 -33.32 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 110.626 -2.988 . . . . 0.0 115.403 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.647 ' H ' ' HB ' ' A' ' 451' ' ' THR . 48.4 m-20 -142.78 -178.67 5.91 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -63.66 -56.59 14.62 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.42 -25.11 67.87 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 176.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.647 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 17.8 m -59.34 -42.68 92.05 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 119.493 1.042 . . . . 0.0 109.889 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 53.0 mtt180 -61.34 -30.0 70.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.557 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -30.93 59.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.971 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 2.5 mm-40 -80.86 -45.17 17.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.416 1.103 . . . . 0.0 111.498 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 43.7 p -101.36 -4.34 27.14 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.894 -167.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.736 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.5 t80 -49.01 -52.09 27.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.661 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.67 HG23 ' HB1' ' A' ' 405' ' ' ALA . 27.0 mm -70.95 -27.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.429 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.16 -42.73 65.58 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 463' ' ' VAL . 75.8 m-70 -67.03 -30.97 71.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.75 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.782 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -65.59 -53.7 38.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.207 1.003 . . . . 0.0 109.23 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.652 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.4 m-80 -61.94 -32.39 72.81 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.071 172.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.71 -52.73 62.11 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.002 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.021 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.9 t -62.78 -34.89 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 121.858 0.837 . . . . 0.0 110.32 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.7 m-30 -61.63 -15.13 36.81 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.014 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 45.7 mm-40 -91.16 -49.52 6.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.941 -1.099 . . . . 0.0 112.696 176.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.73 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.24 -39.77 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.997 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.774 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.6 mt -84.44 -16.61 42.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.801 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.88 50.02 60.32 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 111.855 -2.43 . . . . 0.0 113.599 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.715 HD11 HD12 ' A' ' 467' ' ' LEU . 0.3 OUTLIER -103.68 -179.28 3.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 123.877 0.871 . . . . 0.0 110.244 -179.156 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.706 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.0 p30 -102.1 -40.27 6.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 168.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -160.56 -76.51 0.06 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 112.524 -2.125 . . . . 0.0 111.052 158.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.719 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -60.07 69.26 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -171.139 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 37.39 40.37 0.63 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 110.738 -2.937 . . . . 0.0 113.654 174.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.706 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.3 mm-40 -77.67 -53.62 7.34 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.098 0.951 . . . . 0.0 111.784 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 67.9 55.08 0.59 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 112.084 -2.325 . . . . 0.0 108.833 -174.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.801 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 110.84 -2.891 . . . . 0.0 111.833 176.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.433 -1.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.715 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 22.6 mt -75.05 126.27 88.3 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-O 121.945 0.878 . . . . 0.0 112.698 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.602 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.0 Cg_endo -83.37 49.56 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.819 3.679 . . . . 0.0 109.522 167.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.761 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -42.49 -42.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.555 -2.111 . . . . 0.0 112.665 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -65.25 -36.99 85.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.241 0.543 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.59 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.6 t-160 -62.7 -47.49 83.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.357 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.637 HG13 HG11 ' A' ' 338' ' ' VAL . 62.3 mt -58.74 -49.88 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.761 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.3 mtp180 -62.11 -29.95 70.68 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 110.683 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.0 m -69.71 -33.78 72.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.37 0.605 . . . . 0.0 110.072 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.545 HG21 HG23 ' A' ' 338' ' ' VAL . 0.5 OUTLIER -66.24 -40.05 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.982 178.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.654 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.14 -36.93 26.94 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.74 1.257 . . . . 0.0 109.677 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.44 32.19 9.73 Favored Glycine 0 C--N 1.305 -1.14 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.803 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 25.5 mt-10 51.8 169.54 0.04 OUTLIER Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 124.626 1.17 . . . . 0.0 113.83 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.643 ' HB3' HD11 ' A' ' 324' ' ' ILE . 52.7 Cg_exo -46.19 148.53 3.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.469 2.779 . . . . 0.0 114.203 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.475 ' HG2' ' H ' ' A' ' 319' ' ' ARG . 40.3 Cg_endo -91.86 -99.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.851 3.034 . . . . 0.0 112.746 -174.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 6.5 mmm180 -97.83 -83.09 0.41 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.154 0.502 . . . . 0.0 110.828 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.405 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 16.9 m-20 -102.67 163.57 17.34 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.479 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.4 Cg_exo -59.72 -47.41 16.12 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.708 2.272 . . . . 0.0 110.379 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.452 ' HA ' HG21 ' A' ' 382' ' ' THR . 81.2 mtt180 -48.65 -28.76 3.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.815 -1.993 . . . . 0.0 112.8 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.85 -23.16 22.87 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.801 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.716 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.2 OUTLIER -50.02 -42.39 70.44 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.728 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 7.5 Cg_endo -48.62 -61.52 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.848 2.365 . . . . 0.0 112.829 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.723 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -61.51 -36.79 75.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-O 122.667 1.222 . . . . 0.0 110.384 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.758 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 54.6 t90 -58.75 -40.72 84.68 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.48 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.803 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.5 OUTLIER -68.45 -50.12 54.86 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.46 -23.23 18.59 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.758 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 1.5 ttt-85 -72.77 -41.61 64.87 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 114.442 -0.879 . . . . 0.0 112.321 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.575 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.4 p30 -106.74 -16.92 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.17 -48.01 6.04 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 37.8 Cg_endo -60.49 -32.72 94.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.536 2.157 . . . . 0.0 111.555 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -72.7 -43.21 63.33 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.658 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.4 mt -58.37 -49.52 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.754 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 28.1 t70 -58.33 -14.57 7.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.044 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.66 6.43 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.364 175.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.637 HG11 HG13 ' A' ' 310' ' ' ILE . 91.2 t -56.99 -70.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 123.698 1.713 . . . . 0.0 110.154 168.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.864 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -92.43 130.6 36.85 Favored Pre-proline 0 N--CA 1.402 -2.864 0 CA-C-N 110.629 -2.987 . . . . 0.0 112.11 -173.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.775 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.7 Cg_endo -74.91 -17.42 19.79 Favored 'Trans proline' 0 CA--C 1.496 -1.394 0 C-N-CA 123.731 2.954 . . . . 0.0 110.631 174.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.465 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.6 p 34.08 67.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 112.216 -2.266 . . . . 0.0 110.107 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.63 ' N ' HD12 ' A' ' 346' ' ' LEU . 35.8 p -78.25 3.17 16.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 112.453 -2.158 . . . . 0.0 113.194 -170.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.79 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 10.2 p -137.93 164.13 43.06 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 343' ' ' THR . 42.2 Cg_exo -63.8 -49.94 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.265 2.644 . . . . 0.0 108.329 172.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.73 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -43.6 -48.69 7.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.982 176.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.79 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.7 mt -56.18 -51.99 66.01 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.521 0.677 . . . . 0.0 110.166 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.712 ' HA ' HD12 ' A' ' 350' ' ' ILE . 2.1 ttm180 -54.9 -47.03 74.87 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.556 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 1.088 ' HG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.45 -48.16 61.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.179 0.514 . . . . 0.0 111.193 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.2 mtp180 -56.45 -41.1 75.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.244 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.864 HD11 ' CD2' ' A' ' 339' ' ' PHE . 42.6 mt -58.63 -54.37 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.492 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.652 ' O ' HD22 ' A' ' 355' ' ' LEU . 20.8 mt -57.71 -54.04 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.952 0.882 . . . . 0.0 110.87 -168.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.489 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -63.95 -34.79 78.76 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.989 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.6 -34.42 74.08 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.336 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.727 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.252 1.0 OUTLIER -56.58 -55.32 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 CA-C-O 122.982 1.372 . . . . 0.0 110.523 175.289 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.727 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.0 OUTLIER -73.06 -27.63 61.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.668 -2.514 . . . . 0.0 110.154 -169.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 39.41 75.35 0.1 Allowed Glycine 0 CA--C 1.524 0.63 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.851 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 112.85 25.08 4.66 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.86 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.788 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 3.9 p-10 -75.14 136.91 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.99 0.424 . . . . 0.0 111.365 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.627 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.1 mp -71.77 98.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.999 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.76 -21.55 4.6 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.221 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.788 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 5.8 mt -61.59 -6.38 2.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 122.939 0.496 . . . . 0.0 112.195 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.489 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 20.7 t -61.06 81.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.217 0.532 . . . . 0.0 110.427 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -62.5 169.25 3.09 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.136 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 366' ' ' GLY . 69.5 p -111.75 161.4 25.8 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.329 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 1.088 ' HA ' ' HG ' ' A' ' 348' ' ' CYS . 2.2 Cg_endo -63.57 7.07 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.202 1.935 . . . . 0.0 112.747 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -117.23 -12.32 8.32 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.689 -0.687 . . . . 0.0 114.679 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.751 ' HB2' HD12 ' A' ' 363' ' ' LEU . 45.9 m-20 -105.67 -20.43 13.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.509 1.147 . . . . 0.0 109.804 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 7.6 p -82.91 20.04 1.26 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.431 -1.713 . . . . 0.0 112.805 -169.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -58.03 -34.83 70.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 122.288 1.042 . . . . 0.0 110.067 -168.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.1 t -130.62 163.67 26.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.202 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.608 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.4 m95 -70.36 -36.59 74.28 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.535 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.4 p30 -63.38 -39.37 94.34 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.439 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 48.1 t -66.36 -42.89 87.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.053 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.65 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -68.35 -51.81 40.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 328' ' ' LEU . 11.9 m -56.88 -45.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.144 0.497 . . . . 0.0 110.087 -178.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.006 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.09 -43.1 95.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.684 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.722 HG21 HD11 ' A' ' 363' ' ' LEU . 40.2 m -68.5 -42.68 78.25 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.558 -173.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -58.74 -34.02 70.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.419 0.554 . . . . 0.0 110.671 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.728 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.6 t80 -73.68 -47.34 40.45 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.501 1.144 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.64 -32.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 CA-C-N 112.678 -2.055 . . . . 0.0 111.336 170.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.63 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -60.29 -41.99 94.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.682 175.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 322' ' ' ARG . 30.3 p -97.4 -23.42 16.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.772 -168.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -110.5 22.91 14.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.75 21.73 23.49 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.315 0.486 . . . . 0.0 114.315 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.2 m 67.01 160.05 0.15 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.225 0.536 . . . . 0.0 111.328 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.518 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -125.31 156.17 70.4 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -97.94 54.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.415 2.743 . . . . 0.0 111.306 165.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.79 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.51 4.21 0.22 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.09 -47.45 61.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.014 0.435 . . . . 0.0 110.585 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.616 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.7 mt-30 -71.47 -27.48 63.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -169.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.839 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.84 -31.18 59.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.59 0.632 . . . . 0.0 111.925 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.682 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -50.09 59.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.476 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.516 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.3 m-20 -68.58 -39.43 80.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.661 0.384 . . . . 0.0 112.002 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.55 -45.92 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.245 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.796 ' O ' HG22 ' A' ' 399' ' ' VAL . 5.9 mm -58.69 -47.27 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.615 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.693 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.8 mmtt -51.42 -42.61 61.61 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 124.077 0.861 . . . . 0.0 111.486 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.52 -44.11 13.78 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.921 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.723 HG12 HG21 ' A' ' 326' ' ' ILE . 1.8 mt -69.2 -40.73 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 117.5 0.65 . . . . 0.0 111.543 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.873 HG12 ' HA ' ' A' ' 404' ' ' VAL . 0.8 OUTLIER -59.35 -42.81 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 109.506 -178.43 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.63 -39.23 93.84 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.087 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -85.66 -53.41 5.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.281 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.554 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -110.64 -32.16 6.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.561 0.696 . . . . 0.0 111.747 -170.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.01 163.13 11.48 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.682 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.873 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.07 -49.81 72.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.164 0.507 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.645 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.76 -50.69 65.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.557 177.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.677 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.53 -44.18 65.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.518 ' HB3' HD11 ' A' ' 457' ' ' ILE . 26.9 t80 -54.81 -46.44 74.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.779 0.799 . . . . 0.0 109.082 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.778 ' O ' ' HG3' ' A' ' 413' ' ' MET . 18.4 m -58.55 -52.02 67.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.958 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.68 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -61.99 -49.09 77.47 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.958 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.538 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.11 -43.28 88.59 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.805 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.631 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -71.29 -32.94 69.25 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.728 0.264 . . . . 0.0 110.673 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.778 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.6 mtm -68.82 -46.2 69.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.923 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.006 HD23 ' HA ' ' A' ' 376' ' ' ALA . 18.5 mt -60.2 -43.35 96.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.292 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.839 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 1.9 m -80.63 7.15 10.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 70.81 46.78 43.59 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.857 171.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.631 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 0.0 OUTLIER 62.3 42.12 9.61 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 123.87 0.868 . . . . 0.0 111.616 177.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.741 ' ND2' HD22 ' A' ' 421' ' ' LEU . 22.3 t30 -113.17 83.21 1.79 Allowed 'General case' 0 CA--C 1.476 -1.878 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 163.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.786 ' HD2' ' HG ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -57.09 -36.93 71.2 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.821 -174.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 41.6 mt-30 -57.29 -51.56 68.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -163.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.803 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 1.7 pt? -60.02 -49.23 78.48 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.392 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.803 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.77 -38.42 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.685 1.231 . . . . 0.0 108.894 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.786 ' HG ' ' HD2' ' A' ' 419' ' ' TYR . 43.6 m -65.31 -41.13 94.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.31 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.83 86.97 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.787 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.625 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.7 mt -71.46 -40.71 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.597 0.713 . . . . 0.0 109.813 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -56.78 -44.67 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.58 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.642 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -57.4 -33.09 67.49 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 124.87 1.268 . . . . 0.0 109.245 -176.137 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.443 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.57 -15.01 77.52 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 112.992 -1.913 . . . . 0.0 112.448 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.75 ' CG ' HG21 ' A' ' 399' ' ' VAL . 9.0 m-85 -102.77 1.12 33.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -57.58 142.01 78.06 Favored Pre-proline 0 N--CA 1.41 -2.464 0 CA-C-O 123.645 1.688 . . . . 0.0 113.333 170.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.807 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 53.1 Cg_endo -68.95 -57.35 0.13 Allowed 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.564 4.843 . . . . 0.0 113.316 -169.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.497 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.62 140.72 16.45 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.736 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.933 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -59.44 -32.43 70.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.688 0.744 . . . . 0.0 111.651 -175.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.857 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.02 -48.43 73.39 Favored 'General case' 0 CA--C 1.509 -0.635 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.045 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -62.39 -36.76 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.337 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.933 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -71.1 -45.98 69.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 45.4 m -72.27 -54.92 8.13 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.359 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.82 76.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.842 HD13 HD22 ' A' ' 460' ' ' LEU . 20.1 mt -66.61 -54.49 22.91 Favored 'General case' 0 CA--C 1.465 -2.3 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.733 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.22 -33.54 28.29 Favored 'General case' 0 N--CA 1.405 -2.715 0 O-C-N 125.781 1.926 . . . . 0.0 109.944 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -72.95 -60.74 2.09 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -71.55 -48.73 46.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.126 0.488 . . . . 0.0 111.472 -171.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -60.22 -25.97 66.03 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.458 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.744 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.0 t70 -73.09 -42.01 63.46 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.33 1.062 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -68.79 -8.31 42.14 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -171.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 47.1 mm-40 -51.78 156.97 1.28 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.518 1.628 . . . . 0.0 115.058 -176.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.5 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -52.92 -31.98 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 110.506 -3.043 . . . . 0.0 115.665 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.651 ' H ' ' HB ' ' A' ' 451' ' ' THR . 55.2 m-20 -140.81 178.9 7.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.78 -56.3 20.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -67.49 -24.97 65.64 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.651 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -57.78 -41.05 81.27 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.774 1.17 . . . . 0.0 109.932 171.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 62.5 mtt180 -60.97 -30.57 70.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.565 ' HB2' ' HD1' ' A' ' 419' ' ' TYR . . . -76.09 -31.44 58.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.35 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.8 mm-40 -81.29 -45.68 15.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.474 1.13 . . . . 0.0 111.883 -172.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.464 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 47.2 p -98.95 -2.3 37.82 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.772 -167.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.645 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -48.89 -55.57 11.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.932 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 405' ' ' ALA . 27.6 mm -70.23 -25.42 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -73.0 -43.21 62.43 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.585 ' O ' HG23 ' A' ' 463' ' ' VAL . 65.9 m-70 -66.15 -32.19 73.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.261 171.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.18 -53.69 45.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.308 1.051 . . . . 0.0 109.34 -178.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.662 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.9 m-80 -62.6 -32.03 72.96 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.3 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.36 -52.55 63.16 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.035 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.045 HG11 ' HA ' ' A' ' 435' ' ' VAL . 34.5 t -63.26 -33.57 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-O 121.802 0.81 . . . . 0.0 110.56 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.4 m-30 -62.54 -15.26 49.8 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.309 168.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 22.4 mm-40 -92.25 -49.31 6.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.007 -1.058 . . . . 0.0 112.64 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.762 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.63 -40.16 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.67 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.857 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.3 mt -84.6 -16.67 41.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.759 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.75 51.79 50.91 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 111.681 -2.509 . . . . 0.0 113.171 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.667 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -103.3 -178.12 3.57 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.723 0.809 . . . . 0.0 110.268 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.585 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 10.8 p30 -101.39 -41.95 6.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 167.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.92 -75.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.322 159.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.807 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 1.3 mpt_? -63.77 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -168.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 40.09 42.16 2.25 Favored Glycine 0 C--N 1.277 -2.72 0 CA-C-N 111.352 -2.658 . . . . 0.0 113.417 173.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.585 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 4.6 mm-40 -81.55 -49.64 10.32 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-O 122.306 1.05 . . . . 0.0 111.278 -172.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 46.8 t 62.1 57.69 1.99 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.346 -2.207 . . . . 0.0 108.433 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.759 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.322 0 CA-C-N 110.934 -2.848 . . . . 0.0 111.418 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 121.175 0.512 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.698 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -75.1 126.66 87.8 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-O 122.005 0.907 . . . . 0.0 111.731 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.6 Cg_endo -72.18 -10.84 26.39 Favored 'Trans proline' 0 CA--C 1.498 -1.307 0 C-N-CA 124.755 3.637 . . . . 0.0 111.298 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.7 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.8 tp 25.12 -61.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 O-C-N 127.13 2.769 . . . . 0.0 116.063 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.565 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.37 -32.78 68.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.196 0.522 . . . . 0.0 110.396 178.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.564 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.6 t-160 -62.27 -48.71 78.71 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.609 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 307' ' ' ILE . 59.8 mt -58.32 -48.87 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 C-N-CA 123.982 0.913 . . . . 0.0 112.78 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 10.5 mtp180 -61.29 -30.48 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 122.141 -0.349 . . . . 0.0 110.827 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 53.1 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.62 0.724 . . . . 0.0 109.962 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.542 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.1 -40.89 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.748 178.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.742 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 32.3 p -82.67 -36.32 26.05 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.941 1.353 . . . . 0.0 109.531 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.64 33.54 8.42 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 112.183 -2.281 . . . . 0.0 110.938 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.539 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.1 mt-10 50.68 174.66 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 124.339 1.055 . . . . 0.0 113.029 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.658 ' HB3' HD11 ' A' ' 324' ' ' ILE . 42.6 Cg_exo -46.09 145.81 4.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.374 2.05 . . . . 0.0 112.467 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 319' ' ' ARG . 48.6 Cg_endo -87.65 -99.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.343 2.695 . . . . 0.0 112.451 -171.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.401 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 4.0 mmm180 -100.82 -76.57 0.56 Allowed 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.723 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.614 ' HB3' ' HG3' ' A' ' 323' ' ' GLU . 1.3 t30 -109.88 150.8 41.85 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.004 -173.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.609 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 47.7 Cg_exo -53.88 -52.83 7.53 Favored 'Trans proline' 0 CA--C 1.504 -1.024 0 C-N-CA 123.04 2.493 . . . . 0.0 111.52 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.572 ' HD2' ' HB ' ' A' ' 382' ' ' THR . 0.0 OUTLIER -59.18 -15.93 17.55 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.052 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.614 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 5.5 mt-10 -81.22 -25.85 36.35 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.658 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -48.58 -44.48 66.87 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.759 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -51.2 -61.9 0.47 Allowed 'Trans proline' 0 CA--C 1.518 -0.308 0 C-N-CA 122.697 2.265 . . . . 0.0 113.159 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.733 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.64 -35.59 60.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 122.919 1.343 . . . . 0.0 110.153 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.842 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 42.7 t90 -59.78 -38.5 82.05 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.88 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.867 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.5 OUTLIER -69.2 -50.6 45.94 Favored 'General case' 0 N--CA 1.407 -2.604 0 O-C-N 121.863 -0.523 . . . . 0.0 112.396 -175.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.94 -22.87 21.16 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.842 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 10.7 ttp85 -71.76 -42.46 67.17 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 113.862 -1.169 . . . . 0.0 112.166 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.573 ' HB2' HG22 ' A' ' 314' ' ' THR . 0.8 OUTLIER -108.3 -15.44 14.47 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.099 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.37 -47.97 6.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 32.1 Cg_endo -59.16 -34.94 98.61 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.557 175.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -71.94 -42.62 66.4 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.771 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 332' ' ' ALA . 88.5 mt -58.87 -49.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.663 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.2 -16.87 5.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.895 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.2 -50.7 5.33 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.17 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.673 HG11 HG13 ' A' ' 310' ' ' ILE . 92.0 t -54.61 -69.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 123.541 1.639 . . . . 0.0 110.176 170.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.838 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -94.51 129.39 36.79 Favored Pre-proline 0 N--CA 1.401 -2.923 0 CA-C-N 110.958 -2.837 . . . . 0.0 112.162 -172.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.782 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.3 Cg_endo -75.5 -16.0 19.38 Favored 'Trans proline' 0 CA--C 1.497 -1.367 0 C-N-CA 123.892 3.061 . . . . 0.0 110.503 174.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.464 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.43 68.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.943 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.655 ' N ' HD12 ' A' ' 346' ' ' LEU . 31.0 p -81.0 10.58 4.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.623 -2.08 . . . . 0.0 113.468 -169.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.78 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.3 p -143.71 162.52 41.09 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.42 -49.34 6.05 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.208 2.606 . . . . 0.0 108.214 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.763 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -46.02 -44.12 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.904 -1.953 . . . . 0.0 111.292 178.036 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.78 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.0 mt -58.59 -52.03 67.38 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.382 0.61 . . . . 0.0 110.746 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.735 ' HA ' HD12 ' A' ' 350' ' ' ILE . 32.6 ttm105 -53.92 -44.85 70.94 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.31 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.867 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.04 -47.4 65.47 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 111.086 -176.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 94.0 mtt180 -57.51 -41.76 81.46 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.036 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.838 HD11 ' CD2' ' A' ' 339' ' ' PHE . 44.8 mt -58.0 -53.77 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.528 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 328' ' ' LEU . 20.6 mt -58.69 -52.84 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.096 0.951 . . . . 0.0 110.815 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -63.36 -35.32 79.99 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.049 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.23 -34.51 74.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 112.076 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.698 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.26 -55.09 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.833 1.302 . . . . 0.0 110.5 174.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.739 HD23 HD22 ' A' ' 358' ' ' ASN . 0.4 OUTLIER -72.7 -26.79 61.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 111.693 -2.503 . . . . 0.0 109.297 -168.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 34.71 60.68 0.63 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.705 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 117.57 74.17 0.49 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.342 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.739 HD22 HD23 ' A' ' 355' ' ' LEU . 20.6 p30 -119.53 168.89 10.54 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 122.668 0.387 . . . . 0.0 110.432 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.536 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -52.84 -61.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 122.991 0.516 . . . . 0.0 111.517 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.411 ' C ' ' HG2' ' A' ' 381' ' ' ARG . . . -156.44 14.05 0.36 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.05 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.68 ' HB3' HD22 ' A' ' 378' ' ' LEU . 5.1 mt -66.74 -4.81 9.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 122.934 0.494 . . . . 0.0 111.953 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.529 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 33.9 t -60.71 87.14 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 109.686 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.812 HD11 HG21 ' A' ' 377' ' ' THR . 0.7 OUTLIER -65.48 178.51 0.95 Allowed 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.249 174.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 43.0 p -122.06 161.13 44.27 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.867 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 8.7 Cg_endo -66.13 4.66 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.038 1.825 . . . . 0.0 112.365 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -110.53 -10.83 20.93 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.809 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.748 ' HB2' HD12 ' A' ' 363' ' ' LEU . 36.7 m-20 -106.42 -21.76 12.99 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.081 0.943 . . . . 0.0 109.828 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.83 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 17.6 p -80.91 18.94 0.92 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.917 -170.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.32 -35.48 73.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 122.291 1.043 . . . . 0.0 109.671 -172.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.19 159.76 33.3 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.229 174.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.628 ' O ' HG13 ' A' ' 375' ' ' VAL . 59.5 m95 -70.29 -36.95 74.68 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.576 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.26 -40.02 84.69 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.483 -175.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 35.4 t -72.77 -42.59 63.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.657 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.32 -51.52 67.32 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.867 HG12 ' HB3' ' A' ' 328' ' ' LEU . 11.2 m -58.52 -45.38 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.458 0.647 . . . . 0.0 109.824 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.039 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.09 -43.31 95.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.648 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.812 HG21 HD11 ' A' ' 363' ' ' LEU . 29.7 m -69.45 -39.21 77.92 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.836 -172.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.69 HD11 HD12 ' A' ' 328' ' ' LEU . 2.5 mt -60.75 -34.37 74.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.586 0.63 . . . . 0.0 110.516 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.759 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 38.0 t80 -73.58 -47.69 38.55 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 122.446 1.117 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -51.1 -32.42 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 112.661 -2.063 . . . . 0.0 111.706 170.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -59.8 -46.79 88.12 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.435 0.636 . . . . 0.0 111.042 174.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.572 ' HB ' ' HD2' ' A' ' 322' ' ' ARG . 43.8 p -93.22 -24.23 18.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.843 -169.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -110.84 23.14 14.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.05 20.75 15.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.415 HG23 HG13 ' A' ' 380' ' ' ILE . 2.6 m 66.27 163.52 0.17 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.279 0.561 . . . . 0.0 111.429 -176.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.537 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -130.55 153.96 81.56 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.077 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -99.31 60.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.421 2.747 . . . . 0.0 111.015 164.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.667 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.4 6.32 0.38 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -174.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -70.24 -48.72 55.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.082 0.467 . . . . 0.0 110.629 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.649 ' O ' HG13 ' A' ' 394' ' ' VAL . 41.2 mt-30 -76.61 -27.37 55.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -169.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.711 ' O ' HG22 ' A' ' 394' ' ' VAL . 3.2 mm? -54.66 -31.45 57.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 -171.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.7 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.76 -53.29 40.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.924 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.611 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 14.2 m-20 -66.21 -37.92 86.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.1 -45.99 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.648 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.0 mm -58.54 -47.59 87.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 34.0 mmtt -52.11 -42.81 63.58 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.354 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.26 -44.33 13.78 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.034 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 326' ' ' ILE . 2.0 mt -68.97 -40.77 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 117.447 0.623 . . . . 0.0 111.233 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.882 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.8 m -58.25 -45.63 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.034 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.474 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.1 t70 -62.34 -37.43 85.61 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.948 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -83.47 -53.14 5.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.615 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.39 -28.6 8.86 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.521 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 119.6 165.89 13.15 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.444 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.882 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.56 -44.07 98.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.31 -51.07 70.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.644 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.43 -49.88 69.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.461 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.678 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.2 -43.62 67.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.547 ' HB3' HD11 ' A' ' 457' ' ' ILE . 28.6 t80 -55.67 -45.72 77.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.816 ' O ' ' HG3' ' A' ' 413' ' ' MET . 16.3 m -57.99 -52.07 67.06 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.702 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.671 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -62.89 -49.23 75.64 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.716 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.57 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.37 -41.81 88.22 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.776 -174.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.786 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.44 -32.15 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 122.245 0.218 . . . . 0.0 111.152 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.816 ' HG3' ' O ' ' A' ' 409' ' ' THR . 60.4 mtm -70.67 -46.56 62.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 109.831 173.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.039 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.4 mt -60.51 -38.68 85.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.352 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 411' ' ' GLY . 4.5 p -77.0 -2.9 36.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.326 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.63 29.12 36.63 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.786 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 3.8 mm-40 68.43 45.55 1.15 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 122.253 1.025 . . . . 0.0 111.534 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.822 ' ND2' HD23 ' A' ' 421' ' ' LEU . 7.0 t30 -116.16 71.96 0.8 Allowed 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 164.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.65 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.2 OUTLIER -48.05 -35.77 11.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.046 -2.343 . . . . 0.0 111.64 -172.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 423' ' ' SER . 33.3 mt-30 -57.29 -49.91 74.58 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -166.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.822 HD23 ' ND2' ' A' ' 418' ' ' ASN . 3.1 pp -59.53 -48.66 80.78 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.237 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.76 -39.8 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.643 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.547 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 44.0 t -59.81 -47.59 85.1 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.793 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -56.02 -37.38 70.93 Favored Glycine 0 C--N 1.32 -0.339 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.052 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.7 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.9 mt -73.02 -42.69 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.548 0.689 . . . . 0.0 110.239 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.6 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -55.94 -44.48 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.727 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.71 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -59.74 -30.12 68.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-O 122.701 1.239 . . . . 0.0 109.236 -173.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.16 -16.82 77.0 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.429 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 15.3 m-85 -101.65 2.46 38.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.09 144.96 74.87 Favored Pre-proline 0 N--CA 1.416 -2.15 0 CA-C-O 123.501 1.62 . . . . 0.0 113.403 168.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.736 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.5 Cg_endo -72.6 -63.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 1 C-N-CA 126.126 4.551 . . . . 0.0 113.281 -173.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.552 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.06 140.23 15.22 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.181 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.83 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.74 -30.69 70.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.2 0.5 . . . . 0.0 111.204 -177.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.752 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.33 -48.16 74.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.005 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.61 -52.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.593 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.83 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.36 -54.66 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.109 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 53.2 m -62.76 -55.79 23.37 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.047 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.43 -45.13 80.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.642 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.0 mt -60.06 -53.46 57.56 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.722 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.704 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.74 -34.15 37.94 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 125.124 1.515 . . . . 0.0 110.403 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.663 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.87 -60.62 2.14 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 174.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -75.64 -51.38 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.541 0.61 . . . . 0.0 112.006 -172.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.32 -24.83 63.65 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.636 -178.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.757 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.1 t70 -73.06 -43.35 62.02 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.573 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.7 mt-30 -69.66 -8.95 52.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -172.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.436 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 20.7 mm-40 -51.89 155.28 1.82 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 123.574 1.654 . . . . 0.0 114.825 -175.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -52.93 -33.32 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 110.752 -2.931 . . . . 0.0 115.335 -171.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.643 ' H ' ' HB ' ' A' ' 451' ' ' THR . 26.5 m-20 -141.73 177.04 8.44 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.94 -52.35 63.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.9 -25.2 67.05 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 174.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.643 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 12.6 m -60.89 -41.43 96.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 119.823 1.192 . . . . 0.0 109.756 172.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 71.8 mtt180 -60.42 -30.71 69.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.921 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 450' ' ' GLN . . . -75.67 -30.33 59.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.835 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -82.05 -44.25 16.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.858 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.506 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -104.32 -0.74 27.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.383 -167.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.676 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.8 t80 -49.12 -54.31 16.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.349 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -71.39 -25.1 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.99 -43.98 64.22 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.632 ' O ' HG23 ' A' ' 463' ' ' VAL . 30.3 m80 -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.91 172.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.77 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.46 -53.77 43.09 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 122.263 1.03 . . . . 0.0 109.13 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -62.21 -30.65 71.23 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.341 -1.754 . . . . 0.0 110.869 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.7 -48.18 67.29 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.771 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.005 HG11 ' HA ' ' A' ' 435' ' ' VAL . 25.9 t -65.0 -35.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.352 174.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.53 -14.44 29.61 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.583 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 2.4 tp10 -92.56 -52.17 4.77 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.404 -0.81 . . . . 0.0 112.114 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.714 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -63.87 -41.15 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.424 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.1 mt -83.39 -16.85 44.32 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.817 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.9 50.8 56.37 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 111.565 -2.561 . . . . 0.0 112.977 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -102.86 -178.9 3.8 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.708 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.0 p30 -101.02 -40.89 7.01 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.509 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -161.02 -75.79 0.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.114 159.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.736 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -61.48 70.57 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -171.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.77 46.54 0.61 Allowed Glycine 0 C--N 1.274 -2.862 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.398 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.708 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 22.9 mm-40 -83.89 -53.81 5.32 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 122.245 1.022 . . . . 0.0 111.245 -173.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.8 t 68.0 56.25 0.54 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.889 -174.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.817 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 110.547 -3.024 . . . . 0.0 111.845 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.431 -1.402 0 CA-C-O 121.136 0.493 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.705 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -74.82 127.54 86.86 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 121.765 0.793 . . . . 0.0 111.5 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -72.41 -12.27 27.18 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.881 3.72 . . . . 0.0 111.107 176.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.696 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.6 tp 26.95 -61.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.087 0 C-N-CA 128.704 2.801 . . . . 0.0 115.975 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.36 -32.08 68.22 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.273 0.559 . . . . 0.0 110.257 178.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.517 ' CG ' HG13 ' A' ' 338' ' ' VAL . 6.7 t-160 -62.08 -49.32 76.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.669 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' A' ' 307' ' ' ILE . 59.2 mt -58.88 -49.05 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 124.213 1.005 . . . . 0.0 113.08 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 4.3 mtp-105 -60.64 -30.57 69.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.864 0.364 . . . . 0.0 111.071 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.1 m -70.44 -33.28 71.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.572 0.701 . . . . 0.0 110.205 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.21 -40.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.8 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.788 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -82.45 -36.61 26.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.969 1.366 . . . . 0.0 109.759 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.98 35.44 8.22 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 112.117 -2.31 . . . . 0.0 111.135 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.531 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 42.8 mt-10 51.49 173.2 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.102 0 C-N-CA 124.196 0.998 . . . . 0.0 113.529 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.609 ' HB3' HD11 ' A' ' 324' ' ' ILE . 23.9 Cg_exo -45.2 142.18 6.16 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.015 2.477 . . . . 0.0 112.343 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.507 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 41.9 Cg_endo -89.71 -100.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.305 2.67 . . . . 0.0 112.896 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.448 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 12.3 mmm180 -94.01 -83.36 0.33 Allowed 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 123.149 0.58 . . . . 0.0 110.935 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 18.0 m-20 -103.29 163.18 18.0 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.769 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 35.2 Cg_exo -59.28 -51.59 6.25 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.499 2.133 . . . . 0.0 110.676 172.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -55.27 -14.82 1.95 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.203 -1.817 . . . . 0.0 113.142 177.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.3 mm-40 -91.64 -26.19 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.419 -0.175 . . . . 0.0 111.405 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.646 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.3 OUTLIER -46.44 -45.12 43.86 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.745 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.6 Cg_endo -47.47 -62.59 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.905 2.404 . . . . 0.0 113.25 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.65 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -63.42 -35.92 74.23 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 122.879 1.323 . . . . 0.0 110.141 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.788 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.6 t90 -57.51 -39.5 76.64 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.74 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.849 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -67.62 -47.5 69.48 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 122.465 0.306 . . . . 0.0 111.716 -175.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.408 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.27 -22.96 16.04 Favored Glycine 0 C--N 1.311 -0.858 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.681 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.441 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -73.16 -42.39 62.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.447 0.642 . . . . 0.0 111.31 175.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.656 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.4 p30 -104.39 -17.61 14.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.698 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.72 -49.44 7.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.7 Cg_endo -61.81 -33.0 86.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.576 2.184 . . . . 0.0 111.466 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -71.9 -43.1 65.92 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.884 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 332' ' ' ALA . 87.7 mt -58.79 -49.3 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.71 173.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.37 -14.5 4.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.921 175.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.12 -44.21 7.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.485 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.647 HG11 HG13 ' A' ' 310' ' ' ILE . 92.1 t -60.74 -70.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 123.466 1.603 . . . . 0.0 109.79 169.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -92.62 130.78 35.83 Favored Pre-proline 0 N--CA 1.403 -2.825 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.265 -173.089 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.789 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.2 Cg_endo -74.78 -16.85 20.6 Favored 'Trans proline' 0 CA--C 1.498 -1.323 0 C-N-CA 123.788 2.992 . . . . 0.0 110.862 173.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 346' ' ' LEU . 3.1 p 33.4 67.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.342 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.652 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.3 p -78.14 4.26 12.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 112.669 -2.06 . . . . 0.0 113.485 -169.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.797 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 13.5 p -139.86 163.35 45.2 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -63.31 -49.23 4.89 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.367 2.711 . . . . 0.0 108.103 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.747 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -44.32 -45.94 8.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.4 176.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.797 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.4 mt -59.22 -51.63 69.17 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 121.64 0.733 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.674 ' HA ' HD12 ' A' ' 350' ' ' ILE . 3.2 ttm180 -54.1 -45.85 71.96 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.262 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 1.006 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.89 -48.75 62.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 111.355 -177.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.646 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 62.9 mtt180 -56.01 -42.62 76.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 339' ' ' PHE . 39.9 mt -57.73 -54.13 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.523 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.55 HD13 ' HB1' ' A' ' 374' ' ' ALA . 19.8 mt -59.43 -52.57 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 122.162 0.982 . . . . 0.0 110.558 -170.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 17.4 m-20 -62.79 -35.18 79.01 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.272 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.41 -36.0 76.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.683 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.58 -53.83 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 CA-C-O 123.107 1.432 . . . . 0.0 110.463 173.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.683 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -72.68 -25.71 61.36 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 111.716 -2.493 . . . . 0.0 109.412 -168.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 75.93 -74.71 1.57 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.895 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -151.39 56.94 0.45 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.332 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.61 HD22 ' HG ' ' A' ' 355' ' ' LEU . 81.7 m-20 -76.91 162.61 27.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.783 -0.245 . . . . 0.0 110.581 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.659 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -37.43 -59.73 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.252 1.021 . . . . 0.0 113.736 -166.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -153.9 16.56 0.62 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.511 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.725 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.3 mt -65.59 -3.87 5.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.942 0.497 . . . . 0.0 112.139 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.541 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.9 t -63.47 84.24 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.529 0.68 . . . . 0.0 110.309 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.82 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -62.63 170.53 2.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.773 0.796 . . . . 0.0 112.388 174.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 366' ' ' GLY . 65.4 p -111.31 156.33 41.32 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.952 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 1.006 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.8 Cg_endo -61.92 11.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.673 2.248 . . . . 0.0 113.794 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.518 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -128.53 -5.65 4.94 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.728 ' HB2' HD12 ' A' ' 363' ' ' LEU . 8.4 m-20 -109.57 -19.91 13.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.205 1.002 . . . . 0.0 110.298 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 15.4 p -88.56 16.27 6.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.595 -168.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.518 HD11 ' O ' ' A' ' 366' ' ' GLY . 1.0 OUTLIER -59.61 -40.84 88.86 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.524 -164.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.62 160.09 21.84 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.523 171.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.626 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.6 m95 -69.88 -35.89 75.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.58 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.44 -40.24 96.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.251 -175.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 36.8 t -68.69 -43.58 75.76 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.938 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.661 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.77 62.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.849 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.1 m -57.22 -44.73 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.057 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.4 -44.75 95.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.019 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.82 HG21 HD11 ' A' ' 363' ' ' LEU . 55.5 m -68.79 -39.42 80.15 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.825 -172.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.725 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.1 mt -60.8 -33.22 72.66 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.849 -0.532 . . . . 0.0 110.57 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.745 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 49.8 t80 -75.0 -46.04 37.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.349 1.071 . . . . 0.0 109.161 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -51.54 -32.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.328 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.0 OUTLIER -59.85 -41.24 90.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 44.5 p -100.03 -23.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.36 -167.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . 0.422 ' HB3' HE22 ' A' ' 390' ' ' GLN . 29.5 m80 -110.22 24.24 13.26 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.43 18.31 29.11 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 114.864 0.705 . . . . 0.0 114.864 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.419 HG23 HG13 ' A' ' 380' ' ' ILE . 1.7 m 66.17 159.37 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.286 0.565 . . . . 0.0 111.385 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.472 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -127.64 152.19 76.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -96.76 53.7 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.351 2.701 . . . . 0.0 111.211 166.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.681 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.17 7.87 0.71 Allowed 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -71.04 -48.59 51.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 0.0 110.389 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.655 ' O ' HG13 ' A' ' 394' ' ' VAL . 56.6 mt-30 -76.2 -26.15 55.86 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.694 ' O ' HG22 ' A' ' 394' ' ' VAL . 3.1 mm? -54.05 -31.36 51.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.332 0.969 . . . . 0.0 111.384 -173.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.709 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.56 -49.79 63.41 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.971 174.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.642 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 36.4 m-20 -69.34 -39.25 78.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.9 m -57.46 -44.07 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.419 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.625 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.7 mm -58.24 -46.94 88.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.676 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.648 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 30.3 mmtt -52.4 -43.41 64.75 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.707 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.562 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.56 -44.34 16.5 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.1 -172.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.4 mt -69.31 -41.4 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 117.519 0.66 . . . . 0.0 111.552 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.4 m -57.64 -43.77 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.822 0.82 . . . . 0.0 109.955 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 399' ' ' VAL . 3.4 t70 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.064 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 70.1 mt-30 -83.78 -54.27 5.02 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.547 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -112.43 -30.46 7.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.796 -166.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.11 163.49 11.55 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.735 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.86 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.38 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.654 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.3 -50.51 71.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.1 0.476 . . . . 0.0 111.448 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.576 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -51.03 65.19 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.5 178.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.674 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.0 -41.85 65.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.548 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 31.6 t80 -57.08 -46.69 82.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.665 0.745 . . . . 0.0 109.086 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.821 ' O ' ' HG3' ' A' ' 413' ' ' MET . 8.5 m -58.69 -52.5 65.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.562 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.682 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.92 -49.01 76.46 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.737 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.95 -42.23 86.17 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.923 -174.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.759 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -32.64 66.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.66 0.23 . . . . 0.0 111.239 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.821 ' HG3' ' O ' ' A' ' 409' ' ' THR . 66.7 mtm -70.63 -46.98 62.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.383 0.611 . . . . 0.0 110.06 174.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.057 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.4 mt -59.23 -38.46 80.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.023 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.635 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.3 OUTLIER -77.45 -14.62 59.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.951 -176.066 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.67 27.03 8.71 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.178 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.759 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 3.9 mm-40 64.35 44.17 4.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.101 0.961 . . . . 0.0 112.292 177.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.685 ' ND2' HD21 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -120.24 69.5 0.86 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 166.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.667 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.8 OUTLIER -47.47 -35.25 8.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 111.568 -2.56 . . . . 0.0 113.477 -165.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' A' ' 423' ' ' SER . 28.0 mt-30 -55.03 -47.74 74.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -163.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.685 HD21 ' ND2' ' A' ' 418' ' ' ASN . 1.9 pp -59.71 -48.99 79.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.384 0.612 . . . . 0.0 110.81 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.629 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.25 -38.87 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.574 1.178 . . . . 0.0 109.263 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.65 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 40.4 t -61.13 -46.53 90.19 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.905 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.77 72.93 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.019 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.709 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.26 -41.91 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.549 0.69 . . . . 0.0 110.162 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.58 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.18 -44.8 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.604 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.755 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.38 -30.77 68.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.618 1.199 . . . . 0.0 109.376 -174.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.68 -14.33 77.93 Favored Glycine 0 C--N 1.299 -1.483 0 CA-C-N 112.845 -1.979 . . . . 0.0 112.503 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.67 ' CG ' HG21 ' A' ' 399' ' ' VAL . 16.5 m-85 -103.83 3.03 33.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.5 144.75 78.25 Favored Pre-proline 0 N--CA 1.411 -2.411 0 CA-C-O 123.541 1.639 . . . . 0.0 112.996 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.746 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 60.9 Cg_endo -72.94 -63.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 1 C-N-CA 126.074 4.516 . . . . 0.0 113.422 -173.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.559 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -104.58 141.86 15.37 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.899 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -65.68 -26.82 67.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.22 0.51 . . . . 0.0 111.216 -176.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.778 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -58.5 -46.33 86.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.029 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -59.39 -52.04 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.629 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.899 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.36 -53.79 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.467 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 94.4 m -61.15 -56.6 18.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.96 -46.24 78.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.519 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.842 ' O ' HD22 ' A' ' 443' ' ' LEU . 54.9 mt -59.95 -53.5 57.08 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.64 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.674 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.5 mm-40 -51.77 -34.48 39.82 Favored 'General case' 0 N--CA 1.415 -2.19 0 O-C-N 124.956 1.41 . . . . 0.0 110.682 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.674 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.29 -61.81 1.69 Allowed 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 175.079 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.55 -50.17 14.59 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.85 -0.531 . . . . 0.0 112.205 -171.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.7 -25.35 62.8 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.34 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.752 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.5 t70 -72.81 -42.74 63.54 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.701 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.8 mt-30 -68.97 -7.6 36.77 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -172.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 4.9 mm-40 -51.66 156.22 1.42 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.516 1.627 . . . . 0.0 114.363 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.487 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.22 -32.37 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 110.719 -2.946 . . . . 0.0 115.38 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.663 ' H ' ' HB ' ' A' ' 451' ' ' THR . 19.1 m-20 -142.02 179.94 6.59 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.442 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 3.6 m-20 -62.65 -55.58 25.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.61 -25.2 67.86 Favored 'General case' 0 N--CA 1.403 -2.795 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.411 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.663 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 23.6 m -60.31 -41.91 94.45 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 119.793 1.179 . . . . 0.0 109.543 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 45.8 mtt180 -60.88 -30.32 70.08 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.851 172.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.548 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.65 -29.47 59.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.921 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.09 -44.66 17.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.788 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.562 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.1 p -106.24 0.39 25.16 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.184 -167.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.9 t80 -48.91 -53.83 17.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.03 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.2 mm -71.06 -25.49 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.562 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.17 -43.42 64.61 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.643 ' O ' HG23 ' A' ' 463' ' ' VAL . 26.8 m80 -65.45 -32.03 73.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.722 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.717 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.14 -53.47 37.42 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.066 0.936 . . . . 0.0 109.512 -178.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.666 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 8.3 m-80 -62.37 -32.31 73.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.068 173.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -61.66 -53.36 57.23 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.893 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.029 HG11 ' HA ' ' A' ' 435' ' ' VAL . 20.9 t -62.7 -34.88 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.858 0 CA-C-O 121.818 0.818 . . . . 0.0 110.4 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.7 -14.7 33.95 Favored 'General case' 0 C--O 1.207 -1.155 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.32 170.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.666 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 43.4 mt-10 -92.99 -48.28 6.59 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.097 -1.002 . . . . 0.0 112.69 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.734 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.6 pt -66.27 -38.1 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.237 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.6 mt -85.27 -17.16 37.78 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.753 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 61.8 55.73 26.8 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.659 -2.518 . . . . 0.0 112.942 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -105.02 -159.21 0.7 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 122.088 0.947 . . . . 0.0 109.644 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.616 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.3 p30 -124.76 -41.39 2.13 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -159.21 -79.59 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 112.251 -2.249 . . . . 0.0 110.619 156.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.746 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 1.3 mpt_? -59.06 68.13 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 33.47 53.58 0.6 Allowed Glycine 0 C--N 1.278 -2.689 0 CA-C-N 111.099 -2.773 . . . . 0.0 113.367 173.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.616 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 5.9 mm-40 -90.13 -49.07 6.78 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 122.4 1.095 . . . . 0.0 111.259 -173.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 27.2 t 62.0 62.58 1.21 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.119 -2.31 . . . . 0.0 108.561 -171.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.753 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.281 0 CA-C-N 110.932 -2.849 . . . . 0.0 112.115 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.428 -1.549 0 CA-C-O 120.857 0.36 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.72 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -74.73 125.43 89.56 Favored Pre-proline 0 N--CA 1.426 -1.65 0 CA-C-O 121.909 0.862 . . . . 0.0 111.852 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 308' ' ' GLN . 17.6 Cg_endo -72.46 -11.32 26.37 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 124.929 3.752 . . . . 0.0 111.372 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.7 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.7 tp 25.66 -60.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 C-N-CA 128.677 2.791 . . . . 0.0 116.34 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.558 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.17 -32.44 68.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.355 0.598 . . . . 0.0 110.138 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.9 t-160 -62.4 -48.95 77.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.66 172.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 307' ' ' ILE . 57.6 mt -58.59 -48.71 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 124.006 0.922 . . . . 0.0 113.172 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.671 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.4 mtp-105 -60.22 -30.11 69.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.14 -0.35 . . . . 0.0 111.41 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 46.9 m -69.6 -35.43 75.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.564 0.697 . . . . 0.0 109.845 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.547 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -66.07 -40.9 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.717 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.846 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -83.35 -36.88 24.03 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.797 1.284 . . . . 0.0 110.235 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.66 36.67 7.8 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.245 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 38.8 mt-10 49.87 175.53 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 124.071 0.948 . . . . 0.0 113.261 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.628 ' HB3' HD11 ' A' ' 324' ' ' ILE . 90.8 Cg_exo -52.44 134.7 52.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.603 2.202 . . . . 0.0 112.48 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.737 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 95.1 Cg_endo -85.23 -90.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.487 2.792 . . . . 0.0 114.788 -174.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.462 ' HG2' ' HB2' ' A' ' 318' ' ' PRO . 6.4 mmm180 -93.76 -78.93 0.42 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.048 0.928 . . . . 0.0 113.033 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.667 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 65.1 m-20 -105.4 -159.93 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.756 -169.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 320' ' ' ASN . 58.6 Cg_endo -90.89 -32.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 121.647 1.565 . . . . 0.0 114.671 159.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 15.72 10.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -169.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.725 ' OE2' ' HG2' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -106.31 -35.83 7.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.671 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.633 ' HA ' ' HB3' ' A' ' 327' ' ' TRP . 0.4 OUTLIER -40.15 -46.15 5.22 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.345 1.458 . . . . 0.0 114.077 178.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.706 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.2 Cg_endo -47.01 -63.04 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.055 2.503 . . . . 0.0 112.814 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.621 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.8 OUTLIER -65.35 -35.53 75.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 123.054 1.407 . . . . 0.0 110.428 -179.047 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.846 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 32.7 t90 -58.34 -34.05 70.2 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.973 177.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.889 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.8 OUTLIER -70.45 -48.04 57.8 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.6 -23.13 19.31 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.793 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.498 ' CD ' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -74.41 -42.94 58.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.247 1.023 . . . . 0.0 110.617 174.137 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.675 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.0 m-20 -95.67 -24.96 16.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.679 -168.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.569 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.1 -49.76 11.28 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 124.418 1.087 . . . . 0.0 113.749 177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 49.3 Cg_endo -63.09 -31.27 75.92 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.544 2.163 . . . . 0.0 111.525 177.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.04 -44.11 55.47 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.689 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.6 HG12 HG23 ' A' ' 310' ' ' ILE . 88.7 mt -58.37 -48.69 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.584 173.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 19.4 t70 -57.09 -17.85 12.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.264 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -44.51 10.15 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.68 HG11 HG13 ' A' ' 310' ' ' ILE . 94.0 t -60.64 -68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 123.587 1.66 . . . . 0.0 110.242 169.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.825 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -96.29 130.07 31.91 Favored Pre-proline 0 N--CA 1.403 -2.802 0 CA-C-N 110.791 -2.913 . . . . 0.0 112.787 -171.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.772 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -75.4 -16.36 19.39 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 123.89 3.06 . . . . 0.0 110.927 174.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.462 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.53 66.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 112.33 -2.214 . . . . 0.0 110.323 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.632 ' N ' HD12 ' A' ' 346' ' ' LEU . 34.8 p -77.88 2.71 16.48 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.681 -2.054 . . . . 0.0 113.225 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.798 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.1 p -138.06 161.36 60.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -63.97 -46.53 8.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.419 2.746 . . . . 0.0 108.454 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.637 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -45.51 -44.2 12.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.425 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.798 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.3 mt -61.35 -52.01 66.43 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.696 0.76 . . . . 0.0 110.459 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.641 ' HA ' HD12 ' A' ' 350' ' ' ILE . 2.6 ttm180 -52.12 -47.32 65.38 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.627 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 1.058 ' HG ' ' HA ' ' A' ' 365' ' ' PRO . 0.5 OUTLIER -69.45 -48.24 61.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.734 -176.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 46.4 mtt180 -56.54 -42.1 77.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.232 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.825 HD11 ' CD2' ' A' ' 339' ' ' PHE . 43.0 mt -57.24 -53.27 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.446 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.61 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -59.4 -52.57 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 122.158 0.98 . . . . 0.0 110.986 -170.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.553 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 25.8 m-20 -63.42 -35.45 80.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.37 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.38 75.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.656 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -57.86 -54.31 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.052 1.406 . . . . 0.0 110.66 173.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.818 HD23 HD22 ' A' ' 358' ' ' ASN . 0.6 OUTLIER -72.12 -24.76 61.52 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.328 -169.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.5 -65.28 1.06 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.849 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -139.51 66.91 0.51 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.233 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.818 HD22 HD23 ' A' ' 355' ' ' LEU . 31.3 p30 -78.75 164.9 24.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.23 0.212 . . . . 0.0 111.283 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.558 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -56.52 -65.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 122.94 0.496 . . . . 0.0 111.289 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -148.55 10.9 1.12 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.565 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.665 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 3.7 mt -65.01 -5.85 7.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.723 0.409 . . . . 0.0 111.408 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.553 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 19.4 t -60.71 82.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.402 0.62 . . . . 0.0 110.596 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.699 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -64.55 170.67 3.8 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.953 0.882 . . . . 0.0 112.629 175.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 33.4 p -118.66 155.5 52.35 Favored Pre-proline 0 N--CA 1.436 -1.17 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.99 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 1.058 ' HA ' ' HG ' ' A' ' 348' ' ' CYS . 1.9 Cg_endo -54.8 -11.28 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.801 2.334 . . . . 0.0 113.419 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.542 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -103.75 -6.31 43.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.139 -0.553 . . . . 0.0 114.471 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.678 ' HB2' HD12 ' A' ' 363' ' ' LEU . 1.3 m-20 -109.83 -18.83 13.33 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.075 0.941 . . . . 0.0 110.777 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.744 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 19.3 p -92.43 18.86 7.85 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.747 -167.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.542 HD11 ' O ' ' A' ' 366' ' ' GLY . 1.8 mt -62.15 -35.71 79.6 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.369 1.081 . . . . 0.0 110.242 -162.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.5 p -116.03 167.31 11.09 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.313 171.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.683 ' O ' HG13 ' A' ' 375' ' ' VAL . 43.1 m95 -70.39 -34.05 72.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.21 -43.56 94.65 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.559 0.695 . . . . 0.0 109.711 -173.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.7 p -66.24 -44.21 84.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.312 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.85 62.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.902 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.0 m -58.13 -44.03 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.644 0.735 . . . . 0.0 109.568 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.033 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.63 -46.01 90.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.777 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.699 HG21 HD11 ' A' ' 363' ' ' LEU . 34.4 m -65.84 -40.74 92.02 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.445 -173.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.7 mt -60.16 -33.55 72.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.677 0.671 . . . . 0.0 110.369 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.706 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 65.8 t80 -73.36 -46.46 49.02 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 122.382 1.087 . . . . 0.0 109.567 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -51.83 -32.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 112.801 -1.999 . . . . 0.0 111.158 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.45 -38.13 83.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 176.399 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 37.2 p -98.25 -22.83 15.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.639 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . 0.442 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 26.6 m80 -110.08 22.19 15.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.91 21.0 28.85 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.4 m 65.98 158.17 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 111.906 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.488 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -126.65 155.35 75.05 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 386' ' ' PHE . 91.5 Cg_endo -101.61 58.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.912 3.075 . . . . 0.0 111.437 166.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.773 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.5 -2.08 0.09 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -69.64 -45.11 69.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.492 . . . . 0.0 110.847 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.626 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.6 mt-30 -74.91 -26.71 59.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.919 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.2 -30.98 51.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.922 0.783 . . . . 0.0 111.787 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.71 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.99 -48.54 66.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.545 173.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 59.1 m-20 -68.47 -41.16 80.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.087 0.555 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.44 -44.93 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.257 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.678 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.4 mm -58.34 -47.39 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.459 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.637 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.3 mmtt -52.2 -43.17 64.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.936 0.772 . . . . 0.0 111.49 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.58 -44.11 17.06 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.15 -172.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.7 mt -69.12 -42.0 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 117.294 0.547 . . . . 0.0 111.596 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -58.71 -43.24 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.884 0.85 . . . . 0.0 109.872 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 399' ' ' VAL . 19.0 t70 -57.16 -44.5 83.51 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.328 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -86.66 -53.3 5.03 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.673 -1.149 . . . . 0.0 113.424 -170.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.579 ' HG3' HG23 ' A' ' 398' ' ' ILE . 0.1 OUTLIER -109.04 -31.44 7.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.427 0.632 . . . . 0.0 111.549 -170.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.62 165.07 11.79 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.841 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.903 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -45.93 96.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -55.91 -50.14 71.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.591 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.515 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -50.82 66.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.369 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.673 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.54 -41.58 63.63 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.561 ' HB3' HD11 ' A' ' 457' ' ' ILE . 45.3 t80 -57.85 -46.51 84.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.572 0.701 . . . . 0.0 109.533 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.744 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.7 m -59.82 -52.71 64.28 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.816 -178.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.715 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -62.06 -49.03 77.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.875 177.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.627 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.78 -41.35 82.97 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.091 -175.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.625 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -72.06 -33.73 68.18 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.643 0.222 . . . . 0.0 110.826 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.902 ' HE3' HG21 ' A' ' 375' ' ' VAL . 62.4 mtm -69.51 -46.63 66.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.042 174.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.033 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.9 mt -58.79 -40.13 83.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.924 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.919 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.5 m -78.84 -14.52 59.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.03 44.08 4.54 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.948 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.582 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 56.58 42.18 27.54 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 124.269 1.028 . . . . 0.0 113.323 178.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.771 ' ND2' HD21 ' A' ' 421' ' ' LEU . 0.1 OUTLIER -119.5 74.27 0.99 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.625 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.7 OUTLIER -49.65 -36.04 23.33 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 111.907 -2.406 . . . . 0.0 113.009 -167.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.5 mt-30 -54.83 -49.24 71.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -163.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.771 HD21 ' ND2' ' A' ' 418' ' ' ASN . 1.6 pp -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.497 0.665 . . . . 0.0 111.184 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.587 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.648 1.213 . . . . 0.0 109.152 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.564 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 41.3 t -61.56 -46.9 87.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.467 -2.152 . . . . 0.0 112.023 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.21 -37.97 75.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.843 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.71 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.4 mt -72.17 -41.47 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 110.048 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.623 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -57.39 -45.05 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.003 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.709 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -61.69 -28.97 69.78 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 122.704 1.24 . . . . 0.0 108.963 -173.036 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.9 -17.86 77.21 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.374 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.73 ' CG ' HG21 ' A' ' 399' ' ' VAL . 11.3 m-85 -101.03 4.16 42.1 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.39 144.29 71.7 Favored Pre-proline 0 N--CA 1.41 -2.448 0 CA-C-O 123.722 1.725 . . . . 0.0 113.226 168.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.823 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.5 Cg_endo -71.37 -58.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.115 1 C-N-CA 126.308 4.672 . . . . 0.0 113.172 -170.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.22 142.38 17.15 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.105 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.827 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.48 -31.74 71.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.043 0.422 . . . . 0.0 111.28 -177.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.757 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.2 -46.47 79.44 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.026 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.4 t -59.44 -51.04 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.785 177.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.827 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.64 -54.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 57.0 m -62.7 -56.44 17.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.551 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.48 -42.83 78.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.484 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.836 ' O ' HD22 ' A' ' 443' ' ' LEU . 54.1 mt -63.42 -53.25 55.34 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.204 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 35.0 mm-40 -51.31 -33.84 30.77 Favored 'General case' 0 N--CA 1.419 -2.014 0 O-C-N 124.959 1.412 . . . . 0.0 110.334 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.687 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.99 -60.96 1.99 Allowed 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 172.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.2 ptp180 -74.03 -53.6 9.67 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.613 -0.679 . . . . 0.0 112.536 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.24 -24.96 63.62 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.63 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.749 ' N ' HD23 ' A' ' 443' ' ' LEU . 8.3 t70 -73.17 -42.16 63.08 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.494 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 35.1 mt-30 -70.64 -7.98 48.35 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.554 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 6.2 mm-40 -51.31 158.46 0.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 123.581 1.657 . . . . 0.0 114.623 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.539 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.08 -32.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 110.543 -3.026 . . . . 0.0 115.33 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.663 ' H ' ' HB ' ' A' ' 451' ' ' THR . 13.6 m-20 -142.75 179.76 6.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.759 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.426 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 11.1 p-10 -61.68 -54.95 35.79 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -65.64 -26.51 67.84 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.663 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.5 m -59.17 -41.19 87.86 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 119.905 1.229 . . . . 0.0 109.678 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 66.7 mtt180 -60.47 -29.57 69.13 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.935 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.554 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -76.61 -33.99 58.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.332 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.5 mm-40 -78.51 -44.63 23.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.941 -171.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.56 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 24.8 p -105.17 0.53 27.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.061 -167.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.703 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.6 t80 -49.19 -54.87 14.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -70.44 -26.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.56 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.23 -42.97 68.19 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 463' ' ' VAL . 30.1 m80 -67.78 -31.89 72.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.745 172.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.74 HD22 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -63.48 -53.39 52.8 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.179 0.99 . . . . 0.0 109.292 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.591 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.4 m-80 -62.89 -31.8 72.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.525 173.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -63.96 -50.99 66.46 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.854 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.026 HG11 ' HA ' ' A' ' 435' ' ' VAL . 31.9 t -63.04 -34.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.906 0.86 . . . . 0.0 110.34 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.534 ' HD1' HD12 ' A' ' 469' ' ' LEU . 19.2 m-30 -61.18 -15.95 39.53 Favored 'General case' 0 C--O 1.205 -1.284 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.185 169.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 462' ' ' ALA . 33.5 mm-40 -90.34 -49.8 6.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 112.789 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.736 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.92 -39.42 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.86 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -84.67 -16.04 43.27 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 171.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.761 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.31 52.02 50.21 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 111.741 -2.482 . . . . 0.0 113.1 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.731 HD11 HD12 ' A' ' 467' ' ' LEU . 0.3 OUTLIER -103.8 177.96 4.69 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 123.583 0.753 . . . . 0.0 109.892 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.65 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.4 p30 -96.55 -41.4 8.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 167.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.416 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -160.42 -74.37 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.356 -2.202 . . . . 0.0 111.19 158.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.823 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -63.15 68.91 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -169.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.476 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 40.09 40.03 1.66 Allowed Glycine 0 C--N 1.278 -2.677 0 CA-C-N 111.176 -2.738 . . . . 0.0 113.48 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.65 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 11.4 mm-40 -78.87 -51.62 9.44 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.142 0.972 . . . . 0.0 111.566 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.9 t 65.18 55.06 1.14 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.306 -173.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.761 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.467 0 CA-C-N 110.637 -2.983 . . . . 0.0 111.928 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.429 -1.516 0 CA-C-O 121.049 0.452 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.702 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.3 mt -73.83 125.85 90.01 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-O 121.716 0.769 . . . . 0.0 111.643 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 308' ' ' GLN . 23.3 Cg_endo -71.75 -15.98 29.95 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 124.555 3.503 . . . . 0.0 110.883 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.744 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.9 tp 30.38 -58.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 C-N-CA 128.673 2.789 . . . . 0.0 116.275 172.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 306' ' ' PRO . 3.3 mm-40 -56.17 -38.84 71.47 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.097 0.951 . . . . 0.0 109.811 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.535 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -59.85 -47.8 84.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.799 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 307' ' ' ILE . 65.2 mt -60.2 -48.22 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 123.861 0.864 . . . . 0.0 113.036 174.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.744 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 5.5 mtp180 -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 O-C-N 122.032 -0.417 . . . . 0.0 110.461 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 23.2 t -70.03 -34.05 72.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.623 . . . . 0.0 109.6 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.568 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.38 -41.59 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.775 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 331' ' ' ASN . 29.8 p -83.0 -36.66 24.85 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.765 1.269 . . . . 0.0 109.671 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.61 34.04 8.79 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.419 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.543 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 51.23 173.1 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.323 0 C-N-CA 124.419 1.087 . . . . 0.0 113.105 -173.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.774 ' HB3' HD11 ' A' ' 324' ' ' ILE . 28.2 Cg_exo -46.16 152.34 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.128 2.552 . . . . 0.0 113.586 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -89.52 -101.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.264 2.643 . . . . 0.0 111.991 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.473 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 13.3 mmt180 -104.38 -82.63 0.51 Allowed 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.126 0.489 . . . . 0.0 111.504 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 22.9 m-80 -98.33 163.14 19.76 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.861 -171.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.15 -51.67 6.26 Favored 'Trans proline' 0 CA--C 1.509 -0.756 0 C-N-CA 123.117 2.545 . . . . 0.0 110.971 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -13.56 2.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.492 -1.686 . . . . 0.0 113.29 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.2 mt-10 -92.86 -31.74 14.87 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.256 -0.177 . . . . 0.0 110.89 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -47.83 -45.03 60.46 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -177.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.738 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.5 Cg_endo -49.64 -61.91 0.5 Allowed 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.974 2.449 . . . . 0.0 112.849 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.677 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.25 -37.19 77.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.686 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 38.3 t90 -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.099 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.848 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.22 -48.18 58.17 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.58 -23.07 18.9 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.827 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.469 ' CD ' HG21 ' A' ' 406' ' ' THR . 1.2 mmm180 -74.57 -43.06 57.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.259 1.028 . . . . 0.0 110.483 174.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.729 ' HB3' HG22 ' A' ' 314' ' ' THR . 48.3 m-20 -95.16 -24.18 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.444 -1.707 . . . . 0.0 113.601 -168.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.04 -50.32 10.87 Favored Pre-proline 0 C--N 1.306 -1.295 0 C-N-CA 124.223 1.009 . . . . 0.0 113.612 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.1 Cg_endo -62.08 -31.76 83.48 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.741 2.294 . . . . 0.0 111.828 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.59 -44.17 57.86 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.549 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.619 HG23 HG23 ' A' ' 310' ' ' ILE . 91.0 mt -58.38 -48.42 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.855 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 19.2 t70 -55.67 -19.61 11.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.07 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.41 -48.07 9.74 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 310' ' ' ILE . 62.2 t -57.89 -72.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-O 123.445 1.593 . . . . 0.0 110.098 169.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.875 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.39 129.56 40.53 Favored Pre-proline 0 N--CA 1.405 -2.686 0 CA-C-N 111.196 -2.729 . . . . 0.0 112.623 -171.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.774 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.7 Cg_endo -74.8 -16.47 20.73 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 123.981 3.12 . . . . 0.0 110.763 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.465 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.36 66.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 112.347 -2.206 . . . . 0.0 110.182 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.688 ' N ' HD12 ' A' ' 346' ' ' LEU . 37.4 p -79.37 8.66 5.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.945 -1.934 . . . . 0.0 113.586 -170.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.5 p -142.23 164.13 35.37 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.417 ' O ' ' SG ' ' A' ' 348' ' ' CYS . 44.6 Cg_exo -63.06 -50.02 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.154 2.569 . . . . 0.0 108.309 172.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.68 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.7 OUTLIER -42.7 -48.23 5.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.972 176.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.1 mt -56.43 -52.61 64.03 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.587 -177.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.718 ' HA ' HD12 ' A' ' 350' ' ' ILE . 39.1 ttm105 -54.72 -45.61 74.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.56 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 1.019 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.48 -48.38 60.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.067 0.461 . . . . 0.0 111.258 -176.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 49.7 mtp180 -55.96 -41.9 75.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.929 177.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.875 HD11 ' CD2' ' A' ' 339' ' ' PHE . 49.0 mt -58.72 -54.29 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.678 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.571 HG23 HD11 ' A' ' 328' ' ' LEU . 19.5 mt -57.85 -52.97 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.109 0.956 . . . . 0.0 110.777 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.499 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.2 m-20 -63.56 -34.98 79.01 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.911 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.16 -38.34 78.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.858 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.13 -52.82 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.001 1.382 . . . . 0.0 110.192 175.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.819 HD23 HD22 ' A' ' 358' ' ' ASN . 0.8 OUTLIER -72.96 -24.81 60.83 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 111.719 -2.491 . . . . 0.0 109.414 -170.157 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.82 -80.35 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 113.656 -1.611 . . . . 0.0 113.013 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.02 72.71 0.29 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.819 HD22 HD23 ' A' ' 355' ' ' LEU . 18.5 p30 -94.59 157.68 15.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 122.541 0.336 . . . . 0.0 111.32 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.4 mp -81.28 89.34 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-O 121.11 0.481 . . . . 0.0 111.83 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.47 -16.97 15.64 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.552 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.726 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.4 mt -60.68 -4.68 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 25.1 t -63.69 81.98 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 110.353 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -61.96 172.46 1.35 Allowed 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.908 174.384 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.557 ' C ' ' H ' ' A' ' 366' ' ' GLY . 44.1 p -112.76 162.71 20.39 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.186 -174.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 1.019 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.0 Cg_endo -67.04 21.21 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.42 2.08 . . . . 0.0 112.583 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -131.66 -12.05 2.04 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.329 -0.85 . . . . 0.0 114.207 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.708 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.5 m-20 -105.2 -20.49 13.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.715 1.245 . . . . 0.0 109.44 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 3.8 p -75.3 19.11 0.18 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.244 -172.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.73 -32.73 70.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.362 1.077 . . . . 0.0 109.814 -170.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.3 35.98 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.266 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.588 ' O ' HG13 ' A' ' 375' ' ' VAL . 65.4 m95 -69.66 -35.49 75.2 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.61 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.4 OUTLIER -60.81 -40.86 94.3 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.804 -175.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 53.9 m -68.92 -43.69 74.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.702 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.53 -52.71 62.38 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.887 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.3 m -57.24 -45.73 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.395 0.617 . . . . 0.0 109.666 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.003 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.68 -45.57 93.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.889 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 363' ' ' LEU . 31.7 m -67.56 -37.69 83.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.594 -172.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -60.95 -35.22 76.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.471 0.578 . . . . 0.0 110.434 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.738 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 55.6 t80 -72.51 -46.91 52.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.561 1.172 . . . . 0.0 109.175 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.07 -32.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.344 171.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.13 -46.58 89.16 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 123.193 0.597 . . . . 0.0 111.175 175.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.7 p -89.12 -23.98 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.531 -171.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . 0.526 ' HB3' HE22 ' A' ' 390' ' ' GLN . 27.2 m80 -111.28 23.22 14.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.0 21.56 24.63 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.745 0.658 . . . . 0.0 114.745 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 67.04 160.36 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.906 0.482 . . . . 0.0 111.413 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -125.45 158.48 64.25 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 389' ' ' HIS . 90.6 Cg_endo -101.33 53.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.894 3.063 . . . . 0.0 111.466 166.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.742 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.83 -14.99 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -175.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.441 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.1 t60 -57.52 -42.59 83.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.881 0.372 . . . . 0.0 110.648 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.664 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.7 mt-30 -75.2 -27.93 59.79 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -171.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.1 mm? -54.16 -31.27 52.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.972 0.806 . . . . 0.0 111.455 -176.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.744 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.37 -51.48 51.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.735 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.605 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 17.9 m-20 -68.97 -37.91 79.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -57.66 -46.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.044 0.449 . . . . 0.0 110.101 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 399' ' ' VAL . 21.8 mm -59.01 -45.87 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.967 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.726 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 37.2 mmtt -52.05 -42.78 63.41 Favored 'General case' 0 C--O 1.244 0.793 0 O-C-N 124.025 0.828 . . . . 0.0 111.531 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.35 -44.19 13.96 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.128 -172.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.677 HG12 HG21 ' A' ' 326' ' ' ILE . 2.5 mt -69.31 -40.81 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 117.429 0.615 . . . . 0.0 111.575 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -58.84 -43.94 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.823 0.821 . . . . 0.0 109.749 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.46 ' N ' HG23 ' A' ' 399' ' ' VAL . 16.2 t70 -59.19 -42.26 90.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.486 177.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 29.2 mm-40 -86.28 -53.1 5.22 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.331 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 398' ' ' ILE . 1.1 mm-40 -109.56 -31.15 7.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.467 0.651 . . . . 0.0 111.622 -170.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.28 164.05 11.67 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.889 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -44.1 98.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 123.104 0.561 . . . . 0.0 112.417 -175.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.667 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.54 -52.27 62.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.57 0.7 . . . . 0.0 111.843 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.515 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.5 -49.69 68.07 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.348 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.671 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.31 -42.18 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 29.1 t80 -55.72 -48.65 74.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.589 0.709 . . . . 0.0 109.371 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.767 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.1 m -58.32 -52.16 66.75 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.752 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.696 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.52 -48.72 79.78 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.604 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.25 -43.7 89.26 Favored Glycine 0 C--N 1.315 -0.603 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.392 -174.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.589 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -72.21 -31.22 65.67 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.795 0.298 . . . . 0.0 110.874 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.887 ' HE3' HG21 ' A' ' 375' ' ' VAL . 63.9 mtm -69.03 -48.97 61.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.35 0.595 . . . . 0.0 109.866 172.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.07 -39.35 81.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.113 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.768 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.4 OUTLIER -77.4 -14.3 59.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.684 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.84 4.88 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.866 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.589 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 1.0 OUTLIER 58.15 43.7 20.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.794 0.838 . . . . 0.0 113.228 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.768 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.2 OUTLIER -124.37 79.92 1.79 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.164 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.759 ' HD2' ' HG ' ' A' ' 423' ' ' SER . 7.5 p90 -62.27 -31.85 72.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.146 -163.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 47.4 mt-30 -53.79 -49.6 67.94 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.377 -164.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.734 HD21 HD22 ' A' ' 418' ' ' ASN . 1.3 pp -59.18 -49.24 78.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.25 0.547 . . . . 0.0 110.671 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.669 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.61 -38.72 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 122.794 1.283 . . . . 0.0 108.917 -178.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.759 ' HG ' ' HD2' ' A' ' 419' ' ' TYR . 64.6 m -66.27 -42.19 88.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.507 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.62 -38.83 89.56 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.254 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.744 HD13 ' HA2' ' A' ' 392' ' ' GLY . 4.3 mt -71.19 -42.07 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.515 0.674 . . . . 0.0 109.917 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -57.26 -44.47 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.334 -1.303 . . . . 0.0 112.606 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.715 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -61.28 -29.27 69.76 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 122.655 1.217 . . . . 0.0 109.143 -172.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.4 -20.24 78.14 Favored Glycine 0 C--N 1.298 -1.578 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.034 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.739 ' CG ' HG21 ' A' ' 399' ' ' VAL . 12.4 m-85 -97.04 0.6 48.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.84 143.31 77.17 Favored Pre-proline 0 N--CA 1.408 -2.529 0 CA-C-O 123.919 1.819 . . . . 0.0 113.267 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.828 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 51.0 Cg_endo -69.43 -60.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 1 C-N-CA 126.372 4.715 . . . . 0.0 112.973 -172.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.522 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.84 141.3 16.12 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.221 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.917 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.33 -26.98 68.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.133 0.467 . . . . 0.0 111.69 -177.07 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.82 -48.29 80.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 169.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.994 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.8 t -58.22 -52.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.038 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.8 -52.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.6 m -62.55 -56.65 15.95 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.216 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.89 -46.01 78.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.485 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 42.8 mt -59.56 -53.49 57.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.9 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.679 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.9 mm-40 -51.95 -34.74 43.35 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 124.932 1.395 . . . . 0.0 110.693 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.668 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -73.24 -60.87 2.04 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 175.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.4 -50.62 13.68 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.693 -0.63 . . . . 0.0 112.306 -172.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.58 -25.34 62.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.675 0.75 . . . . 0.0 111.487 -178.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.76 ' N ' HD23 ' A' ' 443' ' ' LEU . 11.5 t70 -72.6 -42.04 64.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.64 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.668 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -68.78 -7.95 38.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.572 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 15.7 mm-40 -54.46 151.58 7.59 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 123.465 1.602 . . . . 0.0 114.436 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.74 -32.63 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.477 -3.056 . . . . 0.0 116.066 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.654 ' H ' ' HB ' ' A' ' 451' ' ' THR . 25.8 m-20 -135.49 175.77 9.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.449 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 5.8 m-20 -61.73 -56.89 14.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 172.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -62.9 -28.16 69.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 176.292 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.654 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 16.2 m -58.09 -43.18 86.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.803 1.183 . . . . 0.0 110.04 172.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 56.3 mtt180 -61.51 -29.75 70.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 172.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.602 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -75.24 -29.95 60.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.911 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.3 mm-40 -80.46 -45.74 17.08 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.286 1.041 . . . . 0.0 111.837 -173.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.534 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 25.7 p -103.28 -0.47 30.24 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.748 -167.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.649 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.3 t80 -49.22 -55.9 11.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.754 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.2 mm -69.04 -26.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.534 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.08 -43.95 64.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.601 ' O ' HG23 ' A' ' 463' ' ' VAL . 26.6 m80 -65.3 -31.09 72.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.707 171.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.762 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.45 -53.72 32.29 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.312 1.053 . . . . 0.0 109.181 -178.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.23 -30.18 71.37 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.19 -1.823 . . . . 0.0 110.188 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -66.68 -49.24 66.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.017 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.994 HG11 ' HA ' ' A' ' 435' ' ' VAL . 33.6 t -65.61 -35.93 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.579 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.9 m-30 -61.27 -13.98 22.95 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.654 168.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 1.7 tp10 -93.09 -52.52 4.53 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.847 0.832 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.696 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.7 pt -63.79 -41.08 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.239 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.767 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.8 mt -83.8 -16.73 43.54 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 65.89 47.73 72.37 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.446 173.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 467' ' ' LEU . 1.2 mt -101.36 173.11 6.59 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.834 0.854 . . . . 0.0 111.733 -177.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.571 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.2 p30 -85.87 -44.9 12.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.411 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.63 -68.67 0.06 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.474 165.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.828 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 19.0 mmt180 -68.16 47.72 0.05 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -163.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 57.92 34.45 71.86 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.392 171.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.716 HE21 ' HB2' ' A' ' 472' ' ' ARG . 28.4 mm-40 -84.69 -51.45 6.81 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.972 0.892 . . . . 0.0 111.228 -173.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.687 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 45.4 t 68.99 53.59 0.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 112.506 -2.133 . . . . 0.0 109.118 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.289 -2.038 0 CA-C-N 109.474 -3.512 . . . . 0.0 112.61 169.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.429 -1.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.731 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.1 mt -73.32 129.24 86.19 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 122.069 0.938 . . . . 0.0 113.048 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.566 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.0 Cg_endo -84.97 51.48 3.15 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.59 3.526 . . . . 0.0 109.093 165.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.665 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -46.63 -43.54 6.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 112.753 -2.021 . . . . 0.0 112.077 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.477 ' HG2' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -64.5 -35.6 81.47 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.055 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.556 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.45 -47.49 83.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.39 0.614 . . . . 0.0 109.695 172.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.646 HG13 HG11 ' A' ' 338' ' ' VAL . 68.0 mt -59.0 -49.85 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 123.878 0.871 . . . . 0.0 113.197 175.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 33.1 mtp180 -62.25 -28.8 69.96 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.882 0.473 . . . . 0.0 111.013 177.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 62.9 m -69.76 -34.65 74.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.326 0.584 . . . . 0.0 110.114 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.602 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.03 -41.73 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.723 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.754 HG22 ' HB3' ' A' ' 331' ' ' ASN . 31.1 p -83.42 -36.58 24.14 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.813 1.292 . . . . 0.0 110.087 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.84 34.86 8.68 Favored Glycine 0 C--N 1.304 -1.22 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.694 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 50.14 177.89 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.013 0 C-N-CA 124.296 1.038 . . . . 0.0 112.899 -174.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.695 ' HB3' HD11 ' A' ' 324' ' ' ILE . 46.2 Cg_exo -48.34 147.2 9.02 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.529 2.153 . . . . 0.0 112.786 -178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.428 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 51.1 Cg_endo -87.42 -99.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.341 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.41 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 10.3 mmm180 -100.45 -76.57 0.55 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.528 0.68 . . . . 0.0 110.555 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.6 m-20 -104.87 158.42 32.06 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.241 -174.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.454 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 36.6 Cg_exo -59.08 -50.13 9.52 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.824 2.349 . . . . 0.0 110.868 171.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.43 -23.64 2.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.224 -1.807 . . . . 0.0 112.547 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 2.3 mm-40 -87.42 -29.02 21.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.2 OUTLIER -45.05 -46.8 30.71 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.713 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.94 -62.04 0.47 Allowed 'Trans proline' 0 CA--C 1.516 -0.399 0 C-N-CA 122.856 2.371 . . . . 0.0 112.997 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.643 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.56 -36.65 76.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.141 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.738 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 34.7 t90 -57.77 -35.07 70.26 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.096 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.861 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.8 OUTLIER -69.97 -49.17 54.34 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.51 -23.42 19.84 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.661 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 1.0 OUTLIER -74.4 -42.5 59.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.132 0.968 . . . . 0.0 110.471 175.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.754 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.4 m-20 -96.13 -23.47 16.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.918 -169.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.607 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -44.06 -49.38 22.3 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 113.681 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 52.2 Cg_endo -61.39 -33.0 89.58 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.551 2.168 . . . . 0.0 111.542 177.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.3 -43.15 64.61 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 109.519 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.637 HG23 HG23 ' A' ' 310' ' ' ILE . 91.6 mt -58.45 -49.4 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.734 173.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -55.42 -18.84 7.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.327 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.75 -46.68 8.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.145 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.646 HG11 HG13 ' A' ' 310' ' ' ILE . 93.7 t -58.07 -72.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 123.4 1.572 . . . . 0.0 110.228 169.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.83 ' CD2' HD11 ' A' ' 350' ' ' ILE . 1.0 OUTLIER -91.14 131.7 36.18 Favored Pre-proline 0 N--CA 1.405 -2.717 0 CA-C-N 110.813 -2.903 . . . . 0.0 112.538 -170.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.606 ' HB2' HG23 ' A' ' 342' ' ' THR . 8.0 Cg_exo -75.01 -18.02 19.03 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.664 2.909 . . . . 0.0 110.652 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.5 p 33.09 72.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.648 -177.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.606 HG23 ' HB2' ' A' ' 340' ' ' PRO . 60.0 p -81.38 5.83 16.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 112.778 -2.01 . . . . 0.0 113.463 -169.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.843 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.8 p -142.12 161.45 50.78 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.459 ' HB3' HD23 ' A' ' 369' ' ' LEU . 51.2 Cg_exo -62.28 -48.25 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.262 2.641 . . . . 0.0 108.218 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.645 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.9 OUTLIER -41.76 -51.92 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 112.719 -2.037 . . . . 0.0 110.828 176.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.843 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.8 mt -57.09 -52.28 65.9 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.165 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.687 ' HA ' HD12 ' A' ' 350' ' ' ILE . 4.7 ttm180 -53.09 -42.96 66.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.318 -1.765 . . . . 0.0 110.696 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 1.072 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.8 m -70.19 -46.43 64.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 76.0 mtt180 -56.19 -42.83 77.77 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.232 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.83 HD11 ' CD2' ' A' ' 339' ' ' PHE . 48.5 mt -58.17 -53.5 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 O-C-N 123.304 0.377 . . . . 0.0 111.426 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.548 HD13 ' HB1' ' A' ' 374' ' ' ALA . 17.0 mt -57.66 -53.22 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 122.107 0.956 . . . . 0.0 110.841 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.511 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.1 m-20 -63.83 -35.14 79.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.956 -1.474 . . . . 0.0 109.982 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.29 -37.26 77.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.051 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.665 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.251 0.8 OUTLIER -57.26 -53.29 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.481 0 CA-C-O 123.069 1.414 . . . . 0.0 110.119 174.485 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.793 HD23 HD22 ' A' ' 358' ' ' ASN . 0.7 OUTLIER -72.86 -25.29 61.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 111.559 -2.564 . . . . 0.0 109.338 -169.083 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.6 -79.01 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.586 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -119.62 57.4 0.56 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.6 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.793 HD22 HD23 ' A' ' 355' ' ' LEU . 31.5 p30 -76.13 161.74 28.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.254 0.222 . . . . 0.0 110.937 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -55.8 -66.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 122.947 0.499 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.41 15.16 1.1 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.514 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.701 ' HB3' HD22 ' A' ' 378' ' ' LEU . 5.9 mt -66.33 -2.99 5.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.698 0.399 . . . . 0.0 111.477 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.511 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 28.6 t -62.28 80.58 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 110.503 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.901 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.4 mm? -62.12 178.16 0.4 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.731 174.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 44.5 p -116.77 157.39 46.31 Favored Pre-proline 0 CA--C 1.508 -0.669 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 1.072 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 19.5 Cg_endo -66.21 16.69 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.269 1.979 . . . . 0.0 113.528 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.486 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -135.43 6.22 4.23 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.26 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.66 ' HB2' HD12 ' A' ' 363' ' ' LEU . 72.7 m-20 -109.76 -24.81 10.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.402 1.096 . . . . 0.0 109.954 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.901 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 6.5 m -93.97 19.77 8.63 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.076 -168.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -57.05 -39.79 75.57 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.433 -171.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.13 157.58 25.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.851 169.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.699 ' O ' HG13 ' A' ' 375' ' ' VAL . 86.3 m95 -70.14 -34.11 72.65 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 4.8 t0 -54.56 -48.83 71.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.695 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 28.0 t -69.15 -43.13 74.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.825 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.722 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.25 -51.57 67.21 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.861 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.3 m -57.32 -44.5 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.603 0.716 . . . . 0.0 109.621 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 0.98 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.09 -45.86 91.65 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.005 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.779 HG21 HD11 ' A' ' 363' ' ' LEU . 48.8 m -68.55 -38.2 80.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.464 -171.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.21 -34.16 74.64 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.155 0.503 . . . . 0.0 110.411 176.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.713 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 67.5 t80 -73.13 -45.89 54.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.369 1.08 . . . . 0.0 109.4 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.659 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -52.3 -33.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.092 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.61 -39.21 87.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.653 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 50.2 p -98.83 -22.24 15.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.439 -167.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -108.97 22.83 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.642 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.37 19.15 39.1 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.847 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 65.09 159.77 0.11 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 111.694 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -126.27 151.88 72.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -98.96 55.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.535 2.824 . . . . 0.0 110.969 165.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.702 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.21 4.03 0.42 Allowed 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -173.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -71.13 -47.1 59.89 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.638 ' O ' HG13 ' A' ' 394' ' ' VAL . 99.5 mt-30 -74.74 -26.2 59.63 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.733 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.75 -31.3 47.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.004 0.82 . . . . 0.0 111.966 -173.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.775 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.57 -53.2 40.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.438 173.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.691 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 41.4 m-20 -64.99 -39.79 93.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.17 -46.21 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.42 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.624 ' O ' HG22 ' A' ' 399' ' ' VAL . 25.6 mm -58.94 -46.6 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.042 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.691 ' HG3' ' HA ' ' A' ' 393' ' ' ASN . 15.3 mmtt -52.84 -42.02 64.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.879 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.41 15.86 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.092 -173.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.0 mt -69.21 -41.45 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 117.133 0.466 . . . . 0.0 111.439 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.88 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.8 m -58.07 -44.54 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.609 0.719 . . . . 0.0 110.273 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.4 t70 -62.18 -39.03 91.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -84.88 -53.22 5.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.064 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.523 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -110.59 -30.74 7.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.508 -169.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.2 165.87 12.11 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.673 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.88 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.69 -44.83 98.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.55 -53.16 58.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.606 0.717 . . . . 0.0 111.87 -177.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -64.45 -49.77 70.16 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.273 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.68 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.26 -42.69 63.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.682 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 47.1 t80 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.616 0.722 . . . . 0.0 109.524 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.792 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.9 m -59.44 -52.55 65.14 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.613 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.694 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.23 -48.67 80.4 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.645 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.61 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.85 -43.35 87.26 Favored Glycine 0 C--N 1.314 -0.655 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.546 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.673 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.0 OUTLIER -72.56 -31.31 65.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.846 0.323 . . . . 0.0 111.02 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.792 ' HG3' ' O ' ' A' ' 409' ' ' THR . 53.2 mtm -70.08 -47.56 61.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.98 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.5 mt -58.55 -40.99 84.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.261 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.733 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -76.71 -12.62 60.02 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.729 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 88.36 43.73 5.48 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.659 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.578 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 57.73 49.1 12.83 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.496 0.718 . . . . 0.0 112.471 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.859 HD22 HD21 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -129.17 77.98 1.82 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 161.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.675 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 8.3 p90 -62.27 -31.47 72.06 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.341 -163.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 423' ' ' SER . 51.1 mt-30 -53.63 -48.03 69.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.312 -164.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.859 HD21 HD22 ' A' ' 418' ' ' ASN . 1.1 pp -59.35 -50.62 73.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.955 0.407 . . . . 0.0 110.776 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.706 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.06 -38.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 123.021 1.391 . . . . 0.0 108.854 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 42.4 t -62.56 -48.14 80.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.726 -2.488 . . . . 0.0 111.846 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.3 75.5 Favored Glycine 0 C--N 1.316 -0.568 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.402 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.775 HD13 ' HA2' ' A' ' 392' ' ' GLY . 3.9 mt -72.1 -41.48 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.601 0.715 . . . . 0.0 110.025 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.6 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -57.57 -45.6 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.909 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.708 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.8 -29.15 68.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 122.646 1.212 . . . . 0.0 109.371 -173.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.8 -18.46 77.48 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.386 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.698 ' CG ' HG21 ' A' ' 399' ' ' VAL . 18.7 m-85 -100.0 3.17 44.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.02 145.89 70.82 Favored Pre-proline 0 N--CA 1.41 -2.452 0 CA-C-O 123.612 1.672 . . . . 0.0 113.308 168.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.77 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.7 Cg_endo -72.52 -62.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 1 C-N-CA 126.181 4.587 . . . . 0.0 113.378 -173.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.549 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -108.3 141.65 15.84 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.166 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.846 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.71 -29.88 71.0 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.903 0.351 . . . . 0.0 111.057 -177.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.77 -46.43 81.48 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 172.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.999 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.1 t -59.27 -51.59 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.63 176.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.846 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -54.26 -54.85 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.474 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 61.4 m -61.61 -55.94 25.28 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.944 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.03 -46.17 78.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.806 ' O ' HD22 ' A' ' 443' ' ' LEU . 37.1 mt -59.37 -53.15 61.49 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.656 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.743 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 38.0 mm-40 -51.64 -35.09 40.71 Favored 'General case' 0 N--CA 1.419 -2.024 0 O-C-N 124.997 1.436 . . . . 0.0 110.447 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.634 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.74 -60.27 2.31 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 176.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -75.97 -50.86 13.72 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.743 -0.598 . . . . 0.0 112.002 -173.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.88 -24.08 61.76 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.719 0.771 . . . . 0.0 111.807 -179.001 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.746 ' N ' HD23 ' A' ' 443' ' ' LEU . 11.1 t70 -72.18 -42.82 65.41 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.609 176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.02 -7.99 45.55 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.53 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 54.0 mm-40 -51.75 154.77 1.9 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 123.264 1.507 . . . . 0.0 114.43 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.509 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.36 -32.89 20.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 111.17 -2.741 . . . . 0.0 115.613 -172.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.665 ' H ' ' HB ' ' A' ' 451' ' ' THR . 48.1 m-20 -138.04 178.98 6.72 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.418 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.1 p-10 -64.88 -53.57 44.58 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.31 -23.58 65.66 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -59.04 -40.17 84.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 119.891 1.223 . . . . 0.0 109.453 171.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.614 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 72.6 mtp180 -61.23 -29.1 69.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.682 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.32 -34.01 59.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.204 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 455' ' ' THR . 1.3 mm-40 -78.62 -44.92 22.79 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.903 -171.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.556 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 29.9 p -105.33 -1.23 25.42 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.298 -165.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.675 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.5 t80 -48.73 -51.49 28.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.716 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.3 mm -71.94 -26.59 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.556 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.51 -43.03 67.24 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 463' ' ' VAL . 53.7 m-70 -67.15 -30.34 70.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.178 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.784 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -66.66 -53.4 34.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.278 1.037 . . . . 0.0 109.126 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.658 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.6 m-80 -63.49 -31.29 72.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.682 173.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.65 -53.53 53.17 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.192 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.999 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.1 t -62.36 -34.39 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.44 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.88 -15.39 42.2 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.125 169.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 10.9 mm-40 -89.95 -50.69 5.88 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.064 -1.023 . . . . 0.0 112.42 176.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.724 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -65.18 -39.82 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.904 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 469' ' ' LEU . 7.0 mt -84.13 -17.1 41.21 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 66.05 49.56 57.44 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 112.106 -2.315 . . . . 0.0 113.591 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -101.65 175.01 5.7 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.809 0.844 . . . . 0.0 111.064 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.736 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 13.0 p30 -92.58 -43.25 9.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 165.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -161.56 -73.89 0.06 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.475 162.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.77 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 2.0 mpt_? -63.63 67.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.64 40.24 2.04 Favored Glycine 0 C--N 1.277 -2.709 0 CA-C-N 111.369 -2.65 . . . . 0.0 113.33 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.736 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 27.4 mm-40 -80.3 -56.3 4.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.152 0.977 . . . . 0.0 111.449 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 38.2 t 67.87 44.36 1.57 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.281 -2.236 . . . . 0.0 108.219 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.294 -1.809 0 CA-C-N 109.149 -3.66 . . . . 0.0 112.684 170.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.427 -1.576 0 CA-C-O 121.274 0.559 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 307' ' ' ILE . 22.8 mt -74.45 127.01 88.26 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-O 121.844 0.831 . . . . 0.0 112.137 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' A' ' 308' ' ' GLN . 28.2 Cg_endo -74.8 -11.44 21.88 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 124.682 3.588 . . . . 0.0 111.466 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.754 ' H ' HG22 ' A' ' 305' ' ' ILE . 6.1 tp 26.79 -64.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.298 0 C-N-CA 128.37 2.668 . . . . 0.0 115.877 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.657 ' H ' HG23 ' A' ' 307' ' ' ILE . 0.1 OUTLIER -57.66 -30.88 65.78 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.141 0.496 . . . . 0.0 111.246 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.543 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.73 -49.17 77.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.588 169.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.715 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.9 mt -58.55 -48.11 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.036 0.934 . . . . 0.0 112.705 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.682 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.7 mtp180 -59.9 -30.66 69.18 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 122.559 0.344 . . . . 0.0 111.108 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.2 m -70.03 -33.96 72.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.56 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.24 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.903 178.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.75 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.5 p -83.52 -37.19 23.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.83 1.3 . . . . 0.0 110.152 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.5 34.66 8.4 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.252 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.6 mt-10 51.68 172.25 0.03 OUTLIER Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -175.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.584 ' HB3' HD11 ' A' ' 324' ' ' ILE . 22.2 Cg_exo -45.27 143.56 5.15 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.374 2.716 . . . . 0.0 113.189 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.52 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.6 Cg_endo -91.41 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.614 2.876 . . . . 0.0 112.903 -172.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.465 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 7.9 mmm180 -89.29 -81.34 0.28 Allowed 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 123.449 0.699 . . . . 0.0 110.894 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.465 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 16.3 m-20 -112.71 164.94 14.14 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.846 -177.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.414 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 38.6 Cg_exo -58.65 -50.4 9.43 Favored 'Trans proline' 0 CA--C 1.509 -0.735 0 C-N-CA 122.549 2.166 . . . . 0.0 110.483 171.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.403 ' HG2' ' H ' ' A' ' 322' ' ' ARG . 5.1 mmt180 -48.74 -20.63 0.5 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.003 -1.908 . . . . 0.0 112.928 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.1 mt-10 -98.44 -23.46 15.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.7 0.286 . . . . 0.0 111.405 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.655 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.88 -44.34 45.79 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.717 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 6.4 Cg_endo -47.96 -62.76 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.008 2.472 . . . . 0.0 113.086 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.659 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.89 -36.32 75.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.031 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.168 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.75 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 47.5 t90 -57.63 -36.01 71.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.329 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.872 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.93 -48.15 59.62 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.585 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.55 -23.62 20.92 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.786 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.433 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 2.8 mmm180 -73.95 -42.17 60.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.22 1.01 . . . . 0.0 110.551 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.722 ' HB3' HG22 ' A' ' 314' ' ' THR . 47.1 m-20 -95.98 -24.82 16.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.599 -1.637 . . . . 0.0 113.854 -169.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.608 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.94 -50.29 13.6 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 124.296 1.038 . . . . 0.0 113.582 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 51.0 Cg_endo -61.09 -33.16 91.86 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.652 2.235 . . . . 0.0 111.729 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.57 -43.93 62.75 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.622 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.611 HG12 HG23 ' A' ' 310' ' ' ILE . 88.6 mt -57.99 -48.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.74 -17.87 6.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.233 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.92 -44.49 9.06 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.684 HG11 HG13 ' A' ' 310' ' ' ILE . 98.6 t -61.29 -69.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 123.399 1.571 . . . . 0.0 110.222 169.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.854 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -94.47 129.9 35.31 Favored Pre-proline 0 N--CA 1.403 -2.789 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.663 -171.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.774 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 68.0 Cg_endo -72.7 -18.86 24.84 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 123.887 3.058 . . . . 0.0 110.994 173.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.45 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.5 p 33.9 68.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.426 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.4 p -78.37 1.64 21.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.616 -170.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.795 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.4 p -137.59 164.09 43.85 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 343' ' ' THR . 50.3 Cg_exo -62.45 -50.58 4.3 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.145 2.564 . . . . 0.0 108.043 172.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.708 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 4.6 t0 -42.81 -47.34 5.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.013 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.795 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 8.9 mt -56.99 -53.04 62.56 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.797 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.74 ' HA ' HD12 ' A' ' 350' ' ' ILE . 41.3 ttm105 -54.98 -45.81 75.02 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.603 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.991 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.78 -47.8 65.28 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.793 0.33 . . . . 0.0 111.216 -175.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 70.8 mtt180 -56.0 -42.41 76.36 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.079 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.854 HD11 ' CD2' ' A' ' 339' ' ' PHE . 52.6 mt -57.73 -53.48 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.399 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.565 HG12 HD11 ' A' ' 328' ' ' LEU . 23.0 mt -58.47 -52.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 122.203 1.001 . . . . 0.0 110.715 -170.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.549 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 23.3 m-20 -63.0 -36.11 82.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.152 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.63 -34.72 74.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.081 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.679 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.72 -53.92 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 122.925 1.345 . . . . 0.0 110.256 173.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.679 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -71.95 -27.46 62.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.618 -2.537 . . . . 0.0 109.585 -167.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 63.25 -70.79 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.943 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.72 97.29 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.322 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.637 HD22 HD23 ' A' ' 355' ' ' LEU . 26.9 p30 -124.59 164.41 19.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 122.736 0.414 . . . . 0.0 110.447 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.522 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -51.42 -59.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.082 0.467 . . . . 0.0 111.804 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -162.63 20.39 0.17 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.54 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.694 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.9 mt -66.05 -5.28 9.21 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 122.835 0.454 . . . . 0.0 111.615 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.549 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 23.3 t -61.42 83.1 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.205 0.526 . . . . 0.0 110.62 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.751 HD11 HG21 ' A' ' 377' ' ' THR . 0.9 OUTLIER -62.48 173.36 1.25 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.659 175.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 366' ' ' GLY . 71.9 p -113.73 162.43 22.67 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.622 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.991 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 10.5 Cg_endo -68.63 25.92 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.121 1.881 . . . . 0.0 112.386 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -138.01 -6.28 1.5 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.759 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.686 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.1 m-20 -105.65 -20.87 13.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.83 1.3 . . . . 0.0 109.129 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.826 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 2.7 p -79.03 20.69 0.47 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.846 -172.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -61.49 -30.58 70.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.707 1.241 . . . . 0.0 108.495 -172.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 24.9 p -125.73 163.9 21.83 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 112.393 -2.185 . . . . 0.0 109.933 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.619 ' O ' HG13 ' A' ' 375' ' ' VAL . 66.7 m95 -70.92 -33.91 70.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 167.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.51 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -61.24 -44.89 96.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.746 -172.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 29.1 t -69.15 -42.9 75.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.733 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.19 -52.15 66.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.872 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.1 m -58.56 -43.86 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.585 0.707 . . . . 0.0 109.422 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.01 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.2 -46.19 90.0 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.095 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.751 HG21 HD11 ' A' ' 363' ' ' LEU . 37.3 m -66.41 -39.32 88.93 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.324 -173.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -59.69 -35.13 73.87 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.467 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.717 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 66.4 t80 -73.41 -45.96 51.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.491 1.139 . . . . 0.0 109.473 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -53.06 -32.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 112.625 -2.08 . . . . 0.0 111.314 171.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.3 OUTLIER -59.55 -38.69 81.75 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.442 0.697 . . . . 0.0 111.831 177.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 4.4 p -104.64 -20.91 13.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.62 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -108.34 24.46 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.87 21.12 29.0 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 114.587 0.595 . . . . 0.0 114.587 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 62.01 165.92 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.092 0.472 . . . . 0.0 110.976 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.49 ' HB3' HE21 ' A' ' 390' ' ' GLN . 0.2 OUTLIER -130.52 154.21 81.59 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -94.56 47.75 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.386 2.724 . . . . 0.0 110.712 165.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.693 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.27 4.55 0.68 Allowed 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -173.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.08 -43.6 70.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.941 0.4 . . . . 0.0 110.569 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.636 ' O ' HG13 ' A' ' 394' ' ' VAL . 27.3 mt-30 -75.85 -25.4 56.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -170.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.889 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.11 -31.38 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.043 0.838 . . . . 0.0 112.024 -172.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.565 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.86 -50.3 58.85 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.674 174.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.523 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.5 m-20 -69.84 -36.59 75.7 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.987 0.515 . . . . 0.0 111.814 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.1 m -58.85 -48.51 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 399' ' ' VAL . 8.5 mm -58.37 -48.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.882 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 392' ' ' GLY . 0.2 OUTLIER -52.31 -46.32 65.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.312 -177.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -73.29 -44.13 35.85 Favored Glycine 0 C--N 1.31 -0.895 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.382 -176.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.0 mt -69.15 -41.22 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 117.76 0.78 . . . . 0.0 111.582 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.5 m -57.93 -44.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.844 0.83 . . . . 0.0 109.552 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.431 ' N ' HG23 ' A' ' 399' ' ' VAL . 16.6 t70 -55.21 -46.05 75.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.328 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 29.2 mm-40 -85.3 -52.52 5.84 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.601 -170.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.575 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.7 OUTLIER -110.6 -30.39 7.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.52 0.676 . . . . 0.0 111.799 -170.254 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 124.84 166.16 12.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.705 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.875 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -62.95 -46.1 97.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.013 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -53.96 -52.54 60.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.617 0.722 . . . . 0.0 111.999 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.79 -49.91 68.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.308 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.672 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.23 -43.37 64.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.66 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.8 t80 -56.44 -46.72 80.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.524 0.678 . . . . 0.0 109.559 176.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.776 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.8 m -58.69 -52.26 66.47 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.65 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.684 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.7 -48.01 82.7 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.602 176.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.58 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.19 -43.24 89.03 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.664 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -72.2 -31.57 66.0 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.88 0.34 . . . . 0.0 110.69 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.858 ' HE3' HG21 ' A' ' 375' ' ' VAL . 62.5 mtm -70.18 -47.5 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 109.93 173.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.01 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.9 mt -59.18 -40.67 86.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.119 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.889 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.7 m -77.82 -12.76 60.01 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.964 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.61 44.13 4.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.206 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.599 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 58.46 39.99 24.52 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.762 0.825 . . . . 0.0 112.99 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.784 HD22 HD21 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -123.46 79.55 1.7 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 165.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.664 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 7.8 p90 -62.55 -31.12 71.85 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.8 -161.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.529 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.0 mt-30 -54.14 -47.76 71.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -164.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.784 HD21 HD22 ' A' ' 418' ' ' ASN . 1.2 pp -59.21 -49.0 79.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.479 0.656 . . . . 0.0 110.974 177.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.732 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.7 -39.06 80.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.756 1.265 . . . . 0.0 109.208 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 30.0 t -60.8 -47.4 86.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.037 -2.347 . . . . 0.0 111.252 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.11 -38.19 75.4 Favored Glycine 0 C--N 1.315 -0.596 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.7 mt -72.18 -43.99 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.583 0.706 . . . . 0.0 109.985 174.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.615 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -55.8 -44.28 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.73 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.717 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -61.67 -30.26 70.61 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-O 122.586 1.184 . . . . 0.0 108.907 -173.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.39 -18.08 78.07 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.966 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.665 ' CG ' HG21 ' A' ' 399' ' ' VAL . 15.0 m-85 -100.65 3.77 42.73 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -177.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.77 145.4 70.82 Favored Pre-proline 0 N--CA 1.418 -2.069 0 CA-C-O 123.546 1.641 . . . . 0.0 113.721 167.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.755 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 59.2 Cg_endo -72.19 -61.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 1 C-N-CA 126.245 4.63 . . . . 0.0 113.127 -173.038 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.53 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.59 141.11 15.61 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.202 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.868 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.46 -30.69 71.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.107 0.454 . . . . 0.0 111.143 -177.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.77 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.25 -46.67 79.52 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 171.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.061 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.7 t -59.66 -51.38 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.397 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.868 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.81 -54.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 51.8 m -62.73 -56.11 20.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.226 -175.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.24 -45.93 79.81 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.64 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 39.0 mt -59.43 -53.73 54.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.806 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.711 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.2 mm-40 -52.23 -34.16 44.61 Favored 'General case' 0 N--CA 1.417 -2.108 0 O-C-N 125.09 1.494 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.656 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.18 -60.69 2.12 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.25 14.51 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.733 -0.605 . . . . 0.0 112.392 -172.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.08 62.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.596 0.712 . . . . 0.0 111.606 -179.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.767 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.7 t70 -72.19 -41.11 67.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.484 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.656 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -70.29 -8.08 47.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 14.0 mm-40 -56.6 161.27 2.81 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 123.221 1.486 . . . . 0.0 114.371 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.693 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.84 -34.28 25.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 111.216 -2.72 . . . . 0.0 115.78 -169.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.635 ' H ' ' HB ' ' A' ' 451' ' ' THR . 24.6 m-20 -142.32 -178.18 5.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.464 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 10.7 p-10 -63.83 -55.26 24.25 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.528 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.28 -27.12 68.82 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.084 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.693 HG21 ' HB ' ' A' ' 447' ' ' ILE . 8.8 m -58.6 -44.67 89.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.381 0.991 . . . . 0.0 109.864 172.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.0 mtt180 -61.0 -29.89 69.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.189 172.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.66 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.57 -31.47 63.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.91 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.1 mm-40 -78.11 -46.24 21.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.728 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.531 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 27.5 p -103.69 -0.9 28.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.481 -166.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -49.28 -55.34 13.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.828 177.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.8 mm -69.62 -26.7 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.531 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.27 -43.96 66.18 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.616 ' O ' HG23 ' A' ' 463' ' ' VAL . 25.4 m80 -65.53 -30.62 71.39 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.857 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.737 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.91 -53.25 33.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.206 1.003 . . . . 0.0 109.303 -178.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.661 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -63.6 -31.5 72.68 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.719 173.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -62.98 -53.15 58.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.41 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.061 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.5 t -62.41 -33.88 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 121.836 0.827 . . . . 0.0 110.249 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.647 ' HD1' HD12 ' A' ' 469' ' ' LEU . 21.9 m-30 -61.96 -15.15 41.35 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.157 169.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 48.0 mt-10 -91.77 -49.36 6.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.909 -1.119 . . . . 0.0 112.822 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.7 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -64.65 -40.43 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.902 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.77 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.3 mt -83.47 -16.58 45.12 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 172.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.61 51.14 54.6 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 111.68 -2.509 . . . . 0.0 113.028 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.732 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -100.48 -156.93 0.58 Allowed 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 122.16 0.981 . . . . 0.0 109.381 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.731 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.7 p30 -130.01 -41.04 1.3 Allowed 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 171.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.535 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -155.76 -82.19 0.07 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.426 -2.17 . . . . 0.0 110.813 155.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.755 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -57.34 69.62 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -172.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.482 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 36.47 42.79 0.68 Allowed Glycine 0 C--N 1.276 -2.755 0 CA-C-N 111.163 -2.744 . . . . 0.0 113.323 172.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.731 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.1 mm-40 -77.4 -59.51 2.75 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 122.147 0.975 . . . . 0.0 111.421 -172.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 36.7 t 67.15 50.87 0.97 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.185 -2.279 . . . . 0.0 107.976 -173.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.5 OUTLIER . . . . . 0 C--N 1.291 -1.971 0 CA-C-N 109.196 -3.638 . . . . 0.0 112.507 170.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.427 -1.61 0 CA-C-O 120.973 0.416 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.737 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 36.2 mt -74.24 127.67 87.41 Favored Pre-proline 0 N--CA 1.425 -1.681 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.576 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.2 Cg_endo -84.96 50.21 2.8 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 125.011 3.807 . . . . 0.0 109.238 165.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.749 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.6 tp -45.41 -42.42 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.287 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' GLN . . . . . 0.616 ' HA ' ' HD3' ' A' ' 311' ' ' ARG . 26.4 mm-40 -60.86 -44.24 97.28 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.998 0.904 . . . . 0.0 111.653 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . 0.551 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.4 t-160 -58.97 -45.77 89.72 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.357 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 335' ' ' ILE . 67.4 mt -59.22 -49.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.749 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 36.4 mtp180 -60.45 -31.28 70.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.523 -0.735 . . . . 0.0 110.987 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.6 m -69.76 -32.27 70.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.587 0.708 . . . . 0.0 109.881 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.544 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.56 -41.33 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.018 177.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.751 HG22 ' HB3' ' A' ' 331' ' ' ASN . 31.6 p -82.68 -36.7 25.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.728 1.251 . . . . 0.0 110.063 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.14 10.74 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 112.4 -2.182 . . . . 0.0 110.159 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.9 mt-10 49.12 173.57 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.126 0 C-N-CA 124.806 1.243 . . . . 0.0 113.254 -173.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 324' ' ' ILE . 25.0 Cg_exo -45.1 154.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.038 2.492 . . . . 0.0 113.604 -176.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 317' ' ' PRO . 32.6 Cg_endo -93.08 -109.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 123.29 2.66 . . . . 0.0 111.563 -175.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.469 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 14.4 mmm180 -97.2 -80.26 0.44 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.396 0.617 . . . . 0.0 111.058 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.504 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 46.0 m-20 -94.06 156.52 39.01 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.38 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 44.3 Cg_exo -58.53 -49.53 11.75 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.726 2.284 . . . . 0.0 110.483 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.421 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.1 OUTLIER -51.61 -21.94 2.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.194 -1.821 . . . . 0.0 112.665 175.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.0 mt-10 -85.0 -30.06 24.51 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.325 -0.234 . . . . 0.0 111.377 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -47.72 -45.05 59.25 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.718 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.0 Cg_endo -50.43 -62.65 0.37 Allowed 'Trans proline' 0 CA--C 1.517 -0.354 0 C-N-CA 122.802 2.335 . . . . 0.0 113.091 177.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.635 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.4 -35.43 69.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 122.664 1.221 . . . . 0.0 110.091 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . 0.651 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 49.7 t90 -58.46 -37.19 74.95 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.156 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.848 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.14 -47.81 60.13 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.67 -23.64 21.92 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.741 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.495 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.9 OUTLIER -74.08 -43.27 58.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.407 1.098 . . . . 0.0 110.686 174.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.751 ' HB3' HG22 ' A' ' 314' ' ' THR . 52.6 m-20 -94.47 -25.03 17.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.407 -168.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ALA . . . . . 0.546 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.58 -50.3 9.5 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 124.453 1.101 . . . . 0.0 113.719 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.8 Cg_endo -62.78 -30.96 78.47 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.684 2.256 . . . . 0.0 111.801 177.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -73.52 -45.77 51.76 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.527 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 310' ' ' ILE . 88.2 mt -57.17 -48.65 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.878 173.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.45 -16.37 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.769 -1.56 . . . . 0.0 112.14 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.8 -46.28 7.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.412 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.623 HG11 HG13 ' A' ' 310' ' ' ILE . 96.3 t -58.19 -70.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 123.499 1.619 . . . . 0.0 110.187 169.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.855 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.8 OUTLIER -92.64 131.81 33.05 Favored Pre-proline 0 N--CA 1.405 -2.679 0 CA-C-N 110.926 -2.852 . . . . 0.0 112.463 -172.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.779 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -73.25 -18.92 23.02 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 123.635 2.89 . . . . 0.0 110.737 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.7 p 33.26 70.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.54 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.583 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.4 p -81.25 5.64 16.51 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.921 -1.945 . . . . 0.0 113.392 -169.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.781 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.9 p -143.14 158.02 59.31 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 121.517 0.675 . . . . 0.0 109.535 174.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 52.4 Cg_exo -62.08 -38.68 55.03 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 124.368 3.379 . . . . 0.0 109.435 172.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.655 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -52.36 -51.69 57.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 112.295 -2.229 . . . . 0.0 110.634 174.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.781 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.2 mt -58.4 -52.43 65.64 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.52 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.658 ' HA ' HD12 ' A' ' 350' ' ' ILE . 3.8 ttm180 -52.86 -41.48 64.34 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.116 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' CYS . . . . . 0.452 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 45.7 t -69.71 -49.25 55.15 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.913 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.6 mtt180 -58.13 -40.01 80.2 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.855 HD11 ' CD2' ' A' ' 339' ' ' PHE . 50.5 mt -58.68 -54.18 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.505 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.606 HD13 ' HB1' ' A' ' 374' ' ' ALA . 16.5 mt -57.56 -53.54 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 121.954 0.883 . . . . 0.0 111.055 -169.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.456 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 52.0 m-20 -64.14 -34.26 77.64 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.079 -177.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.65 76.45 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.205 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.65 -51.61 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 122.875 1.322 . . . . 0.0 110.425 174.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.724 HD23 HD22 ' A' ' 358' ' ' ASN . 0.3 OUTLIER -72.29 -25.76 61.71 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.81 -2.45 . . . . 0.0 109.298 -170.271 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 66.69 -77.04 0.14 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.169 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.9 92.65 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.191 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.724 HD22 HD23 ' A' ' 355' ' ' LEU . 23.3 p30 -111.89 163.65 13.98 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 122.803 0.441 . . . . 0.0 110.751 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.86 -64.87 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 C-N-CA 122.81 0.444 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -150.55 13.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.687 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.1 mt -64.37 -2.8 2.42 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.651 0.38 . . . . 0.0 111.909 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.456 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.1 t -61.75 84.61 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.26 0.552 . . . . 0.0 110.181 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.9 HD11 HG21 ' A' ' 377' ' ' THR . 2.2 mm? -63.52 -174.96 0.1 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.672 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 48.6 p -125.61 157.7 67.45 Favored Pre-proline 0 CA--C 1.506 -0.738 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 32.3 Cg_exo -46.75 -39.34 23.7 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.912 1.741 . . . . 0.0 110.942 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' GLY . . . . . 0.505 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -83.46 2.67 86.86 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.38 -172.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.69 ' CB ' HD12 ' A' ' 363' ' ' LEU . 44.1 m-20 -108.81 -21.76 12.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.089 0.947 . . . . 0.0 109.778 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 57.8 m -95.38 20.3 9.58 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.383 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.505 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -61.34 -36.25 79.66 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.964 1.364 . . . . 0.0 108.375 -173.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 15.2 p -115.51 163.03 16.34 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 112.189 -2.278 . . . . 0.0 109.491 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 375' ' ' VAL . 35.5 m95 -70.71 -33.51 70.94 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.575 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -64.33 -46.4 83.7 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.806 -170.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.0 t -68.22 -42.61 79.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.358 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.705 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.54 -52.54 64.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.918 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.8 m -58.44 -44.4 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.627 0.727 . . . . 0.0 109.489 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 1.023 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.24 -46.0 92.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.883 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.9 HG21 HD11 ' A' ' 363' ' ' LEU . 33.0 m -67.82 -38.72 83.62 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.517 -172.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 1.8 mt -59.47 -34.62 72.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.346 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.718 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 59.2 t80 -73.53 -46.79 45.54 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.34 1.067 . . . . 0.0 109.263 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -51.92 -32.45 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.279 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.4 mpt_? -59.7 -40.14 86.96 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.537 0.684 . . . . 0.0 111.369 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.9 p -96.79 -22.51 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.75 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -110.0 23.33 14.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.58 21.05 19.94 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.6 m 64.92 159.59 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.237 0.541 . . . . 0.0 111.285 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.543 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -123.83 155.45 66.8 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 389' ' ' HIS . 85.0 Cg_endo -101.2 56.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.027 3.152 . . . . 0.0 111.395 168.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.73 ' HA ' HD23 ' A' ' 391' ' ' LEU . 5.3 mmt 62.44 -19.56 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -173.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.461 ' H ' ' C ' ' A' ' 387' ' ' PRO . 5.9 t60 -56.21 -44.25 79.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.065 0.459 . . . . 0.0 111.31 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.707 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.9 mt-30 -75.04 -28.66 60.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.8 mm? -54.8 -31.53 59.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.313 0.961 . . . . 0.0 111.037 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.689 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.02 -51.58 52.78 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.617 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.595 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 50.4 m-20 -68.1 -39.86 82.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.96 0.504 . . . . 0.0 112.168 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 390' ' ' GLN . 1.9 m -56.82 -45.16 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 399' ' ' VAL . 12.9 mm -58.91 -47.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.832 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.691 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 30.6 mmtt -52.48 -43.13 64.81 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 123.987 0.804 . . . . 0.0 111.325 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.16 -44.63 13.15 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.236 -172.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.8 mt -69.05 -40.61 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 117.603 0.702 . . . . 0.0 111.34 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.5 m -58.35 -44.27 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.802 0.81 . . . . 0.0 109.904 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 399' ' ' VAL . 14.6 t70 -59.17 -43.49 92.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.261 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 30.8 mm-40 -83.52 -52.21 6.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.073 -171.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.561 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -111.13 -30.98 7.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.758 -170.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.81 165.84 12.04 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.678 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.902 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.47 -44.68 98.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.88 -52.45 62.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.464 0.649 . . . . 0.0 111.946 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.504 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.45 -49.57 68.65 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.17 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.668 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.61 -41.63 63.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.623 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 46.2 t80 -58.18 -46.65 85.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.471 0.653 . . . . 0.0 109.489 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.773 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.0 m -58.52 -52.58 65.06 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.674 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.677 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.57 -48.77 78.02 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.568 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.63 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.82 -43.39 87.1 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.903 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.769 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.23 -32.29 66.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.798 0.299 . . . . 0.0 111.184 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.918 ' HE3' HG21 ' A' ' 375' ' ' VAL . 68.5 mtm -69.84 -47.17 63.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.396 0.617 . . . . 0.0 109.855 174.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 1.023 HD23 ' HA ' ' A' ' 376' ' ' ALA . 18.0 mt -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.937 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.623 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.6 OUTLIER -74.81 -16.89 60.69 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.864 -173.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 101.27 29.05 6.52 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.1 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.769 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 4.7 mm-40 59.23 43.61 16.77 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.074 0.95 . . . . 0.0 112.279 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.654 ' ND2' HD21 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -119.09 66.78 0.78 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 167.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.708 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.7 OUTLIER -46.1 -35.03 4.6 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 111.554 -2.566 . . . . 0.0 113.435 -164.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.1 mt-30 -54.54 -46.47 73.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.654 HD21 ' ND2' ' A' ' 418' ' ' ASN . 1.6 pp -60.3 -50.1 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.905 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.805 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.02 -39.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.632 1.206 . . . . 0.0 109.19 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.512 ' HB2' ' HD2' ' A' ' 419' ' ' TYR . 17.2 t -60.15 -46.36 89.95 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.643 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.63 -38.63 82.73 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.746 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.4 mt -71.79 -41.98 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.507 0.67 . . . . 0.0 109.932 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.59 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -57.86 -45.71 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.407 -1.269 . . . . 0.0 112.726 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.751 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.52 -29.92 68.23 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.608 1.194 . . . . 0.0 109.325 -174.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.48 -15.18 77.34 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.625 175.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.704 ' CG ' HG21 ' A' ' 399' ' ' VAL . 13.9 m-85 -102.49 2.62 36.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.68 145.07 78.81 Favored Pre-proline 0 N--CA 1.409 -2.479 0 CA-C-O 123.717 1.722 . . . . 0.0 113.516 168.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.769 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 71.9 Cg_endo -72.12 -55.68 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.426 1 C-N-CA 126.289 4.659 . . . . 0.0 113.618 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.513 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.69 140.59 16.31 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.4 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.875 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.23 -27.31 68.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.155 0.478 . . . . 0.0 111.29 -177.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.13 -48.22 79.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 170.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 1.014 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.3 t -57.71 -51.7 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.788 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.875 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -55.02 -53.05 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 91.8 m -61.52 -56.49 19.48 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.11 -45.34 79.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.519 -177.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.811 ' O ' HD22 ' A' ' 443' ' ' LEU . 41.9 mt -59.57 -53.13 61.59 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.71 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.77 -35.52 44.0 Favored 'General case' 0 N--CA 1.421 -1.905 0 O-C-N 124.844 1.34 . . . . 0.0 110.429 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.662 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.69 -59.83 2.53 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 177.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.76 13.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.416 0.553 . . . . 0.0 112.151 -173.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.811 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.75 -24.32 61.42 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.629 0.728 . . . . 0.0 111.776 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.738 ' N ' HD23 ' A' ' 443' ' ' LEU . 15.9 t70 -71.72 -42.73 66.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.564 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 37.9 mt-30 -69.34 -9.36 52.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -171.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 58.7 mm-40 -52.03 153.65 2.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.377 1.56 . . . . 0.0 114.322 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.503 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.1 -32.81 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.985 -2.825 . . . . 0.0 115.483 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.652 ' H ' ' HB ' ' A' ' 451' ' ' THR . 40.2 m-20 -139.13 178.74 6.95 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 452' ' ' ARG . 7.9 p-10 -64.42 -51.59 62.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -66.79 -25.55 66.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 174.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.652 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 13.6 m -59.43 -42.08 91.04 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 119.798 1.181 . . . . 0.0 109.631 171.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.555 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 54.7 mtt180 -59.89 -30.98 69.38 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.338 171.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.623 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.46 -29.63 59.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.042 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.429 ' HB2' HG23 ' A' ' 455' ' ' THR . 2.7 mm-40 -82.82 -47.18 12.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.094 -172.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.605 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -101.95 -1.53 31.73 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.338 -165.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.666 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.72 -51.72 27.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.1 mm -71.85 -27.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . 0.605 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -70.77 -42.55 70.25 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.636 ' O ' HG23 ' A' ' 463' ' ' VAL . 51.5 m-70 -66.92 -30.72 70.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.169 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.722 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -67.06 -53.27 32.69 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.192 0.996 . . . . 0.0 109.052 -179.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.636 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.98 -32.19 73.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.665 173.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -61.82 -54.41 42.63 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.105 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 1.014 HG11 ' HA ' ' A' ' 435' ' ' VAL . 22.1 t -62.21 -34.42 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 CA-C-O 121.684 0.754 . . . . 0.0 110.589 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.544 ' HD1' HD12 ' A' ' 469' ' ' LEU . 20.4 m-30 -61.8 -15.08 38.69 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.219 170.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 46.3 mm-40 -91.89 -49.56 6.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.954 . . . . 0.0 112.732 176.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.717 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -65.14 -40.06 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -84.11 -16.64 42.9 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.73 50.56 58.02 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.28 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.732 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -100.26 -178.64 3.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.71 0.804 . . . . 0.0 110.364 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.777 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 15.7 p30 -101.11 -43.39 6.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.39 -76.69 0.07 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.273 158.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.769 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -60.23 71.22 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -172.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 36.69 45.84 1.06 Allowed Glycine 0 C--N 1.276 -2.772 0 CA-C-N 110.589 -3.005 . . . . 0.0 113.577 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.777 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 27.5 mm-40 -82.54 -57.83 3.18 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.012 0.911 . . . . 0.0 111.466 -173.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 39.0 t 66.94 42.78 2.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.493 -2.139 . . . . 0.0 108.155 -173.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-N 109.246 -3.616 . . . . 0.0 112.623 170.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.478 0.579 0 N-CA-C 110.512 -0.611 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 301' ' ' ILE . 2.9 mp -76.71 122.49 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.146 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 106.02 -94.91 1.0 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.587 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 83.0 m -156.84 122.12 4.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.362 0.601 . . . . 0.0 110.915 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 304' ' ' VAL . 2.8 p -64.66 130.67 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.538 172.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.753 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 27.8 mt -77.96 122.27 85.24 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-O 121.989 0.9 . . . . 0.0 111.851 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 308' ' ' GLN . 25.4 Cg_endo -72.62 -14.02 27.32 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 124.887 3.725 . . . . 0.0 111.417 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.719 HG23 ' HG2' ' A' ' 308' ' ' GLN . 3.5 tp 34.71 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 C-N-CA 128.296 2.638 . . . . 0.0 116.088 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.719 ' HG2' HG23 ' A' ' 307' ' ' ILE . 61.6 mm-40 -58.71 -34.4 71.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.643 0.777 . . . . 0.0 110.41 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.582 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.6 t-160 -60.93 -47.41 86.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.583 173.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 307' ' ' ILE . 67.7 mt -61.76 -48.41 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 124.157 0.983 . . . . 0.0 112.68 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.694 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 9.5 mtp-105 -58.5 -31.56 67.99 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.655 0.382 . . . . 0.0 111.258 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 38.5 t -69.67 -32.78 71.61 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.56 0.695 . . . . 0.0 109.66 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.529 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.22 -41.23 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.942 177.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.702 HG22 ' HB3' ' A' ' 331' ' ' ASN . 33.6 p -82.33 -36.18 27.16 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.939 1.352 . . . . 0.0 109.807 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.66 32.73 8.39 Favored Glycine 0 N--CA 1.432 -1.576 0 CA-C-N 112.203 -2.271 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.448 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 46.9 mt-10 55.75 165.35 0.06 OUTLIER Pre-proline 0 N--CA 1.437 -1.085 0 C-N-CA 124.062 0.945 . . . . 0.0 113.429 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' A' ' 355' ' ' LEU . 33.1 Cg_exo -44.27 146.73 1.78 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.547 2.831 . . . . 0.0 113.095 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.09 -102.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.739 2.292 . . . . 0.0 111.171 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.46 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 11.2 mmm180 -102.36 -79.94 0.52 Allowed 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.284 0.564 . . . . 0.0 111.188 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 8.6 m-20 -94.75 164.17 20.38 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.51 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.418 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 37.4 Cg_exo -61.73 -48.11 9.67 Favored 'Trans proline' 0 CA--C 1.512 -0.577 0 C-N-CA 122.975 2.45 . . . . 0.0 110.613 168.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -51.29 -25.91 6.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.218 177.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 63.7 mt-10 -81.73 -33.5 31.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 0.0 111.226 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.733 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -48.38 -42.37 52.96 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -173.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.699 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.97 -63.23 0.31 Allowed 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 123.089 2.526 . . . . 0.0 113.019 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.592 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -61.23 -37.25 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.246 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.671 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -57.63 -36.53 71.94 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.569 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.827 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.59 -49.49 47.17 Favored 'General case' 0 N--CA 1.401 -2.916 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.75 -24.11 24.4 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.887 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.552 ' HD2' HG21 ' A' ' 406' ' ' THR . 1.0 OUTLIER -74.48 -42.14 59.52 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.994 0.902 . . . . 0.0 110.882 173.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.702 ' HB3' HG22 ' A' ' 314' ' ' THR . 49.2 m-20 -94.24 -23.63 17.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.522 -168.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.613 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.66 -50.29 9.75 Favored Pre-proline 0 C--N 1.308 -1.239 0 C-N-CA 124.523 1.129 . . . . 0.0 113.829 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 53.3 Cg_endo -63.19 -31.48 74.68 Favored 'Trans proline' 0 CA--C 1.51 -0.693 0 C-N-CA 122.473 2.115 . . . . 0.0 111.557 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.38 -42.44 59.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.501 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.618 HG23 HG23 ' A' ' 310' ' ' ILE . 95.5 mt -58.27 -48.01 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.947 174.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.39 -17.96 2.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.496 -1.684 . . . . 0.0 112.368 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.09 -52.8 5.52 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.03 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.628 HG11 HG13 ' A' ' 310' ' ' ILE . 96.8 t -57.78 -71.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 123.506 1.622 . . . . 0.0 110.238 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.753 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.6 123.46 72.6 Favored Pre-proline 0 N--CA 1.403 -2.82 0 CA-C-N 111.172 -2.74 . . . . 0.0 111.588 -174.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.705 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 74.1 Cg_endo -72.7 -17.22 26.25 Favored 'Trans proline' 0 CA--C 1.495 -1.454 0 C-N-CA 123.947 3.098 . . . . 0.0 110.267 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 32.62 66.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 111.683 -2.508 . . . . 0.0 110.103 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.563 ' N ' HD12 ' A' ' 346' ' ' LEU . 46.6 p -79.08 4.11 15.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.738 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.803 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.2 p -140.74 159.5 62.34 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.697 ' HB3' HD12 ' A' ' 369' ' ' LEU . 70.5 Cg_exo -60.33 -46.21 19.18 Favored 'Trans proline' 0 CA--C 1.498 -1.296 0 C-N-CA 123.571 2.847 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.638 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -41.33 -56.52 2.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.4 175.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.803 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.9 mt -55.85 -51.24 68.22 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.051 -1.432 . . . . 0.0 111.0 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.834 ' HA ' HD12 ' A' ' 350' ' ' ILE . 4.7 ttm180 -49.83 -48.06 51.2 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.959 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 1.117 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.7 m -68.88 -47.1 66.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.949 -177.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.587 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.0 mtp180 -62.37 -34.3 76.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.88 ' O ' HG12 ' A' ' 354' ' ' ILE . 28.1 mt -58.24 -53.04 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.753 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.627 ' O ' HD22 ' A' ' 355' ' ' LEU . 19.7 mt -57.81 -53.89 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 121.922 0.868 . . . . 0.0 111.201 -170.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.566 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 13.5 m-20 -63.89 -35.68 81.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.133 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . 0.566 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.56 -29.91 66.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.68 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.88 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.03 -58.85 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 122.945 1.355 . . . . 0.0 110.118 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.733 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.13 -27.95 57.27 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.182 -167.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.74 -72.56 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.341 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -106.63 52.15 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.562 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.732 HD22 ' HB2' ' A' ' 361' ' ' LEU . 12.7 p-10 -89.88 129.45 36.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 122.861 0.464 . . . . 0.0 109.911 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.662 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -48.24 -71.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.881 -170.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.37 6.68 5.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.523 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.732 ' HB2' HD22 ' A' ' 358' ' ' ASN . 3.5 mt -70.96 -6.19 36.76 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.582 0.706 . . . . 0.0 109.962 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.566 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 19.5 t -63.7 78.89 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.413 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.772 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.9 mm? -61.14 -179.69 0.16 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.184 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 366' ' ' GLY . 49.2 p -119.76 157.71 51.57 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.436 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 1.117 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 57.7 Cg_endo -69.79 25.32 0.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.115 1.876 . . . . 0.0 113.254 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -134.32 -4.0 2.97 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.647 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.563 ' HB2' HD12 ' A' ' 363' ' ' LEU . 1.5 m-20 -106.88 -21.21 13.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.119 0.961 . . . . 0.0 110.451 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.887 ' HB2' ' SG ' ' A' ' 348' ' ' CYS . 3.8 m -94.41 24.16 4.7 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.638 -168.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.9 -35.89 64.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.332 1.063 . . . . 0.0 109.356 -172.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.06 159.48 23.15 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.304 172.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.643 ' O ' HG13 ' A' ' 375' ' ' VAL . 58.7 m95 -69.63 -35.48 75.28 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.562 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.32 -41.96 98.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.969 -175.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 92.0 p -67.47 -44.48 78.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.906 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.586 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -63.43 -52.83 59.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.827 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.3 m -56.11 -45.03 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.453 0.645 . . . . 0.0 109.559 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.04 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.05 -45.66 90.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.999 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.63 HG21 HD11 ' A' ' 363' ' ' LEU . 24.0 m -68.05 -37.24 81.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.289 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -61.73 -34.83 76.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.186 0.517 . . . . 0.0 110.609 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.699 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 68.1 t80 -73.38 -45.15 56.51 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.461 1.124 . . . . 0.0 109.097 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.6 -33.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 112.647 -2.07 . . . . 0.0 111.167 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.41 -44.39 95.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.538 0.685 . . . . 0.0 111.068 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 32.7 p -93.73 -23.68 18.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.82 -167.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.464 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 30.6 m80 -109.55 23.75 14.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.57 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.91 36.15 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.087 -0.506 . . . . 0.0 114.223 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m 66.27 159.54 0.13 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 111.494 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -129.47 151.22 77.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -96.32 54.1 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 110.906 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.688 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.02 8.16 0.72 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -70.69 -45.65 64.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.102 0.477 . . . . 0.0 110.479 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.657 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.6 mt-30 -75.26 -28.17 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -170.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.695 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.34 -31.61 45.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.025 0.829 . . . . 0.0 112.115 -170.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.644 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -53.18 41.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.925 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 18.2 m-20 -67.48 -37.48 82.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.3 m -58.5 -45.75 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 110.616 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 399' ' ' VAL . 9.5 mm -58.25 -47.16 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.855 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.65 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.0 mmtt -52.42 -39.86 61.48 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 124.205 0.94 . . . . 0.0 111.893 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -77.39 -44.62 12.75 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.68 -1.247 . . . . 0.0 113.146 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.4 mt -69.39 -42.72 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 111.749 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.2 m -57.09 -43.96 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.562 0.696 . . . . 0.0 110.226 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 399' ' ' VAL . 6.1 t70 -58.47 -39.76 80.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.861 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 47.7 mt-30 -86.38 -53.62 4.9 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.28 -173.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.515 ' HG3' HG22 ' A' ' 398' ' ' ILE . 0.6 OUTLIER -113.19 -30.85 6.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.107 -166.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.29 165.83 12.09 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.856 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.939 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.1 -43.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.32 -50.57 71.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.92 0.391 . . . . 0.0 111.871 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.566 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.54 -51.42 62.93 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.705 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.878 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.33 -41.41 65.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.582 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 48.0 t80 -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.635 0.731 . . . . 0.0 109.366 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.799 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.3 m -59.91 -53.42 58.1 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.808 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.71 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 117.887 0.312 . . . . 0.0 110.681 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.28 -45.24 83.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.405 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.735 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.4 OUTLIER -70.41 -32.21 69.74 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.645 0.723 . . . . 0.0 111.075 177.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.799 ' HG3' ' O ' ' A' ' 409' ' ' THR . 49.7 mtm -68.65 -48.04 65.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.53 0.681 . . . . 0.0 109.521 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.04 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.3 mt -59.66 -40.14 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.653 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.793 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -78.32 -17.23 56.85 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.803 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 86.78 47.05 4.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.839 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.623 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 57.96 47.54 14.81 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.793 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -125.89 74.36 1.42 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.612 1.673 . . . . 0.0 106.953 161.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.735 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 2.1 p90 -58.57 -33.49 70.0 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.165 -2.288 . . . . 0.0 110.826 -160.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -55.11 -43.45 74.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.495 -165.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.635 HD21 ' ND2' ' A' ' 418' ' ' ASN . 2.0 pp -63.42 -49.63 72.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.242 0.544 . . . . 0.0 110.721 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.68 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.71 -39.45 81.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.834 1.302 . . . . 0.0 109.207 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.556 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 41.2 t -61.91 -44.36 96.95 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.076 -2.329 . . . . 0.0 111.723 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.98 -40.74 82.97 Favored Glycine 0 C--N 1.316 -0.557 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.713 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.6 mt -71.4 -41.92 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.623 0.725 . . . . 0.0 110.167 175.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.4 mm -55.13 -42.74 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.483 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.676 ' HA ' HD23 ' A' ' 430' ' ' LEU . 3.3 tmm_? -58.86 -36.05 73.96 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 123.201 1.477 . . . . 0.0 109.383 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.08 -8.34 69.18 Favored Glycine 0 C--N 1.283 -2.397 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.224 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.1 m-85 -105.6 -0.55 25.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.55 142.84 82.29 Favored Pre-proline 0 N--CA 1.406 -2.637 0 CA-C-O 123.585 1.66 . . . . 0.0 113.017 170.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.754 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 67.6 Cg_endo -70.75 -55.25 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.386 1 C-N-CA 126.164 4.576 . . . . 0.0 113.212 -172.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -118.79 143.5 17.48 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.372 -178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.867 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.31 -26.77 68.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.992 0.396 . . . . 0.0 111.268 -177.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.58 -48.46 79.32 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.985 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.5 t -58.25 -51.54 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.807 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.867 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -55.29 -53.33 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 99.9 m -61.85 -56.67 16.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.169 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.19 -45.93 79.59 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.57 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.811 ' O ' HD22 ' A' ' 443' ' ' LEU . 41.8 mt -59.66 -53.15 61.41 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.651 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.716 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 39.8 mm-40 -51.51 -35.44 40.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 O-C-N 124.882 1.364 . . . . 0.0 110.683 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.39 -60.59 2.17 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -76.09 -50.29 15.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.77 -0.581 . . . . 0.0 111.901 -172.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.811 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.88 63.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.384 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.747 ' N ' HD23 ' A' ' 443' ' ' LEU . 8.2 t70 -73.95 -41.85 61.4 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.129 0.966 . . . . 0.0 110.747 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.18 -8.15 43.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.514 ' HB3' ' CG2' ' A' ' 451' ' ' THR . 51.5 mm-40 -51.77 157.16 1.24 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.377 1.561 . . . . 0.0 114.186 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.431 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -53.87 -32.92 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.841 -2.89 . . . . 0.0 115.191 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.665 ' H ' ' HB ' ' A' ' 451' ' ' THR . 68.9 m-20 -135.18 178.22 7.2 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.417 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.8 p-10 -66.54 -51.48 56.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -69.43 -22.98 63.62 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 31.1 m -57.79 -39.5 77.67 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 119.888 1.222 . . . . 0.0 109.398 170.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.617 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 75.7 mtt180 -60.72 -30.42 69.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.356 172.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.582 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.84 -35.36 59.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.164 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.93 -43.16 25.3 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.654 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 40.2 p -101.46 -2.09 31.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.295 -169.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.685 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.2 t80 -49.04 -54.58 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.827 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.3 mm -69.97 -26.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -42.96 63.59 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 463' ' ' VAL . 39.7 m-70 -67.3 -31.04 71.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.562 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.724 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -64.37 -53.89 41.53 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.174 0.987 . . . . 0.0 109.093 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.45 -30.69 71.42 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.799 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -66.94 -48.67 67.9 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.463 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.985 HG11 ' HA ' ' A' ' 435' ' ' VAL . 34.2 t -65.35 -36.24 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.471 175.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.5 m-30 -60.17 -13.9 14.54 Favored 'General case' 0 C--O 1.202 -1.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.625 168.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.3 tp10 -95.52 -51.93 4.34 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.213 -0.929 . . . . 0.0 112.467 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -62.62 -41.36 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.374 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.805 HD12 HD11 ' A' ' 469' ' ' LEU . 6.7 mt -83.94 -17.51 40.4 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.822 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.31 49.67 60.1 Favored Glycine 0 C--O 1.211 -1.294 0 CA-C-N 111.481 -2.599 . . . . 0.0 113.239 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.805 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -102.86 172.91 6.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 123.951 0.9 . . . . 0.0 110.149 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.735 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.6 p30 -92.64 -39.59 11.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -161.96 -75.57 0.05 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.197 159.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.754 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -66.26 71.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.064 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.47 42.0 2.46 Favored Glycine 0 C--N 1.275 -2.817 0 CA-C-N 110.952 -2.84 . . . . 0.0 113.217 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.735 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.6 mm-40 -80.24 -54.83 5.38 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.472 1.13 . . . . 0.0 111.102 -174.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.1 t 68.91 61.16 0.33 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.372 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.822 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -57.2 -47.66 83.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 111.023 -2.808 . . . . 0.0 111.893 174.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 477' ' ' ARG . 17.7 mmt180 -54.86 142.07 30.81 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.968 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.6 mt -49.26 -55.61 12.09 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.533 -174.34 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 N--CA 1.479 0.623 0 N-CA-C 110.567 -0.59 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.3 mp -80.32 -51.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 140.43 -118.75 1.47 Allowed Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.01 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 26.5 m -130.77 134.81 47.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 0.0 110.707 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.5 t -75.11 123.98 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.636 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.786 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.7 mt -77.2 123.66 87.12 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 122.026 0.917 . . . . 0.0 112.657 -174.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 308' ' ' GLN . 37.4 Cg_endo -73.55 -20.04 20.99 Favored 'Trans proline' 0 CA--C 1.502 -1.106 0 C-N-CA 124.881 3.721 . . . . 0.0 111.116 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.711 HG23 ' HG2' ' A' ' 308' ' ' GLN . 3.6 tp 41.03 -63.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 127.833 2.453 . . . . 0.0 115.584 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.711 ' HG2' HG23 ' A' ' 307' ' ' ILE . 69.7 mm-40 -59.35 -33.67 71.43 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 123.409 0.684 . . . . 0.0 110.631 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.518 ' CG ' HG13 ' A' ' 338' ' ' VAL . 8.7 t-160 -60.5 -47.79 84.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.514 172.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.654 HG13 HG11 ' A' ' 338' ' ' VAL . 64.9 mt -60.28 -48.66 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 123.875 0.87 . . . . 0.0 112.091 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.692 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 14.1 mtp180 -57.5 -30.45 65.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 122.852 0.461 . . . . 0.0 111.798 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -34.17 74.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.462 0.648 . . . . 0.0 109.957 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.504 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.92 -40.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.515 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.743 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 36.3 p -81.91 -36.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.827 1.298 . . . . 0.0 109.793 -176.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 85.93 36.03 10.66 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 112.315 -2.221 . . . . 0.0 111.064 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 34.3 mt-10 53.97 168.21 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.585 ' HG3' HD12 ' A' ' 355' ' ' LEU . 63.7 Cg_exo -47.13 147.13 5.63 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.674 2.916 . . . . 0.0 113.55 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 18.0 Cg_endo -96.94 -105.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.769 2.979 . . . . 0.0 113.378 -170.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.432 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 15.5 mmt180 -86.52 -86.26 0.15 Allowed 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 123.207 0.603 . . . . 0.0 110.687 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 22.6 m-20 -102.9 166.36 12.04 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.036 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.518 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 34.5 Cg_exo -58.35 -50.35 9.94 Favored 'Trans proline' 0 CA--C 1.511 -0.631 0 C-N-CA 122.536 2.158 . . . . 0.0 110.571 169.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.474 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -60.32 -11.72 7.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.295 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 320' ' ' ASN . 1.6 mm-40 -92.19 -22.52 19.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.257 . . . . 0.0 111.591 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.765 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.71 -40.88 56.4 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.74 ' HA ' HD23 ' A' ' 378' ' ' LEU . 7.9 Cg_endo -49.61 -62.56 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.916 2.411 . . . . 0.0 113.05 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.67 ' O ' ' HG3' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -60.46 -37.2 73.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 122.329 1.062 . . . . 0.0 110.303 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.743 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 63.1 t90 -58.56 -38.05 77.02 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.741 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.831 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -70.85 -50.59 33.62 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -54.36 -24.05 28.73 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.554 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 326' ' ' ILE . 21.4 mtp180 -75.21 -40.59 59.08 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 122.271 1.034 . . . . 0.0 112.0 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.618 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.0 m-20 -94.27 -24.41 17.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.511 -1.677 . . . . 0.0 113.195 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.57 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.67 -49.28 13.3 Favored Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 124.635 1.174 . . . . 0.0 113.803 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.5 Cg_endo -60.78 -34.41 91.64 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 122.464 2.109 . . . . 0.0 111.488 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -74.06 -43.39 57.93 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.544 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.621 HG23 HG23 ' A' ' 310' ' ' ILE . 94.1 mt -58.26 -47.08 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.013 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -13.8 2.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.995 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.86 -51.18 4.62 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.26 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.654 HG11 HG13 ' A' ' 310' ' ' ILE . 94.6 t -57.81 -70.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 123.128 1.442 . . . . 0.0 109.846 170.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.811 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.5 OUTLIER -87.4 125.68 64.79 Favored Pre-proline 0 N--CA 1.408 -2.526 0 CA-C-N 111.644 -2.526 . . . . 0.0 111.885 -175.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.671 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.1 Cg_endo -70.83 -19.71 30.68 Favored 'Trans proline' 0 CA--C 1.493 -1.566 0 C-N-CA 123.736 2.957 . . . . 0.0 110.283 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 33.24 70.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.54 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.569 ' N ' HD12 ' A' ' 346' ' ' LEU . 68.7 p -79.96 2.65 22.77 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.684 -2.053 . . . . 0.0 112.821 -170.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.81 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 18.0 p -143.22 161.65 46.8 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-O 121.457 0.646 . . . . 0.0 109.753 177.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.1 -40.67 32.26 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 124.403 3.402 . . . . 0.0 109.8 172.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -47.86 -55.11 10.56 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.625 -2.079 . . . . 0.0 110.298 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.81 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.7 mt -57.64 -51.38 69.76 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.817 -175.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.791 ' HA ' HD12 ' A' ' 350' ' ' ILE . 10.1 ttm180 -52.92 -42.06 65.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.934 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.509 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 42.0 t -68.26 -49.95 57.13 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.972 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.657 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 60.3 mtp180 -61.14 -37.64 83.57 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.476 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.894 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -57.44 -52.64 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 O-C-N 123.371 0.419 . . . . 0.0 111.006 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.613 ' O ' HD22 ' A' ' 355' ' ' LEU . 18.3 mt -58.38 -54.19 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 122.098 0.952 . . . . 0.0 110.964 -172.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.573 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 21.8 m-20 -63.96 -35.62 81.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.004 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . 0.565 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.77 -29.22 65.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.876 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.894 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.8 mm -56.67 -59.49 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 CA-C-O 122.794 1.283 . . . . 0.0 110.161 174.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.765 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.87 -26.3 54.07 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 111.977 -2.374 . . . . 0.0 109.772 -167.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.58 -71.68 1.56 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.065 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -115.85 33.07 5.37 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.949 -176.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.754 HD22 ' HB2' ' A' ' 361' ' ' LEU . 22.6 p-10 -58.32 134.32 56.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.707 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -47.77 -72.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 C-N-CA 124.237 1.015 . . . . 0.0 112.854 -170.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -131.62 7.6 5.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.758 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.754 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.6 mt -70.89 -4.59 25.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.669 0.747 . . . . 0.0 109.942 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.573 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 8.7 t -63.62 80.31 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.994 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.861 HD11 HG21 ' A' ' 377' ' ' THR . 1.7 mm? -60.35 -170.82 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 30.5 p -124.77 157.49 65.88 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.613 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 53.0 Cg_exo -46.65 -37.73 21.05 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.09 1.86 . . . . 0.0 111.491 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.528 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -86.05 2.96 87.62 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.693 -0.685 . . . . 0.0 114.594 -172.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.698 ' HB2' HD12 ' A' ' 363' ' ' LEU . 24.2 m-20 -109.21 -22.15 12.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.916 0.865 . . . . 0.0 110.083 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.732 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 62.7 m -94.3 19.74 9.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.67 -169.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.528 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -58.74 -41.27 86.06 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.897 -170.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.9 157.25 27.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 113.276 -1.783 . . . . 0.0 109.373 170.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.641 ' O ' HG13 ' A' ' 375' ' ' VAL . 51.5 m95 -69.59 -35.89 75.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.433 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.95 -38.56 91.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.352 -174.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 37.1 t -70.25 -44.0 69.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.11 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.551 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -63.33 -52.17 62.98 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.831 HG12 ' HB3' ' A' ' 328' ' ' LEU . 14.9 m -55.63 -46.35 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.494 0.664 . . . . 0.0 110.192 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.089 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -58.52 -37.5 75.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.848 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.861 HG21 HD11 ' A' ' 363' ' ' LEU . 39.0 m -75.29 -41.75 56.37 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.931 -171.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.74 HD23 ' HA ' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -58.82 -34.42 71.5 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.821 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.712 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 30.0 t80 -70.99 -49.1 48.96 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.49 1.138 . . . . 0.0 109.627 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.03 -32.12 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.976 170.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -60.0 -34.4 73.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.878 0.471 . . . . 0.0 111.451 175.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 26.1 p -103.83 -23.34 13.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.956 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -110.12 22.94 14.96 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.15 17.04 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 114.359 0.504 . . . . 0.0 114.359 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.427 HG23 HG13 ' A' ' 380' ' ' ILE . 1.1 m 66.64 154.79 0.09 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.386 0.613 . . . . 0.0 111.236 -175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -119.12 154.57 53.52 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 389' ' ' HIS . 83.2 Cg_endo -96.09 54.55 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.36 2.707 . . . . 0.0 111.207 167.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.783 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.0 -7.44 0.07 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.404 ' H ' ' C ' ' A' ' 387' ' ' PRO . 7.8 t60 -69.21 -43.79 73.4 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.659 0.266 . . . . 0.0 111.235 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.2 mt-30 -69.38 -26.24 64.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.783 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.8 mm? -54.03 -29.82 45.25 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.354 0.525 . . . . 0.0 110.976 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.653 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.24 -53.29 38.61 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.683 172.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.589 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 34.4 m-20 -64.36 -41.38 96.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.861 0.464 . . . . 0.0 111.947 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.72 -45.2 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.249 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.701 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.8 mm -58.05 -47.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.161 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 27.3 mmtt -52.78 -42.62 65.19 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.027 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -75.7 -44.91 18.96 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.494 -1.336 . . . . 0.0 112.637 -173.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.904 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.1 mt -69.87 -41.46 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 117.16 0.48 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.3 m -57.35 -43.57 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.54 0.686 . . . . 0.0 110.381 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 399' ' ' VAL . 2.7 t70 -65.66 -37.43 86.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.975 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 74.4 mt-30 -82.56 -52.63 6.66 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.458 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.563 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -115.14 -30.39 6.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.031 -167.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 128.33 164.69 11.63 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.043 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.937 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -63.75 -43.01 97.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 122.653 0.381 . . . . 0.0 111.783 -176.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.638 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -57.26 -50.41 72.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.294 0.568 . . . . 0.0 111.246 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.563 HG21 ' HD2' ' A' ' 330' ' ' ARG . 1.0 OUTLIER -63.37 -52.04 63.35 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 179.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.904 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.74 -40.41 66.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 176.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.604 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 32.9 t80 -58.4 -43.53 88.61 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.791 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.4 m -62.84 -53.18 58.11 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.624 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.659 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.14 -49.49 77.42 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.249 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.14 -42.34 87.59 Favored Glycine 0 C--N 1.314 -0.649 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.255 -174.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.802 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.17 -31.84 66.29 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 116.686 0.243 . . . . 0.0 110.956 179.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.791 ' HG3' ' O ' ' A' ' 409' ' ' THR . 50.8 mtm -69.51 -47.98 62.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 109.742 173.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.089 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.1 mt -59.02 -40.58 85.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.453 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.674 ' HG ' ' HG ' ' A' ' 391' ' ' LEU . 0.2 OUTLIER -77.08 -8.82 58.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.394 -177.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.42 33.54 7.97 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.952 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.802 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 4.2 mm-40 57.26 48.46 15.03 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.054 -1.073 . . . . 0.0 112.814 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.64 ' ND2' HD21 ' A' ' 421' ' ' LEU . 0.4 OUTLIER -120.17 63.53 0.83 Allowed 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 165.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.792 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 1.0 OUTLIER -44.59 -35.02 2.37 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.426 -2.624 . . . . 0.0 112.871 -163.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 39.5 mt-30 -55.71 -43.01 76.08 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -165.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.64 HD21 ' ND2' ' A' ' 418' ' ' ASN . 1.9 pp -63.39 -48.4 78.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.54 -38.99 79.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.579 1.181 . . . . 0.0 109.059 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.51 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 35.9 t -59.62 -46.34 89.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.356 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.9 -39.03 76.97 Favored Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.207 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.1 -40.56 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.582 0.706 . . . . 0.0 110.24 174.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 404' ' ' VAL . 1.8 mm -58.13 -45.21 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.023 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.665 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.72 -29.53 68.19 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.76 1.267 . . . . 0.0 108.746 -174.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.17 -15.37 74.52 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 112.71 -2.041 . . . . 0.0 112.562 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.604 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 10.2 m-85 -101.17 -0.33 36.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.27 142.9 80.6 Favored Pre-proline 0 N--CA 1.414 -2.263 0 CA-C-O 123.653 1.692 . . . . 0.0 113.626 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.747 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 66.9 Cg_endo -71.71 -61.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.227 4.618 . . . . 0.0 113.603 -172.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.561 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.15 142.17 17.04 Favored Glycine 0 N--CA 1.431 -1.652 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.147 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.918 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.96 -27.47 68.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.316 0.558 . . . . 0.0 111.701 -176.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.809 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.22 -48.89 77.66 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.048 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.2 t -61.61 -37.66 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.485 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.918 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.13 -44.19 65.48 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.261 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 67.1 m -71.9 -54.94 8.47 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.433 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.0 -46.11 78.84 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.414 0.446 . . . . 0.0 111.168 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 460' ' ' LEU . 21.1 mt -60.11 -54.11 49.8 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.47 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.765 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.26 -33.59 29.03 Favored 'General case' 0 N--CA 1.405 -2.69 0 O-C-N 125.487 1.742 . . . . 0.0 111.108 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.1 -59.81 2.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -75.76 -50.19 15.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.978 0.354 . . . . 0.0 111.895 -173.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.768 HD23 ' N ' ' A' ' 444' ' ' ASP . 0.1 OUTLIER -59.0 -24.7 63.01 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.623 -178.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.768 ' N ' HD23 ' A' ' 443' ' ' LEU . 7.2 t70 -73.32 -41.05 63.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.882 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -72.31 -8.16 53.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -172.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.484 ' HB3' HG22 ' A' ' 451' ' ' THR . 6.1 mm-40 -56.85 162.76 2.23 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.176 1.465 . . . . 0.0 114.317 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.771 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -55.82 -33.52 34.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 111.31 -2.677 . . . . 0.0 115.974 -168.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.64 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.9 m-20 -145.03 -175.73 4.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.464 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.7 m-20 -65.11 -56.81 10.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.58 -25.21 67.31 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 177.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.771 HG21 ' HB ' ' A' ' 447' ' ' ILE . 17.0 m -56.85 -44.02 81.74 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.708 1.14 . . . . 0.0 109.47 170.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.728 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 27.6 mtm-85 -62.13 -29.45 70.35 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.774 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.604 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.25 -28.67 62.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.032 0.92 . . . . 0.0 109.449 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -86.21 -43.73 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.22 -171.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.8 p -103.44 -3.99 24.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.932 -169.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.686 ' HB2' ' O ' ' A' ' 452' ' ' ARG . 8.8 t80 -49.12 -53.58 20.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.668 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.638 HG23 ' HB1' ' A' ' 405' ' ' ALA . 21.4 mm -71.17 -25.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.433 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.97 -43.54 62.13 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.559 ' O ' HG23 ' A' ' 463' ' ' VAL . 80.1 m-70 -67.92 -31.1 70.63 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.215 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.812 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.8 -53.98 42.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.165 0.984 . . . . 0.0 109.177 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -61.61 -30.41 70.67 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.785 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -69.06 -47.57 64.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.585 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.048 HG11 ' HA ' ' A' ' 435' ' ' VAL . 45.6 t -66.06 -35.78 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.314 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.535 ' OH ' HG13 ' A' ' 404' ' ' VAL . 20.0 m-30 -61.12 -14.09 21.98 Favored 'General case' 0 C--O 1.2 -1.504 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.647 168.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.569 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 6.3 tp10 -93.36 -52.03 4.71 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.444 -0.785 . . . . 0.0 112.323 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -62.98 -41.31 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.421 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.809 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.7 mt -84.33 -17.12 40.53 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 172.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.741 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 66.1 49.35 58.5 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 111.633 -2.53 . . . . 0.0 113.336 173.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.739 HD11 HD12 ' A' ' 467' ' ' LEU . 0.6 OUTLIER -101.81 -176.59 3.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.056 0.943 . . . . 0.0 110.04 -179.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.744 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.8 p30 -105.11 -40.63 5.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 167.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.452 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -159.06 -79.38 0.06 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.335 -2.211 . . . . 0.0 110.91 158.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.747 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.5 OUTLIER -61.41 73.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -170.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.493 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.73 44.69 0.71 Allowed Glycine 0 C--N 1.274 -2.864 0 CA-C-N 110.462 -3.063 . . . . 0.0 113.227 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.744 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.1 mm-40 -79.66 -55.19 5.19 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.273 1.035 . . . . 0.0 111.223 -173.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.7 t 65.69 47.81 2.07 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.912 -2.403 . . . . 0.0 108.095 -173.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -43.42 -47.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 109.808 -3.36 . . . . 0.0 112.303 176.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 477' ' ' ARG . 12.7 mmt180 -47.48 137.63 8.58 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.266 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.72 -27.56 66.58 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.651 0.78 . . . . 0.0 112.434 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.251 1.167 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.593 176.631 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.476 0.467 0 N-CA-C 110.44 -0.639 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.0 mp -111.89 106.18 20.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -88.35 153.86 24.67 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.762 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.412 ' HB ' HD11 ' A' ' 346' ' ' LEU . 52.9 m -91.97 136.76 32.91 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.392 0.615 . . . . 0.0 111.353 -176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.8 t -83.51 121.25 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.157 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.801 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 47.6 mt -71.11 121.19 83.46 Favored Pre-proline 0 N--CA 1.426 -1.665 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.585 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 57.8 Cg_endo -82.09 58.21 6.56 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 124.92 3.746 . . . . 0.0 109.592 170.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.671 HG12 ' HB1' ' A' ' 353' ' ' ALA . 1.7 tp -45.52 -47.38 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 112.12 -2.309 . . . . 0.0 113.347 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.628 ' HG2' HG23 ' A' ' 307' ' ' ILE . 16.7 mm-40 -65.63 -35.65 81.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.327 0.584 . . . . 0.0 111.282 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.6 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.3 t-160 -61.89 -47.41 85.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.615 173.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.624 HG23 HG23 ' A' ' 335' ' ' ILE . 67.5 mt -61.25 -49.62 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.058 0.943 . . . . 0.0 113.043 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 28.1 mtp180 -59.93 -29.57 68.47 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.05 0.54 . . . . 0.0 111.602 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 69.4 m -69.67 -33.26 72.31 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.606 0.717 . . . . 0.0 110.266 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.502 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -68.27 -40.86 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.936 177.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.664 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 34.4 p -82.13 -36.47 27.43 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.805 1.288 . . . . 0.0 109.928 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.23 34.42 9.67 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 112.323 -2.217 . . . . 0.0 110.813 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 33.2 mt-10 52.46 170.24 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.67 ' HG3' HD12 ' A' ' 355' ' ' LEU . 93.7 Cg_exo -49.63 150.67 8.53 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.213 2.609 . . . . 0.0 113.246 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 42.4 Cg_endo -93.37 -104.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.444 2.763 . . . . 0.0 112.11 -174.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.415 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 20.0 mmt180 -95.17 -84.58 0.33 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 12.1 m-20 -96.07 163.47 20.86 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.876 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.491 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.75 -48.64 12.19 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.732 2.288 . . . . 0.0 110.434 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.46 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -56.36 -17.14 6.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.509 -1.678 . . . . 0.0 113.562 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.528 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 39.7 mt-10 -87.38 -27.97 22.46 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.368 -0.208 . . . . 0.0 110.993 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.719 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.09 -43.69 69.31 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.698 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 3.5 Cg_endo -46.64 -65.35 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.098 2.532 . . . . 0.0 112.997 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.597 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.61 -37.62 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.317 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.664 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.5 t90 -57.68 -34.05 69.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.114 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.832 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.58 -50.23 39.46 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.38 -23.73 27.73 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.903 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.534 ' HD2' HG21 ' A' ' 406' ' ' THR . 2.4 mtm-85 -73.23 -40.78 64.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.317 1.056 . . . . 0.0 110.369 175.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.654 ' HB3' HG22 ' A' ' 314' ' ' THR . 56.6 m-20 -97.75 -24.91 15.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.716 -1.584 . . . . 0.0 114.004 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.63 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.66 -49.72 13.07 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.4 Cg_endo -61.13 -32.93 91.68 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.495 2.13 . . . . 0.0 111.528 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.97 -43.51 57.89 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.483 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 332' ' ' ALA . 92.9 mt -57.44 -47.24 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.942 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 36.9 t70 -55.93 -14.78 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.202 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.82 -47.37 6.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.429 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.6 HG22 ' CD2' ' A' ' 309' ' ' HIS . 92.2 t -63.49 -72.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.296 1.522 . . . . 0.0 109.946 169.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.801 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -84.05 122.48 75.93 Favored Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.665 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.704 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.2 Cg_endo -72.23 -17.25 27.86 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.094 3.196 . . . . 0.0 110.159 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.4 p 33.89 67.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.068 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.559 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.5 p -78.35 0.7 24.5 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.775 -2.012 . . . . 0.0 112.572 -170.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.817 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -138.06 159.09 69.78 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.697 ' HB3' HD12 ' A' ' 369' ' ' LEU . 68.1 Cg_exo -60.53 -44.94 24.0 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 123.583 2.855 . . . . 0.0 108.797 172.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.616 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -44.99 -52.43 8.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.722 -2.035 . . . . 0.0 110.776 176.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.817 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.0 mt -56.94 -52.3 65.73 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.845 ' HA ' HD12 ' A' ' 350' ' ' ILE . 25.3 ttm180 -49.94 -46.23 51.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.603 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.941 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 8.2 m -68.12 -50.86 52.12 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.146 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.694 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 35.2 mtt180 -61.23 -34.82 75.75 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.409 0.443 . . . . 0.0 111.105 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.888 ' O ' HG12 ' A' ' 354' ' ' ILE . 32.7 mt -56.22 -51.5 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.898 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 328' ' ' LEU . 21.7 mt -60.38 -53.84 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 123.832 0.707 . . . . 0.0 111.744 -172.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.694 ' OD1' ' HA ' ' A' ' 349' ' ' ARG . 0.0 OUTLIER -60.41 -36.13 77.42 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.822 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . 0.671 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -71.19 -29.79 65.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.888 HG12 ' O ' ' A' ' 350' ' ' ILE . 4.3 mm -58.03 -59.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 CA-C-O 123.082 1.42 . . . . 0.0 110.493 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.719 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -78.62 -26.96 45.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 111.702 -2.499 . . . . 0.0 110.26 -167.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.85 -78.7 0.2 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 113.903 -1.499 . . . . 0.0 113.023 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -102.4 36.31 4.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.415 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.742 HD22 ' HB2' ' A' ' 361' ' ' LEU . 22.0 p-10 -70.63 131.46 43.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.069 0.461 . . . . 0.0 110.649 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.662 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -49.62 -72.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -169.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.9 2.94 6.91 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.885 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.742 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.2 mt -72.46 -4.62 31.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.943 0.877 . . . . 0.0 109.953 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 8.2 t -69.18 70.55 0.24 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.378 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 367' ' ' ASP . 1.5 mm? -55.03 172.31 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.5 p -120.27 159.4 47.74 Favored Pre-proline 0 N--CA 1.438 -1.047 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.325 -175.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.888 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.1 Cg_endo -53.3 -9.98 1.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.156 2.57 . . . . 0.0 113.215 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -103.49 -17.99 15.8 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.261 0.864 . . . . 0.0 115.261 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.732 ' HB2' HD12 ' A' ' 363' ' ' LEU . 4.9 m-20 -105.72 -23.61 12.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.617 1.208 . . . . 0.0 110.649 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.941 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 8.6 t -96.18 25.24 5.02 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.653 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.39 -37.01 64.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.635 0.731 . . . . 0.0 110.467 -170.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.26 161.2 20.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.514 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.584 ' O ' HG13 ' A' ' 375' ' ' VAL . 30.3 m95 -69.41 -36.67 76.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.535 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.5 OUTLIER -64.31 -40.47 95.98 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.531 -174.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.1 t -69.08 -43.11 75.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.65 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.44 -53.44 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.832 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.6 m -57.55 -43.02 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.624 0.726 . . . . 0.0 109.731 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 0.994 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -64.13 -42.75 96.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.272 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.622 ' CG2' HD21 ' A' ' 363' ' ' LEU . 22.8 m -69.32 -37.93 77.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.768 -173.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.664 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -61.33 -34.61 75.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.58 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.698 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 56.9 t80 -75.33 -43.98 47.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.161 0.982 . . . . 0.0 109.414 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.08 -33.01 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.245 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.6 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.42 -34.63 74.23 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 123.141 0.576 . . . . 0.0 111.956 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.8 p -111.05 -23.53 10.87 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -165.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -109.98 25.6 11.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.63 50.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.959 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 64.12 164.39 0.13 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.023 0.439 . . . . 0.0 111.269 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.513 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -130.41 153.67 81.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -99.37 54.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.571 2.847 . . . . 0.0 111.248 165.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.715 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.5 -0.53 0.18 Allowed 'General case' 0 C--O 1.231 0.1 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -69.13 -44.51 72.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.951 0.405 . . . . 0.0 110.571 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 394' ' ' VAL . 27.6 mt-30 -75.01 -26.03 59.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.2 mm? -53.62 -31.71 48.31 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.28 0.945 . . . . 0.0 111.515 -174.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.707 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.45 -56.26 24.42 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.701 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.516 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 51.6 t30 -64.56 -34.47 78.32 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 110.717 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 391' ' ' LEU . 44.9 t -53.55 -53.64 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.645 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.762 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.0 mm -59.15 -48.26 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 175.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.707 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 39.9 mmtt -52.71 -38.47 60.77 Favored 'General case' 0 C--O 1.243 0.748 0 O-C-N 124.185 0.928 . . . . 0.0 112.056 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.57 -45.26 8.73 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.607 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.959 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.1 mt -70.33 -40.68 78.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 117.762 0.781 . . . . 0.0 111.271 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -57.75 -44.0 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.575 0.702 . . . . 0.0 110.028 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.2 t70 -60.38 -36.62 78.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.576 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -91.19 -55.56 3.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.693 ' HG2' HG21 ' A' ' 406' ' ' THR . 3.0 tp10 -106.42 -34.42 7.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.245 0.545 . . . . 0.0 112.289 -172.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 129.97 167.29 12.03 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.511 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.954 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.55 -43.16 96.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -174.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.612 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.62 -51.0 70.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.693 HG21 ' HG2' ' A' ' 402' ' ' GLU . 0.9 OUTLIER -66.03 -48.79 69.96 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.756 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.959 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.96 -39.68 66.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 41.1 t80 -57.06 -47.2 81.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.676 0.75 . . . . 0.0 109.189 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.79 ' O ' ' HG3' ' A' ' 413' ' ' MET . 15.6 m -59.62 -53.0 63.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.008 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.673 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.49 -49.12 78.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.784 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -56.2 -42.47 88.19 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.18 -174.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.647 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.0 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.944 0.372 . . . . 0.0 110.746 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.804 ' HE3' HG21 ' A' ' 375' ' ' VAL . 65.5 mtm -69.57 -48.31 60.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.418 0.628 . . . . 0.0 110.047 175.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.994 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.0 mt -59.61 -37.56 78.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.376 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.797 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -77.76 -16.22 58.56 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.722 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.95 4.02 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.179 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.572 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 50.19 48.49 22.05 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 124.49 1.116 . . . . 0.0 113.91 -177.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.797 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -121.1 65.06 0.86 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 123.419 1.581 . . . . 0.0 107.294 166.01 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.647 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.4 OUTLIER -44.17 -35.06 2.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.52 -2.582 . . . . 0.0 112.984 -164.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 423' ' ' SER . 53.5 mt-30 -54.66 -45.62 73.89 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -165.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.647 HD21 HD21 ' A' ' 418' ' ' ASN . 2.2 pp -62.75 -48.82 77.52 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.02 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.684 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -61.28 -39.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 122.7 1.238 . . . . 0.0 109.04 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.544 ' HB2' ' HD2' ' A' ' 419' ' ' TYR . 31.3 t -60.27 -46.58 89.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.405 -2.18 . . . . 0.0 111.718 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.85 -38.7 75.04 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.656 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.3 mt -71.96 -40.97 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.441 0.638 . . . . 0.0 110.285 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.531 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -57.94 -44.09 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.618 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.662 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -58.23 -31.95 67.86 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 124.826 1.25 . . . . 0.0 109.046 -175.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.427 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -71.98 -13.36 75.82 Favored Glycine 0 C--N 1.301 -1.409 0 CA-C-N 113.0 -1.909 . . . . 0.0 112.595 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.639 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.0 m-85 -102.52 0.15 33.14 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -58.67 138.76 86.25 Favored Pre-proline 0 N--CA 1.408 -2.574 0 CA-C-O 123.752 1.739 . . . . 0.0 113.126 171.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.736 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 57.7 Cg_endo -68.58 -58.13 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.285 1 C-N-CA 126.34 4.694 . . . . 0.0 113.556 -170.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.538 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.51 143.46 18.1 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.96 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.937 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -27.53 69.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.433 0.617 . . . . 0.0 111.857 -173.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.36 -48.72 78.3 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.048 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.4 t -61.17 -36.9 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.617 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.937 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -73.19 -43.16 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -175.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 24.0 m -71.6 -55.61 7.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.923 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.8 83.51 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.81 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.841 HD13 HD22 ' A' ' 460' ' ' LEU . 29.2 mt -65.02 -54.24 33.47 Favored 'General case' 0 CA--C 1.477 -1.836 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.244 178.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.686 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.2 mp0 -52.18 -33.4 40.49 Favored 'General case' 0 N--CA 1.409 -2.515 0 O-C-N 125.21 1.569 . . . . 0.0 110.372 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.683 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -60.07 2.41 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 172.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -75.1 -49.47 19.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.839 -0.538 . . . . 0.0 112.116 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.81 -24.35 64.08 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.629 0.728 . . . . 0.0 111.774 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.741 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.1 t70 -72.8 -43.4 62.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.528 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.683 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.7 mt-30 -69.67 -8.35 46.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 55.6 mm-40 -51.68 154.96 1.77 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 123.148 1.451 . . . . 0.0 114.267 -176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.562 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -52.68 -32.48 17.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 111.444 -2.616 . . . . 0.0 115.409 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.661 ' H ' ' HB ' ' A' ' 451' ' ' THR . 47.5 m-20 -141.88 178.79 7.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.997 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.01 -51.15 67.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -70.77 -23.71 62.46 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 175.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.661 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -59.58 -40.35 87.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 120.011 1.278 . . . . 0.0 109.264 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.602 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 61.8 mtt180 -60.19 -31.25 69.95 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.36 171.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.536 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.36 -28.99 57.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.079 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.4 -43.84 13.29 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.737 -1.119 . . . . 0.0 112.047 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.499 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -103.06 -1.36 29.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.352 -168.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.724 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.6 t80 -48.88 -55.33 12.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.633 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.9 mm -70.32 -25.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.499 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.56 -43.28 63.65 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.543 ' O ' HG23 ' A' ' 463' ' ' VAL . 49.4 m-70 -67.71 -32.06 72.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.541 172.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.841 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -63.12 -53.39 54.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 122.172 0.987 . . . . 0.0 108.895 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -61.99 -31.1 71.44 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.629 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -67.18 -49.5 64.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.503 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.048 HG11 ' HA ' ' A' ' 435' ' ' VAL . 38.5 t -65.95 -34.38 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.8 m-30 -63.1 -14.6 50.42 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.617 169.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 7.4 tp10 -94.44 -52.29 4.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.889 0.852 . . . . 0.0 111.601 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.78 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.0 pt -63.33 -41.47 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.278 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 469' ' ' LEU . 7.2 mt -83.94 -17.78 39.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.779 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.41 50.13 57.24 Favored Glycine 0 C--O 1.218 -0.882 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.159 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 467' ' ' LEU . 0.6 OUTLIER -100.9 172.78 6.83 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.036 0.934 . . . . 0.0 110.275 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.794 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 16.0 p30 -88.7 -44.16 10.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 166.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -162.18 -72.92 0.05 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.776 162.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.736 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -61.33 68.87 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 35.47 43.92 0.57 Allowed Glycine 0 C--N 1.275 -2.824 0 CA-C-N 110.715 -2.948 . . . . 0.0 113.564 173.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.794 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 30.3 mm-40 -82.25 -55.62 4.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 122.578 1.18 . . . . 0.0 111.054 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 44.2 t 69.12 55.04 0.42 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.368 -2.651 . . . . 0.0 108.307 -172.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -49.33 -46.9 19.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 110.584 -3.007 . . . . 0.0 111.544 174.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.518 ' HG2' HD12 ' A' ' 476' ' ' ILE . 28.9 mmm-85 -60.97 152.44 27.77 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.448 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 59.8 mt -60.48 154.32 21.05 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.721 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.434 -1.265 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.523 -178.058 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.478 0.596 0 N-CA-C 111.095 -0.387 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.7 mp -91.76 125.54 44.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.197 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 100.28 -107.6 3.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.911 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 86.4 m -157.07 127.0 6.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.586 0.708 . . . . 0.0 110.976 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 304' ' ' VAL . 1.5 p -70.21 121.62 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.323 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.841 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 54.4 mt -72.86 124.65 90.98 Favored Pre-proline 0 N--CA 1.423 -1.794 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.317 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 60.5 Cg_endo -83.0 53.78 4.52 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 124.969 3.779 . . . . 0.0 109.797 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.77 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 2.8 tp -43.06 -46.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 112.237 -2.256 . . . . 0.0 113.672 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.619 ' HG2' HG23 ' A' ' 307' ' ' ILE . 54.4 mm-40 -65.59 -36.29 83.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.692 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.4 t-160 -61.09 -46.21 91.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.315 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 335' ' ' ILE . 68.6 mt -62.84 -49.61 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 C-N-CA 124.263 1.025 . . . . 0.0 113.254 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.77 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 22.9 mtp180 -59.27 -30.3 68.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 121.888 -0.507 . . . . 0.0 111.259 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 59.5 m -69.59 -32.72 71.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.557 0.694 . . . . 0.0 110.01 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.552 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.21 -40.58 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.022 177.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 331' ' ' ASN . 35.9 p -82.56 -37.53 25.0 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.788 1.28 . . . . 0.0 109.976 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.04 34.09 7.83 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.817 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 35.7 mt-10 53.52 169.42 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.61 ' HG3' HD12 ' A' ' 355' ' ' LEU . 25.4 Cg_exo -44.06 151.39 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.795 2.997 . . . . 0.0 113.621 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.459 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 17.2 Cg_endo -97.97 -108.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 123.356 2.704 . . . . 0.0 112.601 -174.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.421 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 9.6 mmm180 -92.47 -82.02 0.33 Allowed 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.592 0.71 . . . . 0.0 111.277 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.473 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 28.3 m-20 -102.63 158.63 31.39 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.133 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.468 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.1 Cg_exo -59.4 -49.67 10.1 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.654 2.236 . . . . 0.0 110.685 172.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -22.56 12.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.224 -1.807 . . . . 0.0 113.035 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.473 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -85.97 -24.37 26.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.718 HG12 HD11 ' A' ' 355' ' ' LEU . 0.0 OUTLIER -51.21 -40.95 71.95 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.706 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.4 Cg_endo -49.8 -62.22 0.45 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.903 2.402 . . . . 0.0 112.773 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.593 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -59.09 -37.18 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.236 177.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.668 ' CH2' HG21 ' A' ' 354' ' ' ILE . 55.5 t90 -58.35 -36.46 73.48 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.007 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.81 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.85 -49.99 46.97 Favored 'General case' 0 N--CA 1.396 -3.125 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.535 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.08 -24.04 26.63 Favored Glycine 0 C--N 1.311 -0.824 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.151 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.6 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.3 mtt180 -73.99 -41.68 61.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.042 0.925 . . . . 0.0 110.576 174.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.693 ' HB3' HG22 ' A' ' 314' ' ' THR . 56.9 m-20 -95.68 -23.6 16.93 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.82 -169.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.544 ' N ' ' HD2' ' A' ' 333' ' ' PRO . . . -43.5 -48.89 18.5 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.365 1.066 . . . . 0.0 113.727 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 36.1 Cg_endo -60.03 -34.56 94.73 Favored 'Trans proline' 0 CA--C 1.508 -0.796 0 C-N-CA 122.548 2.166 . . . . 0.0 111.539 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.4 -43.56 60.26 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.476 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.65 HG23 HG23 ' A' ' 310' ' ' ILE . 97.1 mt -57.95 -48.24 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.872 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.56 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 31.8 t70 -54.27 -15.48 1.6 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.199 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.43 -51.65 4.83 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 310' ' ' ILE . 91.1 t -59.17 -72.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 123.255 1.502 . . . . 0.0 109.998 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.841 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.4 OUTLIER -87.98 121.07 70.87 Favored Pre-proline 0 N--CA 1.405 -2.69 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.685 -176.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.605 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.3 Cg_endo -72.92 -20.76 21.81 Favored 'Trans proline' 0 CA--C 1.496 -1.422 0 C-N-CA 123.736 2.957 . . . . 0.0 110.362 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.629 HG22 ' CD2' ' A' ' 339' ' ' PHE . 2.7 t 46.07 61.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 111.715 -2.493 . . . . 0.0 109.92 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.626 ' N ' HD12 ' A' ' 346' ' ' LEU . 35.9 p -75.85 5.56 6.24 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.914 -172.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.758 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -141.89 159.28 59.98 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.538 ' O ' ' HB2' ' A' ' 347' ' ' ARG . 56.2 Cg_exo -61.81 -44.3 21.7 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 123.924 3.083 . . . . 0.0 108.994 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.692 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -50.07 -44.17 51.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.037 -1.892 . . . . 0.0 111.523 175.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.819 ' O ' HG13 ' A' ' 350' ' ' ILE . 14.9 mt -59.21 -52.25 66.47 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.546 ' HD3' HG11 ' A' ' 341' ' ' VAL . 11.5 mmt180 -45.3 -52.44 9.71 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 125.249 1.593 . . . . 0.0 110.66 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.928 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -65.66 -49.2 69.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.713 -175.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.672 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 69.7 mtt180 -61.56 -39.31 90.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.888 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.6 mt -57.31 -55.43 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.788 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.351 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.659 ' O ' HD22 ' A' ' 355' ' ' LEU . 20.1 mt -57.65 -53.34 45.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 O-C-N 124.764 1.29 . . . . 0.0 110.736 -170.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 11.7 m-20 -63.14 -36.46 83.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.211 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . 0.658 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -71.46 -30.61 66.21 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.173 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.888 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.2 mm -56.04 -58.09 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 CA-C-O 122.797 1.284 . . . . 0.0 110.312 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.718 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.99 -26.77 54.27 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.086 -2.325 . . . . 0.0 109.726 -168.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 73.69 -71.47 1.34 Allowed Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.93 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -113.21 37.88 3.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.941 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.724 HD22 ' HB2' ' A' ' 361' ' ' LEU . 20.2 p-10 -66.99 133.61 50.3 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.042 0.448 . . . . 0.0 110.563 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.663 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.1 mp -51.01 -77.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 124.409 1.084 . . . . 0.0 112.871 -169.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -124.92 7.0 8.26 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.492 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.724 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.6 mt -72.39 -4.63 31.19 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.67 0.748 . . . . 0.0 109.655 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.601 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 23.1 t -63.84 76.95 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.332 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.739 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -62.55 173.48 1.24 Allowed 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.7 p -122.05 156.39 59.89 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.896 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.928 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 6.7 Cg_endo -56.76 -3.54 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.856 2.37 . . . . 0.0 114.286 -172.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.477 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -104.59 -12.05 29.42 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.739 ' HB2' HD12 ' A' ' 363' ' ' LEU . 16.1 m-20 -109.25 -20.39 12.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.023 0.916 . . . . 0.0 110.853 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 17.1 p -96.75 15.21 22.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.0 -1.455 . . . . 0.0 111.117 -164.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' A' ' 344' ' ' PRO . 1.3 mt -58.75 -40.98 85.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.879 -161.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.88 163.15 16.98 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.223 170.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.573 ' O ' HG13 ' A' ' 375' ' ' VAL . 41.3 m95 -68.81 -35.74 77.38 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.547 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.2 p30 -62.73 -40.2 96.45 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.875 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.7 m -71.39 -41.04 70.14 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.066 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.568 ' HB1' HD13 ' A' ' 351' ' ' ILE . . . -66.53 -52.19 48.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.81 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.8 m -56.38 -45.36 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.377 0.608 . . . . 0.0 109.86 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.043 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.93 -42.37 93.81 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.105 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.632 ' CG2' HD21 ' A' ' 363' ' ' LEU . 19.6 m -70.81 -36.86 73.15 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.232 -172.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -62.99 -33.32 75.15 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.425 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.706 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.1 t80 -75.6 -44.5 42.63 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.433 1.111 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.45 -33.22 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.503 169.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.6 mpt_? -60.67 -41.69 95.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.168 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 28.7 p -99.91 -22.99 15.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.123 -168.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.591 ' HB3' HE22 ' A' ' 390' ' ' GLN . 36.6 m80 -111.14 22.64 15.01 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.21 20.9 16.97 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.422 HG23 HG13 ' A' ' 380' ' ' ILE . 2.7 m 66.96 159.87 0.14 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.265 0.533 . . . . 0.0 111.519 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -127.93 156.06 76.65 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -97.95 54.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.46 2.773 . . . . 0.0 111.643 168.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.756 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.28 -1.27 0.14 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -69.79 -46.12 66.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.143 0.497 . . . . 0.0 110.938 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.633 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.6 mt-30 -74.7 -25.59 59.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -53.87 -30.62 46.55 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.772 0.715 . . . . 0.0 111.283 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.667 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.47 -50.23 57.64 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.509 174.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.565 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 5.7 m-20 -67.89 -40.56 83.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.852 0.461 . . . . 0.0 111.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.14 -44.12 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.003 0.43 . . . . 0.0 110.438 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.703 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -58.35 -47.12 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.18 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.684 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 32.3 mmtt -53.07 -41.39 64.83 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.097 0.873 . . . . 0.0 111.897 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -76.75 -44.64 14.66 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.025 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.879 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -69.96 -40.81 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 117.302 0.551 . . . . 0.0 111.767 -178.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.871 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.0 m -57.75 -43.47 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.745 0.783 . . . . 0.0 109.721 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.48 ' N ' HG23 ' A' ' 399' ' ' VAL . 17.6 t70 -56.15 -43.7 78.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.252 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 33.1 mm-40 -84.1 -54.27 4.95 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.47 -172.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -110.58 -29.34 8.09 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.516 0.674 . . . . 0.0 112.535 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.78 171.38 14.04 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.688 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.871 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.3 OUTLIER -64.3 -44.42 97.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.672 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.18 -51.05 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.927 0.394 . . . . 0.0 112.005 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.595 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.2 m -64.18 -51.2 64.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.553 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.879 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.55 -43.15 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 30.3 t80 -55.58 -46.32 77.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.686 0.755 . . . . 0.0 109.197 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.831 ' O ' ' HG3' ' A' ' 413' ' ' MET . 13.0 m -57.92 -52.68 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.353 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.674 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -60.66 -48.74 80.45 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.537 ' HA3' HD11 ' A' ' 395' ' ' ILE . . . -56.32 -42.62 89.13 Favored Glycine 0 C--N 1.313 -0.724 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.003 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.861 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -72.71 -32.52 65.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.823 0.311 . . . . 0.0 110.833 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.831 ' HG3' ' O ' ' A' ' 409' ' ' THR . 62.5 mtm -69.36 -46.6 66.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.326 0.584 . . . . 0.0 110.09 174.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.043 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.16 -39.17 85.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.74 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.765 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.5 OUTLIER -77.1 -16.87 59.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.057 -178.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.84 47.01 3.78 Favored Glycine 0 C--N 1.308 -1.018 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.024 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.687 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 0.0 OUTLIER 49.71 48.69 21.24 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.521 1.128 . . . . 0.0 113.892 -177.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.765 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -123.57 66.0 1.01 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.861 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 14.4 p90 -51.48 -31.84 25.02 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 111.814 -2.448 . . . . 0.0 111.701 -161.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 34.1 mt-30 -53.89 -43.25 69.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.596 -165.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.657 HD21 ' ND2' ' A' ' 418' ' ' ASN . 2.0 pp -63.06 -48.1 80.1 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.329 0.585 . . . . 0.0 110.855 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.754 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -62.31 -38.97 82.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.588 1.185 . . . . 0.0 109.101 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 30.7 t -59.64 -45.95 90.45 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.301 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.47 87.27 Favored Glycine 0 C--N 1.316 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.844 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.1 mt -71.09 -41.31 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.501 HD13 HG23 ' A' ' 395' ' ' ILE . 1.6 mm -56.43 -43.98 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.285 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.676 ' HD2' ' O ' ' A' ' 427' ' ' ARG . 1.8 tmm_? -56.97 -35.38 69.08 Favored 'General case' 0 N--CA 1.406 -2.647 0 C-N-CA 124.962 1.305 . . . . 0.0 109.837 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.74 -13.12 74.93 Favored Glycine 0 C--N 1.29 -1.985 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.948 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 11.5 m-85 -100.08 -3.64 31.49 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -59.24 142.96 85.71 Favored Pre-proline 0 N--CA 1.412 -2.329 0 CA-C-O 123.438 1.59 . . . . 0.0 112.875 173.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.781 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 88.5 Cg_endo -72.23 -53.25 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.083 4.522 . . . . 0.0 113.338 -170.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -120.94 140.33 14.08 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.894 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -63.19 -26.53 68.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.164 0.482 . . . . 0.0 111.776 -175.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.683 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.2 -48.46 78.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.018 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.4 t -58.44 -51.89 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.705 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.8 OUTLIER -54.87 -51.43 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 118.096 0.407 . . . . 0.0 109.945 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.447 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 86.4 m -62.67 -57.33 11.39 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 442' ' ' ARG . . . -56.14 -44.76 79.54 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.368 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.85 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.0 mt -59.72 -53.71 54.83 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.73 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.708 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 39.1 mm-40 -51.5 -35.14 39.05 Favored 'General case' 0 N--CA 1.417 -2.123 0 O-C-N 124.899 1.374 . . . . 0.0 110.669 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.624 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.32 -60.37 2.28 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 176.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.74 -51.71 10.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.378 0.535 . . . . 0.0 112.385 -172.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.74 -25.46 63.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.522 0.677 . . . . 0.0 111.575 -177.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.777 ' N ' HD23 ' A' ' 443' ' ' LEU . 10.7 t70 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.657 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 34.6 mt-30 -71.56 -6.85 43.8 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.471 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 25.2 mm-40 -51.86 161.25 0.58 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 123.662 1.696 . . . . 0.0 114.614 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.516 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -56.99 -33.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 110.443 -3.071 . . . . 0.0 115.199 -172.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.683 ' H ' ' HB ' ' A' ' 451' ' ' THR . 66.4 m-20 -138.96 179.99 6.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.441 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 8.9 p-10 -64.43 -55.32 21.67 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -68.28 -23.52 64.77 Favored 'General case' 0 N--CA 1.402 -2.868 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 176.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.683 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 25.4 m -58.82 -41.51 87.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.756 1.162 . . . . 0.0 109.677 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 48.2 mtt180 -60.16 -30.0 69.04 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.201 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.591 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.03 -33.64 59.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 109.877 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.02 -42.83 31.23 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.333 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 38.3 p -101.34 -4.18 27.46 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.375 -169.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.705 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.4 t80 -49.25 -52.82 24.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.846 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 405' ' ' ALA . 22.9 mm -71.75 -27.01 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -72.56 -42.45 64.65 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.583 ' O ' HG23 ' A' ' 463' ' ' VAL . 25.9 m80 -67.6 -31.17 71.03 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.473 -1.694 . . . . 0.0 109.96 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.77 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.41 -54.05 34.32 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 122.188 0.994 . . . . 0.0 109.165 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.733 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -62.26 -32.31 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.034 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.68 -53.27 58.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.922 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.018 HG11 ' HA ' ' A' ' 435' ' ' VAL . 25.9 t -63.45 -34.27 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-O 121.806 0.812 . . . . 0.0 110.287 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.607 ' HD1' HD12 ' A' ' 469' ' ' LEU . 20.2 m-30 -60.93 -14.39 22.22 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.191 169.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.733 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 45.0 mt-10 -93.81 -48.37 6.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.824 -1.173 . . . . 0.0 112.652 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.712 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.4 pt -64.6 -39.94 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.049 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.841 HD12 HD11 ' A' ' 469' ' ' LEU . 7.3 mt -84.46 -16.84 41.11 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.802 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.02 51.05 56.49 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 111.73 -2.486 . . . . 0.0 113.219 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.841 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -101.28 177.4 4.94 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.13 0.972 . . . . 0.0 109.88 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.694 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.5 p30 -96.46 -44.11 7.33 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -157.39 -74.61 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.457 -2.156 . . . . 0.0 110.351 160.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.781 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -59.01 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -172.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.96 42.69 0.37 Allowed Glycine 0 C--N 1.275 -2.854 0 CA-C-N 111.423 -2.626 . . . . 0.0 113.613 173.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.694 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 31.2 mm-40 -81.32 -51.99 7.78 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 122.79 1.281 . . . . 0.0 111.453 -172.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.4 t 68.91 61.47 0.33 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.171 -2.74 . . . . 0.0 109.037 -173.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.802 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -53.44 -48.36 57.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 110.923 -2.853 . . . . 0.0 111.463 175.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -55.31 132.97 49.21 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.009 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.593 HD22 ' H ' ' A' ' 478' ' ' LEU . 2.9 mm? -61.86 -28.9 69.82 Favored 'General case' 0 N--CA 1.418 -2.054 0 C-N-CA 124.515 1.126 . . . . 0.0 112.557 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 . . . . . 0 N--CA 1.436 -1.161 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.169 -179.8 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo . . . . . 0 N--CA 1.479 0.665 0 N-CA-C 110.309 -0.689 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.6 mp -85.08 -56.99 4.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.863 0.363 . . . . 0.0 110.171 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -140.03 55.17 0.64 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.559 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.553 ' HB ' HD11 ' A' ' 346' ' ' LEU . 28.5 m 73.3 116.18 0.05 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.364 1.078 . . . . 0.0 111.926 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.2 p -75.69 131.25 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.043 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.768 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 31.9 mt -78.74 125.56 84.02 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-O 121.89 0.852 . . . . 0.0 111.878 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 308' ' ' GLN . 26.0 Cg_endo -74.97 -12.04 21.57 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.99 3.793 . . . . 0.0 111.663 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.71 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.1 tp 30.31 -64.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 O-C-N 126.973 2.671 . . . . 0.0 115.996 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.709 ' HG2' HG23 ' A' ' 307' ' ' ILE . 66.6 mm-40 -58.24 -33.24 69.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.466 0.65 . . . . 0.0 110.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.543 ' CD2' HG22 ' A' ' 338' ' ' VAL . 5.7 t-160 -61.42 -48.83 79.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.646 172.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 307' ' ' ILE . 64.2 mt -59.06 -48.38 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 124.111 0.965 . . . . 0.0 112.51 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.5 mtp-105 -58.33 -30.83 67.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 122.613 0.365 . . . . 0.0 111.456 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.7 m -69.92 -33.22 71.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.573 0.701 . . . . 0.0 109.882 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.51 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -68.15 -40.49 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.785 178.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.659 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.22 -36.7 26.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.646 1.212 . . . . 0.0 110.024 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.26 34.72 7.91 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 112.387 -2.188 . . . . 0.0 111.107 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 45.9 mt-10 56.77 165.81 0.07 OUTLIER Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.666 ' HG3' HD12 ' A' ' 355' ' ' LEU . 43.0 Cg_exo -44.97 147.31 2.03 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.517 2.812 . . . . 0.0 113.032 175.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 39.6 Cg_endo -93.16 -104.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.358 2.705 . . . . 0.0 112.169 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.413 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 10.8 mmt180 -95.92 -85.21 0.33 Allowed 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 121.259 0.552 . . . . 0.0 111.113 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 16.5 m-20 -97.37 164.46 17.64 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.733 -175.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 -49.39 10.92 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.655 2.237 . . . . 0.0 110.546 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.411 ' HD3' ' H ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -56.55 -13.96 2.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.309 -1.768 . . . . 0.0 113.401 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 14.9 mt-10 -90.52 -29.2 18.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.374 -0.204 . . . . 0.0 111.201 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.746 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -49.7 -42.87 70.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.715 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.8 Cg_endo -47.65 -63.74 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.097 2.531 . . . . 0.0 113.05 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.599 HG13 ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.97 -36.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.428 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.659 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 44.7 t90 -57.82 -36.08 71.74 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.83 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.822 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.55 -49.74 44.83 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.435 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.78 -23.74 23.17 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.804 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.595 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -74.35 -42.19 59.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.947 0.88 . . . . 0.0 110.948 173.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.658 ' HB3' HG22 ' A' ' 314' ' ' THR . 52.6 m-20 -94.78 -24.05 17.26 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.492 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.43 -49.65 12.38 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.8 Cg_endo -61.66 -32.9 87.19 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.564 2.176 . . . . 0.0 111.662 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.75 -44.43 56.22 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.305 -1.77 . . . . 0.0 109.547 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 332' ' ' ALA . 93.6 mt -56.11 -47.74 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.934 173.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.0 -13.96 2.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.6 -1.636 . . . . 0.0 112.327 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.59 -51.15 4.7 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.529 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.587 HG11 HG13 ' A' ' 310' ' ' ILE . 83.2 t -58.68 -71.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 123.351 1.548 . . . . 0.0 109.743 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.768 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -85.29 123.64 72.88 Favored Pre-proline 0 N--CA 1.402 -2.853 0 CA-C-N 111.261 -2.7 . . . . 0.0 111.953 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.726 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.5 Cg_endo -72.36 -17.1 27.52 Favored 'Trans proline' 0 CA--C 1.494 -1.485 0 C-N-CA 124.163 3.242 . . . . 0.0 110.543 175.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.5 p 33.29 69.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 111.907 -2.406 . . . . 0.0 110.088 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.585 ' N ' HD12 ' A' ' 346' ' ' LEU . 62.4 p -80.72 6.06 13.92 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 112.776 -2.011 . . . . 0.0 112.844 -170.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.787 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 14.7 p -143.06 160.71 51.62 Favored Pre-proline 0 N--CA 1.434 -1.233 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.68 ' HB3' HD12 ' A' ' 369' ' ' LEU . 50.6 Cg_exo -62.62 -45.05 15.11 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.591 2.861 . . . . 0.0 108.739 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.653 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -44.78 -52.24 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.784 175.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.787 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.6 mt -56.72 -51.55 68.41 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.852 ' HA ' HD12 ' A' ' 350' ' ' ILE . 17.7 ttm-85 -49.79 -47.84 50.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.595 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 1.084 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -68.15 -48.07 66.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.472 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.653 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 53.7 mtt180 -60.25 -37.77 81.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.113 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.883 ' O ' HG12 ' A' ' 354' ' ' ILE . 30.4 mt -56.87 -52.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.572 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.655 HG12 HD11 ' A' ' 328' ' ' LEU . 21.1 mt -58.56 -53.38 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.905 0.86 . . . . 0.0 111.248 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.564 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 18.6 m-20 -63.13 -36.2 82.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.987 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.89 -29.5 65.61 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.79 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.883 HG12 ' O ' ' A' ' 350' ' ' ILE . 3.5 mm -57.14 -60.13 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.052 1.406 . . . . 0.0 110.067 173.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.746 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -74.55 -27.53 60.56 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 111.961 -2.381 . . . . 0.0 109.883 -167.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.98 -71.68 0.29 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.941 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -111.68 54.05 0.56 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.303 -0.475 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.731 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -84.93 133.28 34.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -47.84 -73.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 124.042 0.937 . . . . 0.0 112.664 -170.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -130.94 8.27 5.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.192 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.731 ' HB2' HD22 ' A' ' 358' ' ' ASN . 3.6 mt -69.98 -5.08 23.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.587 0.708 . . . . 0.0 110.127 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.564 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 25.2 t -59.12 82.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.393 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.749 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.8 OUTLIER -65.55 178.38 1.0 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.791 177.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.7 p -122.02 153.94 61.09 Favored Pre-proline 0 N--CA 1.437 -1.088 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.926 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 3.2 Cg_exo -53.94 -11.14 2.26 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.007 2.472 . . . . 0.0 113.107 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -111.29 -2.19 27.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.749 ' HB2' HD12 ' A' ' 363' ' ' LEU . 19.4 m-20 -106.32 -21.62 13.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.741 1.27 . . . . 0.0 110.542 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 1.084 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 34.8 t -98.24 25.29 6.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.597 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -54.57 -34.3 61.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.127 0.965 . . . . 0.0 109.806 -173.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.42 159.04 24.99 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.869 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.636 ' O ' HG13 ' A' ' 375' ' ' VAL . 46.4 m95 -68.91 -35.71 77.15 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.602 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -59.54 -46.85 87.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.126 -176.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 62.4 m -67.29 -41.9 84.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.111 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.607 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.48 63.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.822 HG12 ' HB3' ' A' ' 328' ' ' LEU . 14.4 m -57.87 -44.43 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.588 0.709 . . . . 0.0 109.603 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.0 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.46 -41.08 96.68 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.102 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.671 HG21 HD11 ' A' ' 363' ' ' LEU . 22.4 m -71.47 -39.14 71.12 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.619 -173.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -61.58 -33.45 73.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.31 0.576 . . . . 0.0 110.328 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.715 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 41.6 t80 -73.08 -47.16 46.97 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.211 1.005 . . . . 0.0 109.489 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.45 -32.77 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 113.14 -1.845 . . . . 0.0 111.796 169.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.26 -32.72 71.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 123.014 0.525 . . . . 0.0 111.564 175.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 30.0 p -109.01 -23.65 11.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.388 -167.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -110.52 22.51 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.23 17.91 33.15 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 114.47 0.548 . . . . 0.0 114.47 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.444 HG23 HG13 ' A' ' 380' ' ' ILE . 2.0 m 66.2 160.41 0.14 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.232 0.539 . . . . 0.0 111.374 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.557 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -128.2 155.67 77.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -101.88 63.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.972 3.115 . . . . 0.0 111.216 164.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.73 ' HA ' HD23 ' A' ' 391' ' ' LEU . 3.4 mmt 53.01 5.55 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -70.32 -48.2 57.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.247 0.546 . . . . 0.0 111.173 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.614 ' O ' HG13 ' A' ' 394' ' ' VAL . 78.1 mt-30 -75.61 -28.69 58.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.872 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -54.62 -31.28 57.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.61 0.641 . . . . 0.0 112.157 -170.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.894 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.42 -51.93 48.22 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.862 -1.161 . . . . 0.0 110.543 173.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.585 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 8.8 m-20 -68.56 -38.21 80.57 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 122.95 0.5 . . . . 0.0 112.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 398' ' ' ILE . 1.6 m -58.16 -44.72 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 399' ' ' VAL . 9.5 mm -58.47 -48.35 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.214 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.2 mmtt -52.8 -40.27 63.11 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 124.051 0.845 . . . . 0.0 112.031 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.94 -44.88 13.0 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.926 -173.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.872 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.3 mt -69.65 -41.9 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 117.33 0.565 . . . . 0.0 111.686 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.899 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.3 m -57.28 -45.21 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.609 0.719 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.9 t70 -60.85 -37.16 81.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.193 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 27.1 mt-30 -88.31 -52.67 5.08 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.557 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -113.26 -30.67 6.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.963 -167.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.69 164.5 11.65 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.754 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.899 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.4 OUTLIER -64.04 -42.54 96.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -175.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.602 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -58.12 -50.32 73.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.791 0.329 . . . . 0.0 111.511 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.595 HG21 ' HD2' ' A' ' 330' ' ' ARG . 0.9 OUTLIER -62.31 -52.41 63.8 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.872 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -42.67 66.18 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.568 ' HB3' HD11 ' A' ' 457' ' ' ILE . 39.1 t80 -56.15 -47.08 78.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.567 0.699 . . . . 0.0 109.226 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.823 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.3 m -58.86 -53.01 63.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.743 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.695 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.67 -49.23 78.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.783 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.08 -43.05 88.47 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.042 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.63 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.03 -31.37 66.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.773 0.287 . . . . 0.0 111.158 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.823 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.2 mtm -70.92 -46.53 62.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.669 0.747 . . . . 0.0 109.599 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.0 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.78 -42.0 92.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.066 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.872 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 74.8 m -78.76 2.48 19.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.34 53.86 9.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.363 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.63 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.4 mp0 46.01 56.98 5.55 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.85 0.86 . . . . 0.0 112.926 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.854 HD22 HD22 ' A' ' 421' ' ' LEU . 48.1 t30 -122.47 65.63 0.94 Allowed 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 162.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.579 ' O ' HG22 ' A' ' 422' ' ' VAL . 0.3 OUTLIER -48.79 -36.28 16.27 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.594 -173.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' A' ' 423' ' ' SER . 45.0 mt-30 -57.08 -50.58 72.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -168.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.854 HD22 HD22 ' A' ' 418' ' ' ASN . 0.2 OUTLIER -59.37 -50.43 73.98 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.365 -178.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.811 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.35 -38.27 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 122.675 1.226 . . . . 0.0 109.233 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 19.2 t -59.94 -49.63 76.94 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.299 -2.228 . . . . 0.0 111.585 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.69 -36.13 77.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.375 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.894 HD13 ' HA2' ' A' ' 392' ' ' GLY . 4.3 mt -72.51 -39.72 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.627 0.727 . . . . 0.0 110.112 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 404' ' ' VAL . 1.7 mm -62.76 -41.63 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.569 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.615 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -57.18 -34.4 68.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 125.916 1.686 . . . . 0.0 108.64 -178.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -73.01 -11.57 78.92 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.725 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.638 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.9 m-85 -105.52 -0.27 26.0 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.7 mm? -58.01 141.35 81.35 Favored Pre-proline 0 N--CA 1.412 -2.328 0 CA-C-O 123.566 1.65 . . . . 0.0 113.411 172.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.755 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 57.6 Cg_endo -70.04 -60.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 1 C-N-CA 126.444 4.763 . . . . 0.0 113.43 -170.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -110.09 141.45 16.23 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.897 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -59.58 -30.07 68.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.361 0.58 . . . . 0.0 111.831 -174.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.824 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.05 -48.96 77.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.009 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.6 t -62.86 -35.6 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.524 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.897 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -72.14 -46.63 57.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 38.4 m -72.65 -54.21 9.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.337 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.53 -46.16 80.76 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.342 0.401 . . . . 0.0 111.348 -174.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.818 HD13 HD22 ' A' ' 460' ' ' LEU . 17.7 mt -60.92 -54.2 47.97 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.71 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.684 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.77 -33.6 35.94 Favored 'General case' 0 N--CA 1.407 -2.596 0 O-C-N 125.709 1.881 . . . . 0.0 110.64 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.66 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.44 -59.86 2.52 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -47.53 27.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.581 0.628 . . . . 0.0 111.66 -173.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 444' ' ' ASP . 0.1 OUTLIER -59.23 -25.24 63.85 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 111.427 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.773 ' N ' HD23 ' A' ' 443' ' ' LEU . 13.4 t70 -73.94 -42.2 60.9 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.795 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.66 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 40.9 mt-30 -70.65 -9.74 57.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -172.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.59 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 38.4 mm-40 -50.28 157.73 0.65 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 123.361 1.553 . . . . 0.0 115.094 -174.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.589 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.27 -32.41 19.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 110.937 -2.847 . . . . 0.0 115.408 -170.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.652 ' H ' ' HB ' ' A' ' 451' ' ' THR . 9.2 m-20 -140.93 178.64 7.22 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.4 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 2.3 m-20 -62.56 -54.51 38.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -66.78 -24.27 66.17 Favored 'General case' 0 N--CA 1.404 -2.736 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 176.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.652 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.5 m -59.45 -40.96 88.55 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 119.992 1.269 . . . . 0.0 109.388 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.59 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 67.0 mtt180 -61.82 -29.29 70.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.304 172.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.492 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -31.73 60.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.041 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -86.05 -42.98 13.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.47 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.502 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.4 p -101.88 -0.94 33.19 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.723 -170.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.652 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.1 t80 -49.29 -55.96 11.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.003 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.621 ' HA ' ' HB2' ' A' ' 460' ' ' LEU . 24.6 mm -70.05 -24.73 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.502 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.72 -44.66 61.42 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.542 ' O ' HG23 ' A' ' 463' ' ' VAL . 47.3 m-70 -65.49 -32.02 73.4 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.15 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.818 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.54 -53.82 41.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.209 1.004 . . . . 0.0 109.263 -178.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -61.96 -30.42 70.91 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.187 -1.824 . . . . 0.0 110.74 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.76 -48.48 66.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.009 HG11 ' HA ' ' A' ' 435' ' ' VAL . 42.2 t -66.76 -34.71 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.489 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.546 ' OH ' HG13 ' A' ' 404' ' ' VAL . 19.2 m-30 -62.21 -13.96 33.09 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.617 167.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.573 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 4.8 tp10 -93.41 -52.94 4.28 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.414 -0.804 . . . . 0.0 112.242 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.739 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.3 pt -62.07 -41.73 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.132 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.4 mt -84.14 -17.34 40.39 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.732 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.63 49.87 57.51 Favored Glycine 0 C--O 1.219 -0.801 0 CA-C-N 111.515 -2.584 . . . . 0.0 113.223 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -102.68 -179.17 3.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 123.861 0.864 . . . . 0.0 110.402 -178.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.643 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.0 p30 -100.82 -40.6 7.23 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -160.73 -76.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 112.418 -2.174 . . . . 0.0 111.121 160.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.755 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -64.32 67.81 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 41.04 39.84 2.16 Favored Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.425 -2.625 . . . . 0.0 113.361 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.643 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 9.9 mm-40 -79.19 -51.87 8.92 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.529 1.157 . . . . 0.0 111.324 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.6 t 64.7 61.44 0.82 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 111.806 -2.452 . . . . 0.0 109.24 -172.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.6 OUTLIER -56.08 -49.77 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 110.391 -3.095 . . . . 0.0 111.49 171.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.564 ' HB2' HD12 ' A' ' 476' ' ' ILE . 0.0 OUTLIER -78.1 -153.62 0.06 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.083 -1.872 . . . . 0.0 112.935 -170.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 53.5 mt -55.1 163.87 0.98 Allowed 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.57 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 N--CA 1.435 -1.213 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.381 177.465 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 110.286 -0.698 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.2 mp -80.88 -63.73 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -129.92 -89.25 0.54 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.979 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.531 ' HB ' HD11 ' A' ' 346' ' ' LEU . 63.6 m -154.91 118.48 4.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.663 0.744 . . . . 0.0 110.922 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.0 p -65.98 125.63 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.582 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.81 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 33.4 mt -74.1 125.57 89.99 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-O 122.222 1.011 . . . . 0.0 112.221 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 308' ' ' GLN . 29.4 Cg_endo -74.58 -16.99 21.07 Favored 'Trans proline' 0 CA--C 1.503 -1.042 0 C-N-CA 124.954 3.77 . . . . 0.0 111.193 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.736 HG23 ' HG2' ' A' ' 308' ' ' GLN . 4.3 tp 36.82 -64.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 C-N-CA 128.225 2.61 . . . . 0.0 115.881 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.736 ' HG2' HG23 ' A' ' 307' ' ' ILE . 62.1 mm-40 -58.58 -34.03 70.62 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.561 0.696 . . . . 0.0 110.344 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.566 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.04 -47.99 83.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.927 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 335' ' ' ILE . 67.6 mt -61.75 -49.22 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 124.253 1.021 . . . . 0.0 112.624 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 0.9 OUTLIER -58.26 -31.4 67.39 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 122.697 0.399 . . . . 0.0 111.369 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 27.5 t -69.88 -33.34 72.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.533 0.682 . . . . 0.0 109.664 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.563 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.82 -41.02 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.659 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 331' ' ' ASN . 35.5 p -82.91 -35.89 25.75 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.733 1.254 . . . . 0.0 110.206 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.27 32.06 12.85 Favored Glycine 0 C--N 1.302 -1.342 0 CA-C-N 112.305 -2.225 . . . . 0.0 110.696 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.4 mt-10 51.79 172.86 0.03 OUTLIER Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 324' ' ' ILE . 71.8 Cg_exo -48.15 149.46 6.05 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.994 2.462 . . . . 0.0 113.687 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.48 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 16.3 Cg_endo -97.62 -106.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.992 3.128 . . . . 0.0 113.183 -171.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.466 ' H ' ' HG2' ' A' ' 319' ' ' ARG . 2.9 mmm180 -88.91 -78.37 0.35 Allowed 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 123.239 0.616 . . . . 0.0 110.506 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.493 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.9 m-20 -108.88 160.69 26.44 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.067 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.3 Cg_exo -60.13 -48.17 12.85 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 122.544 2.163 . . . . 0.0 110.107 168.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.457 ' HA ' HG21 ' A' ' 382' ' ' THR . 1.9 mmt180 -46.83 -26.19 0.92 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.851 -1.977 . . . . 0.0 112.743 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.493 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.8 mm-40 -93.52 -22.0 19.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.701 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.1 OUTLIER -47.71 -42.48 45.4 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.748 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.3 Cg_endo -46.38 -64.8 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.185 2.59 . . . . 0.0 113.009 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.606 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.21 -37.02 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.209 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.72 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 54.5 t90 -58.55 -36.44 73.92 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.139 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.815 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.94 -49.96 46.73 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.512 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -54.22 -23.65 26.2 Favored Glycine 0 C--N 1.311 -0.817 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.156 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 1.7 mtt180 -73.6 -41.73 62.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.128 0.966 . . . . 0.0 110.598 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.725 ' HB3' HG22 ' A' ' 314' ' ' THR . 55.9 m-20 -97.57 -22.7 16.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.023 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.566 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -43.3 -48.65 16.83 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.2 Cg_endo -61.02 -33.67 91.67 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 122.584 2.19 . . . . 0.0 111.606 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.406 ' CB ' HG13 ' A' ' 313' ' ' VAL . . . -73.26 -42.73 62.17 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.559 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 310' ' ' ILE . 98.6 mt -57.79 -49.3 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.055 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 27.3 t70 -53.43 -17.57 2.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.501 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.36 -51.24 5.75 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.024 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.66 HG11 HG13 ' A' ' 310' ' ' ILE . 85.3 t -58.24 -71.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-O 123.354 1.55 . . . . 0.0 110.205 170.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.81 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -87.63 124.43 67.62 Favored Pre-proline 0 N--CA 1.406 -2.675 0 CA-C-N 111.288 -2.687 . . . . 0.0 111.863 -175.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.695 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 65.5 Cg_endo -72.57 -19.24 24.88 Favored 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 123.809 3.006 . . . . 0.0 110.41 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.4 p 33.35 70.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 111.849 -2.432 . . . . 0.0 110.233 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 346' ' ' LEU . 63.4 p -80.83 3.78 21.39 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.749 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.789 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 28.2 p -141.78 154.54 65.9 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -60.15 -36.79 87.47 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 124.323 3.349 . . . . 0.0 109.563 171.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.634 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.7 -53.41 39.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.602 172.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.789 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.8 mt -56.73 -54.76 42.49 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.027 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.617 ' HD2' ' O ' ' A' ' 368' ' ' CYS . 33.3 ttm105 -50.26 -41.17 49.99 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 125.511 1.757 . . . . 0.0 110.61 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.513 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 52.1 t -67.76 -48.94 64.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.666 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.6 mtt180 -61.11 -38.3 85.85 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.598 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.901 ' O ' HG12 ' A' ' 354' ' ' ILE . 1.1 mt -57.14 -54.63 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 C-N-CA 120.254 -0.579 . . . . 0.0 111.528 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.642 ' O ' HD22 ' A' ' 355' ' ' LEU . 14.9 mt -56.98 -54.39 30.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 124.566 1.166 . . . . 0.0 110.812 -171.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.589 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 37.0 m-20 -64.66 -34.57 78.6 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.288 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.12 67.56 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.94 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.901 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.5 mm -56.7 -58.35 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-O 122.821 1.296 . . . . 0.0 110.539 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.701 ' CD1' HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -76.35 -26.71 55.98 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.007 -2.36 . . . . 0.0 109.871 -168.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.28 -68.84 0.68 Allowed Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.763 -1.562 . . . . 0.0 113.611 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -114.92 35.62 4.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.932 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.767 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.0 p-10 -66.95 127.61 33.22 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.047 0.451 . . . . 0.0 110.794 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.668 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -49.0 -70.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.985 -169.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -127.67 5.17 7.05 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.443 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.767 ' HB2' HD22 ' A' ' 358' ' ' ASN . 4.4 mt -72.68 -3.59 25.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.557 0.694 . . . . 0.0 110.199 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.589 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 11.3 t -62.29 83.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.843 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.819 HD11 HG21 ' A' ' 377' ' ' THR . 1.7 mm? -62.7 -174.24 0.06 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.905 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 63.8 p -125.11 157.41 67.21 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 23.4 Cg_exo -49.14 -31.63 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.839 1.693 . . . . 0.0 111.072 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -87.4 -3.78 81.27 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.961 -172.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.754 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.4 m-20 -104.88 -21.0 13.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.223 1.011 . . . . 0.0 109.274 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 65.1 m -86.14 23.69 1.48 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.402 -171.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.86 -36.29 72.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.045 0.926 . . . . 0.0 109.835 -174.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.88 162.43 26.72 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.392 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.612 ' O ' HG13 ' A' ' 375' ' ' VAL . 41.8 m95 -70.62 -36.65 73.59 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.588 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.15 -39.93 83.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.911 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 75.3 p -73.41 -43.69 59.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.29 -52.38 63.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.836 HG21 ' HE3' ' A' ' 413' ' ' MET . 14.0 m -57.28 -44.08 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.611 0.719 . . . . 0.0 109.548 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 0.998 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.08 -44.14 97.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.041 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.819 HG21 HD11 ' A' ' 363' ' ' LEU . 29.3 m -69.34 -38.19 78.04 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.168 -172.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 3.0 mt -61.05 -33.71 73.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 110.473 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.748 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 47.5 t80 -75.76 -45.01 38.7 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.308 1.052 . . . . 0.0 109.233 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -52.12 -33.25 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.147 170.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.9 OUTLIER -60.78 -47.1 87.85 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.734 0.778 . . . . 0.0 110.899 176.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 322' ' ' ARG . 37.8 p -93.93 -23.36 18.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.998 -166.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.478 ' HB3' HE22 ' A' ' 390' ' ' GLN . 52.7 m80 -111.22 23.08 14.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.22 20.84 30.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.639 0.616 . . . . 0.0 114.639 173.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.457 HG23 HG13 ' A' ' 380' ' ' ILE . 2.9 m 64.13 157.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -175.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.498 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.1 OUTLIER -121.81 157.52 57.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.068 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -96.5 52.54 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.481 2.787 . . . . 0.0 111.783 168.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.754 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.02 -8.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -177.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -69.56 -42.81 74.03 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.042 -0.411 . . . . 0.0 110.943 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.691 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.2 mt-30 -68.32 -27.11 66.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.754 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -53.5 -30.16 39.9 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.342 0.519 . . . . 0.0 111.015 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.86 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.81 -51.88 50.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.676 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.569 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.1 m-20 -69.73 -37.0 76.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.982 0.513 . . . . 0.0 112.085 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 390' ' ' GLN . 1.4 m -58.3 -47.72 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.58 ' O ' HG22 ' A' ' 399' ' ' VAL . 4.3 mm -57.99 -48.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 173.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.569 ' HE3' ' HA ' ' A' ' 393' ' ' ASN . 0.2 OUTLIER -52.43 -46.32 66.34 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.836 -177.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.91 50.19 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.018 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.871 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 0.8 OUTLIER -70.59 -41.49 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 117.143 0.472 . . . . 0.0 111.7 -178.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.5 m -56.45 -41.91 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.809 0.814 . . . . 0.0 110.181 -177.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.471 ' N ' HG23 ' A' ' 399' ' ' VAL . 0.8 OUTLIER -67.49 -34.61 77.48 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.07 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -85.47 -54.67 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -107.8 -30.77 8.34 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.692 0.758 . . . . 0.0 112.329 -172.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 121.38 170.71 14.01 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.532 -175.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.789 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.82 -45.11 95.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -172.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.32 -50.57 72.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.612 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.1 m -63.06 -51.15 67.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.871 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.7 -43.93 69.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.544 ' HB3' HD11 ' A' ' 457' ' ' ILE . 34.0 t80 -54.7 -45.23 73.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.735 0.779 . . . . 0.0 109.157 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.841 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.2 m -59.33 -52.65 64.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.502 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.698 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.42 -49.35 77.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.081 176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.592 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.12 -42.83 88.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.906 -173.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.771 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -31.6 65.56 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.541 0.17 . . . . 0.0 111.121 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.841 ' HG3' ' O ' ' A' ' 409' ' ' THR . 57.7 mtm -70.97 -45.58 63.86 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.381 0.61 . . . . 0.0 109.655 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.998 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.3 mt -60.28 -39.44 86.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.481 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.648 ' HB2' HD21 ' A' ' 421' ' ' LEU . 6.6 p -76.44 -2.57 32.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.766 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 79.78 31.04 41.36 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.771 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 4.0 mm-40 68.12 52.63 0.66 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.134 -1.033 . . . . 0.0 111.668 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.722 ' O ' HD23 ' A' ' 421' ' ' LEU . 22.9 t30 -117.41 74.9 0.95 Allowed 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 160.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.712 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.3 OUTLIER -53.98 -35.95 62.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.143 -173.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.545 ' O ' ' HB3' ' A' ' 423' ' ' SER . 25.2 mt-30 -57.61 -49.77 75.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -168.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.779 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 0.2 OUTLIER -59.59 -50.43 73.91 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.34 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.779 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.28 -38.2 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.738 1.256 . . . . 0.0 109.269 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.545 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 24.5 t -59.59 -50.46 73.81 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 112.271 -2.24 . . . . 0.0 111.473 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -58.08 -33.99 71.39 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.302 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.86 HD13 ' HA2' ' A' ' 392' ' ' GLY . 6.1 mt -73.15 -40.91 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.72 0.772 . . . . 0.0 110.484 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.597 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -63.42 -42.75 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.228 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.703 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.1 OUTLIER -59.77 -31.17 69.41 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.714 -176.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.46 -20.12 79.25 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.108 174.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.499 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.0 m-85 -98.45 1.96 47.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -176.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.44 145.64 67.27 Favored Pre-proline 0 N--CA 1.417 -2.09 0 CA-C-O 123.647 1.689 . . . . 0.0 113.83 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.768 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 60.1 Cg_endo -71.53 -64.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 1 C-N-CA 126.099 4.533 . . . . 0.0 113.063 -172.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.566 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.49 140.2 15.28 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.133 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.829 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.16 -27.17 68.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.948 0.374 . . . . 0.0 111.8 -176.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.761 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -59.92 -47.24 86.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.067 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -60.42 -51.7 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.232 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.909 ' O ' ' HG2' ' A' ' 440' ' ' GLN . 0.7 OUTLIER -51.76 -59.52 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 66.5 m -61.21 -55.52 31.14 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.252 -173.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.66 -44.36 81.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.894 -176.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.82 HD21 ' HA ' ' A' ' 460' ' ' LEU . 17.3 mt -59.7 -55.0 39.8 Favored 'General case' 0 CA--C 1.469 -2.155 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.248 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.909 ' HG2' ' O ' ' A' ' 436' ' ' VAL . 5.4 mm100 -53.57 -34.34 57.97 Favored 'General case' 0 N--CA 1.409 -2.52 0 O-C-N 125.627 1.829 . . . . 0.0 109.787 -177.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -71.33 -60.04 2.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 176.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -74.97 -47.77 27.65 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 121.585 -0.697 . . . . 0.0 111.742 -173.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.25 -25.7 64.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.708 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.768 ' N ' HD23 ' A' ' 443' ' ' LEU . 9.2 t70 -73.74 -41.42 62.54 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.418 1.104 . . . . 0.0 110.738 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -69.57 -6.6 32.11 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -173.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 452' ' ' ARG . 38.2 mm-40 -49.63 161.46 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.707 1.718 . . . . 0.0 114.435 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.544 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -57.18 -31.73 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 110.525 -3.034 . . . . 0.0 114.938 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.656 ' H ' ' HB ' ' A' ' 451' ' ' THR . 9.1 m-20 -143.85 -179.22 6.33 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.654 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.485 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 8.5 p-10 -64.42 -53.54 46.84 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 175.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.656 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.3 m -58.53 -39.21 79.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.553 171.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.677 ' HD3' ' O ' ' A' ' 444' ' ' ASP . 30.7 mtm-85 -63.52 -29.57 70.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 450' ' ' GLN . . . -73.93 -31.97 63.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.853 0.835 . . . . 0.0 109.643 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.46 -43.86 13.23 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.436 -1.257 . . . . 0.0 112.435 -170.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.529 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 35.6 p -102.34 -1.41 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.011 -168.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.4 t80 -49.05 -53.28 20.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.9 mm -71.2 -25.82 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.529 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.14 -43.31 64.86 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.566 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.3 m-70 -66.7 -31.15 71.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.615 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.82 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.5 -53.92 35.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.181 0.991 . . . . 0.0 109.293 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.664 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.14 -32.06 72.61 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.136 173.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.93 -53.24 57.16 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.067 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.0 t -63.23 -33.84 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.345 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.8 m-30 -61.28 -15.3 33.81 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.136 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 16.9 mm-40 -91.14 -49.18 6.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.141 -0.974 . . . . 0.0 112.753 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.7 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -65.8 -39.3 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.027 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.3 mt -84.61 -17.52 38.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.733 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 62.3 55.39 27.96 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.627 -2.533 . . . . 0.0 112.986 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.746 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -104.2 -174.12 2.47 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 123.863 0.865 . . . . 0.0 109.642 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.689 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.6 p30 -106.03 -41.17 5.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 166.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -158.7 -78.25 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.009 160.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.768 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.6 OUTLIER -62.61 70.45 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -169.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 38.09 40.82 0.9 Allowed Glycine 0 C--N 1.279 -2.631 0 CA-C-N 110.948 -2.842 . . . . 0.0 113.487 171.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.689 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 18.2 mm-40 -78.12 -52.37 8.83 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 122.631 1.205 . . . . 0.0 111.287 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.4 t 63.47 56.4 1.64 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.716 -2.493 . . . . 0.0 108.065 -171.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.733 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -46.05 -52.65 2.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 110.508 -3.042 . . . . 0.0 111.631 176.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.607 ' C ' ' HD2' ' A' ' 477' ' ' ARG . 0.3 OUTLIER -72.18 153.54 41.56 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.789 177.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 40.4 mt -75.53 149.64 38.33 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.417 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.486 ' HA ' ' NH1' ' A' ' 477' ' ' ARG . 43.0 mt-10 . . . . . 0 N--CA 1.432 -1.355 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.541 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.478 0.598 0 N-CA-C 111.194 -0.349 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.1 mp 64.55 -82.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 123.335 0.654 . . . . 0.0 110.948 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -140.08 26.17 2.61 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.477 ' HB ' HD11 ' A' ' 346' ' ' LEU . 28.1 m 72.18 114.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 122.17 0.986 . . . . 0.0 110.972 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.457 ' H ' HG12 ' A' ' 304' ' ' VAL . 1.6 p -85.12 124.07 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.506 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.785 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.8 mt -70.11 123.95 89.79 Favored Pre-proline 0 N--CA 1.425 -1.709 0 CA-C-O 121.862 0.839 . . . . 0.0 111.806 -175.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 308' ' ' GLN . 20.6 Cg_endo -71.77 -12.23 28.56 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 124.764 3.643 . . . . 0.0 111.23 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 308' ' ' GLN . 4.2 tp 31.32 -64.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.217 0 C-N-CA 128.5 2.72 . . . . 0.0 116.046 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.673 ' HG2' HG23 ' A' ' 307' ' ' ILE . 38.9 mm-40 -57.79 -33.74 68.87 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.616 0.722 . . . . 0.0 110.163 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.588 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.8 t-160 -61.4 -48.82 79.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.682 173.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.639 HG13 HG11 ' A' ' 338' ' ' VAL . 70.1 mt -61.32 -48.89 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 124.135 0.974 . . . . 0.0 112.799 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.667 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 2.0 mtp-105 -58.92 -30.87 68.16 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.242 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 36.9 t -69.82 -34.57 73.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.596 0.712 . . . . 0.0 109.641 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.501 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.1 -40.57 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.707 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.689 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.41 -36.28 26.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 122.912 1.339 . . . . 0.0 109.636 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.65 32.79 8.95 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.119 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 28.1 mt-10 53.42 167.47 0.04 OUTLIER Pre-proline 0 N--CA 1.436 -1.142 0 C-N-CA 124.433 1.093 . . . . 0.0 113.869 -175.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.683 ' HG3' HD12 ' A' ' 355' ' ' LEU . 38.0 Cg_exo -44.03 146.61 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.766 2.977 . . . . 0.0 113.435 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.463 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 28.8 Cg_endo -93.44 -103.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.285 2.657 . . . . 0.0 112.068 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.46 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 12.9 mmm180 -91.77 -91.51 0.16 Allowed 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.117 0.484 . . . . 0.0 110.604 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.533 ' HB3' ' HG2' ' A' ' 322' ' ' ARG . 48.6 m-20 -95.05 164.81 18.36 Favored Pre-proline 0 N--CA 1.439 -0.978 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.14 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.461 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 32.0 Cg_exo -59.0 -47.26 18.56 Favored 'Trans proline' 0 CA--C 1.508 -0.782 0 C-N-CA 122.605 2.203 . . . . 0.0 110.249 167.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.533 ' HG2' ' HB3' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -55.67 -17.99 6.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.248 176.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 3.2 mt-10 -93.46 -23.42 18.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.963 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.712 HG12 HD11 ' A' ' 355' ' ' LEU . 0.1 OUTLIER -52.15 -40.95 77.77 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.745 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.0 Cg_endo -48.97 -64.58 0.21 Allowed 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.96 2.44 . . . . 0.0 112.898 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.594 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.1 mp -57.91 -39.0 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.878 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.689 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 61.8 t90 -56.43 -39.78 73.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.988 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.805 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -67.35 -49.48 63.84 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.407 ' HA3' ' CD1' ' A' ' 410' ' ' LEU . . . -53.66 -23.71 22.17 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.888 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 327' ' ' TRP . 3.4 mtm180 -73.2 -41.13 64.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.264 0.554 . . . . 0.0 111.137 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.574 ' HB2' HG22 ' A' ' 314' ' ' THR . 1.3 p30 -106.08 -15.78 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.712 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.35 -48.08 6.39 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.1 Cg_endo -61.75 -32.36 86.21 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.731 2.287 . . . . 0.0 111.989 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.58 -42.56 58.52 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.513 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 332' ' ' ALA . 95.4 mt -56.73 -48.41 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.946 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 15.2 t70 -50.87 -21.81 1.89 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.73 -1.577 . . . . 0.0 112.764 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -77.7 -48.44 7.91 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.445 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.639 HG11 HG13 ' A' ' 310' ' ' ILE . 88.6 t -60.05 -72.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 123.389 1.566 . . . . 0.0 110.087 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.785 ' CZ ' HG12 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -88.05 122.67 69.84 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.251 -2.704 . . . . 0.0 111.758 -174.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.644 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 70.8 Cg_endo -73.41 -17.76 23.61 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 C-N-CA 123.742 2.961 . . . . 0.0 109.961 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.495 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.44 71.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.422 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.543 ' N ' HD12 ' A' ' 346' ' ' LEU . 45.1 p -85.52 11.34 10.77 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.042 -1.89 . . . . 0.0 113.049 -169.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.78 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.1 p -147.03 157.07 46.94 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 121.437 0.637 . . . . 0.0 109.968 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.533 ' HB3' HD12 ' A' ' 369' ' ' LEU . 73.3 Cg_exo -60.81 -36.85 82.17 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.643 3.562 . . . . 0.0 110.04 173.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.715 ' HA ' ' CB ' ' A' ' 365' ' ' PRO . 0.3 OUTLIER -51.84 -56.96 10.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.621 173.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.78 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 15.2 mt -56.72 -48.92 76.65 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.757 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.527 ' HA ' HD12 ' A' ' 350' ' ' ILE . 24.9 mmt180 -45.46 -52.14 10.62 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 125.295 1.622 . . . . 0.0 109.887 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.556 ' CB ' ' HG ' ' A' ' 368' ' ' CYS . 44.6 t -68.41 -50.87 49.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.825 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.666 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 16.9 mtp180 -61.06 -33.73 73.79 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.907 ' O ' HG12 ' A' ' 354' ' ' ILE . 18.5 mt -58.02 -53.22 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.205 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.594 ' O ' HD22 ' A' ' 355' ' ' LEU . 14.1 mt -59.35 -54.05 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.611 0.719 . . . . 0.0 111.254 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.402 ' HB3' ' OG ' ' A' ' 362' ' ' SER . 0.0 OUTLIER -61.12 -38.06 85.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.039 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . 0.496 ' HB1' HG12 ' A' ' 307' ' ' ILE . . . -70.94 -30.06 66.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.907 HG12 ' O ' ' A' ' 350' ' ' ILE . 5.6 mm -56.62 -57.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 CA-C-O 122.922 1.344 . . . . 0.0 110.418 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.712 HD11 HG12 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -79.96 -27.47 39.73 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.195 -2.275 . . . . 0.0 109.897 -167.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 67.75 -76.93 0.21 Allowed Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.936 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -101.52 38.55 3.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.866 -174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.756 HD22 ' HB2' ' A' ' 361' ' ' LEU . 18.3 p-10 -77.92 125.52 29.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.025 0.44 . . . . 0.0 110.424 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -48.56 -72.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.907 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -123.41 -1.7 9.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.304 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.756 ' HB2' HD22 ' A' ' 358' ' ' ASN . 2.5 mt -68.82 -6.0 24.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 122.193 0.997 . . . . 0.0 109.784 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 352' ' ' ASN . 2.3 t -70.62 75.6 0.58 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.363 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.738 HD11 HG21 ' A' ' 377' ' ' THR . 1.8 mm? -54.19 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.497 ' C ' ' H ' ' A' ' 366' ' ' GLY . 64.3 p -115.6 156.01 46.65 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.715 ' CB ' ' HA ' ' A' ' 345' ' ' ASP . 56.3 Cg_endo -71.91 22.19 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.11 1.874 . . . . 0.0 111.83 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -136.12 -2.55 2.68 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.726 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.589 ' HB2' HD12 ' A' ' 363' ' ' LEU . 45.5 m-20 -104.54 -21.4 13.44 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.285 1.041 . . . . 0.0 109.308 173.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 63.1 m -85.29 21.84 1.63 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.58 -171.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -55.94 -34.78 65.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.367 1.08 . . . . 0.0 110.112 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.04 159.96 31.37 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.697 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.615 ' O ' HG13 ' A' ' 375' ' ' VAL . 56.6 m95 -69.94 -35.77 74.78 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.634 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -57.35 -46.22 83.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.985 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 72.2 m -68.14 -42.14 80.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.072 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.604 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.14 -52.29 59.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.6 m -57.23 -44.12 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.0 109.463 -177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.053 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.139 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.738 HG21 HD11 ' A' ' 363' ' ' LEU . 24.4 m -71.95 -37.56 69.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.371 -172.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 361' ' ' LEU . 2.9 mt -62.02 -34.21 75.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.674 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.745 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.9 t80 -73.46 -47.46 41.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.65 1.214 . . . . 0.0 109.125 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.09 -32.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 112.415 -2.175 . . . . 0.0 111.829 170.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.5 mpt_? -60.4 -40.76 92.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.482 0.658 . . . . 0.0 111.351 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.424 HG21 ' HA ' ' A' ' 322' ' ' ARG . 31.6 p -100.25 -23.55 14.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.384 -166.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -110.39 23.03 14.79 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.89 20.99 21.77 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 123.308 0.38 . . . . 0.0 113.805 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 380' ' ' ILE . 1.9 m 66.79 156.32 0.1 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 111.414 -175.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.493 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.1 OUTLIER -117.87 153.56 50.98 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -95.97 49.85 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.309 2.672 . . . . 0.0 111.348 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.728 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.96 4.61 0.63 Allowed 'General case' 0 C--N 1.339 0.112 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -70.12 -47.1 63.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.241 0.544 . . . . 0.0 110.289 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.566 ' O ' HG23 ' A' ' 394' ' ' VAL . 97.3 mt-30 -73.84 -27.13 60.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.7 mm? -54.66 -31.84 58.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.128 0.877 . . . . 0.0 111.21 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.729 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -55.9 -55.06 30.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.087 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.495 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 7.6 m-20 -62.78 -36.52 83.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.559 0.695 . . . . 0.0 111.238 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.574 HG11 ' CD1' ' A' ' 414' ' ' LEU . 52.6 t -54.95 -53.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.068 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.702 ' O ' HG22 ' A' ' 399' ' ' VAL . 4.6 mm -58.59 -45.93 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.177 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 40.2 mmtt -53.36 -41.07 65.44 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 124.0 0.813 . . . . 0.0 112.154 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.566 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -78.91 -44.54 9.96 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.394 -173.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.899 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 1.0 OUTLIER -69.51 -40.84 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 117.451 0.626 . . . . 0.0 111.4 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.861 HG12 ' HA ' ' A' ' 404' ' ' VAL . 7.8 m -57.9 -41.43 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.908 0.861 . . . . 0.0 110.154 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 399' ' ' VAL . 8.0 t70 -58.15 -41.88 84.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.88 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 75.3 mt-30 -81.62 -55.38 4.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.884 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.493 ' HG3' ' HD2' ' A' ' 330' ' ' ARG . 18.5 mm-40 -111.84 -30.3 7.35 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.001 0.905 . . . . 0.0 112.123 -170.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.4 ' C ' ' HA ' ' A' ' 399' ' ' VAL . . . 119.24 177.32 16.44 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.601 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.861 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.68 -44.45 96.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.227 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.44 -50.74 72.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -66.0 -50.15 65.27 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 122.177 -0.327 . . . . 0.0 110.665 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.899 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -54.09 -41.9 68.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.559 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.2 t80 -56.24 -45.57 79.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.712 0.768 . . . . 0.0 109.212 175.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.843 ' O ' ' HG3' ' A' ' 413' ' ' MET . 11.7 m -59.29 -52.52 65.28 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.505 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.713 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -60.73 -49.54 77.08 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.051 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.544 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.49 -42.25 89.63 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.012 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.727 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.16 -31.98 66.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 122.702 -0.293 . . . . 0.0 111.227 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.843 ' HG3' ' O ' ' A' ' 409' ' ' THR . 61.1 mtm -70.31 -47.36 61.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.224 0.535 . . . . 0.0 109.912 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.053 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.6 mt -60.19 -39.92 88.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.665 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.76 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.6 OUTLIER -75.1 -14.3 60.56 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.427 -177.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 94.28 38.62 5.02 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.721 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.727 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 4.9 mm-40 52.73 54.19 10.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.206 -0.997 . . . . 0.0 112.906 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.76 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.4 OUTLIER -125.45 62.31 1.2 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 164.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.726 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 1.7 p90 -43.77 -33.92 1.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 111.408 -2.633 . . . . 0.0 112.976 -164.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 423' ' ' SER . 31.6 mt-30 -55.02 -44.55 74.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -165.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.608 HD21 HD21 ' A' ' 418' ' ' ASN . 2.3 pp -62.61 -47.85 82.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.047 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.694 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -61.36 -39.63 83.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 122.614 1.197 . . . . 0.0 108.947 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.594 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 40.6 t -58.8 -46.09 88.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 112.434 -2.166 . . . . 0.0 111.478 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.97 -39.79 80.01 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.959 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.9 mt -72.08 -40.49 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.506 0.669 . . . . 0.0 110.17 175.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.594 HG23 HG23 ' A' ' 404' ' ' VAL . 1.7 mm -58.66 -44.56 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 CA-C-N 114.274 -1.33 . . . . 0.0 113.131 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.706 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -60.6 -29.23 69.09 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-O 122.784 1.278 . . . . 0.0 108.731 -174.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -15.75 76.9 Favored Glycine 0 C--N 1.3 -1.453 0 CA-C-N 112.394 -2.184 . . . . 0.0 112.674 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 396' ' ' LYS . 9.7 m-85 -100.98 0.89 39.05 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.99 144.14 76.12 Favored Pre-proline 0 N--CA 1.41 -2.428 0 CA-C-O 123.723 1.725 . . . . 0.0 113.317 170.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.762 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 79.1 Cg_endo -72.23 -51.75 0.2 Allowed 'Trans proline' 0 C--N 1.311 -1.417 1 C-N-CA 126.065 4.51 . . . . 0.0 113.33 -173.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.508 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -122.88 142.34 14.54 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.417 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.883 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.24 -29.22 70.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.106 0.453 . . . . 0.0 111.627 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.741 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.51 -47.83 78.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.007 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -59.02 -51.68 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.596 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.883 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.84 -54.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.259 179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 28.3 m -62.54 -55.88 23.19 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.809 -175.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.46 -44.74 80.81 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.615 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.855 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 40.6 mt -60.93 -55.01 38.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.835 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.671 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -49.93 -32.7 15.45 Favored 'General case' 0 N--CA 1.419 -1.999 0 O-C-N 124.429 1.081 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.39 -60.3 2.3 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 174.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -77.25 -52.22 9.59 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -170.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 1.5 pp -57.28 -24.25 53.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.331 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.671 ' HB2' ' O ' ' A' ' 440' ' ' GLN . 28.5 t70 -71.53 -42.04 68.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.546 1.165 . . . . 0.0 110.019 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.0 mt-30 -71.39 -8.11 51.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.032 -1.895 . . . . 0.0 115.933 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 38.1 mm-40 -54.64 157.85 2.81 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 123.619 1.676 . . . . 0.0 115.022 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -53.48 -33.14 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 110.445 -3.07 . . . . 0.0 115.101 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.664 ' H ' ' HB ' ' A' ' 451' ' ' THR . 29.9 m-20 -138.88 179.65 6.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.27 -52.1 50.89 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.95 -24.22 65.15 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 175.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.664 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.4 m -59.36 -40.75 87.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 171.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 39.0 mtt180 -60.75 -30.81 70.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.408 171.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.559 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -74.31 -32.81 63.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.712 0.768 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.8 -44.6 15.33 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.111 -171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.471 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 42.1 p -99.13 -4.96 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.893 -168.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.724 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.3 t80 -49.04 -51.0 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.664 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.5 mm -72.04 -27.57 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.432 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.52 -42.92 67.36 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 463' ' ' VAL . 53.6 m-70 -66.99 -31.04 71.34 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.81 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.775 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.35 -53.89 36.96 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.116 0.96 . . . . 0.0 109.243 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.55 -31.91 72.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 113.329 -1.76 . . . . 0.0 110.137 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.73 -52.66 62.37 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.178 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.007 HG11 ' HA ' ' A' ' 435' ' ' VAL . 23.5 t -63.45 -33.73 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.186 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 20.2 m-30 -61.8 -15.04 38.36 Favored 'General case' 0 C--O 1.202 -1.447 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.984 169.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 50.0 mm-40 -90.37 -50.01 6.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.575 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.702 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -66.63 -38.89 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.121 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 469' ' ' LEU . 6.5 mt -84.81 -15.64 44.14 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.59 49.02 66.89 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-N 111.822 -2.445 . . . . 0.0 113.213 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.764 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -101.1 -179.1 3.94 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.094 0.958 . . . . 0.0 110.113 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.699 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.4 p30 -104.41 -40.65 6.0 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 167.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -158.42 -79.34 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.278 -2.237 . . . . 0.0 110.955 157.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.762 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -61.37 72.66 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -170.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 38.04 42.83 1.24 Allowed Glycine 0 C--N 1.275 -2.827 0 CA-C-N 110.602 -2.999 . . . . 0.0 113.431 171.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.699 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 15.2 mm-40 -79.04 -54.39 6.06 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 122.288 1.042 . . . . 0.0 111.469 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.6 t 65.75 46.18 2.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.066 -2.333 . . . . 0.0 108.763 -174.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.74 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.7 OUTLIER -46.45 -47.71 6.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 109.505 -3.498 . . . . 0.0 112.346 171.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.537 ' HB2' HD12 ' A' ' 476' ' ' ILE . 0.0 OUTLIER -77.38 -162.65 0.31 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.652 -1.613 . . . . 0.0 113.509 -169.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 72.5 mt -55.24 -59.36 4.89 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.45 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.599 -178.652 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.48 0.703 0 N-CA-C 110.424 -0.645 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.6 mp -86.65 -38.68 12.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.085 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -107.62 136.21 13.28 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.55 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 27.4 m -63.49 123.32 18.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.351 0.596 . . . . 0.0 111.357 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 304' ' ' VAL . 2.3 p -65.1 125.19 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.349 171.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.717 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -75.53 128.15 84.59 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 121.795 0.807 . . . . 0.0 112.187 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 308' ' ' GLN . 13.0 Cg_endo -70.38 -22.35 29.38 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 C-N-CA 124.54 3.493 . . . . 0.0 110.748 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.728 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.7 tp 38.0 -59.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 C-N-CA 128.244 2.618 . . . . 0.0 116.135 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.598 ' HG2' HG23 ' A' ' 307' ' ' ILE . 9.8 mm-40 -57.36 -39.5 76.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.833 0.825 . . . . 0.0 110.132 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.551 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.6 t-160 -58.87 -48.19 82.26 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.609 173.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.9 mt -58.92 -49.07 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.728 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 7.7 mtp180 -61.05 -30.16 70.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.889 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 47.9 t -70.06 -35.17 74.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.416 0.627 . . . . 0.0 109.59 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.55 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.71 -41.03 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.722 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.782 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.7 p -82.94 -36.69 25.0 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 122.914 1.34 . . . . 0.0 109.564 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.25 35.47 9.6 Favored Glycine 0 C--N 1.303 -1.252 0 CA-C-N 112.191 -2.277 . . . . 0.0 110.596 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 51.29 173.24 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.298 0 C-N-CA 124.258 1.023 . . . . 0.0 113.153 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.798 ' HB3' HD11 ' A' ' 324' ' ' ILE . 37.3 Cg_exo -46.77 150.96 2.28 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.986 2.457 . . . . 0.0 113.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.2 Cg_endo -92.07 -104.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.656 2.904 . . . . 0.0 112.751 -172.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -92.29 -79.55 0.38 Allowed 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.538 0.685 . . . . 0.0 110.553 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 323' ' ' GLU . 49.2 m-20 -103.9 161.45 22.91 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.955 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.5 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 45.2 Cg_exo -58.03 -50.37 10.29 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 122.656 2.237 . . . . 0.0 110.413 168.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.1 OUTLIER -49.78 -27.32 4.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.108 -1.86 . . . . 0.0 112.662 175.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -80.52 -29.13 37.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -48.41 -45.53 67.76 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.736 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.0 Cg_endo -50.75 -61.29 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.742 2.295 . . . . 0.0 112.962 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.625 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -61.94 -36.26 72.92 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.01 179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.782 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.4 t90 -58.41 -36.65 73.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.257 -1.792 . . . . 0.0 111.305 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.834 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.02 -48.42 58.13 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.71 -23.2 20.49 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.774 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.52 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.2 OUTLIER -74.97 -43.04 56.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.102 0.953 . . . . 0.0 110.552 174.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.728 ' HB3' HG22 ' A' ' 314' ' ' THR . 46.7 m-20 -95.07 -24.53 16.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.68 -1.6 . . . . 0.0 113.827 -169.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.23 -49.68 11.73 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 124.319 1.048 . . . . 0.0 113.777 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.4 Cg_endo -61.84 -32.57 85.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.522 2.148 . . . . 0.0 111.617 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.64 62.69 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.673 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.641 HG23 HG23 ' A' ' 310' ' ' ILE . 89.3 mt -59.32 -48.78 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.67 173.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.71 -15.98 9.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.213 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -50.36 5.99 Favored Glycine 0 CA--C 1.509 -0.328 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.657 HG11 HG13 ' A' ' 310' ' ' ILE . 70.5 t -54.62 -70.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 123.565 1.65 . . . . 0.0 110.094 169.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.858 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -93.72 132.03 30.81 Favored Pre-proline 0 N--CA 1.405 -2.695 0 CA-C-N 111.052 -2.795 . . . . 0.0 112.464 -171.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.807 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.1 Cg_endo -72.66 -19.48 24.29 Favored 'Trans proline' 0 CA--C 1.497 -1.357 0 C-N-CA 123.65 2.9 . . . . 0.0 111.084 173.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.6 p 32.45 69.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.472 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.618 ' N ' HD12 ' A' ' 346' ' ' LEU . 75.7 p -79.53 4.14 16.66 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.096 -1.866 . . . . 0.0 113.108 -170.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.7 p -142.7 156.15 63.04 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.636 0.732 . . . . 0.0 109.624 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 75.5 Cg_exo -60.5 -38.18 75.32 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 124.357 3.371 . . . . 0.0 109.601 172.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.632 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.4 OUTLIER -51.9 -52.76 47.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.546 174.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.8 mt -56.96 -52.74 64.04 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.818 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.719 ' HA ' HD12 ' A' ' 350' ' ' ILE . 32.1 ttm105 -51.96 -43.89 63.74 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.255 -1.793 . . . . 0.0 110.442 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 368' ' ' CYS . 38.2 t -69.09 -48.73 61.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.341 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 72.7 mtt180 -57.74 -38.1 74.76 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.548 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.858 HD11 ' CD2' ' A' ' 339' ' ' PHE . 52.5 mt -62.14 -54.51 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.941 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.569 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -58.19 -53.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 122.197 0.998 . . . . 0.0 111.02 -168.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 44.4 m-20 -63.49 -34.55 78.02 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.17 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.12 76.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.34 -53.9 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 122.873 1.32 . . . . 0.0 110.721 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.764 HD23 HD22 ' A' ' 358' ' ' ASN . 0.4 OUTLIER -72.89 -25.65 61.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 111.805 -2.452 . . . . 0.0 109.104 -169.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 64.06 -78.19 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.975 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.33 52.57 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.705 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.764 HD22 HD23 ' A' ' 355' ' ' LEU . 29.5 p30 -74.51 160.32 31.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 122.35 0.26 . . . . 0.0 110.664 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.1 mp -56.98 -67.15 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 120.959 0.409 . . . . 0.0 111.337 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -144.98 12.88 1.9 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.896 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.694 ' HB3' HD22 ' A' ' 378' ' ' LEU . 7.0 mt -64.38 -2.37 2.2 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.487 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 38.7 t -62.3 84.28 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.224 0.535 . . . . 0.0 110.288 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.91 HD11 HG21 ' A' ' 377' ' ' THR . 2.3 mm? -61.74 -172.75 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 70.5 p -126.73 155.94 74.35 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 21.5 Cg_exo -48.16 -38.42 32.78 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.531 1.488 . . . . 0.0 110.103 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -81.7 1.51 85.85 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.107 -0.952 . . . . 0.0 114.661 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.738 ' HB2' HD12 ' A' ' 363' ' ' LEU . 26.2 m-20 -109.01 -21.76 12.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.236 1.017 . . . . 0.0 109.539 171.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.654 ' O ' ' HD2' ' A' ' 347' ' ' ARG . 83.9 m -91.07 21.12 4.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.612 -171.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -62.45 -36.81 83.6 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.769 1.271 . . . . 0.0 108.579 -174.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.2 p -117.4 163.9 15.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.247 -2.251 . . . . 0.0 109.634 170.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.633 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.2 m95 -70.63 -34.24 71.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 168.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.59 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.42 -42.48 96.02 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.724 -170.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.6 m -71.33 -42.5 68.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.703 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.03 -52.17 66.13 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.921 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.7 m -58.56 -44.36 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 109.512 -178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.077 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.91 HG21 HD11 ' A' ' 363' ' ' LEU . 54.3 m -70.15 -41.04 74.36 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.825 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.694 HD22 ' HB3' ' A' ' 361' ' ' LEU . 1.8 mt -58.69 -34.45 71.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.562 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.736 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 45.6 t80 -73.52 -46.96 44.61 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.267 1.032 . . . . 0.0 109.766 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.574 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.2 OUTLIER -51.19 -32.9 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.537 170.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.619 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -59.76 -43.1 94.46 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.412 0.625 . . . . 0.0 110.999 174.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 41.4 p -95.54 -23.37 17.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.214 -167.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -110.46 22.22 15.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.06 21.16 30.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 114.436 0.534 . . . . 0.0 114.436 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.414 HG23 HG13 ' A' ' 380' ' ' ILE . 1.8 m 64.81 158.13 0.09 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.441 0.639 . . . . 0.0 111.744 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.468 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.75 156.06 65.63 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -97.83 52.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.322 2.681 . . . . 0.0 111.266 166.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.688 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.8 6.09 0.42 Allowed 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -70.06 -48.29 58.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.215 0.531 . . . . 0.0 110.039 174.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.642 ' O ' HG13 ' A' ' 394' ' ' VAL . 59.0 mt-30 -75.84 -25.21 56.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.902 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -53.64 -31.11 46.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.488 1.04 . . . . 0.0 111.916 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.72 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.24 -54.08 36.51 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.637 172.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 396' ' ' LYS . 17.7 m-20 -63.43 -38.71 92.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.336 0.654 . . . . 0.0 112.458 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -58.89 -46.17 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 120.795 0.331 . . . . 0.0 110.442 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 399' ' ' VAL . 5.5 mm -57.97 -46.83 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.311 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.568 ' HD2' ' OH ' ' A' ' 429' ' ' TYR . 8.1 mtmt -52.15 -46.28 65.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.768 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.55 -44.71 39.66 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.636 -1.268 . . . . 0.0 112.96 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.2 mt -69.93 -41.65 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 117.532 0.666 . . . . 0.0 111.684 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.7 m -57.42 -44.73 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.801 0.81 . . . . 0.0 110.369 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.479 ' N ' HG23 ' A' ' 399' ' ' VAL . 1.6 t70 -67.4 -32.61 73.62 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.919 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.43 -55.28 3.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.688 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.39 -28.12 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.901 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.408 ' HA2' ' NH1' ' A' ' 472' ' ' ARG . . . 121.12 162.16 11.6 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.608 -175.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.903 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -41.34 92.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.667 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.75 -51.86 67.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.846 0.355 . . . . 0.0 111.863 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 330' ' ' ARG . 0.8 OUTLIER -64.04 -49.95 70.34 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.28 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.683 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -51.75 -43.03 62.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.6 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 34.5 t80 -56.18 -47.73 77.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.615 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.769 ' O ' ' HG3' ' A' ' 413' ' ' MET . 2.2 m -57.92 -51.77 68.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.705 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.56 -48.94 78.68 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.821 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.83 -43.59 87.14 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.397 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.689 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.21 -31.67 66.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.887 0.343 . . . . 0.0 110.839 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.921 ' HE3' HG21 ' A' ' 375' ' ' VAL . 69.2 mtm -69.1 -48.57 62.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.291 0.567 . . . . 0.0 110.048 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.077 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.1 mt -59.13 -39.27 81.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.22 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.902 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 4.3 m -78.16 -13.6 59.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 95.92 32.25 6.92 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.33 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.601 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 69.92 37.63 1.74 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.357 0.663 . . . . 0.0 111.876 176.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.87 HD22 HD21 ' A' ' 421' ' ' LEU . 0.1 OUTLIER -120.52 81.24 1.73 Allowed 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.689 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 8.5 p90 -63.15 -31.74 72.95 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.611 -161.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 25.8 mt-30 -54.3 -48.38 71.36 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 113.464 -164.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.87 HD21 HD22 ' A' ' 418' ' ' ASN . 1.4 pp -59.61 -51.36 70.16 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.416 0.626 . . . . 0.0 111.02 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -59.8 -38.44 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.891 1.329 . . . . 0.0 109.241 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 426' ' ' ILE . 43.4 t -63.09 -47.12 84.22 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.025 -2.352 . . . . 0.0 111.873 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.66 -36.27 70.88 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.87 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.72 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.7 mt -72.01 -43.07 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.546 0.689 . . . . 0.0 109.944 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.583 HD13 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -56.09 -45.24 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.718 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.4 OUTLIER -61.45 -29.45 69.97 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 122.608 1.194 . . . . 0.0 108.959 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.06 -16.56 76.76 Favored Glycine 0 C--N 1.299 -1.484 0 CA-C-N 112.688 -2.051 . . . . 0.0 112.462 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.712 ' CG ' HG21 ' A' ' 399' ' ' VAL . 11.8 m-85 -100.68 2.69 41.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.74 143.6 75.82 Favored Pre-proline 0 N--CA 1.411 -2.414 0 CA-C-O 123.658 1.694 . . . . 0.0 113.687 170.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.76 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 72.9 Cg_endo -72.45 -55.09 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.102 1 C-N-CA 126.455 4.77 . . . . 0.0 113.263 -171.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -114.77 140.57 16.45 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.115 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.892 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.054 0.427 . . . . 0.0 111.522 -177.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.789 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.4 -46.66 83.22 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.01 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.8 t -59.17 -51.37 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.553 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.21 -54.4 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.9 m -61.33 -56.64 18.18 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.12 -45.42 79.5 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.533 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.841 ' O ' HD22 ' A' ' 443' ' ' LEU . 43.9 mt -60.11 -53.29 59.5 Favored 'General case' 0 CA--C 1.481 -1.697 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.687 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.716 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 37.8 mm-40 -51.35 -35.15 37.05 Favored 'General case' 0 N--CA 1.415 -2.201 0 O-C-N 125.115 1.509 . . . . 0.0 110.437 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.671 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.64 -60.81 2.05 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 177.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.415 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -76.73 -50.63 13.13 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.84 -0.538 . . . . 0.0 112.3 -172.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.841 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.68 -24.28 61.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.767 0.794 . . . . 0.0 111.518 -178.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.752 ' N ' HD23 ' A' ' 443' ' ' LEU . 16.6 t70 -72.21 -42.87 65.28 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.688 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.26 -8.15 47.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.525 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 55.9 mm-40 -51.32 157.8 0.93 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 123.683 1.706 . . . . 0.0 114.333 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.485 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -55.82 -32.81 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 CA-C-N 110.508 -3.042 . . . . 0.0 115.509 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.664 ' H ' ' HB ' ' A' ' 451' ' ' THR . 31.5 m-20 -140.04 179.11 6.8 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.422 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 7.3 m-20 -62.47 -56.77 14.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.18 -24.77 67.47 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 177.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.664 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 21.1 m -59.55 -41.98 91.35 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 119.492 1.042 . . . . 0.0 109.928 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 52.7 mtt180 -61.32 -29.84 70.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -75.09 -31.84 61.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.141 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.8 mm-40 -79.8 -45.35 18.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.626 -172.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.505 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 43.5 p -101.79 -3.51 27.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.136 -167.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.697 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.7 t80 -48.75 -52.6 22.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 405' ' ' ALA . 22.8 mm -71.45 -25.78 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.505 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.31 -43.4 64.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.621 ' O ' HG23 ' A' ' 463' ' ' VAL . 76.4 m-70 -66.82 -31.39 71.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.725 171.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.762 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.43 -53.87 36.78 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.117 0.961 . . . . 0.0 109.372 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.607 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.1 m-80 -62.0 -32.11 72.56 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.205 172.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.9 -52.02 64.71 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.026 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 435' ' ' VAL . 23.1 t -63.37 -34.83 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 110.271 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.1 m-30 -61.24 -14.21 24.32 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.128 169.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 63.5 mm-40 -91.53 -48.9 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.874 -1.141 . . . . 0.0 112.933 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.694 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -66.24 -39.77 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.881 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.2 mt -84.45 -16.44 42.58 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.806 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.97 51.17 55.61 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 111.674 -2.512 . . . . 0.0 113.348 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.697 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -104.1 -179.52 3.97 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.918 0.887 . . . . 0.0 110.699 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.743 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 15.1 p30 -98.47 -41.28 7.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.83 -74.99 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.252 -2.249 . . . . 0.0 110.839 160.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.76 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -60.26 64.08 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.159 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 43.62 36.89 3.56 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.619 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.743 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 10.4 mm-40 -75.61 -53.39 8.67 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.346 1.069 . . . . 0.0 111.496 -170.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 26.9 t 66.18 59.1 0.69 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.267 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.806 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -52.42 -46.84 47.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 111.247 -2.706 . . . . 0.0 111.635 175.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -50.54 145.96 6.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.118 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 62.0 mt -55.4 152.42 8.68 Favored 'General case' 0 N--CA 1.42 -1.952 0 C-N-CA 123.377 0.671 . . . . 0.0 112.105 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 . . . . . 0 N--CA 1.435 -1.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.101 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.48 0.677 0 N-CA-C 111.073 -0.395 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.2 mp -82.76 -54.66 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.488 . . . . 0.0 110.152 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -149.87 -95.05 0.13 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.874 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 57.9 m -158.88 116.87 2.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.362 0.601 . . . . 0.0 110.515 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 304' ' ' VAL . 1.9 p -62.72 120.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.272 173.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.72 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 20.2 mt -71.17 126.41 91.95 Favored Pre-proline 0 N--CA 1.426 -1.625 0 CA-C-O 121.997 0.903 . . . . 0.0 112.104 -174.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 308' ' ' GLN . 24.4 Cg_endo -73.51 -8.96 22.41 Favored 'Trans proline' 0 CA--C 1.501 -1.136 0 C-N-CA 124.952 3.768 . . . . 0.0 111.382 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.707 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.7 tp 24.8 -64.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.315 0 C-N-CA 128.458 2.703 . . . . 0.0 116.195 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.645 ' H ' HG23 ' A' ' 307' ' ' ILE . 0.2 OUTLIER -57.7 -31.06 66.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.13 0.49 . . . . 0.0 111.337 177.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.544 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.2 t-160 -61.49 -49.05 78.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.498 170.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.671 HG13 HG11 ' A' ' 338' ' ' VAL . 55.1 mt -58.68 -48.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.605 174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.695 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 52.2 mtp180 -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 122.545 0.338 . . . . 0.0 111.52 176.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.9 m -69.84 -33.18 71.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.502 0.668 . . . . 0.0 110.056 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.586 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -67.34 -42.32 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.51 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.774 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.3 p -83.21 -36.4 24.68 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.875 1.322 . . . . 0.0 110.44 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 87.91 33.91 10.53 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 112.248 -2.251 . . . . 0.0 110.834 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.1 mt-10 49.44 176.22 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 124.424 1.09 . . . . 0.0 113.629 -174.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.632 ' HB3' HD11 ' A' ' 324' ' ' ILE . 21.3 Cg_exo -45.6 141.49 8.0 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.913 2.409 . . . . 0.0 112.818 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.469 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 43.6 Cg_endo -87.84 -101.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.156 2.571 . . . . 0.0 112.318 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 8.8 mmm180 -94.22 -80.07 0.41 Allowed 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.484 0.659 . . . . 0.0 110.756 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.534 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 36.4 m-20 -105.87 162.78 18.66 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.811 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.516 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.3 Cg_exo -61.38 -52.37 3.32 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.671 2.247 . . . . 0.0 111.025 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.48 -19.21 2.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.898 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.534 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 3.6 mm-40 -88.56 -26.91 21.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.519 0.199 . . . . 0.0 111.482 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.98 -44.13 45.96 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.717 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.22 -62.13 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.815 2.343 . . . . 0.0 113.044 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.647 HG21 HG12 ' A' ' 398' ' ' ILE . 1.1 mp -62.29 -36.24 73.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 122.441 1.115 . . . . 0.0 110.027 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.774 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 50.1 t90 -57.84 -38.0 74.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.513 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.833 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.97 -48.19 59.28 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.53 -23.48 20.26 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.794 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.538 ' HD2' HG21 ' A' ' 406' ' ' THR . 1.5 mtm-85 -73.84 -43.17 59.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.322 1.058 . . . . 0.0 110.456 174.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.748 ' HB3' HG22 ' A' ' 314' ' ' THR . 51.8 m-20 -95.67 -24.73 16.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.478 -1.692 . . . . 0.0 113.711 -168.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.84 -50.56 10.19 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.1 Cg_endo -60.9 -33.88 91.91 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.623 2.215 . . . . 0.0 111.68 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.27 -44.46 62.76 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.774 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.621 HG23 HG23 ' A' ' 310' ' ' ILE . 87.7 mt -58.07 -48.21 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.635 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.07 -14.94 7.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.282 -1.781 . . . . 0.0 112.046 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.0 -48.7 5.64 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.671 HG11 HG13 ' A' ' 310' ' ' ILE . 92.2 t -55.18 -70.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.617 1.675 . . . . 0.0 109.89 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.846 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -91.67 131.19 36.53 Favored Pre-proline 0 N--CA 1.402 -2.847 0 CA-C-N 110.729 -2.941 . . . . 0.0 112.008 -173.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.789 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.4 Cg_endo -73.39 -18.42 23.09 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 123.634 2.889 . . . . 0.0 110.248 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.6 p 32.87 69.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 111.938 -2.392 . . . . 0.0 110.189 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.592 ' N ' HD12 ' A' ' 346' ' ' LEU . 40.9 p -79.93 3.61 19.41 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 112.729 -2.032 . . . . 0.0 113.119 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.79 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 20.2 p -140.85 156.1 68.84 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.589 0.709 . . . . 0.0 109.509 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.511 ' HB3' HD12 ' A' ' 369' ' ' LEU . 68.7 Cg_exo -60.94 -38.57 68.12 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 124.263 3.308 . . . . 0.0 109.54 172.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.678 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.2 OUTLIER -51.58 -53.08 41.94 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.364 -2.198 . . . . 0.0 110.566 173.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.79 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -56.68 -51.94 66.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.77 0.795 . . . . 0.0 110.311 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 350' ' ' ILE . 10.5 ttm180 -50.62 -44.75 57.28 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.238 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 40.9 t -70.09 -49.34 51.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.738 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 77.8 mtt180 -57.93 -39.3 77.68 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.704 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.846 HD11 ' CD2' ' A' ' 339' ' ' PHE . 37.0 mt -59.71 -54.04 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.689 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.589 HD13 ' HB1' ' A' ' 374' ' ' ALA . 15.9 mt -57.58 -53.34 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-O 122.133 0.968 . . . . 0.0 110.919 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.529 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -64.14 -34.79 78.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.149 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.27 -35.15 75.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.104 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.67 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.25 0.9 OUTLIER -57.9 -54.13 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 122.715 1.245 . . . . 0.0 110.616 174.421 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.736 HD23 HD22 ' A' ' 358' ' ' ASN . 0.3 OUTLIER -72.52 -27.32 62.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 111.758 -2.474 . . . . 0.0 109.037 -168.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 28.1 55.61 0.13 Allowed Glycine 0 CA--C 1.524 0.628 0 O-C-N 125.568 1.793 . . . . 0.0 115.357 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 135.96 45.85 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.667 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.736 HD22 HD23 ' A' ' 355' ' ' LEU . 30.1 p30 -98.3 163.31 12.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.173 0.189 . . . . 0.0 110.762 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.37 -60.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.23 0.538 . . . . 0.0 111.702 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -157.75 16.05 0.31 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.607 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.674 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.4 mt -64.46 -6.32 7.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 122.919 0.488 . . . . 0.0 111.649 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.529 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.9 t -61.43 85.2 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.22 0.533 . . . . 0.0 110.112 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.814 HD11 HG21 ' A' ' 377' ' ' THR . 1.8 mm? -60.64 -172.74 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.652 0.739 . . . . 0.0 112.822 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 80.9 p -126.96 152.68 75.87 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 18.4 Cg_exo -46.55 -34.65 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.979 1.786 . . . . 0.0 111.265 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -86.26 -2.25 85.65 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.65 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.675 ' HB2' HD12 ' A' ' 363' ' ' LEU . 55.6 m-20 -105.48 -21.29 13.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.306 1.051 . . . . 0.0 109.124 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 77.0 m -86.8 22.94 1.82 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.382 -171.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -59.02 -35.98 74.18 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.62 1.2 . . . . 0.0 108.266 -173.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 29.8 p -118.83 163.48 16.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 112.839 -1.982 . . . . 0.0 110.361 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.655 ' O ' HG13 ' A' ' 375' ' ' VAL . 51.8 m95 -71.18 -34.1 70.61 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 167.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.585 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -62.92 -47.07 84.85 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.613 -173.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.3 t -65.86 -42.82 89.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.739 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.745 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.86 -52.53 63.76 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.909 HG21 ' HE3' ' A' ' 413' ' ' MET . 10.4 m -58.84 -44.85 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.613 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.088 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.79 -43.46 98.08 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.949 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.814 HG21 HD11 ' A' ' 363' ' ' LEU . 24.1 m -70.47 -40.42 73.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.749 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.6 mt -59.18 -35.15 73.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.399 0.618 . . . . 0.0 110.439 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.717 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.0 t80 -71.12 -49.08 48.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.344 1.069 . . . . 0.0 109.412 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.554 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.92 -32.41 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.962 170.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.609 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -59.95 -33.02 71.35 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 123.241 0.616 . . . . 0.0 111.698 175.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 29.1 p -106.34 -23.24 12.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.771 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -110.34 22.61 15.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 52.87 21.38 9.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 114.336 0.494 . . . . 0.0 114.336 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.5 m 64.86 161.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.42 0.628 . . . . 0.0 111.022 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.502 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -123.5 157.01 63.37 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -97.67 54.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.361 2.708 . . . . 0.0 111.019 166.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.682 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 56.85 3.14 0.12 Allowed 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -174.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -69.91 -46.85 64.51 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.11 0.481 . . . . 0.0 110.512 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.659 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.8 mt-30 -74.17 -26.72 60.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.95 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.1 mm? -54.69 -31.52 58.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.97 0.805 . . . . 0.0 111.492 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.688 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.72 -53.17 40.9 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.426 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.62 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.8 m-20 -64.88 -40.85 95.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.068 0.547 . . . . 0.0 112.17 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.42 -45.39 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.687 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.8 mm -58.8 -48.45 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.513 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.3 mmtt -52.11 -42.15 63.06 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.893 0.746 . . . . 0.0 111.54 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.34 -45.09 11.71 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.186 -172.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.2 mt -69.75 -40.67 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 117.52 0.66 . . . . 0.0 111.25 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.9 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.8 m -58.35 -45.16 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.66 0.743 . . . . 0.0 110.194 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.481 ' N ' HG23 ' A' ' 399' ' ' VAL . 10.6 t70 -62.94 -35.94 81.78 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.879 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -86.59 -53.47 4.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.046 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -107.66 -29.49 9.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.469 -171.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 120.84 163.79 12.17 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.9 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -42.92 97.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.624 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.14 -51.21 70.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.917 0.389 . . . . 0.0 111.784 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.587 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.16 -50.77 66.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.508 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.692 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.65 -41.73 64.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.618 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.8 t80 -57.1 -46.18 82.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.661 0.743 . . . . 0.0 109.2 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.783 ' O ' ' HG3' ' A' ' 413' ' ' MET . 7.5 m -58.31 -51.85 68.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.642 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.678 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.87 -49.14 76.04 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.723 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.562 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.33 -42.14 88.46 Favored Glycine 0 C--N 1.315 -0.59 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.252 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.744 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.49 -32.01 65.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 116.764 0.282 . . . . 0.0 111.015 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.909 ' HE3' HG21 ' A' ' 375' ' ' VAL . 67.3 mtm -69.97 -48.03 59.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.378 0.609 . . . . 0.0 109.831 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.088 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.6 mt -59.48 -38.55 81.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.388 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.95 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.0 m -77.64 -15.04 59.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.39 28.57 7.96 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 119.936 -1.125 . . . . 0.0 111.526 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.744 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 3.2 mm-40 63.12 46.42 4.65 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.022 0.929 . . . . 0.0 112.302 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.812 HD22 HD21 ' A' ' 421' ' ' LEU . 0.1 OUTLIER -122.69 66.99 0.95 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 165.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.699 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.9 OUTLIER -47.53 -34.38 7.51 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 111.368 -2.651 . . . . 0.0 113.733 -165.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 423' ' ' SER . 48.3 mt-30 -55.45 -44.41 76.33 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -164.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.812 HD21 HD22 ' A' ' 418' ' ' ASN . 1.6 pp -59.56 -50.95 71.91 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.347 0.594 . . . . 0.0 110.624 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.611 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.96 -38.76 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.428 1.109 . . . . 0.0 109.164 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 29.1 t -59.5 -47.85 83.91 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.648 -2.069 . . . . 0.0 112.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.82 73.09 Favored Glycine 0 C--N 1.317 -0.489 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.122 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.681 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.24 -42.2 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.546 0.688 . . . . 0.0 110.085 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.607 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.67 -44.32 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.94 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.724 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.1 OUTLIER -62.7 -27.99 69.63 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 122.901 1.334 . . . . 0.0 108.991 -173.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.42 77.69 Favored Glycine 0 C--N 1.298 -1.537 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.503 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 14.5 m-85 -100.4 3.08 42.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.96 144.87 74.18 Favored Pre-proline 0 N--CA 1.413 -2.308 0 CA-C-O 123.615 1.674 . . . . 0.0 113.439 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.723 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.7 Cg_endo -72.98 -61.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 1 C-N-CA 126.118 4.545 . . . . 0.0 113.305 -174.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.546 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.37 142.69 16.33 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.879 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.27 -29.22 70.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.085 0.443 . . . . 0.0 111.184 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.748 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.26 -47.21 79.02 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.004 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.6 t -58.8 -51.83 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.663 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.879 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.08 -54.44 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.05 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 47.9 m -62.27 -55.77 25.02 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.476 -0.489 . . . . 0.0 112.073 -175.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.35 -45.65 80.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.715 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.838 ' O ' HD22 ' A' ' 443' ' ' LEU . 48.8 mt -60.39 -53.15 60.99 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.759 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.705 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.4 mm-40 -51.75 -34.16 38.06 Favored 'General case' 0 N--CA 1.416 -2.147 0 O-C-N 125.03 1.456 . . . . 0.0 110.644 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.716 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.65 -60.73 2.09 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.405 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.98 -51.43 11.14 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.963 -0.461 . . . . 0.0 112.243 -172.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.838 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.8 -23.85 60.95 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.869 0.842 . . . . 0.0 111.571 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.756 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.5 t70 -71.26 -41.41 70.1 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.666 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.716 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 45.1 mt-30 -72.68 -9.67 58.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -170.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.492 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 5.8 mm-40 -56.48 154.0 9.19 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.79 1.281 . . . . 0.0 113.762 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.496 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -52.7 -33.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.09 -2.323 . . . . 0.0 116.249 -168.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.622 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 27.8 m-20 -135.69 -178.47 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.475 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.4 p-10 -64.07 -54.6 31.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.501 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.6 -24.16 65.45 Favored 'General case' 0 N--CA 1.403 -2.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.609 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 8.6 m -60.25 -44.05 95.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 119.696 1.134 . . . . 0.0 109.427 171.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.5 mtt180 -59.22 -29.98 67.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.172 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.618 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.59 -30.82 59.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.674 0.749 . . . . 0.0 109.627 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.91 -44.97 19.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.222 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.506 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -100.75 -4.19 28.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.723 -1.58 . . . . 0.0 111.818 -168.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.673 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.1 t80 -48.77 -52.5 23.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.809 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 405' ' ' ALA . 23.8 mm -72.87 -25.24 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.11 -43.28 64.99 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 463' ' ' VAL . 72.2 m-70 -67.81 -31.55 71.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.734 -1.576 . . . . 0.0 109.513 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.744 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.74 -53.84 40.88 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.165 0.983 . . . . 0.0 109.304 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.3 -30.6 71.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.619 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 459' ' ' HIS . . . -66.9 -48.81 67.57 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.004 HG11 ' HA ' ' A' ' 435' ' ' VAL . 22.0 t -65.24 -35.82 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.302 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.538 ' OH ' HG13 ' A' ' 404' ' ' VAL . 18.8 m-30 -61.47 -13.17 18.56 Favored 'General case' 0 C--O 1.204 -1.294 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.707 169.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 3.5 tp10 -95.23 -52.6 4.12 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.227 -0.921 . . . . 0.0 112.24 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.724 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -62.75 -41.08 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.317 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.748 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.3 mt -83.97 -16.44 44.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.796 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 65.27 47.57 78.78 Favored Glycine 0 C--O 1.215 -1.039 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.492 172.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -102.31 178.88 4.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.069 0.948 . . . . 0.0 110.478 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.804 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 18.0 p30 -96.54 -40.75 8.9 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 167.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -163.48 -75.12 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.358 160.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.723 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 1.0 OUTLIER -61.61 68.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -171.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 39.55 41.97 1.82 Allowed Glycine 0 C--N 1.274 -2.901 0 CA-C-N 110.626 -2.988 . . . . 0.0 113.375 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.804 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 8.5 mm-40 -79.05 -56.62 4.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.2 1.0 . . . . 0.0 111.635 -171.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 29.8 t 68.9 54.46 0.47 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.283 -173.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.796 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -51.32 -48.01 33.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.139 175.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -50.86 139.59 16.71 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.315 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.97 -26.42 66.0 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.517 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.437 -1.077 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.089 179.496 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.473 0.296 0 N-CA-C 111.063 -0.399 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.05 123.35 44.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 110.61 -154.05 16.8 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.879 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.512 ' HB ' HD11 ' A' ' 346' ' ' LEU . 94.8 m -153.13 120.37 5.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 -177.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.9 p -55.76 119.51 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.252 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.718 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 17.2 mt -75.96 127.85 84.46 Favored Pre-proline 0 N--CA 1.424 -1.76 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.994 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.2 Cg_endo -72.88 -12.18 26.09 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.823 3.682 . . . . 0.0 111.253 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.709 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.9 tp 27.25 -61.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 C-N-CA 128.685 2.794 . . . . 0.0 116.145 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.569 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.81 -31.89 68.86 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.097 0.475 . . . . 0.0 110.305 178.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.559 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.0 t-160 -61.8 -48.58 79.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.615 171.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.0 mt -58.41 -48.9 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 C-N-CA 123.987 0.915 . . . . 0.0 112.638 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.69 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 15.1 mtp180 -60.62 -29.86 69.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 122.222 -0.299 . . . . 0.0 111.074 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 52.8 m -69.76 -34.96 74.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.38 0.609 . . . . 0.0 109.761 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.578 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -65.66 -41.12 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.741 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.772 HG22 ' HB3' ' A' ' 331' ' ' ASN . 30.2 p -83.52 -37.96 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.898 1.332 . . . . 0.0 109.882 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 91.58 35.52 6.87 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.003 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 39.6 mt-10 51.3 177.12 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 124.083 0.953 . . . . 0.0 113.051 -174.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.634 ' HB3' HD11 ' A' ' 324' ' ' ILE . 48.7 Cg_exo -48.59 152.56 4.05 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.633 2.222 . . . . 0.0 113.379 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.522 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 7.5 Cg_endo -98.93 -107.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.076 3.184 . . . . 0.0 112.624 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.466 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 8.6 mmm180 -89.19 -88.83 0.15 Allowed 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.013 0.911 . . . . 0.0 111.97 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.688 ' H ' ' HG2' ' A' ' 323' ' ' GLU . 2.2 m-20 -94.87 157.83 36.1 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.474 -170.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.504 ' HB3' HD13 ' A' ' 359' ' ' ILE . 38.2 Cg_exo -59.32 -50.75 7.76 Favored 'Trans proline' 0 CA--C 1.511 -0.675 0 C-N-CA 122.414 2.076 . . . . 0.0 110.399 166.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.48 23.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.791 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.688 ' HG2' ' H ' ' A' ' 320' ' ' ASN . 3.3 pt-20 -102.94 -20.47 14.23 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.622 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -44.05 -42.65 12.5 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.726 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 10.2 Cg_endo -50.43 -61.44 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.757 HG21 HG12 ' A' ' 398' ' ' ILE . 0.8 OUTLIER -60.01 -34.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.153 178.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.693 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 40.8 t90 -58.8 -36.39 74.38 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.228 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.853 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.81 -49.13 55.67 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.425 ' HA3' HD11 ' A' ' 410' ' ' LEU . . . -54.01 -22.97 22.01 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.758 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.66 ' HD3' HG21 ' A' ' 406' ' ' THR . 0.1 OUTLIER -72.11 -42.4 66.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.215 1.007 . . . . 0.0 110.105 174.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.772 ' HB3' HG22 ' A' ' 314' ' ' THR . 54.7 m-20 -99.79 -24.16 14.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.739 -1.573 . . . . 0.0 114.114 -168.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.626 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.31 -50.01 8.75 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 38.0 Cg_endo -60.73 -33.42 93.13 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.371 2.047 . . . . 0.0 111.529 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.36 -42.23 65.53 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.794 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.633 HG23 HG23 ' A' ' 310' ' ' ILE . 90.4 mt -59.91 -48.5 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.965 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -56.14 -16.54 5.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.24 5.68 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.66 HG11 HG13 ' A' ' 310' ' ' ILE . 96.0 t -55.09 -70.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 123.665 1.698 . . . . 0.0 110.1 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.927 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.75 131.28 34.13 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 110.798 -2.91 . . . . 0.0 111.94 -172.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.798 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 67.9 Cg_endo -72.3 -18.87 26.23 Favored 'Trans proline' 0 CA--C 1.495 -1.464 0 C-N-CA 123.562 2.841 . . . . 0.0 110.524 174.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 341' ' ' VAL . 2.5 p 32.75 69.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 112.107 -2.315 . . . . 0.0 110.32 -178.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.617 ' H ' HD12 ' A' ' 346' ' ' LEU . 46.4 p -80.6 4.46 18.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.034 -1.894 . . . . 0.0 113.206 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.815 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 33.4 p -142.89 157.27 61.57 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-O 121.699 0.761 . . . . 0.0 109.694 174.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 70.0 Cg_exo -60.63 -38.97 68.14 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 124.373 3.382 . . . . 0.0 109.413 172.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.619 ' HA ' ' HB3' ' A' ' 365' ' ' PRO . 11.5 t70 -45.75 -58.83 3.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 112.371 -2.195 . . . . 0.0 110.217 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.815 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.3 mt -56.17 -52.24 65.11 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.815 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.735 ' HA ' HD12 ' A' ' 350' ' ' ILE . 34.3 ttm105 -52.61 -42.99 65.08 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 368' ' ' CYS . 48.6 t -69.49 -49.79 51.36 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 -176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 26.9 mtp180 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.667 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.927 HD11 ' HD2' ' A' ' 339' ' ' PHE . 50.8 mt -62.23 -53.85 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.681 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.584 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -58.19 -53.36 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.078 0.942 . . . . 0.0 111.143 -168.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.548 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -64.3 -35.08 79.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.171 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.18 -32.92 72.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.706 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.36 -55.95 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 CA-C-O 122.925 1.345 . . . . 0.0 110.41 173.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.751 HD23 HD22 ' A' ' 358' ' ' ASN . 1.7 mp -72.94 -26.1 61.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 111.88 -2.418 . . . . 0.0 109.051 -169.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 37.44 59.18 1.29 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 113.694 -1.594 . . . . 0.0 114.609 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 121.02 48.92 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.688 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.751 HD22 HD23 ' A' ' 355' ' ' LEU . 26.7 p30 -87.94 162.61 16.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.69 -63.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 122.828 0.451 . . . . 0.0 111.448 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.11 9.31 0.96 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.512 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.663 ' HB3' HD22 ' A' ' 378' ' ' LEU . 4.8 mt -64.15 -5.38 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 122.955 0.502 . . . . 0.0 111.645 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 48.1 t -61.29 84.28 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.092 0.473 . . . . 0.0 110.546 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.833 HD11 HG21 ' A' ' 377' ' ' THR . 2.2 mm? -62.71 -174.64 0.07 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.877 173.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 71.7 p -128.47 155.79 78.12 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.619 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 35.4 Cg_exo -45.14 -38.12 13.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.965 1.777 . . . . 0.0 111.23 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.571 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -78.47 -4.17 87.02 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.806 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 363' ' ' LEU . 9.4 m-20 -109.5 -20.02 13.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.835 0.826 . . . . 0.0 110.194 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 81.4 m -91.25 21.49 4.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.702 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.571 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.7 OUTLIER -60.48 -38.97 85.98 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.156 -172.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.47 162.39 21.8 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.015 170.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.616 ' O ' HG13 ' A' ' 375' ' ' VAL . 48.0 m95 -69.54 -35.78 75.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.571 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -62.64 -41.77 99.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.783 -174.231 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 66.5 p -67.91 -44.77 76.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.922 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.43 -52.61 62.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.905 HG21 ' HE3' ' A' ' 413' ' ' MET . 15.6 m -57.31 -45.23 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.598 0.714 . . . . 0.0 109.585 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.021 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.17 -44.79 96.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.052 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.833 HG21 HD11 ' A' ' 363' ' ' LEU . 34.5 m -67.37 -39.85 85.7 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.499 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 325' ' ' PRO . 2.4 mt -58.99 -34.9 72.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.445 0.566 . . . . 0.0 110.325 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.726 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 43.7 t80 -73.81 -46.0 48.0 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.309 1.052 . . . . 0.0 109.467 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.591 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.2 mp -51.52 -32.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.322 170.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.624 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -59.83 -36.59 77.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.185 0.594 . . . . 0.0 111.451 176.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 28.0 p -103.26 -22.63 13.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.72 -168.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.404 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 14.0 m80 -110.01 23.01 14.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 56.42 21.45 34.09 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.948 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.456 HG23 HG13 ' A' ' 380' ' ' ILE . 1.7 m 65.07 160.17 0.11 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.179 0.514 . . . . 0.0 110.788 -174.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.505 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -124.92 157.62 65.87 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -101.64 54.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.867 3.045 . . . . 0.0 111.546 166.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.771 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.06 -0.26 0.24 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -70.17 -44.49 68.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.017 0.437 . . . . 0.0 110.906 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.622 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.4 mt-30 -74.65 -27.01 60.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.901 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.41 -30.42 52.26 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.48 0.582 . . . . 0.0 111.638 -174.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.666 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.1 -53.05 39.52 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.795 173.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.614 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 12.3 m-20 -65.61 -39.24 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.4 m -57.97 -45.37 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.052 0.453 . . . . 0.0 110.256 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.764 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.3 mm -58.8 -48.11 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 30.1 mmtt -52.04 -41.26 62.15 Favored 'General case' 0 C--O 1.242 0.682 0 O-C-N 124.195 0.934 . . . . 0.0 111.418 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.63 12.78 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.352 -171.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.757 HG12 HG21 ' A' ' 326' ' ' ILE . 1.3 mt -70.61 -38.65 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 117.624 0.712 . . . . 0.0 112.002 -177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.881 HG12 ' HA ' ' A' ' 404' ' ' VAL . 1.1 m -59.33 -42.33 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.999 0.904 . . . . 0.0 109.136 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -59.18 -44.34 92.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.807 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -83.88 -53.5 5.55 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.491 -172.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.648 ' HB2' ' NH1' ' A' ' 330' ' ' ARG . 8.8 tp10 -112.34 -34.91 5.75 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -171.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 130.1 163.47 11.09 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.57 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.881 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -64.17 -41.28 91.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.18 -50.71 70.44 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.66 HG21 ' HD3' ' A' ' 330' ' ' ARG . 0.9 OUTLIER -65.55 -48.85 71.02 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.091 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.687 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.41 -44.81 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 112.008 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 35.0 t80 -55.66 -45.99 77.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.348 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.77 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.2 m -58.77 -52.58 65.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.758 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.69 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.47 -48.82 79.39 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.508 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.523 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.72 -44.25 86.62 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.685 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.7 -31.17 64.82 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.899 0.35 . . . . 0.0 110.923 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.905 ' HE3' HG21 ' A' ' 375' ' ' VAL . 68.4 mtm -68.61 -49.8 56.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.475 0.655 . . . . 0.0 109.988 172.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.021 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.5 mt -58.56 -39.11 79.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.986 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.901 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.7 m -77.93 -16.45 58.18 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.558 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.23 35.31 6.34 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.169 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.643 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 69.91 39.69 1.39 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.632 0.773 . . . . 0.0 112.571 176.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.899 HD22 HD21 ' A' ' 421' ' ' LEU . 0.1 OUTLIER -121.63 77.46 1.35 Allowed 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.491 -2.041 . . . . 0.0 105.491 164.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.685 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 9.1 p90 -62.04 -31.32 71.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.627 -2.079 . . . . 0.0 110.515 -162.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.553 ' O ' ' HB3' ' A' ' 423' ' ' SER . 23.6 mt-30 -54.38 -48.08 71.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.086 -164.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.899 HD21 HD22 ' A' ' 418' ' ' ASN . 1.6 pp -59.87 -49.69 76.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.717 0.77 . . . . 0.0 110.962 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.616 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.31 -39.04 79.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.633 1.206 . . . . 0.0 109.251 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 38.8 t -60.54 -45.64 93.09 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.444 -2.162 . . . . 0.0 111.375 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -55.94 -39.31 78.24 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.358 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.657 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.26 -42.59 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.643 0.735 . . . . 0.0 109.976 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.58 HD13 HG23 ' A' ' 395' ' ' ILE . 1.5 mm -55.46 -44.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.735 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -60.85 -30.63 70.23 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-O 122.733 1.254 . . . . 0.0 108.987 -173.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.49 -18.24 76.89 Favored Glycine 0 C--N 1.299 -1.502 0 CA-C-N 112.561 -2.109 . . . . 0.0 111.921 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.711 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.35 1.27 44.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.91 141.99 79.84 Favored Pre-proline 0 N--CA 1.408 -2.557 0 CA-C-O 123.771 1.748 . . . . 0.0 112.848 170.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.808 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.7 Cg_endo -70.16 -60.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 1 C-N-CA 126.065 4.51 . . . . 0.0 112.977 -171.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -111.36 134.76 12.34 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.235 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.845 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.6 OUTLIER -49.26 -37.34 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.19 -48.33 73.96 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.039 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -58.13 -52.53 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.637 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.845 HG13 ' HA ' ' A' ' 433' ' ' GLN . 1.6 m -51.81 -53.31 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 117.64 0.2 . . . . 0.0 110.492 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.452 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 59.4 m -68.71 -54.17 17.74 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.837 -174.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.44 -41.44 76.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.161 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.842 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.6 mt -63.37 -53.92 44.91 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.208 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.7 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.68 -33.79 35.46 Favored 'General case' 0 N--CA 1.419 -1.977 0 O-C-N 124.959 1.412 . . . . 0.0 110.279 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.686 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.48 -59.88 2.51 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 173.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.5 ptp180 -73.92 -53.55 9.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.838 0.745 . . . . 0.0 112.616 -172.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.44 -25.0 64.0 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.653 0.74 . . . . 0.0 111.786 -177.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.777 ' N ' HD23 ' A' ' 443' ' ' LEU . 6.3 t70 -72.69 -41.89 64.81 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.32 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.9 mt-30 -69.99 -7.74 43.32 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.573 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 40.4 mm-40 -54.73 158.0 2.81 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 123.206 1.479 . . . . 0.0 114.171 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.607 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -54.19 -33.44 25.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 111.52 -2.582 . . . . 0.0 115.904 -170.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.65 ' H ' ' HB ' ' A' ' 451' ' ' THR . 38.8 m-20 -142.89 178.47 7.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.426 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.0 m-20 -61.48 -55.45 31.03 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -63.82 -27.58 69.27 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.65 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 6.5 m -59.62 -43.81 93.65 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 119.636 1.107 . . . . 0.0 109.941 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.611 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 50.0 mtt180 -60.68 -29.46 69.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.598 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.96 -30.18 58.54 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.131 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 2.9 mm-40 -82.58 -46.49 13.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.273 1.035 . . . . 0.0 111.95 -172.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.523 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -100.54 -1.55 35.28 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.811 -1.54 . . . . 0.0 111.542 -168.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.669 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.8 -51.99 26.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.656 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 405' ' ' ALA . 21.3 mm -72.68 -26.33 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.523 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.44 -42.61 64.85 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.629 ' O ' HG23 ' A' ' 463' ' ' VAL . 56.7 m-70 -67.49 -31.56 71.78 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.611 171.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.758 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.84 -53.84 40.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.172 0.987 . . . . 0.0 109.481 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.68 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.9 m-80 -62.68 -32.03 73.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.006 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -61.85 -53.03 61.41 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.857 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.039 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.4 t -63.05 -34.4 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.712 0.767 . . . . 0.0 110.398 177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -62.17 -15.53 46.78 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.175 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 33.9 mm-40 -92.26 -49.7 6.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 112.475 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.777 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 4.8 pt -64.37 -40.82 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.559 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -83.69 -16.67 44.1 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.719 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.5 51.88 50.84 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.123 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.72 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -102.72 -178.45 3.68 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 123.766 0.826 . . . . 0.0 110.134 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.746 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 13.6 p30 -99.72 -42.98 6.62 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 165.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.61 -75.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.906 160.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.808 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -61.16 64.75 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -169.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 43.81 35.48 3.23 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 111.754 -2.475 . . . . 0.0 113.062 173.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.746 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 29.4 mm-40 -73.61 -57.19 4.16 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 122.093 0.949 . . . . 0.0 111.778 -172.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 68.53 49.34 0.76 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.271 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.719 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.4 OUTLIER -42.59 -50.46 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 109.887 -3.324 . . . . 0.0 111.565 173.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.446 ' C ' ' HD2' ' A' ' 477' ' ' ARG . 0.0 OUTLIER -92.17 141.53 28.48 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.85 175.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 40.0 mt -59.6 139.82 56.87 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 123.042 0.537 . . . . 0.0 111.985 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.435 -1.184 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.575 -178.862 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.475 0.401 0 N-CA-C 110.525 -0.606 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.0 mp -94.05 113.52 28.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.462 ' O ' HD21 ' A' ' 346' ' ' LEU . . . -93.51 1.43 69.21 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.441 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.479 ' HB ' HD11 ' A' ' 346' ' ' LEU . 26.9 m 75.6 117.46 0.06 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 122.259 1.028 . . . . 0.0 111.22 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.2 p -71.84 124.61 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.318 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.708 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 21.5 mt -77.33 126.19 85.32 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.129 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 308' ' ' GLN . 19.0 Cg_endo -71.4 -10.55 27.18 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.733 3.622 . . . . 0.0 111.111 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.688 ' H ' HG22 ' A' ' 305' ' ' ILE . 4.6 tp 26.11 -61.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 128.72 2.808 . . . . 0.0 116.194 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.571 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.48 -32.04 68.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.231 0.539 . . . . 0.0 110.047 178.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.569 ' CD2' HG22 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.07 -49.4 76.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.913 172.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.674 HG13 HG11 ' A' ' 338' ' ' VAL . 54.7 mt -58.76 -49.31 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 123.95 0.9 . . . . 0.0 112.614 175.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 48.1 mtp180 -61.3 -29.61 69.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 123.38 0.672 . . . . 0.0 111.094 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 66.8 m -70.31 -34.03 72.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 110.251 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.643 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.73 -41.68 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.559 178.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.778 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -84.7 -37.69 20.64 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.748 1.261 . . . . 0.0 110.351 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.92 35.4 7.19 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.485 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 19.5 mt-10 50.34 176.39 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.62 ' HG3' ' HA ' ' A' ' 355' ' ' LEU . 73.5 Cg_exo -51.22 129.76 29.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.825 2.35 . . . . 0.0 113.1 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.88 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 82.3 Cg_endo -84.79 -92.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.488 3.459 . . . . 0.0 113.913 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.497 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 5.8 mmm180 -89.54 -77.72 0.38 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.747 0.784 . . . . 0.0 112.355 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.647 ' H ' ' CG ' ' A' ' 323' ' ' GLU . 38.0 m-20 -123.55 175.31 2.86 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.738 -170.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.459 ' HB3' HD13 ' A' ' 359' ' ' ILE . 27.2 Cg_exo -65.97 -56.96 0.26 Allowed 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 121.969 1.779 . . . . 0.0 111.572 167.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -50.68 -21.15 1.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.648 -1.615 . . . . 0.0 114.075 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.823 ' OE1' ' HG2' ' A' ' 318' ' ' PRO . 1.7 pp20? -99.24 -22.29 15.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.04 0.448 . . . . 0.0 111.629 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.67 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.62 -42.69 33.91 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.571 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.73 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -49.73 -59.61 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.815 2.344 . . . . 0.0 112.935 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.627 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -63.66 -35.95 74.7 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.953 -179.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.88 ' CD1' ' HG3' ' A' ' 318' ' ' PRO . 42.6 t90 -58.01 -37.33 74.1 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.289 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.837 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -69.16 -48.14 63.09 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.77 -23.47 22.01 Favored Glycine 0 C--N 1.311 -0.858 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.794 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.478 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 1.4 mmm180 -74.46 -42.8 58.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.119 0.961 . . . . 0.0 110.66 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.751 ' HB3' HG22 ' A' ' 314' ' ' THR . 28.1 m-20 -97.15 -22.75 16.56 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.895 -169.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.671 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.17 -49.64 11.56 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 39.7 Cg_endo -61.31 -32.21 89.67 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.589 2.193 . . . . 0.0 111.7 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.41 -43.99 59.31 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.727 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.0 mt -57.57 -48.49 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.866 173.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.47 -15.71 7.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.166 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.55 -47.25 6.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.259 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.674 HG11 HG13 ' A' ' 310' ' ' ILE . 99.1 t -57.51 -70.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 123.472 1.606 . . . . 0.0 110.128 169.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.887 ' HD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.39 128.74 43.51 Favored Pre-proline 0 N--CA 1.401 -2.92 0 CA-C-N 111.008 -2.815 . . . . 0.0 112.039 -172.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.768 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.9 Cg_endo -73.96 -16.56 22.97 Favored 'Trans proline' 0 CA--C 1.494 -1.49 0 C-N-CA 123.752 2.968 . . . . 0.0 110.442 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.621 HG21 ' HG3' ' A' ' 347' ' ' ARG . 2.8 p 34.01 67.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.222 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.649 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.2 p -80.37 8.07 8.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.83 -1.986 . . . . 0.0 113.118 -170.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.782 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 11.3 p -142.13 161.97 47.98 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -63.27 -47.52 7.77 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.451 2.768 . . . . 0.0 108.487 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.765 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.3 OUTLIER -45.96 -45.88 15.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.002 -1.908 . . . . 0.0 111.081 176.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.782 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.5 mt -58.82 -52.31 66.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.378 0.609 . . . . 0.0 110.419 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.621 ' HG3' HG21 ' A' ' 341' ' ' VAL . 2.1 ttt180 -50.4 -48.82 55.91 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.199 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 1.005 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.2 OUTLIER -69.67 -49.13 56.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.035 0.445 . . . . 0.0 111.522 -175.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.664 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 80.3 mtt180 -56.48 -41.73 77.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.492 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.887 HD11 ' HD2' ' A' ' 339' ' ' PHE . 38.7 mt -57.72 -53.77 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.322 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.591 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.9 mt -58.15 -52.76 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.015 0.912 . . . . 0.0 111.018 -169.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.53 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 19.3 m-20 -63.39 -35.97 82.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.988 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.76 75.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.668 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.39 -54.37 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-O 123.127 1.441 . . . . 0.0 110.21 173.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.668 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -73.83 -26.5 60.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.377 -2.647 . . . . 0.0 109.878 -167.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 17.24 75.72 0.01 OUTLIER Glycine 0 N--CA 1.468 0.816 0 O-C-N 125.706 1.879 . . . . 0.0 115.205 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 137.35 -8.2 3.73 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.086 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.783 HD22 ' HB2' ' A' ' 361' ' ' LEU . 22.1 p-10 -57.14 148.61 21.57 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.667 0.787 . . . . 0.0 111.703 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -56.05 -73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.477 0.711 . . . . 0.0 112.567 -175.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -136.9 11.16 3.93 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.783 ' HB2' HD22 ' A' ' 358' ' ' ASN . 4.6 mt -64.94 -4.68 4.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.87 0.468 . . . . 0.0 111.629 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.53 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.8 t -60.63 82.99 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.379 0.609 . . . . 0.0 110.334 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.799 HD11 HG21 ' A' ' 377' ' ' THR . 0.7 OUTLIER -62.42 173.78 1.13 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.664 0.745 . . . . 0.0 112.604 175.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 76.8 p -115.13 160.97 31.87 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 1.005 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.2 Cg_endo -61.06 -5.02 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.801 1.667 . . . . 0.0 112.26 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -105.84 -11.75 27.66 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' A' ' 363' ' ' LEU . 30.7 m-20 -105.91 -20.89 13.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.569 1.184 . . . . 0.0 110.228 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.853 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 16.8 p -84.9 20.05 1.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.709 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -57.03 -34.18 67.95 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.986 0.898 . . . . 0.0 110.192 -165.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.41 166.1 20.24 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.176 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.573 ' O ' HG13 ' A' ' 375' ' ' VAL . 44.0 m95 -69.66 -36.01 75.66 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.6 p30 -63.36 -39.42 94.47 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.306 -173.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 m -71.37 -41.99 69.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -63.27 -52.34 62.47 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.871 HG21 ' HE3' ' A' ' 413' ' ' MET . 14.6 m -56.77 -44.6 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.554 0.692 . . . . 0.0 109.51 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.041 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.66 -45.53 93.77 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.056 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.799 HG21 HD11 ' A' ' 363' ' ' LEU . 30.7 m -66.96 -39.11 87.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.56 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.26 -33.5 73.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.317 0.508 . . . . 0.0 110.4 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.73 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 48.9 t80 -74.77 -45.63 42.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.311 1.053 . . . . 0.0 109.075 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -51.73 -33.27 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.918 -1.946 . . . . 0.0 111.346 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.4 OUTLIER -60.25 -36.92 78.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 123.311 0.645 . . . . 0.0 111.732 177.026 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 32.5 p -102.77 -23.54 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.044 -167.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -109.83 23.06 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.86 21.24 51.25 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 114.073 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.462 HG23 HG13 ' A' ' 380' ' ' ILE . 2.8 m 64.11 163.74 0.13 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.163 0.506 . . . . 0.0 110.935 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.588 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -129.09 150.52 75.6 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -97.35 59.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.251 2.634 . . . . 0.0 110.893 165.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.679 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.84 4.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.89 -48.82 51.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.635 ' O ' HG13 ' A' ' 394' ' ' VAL . 73.9 mt-30 -74.81 -27.74 60.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -169.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.941 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.4 mm? -54.76 -31.05 58.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.796 0.725 . . . . 0.0 111.892 -172.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.682 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.76 -52.67 44.39 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.438 173.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.599 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 3.5 m-20 -65.75 -39.94 91.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.826 0.45 . . . . 0.0 111.969 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -58.14 -45.06 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.1 mm -58.51 -47.58 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.682 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 33.4 mmtt -52.23 -43.42 64.29 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.901 0.751 . . . . 0.0 111.486 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.69 -44.63 12.16 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.24 -172.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.7 mt -69.05 -41.13 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 117.436 0.618 . . . . 0.0 111.432 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.94 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.9 m -58.13 -45.62 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.706 0.765 . . . . 0.0 109.944 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.475 ' N ' HG23 ' A' ' 399' ' ' VAL . 7.7 t70 -60.88 -38.23 84.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -86.26 -53.25 5.14 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.793 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.612 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.2 OUTLIER -110.67 -30.01 7.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.035 -168.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.02 162.48 11.19 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.853 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.94 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.66 98.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.654 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.22 -50.31 73.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.579 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -63.61 -51.18 66.36 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.577 178.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.678 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.03 -41.88 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.567 ' HB3' HD11 ' A' ' 457' ' ' ILE . 44.4 t80 -58.42 -44.8 89.24 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.827 ' O ' ' HG3' ' A' ' 413' ' ' MET . 9.0 m -59.26 -53.08 62.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.407 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.686 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.57 -49.08 76.67 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.686 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.607 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.1 -42.2 87.08 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.019 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.792 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.39 -32.44 66.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.68 0.24 . . . . 0.0 111.097 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.871 ' HE3' HG21 ' A' ' 375' ' ' VAL . 63.2 mtm -69.55 -46.29 66.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.172 0.511 . . . . 0.0 109.707 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.041 HD23 ' HA ' ' A' ' 376' ' ' ALA . 17.7 mt -60.06 -40.75 90.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.524 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.941 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 9.2 m -78.12 8.0 5.45 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.744 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.38 31.73 56.47 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.792 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 4.7 mm-40 63.87 44.98 4.56 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 123.942 0.897 . . . . 0.0 111.621 -178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.841 ' ND2' HD23 ' A' ' 421' ' ' LEU . 7.4 t30 -114.07 74.01 0.85 Allowed 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 164.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.693 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.5 OUTLIER -51.53 -35.41 40.5 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.32 -2.218 . . . . 0.0 111.288 -171.138 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.532 ' O ' ' HB3' ' A' ' 423' ' ' SER . 39.2 mt-30 -56.65 -50.57 71.69 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -166.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.841 HD23 ' ND2' ' A' ' 418' ' ' ASN . 3.1 pp -59.53 -49.16 78.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.723 0.773 . . . . 0.0 110.564 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.63 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.79 -40.27 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.421 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 48.5 t -59.83 -47.43 85.76 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.507 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.55 -39.51 74.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.961 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.665 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.7 mt -71.92 -42.48 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.387 0.613 . . . . 0.0 110.142 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.58 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -57.07 -44.68 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.93 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.2 OUTLIER -63.51 -27.82 69.53 Favored 'General case' 0 N--CA 1.408 -2.531 0 CA-C-O 122.79 1.281 . . . . 0.0 108.846 -173.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.23 -17.07 77.19 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 112.469 -2.15 . . . . 0.0 112.658 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.707 ' CG ' HG21 ' A' ' 399' ' ' VAL . 9.8 m-85 -99.71 2.43 44.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.31 144.82 76.75 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-O 123.645 1.688 . . . . 0.0 113.898 170.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.787 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.1 Cg_endo -72.36 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.083 1 C-N-CA 126.333 4.689 . . . . 0.0 113.584 -173.07 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.98 139.91 15.25 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.255 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.819 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.61 -29.49 70.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.078 0.439 . . . . 0.0 111.207 -177.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.8 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.85 -48.01 79.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.01 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.79 -51.66 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.644 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.62 -55.22 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 52.6 m -61.4 -55.92 26.08 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.246 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.17 -45.5 79.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.668 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.844 ' O ' HD22 ' A' ' 443' ' ' LEU . 43.1 mt -60.38 -53.31 59.12 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.684 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.718 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 32.5 mm-40 -51.58 -34.6 37.76 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 125.174 1.546 . . . . 0.0 110.563 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.633 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.67 -59.9 2.49 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 175.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.72 -51.98 10.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.735 -0.603 . . . . 0.0 112.43 -173.397 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.84 -23.25 60.36 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.043 0.925 . . . . 0.0 111.409 -177.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.756 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.6 t70 -72.23 -42.93 65.16 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.963 -1.472 . . . . 0.0 110.755 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.5 mt-30 -72.08 -8.29 53.76 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -172.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.529 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 53.1 mm-40 -52.25 155.96 1.83 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 123.366 1.555 . . . . 0.0 114.659 -174.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.601 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.32 -33.76 21.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 111.047 -2.797 . . . . 0.0 115.455 -170.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.653 ' H ' ' HB ' ' A' ' 451' ' ' THR . 15.7 m-20 -141.89 -179.21 6.07 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.929 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.442 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 6.2 p-10 -61.31 -55.55 30.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.485 ' HA ' ' CB ' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.28 -25.23 65.95 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 176.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.653 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 8.8 m -59.81 -42.69 94.03 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 119.861 1.209 . . . . 0.0 109.705 171.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.529 ' CG ' ' HB2' ' A' ' 446' ' ' GLU . 55.7 mtt180 -59.67 -29.91 68.39 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.525 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.38 -31.26 60.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.797 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -83.88 -45.87 12.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.208 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.542 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 34.0 p -100.61 -2.76 31.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.551 -166.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.694 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.4 t80 -49.04 -52.3 26.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.667 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 405' ' ' ALA . 23.7 mm -72.05 -25.72 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.542 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.35 -42.39 65.38 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.64 ' O ' HG23 ' A' ' 463' ' ' VAL . 52.5 m-70 -67.94 -31.47 71.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.686 -1.597 . . . . 0.0 109.718 172.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.733 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -65.27 -53.53 42.76 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.09 0.947 . . . . 0.0 109.33 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.634 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.0 m-80 -62.77 -32.0 73.07 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.161 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.47 -52.47 63.38 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.8 t -62.57 -35.22 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 121.899 0.857 . . . . 0.0 110.344 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.3 m-30 -61.61 -14.51 31.18 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.155 170.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 61.5 mm-40 -93.06 -48.57 6.43 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.001 -1.062 . . . . 0.0 112.777 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.727 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.91 -39.0 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.109 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.5 mt -84.95 -17.12 38.68 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 170.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.738 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.27 53.45 39.54 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 111.698 -2.501 . . . . 0.0 113.161 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.739 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -103.55 -170.29 1.76 Allowed 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 123.856 0.863 . . . . 0.0 110.268 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.673 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.8 p30 -109.86 -42.29 4.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -157.93 -76.41 0.08 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.081 158.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.787 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 4.1 mpt_? -62.15 66.74 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -170.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 41.05 39.5 2.06 Favored Glycine 0 C--N 1.278 -2.679 0 CA-C-N 111.554 -2.567 . . . . 0.0 113.65 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.673 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 10.1 mm-40 -77.76 -51.39 10.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.277 1.037 . . . . 0.0 111.398 -173.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 31.8 t 64.06 56.1 1.45 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.263 -171.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.738 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -45.17 -53.82 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 110.302 -3.135 . . . . 0.0 111.941 177.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.494 ' C ' ' HD2' ' A' ' 477' ' ' ARG . 0.0 OUTLIER -74.3 143.05 45.14 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.842 179.124 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 22.9 tp -49.49 -50.13 42.8 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -167.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.415 ' HB2' ' NE ' ' A' ' 477' ' ' ARG . 42.3 mt-10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.704 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.478 0.587 0 N-CA-C 110.426 -0.644 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.0 mp -90.94 130.09 40.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.761 0.315 . . . . 0.0 110.19 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.37 -92.18 1.77 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.478 ' HB ' HD11 ' A' ' 346' ' ' LEU . 90.5 m -154.32 127.5 8.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.495 0.664 . . . . 0.0 109.714 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 304' ' ' VAL . 1.8 p -75.92 127.71 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.165 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.703 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.5 mt -76.01 126.97 86.2 Favored Pre-proline 0 N--CA 1.422 -1.831 0 CA-C-O 121.77 0.795 . . . . 0.0 111.803 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -71.26 -15.45 31.63 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 124.708 3.606 . . . . 0.0 110.978 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.723 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.2 tp 30.62 -60.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 128.676 2.791 . . . . 0.0 116.279 172.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.615 ' HG2' HG23 ' A' ' 307' ' ' ILE . 7.1 mm-40 -56.64 -39.16 73.19 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.892 0.853 . . . . 0.0 109.958 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.531 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.4 t-160 -58.96 -48.51 81.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.866 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.1 mt -58.75 -48.52 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 123.96 0.904 . . . . 0.0 113.033 174.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.723 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.0 mtp180 -59.59 -29.83 68.24 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 122.726 0.41 . . . . 0.0 110.562 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.1 m -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.565 0.697 . . . . 0.0 109.911 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 338' ' ' VAL . 0.5 OUTLIER -67.91 -40.52 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.918 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.795 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -82.39 -36.18 26.98 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.691 1.234 . . . . 0.0 109.57 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.77 32.5 9.13 Favored Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.52 -2.127 . . . . 0.0 111.184 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 44.0 mt-10 51.62 173.18 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 124.302 1.041 . . . . 0.0 113.273 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.537 ' HB3' HD11 ' A' ' 324' ' ' ILE . 22.6 Cg_exo -44.82 140.38 6.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.011 2.474 . . . . 0.0 112.821 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 319' ' ' ARG . 40.3 Cg_endo -89.15 -100.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.42 2.747 . . . . 0.0 113.072 -171.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.509 ' HG2' ' HB2' ' A' ' 318' ' ' PRO . 5.1 mmt180 -98.23 -81.95 0.43 Allowed 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.381 0.61 . . . . 0.0 110.687 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.741 ' OD1' ' HG2' ' A' ' 322' ' ' ARG . 1.8 t30 -111.93 150.12 41.88 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.147 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.697 ' HD2' ' OD1' ' A' ' 320' ' ' ASN . 56.8 Cg_exo -49.14 -53.53 6.87 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.157 2.572 . . . . 0.0 111.692 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.741 ' HG2' ' OD1' ' A' ' 320' ' ' ASN . 0.0 OUTLIER -63.24 -13.34 36.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.26 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.584 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 30.4 mt-10 -83.16 -28.01 29.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 171.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -48.39 -44.74 65.75 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 378' ' ' LEU . 8.9 Cg_endo -50.21 -59.98 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.754 2.303 . . . . 0.0 112.965 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.641 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.9 OUTLIER -64.75 -34.06 67.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.345 0 CA-C-O 122.9 1.333 . . . . 0.0 110.067 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.795 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 39.5 t90 -57.2 -38.62 73.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.073 -1.876 . . . . 0.0 110.718 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.84 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -67.71 -47.34 69.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-O 120.693 0.283 . . . . 0.0 111.688 -175.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.27 -23.05 16.37 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.88 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.663 ' HD3' ' OE1' ' A' ' 402' ' ' GLU . 3.2 mmm-85 -72.89 -43.9 61.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.735 0.779 . . . . 0.0 111.152 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.621 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.5 p30 -103.02 -17.65 15.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.29 -49.75 6.51 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 174.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 43.0 Cg_endo -62.76 -32.34 78.16 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.566 2.177 . . . . 0.0 111.612 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.13 -42.83 62.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.314 -1.766 . . . . 0.0 109.839 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.7 mt -58.65 -48.66 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.362 173.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.87 -15.03 4.02 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.846 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -81.68 -50.16 5.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.624 HG11 HG13 ' A' ' 310' ' ' ILE . 99.2 t -55.42 -71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 123.742 1.734 . . . . 0.0 109.796 169.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.824 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.8 OUTLIER -89.44 128.7 50.03 Favored Pre-proline 0 N--CA 1.397 -3.116 0 CA-C-N 110.537 -3.028 . . . . 0.0 111.9 -173.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.762 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 66.7 Cg_endo -72.92 -16.72 25.8 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 C-N-CA 123.548 2.832 . . . . 0.0 110.075 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.56 HG21 ' HG2' ' A' ' 347' ' ' ARG . 4.6 p 31.9 69.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.603 ' N ' HD12 ' A' ' 346' ' ' LEU . 39.6 p -79.2 6.33 10.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.671 -2.058 . . . . 0.0 113.408 -167.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 5.1 p -140.73 164.49 36.09 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.659 ' HB3' HD23 ' A' ' 369' ' ' LEU . 47.4 Cg_exo -64.32 -47.81 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.646 2.897 . . . . 0.0 108.655 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.598 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 1.0 OUTLIER -44.81 -48.84 11.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.076 177.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.5 mt -57.86 -50.97 71.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.902 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.584 ' HA ' HD12 ' A' ' 350' ' ' ILE . 55.0 mtt180 -48.4 -48.0 37.29 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.298 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.926 ' SG ' ' HB3' ' A' ' 368' ' ' CYS . 3.8 m -70.13 -48.39 57.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.728 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 84.0 mtt180 -57.4 -40.81 79.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.079 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.824 HD11 ' CD2' ' A' ' 339' ' ' PHE . 48.0 mt -57.89 -53.13 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.497 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.581 HG12 HD11 ' A' ' 328' ' ' LEU . 26.0 mt -59.0 -52.5 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-O 122.117 0.96 . . . . 0.0 111.122 -170.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.598 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 13.6 m-20 -62.53 -35.95 81.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.938 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.75 75.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.244 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.674 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -58.66 -54.87 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-O 123.021 1.391 . . . . 0.0 110.515 173.162 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.721 HD23 HD22 ' A' ' 358' ' ' ASN . 1.1 mp -72.37 -25.7 61.62 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.777 -2.465 . . . . 0.0 109.1 -168.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 68.25 -76.74 0.25 Allowed Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 113.607 -1.633 . . . . 0.0 113.326 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -124.61 69.1 0.49 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.112 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.721 HD22 HD23 ' A' ' 355' ' ' LEU . 30.8 p30 -86.74 163.86 17.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.503 0.321 . . . . 0.0 110.994 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.43 -59.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 122.92 0.488 . . . . 0.0 111.494 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -160.51 16.08 0.19 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.624 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.613 ' HB3' HD12 ' A' ' 378' ' ' LEU . 3.1 mt -67.33 -3.74 8.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.307 0.643 . . . . 0.0 111.189 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.598 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.3 t -62.52 81.67 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.711 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -61.93 174.35 0.87 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.83 0.824 . . . . 0.0 113.019 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 40.4 p -117.52 157.96 46.29 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.151 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.879 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.4 Cg_endo -49.46 -30.23 20.36 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.556 1.504 . . . . 0.0 112.236 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.65 ' HA2' HD21 ' A' ' 369' ' ' LEU . . . -96.36 0.53 61.8 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 115.811 1.085 . . . . 0.0 115.811 -170.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.677 ' HB2' HD12 ' A' ' 363' ' ' LEU . 6.4 m-20 -109.3 -18.37 13.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.686 1.243 . . . . 0.0 110.443 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.926 ' HB3' ' SG ' ' A' ' 348' ' ' CYS . 5.0 t -109.95 21.74 16.47 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.328 -165.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 344' ' ' PRO . 2.1 mt -60.04 -29.51 68.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.861 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 6.0 p -114.56 159.96 19.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.221 -1.809 . . . . 0.0 109.771 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.596 ' O ' HG13 ' A' ' 375' ' ' VAL . 31.0 m95 -70.28 -34.83 73.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.538 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -63.29 -44.84 93.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.887 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.3 t -68.44 -42.85 78.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.466 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.627 ' O ' HD22 ' A' ' 378' ' ' LEU . . . -61.28 -53.13 60.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.847 HG21 ' HE3' ' A' ' 413' ' ' MET . 15.8 m -57.37 -44.96 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.759 0.79 . . . . 0.0 109.259 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 0.999 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -59.81 -45.75 91.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.634 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.677 HG21 HD11 ' A' ' 363' ' ' LEU . 29.5 m -66.76 -39.75 88.01 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.088 -172.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 325' ' ' PRO . 0.1 OUTLIER -60.16 -34.49 73.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.984 1.265 . . . . 0.0 109.832 177.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.687 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 62.1 t80 -72.1 -47.5 50.84 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.494 1.14 . . . . 0.0 109.288 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 0 CA-C-N 112.469 -2.151 . . . . 0.0 111.407 171.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.5 OUTLIER -59.48 -36.19 75.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 123.219 0.608 . . . . 0.0 111.243 176.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 322' ' ' ARG . 34.1 p -102.34 -22.09 14.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.799 -169.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -109.49 23.1 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.25 16.22 26.29 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.448 -0.406 . . . . 0.0 114.034 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.41 HG23 HG13 ' A' ' 380' ' ' ILE . 0.7 OUTLIER 64.68 158.23 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.996 0.518 . . . . 0.0 111.355 -175.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.509 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -124.65 154.05 70.07 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -100.07 59.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.703 2.935 . . . . 0.0 111.209 165.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.742 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.43 -1.24 0.1 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -175.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -69.89 -48.31 59.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.892 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.637 ' O ' HG13 ' A' ' 394' ' ' VAL . 57.9 mt-30 -74.08 -25.43 59.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -169.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.798 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.86 -30.77 47.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.7 0.682 . . . . 0.0 111.657 -175.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.787 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.19 -49.69 62.4 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.549 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.639 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 29.9 m-20 -68.74 -39.88 80.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.774 0.43 . . . . 0.0 112.135 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -57.65 -44.89 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.626 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.2 mm -57.76 -46.77 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.484 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.639 ' HG3' ' HA ' ' A' ' 393' ' ' ASN . 30.3 mmtt -52.23 -44.46 64.84 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.819 0.819 . . . . 0.0 111.365 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.05 17.16 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.191 -172.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.696 HG23 ' HG3' ' A' ' 402' ' ' GLU . 3.9 mt -68.93 -41.51 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 117.156 0.478 . . . . 0.0 111.379 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.5 m -57.85 -44.97 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.615 0.721 . . . . 0.0 110.032 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.476 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.7 t70 -65.97 -37.75 86.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.412 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.67 -51.71 6.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.696 ' HG3' HG23 ' A' ' 398' ' ' ILE . 0.0 OUTLIER -108.95 -29.48 8.57 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.369 -170.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 125.7 160.56 10.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.598 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.804 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.24 -42.96 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -176.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.67 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -57.04 -50.47 72.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.312 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -63.21 -51.3 66.85 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.658 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.1 -41.97 65.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 55.0 t80 -59.24 -44.99 92.33 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.442 0.639 . . . . 0.0 109.524 176.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.774 ' O ' ' HG3' ' A' ' 413' ' ' MET . 4.6 m -60.45 -52.55 64.73 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.49 -178.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.707 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -61.69 -48.58 80.12 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.713 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.638 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.72 -43.75 86.58 Favored Glycine 0 C--N 1.313 -0.745 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.348 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.626 ' HE1' ' HB3' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -72.3 -31.72 65.95 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.821 0.311 . . . . 0.0 110.975 179.067 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.847 ' HE3' HG21 ' A' ' 375' ' ' VAL . 65.2 mtm -69.12 -47.87 63.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.176 0.513 . . . . 0.0 109.915 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.999 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.6 mt -58.66 -39.83 81.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.159 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.798 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.4 OUTLIER -77.65 -14.54 59.6 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.741 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 93.8 32.37 7.63 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.135 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.617 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 71.35 38.53 1.03 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.54 0.736 . . . . 0.0 112.149 176.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.877 HD22 HD21 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -119.99 77.99 1.3 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 165.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.626 ' HB3' ' HE1' ' A' ' 412' ' ' MET . 2.9 p90 -62.18 -32.6 73.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.416 -2.174 . . . . 0.0 110.501 -162.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 31.8 mt-30 -55.11 -46.98 75.61 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.171 0.989 . . . . 0.0 113.359 -164.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.877 HD21 HD22 ' A' ' 418' ' ' ASN . 1.6 pp -60.06 -51.22 70.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.635 0.731 . . . . 0.0 110.777 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.617 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -59.83 -38.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 123.054 1.407 . . . . 0.0 108.893 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 419' ' ' TYR . 1.1 t -61.8 -46.79 88.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 111.891 -2.413 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.64 89.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.111 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.787 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.1 mt -71.25 -41.25 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.57 0.7 . . . . 0.0 109.672 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.77 -46.73 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.596 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.719 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.19 -30.18 68.01 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.518 1.151 . . . . 0.0 109.526 -175.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.409 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.43 -16.59 77.42 Favored Glycine 0 C--N 1.298 -1.57 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.595 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 10.2 m-85 -99.96 0.03 40.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.65 145.05 71.37 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 123.626 1.679 . . . . 0.0 113.268 170.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.719 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.2 Cg_endo -71.24 -58.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 1 C-N-CA 126.22 4.613 . . . . 0.0 113.147 -173.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.524 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -110.97 139.35 15.5 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.407 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.886 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.23 -27.95 69.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.091 0.446 . . . . 0.0 111.286 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.774 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.44 -47.93 80.5 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.021 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.6 -51.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.676 177.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.886 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.94 -53.43 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.469 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 64.8 m -62.18 -56.33 19.82 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.914 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.11 -45.64 79.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.532 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.863 ' O ' HD22 ' A' ' 443' ' ' LEU . 42.7 mt -59.61 -53.77 54.26 Favored 'General case' 0 CA--C 1.481 -1.695 0 C-N-CA 120.276 -0.569 . . . . 0.0 110.619 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.682 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.7 mm-40 -51.79 -34.56 40.44 Favored 'General case' 0 N--CA 1.416 -2.143 0 O-C-N 125.073 1.483 . . . . 0.0 110.596 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.91 -60.99 1.97 Allowed 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 176.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.2 OUTLIER -76.3 -51.44 11.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.894 -0.504 . . . . 0.0 112.232 -172.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.62 -24.49 61.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.622 0.725 . . . . 0.0 111.735 -178.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.749 ' N ' HD23 ' A' ' 443' ' ' LEU . 21.2 t70 -71.71 -42.76 66.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.662 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.4 mt-30 -69.48 -7.86 41.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 43.5 mm-40 -51.7 160.08 0.7 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 123.721 1.724 . . . . 0.0 114.501 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.502 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -56.32 -33.32 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 110.626 -2.988 . . . . 0.0 115.403 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.647 ' H ' ' HB ' ' A' ' 451' ' ' THR . 48.4 m-20 -142.78 -178.67 5.91 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -63.66 -56.59 14.62 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.42 -25.11 67.87 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 176.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.647 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 17.8 m -59.34 -42.68 92.05 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 119.493 1.042 . . . . 0.0 109.889 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 53.0 mtt180 -61.34 -30.0 70.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.557 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.54 -30.93 59.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.971 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 2.5 mm-40 -80.86 -45.17 17.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.416 1.103 . . . . 0.0 111.498 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 43.7 p -101.36 -4.34 27.14 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.894 -167.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.736 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.5 t80 -49.01 -52.09 27.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.661 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.67 HG23 ' HB1' ' A' ' 405' ' ' ALA . 27.0 mm -70.95 -27.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.429 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.16 -42.73 65.58 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 463' ' ' VAL . 75.8 m-70 -67.03 -30.97 71.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.75 171.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.782 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -65.59 -53.7 38.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.207 1.003 . . . . 0.0 109.23 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.652 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.4 m-80 -61.94 -32.39 72.81 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.071 172.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.71 -52.73 62.11 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.002 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.021 HG11 ' HA ' ' A' ' 435' ' ' VAL . 21.9 t -62.78 -34.89 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 121.858 0.837 . . . . 0.0 110.32 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.7 m-30 -61.63 -15.13 36.81 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.014 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 45.7 mm-40 -91.16 -49.52 6.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.941 -1.099 . . . . 0.0 112.696 176.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.73 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.24 -39.77 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.997 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.774 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.6 mt -84.44 -16.61 42.01 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.801 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.88 50.02 60.32 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 111.855 -2.43 . . . . 0.0 113.599 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.715 HD11 HD12 ' A' ' 467' ' ' LEU . 0.3 OUTLIER -103.68 -179.28 3.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 123.877 0.871 . . . . 0.0 110.244 -179.156 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.706 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.0 p30 -102.1 -40.27 6.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 168.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -160.56 -76.51 0.06 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 112.524 -2.125 . . . . 0.0 111.052 158.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.719 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -60.07 69.26 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -171.139 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 37.39 40.37 0.63 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 110.738 -2.937 . . . . 0.0 113.654 174.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.706 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.3 mm-40 -77.67 -53.62 7.34 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 122.098 0.951 . . . . 0.0 111.784 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 30.2 t 67.9 55.08 0.59 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 112.084 -2.325 . . . . 0.0 108.833 -174.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.801 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -51.25 -49.67 29.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 110.84 -2.891 . . . . 0.0 111.833 176.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -50.89 136.12 23.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.434 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.43 -27.82 67.78 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.627 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.434 -1.272 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.07 176.216 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo . . . . . 0 N--CA 1.477 0.545 0 N-CA-C 110.143 -0.753 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 301' ' ' ILE . 3.5 mp -86.63 -52.66 11.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -142.11 54.27 0.61 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.653 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 41.5 m 71.89 117.72 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 122.181 0.991 . . . . 0.0 112.155 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.2 p -78.95 129.86 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.381 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.715 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 22.6 mt -75.05 126.27 88.3 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-O 121.945 0.878 . . . . 0.0 112.698 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.602 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 58.0 Cg_endo -83.37 49.56 3.0 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.819 3.679 . . . . 0.0 109.522 167.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.761 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -42.49 -42.82 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 CA-C-N 112.555 -2.111 . . . . 0.0 112.665 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -65.25 -36.99 85.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.241 0.543 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.59 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.6 t-160 -62.7 -47.49 83.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.357 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.637 HG13 HG11 ' A' ' 338' ' ' VAL . 62.3 mt -58.74 -49.88 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.761 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.3 mtp180 -62.11 -29.95 70.68 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 110.683 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 51.0 m -69.71 -33.78 72.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.37 0.605 . . . . 0.0 110.072 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.545 HG21 HG23 ' A' ' 338' ' ' VAL . 0.5 OUTLIER -66.24 -40.05 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.982 178.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.654 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.1 p -82.14 -36.93 26.94 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.74 1.257 . . . . 0.0 109.677 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.44 32.19 9.73 Favored Glycine 0 C--N 1.305 -1.14 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.803 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 25.5 mt-10 51.8 169.54 0.04 OUTLIER Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 124.626 1.17 . . . . 0.0 113.83 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.643 ' HB3' HD11 ' A' ' 324' ' ' ILE . 52.7 Cg_exo -46.19 148.53 3.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.469 2.779 . . . . 0.0 114.203 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.475 ' HG2' ' H ' ' A' ' 319' ' ' ARG . 40.3 Cg_endo -91.86 -99.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.851 3.034 . . . . 0.0 112.746 -174.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 6.5 mmm180 -97.83 -83.09 0.41 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.154 0.502 . . . . 0.0 110.828 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.405 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 16.9 m-20 -102.67 163.57 17.34 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.479 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 31.4 Cg_exo -59.72 -47.41 16.12 Favored 'Trans proline' 0 CA--C 1.511 -0.638 0 C-N-CA 122.708 2.272 . . . . 0.0 110.379 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.452 ' HA ' HG21 ' A' ' 382' ' ' THR . 81.2 mtt180 -48.65 -28.76 3.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.815 -1.993 . . . . 0.0 112.8 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.85 -23.16 22.87 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.801 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.716 HG12 ' CD1' ' A' ' 355' ' ' LEU . 0.2 OUTLIER -50.02 -42.39 70.44 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.728 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 7.5 Cg_endo -48.62 -61.52 0.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.848 2.365 . . . . 0.0 112.829 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.723 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -61.51 -36.79 75.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-O 122.667 1.222 . . . . 0.0 110.384 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.758 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 54.6 t90 -58.75 -40.72 84.68 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.48 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.803 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.5 OUTLIER -68.45 -50.12 54.86 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.46 -23.23 18.59 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.758 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 1.5 ttt-85 -72.77 -41.61 64.87 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 114.442 -0.879 . . . . 0.0 112.321 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.575 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.4 p30 -106.74 -16.92 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.17 -48.01 6.04 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 37.8 Cg_endo -60.49 -32.72 94.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.536 2.157 . . . . 0.0 111.555 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -72.7 -43.21 63.33 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.658 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 332' ' ' ALA . 89.4 mt -58.37 -49.52 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.754 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 28.1 t70 -58.33 -14.57 7.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.044 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.29 -46.66 6.43 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.364 175.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.637 HG11 HG13 ' A' ' 310' ' ' ILE . 91.2 t -56.99 -70.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 123.698 1.713 . . . . 0.0 110.154 168.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.864 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -92.43 130.6 36.85 Favored Pre-proline 0 N--CA 1.402 -2.864 0 CA-C-N 110.629 -2.987 . . . . 0.0 112.11 -173.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.775 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.7 Cg_endo -74.91 -17.42 19.79 Favored 'Trans proline' 0 CA--C 1.496 -1.394 0 C-N-CA 123.731 2.954 . . . . 0.0 110.631 174.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.465 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.6 p 34.08 67.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 112.216 -2.266 . . . . 0.0 110.107 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.63 ' N ' HD12 ' A' ' 346' ' ' LEU . 35.8 p -78.25 3.17 16.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 112.453 -2.158 . . . . 0.0 113.194 -170.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.79 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 10.2 p -137.93 164.13 43.06 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 343' ' ' THR . 42.2 Cg_exo -63.8 -49.94 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.265 2.644 . . . . 0.0 108.329 172.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.73 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -43.6 -48.69 7.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.982 176.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.79 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.7 mt -56.18 -51.99 66.01 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.521 0.677 . . . . 0.0 110.166 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.712 ' HA ' HD12 ' A' ' 350' ' ' ILE . 2.1 ttm180 -54.9 -47.03 74.87 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.556 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 1.088 ' HG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.45 -48.16 61.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.179 0.514 . . . . 0.0 111.193 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.2 mtp180 -56.45 -41.1 75.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.244 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.864 HD11 ' CD2' ' A' ' 339' ' ' PHE . 42.6 mt -58.63 -54.37 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.492 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.652 ' O ' HD22 ' A' ' 355' ' ' LEU . 20.8 mt -57.71 -54.04 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.952 0.882 . . . . 0.0 110.87 -168.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.489 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 43.4 m-20 -63.95 -34.79 78.76 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.989 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.6 -34.42 74.08 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.336 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.727 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.252 1.0 OUTLIER -56.58 -55.32 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 CA-C-O 122.982 1.372 . . . . 0.0 110.523 175.289 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.727 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.0 OUTLIER -73.06 -27.63 61.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.668 -2.514 . . . . 0.0 110.154 -169.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 39.41 75.35 0.1 Allowed Glycine 0 CA--C 1.524 0.63 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.851 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 112.85 25.08 4.66 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.86 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.788 ' ND2' ' HB2' ' A' ' 361' ' ' LEU . 3.9 p-10 -75.14 136.91 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.99 0.424 . . . . 0.0 111.365 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.627 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.1 mp -71.77 98.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.999 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.76 -21.55 4.6 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.221 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.788 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 5.8 mt -61.59 -6.38 2.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 122.939 0.496 . . . . 0.0 112.195 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.489 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 20.7 t -61.06 81.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.217 0.532 . . . . 0.0 110.427 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -62.5 169.25 3.09 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.136 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 366' ' ' GLY . 69.5 p -111.75 161.4 25.8 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.329 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 1.088 ' HA ' ' HG ' ' A' ' 348' ' ' CYS . 2.2 Cg_endo -63.57 7.07 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.202 1.935 . . . . 0.0 112.747 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -117.23 -12.32 8.32 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.689 -0.687 . . . . 0.0 114.679 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.751 ' HB2' HD12 ' A' ' 363' ' ' LEU . 45.9 m-20 -105.67 -20.43 13.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.509 1.147 . . . . 0.0 109.804 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 7.6 p -82.91 20.04 1.26 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.431 -1.713 . . . . 0.0 112.805 -169.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.2 OUTLIER -58.03 -34.83 70.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 122.288 1.042 . . . . 0.0 110.067 -168.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.1 t -130.62 163.67 26.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.202 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.608 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.4 m95 -70.36 -36.59 74.28 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.535 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 2.4 p30 -63.38 -39.37 94.34 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.439 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 48.1 t -66.36 -42.89 87.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.053 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.65 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -68.35 -51.81 40.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 328' ' ' LEU . 11.9 m -56.88 -45.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.144 0.497 . . . . 0.0 110.087 -178.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.006 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.09 -43.1 95.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.684 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.722 HG21 HD11 ' A' ' 363' ' ' LEU . 40.2 m -68.5 -42.68 78.25 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.558 -173.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -58.74 -34.02 70.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.419 0.554 . . . . 0.0 110.671 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.728 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 35.6 t80 -73.68 -47.34 40.45 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.501 1.144 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -50.64 -32.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 CA-C-N 112.678 -2.055 . . . . 0.0 111.336 170.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.63 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.6 OUTLIER -60.29 -41.99 94.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.682 175.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 322' ' ' ARG . 30.3 p -97.4 -23.42 16.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.772 -168.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -110.5 22.91 14.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.75 21.73 23.49 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.315 0.486 . . . . 0.0 114.315 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 2.2 m 67.01 160.05 0.15 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.225 0.536 . . . . 0.0 111.328 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.518 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -125.31 156.17 70.4 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -97.94 54.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.415 2.743 . . . . 0.0 111.306 165.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.79 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.51 4.21 0.22 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.09 -47.45 61.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.014 0.435 . . . . 0.0 110.585 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.616 ' O ' HG13 ' A' ' 394' ' ' VAL . 75.7 mt-30 -71.47 -27.48 63.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -169.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.839 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.84 -31.18 59.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.59 0.632 . . . . 0.0 111.925 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.682 ' O ' ' HG2' ' A' ' 396' ' ' LYS . . . -54.8 -50.09 59.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.476 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.516 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 6.3 m-20 -68.58 -39.43 80.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.661 0.384 . . . . 0.0 112.002 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.55 -45.92 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.245 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.796 ' O ' HG22 ' A' ' 399' ' ' VAL . 5.9 mm -58.69 -47.27 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.615 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.693 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.8 mmtt -51.42 -42.61 61.61 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 124.077 0.861 . . . . 0.0 111.486 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.52 -44.11 13.78 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.921 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.723 HG12 HG21 ' A' ' 326' ' ' ILE . 1.8 mt -69.2 -40.73 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 117.5 0.65 . . . . 0.0 111.543 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.873 HG12 ' HA ' ' A' ' 404' ' ' VAL . 0.8 OUTLIER -59.35 -42.81 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 109.506 -178.43 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.63 -39.23 93.84 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.087 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -85.66 -53.41 5.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.281 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.554 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.1 OUTLIER -110.64 -32.16 6.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.561 0.696 . . . . 0.0 111.747 -170.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.01 163.13 11.48 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.682 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.873 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.07 -49.81 72.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.164 0.507 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.645 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.76 -50.69 65.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.557 177.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.677 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -52.53 -44.18 65.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.518 ' HB3' HD11 ' A' ' 457' ' ' ILE . 26.9 t80 -54.81 -46.44 74.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.779 0.799 . . . . 0.0 109.082 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.778 ' O ' ' HG3' ' A' ' 413' ' ' MET . 18.4 m -58.55 -52.02 67.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.958 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.68 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -61.99 -49.09 77.47 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.958 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.538 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.11 -43.28 88.59 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.805 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.631 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -71.29 -32.94 69.25 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.728 0.264 . . . . 0.0 110.673 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.778 ' HG3' ' O ' ' A' ' 409' ' ' THR . 63.6 mtm -68.82 -46.2 69.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.923 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.006 HD23 ' HA ' ' A' ' 376' ' ' ALA . 18.5 mt -60.2 -43.35 96.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.292 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.839 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 1.9 m -80.63 7.15 10.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 70.81 46.78 43.59 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.857 171.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.631 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 0.0 OUTLIER 62.3 42.12 9.61 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 123.87 0.868 . . . . 0.0 111.616 177.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.741 ' ND2' HD22 ' A' ' 421' ' ' LEU . 22.3 t30 -113.17 83.21 1.79 Allowed 'General case' 0 CA--C 1.476 -1.878 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 163.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.786 ' HD2' ' HG ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -57.09 -36.93 71.2 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.821 -174.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 41.6 mt-30 -57.29 -51.56 68.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -163.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.803 ' HG ' ' N ' ' A' ' 422' ' ' VAL . 1.7 pt? -60.02 -49.23 78.48 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.392 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.803 ' N ' ' HG ' ' A' ' 421' ' ' LEU . 0.7 OUTLIER -60.77 -38.42 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.685 1.231 . . . . 0.0 108.894 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.786 ' HG ' ' HD2' ' A' ' 419' ' ' TYR . 43.6 m -65.31 -41.13 94.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.31 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.83 86.97 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.787 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.625 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.7 mt -71.46 -40.71 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.597 0.713 . . . . 0.0 109.813 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -56.78 -44.67 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.58 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.642 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -57.4 -33.09 67.49 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 124.87 1.268 . . . . 0.0 109.245 -176.137 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.443 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.57 -15.01 77.52 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 112.992 -1.913 . . . . 0.0 112.448 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.75 ' CG ' HG21 ' A' ' 399' ' ' VAL . 9.0 m-85 -102.77 1.12 33.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.8 mm? -57.58 142.01 78.06 Favored Pre-proline 0 N--CA 1.41 -2.464 0 CA-C-O 123.645 1.688 . . . . 0.0 113.333 170.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.807 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 53.1 Cg_endo -68.95 -57.35 0.13 Allowed 'Trans proline' 0 C--N 1.317 -1.123 1 C-N-CA 126.564 4.843 . . . . 0.0 113.316 -169.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.497 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.62 140.72 16.45 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.736 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.933 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -59.44 -32.43 70.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.688 0.744 . . . . 0.0 111.651 -175.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.857 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.02 -48.43 73.39 Favored 'General case' 0 CA--C 1.509 -0.635 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.045 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -62.39 -36.76 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.337 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.933 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -71.1 -45.98 69.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 45.4 m -72.27 -54.92 8.13 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.359 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.82 76.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.842 HD13 HD22 ' A' ' 460' ' ' LEU . 20.1 mt -66.61 -54.49 22.91 Favored 'General case' 0 CA--C 1.465 -2.3 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.733 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 1.5 mp0 -51.22 -33.54 28.29 Favored 'General case' 0 N--CA 1.405 -2.715 0 O-C-N 125.781 1.926 . . . . 0.0 109.944 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.679 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -72.95 -60.74 2.09 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -71.55 -48.73 46.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.126 0.488 . . . . 0.0 111.472 -171.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -60.22 -25.97 66.03 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.458 179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.744 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.0 t70 -73.09 -42.01 63.46 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.33 1.062 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.5 mt-30 -68.79 -8.31 42.14 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -171.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 47.1 mm-40 -51.78 156.97 1.28 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.518 1.628 . . . . 0.0 115.058 -176.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.5 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.7 mp -52.92 -31.98 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 110.506 -3.043 . . . . 0.0 115.665 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.651 ' H ' ' HB ' ' A' ' 451' ' ' THR . 55.2 m-20 -140.81 178.9 7.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -61.78 -56.3 20.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -67.49 -24.97 65.64 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.651 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -57.78 -41.05 81.27 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.774 1.17 . . . . 0.0 109.932 171.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 62.5 mtt180 -60.97 -30.57 70.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.565 ' HB2' ' HD1' ' A' ' 419' ' ' TYR . . . -76.09 -31.44 58.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.35 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.8 mm-40 -81.29 -45.68 15.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.474 1.13 . . . . 0.0 111.883 -172.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.464 ' OG1' ' HG3' ' A' ' 446' ' ' GLU . 47.2 p -98.95 -2.3 37.82 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.772 -167.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.645 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -48.89 -55.57 11.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.932 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 405' ' ' ALA . 27.6 mm -70.23 -25.42 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -73.0 -43.21 62.43 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.585 ' O ' HG23 ' A' ' 463' ' ' VAL . 65.9 m-70 -66.15 -32.19 73.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.261 171.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.18 -53.69 45.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.308 1.051 . . . . 0.0 109.34 -178.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.662 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.9 m-80 -62.6 -32.03 72.96 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.3 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.36 -52.55 63.16 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.035 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.045 HG11 ' HA ' ' A' ' 435' ' ' VAL . 34.5 t -63.26 -33.57 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-O 121.802 0.81 . . . . 0.0 110.56 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.4 m-30 -62.54 -15.26 49.8 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.309 168.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 22.4 mm-40 -92.25 -49.31 6.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.007 -1.058 . . . . 0.0 112.64 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.762 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.8 pt -64.63 -40.16 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.67 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.857 HD11 ' HB3' ' A' ' 434' ' ' ALA . 5.3 mt -84.6 -16.67 41.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.759 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.75 51.79 50.91 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 111.681 -2.509 . . . . 0.0 113.171 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.667 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -103.3 -178.12 3.57 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.723 0.809 . . . . 0.0 110.268 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.585 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 10.8 p30 -101.39 -41.95 6.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 167.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.92 -75.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.322 159.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.807 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 1.3 mpt_? -63.77 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -168.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 40.09 42.16 2.25 Favored Glycine 0 C--N 1.277 -2.72 0 CA-C-N 111.352 -2.658 . . . . 0.0 113.417 173.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.585 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 4.6 mm-40 -81.55 -49.64 10.32 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-O 122.306 1.05 . . . . 0.0 111.278 -172.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 46.8 t 62.1 57.69 1.99 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.346 -2.207 . . . . 0.0 108.433 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.759 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.2 OUTLIER -49.98 -47.1 23.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 110.934 -2.848 . . . . 0.0 111.418 175.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.409 ' HG2' HD12 ' A' ' 476' ' ' ILE . 14.1 mmm-85 -55.49 133.24 50.0 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.092 177.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.7 -26.04 67.79 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.514 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.437 -1.089 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.869 179.377 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.477 0.512 0 N-CA-C 110.656 -0.555 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.4 mp -84.78 115.31 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 141.23 172.42 13.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.864 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.507 ' HB ' HD11 ' A' ' 346' ' ' LEU . 43.6 m -80.2 118.64 22.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.648 0.737 . . . . 0.0 111.239 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.471 ' H ' HG12 ' A' ' 304' ' ' VAL . 1.5 p -69.0 125.87 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.728 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.698 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -75.1 126.66 87.8 Favored Pre-proline 0 N--CA 1.425 -1.686 0 CA-C-O 122.005 0.907 . . . . 0.0 111.731 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.6 Cg_endo -72.18 -10.84 26.39 Favored 'Trans proline' 0 CA--C 1.498 -1.307 0 C-N-CA 124.755 3.637 . . . . 0.0 111.298 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.7 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.8 tp 25.12 -61.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 O-C-N 127.13 2.769 . . . . 0.0 116.063 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.565 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.37 -32.78 68.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.196 0.522 . . . . 0.0 110.396 178.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.564 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.6 t-160 -62.27 -48.71 78.71 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.609 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 307' ' ' ILE . 59.8 mt -58.32 -48.87 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 C-N-CA 123.982 0.913 . . . . 0.0 112.78 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 10.5 mtp180 -61.29 -30.48 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 122.141 -0.349 . . . . 0.0 110.827 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 53.1 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.62 0.724 . . . . 0.0 109.962 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.542 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.1 -40.89 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.748 178.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.742 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 32.3 p -82.67 -36.32 26.05 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.941 1.353 . . . . 0.0 109.531 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 90.64 33.54 8.42 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 112.183 -2.281 . . . . 0.0 110.938 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.539 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.1 mt-10 50.68 174.66 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 124.339 1.055 . . . . 0.0 113.029 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.658 ' HB3' HD11 ' A' ' 324' ' ' ILE . 42.6 Cg_exo -46.09 145.81 4.97 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.374 2.05 . . . . 0.0 112.467 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 319' ' ' ARG . 48.6 Cg_endo -87.65 -99.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.343 2.695 . . . . 0.0 112.451 -171.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.401 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 4.0 mmm180 -100.82 -76.57 0.56 Allowed 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.723 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.614 ' HB3' ' HG3' ' A' ' 323' ' ' GLU . 1.3 t30 -109.88 150.8 41.85 Favored Pre-proline 0 N--CA 1.437 -1.1 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.004 -173.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.609 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 47.7 Cg_exo -53.88 -52.83 7.53 Favored 'Trans proline' 0 CA--C 1.504 -1.024 0 C-N-CA 123.04 2.493 . . . . 0.0 111.52 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.572 ' HD2' ' HB ' ' A' ' 382' ' ' THR . 0.0 OUTLIER -59.18 -15.93 17.55 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.052 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.614 ' HG3' ' HB3' ' A' ' 320' ' ' ASN . 5.5 mt-10 -81.22 -25.85 36.35 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.658 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -48.58 -44.48 66.87 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.759 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.5 Cg_endo -51.2 -61.9 0.47 Allowed 'Trans proline' 0 CA--C 1.518 -0.308 0 C-N-CA 122.697 2.265 . . . . 0.0 113.159 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.733 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -59.64 -35.59 60.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 122.919 1.343 . . . . 0.0 110.153 178.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.842 ' O ' ' HB3' ' A' ' 330' ' ' ARG . 42.7 t90 -59.78 -38.5 82.05 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.88 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.867 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.5 OUTLIER -69.2 -50.6 45.94 Favored 'General case' 0 N--CA 1.407 -2.604 0 O-C-N 121.863 -0.523 . . . . 0.0 112.396 -175.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.412 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.94 -22.87 21.16 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.842 ' HB3' ' O ' ' A' ' 327' ' ' TRP . 10.7 ttp85 -71.76 -42.46 67.17 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 113.862 -1.169 . . . . 0.0 112.166 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.573 ' HB2' HG22 ' A' ' 314' ' ' THR . 0.8 OUTLIER -108.3 -15.44 14.47 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -176.099 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.37 -47.97 6.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 32.1 Cg_endo -59.16 -34.94 98.61 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.557 175.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -71.94 -42.62 66.4 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.771 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 332' ' ' ALA . 88.5 mt -58.87 -49.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.663 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.2 -16.87 5.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.895 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.2 -50.7 5.33 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.17 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.673 HG11 HG13 ' A' ' 310' ' ' ILE . 92.0 t -54.61 -69.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 123.541 1.639 . . . . 0.0 110.176 170.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.838 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -94.51 129.39 36.79 Favored Pre-proline 0 N--CA 1.401 -2.923 0 CA-C-N 110.958 -2.837 . . . . 0.0 112.162 -172.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.782 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.3 Cg_endo -75.5 -16.0 19.38 Favored 'Trans proline' 0 CA--C 1.497 -1.367 0 C-N-CA 123.892 3.061 . . . . 0.0 110.503 174.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.464 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.43 68.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 112.176 -2.284 . . . . 0.0 109.943 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.655 ' N ' HD12 ' A' ' 346' ' ' LEU . 31.0 p -81.0 10.58 4.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.623 -2.08 . . . . 0.0 113.468 -169.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.78 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 8.3 p -143.71 162.52 41.09 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.42 -49.34 6.05 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.208 2.606 . . . . 0.0 108.214 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.763 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -46.02 -44.12 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.904 -1.953 . . . . 0.0 111.292 178.036 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.78 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.0 mt -58.59 -52.03 67.38 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.382 0.61 . . . . 0.0 110.746 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.735 ' HA ' HD12 ' A' ' 350' ' ' ILE . 32.6 ttm105 -53.92 -44.85 70.94 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.31 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.867 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.04 -47.4 65.47 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 111.086 -176.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 94.0 mtt180 -57.51 -41.76 81.46 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.036 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.838 HD11 ' CD2' ' A' ' 339' ' ' PHE . 44.8 mt -58.0 -53.77 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.528 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 328' ' ' LEU . 20.6 mt -58.69 -52.84 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.096 0.951 . . . . 0.0 110.815 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 362' ' ' SER . 27.4 m-20 -63.36 -35.32 79.99 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.049 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.23 -34.51 74.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 112.076 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.698 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.9 OUTLIER -58.26 -55.09 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.833 1.302 . . . . 0.0 110.5 174.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.739 HD23 HD22 ' A' ' 358' ' ' ASN . 0.4 OUTLIER -72.7 -26.79 61.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 111.693 -2.503 . . . . 0.0 109.297 -168.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 34.71 60.68 0.63 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.705 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 117.57 74.17 0.49 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.342 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.739 HD22 HD23 ' A' ' 355' ' ' LEU . 20.6 p30 -119.53 168.89 10.54 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 122.668 0.387 . . . . 0.0 110.432 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.536 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -52.84 -61.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 122.991 0.516 . . . . 0.0 111.517 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.411 ' C ' ' HG2' ' A' ' 381' ' ' ARG . . . -156.44 14.05 0.36 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.05 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.68 ' HB3' HD22 ' A' ' 378' ' ' LEU . 5.1 mt -66.74 -4.81 9.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 122.934 0.494 . . . . 0.0 111.953 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.529 ' HA ' ' OD1' ' A' ' 352' ' ' ASN . 33.9 t -60.71 87.14 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 109.686 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.812 HD11 HG21 ' A' ' 377' ' ' THR . 0.7 OUTLIER -65.48 178.51 0.95 Allowed 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.249 174.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 43.0 p -122.06 161.13 44.27 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.867 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 8.7 Cg_endo -66.13 4.66 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.038 1.825 . . . . 0.0 112.365 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -110.53 -10.83 20.93 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.809 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.748 ' HB2' HD12 ' A' ' 363' ' ' LEU . 36.7 m-20 -106.42 -21.76 12.99 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 122.081 0.943 . . . . 0.0 109.828 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.748 ' HG ' ' HA ' ' A' ' 365' ' ' PRO . 17.6 p -80.91 18.94 0.92 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.917 -170.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.32 -35.48 73.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 122.291 1.043 . . . . 0.0 109.671 -172.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.19 159.76 33.3 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.229 174.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.628 ' O ' HG13 ' A' ' 375' ' ' VAL . 59.5 m95 -70.29 -36.95 74.68 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.576 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.4 m-20 -59.26 -40.02 84.69 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.483 -175.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 35.4 t -72.77 -42.59 63.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.657 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.32 -51.52 67.32 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.867 HG12 ' HB3' ' A' ' 328' ' ' LEU . 11.2 m -58.52 -45.38 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.458 0.647 . . . . 0.0 109.824 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.039 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.09 -43.31 95.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.648 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.812 HG21 HD11 ' A' ' 363' ' ' LEU . 29.7 m -69.45 -39.21 77.92 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.836 -172.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.69 HD11 HD12 ' A' ' 328' ' ' LEU . 2.5 mt -60.75 -34.37 74.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.586 0.63 . . . . 0.0 110.516 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.759 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 38.0 t80 -73.58 -47.69 38.55 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 122.446 1.117 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 0.3 OUTLIER -51.1 -32.42 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 112.661 -2.063 . . . . 0.0 111.706 170.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.8 OUTLIER -59.8 -46.79 88.12 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.435 0.636 . . . . 0.0 111.042 174.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.572 ' HB ' ' HD2' ' A' ' 322' ' ' ARG . 43.8 p -93.22 -24.23 18.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.843 -169.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -110.84 23.14 14.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.05 20.75 15.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.415 HG23 HG13 ' A' ' 380' ' ' ILE . 2.6 m 66.27 163.52 0.17 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.279 0.561 . . . . 0.0 111.429 -176.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.537 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -130.55 153.96 81.56 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.077 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -99.31 60.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.421 2.747 . . . . 0.0 111.015 164.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.667 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 57.4 6.32 0.38 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -174.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -70.24 -48.72 55.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.082 0.467 . . . . 0.0 110.629 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.649 ' O ' HG13 ' A' ' 394' ' ' VAL . 41.2 mt-30 -76.61 -27.37 55.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -169.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.711 ' O ' HG22 ' A' ' 394' ' ' VAL . 3.2 mm? -54.66 -31.45 57.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 -171.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.7 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.76 -53.29 40.26 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.924 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.611 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 14.2 m-20 -66.21 -37.92 86.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.6 m -58.1 -45.99 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.648 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.0 mm -58.54 -47.59 87.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 392' ' ' GLY . 34.0 mmtt -52.11 -42.81 63.58 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.354 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -77.26 -44.33 13.78 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.034 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 326' ' ' ILE . 2.0 mt -68.97 -40.77 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 117.447 0.623 . . . . 0.0 111.233 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.882 HG12 ' HA ' ' A' ' 404' ' ' VAL . 4.8 m -58.25 -45.63 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.034 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.474 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.1 t70 -62.34 -37.43 85.61 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.948 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -83.47 -53.14 5.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.615 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.39 -28.6 8.86 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.521 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 119.6 165.89 13.15 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.444 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.882 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.56 -44.07 98.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -57.31 -51.07 70.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.644 ' O ' ' HB ' ' A' ' 409' ' ' THR . 1.0 OUTLIER -64.43 -49.88 69.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.461 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.678 ' CB ' ' HB ' ' A' ' 398' ' ' ILE . . . -53.2 -43.62 67.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.547 ' HB3' HD11 ' A' ' 457' ' ' ILE . 28.6 t80 -55.67 -45.72 77.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.816 ' O ' ' HG3' ' A' ' 413' ' ' MET . 16.3 m -57.99 -52.07 67.06 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.702 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.671 ' HG ' ' HA ' ' A' ' 326' ' ' ILE . 2.6 mm? -62.89 -49.23 75.64 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.716 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.57 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.37 -41.81 88.22 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.776 -174.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.786 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.44 -32.15 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 122.245 0.218 . . . . 0.0 111.152 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.816 ' HG3' ' O ' ' A' ' 409' ' ' THR . 60.4 mtm -70.67 -46.56 62.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 109.831 173.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.039 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.4 mt -60.51 -38.68 85.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.352 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 411' ' ' GLY . 4.5 p -77.0 -2.9 36.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.326 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.63 29.12 36.63 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.786 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 3.8 mm-40 68.43 45.55 1.15 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 122.253 1.025 . . . . 0.0 111.534 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.822 ' ND2' HD23 ' A' ' 421' ' ' LEU . 7.0 t30 -116.16 71.96 0.8 Allowed 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 164.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.65 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.2 OUTLIER -48.05 -35.77 11.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.046 -2.343 . . . . 0.0 111.64 -172.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 423' ' ' SER . 33.3 mt-30 -57.29 -49.91 74.58 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -166.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.822 HD23 ' ND2' ' A' ' 418' ' ' ASN . 3.1 pp -59.53 -48.66 80.78 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.237 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -59.76 -39.8 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.643 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.547 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 44.0 t -59.81 -47.59 85.1 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.793 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -56.02 -37.38 70.93 Favored Glycine 0 C--N 1.32 -0.339 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.052 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.7 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.9 mt -73.02 -42.69 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.548 0.689 . . . . 0.0 110.239 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.6 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -55.94 -44.48 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.727 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.71 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -59.74 -30.12 68.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-O 122.701 1.239 . . . . 0.0 109.236 -173.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.16 -16.82 77.0 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.429 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CG ' HG21 ' A' ' 399' ' ' VAL . 15.3 m-85 -101.65 2.46 38.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.09 144.96 74.87 Favored Pre-proline 0 N--CA 1.416 -2.15 0 CA-C-O 123.501 1.62 . . . . 0.0 113.403 168.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.736 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 60.5 Cg_endo -72.6 -63.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 1 C-N-CA 126.126 4.551 . . . . 0.0 113.281 -173.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.552 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.06 140.23 15.22 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.181 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.83 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.74 -30.69 70.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.2 0.5 . . . . 0.0 111.204 -177.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.752 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -55.33 -48.16 74.6 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.005 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.0 t -58.61 -52.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.593 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.83 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.36 -54.66 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.109 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 53.2 m -62.76 -55.79 23.37 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.047 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.43 -45.13 80.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.642 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 40.0 mt -60.06 -53.46 57.56 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.722 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.704 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.74 -34.15 37.94 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 125.124 1.515 . . . . 0.0 110.403 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.663 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.3 OUTLIER -72.87 -60.62 2.14 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 174.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -75.64 -51.38 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.541 0.61 . . . . 0.0 112.006 -172.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.32 -24.83 63.65 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.636 -178.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.757 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.1 t70 -73.06 -43.35 62.02 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.573 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.7 mt-30 -69.66 -8.95 52.05 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -172.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.436 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 20.7 mm-40 -51.89 155.28 1.82 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 123.574 1.654 . . . . 0.0 114.825 -175.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -52.93 -33.32 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 110.752 -2.931 . . . . 0.0 115.335 -171.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.643 ' H ' ' HB ' ' A' ' 451' ' ' THR . 26.5 m-20 -141.73 177.04 8.44 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.94 -52.35 63.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -65.9 -25.2 67.05 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 174.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.643 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 12.6 m -60.89 -41.43 96.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 119.823 1.192 . . . . 0.0 109.756 172.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 71.8 mtt180 -60.42 -30.71 69.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.921 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 450' ' ' GLN . . . -75.67 -30.33 59.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.835 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -82.05 -44.25 16.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.858 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.506 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.6 p -104.32 -0.74 27.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.256 -1.338 . . . . 0.0 112.383 -167.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.676 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.8 t80 -49.12 -54.31 16.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.349 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -71.39 -25.1 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.99 -43.98 64.22 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.632 ' O ' HG23 ' A' ' 463' ' ' VAL . 30.3 m80 -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.91 172.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.77 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -64.46 -53.77 43.09 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 122.263 1.03 . . . . 0.0 109.13 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -62.21 -30.65 71.23 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.341 -1.754 . . . . 0.0 110.869 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 465' ' ' GLU . . . -67.7 -48.18 67.29 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.771 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.005 HG11 ' HA ' ' A' ' 435' ' ' VAL . 25.9 t -65.0 -35.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.352 174.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.53 -14.44 29.61 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.583 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 2.4 tp10 -92.56 -52.17 4.77 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.404 -0.81 . . . . 0.0 112.114 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.714 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -63.87 -41.15 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.424 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.1 mt -83.39 -16.85 44.32 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.817 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 64.9 50.8 56.37 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 111.565 -2.561 . . . . 0.0 112.977 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 467' ' ' LEU . 0.4 OUTLIER -102.86 -178.9 3.8 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.708 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.0 p30 -101.02 -40.89 7.01 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.509 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -161.02 -75.79 0.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.114 159.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.736 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.8 OUTLIER -61.48 70.57 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -171.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 34.77 46.54 0.61 Allowed Glycine 0 C--N 1.274 -2.862 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.398 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.708 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 22.9 mm-40 -83.89 -53.81 5.32 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 122.245 1.022 . . . . 0.0 111.245 -173.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 41.8 t 68.0 56.25 0.54 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.889 -174.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.817 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -50.85 -48.37 28.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 110.547 -3.024 . . . . 0.0 111.845 175.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -48.85 134.33 16.72 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.213 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 79.9 mt -56.91 -28.09 61.6 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 123.977 0.911 . . . . 0.0 113.381 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.838 178.56 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 301' ' ' ILE . 1.1 Cg_endo . . . . . 0 N--CA 1.478 0.562 0 N-CA-C 111.077 -0.394 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 300' ' ' PRO . 1.8 mp 73.82 -51.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.032 0.533 . . . . 0.0 111.725 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 109.3 -146.81 16.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.906 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.675 ' HB ' HD11 ' A' ' 346' ' ' LEU . 95.8 m -155.94 125.97 6.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 0.0 109.729 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.24 121.9 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.286 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.705 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 19.2 mt -74.82 127.54 86.86 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 121.765 0.793 . . . . 0.0 111.5 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 308' ' ' GLN . 18.5 Cg_endo -72.41 -12.27 27.18 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.881 3.72 . . . . 0.0 111.107 176.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.696 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.6 tp 26.95 -61.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.087 0 C-N-CA 128.704 2.801 . . . . 0.0 115.975 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.36 -32.08 68.22 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.273 0.559 . . . . 0.0 110.257 178.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.517 ' CG ' HG13 ' A' ' 338' ' ' VAL . 6.7 t-160 -62.08 -49.32 76.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.669 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' A' ' 307' ' ' ILE . 59.2 mt -58.88 -49.05 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 124.213 1.005 . . . . 0.0 113.08 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 4.3 mtp-105 -60.64 -30.57 69.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.864 0.364 . . . . 0.0 111.071 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.1 m -70.44 -33.28 71.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.572 0.701 . . . . 0.0 110.205 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.21 -40.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.8 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.788 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.9 p -82.45 -36.61 26.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.969 1.366 . . . . 0.0 109.759 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.98 35.44 8.22 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 112.117 -2.31 . . . . 0.0 111.135 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.531 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 42.8 mt-10 51.49 173.2 0.03 OUTLIER Pre-proline 0 N--CA 1.437 -1.102 0 C-N-CA 124.196 0.998 . . . . 0.0 113.529 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.609 ' HB3' HD11 ' A' ' 324' ' ' ILE . 23.9 Cg_exo -45.2 142.18 6.16 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.015 2.477 . . . . 0.0 112.343 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.507 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 41.9 Cg_endo -89.71 -100.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.305 2.67 . . . . 0.0 112.896 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.448 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 12.3 mmm180 -94.01 -83.36 0.33 Allowed 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 123.149 0.58 . . . . 0.0 110.935 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 18.0 m-20 -103.29 163.18 18.0 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.769 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 35.2 Cg_exo -59.28 -51.59 6.25 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.499 2.133 . . . . 0.0 110.676 172.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.0 OUTLIER -55.27 -14.82 1.95 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.203 -1.817 . . . . 0.0 113.142 177.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.3 mm-40 -91.64 -26.19 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.419 -0.175 . . . . 0.0 111.405 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.646 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.3 OUTLIER -46.44 -45.12 43.86 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.745 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 5.6 Cg_endo -47.47 -62.59 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.905 2.404 . . . . 0.0 113.25 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.65 HG21 HG12 ' A' ' 398' ' ' ILE . 0.9 OUTLIER -63.42 -35.92 74.23 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 122.879 1.323 . . . . 0.0 110.141 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.788 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 42.6 t90 -57.51 -39.5 76.64 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.74 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.849 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.6 OUTLIER -67.62 -47.5 69.48 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 122.465 0.306 . . . . 0.0 111.716 -175.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.408 ' HA3' ' HE1' ' A' ' 413' ' ' MET . . . -53.27 -22.96 16.04 Favored Glycine 0 C--N 1.311 -0.858 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.681 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.441 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -73.16 -42.39 62.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.447 0.642 . . . . 0.0 111.31 175.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.656 ' OD1' HD23 ' A' ' 328' ' ' LEU . 1.4 p30 -104.39 -17.61 14.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.698 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -40.72 -49.44 7.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 40.7 Cg_endo -61.81 -33.0 86.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.576 2.184 . . . . 0.0 111.466 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -71.9 -43.1 65.92 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.884 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 332' ' ' ALA . 87.7 mt -58.79 -49.3 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.71 173.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.37 -14.5 4.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.921 175.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.12 -44.21 7.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.485 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.647 HG11 HG13 ' A' ' 310' ' ' ILE . 92.1 t -60.74 -70.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 123.466 1.603 . . . . 0.0 109.79 169.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -92.62 130.78 35.83 Favored Pre-proline 0 N--CA 1.403 -2.825 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.265 -173.089 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.789 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 73.2 Cg_endo -74.78 -16.85 20.6 Favored 'Trans proline' 0 CA--C 1.498 -1.323 0 C-N-CA 123.788 2.992 . . . . 0.0 110.862 173.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 346' ' ' LEU . 3.1 p 33.4 67.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.342 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.652 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.3 p -78.14 4.26 12.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 112.669 -2.06 . . . . 0.0 113.485 -169.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.797 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 13.5 p -139.86 163.35 45.2 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -63.31 -49.23 4.89 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.367 2.711 . . . . 0.0 108.103 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.747 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.4 OUTLIER -44.32 -45.94 8.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.4 176.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.797 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 10.4 mt -59.22 -51.63 69.17 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 121.64 0.733 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.674 ' HA ' HD12 ' A' ' 350' ' ' ILE . 3.2 ttm180 -54.1 -45.85 71.96 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.262 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 1.006 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.89 -48.75 62.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 111.355 -177.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.646 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 62.9 mtt180 -56.01 -42.62 76.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 339' ' ' PHE . 39.9 mt -57.73 -54.13 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.523 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.55 HD13 ' HB1' ' A' ' 374' ' ' ALA . 19.8 mt -59.43 -52.57 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 122.162 0.982 . . . . 0.0 110.558 -170.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 17.4 m-20 -62.79 -35.18 79.01 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.272 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.41 -36.0 76.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.683 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.58 -53.83 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 CA-C-O 123.107 1.432 . . . . 0.0 110.463 173.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.683 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.7 OUTLIER -72.68 -25.71 61.36 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 111.716 -2.493 . . . . 0.0 109.412 -168.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 75.93 -74.71 1.57 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.895 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -151.39 56.94 0.45 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.332 -177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.61 HD22 ' HG ' ' A' ' 355' ' ' LEU . 81.7 m-20 -76.91 162.61 27.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.783 -0.245 . . . . 0.0 110.581 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.659 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -37.43 -59.73 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.252 1.021 . . . . 0.0 113.736 -166.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -153.9 16.56 0.62 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.511 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.725 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.3 mt -65.59 -3.87 5.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.942 0.497 . . . . 0.0 112.139 -175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.541 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 22.9 t -63.47 84.24 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.529 0.68 . . . . 0.0 110.309 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.82 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -62.63 170.53 2.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.773 0.796 . . . . 0.0 112.388 174.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 366' ' ' GLY . 65.4 p -111.31 156.33 41.32 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.952 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 1.006 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 1.8 Cg_endo -61.92 11.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.673 2.248 . . . . 0.0 113.794 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.518 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -128.53 -5.65 4.94 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.728 ' HB2' HD12 ' A' ' 363' ' ' LEU . 8.4 m-20 -109.57 -19.91 13.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.205 1.002 . . . . 0.0 110.298 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 15.4 p -88.56 16.27 6.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.595 -168.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.518 HD11 ' O ' ' A' ' 366' ' ' GLY . 1.0 OUTLIER -59.61 -40.84 88.86 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.524 -164.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.62 160.09 21.84 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.523 171.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.626 ' O ' HG13 ' A' ' 375' ' ' VAL . 55.6 m95 -69.88 -35.89 75.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.58 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.0 OUTLIER -63.44 -40.24 96.63 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.251 -175.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 36.8 t -68.69 -43.58 75.76 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.938 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.661 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.77 62.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.849 HG12 ' HB3' ' A' ' 328' ' ' LEU . 15.1 m -57.22 -44.73 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.057 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -60.4 -44.75 95.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.019 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.82 HG21 HD11 ' A' ' 363' ' ' LEU . 55.5 m -68.79 -39.42 80.15 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.825 -172.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.725 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.1 mt -60.8 -33.22 72.66 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.849 -0.532 . . . . 0.0 110.57 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.745 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 49.8 t80 -75.0 -46.04 37.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.349 1.071 . . . . 0.0 109.161 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 377' ' ' THR . 1.1 mp -51.54 -32.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.328 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.0 OUTLIER -59.85 -41.24 90.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 44.5 p -100.03 -23.44 14.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.36 -167.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.422 ' HB3' HE22 ' A' ' 390' ' ' GLN . 29.5 m80 -110.22 24.24 13.26 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 57.43 18.31 29.11 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 114.864 0.705 . . . . 0.0 114.864 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.419 HG23 HG13 ' A' ' 380' ' ' ILE . 1.7 m 66.17 159.37 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.286 0.565 . . . . 0.0 111.385 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.472 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -127.64 152.19 76.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -96.76 53.7 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.351 2.701 . . . . 0.0 111.211 166.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.681 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.17 7.87 0.71 Allowed 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -71.04 -48.59 51.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 0.0 110.389 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.655 ' O ' HG13 ' A' ' 394' ' ' VAL . 56.6 mt-30 -76.2 -26.15 55.86 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.694 ' O ' HG22 ' A' ' 394' ' ' VAL . 3.1 mm? -54.05 -31.36 51.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.332 0.969 . . . . 0.0 111.384 -173.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.709 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.56 -49.79 63.41 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.971 174.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.642 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 36.4 m-20 -69.34 -39.25 78.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.9 m -57.46 -44.07 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.419 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.625 ' O ' HG22 ' A' ' 399' ' ' VAL . 6.7 mm -58.24 -46.94 88.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.676 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.648 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 30.3 mmtt -52.4 -43.41 64.75 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.707 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.562 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -76.56 -44.34 16.5 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.1 -172.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.674 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.4 mt -69.31 -41.4 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 117.519 0.66 . . . . 0.0 111.552 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.4 m -57.64 -43.77 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.822 0.82 . . . . 0.0 109.955 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 399' ' ' VAL . 3.4 t70 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.064 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 70.1 mt-30 -83.78 -54.27 5.02 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.547 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.4 OUTLIER -112.43 -30.46 7.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.796 -166.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.11 163.49 11.55 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.735 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.86 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.17 -43.38 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.654 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -56.3 -50.51 71.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.1 0.476 . . . . 0.0 111.448 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.576 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -51.03 65.19 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.5 178.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.674 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -53.0 -41.85 65.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.548 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 31.6 t80 -57.08 -46.69 82.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.665 0.745 . . . . 0.0 109.086 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.821 ' O ' ' HG3' ' A' ' 413' ' ' MET . 8.5 m -58.69 -52.5 65.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.562 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.682 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.92 -49.01 76.46 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.737 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 415' ' ' SER . . . -55.95 -42.23 86.17 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.923 -174.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.759 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.46 -32.64 66.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.66 0.23 . . . . 0.0 111.239 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.821 ' HG3' ' O ' ' A' ' 409' ' ' THR . 66.7 mtm -70.63 -46.98 62.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.383 0.611 . . . . 0.0 110.06 174.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.057 HD23 ' HA ' ' A' ' 376' ' ' ALA . 14.4 mt -59.23 -38.46 80.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.023 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.635 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.3 OUTLIER -77.45 -14.62 59.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.951 -176.066 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.67 27.03 8.71 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.178 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.759 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 3.9 mm-40 64.35 44.17 4.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.101 0.961 . . . . 0.0 112.292 177.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.685 ' ND2' HD21 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -120.24 69.5 0.86 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 166.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.667 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.8 OUTLIER -47.47 -35.25 8.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 111.568 -2.56 . . . . 0.0 113.477 -165.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' A' ' 423' ' ' SER . 28.0 mt-30 -55.03 -47.74 74.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -163.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.685 HD21 ' ND2' ' A' ' 418' ' ' ASN . 1.9 pp -59.71 -48.99 79.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.384 0.612 . . . . 0.0 110.81 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.629 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.25 -38.87 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.574 1.178 . . . . 0.0 109.263 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.65 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 40.4 t -61.13 -46.53 90.19 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 112.578 -2.101 . . . . 0.0 111.905 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.77 72.93 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.019 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.709 HD13 ' HA2' ' A' ' 392' ' ' GLY . 1.6 mt -72.26 -41.91 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.549 0.69 . . . . 0.0 110.162 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.58 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -56.18 -44.8 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.604 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.755 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.38 -30.77 68.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.618 1.199 . . . . 0.0 109.376 -174.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.68 -14.33 77.93 Favored Glycine 0 C--N 1.299 -1.483 0 CA-C-N 112.845 -1.979 . . . . 0.0 112.503 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.67 ' CG ' HG21 ' A' ' 399' ' ' VAL . 16.5 m-85 -103.83 3.03 33.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.5 144.75 78.25 Favored Pre-proline 0 N--CA 1.411 -2.411 0 CA-C-O 123.541 1.639 . . . . 0.0 112.996 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.746 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 60.9 Cg_endo -72.94 -63.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 1 C-N-CA 126.074 4.516 . . . . 0.0 113.422 -173.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.559 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -104.58 141.86 15.37 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.899 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -65.68 -26.82 67.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.22 0.51 . . . . 0.0 111.216 -176.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.778 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -58.5 -46.33 86.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.029 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.9 t -59.39 -52.04 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.629 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.899 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.36 -53.79 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.467 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 94.4 m -61.15 -56.6 18.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.96 -46.24 78.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.519 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.842 ' O ' HD22 ' A' ' 443' ' ' LEU . 54.9 mt -59.95 -53.5 57.08 Favored 'General case' 0 CA--C 1.482 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.64 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.674 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.5 mm-40 -51.77 -34.48 39.82 Favored 'General case' 0 N--CA 1.415 -2.19 0 O-C-N 124.956 1.41 . . . . 0.0 110.682 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.674 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.29 -61.81 1.69 Allowed 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 175.079 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.55 -50.17 14.59 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.85 -0.531 . . . . 0.0 112.205 -171.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.7 -25.35 62.8 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.34 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.752 ' N ' HD23 ' A' ' 443' ' ' LEU . 14.5 t70 -72.81 -42.74 63.54 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.701 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 36.8 mt-30 -68.97 -7.6 36.77 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -172.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 451' ' ' THR . 4.9 mm-40 -51.66 156.22 1.42 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 123.516 1.627 . . . . 0.0 114.363 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.487 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.22 -32.37 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 110.719 -2.946 . . . . 0.0 115.38 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.663 ' H ' ' HB ' ' A' ' 451' ' ' THR . 19.1 m-20 -142.02 179.94 6.59 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.442 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 3.6 m-20 -62.65 -55.58 25.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.61 -25.2 67.86 Favored 'General case' 0 N--CA 1.403 -2.795 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.411 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.663 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 23.6 m -60.31 -41.91 94.45 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 119.793 1.179 . . . . 0.0 109.543 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 45.8 mtt180 -60.88 -30.32 70.08 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.851 172.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.548 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.65 -29.47 59.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.921 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.09 -44.66 17.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.788 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.562 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 30.1 p -106.24 0.39 25.16 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.184 -167.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 460' ' ' LEU . 7.9 t80 -48.91 -53.83 17.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.03 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.2 mm -71.06 -25.49 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.562 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.17 -43.42 64.61 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.643 ' O ' HG23 ' A' ' 463' ' ' VAL . 26.8 m80 -65.45 -32.03 73.43 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.722 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.717 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.14 -53.47 37.42 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.066 0.936 . . . . 0.0 109.512 -178.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.666 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 8.3 m-80 -62.37 -32.31 73.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.068 173.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -61.66 -53.36 57.23 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.893 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.029 HG11 ' HA ' ' A' ' 435' ' ' VAL . 20.9 t -62.7 -34.88 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.858 0 CA-C-O 121.818 0.818 . . . . 0.0 110.4 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.7 -14.7 33.95 Favored 'General case' 0 C--O 1.207 -1.155 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.32 170.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.666 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 43.4 mt-10 -92.99 -48.28 6.59 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.097 -1.002 . . . . 0.0 112.69 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.734 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.6 pt -66.27 -38.1 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.237 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.6 mt -85.27 -17.16 37.78 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.753 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 61.8 55.73 26.8 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 111.659 -2.518 . . . . 0.0 112.942 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 467' ' ' LEU . 0.5 OUTLIER -105.02 -159.21 0.7 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 122.088 0.947 . . . . 0.0 109.644 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.616 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.3 p30 -124.76 -41.39 2.13 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -159.21 -79.59 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 112.251 -2.249 . . . . 0.0 110.619 156.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.746 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 1.3 mpt_? -59.06 68.13 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 471' ' ' ALA . . . 33.47 53.58 0.6 Allowed Glycine 0 C--N 1.278 -2.689 0 CA-C-N 111.099 -2.773 . . . . 0.0 113.367 173.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.616 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 5.9 mm-40 -90.13 -49.07 6.78 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 122.4 1.095 . . . . 0.0 111.259 -173.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 27.2 t 62.0 62.58 1.21 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.119 -2.31 . . . . 0.0 108.561 -171.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.753 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -50.71 -50.36 23.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 110.932 -2.849 . . . . 0.0 112.115 177.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.651 ' HD2' ' N ' ' A' ' 478' ' ' LEU . 0.1 OUTLIER -75.4 -176.16 3.05 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.154 178.387 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.651 ' N ' ' HD2' ' A' ' 477' ' ' ARG . 84.9 mt -53.17 -175.18 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-N 113.891 -1.504 . . . . 0.0 112.67 -178.333 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.465 ' HB2' HD12 ' A' ' 301' ' ' ILE . 51.7 Cg_exo . . . . . 0 N--CA 1.482 0.813 0 N-CA-C 111.425 -0.26 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 300' ' ' PRO . 2.6 mp -99.35 -62.35 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.82 0.343 . . . . 0.0 110.661 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -123.82 73.23 0.41 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.252 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.467 ' HB ' HD11 ' A' ' 346' ' ' LEU . 25.0 m 72.35 118.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.352 1.072 . . . . 0.0 112.222 177.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.1 p -79.3 130.07 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.335 176.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.72 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 18.3 mt -74.73 125.43 89.56 Favored Pre-proline 0 N--CA 1.426 -1.65 0 CA-C-O 121.909 0.862 . . . . 0.0 111.852 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 308' ' ' GLN . 17.6 Cg_endo -72.46 -11.32 26.37 Favored 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 124.929 3.752 . . . . 0.0 111.372 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.7 ' H ' HG22 ' A' ' 305' ' ' ILE . 5.7 tp 25.66 -60.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 C-N-CA 128.677 2.791 . . . . 0.0 116.34 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.558 ' N ' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -58.17 -32.44 68.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.355 0.598 . . . . 0.0 110.138 178.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.9 t-160 -62.4 -48.95 77.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.66 172.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 307' ' ' ILE . 57.6 mt -58.59 -48.71 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 C-N-CA 124.006 0.922 . . . . 0.0 113.172 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.671 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 6.4 mtp-105 -60.22 -30.11 69.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.14 -0.35 . . . . 0.0 111.41 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 46.9 m -69.6 -35.43 75.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.564 0.697 . . . . 0.0 109.845 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.547 HG12 HG23 ' A' ' 314' ' ' THR . 0.6 OUTLIER -66.07 -40.9 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.717 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.846 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 30.3 p -83.35 -36.88 24.03 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.797 1.284 . . . . 0.0 110.235 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.66 36.67 7.8 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.245 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 38.8 mt-10 49.87 175.53 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 124.071 0.948 . . . . 0.0 113.261 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.628 ' HB3' HD11 ' A' ' 324' ' ' ILE . 90.8 Cg_exo -52.44 134.7 52.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.603 2.202 . . . . 0.0 112.48 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.737 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 95.1 Cg_endo -85.23 -90.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.487 2.792 . . . . 0.0 114.788 -174.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.462 ' HG2' ' HB2' ' A' ' 318' ' ' PRO . 6.4 mmm180 -93.76 -78.93 0.42 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.048 0.928 . . . . 0.0 113.033 -169.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.667 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 65.1 m-20 -105.4 -159.93 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.756 -169.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 320' ' ' ASN . 58.6 Cg_endo -90.89 -32.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 121.647 1.565 . . . . 0.0 114.671 159.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 15.72 10.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -169.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.725 ' OE2' ' HG2' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -106.31 -35.83 7.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.671 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.633 ' HA ' ' HB3' ' A' ' 327' ' ' TRP . 0.4 OUTLIER -40.15 -46.15 5.22 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.345 1.458 . . . . 0.0 114.077 178.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.706 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 4.2 Cg_endo -47.01 -63.04 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.055 2.503 . . . . 0.0 112.814 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.621 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 0.8 OUTLIER -65.35 -35.53 75.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 123.054 1.407 . . . . 0.0 110.428 -179.047 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.846 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 32.7 t90 -58.34 -34.05 70.2 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.973 177.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.889 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.8 OUTLIER -70.45 -48.04 57.8 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.6 -23.13 19.31 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.793 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.498 ' CD ' HG21 ' A' ' 406' ' ' THR . 0.5 OUTLIER -74.41 -42.94 58.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.247 1.023 . . . . 0.0 110.617 174.137 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.675 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.0 m-20 -95.67 -24.96 16.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.641 -1.618 . . . . 0.0 113.679 -168.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.569 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.1 -49.76 11.28 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 124.418 1.087 . . . . 0.0 113.749 177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 49.3 Cg_endo -63.09 -31.27 75.92 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.544 2.163 . . . . 0.0 111.525 177.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.04 -44.11 55.47 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.689 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.6 HG12 HG23 ' A' ' 310' ' ' ILE . 88.7 mt -58.37 -48.69 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.584 173.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 19.4 t70 -57.09 -17.85 12.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.264 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.84 -44.51 10.15 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.68 HG11 HG13 ' A' ' 310' ' ' ILE . 94.0 t -60.64 -68.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 123.587 1.66 . . . . 0.0 110.242 169.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.825 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -96.29 130.07 31.91 Favored Pre-proline 0 N--CA 1.403 -2.802 0 CA-C-N 110.791 -2.913 . . . . 0.0 112.787 -171.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.772 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -75.4 -16.36 19.39 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 123.89 3.06 . . . . 0.0 110.927 174.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.462 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.9 p 33.53 66.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 112.33 -2.214 . . . . 0.0 110.323 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.632 ' N ' HD12 ' A' ' 346' ' ' LEU . 34.8 p -77.88 2.71 16.48 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.681 -2.054 . . . . 0.0 113.225 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.798 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.1 p -138.06 161.36 60.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -63.97 -46.53 8.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.419 2.746 . . . . 0.0 108.454 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.637 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.2 OUTLIER -45.51 -44.2 12.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.425 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.798 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 11.3 mt -61.35 -52.01 66.43 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.696 0.76 . . . . 0.0 110.459 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.641 ' HA ' HD12 ' A' ' 350' ' ' ILE . 2.6 ttm180 -52.12 -47.32 65.38 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.627 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 1.058 ' HG ' ' HA ' ' A' ' 365' ' ' PRO . 0.5 OUTLIER -69.45 -48.24 61.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.734 -176.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 46.4 mtt180 -56.54 -42.1 77.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.232 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.825 HD11 ' CD2' ' A' ' 339' ' ' PHE . 43.0 mt -57.24 -53.27 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.446 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.61 HD13 ' HB1' ' A' ' 374' ' ' ALA . 18.2 mt -59.4 -52.57 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 122.158 0.98 . . . . 0.0 110.986 -170.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.553 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 25.8 m-20 -63.42 -35.45 80.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.37 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.38 75.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.656 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.8 OUTLIER -57.86 -54.31 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.052 1.406 . . . . 0.0 110.66 173.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.818 HD23 HD22 ' A' ' 358' ' ' ASN . 0.6 OUTLIER -72.12 -24.76 61.52 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.328 -169.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.5 -65.28 1.06 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.849 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -139.51 66.91 0.51 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.233 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.818 HD22 HD23 ' A' ' 355' ' ' LEU . 31.3 p30 -78.75 164.9 24.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.23 0.212 . . . . 0.0 111.283 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.558 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -56.52 -65.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 122.94 0.496 . . . . 0.0 111.289 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -148.55 10.9 1.12 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.565 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.665 ' HB2' ' ND2' ' A' ' 358' ' ' ASN . 3.7 mt -65.01 -5.85 7.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.723 0.409 . . . . 0.0 111.408 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.553 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 19.4 t -60.71 82.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.402 0.62 . . . . 0.0 110.596 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.699 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -64.55 170.67 3.8 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.953 0.882 . . . . 0.0 112.629 175.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . . . . . . . . . 33.4 p -118.66 155.5 52.35 Favored Pre-proline 0 N--CA 1.436 -1.17 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.99 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 1.058 ' HA ' ' HG ' ' A' ' 348' ' ' CYS . 1.9 Cg_endo -54.8 -11.28 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.801 2.334 . . . . 0.0 113.419 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.542 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -103.75 -6.31 43.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.139 -0.553 . . . . 0.0 114.471 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.678 ' HB2' HD12 ' A' ' 363' ' ' LEU . 1.3 m-20 -109.83 -18.83 13.33 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.075 0.941 . . . . 0.0 110.777 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.744 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 19.3 p -92.43 18.86 7.85 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.747 -167.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.542 HD11 ' O ' ' A' ' 366' ' ' GLY . 1.8 mt -62.15 -35.71 79.6 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.369 1.081 . . . . 0.0 110.242 -162.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.5 p -116.03 167.31 11.09 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.313 171.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.683 ' O ' HG13 ' A' ' 375' ' ' VAL . 43.1 m95 -70.39 -34.05 72.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.5 m-20 -64.21 -43.56 94.65 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.559 0.695 . . . . 0.0 109.711 -173.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.7 p -66.24 -44.21 84.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.312 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -64.02 -51.85 62.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.902 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.0 m -58.13 -44.03 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.644 0.735 . . . . 0.0 109.568 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.033 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.63 -46.01 90.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.777 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.699 HG21 HD11 ' A' ' 363' ' ' LEU . 34.4 m -65.84 -40.74 92.02 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.445 -173.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.7 mt -60.16 -33.55 72.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.677 0.671 . . . . 0.0 110.369 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.706 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 65.8 t80 -73.36 -46.46 49.02 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 122.382 1.087 . . . . 0.0 109.567 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -51.83 -32.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 112.801 -1.999 . . . . 0.0 111.158 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.45 -38.13 83.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 176.399 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 37.2 p -98.25 -22.83 15.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.639 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.442 ' HB3' ' OE1' ' A' ' 390' ' ' GLN . 26.6 m80 -110.08 22.19 15.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.91 21.0 28.85 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.4 m 65.98 158.17 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 111.906 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.488 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -126.65 155.35 75.05 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 386' ' ' PHE . 91.5 Cg_endo -101.61 58.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.912 3.075 . . . . 0.0 111.437 166.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.773 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 58.5 -2.08 0.09 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -69.64 -45.11 69.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.492 . . . . 0.0 110.847 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.626 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.6 mt-30 -74.91 -26.71 59.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.919 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.6 mm? -54.2 -30.98 51.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.922 0.783 . . . . 0.0 111.787 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.71 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.99 -48.54 66.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.545 173.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 59.1 m-20 -68.47 -41.16 80.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.087 0.555 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.44 -44.93 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.257 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.678 ' O ' HG22 ' A' ' 399' ' ' VAL . 7.4 mm -58.34 -47.39 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.459 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.637 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.3 mmtt -52.2 -43.17 64.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.936 0.772 . . . . 0.0 111.49 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.58 -44.11 17.06 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.15 -172.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.7 mt -69.12 -42.0 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 117.294 0.547 . . . . 0.0 111.596 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -58.71 -43.24 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.884 0.85 . . . . 0.0 109.872 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 399' ' ' VAL . 19.0 t70 -57.16 -44.5 83.51 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.328 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -86.66 -53.3 5.03 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.673 -1.149 . . . . 0.0 113.424 -170.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.579 ' HG3' HG23 ' A' ' 398' ' ' ILE . 0.1 OUTLIER -109.04 -31.44 7.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.427 0.632 . . . . 0.0 111.549 -170.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 127.62 165.07 11.79 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.841 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.903 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.3 -45.93 96.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -55.91 -50.14 71.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.591 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.515 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.42 -50.82 66.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.369 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.673 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.54 -41.58 63.63 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.561 ' HB3' HD11 ' A' ' 457' ' ' ILE . 45.3 t80 -57.85 -46.51 84.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.572 0.701 . . . . 0.0 109.533 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.744 ' O ' ' HG3' ' A' ' 413' ' ' MET . 6.7 m -59.82 -52.71 64.28 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.816 -178.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.715 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.8 mm? -62.06 -49.03 77.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.875 177.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.627 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.78 -41.35 82.97 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.091 -175.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.625 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -72.06 -33.73 68.18 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.643 0.222 . . . . 0.0 110.826 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.902 ' HE3' HG21 ' A' ' 375' ' ' VAL . 62.4 mtm -69.51 -46.63 66.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.042 174.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.033 HD23 ' HA ' ' A' ' 376' ' ' ALA . 15.9 mt -58.79 -40.13 83.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.924 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.919 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 3.5 m -78.84 -14.52 59.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.03 44.08 4.54 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.948 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.582 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.0 OUTLIER 56.58 42.18 27.54 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 124.269 1.028 . . . . 0.0 113.323 178.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.771 ' ND2' HD21 ' A' ' 421' ' ' LEU . 0.1 OUTLIER -119.5 74.27 0.99 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.625 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.7 OUTLIER -49.65 -36.04 23.33 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 111.907 -2.406 . . . . 0.0 113.009 -167.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.5 mt-30 -54.83 -49.24 71.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -163.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.771 HD21 ' ND2' ' A' ' 418' ' ' ASN . 1.6 pp -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.497 0.665 . . . . 0.0 111.184 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.587 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.648 1.213 . . . . 0.0 109.152 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.564 ' HG ' ' HE2' ' A' ' 456' ' ' PHE . 41.3 t -61.56 -46.9 87.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.467 -2.152 . . . . 0.0 112.023 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.21 -37.97 75.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.843 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.71 HD13 ' HA2' ' A' ' 392' ' ' GLY . 2.4 mt -72.17 -41.47 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 110.048 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.623 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -57.39 -45.05 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.003 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.709 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -61.69 -28.97 69.78 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 122.704 1.24 . . . . 0.0 108.963 -173.036 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.9 -17.86 77.21 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.374 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.73 ' CG ' HG21 ' A' ' 399' ' ' VAL . 11.3 m-85 -101.03 4.16 42.1 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.39 144.29 71.7 Favored Pre-proline 0 N--CA 1.41 -2.448 0 CA-C-O 123.722 1.725 . . . . 0.0 113.226 168.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.823 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 58.5 Cg_endo -71.37 -58.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.115 1 C-N-CA 126.308 4.672 . . . . 0.0 113.172 -170.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -112.22 142.38 17.15 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.105 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.827 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -61.48 -31.74 71.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.043 0.422 . . . . 0.0 111.28 -177.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.757 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.2 -46.47 79.44 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.026 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.4 t -59.44 -51.04 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.785 177.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.827 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -53.64 -54.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 57.0 m -62.7 -56.44 17.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.551 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.48 -42.83 78.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.484 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.836 ' O ' HD22 ' A' ' 443' ' ' LEU . 54.1 mt -63.42 -53.25 55.34 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.204 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 35.0 mm-40 -51.31 -33.84 30.77 Favored 'General case' 0 N--CA 1.419 -2.014 0 O-C-N 124.959 1.412 . . . . 0.0 110.334 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.687 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.99 -60.96 1.99 Allowed 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 172.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 6.2 ptp180 -74.03 -53.6 9.67 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.613 -0.679 . . . . 0.0 112.536 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -59.24 -24.96 63.62 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.63 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.749 ' N ' HD23 ' A' ' 443' ' ' LEU . 8.3 t70 -73.17 -42.16 63.08 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.494 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 35.1 mt-30 -70.64 -7.98 48.35 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.554 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 6.2 mm-40 -51.31 158.46 0.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 123.581 1.657 . . . . 0.0 114.623 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.539 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.9 mp -53.08 -32.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 110.543 -3.026 . . . . 0.0 115.33 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.663 ' H ' ' HB ' ' A' ' 451' ' ' THR . 13.6 m-20 -142.75 179.76 6.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.759 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.426 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 11.1 p-10 -61.68 -54.95 35.79 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -65.64 -26.51 67.84 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.663 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 24.5 m -59.17 -41.19 87.86 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 119.905 1.229 . . . . 0.0 109.678 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 66.7 mtt180 -60.47 -29.57 69.13 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.935 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.554 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -76.61 -33.99 58.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.332 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.5 mm-40 -78.51 -44.63 23.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.941 -171.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.56 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 24.8 p -105.17 0.53 27.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.061 -167.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.703 ' CE1' HD23 ' A' ' 460' ' ' LEU . 5.6 t80 -49.19 -54.87 14.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 405' ' ' ALA . 25.3 mm -70.44 -26.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.56 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.23 -42.97 68.19 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 463' ' ' VAL . 30.1 m80 -67.78 -31.89 72.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.745 172.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.74 HD22 ' CD1' ' A' ' 439' ' ' LEU . 0.2 OUTLIER -63.48 -53.39 52.8 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.179 0.99 . . . . 0.0 109.292 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.591 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.4 m-80 -62.89 -31.8 72.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.525 173.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -63.96 -50.99 66.46 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.854 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.026 HG11 ' HA ' ' A' ' 435' ' ' VAL . 31.9 t -63.04 -34.52 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.906 0.86 . . . . 0.0 110.34 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.534 ' HD1' HD12 ' A' ' 469' ' ' LEU . 19.2 m-30 -61.18 -15.95 39.53 Favored 'General case' 0 C--O 1.205 -1.284 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.185 169.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 462' ' ' ALA . 33.5 mm-40 -90.34 -49.8 6.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 112.789 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.736 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.7 pt -65.92 -39.42 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.86 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -84.67 -16.04 43.27 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 171.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.761 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 63.31 52.02 50.21 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 111.741 -2.482 . . . . 0.0 113.1 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.731 HD11 HD12 ' A' ' 467' ' ' LEU . 0.3 OUTLIER -103.8 177.96 4.69 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 123.583 0.753 . . . . 0.0 109.892 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.65 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.4 p30 -96.55 -41.4 8.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 167.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.416 ' HB3' ' HD3' ' A' ' 472' ' ' ARG . . . -160.42 -74.37 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.356 -2.202 . . . . 0.0 111.19 158.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.823 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -63.15 68.91 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -169.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.476 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 40.09 40.03 1.66 Allowed Glycine 0 C--N 1.278 -2.677 0 CA-C-N 111.176 -2.738 . . . . 0.0 113.48 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.65 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 11.4 mm-40 -78.87 -51.62 9.44 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.142 0.972 . . . . 0.0 111.566 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 28.9 t 65.18 55.06 1.14 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.306 -173.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.761 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.3 OUTLIER -53.6 -47.26 61.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 110.637 -2.983 . . . . 0.0 111.928 176.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 477' ' ' ARG . 8.3 mmm-85 -51.49 145.68 8.41 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.943 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.1 -25.79 68.53 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.351 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.439 -1.014 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.146 178.103 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.408 ' O ' ' HB ' ' A' ' 301' ' ' ILE . 5.1 Cg_exo . . . . . 0 N--CA 1.476 0.478 0 N-CA-C 110.571 -0.588 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 300' ' ' PRO . 2.3 mp 71.33 -59.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.185 0.594 . . . . 0.0 111.096 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 346' ' ' LEU . . . 167.94 -19.27 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 58.6 m 76.97 113.7 0.07 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.183 0.992 . . . . 0.0 111.69 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.0 p -66.54 127.32 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.725 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.702 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 24.3 mt -73.83 125.85 90.01 Favored Pre-proline 0 N--CA 1.422 -1.863 0 CA-C-O 121.716 0.769 . . . . 0.0 111.643 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 308' ' ' GLN . 23.3 Cg_endo -71.75 -15.98 29.95 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 124.555 3.503 . . . . 0.0 110.883 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.744 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 5.9 tp 30.38 -58.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.503 0 C-N-CA 128.673 2.789 . . . . 0.0 116.275 172.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 306' ' ' PRO . 3.3 mm-40 -56.17 -38.84 71.47 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.097 0.951 . . . . 0.0 109.811 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.535 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -59.85 -47.8 84.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.799 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 307' ' ' ILE . 65.2 mt -60.2 -48.22 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 123.861 0.864 . . . . 0.0 113.036 174.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.744 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 5.5 mtp180 -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.432 -1.337 0 O-C-N 122.032 -0.417 . . . . 0.0 110.461 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 23.2 t -70.03 -34.05 72.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.409 0.623 . . . . 0.0 109.6 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.568 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.38 -41.59 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.775 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 331' ' ' ASN . 29.8 p -83.0 -36.66 24.85 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.765 1.269 . . . . 0.0 109.671 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.61 34.04 8.79 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.419 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.543 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 51.23 173.1 0.03 OUTLIER Pre-proline 0 N--CA 1.433 -1.323 0 C-N-CA 124.419 1.087 . . . . 0.0 113.105 -173.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.774 ' HB3' HD11 ' A' ' 324' ' ' ILE . 28.2 Cg_exo -46.16 152.34 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.128 2.552 . . . . 0.0 113.586 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -89.52 -101.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.264 2.643 . . . . 0.0 111.991 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.473 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 13.3 mmt180 -104.38 -82.63 0.51 Allowed 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.126 0.489 . . . . 0.0 111.504 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 22.9 m-80 -98.33 163.14 19.76 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.861 -171.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.15 -51.67 6.26 Favored 'Trans proline' 0 CA--C 1.509 -0.756 0 C-N-CA 123.117 2.545 . . . . 0.0 110.971 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -13.56 2.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.492 -1.686 . . . . 0.0 113.29 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.2 mt-10 -92.86 -31.74 14.87 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.256 -0.177 . . . . 0.0 110.89 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -47.83 -45.03 60.46 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -177.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.738 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 8.5 Cg_endo -49.64 -61.91 0.5 Allowed 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.974 2.449 . . . . 0.0 112.849 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.677 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.25 -37.19 77.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.686 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 38.3 t90 -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.099 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.848 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.22 -48.18 58.17 Favored 'General case' 0 N--CA 1.406 -2.643 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.58 -23.07 18.9 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.827 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.469 ' CD ' HG21 ' A' ' 406' ' ' THR . 1.2 mmm180 -74.57 -43.06 57.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.259 1.028 . . . . 0.0 110.483 174.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.729 ' HB3' HG22 ' A' ' 314' ' ' THR . 48.3 m-20 -95.16 -24.18 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.444 -1.707 . . . . 0.0 113.601 -168.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.04 -50.32 10.87 Favored Pre-proline 0 C--N 1.306 -1.295 0 C-N-CA 124.223 1.009 . . . . 0.0 113.612 176.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.1 Cg_endo -62.08 -31.76 83.48 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.741 2.294 . . . . 0.0 111.828 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -73.59 -44.17 57.86 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.549 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.619 HG23 HG23 ' A' ' 310' ' ' ILE . 91.0 mt -58.38 -48.42 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.855 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 339' ' ' PHE . 19.2 t70 -55.67 -19.61 11.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.07 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.41 -48.07 9.74 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 310' ' ' ILE . 62.2 t -57.89 -72.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-O 123.445 1.593 . . . . 0.0 110.098 169.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.875 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.6 OUTLIER -92.39 129.56 40.53 Favored Pre-proline 0 N--CA 1.405 -2.686 0 CA-C-N 111.196 -2.729 . . . . 0.0 112.623 -171.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.774 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.7 Cg_endo -74.8 -16.47 20.73 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 123.981 3.12 . . . . 0.0 110.763 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.465 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.4 p 34.36 66.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 112.347 -2.206 . . . . 0.0 110.182 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.688 ' N ' HD12 ' A' ' 346' ' ' LEU . 37.4 p -79.37 8.66 5.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.945 -1.934 . . . . 0.0 113.586 -170.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.775 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.5 p -142.23 164.13 35.37 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.417 ' O ' ' SG ' ' A' ' 348' ' ' CYS . 44.6 Cg_exo -63.06 -50.02 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.154 2.569 . . . . 0.0 108.309 172.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.68 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 0.7 OUTLIER -42.7 -48.23 5.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.972 176.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.775 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 9.1 mt -56.43 -52.61 64.03 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.587 -177.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.718 ' HA ' HD12 ' A' ' 350' ' ' ILE . 39.1 ttm105 -54.72 -45.61 74.07 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.56 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 1.019 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -69.48 -48.38 60.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.067 0.461 . . . . 0.0 111.258 -176.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 49.7 mtp180 -55.96 -41.9 75.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.929 177.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.875 HD11 ' CD2' ' A' ' 339' ' ' PHE . 49.0 mt -58.72 -54.29 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.678 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.571 HG23 HD11 ' A' ' 328' ' ' LEU . 19.5 mt -57.85 -52.97 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.109 0.956 . . . . 0.0 110.777 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.499 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.2 m-20 -63.56 -34.98 79.01 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.911 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.16 -38.34 78.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.858 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.13 -52.82 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 123.001 1.382 . . . . 0.0 110.192 175.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.819 HD23 HD22 ' A' ' 358' ' ' ASN . 0.8 OUTLIER -72.96 -24.81 60.83 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 111.719 -2.491 . . . . 0.0 109.414 -170.157 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.82 -80.35 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 113.656 -1.611 . . . . 0.0 113.013 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -118.02 72.71 0.29 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.819 HD22 HD23 ' A' ' 355' ' ' LEU . 18.5 p30 -94.59 157.68 15.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 122.541 0.336 . . . . 0.0 111.32 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.4 mp -81.28 89.34 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-O 121.11 0.481 . . . . 0.0 111.83 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.47 -16.97 15.64 Favored Glycine 0 C--N 1.305 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.552 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.726 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.4 mt -60.68 -4.68 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 25.1 t -63.69 81.98 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 110.353 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 377' ' ' THR . 0.8 OUTLIER -61.96 172.46 1.35 Allowed 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.908 174.384 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.557 ' C ' ' H ' ' A' ' 366' ' ' GLY . 44.1 p -112.76 162.71 20.39 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.186 -174.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 1.019 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 2.0 Cg_endo -67.04 21.21 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.42 2.08 . . . . 0.0 112.583 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -131.66 -12.05 2.04 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.329 -0.85 . . . . 0.0 114.207 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.708 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.5 m-20 -105.2 -20.49 13.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.715 1.245 . . . . 0.0 109.44 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 3.8 p -75.3 19.11 0.18 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.244 -172.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -59.73 -32.73 70.82 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.362 1.077 . . . . 0.0 109.814 -170.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.3 35.98 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.266 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.588 ' O ' HG13 ' A' ' 375' ' ' VAL . 65.4 m95 -69.66 -35.49 75.2 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.61 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 0.4 OUTLIER -60.81 -40.86 94.3 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.804 -175.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 53.9 m -68.92 -43.69 74.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.702 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.53 -52.71 62.38 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.887 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.3 m -57.24 -45.73 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.395 0.617 . . . . 0.0 109.666 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.003 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.68 -45.57 93.43 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.889 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 363' ' ' LEU . 31.7 m -67.56 -37.69 83.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.594 -172.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' A' ' 361' ' ' LEU . 2.4 mt -60.95 -35.22 76.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.471 0.578 . . . . 0.0 110.434 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.738 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 55.6 t80 -72.51 -46.91 52.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.561 1.172 . . . . 0.0 109.175 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -52.07 -32.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.344 171.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.7 OUTLIER -60.13 -46.58 89.16 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 123.193 0.597 . . . . 0.0 111.175 175.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.7 p -89.12 -23.98 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.531 -171.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.526 ' HB3' HE22 ' A' ' 390' ' ' GLN . 27.2 m80 -111.28 23.22 14.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.0 21.56 24.63 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.745 0.658 . . . . 0.0 114.745 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 m 67.04 160.36 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.906 0.482 . . . . 0.0 111.413 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.2 OUTLIER -125.45 158.48 64.25 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 389' ' ' HIS . 90.6 Cg_endo -101.33 53.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.894 3.063 . . . . 0.0 111.466 166.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.742 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.83 -14.99 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -175.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.441 ' H ' ' C ' ' A' ' 387' ' ' PRO . 6.1 t60 -57.52 -42.59 83.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.881 0.372 . . . . 0.0 110.648 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.664 ' O ' HG13 ' A' ' 394' ' ' VAL . 28.7 mt-30 -75.2 -27.93 59.79 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -171.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.1 mm? -54.16 -31.27 52.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.972 0.806 . . . . 0.0 111.455 -176.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.744 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.37 -51.48 51.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.735 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.605 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 17.9 m-20 -68.97 -37.91 79.06 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.7 m -57.66 -46.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.044 0.449 . . . . 0.0 110.101 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 399' ' ' VAL . 21.8 mm -59.01 -45.87 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.967 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.726 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 37.2 mmtt -52.05 -42.78 63.41 Favored 'General case' 0 C--O 1.244 0.793 0 O-C-N 124.025 0.828 . . . . 0.0 111.531 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.35 -44.19 13.96 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.128 -172.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.677 HG12 HG21 ' A' ' 326' ' ' ILE . 2.5 mt -69.31 -40.81 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 117.429 0.615 . . . . 0.0 111.575 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -58.84 -43.94 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.823 0.821 . . . . 0.0 109.749 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.46 ' N ' HG23 ' A' ' 399' ' ' VAL . 16.2 t70 -59.19 -42.26 90.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.486 177.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 29.2 mm-40 -86.28 -53.1 5.22 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.331 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 398' ' ' ILE . 1.1 mm-40 -109.56 -31.15 7.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.467 0.651 . . . . 0.0 111.622 -170.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.28 164.05 11.67 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.889 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.48 -44.1 98.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 123.104 0.561 . . . . 0.0 112.417 -175.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.667 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.54 -52.27 62.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.57 0.7 . . . . 0.0 111.843 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.515 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.5 -49.69 68.07 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.348 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.671 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.31 -42.18 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 29.1 t80 -55.72 -48.65 74.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.589 0.709 . . . . 0.0 109.371 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.767 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.1 m -58.32 -52.16 66.75 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.752 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.696 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.52 -48.72 79.78 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.604 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.25 -43.7 89.26 Favored Glycine 0 C--N 1.315 -0.603 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.392 -174.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.589 ' CE ' ' HA ' ' A' ' 417' ' ' GLN . 0.1 OUTLIER -72.21 -31.22 65.67 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.795 0.298 . . . . 0.0 110.874 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.887 ' HE3' HG21 ' A' ' 375' ' ' VAL . 63.9 mtm -69.03 -48.97 61.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.35 0.595 . . . . 0.0 109.866 172.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.6 mt -59.07 -39.35 81.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.113 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.768 ' HB3' ' ND2' ' A' ' 418' ' ' ASN . 0.4 OUTLIER -77.4 -14.3 59.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.684 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.84 4.88 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.866 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.589 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 1.0 OUTLIER 58.15 43.7 20.21 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.794 0.838 . . . . 0.0 113.228 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.768 ' ND2' ' HB3' ' A' ' 415' ' ' SER . 0.2 OUTLIER -124.37 79.92 1.79 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.164 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.759 ' HD2' ' HG ' ' A' ' 423' ' ' SER . 7.5 p90 -62.27 -31.85 72.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.146 -163.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 419' ' ' TYR . 47.4 mt-30 -53.79 -49.6 67.94 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.377 -164.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.734 HD21 HD22 ' A' ' 418' ' ' ASN . 1.3 pp -59.18 -49.24 78.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.25 0.547 . . . . 0.0 110.671 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.669 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.61 -38.72 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 122.794 1.283 . . . . 0.0 108.917 -178.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.759 ' HG ' ' HD2' ' A' ' 419' ' ' TYR . 64.6 m -66.27 -42.19 88.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.507 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.62 -38.83 89.56 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.254 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.744 HD13 ' HA2' ' A' ' 392' ' ' GLY . 4.3 mt -71.19 -42.07 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.515 0.674 . . . . 0.0 109.917 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' A' ' 423' ' ' SER . 1.6 mm -57.26 -44.47 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.334 -1.303 . . . . 0.0 112.606 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.715 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -61.28 -29.27 69.76 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 122.655 1.217 . . . . 0.0 109.143 -172.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.4 -20.24 78.14 Favored Glycine 0 C--N 1.298 -1.578 0 CA-C-N 112.657 -2.065 . . . . 0.0 112.034 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.739 ' CG ' HG21 ' A' ' 399' ' ' VAL . 12.4 m-85 -97.04 0.6 48.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.84 143.31 77.17 Favored Pre-proline 0 N--CA 1.408 -2.529 0 CA-C-O 123.919 1.819 . . . . 0.0 113.267 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.828 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 51.0 Cg_endo -69.43 -60.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 1 C-N-CA 126.372 4.715 . . . . 0.0 112.973 -172.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.522 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -109.84 141.3 16.12 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.221 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.917 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.33 -26.98 68.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.133 0.467 . . . . 0.0 111.69 -177.07 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.82 -48.29 80.17 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 169.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.994 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.8 t -58.22 -52.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.038 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -54.8 -52.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 95.6 m -62.55 -56.65 15.95 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.216 -176.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -55.89 -46.01 78.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.485 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 42.8 mt -59.56 -53.49 57.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.9 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.679 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.9 mm-40 -51.95 -34.74 43.35 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 124.932 1.395 . . . . 0.0 110.693 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.668 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.5 OUTLIER -73.24 -60.87 2.04 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 175.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.4 -50.62 13.68 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.693 -0.63 . . . . 0.0 112.306 -172.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.58 -25.34 62.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.675 0.75 . . . . 0.0 111.487 -178.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.76 ' N ' HD23 ' A' ' 443' ' ' LEU . 11.5 t70 -72.6 -42.04 64.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.64 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.668 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -68.78 -7.95 38.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.572 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 15.7 mm-40 -54.46 151.58 7.59 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 123.465 1.602 . . . . 0.0 114.436 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.74 -32.63 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 110.477 -3.056 . . . . 0.0 116.066 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.654 ' H ' ' HB ' ' A' ' 451' ' ' THR . 25.8 m-20 -135.49 175.77 9.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.449 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 5.8 m-20 -61.73 -56.89 14.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 172.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -62.9 -28.16 69.86 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 176.292 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.654 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 16.2 m -58.09 -43.18 86.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.803 1.183 . . . . 0.0 110.04 172.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 56.3 mtt180 -61.51 -29.75 70.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 172.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.602 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -75.24 -29.95 60.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.911 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 5.3 mm-40 -80.46 -45.74 17.08 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.286 1.041 . . . . 0.0 111.837 -173.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.534 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 25.7 p -103.28 -0.47 30.24 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.748 -167.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.649 ' CE1' HD23 ' A' ' 460' ' ' LEU . 8.3 t80 -49.22 -55.9 11.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.754 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.2 mm -69.04 -26.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.534 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -72.08 -43.95 64.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.601 ' O ' HG23 ' A' ' 463' ' ' VAL . 26.6 m80 -65.3 -31.09 72.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.707 171.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.762 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.45 -53.72 32.29 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.312 1.053 . . . . 0.0 109.181 -178.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.23 -30.18 71.37 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.19 -1.823 . . . . 0.0 110.188 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -66.68 -49.24 66.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.017 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.994 HG11 ' HA ' ' A' ' 435' ' ' VAL . 33.6 t -65.61 -35.93 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.579 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 469' ' ' LEU . 17.9 m-30 -61.27 -13.98 22.95 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.654 168.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 462' ' ' ALA . 1.7 tp10 -93.09 -52.52 4.53 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.847 0.832 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.696 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.7 pt -63.79 -41.08 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.239 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.767 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.8 mt -83.8 -16.73 43.54 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 65.89 47.73 72.37 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.446 173.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 467' ' ' LEU . 1.2 mt -101.36 173.11 6.59 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 123.834 0.854 . . . . 0.0 111.733 -177.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.571 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 11.2 p30 -85.87 -44.9 12.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.411 ' HA ' ' CE1' ' A' ' 464' ' ' TYR . . . -161.63 -68.67 0.06 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.474 165.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.828 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 19.0 mmt180 -68.16 47.72 0.05 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -163.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 57.92 34.45 71.86 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.392 171.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.716 HE21 ' HB2' ' A' ' 472' ' ' ARG . 28.4 mm-40 -84.69 -51.45 6.81 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.972 0.892 . . . . 0.0 111.228 -173.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.687 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 45.4 t 68.99 53.59 0.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 112.506 -2.133 . . . . 0.0 109.118 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.633 HD12 ' HG2' ' A' ' 477' ' ' ARG . 0.3 OUTLIER -39.79 -44.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 109.474 -3.512 . . . . 0.0 112.61 169.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.633 ' HG2' HD12 ' A' ' 476' ' ' ILE . 13.7 mmm-85 -46.47 138.47 5.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.559 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 67.7 mt -58.33 158.82 6.81 Favored 'General case' 0 N--CA 1.422 -1.858 0 C-N-CA 123.996 0.918 . . . . 0.0 112.914 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.435 -1.195 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.136 177.113 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.474 0.341 0 N-CA-C 111.756 -0.132 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 301' ' ' ILE . 3.5 mp 61.21 84.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.475 0.655 . . . . 0.0 109.88 -176.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 111.05 -173.9 16.39 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.038 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.477 ' HB ' HD11 ' A' ' 346' ' ' LEU . 54.0 m -81.35 116.17 21.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.608 0.718 . . . . 0.0 111.358 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 304' ' ' VAL . 1.5 p -64.57 122.9 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.702 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.731 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 43.1 mt -73.32 129.24 86.19 Favored Pre-proline 0 N--CA 1.423 -1.802 0 CA-C-O 122.069 0.938 . . . . 0.0 113.048 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.566 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 61.0 Cg_endo -84.97 51.48 3.15 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.59 3.526 . . . . 0.0 109.093 165.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.665 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.0 tp -46.63 -43.54 6.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 112.753 -2.021 . . . . 0.0 112.077 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.477 ' HG2' HG23 ' A' ' 307' ' ' ILE . 0.0 OUTLIER -64.5 -35.6 81.47 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.055 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.556 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.6 t-160 -62.45 -47.49 83.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.39 0.614 . . . . 0.0 109.695 172.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.646 HG13 HG11 ' A' ' 338' ' ' VAL . 68.0 mt -59.0 -49.85 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 123.878 0.871 . . . . 0.0 113.197 175.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 33.1 mtp180 -62.25 -28.8 69.96 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.882 0.473 . . . . 0.0 111.013 177.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 62.9 m -69.76 -34.65 74.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.326 0.584 . . . . 0.0 110.114 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.602 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -66.03 -41.73 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.723 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.754 HG22 ' HB3' ' A' ' 331' ' ' ASN . 31.1 p -83.42 -36.58 24.14 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.813 1.292 . . . . 0.0 110.087 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.84 34.86 8.68 Favored Glycine 0 C--N 1.304 -1.22 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.694 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 26.7 mt-10 50.14 177.89 0.02 OUTLIER Pre-proline 0 N--CA 1.439 -1.013 0 C-N-CA 124.296 1.038 . . . . 0.0 112.899 -174.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.695 ' HB3' HD11 ' A' ' 324' ' ' ILE . 46.2 Cg_exo -48.34 147.2 9.02 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.529 2.153 . . . . 0.0 112.786 -178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.428 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 51.1 Cg_endo -87.42 -99.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.341 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.41 ' H ' ' HG2' ' A' ' 318' ' ' PRO . 10.3 mmm180 -100.45 -76.57 0.55 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.528 0.68 . . . . 0.0 110.555 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 323' ' ' GLU . 53.6 m-20 -104.87 158.42 32.06 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.241 -174.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.454 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 36.6 Cg_exo -59.08 -50.13 9.52 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.824 2.349 . . . . 0.0 110.868 171.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.43 -23.64 2.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.224 -1.807 . . . . 0.0 112.547 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 320' ' ' ASN . 2.3 mm-40 -87.42 -29.02 21.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.2 OUTLIER -45.05 -46.8 30.71 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.713 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.2 Cg_endo -49.94 -62.04 0.47 Allowed 'Trans proline' 0 CA--C 1.516 -0.399 0 C-N-CA 122.856 2.371 . . . . 0.0 112.997 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.643 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.56 -36.65 76.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.141 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.738 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 34.7 t90 -57.77 -35.07 70.26 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.096 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.861 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.8 OUTLIER -69.97 -49.17 54.34 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.51 -23.42 19.84 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.661 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 1.0 OUTLIER -74.4 -42.5 59.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.132 0.968 . . . . 0.0 110.471 175.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.754 ' HB3' HG22 ' A' ' 314' ' ' THR . 43.4 m-20 -96.13 -23.47 16.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.918 -169.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.607 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -44.06 -49.38 22.3 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 113.681 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 52.2 Cg_endo -61.39 -33.0 89.58 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.551 2.168 . . . . 0.0 111.542 177.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.3 -43.15 64.61 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 109.519 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.637 HG23 HG23 ' A' ' 310' ' ' ILE . 91.6 mt -58.45 -49.4 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.734 173.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -55.42 -18.84 7.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.327 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.75 -46.68 8.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.145 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.646 HG11 HG13 ' A' ' 310' ' ' ILE . 93.7 t -58.07 -72.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 123.4 1.572 . . . . 0.0 110.228 169.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.83 ' CD2' HD11 ' A' ' 350' ' ' ILE . 1.0 OUTLIER -91.14 131.7 36.18 Favored Pre-proline 0 N--CA 1.405 -2.717 0 CA-C-N 110.813 -2.903 . . . . 0.0 112.538 -170.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.606 ' HB2' HG23 ' A' ' 342' ' ' THR . 8.0 Cg_exo -75.01 -18.02 19.03 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.664 2.909 . . . . 0.0 110.652 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.5 p 33.09 72.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.648 -177.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.606 HG23 ' HB2' ' A' ' 340' ' ' PRO . 60.0 p -81.38 5.83 16.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 112.778 -2.01 . . . . 0.0 113.463 -169.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.843 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 12.8 p -142.12 161.45 50.78 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.459 ' HB3' HD23 ' A' ' 369' ' ' LEU . 51.2 Cg_exo -62.28 -48.25 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.262 2.641 . . . . 0.0 108.218 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.645 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.9 OUTLIER -41.76 -51.92 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 112.719 -2.037 . . . . 0.0 110.828 176.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.843 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 13.8 mt -57.09 -52.28 65.9 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.165 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.687 ' HA ' HD12 ' A' ' 350' ' ' ILE . 4.7 ttm180 -53.09 -42.96 66.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.318 -1.765 . . . . 0.0 110.696 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 1.072 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 1.8 m -70.19 -46.43 64.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 76.0 mtt180 -56.19 -42.83 77.77 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.232 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.83 HD11 ' CD2' ' A' ' 339' ' ' PHE . 48.5 mt -58.17 -53.5 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 O-C-N 123.304 0.377 . . . . 0.0 111.426 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.548 HD13 ' HB1' ' A' ' 374' ' ' ALA . 17.0 mt -57.66 -53.22 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 122.107 0.956 . . . . 0.0 110.841 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.511 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 29.1 m-20 -63.83 -35.14 79.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.956 -1.474 . . . . 0.0 109.982 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.29 -37.26 77.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.051 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.665 ' HB ' HD13 ' A' ' 355' ' ' LEU 0.251 0.8 OUTLIER -57.26 -53.29 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.481 0 CA-C-O 123.069 1.414 . . . . 0.0 110.119 174.485 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.793 HD23 HD22 ' A' ' 358' ' ' ASN . 0.7 OUTLIER -72.86 -25.29 61.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 111.559 -2.564 . . . . 0.0 109.338 -169.083 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 65.6 -79.01 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.665 -1.607 . . . . 0.0 113.586 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -119.62 57.4 0.56 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.6 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.793 HD22 HD23 ' A' ' 355' ' ' LEU . 31.5 p30 -76.13 161.74 28.58 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.254 0.222 . . . . 0.0 110.937 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -55.8 -66.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 122.947 0.499 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -149.41 15.16 1.1 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.514 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.701 ' HB3' HD22 ' A' ' 378' ' ' LEU . 5.9 mt -66.33 -2.99 5.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.698 0.399 . . . . 0.0 111.477 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.511 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 28.6 t -62.28 80.58 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 110.503 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.901 ' HB3' ' SG ' ' A' ' 368' ' ' CYS . 1.4 mm? -62.12 178.16 0.4 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.731 174.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 44.5 p -116.77 157.39 46.31 Favored Pre-proline 0 CA--C 1.508 -0.669 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 1.072 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 19.5 Cg_endo -66.21 16.69 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.269 1.979 . . . . 0.0 113.528 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.486 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -135.43 6.22 4.23 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.26 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.66 ' HB2' HD12 ' A' ' 363' ' ' LEU . 72.7 m-20 -109.76 -24.81 10.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.402 1.096 . . . . 0.0 109.954 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.901 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 6.5 m -93.97 19.77 8.63 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.076 -168.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.4 OUTLIER -57.05 -39.79 75.57 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.433 -171.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.13 157.58 25.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.851 169.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.699 ' O ' HG13 ' A' ' 375' ' ' VAL . 86.3 m95 -70.14 -34.11 72.65 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.597 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 4.8 t0 -54.56 -48.83 71.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.695 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 28.0 t -69.15 -43.13 74.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.825 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.722 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -62.25 -51.57 67.21 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.861 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.3 m -57.32 -44.5 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.603 0.716 . . . . 0.0 109.621 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 0.98 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.09 -45.86 91.65 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.005 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.779 HG21 HD11 ' A' ' 363' ' ' LEU . 48.8 m -68.55 -38.2 80.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.464 -171.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.0 mt -61.21 -34.16 74.64 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.155 0.503 . . . . 0.0 110.411 176.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.713 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 67.5 t80 -73.13 -45.89 54.25 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.369 1.08 . . . . 0.0 109.4 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.659 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -52.3 -33.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.092 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.1 mpt_? -60.61 -39.21 87.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.653 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 50.2 p -98.83 -22.24 15.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.439 -167.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -108.97 22.83 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.642 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 58.37 19.15 39.1 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.847 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 65.09 159.77 0.11 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 111.694 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' A' ' 391' ' ' LEU . 0.2 OUTLIER -126.27 151.88 72.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -98.96 55.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.535 2.824 . . . . 0.0 110.969 165.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.702 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 59.21 4.03 0.42 Allowed 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -173.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -71.13 -47.1 59.89 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.638 ' O ' HG13 ' A' ' 394' ' ' VAL . 99.5 mt-30 -74.74 -26.2 59.63 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.733 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 3.7 mm? -53.75 -31.3 47.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.004 0.82 . . . . 0.0 111.966 -173.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.775 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.57 -53.2 40.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.438 173.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.691 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 41.4 m-20 -64.99 -39.79 93.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.5 m -57.17 -46.21 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.42 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.624 ' O ' HG22 ' A' ' 399' ' ' VAL . 25.6 mm -58.94 -46.6 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.042 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.691 ' HG3' ' HA ' ' A' ' 393' ' ' ASN . 15.3 mmtt -52.84 -42.02 64.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.879 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.41 15.86 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.092 -173.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.0 mt -69.21 -41.45 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 117.133 0.466 . . . . 0.0 111.439 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.88 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.8 m -58.07 -44.54 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.609 0.719 . . . . 0.0 110.273 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 399' ' ' VAL . 5.4 t70 -62.18 -39.03 91.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -84.88 -53.22 5.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.064 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.523 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -110.59 -30.74 7.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.508 -169.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.2 165.87 12.11 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.673 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.88 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.69 -44.83 98.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.55 -53.16 58.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.606 0.717 . . . . 0.0 111.87 -177.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -64.45 -49.77 70.16 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.273 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.68 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.26 -42.69 63.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.682 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 47.1 t80 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.616 0.722 . . . . 0.0 109.524 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.792 ' O ' ' HG3' ' A' ' 413' ' ' MET . 3.9 m -59.44 -52.55 65.14 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.613 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.694 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.23 -48.67 80.4 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.645 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.61 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.85 -43.35 87.26 Favored Glycine 0 C--N 1.314 -0.655 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.546 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.673 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.0 OUTLIER -72.56 -31.31 65.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.846 0.323 . . . . 0.0 111.02 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.792 ' HG3' ' O ' ' A' ' 409' ' ' THR . 53.2 mtm -70.08 -47.56 61.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.98 HD23 ' HA ' ' A' ' 376' ' ' ALA . 19.5 mt -58.55 -40.99 84.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.261 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.733 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 0.5 OUTLIER -76.71 -12.62 60.02 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.729 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 88.36 43.73 5.48 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.659 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.578 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.8 OUTLIER 57.73 49.1 12.83 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.496 0.718 . . . . 0.0 112.471 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.859 HD22 HD21 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -129.17 77.98 1.82 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 161.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.675 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 8.3 p90 -62.27 -31.47 72.06 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.341 -163.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 423' ' ' SER . 51.1 mt-30 -53.63 -48.03 69.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.312 -164.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.859 HD21 HD22 ' A' ' 418' ' ' ASN . 1.1 pp -59.35 -50.62 73.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.955 0.407 . . . . 0.0 110.776 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.706 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.06 -38.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 123.021 1.391 . . . . 0.0 108.854 -178.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 42.4 t -62.56 -48.14 80.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.726 -2.488 . . . . 0.0 111.846 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.3 75.5 Favored Glycine 0 C--N 1.316 -0.568 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.402 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.775 HD13 ' HA2' ' A' ' 392' ' ' GLY . 3.9 mt -72.1 -41.48 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.601 0.715 . . . . 0.0 110.025 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.6 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -57.57 -45.6 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.909 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.708 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.8 -29.15 68.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 122.646 1.212 . . . . 0.0 109.371 -173.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -71.8 -18.46 77.48 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.386 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.698 ' CG ' HG21 ' A' ' 399' ' ' VAL . 18.7 m-85 -100.0 3.17 44.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.02 145.89 70.82 Favored Pre-proline 0 N--CA 1.41 -2.452 0 CA-C-O 123.612 1.672 . . . . 0.0 113.308 168.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.77 ' CB ' ' HA ' ' A' ' 472' ' ' ARG . 59.7 Cg_endo -72.52 -62.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 1 C-N-CA 126.181 4.587 . . . . 0.0 113.378 -173.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.549 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -108.3 141.65 15.84 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.166 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.846 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.71 -29.88 71.0 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.903 0.351 . . . . 0.0 111.057 -177.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.77 -46.43 81.48 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 172.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.999 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.1 t -59.27 -51.59 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.63 176.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.846 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -54.26 -54.85 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.474 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 61.4 m -61.61 -55.94 25.28 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.944 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.03 -46.17 78.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.806 ' O ' HD22 ' A' ' 443' ' ' LEU . 37.1 mt -59.37 -53.15 61.49 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.656 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.743 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 38.0 mm-40 -51.64 -35.09 40.71 Favored 'General case' 0 N--CA 1.419 -2.024 0 O-C-N 124.997 1.436 . . . . 0.0 110.447 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.634 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.74 -60.27 2.31 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 176.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.3 OUTLIER -75.97 -50.86 13.72 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.743 -0.598 . . . . 0.0 112.002 -173.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.88 -24.08 61.76 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.719 0.771 . . . . 0.0 111.807 -179.001 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.746 ' N ' HD23 ' A' ' 443' ' ' LEU . 11.1 t70 -72.18 -42.82 65.41 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.609 176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 38.0 mt-30 -70.02 -7.99 45.55 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.53 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 54.0 mm-40 -51.75 154.77 1.9 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 123.264 1.507 . . . . 0.0 114.43 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.509 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.36 -32.89 20.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 111.17 -2.741 . . . . 0.0 115.613 -172.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.665 ' H ' ' HB ' ' A' ' 451' ' ' THR . 48.1 m-20 -138.04 178.98 6.72 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.418 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 9.1 p-10 -64.88 -53.57 44.58 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -67.31 -23.58 65.66 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 19.2 m -59.04 -40.17 84.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 119.891 1.223 . . . . 0.0 109.453 171.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.614 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 72.6 mtp180 -61.23 -29.1 69.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 172.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.682 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -76.32 -34.01 59.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.204 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 455' ' ' THR . 1.3 mm-40 -78.62 -44.92 22.79 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.903 -171.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.556 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 29.9 p -105.33 -1.23 25.42 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.298 -165.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.675 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.5 t80 -48.73 -51.49 28.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.716 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.3 mm -71.94 -26.59 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.556 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.51 -43.03 67.24 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 463' ' ' VAL . 53.7 m-70 -67.15 -30.34 70.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.178 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.784 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -66.66 -53.4 34.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.278 1.037 . . . . 0.0 109.126 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.658 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 7.6 m-80 -63.49 -31.29 72.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.682 173.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 465' ' ' GLU . . . -62.65 -53.53 53.17 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.192 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.999 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.1 t -62.36 -34.39 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.44 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 469' ' ' LEU . 19.8 m-30 -61.88 -15.39 42.2 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.125 169.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 10.9 mm-40 -89.95 -50.69 5.88 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.064 -1.023 . . . . 0.0 112.42 176.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.724 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.4 pt -65.18 -39.82 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.904 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 469' ' ' LEU . 7.0 mt -84.13 -17.1 41.21 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 66.05 49.56 57.44 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 112.106 -2.315 . . . . 0.0 113.591 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 467' ' ' LEU . 0.8 OUTLIER -101.65 175.01 5.7 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.809 0.844 . . . . 0.0 111.064 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.736 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 13.0 p30 -92.58 -43.25 9.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 165.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -161.56 -73.89 0.06 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.475 162.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.77 ' HA ' ' CB ' ' A' ' 431' ' ' PRO . 2.0 mpt_? -63.63 67.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 40.64 40.24 2.04 Favored Glycine 0 C--N 1.277 -2.709 0 CA-C-N 111.369 -2.65 . . . . 0.0 113.33 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.736 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 27.4 mm-40 -80.3 -56.3 4.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.152 0.977 . . . . 0.0 111.449 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 38.2 t 67.87 44.36 1.57 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.281 -2.236 . . . . 0.0 108.219 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.663 HD12 ' HG2' ' A' ' 477' ' ' ARG . 0.4 OUTLIER -37.51 -44.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 109.149 -3.66 . . . . 0.0 112.684 170.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.663 ' HG2' HD12 ' A' ' 476' ' ' ILE . 15.7 mmm180 -48.63 128.92 15.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.155 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.5 mt -71.55 -36.75 71.05 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.021 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 . . . . . 0 N--CA 1.432 -1.374 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.446 179.147 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.475 0.396 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.8 mp 60.13 78.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.998 0.904 . . . . 0.0 109.795 -175.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 83.51 -177.17 52.66 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.26 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 81.7 m -73.77 128.73 36.31 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.494 0.664 . . . . 0.0 111.254 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 1.6 p -64.46 122.28 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.413 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 307' ' ' ILE . 22.8 mt -74.45 127.01 88.26 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-O 121.844 0.831 . . . . 0.0 112.137 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' A' ' 308' ' ' GLN . 28.2 Cg_endo -74.8 -11.44 21.88 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 124.682 3.588 . . . . 0.0 111.466 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.754 ' H ' HG22 ' A' ' 305' ' ' ILE . 6.1 tp 26.79 -64.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.298 0 C-N-CA 128.37 2.668 . . . . 0.0 115.877 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.657 ' H ' HG23 ' A' ' 307' ' ' ILE . 0.1 OUTLIER -57.66 -30.88 65.78 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.141 0.496 . . . . 0.0 111.246 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.543 ' CG ' HG13 ' A' ' 338' ' ' VAL . 7.3 t-160 -61.73 -49.17 77.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.588 169.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.715 HD12 ' HA ' ' A' ' 307' ' ' ILE . 60.9 mt -58.55 -48.11 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.036 0.934 . . . . 0.0 112.705 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.682 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 12.7 mtp180 -59.9 -30.66 69.18 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 122.559 0.344 . . . . 0.0 111.108 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 49.2 m -70.03 -33.96 72.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.56 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.24 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.903 178.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.75 ' HB ' ' CZ2' ' A' ' 327' ' ' TRP . 31.5 p -83.52 -37.19 23.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.83 1.3 . . . . 0.0 110.152 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.5 34.66 8.4 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.252 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 37.6 mt-10 51.68 172.25 0.03 OUTLIER Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -175.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.584 ' HB3' HD11 ' A' ' 324' ' ' ILE . 22.2 Cg_exo -45.27 143.56 5.15 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.374 2.716 . . . . 0.0 113.189 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.52 ' HG3' ' CD1' ' A' ' 327' ' ' TRP . 32.6 Cg_endo -91.41 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.614 2.876 . . . . 0.0 112.903 -172.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.465 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 7.9 mmm180 -89.29 -81.34 0.28 Allowed 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 123.449 0.699 . . . . 0.0 110.894 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.465 ' H ' ' HB2' ' A' ' 319' ' ' ARG . 16.3 m-20 -112.71 164.94 14.14 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.846 -177.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.414 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 38.6 Cg_exo -58.65 -50.4 9.43 Favored 'Trans proline' 0 CA--C 1.509 -0.735 0 C-N-CA 122.549 2.166 . . . . 0.0 110.483 171.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.403 ' HG2' ' H ' ' A' ' 322' ' ' ARG . 5.1 mmt180 -48.74 -20.63 0.5 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.003 -1.908 . . . . 0.0 112.928 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 1.1 mt-10 -98.44 -23.46 15.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.7 0.286 . . . . 0.0 111.405 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.655 ' N ' ' HD2' ' A' ' 325' ' ' PRO . 0.2 OUTLIER -46.88 -44.34 45.79 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.717 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 6.4 Cg_endo -47.96 -62.76 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.008 2.472 . . . . 0.0 113.086 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.659 HG21 HG12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -62.89 -36.32 75.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.031 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.168 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.75 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 47.5 t90 -57.63 -36.01 71.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.329 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.872 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -69.93 -48.15 59.62 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.585 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.55 -23.62 20.92 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.786 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.433 ' HG3' ' HA ' ' A' ' 327' ' ' TRP . 2.8 mmm180 -73.95 -42.17 60.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.22 1.01 . . . . 0.0 110.551 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.722 ' HB3' HG22 ' A' ' 314' ' ' THR . 47.1 m-20 -95.98 -24.82 16.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.599 -1.637 . . . . 0.0 113.854 -169.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.608 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -42.94 -50.29 13.6 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 124.296 1.038 . . . . 0.0 113.582 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 51.0 Cg_endo -61.09 -33.16 91.86 Favored 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 122.652 2.235 . . . . 0.0 111.729 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.57 -43.93 62.75 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.622 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.611 HG12 HG23 ' A' ' 310' ' ' ILE . 88.6 mt -57.99 -48.25 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.74 -17.87 6.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.233 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.92 -44.49 9.06 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.684 HG11 HG13 ' A' ' 310' ' ' ILE . 98.6 t -61.29 -69.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 123.399 1.571 . . . . 0.0 110.222 169.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.854 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.7 OUTLIER -94.47 129.9 35.31 Favored Pre-proline 0 N--CA 1.403 -2.789 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.663 -171.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.774 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 68.0 Cg_endo -72.7 -18.86 24.84 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 123.887 3.058 . . . . 0.0 110.994 173.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.45 HG23 ' CB ' ' A' ' 346' ' ' LEU . 2.5 p 33.9 68.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 112.487 -2.142 . . . . 0.0 110.426 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.4 p -78.37 1.64 21.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.616 -170.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.795 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 19.4 p -137.59 164.09 43.85 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 343' ' ' THR . 50.3 Cg_exo -62.45 -50.58 4.3 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.145 2.564 . . . . 0.0 108.043 172.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.708 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 4.6 t0 -42.81 -47.34 5.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.013 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.795 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 8.9 mt -56.99 -53.04 62.56 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.797 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.74 ' HA ' HD12 ' A' ' 350' ' ' ILE . 41.3 ttm105 -54.98 -45.81 75.02 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.603 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.991 ' SG ' ' HA ' ' A' ' 365' ' ' PRO . 0.1 OUTLIER -68.78 -47.8 65.28 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.793 0.33 . . . . 0.0 111.216 -175.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 70.8 mtt180 -56.0 -42.41 76.36 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.079 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.854 HD11 ' CD2' ' A' ' 339' ' ' PHE . 52.6 mt -57.73 -53.48 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.399 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.565 HG12 HD11 ' A' ' 328' ' ' LEU . 23.0 mt -58.47 -52.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 122.203 1.001 . . . . 0.0 110.715 -170.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.549 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 23.3 m-20 -63.0 -36.11 82.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.152 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.63 -34.72 74.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.081 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.679 ' HB ' HD13 ' A' ' 355' ' ' LEU . 0.8 OUTLIER -58.72 -53.92 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 122.925 1.345 . . . . 0.0 110.256 173.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.679 HD13 ' HB ' ' A' ' 354' ' ' ILE . 0.4 OUTLIER -71.95 -27.46 62.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.618 -2.537 . . . . 0.0 109.585 -167.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 63.25 -70.79 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.028 -1.442 . . . . 0.0 113.943 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.72 97.29 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.514 -0.374 . . . . 0.0 112.322 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.637 HD22 HD23 ' A' ' 355' ' ' LEU . 26.9 p30 -124.59 164.41 19.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 122.736 0.414 . . . . 0.0 110.447 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.522 HD12 ' H ' ' A' ' 359' ' ' ILE . 2.0 mp -51.42 -59.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.082 0.467 . . . . 0.0 111.804 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -162.63 20.39 0.17 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.54 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.694 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.9 mt -66.05 -5.28 9.21 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 122.835 0.454 . . . . 0.0 111.615 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.549 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 23.3 t -61.42 83.1 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.205 0.526 . . . . 0.0 110.62 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.751 HD11 HG21 ' A' ' 377' ' ' THR . 0.9 OUTLIER -62.48 173.36 1.25 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.659 175.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 366' ' ' GLY . 71.9 p -113.73 162.43 22.67 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.622 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.991 ' HA ' ' SG ' ' A' ' 348' ' ' CYS . 10.5 Cg_endo -68.63 25.92 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.121 1.881 . . . . 0.0 112.386 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 364' ' ' THR . . . -138.01 -6.28 1.5 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.759 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.686 ' HB2' HD12 ' A' ' 363' ' ' LEU . 37.1 m-20 -105.65 -20.87 13.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.83 1.3 . . . . 0.0 109.129 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.826 ' SG ' ' SG ' ' A' ' 348' ' ' CYS . 2.7 p -79.03 20.69 0.47 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.616 -2.084 . . . . 0.0 112.846 -172.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 369' ' ' LEU . 0.1 OUTLIER -61.49 -30.58 70.7 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.707 1.241 . . . . 0.0 108.495 -172.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 24.9 p -125.73 163.9 21.83 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 112.393 -2.185 . . . . 0.0 109.933 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.619 ' O ' HG13 ' A' ' 375' ' ' VAL . 66.7 m95 -70.92 -33.91 70.99 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 167.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.51 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 1.7 m-20 -61.24 -44.89 96.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.746 -172.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 29.1 t -69.15 -42.9 75.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.733 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.19 -52.15 66.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.872 HG12 ' HB3' ' A' ' 328' ' ' LEU . 13.1 m -58.56 -43.86 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.585 0.707 . . . . 0.0 109.422 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.01 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -62.2 -46.19 90.0 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.095 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.751 HG21 HD11 ' A' ' 363' ' ' LEU . 37.3 m -66.41 -39.32 88.93 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.324 -173.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 2.4 mt -59.69 -35.13 73.87 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.467 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.717 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 66.4 t80 -73.41 -45.96 51.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 122.491 1.139 . . . . 0.0 109.473 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.3 mp -53.06 -32.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 112.625 -2.08 . . . . 0.0 111.314 171.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 0.3 OUTLIER -59.55 -38.69 81.75 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.442 0.697 . . . . 0.0 111.831 177.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 4.4 p -104.64 -20.91 13.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.62 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -108.34 24.46 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 55.87 21.12 29.0 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 114.587 0.595 . . . . 0.0 114.587 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m 62.01 165.92 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.092 0.472 . . . . 0.0 110.976 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.49 ' HB3' HE21 ' A' ' 390' ' ' GLN . 0.2 OUTLIER -130.52 154.21 81.59 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -94.56 47.75 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.386 2.724 . . . . 0.0 110.712 165.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.693 ' HA ' HD23 ' A' ' 391' ' ' LEU . 0.0 OUTLIER 60.27 4.55 0.68 Allowed 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -173.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -70.08 -43.6 70.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.941 0.4 . . . . 0.0 110.569 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.636 ' O ' HG13 ' A' ' 394' ' ' VAL . 27.3 mt-30 -75.85 -25.4 56.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -170.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.889 ' HG ' ' OG ' ' A' ' 415' ' ' SER . 2.9 mm? -53.11 -31.38 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.043 0.838 . . . . 0.0 112.024 -172.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.565 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -54.86 -50.3 58.85 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.674 174.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.523 ' HA ' ' HE3' ' A' ' 396' ' ' LYS . 5.5 m-20 -69.84 -36.59 75.7 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.987 0.515 . . . . 0.0 111.814 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 391' ' ' LEU . 1.1 m -58.85 -48.51 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 399' ' ' VAL . 8.5 mm -58.37 -48.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.882 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 392' ' ' GLY . 0.2 OUTLIER -52.31 -46.32 65.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.312 -177.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -73.29 -44.13 35.85 Favored Glycine 0 C--N 1.31 -0.895 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.382 -176.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 3.0 mt -69.15 -41.22 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 117.76 0.78 . . . . 0.0 111.582 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 404' ' ' VAL . 6.5 m -57.93 -44.21 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.844 0.83 . . . . 0.0 109.552 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.431 ' N ' HG23 ' A' ' 399' ' ' VAL . 16.6 t70 -55.21 -46.05 75.9 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.328 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 29.2 mm-40 -85.3 -52.52 5.84 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.601 -170.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.575 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.7 OUTLIER -110.6 -30.39 7.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.52 0.676 . . . . 0.0 111.799 -170.254 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 124.84 166.16 12.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.705 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.875 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -62.95 -46.1 97.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.013 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -53.96 -52.54 60.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.617 0.722 . . . . 0.0 111.999 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.9 OUTLIER -64.79 -49.91 68.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.308 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.672 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.23 -43.37 64.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.66 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 38.8 t80 -56.44 -46.72 80.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.524 0.678 . . . . 0.0 109.559 176.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.776 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.8 m -58.69 -52.26 66.47 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.65 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.684 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -61.7 -48.01 82.7 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.602 176.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.58 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -56.19 -43.24 89.03 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.664 ' HE3' ' HB3' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -72.2 -31.57 66.0 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.88 0.34 . . . . 0.0 110.69 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.858 ' HE3' HG21 ' A' ' 375' ' ' VAL . 62.5 mtm -70.18 -47.5 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 109.93 173.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.01 HD23 ' HA ' ' A' ' 376' ' ' ALA . 16.9 mt -59.18 -40.67 86.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.119 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.889 ' OG ' ' HG ' ' A' ' 391' ' ' LEU . 10.7 m -77.82 -12.76 60.01 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.964 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.61 44.13 4.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.206 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.599 ' HA ' ' CE ' ' A' ' 412' ' ' MET . 0.9 OUTLIER 58.46 39.99 24.52 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.762 0.825 . . . . 0.0 112.99 179.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.784 HD22 HD21 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -123.46 79.55 1.7 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 165.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.664 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 7.8 p90 -62.55 -31.12 71.85 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.8 -161.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.529 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.0 mt-30 -54.14 -47.76 71.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -164.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.784 HD21 HD22 ' A' ' 418' ' ' ASN . 1.2 pp -59.21 -49.0 79.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.479 0.656 . . . . 0.0 110.974 177.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.732 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.7 OUTLIER -60.7 -39.06 80.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.756 1.265 . . . . 0.0 109.208 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 420' ' ' GLN . 30.0 t -60.8 -47.4 86.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.037 -2.347 . . . . 0.0 111.252 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.11 -38.19 75.4 Favored Glycine 0 C--N 1.315 -0.596 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 422' ' ' VAL . 1.7 mt -72.18 -43.99 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.583 0.706 . . . . 0.0 109.985 174.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.615 HG23 HG23 ' A' ' 404' ' ' VAL . 1.5 mm -55.8 -44.28 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.73 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.717 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.3 OUTLIER -61.67 -30.26 70.61 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-O 122.586 1.184 . . . . 0.0 108.907 -173.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -72.39 -18.08 78.07 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.966 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.665 ' CG ' HG21 ' A' ' 399' ' ' VAL . 15.0 m-85 -100.65 3.77 42.73 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -177.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -57.77 145.4 70.82 Favored Pre-proline 0 N--CA 1.418 -2.069 0 CA-C-O 123.546 1.641 . . . . 0.0 113.721 167.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.755 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 59.2 Cg_endo -72.19 -61.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 1 C-N-CA 126.245 4.63 . . . . 0.0 113.127 -173.038 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.53 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -107.59 141.11 15.61 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.202 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.868 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -62.46 -30.69 71.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.107 0.454 . . . . 0.0 111.143 -177.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.77 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -56.25 -46.67 79.52 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 171.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.061 ' HA ' HG11 ' A' ' 463' ' ' VAL . 2.7 t -59.66 -51.38 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.397 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.868 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.7 OUTLIER -53.81 -54.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 51.8 m -62.73 -56.11 20.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.226 -175.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.24 -45.93 79.81 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.64 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 443' ' ' LEU . 39.0 mt -59.43 -53.73 54.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.806 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.711 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 34.2 mm-40 -52.23 -34.16 44.61 Favored 'General case' 0 N--CA 1.417 -2.108 0 O-C-N 125.09 1.494 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.656 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -73.18 -60.69 2.12 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.25 14.51 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.733 -0.605 . . . . 0.0 112.392 -172.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.63 -25.08 62.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.596 0.712 . . . . 0.0 111.606 -179.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.767 ' N ' HD23 ' A' ' 443' ' ' LEU . 12.7 t70 -72.19 -41.11 67.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.484 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.656 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 39.2 mt-30 -70.29 -8.08 47.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 14.0 mm-40 -56.6 161.27 2.81 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 123.221 1.486 . . . . 0.0 114.371 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.693 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.84 -34.28 25.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 111.216 -2.72 . . . . 0.0 115.78 -169.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.635 ' H ' ' HB ' ' A' ' 451' ' ' THR . 24.6 m-20 -142.32 -178.18 5.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.464 ' O ' ' HE1' ' A' ' 419' ' ' TYR . 10.7 p-10 -63.83 -55.26 24.25 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.528 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -64.28 -27.12 68.82 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.084 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.693 HG21 ' HB ' ' A' ' 447' ' ' ILE . 8.8 m -58.6 -44.67 89.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.381 0.991 . . . . 0.0 109.864 172.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 44.0 mtt180 -61.0 -29.89 69.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.189 172.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.66 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -73.57 -31.47 63.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.91 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 450' ' ' GLN . 3.1 mm-40 -78.11 -46.24 21.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.728 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.531 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 27.5 p -103.69 -0.9 28.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.481 -166.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.8 t80 -49.28 -55.34 13.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.828 177.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 405' ' ' ALA . 26.8 mm -69.62 -26.7 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.531 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -71.27 -43.96 66.18 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.616 ' O ' HG23 ' A' ' 463' ' ' VAL . 25.4 m80 -65.53 -30.62 71.39 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.857 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.737 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.1 OUTLIER -66.91 -53.25 33.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.206 1.003 . . . . 0.0 109.303 -178.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.661 ' O ' ' HG3' ' A' ' 465' ' ' GLU . 7.7 m-80 -63.6 -31.5 72.68 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.719 173.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -62.98 -53.15 58.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.41 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.061 HG11 ' HA ' ' A' ' 435' ' ' VAL . 26.5 t -62.41 -33.88 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 121.836 0.827 . . . . 0.0 110.249 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.647 ' HD1' HD12 ' A' ' 469' ' ' LEU . 21.9 m-30 -61.96 -15.15 41.35 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.157 169.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 461' ' ' ASN . 48.0 mt-10 -91.77 -49.36 6.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.909 -1.119 . . . . 0.0 112.822 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.7 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 5.9 pt -64.65 -40.43 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.902 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.77 HD11 ' HB3' ' A' ' 434' ' ' ALA . 7.3 mt -83.47 -16.58 45.12 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 172.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.61 51.14 54.6 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 111.68 -2.509 . . . . 0.0 113.028 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.732 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -100.48 -156.93 0.58 Allowed 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 122.16 0.981 . . . . 0.0 109.381 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.731 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 12.7 p30 -130.01 -41.04 1.3 Allowed 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 171.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.535 ' HA ' ' CZ ' ' A' ' 464' ' ' TYR . . . -155.76 -82.19 0.07 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.426 -2.17 . . . . 0.0 110.813 155.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.755 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.3 OUTLIER -57.34 69.62 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -172.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.482 ' N ' ' HB2' ' A' ' 431' ' ' PRO . . . 36.47 42.79 0.68 Allowed Glycine 0 C--N 1.276 -2.755 0 CA-C-N 111.163 -2.744 . . . . 0.0 113.323 172.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.731 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 26.1 mm-40 -77.4 -59.51 2.75 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 122.147 0.975 . . . . 0.0 111.421 -172.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 36.7 t 67.15 50.87 0.97 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.185 -2.279 . . . . 0.0 107.976 -173.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 468' ' ' GLY . 0.5 OUTLIER -38.37 -41.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 109.196 -3.638 . . . . 0.0 112.507 170.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.526 ' HG3' ' HA3' ' A' ' 468' ' ' GLY . 8.9 mmt180 -45.45 146.45 1.01 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.279 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.33 -15.51 36.57 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 . . . . . 0 C--O 1.251 1.165 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.322 179.231 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 110.076 -0.779 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 301' ' ' ILE . 2.3 mp -64.89 -47.48 88.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -70.18 158.79 53.51 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.304 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.458 ' HB ' HD11 ' A' ' 346' ' ' LEU . 29.0 m -70.36 119.19 14.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.461 0.648 . . . . 0.0 111.282 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 304' ' ' VAL . 2.1 p -67.71 125.09 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.203 173.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.737 HG12 ' CZ ' ' A' ' 339' ' ' PHE . 36.2 mt -74.24 127.67 87.41 Favored Pre-proline 0 N--CA 1.425 -1.681 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.576 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 59.2 Cg_endo -84.96 50.21 2.8 Favored 'Trans proline' 0 CA--C 1.504 -1.001 0 C-N-CA 125.011 3.807 . . . . 0.0 109.238 165.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.749 ' O ' ' HG3' ' A' ' 311' ' ' ARG . 4.6 tp -45.41 -42.42 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.287 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' GLN . . . . . 0.616 ' HA ' ' HD3' ' A' ' 311' ' ' ARG . 26.4 mm-40 -60.86 -44.24 97.28 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.998 0.904 . . . . 0.0 111.653 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . 0.551 ' CD2' HG22 ' A' ' 338' ' ' VAL . 6.4 t-160 -58.97 -45.77 89.72 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.357 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 335' ' ' ILE . 67.4 mt -59.22 -49.13 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.749 ' HG3' ' O ' ' A' ' 307' ' ' ILE . 36.4 mtp180 -60.45 -31.28 70.27 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.523 -0.735 . . . . 0.0 110.987 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 43.6 m -69.76 -32.27 70.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.587 0.708 . . . . 0.0 109.881 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.544 HG12 HG23 ' A' ' 314' ' ' THR . 0.5 OUTLIER -67.56 -41.33 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.018 177.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.751 HG22 ' HB3' ' A' ' 331' ' ' ASN . 31.6 p -82.68 -36.7 25.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.728 1.251 . . . . 0.0 110.063 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.14 10.74 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 112.4 -2.182 . . . . 0.0 110.159 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 317' ' ' PRO . 30.9 mt-10 49.12 173.57 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.126 0 C-N-CA 124.806 1.243 . . . . 0.0 113.254 -173.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 324' ' ' ILE . 25.0 Cg_exo -45.1 154.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.038 2.492 . . . . 0.0 113.604 -176.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 317' ' ' PRO . 32.6 Cg_endo -93.08 -109.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 123.29 2.66 . . . . 0.0 111.563 -175.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.469 ' HB2' ' H ' ' A' ' 320' ' ' ASN . 14.4 mmm180 -97.2 -80.26 0.44 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.396 0.617 . . . . 0.0 111.058 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.504 ' HB2' ' HG3' ' A' ' 323' ' ' GLU . 46.0 m-20 -94.06 156.52 39.01 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.38 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 324' ' ' ILE . 44.3 Cg_exo -58.53 -49.53 11.75 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.726 2.284 . . . . 0.0 110.483 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.421 ' H ' ' HG2' ' A' ' 322' ' ' ARG . 0.1 OUTLIER -51.61 -21.94 2.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.194 -1.821 . . . . 0.0 112.665 175.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' A' ' 320' ' ' ASN . 2.0 mt-10 -85.0 -30.06 24.51 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.325 -0.234 . . . . 0.0 111.377 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 317' ' ' PRO . 0.1 OUTLIER -47.72 -45.05 59.25 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.718 ' CB ' ' HB2' ' A' ' 379' ' ' PHE . 9.0 Cg_endo -50.43 -62.65 0.37 Allowed 'Trans proline' 0 CA--C 1.517 -0.354 0 C-N-CA 122.802 2.335 . . . . 0.0 113.091 177.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.635 ' HA ' ' HG ' ' A' ' 410' ' ' LEU . 1.0 OUTLIER -62.4 -35.43 69.64 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 122.664 1.221 . . . . 0.0 110.091 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . 0.651 ' CZ2' ' HB ' ' A' ' 314' ' ' THR . 49.7 t90 -58.46 -37.19 74.95 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.156 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.848 ' HB3' HG12 ' A' ' 375' ' ' VAL . 0.7 OUTLIER -70.14 -47.81 60.13 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -53.67 -23.64 21.92 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.741 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.495 ' HD2' HG21 ' A' ' 406' ' ' THR . 0.9 OUTLIER -74.08 -43.27 58.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.407 1.098 . . . . 0.0 110.686 174.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.751 ' HB3' HG22 ' A' ' 314' ' ' THR . 52.6 m-20 -94.47 -25.03 17.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.407 -168.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ALA . . . . . 0.546 ' HA ' HD12 ' A' ' 335' ' ' ILE . . . -41.58 -50.3 9.5 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 124.453 1.101 . . . . 0.0 113.719 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 332' ' ' ALA . 56.8 Cg_endo -62.78 -30.96 78.47 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 122.684 2.256 . . . . 0.0 111.801 177.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 331' ' ' ASN . . . -73.52 -45.77 51.76 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.527 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 310' ' ' ILE . 88.2 mt -57.17 -48.65 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.878 173.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.45 -16.37 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.769 -1.56 . . . . 0.0 112.14 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -80.8 -46.28 7.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.412 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.623 HG11 HG13 ' A' ' 310' ' ' ILE . 96.3 t -58.19 -70.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 123.499 1.619 . . . . 0.0 110.187 169.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.855 ' CD2' HD11 ' A' ' 350' ' ' ILE . 0.8 OUTLIER -92.64 131.81 33.05 Favored Pre-proline 0 N--CA 1.405 -2.679 0 CA-C-N 110.926 -2.852 . . . . 0.0 112.463 -172.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.779 ' HD2' ' CD1' ' A' ' 339' ' ' PHE . 72.0 Cg_endo -73.25 -18.92 23.02 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 123.635 2.89 . . . . 0.0 110.737 173.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 339' ' ' PHE . 2.7 p 33.26 70.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.54 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.583 ' N ' HD12 ' A' ' 346' ' ' LEU . 41.4 p -81.25 5.64 16.51 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.921 -1.945 . . . . 0.0 113.392 -169.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.781 ' OG1' ' HG ' ' A' ' 346' ' ' LEU . 16.9 p -143.14 158.02 59.31 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-O 121.517 0.675 . . . . 0.0 109.535 174.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 343' ' ' THR . 52.4 Cg_exo -62.08 -38.68 55.03 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 124.368 3.379 . . . . 0.0 109.435 172.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.655 ' O ' ' HG3' ' A' ' 349' ' ' ARG . 0.3 OUTLIER -52.36 -51.69 57.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 112.295 -2.229 . . . . 0.0 110.634 174.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.781 ' HG ' ' OG1' ' A' ' 343' ' ' THR . 12.2 mt -58.4 -52.43 65.64 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.52 -177.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.658 ' HA ' HD12 ' A' ' 350' ' ' ILE . 3.8 ttm180 -52.86 -41.48 64.34 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.032 -1.895 . . . . 0.0 110.116 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' CYS . . . . . 0.452 ' HA ' ' SG ' ' A' ' 368' ' ' CYS . 45.7 t -69.71 -49.25 55.15 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.913 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 345' ' ' ASP . 69.6 mtt180 -58.13 -40.01 80.2 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.855 HD11 ' CD2' ' A' ' 339' ' ' PHE . 50.5 mt -58.68 -54.18 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.505 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.606 HD13 ' HB1' ' A' ' 374' ' ' ALA . 16.5 mt -57.56 -53.54 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 121.954 0.883 . . . . 0.0 111.055 -169.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.456 ' CG ' ' HA ' ' A' ' 362' ' ' SER . 52.0 m-20 -64.14 -34.26 77.64 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.079 -177.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.65 76.45 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.205 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 350' ' ' ILE . 0.7 OUTLIER -57.65 -51.61 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 122.875 1.322 . . . . 0.0 110.425 174.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.724 HD23 HD22 ' A' ' 358' ' ' ASN . 0.3 OUTLIER -72.29 -25.76 61.71 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.81 -2.45 . . . . 0.0 109.298 -170.271 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 66.69 -77.04 0.14 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.533 -1.667 . . . . 0.0 113.169 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -126.9 92.65 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.191 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.724 HD22 HD23 ' A' ' 355' ' ' LEU . 23.3 p30 -111.89 163.65 13.98 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 122.803 0.441 . . . . 0.0 110.751 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 359' ' ' ILE . 2.0 mp -53.86 -64.87 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 C-N-CA 122.81 0.444 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . -150.55 13.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.687 ' HB3' HD22 ' A' ' 378' ' ' LEU . 6.1 mt -64.37 -2.8 2.42 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.651 0.38 . . . . 0.0 111.909 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.456 ' HA ' ' CG ' ' A' ' 352' ' ' ASN . 32.1 t -61.75 84.61 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.26 0.552 . . . . 0.0 110.181 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.9 HD11 HG21 ' A' ' 377' ' ' THR . 2.2 mm? -63.52 -174.96 0.1 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.672 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 365' ' ' PRO . 48.6 p -125.61 157.7 67.45 Favored Pre-proline 0 CA--C 1.506 -0.738 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 345' ' ' ASP . 32.3 Cg_exo -46.75 -39.34 23.7 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.912 1.741 . . . . 0.0 110.942 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.505 ' O ' HD11 ' A' ' 369' ' ' LEU . . . -83.46 2.67 86.86 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.38 -172.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.69 ' CB ' HD12 ' A' ' 363' ' ' LEU . 44.1 m-20 -108.81 -21.76 12.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.089 0.947 . . . . 0.0 109.778 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 363' ' ' LEU . 57.8 m -95.38 20.3 9.58 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.383 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.505 HD11 ' O ' ' A' ' 366' ' ' GLY . 0.2 OUTLIER -61.34 -36.25 79.66 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.964 1.364 . . . . 0.0 108.375 -173.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 15.2 p -115.51 163.03 16.34 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 112.189 -2.278 . . . . 0.0 109.491 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 375' ' ' VAL . 35.5 m95 -70.71 -33.51 70.94 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.575 ' HA ' ' SD ' ' A' ' 413' ' ' MET . 3.6 m-20 -64.33 -46.4 83.7 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.806 -170.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.0 t -68.22 -42.61 79.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.358 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.705 ' O ' ' HG ' ' A' ' 378' ' ' LEU . . . -61.54 -52.54 64.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.918 HG21 ' HE3' ' A' ' 413' ' ' MET . 12.8 m -58.44 -44.4 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.627 0.727 . . . . 0.0 109.489 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 1.023 ' HA ' HD23 ' A' ' 414' ' ' LEU . . . -61.24 -46.0 92.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.883 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.9 HG21 HD11 ' A' ' 363' ' ' LEU . 33.0 m -67.82 -38.72 83.62 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.517 -172.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 374' ' ' ALA . 1.8 mt -59.47 -34.62 72.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.346 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.718 ' HB2' ' CB ' ' A' ' 325' ' ' PRO . 59.2 t80 -73.53 -46.79 45.54 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.34 1.067 . . . . 0.0 109.263 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 376' ' ' ALA . 1.4 mp -51.92 -32.45 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.279 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 378' ' ' LEU . 1.4 mpt_? -59.7 -40.14 86.96 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.537 0.684 . . . . 0.0 111.369 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.9 p -96.79 -22.51 16.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.75 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -110.0 23.33 14.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 54.58 21.05 19.94 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.6 m 64.92 159.59 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.237 0.541 . . . . 0.0 111.285 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.543 ' HB3' ' HB2' ' A' ' 390' ' ' GLN . 0.1 OUTLIER -123.83 155.45 66.8 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 389' ' ' HIS . 85.0 Cg_endo -101.2 56.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.027 3.152 . . . . 0.0 111.395 168.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.73 ' HA ' HD23 ' A' ' 391' ' ' LEU . 5.3 mmt 62.44 -19.56 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -173.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.461 ' H ' ' C ' ' A' ' 387' ' ' PRO . 5.9 t60 -56.21 -44.25 79.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.065 0.459 . . . . 0.0 111.31 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.707 ' O ' HG13 ' A' ' 394' ' ' VAL . 77.9 mt-30 -75.04 -28.66 60.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 388' ' ' MET . 3.8 mm? -54.8 -31.53 59.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.313 0.961 . . . . 0.0 111.037 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.689 ' HA2' HD13 ' A' ' 425' ' ' ILE . . . -55.02 -51.58 52.78 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.617 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.595 ' HA ' ' HG3' ' A' ' 396' ' ' LYS . 50.4 m-20 -68.1 -39.86 82.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.96 0.504 . . . . 0.0 112.168 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 390' ' ' GLN . 1.9 m -56.82 -45.16 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 399' ' ' VAL . 12.9 mm -58.91 -47.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.832 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.691 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 30.6 mmtt -52.48 -43.13 64.81 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 123.987 0.804 . . . . 0.0 111.325 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 401' ' ' GLN . . . -77.16 -44.63 13.15 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.236 -172.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 407' ' ' ALA . 2.8 mt -69.05 -40.61 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 117.603 0.702 . . . . 0.0 111.34 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.5 m -58.35 -44.27 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.802 0.81 . . . . 0.0 109.904 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 399' ' ' VAL . 14.6 t70 -59.17 -43.49 92.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.261 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 30.8 mm-40 -83.52 -52.21 6.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.073 -171.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.561 ' HG3' ' CG2' ' A' ' 398' ' ' ILE . 0.5 OUTLIER -111.13 -30.98 7.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.758 -170.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 126.81 165.84 12.04 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.678 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.902 ' HA ' HG12 ' A' ' 399' ' ' VAL . 0.2 OUTLIER -63.47 -44.68 98.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 457' ' ' ILE . . . -54.88 -52.45 62.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.464 0.649 . . . . 0.0 111.946 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.504 ' O ' ' HB ' ' A' ' 409' ' ' THR . 0.8 OUTLIER -65.45 -49.57 68.65 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.17 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.668 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -52.61 -41.63 63.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.623 ' OH ' ' HA ' ' A' ' 453' ' ' ALA . 46.2 t80 -58.18 -46.65 85.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.471 0.653 . . . . 0.0 109.489 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.773 ' O ' ' HG3' ' A' ' 413' ' ' MET . 5.0 m -58.52 -52.58 65.06 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.674 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.677 HD13 ' CE ' ' A' ' 413' ' ' MET . 2.7 mm? -62.57 -48.77 78.02 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.568 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.63 ' HA2' HD12 ' A' ' 414' ' ' LEU . . . -55.82 -43.39 87.1 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.903 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.769 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -72.23 -32.29 66.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.798 0.299 . . . . 0.0 111.184 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.918 ' HE3' HG21 ' A' ' 375' ' ' VAL . 68.5 mtm -69.84 -47.17 63.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.396 0.617 . . . . 0.0 109.855 174.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 1.023 HD23 ' HA ' ' A' ' 376' ' ' ALA . 18.0 mt -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.937 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.623 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 0.6 OUTLIER -74.81 -16.89 60.69 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.864 -173.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 101.27 29.05 6.52 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.1 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.769 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 4.7 mm-40 59.23 43.61 16.77 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.074 0.95 . . . . 0.0 112.279 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.654 ' ND2' HD21 ' A' ' 421' ' ' LEU . 0.2 OUTLIER -119.09 66.78 0.78 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 167.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.708 ' HB3' ' HE3' ' A' ' 412' ' ' MET . 0.7 OUTLIER -46.1 -35.03 4.6 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 111.554 -2.566 . . . . 0.0 113.435 -164.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 423' ' ' SER . 37.1 mt-30 -54.54 -46.47 73.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.654 HD21 ' ND2' ' A' ' 418' ' ' ASN . 1.6 pp -60.3 -50.1 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.391 . . . . 0.0 110.905 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.805 ' HA ' HD12 ' A' ' 425' ' ' ILE . 0.6 OUTLIER -60.02 -39.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.632 1.206 . . . . 0.0 109.19 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.512 ' HB2' ' HD2' ' A' ' 419' ' ' TYR . 17.2 t -60.15 -46.36 89.95 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.643 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -56.63 -38.63 82.73 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.746 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 422' ' ' VAL . 2.4 mt -71.79 -41.98 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.507 0.67 . . . . 0.0 109.932 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.59 HG23 HG23 ' A' ' 404' ' ' VAL . 1.6 mm -57.86 -45.71 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.407 -1.269 . . . . 0.0 112.726 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.751 ' HA ' HD23 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -59.52 -29.92 68.23 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.608 1.194 . . . . 0.0 109.325 -174.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 427' ' ' ARG . . . -72.48 -15.18 77.34 Favored Glycine 0 C--N 1.299 -1.493 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.625 175.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.704 ' CG ' HG21 ' A' ' 399' ' ' VAL . 13.9 m-85 -102.49 2.62 36.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 427' ' ' ARG . 3.9 mm? -58.68 145.07 78.81 Favored Pre-proline 0 N--CA 1.409 -2.479 0 CA-C-O 123.717 1.722 . . . . 0.0 113.516 168.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.769 ' HB3' ' HA ' ' A' ' 472' ' ' ARG . 71.9 Cg_endo -72.12 -55.68 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.426 1 C-N-CA 126.289 4.659 . . . . 0.0 113.618 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.513 ' H ' ' HG2' ' A' ' 431' ' ' PRO . . . -115.69 140.59 16.31 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.4 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.875 ' HA ' HG13 ' A' ' 436' ' ' VAL . 0.0 OUTLIER -64.23 -27.31 68.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.155 0.478 . . . . 0.0 111.29 -177.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 467' ' ' LEU . . . -57.13 -48.22 79.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 170.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 1.014 ' HA ' HG11 ' A' ' 463' ' ' VAL . 3.3 t -57.71 -51.7 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.788 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.875 HG13 ' HA ' ' A' ' 433' ' ' GLN . 0.6 OUTLIER -55.02 -53.05 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 436' ' ' VAL . 91.8 m -61.52 -56.49 19.48 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 441' ' ' GLN . . . -56.11 -45.34 79.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.519 -177.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.811 ' O ' HD22 ' A' ' 443' ' ' LEU . 41.9 mt -59.57 -53.13 61.59 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.71 ' O ' ' HB2' ' A' ' 444' ' ' ASP . 36.8 mm-40 -51.77 -35.52 44.0 Favored 'General case' 0 N--CA 1.421 -1.905 0 O-C-N 124.844 1.34 . . . . 0.0 110.429 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.662 ' O ' ' HG3' ' A' ' 445' ' ' GLN . 0.4 OUTLIER -72.69 -59.83 2.53 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 177.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.48 -50.76 13.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.416 0.553 . . . . 0.0 112.151 -173.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.811 HD22 ' O ' ' A' ' 439' ' ' LEU . 0.0 OUTLIER -58.75 -24.32 61.42 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.629 0.728 . . . . 0.0 111.776 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.738 ' N ' HD23 ' A' ' 443' ' ' LEU . 15.9 t70 -71.72 -42.73 66.97 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.564 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 441' ' ' GLN . 37.9 mt-30 -69.34 -9.36 52.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -171.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 452' ' ' ARG . 58.7 mm-40 -52.03 153.65 2.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.377 1.56 . . . . 0.0 114.322 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.503 ' HB ' HG21 ' A' ' 451' ' ' THR . 1.8 mp -53.1 -32.81 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.985 -2.825 . . . . 0.0 115.483 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.652 ' H ' ' HB ' ' A' ' 451' ' ' THR . 40.2 m-20 -139.13 178.74 6.95 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 452' ' ' ARG . 7.9 p-10 -64.42 -51.59 62.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -66.79 -25.55 66.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 174.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.652 ' HB ' ' H ' ' A' ' 448' ' ' ASP . 13.6 m -59.43 -42.08 91.04 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 119.798 1.181 . . . . 0.0 109.631 171.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.555 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 54.7 mtt180 -59.89 -30.98 69.38 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.338 171.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.623 ' HA ' ' OH ' ' A' ' 408' ' ' TYR . . . -75.46 -29.63 59.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.042 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.429 ' HB2' HG23 ' A' ' 455' ' ' THR . 2.7 mm-40 -82.82 -47.18 12.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.094 -172.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.605 ' HB ' ' NE2' ' A' ' 458' ' ' GLN . 31.0 p -101.95 -1.53 31.73 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.338 -165.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.666 ' CE1' HD23 ' A' ' 460' ' ' LEU . 6.1 t80 -48.72 -51.72 27.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 405' ' ' ALA . 24.1 mm -71.85 -27.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . 0.605 ' NE2' ' HB ' ' A' ' 455' ' ' THR . 0.0 OUTLIER -70.77 -42.55 70.25 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.636 ' O ' HG23 ' A' ' 463' ' ' VAL . 51.5 m-70 -66.92 -30.72 70.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.788 -1.551 . . . . 0.0 110.169 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.722 ' HA ' HD21 ' A' ' 439' ' ' LEU . 0.2 OUTLIER -67.06 -53.27 32.69 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.192 0.996 . . . . 0.0 109.052 -179.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.636 ' O ' ' HG2' ' A' ' 465' ' ' GLU . 8.7 m-80 -62.98 -32.19 73.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.665 173.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 459' ' ' HIS . . . -61.82 -54.41 42.63 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.105 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 1.014 HG11 ' HA ' ' A' ' 435' ' ' VAL . 22.1 t -62.21 -34.42 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 CA-C-O 121.684 0.754 . . . . 0.0 110.589 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.544 ' HD1' HD12 ' A' ' 469' ' ' LEU . 20.4 m-30 -61.8 -15.08 38.69 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.219 170.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 461' ' ' ASN . 46.3 mm-40 -91.89 -49.56 6.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.954 . . . . 0.0 112.732 176.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.717 ' CD1' ' HA ' ' A' ' 463' ' ' VAL . 6.2 pt -65.14 -40.06 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.873 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 434' ' ' ALA . 6.9 mt -84.11 -16.64 42.9 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 475' ' ' SER . . . 64.73 50.56 58.02 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.28 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.732 HD11 HD12 ' A' ' 467' ' ' LEU . 0.9 OUTLIER -100.26 -178.64 3.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.71 0.804 . . . . 0.0 110.364 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.777 ' ND2' ' HG3' ' A' ' 474' ' ' GLN . 15.7 p30 -101.11 -43.39 6.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 473' ' ' GLY . . . -159.39 -76.69 0.07 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 112.52 -2.127 . . . . 0.0 110.273 158.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.769 ' HA ' ' HB3' ' A' ' 431' ' ' PRO . 0.9 OUTLIER -60.23 71.22 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -172.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 431' ' ' PRO . . . 36.69 45.84 1.06 Allowed Glycine 0 C--N 1.276 -2.772 0 CA-C-N 110.589 -3.005 . . . . 0.0 113.577 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.777 ' HG3' ' ND2' ' A' ' 470' ' ' ASN . 27.5 mm-40 -82.54 -57.83 3.18 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.012 0.911 . . . . 0.0 111.466 -173.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 468' ' ' GLY . 39.0 t 66.94 42.78 2.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.493 -2.139 . . . . 0.0 108.155 -173.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.654 HD12 ' HG2' ' A' ' 477' ' ' ARG . 0.4 OUTLIER -36.53 -44.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 109.246 -3.616 . . . . 0.0 112.623 170.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.654 ' HG2' HD12 ' A' ' 476' ' ' ILE . 11.4 mmm-85 -44.56 131.56 6.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.974 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.75 -26.82 67.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.931 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.457 -179.412 . . . . . . . . 0 0 . 1 stop_ save_